PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, CY; Borsuk, ME; Bugge, DM; Hollweg, T; Balcom, PH; Ward, DM; Williams, J; Mason, RP				Chen, Celia Y.; Borsuk, Mark E.; Bugge, Deenie M.; Hollweg, Terill; Balcom, Prentiss H.; Ward, Darren M.; Williams, Jason; Mason, Robert P.			Benthic and Pelagic Pathways of Methylmercury Bioaccumulation in Estuarine Food Webs of the Northeast United States	PLOS ONE			English	Article							SUBMARINE GROUNDWATER DISCHARGE; DISSOLVED ORGANIC-CARBON; SAN-FRANCISCO-BAY; INORGANIC MERCURY; GAS-CHROMATOGRAPHY; CONTINENTAL-SHELF; METHYL MERCURY; CHESAPEAKE BAY; TRACE-METALS; SEDIMENTS	Methylmercury (MeHg) is a contaminant of global concern that bioaccumulates and bioamagnifies in marine food webs. Lower trophic level fauna are important conduits of MeHg from sediment and water to estuarine and coastal fish harvested for human consumption. However, the sources and pathways of MeHg to these coastal fisheries are poorly known particularly the potential for transfer of MeHg from the sediment to biotic compartments. Across a broad gradient of human land impacts, we analyzed MeHg concentrations in food webs at ten estuarine sites in the Northeast US (from the Hackensack Meadowlands, NJ to the Gulf of Maine). MeHg concentrations in water column particulate material, but not in sediments, were predictive of MeHg concentrations in fish (killifish and Atlantic silversides). Moreover, MeHg concentrations were higher in pelagic fauna than in benthic-feeding fauna suggesting that MeHg delivery to the water column from methylation sites from within or outside of the estuary may be an important driver of MeHg bioaccumulation in estuarine pelagic food webs. In contrast, bulk sediment MeHg concentrations were only predictive of concentrations of MeHg in the infaunal worms. Our results across a broad gradient of sites demonstrate that the pathways of MeHg to lower trophic level estuarine organisms are distinctly different between benthic deposit feeders and forage fish. Thus, even in systems with contaminated sediments, transfer of MeHg into estuarine food webs maybe driven more by the efficiency of processes that determine MeHg input and bioavailability in the water column.	[Chen, Celia Y.; Bugge, Deenie M.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Borsuk, Mark E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Hollweg, Terill] Stratus Consulting, Boulder, CO USA; [Balcom, Prentiss H.; Mason, Robert P.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Ward, Darren M.] Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA; [Williams, Jason] Washington State Univ, Dept Civil & Environm Engn, Pullman, WA 99164 USA	Dartmouth College; Dartmouth College; University of Connecticut; California State University System; California State Polytechnic University, Humboldt; Washington State University	Chen, CY (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	Celia.Y.Chen@dartmouth.edu	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	NIH from the National Institute of Environmental Health Sciences [P42 ES007373]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	NIH from the National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described was supported by NIH Grant Number P42 ES007373 from the National Institute of Environmental Health Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcom PH, 2004, MAR CHEM, V90, P53, DOI 10.1016/j.marchem.2004.02.020; Balcom PH, 2008, MAR CHEM, V109, P1, DOI 10.1016/j.marchem.2007.09.005; Beck AJ, 2009, ESTUAR COAST, V32, P535, DOI 10.1007/s12237-009-9140-5; Benoit JM, 1998, BIOGEOCHEMISTRY, V40, P249, DOI 10.1023/A:1005905700864; Benoit JM, 2003, ACS SYM SER, V835, P262; BLOOM N, 1989, CAN J FISH AQUAT SCI, V46, P1131, DOI 10.1139/f89-147; BLOOM N, 1988, ANAL CHIM ACTA, V208, P151, DOI 10.1016/S0003-2670(00)80743-6; BLOOM NS, 1983, MAR CHEM, V14, P49, DOI 10.1016/0304-4203(83)90069-5; Bone SE, 2007, ENVIRON SCI TECHNOL, V41, P3090, DOI 10.1021/es0622453; Chasar LC, 2009, ENVIRON SCI TECHNOL, V43, P2733, DOI 10.1021/es8027567; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Cleckner LB, 2003, J GREAT LAKES RES, V29, P134, DOI 10.1016/S0380-1330(03)70422-5; Coelho JP, 2008, MAR POLLUT BULL, V56, P1104, DOI 10.1016/j.marpolbul.2008.03.020; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Conaway CH, 2003, MAR CHEM, V80, P199, DOI 10.1016/S0304-4203(02)00135-4; Davis JA, 2012, ENVIRON RES, V119, P3, DOI 10.1016/j.envres.2012.10.002; Deegan LA, 1997, MAR ECOL PROG SER, V147, P31, DOI 10.3354/meps147031; DRISCOLL CT, 1995, WATER AIR SOIL POLL, V80, P499, DOI 10.1007/BF01189700; FITZGERALD WF, 1979, ANAL CHEM, V51, P1714, DOI 10.1021/ac50047a030; Fitzgerald WF, 2010, SYNTHESIS ASSESSMENT; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Fry B, 2008, MAR ECOL PROG SER, V369, P193, DOI 10.3354/meps07644; Fry B, 2012, ECOL APPL, V22, P606, DOI 10.1890/11-0921.1; Gagnon C, 1997, ENVIRON SCI TECHNOL, V31, P993, DOI 10.1021/es960364k; Galvan K, 2011, J EXP MAR BIOL ECOL, V410, P1, DOI 10.1016/j.jembe.2011.08.007; Gehrke GE, 2011, ENVIRON SCI TECHNOL, V45, P1264, DOI 10.1021/es103053y; GILL GA, 1985, DEEP-SEA RES, V32, P287, DOI 10.1016/0198-0149(85)90080-9; Gorski PR, 2008, ENVIRON POLLUT, V154, P116, DOI 10.1016/j.envpol.2007.12.004; GRIEB TM, 1990, ENVIRON TOXICOL CHEM, V9, P919, DOI [10.1897/1552-8618(1990)9[919:FAMAIF]2.0.CO;2, 10.1002/etc.5620090710]; Guo LD, 2001, ENVIRON SCI TECHNOL, V35, P885, DOI 10.1021/es001758l; Haas HL, 2009, J EXP MAR BIOL ECOL, V369, P8, DOI 10.1016/j.jembe.2008.09.027; Hall BD, 1997, WATER AIR SOIL POLL, V100, P13; Hammerschmidt CR, 2008, MAR CHEM, V109, P165, DOI 10.1016/j.marchem.2008.01.007; Hammerschmidt CR, 2006, GEOCHIM COSMOCHIM AC, V70, P918, DOI 10.1016/j.gca.2005.10.020; Hammerschmidt CR, 2004, MAR CHEM, V90, P31, DOI 10.1016/j.marchem.2004.02.024; Hesterberg D, 2001, ENVIRON SCI TECHNOL, V35, P2741, DOI 10.1021/es001960o; Heyes A, 2006, MAR CHEM, V102, P134, DOI 10.1016/j.marchem.2005.09.018; Hollweg TA, 2010, LIMNOL OCEANOGR, V55, P2703, DOI 10.4319/lo.2010.55.6.2703; Hollweg TA, 2009, MAR CHEM, V114, P86, DOI 10.1016/j.marchem.2009.04.004; HORVAT M, 1993, ANAL CHIM ACTA, V282, P153, DOI 10.1016/0003-2670(93)80364-Q; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Kim EH, 2004, MAR CHEM, V86, P121, DOI 10.1016/j.marchem.2003.12.004; Kim EH, 2006, MAR CHEM, V102, P300, DOI 10.1016/j.marchem.2006.05.006; Kim E, 2008, ECOL MODEL, V218, P267, DOI 10.1016/j.ecolmodel.2008.07.008; King JK, 1999, ENVIRON TOXICOL CHEM, V18, P1362, DOI 10.1002/etc.5620180704; Kiviat E, 2002, HACKENSACK MEADOWLAN; Langer C. S., 2001, Wetlands Ecology and Management, V9, P295, DOI 10.1023/A:1011816819369; Lawrence AL, 2001, ENVIRON POLLUT, V111, P217, DOI 10.1016/S0269-7491(00)00072-5; Lawrence AL, 1999, ENVIRON SCI TECHNOL, V33, P1871, DOI 10.1021/es981328j; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Liu B, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000752; Mason RP, 2006, MAR CHEM, V102, P96, DOI 10.1016/j.marchem.2005.09.021; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Mason RP, 1999, ENVIRON TOXICOL CHEM, V18, P2438, DOI 10.1002/etc.5620181109; Mason RP, 1999, MAR CHEM, V65, P77, DOI 10.1016/S0304-4203(99)00012-2; MASON RP, 1995, WATER AIR SOIL POLL, V80, P915, DOI 10.1007/BF01189744; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; Mikac N, 1999, APPL ORGANOMET CHEM, V13, P715, DOI 10.1002/(SICI)1099-0739(199910)13:10<715::AID-AOC918>3.0.CO;2-4; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Pan JF, 2004, MAR ECOL PROG SER, V276, P125, DOI 10.3354/meps276125; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pickhardt PC, 2007, ENVIRON SCI TECHNOL, V41, P125, DOI 10.1021/es060966w; Pickhardt PC, 2006, ENVIRON TOXICOL CHEM, V25, P2132, DOI 10.1897/05-595R.1; Point D, 2007, ANAL BIOANAL CHEM, V389, P787, DOI 10.1007/s00216-007-1516-4; Power M, 2002, J APPL ECOL, V39, P819, DOI 10.1046/j.1365-2664.2002.00758.x; Rolfhus KR, 2001, GEOCHIM COSMOCHIM AC, V65, P407, DOI 10.1016/S0016-7037(00)00519-6; Rolfhus KR, 2011, ECOTOXICOLOGY, V20, P1520, DOI 10.1007/s10646-011-0733-y; Rutkiewicz J, 2011, ECOTOXICOLOGY, V20, P1669, DOI 10.1007/s10646-011-0730-1; Schartup AT, 2013, ENVIRON SCI TECHNOL, V47, P695, DOI 10.1021/es302566w; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Shanley J.B., 2002, EOS T AM GEOPHYS UN, V83, P45; Skyllberg U, 2006, ENVIRON SCI TECHNOL, V40, P4174, DOI 10.1021/es0600577; Skyllberg U, 2010, ENVIRON SCI TECHNOL, V44, P1254, DOI 10.1021/es902091w; Stewart AR, 2008, CAN J FISH AQUAT SCI, V65, P2351, DOI 10.1139/F08-140; Sunderland EM, 2007, ENVIRON HEALTH PERSP, V115, P235, DOI 10.1289/ehp.9377; Sunderland EM, 2012, ENVIRON RES, V119, P27, DOI 10.1016/j.envres.2012.03.011; Sunderland EM, 2010, ENVIRON SCI TECHNOL, V44, P1698, DOI 10.1021/es9032524; Taylor DL, 2012, MAR POLLUT BULL, V64, P807, DOI 10.1016/j.marpolbul.2012.01.013; Taylor VF, 2008, ANAL BIOANAL CHEM, V392, P1283, DOI 10.1007/s00216-008-2403-3; Tseng CM, 2004, ANAL CHEM, V76, P7131, DOI 10.1021/ac049118e; United States :Environmental Protection Agency, 1998, 7473SW846 EPA; [USEPA] United States Environmental Protection Agency, 2001, EPA821R01020; USEPA United States Environmental Protection Agency, 2002, EPA821R02019; Watras CJ, 1998, SCI TOTAL ENVIRON, V219, P183, DOI 10.1016/S0048-9697(98)00228-9; WATRAS CJ, 1995, WATER AIR SOIL POLL, V84, P253, DOI 10.1007/BF00475343; WEIS P, 1986, ENVIRON POLLUT A, V40, P303, DOI 10.1016/0143-1471(86)90064-4; Wiener JG, 2012, ENVIRON POLLUT, V161, P350, DOI 10.1016/j.envpol.2011.09.025; Williams JJ, 2010, ENVIRON TOXICOL CHEM, V29, P1755, DOI 10.1002/etc.207; Wyn B, 2009, CAN J FISH AQUAT SCI, V66, P1532, DOI 10.1139/F09-097; Yee D, 2011, ENVIRON TOXICOL CHEM, V30, P88, DOI 10.1002/etc.366	95	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89305	10.1371/journal.pone.0089305	http://dx.doi.org/10.1371/journal.pone.0089305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25144712	gold, Green Published, Green Submitted			2022-12-27	WOS:000331706700137
J	Chen, CJ; Wu, TL; Lu, PL; Chen, YT; Fung, CP; Chuang, YC; Lin, JC; Siu, LK				Chen, Chao-Ju; Wu, Tsu-Lan; Lu, Po-Liang; Chen, Ying-Tsong; Fung, Chang-Phone; Chuang, Yin-Ching; Lin, Jung-Chung; Siu, L. Kristopher			Closely Related NDM-1-Encoding Plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan	PLOS ONE			English	Article							BETA-LACTAMASE; 1ST IDENTIFICATION; RESISTANCE; STRAINS; PATIENT; OXYTOCA; NDM-1; INCN	Objective: Two plasmids carrying bla(NDM-1) isolated from carbapenem-resistant Klebsiella pneumoniae (CR-KP) and carbapenem-resistant Escherichia coli (CR-EC) were sequenced. CR-KP and CR-EC were isolated from two Taiwanese patients without travel histories. Methods: Complete sequencing of the plasmids (pLK75 and pLK78) was conducted using a shotgun approach. Annotation of the contigs was performed using the RAST Server, followed by manual inspection and correction. Results: These similar plasmids were obtained from two patients with overlapping stays at the same hospital. The pLK75 and pLK78 plasmids were 56,489-bp and 56,072-bp in length, respectively. Plasmid annotation revealed a common backbone similar to the IncN plasmid pR46. The regions flanking the bla(NDM-1) genes in these plasmids were very similar to plasmid pNDM-HU01 in Japan, which contains a complex class 1 integron located next to an ISCR1 element. The ISCR1 element has been suggested to provide a powerful mechanism for mobilising antibiotic resistance genes. Conclusion: Two indigenous NDM-1-producing Enterobacteriaceae cases were identified for the first time in Taiwan, highlighting the alarming introduction of NDM-1-producing Enterobacteriaceae in this region.	[Chen, Chao-Ju; Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Chao-Ju; Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Wu, Tsu-Lan] Linkou Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Dept Med, Infect Dis Sect, Taipei, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med & Med Res, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Lin, Jung-Chung; Siu, L. Kristopher] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Lin, Jung-Chung] Natl Def Med Ctr, Inst Microbiol & Immunol, Taipei, Taiwan; [Siu, L. Kristopher] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Siu, L. Kristopher] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; National Chung Hsing University; National Chung Hsing University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Chi Mei Hospital; Chi Mei Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; China Medical University Taiwan; National Health Research Institutes - Taiwan	Lin, JC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan.	linjungchung1@yahoo.com.tw	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	Taiwan Centers for Diseases Control [DOH101-DC-1024, DOH102-DC-1508]; National Health Research Institutes; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	Taiwan Centers for Diseases Control; National Health Research Institutes(National Health Research Institutes, Japan); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the project grants, DOH101-DC-1024 and DOH102-DC-1508, from Taiwan Centers for Diseases Control and National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Chen YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048737; Chen YT, 2009, ANTIMICROB AGENTS CH, V53, P1235, DOI 10.1128/AAC.00970-08; CLSI, 2013, PERFORMANCE STANDARD; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HALL RM, 1987, NUCLEIC ACIDS RES, V15, P7491, DOI 10.1093/nar/15.18.7491; Huang TW, 2013, ANTIMICROB AGENTS CH, V57, P4072, DOI 10.1128/AAC.02266-12; Huang TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062774; Humphrey B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-53; Kim MN, 2012, J CLIN MICROBIOL, V50, P1433, DOI 10.1128/JCM.06855-11; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lai CC, 2011, DIAGN MICR INFEC DIS, V71, P474, DOI 10.1016/j.diagmicrobio.2011.09.004; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089893; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Siu LK, 1997, ANTIMICROB AGENTS CH, V41, P468, DOI 10.1128/AAC.41.2.468; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Wang SJ, 2013, DIAGN MICR INFEC DIS, V76, P248, DOI 10.1016/j.diagmicrobio.2013.02.003; Wu HS, 2010, J CHIN MED ASSOC, V73, P596, DOI 10.1016/S1726-4901(10)70129-5; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	22	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104899	10.1371/journal.pone.0104899	http://dx.doi.org/10.1371/journal.pone.0104899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144712	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100028
J	Chen, CB; Zhou, H; Zhang, XL; Ma, XL; Liu, ZJ; Liu, XG				Chen, Changbao; Zhou, Hua; Zhang, Xiaolin; Ma, Xinlong; Liu, Zhongjun; Liu, Xiaoguang			Elevated Levels of Dickkopf-1 Are Associated with beta-Catenin Accumulation and Poor Prognosis in Patients with Chondrosarcoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CANCER BONE METASTASES; HEPATOCELLULAR CARCINOMAS; NUCLEAR ACCUMULATION; EXPRESSION; PROTEIN; GENE; DKK1; REGULATOR; OSTEOSARCOMA	Background: Dickkopf-1 (DKK1) is an antagonist of Wnt/beta-catenin signaling implicated in tumorigenesis. However, the biological role of DKK1 and beta-catenin involved in chondrosarcoma has not been sufficiently investigated. This study was designed to investigate the expression profiles of DKK1 and beta-catenin, and to clarify their clinical values in chondrosarcoma. Methods: The mRNA and protein levels of DKK1 and beta-catenin in fresh chondrosarcoma and the corresponding non-tumor tissues were analyzed by Real-time PCR and Western blot, respectively. The protein expression patterns of DKK1 and bcatenin were investigated by immunohistochemistry. The associations among DKK1 level, beta-catenin accumulation, clinicopathological factors and the overall survival were separately evaluated. Results: Both DKK1 and beta-catenin levels were remarkably elevated in chondrosarcoma compared with the corresponding non-tumor tissues. High DKK1 level and positive beta-catenin accumulation in chondrosarcoma specimens were 58.7% and 53.9%, respectively. Elevated DKK1 level significantly correlated with positive beta-catenin accumulation, and they were remarkably associated with histological grade and Musculoskeletal Tumor Society stage. Furthermore, DKK1 level and bcatenin accumulation had significant impacts on the prognosis of chondrosarcoma patients. Multivariate analysis revealed that DKK1 level was an independent prognostic factor for overall survival. Conclusions: Elevated DKK1 levels associated with beta-catenin accumulation play a crucial role in chondrosarcoma. DKK1 can serve as a novel predictor of poor prognosis in patients with chondrosarcoma.	[Chen, Changbao; Zhang, Xiaolin; Ma, Xinlong] Tianjin Hosp, Dept Spinal Surg, Tianjin, Peoples R China; [Zhou, Hua; Liu, Zhongjun; Liu, Xiaoguang] Peking Univ, Dept Orthopaed Surg, Hosp 3, Beijing 100871, Peoples R China	Peking University	Ma, XL (corresponding author), Tianjin Hosp, Dept Spinal Surg, Tianjin, Peoples R China.	richivaldchen@gmail.com	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	National Natural Sciences Foundation of China [81102037]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Natural Sciences Foundation of China (81102037). http://www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Bertoni F., 2002, WHO CLASSIFICATION T, P247; Bovee JVMG, 2005, LANCET ONCOL, V6, P599, DOI 10.1016/S1470-2045(05)70282-5; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chen C, 2001, ANN SURG ONCOL, V18, P2364; Chen CB, 2011, J ORTHOP RES, V29, P143, DOI 10.1002/jor.21193; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Hall CL, 2006, J CELL BIOCHEM, V97, P661, DOI 10.1002/jcb.20735; Hameetman L, 2006, J PATHOL, V209, P501, DOI 10.1002/path.2008; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Lee N, 2007, BRIT J CANCER, V97, P1552, DOI 10.1038/sj.bjc.6604069; Li XQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-114; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Menezes ME, 2012, INT J CANCER, V130, P1477, DOI 10.1002/ijc.26449; Mitani T, 2012, J BIOL CHEM, V287, P33594, DOI 10.1074/jbc.M112.388298; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; O'Shea PJ, 2012, J BIOL CHEM, V287, P17812, DOI 10.1074/jbc.M111.311464; Rozeman LB, 2006, INT ORTHOP, V30, P437, DOI 10.1007/s00264-006-0212-x; Saito T, 2000, J PATHOL, V192, P342, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH705>3.0.CO;2-R; Schrage YM, 2009, AM J PATHOL, V174, P979, DOI 10.2353/ajpath.2009.080623; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Terris B, 1999, ONCOGENE, V18, P6583, DOI 10.1038/sj.onc.1203051; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9; Xu WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037624; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020	37	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105414	10.1371/journal.pone.0105414	http://dx.doi.org/10.1371/journal.pone.0105414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144712	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100065
J	Brown, KA; Fisman, DN; Moineddin, R; Daneman, N				Brown, Kevin A.; Fisman, David N.; Moineddin, Rahim; Daneman, Nick			The Magnitude and Duration of Clostridium difficile Infection Risk Associated with Antibiotic Therapy: A Hospital Cohort Study	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; DISEASE; ACQUISITION; INFLUENZA; PRESSURE; EXPOSURE; DIARRHEA; UPDATE; HEALTH; ONSET	Antibiotic therapy is the principal risk factor for Clostridium difficile infection (CDI), but little is known about how risks cumulate over the course of therapy and abate after cessation. We prospectively identified CDI cases among adults hospitalized at a tertiary hospital between June 2010 and May 2012. Poisson regression models included covariates for time since admission, age, hospitalization history, disease pressure, and intensive care unit stay. Impacts of antibiotic use through time were modeled using 4 measures: current antibiotic receipt, time since most recent receipt, time since first receipt during a hospitalization, and duration of receipt. Over the 24-month study period, we identified 127 patients with new onset nosocomial CDI (incidence rate per 10,000 patient days [IR] = 5.86). Of the 4 measures, time since most recent receipt was the strongest independent predictor of CDI incidence. Relative to patients with no prior receipt of antibiotics in the last 30 days (IR = 2.95), the incidence rate of CDI was 2.41 times higher (95% confidence interval [CI] 1.41, 4.13) during antibiotic receipt and 2.16 times higher when patients had receipt in the prior 1-5 days (CI 1.17, 4.00). The incidence rates of CDI following 1-3, 4-6 and 7-11 days of antibiotic exposure were 1.60 (CI 0.85, 3.03), 2.27 (CI 1.24, 4.16) and 2.10 (CI 1.12, 3.94) times higher compared to no prior receipt. These findings are consistent with studies showing higher risk associated with longer antibiotic use in hospitalized patients, but suggest that the duration of increased risk is shorter than previously thought.	[Brown, Kevin A.; Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Daneman, Nick] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Infect Dis, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Brown, KA (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	kevin.brown@mail.utoronto.ca		Brown, Kevin Antoine/0000-0002-1483-2188	Frederick Banting and Charles Best Canada; Canadian Institutes of Health Research (CIHR); Clinician Scientist Salary Award from CIHR; Institute of Population and Public Health of the CIHR	Frederick Banting and Charles Best Canada(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Clinician Scientist Salary Award from CIHR(Canadian Institutes of Health Research (CIHR)); Institute of Population and Public Health of the CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a Frederick Banting and Charles Best Canada Graduate Scholarship awarded to K.A.B. from the Canadian Institutes of Health Research (CIHR, http://www.cihr.ca/). N.D. is supported by a Clinician Scientist Salary Award from CIHR. D.N.F. received a grant from the Institute of Population and Public Health of the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamowicz M, 2012, STAT MED, V31, P1014, DOI 10.1002/sim.4343; Ajao AO, 2011, INFECT CONT HOSP EP, V32, P481, DOI 10.1086/659403; Baines SD, 2013, J ANTIMICROB CHEMOTH, V68, P1139, DOI 10.1093/jac/dks529; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Bliss DZ, 1998, ANN INTERN MED, V129, P1012, DOI 10.7326/0003-4819-129-12-199812150-00004; Breslow N E, 1987, IARC Sci Publ, P1; Breslow N E, 1980, IARC Sci Publ, P5; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; Brown KA, 2013, AM J EPIDEMIOL, V178, P118, DOI 10.1093/aje/kws463; Brown KA, 2013, ANTIMICROB AGENTS CH, V57, P2326, DOI 10.1128/AAC.02176-12; Chang HT, 2007, INFECT CONT HOSP EP, V28, P926, DOI 10.1086/519178; Cherrie JW, 2006, ANN OCCUP HYG, V50, P693, DOI 10.1093/annhyg/me1035; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Delaney JAC, 2007, EMERG INFECT DIS, V13, P761, DOI 10.3201/eid1305.061124; Dial S, 2008, CAN MED ASSOC J, V179, P767, DOI 10.1503/cmaj.071812; Dubberke ER, 2007, ARCH INTERN MED, V167, P1092, DOI 10.1001/archinte.167.10.1092; Dubberke ER, 2009, INFECT CONT HOSP EP, V30, P332, DOI 10.1086/596604; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Gilca R, 2012, ANTIMICROB AGENTS CH, V56, P639, DOI 10.1128/AAC.05411-11; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; HALLORAN ME, 1991, EPIDEMIOLOGY, V2, P331, DOI 10.1097/00001648-199109000-00004; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Jump RLP, 2011, ANTIMICROB AGENTS CH, V55, P546, DOI 10.1128/AAC.00839-10; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Palmore TN, 2005, INFECT CONT HOSP EP, V26, P680, DOI 10.1086/502602; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P382, DOI 10.1086/651095; Provincial Infectious Diseases Advisory Committee, 2007, BEST PRACT DOC MAN C; Schumacher M, 2013, INT J EPIDEMIOL, V42, P1502, DOI 10.1093/ije/dyt111; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Stevens V, 2011, AM J EPIDEMIOL, V173, pS272; Stevens V, 2011, CLIN INFECT DIS, V53, P42, DOI 10.1093/cid/cir301; TANCREDE C, 1992, EUR J CLIN MICROBIOL, V11, P1012, DOI 10.1007/BF01967791; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUID ATC CLASS DDD A	38	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105454	10.1371/journal.pone.0105454	http://dx.doi.org/10.1371/journal.pone.0105454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157757	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200032
J	de Rezende, MM; D'Almeida, V				de Rezende, Marina Mastelaro; D'Almeida, Vania			Central and Systemic Responses to Methionine-Induced Hyperhomocysteinemia in Mice	PLOS ONE			English	Article							PLASMA TOTAL HOMOCYSTEINE; OXIDATIVE STRESS; BDNF; EXPLORATION; NEURONS; MODELS; RATS	Hyperhomocysteinemia has been considered a risk factor for neuropsychiatric disorders, but the mechanisms involved in this process have not been completely elucidated. The aim of this study was to analyze the influence of hyperhomocysteinemia induction by methionine supplementation considering different levels and periods of exposure in mice. For this purpose, methionine supplementation at concentrations of 0.5 and 1% were administered in water to increase homocysteinemia in male C57BL/6 mice, and was maintained for 3 time periods (2, 4 and 6 months of treatment). The results from one-carbon metabolism parameters, brain-derived neurotrophic factor (BDNF) concentrations and behavioral evaluation were compared. The 0.5% supplementation was efficient in increasing plasma homocysteine levels after 2 and 6 months. The 1% supplementation, increased plasma homocysteine after 2, 4 and 6 months. Little influence was observed in cysteine and glutathione concentrations. Frontal cortex BDNF levels showed a lack of treatment influence in all periods; only the expected decrease due to increasing age was observed. Moreover, the only behavioral alteration observed using a novel object recognition task was that which was expected with increasing age. We found that responses to hyperhomocysteinemia varied based on how it was reached, and the length of toxicity. Moreover, hyperhomocysteinemia can affect the normal pattern of one carbon metabolism during age increase in mice. These findings allow the establishment of a reliable animal model for studies in this field.	[de Rezende, Marina Mastelaro; D'Almeida, Vania] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	D'Almeida, V (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil.	vaniadalmeida@uol.com.br	D'Almeida, Vânia/AAV-3955-2020; D'Almeida, Vania/AAB-7115-2020	D'Almeida, Vânia/0000-0003-0947-5312; 	FAPESP (Fundo de Amparo a Pesquisa do Estado de Sao Paulo) [2010/00075-2, 2011/15699-4]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	FAPESP (Fundo de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (Fundo de Amparo a Pesquisa do Estado de Sao Paulo) - Process # 2010/00075-2 and # 2011/15699-4 scholarship to MMR (http://www.fapesp.br/); and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) - fellowship to VD (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman LA, 2005, DEV BRAIN RES, V158, P59, DOI 10.1016/j.devbrainres.2005.06.002; Calegare BFA, 2010, PSYCHONEUROENDOCRINO, V35, P775, DOI 10.1016/j.psyneuen.2009.11.004; Andersen M. L., 2004, PRINCIPIOS ETICOS PR; BERNARDIS LL, 1968, J ENDOCRINOL, V40, P527, DOI 10.1677/joe.0.0400527; Cai BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063561; COELHO CND, 1990, TERATOLOGY, V42, P437, DOI 10.1002/tera.1420420412; Dayal S, 2008, ARTERIOSCL THROM VAS, V28, P1596, DOI 10.1161/ATVBAHA.108.166421; Elias MF, 2005, AM J EPIDEMIOL, V162, P644, DOI 10.1093/aje/kwi259; Gao L, 2012, NEUROL SCI, V33, P39, DOI 10.1007/s10072-011-0645-x; Heyser CJ, 2012, BEHAV PROCESS, V89, P232, DOI 10.1016/j.beproc.2011.12.004; Hooshmand B, 2013, BRAIN, V136, P2707, DOI 10.1093/brain/awt206; Imamura K, 2007, NEUROREPORT, V18, P1319, DOI 10.1097/WNR.0b013e3282aaa0b4; Jadavji NM, 2012, MOL GENET METAB, V106, P149, DOI 10.1016/j.ymgme.2012.03.020; Kado DM, 2002, AM J MED, V113, P537, DOI 10.1016/S0002-9343(02)01269-X; Kapczinski F, 2008, REV BRAS PSIQUIATR, V30, P243, DOI 10.1590/S1516-44462008000300011; Kinoshita M, 2013, EPIGENETICS-US, V8, P584, DOI 10.4161/epi.24621; Lalonde R, 2008, BRAIN RES, V1188, P122, DOI 10.1016/j.brainres.2007.10.068; Light KR, 2011, BEHAV BRAIN RES, V223, P297, DOI 10.1016/j.bbr.2011.04.050; Likogianni V, 2006, CLIN CHIM ACTA, V372, P140, DOI 10.1016/j.cca.2006.03.035; Loas G, 1996, J AFFECT DISORDERS, V41, P39, DOI 10.1016/0165-0327(96)00065-1; Lominadze D, 2012, MOL CELL BIOCHEM, V371, P89, DOI 10.1007/s11010-012-1425-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makhro AV, 2008, B EXP BIOL MED+, V146, P33, DOI 10.1007/s10517-008-0233-0; Martins PJF, 2005, LIFE SCI, V76, P2621, DOI 10.1016/j.lfs.2004.12.011; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Matte C, 2009, NEUROSCIENCE, V163, P1039, DOI 10.1016/j.neuroscience.2009.07.023; Mattson MP, 2003, NEUROLOGY, V60, P690, DOI 10.1212/01.WNL.0000042785.02850.11; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P140, DOI 10.1016/j.bcp.2013.06.016; Muehlmann AM, 2012, BEHAV BRAIN RES, V235, P143, DOI 10.1016/j.bbr.2012.07.041; Nabi H, 2013, PSYCHONEUROENDOCRINO, V38, P2309, DOI 10.1016/j.psyneuen.2013.04.018; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Rhodehouse BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063951; Ryabinin AE, 2002, PHARMACOL BIOCHEM BE, V71, P307, DOI 10.1016/S0091-3057(01)00661-X; Sachdev PS, 2005, PROG NEURO-PSYCHOPH, V29, P1152, DOI 10.1016/j.pnpbp.2005.06.026; Souchet B, 2014, J MOL NEUROSCI; Swart KMA, 2013, J NUTR HEALTH AGING, V17, P578, DOI 10.1007/s12603-013-0047-2; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Topaloglu AK, 2001, PEDIATR RES, V49, P796, DOI 10.1203/00006450-200106000-00014; Vanzin CS, 2011, MOL GENET METAB, V104, P112, DOI 10.1016/j.ymgme.2011.06.013; Vuksan-Cusa B, 2013, NORD J PSYCHIAT, V67, P320, DOI 10.3109/08039488.2012.745601; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Yabuki Y, 2013, NEUROSCIENCE, V250, P394, DOI 10.1016/j.neuroscience.2013.07.017	44	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105704	10.1371/journal.pone.0105704	http://dx.doi.org/10.1371/journal.pone.0105704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153079	Green Published, gold			2022-12-27	WOS:000340952200071
J	Elizur, SE; Lebovitz, O; Derech-Haim, S; Dratviman-Storobinsky, O; Feldman, B; Dor, J; Orvieto, R; Cohen, Y				Elizur, Shai E.; Lebovitz, Oshrit; Derech-Haim, Sanaz; Dratviman-Storobinsky, Olga; Feldman, Baruch; Dor, Jehoshua; Orvieto, Raoul; Cohen, Yoram			Elevated Levels of FMR1 mRNA in Granulosa Cells Are Associated with Low Ovarian Reserve in FMR1 Premutation Carriers	PLOS ONE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; CGG REPEAT NUMBER; FRAGILE; FAILURE; INTERMEDIATE; WOMEN	Aim: To assess the role of mRNA accumulation in granulosa cells as the cause of low ovarian response among FMR1 premutation carriers undergoing pre-implantation genetic diagnosis (PGD). Design: Case control study in an academic IVF unit. Twenty-one consecutive FMR1 premutation carriers and 15 control women were included. After oocyte retrieval the granulosa cells mRNA levels of FMR1 was measured using RT-PCR. Results: In FMR1 premutation carriers, there was a significant non-linear association between the number of CGG repeats and the number of retrieved oocytes (p<0.0001) and a trend to granulosa cells FMR1 mRNA levels (p = 0.07). The lowest number of retrieved oocytes and the highest level of mRNA were seen in women with mid-size CGG repeats (80-120). A significant negative linear correlation was observed between the granulosa cells FMR1 mRNA levels and the number of retrieved oocytes (R-2 linear = 0.231, P = 0.02). Conclusion: We suggest that there is a no-linear association between the number of CGG repeats and ovarian function, resulting from an increased granulosa cells FMR1 mRNA accumulation in FMR1 carriers in the mid-range (80-120 repeats).	[Cohen, Yoram] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Ramat Gan, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Cohen, Y (corresponding author), Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Ramat Gan, Israel.	ycohen1@gmail.com	Lebovitz, Oshrit/AAF-4482-2021	Lebovitz, Oshrit/0000-0003-1171-110X				Allen EG, 2007, HUM REPROD, V22, P2142, DOI 10.1093/humrep/dem148; Allen EG, 2004, HUM GENET, V114, P439, DOI 10.1007/s00439-004-1086-x; Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Bardoni B, 2002, CURR OPIN GENET DEV, V12, P284, DOI 10.1016/S0959-437X(02)00300-3; Berry-Kravis E, 2007, MOVEMENT DISORD, V22, P2018, DOI 10.1002/mds.21493; Bianchi E, 2010, HUM MOL GENET, V19, P4886, DOI 10.1093/hmg/ddq422; Bibi G, 2010, FERTIL STERIL, V94, P869, DOI 10.1016/j.fertnstert.2009.04.047; Bodega B, 2006, HUM REPROD, V21, P952, DOI 10.1093/humrep/dei432; Bretherick KL, 2005, HUM GENET, V117, P376, DOI 10.1007/s00439-005-1326-8; Coffee B, 2009, CURR PROTOC HUM  APR; Conway GS, 1999, HUM REPROD, V14, P574; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Ennis S, 2006, EUR J HUM GENET, V14, P253, DOI 10.1038/sj.ejhg.5201510; Gleicher N, 2009, REPROD BIOMED ONLINE, V19, P385, DOI 10.1016/S1472-6483(10)60173-3; Gleicher N, 2009, FERTIL STERIL, V91, P1707, DOI 10.1016/j.fertnstert.2008.01.099; Hundscheid RDL, 2001, HUM REPROD, V16, P457, DOI 10.1093/humrep/16.3.457; Li YJ, 2012, BRAIN RES, V1462, P112, DOI 10.1016/j.brainres.2012.02.057; Murray A, 1999, HUM REPROD, V14, P1217, DOI 10.1093/humrep/14.5.1217; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; Platteau P, 2002, HUM REPROD, V17, P2807, DOI 10.1093/humrep/17.11.2807; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shrim A, 2006, REPROD BIOMED ONLINE, V12, P418, DOI 10.1016/S1472-6483(10)61993-1; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Welt CK, 2004, J CLIN ENDOCR METAB, V89, P4569, DOI 10.1210/jc.2004-0347; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004	26	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105121	10.1371/journal.pone.0105121	http://dx.doi.org/10.1371/journal.pone.0105121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153074	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200039
J	Kobayashi, K; Okabe, H; Kawano, S; Hidaka, Y; Hara, K				Kobayashi, Katsuhiro; Okabe, Hirotaka; Kawano, Shinya; Hidaka, Yoshiki; Hara, Kazuhiro			Biophoton Emission Induced by Heat Shock	PLOS ONE			English	Article							STRESS; ULTRAWEAK	Ultraweak biophoton emission originates from the generation of reactive oxygen species (ROS) that are produced in mitochondria as by-products of cellular respiration. In healthy cells, the concentration of ROS is minimized by a system of biological antioxidants. However, heat shock changes the equilibrium between oxidative stress and antioxidant activity, that is, a rapid rise in temperature induces biophoton emission from ROS. Although the rate and intensity of biophoton emission was observed to increase in response to elevated temperatures, pretreatment at lower high temperatures inhibited photon emission at higher temperatures. Biophoton measurements are useful for observing and evaluating heat shock.	[Kobayashi, Katsuhiro; Okabe, Hirotaka; Hara, Kazuhiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Okabe, Hirotaka; Kawano, Shinya; Hidaka, Yoshiki; Hara, Kazuhiro] Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kobayashi, K (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	kobayashi@athena.ap.kyushu-u.ac.jp		Hara, Kazuhiro/0000-0001-8410-8550	JSPS KAKENHI Grant [14593004, 17500307]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (http://www.jsps.go.jp/) KAKENHI Grant Numbers 14593004 and 17500307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi R, 2008, LUMINESCENCE, V23, P59; Anshu R, 2011, J BIOMEDICAL OPTICS, V16; Chen WL, 2003, LUMINESCENCE, V18, P37, DOI 10.1002/bio.703; CILENTO G, 1995, FREE RADICAL BIO MED, V19, P103, DOI 10.1016/0891-5849(95)00002-F; Fedoroff N, 2006, ANN BOT-LONDON, V98, P289, DOI 10.1093/aob/mcl128; Fryer MJ, 2002, J EXP BOT, V53, P1249, DOI 10.1093/jexbot/53.372.1249; Havaux M, 2003, TRENDS PLANT SCI, V8, P409, DOI 10.1016/S1360-1385(03)00185-7; Havaux M, 2006, TRENDS PLANT SCI, V11, P480, DOI 10.1016/j.tplants.2006.08.001; HIDEG E, 1991, BIOCHIM BIOPHYS ACTA, V1098, P27; Inagaki H, 2008, WEED BIOL MANAG, V8, P78, DOI 10.1111/j.1445-6664.2008.00278.x; Jaskowska A, 2001, LUMINESCENCE, V16, P51, DOI 10.1002/bio.610; Kageyama C, 2006, PLANT PHYSIOL BIOCH, V44, P901, DOI 10.1016/j.plaphy.2006.09.010; KAI S, 1994, PHYSICA A, V210, P391, DOI 10.1016/0378-4371(94)90087-6; Kai S, 1995, JPN J APPL PHYS 1, V34, P6530, DOI 10.1143/JJAP.34.6530; Kang JH, 2008, J KOREAN PHYS SOC, V52, P132, DOI 10.3938/jkps.52.132; Kataoka Y, 2001, BIOCHEM BIOPH RES CO, V285, P1007, DOI 10.1006/bbrc.2001.5285; Katherine C, 2004, J ALTERN COMPLEM MED, V10, P23; Kawabata R, 2005, JPN J APPL PHYS 1, V44, P1115, DOI 10.1143/JJAP.44.1115; Kawabata R, 2004, JPN J APPL PHYS 1, V43, P5646, DOI 10.1143/JJAP.43.5646; Kim J, 2005, J HEALTH SCI, V51, P155, DOI 10.1248/jhs.51.155; Kim J, 2007, J HEALTH SCI, V53, P481, DOI 10.1248/jhs.53.481; Kim J, 2006, ELECTROMAGN BIOL MED, V25, P97, DOI 10.1080/15368370600719000; Kobayashi M, 1997, PHOTOCHEM PHOTOBIOL, V65, P535, DOI 10.1111/j.1751-1097.1997.tb08600.x; Kobayashi M, 1999, NEUROSCI RES, V34, P103, DOI 10.1016/S0168-0102(99)00040-1; Kobayashi M, 2007, J EXP BOT, V58, P465, DOI 10.1093/jxb/erl215; Laager FM, 2009, ELECTROMAGN BIOL MED, V28, P240, DOI [10.3109/15368370903065820, 10.1080/15368370903065820]; Makino T, 1996, PHOTOCHEM PHOTOBIOL, V64, P953, DOI 10.1111/j.1751-1097.1996.tb01860.x; Mansfield JW, 2005, TRENDS PLANT SCI, V10, P307, DOI 10.1016/j.tplants.2005.05.007; Moud A. M., 2008, World Journal of Agricultural Sciences, V4, P351; Ohya T, 2003, JPN J APPL PHYS 1, V42, P7625, DOI 10.1143/JJAP.42.7625; Ohya T, 2002, JPN J APPL PHYS 1, V41, P4766, DOI 10.1143/JJAP.41.4766; Ohya T, 2000, JPN J APPL PHYS 1, V39, P3696, DOI 10.1143/JJAP.39.3696; Popp F.-A., 1994, Modern Physics Letters B, V8, P1269, DOI 10.1142/S0217984994001266; POPP F A, 1981, Collective Phenomena (London), V3, P187; POPP FA, 1988, EXPERIENTIA, V44, P543, DOI 10.1007/BF01953300; Prasad A, 2011, J BIOPHOTONICS, V4, P840, DOI 10.1002/jbio.201100073; Rastogi A, 2010, SKIN RES TECHNOL, V16, P365, DOI 10.1111/j.1600-0846.2010.00442.x; Rastogi A, 2010, PLANT PHYSIOL BIOCH, V48, P117, DOI 10.1016/j.plaphy.2009.12.011; Sauermann G, 1999, METHOD ENZYMOL, V300, P419; Slawinski J, 2005, FORSCH KOMP KLAS NAT, V12, P90, DOI 10.1159/000083971; SLAWINSKI J, 1981, J LUMIN, V24-5, P791, DOI 10.1016/0022-2313(81)90093-4; SLAWINSKI J, 1987, J PLANT PHYSIOL, V130, P111, DOI 10.1016/S0176-1617(87)80215-8; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Takashi I, 1995, NEURO REP, V6, P658; Takeda M, 2004, CANCER SCI, V95, P656, DOI 10.1111/j.1349-7006.2004.tb03325.x; Takeda M, 1998, CANCER LETT, V127, P155, DOI 10.1016/S0304-3835(98)00064-0; URSINI F, 1989, J BIOLUM CHEMILUM, V4, P241, DOI 10.1002/bio.1170040134; Van Wijk EPA, 2010, J PHOTOCH PHOTOBIO B, V98, P199, DOI 10.1016/j.jphotobiol.2010.01.003; Van Wijk R, 2006, J PHOTOCH PHOTOBIO B, V83, P69, DOI 10.1016/j.jphotobiol.2005.12.005; VANWIJK R, 1992, EXPERIENTIA, V48, P1029; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Winkler R, 2009, PHOTOCHEM PHOTOBIOL, V85, P962, DOI 10.1111/j.1751-1097.2009.00537.x; Yoshinaga N, 2006, NATURWISSENSCHAFTEN, V93, P38, DOI 10.1007/s00114-005-0059-9	53	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105700	10.1371/journal.pone.0105700	http://dx.doi.org/10.1371/journal.pone.0105700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153902	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200070
J	Mansilla, MJ; Costa, C; Eixarch, H; Tepavcevic, V; Castillo, M; Martin, R; Lubetzki, C; Aigrot, MS; Montalban, X; Espejo, C				Mansilla, M. Jose; Costa, Carme; Eixarch, Herena; Tepavcevic, Vanja; Castillo, Mireia; Martin, Roland; Lubetzki, Catherine; Aigrot, Marie-Stephane; Montalban, Xavier; Espejo, Carmen			Hsp70 Regulates Immune Response in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; EXPRESSION; CYTOKINE; RECEPTOR; ASSOCIATION; RELEASE; PATHWAY; BINDING; STRESS	Heat shock protein (Hsp)70 is one of the most important stress-inducible proteins. Intracellular Hsp70 not only mediates chaperone-cytoprotective functions but can also block multiple steps in the apoptosis pathway. In addition, Hsp70 is actively released into the extracellular milieu, thereby promoting innate and adaptive immune responses. Thus, Hsp70 may be a critical molecule in multiple sclerosis (MS) pathogenesis and a potential target in this disease due to its immunological and cytoprotective functions. To investigate the role of Hsp70 in MS pathogenesis, we examined its immune and cytoprotective roles using both in vitro and in vivo experimental procedures. We found that Hsp70.1-deficient mice were more resistant to developing experimental autoimmune encephalomyelitis (EAE) compared with their wild-type (WT) littermates, suggesting that Hsp70.1 plays a critical role in promoting an effective myelin oligodendrocyte glycoprotein (MOG)-specific T cell response. Conversely, Hsp70.1-deficient mice that developed EAE showed an increased level of autoreactive T cells to achieve the same production of cytokines compared with the WT mice. Although a neuroprotective role of HSP70 has been suggested, Hsp70.1-deficient mice that developed EAE did not exhibit increased demyelination compared with the control mice. Accordingly, Hsp70 deficiency did not influence the vulnerability to apoptosis of oligodendrocyte precursor cells (OPCs) in culture. Thus, the immunological role of Hsp70 may be relevant in EAE, and specific therapies down-regulating Hsp70 expression may be a promising approach to reduce the early autoimmune response in MS patients.	[Mansilla, M. Jose; Costa, Carme; Eixarch, Herena; Castillo, Mireia; Montalban, Xavier; Espejo, Carmen] Hosp Univ Vall dHebron, Vall dHebron Inst Recerca VHIR, Ctr Esclerosi Multiple Catalunya Cemcat, Serv Neurol Neuroimmunol, Barcelona, Spain; [Mansilla, M. Jose; Costa, Carme; Eixarch, Herena; Castillo, Mireia; Montalban, Xavier; Espejo, Carmen] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Tepavcevic, Vanja; Lubetzki, Catherine; Aigrot, Marie-Stephane] Univ Paris 06, Sorbonne Univ, ICM GH Pitie Salpetriere, Inserm,CNRS,UMR 7225,U1127,UM 75, Paris, France; [Martin, Roland] Univ Zurich Hosp, Neurol Clin, Dept Neuroimmunol & Multiple Sclerosis Res, CH-8091 Zurich, Switzerland	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Zurich; University Zurich Hospital	Espejo, C (corresponding author), Hosp Univ Vall dHebron, Vall dHebron Inst Recerca VHIR, Ctr Esclerosi Multiple Catalunya Cemcat, Serv Neurol Neuroimmunol, Barcelona, Spain.	carmen.espejo@vhir.org	Espejo, Carmen/E-5989-2018; Costa, Carme/AAF-9852-2019; Montalban, Xavier/J-5938-2016; Tepavcevic, Vanja/ABI-5461-2020	Espejo, Carmen/0000-0001-9949-5901; Montalban, Xavier/0000-0002-0098-9918; Tepavcevic, Vanja/0000-0003-3230-4888; Eixarch, Herena/0000-0001-7525-9533; Costa, Carme/0000-0001-9577-3839; Castillo Juarez, Mireia/0000-0001-8979-3219; MANSILLA LOPEZ, MARIA JOSE/0000-0002-5044-6313	"Red Espanola de Esclerosis Multiple (REEM)" - Fondo de Investigacion Sanitaria (FIS), Ministry of Economy and Competition, Spain [RD12/0032]; "Ajuts per donar Suportals Grups de Recerca de Catalunya" - "Agencia de Gestio d'Ajuts Universitarisi de Recerca'' (AGAUR), Generalitat de Catalunya, Spain [2009 SGR 0793]; "Miguel Servet'' program from the FIS, Ministry of Economy and Competition, Spain [CP07/00146]; "Investissements d'avenir'' [ANR-10-IAIHU-06]; Sara Borrell program from the FIS, Ministry of Economy and Competition, Spain [CD09/00363]	"Red Espanola de Esclerosis Multiple (REEM)" - Fondo de Investigacion Sanitaria (FIS), Ministry of Economy and Competition, Spain; "Ajuts per donar Suportals Grups de Recerca de Catalunya" - "Agencia de Gestio d'Ajuts Universitarisi de Recerca'' (AGAUR), Generalitat de Catalunya, Spain(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); "Miguel Servet'' program from the FIS, Ministry of Economy and Competition, Spain; "Investissements d'avenir''(French National Research Agency (ANR)); Sara Borrell program from the FIS, Ministry of Economy and Competition, Spain	"Red Espanola de Esclerosis Multiple (REEM)'' (RD12/0032) sponsored by the Fondo de Investigacion Sanitaria (FIS), Ministry of Economy and Competition, Spain. "Ajuts per donar Suportals Grups de Recerca de Catalunya (2009 SGR 0793)'', sponsored by the "Agencia de Gestio d'Ajuts Universitarisi de Recerca'' (AGAUR), Generalitat de Catalunya, Spain. CE is partially supported by the "Miguel Servet'' program (CP07/00146) from the FIS, Ministry of Economy and Competition, Spain. HE is supported by the Sara Borrell program (CD09/00363) from the FIS, Ministry of Economy and Competition, Spain. VT was supported by "Investissements d'avenir'' ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino DA, 1997, J NEUROPATH EXP NEUR, V56, P664; AQUINO DA, 1993, J NEUROCHEM, V61, P1340, DOI 10.1111/j.1471-4159.1993.tb13627.x; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Baker D, 2012, J NEUROIMMUNOL, V242, P78, DOI 10.1016/j.jneuroim.2011.11.003; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Bland JM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3166; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Cwiklinska H, 2003, INT IMMUNOL, V15, P241, DOI 10.1093/intimm/dxg022; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; DSOUZA SD, 1994, J NEUROIMMUNOL, V50, P17, DOI 10.1016/0165-5728(94)90210-0; Espejo C, 2001, EXP NEUROL, V172, P460, DOI 10.1006/exnr.2001.7815; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; GAO YL, 1995, J IMMUNOL, V154, P3548; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HUNT CR, 1993, GENOMICS, V16, P193, DOI 10.1006/geno.1993.1158; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Mansilla MJ, 2012, MOL MED, V18, P1018, DOI 10.2119/molmed.2012.00119; Kwon SB, 2002, J DERMATOL SCI, V28, P144, DOI 10.1016/S0923-1811(01)00156-6; Lehner T, 2000, EUR J IMMUNOL, V30, P594, DOI 10.1002/1521-4141(200002)30:2<594::AID-IMMU594>3.3.CO;2-T; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LUBETZKI C, 1991, J NEUROCHEM, V56, P671, DOI 10.1111/j.1471-4159.1991.tb08202.x; Lund BT, 2006, J NEUROL SCI, V249, P122, DOI 10.1016/j.jns.2006.05.066; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mansilla MJ, 2013, AUTOIMMUNIT IN PRESS; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Mycko MA, 2008, EUR J IMMUNOL, V38, P1999, DOI 10.1002/eji.200737661; Mycko MP, 2004, J IMMUNOL, V172, P202, DOI 10.4049/jimmunol.172.1.202; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; Tytell M, 2001, Expert Opin Ther Targets, V5, P267, DOI 10.1517/14728222.5.2.267; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; WELCH WJ, 1993, PHILOS T ROY SOC B, V339, P327, DOI 10.1098/rstb.1993.0031	43	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105737	10.1371/journal.pone.0105737	http://dx.doi.org/10.1371/journal.pone.0105737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153885	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000340952200077
J	Rossignol, R; Ranchon-Cole, I; Paris, A; Herzine, A; Perche, A; Laurenceau, D; Bertrand, P; Cercy, C; Pichon, J; Mortaud, S; Briault, S; Menuet, A; Perche, O				Rossignol, Rafaelle; Ranchon-Cole, Isabelle; Paris, Arnaud; Herzine, Ameziane; Perche, Astrid; Laurenceau, David; Bertrand, Pauline; Cercy, Christine; Pichon, Jacques; Mortaud, Stephane; Briault, Sylvain; Menuet, Arnaud; Perche, Olivier			Visual Sensorial Impairments in Neurodevelopmental Disorders: Evidence for a Retinal Phenotype in Fragile X Syndrome	PLOS ONE			English	Article							FMR1 KNOCKOUT MICE; MENTAL-RETARDATION PROTEIN; SYNDROME MOUSE MODEL; RECEPTOR-DEPENDENT TRANSLATION; SYNAPTIC DEVELOPMENT; SOCIAL-INTERACTION; RHODOPSIN CONTENT; DENDRITIC SPINES; AUTISM; PSD-95	Visual sensory impairments are common in Mental Deficiency (MD) and Autism Spectrum Disorder (ASD). These defects are linked to cerebral dysfunction in the visual cortical area characterized by the deregulation of axon growth/guidance and dendrite spine immaturity of neurons. However, visual perception had not been addressed, although the retina is part of the central nervous system with a common embryonic origin. Therefore, we investigated retinal perception, the first event of vision, in a murine model of MD with autistic features. We document that retinal function is altered in Fmr1 KO mice, a model of human Fragile X Syndrome. Indeed, In Fmr1 KO mice had a lower retinal function characterized by a decreased photoreceptors neuron response, due to a 40% decrease in Rhodopsin content and to Rod Outer Segment destabilization. In addition, we observed an alteration of the visual signal transmission between photoreceptors and the inner retina which could be attributed to deregulations of pre- and post-synaptic proteins resulting in retinal neurons synaptic destabilization and to retinal neurons immaturity. Thus, for the first time, we demonstrated that retinal perception is altered in a murine model of MD with autistic features and that there are strong similarities between cerebral and retinal cellular and molecular defects. Our results suggest that both visual perception and integration must be taken into account in assessing visual sensory impairments in MD and ASD.	[Rossignol, Rafaelle; Paris, Arnaud; Herzine, Ameziane; Pichon, Jacques; Mortaud, Stephane; Briault, Sylvain; Menuet, Arnaud; Perche, Olivier] CNRS, UMR7355, F-45071 Orleans, France; [Rossignol, Rafaelle; Paris, Arnaud; Herzine, Ameziane; Pichon, Jacques; Mortaud, Stephane; Briault, Sylvain; Menuet, Arnaud; Perche, Olivier] Univ Orleans, Orleans, France; [Perche, Astrid; Laurenceau, David; Briault, Sylvain; Perche, Olivier] Reg Hosp, Dept Genet, Orleans, France; [Ranchon-Cole, Isabelle; Bertrand, Pauline; Cercy, Christine] Univ Clermont 1, Lab Sensorial Biophys, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Centre Hospitalier Regional d'Orleans; Universite Clermont Auvergne (UCA)	Perche, O (corresponding author), CNRS, UMR7355, F-45071 Orleans, France.	operche@cnrs-orleans.fr		Ranchon-Cole, Isabelle/0000-0002-7092-6744; Mortaud, Stephane/0000-0003-0873-4781; Perche, Olivier/0000-0002-6513-5534	CNRS; Regional Hospital of Orleans; University of Orleans; FEDER [35106]; FRAXA Research Foundation	CNRS(Centre National de la Recherche Scientifique (CNRS)); Regional Hospital of Orleans; University of Orleans; FEDER(European Commission); FRAXA Research Foundation	Research was supported by CNRS, Regional Hospital of Orleans, University of Orleans, FEDER 35106, and FRAXA Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; BAKKER CE, 1994, CELL, V78, P23; Baranek GT, 2006, J CHILD PSYCHOL PSYC, V47, P591, DOI 10.1111/j.1469-7610.2005.01546.x; Baranek GT, 2002, AM J OCCUP THER, V56, P538, DOI 10.5014/ajot.56.5.538; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Battaglia A, 2011, ARCH ITAL BIOL, V149, P193, DOI 10.4449/aib.v149i2.1362; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berman RF, 2012, EPILEPSIA, V53, P150, DOI 10.1111/j.1528-1167.2012.03486.x; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; BIERSDORFF KK, 1994, AM J MENT RETARD, V98, P619; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Bonetti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015211; Braun K, 2000, CEREB CORTEX, V10, P1045, DOI 10.1093/cercor/10.10.1045; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Davidovic L, 2011, GENOME RES, V21, P2190, DOI 10.1101/gr.116764.110; Dolen G, 2009, J NEURODEV DISORD, V1, P133, DOI 10.1007/s11689-009-9015-x; Farzin F, 2011, BRAIN, V134, P3355, DOI 10.1093/brain/awr249; FOX DA, 1989, EXP EYE RES, V48, P237, DOI 10.1016/S0014-4835(89)80073-9; Frishman LJ, 2006, ORIGINS ELECTRORETIN, P139; Fulton AB, 1999, INVEST OPHTH VIS SCI, V40, P1878; Granit R, 1933, J PHYSIOL-LONDON, V77, P207, DOI 10.1113/jphysiol.1933.sp002964; HOFMANN KP, 1985, J BIOL CHEM, V260, P7990; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; KANEKO A, 1979, ANNU REV NEUROSCI, V2, P169, DOI 10.1146/annurev.ne.02.030179.001125; Klemmer P, 2011, J BIOL CHEM, V286, P25495, DOI 10.1074/jbc.M110.210260; Kogan CS, 2004, BRAIN, V127, P591, DOI 10.1093/brain/awh069; Krueger DD, 2011, P NATL ACAD SCI USA, V108, P2587, DOI 10.1073/pnas.1013855108; LAMB TD, 1992, TRENDS NEUROSCI, V15, P291, DOI 10.1016/0166-2236(92)90079-N; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lane AE, 2010, J AUTISM DEV DISORD, V40, P112, DOI 10.1007/s10803-009-0840-2; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Lee ES, 2007, INVEST OPHTH VIS SCI, V48, P2868, DOI 10.1167/iovs.06-0035; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Levenga J, 2011, NEUROBIOL LEARN MEM, V95, P467, DOI 10.1016/j.nlm.2011.02.009; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nader R, 2004, CLIN J PAIN, V20, P88, DOI 10.1097/00002508-200403000-00005; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Perche O, 2009, EXP EYE RES, V89, P989, DOI 10.1016/j.exer.2009.08.012; Perche O, 2007, INVEST OPHTH VIS SCI, V48, P2753, DOI 10.1167/iovs.06-1258; Perche O, 2013, EUR J MED GENET, V56, P635, DOI 10.1016/j.ejmg.2013.07.007; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Price BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049889; Purves D., 2001, NEUROSCIENCE; Shi D, 2012, J NEUROCHEM, V123, P971, DOI 10.1111/jnc.12048; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Westmark CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00057; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhu ZW, 2011, NEUROPATHOLOGY, V31, P223, DOI 10.1111/j.1440-1789.2010.01165.x; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	65	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105996	10.1371/journal.pone.0105996	http://dx.doi.org/10.1371/journal.pone.0105996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153086	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200103
J	Rytter, MJH; Kolte, L; Briend, A; Friis, H; Christensen, VB				Rytter, Maren Johanne Heilskov; Kolte, Lilian; Briend, Andre; Friis, Henrik; Christensen, Vibeke Brix			The Immune System in Children with Malnutrition-A Systematic Review	PLOS ONE			English	Review							PROTEIN-CALORIE MALNUTRITION; SEVERELY MALNOURISHED CHILDREN; CELL-MEDIATED-IMMUNITY; ACUTE-PHASE RESPONSE; LYMPHOCYTE-TRANSFORMATION INVITRO; PERIPHERAL-BLOOD LYMPHOCYTES; ROSETTE INHIBITORY SUBSTANCE; MARASMIC MALAWIAN CHILDREN; NITROBLUE TETRAZOLIUM TEST; WELL-NOURISHED CHILDREN	Background: Malnourished children have increased risk of dying, with most deaths caused by infectious diseases. One mechanism behind this may be impaired immune function. However, this immune deficiency of malnutrition has not previously been systematically reviewed. Objectives: To review the scientific literature about immune function in children with malnutrition. Methods: A systematic literature search was done in PubMed, and additional articles identified in reference lists and by correspondence with experts in the field. The inclusion criteria were studies investigating immune parameters in children aged 1-60 months, in relation to malnutrition, defined as wasting, underweight, stunting, or oedematous malnutrition. Results: The literature search yielded 3402 articles, of which 245 met the inclusion criteria. Most were published between 1970 and 1990, and only 33 after 2003. Malnutrition is associated with impaired gut-barrier function, reduced exocrine secretion of protective substances, and low levels of plasma complement. Lymphatic tissue, particularly the thymus, undergoes atrophy, and delayed-type hypersensitivity responses are reduced. Levels of antibodies produced after vaccination are reduced in severely malnourished children, but intact in moderate malnutrition. Cytokine patterns are skewed towards a Th2-response. Other immune parameters seem intact or elevated: leukocyte and lymphocyte counts are unaffected, and levels of immunoglobulins, particularly immunoglobulin A, are high. The acute phase response appears intact, and sometimes present in the absence of clinical infection. Limitations to the studies include their observational and often cross-sectional design and frequent confounding by infections in the children studied. Conclusion: The immunological alterations associated with malnutrition in children may contribute to increased mortality. However, the underlying mechanisms are still inadequately understood, as well as why different types of malnutrition are associated with different immunological alterations. Better designed prospective studies are needed, based on current understanding of immunology and with state-of-the-art methods.	[Rytter, Maren Johanne Heilskov; Briend, Andre; Friis, Henrik] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Frederiksberg, Denmark; [Kolte, Lilian] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Briend, Andre] Univ Tampere, Sch Med, Dept Int Hlth, FIN-33101 Tampere, Finland; [Christensen, Vibeke Brix] Univ Copenhagen, Hosp Rigshosp, Dept Paediat, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Tampere University; Rigshospitalet; University of Copenhagen	Rytter, MJH (corresponding author), Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Frederiksberg, Denmark.	marenrytter@hotmail.com	Friis, Henrik/P-2891-2019; Rytter, Maren JH/G-3279-2016; Friis, Henrik/N-2047-2014	Friis, Henrik/0000-0002-2848-2940; Rytter, Maren JH/0000-0002-9490-9586; Friis, Henrik/0000-0002-2848-2940; Christensen, Vibeke Brix/0000-0002-0890-3832	University of Copenhagen	University of Copenhagen	The work was supported by a PhD grant from University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASSY AS, 1974, J TROP MED HYG, V77, P13; Abdulrhman MA, 2011, J MED FOOD, V14, P551, DOI 10.1089/jmf.2010.0082; ABIODUN PO, 1987, J PEDIATR GASTR NUTR, V6, P271, DOI 10.1097/00005176-198703000-00019; ABIODUN PO, 1985, EUR J PEDIATR, V144, P368, DOI 10.1007/BF00441779; Abo-Shousha Seham A, 2005, Egypt J Immunol, V12, P125; Abu Faddan NH, 2010, ANN PEDIAT CARDIOL, V3, P113, DOI 10.4103/0974-2069.74036; ADESOLA AO, 1968, BRIT J SURG, V55, P866; Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Akenami FOT, 1997, J PEDIATR GASTR NUTR, V24, P183, DOI 10.1097/00005176-199702000-00012; Alcoba G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053184; ALTAY C, 1972, J PEDIATR-US, V81, P392, DOI 10.1016/S0022-3476(72)80319-6; Amadi B, 2001, J PEDIATR GASTR NUTR, V32, P550, DOI 10.1097/00005176-200105000-00011; Amadi B, 2009, AM J CLIN NUTR, V89, P592, DOI 10.3945/ajcn.2008.27092; [Anonymous], 1970, LANCET, V2, P302; AREF GH, 1982, J TROP MED HYG, V85, P109; AREF GH, 1970, J TROP MED HYG, V73, P186; Aslan Y., 1996, Central African Journal of Medicine, V42, P179; Asturias EJ, 2009, VACCINE, V27, P3650, DOI 10.1016/j.vaccine.2009.03.035; AWDEH ZL, 1977, ACTA PAEDIATR SCAND, V66, P689, DOI 10.1111/j.1651-2227.1977.tb07972.x; Bachou H, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-27; BAER CL, 1986, W INDIAN MED J, V35, P106; BANG BG, 1975, P SOC EXP BIOL MED, V149, P199, DOI 10.3181/00379727-149-38772; BARONE KS, 1993, CELL IMMUNOL, V148, P226, DOI 10.1006/cimm.1993.1105; Bartz S, 2014, J CLIN ENDOCR METAB, V99, P2128, DOI 10.1210/jc.2013-4018; Basso AS, 2009, CELL RES, V19, P399, DOI 10.1038/cr.2009.26; BEATTY DW, 1979, CLIN EXP IMMUNOL, V35, P433; BEATTY DW, 1983, J CLIN LAB IMMUNOL, V12, P31; BEATTY DW, 1978, CLIN EXP IMMUNOL, V32, P134; BEHRENS RH, 1987, AM J CLIN NUTR, V45, P1433, DOI 10.1093/ajcn/45.6.1433; BELL RG, 1976, AM J CLIN NUTR, V29, P392, DOI 10.1093/ajcn/29.4.392; Berczi I, 2009, ANN NY ACAD SCI, V1153, P220, DOI 10.1111/j.1749-6632.2008.03975.x; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhaskaram C, 1974, J Trop Pediatr Environ Child Health, V20, P284; Bhaskaram P, 1982, Indian J Pediatr, V49, P497, DOI 10.1007/BF02834553; BHASKARAM P, 1982, INDIAN J MED RES, V76, P849; BHASKARAM P, 1980, INDIAN J MED RES, V71, P247; BHASKARAM P, 1986, ARCH DIS CHILD, V61, P182, DOI 10.1136/adc.61.2.182; BHASKARAM P, 1986, HUM NUTR-CLIN NUTR, V40C, P295; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Boaz RT, 2013, INDIAN PEDIATR, V50, P152, DOI 10.1007/s13312-013-0030-3; Brewster DR, 1997, ARCH DIS CHILD, V76, P236, DOI 10.1136/adc.76.3.236; BROWN R E, 1965, East Afr Med J, V42, P221; BROWN RE, 1966, TROP GEOGR MED, V18, P125; BROWN RE, 1966, TROP GEOGR MED, V18, P129; BRUNSER O, 1976, GASTROENTEROLOGY, V70, P495; BRUNSER O, 1966, PEDIATRICS, V38, P605; BRUNSER O, 1968, AM J CLIN NUTR, V21, P976, DOI 10.1093/ajcn/21.9.976; BRUSSOW H, 1995, CLIN DIAGN LAB IMMUN, V2, P62; BUCHANAN N, 1973, S AFR MED J, V47, P1179; BURMAN D, 1965, ARCH DIS CHILD, V40, P526, DOI 10.1136/adc.40.213.526; Campbell DI, 2003, PEDIATR RES, V54, P306, DOI 10.1203/01.PDR.0000076666.16021.5E; Campbell DI, 2003, J NUTR, V133, P1332; Casazza L J, 1972, Paediatr Indones, V12, P263; CASTILLODURAN C, 1987, AM J CLIN NUTR, V45, P602, DOI 10.1093/ajcn/45.3.602; Chen M, 2010, J AUTOIMMUN, V34, pJ276, DOI 10.1016/j.jaut.2009.11.014; CHEVALIER P, 1995, LANCET, V345, P1046, DOI 10.1016/S0140-6736(95)90783-1; Chevalier P, 1998, J TROP PEDIATRICS, V44, P304, DOI 10.1093/tropej/44.5.304; Chevalier P, 1997, NUTR RES, V17, P1271, DOI 10.1016/S0271-5317(97)00110-3; Chevalier Philipe, 1994, Journal of Nutritional Immunology, V3, P27, DOI 10.1300/J053v03n01_04; CHHANGANI L, 1985, Indian Journal of Pathology and Microbiology, V28, P199; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; CHOPRA K, 1989, J TROP PEDIATRICS, V35, P19, DOI 10.1093/tropej/35.1.19; Cobbold SP, 2013, IMMUNOLOGY, V140, P391, DOI 10.1111/imm.12162; COHEN S, 1962, CLIN SCI, V23, P351; Collinson AC, 2003, ACTA PAEDIATR, V92, P1014, DOI 10.1080/08035250310004379; Cripps Allan W., 2008, Papua New Guinea Medical Journal, V51, P120; CRUZ JR, 1987, J PEDIATR GASTR NUTR, V6, P387, DOI 10.1097/00005176-198705000-00015; DAO H, 1992, J TROP PEDIATRICS, V38, P179, DOI 10.1093/tropej/38.4.179; De Mello-Coelho V, 1998, Dev Immunol, V6, P317, DOI 10.1155/1998/89782; Degn SE, 2007, IMMUNOBIOLOGY, V212, P301, DOI 10.1016/j.imbio.2006.12.004; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; DOHERTY JF, 1989, W INDIAN MED J, V38, P209; DOHERTY JF, 1994, CLIN SCI, V86, P347, DOI 10.1042/cs0860347; DOHERTY JF, 1993, CLIN SCI, V84, P169, DOI 10.1042/cs0840169; DOUGLAS SD, 1974, CLIN EXP IMMUNOL, V17, P121; Dulger H, 2002, MEDIAT INFLAMM, V11, P363, DOI 10.1080/0962935021000051566; DUTZ W, 1974, Z KINDERHEILKD, V117, P241, DOI 10.1007/BF00440491; EDELMAN R, 1973, LANCET, V1, P506; EDELMAN R, 1973, LANCET, V1, P1244; Ekanem EE, 1997, ACTA PAEDIATR, V86, P1317, DOI 10.1111/j.1651-2227.1997.tb14905.x; EKUNWE EO, 1985, J TROP PEDIATRICS, V31, P290, DOI 10.1093/tropej/31.6.290; El-Hodhod MAA, 2005, NUTR RES, V25, P21, DOI 10.1016/j.nutres.2004.10.005; El-Sayed HL, 2006, EUR J CLIN NUTR, V60, P502, DOI 10.1038/sj.ejcn.1602344; ElGamal Y, 1996, J TROP PEDIATRICS, V42, P144, DOI 10.1093/tropej/42.3.144; ELGHOLMY A, 1970, J TROP MED HYG, V73, P192; ELGHOLMY A, 1970, J TROP MED HYG, V73, P196; ELMOLLA A, 1973, J TROP MED HYG, V76, P248; FAKHIR S, 1989, J TROP PEDIATRICS, V35, P175, DOI 10.1093/tropej/35.4.175; Fakhir S, 1988, Indian Pediatr, V25, P1017; FAKHIR S, 1988, Indian Pediatrics, V25, P960; FERGUSON AC, 1974, J PEDIATR-US, V85, P717, DOI 10.1016/S0022-3476(74)80527-5; Fillol F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-116; Fongwo N P, 1999, Afr J Med Med Sci, V28, P17; Forte W C, 1992, Allergol Immunopathol (Madr), V20, P157; Forte W C N, 2003, Allergol Immunopathol (Madr), V31, P83, DOI 10.1157/13045074; FORTE WCN, 1984, ALLERGOL IMMUNOPATH, V12, P489; FREYRE EA, 1973, J PEDIATR-US, V82, P523, DOI 10.1016/S0022-3476(73)80137-4; Garly ML, 2008, J PEDIATR-US, V153, P683, DOI 10.1016/j.jpeds.2008.04.069; GEEFHUYSEN J, 1971, BMJ-BRIT MED J, V4, P527, DOI 10.1136/bmj.4.5786.527; GILMAN RH, 1988, GASTROENTEROLOGY, V94, P1308, DOI 10.1016/0016-5085(88)90668-3; Giovambattista A, 2000, MEDICINA-BUENOS AIRE, V60, P339; GOLDEN MHN, 1987, P NUTR SOC, V46, P53, DOI 10.1079/PNS19870008; GOLDEN MHN, 1977, LANCET, V2, P1057; GOLDEN MHN, 1978, LANCET, V1, P1226; Gonzalez C, 2002, TERATOGEN CARCIN MUT, V22, P147, DOI 10.1002/tcm.10007; Gonzalez C, 2002, ENVIRON MOL MUTAGEN, V39, P33, DOI 10.1002/em.10038; Gonzalez C, 2006, CELL BIOL INT, V30, P610, DOI 10.1016/j.cellbi.2006.02.011; Gonzalez-Martinez H, 2008, J CLIN IMMUNOL, V28, P593, DOI 10.1007/s10875-008-9204-5; Gonzalez-Torres C, 2013, NUTRIENTS, V5, P579, DOI 10.3390/nu5020579; Goyal H K, 1981, Indian Pediatr, V18, P287; GRACE HJ, 1972, S AFR MED J, V46, P402; GRACEY M, 1977, ARCH DIS CHILD, V52, P325, DOI 10.1136/adc.52.4.325; GRACEY M, 1974, AM J CLIN NUTR, V27, P345, DOI 10.1093/ajcn/27.4.345; GREEN F, 1980, ARCH DIS CHILD, V55, P380, DOI 10.1136/adc.55.5.380; GREENWOOD BM, 1986, ANN TROP MED PARASIT, V80, P537, DOI 10.1080/00034983.1986.11812062; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P340, DOI 10.1016/0035-9203(80)90095-4; Gui JG, 2012, AGING DIS, V3, P280; Haeryfar SMM, 2001, CELL MOL BIOL, V47, P145; HAFEZ M, 1977, J TROP MED HYG, V80, P36; Hagel I, 2003, J TROP PEDIATRICS, V49, P136, DOI 10.1093/tropej/49.3.136; HALLER L, 1978, CLIN EXP IMMUNOL, V34, P248; HALSEY NA, 1985, NEW ENGL J MED, V313, P544, DOI 10.1056/NEJM198508293130904; Hansen BR, 2009, AIDS, V23, P2123, DOI 10.1097/QAD.0b013e3283303307; HARLAND PSE, 1965, LANCET, V2, P719; Hassanein ES, 1998, J TROP PEDIATRICS, V44, P362, DOI 10.1093/tropej/44.6.362; Hasselbalch H, 1999, ACTA RADIOL, V40, P41; Hasselbalch H, 1996, ACTA PAEDIATR, V85, P1029, DOI 10.1111/j.1651-2227.1996.tb14211.x; Heilskov S, 2014, J EUR ACAD DERMATOL, V28, P995, DOI 10.1111/jdv.12452; Hemalatha R, 2002, INDIAN J MED RES, V115, P55; HERESI GP, 1981, AM J CLIN NUTR, V34, P909, DOI 10.1093/ajcn/34.5.909; HEYWORTH B, 1975, CLIN EXP IMMUNOL, V22, P72; HEYWORTH B, 1977, T ROY SOC TROP MED H, V71, P251, DOI 10.1016/0035-9203(77)90019-0; Hossain MI, 2010, J PEDIATR GASTR NUTR, V51, P638, DOI 10.1097/MPG.0b013e3181eb3128; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Hughes SM, 2009, J IMMUNOL, V183, P2818, DOI 10.4049/jimmunol.0803518; Hughes SM, 2009, PEDIATRICS, V123, pE347, DOI 10.1542/peds.2008-1316; IBRAHIM AM, 1978, Z ERNAHRUNGSWISS, V17, P145, DOI 10.1007/BF02020904; Idris S, 1983, Ann Trop Paediatr, V3, P63; Ikeogu MO, 1997, ARCH DIS CHILD, V76, P124, DOI 10.1136/adc.76.2.124; Iputo JE, 2002, SAMJ S AFR MED J, V92, P310; Jahoor F, 2008, ANN TROP PAEDIATR, V28, P87, DOI 10.1179/146532808X302107; JAMBON B, 1988, AM J CLIN NUTR, V48, P335, DOI 10.1093/ajcn/48.2.335; JOFFE MI, 1983, J CLIN LAB IMMUNOL, V10, P97; KAHN E, 1957, AM J CLIN NUTR, V5, P70, DOI 10.1093/ajcn/5.1.70; KASCHULA ROC, 1979, ISRAEL J MED SCI, V15, P356; KEET MP, 1969, ARCH DIS CHILD, V44, P600, DOI 10.1136/adc.44.237.600; Keusch G, 1977, HUMORAL CELLULAR ASP, P245; Keusch G, 1977, ROSETTE FORMING LYMP, V1977, P117; Keusch GT, 2013, FOOD NUTR BULL, V34, P357, DOI 10.1177/156482651303400308; KEUSCH GT, 1987, J PEDIATR GASTR NUTR, V6, P265, DOI 10.1097/00005176-198703000-00018; KEUSCH GT, 1984, J PEDIATR-US, V105, P434, DOI 10.1016/S0022-3476(84)80022-0; Khatun F, 2011, EPIDEMIOL INFECT, V139, P446, DOI 10.1017/S0950268810001093; Kielman A, 1977, MALNUTRITION IMMUNE, P429; KOBIELOWA Z, 1979, ACTA MED POL, V20, P265; KULAPONGS P, 1977, AM J CLIN NUTR, V30, P367, DOI 10.1093/ajcn/30.3.367; Kulapongs P, 1977, IN VITRO CELL MEDIAT, V1977; KUMAR R, 1984, Indian Pediatrics, V21, P541; Leitzmann C, 1977, MALNUTRITION IMMUNE, P253; Lo MS, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-42; LOMNITZER R, 1976, S AFR MED J, V50, P1820; Lotfy Omayma A., 1998, Journal of the Egyptian Society of Parasitology, V28, P413; MACHADO RMP, 1985, J TROP PEDIATRICS, V31, P74, DOI 10.1093/tropej/31.2.74; MAHALANABIS D, 1979, AM J CLIN NUTR, V32, P992, DOI 10.1093/ajcn/32.5.992; Malave I, 1998, J TROP PEDIATRICS, V44, P256, DOI 10.1093/tropej/44.5.256; Manary MJ, 2004, BRIT J NUTR, V92, P589, DOI 10.1079/BJN20041242; Manary MJ, 2004, PEDIATR RES, V55, P940, DOI 10.1203/01.pdr.0000127017.44938.6d; Marei Mohammad A., 1998, Journal of the Egyptian Society of Parasitology, V28, P907; MATA LJ, 1972, AM J CLIN NUTR, V25, P1118; Matee M I, 1995, Oral Dis, V1, P37; MAYATEPEK E, 1993, LANCET, V342, P958, DOI 10.1016/0140-6736(93)92003-C; McFarlane H, 1977, MALNUTRITION IMMUNE, P403; McMurray D N, 1979, Bull Pan Am Health Organ, V13, P52; MCMURRAY DN, 1977, AM J CLIN NUTR, V30, P1944, DOI 10.1093/ajcn/30.12.1944; MCMURRAY DN, 1981, AM J CLIN NUTR, V34, P68, DOI 10.1093/ajcn/34.1.68; MCMURRAY DN, 1981, AM J CLIN NUTR, V34, P2117, DOI 10.1093/ajcn/34.10.2117; Miedema F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00298; Miller EM, 2012, AM J PHYS ANTHROPOL, V149, P136, DOI 10.1002/ajpa.22108; Mishra OP, 2001, J TROP PEDIATRICS, V47, P77, DOI 10.1093/tropej/47.2.77; Mondal D, 2009, AM J TROP MED HYG, V80, P824, DOI 10.4269/ajtmh.2009.80.824; Monira S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00228; Monk JM, 2012, BRIT J NUTR, V107, P1249, DOI 10.1017/S0007114511004399; Monk JM, 2011, INT J ENV RES PUB HE, V8, P117, DOI 10.3390/ijerph8010117; MOORE DL, 1977, IMMUNOLOGY, V33, P777; MOORE DL, 1974, CLIN EXP IMMUNOL, V17, P647; Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x; Moore SE, 2014, INT J EPIDEMIOL, V43, P216, DOI 10.1093/ije/dyt232; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; Morlese JF, 1998, AM J PHYSIOL-ENDOC M, V275, pE112, DOI 10.1152/ajpendo.1998.275.1.E112; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; MURTHY PB, 1982, BRIT J NUTR, V47, P445, DOI 10.1079/BJN19820056; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; NAEYE RL, 1965, J PEDIATR-US, V67, P447, DOI 10.1016/S0022-3476(65)80406-1; NAHANI J, 1976, NUTR METAB, V20, P302; Najera O, 2007, CLIN EXP IMMUNOL, V148, P501, DOI 10.1111/j.1365-2249.2007.03369.x; Najera O, 2004, CLIN DIAGN LAB IMMUN, V11, P577, DOI 10.1128/CDLI.11.3.577-580.2004; Najera O, 2001, CLIN EXP IMMUNOL, V126, P461, DOI 10.1046/j.1365-2249.2001.01694.x; Najera O, 2002, J NUTR IMMUNOL, V5, P85, DOI [10.1300/J053v05n03_07, DOI 10.1300/J053V05N03_07]; NAJJAR SS, 1969, ARCH DIS CHILD, V44, P120, DOI 10.1136/adc.44.233.120; Nassar M. F., 2009, Eastern Mediterranean Health Journal, V15, P574; Nassar M. F., 2007, Eastern Mediterranean Health Journal, V13, P1031; Ndagije F, 2007, ANN TROP PAEDIATR, V27, P269, DOI 10.1179/146532807X245652; NETO UF, 1976, ACTA PAEDIATR SCAND, V65, P609, DOI 10.1111/j.1651-2227.1976.tb04940.x; Ngom PT, 2004, AM J CLIN NUTR, V80, P722; Noureldin Mohamed S. A., 1999, Journal of the Egyptian Society of Parasitology, V29, P951; OLUSI SO, 1980, CLIN IMMUNOL IMMUNOP, V15, P687, DOI 10.1016/0090-1229(80)90013-6; OLUSI SO, 1975, CLIN CHIM ACTA, V62, P107, DOI 10.1016/0009-8981(75)90286-7; OLUSI SO, 1976, TROP GEOGR MED, V28, P323; OMOIKE IU, 1989, J PEDIATR GASTR NUTR, V9, P314, DOI 10.1097/00005176-198910000-00009; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; ORTIZ R, 1995, MUTAT RES-ENVIR MUTA, V334, P235, DOI 10.1016/0165-1161(95)90016-0; OZKAN H, 1993, J TROP PEDIATRICS, V39, P257, DOI 10.1093/tropej/39.4.257; Palacio A, 2002, J CLIN ENDOCR METAB, V87, P3040, DOI 10.1210/jc.87.7.3040; PARENT G, 1994, AM J CLIN NUTR, V60, P274, DOI 10.1093/ajcn/60.2.274; PARENT MA, 1974, S AFR MED J, V48, P1375; PAUL S, 1979, INDIAN PEDIATR, V16, P3; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Peter C, 2010, CURR OPIN IMMUNOL, V22, P655, DOI 10.1016/j.coi.2010.08.010; Powell G M, 1982, Ann Trop Paediatr, V2, P143; Prendergast A, 2012, AM J TROP MED HYG, V86, P756, DOI 10.4269/ajtmh.2012.11-0743; PRETORIUS PJ, 1962, AM J CLIN NUTR, V10, P379, DOI 10.1093/ajcn/10.5.379; PURI V, 1980, INDIAN PEDIATR, V17, P127; PURTILO DT, 1976, AM J TROP MED HYG, V25, P229, DOI 10.4269/ajtmh.1976.25.229; PURTILO DT, 1975, ARCH DIS CHILD, V50, P149, DOI 10.1136/adc.50.2.149; RABSON AR, 1975, BRIT MED J, V1, P40, DOI 10.1136/bmj.1.5948.40; RAMAN T S R, 1992, Indian Pediatrics, V29, P355; RAZBAN SZ, 1975, J TROP MED HYG, V78, P264; REDDY V, 1976, AM J CLIN NUTR, V29, P3, DOI 10.1093/ajcn/29.1.3; REDDY V, 1976, ARCH DIS CHILD, V51, P871, DOI 10.1136/adc.51.11.871; REDDY V, 1964, INDIAN J MED RES, V52, P1154; REDMOND AOB, 1971, ARCH DIS CHILD, V46, P470, DOI 10.1136/adc.46.248.470; Reid M, 2002, AM J CLIN NUTR, V76, P1409, DOI 10.1093/ajcn/76.6.1409; Rich K, 1977, MALNUTRITION IMMUNE, P271; Rikimaru T, 1998, EUR J CLIN NUTR, V52, P344, DOI 10.1038/sj.ejcn.1600560; Rodriguez L, 2007, CLIN EXP IMMUNOL, V148, P478, DOI 10.1111/j.1365-2249.2007.03361.x; Rodriguez L, 2005, CLIN DIAGN LAB IMMUN, V12, P502, DOI 10.1128/CDLI.12.4.502-507.2005; ROEDIGER WEW, 1990, DIS COLON RECTUM, V33, P858, DOI 10.1007/BF02051922; ROMER H, 1983, J PEDIATR GASTR NUTR, V2, P459, DOI 10.1097/00005176-198302030-00011; ROSEN E U, 1971, South African Medical Journal, V45, P980; ROSEN EU, 1975, ARCH DIS CHILD, V50, P220, DOI 10.1136/adc.50.3.220; Sakamoto M, 1992, World Rev Nutr Diet, V67, P114; SALIMONU LS, 1982, CLIN IMMUNOL IMMUNOP, V24, P1, DOI 10.1016/0090-1229(82)90082-4; SALIMONU LS, 1982, CLIN EXP IMMUNOL, V47, P626; SALIMONU LS, 1985, ANN TROP PAEDIATR, V5, P137, DOI 10.1080/02724936.1985.11748379; SALIMONU LS, 1983, CELL IMMUNOL, V82, P210, DOI 10.1016/0008-8749(83)90154-5; SALIMONU LS, 1982, BRIT J NUTR, V48, P7, DOI 10.1079/BJN19820082; SATYANARAYANA K, 1980, AM J CLIN NUTR, V33, P2334, DOI 10.1093/ajcn/33.11.2334; Sauerwein RW, 1997, AM J CLIN NUTR, V65, P1534, DOI 10.1093/ajcn/65.5.1534; Savino W, 2002, SCAND J IMMUNOL, V55, P442, DOI 10.1046/j.1365-3083.2002.01077.x; SAXINGER WC, 1985, SCIENCE, V227, P1036, DOI 10.1126/science.2983417; SCHELP FP, 1980, BRIT J NUTR, V43, P381, DOI 10.1079/BJN19800101; Scheutz F, 1997, COMMUNITY DENT ORAL, V25, P193, DOI 10.1111/j.1600-0528.1997.tb00925.x; SCHLESINGER L, 1992, AM J CLIN NUTR, V56, P491, DOI 10.1093/ajcn/56.3.491; SCHLESINGER L, 1974, AM J CLIN NUTR, V27, P615, DOI 10.1093/ajcn/27.6.615; Schlesinger L, 1977, MALNUTRITION IMMUNE, V1977; SCHNEIDER RE, 1972, AM J CLIN NUTR, V25, P1092; SCHONLAND M, 1972, Journal of Tropical Pediatrics and Environmental Child Health, V18, P217; SCHOPFER K, 1976, BRIT J HAEMATOL, V32, P573, DOI 10.1111/j.1365-2141.1976.tb00961.x; SCHOPFER K, 1976, J LAB CLIN MED, V88, P450; SCHOPFER K, 1976, CLIN IMMUNOL IMMUNOP, V5, P21, DOI 10.1016/0090-1229(76)90146-X; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; SETH V, 1981, INDIAN J MED RES, V74, P392; Shashidhar S, 1976, Indian J Pediatr, V43, P145, DOI 10.1007/BF02894339; SHILOTRI PG, 1976, CLIN CHIM ACTA, V71, P511, DOI 10.1016/0009-8981(76)90103-0; SHINER M, 1973, EXP MOL PATHOL, V19, P61, DOI 10.1016/0014-4800(73)90041-5; Shousha S, 1974, J Egypt Med Assoc, V57, P298; SHOUSHA S, 1972, J CLIN PATHOL, V25, P494, DOI 10.1136/jcp.25.6.494; SIMS RT, 1968, BRIT J DERMATOL, V80, P822, DOI 10.1111/j.1365-2133.1968.tb11952.x; SIRISINHA S, 1975, PEDIATRICS, V55, P166; SIRISINHA S, 1973, LANCET, V1, P1016; SMEDMAN L, 1988, ACTA PAEDIATR SCAND, V77, P885, DOI 10.1111/j.1651-2227.1988.tb10773.x; SMEDMAN L, 1986, ANN TROP PAEDIATR, V6, P149, DOI 10.1080/02724936.1986.11748428; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smith N, 1977, CELLULAR IMMUNE RESP, V1977; Smith R, 2005, BMJ-BRIT MED J, V331, P288, DOI 10.1136/bmj.331.7511.288; SMYTHE PM, 1971, LANCET, V2, P939; Soler-Cataluna JJ, 2005, CHEST, V128, P2108, DOI 10.1378/chest.128.4.2108; Solis B, 2002, EUR J CLIN NUTR, V56, pS57, DOI 10.1038/sj.ejcn.1601488; STANFIELD JP, 1965, LANCET, V2, P519; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; SULLIVAN PB, 1992, J PEDIATR GASTR NUTR, V14, P208, DOI 10.1097/00005176-199202000-00016; SUSKIND R, 1976, AM J CLIN NUTR, V29, P836, DOI 10.1093/ajcn/29.8.836; SUSKIND R, 1976, AM J CLIN NUTR, V29, P1089, DOI 10.1093/ajcn/29.10.1089; Suskind R, 1977, MALNUTRITION IMMUNE, V1977; TADDESSE WW, 1988, E AFR MED J, V65, P393; TEJADA C, 1964, J PEDIATR-US, V64, P753, DOI 10.1016/S0022-3476(64)80625-9; THAVARAJ V, 1989, J TROP PEDIATRICS, V35, P105, DOI 10.1093/tropej/35.3.105; THERON JJ, 1971, EXP MOL PATHOL, V14, P184, DOI 10.1016/0014-4800(71)90064-5; Tomkins A, 1989, 5 UN ADM COMM COORD; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; Vasquez-Garibay E, 2004, ARCH MED RES, V35, P284, DOI 10.1016/j.arcmed.2004.03.002; Vasquez-Garibay E, 2002, J PEDIATR GASTR NUTR, V34, P296, DOI 10.1097/00005176-200203000-00015; Waibale P, 1999, INT J EPIDEMIOL, V28, P341, DOI 10.1093/ije/28.2.341; Wander K, 2013, AM J PHYS ANTHROPOL, V151, P183, DOI 10.1002/ajpa.22250; Waterlow JC, 1992, PROTEIN ENERGY MALNU; WATSON CE, 1970, ARCH DIS CHILD, V45, P282, DOI 10.1136/adc.45.240.282; WATSON RR, 1978, P SOC EXP BIOL MED, V157, P215, DOI 10.3181/00379727-157-40024; WATSON RR, 1985, AM J CLIN NUTR, V42, P281, DOI 10.1093/ajcn/42.2.281; WATTS T, 1969, Journal of Tropical Pediatrics, V15, P155; WESLEY A, 1979, T ROY SOC TROP MED H, V73, P710, DOI 10.1016/0035-9203(79)90026-9; WILLIAMS Cicely D., 1935, Lancet, P1151; WOLFSDORF J, 1974, S AFR MED J, V48, P528; Yakubu A M, 1982, Ann Trop Paediatr, V2, P139; YODER MC, 1987, J PEDIATR GASTR NUTR, V6, P84, DOI 10.1097/00005176-198701000-00015; ZIEGLER HD, 1975, JOHNS HOPKINS MED J, V137, P59	304	291	295	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105017	10.1371/journal.pone.0105017	http://dx.doi.org/10.1371/journal.pone.0105017			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153531	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200035
J	Tsui, CKM; Farfan, L; Roe, AD; Rice, AV; Cooke, JEK; El-Kassaby, YA; Hamelin, RC				Tsui, Clement Kin-Ming; Farfan, Lina; Roe, Amanda D.; Rice, Adrianne V.; Cooke, Janice E. K.; El-Kassaby, Yousry A.; Hamelin, Richard C.			Population Structure of Mountain Pine Beetle Symbiont Leptographium longiclavatum and the Implication on the Multipartite Beetle-Fungi Relationships	PLOS ONE			English	Article							BLUE-STAIN FUNGI; APPROXIMATE BAYESIAN COMPUTATION; INVASIVE BARK BEETLE; DENDROCTONUS-PONDEROSAE; OPHIOSTOMA-CLAVIGERUM; RANGE EXPANSION; COMPARATIVE PHYLOGEOGRAPHY; GENETIC DIFFERENTIATION; GROSMANNIA-CLAVIGERA; MICROSATELLITE DATA	Over 18 million ha of forests have been destroyed in the past decade in Canada by the mountain pine beetle (MPB) and its fungal symbionts. Understanding their population dynamics is critical to improving modeling of beetle epidemics and providing potential clues to predict population expansion. Leptographium longiclavatum and Grosmannia clavigera are fungal symbionts of MPB that aid the beetle to colonize and kill their pine hosts. We investigated the genetic structure and demographic expansion of L. longiclavatum in populations established within the historic distribution range and in the newly colonized regions. We identified three genetic clusters/populations that coincide with independent geographic locations. The genetic profiles of the recently established populations in northern British Columbia (BC) and Alberta suggest that they originated from central and southern BC. Approximate Bayesian Computation supports the scenario that this recent expansion represents an admixture of individuals originating from BC and the Rocky Mountains. Highly significant correlations were found among genetic distance matrices of L. longiclavatum, G. clavigera, and MPB. This highlights the concordance of demographic processes in these interacting organisms sharing a highly specialized niche and supports the hypothesis of long-term multipartite beetle-fungus co-evolutionary history and mutualistic relationships.	[Tsui, Clement Kin-Ming; Farfan, Lina; El-Kassaby, Yousry A.; Hamelin, Richard C.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Roe, Amanda D.; Rice, Adrianne V.; Cooke, Janice E. K.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hamelin, Richard C.] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada	University of British Columbia; University of Alberta; Natural Resources Canada; Canadian Forest Service	Hamelin, RC (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	richard.hamelin@ubc.ca	El-Kassaby, Yousry A/K-9856-2016; Cooke, Janice E/G-5906-2011; Tsui, Clement/F-6416-2013; Cooke, Janice/W-8452-2019; Hamelin, Richard/F-7006-2010	El-Kassaby, Yousry A/0000-0002-4887-8977; Cooke, Janice E/0000-0002-4990-628X; Tsui, Clement/0000-0001-5129-1037; Cooke, Janice/0000-0002-4990-628X; Roe, Amanda/0000-0003-1502-7276; Hamelin, Richard/0000-0003-4006-532X	Genome Canada; Genome British Columbia; Genome Alberta; Government of Alberta [AAET/AFRI-859-G07]	Genome Canada(Genome Canada); Genome British Columbia; Genome Alberta; Government of Alberta	Funding for this research was provided by Genome Canada, Genome British Columbia, Genome Alberta and the Government of Alberta (AAET/AFRI-859-G07) in support of the Tria I and Tria II Projects (http://www.thetriaproject.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Alamouti SM, 2011, MOL ECOL, V20, P2581, DOI 10.1111/j.1365-294X.2011.05109.x; Aukema BH, 2006, ECOGRAPHY, V29, P427, DOI 10.1111/j.2006.0906-7590.04445.x; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; BRIDGES JR, 1983, ENVIRON ENTOMOL, V12, P858, DOI 10.1093/ee/12.3.858; Brown AMV, 2014, MOL ECOL, V23, P1516, DOI 10.1111/mec.12366; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Caldera EJ, 2012, AM NAT, V180, P604, DOI 10.1086/667886; Carroll AL, 2004, PACIF FOR C, V399, P223; Coletta HD, 2011, APPL ENVIRON MICROB, V77, P2596, DOI 10.1128/AEM.02172-10; Corander J, 2003, GENETICS, V163, P367; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cornuet JM, 1996, GENETICS, V144, P2001; Cullingham CI, 2012, ECOL EVOL, V2, P908, DOI 10.1002/ece3.102; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Da Silva FM, 2007, MOL ECOL, V16, P3361, DOI 10.1111/j.1365-294X.2007.03371.x; de la Giroday HMC, 2012, J BIOGEOGR, V39, P1112, DOI 10.1111/j.1365-2699.2011.02673.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frago E, 2012, TRENDS ECOL EVOL, V27, P705, DOI 10.1016/j.tree.2012.08.013; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; Goodsman DW, 2012, ENVIRON ENTOMOL, V41, P478, DOI 10.1603/EN11205; Hedrick PW., 2009, GENETICS POPULATIONS; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; James PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025359; Johannesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051809; Khadempour L, 2012, MICROB ECOL, V64, P909, DOI 10.1007/s00248-012-0077-z; Klepzig KD, 2009, ENVIRON ENTOMOL, V38, P67, DOI 10.1603/022.038.0109; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lee S, 2007, PHYTOPATHOLOGY, V97, P1177, DOI 10.1094/PHYTO-97-9-1177; Lee S, 2005, MYCOL RES, V109, P1162, DOI 10.1017/S0953756205003588; Lee S, 2006, FUNGAL DIVERS, V22, P91; Legendre P, 2004, AUST NZ J STAT, V46, P615, DOI 10.1111/j.1467-842X.2004.00357.x; Lim YW, 2004, FEMS MICROBIOL LETT, V237, P89, DOI 10.1111/j.1574-6968.2004.tb09682.x; Lu M, 2011, ECOLOGY, V92, P2013, DOI 10.1890/11-0687.1; Marin M, 2009, FOREST PATHOL, V39, P249, DOI 10.1111/j.1439-0329.2009.00585.x; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Mock KE, 2007, MOL ECOL, V16, P553, DOI 10.1111/j.1365-294X.2006.03158.x; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; NEI M, 1978, GENETICS, V89, P583; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Popa V, 2012, PEST MANAG SCI, V68, P963, DOI 10.1002/ps.3307; Pritchard JK, 2000, GENETICS, V155, P945; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rice AV, 2008, FOREST PATHOL, V38, P113, DOI 10.1111/j.1439-0329.2007.00525.x; Rice AV, 2007, CAN J BOT, V85, P316, DOI 10.1139/B07-016; Rice AV, 2009, FOREST PATHOL, V39, P323, DOI 10.1111/j.1439-0329.2009.00593.x; Robertson C, 2009, J BIOGEOGR, V36, P1446, DOI 10.1111/j.1365-2699.2009.02100.x; Roe AD, 2011, MICROB ECOL, V62, P347, DOI 10.1007/s00248-011-9841-8; Roe AD, 2011, MOL ECOL, V20, P584, DOI 10.1111/j.1365-294X.2010.04953.x; Roe AD, 2010, MOL ECOL RESOUR, V10, P946, DOI 10.1111/j.1755-0998.2010.02844.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; Samarasekera GDNG, 2012, MOL ECOL, V21, P2931, DOI 10.1111/j.1365-294X.2012.05587.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Six Diana L., 2012, Insects, V3, P339, DOI 10.3390/insects3010339; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Six DL, 1998, ENVIRON ENTOMOL, V27, P1393, DOI 10.1093/ee/27.6.1393; Six DL, 2003, CAN J FOREST RES, V33, P1331, DOI [10.1139/x03-047, 10.1139/X03-047]; Six DL, 2004, SYMBIOSIS, V37, P207; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Solheim H, 1998, CAN J BOT, V76, P561, DOI 10.1139/cjb-76-4-561; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Tsui CKM, 2009, MOL ECOL RESOUR, V9, P1501, DOI 10.1111/j.1755-0998.2009.02717.x; Tsui CKM, 2013, G3-GENES GENOM GENET, V3, P465, DOI 10.1534/g3.112.004986; Tsui CKM, 2012, MOL ECOL, V21, P71, DOI 10.1111/j.1365-294X.2011.05366.x; Vollmer SA, 2011, ENVIRON MICROBIOL, V13, P184, DOI 10.1111/j.1462-2920.2010.02319.x; Wang B, 2012, B ENTOMOL RES, V102, P71, DOI 10.1017/S000748531100037X; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yamaoka Y, 1995, EUR J FOREST PATHOL, V25, P401	88	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105455	10.1371/journal.pone.0105455	http://dx.doi.org/10.1371/journal.pone.0105455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153489	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200050
J	Mayola, A; Irazoki, O; Martinez, IA; Petrov, D; Menolascina, F; Stocker, R; Reyes-Darias, JA; Krell, T; Barbe, J; Campoy, S				Mayola, Albert; Irazoki, Oihane; Martinez, Ignacio A.; Petrov, Dmitri; Menolascina, Filippo; Stocker, Roman; Reyes-Darias, Jose A.; Krell, Tino; Barbe, Jordi; Campoy, Susana			RecA Protein Plays a Role in the Chemotactic Response and Chemoreceptor Clustering of Salmonella enterica	PLOS ONE			English	Article							RECOMBINATIONAL DNA-REPAIR; ESCHERICHIA-COLI; BACTERIAL MOTILITY; SWARMING MOTILITY; ATP HYDROLYSIS; SYSTEM; CLEAVAGE; GENES; TYPHIMURIUM; MUTAGENESIS	The RecA protein is the main bacterial recombinase and the activator of the SOS system. In Escherichia coli and Salmonella enterica sv. Typhimurium, RecA is also essential for swarming, a flagellar-driven surface translocation mechanism widespread among bacteria. In this work, the direct interaction between RecA and the CheW coupling protein was confirmed, and the motility and chemotactic phenotype of a S. Typhimurium Delta recA mutant was characterized through microfluidics, optical trapping, and quantitative capillary assays. The results demonstrate the tight association of RecA with the chemotaxis pathway and also its involvement in polar chemoreceptor cluster formation. RecA is therefore necessary for standard flagellar rotation switching, implying its essential role not only in swarming motility but also in the normal chemotactic response of S. Typhimurium.	[Mayola, Albert; Irazoki, Oihane; Barbe, Jordi; Campoy, Susana] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain; [Martinez, Ignacio A.; Petrov, Dmitri] ICFO, Castelldefels, Spain; [Menolascina, Filippo; Stocker, Roman] MIT, Dept Civil & Environm Engn, Cambridge, MA USA; [Reyes-Darias, Jose A.; Krell, Tino] CSIC, Environm Protect Dept, Estn Expt Zaidin, Granada, Spain	Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Massachusetts Institute of Technology (MIT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Campoy, S (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain.	Susana.Campoy@uab.cat	Campoy, Susana/C-7335-2008; Martinez, Ignacio A A/C-2024-2015; Krell, Tino/G-7296-2015; Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019; campoy, susana/E-4346-2010; Barbe, Jordi/G-5212-2015; irazoki, oihane/G-8416-2015	Campoy, Susana/0000-0003-1369-0197; Martinez, Ignacio A A/0000-0002-0208-7790; Krell, Tino/0000-0002-9040-3166; Stocker, Roman/0000-0002-3199-0508; campoy, susana/0000-0003-1369-0197; Barbe, Jordi/0000-0003-4408-013X; irazoki, oihane/0000-0002-8896-7480; Menolascina, Filippo/0000-0002-4937-7912	Spanish Ministry of Science and Innovation [BFU2011-23478, FIS200800114, FIS2011-24409]; Generalitat de Catalunya [2009SGR159, 2014SGR572]; Fundacio Privada Cellex Barcelona and the National Institute of Health [1R01GM100473]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100473] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio Privada Cellex Barcelona and the National Institute of Health(Foundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge financial support from the Spanish Ministry of Science and Innovation (grant BFU2011-23478 to JB and FIS200800114 and FIS2011-24409 to DP), Generalitat de Catalunya (grant 2009SGR159 to DP and 2014SGR572 to JB), Fundacio Privada Cellex Barcelona and the National Institute of Health (grant 1R01GM100473 to RS). The funders had no role in the design of the study, in data collection and analysis, in the decision to publish, or in the preparation of the manuscript.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; Altindal T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018231; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; BARBE J, 1986, J BACTERIOL, V167, P1055, DOI 10.1128/jb.167.3.1055-1057.1986; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Borloo J, 2007, J PROTEOME RES, V6, P2587, DOI 10.1021/pr070037j; Brennan CA, 2013, APPL ENVIRON MICROB, V79, P1889, DOI 10.1128/AEM.03794-12; BRYANT FR, 1986, J BIOL CHEM, V261, P2988; Burkart M, 1998, P NATL ACAD SCI USA, V95, P2568, DOI 10.1073/pnas.95.5.2568; Campoy S, 2002, INFECT IMMUN, V70, P4721, DOI 10.1128/IAI.70.8.4721-4725.2002; Cardozo MJ, 2010, MOL MICROBIOL, V75, P1171, DOI 10.1111/j.1365-2958.2009.07032.x; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; DEFRANCO AL, 1979, J BACTERIOL, V139, P107, DOI 10.1128/JB.139.1.107-114.1979; EGUCHI Y, 1988, J MOL BIOL, V202, P565, DOI 10.1016/0022-2836(88)90286-0; Eisen JA, 1995, J MOL EVOL, V41, P1105; Gomez-Gomez JM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-14; Green MR, 2012, MOL CLONING LAB MANU, V1; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; KAWASHIMA H, 1984, MOL GEN GENET, V193, P288, DOI 10.1007/BF00330682; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Keyamura K, 2013, J BIOL CHEM, V288, P29229, DOI 10.1074/jbc.M113.485474; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; Koch M, 2012, NAT PHOTONICS, V6, P680, DOI [10.1038/nphoton.2012.232, 10.1038/NPHOTON.2012.232]; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Landry MP, 2009, BIOPHYS J, V97, P2128, DOI 10.1016/j.bpj.2009.07.048; LIU JD, 1989, P NATL ACAD SCI USA, V86, P8703, DOI 10.1073/pnas.86.22.8703; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MANSON MD, 1992, ADV MICROB PHYSIOL, V33, P277, DOI 10.1016/S0065-2911(08)60219-2; Mariconda S, 2006, MOL MICROBIOL, V60, P1590, DOI 10.1111/j.1365-2958.2006.05208.x; Martinez IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061630; Medina-Ruiz L, 2010, INFECT IMMUN, V78, P3217, DOI 10.1128/IAI.01321-09; Min TL, 2009, NAT METHODS, V6, P831, DOI [10.1038/NMETH.1380, 10.1038/nmeth.1380]; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Partridge JD, 2013, J BACTERIOL, V195, P919, DOI 10.1128/JB.02064-12; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Raterman EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054133; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; ROBERTS JW, 1975, P NATL ACAD SCI USA, V72, P147, DOI 10.1073/pnas.72.1.147; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; SAUER RT, 1982, J BIOL CHEM, V257, P4458; SMITH RA, 1980, P NATL ACAD SCI-BIOL, V77, P5370, DOI 10.1073/pnas.77.9.5370; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; WARRICK HM, 1977, J BACTERIOL, V130, P223, DOI 10.1128/JB.130.1.223-231.1977	57	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105578	10.1371/journal.pone.0105578	http://dx.doi.org/10.1371/journal.pone.0105578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147953	Green Published, gold			2022-12-27	WOS:000341230600060
J	Mukherjee, A; Lal, R				Mukherjee, Atanu; Lal, Rattan			Comparison of Soil Quality Index Using Three Methods	PLOS ONE			English	Article							CROPPING SYSTEM; TILLAGE; FERTILIZATION; MANAGEMENT; CALIFORNIA; FRAMEWORK	Assessment of management-induced changes in soil quality is important to sustaining high crop yield. A large diversity of cultivated soils necessitate identification development of an appropriate soil quality index (SQI) based on relative soil properties and crop yield. Whereas numerous attempts have been made to estimate SQI for major soils across the World, there is no standard method established and thus, a strong need exists for developing a user-friendly and credible SQI through comparison of various available methods. Therefore, the objective of this article is to compare three widely used methods to estimate SQI using the data collected from 72 soil samples from three on-farm study sites in Ohio. Additionally, challenge lies in establishing a correlation between crop yield versus SQI calculated either depth wise or in combination of soil layers as standard methodology is not yet available and was not given much attention to date. Predominant soils of the study included one organic (Mc), and two mineral (CrB, Ko) soils. Three methods used to estimate SQI were: (i) simple additive SQI (SQI-1), (ii) weighted additive SQI (SQI-2), and (iii) statistically modeled SQI (SQI-3) based on principal component analysis (PCA). The SQI varied between treatments and soil types and ranged between 0-0.9 (1 being the maximum SQI). In general, SQIs did not significantly differ at depths under any method suggesting that soil quality did not significantly differ for different depths at the studied sites. Additionally, data indicate that SQI-3 was most strongly correlated with crop yield, the correlation coefficient ranged between 0.74-0.78. All three SQIs were significantly correlated (r = 0.92-0.97) to each other and with crop yield (r = 0.65-0.79). Separate analyses by crop variety revealed that correlation was low indicating that some key aspects of soil quality related to crop response are important requirements for estimating SQI.	[Mukherjee, Atanu; Lal, Rattan] Ohio State Univ, Carbon Management & Sequestrat Ctr, Sch Environm & Nat Resources, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Mukherjee, A (corresponding author), Ohio State Univ, Carbon Management & Sequestrat Ctr, Sch Environm & Nat Resources, Columbus, OH 43210 USA.	mukherjee.70@osu.edu	Lal, Rattan/D-2505-2013		USDA-NIFA [2011-68002-30190]; Cropping Systems Coordinated Agricultural Project (CAP): Climate Change, Mitigation, and Adaptation in Corn-based Cropping Systems	USDA-NIFA(United States Department of Agriculture (USDA)); Cropping Systems Coordinated Agricultural Project (CAP): Climate Change, Mitigation, and Adaptation in Corn-based Cropping Systems	This research was part of a collaborative project supported by the USDA-NIFA, award number: 2011-68002-30190, "Cropping Systems Coordinated Agricultural Project (CAP): Climate Change, Mitigation, and Adaptation in Corn-based Cropping Systems'' (sustainablecorn.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher M.C., 2007, SOIL VITAL SIGNS NEW; Andrews SS, 2002, AGR ECOSYST ENVIRON, V90, P25, DOI 10.1016/S0167-8809(01)00174-8; Andrews SS, 2001, ECOL APPL, V11, P1573, DOI 10.1890/1051-0761(2001)011[1573:DASQAT]2.0.CO;2; Andrews SS, 2004, SOIL SCI SOC AM J, V68, P1945, DOI 10.2136/sssaj2004.1945; Andrews SS, 2002, AGRON J, V94, P12, DOI 10.2134/agronj2002.0012; [Anonymous], 2002, SSSA BOOK SER 4, DOI DOI 10.2136/SSSAB00KSER5.4.C9; Bhardwaj AK, 2011, AGR ECOSYST ENVIRON, V140, P419, DOI 10.1016/j.agee.2011.01.005; Brady N.C., 1984, NATURE PROPERTIES SO, Vninth; Brzezinska M, 2011, LAND DEGRAD DEV, V22, P586, DOI 10.1002/ldr.1036; Carter M. R., 2006, ENCY SOIL SCI, P1412; Chhabra A, 2003, FOREST ECOL MANAG, V173, P187, DOI 10.1016/S0378-1127(02)00016-6; Dane JH., 2002, METHODS SOIL ANAL 4, V3, P671, DOI [10.2136/sssabookser5.4, DOI 10.2136/SSSABOOKSER5.4]; Diack M., 2001, DEV SOIL QUALITY IND, P550; Doran J., 1994, FRAMEWORK EVALUATING; Doran J. W., 1994, SSSA SPECIAL PUBLICA, V35, P3, DOI DOI 10.1016/0016-7061(95)90042-X; Doran J.W., 1996, METHODS ASSESSING SO, P25, DOI [10.2136/sssaspecpub49.c2, DOI 10.2136/SSSASPECPUB49.C2]; Dunteman G.H., 1989, PRINCIPAL COMPONENTS; Feiza V, 2011, J FOOD AGRIC ENVIRON, V9, P1088; Fernandes JC, 2011, SOIL TILL RES, V112, P167, DOI 10.1016/j.still.2011.01.001; Herrick JE, 2002, SOIL SCI SOC AM J, V66, P1320, DOI 10.2136/sssaj2002.1320; Jokela W, 2011, AGRON J, V103, P1552, DOI 10.2134/agronj2010.0454; JOLLIFFE I., 2005, PRINCIPAL COMPONENT; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Karlen DL, 1997, SOIL SCI SOC AM J, V61, P4, DOI 10.2136/sssaj1997.03615995006100010001x; KARLEN DL, 1994, SSSA SPEC PUBL, V35, P53, DOI DOI 10.2136/SSSASPECPUB35.C4; Lal R, 1994, USDA SMSS TECHNICAL, V21; Larson WE, 1991, CONSERVATION ENHANCE; Li Q, 2013, J PLANT NUTR SOIL SC, V176, P249, DOI 10.1002/jpln.201100395; Liebig MA, 2001, AGRON J, V93, P313, DOI 10.2134/agronj2001.932313x; Mandal UK, 2011, SOIL SCI SOC AM J, V75, P1144, DOI 10.2136/sssaj2009.0361; Masto RE, 2008, ENVIRON MONIT ASSESS, V136, P419, DOI 10.1007/s10661-007-9697-z; MAURYA PR, 1980, EXP AGR, V16, P185, DOI 10.1017/S0014479700010899; Microsoft, 2007, MICR EXC; Mukherjee A, 2014, SHORT TERM EFF UNPUB; Mukherjee A, 2014, SOIL TILLAGE R UNPUB; Navas M, 2011, APPL SOIL ECOL, V49, P242, DOI 10.1016/j.apsoil.2011.04.017; SAS, 2012, SAS VERS 9 2, P27513; Sigmaplot, 2012, SIGM VERS 12; Sokoowska Z, 2011, EFFECT PHOSPHATES DI; SPSS, 2014, IBM SPSS VERS 21 0; Stocking MA, 2003, SCIENCE, V302, P1356, DOI 10.1126/science.1088579; Walczak R., 2002, International Agrophysics, V16, P161; Wander MM, 1999, SOIL SCI SOC AM J, V63, P961, DOI 10.2136/sssaj1999.634961x; YODER ROBERT E., 1936, JOUR AMER SOC AGRON, V28, P337; YOUKER R. E., 1957, SOIL SCI, V83, P291, DOI 10.1097/00010694-195704000-00004; Zobeck TM, 2008, J SOIL WATER CONSERV, V63, P329, DOI 10.2489/jswc.63.5.329; Zornoza R, 2008, SOIL BIOL BIOCHEM, V40, P2079, DOI 10.1016/j.soilbio.2008.01.014; Zornoza R, 2007, SCI TOTAL ENVIRON, V378, P233, DOI 10.1016/j.scitotenv.2007.01.052	48	126	128	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105981	10.1371/journal.pone.0105981	http://dx.doi.org/10.1371/journal.pone.0105981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148036	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600103
J	Totzeck, M; Hendgen-Cotta, UB; Kelm, M; Rassaf, T				Totzeck, Matthias; Hendgen-Cotta, Ulrike B.; Kelm, Malte; Rassaf, Tienush			Crosstalk between Nitrite, Myoglobin and Reactive Oxygen Species to Regulate Vasodilation under Hypoxia	PLOS ONE			English	Article							ARTERIAL SMOOTH-MUSCLE; ISCHEMIA-REPERFUSION; DIETARY NITRATE; BLOOD-PRESSURE; IN-VIVO; CIRCULATING NITRITE; CORONARY FLOW; OXIDE; MECHANISMS; REDUCTASE	The systemic response to decreasing oxygen levels is hypoxic vasodilation. While this mechanism has been known for more than a century, the underlying cellular events have remained incompletely understood. Nitrite signaling is critically involved in vessel relaxation under hypoxia. This can be attributed to the presence of myoglobin in the vessel wall together with other potential nitrite reductases, which generate nitric oxide, one of the most potent vasodilatory signaling molecules. Questions remain relating to the precise concentration of nitrite and the exact dose-response relations between nitrite and myoglobin under hypoxia. It is furthermore unclear whether regulatory mechanisms exist which balance this interaction. Nitrite tissue levels were similar across all species investigated. We then investigated the exact fractional myoglobin desaturation in an ex vivo approach when gassing with 1% oxygen. Within a short time frame myoglobin desaturated to 58 +/- 12%. Given that myoglobin significantly contributes to nitrite reduction under hypoxia, dose-response experiments using physiological to pharmacological nitrite concentrations were conducted. Along all concentrations, abrogation of myoglobin in mice impaired vasodilation. As reactive oxygen species may counteract the vasodilatory response, we used superoxide dismutase and its mimic tempol as well as catalase and ebselen to reduce the levels of reactive oxygen species during hypoxic vasodilation. Incubation of tempol in conjunction with catalase alone and catalase/ebselen increased the vasodilatory response to nitrite. Our study shows that modest hypoxia leads to a significant nitrite-dependent vessel relaxation. This requires the presence of vascular myoglobin for both physiological and pharmacological nitrite levels. Reactive oxygen species, in turn, modulate this vasodilation response.	[Totzeck, Matthias; Hendgen-Cotta, Ulrike B.; Kelm, Malte; Rassaf, Tienush] Univ Hosp Dusseldorf, Fac Med, Dept Med, Div Cardiol Pulm Dis & Vasc Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Rassaf, T (corresponding author), Univ Hosp Dusseldorf, Fac Med, Dept Med, Div Cardiol Pulm Dis & Vasc Med, Dusseldorf, Germany.	Tienush.Rassaf@med.uni-duesseldorf.de		Kelm, Malte/0000-0003-0060-1052	DFG [RA969/7-2, RA969/4-2]; Deutsche Herzstiftung; Forschungskommission of the Heinrich-Heine-University Dusseldorf	DFG(German Research Foundation (DFG)); Deutsche Herzstiftung; Forschungskommission of the Heinrich-Heine-University Dusseldorf	TR is a Heisenberg professor funded by the DFG (RA969/7-2). TR was supported by a grant from the DFG (RA969/4-2). MT was supported by a grant from the Deutsche Herzstiftung and by a grant from the Forschungskommission of the Heinrich-Heine-University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 1996, J VASC RES, V33, P347, DOI 10.1159/000159163; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; BUSSE R, 1984, PFLUG ARCH EUR J PHY, V401, P77, DOI 10.1007/BF00581536; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Curtis E, 2012, ANTIOXID REDOX SIGN, V17, P951, DOI 10.1089/ars.2011.4242; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; Deussen A, 2006, BASIC RES CARDIOL, V101, P453, DOI 10.1007/s00395-006-0621-4; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Feelisch M, 2008, J BIOL CHEM, V283, P33927, DOI 10.1074/jbc.M806654200; FREDRICKS KT, 1994, AM J PHYSIOL, V267, pH706, DOI 10.1152/ajpheart.1994.267.2.H706; FURCHGOTT RF, 1953, J PHARMACOL EXP THER, V108, P129; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao Q, 2009, AM J PHYSIOL-HEART C, V297, pH2262, DOI 10.1152/ajpheart.00817.2009; Gladwin MT, 2008, CIRCULATION, V117, P594, DOI 10.1161/CIRCULATIONAHA.107.753897; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2011, JAMA-J AM MED ASSOC, V305, P893, DOI 10.1001/jama.2011.235; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; Godecke A, 1998, CIRC RES, V82, P186; GRASER T, 1992, J CARDIOVASC PHARM, V20, pS117; Hall JE., 2011, TXB MED PHYSL; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Hendgen-Cotta UB, 2012, CIRCULATION, V126, P1983, DOI 10.1161/CIRCULATIONAHA.112.112912; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; Isbell TS, 2008, NAT MED, V14, P773, DOI 10.1038/nm1771; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Jansson EA, 2008, NAT CHEM BIOL, V4, P411, DOI 10.1038/nchembio.92; Kapil V, 2010, HYPERTENSION, V56, P274, DOI 10.1161/HYPERTENSIONAHA.110.153536; Kim-Shapiro DB, 2014, NITRIC OXIDE-BIOL CH, V38, P58, DOI 10.1016/j.niox.2013.11.002; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800; Liaw N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101721; Luedike P, 2012, CIRCULATION, V125, P1880, DOI 10.1161/CIRCULATIONAHA.111.069104; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Maher AR, 2008, CIRCULATION, V117, P670, DOI 10.1161/CIRCULATIONAHA.107.719591; Modin A, 2001, ACTA PHYSIOL SCAND, V171, P9, DOI 10.1046/j.1365-201x.2001.171001009.x; NAKHOSTINE N, 1994, PFLUG ARCH EUR J PHY, V428, P526, DOI 10.1007/BF00374574; NAKHOSTINE N, 1993, AM J PHYSIOL, V265, pH1289, DOI 10.1152/ajpheart.1993.265.4.H1289; OKADA T, 1991, J MOL CELL CARDIOL, V23, P939, DOI 10.1016/0022-2828(91)90136-A; Pinder AG, 2009, BRIT J PHARMACOL, V157, P1523, DOI 10.1111/j.1476-5381.2009.00340.x; Prieto D, 2010, AM J PHYSIOL-HEART C, V299, pH915, DOI 10.1152/ajpheart.00382.2010; Rammos C, 2014, J AM COLL CARDIOL, V63, P1584, DOI 10.1016/j.jacc.2013.08.691; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Rassaf T, 2014, CIRC RES, V114, P1601, DOI 10.1161/CIRCRESAHA.114.303822; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; Sandvik GK, 2012, AM J PHYSIOL-REG I, V302, pR468, DOI 10.1152/ajpregu.00538.2011; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Totzeck M, 2012, NITRIC OXIDE-BIOL CH, V27, P75, DOI 10.1016/j.niox.2012.05.003; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Totzeck M, 2012, NITRIC OXIDE-BIOL CH, V26, P211, DOI 10.1016/j.niox.2012.03.001; Totzeck M, 2011, CRIT CARE MED, V39, P1837, DOI 10.1097/CCM.0b013e31821b8180; Vanin AF, 2007, CELL MOL LIFE SCI, V64, P96, DOI 10.1007/s00018-006-6374-2; VONBECKERATH N, 1991, J PHYSIOL-LONDON, V442, P297, DOI 10.1113/jphysiol.1991.sp018794; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; WEI HM, 1989, AM J PHYSIOL, V257, pH1043, DOI 10.1152/ajpheart.1989.257.4.H1043; Wolin MS, 2009, AM J PHYSIOL-HEART C, V296, pH539, DOI 10.1152/ajpheart.01167.2008; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077	65	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105951	10.1371/journal.pone.0105951	http://dx.doi.org/10.1371/journal.pone.0105951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148388	Green Submitted, gold, Green Published			2022-12-27	WOS:000341230600100
J	Wardman, JH; Fricker, LD				Wardman, Jonathan H.; Fricker, Lloyd D.			ProSAAS-Derived Peptides Are Differentially Processed and Sorted in Mouse Brain and AtT-20 Cells	PLOS ONE			English	Article							PROPROTEIN CONVERTASES FURIN; PROHORMONE CONVERTASE-2; SECRETORY GRANULES; CARBOXYPEPTIDASE-E; BODY-WEIGHT; NEUROPEPTIDES; PRECURSOR; IDENTIFICATION; PURIFICATION; PEPTIDOMICS	ProSAAS is the precursor for some of the most abundant peptides found in mouse brain and other tissues, including peptides named SAAS, PEN, and LEN. Both SAAS and LEN are found in big and little forms due to differential processing. Initial processing of proSAAS is mediated by furin (and/or furin-like enzymes) and carboxypeptidase D, while the smaller forms are generated by secretory granule prohormone convertases and carboxypeptidase E. In mouse hypothalamus, PEN and big LEN colocalize with neuropeptide Y. In the present study, little LEN and SAAS were detected in mouse hypothalamus but not in cell bodies of neuropeptide Y-expressing neurons. PEN and big LEN show substantial colocalization in hypothalamus, but big LEN and little LEN do not. An antiserum to SAAS that detects both big and little forms of this peptide did not show substantial colocalization with PEN or big LEN. To further study this, the AtT-20 cells mouse pituitary corticotrophic cell line was transfected with rat proSAAS and the distribution of peptides examined. As found in mouse hypothalamus, only some of the proSAAS-derived peptides colocalized with each other in AtT-20 cells. The two sites within proSAAS that are known to be efficiently cleaved by furin were altered by site-directed mutagenesis to convert the P4 Arg into Lys; this change converts the sequences from furin consensus sites into prohormone convertase consensus sites. Upon expression of the mutated form of proSAAS in AtT-20 cells, there was significantly more colocalization of proSAAS-derived peptides PEN and SAAS. Taken together, these results indicate that proSAAS is initially cleaved in the Golgi or trans-Golgi network by furin and/or furin-like enzymes and the resulting fragments are sorted into distinct vesicles and further processed by additional enzymes into the mature peptides.	[Wardman, Jonathan H.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Fricker, Lloyd D.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	lloyd.fricker@einstein.yu.edu			National Institutes of Health [DA-004494]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by National Institutes of Health grant DA-004494 (LDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072529; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Bicknell AB, 2008, J NEUROENDOCRINOL, V20, P692, DOI 10.1111/j.1365-2826.2008.01709.x; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; Brakch N, 1997, BIOCHEMISTRY-US, V36, P16309, DOI 10.1021/bi9714767; BRESLIN MB, 1993, J BIOL CHEM, V268, P27084; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Feng Y, 2001, NEUROSCIENCE, V105, P469, DOI 10.1016/S0306-4522(01)00200-7; Feng Yun, 2002, Brain Res Gene Expr Patterns, V1, P135; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; Fricker L.D., 2012, NEUROPEPTIDES OTHER; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; GREENE D, 1992, BIOCHEM J, V285, P613, DOI 10.1042/bj2850613; Hatcher NG, 2008, P NATL ACAD SCI USA, V105, P12527, DOI 10.1073/pnas.0804340105; Hoshino A., 2012, C SERIES NEUROPEPTID, V1, P1; MATSUUCHI L, 1988, J CELL BIOL, V106, P239, DOI 10.1083/jcb.106.2.239; Merighi A, 2002, PROG NEUROBIOL, V66, P161, DOI 10.1016/S0301-0082(01)00031-4; Morgan DJ, 2010, J NEUROCHEM, V113, P1275, DOI 10.1111/j.1471-4159.2010.06706.x; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mzhavia N, 2002, BIOCHEM J, V361, P67, DOI 10.1042/0264-6021:3610067; Mzhavia N, 2001, J BIOL CHEM, V276, P6207, DOI 10.1074/jbc.M009067200; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Perello M, 2008, J BIOL CHEM, V283, P19936, DOI 10.1074/jbc.M800732200; Sayah M, 2001, J NEUROCHEM, V76, P1833, DOI 10.1046/j.1471-4159.2001.00165.x; SEIDAH NG, 2004, HDB PROTEOLYTIC ENZY, P1861; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; SOSSIN WS, 1989, NEURON, V2, P1407, DOI 10.1016/0896-6273(89)90186-4; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Wardman JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028152; Wardman JH, 2010, J NEUROCHEM, V114, P215, DOI 10.1111/j.1471-4159.2010.06760.x; Wei SW, 2004, J ENDOCRINOL, V180, P357, DOI 10.1677/joe.0.1800357; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; Zhang X, 2010, J NEUROCHEM, V112, P1168, DOI 10.1111/j.1471-4159.2009.06530.x; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	41	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104232	10.1371/journal.pone.0104232	http://dx.doi.org/10.1371/journal.pone.0104232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148519	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600011
J	Acedo-Carmona, C; Gomila, A				Acedo-Carmona, Cristina; Gomila, Antoni			Personal Trust Increases Cooperation beyond General Trust	PLOS ONE			English	Article							INTERPERSONAL-TRUST; EVOLUTION; BEHAVIOR; RECIPROCITY; NETWORKS; ORIGINS; SCALE	In this paper we present a new methodology which, while allowing for anonymous interaction, it also makes possible to compare decisions of cooperating or defecting when playing games within a group, according to whether or not players personally trust each other. The design thus goes beyond standard approaches to the role of trust in fostering cooperation, which is restricted to general trust. It also allows considering the role of the topology of the social network involved may play in the level of cooperation found. The results of this work support the idea that personal trust promotes cooperation beyond the level of general trust. We also found that this effect carries over to the whole group, making it more cohesive, but that higher levels of cohesion rely on a particular topology. As a conclusion, we hypothesize that personal trust is a psychological mechanism evolved to make human social life possible in the small groups our ancestors lived in, and that this mechanism persists and plays a role in sustaining cooperation and social cohesion.	[Acedo-Carmona, Cristina; Gomila, Antoni] Univ Balear Islands, Dept Psychol, Palma De Mallorca, Spain		Acedo-Carmona, C (corresponding author), Univ Balear Islands, Dept Psychol, Palma De Mallorca, Spain.	cristina.acedo@uib.es	Gomila, Antoni/I-1342-2012; Carmona, Cristina Flores Acedo/AAA-4808-2019	Acedo-Carmona, Cristina/0000-0001-5615-156X	Spanish Ministerio de Economia y Competitividad [FFI2010-20759]; Spanish Ministerio de Educacion y Cultura [AP2009-2423]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Spanish Ministerio de Educacion y Cultura(German Research Foundation (DFG))	This research was supported by the Spanish Ministerio de Economia y Competitividad, through project no FFI2010-20759, and the Spanish Ministerio de Educacion y Cultura, through the doctoral grant no AP2009-2423 awarded to Cristina Acedo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo C, 2013, ANN NY ACAD SCI, V1299, P77, DOI 10.1111/nyas.12142; Acedo-Carmona C., 2012, ASIAN C PSYCHOL BEHA, V5, P492; Almond Gabriel A., 1963, CIVIC CULTURE POLITI; Arrow K. J., 1974, LIMITS ORG; Balliet D, 2013, PSYCHOL BULL, V139, P1090, DOI 10.1037/a0030939; Barnes JA, 1954, HUM RELAT, V7, P39, DOI 10.1177/001872675400700102; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Binmore K, 2010, J ECON BEHAV ORGAN, V73, P87, DOI 10.1016/j.jebo.2008.10.019; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bohm R, 2012, PLOS ONE, V8, DOI [10.1371/journal.-pone.0056152, DOI 10.1371/JOURNAL.-PONE.0056152]; Bouma J, 2008, J ENVIRON ECON MANAG, V56, P155, DOI 10.1016/j.jeem.2008.03.004; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Christie R., 1970, STUDIES MACHIAVELLIA; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Cozzolino PJ, 2011, BRIT J SOC PSYCHOL, V50, P302, DOI 10.1348/014466610X519610; Curry O, 2011, BIOL LETTERS, V7, P651, DOI 10.1098/rsbl.2010.1202; DAWES RM, 1988, J ECON PERSPECT, V2, P187, DOI 10.1257/jep.2.3.187; Delhey J, 2003, EUR SOC, V5, P93, DOI 10.1080/1461669032000072256; Deutsch M., 1973, RESOLUTION CONFLICT; Deutsch M., 1958, J CONFLICT RESOLUT, V2, P265, DOI [DOI 10.1177/002200275800200401, 10.1177/002200275800200401]; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehrler S, 2013, EVOL HUM BEHAV, V34, P139, DOI 10.1016/j.evolhumbehav.2012.11.005; FEY W F, 1955, J Abnorm Psychol, V50, P274, DOI 10.1037/h0046876; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Freeman L., 2004, DEV SOCIAL NETWORK A; FUKUYAMA FRANCIS, 1996, TRUST SOCIAL VIRTUES, DOI DOI 10.1145/355112.355120; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Gracia-Lazaro C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00325; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; HOLLAND PW, 1971, COMP GROUP STUD, V2, P107, DOI 10.1177/104649647100200201; INGLEHART R, 1988, AM POLIT SCI REV, V82, P1203, DOI 10.2307/1961756; JOHNSONGEORGE C, 1982, J PERS SOC PSYCHOL, V43, P1306, DOI 10.1037/0022-3514.43.6.1306; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Lee D, 2011, J APPL SOC PSYCHOL, V41, P1603, DOI 10.1111/j.1559-1816.2011.00776.x; Lewis JD, 2001, SOC FORCES, V63, P967; LUHMANN Niklas, 1979, TRUST POWER; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Mitchell J.C, 1969, CONCEPT USE SOCIAL N; Murphy JT, 2006, PROG HUM GEOG, V30, P427, DOI 10.1191/0309132506ph617oa; Newman M. E. J., 2003, STRUCTURE DYNAMICS N; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ostrom E., 2005, TRUST RECIPROCITY IN; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Putnam R., 2000, BOWLING ALONE COLLAP; Putnam RD, 1994, COMUNIDADE DEMOCRACI; Radcliffe-Brown AR, 1940, J R ANTHROPOL INST G, V70, P1, DOI 10.2307/2844197; REMPEL JK, 1985, J PERS SOC PSYCHOL, V49, P95, DOI 10.1037/0022-3514.49.1.95; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rigdon ML, 2007, ECON J, V117, P991, DOI 10.1111/j.1468-0297.2007.02075.x; Rosas A, 2013, REV INT FILOSOFIA, V18, P255; Rosenberg M, 1957, OCCUPATIONS VALUES; Rothstein Bo, 2005, SOCIAL TRAPS PROBLEM; ROTTER JB, 1967, J PERS, V35, P651, DOI 10.1111/j.1467-6494.1967.tb01454.x; Smith LGE, 2009, EUR J SOC PSYCHOL, V39, P130, DOI 10.1002/ejsp.464; Stolle D, 1998, POLIT PSYCHOL, V19, P497, DOI 10.1111/0162-895X.00115; Survey Research Center, 1969, 1964 EL STUD; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Tang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088412; Tanghe J, 2010, BRIT J MANAGE, V21, P359, DOI 10.1111/j.1467-8551.2009.00643.x; Tilly Charles., 2005, TRUST RULE; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White DR, 2001, SOCIOL METHODOL, V31, P305, DOI 10.1111/0081-1750.00098; Wrightsman L., 1974, ASSUMPTIONS HUMAN NA; WRIGHTSMAN LS, 1964, PSYCHOL REP, V14, P743, DOI 10.2466/pr0.1964.14.3.743; Yamagishi T, 2011, SCI MIND, P1, DOI 10.1007/978-4-431-53936-0; Zhou WX, 2005, P ROY SOC B-BIOL SCI, V272, P439, DOI 10.1098/rspb.2004.2970; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	81	18	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105559	10.1371/journal.pone.0105559	http://dx.doi.org/10.1371/journal.pone.0105559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144539	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100086
J	Elkins, CM; Qi, QM; Fuller, GG				Elkins, Claire M.; Qi, Qin M.; Fuller, Gerald G.			Corneal Cell Adhesion to Contact Lens Hydrogel Materials Enhanced via Tear Film Protein Deposition	PLOS ONE			English	Article							SILICONE-HYDROGEL; INTEGRIN BINDING; LYSOZYME DEPOSITION; SURFACE; SPECIFICITY; WEAR; DIFFERENTIATION; PRESSURE; IMPACT	Tear film protein deposition on contact lens hydrogels has been well characterized from the perspective of bacterial adhesion and viability. However, the effect of protein deposition on lens interactions with the corneal epithelium remains largely unexplored. The current study employs a live cell rheometer to quantify human corneal epithelial cell adhesion to soft contact lenses fouled with the tear film protein lysozyme. PureVision balafilcon A and AirOptix lotrafilcon B lenses were soaked for five days in either phosphate buffered saline (PBS), borate buffered saline (BBS), or Sensitive Eyes Plus Saline Solution (Sensitive Eyes), either pure or in the presence of lysozyme. Treated contact lenses were then contacted to a live monolayer of corneal epithelial cells for two hours, after which the contact lens was sheared laterally. The apparent cell monolayer relaxation modulus was then used to quantify the extent of cell adhesion to the contact lens surface. For both lens types, lysozyme increased corneal cell adhesion to the contact lens, with the apparent cell monolayer relaxation modulus increasing up to an order of magnitude in the presence of protein. The magnitude of this increase depended on the identity of the soaking solution: lenses soaked in borate-buffered solutions (BBS, Sensitive Eyes) exhibited a much greater increase in cell attachment upon protein addition than those soaked in PBS. Significantly, all measurements were conducted while subjecting the cells to moderate surface pressures and shear rates, similar to those experienced by corneal cells in vivo.	[Elkins, Claire M.; Qi, Qin M.; Fuller, Gerald G.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University	Elkins, CM (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	cma9@stanford.edu		Fuller, Gerald/0000-0002-2924-053X	Bausch Lomb	Bausch Lomb	This work was supported in part by funding from Bausch & Lomb. All other funding was provided from completely unrestricted, non-commercial funds internal to the authors' laboratory at Stanford University. This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andrade JD, 1986, ABSTR PRORGR 11 REUN, P3; Andrasko Gary, 2008, Optometry, V79, P444, DOI 10.1016/j.optm.2008.04.097; CONWAY HD, 1983, J BIOMECH ENG-T ASME, V105, P47, DOI 10.1115/1.3138383; Duench S, 2013, OPTOMETRY VISION SCI, V90, P546, DOI 10.1097/OPX.0b013e318294c2a6; Dunn AC, 2008, TRIBOL LETT, V30, P13, DOI 10.1007/s11249-008-9306-5; Flanagan JL, 2009, BIOCHIMIE, V91, P35, DOI 10.1016/j.biochi.2008.07.007; Garrett Q, 1999, INVEST OPHTH VIS SCI, V40, P897; Jones L, 2002, OPTOMETRY VISION SCI, V79, P753, DOI 10.1097/00006324-200212000-00007; Jones L, 2003, EYE CONTACT LENS, V29, P75; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537; Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062; KLOTZ SA, 1987, ARCH OPHTHALMOL-CHIC, V105, P974; LEAHY CD, 1990, OPTOMETRY VISION SCI, V67, P504, DOI 10.1097/00006324-199007000-00008; Leiske DL, 2010, EXP EYE RES, V90, P598, DOI 10.1016/j.exer.2010.02.004; Lin Meng C, 2003, Cont Lens Anterior Eye, V26, P11, DOI 10.1016/S1367-0484(02)00088-7; LIN S T, 1991, CLAO Journal, V17, P44; MARTIN DK, 1986, PHYS MED BIOL, V31, P635, DOI 10.1088/0031-9155/31/6/005; McNamara NA, 1998, OPHTHALMOLOGY, V105, P2330, DOI 10.1016/S0161-6420(98)91237-4; Nairn J. A., 1995, P ANTEC ANN TECH C, V6, P1; Ng A, 2013, J BIOMED MATER RES B, P1; Ng A, 2012, OPTOMETRY VISION SCI, V89, P392, DOI 10.1097/OPX.0b013e31824c0c4a; Pucker AD, 2010, INVEST OPHTH VIS SCI, V51, P6334, DOI 10.1167/iovs.10-5836; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rosenfeld L, 2013, INVEST OPHTH VIS SCI, V54, P2720, DOI 10.1167/iovs.12-10987; SACK RA, 1987, INVEST OPHTH VIS SCI, V28, P842; SACK RA, 1992, INVEST OPHTH VIS SCI, V33, P626; Soltys-Robitaille CE, 2001, BIOMATERIALS, V22, P3257, DOI 10.1016/S0142-9612(01)00163-6; Subbaraman LN, 2006, CURR EYE RES, V31, P787, DOI 10.1080/02713680600888799; Subbaraman LN, 2011, OPTOMETRY VISION SCI, V88, P959, DOI 10.1097/OPX.0b013e31821ffccb; Suwala Maciej, 2007, Eye Contact Lens, V33, P138, DOI 10.1097/01.icl.0000244155.87409.f6; TRIPATHI PC, 1992, INVEST OPHTH VIS SCI, V33, P121; White P, 2012, CONTACT LENS SPECTR, P1; Willcox MDP, 2001, BIOMATERIALS, V22, P3235, DOI 10.1016/S0142-9612(01)00161-2; Williams TJ, 2003, CURR EYE RES, V27, P227, DOI 10.1076/ceyr.27.4.227.16602	36	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105512	10.1371/journal.pone.0105512	http://dx.doi.org/10.1371/journal.pone.0105512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144576	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100076
J	Greiner, ER; Kelly, JW; Palhano, FL				Greiner, Erin R.; Kelly, Jeffery W.; Palhano, Fernando L.			Immunoprecipitation of Amyloid Fibrils by the Use of an Antibody that Recognizes a Generic Epitope Common to Amyloid Fibrils	PLOS ONE			English	Article							NUCLEATED CONFORMATIONAL CONVERSION; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PROTEIN AGGREGATION; YEAST PRION; DOMAIN; FORMS; IDENTIFICATION; OLIGOMERS	Amyloid fibrils are associated with many maladies, including Alzheimer's disease (AD). The isolation of amyloids from natural materials is very challenging because the extreme structural stability of amyloid fibrils makes it difficult to apply conventional protein science protocols to their purification. A protocol to isolate and detect amyloids is desired for the diagnosis of amyloid diseases and for the identification of new functional amyloids. Our aim was to develop a protocol to purify amyloid from organisms, based on the particular characteristics of the amyloid fold, such as its resistance to proteolysis and its capacity to be recognized by specific conformational antibodies. We used a two-step strategy with proteolytic digestion as the first step followed by immunoprecipitation using the amyloid conformational antibody LOC. We tested the efficacy of this method using as models amyloid fibrils produced in vitro, tissue extracts from C. elegans that overexpress A beta peptide, and cerebrospinal fluid (CSF) from patients diagnosed with AD. We were able to immunoprecipitate A beta(1-40) amyloid fibrils, produced in vitro and then added to complex biological extracts, but not alpha-synuclein and gelsolin fibrils. This method was useful for isolating amyloid fibrils from tissue homogenates from a C. elegans AD model, especially from aged worms. Although we were able to capture picogram quantities of A beta(1-40) amyloid fibrils produced in vitro when added to complex biological solutions, we could not detect any A beta amyloid aggregates in CSF from AD patients. Our results show that although immunoprecipitation using the LOC antibody is useful for isolating A beta(1-40) amyloid fibrils, it fails to capture fibrils of other amyloidogenic proteins, such as alpha-synuclein and gelsolin. Additional research might be needed to improve the affinity of these amyloid conformational antibodies for an array of amyloid fibrils without compromising their selectivity before application of this protocol to the isolation of amyloids.	[Greiner, Erin R.; Kelly, Jeffery W.; Palhano, Fernando L.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Greiner, Erin R.; Kelly, Jeffery W.; Palhano, Fernando L.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Greiner, Erin R.; Kelly, Jeffery W.; Palhano, Fernando L.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Palhano, Fernando L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, Rio De Janeiro, Brazil	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Universidade Federal do Rio de Janeiro	Palhano, FL (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	palhano@bioqmed.ufrj.br	Palhano, Fernando/AAB-3144-2021	Palhano, Fernando/0000-0001-5336-632X	NIA NIH HHS [AG031097, P01 AG031097] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG031097] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Berkelman Tom, 2008, V424, P51, DOI 10.1007/978-1-60327-064-9_5; Bieschke J, 2009, PROTEIN SCI, V18, P2231, DOI 10.1002/pro.234; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COOPER AF, 1970, J NEMATOL, V2, P305; De Genst Erwin, 2012, Methods Mol Biol, V911, P533, DOI 10.1007/978-1-61779-968-6_34; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Angarica VE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-102; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Gao CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015725; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Glenner GG, 2012, BIOCHEM BIOPH RES CO, V425, P534, DOI 10.1016/j.bbrc.2012.08.020; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; HALTIA M, 1990, BIOCHEM BIOPH RES CO, V167, P927, DOI 10.1016/0006-291X(90)90612-Q; Haupt C, 2011, J MOL BIOL, V408, P529, DOI 10.1016/j.jmb.2011.02.032; Hazenberg BPC, 2007, AMYLOID, V14, P133, DOI 10.1080/13506120701260224; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Kryndushkin D, 2013, J BIOL CHEM, V288, P27100, DOI 10.1074/jbc.M113.485359; Ladiwala ARA, 2012, P NATL ACAD SCI USA, V109, P19965, DOI 10.1073/pnas.1208797109; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Leonhardt RM, 2013, MOL BIOL CELL, V24, P964, DOI 10.1091/mbc.E12-10-0742; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; MAURY CPJ, 1990, FEBS LETT, V260, P85, DOI 10.1016/0014-5793(90)80072-Q; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Murray AN, 2010, PROTEIN SCI, V19, P836, DOI 10.1002/pro.363; Santos AN, 2007, J ALZHEIMERS DIS, V11, P117; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Page LJ, 2009, P NATL ACAD SCI USA, V106, P11125, DOI 10.1073/pnas.0811753106; Palgunow D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046198; Palhano FL, 2009, BIOCHEMISTRY-US, V48, P6811, DOI 10.1021/bi9000276; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Solis GM, 2011, JOVE-J VIS EXP, DOI 10.3791/2496; Solomon JP, 2009, BIOCHEMISTRY-US, V48, P11370, DOI 10.1021/bi901368e; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; van Ham TJ, 2010, CELL, V142, P601, DOI 10.1016/j.cell.2010.07.020; Villar-Pique A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013625; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Yam AY, 2011, BIOCHEMISTRY-US, V50, P4322, DOI 10.1021/bi200215j; Zougman A, 2008, J PROTEOME RES, V7, P386, DOI 10.1021/pr070501k	72	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105433	10.1371/journal.pone.0105433	http://dx.doi.org/10.1371/journal.pone.0105433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144803	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100070
J	Molelekwa, GF; Mukhola, MS; Van der Bruggen, B; Luis, P				Molelekwa, Gomotsegang F.; Mukhola, Murembiwa S.; Van der Bruggen, Bart; Luis, Patricia			Preliminary Studies on Membrane Filtration for the Production of Potable Water: A Case of Tshaanda Rural Village in South Africa	PLOS ONE			English	Article							POINT-OF-USE; HOUSEHOLD DRINKING-WATER; MICROBIOLOGICAL QUALITY; ESCHERICHIA-COLI; SURFACE-WATER; VENDA COMMUNITIES; DIARRHEAL DISEASE; PUBLIC-HEALTH; TECHNOLOGY; ULTRAFILTRATION	Ultrafiltration (UF) systems have been used globally for treating water from resources including rivers, reservoirs, and lakes for the production of potable water in the past decade. UF membranes with a pore size of between 0.1 and 0.01 micrometres provide an effective barrier for bacteria, viruses, suspended particles, and colloids. The use of UF membrane technology in treating groundwater for the supply of potable water in the impoverished and rural village, Tshaanda (i.e., the study area) is demonstrated. The technical and administrative processes that are critical for the successful installation of the pilot plant were developed. Given the rural nature of Tshaanda, the cultural and traditional protocols were observed. Preliminary results of the water quality of untreated water and the permeate are presented. Escherichia coli in the untreated water during the dry season (i.e., June and July) was 2 cfu/100 ml and was <1 cfu/100 ml (undetected) following UF, which complied with the WHO and South African National Standards and Guidelines of,1 cfu/100 ml. During the wet/rainy season (February) total coliform was unacceptably high (>2419.2 cfu/100 ml) before UF. Following UF, it dramatically reduced to acceptable level (7 cfu/100 ml) which is within the WHO recommended level of,10 cfu/100 ml. Additionally, during the wet/rainy season E. coli and enterococci were unacceptably high (40.4 cfu/100 ml and 73.3 cfu/100 ml, respectively) before UF but were completely removed following UF, which are within the WHO and SANS recommended limit. The values for electrical conductivity (EC) and turbidity were constantly within the WHO recommended limits of 300 mu S/cm corrected at 25 degrees C and <5 NTU, respectively, before and after UF, during dry season and wet season. This suggests that there is no need for pre-treatment of the water for suspended particles and colloids. Considering these data, it can be concluded that the water is suitable for human consumption, following UF.	[Molelekwa, Gomotsegang F.; Van der Bruggen, Bart] Katholieke Univ Leuven, Dept Chem Engn, ProcESS, Leuven, Belgium; [Molelekwa, Gomotsegang F.; Mukhola, Murembiwa S.] Tshwane Univ Technol, Dept Environm Hlth, Pretoria, South Africa; [Luis, Patricia] Catholic Univ Louvain, Mat & Proc Engn iMMC IMAP, Louvain, Belgium	KU Leuven; Tshwane University of Technology; Universite Catholique Louvain	Molelekwa, GF (corresponding author), Katholieke Univ Leuven, Dept Chem Engn, ProcESS, Leuven, Belgium.	gomotsegangfred.molelekwa@cit.kuleuven.be	Van der Bruggen, Bart/AAR-3676-2020	Luis, Patricia/0000-0002-7449-3309	VLIR-UOS, Belgium [ZEIN2011PR386]	VLIR-UOS, Belgium	The funding was received from VLIR-UOS, Belgium (Project No.: ZEIN2011PR386, URL: http://www.vliruos.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MANAGING WATER HOME; Arnal JMA, 2002, DESALINATION, V145, P305, DOI 10.1016/S0011-9164(02)00427-7; Bhausaheb M.G.S., 2011, INT SCH RES NOTICES, V2011; Boulestreau M, 2012, DESALIN WATER TREAT, V42, P125, DOI 10.1080/19443994.2012.683073; Brown JM, 2008, WATER SCI TECHNOL, V58, P757, DOI 10.2166/wst.2008.439; Cameron J., 2011, VALUING WATER VALUIN; Cameron J, 2011, SCI TOTAL ENVIRON, V410, P8, DOI 10.1016/j.scitotenv.2011.09.054; CARTWRIGHT PS, 1991, DESALINATION, V83, P225, DOI 10.1016/0011-9164(91)85097-E; Clasen T, 2009, AM J TROP MED HYG, V80, P819, DOI 10.4269/ajtmh.2009.80.819; Clasen Thomas F., 2003, Journal of Water and Health, V1, P109; de la Harpe J, 2011, S AFRICA LESSONS RUR; Department of Water Affairs (DWA), 2012, BRIEF PORTF COMM WAT; Dobrowsky PH, 2014, APPL ENVIRON MICROB, V80, P1633, DOI 10.1128/AEM.03061-13; du Preez M, 2008, WATER SA, V34, P107; du Preez M, 2008, AM J TROP MED HYG, V79, P696, DOI 10.4269/ajtmh.2008.79.696; DWAF (Department of Water Affairs and Forestry), 1996, DOMESTIC WATER USE, V1; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; Esrey SA, 1985, CORNELL INT NUTR MON, V15, P1; Fane AG, 2011, TREATISE ON WATER SCIENCE, VOL 4: WATER-QUALITY ENGINEERING, P301; Ferella F, 2013, DESALINATION, V313, P1, DOI 10.1016/j.desal.2012.11.039; Fernandez G, 2012, DESALIN WATER TREAT, V42, P73, DOI 10.5004/dwt.2012.2460; Gundry S, 2013, WATER PRACTICE TECHN, V1, P1; Gundry SW, 2009, J WATER HEALTH, V7, P259, DOI 10.2166/wh.2009.032; Hofman JAMH, 1998, DESALINATION, V119, P113, DOI 10.1016/S0011-9164(98)00129-5; KUNIKANE S, 1995, J MEMBRANE SCI, V102, P149, DOI 10.1016/0376-7388(94)00292-7; Laine JM, 2000, DESALINATION, V131, P17, DOI 10.1016/S0011-9164(00)90002-X; Landre JPB, 1998, LETT APPL MICROBIOL, V26, P352, DOI 10.1046/j.1472-765X.1998.00347.x; Manjunath D, 2013, DESALIN WATER TREAT, V51, P5873, DOI 10.1080/19443994.2013.770436; Momba MNB, 2009, WATER SA, V35, P485; Momba MNB, 2003, J WATER SUPPLY RES T, V52, P67, DOI 10.2166/aqua.2003.0007; Mpenyana-Monyatsi L, 2012, POL J ENVIRON STUD, V21, P1349; Muhammad N, 2009, J ENVIRON ENG-ASCE, V135, P1181, DOI 10.1061/(ASCE)EE.1943-7870.0000084; Murthy ZVP, 2009, GLOBAL NEST J, V11, P235; Obi CL, 2003, WATER SCI TECHNOL, V47, P59, DOI 10.2166/wst.2003.0161; Obi CL, 2002, WATER SA, V28, P287; Pearce GK, 2007, DESALINATION, V203, P286, DOI 10.1016/j.desal.2006.04.011; Peter-Varbanets M., 2011, P 35 WEDC INT C FUTU; Peter-Varbanets M, 2009, WATER RES, V43, P245, DOI 10.1016/j.watres.2008.10.030; Potgieter N, 2006, WATER SCI TECHNOL, V54, P371, DOI 10.2166/wst.2006.890; Potgieter N, 2005, J HEALTH POPUL NUTR, V23, P150; Potgieter N, 2009, WATER SA, V35, P505; RACHWAL AJ, 1994, DESALINATION, V97, P427, DOI 10.1016/0011-9164(94)00105-7; Rosa G, 2010, AM J TROP MED HYG, V82, P289, DOI 10.4269/ajtmh.2010.09-0382; South African Bureau of Standards, 2011, DRINK WAT SANS 241 1; Statistics South Africa, 2012, CENS 2011 STAT REL P; Trevett Andrew Francis, 2005, Journal of Water and Health, V3, P259; Van der Bruggen B, 2003, ENVIRON POLLUT, V122, P435, DOI 10.1016/S0269-7491(02)00308-1; Varkey AJ, 2012, WATER SA, V38, P721, DOI 10.4314/wsa.v38i5.10; Ventresque C, 1997, DESALINATION, V113, P263, DOI 10.1016/S0011-9164(97)00138-0; Wall K, 2011, SAICE INFRASTRUCTURE; WATSON BM, 1989, DESALINATION, V72, P11, DOI 10.1016/0011-9164(89)80024-4; WHO, 2008, GUID DRINK WAT QUAL; WHO, 2011, GUID DRINK WAT QUAL; WHO and UNICEF, 2013, PROGR DRINK WAT SAN; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2012, PROGR DRINK WAT SAN; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Yu ZX, 2012, DESALINATION, V285, P73, DOI 10.1016/j.desal.2011.09.036; Zamxaka M, 2004, WATER SA, V30, P333; Zheng X, 2012, DESALIN WATER TREAT, V49, P281, DOI 10.1080/19443994.2012.719337	61	11	11	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105057	10.1371/journal.pone.0105057	http://dx.doi.org/10.1371/journal.pone.0105057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144640	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100037
J	Melo, GC; Monteiro, WM; Siqueira, AM; Silva, SR; Magalhaes, BML; Alencar, ACC; Kuehn, A; del Portillo, HA; Fernandez-Becerra, C; Lacerda, MVG				Melo, Gisely C.; Monteiro, Wuelton M.; Siqueira, Andre M.; Silva, Siuhelem R.; Magalhaes, Belisa M. L.; Alencar, Aline C. C.; Kuehn, Andrea; del Portillo, Hernando A.; Fernandez-Becerra, Carmen; Lacerda, Marcus V. G.			Expression Levels of pvcrt-o and pvmdr-1 Are Associated with Chloroquine Resistance and Severe Plasmodium vivax Malaria in Patients of the Brazilian Amazon	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PAPUA-NEW-GUINEA; FALCIPARUM; GENES; PARASITES; PFCRT; CHEMORESISTANCE; INDONESIA; EFFICACY; DISEASE	Molecular markers associated with the increase of chloroquine resistance and disease severity in Plasmodium vivax are needed. The objective of this study was to evaluate the expression levels of pvcrt-o and pvmdr-1 genes in a group of patients presenting CQRPv and patients who developed severe complications triggered exclusively by P. vivax infection. Two different sets of patients were included to this comprehensive study performed in the Brazilian Amazon: 1) patients with clinically characterized chloroquine-resistant P. vivax compared with patients with susceptible parasites from in vivo studies and 2) patients with severe vivax malaria compared with patients without severity. Quantitative real-time PCR was performed to compare the transcript levels of two main transporters genes, P. vivax chloroquine resistance transporter (pvcrt-o) and the P. vivax multidrug resistance transporter (pvmdr-1). Twelve chloroquine resistant cases and other 15 isolates from susceptible cases were included in the first set of patients. For the second set, seven patients with P. vivax-attributed severe and 10 mild manifestations were included. Parasites from patients with chloroquine resistance presented up to 6.1 (95% CI: 3.8-14.3) and 2.4 (95% CI: 0.53-9.1) fold increase in pvcrt-o and pvmdr-1 expression levels, respectively, compared to the susceptible group. Parasites from the severe vivax group had a 2.9 (95% CI: 1.1-8.3) and 4.9 (95% CI: 2.3-18.8) fold increase in pvcrt-o and pvmdr-1 expression levels as compared to the control group with mild disease. These findings suggest that chloroquine resistance and clinical severity in P. vivax infections are strongly associated with increased expression levels of the pvcrt-o and pvmdr-1 genes likely involved in chloroquine resistance.	[Melo, Gisely C.; Monteiro, Wuelton M.; Siqueira, Andre M.; Magalhaes, Belisa M. L.; Alencar, Aline C. C.; Lacerda, Marcus V. G.] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Monteiro, Wuelton M.; Kuehn, Andrea; Lacerda, Marcus V. G.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Silva, Siuhelem R.] Univ Paulista, UNIP, Manaus, Amazonas, Brazil; [Kuehn, Andrea; del Portillo, Hernando A.; Fernandez-Becerra, Carmen] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, CRESIB, Barcelona, Spain; [del Portillo, Hernando A.] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain	Universidade do Estado do Amazonas; Universidade Paulista; ISGlobal; CRESIB; University of Barcelona; ICREA	Fernandez-Becerra, C (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, CRESIB, Barcelona, Spain.	carmen.fernandez@cresib.cat; marcuslacerda.br@gmail.com	Fernandez Becerra, Carmen/L-2069-2014; melo, gisely/GZK-5350-2022; Siqueira, Andre M/G-1340-2010; del Portillo Obando, Hernando A/L-2131-2014	Fernandez Becerra, Carmen/0000-0001-5154-0013; Siqueira, Andre M/0000-0003-2208-0294; del Portillo Obando, Hernando A/0000-0002-5278-3452	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [575788/2008-9]; Strategic Program for Science, Technology & Innovation of FAPEAM (PECTI-SAUDE); National Council for Scientific and Technological Development (CNPq); ICREA Funding Source: Custom	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Strategic Program for Science, Technology & Innovation of FAPEAM (PECTI-SAUDE); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ICREA(ICREA)	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant number 575788/2008-9). CFB received a visiting fellowship from the Strategic Program for Science, Technology & Innovation of FAPEAM (PECTI-SAUDE). MVGL has a Level 1 Productivity Fellowship from the National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alecrim MdG, 1999, REV SOC BRAS MED TRO, V32, P67; Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; [Anonymous], 2012, MAN SEV MAL PRACT HD; Baird JK, 2011, ANTIMICROB AGENTS CH, V55, P1827, DOI 10.1128/AAC.01296-10; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08; Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830; Lanca EFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035406; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Das S, 2013, AM J TROP MED HYG, V88, P828, DOI 10.4269/ajtmh.11-0795; Epidemiologica D d V, 2009, MANUAL DIAGNOSTICO L; Fernandez-Becerra C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-55; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; Gama BE, 2011, MEM I OSWALDO CRUZ, V106, P159, DOI 10.1590/S0074-02762011000900020; Gama BE, 2009, MEM I OSWALDO CRUZ, V104, P1009, DOI 10.1590/S0074-02762009000700012; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615; Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marfurt J, 2007, AM J TROP MED HYG, V77, P947, DOI 10.4269/ajtmh.2007.77.947; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Naing C, 2010, T ROY SOC TROP MED H, V104, P695, DOI 10.1016/j.trstmh.2010.08.009; Ngo T, 2003, AM J TROP MED HYG, V68, P350, DOI 10.4269/ajtmh.2003.68.350; Nomura T, 2001, J INFECT DIS, V183, P1653, DOI 10.1086/320707; Orjuela-Sanchez P, 2009, ANTIMICROB AGENTS CH, V53, P3561, DOI 10.1128/AAC.00004-09; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Reilly HB, 2007, INT J PARASITOL, V37, P1599, DOI 10.1016/j.ijpara.2007.05.003; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Sa JM, 2006, MOL BIOCHEM PARASIT, V150, P219, DOI 10.1016/j.molbiopara.2006.08.006; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Vargas-Rodriguez R D, 2012, AM J TROP MED HYG; WHO, 2006, GUID TREATM MAL; WHO, 2010, MAL REP 2010	39	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105922	10.1371/journal.pone.0105922	http://dx.doi.org/10.1371/journal.pone.0105922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157811	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200077
J	Sanchez, C; Bueno-Orovio, A; Wettwer, E; Loose, S; Simon, J; Ravens, U; Pueyo, E; Rodriguez, B				Sanchez, Carlos; Bueno-Orovio, Alfonso; Wettwer, Erich; Loose, Simone; Simon, Jana; Ravens, Ursula; Pueyo, Esther; Rodriguez, Blanca			Inter-Subject Variability in Human Atrial Action Potential in Sinus Rhythm versus Chronic Atrial Fibrillation	PLOS ONE			English	Article							CELLULAR ELECTROPHYSIOLOGY; MATHEMATICAL-MODEL; CARDIAC REPOLARIZATION; SENSITIVITY-ANALYSIS; NA+/CA2+ EXCHANGER; OUTWARD CURRENTS; IONIC MECHANISMS; SYSTEMS BIOLOGY; I-KUR; ALTERNANS	Aims: Human atrial electrophysiology exhibits high inter-subject variability in both sinus rhythm (SR) and chronic atrial fibrillation (cAF) patients. Variability is however rarely investigated in experimental and theoretical electrophysiological studies, thus hampering the understanding of its underlying causes but also its implications in explaining differences in the response to disease and treatment. In our study, we aim at investigating the ability of populations of human atrial cell models to capture the inter-subject variability in action potential (AP) recorded in 363 patients both under SR and cAF conditions. Methods and Results: Human AP recordings in atrial trabeculae (n = 469) from SR and cAF patients were used to calibrate populations of computational SR and cAF atrial AP models. Three populations of over 2000 sampled models were generated, based on three different human atrial AP models. Experimental calibration selected populations of AP models yielding AP with morphology and duration in range with experimental recordings. Populations using the three original models can mimic variability in experimental AP in both SR and cAF, with median conductance values in SR for most ionic currents deviating less than 30% from their original peak values. All cAF populations show similar variations in G(K1), G(Kur) and G(to), consistent with AF-related remodeling as reported in experiments. In all SR and cAF model populations, inter-subject variability in I-K1 and I-NaK underlies variability in APD(90), variability in I-Kur, I-CaL and I-NaK modulates variability in APD(50) and combined variability in I-to and I-Kur determines variability in APD(20). The large variability in human atrial AP triangulation is mostly determined by I-K1 and either I-NaK or I-NaCa depending on the model. Conclusion: Experimentally-calibrated human atrial AP models populations mimic AP variability in SR and cAF patient recordings, and identify potential ionic determinants of inter-subject variability in human atrial AP duration and morphology in SR versus cAF.	[Sanchez, Carlos; Pueyo, Esther] Univ Zaragoza, Aragon Inst Engn Res I3A, Biosignal Interpretat & Computat Simulat BSICoS, Zaragoza, Spain; [Sanchez, Carlos; Pueyo, Esther] Univ Zaragoza, Aragon Hlth Res Inst IIS, Zaragoza, Spain; [Sanchez, Carlos; Pueyo, Esther] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain; [Sanchez, Carlos; Bueno-Orovio, Alfonso; Rodriguez, Blanca] Univ Oxford, Dept Comp Sci, Oxford, England; [Wettwer, Erich; Loose, Simone; Simon, Jana; Ravens, Ursula] Tech Univ Dresden, Dept Pharmacol & Toxicol, Dresden, Germany	University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Oxford; Technische Universitat Dresden	Rodriguez, B (corresponding author), Univ Oxford, Dept Comp Sci, Oxford, England.	blanca.rodriguez@cs.ox.ac.uk	Sánchez, Carlos/C-8825-2012; Pueyo, Esther/C-6945-2009; Bueno-Orovio, Alfonso/K-7225-2013	Sánchez, Carlos/0000-0003-4273-5403; Pueyo, Esther/0000-0002-1960-407X; Bueno-Orovio, Alfonso/0000-0002-1634-3601; Rodriguez, Blanca/0000-0001-6361-3339	Ministerio de Economia y Competitividad, Spain [TEC2010-19410]; European Union 'EUTRAF' [FP7-HEALTH-261057]; Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences	Ministerio de Economia y Competitividad, Spain; European Union 'EUTRAF'; Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences(Wellcome Trust)	CS and EP: Grant TEC2010-19410 from Ministerio de Economia y Competitividad, Spain (http://www.mineco.es). EP: Ramon y Cajal program from Ministerio de Economia y Competitividad, Spain (http://www.mineco.es). EW, SL, JS and UR: European Union 'EUTRAF' Grant FP7-HEALTH-261057 (http://www.eutraf.eu). ABO and BR: BR's Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054635; Amos GJ, 1996, J PHYSIOL-LONDON, V491, P31, DOI 10.1113/jphysiol.1996.sp021194; Blaauw Y, 2004, CIRCULATION, V110, P1717, DOI 10.1161/01.CIR.0000143050.22291.2E; Britton OJ, 2013, P NATL ACAD SCI USA, V110, pE2098, DOI 10.1073/pnas.1304382110; Bueno-Orovio A, 2014, PFLUG ARCH EUR J PHY, V466, P183, DOI 10.1007/s00424-013-1293-1; Carusi A, 2012, AM J PHYSIOL-HEART C, V303, pH144, DOI 10.1152/ajpheart.01151.2011; Cherry EM, 2008, PROG BIOPHYS MOL BIO, V98, P24, DOI 10.1016/j.pbiomolbio.2008.05.002; Cherry EM, 2008, J THEOR BIOL, V254, P674, DOI 10.1016/j.jtbi.2008.06.030; Courtemanche M, 1999, CARDIOVASC RES, V42, P477, DOI 10.1016/S0008-6363(99)00034-6; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Davies MR, 2012, AM J PHYSIOL-HEART C, V302, pH1466, DOI 10.1152/ajpheart.00808.2011; Diaz ME, 2004, CIRC RES, V94, P650, DOI 10.1161/01.RES.0000119923.64774.72; Dobrev D, 2000, CIRCULATION, V102, P692, DOI 10.1161/01.CIR.102.6.692; Dossel O, 2012, MED BIOL ENG COMPUT, V50, P773, DOI 10.1007/s11517-012-0924-6; Feng JL, 1998, CIRC RES, V83, P541, DOI 10.1161/01.RES.83.5.541; FIREK L, 1995, CARDIOVASC RES, V30, P31, DOI 10.1016/0008-6363(95)00014-3; Forini F, 2004, THYROID, V14, P493, DOI 10.1089/1050725041517084; Franz MR, 2012, EUROPACE, V14, pV58, DOI 10.1093/europace/eus273; Gemmell P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090112; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Gray DF, 1998, J PHARMACOL EXP THER, V284, P75; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Jost N, 2013, BRIT J PHARMACOL, V170, P768, DOI 10.1111/bph.12228; Kharche S, 2008, PROG BIOPHYS MOL BIO, V98, P186, DOI 10.1016/j.pbiomolbio.2008.10.010; Koller ML, 1998, AM J PHYSIOL-HEART C, V275, pH1635, DOI 10.1152/ajpheart.1998.275.5.H1635; Krueger MW, 2013, IEEE T MED IMAGING, V32, P73, DOI 10.1109/TMI.2012.2201948; Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666, DOI 10.1152/ajpheart.1996.271.4.H1666; Loose S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00026; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Maleckar MM, 2009, AM J PHYSIOL-HEART C, V297, pH1398, DOI 10.1152/ajpheart.00411.2009; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Milberg P, 2012, HEART RHYTHM, V9, P570, DOI 10.1016/j.hrthm.2011.11.004; Nattel S, 2000, ANNU REV PHYSIOL, V62, P51, DOI 10.1146/annurev.physiol.62.1.51; Nygren A, 1998, CIRC RES, V82, P63; Office of Health Economics, 2009, EST DIR COSTS ATR FI; Pandit SV, 2005, BIOPHYS J, V88, P3806, DOI 10.1529/biophysj.105.060459; Piccini JP, 2009, J AM COLL CARDIOL, V54, P1089, DOI 10.1016/j.jacc.2009.04.085; Pruvot EJ, 2004, CIRC RES, V94, P1083, DOI 10.1161/01.RES.0000125629.72053.95; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Pueyo E, 2010, AM J PHYSIOL-HEART C, V298, pH1577, DOI 10.1152/ajpheart.00936.2009; Quinn TA, 2013, CARDIOVASC RES, V97, P601, DOI 10.1093/cvr/cvt003; Ramirez RJ, 2000, AM J PHYSIOL-HEART C, V279, pH1767, DOI 10.1152/ajpheart.2000.279.4.H1767; Ravens U, 2013, J PHYSIOL-LONDON, V591, P4087, DOI 10.1113/jphysiol.2013.256115; Romero L, 2011, PROG BIOPHYS MOL BIO, V107, P60, DOI 10.1016/j.pbiomolbio.2011.06.012; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Sanchez C, 2012, AM J PHYSIOL-HEART C, V302, pH1146, DOI 10.1152/ajpheart.00668.2011; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Sarkar AX, 2011, HEART RHYTHM, V8, P1749, DOI 10.1016/j.hrthm.2011.05.023; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Sobie EA, 2011, IEEE ENG MED BIO, P4657, DOI 10.1109/IEMBS.2011.6091153; Syed Z, 2005, MED BIOL ENG COMPUT, V43, P561, DOI 10.1007/BF02351029; Tieleman RG, 1997, CIRCULATION, V95, P1945; Tobin AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006742; VanWagoner DR, 1997, CIRC RES, V80, P772; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Wettwer E, 2004, CIRCULATION, V110, P2299, DOI 10.1161/01.CIR.0000145155.60288.71; Wettwer E, 2013, CARDIOVASC RES, V98, P145, DOI 10.1093/cvr/cvt006; Wilhelms M, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00487; Xiao L, 2008, CIRCULATION, V118, P983, DOI 10.1161/CIRCULATIONAHA.107.758672; Yue LX, 1996, AM J PHYSIOL-HEART C, V270, pH2157, DOI 10.1152/ajpheart.1996.270.6.H2157	66	61	62	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105897	10.1371/journal.pone.0105897	http://dx.doi.org/10.1371/journal.pone.0105897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157495	gold, Green Published, Green Submitted			2022-12-27	WOS:000341303200074
J	Santana, EA; Harrison, A; Zhang, XJ; Baker, BD; Kelly, BJ; White, P; Liu, YL; Munson, RS				Santana, Estevan A.; Harrison, Alistair; Zhang, Xinjun; Baker, Beth D.; Kelly, Benjamin J.; White, Peter; Liu, Yunlong; Munson, Robert S., Jr.			HrrF Is the Fur-Regulated Small RNA in Nontypeable Haemophilus influenzae	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; RYHB SMALL RNA; ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASE; NUCLEOTIDE-SEQUENCE; CHINCHILLA MODEL; OTITIS-MEDIA; IN-VIVO; IRON; EXPRESSION	Nontypeable Haemophilus influenzae (NTHi) are Gram-negative commensal bacteria that reside in the nasopharynx. NTHi can also cause multiple upper and lower respiratory tract diseases that include sinusitis, conjunctivitis, bronchitis, and otitis media. In numerous bacterial species the ferric uptake regulator (Fur) acts as a global regulator of iron homeostasis by negatively regulating the expression of iron uptake systems. However in NTHi strain 86-028NP and numerous other bacterial species there are multiple instances where Fur positively affects gene expression. It is known that many instances of positive regulation by Fur occur indirectly through a small RNA intermediate. However, no examples of small RNAs have been described in NTHi. Therefore we used RNA-Seq analysis to analyze the transcriptome of NTHi strain 86-028NPrpsL and an isogenic 86-028NPrpsL Delta fur strain to identify Fur-regulated intergenic transcripts. From this analysis we identified HrrF, the first small RNA described in any Haemophilus species. Orthologues of this small RNA exist only among other Pasteurellaceae. Our analysis showed that HrrF is maximally expressed when iron levels are low. Additionally, Fur was shown to bind upstream of the hrrF promoter. RNA-Seq analysis was used to identify targets of HrrF which include genes whose products are involved in molybdate uptake, deoxyribonucleotide synthesis, and amino acid biosynthesis. The stability of HrrF is not dependent on the RNA chaperone Hfq. This study is the first step in an effort to investigate the role small RNAs play in altering gene expression in response to iron limitation in NTHi.	[Santana, Estevan A.; Harrison, Alistair; Baker, Beth D.; Kelly, Benjamin J.; White, Peter; Munson, Robert S., Jr.] Res Inst Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Kelly, Benjamin J.; White, Peter] Res Inst Nationwide Childrens Hosp, Biomed Genom Core, Columbus, OH USA; [Santana, Estevan A.; Harrison, Alistair; Baker, Beth D.; Munson, Robert S., Jr.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Santana, Estevan A.; Munson, Robert S., Jr.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Zhang, Xinjun; Liu, Yunlong] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington	Munson, RS (corresponding author), Res Inst Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.	robert.munson@nationwidechildrens.org	White, Peter/E-4301-2011	White, Peter/0000-0002-5218-5903	National Institute of Allergy and Infectious Diseases/National Institutes of Health [R01 A1077897]; The Ohio State University College of Medicine Systems in Integrative Biology Training Program; Dean's Graduate Enrichment Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026942] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The Ohio State University College of Medicine Systems in Integrative Biology Training Program; Dean's Graduate Enrichment Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant R01 A1077897 to RSM from the National Institute of Allergy and Infectious Diseases/National Institutes of Health. EAS was also supported by The Ohio State University College of Medicine Systems in Integrative Biology Training Program and the Dean's Graduate Enrichment Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe JJ, 2012, MOL ORAL MICROBIOL, V27, P327, DOI 10.1111/j.2041-1014.2012.00645.x; Andrews SC, 2011, MOL MICROBIOL, V80, P286, DOI 10.1111/j.1365-2958.2011.07594.x; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Bakaletz LO, 1997, VACCINE, V15, P955, DOI 10.1016/S0264-410X(96)00298-8; BAKALETZ LO, 1988, INFECT IMMUN, V56, P331, DOI 10.1128/IAI.56.2.331-335.1988; Boor KJ, 2006, PLOS BIOL, V4, P18, DOI 10.1371/journal.pbio.0040023; Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Carpenter BM, 2013, J BACTERIOL, V195, P5526, DOI 10.1128/JB.01026-13; Carruthers MD, 2012, J BACTERIOL, V194, P1927, DOI 10.1128/JB.06540-11; Coleman HN, 2003, J CLIN MICROBIOL, V41, P4408, DOI 10.1128/JCM.41.9.4408-4410.2003; Davis BM, 2005, J BACTERIOL, V187, P4005, DOI 10.1128/JB.187.12.4005-4014.2005; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Deng ZL, 2012, RES MICROBIOL, V163, P413, DOI 10.1016/j.resmic.2012.05.006; DIXON LG, 1994, PLASMID, V32, P228, DOI 10.1006/plas.1994.1060; Ducey TF, 2009, MICROB PATHOGENESIS, V46, P166, DOI 10.1016/j.micpath.2008.12.003; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Harrison A, 2013, INFECT IMMUN, V81, P1221, DOI 10.1128/IAI.01227-12; Hasan AA, 1997, FEMS MICROBIOL LETT, V150, P19, DOI 10.1016/S0378-1097(97)00089-X; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hempel RJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-134; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; Huang SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-148; HUMBERT R, 1980, J BACTERIOL, V142, P212, DOI 10.1128/JB.142.1.212-220.1980; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Johnston JW, 2009, CURR PROTOC MICROBIO; Jung YS, 2008, CURR MICROBIOL, V57, P593, DOI 10.1007/s00284-008-9248-z; KOLLING R, 1985, J BACTERIOL, V164, P310; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Marles-Wright J, 2007, CURR OPIN STRUC BIOL, V17, P755, DOI 10.1016/j.sbi.2007.08.004; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Mason KM, 2006, MOL MICROBIOL, V62, P1357, DOI 10.1111/j.1365-2958.2006.05460.x; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; Mason KM, 2003, INFECT IMMUN, V71, P3454, DOI 10.1128/IAI.71.6.3454-3462.2003; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Mellin JR, 2010, MICROBIOL-SGM, V156, P2316, DOI 10.1099/mic.0.039040-0; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; MORTON DJ, 1993, INFECT IMMUN, V61, P4033, DOI 10.1128/IAI.61.10.4033-4037.1993; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Oglesby-Sherrouse AG, 2013, METALLOMICS, V5, P276, DOI 10.1039/c3mt20224k; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Poje Grant, 2003, Methods Mol Med, V71, P57; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Read TD, 1997, MOL MICROBIOL, V23, P627, DOI 10.1046/j.1365-2958.1997.d01-1862.x; Read TD, 2000, INFECT IMMUN, V68, P6896, DOI 10.1128/IAI.68.12.6896-6902.2000; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sauer E, 2013, RNA BIOL, V10, P610, DOI 10.4161/rna.24201; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Storz G, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P157; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101	70	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105644	10.1371/journal.pone.0105644	http://dx.doi.org/10.1371/journal.pone.0105644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157846	gold, Green Submitted, Green Published			2022-12-27	WOS:000341303200042
J	Chen, Y; Liu, Y; Wang, X; Li, K; Chen, P				Chen, Yuan; Liu, Yang; Wang, Xin; Li, Kai; Chen, Pu			Preparation of High Purity Crystalline Silicon by Electro-Catalytic Reduction of Sodium Hexafluorosilicate with Sodium below 180 degrees C	PLOS ONE			English	Article							ELECTROCHEMICAL REDUCTION; DIOXIDE	The growing field of silicon solar cells requires a substantial reduction in the cost of semiconductor grade silicon, which has been mainly produced by the rod-based Siemens method. Because silicon can react with almost all of the elements and form a number of alloys at high temperatures, it is highly desired to obtain high purity crystalline silicon at relatively low temperatures through low cost process. Here we report a fast, complete and inexpensive reduction method for converting sodium hexafluorosilicate into silicon at a relatively low reaction temperature (similar to 200 degrees C). This temperature could be further decreased to less than 180 degrees C in combination with an electrochemical approach. The residue sodium fluoride is dissolved away by pure water and hydrochloric acid solution in later purifying processes below 15 degrees C. High purity silicon in particle form can be obtained. The relative simplicity of this method might lead to a low cost process in producing high purity silicon.	[Chen, Yuan; Liu, Yang; Wang, Xin; Li, Kai; Chen, Pu] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Chen, P (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca	王, 新/O-4150-2016; 王, 新/GQY-6333-2022	王, 新/0000-0002-4771-8453; 	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI); Canada Research Chairs (CRC) program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs (CRC) program(Canada Research Chairs)	This research was financially supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Foundation for Innovation (CFI) and the Canada Research Chairs (CRC) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZH, 2007, NATURE, V446, P172, DOI 10.1038/nature05570; Chen GZ, 2000, NATURE, V407, P361, DOI 10.1038/35030069; Cho SK, 2012, ANGEW CHEM INT EDIT, V51, P12740, DOI 10.1002/anie.201206789; Haynes W. M., 2012, CRC HDB CHEM PHYS; HEATH JR, 1992, SCIENCE, V258, P1131, DOI 10.1126/science.258.5085.1131; Jin X., 2004, ANGEW CHEM, V116, P751; Nohira T, 2003, NAT MATER, V2, P397, DOI 10.1038/nmat900; Zulehner W., 1995, ULLMANNS ENCY IND A, VA23, P721	8	1	1	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105537	10.1371/journal.pone.0105537	http://dx.doi.org/10.1371/journal.pone.0105537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153509	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200058
J	Kabisch, R; Mejias-Luque, R; Gerhard, M; Prinz, C				Kaebisch, Romy; Mejias-Luque, Raquel; Gerhard, Markus; Prinz, Christian			Involvement of Toll-Like Receptors on Helicobacter pylori-Induced Immunity	PLOS ONE			English	Article							DENDRITIC CELL MATURATION; REGULATORY T-CELLS; GASTRIC-CANCER; RECOGNITION; INFECTION; INTERFERON; ACTIVATION; EXPRESSION; CYTOKINES; RESPONSES	Dendritic cells (DCs) play a major role in the innate immune response since they recognize a broad repertoire of PAMPs mainly via Toll-like receptors (TLRs). During Helicobacter pylori (H. pylori) infection, TLRs have been shown to be important to control cytokine response particularly in murine DCs. In the present study we analyzed the effect of blocking TLRs on human DCs. Co-incubation of human DCs with H. pylori resulted in the release of the pro-inflammatory cytokines IL-12p70, IL-6 and IL-10. Release of IL-12p70 and IL-10 was predominantly influenced when TLR4 signaling was blocked by adding specific antibodies, suggesting a strong influence on subsequent T cell responses through TLR4 activation on DCs. Co-incubation of H. pylori-primed DC with allogeneic CD4(+) T cells resulted in the production of IFN-gamma and IL-17A as well as the expression of Foxp3, validating a mixed Th1/Th17 and T-reg response in vitro. Neutralization of TLR4 during H. pylori infection resulted in significantly decreased amounts of IL-17A and IFN-gamma and reduced levels of Foxp3-expressing and IL-10-secreting T cells. Our findings suggest that DC cytokine secretion induced upon TLR4-mediated recognition of H. pylori influences inflammatory and regulatory T cell responses, which might facilitate the chronic bacterial persistence.	[Kaebisch, Romy; Mejias-Luque, Raquel; Gerhard, Markus] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-80290 Munich, Germany; [Prinz, Christian] Univ Witten Herdecke, Lehrstuhl Innere Med 1, Wuppertal, Germany	Technical University of Munich; Witten Herdecke University	Prinz, C (corresponding author), Univ Witten Herdecke, Lehrstuhl Innere Med 1, Wuppertal, Germany.	christian.prinz@helios-kliniken.de	Gerhard, Markus/P-8996-2019; Gerhard, Markus/N-3387-2014	Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Mejias-Luque, Raquel/0000-0002-4602-4927	Deutsche Forschungsgemeinschaft (German Research Scoiety = DFG) [PR 411/12-1]	Deutsche Forschungsgemeinschaft (German Research Scoiety = DFG)	Supported by the Deutsche Forschungsgemeinschaft (German Research Scoiety = DFG), Project Number Prinz = PR 411/12-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; BUELENS C, 1995, EUR J IMMUNOL, V25, P2668, DOI 10.1002/eji.1830250940; CARUSO ML, 1990, J CLIN GASTROENTEROL, V12, P601, DOI 10.1097/00004836-199010000-00025; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Chang LL, 2012, APPL MICROBIOL BIOT, V96, P211, DOI 10.1007/s00253-012-4034-z; DElios MM, 1997, EUR J IMMUNOL, V27, P1751, DOI 10.1002/eji.1830270723; DIXON MF, 1994, SCAND J GASTROENTERO, V29, P7, DOI 10.3109/00365529409105353; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Enarsson K, 2006, CLIN IMMUNOL, V121, P358, DOI 10.1016/j.clim.2006.07.002; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kaebisch R, 2014, J IMMUNOL, V192, P316, DOI 10.4049/jimmunol.1302476; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Lagunes-Servin H, 2013, HELICOBACTER, V18, P423, DOI 10.1111/hel.12067; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110; Oertli M, 2012, GUT MICROBES, V3, P566, DOI 10.4161/gmic.21750; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Straubinger RK, 2003, INFECT IMMUN, V71, P2693, DOI 10.1128/IAI.71.5.2693-2703.2003; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003	36	14	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104804	10.1371/journal.pone.0104804	http://dx.doi.org/10.1371/journal.pone.0104804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153703	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200028
J	Kelhala, HL; Palatsi, R; Fyhrquist, N; Lehtimaki, S; Vayrynen, JP; Kallioinen, M; Kubin, ME; Greco, D; Tasanen, K; Alenius, H; Bertino, B; Carlavan, I; Mehul, B; Deret, S; Reiniche, P; Martel, P; Marty, C; Blume-Peytavi, U; Voegel, JJ; Lauerma, A				Kelhala, Hanna-Leena; Palatsi, Riitta; Fyhrquist, Nanna; Lehtimaki, Sari; Vayrynen, Juha P.; Kallioinen, Matti; Kubin, Minna E.; Greco, Dario; Tasanen, Kaisa; Alenius, Harri; Bertino, Beatrice; Carlavan, Isabelle; Mehul, Bruno; Deret, Sophie; Reiniche, Pascale; Martel, Philippe; Marty, Carine; Blume-Peytavi, Ulrike; Voegel, Johannes J.; Lauerma, Antti			IL-17/Th17 Pathway Is Activated in Acne Lesions	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INFLAMMATORY CYTOKINE RESPONSES; GELATINASE-ASSOCIATED LIPOCALIN; INNATE IMMUNE-RESPONSE; REGULATORY T-CELLS; PROPIONIBACTERIUM-ACNES; TH17 CELLS; ANTIMICROBIAL PEPTIDES; HUMAN KERATINOCYTES; UP-REGULATION	The mechanisms of inflammation in acne are currently subject of intense investigation. This study focused on the activation of adaptive and innate immunity in clinically early visible inflamed acne lesions and was performed in two independent patient populations. Biopsies were collected from lesional and non-lesional skin of acne patients. Using Affymetrix Genechips, we observed significant elevation of the signature cytokines of the Th17 lineage in acne lesions compared to non-lesional skin. The increased expression of IL-17 was confirmed at the RNA and also protein level with real-time PCR (RTPCR) and Luminex technology. Cytokines involved in Th17 lineage differentiation (IL-1 beta, IL-6, TGF-beta, IL23p19) were remarkably induced at the RNA level. In addition, proinflammatory cytokines and chemokines (TNF-alpha, IL-8, CSF2 and CCL20), Th1 markers (IL12p40, CXCR3, T-bet, IFN-gamma), T regulatory cell markers (Foxp3, IL-10, TGF-beta) and IL-17 related antimicrobial peptides (S100A7, S100A9, lipocalin, hBD2, hBD3, hCAP18) were induced. Importantly, immunohistochemistry revealed significantly increased numbers of IL-17A positive T cells and CD83 dendritic cells in the acne lesions. In summary our results demonstrate the presence of IL-17A positive T cells and the activation of Th17-related cytokines in acne lesions, indicating that the Th17 pathway is activated and may play a pivotal role in the disease process, possibly offering new targets of therapy.	[Kelhala, Hanna-Leena; Palatsi, Riitta; Kubin, Minna E.; Tasanen, Kaisa] Univ Oulu, Dept Dermatol, SF-90220 Oulu, Finland; [Kelhala, Hanna-Leena; Palatsi, Riitta; Kubin, Minna E.; Tasanen, Kaisa] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Fyhrquist, Nanna; Lehtimaki, Sari; Greco, Dario; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Syst Toxicol, Helsinki, Finland; [Vayrynen, Juha P.; Kallioinen, Matti] Univ Oulu, Dept Pathol, Oulu, Finland; [Vayrynen, Juha P.; Kallioinen, Matti] Oulu Univ Hosp, Oulu, Finland; [Bertino, Beatrice; Carlavan, Isabelle; Mehul, Bruno; Deret, Sophie; Reiniche, Pascale; Voegel, Johannes J.] Galderma R&D, Res, Sophia Antipolis, France; [Martel, Philippe; Marty, Carine] Galderma R&D, Early Dev, Sophia Antipolis, France; [Blume-Peytavi, Ulrike] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Lauerma, Antti] Univ Helsinki, Dept Dermatol, Helsinki, Finland; [Lauerma, Antti] Univ Helsinki, Cent Hosp, Helsinki, Finland	University of Oulu; University of Oulu; Finnish Institute of Occupational Health; University of Oulu; University of Oulu; Galderma R&D SNC; Galderma R&D SNC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Voegel, JJ (corresponding author), Galderma R&D, Res, Sophia Antipolis, France.	johannes.voegel@galderma.com; antti.lauerma@hus.fi	Lauerma, Antti/J-8180-2016; Väyrynen, Juha P/B-5023-2018; Greco, Dario/T-7113-2019	Väyrynen, Juha P/0000-0002-8683-2996; Greco, Dario/0000-0001-9195-9003; Blume-Peytavi, Ulrike/0000-0003-3528-3752; Tasanen, Kaisa/0000-0001-8056-5949; Fyhrquist, Nanna Theresia/0000-0002-5408-0005; Alenius, Harri/0000-0003-0106-8923	Oulu University Hospital Medical Research Center; Finnish Society of Dermatology; Helsinki-Uusimaa Hospital District Research Funds; Galderma R D; Galderma RD	Oulu University Hospital Medical Research Center; Finnish Society of Dermatology; Helsinki-Uusimaa Hospital District Research Funds; Galderma R D; Galderma RD	Funded by Oulu University Hospital Medical Research Center, by Finnish Society of Dermatology, by Helsinki-Uusimaa Hospital District Research Funds and by Galderma R & D internal funding. The funder Galderma R&D provided support in the form of salaries for authors (BB, IC, BM, SD, PR, PM, CM, JJV), but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agak GW, 2014, J INVEST DERMATOL, V134, P366, DOI 10.1038/jid.2013.334; Alestas T, 2006, J MOL MED, V84, P75, DOI 10.1007/s00109-005-0715-8; Bangert C, 2011, CLIN DERMATOL, V29, P360, DOI 10.1016/j.clindermatol.2011.01.006; Begon E, 2007, EUR J DERMATOL, V17, P497; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Chronnell CMT, 2001, J INVEST DERMATOL, V117, P1120, DOI 10.1046/j.0022-202x.2001.01569.x; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dispenza MC, 2012, J INVEST DERMATOL, V132, P2198, DOI 10.1038/jid.2012.111; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fogel P, 2007, BIOINFORMATICS, V23, P44, DOI 10.1093/bioinformatics/btl550; Furusawa H, 2012, RESPIR INVESTIG, V50, P104, DOI 10.1016/j.resinv.2012.07.001; Ganceviciene R, 2006, DERMATOLOGY, V213, P270, DOI 10.1159/000095058; Georgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005; Guy R, 1998, J INVEST DERMATOL, V110, P410, DOI 10.1046/j.1523-1747.1998.00143.x; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; INGHAM E, 1992, J INVEST DERMATOL, V98, P895, DOI 10.1111/1523-1747.ep12460324; Jeremy AHT, 2003, J INVEST DERMATOL, V121, P20, DOI 10.1046/j.1523-1747.2003.12321.x; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; Kim J, 2005, DERMATOLOGY, V211, P193, DOI 10.1159/000087011; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Kistowska M, 2014, J INVEST DERMATOL, V134, P677, DOI 10.1038/jid.2013.438; KNUTSON DD, 1974, J INVEST DERMATOL, V62, P288, DOI 10.1111/1523-1747.ep12676804; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Layton AM, 1998, EXP DERMATOL, V7, P191, DOI 10.1111/j.1600-0625.1998.tb00323.x; Lee DY, 2008, J INVEST DERMATOL, V128, P1863, DOI 10.1038/sj.jid.5701235; Lehtimaki S, 2012, J INVEST DERMATOL, V132, P2744, DOI 10.1038/jid.2012.212; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Loser K, 2012, J INVEST DERMATOL, V132, P864, DOI 10.1038/jid.2011.375; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Lumsden KR, 2011, BRIT J DERMATOL, V165, P302, DOI 10.1111/j.1365-2133.2011.10362.x; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; Mouser PE, 2003, J INVEST DERMATOL, V121, P1226, DOI 10.1046/j.1523-1747.2003.12550_6.x; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; NORRIS JFB, 1988, BRIT J DERMATOL, V118, P651, DOI 10.1111/j.1365-2133.1988.tb02566.x; Oeff MK, 2006, DERMATOLOGY, V213, P266, DOI 10.1159/000095056; Qin M, 2014, J INVEST DERMATOL, V134, P381, DOI 10.1038/jid.2013.309; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Sabat R, 2011, J DTSCH DERMATOL GES, V9, P518, DOI 10.1111/j.1610-0387.2011.07611.x; Shaheen B, 2011, BRIT J DERMATOL, V165, P474, DOI 10.1111/j.1365-2133.2011.10375.x; Sugisaki H, 2009, J DERMATOL SCI, V55, P47, DOI 10.1016/j.jdermsci.2009.02.015; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Thiboutot DM, 2014, J INVEST DERMATOL, V134, P307, DOI 10.1038/jid.2013.400; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Vayrynen JP, 2012, VIRCHOWS ARCH, V460, P455, DOI 10.1007/s00428-012-1232-0; Wolk K, 2011, J IMMUNOL, V186, P1228, DOI 10.4049/jimmunol.0903907; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Zouboulis CC, 2014, J EUR ACAD DERMATOL, V28, P527, DOI 10.1111/jdv.12298	56	92	102	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105238	10.1371/journal.pone.0105238	http://dx.doi.org/10.1371/journal.pone.0105238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153527	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200043
J	Safren, SA; Biello, KB; Smeaton, L; Mimiaga, MJ; Walawander, A; Lama, JR; Rana, A; Nyirenda, M; Kayoyo, VM; Samaneka, W; Joglekar, A; Celentano, D; Martinez, A; Remmert, JE; Nair, A; Lalloo, UG; Kumarasamy, N; Hakim, J; Campbell, TB				Safren, Steven A.; Biello, Katie B.; Smeaton, Laura; Mimiaga, Matthew J.; Walawander, Ann; Lama, Javier R.; Rana, Aadia; Nyirenda, Mulinda; Kayoyo, Virginia M.; Samaneka, Wadzanai; Joglekar, Anjali; Celentano, David; Martinez, Ana; Remmert, Jocelyn E.; Nair, Aspara; Lalloo, Umesh G.; Kumarasamy, Nagalingeswaran; Hakim, James; Campbell, Thomas B.		PEARLS ACTG A175 Study Team	Psychosocial Predictors of Non-Adherence and Treatment Failure in a Large Scale Multi-National Trial of Antiretroviral Therapy for HIV: Data from the ACTG A5175/PEARLS Trial	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; QUALITY-OF-LIFE; CLINICAL-TRIALS; MEDICATIONS; BARRIERS	Background: PEARLS, a large scale trial of antiretroviral therapy (ART) for HIV (n = 1,571, 9 countries, 4 continents), found that a once-daily protease inhibitor (PI) based regimen (ATV+DDI+FTC), but not a once-daily non-nucleoside reverse transcriptase inhibitor/nucleoside reverse transcriptase inhibitor (NNRTI/NRTI) regimen (EFV+FTC/TDF), had inferior efficacy compared to a standard of care twice-daily NNRTI/NRTI regimen (EFV+3TC/ZDV). The present study examined nonadherence in PEARLS. Methods: Outcomes: non-adherence assessed by pill count and by self-report, and time to treatment failure. Longitudinal predictors: regimen, quality of life (general health perceptions = QOL-health, mental health = QOL-mental health), social support, substance use, binge drinking, and sexual behaviors. "Life-Steps'' adherence counseling was provided. Results: In both pill-count and self-report multivariable models, both once-a-day regimens had lower levels of non-adherence than the twice-a-day standard of care regimen; although these associations attenuated with time in the self-report model. In both multivariable models, hard-drug use was associated with non-adherence, living in Africa and better QOL-health were associated with less nonadherence. According to pill-count, unprotected sex was associated with non-adherence. According to self-report, soft-drug use was associated with nonadherence and living in Asia was associated with less nonadherence. Both pill-count (HR = 1.55, 95% CI: 1.15, 2.09, p<.01) and self-report (HR = 1.13, 95% CI: 1.08, 1.13, p<.01) nonadherence were significant predictors of treatment failure over 72 weeks. In multivariable models (including pill-count or self-report nonadherence), worse QOL-health, age group (younger), and region were also significant predictors of treatment failure. Conclusion: In the context of a large, multi-national, multi-continent, clinical trial there were variations in adherence over time, with more simplified regimens generally being associated with better adherence. Additionally, variables such as QOL-health, regimen, drug-use, and region play a role. Self-report and pill-count adherence, as well as additional psychosocial variables, such QOL-health, age, and region, were, in turn, associated with treatment failure.	[Safren, Steven A.; Mimiaga, Matthew J.; Remmert, Jocelyn E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Safren, Steven A.; Mimiaga, Matthew J.] Harvard Univ, Sch Med, Boston, MA USA; [Safren, Steven A.; Biello, Katie B.; Mimiaga, Matthew J.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Biello, Katie B.; Smeaton, Laura; Mimiaga, Matthew J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Walawander, Ann; Nair, Aspara] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA; [Lama, Javier R.] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Rana, Aadia] Miriam Hosp, Alpert Med Sch, Providence, RI 02906 USA; [Nyirenda, Mulinda] Johns Hopkins Res Project, Coll Med, Blantyre, Malawi; [Kayoyo, Virginia M.] Univ North Carolina Project, Lilongwe, Malawi; [Samaneka, Wadzanai] Univ Zimbabwe, Univ Calif San Francisco, Collaborat Res Program, Harare, Zimbabwe; [Joglekar, Anjali] Natl AIDS Res Inst, Pune, Maharashtra, India; [Celentano, David] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Martinez, Ana] NIH NIAD DAIDS Pharmaceut Affairs, Bethesda, MD USA; [Lalloo, Umesh G.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Kumarasamy, Nagalingeswaran] YRGCARE Med Ctr, Madras, Tamil Nadu, India; [Hakim, James] Univ Zimbabwe, Harare, Zimbabwe; [Campbell, Thomas B.] Univ Colorado Denver, Aurora, CO USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Fenway Health; Harvard University; Harvard T.H. Chan School of Public Health; Frontier Science Foundation; Brown University; Lifespan Health Rhode Island; Miriam Hospital; University of Malawi; University of Zimbabwe; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Kwazulu Natal; University of Zimbabwe; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Safren, SA (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	ssafren@mgh.harvard.edu	Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Nyirenda, Mulinda/0000-0003-2037-7449; Bollinger, Robert/0000-0002-6798-6834; Rana, Aadia/0000-0002-1963-528X	National Institute of Allergy and Infectious Diseases [U01AI068636]; National Institute of Mental Health (NIMH), National Institute of Dental and Craniofacial Research (NIDCR); General Clinical Research Center Units - National Center for Research Resources; AIDS Clinical Trials Group (ACTG) - National Institute of Allergy and Infectious Diseases, National Institutes of Health: grants [AI68636, AI68634, AI69450]; Clinical Trials Units (CTU): YRG CARE Medical Ctr., VHS CRS (Site 11701) CTU Grant [U01A1069432]; Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz CRS (Site 12101) CTU Grant [U01AI069476]; College of Med. JHU CRS (Site 30301) CTU Grant [1U01AI069518-01]; Durban Adult HIV CRS (Site 11201) CTU Grant [1U01AI069426-01]; UNC Project, Lilongwe (Site 12001) CTU Grant [5 U01 AI069518-04]; UZ-Parienyatwa CRS (Site 30313) CTU Grant [1U01AI069436-01]; Clinical HIV Research Unit University of Witwatersrand (Site 11101) CTU Grant [AI069463]; Chiang Mai Univ. ACTG CRS (Site 11501) CTU Grant [5 U01 AI069399-04]; Hospital Conceicao, Porto Alegre (Site 12201) CTU Grant [5U01AI069401]; Les Centres GHESKIO (Site 30022) CTU Grant [U01 AI069421-05]; National AIDS Research Institute (Site 11601); NARI Clinic at Gadikhana Dr. Kotnis Municipal Disp (Site 11602); NARI Clinic at NIV CRS (Site 11603) CTU Grant [5U01AI069417-04]; Asociacion Civil Impacta Salud y Educacion -Miraflores, CRS (Site 11301); Investigaciones Medicas en Salud -INMENSA. Lince CRS (Site 11302)-CTU Grant [5U01AI069438]; UT Southwestern Medical Center at Dallas (Site 3751) CTU Grant [3U01AI046376-05S4]; University of Cincinnati (Site 2401) CTU Grant [1U01AI069513-01]; UC Davis School of Medicine (Site 3851,3852) CTU Grant [AI38858-09S1]; University of Colorado Hospital (Site 6101) CTU Grant [AI69450, RR025780]; The Ohio State University (Site 2301) CTU Grant [AI069474]; Northwestern University CRS (Site 2701); Rush University Medical Center (Site 2702) CTU Grant [AI069471]; University of Minnesota (Site 1501) CTU Grant [AI27661]; Washington University (Site 2101) CTU Grant [U01AI069495]; Duke University Medical Center (Site 1601) CTU Grant [5U01 AI069 484-02]; Beth Israel Medical Center (Site 2851) CTU Grant [AI46370]; The Miriam Hospital (Site 2951) CTU Grant [AI069472]; University of Southern California (Site 1201) CTU Grant [AI069428]; UCLA CARE Center (Site 601); Harbor-UCLA (Site 603)-CTU Grant [AI069424]; GCRC Grant [RR00424]; University of North Carolina (Site 3201,3206) CTU Grant [AI069423-03]; CFAR Grant [AI050410, P30-AI045008-11]; CTSA Grant [UL 1RR 025747, UL1RR024156]; Vanderbilt Therapeutics (Site 3652) CTU Grant [AI-069439]; Hosp. of the Univ. of Pennsylvania (Site 6201) CTU Grant [001-AI069467-04]; Columbia University -HIV Prevention and Treatment CRS (Site 30329) CTU Grant [AI069470]; New York University/NYC HHC at Bellevue Hospital Center (Site 401) CTU Grant [AI27665, AI069532]; University of Texas Medical Branch, Galveston (Site 6301) CTU Grant [AI032782]; University of Rochester (Site 1101); AIDS Care (Site 1108) CTU Grant [U01AI069511-02]; Cook County Hospital Core Center (Site 2705) CTU Grant [AI25915]; University of Hawaii at Manoa (Site 5201) CTU Grant [AI34853]; Cornell CRS (Site 7804) CTU Grant [AI-69419]; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline;  [MOI-RR00865];  [RR024996];  [K24 MH094214]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042, UL1TR001082, UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156, UL1RR025747, UL1RR025780, M01RR000865, UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI025915, U01AI069474, U01AI069438, UM1AI069399, U01AI069423, U01AI069518, UM1AI069532, U01AI069484, U01AI069470, UM1AI069428, UM1AI069467, UM1AI068636, UM1AI069419, U01AI069472, U01AI068636, U01AI069511, U01AI069471, P30AI050410, P30AI045008, U01AI069424, U01AI046370, U01AI069401, UM1AI069424, UM1AI069463, U01AI069436, UM1AI069470, UM1AI069432, U01AI069463, U01AI069476, U01AI046376, UM1AI069474, UM1AI069472, U01AI069419, UM1AI069439, U01AI069421, U01AI032782, U01AI069439, U01AI027661, U01AI069450, UM1AI069423, U01AI069399, U01AI038858, U01AI068634, U01AI069532, U01AI027665, UM1AI069471, UM1AI069450, U01AI069426, UM1AI068634, U01AI069417, U01AI069495, U01AI069467, U01AI069428, U01AI034853, U01AI069513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH094214] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH), National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute of Dental & Craniofacial Research (NIDCR)); General Clinical Research Center Units - National Center for Research Resources; AIDS Clinical Trials Group (ACTG) - National Institute of Allergy and Infectious Diseases, National Institutes of Health: grants; Clinical Trials Units (CTU): YRG CARE Medical Ctr., VHS CRS (Site 11701) CTU Grant; Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz CRS (Site 12101) CTU Grant; College of Med. JHU CRS (Site 30301) CTU Grant; Durban Adult HIV CRS (Site 11201) CTU Grant; UNC Project, Lilongwe (Site 12001) CTU Grant; UZ-Parienyatwa CRS (Site 30313) CTU Grant; Clinical HIV Research Unit University of Witwatersrand (Site 11101) CTU Grant; Chiang Mai Univ. ACTG CRS (Site 11501) CTU Grant; Hospital Conceicao, Porto Alegre (Site 12201) CTU Grant; Les Centres GHESKIO (Site 30022) CTU Grant; National AIDS Research Institute (Site 11601); NARI Clinic at Gadikhana Dr. Kotnis Municipal Disp (Site 11602); NARI Clinic at NIV CRS (Site 11603) CTU Grant; Asociacion Civil Impacta Salud y Educacion -Miraflores, CRS (Site 11301); Investigaciones Medicas en Salud -INMENSA. Lince CRS (Site 11302)-CTU Grant; UT Southwestern Medical Center at Dallas (Site 3751) CTU Grant; University of Cincinnati (Site 2401) CTU Grant; UC Davis School of Medicine (Site 3851,3852) CTU Grant; University of Colorado Hospital (Site 6101) CTU Grant; The Ohio State University (Site 2301) CTU Grant; Northwestern University CRS (Site 2701); Rush University Medical Center (Site 2702) CTU Grant; University of Minnesota (Site 1501) CTU Grant; Washington University (Site 2101) CTU Grant; Duke University Medical Center (Site 1601) CTU Grant; Beth Israel Medical Center (Site 2851) CTU Grant; The Miriam Hospital (Site 2951) CTU Grant; University of Southern California (Site 1201) CTU Grant; UCLA CARE Center (Site 601); Harbor-UCLA (Site 603)-CTU Grant; GCRC Grant; University of North Carolina (Site 3201,3206) CTU Grant; CFAR Grant; CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Vanderbilt Therapeutics (Site 3652) CTU Grant; Hosp. of the Univ. of Pennsylvania (Site 6201) CTU Grant; Columbia University -HIV Prevention and Treatment CRS (Site 30329) CTU Grant; New York University/NYC HHC at Bellevue Hospital Center (Site 401) CTU Grant; University of Texas Medical Branch, Galveston (Site 6301) CTU Grant; University of Rochester (Site 1101); AIDS Care (Site 1108) CTU Grant; Cook County Hospital Core Center (Site 2705) CTU Grant; University of Hawaii at Manoa (Site 5201) CTU Grant; Cornell CRS (Site 7804) CTU Grant; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by Award Number U01AI068636 from the National Institute of Allergy and Infectious Diseases and supported by National Institute of Mental Health (NIMH), National Institute of Dental and Craniofacial Research (NIDCR). The project was also supported in part by the General Clinical Research Center Units funded by the National Center for Research Resources. This work was also supported in part by the AIDS Clinical Trials Group (ACTG), funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health: grants AI68636, AI68634, AI69450 and the following grants to individual Clinical Trials Units (CTU): YRG CARE Medical Ctr., VHS CRS (Site 11701) CTU Grant #U01A1069432; Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz CRS (Site 12101) CTU Grant # U01AI069476; College of Med. JHU CRS (Site 30301) CTU Grant # 1U01AI069518-01; Durban Adult HIV CRS (Site 11201) CTU Grant # 1U01AI069426-01; UNC Project, Lilongwe (Site 12001) CTU Grant # 5 U01 AI069518-04; UZ-Parienyatwa CRS (Site 30313) CTU Grant # 1U01AI069436-01; Clinical HIV Research Unit University of Witwatersrand (Site 11101) CTU Grant # AI069463; Chiang Mai Univ. ACTG CRS (Site 11501) CTU Grant # 5 U01 AI069399-04; Hospital Conceicao, Porto Alegre (Site 12201) CTU Grant # 5U01AI069401; Les Centres GHESKIO (Site 30022) CTU Grant # U01 AI069421-05; National AIDS Research Institute (Site 11601); NARI Clinic at Gadikhana Dr. Kotnis Municipal Disp (Site 11602); NARI Clinic at NIV CRS (Site 11603) CTU Grant # 5U01AI069417-04; Asociacion Civil Impacta Salud y Educacion -Miraflores, CRS (Site 11301); Investigaciones Medicas en Salud -INMENSA. Lince CRS (Site 11302)-CTU Grant # 5U01AI069438; UT Southwestern Medical Center at Dallas (Site 3751) CTU Grant # 3U01AI046376-05S4; University of Cincinnati (Site 2401) CTU Grant # 1U01AI069513-01; UC Davis School of Medicine (Site 3851,3852) CTU Grant # AI38858-09S1; University of Colorado Hospital (Site 6101) CTU Grant # AI69450; RR025780; The Ohio State University (Site 2301) CTU Grant # AI069474; Northwestern University CRS (Site 2701); Rush University Medical Center (Site 2702) CTU Grant # AI069471; University of Minnesota (Site 1501) CTU Grant # AI27661; Washington University (Site 2101) CTU Grant # U01AI069495; Duke University Medical Center (Site 1601) CTU Grant # 5U01 AI069 484-02; Beth Israel Medical Center (Site 2851) CTU Grant # AI46370; The Miriam Hospital (Site 2951) CTU Grant # AI069472; University of Southern California (Site 1201) CTU Grant # AI069428; UCLA CARE Center (Site 601); Harbor-UCLA (Site 603)-CTU Grant # AI069424; Grant # MOI-RR00865; GCRC Grant # RR00424; University of North Carolina (Site 3201,3206) CTU Grant # AI069423-03; CFAR Grant # AI050410; CTSA Grant # UL 1RR 025747; Vanderbilt Therapeutics (Site 3652) CTU Grant # AI-069439; Hosp. of the Univ. of Pennsylvania (Site 6201) CTU Grant # 001-AI069467-04; CFAR Grant # P30-AI045008-11; Columbia University -HIV Prevention and Treatment CRS (Site 30329) CTU Grant # AI069470; CTSA Grant # UL1RR024156; New York University/NYC HHC at Bellevue Hospital Center (Site 401) CTU Grant # AI27665 and AI069532; The University of Texas Medical Branch, Galveston (Site 6301) CTU Grant # AI032782; University of Rochester (Site 1101); AIDS Care (Site 1108) CTU Grant # U01AI069511-02; Cook County Hospital Core Center (Site 2705) CTU Grant # AI25915; University of Hawaii at Manoa (Site 5201) CTU Grant # AI34853; Cornell CRS (Site 7804) CTU Grant # AI-69419; Grant # RR024996.; Finally, some of the author time was supported by grant K24 MH094214 (Safren). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The NIAID provided recommendations on the study design and approved the final study design and provided editorial review as a substudy team member, but had no role in data collection or analysis, or decision to publish. The pharmaceutical sponsors (Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, and GlaxoSmithKline) provided study drug and Gilead Sciences provided funding to purchase study drug that was not otherwise available. Bristol Myers Squibb provided atazanavir, didanosine-EC and efavirenz (with consent of Merck); Gilead Sciences, Inc. provided emtricitabine, tenofovir-DF, emtricitabine/tenofovirDF; GlaxoSmithKline provided lamivudine, zidovudine and lamivudine/zidovudine; and Boehringer Ingelheim Pharmaceuticals, Inc. provided nevirapine. Representatives of the pharmaceutical company sponsors participated as study team members and authors of this manuscript, but did not participate in data collection, data analyses, or interpretation. Bristol Myers Squibb, Gilead Sciences Inc., GlaxoSmithKline and Boehringer Ingelheim Pharmaceuticals, Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Finally, some of the author time was supported by grant K24 MH094214 (Safren).	ACTG, 1999, ACTG QOL 601 602 QOL; Adakun SA, 2013, JAIDS-J ACQ IMM DEF, V62, P317, DOI 10.1097/QAI.0b013e3182800daf; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Barnighausen T, 2007, THERAPY, V4, P753; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Cattell RB, 1966, MULTIVAR BEHAV RES, V1; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Fogarty L, 2002, PATIENT EDUC COUNS, V46, P93, DOI 10.1016/S0738-3991(01)00219-1; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kunutsor S, 2010, JAIDS-J ACQ IMM DEF, V55, P221, DOI 10.1097/QAI.0b013e3181e255ec; Malow R, 2013, AIDS BEHAV, V17, P1221, DOI 10.1007/s10461-012-0400-1; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Nsimba SE, 2010, J AIDS CLIN RES, V1; O'Connor JL, 2013, J INFECT DIS, V208, P40, DOI 10.1093/infdis/jis731; Reda AA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/574656; Reynolds NR, 2007, JAIDS-J ACQ IMM DEF, V46, P402, DOI 10.1097/QAI.0b013e318158a44f; Sabin LL, 2008, AIDS CARE, V20, P1242, DOI 10.1080/09540120801918651; Safren SA, 2012, AIDS BEHAV, V16, P266, DOI 10.1007/s10461-011-9947-5; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Wu AW, 2005, HIV CLIN TRIALS, V6, P147, DOI 10.1310/BPNB-XELF-AXFQ-QQTL	22	39	39	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104178	10.1371/journal.pone.0104178	http://dx.doi.org/10.1371/journal.pone.0104178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153084	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200015
J	Varga, Z; Tubbs, RR; Moch, H				Varga, Zsuzsanna; Tubbs, Raymond R.; Moch, Holger			Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification	PLOS ONE			English	Article							CORE-NEEDLE BIOPSIES; SINGLE INSTITUTION; FISH; CARCINOMA; RECOMMENDATIONS; TECHNOLOGIES; TRASTUZUMAB; RELIABILITY; EXPRESSION; EXPERIENCE	Introduction: HER2 status assessment became a mandatory test assay in breast cancer, giving prognostic and predictive information including eligibility for adjuvant anti-HER2 therapy. Precise and reliable assessment of HER2 status is therefore of utmost importance. In this study we analyzed breast cancer samples by a novel technology for concomitant detection of the HER2 protein and gene copy number. Methods: Tissue microarrays containing 589 invasive breast cancer samples were analyzed with a double immunohistochemistry (IHC) and silver labeled in situ hybridization (SISH) assay simultaneously detecting HER2 protein and gene copy number in the same tumor cells. This bright-field assay was analyzed using scores according to the modified ASCO guidelines and the results were correlated with patient prognosis. Results: Overall concordance rate between protein expression and the presence of gene amplification was 98%. Fifty-seven of 60 tumors (95%) with IHC score 3+, 6 of 10 tumors with IHC score 2+ (60%) and only 3 of 519 tumors (0.6%) with IHC score 0/1+ were amplified by SISH. Patients with gene amplification despite IHC score 0/1+ had a tendency for worse overall survival (p = 0.088, reaching nearly statistical significance) compared to IHC score 0/1+ without amplification. In contrast, there was no difference in overall survival in IHC score 3+/2+ tumors with and without gene amplification. Conclusions: The novel double IHC and SISH assay for HER2 is efficient in the identification of breast cancer with discordant HER2 protein and HER2 gene status, especially for the prognostically relevant groups of HER2 protein negative tumors with HER2 amplification and HER2 protein positive tumors without HER2 amplification. Breast cancer without HER2 amplification among IHC score 2+/3+ tumors (10% in our cohort) suggests that other mechanisms than gene amplification contribute to protein overexpression in these cells.	[Varga, Zsuzsanna; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Tubbs, Raymond R.] Cleveland Clin, Sect Mol Pathol, Cleveland, OH 44106 USA	University of Zurich; University Zurich Hospital; Cleveland Clinic Foundation	Varga, Z (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	zsuzsanna.varga@usz.ch			NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Arnouldi L, 2012, MODERN PATHOL, V25, P675, DOI 10.1038/modpathol.2011.201; Downs-Kelly E, 2005, AM J SURG PATHOL, V29, P1505, DOI 10.1097/01.pas.0000172294.67409.4f; Dowsett M, 2007, MODERN PATHOL, V20, P584, DOI 10.1038/modpathol.3800774; Dowsett M, 2009, J CLIN ONCOL, V27, P2962, DOI 10.1200/JCO.2008.19.7939; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Francis GD, 2009, DIAGN MOL PATHOL, V18, P88, DOI 10.1097/PDM.0b013e31816f6374; Fritzsche FR, 2010, AM J SURG PATHOL, V34, P1180, DOI 10.1097/PAS.0b013e3181e70e15; Gown AM, 2008, MODERN PATHOL, V21, P1271, DOI 10.1038/modpathol.2008.83; Hanna W.M., 2013, MOD PATHOL; Hicks DG, 2005, HUM PATHOL, V36, P250, DOI 10.1016/j.humpath.2004.11.010; Hirschmann A, 2012, AM J CLIN PATHOL, V138, P837, DOI 10.1309/AJCPL5IV0LAWSERG; Jacquemier J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-351; Lebeau A, 2010, J CLIN ONCOL, V28, P3264, DOI 10.1200/JCO.2009.25.9366; Lee Y, 2012, ARCH MED RES, V43, P139, DOI 10.1016/j.arcmed.2012.03.010; Martin Vittoria, 2012, Patholog Res Int, V2012, P261857, DOI 10.1155/2012/261857; Mass Robert D, 2005, Clin Breast Cancer, V6, P240, DOI 10.3816/CBC.2005.n.026; Moelans CB, 2011, CRIT REV ONCOL HEMAT, V80, P380, DOI 10.1016/j.critrevonc.2010.12.005; Moelans CB, 2010, CLIN CANCER RES, V16, P6177, DOI 10.1158/1078-0432.CCR-10-0773; Papouchado BG, 2010, AM J SURG PATHOL, V34, P767, DOI 10.1097/PAS.0b013e3181d96231; Park K, 2011, J BREAST CANCER, V14, P276, DOI 10.4048/jbc.2011.14.4.276; Penault-Llorca F, 2013, BREAST, V22, P200, DOI 10.1016/j.breast.2012.12.004; Penault-Llorca F, 2009, AM J CLIN PATHOL, V132, P539, DOI 10.1309/AJCPV2I0HGPMGBSQ; Perez EA, 2010, J CLIN ONCOL, V28, P4307, DOI 10.1200/JCO.2009.26.2154; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Schiavon BN, 2012, AM J SURG PATHOL, V36, P1489, DOI 10.1097/PAS.0b013e3182635987; Schnitt SJ, 2001, AM J CLIN PATHOL, V116, P806; Theurillat JP, 2007, CANCER IMMUNOL IMMUN, V56, P1723, DOI 10.1007/s00262-007-0316-1; Tubbs R, 2004, J MOL HISTOL, V35, P589; Tubbs RR, 2007, DIAGN MOL PATHOL, V16, P207, DOI 10.1097/PDM.0b013e318064c72a; Varga Z, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-615; Wolff A.C., 2013, J CLIN ONCOL; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wulf MA, 2012, AM J SURG PATHOL, V36, P1801, DOI 10.1097/PAS.0b013e31826ff153; Zabaglo L, 2013, ANN ONCOL	34	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105961	10.1371/journal.pone.0105961	http://dx.doi.org/10.1371/journal.pone.0105961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153153	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000340952200097
J	Fernandez-Fuente, M; Terracciano, CM; Martin-Duque, P; Brown, SC; Vassaux, G; Piercy, RJ				Fernandez-Fuente, Marta; Terracciano, Cesare M.; Martin-Duque, Pilar; Brown, Susan C.; Vassaux, Georges; Piercy, Richard J.			Calcium Homeostasis in Myogenic Differentiation Factor 1 (MyoD)-Transformed, Virally-Transduced, Skin-Derived Equine Myotubes	PLOS ONE			English	Article							CENTRAL CORE DISEASE; RYANODINE RECEPTOR MUTATIONS; RECESSIVE RYR1 MUTATIONS; CA2+ RELEASE CHANNEL; MALIGNANT HYPERTHERMIA; SKELETAL-MUSCLE; EXERTIONAL RHABDOMYOLYSIS; DERMAL FIBROBLASTS; DANTROLENE SODIUM; GENE	Dysfunctional skeletal muscle calcium homeostasis plays a central role in the pathophysiology of several human and animal skeletal muscle disorders, in particular, genetic disorders associated with ryanodine receptor 1 (RYR1) mutations, such as malignant hyperthermia, central core disease, multiminicore disease and certain centronuclear myopathies. In addition, aberrant skeletal muscle calcium handling is believed to play a pivotal role in the highly prevalent disorder of Thoroughbred racehorses, known as Recurrent Exertional Rhabdomyolysis. Traditionally, such defects were studied in human and equine subjects by examining the contractile responses of biopsied muscle strips exposed to caffeine, a potent RYR1 agonist. However, this test is not widely available and, due to its invasive nature, is potentially less suitable for valuable animals in training or in the human paediatric setting. Furthermore, increasingly, RYR1 gene polymorphisms (of unknown pathogenicity and significance) are being identified through next generation sequencing projects. Consequently, we have investigated a less invasive test that can be used to study calcium homeostasis in cultured, skin-derived fibroblasts that are converted to the muscle lineage by viral transduction with a MyoD (myogenic differentiation 1) transgene. Similar models have been utilised to examine calcium homeostasis in human patient cells, however, to date, there has been no detailed assessment of the cells' calcium homeostasis, and in particular, the responses to agonists and antagonists of RYR1. Here we describe experiments conducted to assess calcium handling of the cells and examine responses to treatment with dantrolene, a drug commonly used for prophylaxis of recurrent exertional rhabdomyolysis in horses and malignant hyperthermia in humans.	[Fernandez-Fuente, Marta; Piercy, Richard J.] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Comparat Neuromuscular Dis Lab, London, England; [Terracciano, Cesare M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, Lab Cell Electrophysiol, London, England; [Martin-Duque, Pilar] Univ Francisco Vitoria, Fac Ciencias Biosanitarias, Madrid, Spain; [Brown, Susan C.] Univ London Royal Vet Coll, London, England; [Vassaux, Georges] Commissariat Energie Atom, DSV, iBEB, Lab TIRO,UMRE 4320, Nice, France	University of London; University of London Royal Veterinary College; Imperial College London; Universidad Francisco de Vitoria; University of London; University of London Royal Veterinary College; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Cote d'Azur	Piercy, RJ (corresponding author), Univ London Royal Vet Coll, Dept Clin Sci & Serv, Comparat Neuromuscular Dis Lab, 32 Belgrave Sq, London, England.	rpiercy@rvc.ac.uk	Martin-Duque, Pilar/AAF-2581-2020; Vassaux, Georges/N-9724-2016	Vassaux, Georges/0000-0002-1149-7716; Brown, Sue/0000-0001-8112-933X	Horserace Betting Levy Board	Horserace Betting Levy Board	This work has been funded by Horserace Betting Levy Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J CELL SCI, V117, P6523, DOI 10.1242/jcs.01574; Aleman M, 2004, MUSCLE NERVE, V30, P356, DOI 10.1002/mus.20084; ANDERSON K, 1995, J GEN PHYSIOL, V105, P363, DOI 10.1085/jgp.105.3.363; Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198; Bannister RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/390493; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Burton N M, 2000, Methods Cell Sci, V22, P51, DOI 10.1023/A:1009830114804; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cole FL, 2004, VET REC, V155, P625, DOI 10.1136/vr.155.20.625; COURT MH, 1987, J VET PHARMACOL THER, V10, P218, DOI 10.1111/j.1365-2885.1987.tb00532.x; Csernoch L, 1999, J PHYSIOL-LONDON, V515, P843, DOI 10.1111/j.1469-7793.1999.843ab.x; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; Dlamini N, 2013, NEUROMUSCULAR DISORD, V23, P540, DOI 10.1016/j.nmd.2013.03.008; Dranchak PK, 2006, AM J VET RES, V67, P1395, DOI 10.2460/ajvr.67.8.1395; Drogemuller C, 2008, GENOMICS, V92, P474, DOI 10.1016/j.ygeno.2008.07.014; Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200; Eltit JM, 2010, J BIOL CHEM, V285, P13781, DOI 10.1074/jbc.M110.107300; Eltit JM, 2011, P NATL ACAD SCI USA, V108, P7046, DOI 10.1073/pnas.1018380108; Fernandez-Fuente M, 2008, AM J VET RES, V69, P1637, DOI 10.2460/ajvr.69.12.1637; Fernandez-Fuente M, 2014, NEUROMUSCULAR DISORD, V24, P250, DOI 10.1016/j.nmd.2013.11.009; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GARCIA J, 1991, J PHYSIOL-LONDON, V440, P403, DOI 10.1113/jphysiol.1991.sp018715; Ghassemi F, 2009, CELL CALCIUM, V45, P192, DOI 10.1016/j.ceca.2008.10.001; Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013; Glahn KPE, 2010, BRIT J ANAESTH, V105, P417, DOI 10.1093/bja/aeq243; Gyorke S, 1997, J PHYSIOL-LONDON, V500, P297; HARRISON G G, 1972, Journal of the South African Veterinary Association, V43, P57; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HEALY JMS, 1990, BIOCHEM SOC T, V18, P326, DOI 10.1042/bst0180326; Hollingworth S, 2006, J GEN PHYSIOL, V127, P291, DOI 10.1085/jgp.200509477; Hovnanian A., 2007, V45, P337; Huang JB, 2006, AM J PHYSIOL-CELL PH, V290, pC1572, DOI 10.1152/ajpcell.00226.2005; HULL MJ, 1971, J ORAL SURG, V29, P640; Isgren CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011594; Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; Klein A, 2012, HUM MUTAT, V33, P981, DOI 10.1002/humu.22056; Knych HKD, 2011, J VET PHARMACOL THER, V34, P238, DOI 10.1111/j.1365-2885.2010.01214.x; LARACH MG, 1989, ANESTH ANALG, V69, P511; Larsen Jan, 2011, BMC Res Notes, V4, P490, DOI 10.1186/1756-0500-4-490; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Laver DR, 2011, J MOL CELL CARDIOL, V51, P357, DOI 10.1016/j.yjmcc.2011.05.009; Lentz LR, 1999, AM J VET RES, V60, P684; LOPEZ JR, 1986, MUSCLE NERVE, V9, P85; LOPEZ JR, 1985, MUSCLE NERVE, V8, P355, DOI 10.1002/mus.880080502; Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164; MA J, 1993, J GEN PHYSIOL, V102, P423, DOI 10.1085/jgp.102.3.423; MacLeay JM, 1999, AM J VET RES, V60, P1562; MARGRETH A, 1993, BIOCHEM BIOPH RES CO, V197, P1303, DOI 10.1006/bbrc.1993.2619; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; McKenzie EC, 2010, EQUINE VET J, V42, P613, DOI 10.1111/j.2042-3306.2010.00262.x; McKenzie EC, 2004, AM J VET RES, V65, P74, DOI 10.2460/ajvr.2004.65.74; Mickelson JR, 1996, PHYSIOL REV, V76, P537, DOI 10.1152/physrev.1996.76.2.537; Roberts MC, 2001, ANESTHESIOLOGY, V95, P716, DOI 10.1097/00000542-200109000-00026; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879; Tong JF, 1999, J BIOL CHEM, V274, P693, DOI 10.1074/jbc.274.2.693; Upjohn MM, 2005, VET REC, V156, P763, DOI 10.1136/vr.156.24.763; Voermans NC, 2012, NEUROMUSCULAR DISORD, V22, P944, DOI 10.1016/j.nmd.2012.03.012; Walmsley GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008647; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; YASIN R, 1977, J NEUROL SCI, V32, P347, DOI 10.1016/0022-510X(77)90018-1; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005; Zhou HY, 2006, AM J HUM GENET, V79, P859, DOI 10.1086/508500; Zhou HY, 2006, HUM MOL GENET, V15, P2791, DOI 10.1093/hmg/ddl221; Zhou HY, 2013, HUM MUTAT, V34, P986, DOI 10.1002/humu.22326; Zvaritch E, 2009, P NATL ACAD SCI USA, V106, P21813, DOI 10.1073/pnas.0912126106	69	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105971	10.1371/journal.pone.0105971	http://dx.doi.org/10.1371/journal.pone.0105971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148524	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000341230600101
J	Ferreira, AR; Singh, B; Cabrera-Mora, M; De Souza, ACM; Marques, MTQ; Porto, LCS; Santos, F; Banic, DM; Calvo-Calle, JM; Oliveira-Ferreira, J; Moreno, A; Lima, JDC				Ferreira, Amanda Ribeiro; Singh, Balwan; Cabrera-Mora, Monica; Magri De Souza, Alana Cristina; Queiroz Marques, Maria Teresa; Sobrino Porto, Luis Cristovao; Santos, Fatima; Banic, Dalma Maria; Calvo-Calle, J. Mauricio; Oliveira-Ferreira, Joseli; Moreno, Alberto; Lima-Junior, Josue Da Costa			Evaluation of Naturally Acquired IgG Antibodies to a Chimeric and Non-Chimeric Recombinant Species of Plasmodium vivax Reticulocyte Binding Protein-1: Lack of Association with HLA-DRB1*/DQB1*in Malaria Exposed Individuals from the Brazilian Amazon	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; CELLULAR IMMUNE-RESPONSES; PROTECTIVE IMMUNITY; NAIVE VOLUNTEERS; CLINICAL MALARIA; FALCIPARUM; VACCINE; IMMUNOGENICITY; ANTIGENS; SAFETY	The development of modular constructs that include antigenic regions targeted by protective immune responses is an attractive approach for subunit vaccine development. However, a main concern of using these vaccine platforms is how to preserve the antigenic identity of conformational B cell epitopes. In the present study we evaluated naturally acquired antibody responses to a chimeric protein engineered to contain a previously defined immunodominant domain of the Plasmodium vivax reticulocyte binding protein-1 located between amino acid positions K-435-I-777. The construct also includes three regions of the cognate protein (F-571-D-587, I-1745-S-1786 and L-2235-E-2263) predicted to contain MHC class II promiscuous T cell epitopes. Plasma samples from 253 naturally exposed individuals were tested against this chimeric protein named PvRMC-RBP1 and a control protein that includes the native sequence PvRBP1(23-751) in comparative experiments to study the frequency of total IgG and IgG subclass reactivity. HLA-DRB1 and HLA-DQB1 allelic groups were typed by PCR-SSO to evaluate the association between major HLA class II alleles and antibody responses. We found IgG antibodies that recognized the chimeric PvRMC-RBP1 and the PvRBP1(23-751) in 47.1% and 60% of the studied population, respectively. Moreover, the reactivity index against both proteins were comparable and associated with time of exposure (p<0.0001) and number of previous malaria episodes (p<0.005). IgG subclass profile showed a predominance of cytophilic IgG1 over other subclasses against both proteins tested. Collectively these studies suggest that the chimeric PvRMC-RBP1 protein retained antigenic determinants in the PvRBP1(435-777) native sequence. Although 52.9% of the population did not present detectable titers of antibodies to PvRMC-RBP1, genetic restriction to this chimeric protein does not seem to occur, since no association was observed between the HLA-DRB1* or HLA-DQB1* alleles and the antibody responses. This experimental evidence strongly suggests that the identity of the conformational B cell epitopes is preserved in the chimeric protein.	[Ferreira, Amanda Ribeiro; Magri De Souza, Alana Cristina; Oliveira-Ferreira, Joseli; Lima-Junior, Josue Da Costa] Fiocruz MS, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, Brazil; [Singh, Balwan; Cabrera-Mora, Monica; Moreno, Alberto] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Queiroz Marques, Maria Teresa; Sobrino Porto, Luis Cristovao] Univ Estado Rio De Janeiro, Histocompatibil & Cryopreservat Lab, Rio De Janeiro, Brazil; [Santos, Fatima] Natl Hlth Fdn, Dept Entomol, Cent Lab, Porto Velho, RO, Portugal; [Banic, Dalma Maria] Fiocruz MS, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Lab Simuliidae & Onchocerciasis, Rio De Janeiro, Brazil; [Calvo-Calle, J. Mauricio] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Moreno, Alberto] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA	Fundacao Oswaldo Cruz; Emory University; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; University of Massachusetts System; University of Massachusetts Worcester; Emory University	Moreno, A (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	alberto.moreno@emory.edu; josue@ioc.fiocruz.br	Porto, Luis Cristovao M S/I-2984-2013; Porto, Luis Cristovao/U-6499-2019; da Costa Lima-Junior, Josue/AAI-4746-2021; Lima-Junior, Josué C/B-1361-2014; Oliveira-Ferreira, Joseli/E-7942-2014	Porto, Luis Cristovao M S/0000-0003-1499-1821; Porto, Luis Cristovao/0000-0003-1499-1821; da Costa Lima-Junior, Josue/0000-0002-5848-404X; Lima-Junior, Josué C/0000-0002-5848-404X; Moreno, Alberto/0000-0002-3031-7194; Oliveira-Ferreira, Joseli/0000-0002-6063-465X	Brazilian National Research Council - CNPq; Fiocruz; US National Institutes of Health, NIAID [R01-AI064766, R21AI094402-01, R21AI095718-01]; Yerkes National Primate Research Center Base [RR00165]; National Center for Research Resources of the National Institutes of Health; CNPq Fellowship;  [NIH-U19-57319]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094402, R01AI064766, R21AI095718] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Brazilian National Research Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fiocruz; US National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Yerkes National Primate Research Center Base; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CNPq Fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Brazilian National Research Council - CNPq, Fiocruz, US National Institutes of Health, NIAID grant R01-AI064766, R21AI094402-01 and R21AI095718-01 and the Yerkes National Primate Research Center Base Grant No RR00165 awarded by the National Center for Research Resources of the National Institutes of Health. JMCC's involvement was supported by NIH-U19-57319. ARF was the recipient of a CNPq Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Herrera M, 2011, AM J TROP MED HYG, V84, P35, DOI 10.4269/ajtmh.2011.09-0507; Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366; Bastos MS, 2007, CLIN VACCINE IMMUNOL, V14, P1249, DOI 10.1128/CVI.00243-07; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Caro-Aguilar I, 2005, MICROBES INFECT, V7, P1324, DOI 10.1016/j.micinf.2005.04.020; CHIZZOLINI C, 1991, AM J TROP MED HYG, V45, P57, DOI 10.4269/ajtmh.1991.45.57; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; GOOD MF, 1988, SCIENCE, V242, P574, DOI 10.1126/science.2902690; GORDON DM, 1990, AM J TROP MED HYG, V42, P527, DOI 10.4269/ajtmh.1990.42.527; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Herrera S, 2005, AM J TROP MED HYG, V73, P3, DOI 10.4269/ajtmh.2005.73.3; HERRINGTON DA, 1991, AM J TROP MED HYG, V45, P695, DOI 10.4269/ajtmh.1991.45.695; Jepsen MPG, 2013, J INFECT DIS, V208, P479, DOI 10.1093/infdis/jit185; Jiang JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063888; John CC, 2004, INFECT IMMUN, V72, P5135, DOI 10.1128/IAI.72.9.5135-5142.2004; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Lima JC, 2011, VACCINE, V29, P1801, DOI 10.1016/j.vaccine.2010.12.099; Lima-Junior JC, 2008, VACCINE, V26, P6645, DOI 10.1016/j.vaccine.2008.09.029; Lima JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036419; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Mourao LC, 2012, MICROBES INFECT, V14, P730, DOI 10.1016/j.micinf.2012.02.011; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; Nishioka M, 2001, J BIOTECHNOL, V88, P141, DOI 10.1016/S0168-1656(01)00275-9; Oliveira-Ferreira J, 2004, ACTA TROP, V92, P63, DOI 10.1016/j.actatropica.2004.02.011; Oliveira-Ferreira J, 2004, VACCINE, V22, P2023, DOI 10.1016/j.vaccine.2003.07.021; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Silva-Flannery LM, 2009, MICROBES INFECT, V11, P83, DOI 10.1016/j.micinf.2008.10.009; Singh AP, 2005, MOL MICROBIOL, V55, P1925, DOI 10.1111/j.1365-2958.2005.04523.x; Singh B, 2012, INFECT IMMUN, V80, P1491, DOI 10.1128/IAI.05980-11; Singh B, 2010, VACCINE, V28, P2580, DOI 10.1016/j.vaccine.2010.01.019; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Stanisic DI, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002498; Stanisic DI, 2003, INFECT IMMUN, V71, P5700, DOI 10.1128/IAI.71.10.5700-5713.2003; Storti-Melo LM, 2012, ACTA TROP, V121, P152, DOI 10.1016/j.actatropica.2011.10.009; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; Tran TM, 2005, AM J TROP MED HYG, V73, P244, DOI 10.4269/ajtmh.2005.73.244; Vargas-Serrato E, 2002, MOL BIOCHEM PARASIT, V120, P41, DOI 10.1016/S0166-6851(01)00433-9; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wu Yu-Huan, 2008, P3; Yone CLRP, 2005, INFECT IMMUN, V73, P2281, DOI 10.1128/IAI.73.4.2281-2287.2005; Zakeri S, 2011, AM J TROP MED HYG, V84, P944, DOI 10.4269/ajtmh.2011.11-0001	53	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105828	10.1371/journal.pone.0105828	http://dx.doi.org/10.1371/journal.pone.0105828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148251	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600087
J	Tanabe, T; Kato, A; Shiuchi, K; Miyamoto, K; Tsujibo, H; Maki, J; Yamamoto, S; Funahashi, T				Tanabe, Tomotaka; Kato, Ayaka; Shiuchi, Keiichi; Miyamoto, Katsushiro; Tsujibo, Hiroshi; Maki, Jun; Yamamoto, Shigeo; Funahashi, Tatsuya			Regulation of the Expression of the Vibrio parahaemolyticus peuA Gene Encoding an Alternative Ferric Enterobactin Receptor	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; IRON TRANSPORT; PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; IDENTIFICATION; PROTEIN; SIDEROPHORE; SYSTEM; TRANSDUCTION	A pvsB-vctA-irgA triple deletion mutant of Vibrio parahaemolyticus can utilize enterobactin under iron-limiting conditions by inducing a previously undescribed receptor, PeuA (VPA0150), in response to extracellular alkaline pH and enterobactin. In silico analyses revealed the existence of a two-component regulatory system operon, peuRS, immediately upstream of peuA, which constitutes an operon with the TonB2 system genes. Both the peuRS and peuA-tonB2 operons were found to be upregulated under iron-limiting conditions in a ferric uptake regulator (Fur)-dependent manner. The involvement of peuA and peuRS in enterobactin utilization was analyzed by complementation experiments using deletion mutants. Primer extension analysis indicated that, under iron-limiting conditions, the transcription of peuA was initiated from the +1 site at pH 7.0 and from both the +1 and +39 sites at pH 8.0 in the presence of enterobactin. The +39 transcript was absent from the peuRS deletion mutant. Secondary structure prediction of their 5'-untranslated regions suggested that translation initiation is blocked in the +1 transcript, but not in the +39 transcript. Consistent with this, in vitro translation analysis demonstrated that production of PeuA was determined only by the +39 transcript. These studies establish a novel gene regulation mechanism in which the two-component regulatory system PeuRS enhances expression of the alternative +39 transcript that possesses non-inhibitory structure, allowing the peuA expression to be regulated at the translation stage.	[Tanabe, Tomotaka; Kato, Ayaka; Yamamoto, Shigeo; Funahashi, Tatsuya] Matsuyama Univ, Coll Pharmaceut Sci, Lab Hyg Chem, Matsuyama, Ehime, Japan; [Shiuchi, Keiichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Miyamoto, Katsushiro; Tsujibo, Hiroshi] Osaka Univ Pharmaceut Sci, Dept Microbiol, Takatsuki, Osaka, Japan; [Maki, Jun] Matsuyama Univ, Coll Pharmaceut Sci, Infect Dis Lab, Matsuyama, Ehime, Japan	Okayama University; Osaka University of Pharmaceutical Sciences	Tanabe, T (corresponding author), Matsuyama Univ, Coll Pharmaceut Sci, Lab Hyg Chem, Matsuyama, Ehime, Japan.	ttanabe@cc.matsuyama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25870987]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (25870987) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT LM, 1989, ANNU REV GENET, V23, P311, DOI 10.1146/annurev.ge.23.120189.001523; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson MT, 2004, J BACTERIOL, V186, P7302, DOI 10.1128/JB.186.21.7302-7311.2004; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Braun V., 1991, HDB MICROBIAL IRON C, P107; Brickman T, 2009, BIOMETALS, V22, P33, DOI 10.1007/s10534-008-9189-9; Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DEAN CR, 1993, MOL MICROBIOL, V8, P1095, DOI 10.1111/j.1365-2958.1993.tb01654.x; DEAN CR, 1993, J BACTERIOL, V175, P317, DOI 10.1128/JB.175.2.317-324.1993; Dean CR, 1996, J BACTERIOL, V178, P5361, DOI 10.1128/jb.178.18.5361-5369.1996; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Earhart CF, 2004, IRON TRANSPORT IN BACTERIA, P133; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fiedler HP, 2001, FEMS MICROBIOL LETT, V196, P147, DOI 10.1016/S0378-1097(01)00053-2; Funahashi T, 2003, MICROBIOL-SGM, V149, P1217, DOI 10.1099/mic.0.26066-0; Funahashi T, 2002, J BACTERIOL, V184, P936, DOI 10.1128/jb.184.4.936-946.2002; Funahashi T, 2009, BIOL PHARM BULL, V32, P359, DOI 10.1248/bpb.32.359; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HANTKE K, 1983, MOL GEN GENET, V191, P301, DOI 10.1007/BF00334830; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hollander A, 2011, INFECT IMMUN, V79, P4764, DOI 10.1128/IAI.05806-11; Igbinosa EO, 2008, RES MICROBIOL, V159, P495, DOI 10.1016/j.resmic.2008.07.001; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Kuroda T, 2005, MICROBIOL IMMUNOL, V49, P711, DOI 10.1111/j.1348-0421.2005.tb03662.x; LUNDRIGAN MD, 1986, J BIOL CHEM, V261, P797; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mey AR, 2002, INFECT IMMUN, V70, P3419, DOI 10.1128/IAI.70.7.3419-3426.2002; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Naka H, 2012, BIOMETALS, V25, P125, DOI 10.1007/s10534-011-9488-4; NAKAYAMA S, 1995, J BACTERIOL, V177, P5062, DOI 10.1128/jb.177.17.5062-5069.1995; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Schmitt MP, 1999, J BACTERIOL, V181, P5330, DOI 10.1128/JB.181.17.5330-5340.1999; Schubert S, 1999, J BACTERIOL, V181, P6387, DOI 10.1128/JB.181.20.6387-6395.1999; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Tanabe T, 2003, J BACTERIOL, V185, P6938, DOI 10.1128/JB.185.23.6938-6949.2003; Tanabe T, 2012, MICROBIOL-SGM, V158, P2039, DOI 10.1099/mic.0.059568-0; Tanabe T, 2011, FEMS MICROBIOL LETT, V324, P73, DOI 10.1111/j.1574-6968.2011.02389.x; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; Vogt SL, 2012, FEMS MICROBIOL LETT, V326, P2, DOI 10.1111/j.1574-6968.2011.02406.x; WEBER RF, 1988, J MOL BIOL, V203, P467, DOI 10.1016/0022-2836(88)90013-7; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024; YAMAMOTO S, 1995, MICROBIOL IMMUNOL, V39, P759, DOI 10.1111/j.1348-0421.1995.tb03268.x; YAMAMOTO S, 1994, J BIOCHEM-TOKYO, V115, P868, DOI 10.1093/oxfordjournals.jbchem.a124432	57	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105749	10.1371/journal.pone.0105749	http://dx.doi.org/10.1371/journal.pone.0105749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148374	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600076
J	Haslik, W; Pluschnig, U; Steger, GG; Zielinski, CC; Schrogendorfer, KF; Nedomansky, J; Bartsch, R; Mader, RM				Haslik, Werner; Pluschnig, Ursula; Steger, Guenther G.; Zielinski, Christoph C.; Schroegendorfer, K. F.; Nedomansky, Jakob; Bartsch, Rupert; Mader, Robert M.			Indocyanine Green Video Angiography Predicts Outcome of Extravasation Injuries	PLOS ONE			English	Article							ADRIAMYCIN EXTRAVASATION; MANAGEMENT; NECROSIS; SURGERY; ULCERS; BURNS	Background: Extravasation of cytotoxic drugs is a serious complication of systemic cancer treatment. Still, a reliable method for early assessment of tissue damage and outcome prediction is missing. Here, we demonstrate that the evaluation of blood flow by indocyanine green (ICG) angiography in the extravasation area predicts for the need of surgical intervention. Methods: Twenty-nine patients were evaluated by ICG angiography after extravasation of vesicant or highly irritant cytotoxic drugs administered by peripheral i.v. infusion. Tissue perfusion as assessed by this standardized method was correlated with clinical outcome. Results: The perfusion index at the site of extravasation differed significantly between patients with reversible tissue damage and thus healing under conservative management (N = 22) versus those who needed surgical intervention due to the development of necrosis (N = 7; P = 0.0001). Furthermore, in patients benefiting from conservative management, the perfusion index was significantly higher in the central extravasation area denoting hyperemia, when compared with the peripheral area (P = 0.0001). Conclusions: In this patient cohort, ICG angiography as indicator of local perfusion within the extravasation area was of prognostic value for tissue damage. ICG angiography could thus be used for the early identification of patients at risk for irreversible tissue damage after extravasation of cytotoxic drugs.	[Haslik, Werner; Schroegendorfer, K. F.; Nedomansky, Jakob] Med Univ Vienna, Ctr Comprehens Canc, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria; [Pluschnig, Ursula; Steger, Guenther G.; Zielinski, Christoph C.; Bartsch, Rupert; Mader, Robert M.] Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Div Clin Oncol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Mader, RM (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Div Clin Oncol, Vienna, Austria.	robert.mader@meduniwien.ac.at		Mader, Robert/0000-0003-3017-8240; Schrogendorfer, Klaus F./0000-0003-0071-2334; Haslik, Werner/0000-0002-2731-2720; Nedomansky, Jakob/0000-0002-5090-1144				Askar I, 2002, ANN PLAS SURG, V49, P297, DOI 10.1097/00000637-200209000-00010; BARLOCK AL, 1979, AM J NURS, V79, P94, DOI 10.2307/3462426; Brown RFR, 1998, BURNS, V24, P692, DOI 10.1016/S0305-4179(98)00105-3; Giunta RE, 2005, BRIT J PLAST SURG, V58, P695, DOI 10.1016/j.bjps.2005.02.018; Haslik W, 2004, BURNS, V30, P232, DOI 10.1016/j.burns.2003.10.016; Kamolz LP, 2006, J TRAUMA, V61, P635, DOI 10.1097/01.ta.0000233910.47550.9c; Kamolz LP, 2003, BURNS, V29, P785, DOI 10.1016/S0305-4179(03)00200-6; LAUGHLIN RA, 1979, AM J SURG, V137, P408, DOI 10.1016/0002-9610(79)90077-1; Mader I, 2010, EXTRAVASATION OF CYTOTOXIC AGENTS: COMPENDIUM FOR PREVENTION AND MANAGEMENT, SECOND EDITION, P1, DOI 10.1007/978-3-211-88893-3; PETRO JA, 1979, SURG FORUM, V30, P535; Polom K, 2011, CANCER-AM CANCER SOC, V117, P4812, DOI 10.1002/cncr.26087; RUDOLPH R, 1976, CANCER, V38, P1087, DOI 10.1002/1097-0142(197609)38:3<1087::AID-CNCR2820380308>3.0.CO;2-X; Yannuzzi LA, 2011, AM J OPHTHALMOL, V151, P745, DOI 10.1016/j.ajo.2011.01.043	13	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103649	10.1371/journal.pone.0103649	http://dx.doi.org/10.1371/journal.pone.0103649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144707	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100008
J	Hsiao, PC; Chou, YE; Tan, P; Lee, WJ; Yang, SF; Chow, JM; Chen, HY; Lin, CH; Lee, LM; Chien, MH				Hsiao, Pei-Ching; Chou, Ying-Erh; Tan, Peng; Lee, Wei-Jiunn; Yang, Shun-Fa; Chow, Jyh-Ming; Chen, Hui-Yu; Lin, Chien-Huang; Lee, Liang-Ming; Chien, Ming-Hsien			Pterostilbene Simultaneously Induced G0/G1-Phase Arrest and MAPK-Mediated Mitochondrial-Derived Apoptosis in Human Acute Myeloid Leukemia Cell Lines	PLOS ONE			English	Article							CANCER-CELLS; CYCLE ARREST; IN-VITRO; CARCINOMA-CELLS; DEATH PROGRAM; LUNG-CANCER; RESVERATROL; INDUCTION; THERAPY; GROWTH	Background: Pterostilbene (PTER) is a dimethylated analog of the phenolic phytoalexin, resveratrol, with higher anticancer activity in various tumors. Herein, the molecular mechanisms by which PTER exerts its anticancer effects against acute myeloid leukemia (AML) cells were investigated. Methodology and Principal Findings: Results showed that PTER suppressed cell proliferation in various AML cell lines. PTER-induced G0/G1-phase arrest occurred when expressions of cyclin D3 and cyclin-dependent kinase (CDK)2/6 were inhibited. PTER-induced cell apoptosis occurred through activation of caspases-8-9/-3, and a mitochondrial membrane permeabilization (MMP)-dependent pathway. Moreover, treatment of HL-60 cells with PTER induced sustained activation of extracellular signal-regulated kinase (ERK)1/2 and c-Jun N-terminal kinase (JNK)1/2, and inhibition of both MAPKs by their specific inhibitors significantly abolished the PTER-induced activation of caspases-8/-9/-3. Of note, PTER-induced cell growth inhibition was only partially reversed by the caspase-3-specific inhibitor, Z-DEVE-FMK, suggesting that this compound may also act through a caspase-independent pathway. Interestingly, we also found that PTER promoted disruption of lysosomal membrane permeabilization (LMP) and release of activated cathepsin B. Conclusion: Taken together, our results suggest that PTER induced HL-60 cell death via MAPKs-mediated mitochondria apoptosis pathway and loss of LMP might be another cause for cell apoptosis induced by PTER.	[Hsiao, Pei-Ching] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsiao, Pei-Ching] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Chou, Ying-Erh; Yang, Shun-Fa; Chen, Hui-Yu] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tan, Peng; Chien, Ming-Hsien] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Lee, Wei-Jiunn; Lee, Liang-Ming] Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chow, Jyh-Ming] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Taipei, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Lee, LM (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan.	lm@tmu.edu.tw; mhchien1976@gmail.com	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Lin, Chien-Huang/0000-0002-0916-8737	Wan Fang Hospital-Taipei Medical University [103 swf03, 103 TMU-WFH-04]; Chung Shan Medical University Hospital, Taiwan [CSH-2014-C-020]	Wan Fang Hospital-Taipei Medical University; Chung Shan Medical University Hospital, Taiwan	This study was supported by no. 103 swf03 and 103 TMU-WFH-04 from Wan Fang Hospital-Taipei Medical University. This study was also supported by a grant (CSH-2014-C-020) from Chung Shan Medical University Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Bishop JF, 1997, SEMIN ONCOL, V24, P57; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973; Carter BZ, 2012, LEUKEMIA, V26, P443, DOI 10.1038/leu.2011.246; Chen TF, 2008, J AGR FOOD CHEM, V56, P10574, DOI 10.1021/jf802125t; Chien MH, 2009, CARCINOGENESIS, V30, P2005, DOI 10.1093/carcin/bgp244; Chinkwo KA, 2005, J ETHNOPHARMACOL, V98, P163, DOI 10.1016/j.jep.2005.01.016; Cichocki M, 2008, MOL NUTR FOOD RES, V52, pS62, DOI 10.1002/mnfr.200700466; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Garcia-Zepeda SP, 2013, EUR J CANC PREV; Gautam SC, 2000, BONE MARROW TRANSPL, V25, P639, DOI 10.1038/sj.bmt.1702189; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Hwang JM, 2009, MOL CELL BIOCHEM, V327, P135, DOI 10.1007/s11010-009-0051-3; Jacks T, 1996, NATURE, V381, P643, DOI 10.1038/381643a0; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; Liu P, 2013, CLIN TRANSL ONCOL; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524; Mgbonyebi OP, 1998, INT J ONCOL, V12, P865; Nutakul W, 2011, J AGR FOOD CHEM, V59, P10964, DOI 10.1021/jf202846b; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pan MH, 2007, J AGR FOOD CHEM, V55, P7777, DOI 10.1021/jf071520h; Pan ZQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-7; Ralph SJ, 2009, MOL NUTR FOOD RES, V53, P9, DOI 10.1002/mnfr.200800044; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Roslie H, 2012, J TOXICOL SCI, V37, P13, DOI 10.2131/jts.37.13; Schneider JG, 2010, J SURG RES, V161, P18, DOI 10.1016/j.jss.2009.06.027; Schneider Y, 2000, CANCER LETT, V158, P85, DOI 10.1016/S0304-3835(00)00511-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sheth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051655; Siedlecka-Kroplewska K, 2012, FOLIA HISTOCHEM CYTO, V50, P574, DOI [10.5603/FHC.2012.0080, 10.5603/20257]; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tsan MF, 2000, BRIT J HAEMATOL, V109, P405, DOI 10.1046/j.1365-2141.2000.01980.x; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang TTY, 2010, MOL NUTR FOOD RES, V54, P335, DOI 10.1002/mnfr.200900143; Wang YS, 2012, AM J TRANSL RES, V4, P44; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Zhang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046853	49	41	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105342	10.1371/journal.pone.0105342	http://dx.doi.org/10.1371/journal.pone.0105342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144448	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100055
J	Okulicz, JF; Mesner, O; Ganesan, A; O'Bryan, TA; Deiss, RG; Agan, BK				Okulicz, Jason F.; Mesner, Octavio; Ganesan, Anuradha; O'Bryan, Thomas A.; Deiss, Robert G.; Agan, Brian K.			Hepatitis B Vaccine Responsiveness and Clinical Outcomes in HIV Controllers	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; T-CELL COUNT; INFECTED INDIVIDUALS; VIRUS VACCINE; ELITE CONTROLLERS; NATURAL-HISTORY; LONG-TERM; LOW-LEVEL; ANTIGEN; ADULTS	Background: Hepatitis B virus (HBV) vaccine responsiveness is associated with reduced risk of AIDS or death in HIV-infected individuals. Although HIV controllers (HIC) typically have favorable immunologic and clinical characteristics compared to non-controllers, vaccine responsiveness has not been studied. Methods and Findings: In the U.S. Military HIV Natural History Study, HBV vaccine response was defined as antibody to hepatitis B surface antigen (anti-HBs) >= 10 IU/L after last vaccination. For determination of vaccine responsiveness, HIC (n = 44) and treatment-naive non-controllers (n = 476) were not on highly active antiretroviral therapy (HAART) when vaccinated while treated non-controllers (n = 284) received all HBV vaccine doses during viral load (VL)-suppressive HAART. Progression to AIDS or death was also compared for all HIC (n = 143) and non-controllers (n = 1566) with documented anti-HBs regardless of the timing of HBV vaccination. Positive vaccine responses were more common in HIC (65.9%) compared to HAART-naive non-controllers (36.6%; P<0.001), but similar to non-controllers on HAART (59.9%; P = 0.549). Factors associated with vaccine response for HIC compared to HAART-naive non-controllers include HIC status (OR 2.65, 95% CI 1.23-5.89; P - 0.014), CD4 count at last vaccination (OR 1.28, 1.15-1.45 for every 100 cells/uL; P<0.001), and number of vaccine doses administered (OR 0.56, 0.35-0.88; P = 0.011). When HIC were compared to non-controllers on HAART, only CD4 count at last vaccination was significant (OR 1.23, 1.1-1.38 for every 100 cells/uL; P<0.001). The rate of AIDS or death per 100 person/years for HIC compared to non-controllers was 0.14 (95% CI 0-0.76) versus 0.98 (95% CI 0.74-1.28) for vaccine responders and 0 (95% CI 0-2.22) versus 4.11 (95% CI 3.38-4.96) for non-responders, respectively. Conclusions: HIC have improved HBV vaccine responsiveness compared to treatment-naive non-controllers, but similar to those on VL-suppressive HAART. Progression to AIDS or death can be predicted by HBV vaccine responder status for non-controllers, however these events are rarely observed in HIC.	[Okulicz, Jason F.; Mesner, Octavio; Ganesan, Anuradha; O'Bryan, Thomas A.; Deiss, Robert G.; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Okulicz, Jason F.; O'Bryan, Thomas A.] San Antonio Mil Med Ctr, Infect Dis Serv, San Antonio, TX USA; [Ganesan, Anuradha] Walter Reed Natl Mil Med Ctr, Infect Dis Serv, Bethesda, MD USA; [Deiss, Robert G.] Naval Med Ctr San Diego, Infect Dis Clin, San Diego, CA USA	Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; Naval Medical Center San Diego	Okulicz, JF (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.	jason.f.okulicz.mil@mail.mil		Agan, Brian/0000-0002-5114-1669; Mesner, Octavio/0000-0002-6024-9508	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) through the Uniformed Services University of the Health Sciences [IDCRP-000-05]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement [Y1-AI-5072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work (IDCRP-000-05) was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2013, CLIN INFECT DIS; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bauer T, 2006, VACCINE, V24, P572, DOI 10.1016/j.vaccine.2005.08.058; Brandt L, 2011, JAIDS-J ACQ IMM DEF, V57, P101, DOI 10.1097/QAI.0b013e318215a991; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; COLLIER AC, 1988, ANN INTERN MED, V109, P101, DOI 10.7326/0003-4819-109-2-101; Cooper CL, 2005, AIDS, V19, P1473, DOI 10.1097/01.aids.0000183514.37513.d2; Balado MDD, 2010, J INFECT DIS, V202, P362, DOI 10.1086/653707; Fonseca MO, 2005, VACCINE, V23, P2902, DOI 10.1016/j.vaccine.2004.11.057; Gaardbo JC, 2013, J ACQUIR IMMUNE DEFI; Goncalves L, 2004, VIROLOGY, V326, P20, DOI 10.1016/j.virol.2004.04.042; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Landrum ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033488; Landrum ML, 2009, VACCINE, V27, P4731, DOI 10.1016/j.vaccine.2009.04.016; Lao-Araya M, 2007, VACCINE, V25, P5324, DOI 10.1016/j.vaccine.2007.05.006; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Moir S, 2003, P NATL ACAD SCI USA, V100, P6057, DOI 10.1073/pnas.0730819100; Okulicz JF, 2010, CLIN INFECT DIS, V50, P1187, DOI 10.1086/651421; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Overton ET, 2005, CLIN INFECT DIS, V41, P1045, DOI 10.1086/433180; Pasricha N, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-65; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Potsch DV, 2012, VACCINE, V30, P5973, DOI 10.1016/j.vaccine.2012.07.028; Sajadi MM, 2009, JAIDS-J ACQ IMM DEF, V50, P403, DOI 10.1097/QAI.0b013e3181945f1e; Shafran SD, 2007, HIV MED, V8, P295, DOI 10.1111/j.1468-1293.2007.00473.x; Tsai IJ, 2000, VACCINE, V19, P437, DOI 10.1016/S0264-410X(00)00205-X; van den Berg R, 2009, AIDS REV, V11, P157; Vingert B, 2012, J VIROL, V86, P10661, DOI 10.1128/JVI.00056-12; Whittall T, 2011, CLIN EXP IMMUNOL, V166, P208, DOI 10.1111/j.1365-2249.2011.04463.x; Yao ZQ, 2013, ARCH IMMUNOL THER EX, V61, P193, DOI 10.1007/s00005-013-0219-0	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105591	10.1371/journal.pone.0105591	http://dx.doi.org/10.1371/journal.pone.0105591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144773	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100090
J	Zhao, L; Luo, L; Jia, WK; Xiao, J; Huang, G; Tian, G; Li, JW; Xiao, YB				Zhao, Liang; Luo, Lin; Jia, Weikun; Xiao, Juan; Huang, Gang; Tian, Geng; Li, Jingwei; Xiao, Yingbin			Serum Diamine Oxidase as a Hemorrhagic Shock Biomarker in a Rabbit Model	PLOS ONE			English	Article							MULTIPLE-ORGAN FAILURE; GUT BARRIER FAILURE; TRAUMA-HEMORRHAGE; MESENTERIC LYMPH; ISCHAEMIA/REPERFUSION INJURY; MYELOPEROXIDASE ACTIVITY; BACTERIAL TRANSLOCATION; NEUTROPHIL INFILTRATION; CYTOKINE RESPONSE; MUCUS LAYER	Background: In prolonged hemorrhagic shock, reductions in intestinal mucosal blood perfusion lead to mucosal barrier damage and systemic inflammation. Gastrointestinal failure in critically ill patients has a poor prognosis, so early assessment of mucosal barrier injury in shock patients is clinically relevant. Unfortunately, there is no serum marker that can accurately assess intestinal ischemia-reperfusion injury. Objective: The aim of this study was to assess if serum diamine oxidase levels can reflect intestinal mucosal injury subsequent to prolonged hemorrhagic shock. Methods: Thirty New Zealand white rabbits were divided into three groups: a control group, a medium blood pressure (BP) group (exsanguinated to a shock BP of 50 to 41 mm Hg), and a low BP group (exsanguinated to a shock blood pressure of 40 to 31 mm Hg), in which the shock BP was sustained for 180 min prior to fluid resuscitation. Results: The severity of hemorrhagic shock in the low BP group was significantly greater than that of the medium BP group according to the post-resuscitation BP, serum tumor necrosis factor (TNF)-alpha, and arterial lactate. Intestinal damage was significantly more severe in the low BP group according to Chiu's scoring, claudin-1, intercellular adhesion molecule (ICAM)-1, and myeloperoxidase expression. Serum diamine oxidase was significantly increased in the low BP group compared to the medium BP and control groups and was negatively correlated with shock BP. Conclusion: Serum diamine oxidase can be used as a serological marker in evaluating intestinal injury and shows promise as an indicator of hemorrhagic shock severity.	[Zhao, Liang; Luo, Lin; Jia, Weikun; Xiao, Juan; Huang, Gang; Tian, Geng; Li, Jingwei; Xiao, Yingbin] Third Mil Med Univ, Xinqiao Hosp, Dept Cardiovasc Surg, Chongqing, Peoples R China	Army Medical University	Xiao, YB (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Cardiovasc Surg, Chongqing, Peoples R China.	xyb023@126.com		Li, Jing-Wei/0000-0003-1638-2317	Military Clinical High Technology Major Project of China [2010gxjs069]	Military Clinical High Technology Major Project of China	This study was supported by the Military Clinical High Technology Major Project of China (grant number: 2010gxjs069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser AR, 2013, INTENS CARE MED, V39, P899, DOI 10.1007/s00134-013-2831-1; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; BOUNOUS G, 1984, DIGEST DIS SCI, V29, P872, DOI 10.1007/BF01318436; BRAGG LE, 1991, J SURG RES, V50, P228, DOI 10.1016/0022-4804(91)90183-M; Cai CM, 2012, HEPATO-GASTROENTEROL, V59, P155, DOI 10.5754/hge11226; Cakmaz R, 2013, LIBYAN J MED, V8, DOI 10.3402/ljm.v8i0.20596; Caputo FJ, 2007, SHOCK, V28, P441, DOI 10.1097/shk.0b013e31804858f2; Childs EW, 1999, SHOCK, V11, P248, DOI 10.1097/00024382-199904000-00004; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Ciesla DJ, 2005, ARCH SURG-CHICAGO, V140, P432, DOI 10.1001/archsurg.140.5.432; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; DAGOSTINO L, 1984, ENZYME, V31, P217, DOI 10.1159/000469529; Dayal SD, 2002, SHOCK, V17, P491, DOI 10.1097/00024382-200206000-00009; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Fazal N, 2000, CRIT CARE MED, V28, P1550, DOI 10.1097/00003246-200005000-00048; Fishman JE, 2013, AM J PHYSIOL-GASTR L, V304, pG57, DOI 10.1152/ajpgi.00170.2012; Frink M, 2007, MOL IMMUNOL, V44, P2625, DOI 10.1016/j.molimm.2006.12.009; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hierholzer C, 2004, AM J PHYSIOL-GASTR L, V286, pG225, DOI 10.1152/ajpgi.00447.2002; Homma H, 2005, AM J PHYSIOL-GASTR L, V288, pG466, DOI 10.1152/ajpgi.00036.2004; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; Jastrow KM, 2009, J AM COLL SURGEONS, V209, P320, DOI 10.1016/j.jamcollsurg.2009.05.002; KUROSE I, 1994, CIRC RES, V74, P336, DOI 10.1161/01.RES.74.2.336; Lee CC, 2007, ANN EMERG MED, V49, P37, DOI 10.1016/j.annemergmed.2006.05.031; Lu Q, 2004, CRIT CARE MED, V32, P2464, DOI 10.1097/01.CCM.0000147833.51214.03; Lu Q, 2011, J TRAUMA, V70, P630, DOI 10.1097/TA.0b013e3181e1221b; Mondello S, 2010, EUR J PHARMACOL, V643, P304, DOI 10.1016/j.ejphar.2010.06.044; Moomey CB, 1999, CRIT CARE MED, V27, P154, DOI 10.1097/00003246-199901000-00044; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Puleo F, 2011, SEMIN RESP CRIT CARE, V32, P626, DOI 10.1055/s-0031-1287871; Reintam A, 2008, CRIT CARE, V12, DOI 10.1186/cc6958; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Sambol JT, 2009, J APPL PHYSIOL, V106, P57, DOI 10.1152/japplphysiol.90937.2008; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sheng WH, 2005, J FORMOS MED ASSOC, V104, P715; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Tamion F, 1997, AM J PHYSIOL-GASTR L, V273, pG314, DOI 10.1152/ajpgi.1997.273.2.G314; Wanner GA, 1999, SHOCK, V11, P391; WOLVEKAMP MCJ, 1994, DIGEST DIS, V12, P2; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P277, DOI 10.1189/jlb.0705363	47	29	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e102285	10.1371/journal.pone.0102285	http://dx.doi.org/10.1371/journal.pone.0102285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144315	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100003
J	Miotto, EC; Balardin, JB; Vieira, G; Sato, JR; Martin, MDM; Scaff, M; Teixeira, MJ; Amaro, E				Miotto, Eliane C.; Balardin, Joana B.; Vieira, Gilson; Sato, Joao R.; Martin, Maria da Graca M.; Scaff, Milberto; Teixeira, Manoel J.; Amaro Junior, Edson			Right Inferior Frontal Gyrus Activation Is Associated with Memory Improvement in Patients with Left Frontal Low-Grade Glioma Resection	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN; PLASTICITY; STRATEGIES; LOBES	Patients with low-grade glioma (LGG) have been studied as a model of functional brain reorganization due to their slow-growing nature. However, there is no information regarding which brain areas are involved during verbal memory encoding after extensive left frontal LGG resection. In addition, it remains unknown whether these patients can improve their memory performance after instructions to apply efficient strategies. The neural correlates of verbal memory encoding were investigated in patients who had undergone extensive left frontal lobe (LFL) LGG resections and healthy controls using fMRI both before and after directed instructions were given for semantic organizational strategies. Participants were scanned during the encoding of word lists under three different conditions before and after a brief period of practice. The conditions included semantically unrelated (UR), related-non-structured (RNS), and related-structured words (RS), allowing for different levels of semantic organization. All participants improved on memory recall and semantic strategy application after the instructions for the RNS condition. Healthy subjects showed increased activation in the left inferior frontal gyrus (IFG) and middle frontal gyrus (MFG) during encoding for the RNS condition after the instructions. Patients with LFL excisions demonstrated increased activation in the right IFG for the RNS condition after instructions were given for the semantic strategies. Despite extensive damage in relevant areas that support verbal memory encoding and semantic strategy applications, patients that had undergone resections for LFL tumor could recruit the right-sided contralateral homologous areas after instructions were given and semantic strategies were practiced. These results provide insights into changes in brain activation areas typically implicated in verbal memory encoding and semantic processing.	[Miotto, Eliane C.; Balardin, Joana B.; Scaff, Milberto; Teixeira, Manoel J.] Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil; [Vieira, Gilson; Martin, Maria da Graca M.; Amaro Junior, Edson] Univ Sao Paulo, Dept Radiol, Sao Paulo, Brazil; [Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Miotto, EC (corresponding author), Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil.	ecmiotto@usp.br	amaro, edson/GLR-7735-2022; Amaro, Edson/B-6653-2009; Vieira, Gilson/H-9984-2015; Miotto, Eliane C/B-5380-2013; Balardin, Joana/I-5561-2016	amaro, edson/0000-0002-5889-1382; Amaro, Edson/0000-0002-5889-1382; Vieira, Gilson/0000-0001-5877-2810; Miotto, Eliane C/0000-0003-2711-1627; Sato, Joao Ricardo/0000-0002-7503-9781	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2000/11802-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP N. 2000/11802-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MP, 2009, J COGNITIVE NEUROSCI, V21, P1422, DOI 10.1162/jocn.2009.21094; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; Champod AS, 2010, J NEUROSCI, V30, P3849, DOI 10.1523/JNEUROSCI.0097-10.2010; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Duffau H, 2003, J NEUROL NEUROSUR PS, V74, P901, DOI 10.1136/jnnp.74.7.901; Duffau H, 2012, CORTEX, V48, P120, DOI 10.1016/j.cortex.2011.04.029; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Fridriksson J, 2012, NEUROIMAGE, V60, P854, DOI 10.1016/j.neuroimage.2011.12.057; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Kirchhoff BA, 2012, CEREB CORTEX, V22, P788, DOI 10.1093/cercor/bhr129; Klein M, 2012, J NEURO-ONCOL, V108, P309, DOI 10.1007/s11060-012-0811-x; Miotto EC, 1996, CORTEX, V32, P613, DOI 10.1016/S0010-9452(96)80034-7; Miotto EC, 2006, HUM BRAIN MAPP, V27, P288, DOI 10.1002/hbm.20184; Miotto EC, 2013, CLIN NEUROL NEUROSUR, V115, P309, DOI 10.1016/j.clineuro.2012.05.024; Miotto EC, 2011, ARQ NEURO-PSIQUIAT, V69, P596, DOI 10.1590/S0004-282X2011000500005; Nascimento E., 2004, WAIS III ESCALA INTE; Rey A., 1958, LEXAMEN CLINIQUE PSY; Richardson JD, 2011, BEHAV NEUROL, V24, P117, DOI [10.3233/BEN-2011-0283, 10.1155/2011/380810]; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Warrington E.K., 1984, RECOGNITION MEMORY T	25	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105987	10.1371/journal.pone.0105987	http://dx.doi.org/10.1371/journal.pone.0105987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157573	gold, Green Published, Green Submitted			2022-12-27	WOS:000341303200084
J	Bonardi, D; Ravasio, V; Borsani, G; d'Azzo, A; Bresciani, R; Monti, E; Giacopuzzi, E				Bonardi, Dario; Ravasio, Viola; Borsani, Giuseppe; d'Azzo, Alessandra; Bresciani, Roberto; Monti, Eugenio; Giacopuzzi, Edoardo			In Silico Identification of New Putative Pathogenic Variants in the Neu1 Sialidase Gene Affecting Enzyme Function and Subcellular Localization	PLOS ONE			English	Article							HUMAN LYSOSOMAL NEURAMINIDASE; ELASTIN-DERIVED PEPTIDES; SIALIDOSIS; MUTATIONS; PREVALENCE; DEFICIENCY; INSIGHTS; DISEASE; GENOMES; IMPACT	The NEU1 gene is the first identified member of the human sialidases, glycohydrolitic enzymes that remove the terminal sialic acid from oligosaccharide chains. Mutations in NEU1 gene are causative of sialidosis (MIM 256550), a severe lysosomal storage disorder showing autosomal recessive mode of inheritance. Sialidosis has been classified into two subtypes: sialidosis type I, a normomorphic, late-onset form, and sialidosis type II, a more severe neonatal or early-onset form. A total of 50 causative mutations are reported in HGMD database, most of which are missense variants. To further characterize the NEU1 gene and identify new functionally relevant protein isoforms, we decided to study its genetic variability in the human population using the data generated by two large sequencing projects: the 1000 Genomes Project (1000G) and the NHLBI GO Exome Sequencing Project (ESP). Together these two datasets comprise a cohort of 7595 sequenced individuals, making it possible to identify rare variants and dissect population specific ones. By integrating this approach with biochemical and cellular studies, we were able to identify new rare missense and frameshift alleles in NEU1 gene. Among the 9 candidate variants tested, only two resulted in significantly lower levels of sialidase activity (p<0.05), namely c.650T>C and c.700G>A. These two mutations give rise to the amino acid substitutions p.V217A and p.D234N, respectively. NEU1 variants including either of these two amino acid changes have 44% and 25% residual sialidase activity when compared to the wild-type enzyme, reduced protein levels and altered subcellular localization. Thus they may represent new, putative pathological mutations resulting in sialidosis type I. The in silico approach used in this study has enabled the identification of previously unknown NEU1 functional alleles that are widespread in the population and could be tested in future functional studies.	[Bonardi, Dario; Bresciani, Roberto; Monti, Eugenio] Univ Brescia, Unit Biotechnol, Dept Mol & Translat Med, Brescia, Lombardy, Italy; [Ravasio, Viola; Borsani, Giuseppe; Giacopuzzi, Edoardo] Univ Brescia, Unit Biol & Genet, Dept Mol & Translat Med, Brescia, Lombardy, Italy; [d'Azzo, Alessandra] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	University of Brescia; University of Brescia; St Jude Children's Research Hospital	Giacopuzzi, E (corresponding author), Univ Brescia, Unit Biol & Genet, Dept Mol & Translat Med, Brescia, Lombardy, Italy.	edoardo.giacopuzzi@unibs.it	Bresciani, Roberto/AAA-9728-2020; Borsani, Giuseppe/B-1709-2010	Bresciani, Roberto/0000-0002-7881-7550; Giacopuzzi, Edoardo/0000-0002-5692-366X; MONTI, Eugenio/0000-0002-4742-7445; Borsani, Giuseppe/0000-0003-0110-1148	"Ministero dell'Istruzione, dell'Universita e della Ricerca'' (MIUR); Regione Lombardia; Network Enable Drug Discovery (NEDD)	"Ministero dell'Istruzione, dell'Universita e della Ricerca'' (MIUR)(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia); Network Enable Drug Discovery (NEDD)	This work was supported by "Ministero dell'Istruzione, dell'Universita e della Ricerca'' (MIUR) funds to GB and EM, and was partly supported by Regione Lombardia (http://www.regione.lombardia.it), and Network Enable Drug Discovery (NEDD) grant to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Annunziata I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3734; Blaise S, 2013, DIABETES, V62, P3807, DOI 10.2337/db13-0508; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2000, HUM MOL GENET, V9, P2715, DOI 10.1093/hmg/9.18.2715; Bonten EJ, 2009, J BIOL CHEM, V284, P28430, DOI 10.1074/jbc.M109.031419; Buschiazzo A, 2008, CURR OPIN CHEM BIOL, V12, P565, DOI 10.1016/j.cbpa.2008.06.017; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; d'Azzo A, 2010, BIOCHEM SOC T, V38, P1453, DOI 10.1042/BST0381453; Dridi L, 2013, DIABETES, V62, P2338, DOI 10.2337/db12-1825; Gayral S, 2014, CARDIOVASC RES, V102, P118, DOI 10.1093/cvr/cvt336; Giacopuzzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044193; Giacopuzzi E, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-45; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LOWDEN JA, 1979, AM J HUM GENET, V31, P1; Lukong KE, 2001, J BIOL CHEM, V276, P17286, DOI 10.1074/jbc.M100460200; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Naganawa Y, 2000, J HUM GENET, V45, P241, DOI 10.1007/s100380070034; Natori Y, 2013, BIOL PHARM BULL, V36, P1027, DOI 10.1248/bpb.b12-00995; Pattison S, 2004, HUM MUTAT, V23, P32, DOI 10.1002/humu.10278; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seyrantepe V, 2003, HUM MUTAT, V22, P343, DOI 10.1002/humu.10268; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; van der Spoel A, 1998, EMBO J, V17, P1588, DOI 10.1093/emboj/17.6.1588; Wang D, 2009, BBA-GEN SUBJECTS, V1790, P275, DOI 10.1016/j.bbagen.2009.01.006; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	33	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104229	10.1371/journal.pone.0104229	http://dx.doi.org/10.1371/journal.pone.0104229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153125	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200016
J	Downey, SS; Bocaege, E; Kerig, T; Edinborough, K; Shennan, S				Downey, Sean S.; Bocaege, Emmy; Kerig, Tim; Edinborough, Kevan; Shennan, Stephen			The Neolithic Demographic Transition in Europe: Correlation with Juvenility Index Supports Interpretation of the Summed Calibrated Radiocarbon Date Probability Distribution (SCDPD) as a Valid Demographic Proxy	PLOS ONE			English	Article							POPULATION; SETTLEMENT	Analysis of the proportion of immature skeletons recovered from European prehistoric cemeteries has shown that the transition to agriculture after 9000 BP triggered a long- term increase in human fertility. Here we compare the largest analysis of European cemeteries to date with an independent line of evidence, the summed calibrated date probability distribution of radiocarbon dates (SCDPD) from archaeological sites. Our cemetery reanalysis confirms increased growth rates after the introduction of agriculture; the radiocarbon analysis also shows this pattern, and a significant correlation between both lines of evidence confirms the demographic validity of SCDPDs. We analyze the areal extent of Neolithic enclosures and demographic data from ethnographically known farming and foraging societies and we estimate differences in population levels at individual sites. We find little effect on the overall shape and precision of the SCDPD and we observe a small increase in the correlation with the cemetery trends. The SCDPD analysis supports the hypothesis that the transition to agriculture dramatically increased demographic growth, but it was followed within centuries by a general pattern of collapse even after accounting for higher settlement densities during the Neolithic. The study supports the unique contribution of SCDPDs as a valid demographic proxy for the demographic patterns associated with early agriculture.	[Downey, Sean S.] Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA; [Downey, Sean S.; Bocaege, Emmy; Kerig, Tim; Edinborough, Kevan; Shennan, Stephen] UCL, Inst Archaeol, London, England; [Kerig, Tim] Univ Cologne, Res Training Grp Archaeol Premodern Econ 1878, D-50931 Cologne, North Rhine Wes, Germany	University System of Maryland; University of Maryland College Park; University of London; University College London; University of Cologne	Downey, SS (corresponding author), Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA.	sdowney2@umd.edu	Edinborough, Kevan/ABE-9343-2021	Edinborough, Kevan/0000-0002-7668-0749; Bocaege, Emmy/0000-0002-9988-3530	European Research Council [249390]	European Research Council(European Research Council (ERC)European Commission)	The work described here was supported by European Research Council Advanced Grant #249390 to Shennan (http://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; Barry S., 2006, HISTOIRE, P45; Bellwood P, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P13, DOI 10.1007/978-1-4020-8539-0_2; Binford L.R., 1968, NEW PERSPECTIVES ARC, P313; BOCQUET JP, 1977, HOMME, V17, P65; Bocquet-Appel JP, 2006, CURR ANTHROPOL, V47, P341, DOI 10.1086/498948; Bocquet-Appel JP, 2011, CURR ANTHROPOL, V52, pS497, DOI 10.1086/659243; Bocquet-Appel JP, 2011, SCIENCE, V333, P560, DOI 10.1126/science.1208880; Bocquet-Appel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P35, DOI 10.1007/978-1-4020-8539-0_3; Bocquet-Appel JP, 2009, CURR ANTHROPOL, V50, P657, DOI 10.1086/605552; Bocquet-Appel JP, 2002, CURR ANTHROPOL, V43, P637, DOI 10.1086/342429; BocquetAppel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P1, DOI 10.1007/978-1-4020-8539-0; Collard M, 2010, J ARCHAEOL SCI, V37, P866, DOI 10.1016/j.jas.2009.11.016; Conneller C, 2012, ANTIQUITY, V86, P1004, DOI 10.1017/S0003598X00048213; Dyson T, 2010, ZED BOOKS; Emmott S., 2013, 10 BILLION; Guerrero E, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P57, DOI 10.1007/978-1-4020-8539-0_4; Heaton TJ, 2009, RADIOCARBON, V51, P1151, DOI 10.1017/S0033822200034214; Hoppa R.D., 2002, PALEODEMOGRAPHY AGE; Jackes M, 2001, IRON GATES PREHISTOR, P77; Jackes M, 2009, FRONT ORAL BIOL, V13, P167, DOI 10.1159/000242412; Jackes Mary K., 1988, RIV ANTROPOLOGIA S, V66, P141; Kennett DJ, 2002, RADIOCARBON, V44, P53, DOI 10.1017/S0033822200064663; Kohler TA, 2008, AM ANTIQUITY, V73, P645, DOI 10.2307/25470522; Meiklejohn C., 1997, INTEGRATING ARCHAEOL, P311; Murdock GP, 2003, STANDARD CROSS CULTU; Ortman SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087902; Parnell AC, 2008, QUATERNARY SCI REV, V27, P1872, DOI 10.1016/j.quascirev.2008.07.009; Redman CL, 2005, AM ANTHROPOL, V107, P70, DOI 10.1525/aa.2005.107.1.070; RICK JW, 1987, AM ANTIQUITY, V52, P55, DOI 10.2307/281060; Schreiber KJ, 1996, AM ANTIQUITY, V61, P573, DOI 10.2307/281841; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; SUMNER WM, 1989, AM ANTHROPOL, V91, P631, DOI 10.1525/aa.1989.91.3.02a00060; Team R, 2008, R LANG ENV STAT COMP; Terberger T, 2004, WORKSH UISPP COMM 32; Turchin P, 2009, ANN NY ACAD SCI, V1162, P1, DOI 10.1111/j.1749-6632.2009.04447.x; Valeggia C, 2004, J BIOSOC SCI, V36, P573, DOI 10.1017/S0021932003006382; Whitelaw Todd., 1989, THESIS U CAMBRIDGE	39	58	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105730	10.1371/journal.pone.0105730	http://dx.doi.org/10.1371/journal.pone.0105730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AN9TR	25153481	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000340952200074
J	Nilsen, A; Fusser, M; Greggains, G; Fedorcsak, P; Klungland, A				Nilsen, Anja; Fusser, Markus; Greggains, Gareth; Fedorcsak, Peter; Klungland, Arne			ALKBH4 Depletion in Mice Leads to Spermatogenic Defects	PLOS ONE			English	Article							MEIOTIC PROPHASE; SYNAPTONEMAL COMPLEX; ACTIN; MOUSE; RNA; DYNAMICS; DIFFERENTIATION; RECOMBINATION; DEMETHYLATION; TRANSCRIPTION	ALKBH4, an AlkB homologue in the 2-oxoglutarate and Fe2+ dependent hydroxylase family, has previously been shown to regulate the level of monomethylated lysine-84 in actin and thereby indirectly influences the ability of non-muscular myosin II to bind actin filaments. ALKBH4 modulates fundamental processes including cytokinesis and cell motility, and its depletion is lethal during early preimplantation embryo stage. The aim of this study was to investigate the effect of ALKBH4 deficiency in a physiological context, using inducible Alkbh4 knockout mice. Here, we report that ALKBH4 is essential for the development of spermatocytes during the prophase of meiosis, and that ALKBH4 depletion leads to insufficient establishment of the synaptonemal complex. We also show that ALKBH4 is localized in nucleolar structures of Sertoli cells, spermatogonia and primary spermatocytes.	[Nilsen, Anja; Fusser, Markus; Klungland, Arne] Univ Oslo, Oslo Univ Hosp, Inst Med Microbiol, Rikshosp, Oslo, Norway; [Greggains, Gareth; Fedorcsak, Peter] Oslo Univ Hosp, Rikshosp, Sect Reprod Med, Dept Gynecol, Oslo, Norway; [Klungland, Arne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Fedorcsak, P (corresponding author), Oslo Univ Hosp, Rikshosp, Sect Reprod Med, Dept Gynecol, Oslo, Norway.	peter.fedorcsak@medisin.uio.no; arne.klungland@rr-research.no	Klungland, Arne/X-1233-2019	Klungland, Arne/0000-0001-7274-3661; Greggains, Gareth/0000-0003-2424-4694	Norwegian Research Council; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Norwegian Research Council and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAVIND L, 2001, GENOME BIOL, V2; Bass HW, 2003, CELL MOL LIFE SCI, V60, P2319, DOI 10.1007/s00018-003-3312-4; Bjornstad LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049045; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Farrants AKO, 2008, FEBS LETT, V582, P2041, DOI 10.1016/j.febslet.2008.04.032; FAWCETT DW, 1959, J BIOPHYS BIOCHEM CY, V5, P453, DOI 10.1083/jcb.5.3.453; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Kerr JB, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P827; KIERSZENBAUM AL, 1974, J CELL BIOL, V60, P39, DOI 10.1083/jcb.60.1.39; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Lui DY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003197; MacQueen AJ, 2011, TRENDS CELL BIOL, V21, P393, DOI 10.1016/j.tcb.2011.03.004; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Percipalle P, 2009, CELL MOL LIFE SCI, V66, P2151, DOI 10.1007/s00018-009-0012-8; Qi TY, 2011, J BIOL CHEM, V286, P15171, DOI 10.1074/jbc.M110.184374; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; SCHWARZACHER HG, 1993, ANAT EMBRYOL, V188, P515; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Tres LL, 2005, MOL REPROD DEV, V72, P1, DOI 10.1002/mrd.20334; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Vogl AW, 2009, SERTOLI CELL CYTOSKE, P186; Xiao Xiang, 2007, Journal of Zhejiang University-Science B, V8, P498, DOI 10.1631/jzus.2007.B0498; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	40	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105113	10.1371/journal.pone.0105113	http://dx.doi.org/10.1371/journal.pone.0105113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153837	Green Submitted, gold, Green Published			2022-12-27	WOS:000340952200037
J	Ojha, D; Mukherjee, H; Mondal, S; Jena, A; Dwivedi, VP; Mondal, KC; Malhotra, B; Samanta, A; Chattopadhyay, D				Ojha, Durbadal; Mukherjee, Hemanta; Mondal, Supriya; Jena, Aditya; Dwivedi, Ved Prakash; Mondal, Keshab C.; Malhotra, Bharti; Samanta, Amalesh; Chattopadhyay, Debprasad			Anti-Inflammatory Activity of Odina wodier Roxb, an Indian Folk Remedy, through Inhibition of Toll-Like Receptor 4 Signaling Pathway	PLOS ONE			English	Article							NITRIC-OXIDE; PERMEABILITY; INFLAMMATION; INNATE; FAMILY; TLR4; MICE; LPS	Inflammation is part of self-limiting non-specific immune response, which occurs during bodily injury. In some disorders the inflammatory process becomes continuous, leading to the development of chronic inflammatory diseases including cardiovascular diseases, diabetes, cancer etc. Several Indian tribes used the bark of Odina wodier (OWB) for treating inflammatory disorders. Thus, we have evaluated the immunotherapeutic potential of OWB methanol extract and its major constituent chlorogenic acid (CA), using three popular in vivo antiinflammatory models: Carrageenan-and Dextran-induced paw edema, Cotton pellet granuloma, and Acetic acid-induced vascular permeability. To elucidate the possible antiinflammatory mechanism of action we determine the level of major inflammatory mediators (NO, iNOS, COX-2-dependent prostaglandin E2 or PGE2), and pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6, and IL-12). Further, we determine the toll-like receptor 4 (TLR4), Myeloid differentiation primary response gene 88 (MyD88), c-Jun N-terminal kinases (JNK), nuclear factor kappa-B cells (NF-kappa B), and NF-kappa B inhibitor alpha (IK-B alpha) by protein and mRNA expression, and Western blot analysis in drug treated LPS-induced murine macrophage model. Moreover, we determined the acute and sub-acute toxicity of OWB extract in BALB/c mice. Our study demonstrated a significant anti-inflammatory activity of OWB extract and CA along with the inhibition of TNF-alpha, IL-1 beta, IL-6 and IL-12 expressions. Further, the expression of TLR4, NF-kappa Bp65, MyD88, iNOS and COX-2 molecules were reduced in drug-treated groups, but not in the LPS-stimulated untreated or control groups, Thus, our results collectively indicated that the OWB extract and CA can efficiently inhibit inflammation through the down regulation of TLR4/MyD88/NF-kappa B signaling pathway.	[Ojha, Durbadal; Mukherjee, Hemanta; Mondal, Supriya; Jena, Aditya; Dwivedi, Ved Prakash; Chattopadhyay, Debprasad] ID & BG Hosp, ICMR Virus Unit, Kolkata, India; [Ojha, Durbadal; Samanta, Amalesh] Jadavpur Univ, Dept Pharmaceut Technol, Div Microbiol, Kolkata, India; [Mondal, Keshab C.] Vidyasagar Univ, Dept Microbiol, Midnapore, W Bengal, India; [Malhotra, Bharti] SMS Med Coll & Hosp, Dept Microbiol, Jaipur, Rajasthan, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; Jadavpur University; Vidyasagar University; SMS Medical College & Hospital	Samanta, A (corresponding author), Jadavpur Univ, Dept Pharmaceut Technol, Div Microbiol, Kolkata, India.	asamanta61@yahoo.co.in; debprasadc@yahoo.co.in	; Mondal, Keshab Chandra/B-3538-2019	CHATTOPADHYAY, Dr DEBPRASAD/0000-0002-7999-329X; Mondal, Keshab Chandra/0000-0003-3180-1567; Dwivedi, Ved Prakash/0000-0003-4321-2567				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arunachalam G, 2002, PHYTOMEDICINE, V9, P632, DOI 10.1078/094471102321616445; Bag P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077937; BETZ M, 1991, J IMMUNOL, V146, P108; Biswajit Mukherjee, 2006, Trends in Applied Sciences Research, V1, P309; Brown JN., 2006, GOODMAN GILMANS PHAR, V11, P645; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Chagas-Paula DA, 2011, J ETHNOPHARMACOL, V136, P355, DOI 10.1016/j.jep.2011.04.067; Chattopadhyay D, 2002, J ETHNOPHARMACOL, V82, P229, DOI 10.1016/S0378-8741(02)00165-4; Chattopadhyay D., 2012, EVIDENCED BASED COMP, V2012, DOI [10.1155/2012/254849, DOI 10.1155/2012/254849]; Chattopadhyay D, 2008, BIOTECHNOL ANN REV, V14, P297, DOI 10.1016/S1387-2656(08)00012-4; COLDITZ IG, 1985, SURV SYN PATHOL RES, V4, P44; dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Gaddi A, 2004, ARCH GERONTOL GERIAT, V38, P201, DOI 10.1016/j.archger.2003.10.001; Ghosh S, 2013, MED CHEM RES, V22, P4347, DOI 10.1007/s00044-012-0449-4; Griffon B, 1998, HEPATOLOGY, V28, P1300, DOI 10.1002/hep.510280519; Harbrecht BG, 1997, J LEUKOCYTE BIOL, V61, P712, DOI 10.1002/jlb.61.6.712; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Heller A, 1998, DRUGS, V55, P487, DOI 10.2165/00003495-199855040-00001; Imler JL, 2003, NAT IMMUNOL, V4, P105, DOI 10.1038/ni0203-105; Jagavelu K, 2010, HEPATOLOGY, V52, P590, DOI 10.1002/hep.23739; KASAMA T, 1993, J EXP MED, V178, P63, DOI 10.1084/jem.178.1.63; Kirtikar KR, 1999, INDIAN MED PLANTS; KLINGEMANN HG, 1986, BLOOD, V68, P102; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MAROTTA P, 1992, BRIT J PHARMACOL, V107, P640, DOI 10.1111/j.1476-5381.1992.tb14499.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MIZUSHIM.Y, 1965, LANCET, V1, P169; MOTA MLR, 1985, J ETHNOPHARMACOL, V13, P289, DOI 10.1016/0378-8741(85)90074-1; Mukherjee H, 2013, MICROBIOL RES, V168, P238, DOI 10.1016/j.micres.2012.11.002; Muthu C, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-43; Nagy LE, 2003, EXP BIOL MED, V228, P882, DOI 10.1177/153537020322800803; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ojha D, 2013, J APPL MICROBIOL, V115, P1317, DOI 10.1111/jam.12330; REED L. J., 1938, AMER JOUR HYG, V27, P493; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sur TK, 2002, PHYTOTHER RES, V16, P669, DOI 10.1002/ptr.942; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; WHITTLE BA, 1964, BRIT J PHARM CHEMOTH, V22, P246, DOI 10.1111/j.1476-5381.1964.tb02030.x; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; WILLIAMS TJ, 1973, NATURE, V246, P215, DOI 10.1038/246215a0	47	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104939	10.1371/journal.pone.0104939	http://dx.doi.org/10.1371/journal.pone.0104939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153081	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200031
J	Sivertsen, A; Billstrom, H; Melefors, O; Liljequist, BO; Wisell, KT; Ullberg, M; Ozenci, V; Sundsfjord, A; Hegstad, K				Sivertsen, Audun; Billstrom, Hanna; Melefors, Ojar; Liljequist, Barbro Olsson; Wisell, Karin Tegmark; Ullberg, Mans; Ozenci, Volkan; Sundsfjord, Arnfinn; Hegstad, Kristin			A Multicentre Hospital Outbreak in Sweden Caused by Introduction of a vanB2 Transposon into a Stably Maintained pRUM-Plasmid in an Enterococcus faecium ST192 Clone	PLOS ONE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; GENE-CLUSTER; GLYCOPEPTIDE RESISTANCE; MULTIDRUG-RESISTANT; AXE-TXE; FAECALIS; STRAINS; SUSCEPTIBILITY; DETERMINANTS; TRANSITION	The clonal dissemination of VanB-type vancomycin-resistant Enterococcus faecium (VREfm) strains in three Swedish hospitals between 2007 and 2011 prompted further analysis to reveal the possible origin and molecular characteristics of the outbreak strain. A representative subset of VREfm isolates (n = 18) and vancomycin-susceptible E. faecium (VSEfm, n = 2) reflecting the spread in time and location was approached by an array of methods including: selective whole genome sequencing (WGS; n = 3), multi locus sequence typing (MLST), antimicrobial susceptibility testing, virulence gene profiling, identification of mobile genetic elements conferring glycopeptide resistance and their ability to support glycopeptide resistance transfer. In addition, a single VREfm strain with an unrelated PFGE pattern collected prior to the outbreak was examined by WGS. MLST revealed a predominance of ST192, belonging to a hospital adapted high-risk lineage harbouring several known virulence determinants (n >= 10). The VREfm outbreak strain was resistant to ampicillin, gentamicin, ciprofloxacin and vancomycin, and susceptible to teicoplanin. Consistently, a vanB2-subtype as part of Tn1549/Tn5382 with a unique genetic signature was identified in the VREfm outbreak strains. Moreover, Southern blot hybridisation analyses of PFGE separated S1 nuclease-restricted total DNAs and filter mating experiments showed that vanB2-Tn1549/Tn5382 was located in a 70-kb sized rep(17/pRUM) plasmid readily transferable between E. faecium. This plasmid contained an axe-txe toxin-antitoxin module associated with stable maintenance. The two clonally related VSEfm harboured a 40 kb rep(17/pRUM) plasmid absent of the 30 kb vanB2-Tn1549/Tn5382 gene complex. Otherwise, these two isolates were similar to the VREfm outbreak strain in virulence-and resistance profile. In conclusion, our observations support that the origin of the multicentre outbreak was caused by an introduction of vanB2-Tn1549/Tn5382 into a rep(17/pRUM) plasmid harboured in a pre-existing high-risk E. faecium ST192 clone. The subsequent dissemination of VREfm to other centres was primarily caused by clonal spread rather than plasmid transfer to pre-existing high-risk clones.	[Sivertsen, Audun; Sundsfjord, Arnfinn; Hegstad, Kristin] Univ Tromso, Arctic Univ Norway, Fac Hlth Sci, Res Grp Host Microbe Interact, Tromso, Norway; [Billstrom, Hanna; Melefors, Ojar; Liljequist, Barbro Olsson; Wisell, Karin Tegmark] Publ Hlth Agcy Sweden, Unit Antibiot & Infect Control, Solna, Sweden; [Ullberg, Mans; Ozenci, Volkan] Karolinska Univ Hosp, Dept Clin Microbiol, Huddinge, Sweden; [Sundsfjord, Arnfinn; Hegstad, Kristin] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway	UiT The Arctic University of Tromso; Public Health Agency of Sweden; Karolinska Institutet; Karolinska University Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway	Hegstad, K (corresponding author), Univ Tromso, Arctic Univ Norway, Fac Hlth Sci, Res Grp Host Microbe Interact, Tromso, Norway.	Kristin.Hegstad@uit.no	Melefors, Öjar/N-6164-2015; Özenci, Volkan/H-3116-2019; Sundsfjord, Arnfinn/F-9668-2018	Melefors, Öjar/0000-0003-4115-1190; Özenci, Volkan/0000-0002-8069-4027; Sundsfjord, Arnfinn/0000-0002-3728-2270; Sivertsen, Audun/0000-0002-4283-6397; Hegstad, Kristin/0000-0002-1314-0497	Northern Norway Regional Health Authority Medical Research Program	Northern Norway Regional Health Authority Medical Research Program	This work was supported by research grants from the Northern Norway Regional Health Authority Medical Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bjorkeng E, 2011, APMIS, V119, P247, DOI 10.1111/j.1600-0463.2011.02724.x; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P2667, DOI 10.1128/AAC.01516-07; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; Dahl KH, 1999, ANTIMICROB AGENTS CH, V43, P1105, DOI 10.1128/AAC.43.5.1105; Dahl KH, 2000, MICROBIOL-SGM, V146, P1469, DOI 10.1099/00221287-146-6-1469; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; El Amin N, 1999, ANTIMICROB AGENTS CH, V43, P947, DOI 10.1128/AAC.43.4.947; Freitas AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060589; Gilmore MS, 2013, CURR OPIN MICROBIOL, V16, P10, DOI 10.1016/j.mib.2013.01.006; Grabsch EA, 2008, J CLIN MICROBIOL, V46, P1961, DOI 10.1128/JCM.01778-07; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Granlund M, 2006, J HOSP INFECT, V62, P254, DOI 10.1016/j.jhin.2005.06.031; Hegstad K, 2010, CLIN MICROBIOL INFEC, V16, P541, DOI 10.1111/j.1469-0691.2010.03226.x; Hegstad K, 2014, J CLIN MICROBIOL, V52, P1582, DOI 10.1128/JCM.03544-13; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hendrickx APA, 2007, J BACTERIOL, V189, P8321, DOI 10.1128/JB.00664-07; Hendrickx APA, 2009, INFECT IMMUN, V77, P5097, DOI 10.1128/IAI.00275-09; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Howden BP, 2013, MBIO, V4, DOI 10.1128/mBio.00412-13; Jensen LB, 2010, J MICROBIOL METH, V80, P25, DOI 10.1016/j.mimet.2009.10.012; Johnsen PJ, 2009, LANCET INFECT DIS, V9, P357, DOI 10.1016/S1473-3099(09)70105-7; Johnsen PJ, 2005, APPL ENVIRON MICROB, V71, P159, DOI 10.1128/AEM.71.1.159-168.2005; Johnson PDR, 2010, J INFECT DIS, V202, P1278, DOI 10.1086/656319; Karki S, 2013, J CLIN MICROBIOL, V51, P3374, DOI 10.1128/JCM.01501-13; Launay A, 2006, ANTIMICROB AGENTS CH, V50, P1054, DOI 10.1128/AAC.50.3.1054-1062.2006; Leavis H, 2004, J BACTERIOL, V186, P672, DOI 10.1128/JB.186.3.672-682.2004; Leavis HL, 2006, J CLIN MICROBIOL, V44, P1059, DOI 10.1128/JCM.44.3.1059-1064.2006; Lebreton F, 2011, ANTIMICROB AGENTS CH, V55, P4606, DOI 10.1128/AAC.00714-11; Morrison D, 1999, J CLIN MICROBIOL, V37, P1084, DOI 10.1128/JCM.37.4.1084-1091.1999; Nallapareddy SR, 2008, INFECT IMMUN, V76, P4110, DOI 10.1128/IAI.00375-08; POYART C, 1994, FEMS MICROBIOL LETT, V122, P173, DOI 10.1111/j.1574-6968.1994.tb07161.x; Rathnayake IU, 2012, SYST APPL MICROBIOL, V35, P326, DOI 10.1016/j.syapm.2012.05.004; Rosvoll TCS, 2012, FEMS IMMUNOL MED MIC, V66, P166, DOI 10.1111/j.1574-695X.2012.00997.x; Rosvoll TCS, 2010, FEMS IMMUNOL MED MIC, V58, P254, DOI 10.1111/j.1574-695X.2009.00633.x; Saeedi B, 2002, APMIS, V110, P869, DOI 10.1034/j.1600-0463.2002.1101205.x; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; Soderblom T., 2010, EURO SURVEILL, V15, P19620; Werner G, 2003, J CLIN MICROBIOL, V41, P1499, DOI 10.1128/JCM.41.4.1499-1506.2003; Werner G, 2008, EUROSURVEILLANCE, V13, P1; Werner G, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-21; Werner G, 2010, INT J ANTIMICROB AG, V35, P119, DOI 10.1016/j.ijantimicag.2009.10.012; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Xu XG, 2010, ANTIMICROB AGENTS CH, V54, P4643, DOI 10.1128/AAC.01710-09	50	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103274	10.1371/journal.pone.0103274	http://dx.doi.org/10.1371/journal.pone.0103274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153894	Green Submitted, gold, Green Published			2022-12-27	WOS:000340952200006
J	Li, WH; Chang, CH; Huang, CW; Wei, CC; Liao, VHC				Li, Wen-Hsuan; Chang, Chun-Han; Huang, Chi-Wei; Wei, Chia-Cheng; Liao, Vivian Hsiu-Chuan			Selenite Enhances Immune Response against Pseudomonas aeruginosa PA14 via SKN-1 in Caenorhabditis elegans	PLOS ONE			English	Article							OXIDATIVE-STRESS-RESPONSE; TRANSCRIPTION FACTOR SKN-1; BIOFILM FORMATION; INNATE IMMUNITY; HUMAN-DISEASE; C. ELEGANS; VIRULENCE; SELENOPROTEINS; INFECTION; TRXR-1	Background: Selenium (Se) is an important nutrient that carries out many biological processes including maintaining optimal immune function. Here, inorganic selenite (Se(IV)) was evaluated for its pathogen resistance and potential-associated factors in Caenorhabditis elegans. The immune effects of Se(IV) were investigated by examining the responses of C. elegans to Pseudomonas aerugonisa PA14 strain. Principal Findings: Se(IV)-treated C. elegans showed increased survival under PA14 infection compared with untreated controls. The significant pathogen resistance of Se(IV) on C. elegans might not be attributed to the effects of Se(IV) on PA14 as Se(IV) showed no effect on bacterial quorum-sensing and virulence factors of PA14. This study showed that Se(IV) enhanced the expression of a gene pivotal for the innate immunity in C. elegans. The study found that the pathogen-resistant phenotypes contributed by Se(IV) was absent from the skn-1 mutant worms. Moreover, Se(IV) influenced the subcellular distribution of SKN-1/Nrf in C. elegans upon PA14 infection. Furthermore, Se(IV) increased mRNA levels of SKN-1 target genes (gst-4 and gcs-1). Conclusions: This study found evidence of Se(IV) protecting C. elegans against P. aeruginosa PA14 infection by exerting effects on the innate immunity of C. elegans that is likely mediated via regulation of a SKN-1-dependent signaling pathway.	[Li, Wen-Hsuan; Chang, Chun-Han; Huang, Chi-Wei; Wei, Chia-Cheng; Liao, Vivian Hsiu-Chuan] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan	National Taiwan University	Liao, VHC (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	vivianliao@ntu.edu.tw		Chang, Chun-Han/0000-0002-1920-1262; Huang, Chi-Wei/0000-0001-9830-144X; Wei, Chia-Cheng/0000-0002-0694-7284; Liao, Vivian/0000-0002-4676-9953	Ministry of Science and Technology of Taiwan [NSC 101-2313-B-002-041-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was financially supported by grant (NSC 101-2313-B-002-041-MY3) from the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw/) to VHCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; BAINBRIDGE DR, 1976, IMMUNOLOGY, V30, P135; Beck MA, 2003, J NUTR, V133, p1463S, DOI 10.1093/jn/133.5.1463S; BEHNE D, 1983, J NUTR, V113, P456, DOI 10.1093/jn/113.2.456; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Brown K M, 2001, Public Health Nutr, V4, P593; Campa A, 1999, J ACQ IMMUN DEF SYND, V20, P508, DOI 10.1097/00042560-199904150-00015; Dharmalingam K, 2012, J ETHNOPHARMACOL, V139, P657, DOI 10.1016/j.jep.2011.12.016; DOW JM, 1990, APPL ENVIRON MICROB, V56, P2994, DOI 10.1128/AEM.56.10.2994-2998.1990; Durai S, 2013, J APPL MICROBIOL, V115, P1329, DOI 10.1111/jam.12335; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Ewbank JJ, 2006, SIGNALING IMMUNE RES, P1; Gander S, 1996, J ANTIMICROB CHEMOTH, V37, P1047, DOI 10.1093/jac/37.6.1047; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hoffmann PR, 2008, MOL NUTR FOOD RES, V52, P1273, DOI 10.1002/mnfr.200700330; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Husain FM, 2013, J BIOSCIENCES, V38, P835, DOI 10.1007/s12038-013-9385-9; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kandasamy S, 2012, MAR DRUGS, V10, P84, DOI 10.3390/md10010084; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; KING EO, 1954, J LAB CLIN MED, V44, P301; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Li W, 2012, MOL CELLS, V34, P209, DOI 10.1007/s10059-012-0155-6; Li WH, 2014, MOL NUTR FOOD RES, V58, P863, DOI 10.1002/mnfr.201300404; Li WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062387; Li WH, 2011, FOOD CHEM TOXICOL, V49, P812, DOI 10.1016/j.fct.2010.12.002; Liu JH, 2013, APPL ENVIRON MICROB, V79, P7343, DOI 10.1128/AEM.01927-13; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Papp D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002673; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Rudrappa T, 2008, J AGR FOOD CHEM, V56, P1955, DOI 10.1021/jf072591j; Sarabhai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053441; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; SPALLHOLZ JE, 1990, ANN NY ACAD SCI, V587, P123, DOI 10.1111/j.1749-6632.1990.tb00140.x; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tan MW, 2011, CELL MICROBIOL, V13, P497, DOI 10.1111/j.1462-5822.2011.01570.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; Wagner Victoria E., 2008, P129; Yu MW, 1999, AM J EPIDEMIOL, V150, P367, DOI 10.1093/oxfordjournals.aje.a010016; Yu SY, 1997, BIOL TRACE ELEM RES, V56, P117, DOI 10.1007/BF02778987	61	5	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105810	10.1371/journal.pone.0105810	http://dx.doi.org/10.1371/journal.pone.0105810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147937	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230600084
J	Lungu, O; Monchi, O; Albouy, G; Jubault, T; Ballarin, E; Burnod, Y; Doyon, J				Lungu, Ovidiu; Monchi, Oury; Albouy, Genevieve; Jubault, Thomas; Ballarin, Emanuelle; Burnod, Yves; Doyon, Julien			Striatal and Hippocampal Involvement in Motor Sequence Chunking Depends on the Learning Strategy	PLOS ONE			English	Article							BASAL GANGLIA; SKILLED PERFORMANCE; MOVEMENT CHUNKING; TIME-COURSE; MEMORY; CONSOLIDATION; ACQUISITION; PLASTICITY; BRAIN; TASK	Motor sequences can be learned using an incremental approach by starting with a few elements and then adding more as training evolves (e.g., learning a piano piece); conversely, one can use a global approach and practice the whole sequence in every training session (e.g., shifting gears in an automobile). Yet, the neural correlates associated with such learning strategies in motor sequence learning remain largely unexplored to date. Here we used functional magnetic resonance imaging to measure the cerebral activity of individuals executing the same 8-element sequence after they completed a 4-days training regimen (2 sessions each day) following either a global or incremental strategy. A network comprised of striatal and fronto-parietal regions was engaged significantly regardless of the learning strategy, whereas the global training regimen led to additional cerebellar and temporal lobe recruitment. Analysis of chunking/grouping of sequence elements revealed a common prefrontal network in both conditions during the chunk initiation phase, whereas execution of chunk cores led to higher mediotemporal activity (involving the hippocampus) after global than incremental training. The novelty of our results relate to the recruitment of mediotemporal regions conditional of the learning strategy. Thus, the present findings may have clinical implications suggesting that the ability of patients with lesions to the medial temporal lobe to learn and consolidate new motor sequences may benefit from using an incremental strategy.	[Lungu, Ovidiu; Monchi, Oury; Albouy, Genevieve; Jubault, Thomas; Doyon, Julien] UNF, Montreal, PQ, Canada; [Lungu, Ovidiu; Monchi, Oury; Albouy, Genevieve; Jubault, Thomas; Doyon, Julien] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Lungu, Ovidiu] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Lungu, Ovidiu] Donald Berman Maimonides Geriatr Ctr, Ctr Res Aging, Montreal, PQ, Canada; [Albouy, Genevieve; Doyon, Julien] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Ballarin, Emanuelle] Univ Lyon 2, Grad Program Neuropsychol, Lyon, France; [Burnod, Yves] Univ Paris 06, INSERM, U678, Paris, France; [Monchi, Oury] Univ Montreal, Dept Radiol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite Lyon 2; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Montreal	Lungu, O (corresponding author), UNF, Montreal, PQ, Canada.	o.lungu@umontreal.ca	Monchi, Oury/N-8417-2019; ALBOUY, Genevieve/K-5350-2015; ALBOUY, Genevieve/P-4723-2019	ALBOUY, Genevieve/0000-0002-5437-023X; ALBOUY, Genevieve/0000-0002-5437-023X; Lungu, Ovidiu/0000-0001-6608-5818	Canadian Institutes of Health Research [MOP86463]; Natural Sciences and Engineering Research Council of Canada [42909-2009, 327518]; Ministere du Developpement economique, de l'Innovation et de l'Exportation (MDEIE) du Quebec, Quebec, QC, Canada; Fondation FYSSEN, France; C.I.H.R. postdoctoral grant	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministere du Developpement economique, de l'Innovation et de l'Exportation (MDEIE) du Quebec, Quebec, QC, Canada; Fondation FYSSEN, France; C.I.H.R. postdoctoral grant(Canadian Institutes of Health Research (CIHR))	The work received the following support: Julien Doyon: Canadian Institutes of Health Research (MOP86463), Natural Sciences and Engineering Research Council of Canada (42909-2009); Ovidiu Lungu: Postdoctoral fellowship from the Ministere du Developpement economique, de l'Innovation et de l'Exportation (MDEIE) du Quebec, Quebec, QC, Canada; Genevieve Albouy: Supported by a Postdoctoral fellowship from the Fondation FYSSEN, France and a C.I.H.R. postdoctoral grant; and Oury Monchi: Natural Sciences and Engineering Research Council of Canada (No 327518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi-Japha E, 2008, J EXP PSYCHOL LEARN, V34, P1544, DOI 10.1037/a0013217; Albouy G., 2012, J SLEEP RES; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052805; Albouy G, 2012, NEUROIMAGE, V60, P324, DOI 10.1016/j.neuroimage.2011.12.049; Bapi RS, 2000, EXP BRAIN RES, V132, P149, DOI 10.1007/s002219900332; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Barakat M, 2012, SLEEP SPINDLES PREDI; Beldarrain MG, 2008, CLIN NEUROL NEUROSUR, V110, P245, DOI 10.1016/j.clineuro.2007.11.004; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Cameron IGM, 2009, EUR J NEUROSCI, V29, P2413, DOI 10.1111/j.1460-9568.2009.06776.x; Cavaco S, 2004, BRAIN, V127, P1853, DOI 10.1093/brain/awh208; Curran T, 1997, J COGNITIVE NEUROSCI, V9, P522, DOI 10.1162/jocn.1997.9.4.522; Daniel R, 2011, J COGNITIVE NEUROSCI, V23, P1781, DOI 10.1162/jocn.2010.21541; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; DeCoteau WE, 2000, BEHAV NEUROSCI, V114, P1096, DOI 10.1037//0735-7044.114.6.1096; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Donohue SE, 2005, NEUROIMAGE, V26, P1140, DOI 10.1016/j.neuroimage.2005.03.019; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Ergorul C, 2006, J NEUROSCI, V26, P4111, DOI 10.1523/JNEUROSCI.0441-06.2006; Fernandez-Seara MA, 2009, NEUROIMAGE, V47, P1797, DOI 10.1016/j.neuroimage.2009.05.061; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Francois-Brosseau FE, 2009, EUR J NEUROSCI, V29, P1277, DOI 10.1111/j.1460-9568.2009.06671.x; Ganor-Stern D, 2013, ACTA PSYCHOL, V144, P180, DOI 10.1016/j.actpsy.2013.06.001; Gheysen F, 2010, EXP BRAIN RES, V202, P795, DOI 10.1007/s00221-010-2186-6; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Hansen S, 2005, RES Q EXERCISE SPORT, V76, P60; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P1877, DOI 10.1016/j.neuropsychologia.2004.05.008; Jamadar S, 2010, NEUROIMAGE, V51, P432, DOI 10.1016/j.neuroimage.2010.01.090; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Levesque M, 2007, EXP BRAIN RES, V182, P499, DOI 10.1007/s00221-007-1010-4; Ma LS, 2010, BRAIN RES, V1318, P64, DOI 10.1016/j.brainres.2009.12.073; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; Nee DE, 2009, NEUROIMAGE, V45, P963, DOI 10.1016/j.neuroimage.2009.01.005; Penny W., 2003, HUMAN BRAIN FUNCTION; ROSENBAUM DA, 1983, J EXP PSYCHOL HUMAN, V9, P86, DOI 10.1037/0096-1523.9.1.86; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Souza MJ, 2009, NEUROIMAGE, V46, P299, DOI 10.1016/j.neuroimage.2009.01.046; Spiers HJ, 2001, NEUROCASE, V7, P357, DOI 10.1076/neur.7.5.357.16245; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Touron DR, 2006, PSYCHON B REV, V13, P781, DOI 10.3758/BF03193997; Tremblay PL, 2010, EXP BRAIN RES, V205, P375, DOI 10.1007/s00221-010-2372-6; Tremblay PL, 2009, BEHAV BRAIN RES, V198, P231, DOI 10.1016/j.bbr.2008.11.002; Tubau E, 2004, PSYCHOL RES-PSYCH FO, V68, P55, DOI 10.1007/s00426-003-0139-4; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038	59	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e103885	10.1371/journal.pone.0103885	http://dx.doi.org/10.1371/journal.pone.0103885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25148078	Green Published, gold			2022-12-27	WOS:000341230600008
J	Overeem, KR; Gabriel, PO; Zirpoli, JA; Black, JM				Overeem, Katlin R.; Gabriel, Pia O.; Zirpoli, Jeff A.; Black, Jeffrey M.			Steller Sex: Infidelity and Sexual Selection in a Social Corvid (Cyanocitta stelleri)	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; PLUMAGE COLOR; GENETIC MONOGAMY; PARENTAL CARE; MEXICAN JAY; BODY-SIZE; BLUE TITS; BIRDS; FERTILIZATION; EVOLUTION	Genetic analysis of avian mating systems has revealed that more than 70% of monogamous species show incidence of offspring parentage that does not match the social partner. Extra-pair parentage (EPP) has been linked to a variety of factors, including size and symmetry of ornamental traits, coloration, resource availability, and local conspecific density. We examined how ornamental plumage traits of individual Steller's jays (Cyanocitta stelleri) and territory characteristics influence genetic fidelity of socially monogamous pairs. We used seven highly polymorphic microsatellite markers to assign paternity to 79 offspring, and identified 12 (15.2%) as extra-pair young (EPY). Steller's jays with extra-pair young had significantly lower values of feather brightness and hue, indicating more ultraviolet-blue shifted coloration, and nested in closer proximity to the forest edge than Steller's jays with no detected EPY. Body size, crest height, asymmetry of ornamental crest stripes, as well as vegetative composition of territories and their proximity to supplemental feeders appeared to have little relationship to EPP. These results indicate that extra-pair parentage plays a role in the evolution of secondary sexual characteristics in both sexes, and suggest local density and availability of resources may influence Steller's jay mating dynamics.	[Overeem, Katlin R.; Gabriel, Pia O.; Zirpoli, Jeff A.; Black, Jeffrey M.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt	Overeem, KR (corresponding author), Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA.	Katlinovereem@yahoo.com			Humboldt State University's [5741]	Humboldt State University's	This work was supported by Humboldt State University's Small Grant (No. 5741), obtained by POG and JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Anderson D. R., 2008, MODEL BASED INFERENC; Andersson Staffan, 2006, P41; Armenta JK, 2008, J EXP BIOL, V211, P2423, DOI 10.1242/jeb.013094; Arnold KE, 2002, P ROY SOC B-BIOL SCI, V269, P1263, DOI 10.1098/rspb.2002.2013; Balenger S, 2009, BEHAV ECOL SOCIOBIOL, V63, P403, DOI 10.1007/s00265-008-0674-5; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Birkhead T.R., 1996, Oxford Ornithology Series, V6, P323; BIRKHEAD TR, 1995, ANIM BEHAV, V49, P843, DOI 10.1016/0003-3472(95)80217-7; Birkhead TR, 1992, SPERM COMPETITION BI; Bitton PP, 2007, ANIM BEHAV, V74, P1777, DOI 10.1016/j.anbehav.2007.03.018; Black Jeffrey M., 1996, Oxford Ornithology Series, V6, P3; Bouwman KM, 2005, BEHAV ECOL, V16, P499, DOI 10.1093/beheco/ari021; Brand LA, 2001, AUK, V118, P678, DOI 10.1642/0004-8038(2001)118[0678:ROPBTF]2.0.CO;2; BROWN J.L., 1964, INTEGRATION AGONISTI; Burg TM, 2005, MOL ECOL, V14, P3745, DOI 10.1111/j.1365-294X.2005.02710.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Charmantier A, 2004, BEHAV ECOL SOCIOBIOL, V56, P360, DOI 10.1007/s00265-004-0794-5; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Darwin C., 1871, P423; Doucet SM, 2002, CONDOR, V104, P30, DOI 10.1650/0010-5422(2002)104[0030:SPCMBS]2.0.CO;2; Doucet SM, 2004, P ROY SOC B-BIOL SCI, V271, P1663, DOI 10.1098/rspb.2004.2779; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Evans KL, 2010, BIOL REV, V85, P643, DOI 10.1111/j.1469-185X.2010.00121.x; Ferns PN, 2004, ANIM BEHAV, V67, P261, DOI 10.1016/j.anbehav.2003.05.006; Fishman MA, 2002, B MATH BIOL, V64, P809, DOI 10.1006/bulm.2002.0301; Gabriel PO, 2012, AUK, V129, P377, DOI 10.1525/auk.2012.11234; Gabriel PO, 2012, ETHOLOGY, V118, P76, DOI 10.1111/j.1439-0310.2011.01990.x; Gabriel PO, 2010, ANIM BEHAV, V80, P689, DOI 10.1016/j.anbehav.2010.07.004; Gienapp P, 2010, PLOS ONE, V5, P1; Gomez D, 2004, ECOL LETT, V7, P279, DOI 10.1111/j.1461-0248.2004.00584.x; Gowaty Patricia Adair, 1996, Oxford Ornithology Series, V6, P21; Greene E., 1998, BIRDS N AM; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griggio M, 2010, ECOL RES, V25, P77, DOI 10.1007/s11284-009-0632-3; Hausmann F, 2003, P ROY SOC B-BIOL SCI, V270, P61, DOI 10.1098/rspb.2002.2200; Henderson IG, 2000, J AVIAN BIOL, V31, P177, DOI 10.1034/j.1600-048X.2000.310209.x; HOPE S, 1980, AM NAT, V116, P788, DOI 10.1086/283670; Hunt S, 1999, ANIM BEHAV, V58, P809, DOI 10.1006/anbe.1999.1214; Jawor JM, 2004, ANIM BEHAV, V67, P875, DOI 10.1016/j.anbehav.2003.05.015; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Jones IL, 1999, ANIM BEHAV, V57, P521, DOI 10.1006/anbe.1998.1012; Kalinowski RS, 2010, CONDOR, V112, P274, DOI 10.1525/cond.2010.090037; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Keyser AJ, 1999, P ROY SOC B-BIOL SCI, V266, P771, DOI 10.1098/rspb.1999.0704; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Lack D., 1968, pvii; Li SH, 2000, ANIM BEHAV, V60, P867, DOI 10.1006/anbe.2000.1554; Li SH, 1997, MOL ECOL, V6, P499, DOI 10.1046/j.1365-294X.1997.00215.x; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Moller AP, 1998, AM NAT, V151, P236, DOI 10.1086/286114; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; MOLLER AP, 1992, NATURE, V357, P238, DOI 10.1038/357238a0; Moller AP, 1997, ASYMMETRY DEV STABIL; Montgomerie, 2008, CLR VERSION 1 05; Montgomerie Robert, 2006, P90; Newton I., 1998, POPULATION LIMITATIO; O'Brien EL, 2011, BEHAV ECOL, V22, P66, DOI 10.1093/beheco/arq167; Ornborg J, 2002, BIOL J LINN SOC, V76, P237, DOI 10.1046/j.1095-8312.2002.00061.x; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; Prum RO, 2006, BIRD COLORATION, V1, P295; Quinn JS, 1999, BEHAV ECOL SOCIOBIOL, V45, P1, DOI 10.1007/s002650050534; Rockwell C, 2012, BEHAV ECOL, V23, P676, DOI 10.1093/beheco/ars015; Saino N, 1997, EVOLUTION, V51, P562, DOI 10.1111/j.1558-5646.1997.tb02443.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shawkey MD, 2006, J EXP BIOL, V209, P1245, DOI 10.1242/jeb.02115; Siefferman L, 2005, J AVIAN BIOL, V36, P428, DOI 10.1111/j.0908-8857.2005.03401.x; Siefferman L, 2008, J ORNITHOL, V149, P357, DOI 10.1007/s10336-008-0289-7; Stenzler LM, 2002, MOL ECOL NOTES, V2, P547, DOI 10.1046/j.1471-8286.2002.00312.x; Thery Marc, 2006, P148; Townsend AK, 2011, BEHAV ECOL, V22, P464, DOI 10.1093/beheco/arq227; Townsend AK, 2009, ANIM BEHAV, V77, P503, DOI 10.1016/j.anbehav.2008.10.030; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; Whittingham LA, 2001, CURR ORNITHOL, V16, P257; Zirpoli JA, 2013, ETHOL ECOL EVOL, V25, P103, DOI 10.1080/03949370.2012.742462	80	4	4	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105257	10.1371/journal.pone.0105257	http://dx.doi.org/10.1371/journal.pone.0105257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148039	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600037
J	Wang, YL; Yan, GQ				Wang, Yiling; Yan, Guiqin			Molecular Phylogeography and Population Genetic Structure of O-longilobus and O-taihangensis (Opisthopappus) on the Taihang Mountains	PLOS ONE			English	Article							2 REFUGE AREAS; CHLOROPLAST DNA PHYLOGEOGRAPHY; EAST-ASIA; TEMPERATE PLANTS; CLIMATIC OSCILLATIONS; SEQUENCE VARIATION; ADJACENT REGIONS; NUCLEAR-DNA; CHINA; DIVERSITY	Historic events such as the uplift of mountains and climatic oscillations in the Quaternary periods greatly affected the evolution and modern distribution of the flora. We sequenced the trnL-trnF, ndhJ-trnL and ITS from populations throughout the known distributions of O. longilobus and O. taihangensis to understand the evolutionary history and the divergence related to the past shifts of habitats in the Taihang Mountains regions. The results showed high genetic diversity and pronounced genetic differentiation among the populations of the two species with a significant phylogeographical pattern (N-ST>G(ST), P<0.05), which imply restricted gene flow among the populations and significant geographical or environmental isolation. Ten chloroplast DNA (cpDNA) and eighteen nucleus ribosome DNA (nrDNA) haplotypes were identified and clustered into two lineages. Two corresponding refuge areas were revealed across the entire distribution ranges of O. longilobus and at least three refuge areas for O. taihangensis. O. longilobus underwent an evolutionary historical process of long-distance dispersal and colonization, whereas O. taihangensis underwent a population expansion before the main uplift of Taihang Mountains. The differentiation time between O. longilobus and O. taihangensis is estimated to have occurred at the early Pleistocene. Physiographic complexity and paleovegetation transition of Taihang Mountains mainly shaped the specific formation and effected the present distribution of these two species. The results therefore support the inference that Quaternary refugial isolation promoted allopatric speciation in Taihang Mountains. This may help to explain the existence of high diversity and endemism of plant species in central/northern China.	[Wang, Yiling; Yan, Guiqin] Shanxi Normal Univ, Coll Life Sci, Linfen, Peoples R China	Shanxi Normal University	Yan, GQ (corresponding author), Shanxi Normal Univ, Coll Life Sci, Linfen, Peoples R China.	guiqiny@dns.sxnu.edu.cn			Natural Science Foundation of Shanxi Normal University [ZR1106]; Natural Science Foundation of Shanxi Province, China [2011011031-2]; High-tech Industrialization project of Shanxi Province, China [20110014]	Natural Science Foundation of Shanxi Normal University; Natural Science Foundation of Shanxi Province, China(Natural Science Foundation of Shanxi Province); High-tech Industrialization project of Shanxi Province, China	The study was financially supported by Natural Science Foundation of Shanxi Normal University (ZR1106), Natural Science Foundation of Shanxi Province, China (2011011031-2) and High-tech Industrialization project of Shanxi Province, China (20110014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Cao MM, 2012, MOL PHYLOGENET EVOL, V65, P823, DOI 10.1016/j.ympev.2012.08.004; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; Chou YW, 2011, J BIOGEOGR, V38, P1992, DOI 10.1111/j.1365-2699.2011.02537.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Ding B. Z., 1998, FLORA HENANICA; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gong M., 2010, THESIS CHINESE ACAD; Gong W, 2008, MOL PHYLOGENET EVOL, V48, P1094, DOI 10.1016/j.ympev.2008.05.003; GRAUR D, FUNDAMENTALS MOL EVO; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hu X, 2008, THESIS BEIJING FORES; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; LIU KB, 1988, QUATERNARY SCI REV, V7, P1, DOI 10.1016/0277-3791(88)90089-3; Liu L, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085920, 10.1371/journal.pone.0088791]; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qian H, 2001, NATURE, V413, P130, DOI 10.1038/35093169; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; Rambaut A, 2009, TRACER V1 5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian B, 2009, J BIOGEOGR, V36, P2148, DOI 10.1111/j.1365-2699.2009.02157.x; Till-Bottraud I, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P23; Turchetto-Zolet AC, 2012, MOL PHYLOGENET EVOL, V65, P174, DOI 10.1016/j.ympev.2012.06.012; Vijverberg K, 1999, MOL BIOL EVOL, V16, P1329, DOI 10.1093/oxfordjournals.molbev.a026043; Wang F.Z., 1978, FLORA CHINA, P73; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wang YL, 2010, MOL PHYLOGENET EVOL, V55, P721, DOI 10.1016/j.ympev.2010.02.010; Wang YL, 2013, PLANT SYST EVOL, V299, P1849, DOI 10.1007/s00606-013-0840-8; Wang YL, 2013, BIOCHEM SYST ECOL, V49, P115, DOI 10.1016/j.bse.2013.03.014; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu C, 1999, N CHINA EARTHQUAKE S, V17, P1, DOI DOI 10.1007/S11430-012-4516-Y; Wu C.Y., 1995, VEGETATION CHINA; Xie KQ, 2013, BIOCHEM SYST ECOL, V50, P39, DOI 10.1016/j.bse.2013.03.031; Xu JW, 2012, MOL PHYLOGENET EVOL, V64, P118, DOI 10.1016/j.ympev.2012.03.009; YANG XL, 1999, GEOGRAPHY TERRITORIA, V15, P81; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang RY, 2012, MOL PHYLOGENET EVOL, V65, P562, DOI 10.1016/j.ympev.2012.07.011; Zhang YH, 2010, MOL PHYLOGENET EVOL, V57, P1162, DOI 10.1016/j.ympev.2010.08.033; Zhao C, 2013, MOL PHYLOGENET EVOL, V68, P628, DOI 10.1016/j.ympev.2013.04.007; ZHAO SL, 1990, OCEANOL LIMNOL SIN, V8, P289; Zhao YP, 2013, MOL PHYLOGENET EVOL, V68, P300, DOI 10.1016/j.ympev.2013.03.025; Zhou TH, 2010, MOL PHYLOGENET EVOL, V57, P176, DOI 10.1016/j.ympev.2010.07.001; Zhu LM, 2008, THESIS HEBEI U	73	15	15	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104773	10.1371/journal.pone.0104773	http://dx.doi.org/10.1371/journal.pone.0104773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148249	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600021
J	Wei, W; Fan, ZS; Wang, LH; Li, ZW; Jiao, WZ; Li, Y				Wei, Wen; Fan, Zhaoshan; Wang, Lihua; Li, Zhiwei; Jiao, Wanzhen; Li, Yun			Correlation Analysis between Central Corneal Thickness and Intraocular Pressure in Juveniles in Northern China: The Jinan City Eye Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; APPLANATION TONOMETRY; REFRACTIVE ERROR; CHILDREN; SCHOOLCHILDREN; POPULATION; MYOPIA; AGE; PACHYMETRY; CURVATURE	Purpose: To determine the distributions and relation of central corneal thickness (CCT) and intraocular pressure (IOP) by NT-530P in Chinese juveniles, and the effect of gender, age, height, weight and refractive errors on the CTT and IOP. Methods: CCT and IOP of 982 eyes in 514 juveniles aged from 7 to 18 years were measured with NT-530P. Multi-linear regression and ANOVA analysis were used to analyze the relation of CCT and IOP, and the effect of gender, age, height, weight, refractive condition on CCT and IOP respectively. Results: The mean CCT and IOP were 554.19 +/- 35.46 mu m and 15.31 +/- 2.57 mmHg. There were significant correlations between the CCT and IOP values. Linear regression analysis revealed a positive correlation between CCT and IOP (r = 0.44, P<0.05). Linear regression equation: IOP = -2.35+0.032CCT, which means the IOP will increase 0.32 mm Hg for every 10-mu m increase in CCT. The mean of Corrected IOP (CIOP) was 15.32 +/- 2.38 mmHg and had no relation with CCT. There was a negative correlation between refraction degree and CCT (P<0.05), but no correlation between refraction degree and IOP. Multi-linear regression model revealed that the height, weight, age and gender have no effect on the distribution of CCT and IOP respectively. Conclusions: There is a 0.32 mmHg increase in IOP for every 10-mu m increase in CCT. The height, weight, age and gender has no effect on the distribution of CCT and IOP. CCT will become thinner with myopia diopters increases in juveniles. The measurement of CCT is helpful in evaluating the actual IOP correctly.	[Wei, Wen; Fan, Zhaoshan; Wang, Lihua; Li, Zhiwei; Jiao, Wanzhen; Li, Yun] Shandong Univ, Shandong Prov Hosp, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, Y (corresponding author), Shandong Univ, Shandong Prov Hosp, Jinan 250100, Peoples R China.	liyun32008@163.com			shandong provincial technical development project [2012GSP11822]; shandong medical technical development project [2011HZ076]	shandong provincial technical development project; shandong medical technical development project	This research was supported by shandong provincial technical development project (2012GSP11822) and shandong medical technical development project (2011HZ076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mohtaseb ZN, 2013, GRAEF ARCH CLIN EXP, V251, P1855, DOI 10.1007/s00417-013-2280-0; Bradfield YS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1132, DOI 10.1001/archophthalmol.2011.225; Bresson-Dumont H, 2009, J FR OPHTALMOL, V32, P176, DOI 10.1016/j.jfo.2009.03.008; Bron AM, 1999, GRAEF ARCH CLIN EXP, V237, P220, DOI 10.1007/s004170050222; Chang SW, 2001, BRIT J OPHTHALMOL, V85, P916, DOI 10.1136/bjo.85.8.916; Chatterjee A, 1997, OPHTHALMOLOGY, V104, P355, DOI 10.1016/S0161-6420(97)30308-X; Dai E, 2006, J AAPOS, V10, P22, DOI 10.1016/j.jaapos.2005.12.007; DAVID R, 1985, ARCH OPHTHALMOL-CHIC, V103, P1812; Detry-Morel M, 2011, J FR OPHTALMOL, V34, P392, DOI 10.1016/j.jfo.2011.03.009; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Doughty MJ, 2002, OPHTHAL PHYSL OPT, V22, P491, DOI 10.1046/j.1475-1313.2002.00053.x; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P34; Garcia-Resua C, 2013, CLIN EXP OPTOM, V96, P286, DOI 10.1111/j.1444-0938.2012.00818.x; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Haider KM, 2008, J PEDIAT OPHTH STRAB, V45, P227, DOI 10.3928/01913913-20080701-07; Heidary F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025208; Herndon LW, 1997, ARCH OPHTHALMOL-CHIC, V115, P1137, DOI 10.1001/archopht.1997.01100160307007; Hussein MAW, 2004, AM J OPHTHALMOL, V138, P744, DOI 10.1016/j.ajo.2004.06.030; Jorge J, 2013, CLIN OPHTHALMOL, V7, P417, DOI 10.2147/OPTH.S35121; Kniestedt C, 2005, ARCH OPHTHALMOL-CHIC, V123, P1532, DOI 10.1001/archopht.123.11.1532; Krzyzanowska-Berkowska P, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-61; La Rosa FA, 2001, ARCH OPHTHALMOL-CHIC, V119, P23; Lee AJ, 2004, BRIT J OPHTHALMOL, V88, P5, DOI 10.1136/bjo.88.1.5; Lee YG, 2011, OPTOMETRY VISION SCI, V88, P843, DOI 10.1097/OPX.0b013e31821896f1; Lei G, 2008, CHINESE J PRACTICAL, V26, P907; Li J H, 1994, Zhonghua Yan Ke Za Zhi, V30, P445; Liu ZG, 2000, OPHTHALMOLOGY, V107, P105, DOI 10.1016/S0161-6420(99)00027-5; Manny RE, 2011, OPTOMETRY VISION SCI, V88, P1445, DOI 10.1097/OPX.0b013e318230f559; Mastropasqua L, 1992, Eur J Ophthalmol, V2, P33; Muir KW, 2004, OPHTHALMOLOGY, V111, P2220, DOI 10.1016/j.ophtha.2004.06.020; Muller A, 2000, BRIT J OPHTHALMOL, V84, P692, DOI 10.1136/bjo.84.7.692; Nomura H, 2004, OPHTHAL PHYSL OPT, V24, P41, DOI 10.1046/j.1475-1313.2003.00158.x; Osmera J, 2009, Cesk Slov Oftalmol, V65, P19; QUINN GE, 1995, OPHTHALMOLOGY, V102, P180; Sakalar YB, 2012, OPHTHAL EPIDEMIOL, V19, P83, DOI 10.3109/09286586.2011.649227; Sauer A, 2011, J FR OPHTALMOL, V34, P238, DOI 10.1016/j.jfo.2011.01.010; Shisheng Z, 2002, CHINESE J OPTOMETRY, V4, P43; Sihota R, 2006, J PEDIAT OPHTH STRAB, V43, P14, DOI 10.3928/01913913-20060101-01; Tong L, 2004, INVEST OPHTH VIS SCI, V45, P4004, DOI 10.1167/iovs.04-0121; Tuulonen A, 2003, ACTA OPHTHALMOL SCAN, V81, P3, DOI 10.1034/j.1600-0420.2003.00021.x; Wang W-Q, 2005, INT EYE SCI, V5, P93; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Yildirim N, 2007, J PEDIAT OPHTH STRAB, V44, P216, DOI 10.3928/01913913-20070701-02; Zheng YF, 2008, CORNEA, V27, P776, DOI 10.1097/ICO.0b013e31816f62d3	45	24	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104842	10.1371/journal.pone.0104842	http://dx.doi.org/10.1371/journal.pone.0104842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148520	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600023
J	Benjamin, R; Banerjee, A; Balakrishnan, K; Sivangala, R; Gaddam, S; Banerjee, S				Benjamin, Ronald; Banerjee, Atoshi; Balakrishnan, Kannan; Sivangala, Ramya; Gaddam, Sumanlatha; Banerjee, Sharmistha			Mycobacterial and HIV Infections Up-Regulated Human Zinc Finger Protein 134, a Novel Positive Regulator of HIV-1 LTR Activity and Viral Propagation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; TRANSCRIPTION FACTORS; DNA-BINDING; IN-VITRO; T-CELLS; PULMONARY TUBERCULOSIS; ALVEOLAR MACROPHAGES; TYPE-1 TRANSCRIPTION; KINASE-C	Background: Concurrent occurrence of HIV and Tuberculosis (TB) infections influence the cellular environment of the host for synergistic existence. An elementary approach to understand such coalition at the molecular level is to understand the interactions of the host and the viral factors that subsequently effect viral replication. Long terminal repeats (LTR) of HIV genome serve as a template for binding trans-acting viral and cellular factors that regulate its transcriptional activity, thereby, deciding the fate of HIV pathogenesis, making it an ideal system to explore the interplay between HIV and the host. Methodology/Principal Findings: In this study, using biotinylated full length HIV-1 LTR sequence as bait followed by MALDI analyses, we identified and further characterized human-Zinc-finger-protein-134 (hZNF-134) as a novel positive regulator of HIV-1 that promoted LTR-driven transcription and viral production. Over-expression of hZNF-134 promoted LTR driven luciferase activity and viral transcripts, resulting in increased virus production while siRNA mediated knockdown reduced both the viral transcripts and the viral titers, establishing hZNF-134 as a positive effector of HIV-1. HIV, Mycobacteria and HIV-TB co-infections increased hZNF-134 expressions in PBMCs, the impact being highest by mycobacteria. Corroborating these observations, primary TB patients (n = 22) recorded extraordinarily high transcript levels of hZNF-134 as compared to healthy controls (n = 16). Conclusions/Significance: With these observations, it was concluded that hZNF-134, which promoted HIV-1 LTR activity acted as a positive regulator of HIV propagation in human host. High titers of hZNF-134 transcripts in TB patients suggest that up-regulation of such positive effectors of HIV-1 upon mycobacterial infection can be yet another mechanism by which mycobacteria assists HIV-1 propagation during HIV-TB co-infections. hZNF-134, an uncharacterized host protein, thus assumes a novel regulatory role during HIV-host interactions. Our study provides new insights into the emerging role of zinc finger proteins in HIV-1 pathogenesis.	[Benjamin, Ronald; Banerjee, Atoshi; Balakrishnan, Kannan; Banerjee, Sharmistha] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Telangana, India; [Sivangala, Ramya; Gaddam, Sumanlatha] AC Guards, Bhagwan Mahavir Med Res Ctr, Dept Immunol, Hyderabad, Telangana, India; [Gaddam, Sumanlatha] Osmania Univ, Dept Genet, Hyderabad 500007, Telangana, India	University of Hyderabad; Osmania University	Banerjee, S (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Telangana, India.	sbsl@uohyd.ernet.in	Babu, Ronald/AAT-6101-2020; Banerjee, Atoshi/AAU-9256-2020; Banerjee, Atoshi/M-6404-2018	Babu, Ronald/0000-0003-2622-9359; Banerjee, Atoshi/0000-0002-3134-1268; Banerjee, Atoshi/0000-0002-3134-1268	Department of Biotechnology (CoE) [BT/PR3260/BRB/10/967/2011]; Department of Science and Technology [DST/INT/Spain/P-26/2011]; CSIR; UGC; DST-FIST; DST-PURSE; DBT-CREBB; XIIth Plan; Department of Biotechnology (IYBA) [BT/PR3260/BRB/10/967/2011]	Department of Biotechnology (CoE); Department of Science and Technology(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India); DST-FIST(Department of Science & Technology (India)); DST-PURSE; DBT-CREBB(Department of Biotechnology (DBT) India); XIIth Plan; Department of Biotechnology (IYBA)	This work was supported by grants from Department of Biotechnology (BT/PR3260/BRB/10/967/2011, CoE and IYBA) and Department of Science and Technology (DST/INT/Spain/P-26/2011) to SB. Funding from CSIR to AB and UGC to RB are acknowledged. The core financial support to the Department and University by DST-FIST, DST-PURSE, DBT-CREBB and XIIth Plan grants are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Banerjee A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-18; Banerjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072905; Bargonetti J, 1997, CELL MOL BIOL, V43, P935; Benjamin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070250; Bernier R, 1998, J GEN VIROL, V79, P1353, DOI 10.1099/0022-1317-79-6-1353; Bhat KH, 2012, J BIOL CHEM, V287, P16930, DOI 10.1074/jbc.M111.327825; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chen KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034240; Dandekar DH, 2005, ANAL BIOCHEM, V342, P341, DOI 10.1016/j.ab.2005.02.006; Dash PK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-25; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; Haedicke J, 2009, P NATL ACAD SCI USA, V106, P14040, DOI 10.1073/pnas.0900502106; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Herchenroder O, 1999, BBA-GENE STRUCT EXPR, V1445, P216, DOI 10.1016/S0167-4781(99)00046-9; HO WZ, 1991, J ACQ IMMUN DEF SYND, V4, P1098; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; Horiba M, 2007, J GEN VIROL, V88, P236, DOI 10.1099/vir.0.82066-0; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Hoshino Y, 2007, J INFECT DIS, V195, P1303, DOI 10.1086/513438; JAKOBOVITS A, 1990, EMBO J, V9, P1165, DOI 10.1002/j.1460-2075.1990.tb08223.x; Jeanson L, 2002, J BIOL CHEM, V277, P4918, DOI 10.1074/jbc.M110830200; Kitaura H, 2001, FEMS IMMUNOL MED MIC, V31, P97, DOI 10.1016/S0928-8244(01)00249-8; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kumar S, 1996, J BIOL CHEM, V271, P30864, DOI 10.1074/jbc.271.48.30451; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lazdins JK, 1997, J EXP MED, V185, P81, DOI 10.1084/jem.185.1.81; LEGRANDPOELS S, 1993, J PHOTOCH PHOTOBIO B, V17, P229, DOI 10.1016/1011-1344(93)80020-A; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; Manavathi B, 2012, J BIOL CHEM, V287, P5600, DOI 10.1074/jbc.M111.289843; MARGOLIS DM, 1994, J VIROL, V68, P905, DOI 10.1128/JVI.68.2.905-910.1994; Millhouse S, 1998, J NEUROVIROL, V4, P312, DOI 10.3109/13550289809114532; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Rabbi MF, 1998, VIROLOGY, V245, P257, DOI 10.1006/viro.1998.9158; Reed-Inderbitzin E, 2003, VIROLOGY, V314, P680, DOI 10.1016/S0042-6822(03)00508-7; Reynolds L, 2003, P NATL ACAD SCI USA, V100, P1615, DOI 10.1073/pnas.252770699; Roesch F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002792; Romanchikova N, 2003, IMMUNOBIOLOGY, V208, P361, DOI 10.1078/0171-2985-00283; Sakkhachornphop S, 2012, HUM GENE THER, V23, P932, DOI 10.1089/hum.2011.124; Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; STEWART DJ, 1994, INT J RADIAT ONCOL, V28, P531, DOI 10.1016/0360-3016(94)90082-5; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Toossi Z, 1997, J ACQ IMMUN DEF SYND, V15, P325, DOI 10.1097/00042560-199708150-00001; Toossi Z, 2004, J LAB CLIN MED, V144, P108, DOI 10.1016/j.lab.2004.05.012; Towatari M, 1998, AIDS, V12, P253, DOI 10.1097/00002030-199803000-00002; Turk G, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-14; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Xiong XF, 2007, BIOCHEM BIOPH RES CO, V358, P29, DOI 10.1016/j.bbrc.2007.04.048; YANG ZY, 1993, NUCLEIC ACIDS RES, V21, P2831, DOI 10.1093/nar/21.12.2831; YOON JB, 1994, MOL CELL BIOL, V14, P1776, DOI 10.1128/MCB.14.3.1776	61	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104908	10.1371/journal.pone.0104908	http://dx.doi.org/10.1371/journal.pone.0104908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144775	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100030
J	Du, ZJ; Wang, L; Zhao, YH; Cao, J; Wang, T; Liu, P; Zhang, YB; Yang, XJ; Cheng, XB; Liu, BL; Lei, DL				Du, Zhaojie; Wang, Lei; Zhao, Yinghua; Cao, Jian; Wang, Tao; Liu, Peng; Zhang, Yabo; Yang, Xinjie; Cheng, Xiaobing; Liu, Baolin; Lei, Delin			Sympathetic Denervation-Induced MSC Mobilization in Distraction Osteogenesis Associates with Inhibition of MSC Migration and Osteogenesis by Norepinephrine/adrb3	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; NERVOUS-SYSTEM; HUMAN OSTEOBLASTS; TENSION-STRESS; RABBIT MODEL; PROLIFERATION; INNERVATION; DIFFERENTIATION; REGENERATION	The sympathetic nervous system regulates bone formation and resorption under physiological conditions. However, it is still unclear how the sympathetic nerves affect stem cell migration and differentiation in bone regeneration. Distraction osteogenesis is an ideal model of bone regeneration due to its special nature as a self-engineering tissue. In this study, a rat model of mandibular distraction osteogenesis with transection of cervical sympathetic trunk was used to demonstrate that sympathetic denervation can deplete norepinephrine (NE) in distraction-induced bone callus, down-regulate beta 3-adrenergic receptor (adrb3) in bone marrow mesenchymal stem cells (MSCs), and promote MSC migration from perivascular regions to bone-forming units. An in vitro Transwell assay was here used to demonstrate that NE can inhibit stroma-derived factor-1 (SDF-1)-induced MSC migration and expression of the migration-related gene matrix metalloproteinase-2 (MMP-2) and downregulate that of the anti-migration gene tissue inhibitor of metalloproteinase-3 (TIMP-3). Knockdown of adrb3 using siRNA abolishes inhibition of MSC migration. An in vitro osteogenic assay was used to show that NE can inhibit the formation of MSC bone nodules and expression of the osteogenic marker genes alkaline phosphatase (ALP), osteocalcin (OCN), and runt-related transcription factor-2 (RUNX2), but knockdown of adrb3 by siRNA can abolish such inhibition of the osteogenic differentiation of MSCs. It is here concluded that sympathetic denervation-induced MSC mobilization in rat mandibular distraction osteogenesis is associated with inhibition of MSC migration and osteogenic differentiation by NE/adrb3 in vitro. These findings may facilitate understanding of the relationship of MSC mobilization and sympathetic nervous system across a wide spectrum of tissue regeneration processes.	[Du, Zhaojie; Wang, Lei; Cao, Jian; Wang, Tao; Liu, Peng; Zhang, Yabo; Yang, Xinjie; Cheng, Xiaobing; Liu, Baolin; Lei, Delin] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Du, Zhaojie] 425 Hosp PLA, Dept Oral & Maxillofacial Surg, Sanya, Peoples R China; [Zhao, Yinghua] Xi An Jiao Tong Univ, Stomatol Hosp, Dept Prosthodont, Xian 710049, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University	Wang, L (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.	wanglzyh@fmmu.edu.cn; leidelin@fmmu.edu.cn			National Natural Science Foundation of China [81270015, 30901685, 81070811]; State Key Laboratory of Military Stomatology, School of Stomatology, the Fourth Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Military Stomatology, School of Stomatology, the Fourth Military Medical University	This work was supported by the National Natural Science Foundation of China (No. 81270015 and No. 30901685 to Lei Wang, No. 81070811 to Delin Lei) and an independent grant from State Key Laboratory of Military Stomatology, School of Stomatology, the Fourth Military Medical University (to Delin Lei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet N, 2005, MED SCI SPORT EXER, V37, P1493, DOI 10.1249/01.mss.0000177592.82507.95; Brodal P., 2004, CENTRAL NERVOUS SYST, P369; Castro-Govea Y, 2012, J CRANIOFAC SURG, V23, P392, DOI 10.1097/SCS.0b013e318240fe9b; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; Du ZJ, 2011, BRIT J ORAL MAX SURG, V49, P557, DOI 10.1016/j.bjoms.2011.07.002; DUNCAN CP, 1977, J BONE JOINT SURG BR, V59, P323, DOI 10.1302/0301-620X.59B3.19482; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Feng X, 2008, BRIT J ORAL MAX SURG, V46, P527, DOI 10.1016/j.bjoms.2008.03.005; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Garcia-Castellano J M, 2000, Iowa Orthop J, V20, P49; Haasper C, 2008, EXP TOXICOL PATHOL, V59, P355, DOI [10.1016/j.etp.2007.11.013, 10.1016/j.etp.2007.11.008]; Han J, 2009, ARCH BIOCHEM BIOPHYS, V490, P96, DOI 10.1016/j.abb.2009.08.009; ILIZAROV GA, 1990, CLIN ORTHOP RELAT R, P8; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076; Kodama D, 2013, BRIT J PHARMACOL, V168, P1230, DOI 10.1111/bph.12000; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; MCCARTHY JG, 1992, PLAST RECONSTR SURG, V89, P1, DOI 10.1097/00006534-199289010-00001; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MOORE RE, 1993, BONE MINER, V23, P301, DOI 10.1016/S0169-6009(08)80105-5; NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109; Ortakoglu Kerim, 2007, Head Face Med, V3, P7, DOI 10.1186/1746-160X-3-7; Patel NJ, 2010, EUR J PHARMACOL, V633, P1, DOI 10.1016/j.ejphar.2010.01.012; Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200; Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008; Rosa-Ranal M, 2001, REV INVEST CLIN, V53, P362; Sato K, 2010, ORAL SURG ORAL MED O, V110, P32, DOI 10.1016/j.tripleo.2009.11.005; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Smith P, 1998, UROLOGY, V51, P663, DOI 10.1016/S0090-4295(97)00695-X; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Suzuki A, 1998, BONE, V23, P197, DOI 10.1016/S8756-3282(98)00099-4; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tang Y, 1999, J NEUROIMMUNOL, V96, P182, DOI 10.1016/S0165-5728(99)00032-6; Torres KCL, 2005, J NEUROIMMUNOL, V166, P144, DOI 10.1016/j.jneuroim.2005.06.006; Wang L, 2012, J DENT RES, V91, P1003, DOI 10.1177/0022034512460404; Wang L, 2010, BRIT J ORAL MAX SURG, V48, P515, DOI 10.1016/j.bjoms.2009.08.042; Wang L, 2006, J ORTHOP RES, V24, P2238, DOI 10.1002/jor.20269; Wang T, 2012, J CRANIOFAC SURG, V23, P1524, DOI 10.1097/SCS.0b013e31825daab2; Wiley LA, 2005, INVEST OPHTH VIS SCI, V46, P744, DOI 10.1167/iovs.04-1023; Wu YJ, 2012, STEM CELL REV REP, V8, P243, DOI 10.1007/s12015-011-9293-z; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318	46	18	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105976	10.1371/journal.pone.0105976	http://dx.doi.org/10.1371/journal.pone.0105976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144690	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100128
J	Kayode, GA; Amoakoh-Coleman, M; Brown-Davies, C; Grobbee, DE; Agyepong, IA; Ansah, E; Klipstein-Grobusch, K				Kayode, Gbenga A.; Amoakoh-Coleman, Mary; Brown-Davies, Charles; Grobbee, Diederick E.; Agyepong, Irene Akua; Ansah, Evelyn; Klipstein-Grobusch, Kerstin			Quantifying the Validity of Routine Neonatal Healthcare Data in the Greater Accra Region, Ghana	PLOS ONE			English	Article							QUALITY	Objectives: The District Health Information Management System-2 (DHIMS-2) is the database for storing health service data in Ghana, and similar to other low and middle income countries, paper-based data collection is being used by the Ghana Health Service. As the DHIMS-2 database has not been validated before this study aimed to evaluate its validity. Methods: Seven out of ten districts in the Greater Accra Region were randomly sampled; the district hospital and a polyclinic in each district were recruited for validation. Seven pre-specified neonatal health indicators were considered for validation: antenatal registrants, deliveries, total births, live birth, stillbirth, low birthweight, and neonatal death. Data were extracted on these health indicators from the primary data (hospital paper-registers) recorded from January to March 2012. We examined all the data captured during this period as these data have been uploaded to the DHIMS-2 database. The differences between the values of the health indicators obtained from the primary data and that of the facility and DHIMS-2 database were used to assess the accuracy of the database while its completeness was estimated by the percentage of missing data in the primary data. Results: About 41,000 data were assessed and in almost all the districts, the error rates of the DHIMS-2 data were less than 2.1% while the percentages of missing data were below 2%. At the regional level, almost all the health indicators had an error rate below 1% while the overall error rate of the DHIMS-2 database was 0.68% (95% C I = 0.61-0.75) and the percentage of missing data was 3.1% (95% C I = 2.96-3.24). Conclusion: This study demonstrated that the percentage of missing data in the DHIMS-2 database was negligible while its accuracy was close to the acceptable range for high quality data.	[Kayode, Gbenga A.; Amoakoh-Coleman, Mary; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Amoakoh-Coleman, Mary; Brown-Davies, Charles; Agyepong, Irene Akua; Ansah, Evelyn] Greater Accra Reg, Ghana Hlth Serv, Accra, Ghana; [Agyepong, Irene Akua] Univ Ghana, Sch Publ Hlth, Legon, Accra, Ghana; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Div Epidemiol & Biostat, Johannesburg, South Africa	Utrecht University; Utrecht University Medical Center; Ghana Health Service; University of Ghana; University of Witwatersrand	Kayode, GA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	g.a.kayode@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016; Kayode, Gabenga A./C-8992-2015	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Kayode, Gabenga A./0000-0001-6313-010X; Agyepong, Irene Akua/0000-0002-0193-5882; Ansah, Evelyn/0000-0003-0401-8606	Netherlands Organisation for Scientific Research/WOTRO Science for Development [07.45.102.00]	Netherlands Organisation for Scientific Research/WOTRO Science for Development	The authors gratefully acknowledge the financial support from the Netherlands Organisation for Scientific Research/WOTRO Science for Development (Grant Number: 07.45.102.00) for conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 1997, CERTIFIED QUALITY AU; [Anonymous], SPSS SOFTW VERS 17; [Anonymous], 2008, GHANA DEMOGRAPHIC HL; [Anonymous], GOOD CLIN DAT MAN; European Medicines Agency, 2002, INT C HARM GOOD CLIN; Fong DYT, 2001, DRUG INF J, V35, P839, DOI 10.1177/009286150103500321; Ghana Statistical Service, 2011, 2010 GHAN POP HOUS C; Goldberg Saveli I, 2008, AMIA Annu Symp Proc, P242; McFadden E., 1998, MANAGEMENT DATA CLIN; Nahm ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003049; Shea H, 2002, DATA BASIC, V6, P10; Shein-Chung c, 2004, DESIGN ANAL CLIN TRI, P628; Simba DO, 2005, S AFR J INFORM MANAG, V7; Society for Clinical Data Management, 2011, GOOD CLIN DAT MAN PR; Society for Clinical Data Management, 2000, GOOD CLIN DAT MAN PR; US Department of Health and Human Services Food and Drug Administration, 1996, GUID IND E6 GOOD CLI	16	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104053	10.1371/journal.pone.0104053	http://dx.doi.org/10.1371/journal.pone.0104053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144222	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100012
J	Monori-Kiss, A; Monos, E; Nadasy, GL				Monori-Kiss, Anna; Monos, Emil; Nadasy, Gyoergy L.			Quantitative Analysis of Vasodilatory Action of Quercetin on Intramural Coronary Resistance Arteries of the Rat In Vitro	PLOS ONE			English	Article							RED WINE POLYPHENOLS; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE; FLAVONOID ANTIOXIDANT; BLOOD-PRESSURE; METABOLITES; CONDUCTANCE; RELAXATION; PLASMA; RUTIN	Background: Dietary quercetin improves cardiovascular health, relaxes some vascular smooth muscle and has been demonstrated to serve as a substrate for the cyclooxygenase enzyme. Aims: 1. To test quantitatively a potential direct vasodilatory effect on intramural coronary resistance artery segments, in different concentrations. 2. To scale vasorelaxation at different intraluminal pressure loads on such vessels of different size. 3. To test the potential role of prostanoids in vasodilatation induced by quercetin. Methods: Coronary arterioles (70-240 mu m) were prepared from 24 rats and pressurized in PSS, using a pressure microangiometer. Results: The spontaneous tone that developed at 50 mmHg was relaxed by quercetin in the 10(-9) moles/lit concentration (p<0.05), while 10(-5) moles/lit caused full relaxation. Significant relaxation was observed at all pressure levels (10-100 mmHg) at 10(-7) moles/lit concentration of quercetin. The cyclooxygenase blocker indomethacin (10(-5) moles/lit) induced no relaxation but contraction when physiological concentrations of quercetin were present in the tissue bath (p<0.02 with Anova), this contraction being more prominent in smaller vessels and in the higher pressure range (p<0.05, Pearson correlation). A further 2-8% contraction could be elicited by the NO blocker L-NAME (10(-4) moles/lit). Conclusion: These results demonstrate that circulating levels of quercetin (10(-7) moles/lit) exhibit a substantial coronary vasodilatory effect. The extent of it is commeasurable with that of several other physiological mechanisms of coronary blood flow control. At least part of this relaxation is the result of an altered balance toward the production of endogenous vasodilatory prostanoids in the coronary arteriole wall.	[Monori-Kiss, Anna; Monos, Emil; Nadasy, Gyoergy L.] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary	Semmelweis University	Monori-Kiss, A (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary.	monorikiss.anna@med.semmelweis-univ.hu			Hungarian National grant [OTKA TO 32019]; Hungarian Hypertension Society; Hungarian Kidney Foundation	Hungarian National grant; Hungarian Hypertension Society; Hungarian Kidney Foundation	The study was supported by Hungarian National grant OTKA TO 32019, by the Hungarian Hypertension Society and the Hungarian Kidney Foundation. The Hungarian Ministry of Human Resources assured a PhD stipend for the first author (AM-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fayez M, 2006, CANCER CHEMOTH PHARM, V58, P816, DOI 10.1007/s00280-006-0228-3; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Fusi F, 2003, EUR J NUTR, V42, P10, DOI 10.1007/s00394-003-0395-5; Ibarra M, 2002, PLANTA MED, V68, P307, DOI 10.1055/s-2002-26752; Kim DH, 1998, ARCH PHARM RES, V21, P17, DOI 10.1007/BF03216747; Kurin E, 2012, PLANTA MED, V78, P772, DOI 10.1055/s-0031-1298440; Machha A, 2007, NITRIC OXIDE-BIOL CH, V16, P442, DOI 10.1016/j.niox.2007.04.001; Maciel RM, 2013, RES VET SCI, V95, P389, DOI 10.1016/j.rvsc.2013.04.028; MANACH C, 1995, J NUTR, V125, P1911, DOI 10.1093/jn/125.7.1911; Medina-Remon A, 2011, NUTR METAB CARDIOVAS, V21, P323, DOI 10.1016/j.numecd.2009.10.019; Molina MF, 2003, BIOL PHARM BULL, V26, P1398, DOI 10.1248/bpb.26.1398; Mullen W, 2004, J CHROMATOGR A, V1058, P163, DOI 10.1016/j.chroma.2004.08.117; Nadasy GL, 2001, MICROVASC RES, V61, P282, DOI 10.1006/mvre.2000.2297; Pechanova O, 2004, J HYPERTENS, V22, P1551, DOI 10.1097/01.hjh.0000133734.32125.c7; Perez-Vizcaino F, 2002, J PHARMACOL EXP THER, V302, P66, DOI 10.1124/jpet.302.1.66; Perez-Vizcaino F, 2012, J SCI FOOD AGR, V92, P1822, DOI 10.1002/jsfa.5697; Rendig SV, 1998, FASEB J, V12, pA405; Rendig SV, 2001, J CARDIOVASC PHARM, V38, P219, DOI 10.1097/00005344-200108000-00007; Rezaei-Sadabady R, 2016, ARTIF CELL NANOMED B, V44, P128, DOI 10.3109/21691401.2014.926456; Rusznyak S, 1936, NATURE, V138, P27, DOI 10.1038/138027a0; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Suri S, 2010, BRIT J PHARMACOL, V159, P566, DOI 10.1111/j.1476-5381.2009.00556.x; Szekacs B, 1996, PROSTAG OTH LIPID M, V52, P221, DOI 10.1016/S0090-6980(96)00099-8; Szekeres M, 2004, J CARDIOVASC PHARM, V43, P242, DOI 10.1097/00005344-200402000-00012; Szekeres M, 2001, J CARDIOVASC PHARM, V38, P584, DOI 10.1097/00005344-200110000-00011; Szekeres M., 2006, ACTA PHYSIOLOGICA HUNGARICA, V93, P1, DOI 10.1556/APhysiol.93.2006.1.1; Taubert D, 2002, J CARDIOVASC PHARM, V40, P701, DOI 10.1097/00005344-200211000-00008; VICKERY HB, 1950, SCIENCE, V112, P628; Wang P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012316; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Xu YC, 2007, PHYTOCHEMISTRY, V68, P1179, DOI 10.1016/j.phytochem.2007.02.013; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7	33	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105587	10.1371/journal.pone.0105587	http://dx.doi.org/10.1371/journal.pone.0105587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144688	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100088
J	Faye, E; Herrera, M; Bellomo, L; Silvain, JF; Dangles, O				Faye, Emile; Herrera, Mario; Bellomo, Lucio; Silvain, Jean-Francois; Dangles, Olivier			Strong Discrepancies between Local Temperature Mapping and Interpolated Climatic Grids in Tropical Mountainous Agricultural Landscapes	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; POTATO TUBERWORM; MICROCLIMATES; PROJECTIONS; CHALLENGES; ECTOTHERMS; MOVEMENT; MINIMUM; TERRAIN; BIOLOGY	Bridging the gap between the predictions of coarse-scale climate models and the fine-scale climatic reality of species is a key issue of climate change biology research. While it is now well known that most organisms do not experience the climatic conditions recorded at weather stations, there is little information on the discrepancies between microclimates and global interpolated temperatures used in species distribution models, and their consequences for organisms' performance. To address this issue, we examined the fine-scale spatiotemporal heterogeneity in air, crop canopy and soil temperatures of agricultural landscapes in the Ecuadorian Andes and compared them to predictions of global interpolated climatic grids. Temperature time-series were measured in air, canopy and soil for 108 localities at three altitudes and analysed using Fourier transform. Discrepancies between local temperatures vs. global interpolated grids and their implications for pest performance were then mapped and analysed using GIS statistical toolbox. Our results showed that global interpolated predictions over-estimate by 77.5 +/- 10% and under-estimate by 82.1 +/- 12% local minimum and maximum air temperatures recorded in the studied grid. Additional modifications of local air temperatures were due to the thermal buffering of plant canopies (from -2.7 degrees K during daytime to 1.3 degrees K during night-time) and soils (from -4.9 degrees K during daytime to 6.7 degrees K during night-time) with a significant effect of crop phenology on the buffer effect. This discrepancies between interpolated and local temperatures strongly affected predictions of the performance of an ectothermic crop pest as interpolated temperatures predicted pest growth rates 2.3-4.3 times lower than those predicted by local temperatures. This study provides quantitative information on the limitation of coarse-scale climate data to capture the reality of the climatic environment experienced by living organisms. In highly heterogeneous region such as tropical mountains, caution should therefore be taken when using global models to infer local-scale biological processes.	[Faye, Emile; Silvain, Jean-Francois; Dangles, Olivier] CNRS, UPR 9034, UR 072, Lab Evolut Genomes & Speciat,IRD, Gif Sur Yvette, France; [Faye, Emile; Silvain, Jean-Francois; Dangles, Olivier] Univ Paris 11, Orsay, France; [Faye, Emile] Univ Paris 04, UPMC Univ Paris06, Paris, France; [Faye, Emile; Herrera, Mario; Dangles, Olivier] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Quito, Ecuador; [Bellomo, Lucio] Univ Toulon & Var, MIO, CNRS INSU, IRD,UM 110, La Garde, France; [Dangles, Olivier] Univ Mayor San Andres, Inst Ecol, La Paz, Bolivia	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica del Ecuador; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon; Universidad Mayor de San Andres	Faye, E (corresponding author), CNRS, UPR 9034, UR 072, Lab Evolut Genomes & Speciat,IRD, Gif Sur Yvette, France.	ehfaye@gmail.com; olivier.dangles@ird.fr	Dangles, Olivier/C-4924-2009	Dangles, Olivier/0000-0002-1987-8433; Herrera Defaz, Mario/0000-0002-4444-2279; Faye, Emile/0000-0001-7764-3256	Agence Nationale pour la Recherche (ANR) [ANR-12-JSV7-0013-01]; McKnight Foundation	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); McKnight Foundation	This work was partly conducted within the project "Adaptive management in insect pest control in thermally heterogeneous agricultural landscapes" (ANR-12-JSV7-0013-01) funded by the Agence Nationale pour la Recherche (ANR, http://www.agence-nationale-recherche.fr/). A financial support of the McKnight Foundation (http://www.mcknight.org/) to EF during the fieldwork of this study is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken GS, 2014, FUNCT ECOL, V28, P96, DOI 10.1111/1365-2435.12149; BALDOCCHI DD, 1983, AGR METEOROL, V28, P321, DOI 10.1016/0002-1571(83)90009-2; Beaumont LJ, 2007, GLOBAL CHANGE BIOL, V13, P1368, DOI 10.1111/j.1365-2486.2007.01357.x; Bennie J, 2013, ECOL LETT, V117, P285; Bloomfield P., 2004, FOURIER ANAL TIME SE; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Cameron PJ, 2002, ENVIRON ENTOMOL, V31, P65, DOI 10.1603/0046-225X-31.1.65; CLOUDSLEYTHOMPS.JL, 1962, ANNU REV ENTOMOL, V7, P199, DOI 10.1146/annurev.en.07.010162.001215; Crespo-Perez V, 2013, B ENTOMOL RES, V103, P336, DOI 10.1017/S0007485312000776; Crespo-Perez V, 2011, LANDSCAPE ECOL, V26, P1447, DOI 10.1007/s10980-011-9649-4; Dangles O, 2008, ECOL APPL, V18, P1795, DOI 10.1890/07-1638.1; Dangles O, 2010, AMBIO, V39, P325, DOI 10.1007/s13280-010-0041-4; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dillon ME, 2012, J THERM BIOL, V37, P631, DOI 10.1016/j.jtherbio.2012.07.004; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick EA, 1964, ARCH METEOR GEOPHY B, V13, P270; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Geiger R., 1965, CLIMATE NEAR GROUND; Gilbert E, 2004, B MATH BIOL, V66, P1821, DOI 10.1016/j.bulm.2004.04.003; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanafi A, 1999, POTATO RES, V42, P373, DOI 10.1007/BF02357863; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jones, 1992, PLANTS MICROCLIMATES; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney MR, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.6; Kearney MR, 2014, METHODS ECOL EVOL, V5, P273, DOI 10.1111/2041-210X.12148; Kinahan AA, 2007, J THERM BIOL, V32, P47, DOI 10.1016/j.jtherbio.2006.09.002; Logan ML, 2013, GLOBAL CHANGE BIOL, V19, P3093, DOI 10.1111/gcb.12253; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; Rondon SI, 2010, AM J POTATO RES, V87, P149, DOI 10.1007/s12230-009-9123-x; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Scherrer D, 2010, GLOBAL CHANGE BIOL, V16, P2602, DOI 10.1111/j.1365-2486.2009.02122.x; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Sears MW, 2011, INTEGR COMP BIOL, V51, P666, DOI 10.1093/icb/icr111; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; TRACY CR, 1977, SCIENCE, V198, P1034, DOI 10.1126/science.929184; Unwin D.M., 1991, INSECTS PLANTS MICRO; Warren RJ, 2013, GLOBAL CHANGE BIOL, V19, P2082, DOI 10.1111/gcb.12169; Wilhelm WW, 2000, CROP SCI, V40, P1179, DOI 10.2135/cropsci2000.4041179x; WILLMER PG, 1982, ADV INSECT PHYSIOL, V16, P1, DOI 10.1016/S0065-2806(08)60151-4	44	25	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105541	10.1371/journal.pone.0105541	http://dx.doi.org/10.1371/journal.pone.0105541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141212	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200096
J	Brownhill, S; Cohen, D; Burchill, S				Brownhill, Samantha; Cohen, Dena; Burchill, Sue			Proliferation Index: A Continuous Model to Predict Prognosis in Patients with Tumours of the Ewing's Sarcoma Family	PLOS ONE			English	Article							CASPASE-8 PROTEIN EXPRESSION; APOPTOTIC INDEX; CELL-PROLIFERATION; CLINICOPATHOLOGICAL SIGNIFICANCE; C-MYC; CARCINOMA; BONE; P53; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA	The prognostic value of proliferation index (PI) and apoptotic index (AI), caspase-8, -9 and -10 expression have been investigated in primary Ewing's sarcoma family of tumours (ESFT). Proliferating cells, detected by immunohistochemistry for Ki-67, were identified in 91% (91/100) of tumours with a median PI of 14 (range 0-87). Apoptotic cells, identified using the TUNEL assay, were detected in 96% (76/79) of ESFT; the median AI was 3 (range 0-33). Caspase-8 protein expression was negative (0) in 14% (11/79), low (1) in 33% (26/79), medium (2) in 38% (30/79) and high (3) in 15% (12/79) of tumours, caspase-9 expression was low (1) in 66% (39/59) and high (3) in 34% (20/59), and caspase-10 protein was low (1) in 37% (23/62) and negative (0) in 63% (39/62) of primary ESFT. There was no apparent relationship between caspase-8, -9 and -10 expression, PI and AI. PI was predictive of relapse-free survival (RFS; p = 0.011) and overall survival (OS; p = <0.001) in a continuous model, whereas AI did not predict outcome. Patients with tumours expressing low levels of caspase-9 protein had a trend towards a worse RFS than patients with tumours expressing higher levels of caspase-9 protein (p = 0.054, log rank test), although expression of caspases-8, -9 and/or -10 did not significantly predict RFS or OS. In a multivariate analysis model that included tumour site, tumour volume, the presence of metastatic disease at diagnosis, PI and AI, PI independently predicts OS (p = 0.003). Consistent with previous publications, patients with pelvic tumours had a significantly worse OS than patients with tumours at other sites (p = 0.028); patients with a pelvic tumour and a PI >= 20 had a 6 fold-increased risk of death. These studies advocate the evaluation of PI in a risk model of outcome for patients with ESFT.	[Brownhill, Samantha; Burchill, Sue] St James Univ Hosp, Leeds Inst Canc & Pathol, Childrens Canc Res Grp, Leeds, W Yorkshire, England; [Cohen, Dena] St James Univ Hosp, Leeds Inst Canc & Pathol, Clin Trials Res Unit, Leeds, W Yorkshire, England	Saint James's University Hospital; Saint James's University Hospital; University of Leeds	Brownhill, S (corresponding author), St James Univ Hosp, Leeds Inst Canc & Pathol, Childrens Canc Res Grp, Leeds, W Yorkshire, England.	s.c.brownhill@leeds.ac.uk		Howard, Dena/0000-0003-3333-9783	Cancer Research UK [CA1010/A2862]; Bone Cancer Research Trust (BCRT)	Cancer Research UK(Cancer Research UK); Bone Cancer Research Trust (BCRT)	This work was funded by Cancer Research UK (CA1010/A2862; http://www.cancerresearchuk.org) and the Bone Cancer Research Trust (BCRT; http://www.bcrt.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens S, 1999, MED PEDIATR ONCOL, V32, P186, DOI 10.1002/(SICI)1096-911X(199903)32:3<186::AID-MPO5>3.0.CO;2-D; Ali HR, 2012, J PATHOL, V226, P97, DOI 10.1002/path.2976; Amir G, 2002, HUM PATHOL, V33, P170, DOI 10.1053/hupa.2002.31475; Andressakis D, 2008, J LARYNGOL OTOL, V122, P1213, DOI 10.1017/S0022215108002636; Lopez-Guerrero JA, 2011, INT J CANCER, V128, P1139, DOI 10.1002/ijc.25424; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bacci G, 2000, J CLIN ONCOL, V18, P4, DOI 10.1200/JCO.2000.18.1.4; Bendardaf R, 2003, ONCOLOGY-BASEL, V64, P435, DOI 10.1159/000070304; Burchill SA, 2003, J CLIN PATHOL, V56, P96, DOI 10.1136/jcp.56.2.96; Craft AW, 1997, EUR J CANCER, V33, P1061, DOI 10.1016/S0959-8049(97)00043-9; Dalal S, 2005, CLIN CANCER RES, V11, P2364, DOI 10.1158/1078-0432.CCR-04-1201; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Fulda S, 2006, CANCER RES, V66, P10016, DOI 10.1158/0008-5472.CAN-05-4079; Gasinska A, 2002, NEOPLASMA, V49, P379; Harada K, 2002, CANCER RES, V62, P5897; Ibrahim T, 2013, ONCOLOGY-BASEL, V84, P150, DOI 10.1159/000345795; Jia YN, 2012, TUMOR BIOL, V33, P1151, DOI 10.1007/s13277-012-0357-8; Kaseta MKA, 2007, HYBRIDOMA, V26, P355, DOI 10.1089/hyb.2007.0519; Kobayashi T, 2007, CLIN CANCER RES, V13, P3868, DOI 10.1158/1078-0432.CCR-06-2730; Leung TW, 2004, GYNECOL ONCOL, V92, P866, DOI 10.1016/j.ygyno.2003.11.051; Lissat A, 2007, AM J PATHOL, V170, P1917, DOI 10.2353/ajpath.2007.060993; Liu LX, 2002, WORLD J GASTROENTERO, V8, P580, DOI 10.3748/wjg.v8.i4.580; Lopez-Beltran A, 2004, EUR UROL, V45, P606, DOI 10.1016/j.eururo.2003.11.011; Martinez R, 2007, CARCINOGENESIS, V28, P1264, DOI 10.1093/carcin/bgm014; Mejia C, 2003, ONCOL REP, V10, P243; NESBIT ME, 1990, J CLIN ONCOL, V8, P1664, DOI 10.1200/JCO.1990.8.10.1664; Oudejans JJ, 2005, MODERN PATHOL, V18, P877, DOI 10.1038/modpathol.3800398; Pingoud-Meier C, 2003, CLIN CANCER RES, V9, P6401; Rioux-Leclercq N, 2000, UROLOGY, V55, P501, DOI 10.1016/S0090-4295(99)00550-6; Rosito P, 1999, CANCER-AM CANCER SOC, V86, P421, DOI 10.1002/(SICI)1097-0142(19990801)86:3<421::AID-CNCR10>3.0.CO;2-O; Royston P, 2004, STAT MED, V23, P2509, DOI 10.1002/sim.1815; de Hooge ASK, 2007, CLIN CANCER RES, V13, P206, DOI 10.1158/1078-0432.CCR-06-1457; Santon A, 2011, HISTOPATHOLOGY, V58, P1072, DOI 10.1111/j.1365-2559.2011.03803.x; Shen XG, 2011, INT J COLORECTAL DIS, V26, P1519, DOI 10.1007/s00384-011-1239-z; Sinicrope FA, 1999, CLIN CANCER RES, V5, P1793; Sollazzo MR, 1999, TUMORI, V85, P167, DOI 10.1177/030089169908500304; Stammler G, 1997, APOPTOSIS, V2, P377, DOI 10.1023/A:1026405707823; Stearns V, 2003, CLIN CANCER RES, V9, P124; Strater J, 2010, INT J CANCER, V127, P873, DOI 10.1002/ijc.25111; Takita J, 2000, MED PEDIATR ONCOL, V35, P541, DOI 10.1002/1096-911X(20001201)35:6<541::AID-MPO9>3.0.CO;2-T; Tang LH, 2012, AM J SURG PATHOL, V36, P1761, DOI 10.1097/PAS.0b013e318263207c; Tannapfel A, 1997, ANTICANCER RES, V17, P1155; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Terrier P, 1996, SEMIN DIAGN PATHOL, V13, P250; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; Van Valen F, 2000, INT J CANCER, V88, P252, DOI 10.1002/1097-0215(20001015)88:2<252::AID-IJC17>3.0.CO;2-U; van Valen Frans, 2012, Sarcoma, V2012, P782970, DOI 10.1155/2012/782970; White DE, 2010, BR J CANC; Wu X, 2012, CANCER EPIDEMIOL, V36, P212, DOI 10.1016/j.canep.2011.08.002; Xu B, 2008, ONCOLOGY-BASEL, V74, P229, DOI 10.1159/000151392; Yamasaki F, 1997, GYNECOL ONCOL, V66, P439, DOI 10.1006/gyno.1997.4783; Yang QW, 2007, CLIN CANCER RES, V13, P3191, DOI 10.1158/1078-0432.CCR-06-2846	53	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104106	10.1371/journal.pone.0104106	http://dx.doi.org/10.1371/journal.pone.0104106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157404	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200010
J	Chen, C; Li, P; Wang, RH; Schaal, BA; Fu, CX				Chen, Chuan; Li, Pan; Wang, Rui-Hong; Schaal, Barbara A.; Fu, Cheng-Xin			The Population Genetics of Cultivation: Domestication of a Traditional Chinese Medicine, Scrophularia ningpoensis Hemsl. (Scrophulariaceae)	PLOS ONE			English	Article							CINNAMIC ACID; WILD; DIVERSITY; PLANT; EVOLUTION; PHYLOGEOGRAPHY; CHLOROPLAST; INFERENCE; L.; HARPAGOSIDE	Background: Domestic cultivation of medicinal plants is an important strategy for protecting these species from over harvesting. Some species of medicinal plants have been brought into cultivation for more than hundreds years. Concerns about severe loss of genetic diversity and sustainable cultivation can potentially limit future use of these valuable plants. Genetic studies with comprehensive sampling of multiple medicinal species by molecular markers will allow for assessment and management of these species. Here we examine the population genetic consequences of cultivation and domestication in Scrophularia ningpoensis Hemsl. We used chloroplast DNA and genomic AFLP markers to clarify not only the effects of domestication on genetic diversity, but also determine the geographic origins of cultivars and their genetic divergence from native populations. These results will allow both better management of cultivated populations, but also provide insights for crop improvement. Results: Twenty-one cpDNA haplotypes of S. ningpoensis were identified. Wild populations contain all haplotypes, whereas only three haplotypes were found in cultivated populations with wild populations having twice the haplotype diversity of cultivated populations. Genetic differentiation between cultivated populations and wild populations was significant. Genomic AFLP markers revealed similar genetic diversity patterns. Furthermore, Structure analysis grouped all wild populations into two gene pools; two of which shared the same gene pool with cultivated S. ningpoensis. The result of Neighbor-Joining analysis was consistent with the structure analysis. In principal coordinate analysis, three cultivated populations from Zhejiang Province grouped together and were separated from other cultivated populations. Conclusions: These results suggest that cultivated S. ningpoensis has experienced dramatic loss of genetic diversity under anthropogenic influence. We postulate that strong artificial selection for medicinal quality has resulted in genetic differentiation between cultivated and wild populations. Furthermore, it appears that wild populations in Jiangxi-Hunan area were involved in the origin of cultivated S. ningpoensis.	[Chen, Chuan; Li, Pan; Wang, Rui-Hong; Fu, Cheng-Xin] Zhejiang Univ, Coll Life Sci, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Chuan] Hangzhou Bot Garden, Hangzhou, Zhejiang, Peoples R China; [Schaal, Barbara A.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Zhejiang University; Washington University (WUSTL)	Schaal, BA (corresponding author), Washington Univ, Dept Biol, St Louis, MO 63130 USA.	schaal@biology.wustl.edu; cxfu@zju.edu.cn			Key Breeding Project of Zhejiang Province [2012C12912]; National Natural Science Foundation of China [31070205]; Science and Technology Development Project of Hangzhou West Lake Scenic Area Management Committee [2012002]	Key Breeding Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Hangzhou West Lake Scenic Area Management Committee	This research was supported by the Key Breeding Project of Zhejiang Province (2012C12912), the National Natural Science Foundation of China (31070205), and Science and Technology Development Project of Hangzhou West Lake Scenic Area Management Committee (2012002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; [Anonymous], 1992, ILLUSTRATED CHINESE; [Anonymous], UTILIZATION CONSERVA; [Anonymous], 1991, CONSERVATION; Bagdonaite E, 2012, IND CROP PROD, V35, P302, DOI 10.1016/j.indcrop.2011.07.018; Bernath J, 1999, ACTA HORTIC, P31, DOI 10.17660/ActaHortic.1999.500.2; Canter PH, 2005, TRENDS BIOTECHNOL, V23, P180, DOI 10.1016/j.tibtech.2005.02.002; Cirak C, 2012, ACTA PHYSIOL PLANT, V34, P1313, DOI 10.1007/s11738-012-0928-8; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Diaz AM, 2004, LIFE SCI, V74, P2515, DOI 10.1016/j.lfs.2003.10.008; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; El-Domyati FM, 2011, J MED PLANTS RES, V5, P1918; Excoffier L, 1995, AMOVA ANAL MOL VARIA; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fernie AR, 2007, PHYTOCHEMISTRY, V68, P2861, DOI 10.1016/j.phytochem.2007.07.010; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Frankel O.H., 1995, CONSERVATION PLANT B; FU YX, 1993, GENETICS, V133, P693; Galindez JD, 2002, PHARM BIOL, V40, P45; Gao Wenyuan, 2005, Plant Genetic Resources Characterization and Utilization, V3, P116, DOI 10.1079/PGR200577; Garcia D, 1996, FARMACO, V51, P443; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; He JS, 2009, GENETICA, V135, P233, DOI 10.1007/s10709-008-9272-8; Hong D, 1994, FLORA CHINA; Huang S, 1982, SHEN NONG BEN CAO JI; KAJIMOTO T, 1989, PHYTOCHEMISTRY, V28, P2701, DOI 10.1016/S0031-9422(00)98071-3; Lambert J, 1997, MED PLANTS RESCUING, V355, P8; Li YM, 2004, VIB SPECTROSC, V36, P227, DOI 10.1016/j.vibspec.2003.12.009; Li YY, 2005, CONSERV BIOL, V19, P224, DOI 10.1111/j.1523-1739.2005.00025.x; LIU L, 1995, INT J CANCER, V62, P345, DOI 10.1002/ijc.2910620319; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Miller M.A., 2010, P GAT COMP ENV WORKS; MILLIGAN BG, 1994, MOL ECOL, V3, P423, DOI 10.1111/j.1365-294X.1994.tb00082.x; Miyazawa M, 1998, J AGR FOOD CHEM, V46, P904, DOI 10.1021/jf9704221; National Pharmacopoeia Committee, 2010, CHIN PHARM 1; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander JAA., 2004, BIOINFORMATICS; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Olsen KM, 2007, MOL ECOL, V16, P2838, DOI 10.1111/j.1365-294X.2007.03359.x; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Palevitch D., 1991, CONSERVATION MED PLA, P167; Pons O, 1996, GENETICS, V144, P1237; Pritchard JK, 2000, GENETICS, V155, P945; Qiu YX, 2009, PLANTA MED, V75, P94, DOI 10.1055/s-0028-1088365; Ran M., 1999, GUIDELINES MODERN CU; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sagare AP, 2001, BIOL PHARM BULL, V24, P1311, DOI 10.1248/bpb.24.1311; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schippmann, 1997, TRADE SURVEY MED PLA; Schippmann U., 2002, BIODIVERSITY ECOSYST; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Shi W, 2008, PLANT BIOLOGY, V10, P485, DOI 10.1111/j.1438-8677.2008.00035.x; Singh SK, 2013, J ESSENT OIL RES, V25, P154, DOI 10.1080/10412905.2013.767757; SONNANTE G, 1994, THEOR APPL GENET, V89, P629, DOI 10.1007/BF00222458; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Su S, 1975, TU JING B CAO; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uniyal RC, 2000, CULTIVATION MED PLAN, P20; Verma RS, 2013, CHEM BIODIVERS, V10, P628, DOI 10.1002/cbdv.201200054; Vines G, 2004, SALISBURY PLANTLIFE, P1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang JK, 2007, HIST GENUINE CHARACT; WHO IUCN WWF, 1993, GUID CONS MED PLANTS, P21; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Woo YA, 1999, J PHARMACEUT BIOMED, V21, P407, DOI 10.1016/S0731-7085(99)00145-4; Xu CB, 2007, TEXTUAL RES COMMON C; Xu XW, 2008, THEOR APPL GENET, V116, P835, DOI 10.1007/s00122-008-0717-3; Yang ST, 2011, PLANTA MED, V77, P865, DOI 10.1055/s-0030-1250601; Yuan QJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-29; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zhang DQ, 2010, BIOCHEM SYST ECOL, V38, P236, DOI 10.1016/j.bse.2009.12.029; Zhang Q, 2012, PLANT MOL BIOL REP, V30, P539, DOI 10.1007/s11105-011-0366-6; Zhang XG, 2009, CHROMATOGRAPHIA, V69, P51, DOI 10.1365/s10337-008-0851-8	88	9	9	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105064	10.1371/journal.pone.0105064	http://dx.doi.org/10.1371/journal.pone.0105064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157628	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200022
J	Dehmel, S; Lowel, S				Dehmel, Susanne; Loewel, Siegrid			Cortico-Cortical Interactions Influence Binocularity of the Primary Visual Cortex of Adult Mice	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; CALLOSAL CONNECTIONS; INTERHEMISPHERIC CONNECTIONS; CORTICOTHALAMIC PROJECTIONS; CONTRALATERAL THALAMUS; CORTICAL PROJECTIONS; RETICULAR NUCLEUS; PREFRONTAL CORTEX; INTRINSIC SIGNAL; LAYER 6	Electrophysiological studies have revealed that a large proportion of the mouse primary visual cortex ( V1) receives input also from the ipsilateral eye. This is surprising as most optic nerve fibers cross at the optic chiasm in mice. Inactivating V1 of one hemisphere has recently demonstrated a strong contribution of one hemisphere's activity on binocularity of single units and visually evoked potentials of V1 in the other hemisphere of young rats and of single units in young adult mice. Here we used intrinsic signal optical imaging to quantitatively study the influence of cortico-cortical connections on the magnitude of neuronal activation in the entire binocular zone of adult mouse V1. We simultaneously measured V1-activity of both hemispheres in adult C57BL/6J mice before and after blocking sensory-driven activity in one hemisphere with muscimol. In V1 contralateral to the inactivation, ipsilateral eye evoked activity was reduced by on average 18% while contralateral eye evoked activity did not change. Our results clearly show that cortico-cortical interactions exert a global amplification of ipsilateral eye evoked activity in adult mouse V1.	[Dehmel, Susanne; Loewel, Siegrid] Univ Gottingen, Johann Friedrich Blumbach Inst Zool & Anthropol, Dept Syst Neurosci Bernstein Fokus Neurotechn, D-37073 Gottingen, Germany; [Dehmel, Susanne; Loewel, Siegrid] Univ Gottingen, Sensory Collaborat Res Ctr 889, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Dehmel, S (corresponding author), Univ Gottingen, Johann Friedrich Blumbach Inst Zool & Anthropol, Dept Syst Neurosci Bernstein Fokus Neurotechn, D-37073 Gottingen, Germany.	sdehmel@gwdg.de	889, CRC/L-1607-2018	889, CRC/0000-0002-6678-3138	Federal Ministry of Education and Research (BMBF), Germany [01GQ0810]; Deutsche Forschungsgemeinschaft through the Collaborative Research Center [889]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft through the Collaborative Research Center(German Research Foundation (DFG))	This study was supported by the Federal Ministry of Education and Research (BMBF), Germany, grant 01GQ0810 (to S. L.), and by a grant from the Deutsche Forschungsgemeinschaft through the Collaborative Research Center 889 "Cellular Mechanisms of Sensory Processing'' (to S. L., Project B5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Alloway KD, 2008, J COMP NEUROL, V510, P100, DOI 10.1002/cne.21782; BATTAGLIA G, 1994, J COMP NEUROL, V347, P127, DOI 10.1002/cne.903470110; BECKSTEAD RM, 1979, J COMP NEUROL, V184, P43, DOI 10.1002/cne.901840104; Briggs F, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.003.2010; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cerri C, 2010, EUR J NEUROSCI, V32, P1163, DOI 10.1111/j.1460-9568.2010.07363.x; CHEN S, 1992, NEUROSCI LETT, V147, P85, DOI 10.1016/0304-3940(92)90780-B; CUSICK CG, 1981, BRAIN RES, V214, P239, DOI 10.1016/0006-8993(81)91192-6; DIAO YC, 1983, EXP BRAIN RES, V49, P410; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRAFSTEIN B, 1971, SCIENCE, V172, P177, DOI 10.1126/science.172.3979.177; Greifzu F, 2011, P NATL ACAD SCI USA, V108, P15450, DOI 10.1073/pnas.1016458108; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Houzel JC, 2002, BRAZ J MED BIOL RES, V35, P1441, DOI 10.1590/S0100-879X2002001200005; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Khibnik LA, 2010, NEURON, V66, P493, DOI 10.1016/j.neuron.2010.04.012; LEONARD CM, 1969, BRAIN RES, V12, P321, DOI 10.1016/0006-8993(69)90003-1; LEWIS JW, 1995, J COMP NEUROL, V361, P119, DOI 10.1002/cne.903610110; Li L, 2006, EXP BRAIN RES, V172, P397, DOI 10.1007/s00221-005-0337-y; Ludvig N, 2012, BRAIN RES, V1441, P1, DOI 10.1016/j.brainres.2011.12.050; METIN C, 1988, EXP BRAIN RES, V69, P594; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; MOLINARI M, 1985, EXP BRAIN RES, V57, P305; OLAVARRIA J, 1983, BRAIN RES, V279, P233, DOI 10.1016/0006-8993(83)90182-8; OLAVARRIA J, 1984, J COMP NEUROL, V230, P249, DOI 10.1002/cne.902300209; OLAVARRIA J, 1985, J COMP NEUROL, V239, P1, DOI 10.1002/cne.902390102; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; PAYNE BR, 1984, EXP BRAIN RES, V53, P462; RAOS V, 1993, J COMP NEUROL, V332, P145, DOI 10.1002/cne.903320202; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Restani L, 2009, NEURON, V64, P707, DOI 10.1016/j.neuron.2009.10.019; RHOADES RW, 1984, EXP BRAIN RES, V56, P92; ROUILLER EM, 1991, NEUROSCI LETT, V125, P93, DOI 10.1016/0304-3940(91)90139-K; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; Schmidt KE, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/397176; Shibata H, 2005, BRAIN RES, V1059, P93, DOI 10.1016/j.brainres.2005.08.025; VALVERDE F., 1968, BRAIN RES, V9, P145, DOI 10.1016/0006-8993(68)90264-3; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; Zhao XY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3088	43	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105745	10.1371/journal.pone.0105745	http://dx.doi.org/10.1371/journal.pone.0105745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157503	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200056
J	Samanta, K; Bakowski, D; Parekh, AB				Samanta, Krishna; Bakowski, Daniel; Parekh, Anant B.			Key Role for Store-Operated Ca2+ Channels in Activating Gene Expression in Human Airway Bronchial Epithelial Cells	PLOS ONE			English	Article							CURRENT I-CRAC; BASOPHILIC LEUKEMIA-CELLS; EPIDERMAL-GROWTH-FACTOR; CALCIUM CURRENT; RBL-1 CELLS; MAST-CELLS; RELEASE; ASTHMA; INFLUX; SECRETION	Ca2+ entry into airway epithelia is important for activation of the NFAT family of transcription factors and expression of genes including epidermal growth factor that help orchestrate local inflammatory responses. However, the identity of epithelial Ca2+ channel that activates these transcriptional responses is unclear. In many other non-excitable cells, store-operated Ca2+ entry is a major route for Ca2+ influx and is mediated by STIM1 and Orai1 proteins. This study was performed to determine if store-operated Ca2+ channels were expressed in human bronchial epithelial cells and, if so, whether they coupled Ca2+ entry to gene expression. Cytoplasmic Ca2+ measurements, patch clamp recordings, RNAi knockdown and functional assays were used to identify and then investigate the role of these Ca2+ channels in activating the NFAT and c-fos pathways and EGF expression. STIM1 and Orai1 mRNA transcripts as well as proteins were robustly in epithelial cells and formed functional Ca2+ channels. Ca2+ entry through the channels activated expression of c-fos and EGF as well as an NFAT-dependent reporter gene. Store-operated Ca2+ entry was also important for epithelial cell migration in a scrape wound assay. These findings indicate that store-operated Ca2+ channels play an important role in stimulating airway epithelial cell gene expression and therefore comprise a novel potential therapeutic target for the treatment of chronic asthma and related airway disorders.	[Samanta, Krishna; Bakowski, Daniel; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council [G0901791]; American Asthma Foundation; Medical Research Council [G1000813] Funding Source: researchfish; MRC [G1000813] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Asthma Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding provided by Medical Research Council G0901791 and American Asthma Foundation Senior Investigator Award to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Bakowski D, 2000, J PHYSIOL-LONDON, V529, P295, DOI 10.1111/j.1469-7793.2000.00295.x; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Balghi H, 2011, FASEB J, V25, P4274, DOI 10.1096/fj.11-187682; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Chustz RT, 2011, AM J RESP CELL MOL, V45, P145, DOI 10.1165/rcmb.2010-0075OC; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Di Capite J, 2009, J ALLERGY CLIN IMMUN, V124, P1014, DOI 10.1016/j.jaci.2009.08.030; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; ELLIS EF, 1983, J ALLERGY CLIN IMMUN, V72, P526, DOI 10.1016/0091-6749(83)90479-7; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fierro L, 1999, J PHYSIOL-LONDON, V520, P407, DOI 10.1111/j.1469-7793.1999.00407.x; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kar P, 2012, CURR BIOL, V22, P242, DOI 10.1016/j.cub.2011.12.025; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Li MC, 2011, J ALLERGY CLIN IMMUN, V128, P626, DOI 10.1016/j.jaci.2011.04.032; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; NOAH TL, 1991, AM J RESP CELL MOL, V5, P484, DOI 10.1165/ajrcmb/5.5.484; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Post S, 2013, ALLERGY, V68, P1117, DOI 10.1111/all.12202; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Ramadas RA, 2011, AM J RESP CELL MOL, V44, P134, DOI 10.1165/rcmb.2009-0315OC; ROBERTS ML, 1978, BIOCHIM BIOPHYS ACTA, V540, P246, DOI 10.1016/0304-4165(78)90137-X; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Seys SF, 2013, THORAX, V68, P906, DOI 10.1136/thoraxjnl-2013-203280; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Tourdot S, 2008, CLIN EXP ALLERGY, V38, P1016, DOI 10.1111/j.1365-2222.2008.02974.x; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Xiao B, 2011, NATURE; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	45	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105586	10.1371/journal.pone.0105586	http://dx.doi.org/10.1371/journal.pone.0105586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157492	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200038
J	Ahlgren, KM; Fall, T; Landegren, N; Grimelius, L; von Euler, H; Sundberg, K; Lindblad-Toh, K; Lobell, A; Hedhammar, A; Andersson, G; Hansson-Hamlin, H; Lernmark, A; Kampe, O				Ahlgren, Kerstin M.; Fall, Tove; Landegren, Nils; Grimelius, Lars; von Euler, Henrik; Sundberg, Katarina; Lindblad-Toh, Kerstin; Lobell, Anna; Hedhammar, Ake; Andersson, Goran; Hansson-Hamlin, Helene; Lernmark, Ake; Kampe, Olle			Lack of Evidence for a Role of Islet Autoimmunity in the Aetiology of Canine Diabetes Mellitus	PLOS ONE			English	Article							DOGS; AUTOANTIBODIES	Aims/Hypothesis: Diabetes mellitus is one of the most common endocrine disorders in dogs and is commonly proposed to be of autoimmune origin. Although the clinical presentation of human type 1 diabetes (T1D) and canine diabetes are similar, the aetiologies may differ. The aim of this study was to investigate if autoimmune aetiology resembling human T1D is as prevalent in dogs as previously reported. Methods: Sera from 121 diabetic dogs representing 40 different breeds were tested for islet cell antibodies (ICA) and GAD65 autoantibodies (GADA) and compared with sera from 133 healthy dogs. ICA was detected by indirect immunofluorescence using both canine and human frozen sections. GADA was detected by in vitro transcription and translation (ITT) of human and canine GAD65, followed by immune precipitation. Sections of pancreata from five diabetic dogs and two control dogs were examined histopathologically including immunostaining for insulin, glucagon, somatostatin and pancreas polypeptide. Results: None of the canine sera analysed tested positive for ICA on sections of frozen canine or human ICA pancreas. However, serum from one diabetic dog was weakly positive in the canine GADA assay and serum from one healthy dog was weakly positive in the human GADA assay. Histopathology showed marked degenerative changes in endocrine islets, including vacuolisation and variable loss of immune-staining for insulin. No sign of inflammation was noted. Conclusions/Interpretations: Contrary to previous observations, based on results from tests for humoral autoreactivity towards islet proteins using four different assays, and histopathological examinations, we do not find any support for an islet autoimmune aetiology in canine diabetes mellitus.	[Ahlgren, Kerstin M.; Landegren, Nils; Lobell, Anna; Kampe, Olle] Uppsala Univ, Dept Med Sci, Sci Life Lab, Uppsala, Sweden; [Fall, Tove] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Grimelius, Lars] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [von Euler, Henrik; Hedhammar, Ake; Hansson-Hamlin, Helene] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Sundberg, Katarina; Andersson, Goran] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Broad Inst Harvard & MIT, Cambridge, MA USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Lernmark, Ake] Lund Univ, Dept Clin Sci, Diabet & Celiac Dis Unit, Malmo, Sweden	Uppsala University; Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Lund University	Fall, T (corresponding author), Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden.	tove.fall@medsci.uu.se	Andersson, Goran/AAK-6564-2020; Lernmark, Åke/F-8140-2015; Fall, Tove/O-7226-2014; Ronnberg, HENRIK Paul Olof/AAP-9678-2021	Andersson, Goran/0000-0001-5131-3144; Lernmark, Åke/0000-0003-1735-0499; Ronnberg, HENRIK Paul Olof/0000-0001-6098-5364; Hedhammar, Ake/0000-0001-7048-3851; Kampe, Olle/0000-0001-6091-9914; Hamlin, Helene/0000-0002-8015-4688	European Commission (FP7-LUPA) [GA-201370]; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; NovoNordisk Foundation; Agria Djurforsakringar Research Foundation; ESF; Novo Nordisk Fonden [NNF13OC0005975, NNF14OC0011003] Funding Source: researchfish	European Commission (FP7-LUPA)(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; NovoNordisk Foundation(Novo Nordisk Foundation); Agria Djurforsakringar Research Foundation; ESF(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the European Commission (FP7-LUPA, GA-201370), the Swedish Research Council, the Torsten and Ragnar Soderberg Foundation, The NovoNordisk Foundation and Agria Djurforsakringar Research Foundation. KLT is the recipient of EURYI award from the ESF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEJANDRO R, 1988, J AM VET MED ASSOC, V193, P1050; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Catchpole B, 2005, DIABETOLOGIA, V48, P1948, DOI 10.1007/s00125-005-1921-1; Davison LJ, 2008, VET IMMUNOL IMMUNOP, V126, P83, DOI 10.1016/j.vetimm.2008.06.016; Davison LJ, 2011, RES VET SCI, V91, P58, DOI 10.1016/j.rvsc.2010.08.007; EIGENMANN JE, 1983, ACTA ENDOCRINOL-COP, V104, P167, DOI 10.1530/acta.0.1040167; Fall T, 2008, VET REC, V163, P266, DOI 10.1136/vr.163.9.266; Fall T, 2010, J VET INTERN MED, V24, P1322, DOI 10.1111/j.1939-1676.2010.0630.x; Fall T, 2007, J VET INTERN MED, V21, P1209, DOI 10.1892/07-021.1; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gepts W, 1967, Diabetologia, V3, P249, DOI 10.1007/BF01222202; HOENIG M, 1992, VET IMMUNOL IMMUNOP, V32, P195, DOI 10.1016/0165-2427(92)90046-S; IMAMURA T, 1988, DIABETES, V37, P600, DOI 10.2337/diabetes.37.5.600; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; LING GV, 1977, J AM VET MED ASSOC, V170, P521; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Rand JS, 2004, J NUTR, V134, p2072S, DOI 10.1093/jn/134.8.2072S	19	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105473	10.1371/journal.pone.0105473	http://dx.doi.org/10.1371/journal.pone.0105473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153886	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200053
J	Defrancesco, M; Egger, K; Marksteiner, J; Esterhammer, R; Hinterhuber, H; Deisenhammer, EA; Schocke, M				Defrancesco, Michaela; Egger, Karl; Marksteiner, Josef; Esterhammer, Regina; Hinterhuber, Hartmann; Deisenhammer, Eberhard A.; Schocke, Michael			Changes in White Matter Integrity before Conversion from Mild Cognitive Impairment to Alzheimer's Disease	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER; BRAIN ATROPHY; PROGRESSION; MCI; NEUROPATHOLOGY; VALIDATION; DIAGNOSIS; DEMENTIA; PET	Background: Mild cognitive impairment (MCI) may represent an early stage of dementia conferring a particularly high annual risk of 15-20% of conversion to Alzheimer's disease (AD). Recent findings suggest that not only gray matter (GM) loss but also a decline in white matter (WM) integrity may be associated with imminent conversion from MCI to AD. Objective: In this study we used Voxel-based morphometry (VBM) to examine if gray matter loss and/or an increase of the apparent diffusion coefficient (ADC) reflecting mean diffusivity (MD) are an early marker of conversion from MCI to AD in a high risk population. Method: Retrospective neuropsychological and clinical data were collected for fifty-five subjects (MCI converters n = 13, MCI non-converters n = 14, healthy controls n = 28) at baseline and one follow-up visit. All participants underwent diffusion weighted imaging (DWI) and T1-weighted structural magnetic resonance imaging scans at baseline to analyse changes in GM density and WM integrity using VBM. Results: At baseline MCI converters showed impaired performance in verbal memory and naming compared to MCI non-converters. Further, MCI converters showed decreased WM integrity in the frontal, parietal, occipital, as well as the temporal lobe prior to conversion to AD. Multiple regression analysis showed a positive correlation of gray matter atrophy with specific neuropsychological test results. Conclusion: Our results suggest that additionally to morphological changes of GM a reduced integrity of WM indicates an imminent progression from MCI stage to AD. Therefore, we suggest that DWI is useful in the early diagnosis of AD.	[Defrancesco, Michaela; Hinterhuber, Hartmann; Deisenhammer, Eberhard A.] Med Univ Innsbruck, Dept Gen Psychiat, A-6020 Innsbruck, Austria; [Esterhammer, Regina; Schocke, Michael] Med Univ Innsbruck, Dept Radiol 1, A-6020 Innsbruck, Austria; [Marksteiner, Josef] LKH Hall, Dept Psychiat, Hall In Tirol, Austria; [Egger, Karl] Univ Clin Freiburg, Dept Neuroradiol, Freiburg, Germany	Medical University of Innsbruck; Medical University of Innsbruck; University of Freiburg	Defrancesco, M (corresponding author), Med Univ Innsbruck, Dept Gen Psychiat, A-6020 Innsbruck, Austria.	Michaela.defrancesco@i-med.ac.at	Schocke, Michael/AAC-3666-2020	Defrancesco, Michaela/0000-0001-9613-9485				Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; BRAAK H, 1991, ACTA NEUROPATHOL, V81, P261, DOI 10.1007/BF00305867; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cherubini A, 2010, J ALZHEIMERS DIS, V19, P1273, DOI 10.3233/JAD-2010-091186; Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; Defrancesco M, 2013, J ALZHEIMERS DIS, V34, P665, DOI 10.3233/JAD-122095; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Ferreira LK, 2011, NEUROBIOL AGING, V32, P1733, DOI 10.1016/j.neurobiolaging.2009.11.008; Fleisher AS, 2012, LANCET NEUROL, V11, P1057, DOI 10.1016/S1474-4422(12)70227-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Gold BT, 2012, BBA-MOL BASIS DIS, V1822, P416, DOI 10.1016/j.bbadis.2011.07.009; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hamalainen A, 2007, NEUROIMAGE, V37, P1122, DOI 10.1016/j.neuroimage.2007.06.016; Hakulinen U, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-30; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Kantarci K, 2005, NEUROLOGY, V64, P902, DOI 10.1212/01.WNL.0000153076.46126.E9; Kantarci K, 2001, RADIOLOGY, V219, P101, DOI 10.1148/radiology.219.1.r01ap14101; Karas G, 2008, AM J NEURORADIOL, V29, P944, DOI 10.3174/ajnr.A0949; Koivunen J, 2011, NEUROLOGY, V76, P1085, DOI 10.1212/WNL.0b013e318212015e; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Liu J, 2013, PLOS ONE, V3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MORRIS JC, 1988, ANN NEUROL, V24, P17, DOI 10.1002/ana.410240105; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Ray KM, 2006, RADIOLOGY, V241, P197, DOI 10.1148/radiol.2411051051; Reiman EM, 2010, BIOMARK MED, V4, P3, DOI [10.2217/bmm.09.91, 10.2217/BMM.09.91]; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Ritchie K, 2000, LANCET, V355, P225, DOI 10.1016/S0140-6736(99)06155-3; Rosen S, 2013, MOL NEURODEGENER, P8; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Sandson TA, 1999, DEMENT GERIATR COGN, V10, P166, DOI 10.1159/000017099; Satzger W, 2001, NERVENARZT, V72, P196, DOI 10.1007/s001150050739; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schocke MFH, 2004, NEUROIMAGE, V21, P1443, DOI 10.1016/j.neuroimage.2003.12.005; Smith CD, 2010, NEUROBIOL AGING, V31, P1122, DOI 10.1016/j.neurobiolaging.2008.08.006; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; Wang PJ, 2006, NEUROBIOL AGING, V27, P1613, DOI 10.1016/j.neurobiolaging.2005.09.035; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zhuang L, 2013, PLOS ONE, V8	52	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106062	10.1371/journal.pone.0106062	http://dx.doi.org/10.1371/journal.pone.0106062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153085	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200111
J	de Costa, F; Yendo, ACA; Cibulski, SP; Fleck, JD; Roehe, PM; Spilki, FR; Gosmann, G; Fett-Neto, AG				de Costa, Fernanda; Yendo, Anna Carolina A.; Cibulski, Samuel P.; Fleck, Juliane D.; Roehe, Paulo M.; Spilki, Fernando R.; Gosmann, Grace; Fett-Neto, Arthur G.			Alternative Inactivated Poliovirus Vaccines Adjuvanted with Quillaja brasiliensis or Quil-A Saponins Are Equally Effective in Inducing Specific Immune Responses	PLOS ONE			English	Article							MUCOSAL ADJUVANT; IMMUNOADJUVANT; INDUCTION; TYPE-1; LEAVES; MICE	Inactivated polio vaccines (IPV) have an important role at the final stages of poliomyelitis eradication programs, reducing the risks associated with the use of attenuated polio vaccine (OPV). An affordable option to enhance vaccine immunogenicity and reduce costs of IPV may be the use of an effective and renewable adjuvant. In the present study, the adjuvant activity of aqueous extract (AE) and saponin fraction QB-90 from Quillaja brasiliensis using poliovirus antigen as model were analyzed and compared to a preparation adjuvanted with Quil-A, a well-known saponin-based commercial adjuvant. Experimental vaccines were prepared with viral antigen plus saline (control), Quil-A (50 mu g), AE (400 mu g) or QB-90 (50 mu g). Sera from inoculated mice were collected at days 0, 28, 42 and 56 post-inoculation of the first dose of vaccine. Serum levels of specific IgG, IgG1 and IgG2a were significantly enhanced by AE, QB-90 and Quil-A compared to control group on day 56. The magnitude of enhancement was statistically equivalent for QB-90 and Quil-A. The cellular response was evaluated through DTH and analysis of IFN-gamma and IL-2 mRNA levels using in vitro reestimulated splenocytes. Results indicated that AE and QB-90 were capable of stimulating the generation of Th1 cells against the administered antigen to the same extent as Quil-A. Mucosal immune response was enhanced by the vaccine adjuvanted with QB-90 as demonstrated by increases of specific IgA titers in bile, feces and vaginal washings, yielding comparable or higher titers than Quil-A. The results obtained indicate that saponins from Q. brasiliensis are potent adjuvants of specific cellular and humoral immune responses and represent a viable option to Quil-A.	[de Costa, Fernanda; Yendo, Anna Carolina A.; Fett-Neto, Arthur G.] Fed Univ Rio Grande UFRGS, Ctr Biotechnol, Plant Physiol Lab, Porto Alegre, RS, Brazil; [de Costa, Fernanda; Yendo, Anna Carolina A.; Fett-Neto, Arthur G.] Univ Fed Rio Grande Sul UFRGS, Dept Bot, Porto Alegre, RS, Brazil; [de Costa, Fernanda; Yendo, Anna Carolina A.; Gosmann, Grace] Univ Fed Rio Grande do Sul, Fac Pharm, Porto Alegre, RS, Brazil; [Cibulski, Samuel P.; Roehe, Paulo M.] Inst Vet Res Desiderio Finamor IPVDF, Fepagro Anim Hlth, Eldorado Do Sul, Brazil; [Cibulski, Samuel P.; Roehe, Paulo M.] Univ Fed Rio Grande do Sul, Dept Microbiol, Virol Lab, Porto Alegre, RS, Brazil; [Fleck, Juliane D.; Spilki, Fernando R.] Feevale Univ, Mol Microbiol Lab, Novo Hamburgo, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Feevale	Fett-Neto, AG (corresponding author), Fed Univ Rio Grande UFRGS, Ctr Biotechnol, Plant Physiol Lab, Porto Alegre, RS, Brazil.	fettneto@cbiot.ufrgs.br	Fett-Neto, Arthur G/B-6944-2013; Gosmann, Grace/AAJ-9760-2020; Spilki, Fernando/E-3736-2010; Fleck, Juliane Deise/AAX-3826-2020; ROEHE, PAULO MICHEL/K-1208-2012; de Costa, Fernanda/Q-1771-2015; Cibulski, Samuel P/G-5190-2017; Gosmann, Grace/G-3331-2012	Fett-Neto, Arthur G/0000-0001-5477-2610; Gosmann, Grace/0000-0001-6823-8312; Spilki, Fernando/0000-0001-5804-7045; Fleck, Juliane Deise/0000-0002-3523-3192; ROEHE, PAULO MICHEL/0000-0002-2370-7661; Gosmann, Grace/0000-0001-6823-8312; Cibulski, Samuel/0000-0003-0503-8692; de Costa, Fernanda/0000-0002-3321-3921	Brazilian Agencies National Comission for Improvement of Higher Education Personnel [CGCI 040/2011]; National Council for Scientific and Technological Development [306079/2013-5]	Brazilian Agencies National Comission for Improvement of Higher Education Personnel; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the Brazilian Agencies National Comission for Improvement of Higher Education Personnel (www.capes.gov.br, Capes-Udelar number CGCI 040/2011) to GG and National Council for Scientific and Technological Development (www.cnpq.br, CNPq number 306079/2013-5) to AGFN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhate G, 2013, INT J PHARMACEUT, V441, P636, DOI 10.1016/j.ijpharm.2012.10.033; Bhutta ZA, 2013, JAMA-J AM MED ASSOC, V310, P905, DOI 10.1001/jama.2013.276583; Boyaka PN, 2001, J IMMUNOL, V166, P2283, DOI 10.4049/jimmunol.166.4.2283; Broere F, 2011, PRINCIPLES IMMUNOPHA, P15, DOI [DOI 10.1007/978-3-0346-0136-8_2, 10.1007/978-3-0346-0136-8_2]; Buisman AM, 2000, J INFECT DIS, V181, P815, DOI 10.1086/315326; de Costa F, 2011, MINI-REV MED CHEM, V11, P857, DOI 10.2174/138955711796575470; de Costa F, 2013, PLANT PHYSIOL BIOCH, V66, P56, DOI 10.1016/j.plaphy.2013.02.003; ELSON CO, 1984, J IMMUNOL, V132, P2736; Fleck JD, 2006, VACCINE, V24, P7129, DOI 10.1016/j.vaccine.2006.06.059; Fleck JD, 2009, IN VITRO CELL DEV-PL, V45, P715, DOI 10.1007/s11627-009-9222-x; Freshney RI, 2010, SUBCULTURE CELL LINE, P187; Grassly NC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0140; Hawken J, 2012, VACCINE, V30, P6971, DOI 10.1016/j.vaccine.2012.09.059; Heinsbroek E, 2010, VACCINE, V28, P3778, DOI 10.1016/j.vaccine.2010.02.095; Hernandez A, 2005, VET IMMUNOL IMMUNOP, V104, P45, DOI 10.1016/j.vetimm.2004.10.006; Kauffmann C, 2004, NAT PROD RES, V18, P153, DOI 10.1080/14786410310001608055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangal TD, 2013, AM J EPIDEMIOL, V178, P1579, DOI 10.1093/aje/kwt203; Mastelic Beatris, 2010, Biologicals, V38, P594, DOI 10.1016/j.biologicals.2010.06.002; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Reitz R., 1996, FLORA ILUSTRADA CATA; SALK JE, 1960, ANN NY ACAD SCI, V83, P609, DOI 10.1111/j.1749-6632.1960.tb40933.x; San Martin R, 1999, ECON BOT, V53, P302, DOI 10.1007/BF02866642; Sasaki S, 1998, J VIROL, V72, P4931, DOI 10.1128/JVI.72.6.4931-4939.1998; Silveira F, 2011, VACCINE, V29, P9177, DOI 10.1016/j.vaccine.2011.09.137; Spilki FR, 2005, J VIROL METHODS, V129, P191, DOI 10.1016/j.jviromet.2005.06.008; Steil BP, 2014, VACCINE, V32, P558, DOI 10.1016/j.vaccine.2013.11.101; Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091; Yoshino N, 2009, VACCINE, V27, P4808, DOI 10.1016/j.vaccine.2009.05.081	29	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105374	10.1371/journal.pone.0105374	http://dx.doi.org/10.1371/journal.pone.0105374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148077	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600044
J	Ulrich, D; Edwards, SL; Letouzey, V; Su, K; White, JF; Rosamilia, A; Gargett, CE; Werkmeister, JA				Ulrich, Daniela; Edwards, Sharon L.; Letouzey, Vincent; Su, Kai; White, Jacinta F.; Rosamilia, Anna; Gargett, Caroline E.; Werkmeister, Jerome A.			Regional Variation in Tissue Composition and Biomechanical Properties of Postmenopausal Ovine and Human Vagina	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; COLLAGENS; WOMEN; PREVALENCE; ELASTIN	Objective: There are increasing numbers of reports describing human vaginal tissue composition in women with and without pelvic organ prolapse with conflicting results. The aim of this study was to compare ovine and human posterior vaginal tissue in terms of histological and biochemical tissue composition and to assess passive biomechanical properties of ovine vagina to further characterise this animal model for pelvic organ prolapse research. Study Design: Vaginal tissue was collected from ovariectomised sheep (n = 6) and from postmenopausal women (n = 7) from the proximal, middle and distal thirds. Tissue histology was analyzed using Masson's Trichrome staining; total collagen was quantified by hydroxyproline assays, collagen III/I+III ratios by delayed reduction SDS PAGE, glycosaminoglycans by dimethylmethylene blue assay, and elastic tissue associated proteins (ETAP) by amino acid analysis. Young's modulus, maximum stress/strain, and permanent strain following cyclic loading were determined in ovine vagina. Results: Both sheep and human vaginal tissue showed comparable tissue composition. Ovine vaginal tissue showed significantly higher total collagen and glycosaminoglycan values (p<0.05) nearest the cervix. No significant differences were found along the length of the human vagina for collagen, GAG or ETAP content. The proximal region was the stiffest (Young's modulus, p<0.05), strongest (maximum stress, p<0.05) compared to distal region, and most elastic (permanent strain). Conclusion: Sheep tissue composition and mechanical properties showed regional differences along the postmenopausal vaginal wall not apparent in human vagina, although the absolute content of proteins were similar. Knowledge of this baseline variation in the composition and mechanical properties of the vaginal wall will assist future studies using sheep as a model for vaginal surgery.	[Ulrich, Daniela; Letouzey, Vincent; Gargett, Caroline E.] MIMR PHI Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Edwards, Sharon L.; Su, Kai; White, Jacinta F.; Werkmeister, Jerome A.] CSIRO, Mfg Flagship, Clayton, Vic, Australia; [Letouzey, Vincent] Caremeau Univ Hosp, Dept Gynecol & Obstet, Nimes, France; [Ulrich, Daniela; Rosamilia, Anna; Gargett, Caroline E.] Monash Univ, Monash Med Ctr, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia	Prince Henry's Institute of Medical Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universite de Montpellier; CHU de Nimes; Monash University	Werkmeister, JA (corresponding author), CSIRO, Mfg Flagship, Clayton, Vic, Australia.	Jerome.Werkmeister@csiro.au	Gold, Daniela/ABE-4818-2020; White, Jacinta F/D-6961-2013; Gargett, Caroline E/Q-7911-2019; Gargett, Caroline Eve/I-4895-2019	Gold, Daniela/0000-0002-7196-454X; White, Jacinta F/0000-0002-4855-0170; Gargett, Caroline E/0000-0002-3590-2077; 	National Health and Medical Research Council (NHMRC) of Australia [1021126]; South East Melbourne Alliance for Regenerative Therapies; Australian Gynaecological Endoscopic Society grant; Victorian Government's Operational Infrastructure Support Program;  [1042298]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); South East Melbourne Alliance for Regenerative Therapies; Australian Gynaecological Endoscopic Society grant; Victorian Government's Operational Infrastructure Support Program; 	This study was supported by the National Health and Medical Research Council (NHMRC) of Australia grant (1021126) (CEG, JAW, AR) and Senior Research Fellowship (1042298) (CEG), South East Melbourne Alliance for Regenerative Therapies (CEG, JAW, AR, SE), Australian Gynaecological Endoscopic Society grant (AR) and Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitch SD, 2009, EUR J OBSTET GYN R B, V144, pS146, DOI 10.1016/j.ejogrb.2009.02.022; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; CHAN D, 1984, ANAL BIOCHEM, V139, P322, DOI 10.1016/0003-2697(84)90012-5; CHANDRASEKHAR S, 1987, ANAL BIOCHEM, V161, P103, DOI 10.1016/0003-2697(87)90658-0; Couri Bruna M, 2012, Expert Rev Obstet Gynecol, V7, P249; De Landsheere L, 2013, INT UROGYNECOL J, V24, P2011, DOI 10.1007/s00192-013-2111-1; DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717, DOI 10.1016/0002-9378(92)91562-O; Ennen S, 2011, THERIOGENOLOGY, V75, P212, DOI 10.1016/j.theriogenology.2010.08.007; Gabriel B, 2011, INT UROGYNECOL J, V22, P23, DOI 10.1007/s00192-010-1237-7; Gerhard Meisenberg WHSPD, 2006, PRINCIPLES MED BIOCH; Gyhagen M, 2013, BJOG-INT J OBSTET GY, V120, P152, DOI 10.1111/1471-0528.12020; Jean-Charles C, 2010, INT UROGYNECOL J, V21, P1535, DOI 10.1007/s00192-010-1208-z; Kannan K, 2011, J OBSTET GYNAECOL, V31, P250, DOI 10.3109/01443615.2011.553690; Moalli PA, 2005, OBSTET GYNECOL, V106, P953, DOI 10.1097/01.AOG.0000182584.15087.dd; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4; Rubod C, 2012, J UROLOGY, V79; Rubod C, 2008, INT UROGYNECOL J, V19, P811, DOI 10.1007/s00192-007-0533-3; Rubod C, 2007, J UROLOGY, V178, P320, DOI 10.1016/j.juro.2007.03.040; Skoczylas LC, 2013, REPROD SCI, V20, P382, DOI 10.1177/1933719112472733; SYKES B, 1976, BIOCHEM BIOPH RES CO, V72, P1472, DOI 10.1016/S0006-291X(76)80180-5; Ulrich D, TISSUE ENG, V20, P785; Ulrich D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093172; Ulrich D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050044; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; WOESSNER JF, 1963, BIOCHEM J, V89, P75, DOI 10.1042/bj0890075; Zong WJ, 2010, OBSTET GYNECOL, V115, P953, DOI 10.1097/AOG.0b013e3181da7946	27	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104972	10.1371/journal.pone.0104972	http://dx.doi.org/10.1371/journal.pone.0104972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148261	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600027
J	Wang, HL; Wang, MJ; Tan, H; Li, Y; Zhang, ZD; Song, JN				Wang, Huilin; Wang, Mingjun; Tan, Hao; Li, Yuan; Zhang, Ziding; Song, Jiangning			PredPPCrys: Accurate Prediction of Sequence Cloning, Protein Production, Purification and Crystallization Propensity from Protein Sequences Using Multi-Step Heterogeneous Feature Fusion and Selection	PLOS ONE			English	Article							WEB SERVER; DATABASE; PEPTIDES; FOREST; SITES; SCALE	X-ray crystallography is the primary approach to solve the three-dimensional structure of a protein. However, a major bottleneck of this method is the failure of multi-step experimental procedures to yield diffraction-quality crystals, including sequence cloning, protein material production, purification, crystallization and ultimately, structural determination. Accordingly, prediction of the propensity of a protein to successfully undergo these experimental procedures based on the protein sequence may help narrow down laborious experimental efforts and facilitate target selection. A number of bioinformatics methods based on protein sequence information have been developed for this purpose. However, our knowledge on the important determinants of propensity for a protein sequence to produce high diffraction-quality crystals remains largely incomplete. In practice, most of the existing methods display poorer performance when evaluated on larger and updated datasets. To address this problem, we constructed an up-to-date dataset as the benchmark, and subsequently developed a new approach termed 'PredPPCrys' using the support vector machine (SVM). Using a comprehensive set of multifaceted sequence-derived features in combination with a novel multi-step feature selection strategy, we identified and characterized the relative importance and contribution of each feature type to the prediction performance of five individual experimental steps required for successful crystallization. The resulting optimal candidate features were used as inputs to build the first-level SVM predictor (PredPPCrys I). Next, prediction outputs of PredPPCrys I were used as the input to build second-level SVM classifiers (PredPPCrys II), which led to significantly enhanced prediction performance. Benchmarking experiments indicated that our PredPPCrys method outperforms most existing procedures on both up-to-date and previous datasets. In addition, the predicted crystallization targets of currently non-crystallizable proteins were provided as compendium data, which are anticipated to facilitate target selection and design for the worldwide structural genomics consortium.	[Wang, Huilin; Wang, Mingjun; Li, Yuan; Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China; [Wang, Huilin; Wang, Mingjun; Li, Yuan; Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Tan, Hao; Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Zhang, Ziding] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Song, Jiangning] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3004, Australia	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Monash University; China Agricultural University; Monash University	Zhang, ZD (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	Jiangning.Song@monash.edu; zidingzhang@cau.edu.cn	, zidingzhang/E-9320-2011; Song, Jiangning/F-9787-2010	, zidingzhang/0000-0002-9296-571X; Song, Jiangning/0000-0001-8031-9086	National Natural Science Foundation of China [61202167, 61303169, 31350110507, 11250110508]; National Health and Medical Research Council of Australia (NHMRC) [490989]; Hundred Talents Program of the Chinese Academy of Sciences (CAS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hundred Talents Program of the Chinese Academy of Sciences (CAS)	This work was financially supported by the National Natural Science Foundation of China (61202167, 61303169, 31350110507, 11250110508) and the National Health and Medical Research Council of Australia (NHMRC) (490989). JS is an NHMRC Peter Doherty Fellow and a recipient of the Hundred Talents Program of the Chinese Academy of Sciences (CAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babnigg Gyoergy, 2010, Journal of Structural and Functional Genomics, V11, P71, DOI 10.1007/s10969-010-9080-0; Berman HM, 2009, NUCLEIC ACIDS RES, V37, pD365, DOI 10.1093/nar/gkn790; Bertone P, 2001, NUCLEIC ACIDS RES, V29, P2884, DOI 10.1093/nar/29.13.2884; Burley SK, 2000, NAT STRUCT BIOL, V7, P932, DOI 10.1038/80697; Cai YD, 2008, BIOCHEM BIOPH RES CO, V372, P862, DOI 10.1016/j.bbrc.2008.05.143; Cai YD, 2012, AMINO ACIDS, V42, P1387, DOI 10.1007/s00726-011-0835-0; Chang CCH, 2013, BRIEF BIOINFOR; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Charoenkwan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072368; Chayen NE, 2004, CURR OPIN STRUC BIOL, V14, P577, DOI 10.1016/j.sbi.2004.08.002; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300; Chen Z, 2013, BBA-PROTEINS PROTEOM, V1834, P1461, DOI 10.1016/j.bbapap.2013.04.006; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Creamer TP, 2000, PROTEINS, V40, P443, DOI 10.1002/1097-0134(20000815)40:3<443::AID-PROT100>3.3.CO;2-C; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Ellrott K, 2011, NUCLEIC ACIDS RES, V39, pD494, DOI 10.1093/nar/gkq902; Goh CS, 2004, J MOL BIOL, V336, P115, DOI 10.1016/j.jmb.2003.11.053; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Jahandideh S, 2014, ACTA CRYSTALLOGR D, V70, P627, DOI 10.1107/S1399004713032070; Jahandideh S, 2012, J THEOR BIOL, V306, P115, DOI 10.1016/j.jtbi.2012.04.028; Joachimiak A, 2009, CURR OPIN STRUC BIOL, V19, P573, DOI 10.1016/j.sbi.2009.08.002; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P423, DOI 10.2174/092986610790963726; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Kurgan L, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-50; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu BH, 2007, BIOCHEM BIOPH RES CO, V358, P136, DOI 10.1016/j.bbrc.2007.04.097; Mizianty MJ, 2012, PROTEIN PEPTIDE LETT, V19, P40; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Niu S, 2010, J PROTEOME RES, V9, P6490, DOI 10.1021/pr1007152; Overton IM, 2008, BIOINFORMATICS, V24, P901, DOI 10.1093/bioinformatics/btn055; Overton IM, 2006, FEBS LETT, V580, P4005, DOI 10.1016/j.febslet.2006.06.015; Overton IM, 2011, PROTEINS, V79, P1027, DOI 10.1002/prot.22914; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rucker AL, 2002, PROTEIN SCI, V11, P980, DOI 10.1110/ps.4550102; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Smialowski P, 2006, PROTEINS, V62, P343, DOI 10.1002/prot.20789; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Terwilliger Thomas C., 2011, Journal of Structural and Functional Genomics, V12, P43, DOI 10.1007/s10969-011-9114-2; Wang MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043847; Wang XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026767; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Xia JF, 2010, PROTEIN PEPTIDE LETT, V17, P137, DOI 10.2174/092986610789909403; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203; Zheng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049716; Zheng LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028221; Zhu L, 2010, J COMPUT CHEM, V31, P1478, DOI 10.1002/jcc.21433	56	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105902	10.1371/journal.pone.0105902	http://dx.doi.org/10.1371/journal.pone.0105902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148528	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600095
J	Baron, M; Belo, R; Cathelin, D; Moreira-Teixeira, L; Cartery, C; Rondeau, E; Mesnard, L; Leite-de-Moraes, M				Baron, Marine; Belo, Renata; Cathelin, Dominique; Moreira-Teixeira, Lucia; Cartery, Claire; Rondeau, Eric; Mesnard, Laurent; Leite-de-Moraes, Maria			Innate-Like and Conventional T Cell Populations from Hemodialyzed and Kidney Transplanted Patients Are Equally Compromised	PLOS ONE			English	Article							STAGE RENAL-DISEASE; INVARIANT NKT CELLS; IMMUNITY; DIALYSIS; SUBSETS; DEFECTS; BIOLOGY; MICE	Clinicians are well aware of existing pharmacologically-induced immune deficient status in kidney-transplanted patients that will favor their susceptibility to bacterial or viral infections. Previous studies indicated that advanced Stage 4-5 Chronic Kidney Disease might also be regarded as an immune deficiency-like status as well, even though the mechanisms are not fully understood. Here, we analyzed the ex vivo frequency and the functional properties of both conventional and innate-like T (ILT) lymphocyte subsets in the peripheral blood of 35 patients on hemodialysis, 29 kidney transplanted patients and 38 healthy donors. We found that peripheral blood cell count of ILT cells, as iNKT (invariant Natural Killer T) and MAIT (mucosal-associated invariant T), were significantly decreased in hemodialyzed patients compared to healthy controls. This deficiency was also observed regarding conventional T cells, including the IL-17-producing CD4(+) Th17 cells. Pertaining to regulatory T cells, we also noticed major modifications in the global frequency of CD4(+)CD25(+)Foxp3(+) T lymphocytes, including the resting suppressive CD45RA(+)Foxp3(lo) and activated suppressive CD45RA(-)Foxp3(hi) T cell subpopulations. We found no significant differences between the immune status of hemodialyzed and kidney-transplanted subjects. In conclusion, we demonstrated that both ILT and conventional T cell numbers are equally impaired in hemodialyzed and kidney-transplanted patients.	[Baron, Marine; Belo, Renata; Moreira-Teixeira, Lucia; Leite-de-Moraes, Maria] Univ Paris 05, Hop Necker Enfants Malad, Sorbonne Paris Cite, INEM,CNRS UMR 8253,INSERM UMR 1151, Paris, France; [Cathelin, Dominique; Rondeau, Eric; Mesnard, Laurent] Univ Paris 06, Hop Tenon, AP HP, INSERM UMR S 702, Paris, France; [Cathelin, Dominique; Rondeau, Eric; Mesnard, Laurent] Univ Paris 06, Hop Tenon, AP HP, Paris, France; [Cartery, Claire] Hop Tenon, AP HP, F-75970 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Mesnard, L (corresponding author), Univ Paris 06, Hop Tenon, AP HP, INSERM UMR S 702, Paris, France.	laurent.mesnard@tnn.aphp.fr; maria.leite-de-moraes@parisdescartes.fr	de Moraes, Maria Leite/AAV-9159-2020; Moreira-Teixeira, Lúcia/AAH-4216-2020	de Moraes, Maria Leite/0000-0002-2891-2269; Moreira-Teixeira, Lúcia/0000-0002-4817-8196; baron, marine/0000-0003-0212-8684	CNRS (Centre National de la Recherche Scientifique); Rene Descartes University; INSERM (Institut National de la Sante et de la Recherche Medicale); FRM (Fondation pour la Recherche Medicale); Day Solvay Foundation; FCT (Fundacao para a Ciencia e a Tecnologia)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Rene Descartes University; INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); Day Solvay Foundation(Solvay SA); FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology)	This work was supported by research grants from CNRS (Centre National de la Recherche Scientifique), Rene Descartes University, INSERM (Institut National de la Sante et de la Recherche Medicale), FRM (Fondation pour la Recherche Medicale), Day Solvay Foundation and FCT (Fundacao para a Ciencia e a Tecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605; DEENITCHINA SS, 1995, AM J NEPHROL, V15, P57, DOI 10.1159/000168802; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Jaber BL, 2005, KIDNEY INT, V67, P2508, DOI 10.1111/j.1523-1755.2005.00364.x; Jaber BL, 2001, KIDNEY INT, V59, pS197, DOI 10.1046/j.1523-1755.2001.59780197.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim YG, 2012, AM J NEPHROL, V36, P472, DOI 10.1159/000343571; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; LEWIS SL, 1987, AM J KIDNEY DIS, V9, P381, DOI 10.1016/S0272-6386(87)80141-5; Mesnard L, 2009, J AM SOC NEPHROL, V20, P1282, DOI 10.1681/ASN.2008040433; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moreira-Teixeira L, 2012, J IMMUNOL, V188, P624, DOI 10.4049/jimmunol.1102281; Moreira-Teixeira L, 2011, J IMMUNOL, V186, P5758, DOI 10.4049/jimmunol.1003043; Paget C, 2013, MUCOSAL IMMUNOL, V6, P1054, DOI 10.1038/mi.2013.59; Peraldi MN, 2013, BLOOD PURIFICAT, V35, P14, DOI 10.1159/000350839; RASKA K, 1983, AM J MED, V75, P734, DOI 10.1016/0002-9343(83)90401-1; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; VANHOLDER R, 1993, J AM SOC NEPHROL, V3, P1541; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	23	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105422	10.1371/journal.pone.0105422	http://dx.doi.org/10.1371/journal.pone.0105422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144742	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100068
J	Guo, MZ; Pan, YL; Zhang, R; Cao, Y; Chen, JZ; Pan, YJ				Guo, Mengzhe; Pan, Youlu; Zhang, Rong; Cao, Yang; Chen, Jianzhong; Pan, Yuanjiang			The Specific Cleavage of Lactone Linkage to Open-Loop in Cyclic Lipopeptide during Negative ESI Tandem Mass Spectrometry: The Hydrogen Bond Interaction Effect of 4-Ethyl Guaiacol	PLOS ONE			English	Article							COLLISION-INDUCED DISSOCIATION; ASPARTIC-ACID; POSTTRANSLATIONAL MODIFICATIONS; DEPROTONATED PEPTIDES; GLUTAMIC-ACID; FRAGMENTATION; SURFACTIN; DISULFIDES; LICHENYSIN; IONS	Mass spectrometry is a valuable tool for the analysis and identification of chemical compounds, particularly proteins and peptides. Lichenysins G, the major cyclic lipopeptide of lichenysin, and the non-covalent complex of lichenysins G and 4-ethylguaiacol were investigated with negative ion ESI tandem mass spectrometry. The different fragmentation mechanisms for these compounds were investigated. Our study shows the 4-ethylguaiacol hydrogen bond with the carbonyl oxygen of the ester group in the loop of lichenysins G. With the help of this hydrogen bond interaction, the ring structure preferentially opens in lactone linkage rather than O-C bond of the ester-group to produce alcohol and ketene. Isothermal titration H-1-NMR analysis verified the hydrogen bond and determined the proportion of subject and ligand in the non-covalent complex to be 1:1. Theoretical calculations also suggest that the addition of the ligand can affect the energy of the transition structures (TS) during loop opening.	[Guo, Mengzhe; Pan, Yuanjiang] Zhejiang Univ, Dept Chem, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Youlu; Cao, Yang; Chen, Jianzhong] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Rong] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China	Zhejiang University; Zhejiang University; Jiangnan University	Pan, YJ (corresponding author), Zhejiang Univ, Dept Chem, Hangzhou 310003, Zhejiang, Peoples R China.	panyuanjiang@zju.edu.cn			Natural Science Foundation of China [21025207]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by contact/grant sponsor: Natural Science Foundation of China Contact/grant number: 21025207, the URL: http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreazza HJ, 2009, RAPID COMMUN MASS SP, V23, P1825, DOI 10.1002/rcm.4081; Benjamin M, 2012, J AM SOC MASS SPECTR, V23, P460; Bilusich D, 2009, MASS SPECTROM REV, V28, P20, DOI 10.1002/mas.20206; Boernsen KO, 2007, J MASS SPECTROM, V42, P793, DOI 10.1002/jms.1215; Chai YF, 2012, ORG BIOMOL CHEM, V10, P791, DOI 10.1039/c1ob06020a; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Graeme C, 2012, ANAL CHEM, V84, P2875; Grangemard I, 1999, J ANTIBIOT, V52, P363, DOI 10.7164/antibiotics.52.363; Grangemard I, 2001, APPL BIOCHEM BIOTECH, V90, P199, DOI 10.1385/ABAB:90:3:199; Grau A, 1999, BBA-BIOMEMBRANES, V1418, P307, DOI 10.1016/S0005-2736(99)00039-5; Guo C, 2013, J AM SOC MASS SPECTR, V24, P381, DOI 10.1007/s13361-012-0561-1; Guo C, 2012, ORG BIOMOL CHEM, V10, P7070, DOI 10.1039/c2ob26011e; Harrison AG, 2004, J AM SOC MASS SPECTR, V15, P446, DOI 10.1016/j.jasms.2003.11.018; Harrison AG, 2004, J MASS SPECTROM, V39, P136, DOI 10.1002/jms.515; Harrison AG, 2006, INT J MASS SPECTROM, V255, P111, DOI 10.1016/j.ijms.2005.12.037; LEECK DT, 1994, J AM CHEM SOC, V116, P3028, DOI 10.1021/ja00086a036; Li Z, 2006, J MASS SPECTROM, V41, P939, DOI 10.1002/jms.1053; Madslien EH, 2013, J APPL MICROBIOL, V115, P1068, DOI 10.1111/jam.12299; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P599, DOI 10.1016/1044-0305(92)85001-Z; Men LJ, 2006, RAPID COMMUN MASS SP, V20, P777, DOI 10.1002/rcm.2374; Mor A, 2000, DRUG DEVELOP RES, V50, P440, DOI 10.1002/1098-2299(200007/08)50:3/4<440::AID-DDR27>3.3.CO;2-W; Niessen WMA, 2012, MASS SPECTROM REV, V31, P626, DOI 10.1002/mas.20359; Pathak KV, 2012, J AM SOC MASS SPECTR, V23, P1716, DOI 10.1007/s13361-012-0437-4; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Pu D, 2008, RAPID COMMUN MASS SP, V22, P91, DOI 10.1002/rcm.3337; Rumachik NG, 2012, J AM SOC MASS SPECTR, V23, P718, DOI 10.1007/s13361-011-0331-5; Samantha S, 2012, J AM SOC MASS SPECTR, V23, P1544; Samgina TY, 2013, J AM SOC MASS SPECTR, V24, P1037, DOI 10.1007/s13361-013-0632-y; Thakur SS, 2009, J AM SOC MASS SPECTR, V20, P2221, DOI 10.1016/j.jasms.2009.08.010; Thakur SS, 2009, J AM SOC MASS SPECTR, V20, P783, DOI 10.1016/j.jasms.2008.12.019; Tilvi S, 2007, J MASS SPECTROM, V42, P70, DOI 10.1002/jms.1140; Vrkic AK, 2004, J AM SOC MASS SPECTR, V15, P715, DOI 10.1016/j.jasms.2004.01.008; Xie TZ, 2012, ANGEW CHEM INT EDIT, V51, P1177, DOI 10.1002/anie.201106504; Zhang MX, 2006, ANAL CHEM, V78, P4820, DOI 10.1021/ac060132w	34	5	5	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104835	10.1371/journal.pone.0104835	http://dx.doi.org/10.1371/journal.pone.0104835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144459	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100025
J	Raziorrouh, B; Heeg, M; Kurktschiev, P; Schraut, W; Zachoval, R; Wendtner, C; Wachtler, M; Spannagl, M; Denk, G; Ulsenheimer, A; Bengsch, B; Pircher, H; Diepolder, HM; Gruner, NH; Jung, MC				Raziorrouh, Bijan; Heeg, Malte; Kurktschiev, Peter; Schraut, Winfried; Zachoval, Reinhart; Wendtner, Clemens; Waechtler, Martin; Spannagl, Michael; Denk, Gerald; Ulsenheimer, Axel; Bengsch, Bertram; Pircher, Hanspeter; Diepolder, Helmut M.; Gruener, Norbert H.; Jung, Maria-Christina			Inhibitory Phenotype of HBV-Specific CD4(+) T-Cells Is Characterized by High PD-1 Expression but Absent Coregulation of Multiple Inhibitory Molecules	PLOS ONE			English	Article							HEPATITIS-C; VIRUS; CD8(+); MEMORY; RESTORATION; ACTIVATION; EXHAUSTION; RECEPTORS; INFECTION; EXPANSION	Background: T-cell exhaustion seems to play a critical role in CD8(+) T-cell dysfunction during chronic viral infections. However, up to now little is known about the mechanisms underlying CD4(+) T-cell dysfunction during chronic hepatitis B virus (CHB) infection and the role of inhibitory molecules such as programmed death 1 (PD-1) for CD4(+) T-cell failure. Methods: The expression of multiple inhibitory molecules such as PD-1, CTLA-4, TIM-3, CD244, KLRG1 and markers defining the grade of T-cell differentiation as CCR7, CD45RA, CD57 and CD127 were analyzed on virus-specific CD4(+) T-cells from peripheral blood using a newly established DRB1*01-restricted MHC class II Tetramer. Effects of in vitro PD-L1/2 blockade were defined by investigating changes in CD4(+) T-cell proliferation and cytokine production. Results: CD4(+) T-cell responses during chronic HBV infection was characterized by reduced Tetramer(+)CD4(+) T-cell frequencies, effector memory phenotype, sustained PD-1 but low levels of CTLA-4, TIM-3, KLRG1 and CD244 expression. PD-1 blockade revealed individualized patterns of in vitro responsiveness with partly increased IFN-gamma, IL-2 and TNF-alpha secretion as well as enhanced CD4(+) T-cell expansion almost in treated patients with viral control. Conclusion: HBV-specific CD4(+) T-cells are reliably detectable during different courses of HBV infection by MHC class II Tetramer technology. CD4(+) T-cell dysfunction during chronic HBV is basically linked to strong PD-1 upregulation but absent coregulation of multiple inhibitory receptors. PD-L1/2 neutralization partly leads to enhanced CD4(+) T-cell functionality with heterogeneous patterns of CD4(+) T-cell rejunivation.	[Raziorrouh, Bijan; Heeg, Malte; Kurktschiev, Peter; Schraut, Winfried; Zachoval, Reinhart; Denk, Gerald; Ulsenheimer, Axel; Diepolder, Helmut M.; Gruener, Norbert H.] Univ LMU Munich, Dept Med 2, Munich, Germany; [Raziorrouh, Bijan; Heeg, Malte; Kurktschiev, Peter; Schraut, Winfried; Zachoval, Reinhart; Denk, Gerald; Ulsenheimer, Axel; Diepolder, Helmut M.; Gruener, Norbert H.] Univ LMU Munich, Inst Immunol, Munich, Germany; [Heeg, Malte] Univ Gottingen, Dept Nephrol Rheumatol, D-37073 Gottingen, Germany; [Jung, Maria-Christina] Leberzentrum, Munich, Germany; [Wendtner, Clemens; Waechtler, Martin] Klinikum Munchen Schwabing, Dept Med, Munich, Germany; [Spannagl, Michael] Univ LMU Munich, Lab Immunogenet Mol Diagnost, Munich, Germany; [Bengsch, Bertram] Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany; [Pircher, Hanspeter] Univ Freiburg, Dept Immunol, D-79106 Freiburg, Germany	University of Munich; University of Munich; University of Gottingen; Munchen Klinik; University of Munich; University of Freiburg; University of Freiburg	Raziorrouh, B (corresponding author), Univ LMU Munich, Dept Med 2, Munich, Germany.	Bijan.Raziorrouh@med.uni-muenchen.de	Bengsch, Bertram/ABF-2142-2020	Bengsch, Bertram/0000-0003-2552-740X	HepNet [10.2.1]; BMBF; European Research Network HepaCute; DFG [UL367/1-1]	HepNet; BMBF(Federal Ministry of Education & Research (BMBF)); European Research Network HepaCute; DFG(German Research Foundation (DFG))	This work was supported by: HepNet (Teilprojekt 10.2.1), BMBF, European Research Network HepaCute, DFG (UL367/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; JUNG MC, 1995, J VIROL, V69, P3358, DOI 10.1128/JVI.69.6.3358-3368.1995; JUNG MC, 1991, J HEPATOL, V13, P310, DOI 10.1016/0168-8278(91)90074-L; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Kassu A, 2010, J IMMUNOL, V185, P3007, DOI 10.4049/jimmunol.1000156; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kotturi MF, 2011, J VIROL, V85, P11770, DOI 10.1128/JVI.05477-11; Lucas M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000649; Marcolino I, 2004, EUR J IMMUNOL, V34, P2672, DOI 10.1002/eji.200425282; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Raziorrouh B, 2011, GASTROENTEROLOGY, V141, P1422, DOI 10.1053/j.gastro.2011.07.004; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Sharp ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029154; Ulsenheimer A, 2003, HEPATOLOGY, V37, P1189, DOI 10.1053/jhep.2003.50194; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	31	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105703	10.1371/journal.pone.0105703	http://dx.doi.org/10.1371/journal.pone.0105703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144233	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100112
J	Cope, LM; Fackler, MJ; Lopez-Bujanda, Z; Wolff, AC; Visvanathan, K; Gray, JW; Sukumar, S; Umbricht, CB				Cope, Leslie M.; Fackler, Mary Jo; Lopez-Bujanda, Zoila; Wolff, Antonio C.; Visvanathan, Kala; Gray, Joe W.; Sukumar, Saraswati; Umbricht, Christopher B.			Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome?	PLOS ONE			English	Article							DNA METHYLATION; PROMOTER HYPERMETHYLATION; DRUG DISCOVERY; PREDICTION; CHEMOSENSITIVITY; EVOLUTION; PATTERNS; GENOME; GENES	It is well documented that tumor cells undergo dramatic genetic and epigenetic changes during initial establishment as cell lines and in subsequent serial passaging, and that the resultant cell lines may have evolved significantly from the primary tumors from which they were derived. This has potential implications due to their widespread use in drug response experiments and studies of genomic function. One approach to optimizing the design of such cell line studies is to identify and use the cell lines that faithfully recapitulate critical features of primary tumors. To evaluate the epigenetic fidelity of breast cancer cell lines in the context of primary tumors, we performed methylation profiling of 55 well-characterized breast cancer cell lines on the Illumina HumanMethylation27 BeadChip platform, and compared them to publicly available methylation profiles of primary breast tumors. We found that the DNA methylation profiles of breast cancer cell lines largely retain the features that characterize primary tumors, although there are crucial differences as well. We describe these similarities and differences between primary tumors and breast cancer cell lines in detail, and develop a quantitative measure of similarity that is used to score each cell line with respect to how faithfully its methylation profile mirrors that of primary tumors.	[Cope, Leslie M.; Fackler, Mary Jo; Lopez-Bujanda, Zoila; Wolff, Antonio C.; Visvanathan, Kala; Sukumar, Saraswati; Umbricht, Christopher B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Umbricht, Christopher B.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Sukumar, Saraswati; Umbricht, Christopher B.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Visvanathan, Kala] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Oregon Health & Science University	Umbricht, CB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	cumbrich@jhmi.edu	Wolff, Antonio C./T-8796-2019; Gray, Joe/AAX-9549-2020; Visvanathan, Kala/AAE-4396-2021	Wolff, Antonio C./0000-0003-3734-1063; Lopez Bujanda, Zoila/0000-0001-5729-7309	National Institutes of Health (SPORE Program in Breast Cancer) [P50 CA 88843]; Department of Defense [COE: W81XWH-04-1-0595]; National Institutes of Health [P50 CA 58207, P30 CA 82103, U54 CA 112970, U24 CA 126477, R01 CA 140311]; OHSU Knight Cancer Institute [5P30CA069533-16]; Susan G. Komen Foundation [SAC110012, IIR KG110094]; NATIONAL CANCER INSTITUTE [P50CA058207, R01CA140311, P30CA069533, U54CA112970, P30CA082103, P50CA088843, U24CA126477] Funding Source: NIH RePORTER	National Institutes of Health (SPORE Program in Breast Cancer); Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Knight Cancer Institute; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (SPORE Program in Breast Cancer, P50 CA 88843), and the Department of Defense (COE: W81XWH-04-1-0595) to SS; by National Institutes of Health grants (P50 CA 58207, P30 CA 82103, U54 CA 112970, U24 CA 126477), and by the OHSU Knight Cancer Institute (5P30CA069533-16), and by the Susan G. Komen Foundation (SAC110012) to JWG; and by the Susan G. Komen Foundation (IIR KG110094), and the National Institutes of Health (R01 CA 140311) to CBU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLIN SB, 2004, NOVART FDN SYMP, V259, P234; Baylin SB, 2004, NOVARTIS FDN S, V259, P285; Baylin Stephen B, 2004, Novartis Found Symp, V259, P226; Cheng F, 2011, J THEOR BIOL, V290, P27, DOI 10.1016/j.jtbi.2011.08.009; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fackler MJ, 2004, CANCER RES, V64, P4442, DOI 10.1158/0008-5472.CAN-03-3341; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Ferriss JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030550; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Hastie T., 2009, UNSUPERVISED LEARNIN; Havaleshko DM, 2007, MOL CANCER THER, V6, P578, DOI 10.1158/1535-7163.MCT-06-0497; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JS, 2007, CANC BIOL THER, V6; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Schmidt M, 2007, INT J ONCOL, V30, P565; Smith SC, 2010, CANCER RES, V70, P1753, DOI 10.1158/0008-5472.CAN-09-3562; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Taberlay PC, 2011, PROG DRUG RES, V67, P1, DOI 10.1007/978-3-7643-8989-5_1; VanderKraats ND, 2013, NUCLEIC ACIDS RES, V41, P6816, DOI 10.1093/nar/gkt482; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105545	10.1371/journal.pone.0105545	http://dx.doi.org/10.1371/journal.pone.0105545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157401	gold, Green Published, Green Submitted			2022-12-27	WOS:000341303200037
J	Huang, N; Wang, L; Guo, YQ; Hao, PY; Niu, Z				Huang, Ni; Wang, Li; Guo, Yiqiang; Hao, Pengyu; Niu, Zheng			Modeling Spatial Patterns of Soil Respiration in Maize Fields from Vegetation and Soil Property Factors with the Use of Remote Sensing and Geographical Information System	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; ORGANIC-CARBON; CHLOROPHYLL CONTENT; ECOSYSTEM RESPIRATION; ABIOTIC FACTORS; WATER-CONTENT; INDEXES; FOREST; PLANT; GIS	To examine the method for estimating the spatial patterns of soil respiration (R-s) in agricultural ecosystems using remote sensing and geographical information system (GIS), R-s rates were measured at 53 sites during the peak growing season of maize in three counties in North China. Through Pearson's correlation analysis, leaf area index (LAI), canopy chlorophyll content, aboveground biomass, soil organic carbon (SOC) content, and soil total nitrogen content were selected as the factors that affected spatial variability in R-s during the peak growing season of maize. The use of a structural equation modeling approach revealed that only LAI and SOC content directly affected R-s. Meanwhile, other factors indirectly affected R-s through LAI and SOC content. When three greenness vegetation indices were extracted from an optical image of an environmental and disaster mitigation satellite in China, enhanced vegetation index (EVI) showed the best correlation with LAI and was thus used as a proxy for LAI to estimate R-s at the regional scale. The spatial distribution of SOC content was obtained by extrapolating the SOC content at the plot scale based on the kriging interpolation method in GIS. When data were pooled for 38 plots, a first-order exponential analysis indicated that approximately 73% of the spatial variability in R-s during the peak growing season of maize can be explained by EVI and SOC content. Further test analysis based on independent data from 15 plots showed that the simple exponential model had acceptable accuracy in estimating the spatial patterns of R-s in maize fields on the basis of remotely sensed EVI and GIS-interpolated SOC content, with R-2 of 0.69 and root-mean-square error of 0.51 mu mol CO2 m(-2) s(-1). The conclusions from this study provide valuable information for estimates of R-s during the peak growing season of maize in three counties in North China.	[Huang, Ni; Wang, Li; Hao, Pengyu; Niu, Zheng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Guo, Yiqiang] Land Consolidat & Rehabil Ctr, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.	wangli@radi.ac.cn	HAO, Pengyu/P-1175-2014; Wang, Li/P-9811-2018; niu, zheng/M-9923-2017	HAO, Pengyu/0000-0003-3711-6157; Wang, Li/0000-0002-2929-4255; 	National Natural Science Foundation of China [41301498]; Public Service Sectors (Ministry of Land and Resources) Special Fund Research [201311127]; State Laboratory of Remote Sensing Science [13RC-07]; Major State Basic Research Development Program of China [2013CB733405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Service Sectors (Ministry of Land and Resources) Special Fund Research; State Laboratory of Remote Sensing Science; Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (41301498), the Public Service Sectors (Ministry of Land and Resources) Special Fund Research (201311127), the Special Foundation for Young Scientists of the State Laboratory of Remote Sensing Science (13RC-07), and the Major State Basic Research Development Program of China (2013CB733405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro M, 2013, J SOIL SEDIMENT, V13, P641, DOI 10.1007/s11368-012-0643-5; Bian JH, 2013, J MT SCI-ENGL, V10, P754, DOI 10.1007/s11629-013-2545-4; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Campbell JL, 2004, GLOBAL CHANGE BIOL, V10, P1857, DOI 10.1111/j.1365-2486.2004.00850.x; Ceccato P., 2005, Parassitologia (Rome), V47, P81; Chen ST, 2010, AGR FOREST METEOROL, V150, P590, DOI 10.1016/j.agrformet.2010.02.004; Chevallier F, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007375; Chevallier T, 2000, GEODERMA, V94, P43, DOI 10.1016/S0016-7061(99)00064-6; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P230, DOI 10.1111/j.1365-2486.2005.01062.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Dewan AM, 2009, APPL GEOGR, V29, P390, DOI 10.1016/j.apgeog.2008.12.005; Epron D, 2006, J TROP ECOL, V22, P565, DOI 10.1017/S0266467406003415; FOLEY JA, 1995, TELLUS B, V47, P310, DOI 10.1034/j.1600-0889.47.issue3.3.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Gao YH, 2014, FIELD CROP RES, V156, P40, DOI 10.1016/j.fcr.2013.10.016; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Gitelson AA, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006017; Gitelson AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022688; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; Hirose T, 1997, ECOLOGY, V78, P2339; Huang N, 2014, J GEOPHYS RES-ATMOS, V119, P6393, DOI 10.1002/2013JD020515; Huang N, 2013, PLANT SOIL, V367, P535, DOI 10.1007/s11104-012-1488-9; Huang N, 2013, ECOL INDIC, V26, P117, DOI 10.1016/j.ecolind.2012.10.027; Huang N, 2012, AGR FOREST METEOROL, V160, P80, DOI 10.1016/j.agrformet.2012.03.005; Hudak AT, 2002, REMOTE SENS ENVIRON, V82, P397, DOI 10.1016/S0034-4257(02)00056-1; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Iriondo JM, 2003, BIOL CONSERV, V113, P367, DOI 10.1016/S0006-3207(03)00129-0; Jonsson M, 2010, BIOL LETTERS, V6, P116, DOI 10.1098/rsbl.2009.0613; Keane RE, 2001, INT J WILDLAND FIRE, V10, P301, DOI 10.1071/WF01028; Kim G. S., 2010, AMOS 18 0 STRUCTURAL; Knorr W, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001119; Kou TJ, 2012, SOIL TILL RES, V118, P132, DOI 10.1016/j.still.2011.10.018; Krugh B., 1994, Maize Genetics Cooperation Newsletter, P25; Lal R., 1999, Progress in Environmental Science, V1, P307; Lin ML, 2011, INT J INNOV COMPUT I, V7, P657; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Liu YF, 2013, STAT INTERFACE, V6, P1; Longley PA., 2005, GEOGRAPHIC INFORM SY; Martin JG, 2009, AGR FOREST METEOROL, V149, P1722, DOI 10.1016/j.agrformet.2009.06.002; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; McGrath D, 2003, APPL GEOCHEM, V18, P1629, DOI 10.1016/S0883-2927(03)00045-3; Meng QM, 2009, ISPRS J PHOTOGRAMM, V64, P27, DOI 10.1016/j.isprsjprs.2008.06.006; National Bureau of statistics of China, 2006, CHIN SOC EC STAT YB; Peng Li, 2014, Remote Sensing, V6, P310, DOI 10.3390/rs6010310; Phillips SC, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2008JG000858; Pugesek BH, 2003, STRUCTURAL EQUATION; QI J, 1994, REMOTE SENS ENVIRON, V48, P119, DOI 10.1016/0034-4257(94)90134-1; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Raup B, 2007, COMPUT GEOSCI-UK, V33, P104, DOI 10.1016/j.cageo.2006.05.015; Rayner PJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002254; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Rouse J.W., 1974, NASA GSFC TYPE 3 FIN, P1; Schaefer DA, 2009, SOIL BIOL BIOCHEM, V41, P1000, DOI 10.1016/j.soilbio.2008.11.015; Shalaby A, 2007, APPL GEOGR, V27, P28, DOI 10.1016/j.apgeog.2006.09.004; Suyker AE, 2005, AGR FOREST METEOROL, V131, P180, DOI 10.1016/j.agrformet.2005.05.007; Tsui OW, 2013, REMOTE SENS ENVIRON, V139, P340, DOI 10.1016/j.rse.2013.08.012; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Verstraeten WW, 2010, CLIMATIC CHANGE, V103, P117, DOI 10.1007/s10584-010-9920-8; Wang SD, 2012, PROCEDIA ENVIRON SCI, V13, P140, DOI 10.1016/j.proenv.2012.01.014; Wang SQ, 2003, TELLUS B, V55, P416, DOI 10.1034/j.1600-0889.2003.00039.x; Wang SQ, 2002, INT J REMOTE SENS, V23, P1565, DOI 10.1080/014311602753590887; Wang XD, 2008, J ARID ENVIRON, V72, P1929, DOI 10.1016/j.jaridenv.2008.06.005; Wardlow BD, 2007, REMOTE SENS ENVIRON, V108, P290, DOI 10.1016/j.rse.2006.11.021; Webster KL, 2009, SOIL SCI SOC AM J, V73, P1157, DOI 10.2136/sssaj2008.0310; Webster R., 2007, STAT PRACTICE; Weng QH, 2001, ENVIRON MANAGE, V28, P737, DOI 10.1007/s002670010258; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150; Wilson EH, 2002, REMOTE SENS ENVIRON, V80, P385, DOI 10.1016/S0034-4257(01)00318-2; Wu CY, 2008, AGR FOREST METEOROL, V148, P1230, DOI 10.1016/j.agrformet.2008.03.005; Wu CY, 2010, INT J REMOTE SENS, V31, P2159, DOI 10.1080/01431161003614382; Xiujuan Yu, 2010, Proceedings of the 2010 3rd International Congress on Image and Signal Processing (CISP 2010), P2125, DOI 10.1109/CISP.2010.5647381; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Zhong B, 2014, SCI CHINA EARTH SCI, V57, P1790, DOI 10.1007/s11430-014-4877-5	84	9	11	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105150	10.1371/journal.pone.0105150	http://dx.doi.org/10.1371/journal.pone.0105150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157827	Green Submitted, gold, Green Published			2022-12-27	WOS:000341303200024
J	Teng, Y; Zou, LY; Huang, M; Chen, YD				Teng, Yue; Zou, Luyi; Huang, Ming; Chen, Yadong			Molecular Interaction Mechanism between 2-Mercaptobenzimidazole and Copper-Zinc Superoxide Dismutase	PLOS ONE			English	Article							OXIDATIVE STRESS; FLUORESCENCE; THERMODYNAMICS; GLUTATHIONE; TOXICITY; PROTEINS; BINDING; OXYGEN; DAMAGE; ASSAY	2-Mercaptobenzimidazole (MBI) is widely utilized as a corrosion inhibitor, copper-plating brightener and rubber accelerator. The residue of MBI in the environment is potentially harmful. In the present work, the toxic interaction of MBI with the important antioxidant enzyme copper-zinc superoxide dismutase (Cu/ZnSOD) was investigated using spectroscopic and molecular docking methods. MBI can interact with Cu/ZnSOD to form an MBI-Cu/ZnSOD complex. The binding constant, number of binding sites and thermodynamic parameters were measured, which indicated that MBI could spontaneously bind with Cu/ZnSOD with one binding site through hydrogen bonds and van der Waals forces. MBI bound into the Cu/ZnSOD interface of two subdomains, which caused some microenvironmental and secondary structure changes of Cu/ZnSOD and further resulted in the inhibition of Cu/ZnSOD activity. This work provides direct evidence at a molecular level to show that exposure to MBI could induce changes in the structure and function of the enzyme Cu/ZnSOD. The estimated methods in this work may be applied to probe molecular interactions of biomacromolecules and other pollutants and drugs.	[Teng, Yue; Zou, Luyi; Huang, Ming] Jiangnan Univ, Sch Environm & Civil Engn, Wuxi, Jiangsu, Peoples R China; [Chen, Yadong] China Pharmaceut Univ, Sch Basic Sci, Lab Mol Design & Drug Discovery, Nanjing 210009, Jiangsu, Peoples R China	Jiangnan University; China Pharmaceutical University	Teng, Y (corresponding author), Jiangnan Univ, Sch Environm & Civil Engn, Wuxi, Jiangsu, Peoples R China.	tengyue@jiangnan.edu.cn			National Nature Science Foundation of China (NSFC) [21307043]; Independent Research Project of Jiangnan University [JUSRP1032]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Independent Research Project of Jiangnan University	The work is supported by National Nature Science Foundation of China (NSFC 21307043, Yue Teng received the funding. URL: http://www.nsfc.gov.cn/), Independent Research Project of Jiangnan University (JUSRP1032, Yue Teng received the funding. URL: http://www.sytu.edu.cn/) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaseth J, 2000, J TRACE ELEM EXP MED, V13, P105, DOI 10.1002/(SICI)1520-670X(2000)13:1<105::AID-JTRA12>3.0.CO;2-B; AIRAUDO C B, 1990, Journal of Biomaterials Science Polymer Edition, V1, P231; Amer J, 2006, BRIT J HAEMATOL, V132, P108, DOI 10.1111/j.1365-2141.2005.05834.x; Banaclocha MM, 1997, BRAIN RES, V762, P256, DOI 10.1016/S0006-8993(97)00493-9; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Cheng X L, 1999, Se Pu, V17, P602; Chi ZX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028361; DOERGE DR, 1986, BIOCHEMISTRY-US, V25, P4724, DOI 10.1021/bi00364a041; Finsgar M, 2013, CORROS SCI, V72, P90, DOI 10.1016/j.corsci.2013.03.010; Finsgar M, 2013, CORROS SCI, V72, P82, DOI 10.1016/j.corsci.2013.03.011; GAWORSKI CL, 1991, FUND APPL TOXICOL, V16, P161, DOI 10.1016/0272-0590(91)90144-S; Giustarini D, 2009, CRIT REV CL LAB SCI, V46, P241, DOI 10.3109/10408360903142326; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; Hossain M, 2011, PLOS ONE, V6, P12, DOI DOI 10.1371/J0URNAL.P0NE.0018333; JUNGCLAUS GA, 1978, ENVIRON SCI TECHNOL, V12, P88, DOI 10.1021/es60137a015; Kawasaki Yasushi, 1998, Journal of Toxicological Sciences, V23, P53; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Khramov A, 2005, THIN SOLID FILMS, V483, P191, DOI 10.1016/j.tsf.2004.12.021; Kocer M, 2014, CANCER INVEST, V32, P37, DOI 10.3109/07357907.2013.861475; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4171, DOI 10.1021/bi00745a021; Ma LL, 2009, SPECTROCHIM ACTA A, V73, P330, DOI 10.1016/j.saa.2009.02.041; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Rastegarzadeh S, 2013, ENVIRON MONIT ASSESS, V185, P9037, DOI 10.1007/s10661-013-3233-0; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sakemi K, 2002, ARCH TOXICOL, V76, P682, DOI 10.1007/s00204-002-0392-0; Shinomiya K, 2002, HYPERTENS RES, V25, P91, DOI 10.1291/hypres.25.91; SIES H, 1991, AM J MED, V91, pS31, DOI 10.1016/0002-9343(91)90281-2; SPIES RB, 1987, NATURE, V327, P697, DOI 10.1038/327697a0; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Strasser EM, 2005, BIOCHEM PHARMACOL, V70, P552, DOI 10.1016/j.bcp.2005.05.030; Subapriya R, 2002, CLIN BIOCHEM, V35, P489, DOI 10.1016/S0009-9120(02)00340-5; SUN Y, 1988, CLIN CHEM, V34, P497; Trpkovic A, 2012, ARCH TOXICOL, V86, P1809, DOI 10.1007/s00204-012-0859-6; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Wu TQ, 2007, BIOMACROMOLECULES, V8, P1899, DOI 10.1021/bm061189v; YAMANO T, 1995, FUND APPL TOXICOL, V25, P218, DOI 10.1006/faat.1995.1057; Zhang YZ, 2009, J HAZARD MATER, V163, P1345, DOI 10.1016/j.jhazmat.2008.07.132; Zhou YL, 2005, THERMOCHIM ACTA, V426, P173, DOI 10.1016/j.tca.2004.07.018; Zong WS, 2010, PROTEIN SCI, V19, P263, DOI 10.1002/pro.313	42	14	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106003	10.1371/journal.pone.0106003	http://dx.doi.org/10.1371/journal.pone.0106003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157630	gold, Green Submitted, Green Published			2022-12-27	WOS:000341303200085
J	Horng, GJ				Horng, Gwo-Jiun			Using Cellular Automata for Parking Recommendations in Smart Environments	PLOS ONE			English	Article							ACCESS	In this work, we propose an innovative adaptive recommendation mechanism for smart parking. The cognitive RF module will transmit the vehicle location information and the parking space requirements to the parking congestion computing center (PCCC) when the driver must find a parking space. Moreover, for the parking spaces, we use a cellular automata (CA) model mechanism that can adjust to full and not full parking lot situations. Here, the PCCC can compute the nearest parking lot, the parking lot status and the current or opposite driving direction with the vehicle location information. By considering the driving direction, we can determine when the vehicles must turn around and thus reduce road congestion and speed up finding a parking space. The recommendation will be sent to the drivers through a wireless communication cognitive radio (CR) model after the computation and analysis by the PCCC. The current study evaluates the performance of this approach by conducting computer simulations. The simulation results show the strengths of the proposed smart parking mechanism in terms of avoiding increased congestion and decreasing the time to find a parking space.	Southern Taiwan Univ Sci & Technol, Dept Comp Sci & Informat Engn, Tainan, Taiwan	Southern Taiwan University of Science & Technology	Horng, GJ (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Comp Sci & Informat Engn, Tainan, Taiwan.	grojium@gmail.com	Horng, Gwo-Jiun/AAO-9446-2020	Horng, Gwo-Jiun/0000-0002-0193-2104	National Science Council, Taiwan [NSC 102-2218-E-268-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by National Science Council, Taiwan (NSC 102-2218-E-268-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, E221303 ASTM; Benson JP, 2006, 31 IEEE C LOC COMP; Caliskan M., 2006, PROC 3 INT WORKSHOP, P30, DOI DOI 10.1145/1161064.1161070; Dashtinezhad S, 2004, TRAFFIC VIEW DRIVER; Ding L, 2010, IEEE T VEH TECHNOL, V59, P1969, DOI 10.1109/TVT.2010.2045403; Funck S, 2004, 2004 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P325; Gokulan BP, 2010, IEEE T INTELL TRANSP, V11, P714, DOI 10.1109/TITS.2010.2050688; Kawamura H, 2003, LECT NOTES COMPUT SC, V3012, P48; Mamei M, 2005, IEEE T SYST MAN CY A, V35, P337, DOI 10.1109/TSMCA.2005.846379; Milanes V, 2010, IEEE T INTELL TRANSP, V11, P243, DOI 10.1109/TITS.2009.2036595; Mimbela LEY, 2000, SUMMARY VEHICLE DETE, P211; Missoum S, 2005, STRUCT MULTIDISCIP O, V29, P103, DOI 10.1007/s00158-004-0464-2; Niyato D, 2008, IEEE T WIREL COMMUN, V7, P2651, DOI 10.1109/TWC.2008.070073; Niyato D, 2011, IEEE T MOBILE COMPUT, V10, P573, DOI 10.1109/TMC.2010.191; Ohtani Y, 2010, 8 AS PAC S INF TEL T, P1; Olariu S, 2009, CH CRC COMP INFO SCI, P1, DOI 10.1201/9781420085891; Saad W, 2011, IEEE J SEL AREA COMM, V29, P48, DOI 10.1109/JSAC.2011.110106; Shrestha B, 2008, P IEEE GLOB TEL C GL, P1, DOI DOI 10.1109/GL0C0M.2008.ECP.1000; Stiller C, 2008, AT-AUTOM, V56, P551, DOI 10.1524/auto.2008.9059; Takizawa H, 2004, 2004 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P238; Wang XY, 2010, IEEE T VEH TECHNOL, V59, P1936, DOI 10.1109/TVT.2009.2037641; Yan GJ, 2011, IEEE INTEL TRANSP SY, V3, P18, DOI 10.1109/MITS.2011.940473; Yang K, 2007, IEEE T VEH TECHNOL, V56, P3358, DOI 10.1109/TVT.2007.906875; Zhang X, 2006, IEEE WIREL COMMUN, V13, P44, DOI 10.1109/WC-M.2006.250357; Zhang Y, 2007, VANET'07: PROCEEDINGS OF THE FOURTH ACM INTERNATIONAL WORKSHOP ON VEHICULAR AD HOC NETWORKS, P9; Zhenfeng Zhu, 2007, CVPR '07. IEEE Conference on Computer Vision and Pattern Recognition, P1	26	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105973	10.1371/journal.pone.0105973	http://dx.doi.org/10.1371/journal.pone.0105973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153671	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200099
J	Markowitz, DM; Hancock, JT				Markowitz, David M.; Hancock, Jeffrey T.			Linguistic Traces of a Scientific Fraud: The Case of Diederik Stapel	PLOS ONE			English	Article							DECEPTION; LANGUAGE; DECEIT; LIES	When scientists report false data, does their writing style reflect their deception? In this study, we investigated the linguistic patterns of fraudulent (N = 24; 170,008 words) and genuine publications (N = 25; 189,705 words) first-authored by social psychologist Diederik Stapel. The analysis revealed that Stapel's fraudulent papers contained linguistic changes in scienc-erelated discourse dimensions, including more terms pertaining to methods, investigation, and certainty than his genuine papers. His writing style also matched patterns in other deceptive language, including fewer adjectives in fraudulent publications relative to genuine publications. Using differences in language dimensions we were able to classify Stapel's publications with above chance accuracy. Beyond these discourse dimensions, Stapel included fewer co-authors when reporting fake data than genuine data, although other evidentiary claims (e. g., number of references and experiments) did not differ across the two article types. This research supports recent findings that language cues vary systematically with deception, and that deception can be revealed in fraudulent scientific discourse.	[Markowitz, David M.; Hancock, Jeffrey T.] Cornell Univ, Dept Commun, Ithaca, NY 14850 USA; [Hancock, Jeffrey T.] Cornell Univ, Dept Informat Sci, Ithaca, NY USA	Cornell University; Cornell University	Markowitz, DM (corresponding author), Cornell Univ, Dept Commun, Ithaca, NY 14850 USA.	dmm227@cornell.edu	Markowitz, David/L-5563-2019	Markowitz, David/0000-0002-7159-7014				Ali AM, 2007, CORPORA, V2, P211, DOI 10.3366/cor.2007.2.2.211; Bond GD, 2005, APPL COGNITIVE PSYCH, V19, P313, DOI 10.1002/acp.1087; Cooper J, 2013, J EXP SOC PSYCHOL, V49, P314, DOI 10.1016/j.jesp.2012.12.006; Courtis, 2004, BR ACCOUNT REV, V36, P291, DOI [10.1016/j.bar.2004.03.005, DOI 10.1016/J.BAR.2004.03.005]; Courtis John K., 1998, ACCOUNTING AUDITING, V11, P459, DOI [DOI 10.1108/09513579810231457, 10.1108/09513579810231457]; Ekman P., 2001, TELLING LIES CLUES D, V3rd; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Grieneisen ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044118; Hancock JT, 2008, DISCOURSE PROCESS, V45, P1, DOI 10.1080/01638530701739181; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; Larcker DF, 2012, J ACCOUNT RES, V50, P495, DOI 10.1111/j.1475-679X.2012.00450.x; Levelt Committee; Noort Committee; Drenth Committee, 2012, FLAW SCI FRAUD RES P; McArthur T, 1985, LONGMAN LEXICON CONT; Mehl M. R., 2010, ADV METHODS BEHAV RE; Newman ML, 2003, PERS SOC PSYCHOL B, V29, P665, DOI 10.1177/0146167203029005010; Ott M., 2011, 49 ANN M ASS COMP LI, DOI [10.48550/arXiv.1107.4557, DOI 10.48550/ARXIV.1107.4557]; Pennebaker, 2011, SECRET LIFE PRONOUNS, DOI 10.1387/gogoa.17916; Perez MC, 2010, EXPLORING NEW PATHS, P191; Porter S, 1996, LAW HUMAN BEHAV, V20, P443, DOI 10.1007/BF01498980; Rayson P, 2003, THESIS LANCASTER U U; Rayson P, 2014, CLAWS INPUT OUTPUT F; Rayson P., 2008, INT J CORPUS LINGUIS, V13, P519, DOI [10.1075/ijcl.13.4.06ray, DOI 10.1075/IJCL.13.4.06RAY]; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2013, PSYCHOL SCI, V24, P1875, DOI 10.1177/0956797613480366; Sporer SL, 2009, DETECTION DECEPTION, P64; Toma CL, 2012, J COMMUN, V62, P78, DOI 10.1111/j.1460-2466.2011.01619.x; Vrij A., 2008, DETECTING LIES DECEI; Vrij A., 2006, PRACTICAL PSYCHOL FO, P89; Vrij A, 2008, ENCY PSYCHOL LAW; Yong Ed, 2012, NOBEL LAUREATE CHALL; Zhou L, 2006, SMALL GR RES, V37, P140, DOI 10.1177/1046496405285125; Zhou L, 2004, GROUP DECIS NEGOT, V13, P81, DOI 10.1023/B:GRUP.0000011944.62889.6f	33	35	35	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105937	10.1371/journal.pone.0105937	http://dx.doi.org/10.1371/journal.pone.0105937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153333	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200090
J	Chan, R; Chan, D; Woo, J				Chan, Ruth; Chan, Dicken; Woo, Jean			A Prospective Cohort Study to Examine the Association between Dietary Patterns and Depressive Symptoms in Older Chinese People in Hong Kong	PLOS ONE			English	Article							MEDITERRANEAN DIET; MENTAL-HEALTH; WOMEN; POPULATION; RISK; FOLATE; ADULTS; QUESTIONNAIRE; EPIDEMIOLOGY; HOMOCYSTEINE	Introduction: Dietary patterns are culturally specific and there is limited data on the association of dietary patterns with late-life depression in Chinese. This study examined the associations between dietary patterns and baseline and subsequent depressive symptoms in community-dwelling Chinese older people in Hong Kong. Methods: Participants aged >= 65 year participating in a cohort study examining the risk factors for osteoporosis completed a validated food frequency questionnaire at baseline between 2001 and 2003. Factor analysis was used to identify three dietary patterns: "vegetables-fruits" pattern, "snacks-drinks-milk products" pattern, and "meat-fish" pattern. Depressive symptoms were measured at baseline and 4-year using the validated Geriatric Depression Scale. Multiple logistic regression was used for cross-sectional analysis (n = 2,902) to assess the associations between dietary patterns and the presence of depressive symptoms, and for longitudinal analysis (n = 2,211) on their associations with 4-year depressive symptoms, with adjustment for socio-demographic and lifestyle factors. Results: The highest quartile of "vegetables-fruits" pattern score was associated with reduced likelihood of depressive symptoms [Adjusted OR = 0.55 (95% CI: 0.36-0.83), rho(trend) = 0.017] compared to the lowest quartile at baseline. Similar inverse trend was observed for the highest quartile of "snacks-drinks-milk products" pattern score [Adjusted OR = 0.41 (95% CI: 0.26-0.65), rho(trend)<0.001] compared to the lowest quartile. There was no association of "meat-fish" pattern with the presence of depressive symptoms at baseline. None of the dietary patterns were associated with subsequent depressive symptoms at 4-year. Conclusion: Higher "vegetables-fruits" and "snacks-drinks-milk products" pattern scores were associated with reduced likelihood of baseline depressive symptoms in Chinese older people in Hong Kong. The longitudinal analyses failed to show any causal relationship between dietary patterns and depressive symptoms in this population.	[Chan, Ruth; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Chan, Dicken] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ruthchansm@cuhk.edu.hk	Woo, Jean/K-2625-2014; Chan, Ruth/K-4995-2014	Woo, Jean/0000-0001-7593-3081; Chan, Ruth/0000-0002-5725-4066	Research Grants Council of Hong Kong [CUHK 4101/02M]; Hong Kong Jockey Club Charities Trust; SH Ho Centre for Gerontology and Geriatric; Centre for Nutritional Studies, The Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Jockey Club Charities Trust; SH Ho Centre for Gerontology and Geriatric; Centre for Nutritional Studies, The Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was supported by grants from the Research Grants Council of Hong Kong, CUHK 4101/02M; the Hong Kong Jockey Club Charities Trust; the SH Ho Centre for Gerontology and Geriatric and the Centre for Nutritional Studies, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Blazer DG, 2003, J GERONTOL A-BIOL, V58, P249; Bodnar LM, 2005, BIOL PSYCHIAT, V58, P679, DOI 10.1016/j.biopsych.2005.05.009; Bottiglieri T, 2005, PROG NEURO-PSYCHOPH, V29, P1103, DOI 10.1016/j.pnpbp.2005.06.021; Camfield DA, 2011, BRIT J NUTR, V106, P159, DOI 10.1017/S0007114511000158; Census and Statistics Department, 2006, HONG KONG 2006 POP B; Chan R, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.19; Chocano-Bedoya PO, 2013, AM J CLIN NUTR, V98, P813, DOI 10.3945/ajcn.112.052761; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Crawford GB, 2011, PREV MED, V52, P254, DOI 10.1016/j.ypmed.2011.01.006; Crichton GE, 2013, APPETITE, V70, P53, DOI 10.1016/j.appet.2013.06.088; Fava M, 2009, J CLIN PSYCHIAT, V70, P12, DOI 10.4088/JCP.8157su1c.03; Field A, 2013, DISCOVERING STAT USI; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hodge A, 2013, INT PSYCHOGERIATR, V25, P456, DOI 10.1017/S1041610212001986; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jacka FN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087657; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Jeffery RW, 2009, APPETITE, V52, P238, DOI 10.1016/j.appet.2008.08.008; Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Lee H.-c.B., 1993, CLIN GERONTOLOGIST, V14, P37; Liu B, 2001, INT J FOOD SCI NUTR, V52, P269, DOI 10.1080/09637480120044138; Lucas M, 2014, BRAIN BEHAV IMMUN, V36, P46, DOI 10.1016/j.bbi.2013.09.014; Murakami K, 2010, MOL NUTR FOOD RES, V54, P471, DOI 10.1002/mnfr.200900157; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Paul A.A., 1978, MCCANCE WIDDOWSONS C; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Quirk SE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-175; Reedy J, 2010, AM J EPIDEMIOL, V171, P479, DOI 10.1093/aje/kwp393; Rienks J, 2013, EUR J CLIN NUTR, V67, P75, DOI 10.1038/ejcn.2012.193; Rogers PJ, 2001, P NUTR SOC, V60, P135, DOI 10.1079/PNS200061; Roman MW, 2008, ISSUES MENT HLTH NUR, V29, P929; Ruusunen A, 2014, J AFFECT DISORDERS, V159, P1, DOI 10.1016/j.jad.2014.01.020; Samieri C, 2008, J AM DIET ASSOC, V108, P1461, DOI 10.1016/j.jada.2008.06.437; Sanchez-Villegas A, 2013, BMC MED, P11; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Stanger O, 2009, EXPERT REV NEUROTHER, V9, P1393, DOI 10.1586/ERN.09.75; Sugawara N, 2012, ANN GEN PSYCHIATR, V11, DOI 10.1186/1744-859X-11-24; Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044; Tsai AC, 2012, PUBLIC HEALTH NUTR, V15, P1087, DOI 10.1017/S1368980011002977; van Dam RM, 2005, BRIT J NUTR, V93, P573, DOI 10.1079/BJN20051453; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Weng TT, 2012, PUBLIC HEALTH NUTR, V15, P673, DOI 10.1017/S1368980011003077; Wong SYS, 2005, OSTEOPOROSIS INT, V16, P1933, DOI 10.1007/s00198-005-1968-3; Woo J, 2006, INT J GERIATR PSYCH, V21, P1036, DOI 10.1002/gps.1603; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	52	25	27	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105760	10.1371/journal.pone.0105760	http://dx.doi.org/10.1371/journal.pone.0105760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25148515	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600077
J	Airola, MV; Tumolo, JM; Snider, J; Hannun, YA				Airola, Michael V.; Tumolo, Jessica M.; Snider, Justin; Hannun, Yusuf A.			Identification and Biochemical Characterization of an Acid Sphingomyelinase-Like Protein from the Bacterial Plant Pathogen Ralstonia solanacearum that Hydrolyzes ATP to AMP but Not Sphingomyelin to Ceramide	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ALKALINE SPHINGOMYELINASE; NEUTRAL SPHINGOMYELINASE; STRUCTURAL BASIS; MUTATIONS; ENZYME; GENE; EXPRESSION; DISEASE; TOXIN	Acid sphingomyelinase (aSMase) is a human enzyme that catalyzes the hydrolysis of sphingomyelin to generate the bioactive lipid ceramide and phosphocholine. ASMase deficiency is the underlying cause of the genetic diseases Niemann-Pick Type A and B and has been implicated in the onset and progression of a number of other human diseases including cancer, depression, liver, and cardiovascular disease. ASMase is the founding member of the aSMase protein superfamily, which is a subset of the metallophosphatase (MPP) superfamily. To date, MPPs that share sequence homology with aSMase, termed aSMase-like proteins, have been annotated and presumed to function as aSMases. However, none of these aSMase-like proteins have been biochemically characterized to verify this. Here we identify RsASML, previously annotated as RSp1609: acid sphingomyelinase-like phosphodiesterase, as the first bacterial aSMase-like protein from the deadly plant pathogen Ralstonia solanacearum based on sequence homology with the catalytic and C-terminal domains of human aSMase. A biochemical characterization of RsASML does not support a role in sphingomyelin hydrolysis but rather finds RsASML capable of acting as an ATP diphosphohydrolase, catalyzing the hydrolysis of ATP and ADP to AMP. In addition, RsASML displays a neutral, not acidic, pH optimum and prefers Ni2+ or Mn2+, not Zn2+, for catalysis. This alters the expectation that all aSMase-like proteins function as acid SMases and expands the substrate possibilities of this protein superfamily to include nucleotides. Overall, we conclude that sequence homology with human aSMase is not sufficient to predict substrate specificity, pH optimum for catalysis, or metal dependence. This may have implications to the biochemically uncharacterized human aSMase paralogs, aSMase-like 3a (aSML3a) and aSML3b, which have been implicated in cancer and kidney disease, respectively, and assumed to function as aSMases.	[Airola, Michael V.; Snider, Justin; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Airola, Michael V.; Snider, Justin; Hannun, Yusuf A.] SUNY Stony Brook, Ctr Canc, Stony Brook, NY 11794 USA; [Tumolo, Jessica M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medical University of South Carolina	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	yusuf.hannun@sbumed.org		Airola, Michael/0000-0003-4981-1253; Tumolo, Jessica/0000-0002-1999-5672	National Institutes of Health [NIGMS R37 GM043825, NIGMS F32 GM100679]; MUSC Summer Undergraduate Research Program (SURP); NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, F32GM100679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MUSC Summer Undergraduate Research Program (SURP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health NIGMS R37 GM043825 (to Y.A.H.) and NIGMS F32 GM100679 (to M. V. A.). The MUSC Summer Undergraduate Research Program (SURP) provided additional support (to J.M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Aldon D, 2000, EMBO J, V19, P2304, DOI 10.1093/emboj/19.10.2304; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atilla-Gokcumen GE, 2014, CELL; Bartelsen O, 1998, J BIOTECHNOL, V63, P29, DOI 10.1016/S0168-1656(98)00070-4; Buckhaults P, 2001, CANCER RES, V61, P6996; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Dardis Andrea, 2005, Hum Mutat, V26, P164, DOI 10.1002/humu.9353; Desnick JP, 2010, MOL MED, V16, P316, DOI 10.2119/molmed.2010.00017; Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Duan RD, 2006, BBA-MOL CELL BIOL L, V1761, P281, DOI 10.1016/j.bbalip.2006.03.007; Ferlinz K, 1997, EUR J BIOCHEM, V243, P511, DOI 10.1111/j.1432-1033.1997.511_1a.x; Fornoni A, 2014, NATURE REV NEPHROLOG; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Genin S, 2012, ANNU REV PHYTOPATHOL, V50, P67, DOI 10.1146/annurev-phyto-081211-173000; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Huseby M, 2007, J BACTERIOL, V189, P8719, DOI 10.1128/JB.00741-07; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; Lansmann S, 2003, EUR J BIOCHEM, V270, P1076, DOI 10.1046/j.1432-1033.2003.03435.x; Nambiar PR, 2004, CANCER RES, V64, P6394, DOI 10.1158/0008-5472.CAN-04-0933; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Noto PB, 2012, MOL PHARMACOL, V82, P719, DOI 10.1124/mol.112.078865; Oda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038054; Openshaw AEA, 2005, J BIOL CHEM, V280, P35011, DOI 10.1074/jbc.M506800200; Pavlu H, 1997, J INHERIT METAB DIS, V20, P615, DOI 10.1023/A:1005387932546; Pavlu-Pereira H, 2005, J INHERIT METAB DIS, V28, P203, DOI 10.1007/s10545-005-5671-5; Peeters N, 2013, MOL PLANT PATHOL, V14, P651, DOI 10.1111/mpp.12038; Pittis M G, 2004, Hum Mutat, V24, P186, DOI 10.1002/humu.9263; Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008; Ricci V, 2004, Hum Mutat, V24, P105, DOI 10.1002/humu.9258; Rodriguez-Pascau L, 2009, HUM MUTAT, V30, P1117, DOI 10.1002/humu.21018; Sabourdy F, 2011, BLOOD, V117, P3695, DOI 10.1182/blood-2010-11-318493; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; Sikora J, 2003, ANN HUM GENET, V67, P63, DOI 10.1046/j.1469-1809.2003.00009.x; Simonaro CM, 2002, AM J HUM GENET, V71, P1413, DOI 10.1086/345074; Sinha A, 2013, NATURE REV NEPHROLOG; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; SPENCE MW, 1989, J BIOL CHEM, V264, P5358; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Takahashi T, 1997, HUM PATHOL, V28, P385, DOI 10.1016/S0046-8177(97)90141-6; TITBALL RW, 1991, INFECT IMMUN, V59, P1872, DOI 10.1128/IAI.59.5.1872-1874.1991; Wright KO, 2002, J UROLOGY, V168, P2645, DOI 10.1016/S0022-5347(05)64236-X; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z; Yoo T-H, 2014, J AM SOC NEPHROLOGY; Yu H, 2009, AM J RESP CELL MOL, V41, P367, DOI 10.1165/rcmb.2008-0295OC	53	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105830	10.1371/journal.pone.0105830	http://dx.doi.org/10.1371/journal.pone.0105830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144372	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100124
J	Jayaweera, T; Siriwardana, C; Dharmasiri, S; Quint, M; Gray, WM; Dharmasiri, N				Jayaweera, Thilanka; Siriwardana, Chamindika; Dharmasiri, Sunethra; Quint, Marcel; Gray, William M.; Dharmasiri, Nihal			Alternative Splicing of Arabidopsis IBR5 Pre-mRNA Generates Two IBR5 Isoforms with Distinct and Overlapping Functions	PLOS ONE			English	Article							DROUGHT STRESS TOLERANCE; MAPK PHOSPHATASE IBR5; AUXIN RESPONSES; SIGNAL-TRANSDUCTION; FAMILY; MPK12; EXPRESSION; MECHANISM; MUTANTS; REVEALS	The INDOLE-3-BUTYRIC ACID RESPONSE5 (IBR5) gene encodes a dual specificity phosphatase that regulates plant auxin responses. IBR5 has been predicted to generate two transcripts through alternative splicing, but alternative splicing of IBR5 has not been confirmed experimentally. The previously characterized ibr5-1 null mutant exhibits many auxin related defects such as auxin insensitive primary root growth, defective vascular development, short stature and reduced lateral root development. However, whether all these defects are caused by the lack of phosphatase activity is not clear. Here we describe two new auxin insensitive IBR5 alleles, ibr5-4, a catalytic site mutant, and ibr5-5, a splice site mutant. Characterization of these new mutants indicates that IBR5 is post-transcriptionally regulated to generate two transcripts, AT2G04550.1 and AT2G04550.3, and consequently two IBR5 isoforms, IBR5.1 and IBR5.3. The IBR5.1 isoform exhibits phosphatase catalytic activity that is required for both proper degradation of Aux/IAA proteins and auxin-induced gene expression. These two processes are independently regulated by IBR5.1. Comparison of new mutant alleles with ibr5-1 indicates that all three mutant alleles share many phenotypes. However, each allele also confers distinct defects implicating IBR5 isoform specific functions. Some of these functions are independent of IBR5.1 catalytic activity. Additionally, analysis of these new mutant alleles suggests that IBR5 may link ABP1 and SCFTIR1/AFBs auxin signaling pathways.	[Jayaweera, Thilanka; Siriwardana, Chamindika; Dharmasiri, Sunethra; Dharmasiri, Nihal] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Siriwardana, Chamindika] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Quint, Marcel; Gray, William M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Quint, Marcel] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany	Texas State University System; Texas State University San Marcos; University of Oklahoma System; University of Oklahoma - Norman; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzenbiochemie	Dharmasiri, N (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	nihal@txstate.edu	Gray, William M/F-9402-2010	Gray, William M/0000-0002-1320-290X; Siriwardana, Chamindika/0000-0002-7746-9427; Quint, Marcel/0000-0003-2935-4083	National Science Foundation [IOB-0845305, DBI-0821252]; Texas State University [9000000525]; National Institute of Health [GM067203]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067203] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Texas State University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (IOB-0845305 to ND), (DBI-0821252 to JRK DG), Texas State University (9000000525 to ND), and the National Institute of Health (GM067203 to WG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Villalobos LIAC, 2012, NAT CHEM BIOL, V8, P477, DOI [10.1038/NCHEMBIO.926, 10.1038/nchembio.926]; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Chuang HW, 2004, PLANT CELL, V16, P1883, DOI 10.1105/tpc.021923; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Filichkin SA, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-20; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Freeman J, 2003, CANCER CELL, V02; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jammes F, 2011, PLANT SIGNAL BEHAV, V6, P1875, DOI 10.4161/psb.6.11.17933; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kriechbaumer V, 2012, PLANT J, V70, P292, DOI 10.1111/j.1365-313X.2011.04866.x; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li WF, 2013, PLANT PHYSIOL, V162, P1750, DOI 10.1104/pp.113.217778; Li YG, 2012, PLANT SCI, V188, P10, DOI 10.1016/j.plantsci.2012.02.005; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; Oono Y, 1998, PLANT CELL, V10, P1649, DOI 10.1105/tpc.10.10.1649; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Quint M, 2005, PLANT J, V43, P371, DOI 10.1111/j.1365-313X.2005.02449.x; Rasband W., 2006, IMAGEJ; Remy E, 2013, PLANT CELL, V25, P901, DOI 10.1105/tpc.113.110353; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Strader LC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-41; Strader LC, 2008, GENETICS, V180, P2019, DOI 10.1534/genetics.108.091512; Streitner C, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24638; Tang F, 2013, PLANT MOL BIOL, V1, P8; Tromas A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3496; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Ulm R, 2002, EMBO J, V21, P6483, DOI 10.1093/emboj/cdf646; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Yan K, 2012, MOL CELL, V48, P521, DOI 10.1016/j.molcel.2012.08.032	45	13	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e102301	10.1371/journal.pone.0102301	http://dx.doi.org/10.1371/journal.pone.0102301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144378	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100004
J	Doyle, OM; Westman, E; Marquand, AF; Mecocci, P; Vellas, B; Tsolaki, M; Kloszewska, I; Soininen, H; Lovestone, S; Williams, SCR; Simmons, A				Doyle, Orla M.; Westman, Eric; Marquand, Andre F.; Mecocci, Patrizia; Vellas, Bruno; Tsolaki, Magda; Kloszewska, Iwona; Soininen, Hilkka; Lovestone, Simon; Williams, Steve C. R.; Simmons, Andrew		AddNeuroMed Consortium Alzheimer	Predicting Progression of Alzheimer's Disease Using Ordinal Regression	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GAUSSIAN-PROCESSES; CEREBRAL ATROPHY; BRAIN ATROPHY; MRI; CLASSIFICATION; PATTERNS	We propose a novel approach to predicting disease progression in Alzheimer's disease (AD) - multivariate ordinal regression - which inherently models the ordered nature of brain atrophy spanning normal aging (CTL) to mild cognitive impairment (MCI) to AD. Ordinal regression provides probabilistic class predictions as well as a continuous index of disease progression - the ORCHID (Ordinal Regression Characteristic Index of Dementia) score. We applied ordinal regression to 1023 baseline structural MRI scans from two studies: the US-based Alzheimer's Disease Neuroimaging Initiative (ADNI) and the European based AddNeuroMed program. Here, the acquired AddNeuroMed dataset was used as a completely independent test set for the ordinal regression model trained on the ADNI cohort providing an optimal assessment of model generalizability. Distinguishing CTL-like (CTL and stable MCI) from AD-like (MCI converters and AD) resulted in balanced accuracies of 82% (cross-validation) for ADNI and 79% (independent test set) for AddNeuroMed. For prediction of conversion from MCI to AD, balanced accuracies of 70% (AUC of 0.75) and 75% (AUC of 0.81) were achieved. The ORCHID score was computed for all subjects. We showed that this measure significantly correlated with MMSE at 12 months (rho = -0.64, ADNI and rho = -0.59, AddNeuroMed). Additionally, the ORCHID score can help fractionate subjects with unstable diagnoses (e.g. reverters and healthy controls who later progressed to MCI), moderately late converters (12-24 months) and late converters (24-36 months). A comparison with results in the literature and direct comparison with a binary classifier suggests that the performance of this framework is highly competitive.	[Doyle, Orla M.; Westman, Eric; Marquand, Andre F.; Williams, Steve C. R.; Simmons, Andrew] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England; [Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Lovestone, Simon; Williams, Steve C. R.; Simmons, Andrew] NIHR Biomed Res Ctr Mental Hlth South London, London, England; [Simmons, Andrew] NIHR Biomed Res Unit Dementia South London, London, England; [Mecocci, Patrizia] Univ Perugia, Inst Gerontol & Geriatr, I-06100 Perugia, Italy; [Vellas, Bruno] Univ Toulouse, INSERM, U558, Toulouse, France; [Tsolaki, Magda] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Kloszewska, Iwona] Med Univ Lodz, Lodz, Poland; [Soininen, Hilkka] Univ Eastern Finland, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Williams, Steve C. R.; Simmons, Andrew] Maudsley NHS Fdn Trust, London, England; [Williams, Steve C. R.; Simmons, Andrew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; King's College London; Karolinska Institutet; University of Perugia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Aristotle University of Thessaloniki; Medical University Lodz; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; South London & Maudsley NHS Trust; University of London; King's College London	Doyle, OM (corresponding author), Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England.	orla.doyle@kcl.ac.uk	Marquand, Andre F/B-6050-2012; Simmons, Andrew/B-8848-2008; Mecocci, Patrizia/W-2116-2019; Williams, Steve C/D-6979-2011; Westman, Eric/H-5771-2011	Marquand, Andre F/0000-0001-5903-203X; Simmons, Andrew/0000-0003-2306-5811; Mecocci, Patrizia/0000-0003-0729-5246; Williams, Steve C/0000-0003-4299-1941; Westman, Eric/0000-0002-3115-2977; Tsolaki, Magda/0000-0002-2072-8010; Doyle, Orla/0000-0002-6964-0140; opoku, anita/0000-0001-7243-8157; Lovestone, Simon/0000-0003-0473-4565	Innovative Medicines Initiative [115008]; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust; EPSRC [WT088641/Z/09/Z]; Kuopio University Hospital; NIHR Biomedical Research Centre for Mental Health; NIHR Biomedical Research Unit for Dementia at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Alzheimer's Research UK; Innovative Medicines Initiative; InnoMed, (Innovative Medicines in Europe) an Integrated Project - European Union [FP6-2004-LIFESCIHEALTH-5]; Life Sciences, Genomics and Biotechnology for Health; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Alzheimers Research UK [ARUK-EXT2013-4, ART-PG2010-4] Funding Source: researchfish; Medical Research Council [G0801464] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10053] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, P30AG010129] Funding Source: NIH RePORTER; MRC [G0801464] Funding Source: UKRI	Innovative Medicines Initiative; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Kuopio University Hospital; NIHR Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit for Dementia at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Innovative Medicines Initiative; InnoMed, (Innovative Medicines in Europe) an Integrated Project - European Union; Life Sciences, Genomics and Biotechnology for Health(European Commission); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	OMD is supported by the Innovative Medicines Initiative Joint Undertaking under Grant Agreement No 115008 (NEWMEDS). The Innovative Medicines Initiative Joint Undertaking is a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations. AFM gratefully acknowledges support from King's College London Centre of Excellence in Medical Engineering, funded by the Wellcome Trust and EPSRC under grant no. WT088641/Z/09/Z. EW wishes to thank Swedish Brain Power, the Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro), the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet, Health Research Council of Academy of Finland, University of Eastern Finland UEFBRAIN and EVO funding from Kuopio University Hospital. AS is supported by funds from NIHR Biomedical Research Centre for Mental Health, the NIHR Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, Alzheimer's Research UK and the Innovative Medicines Initiative funded European Medical Information Framework. The AddNeuroMed study was supported by InnoMed, (Innovative Medicines in Europe) an Integrated Project funded by the European Union of the Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5, Life Sciences, Genomics and Biotechnology for Health. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE HealtCTLare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaszewski S, 2013, NEUROBIOL AGING, V34, P2815, DOI 10.1016/j.neurobiolaging.2013.06.015; Bishop CM, 2006, PATTERN RECOGN, Vxx; Chu W, 2005, J MACH LEARN RES, V6, P1019; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Doyle OM, 2013, NEUROIMAGE, V81, P347, DOI 10.1016/j.neuroimage.2013.05.036; Doyle OM, 2013, J PHARMACOL EXP THER, V345, P151, DOI 10.1124/jpet.112.201665; Eskildsen SF, 2013, NEUROIMAGE, V65, P511, DOI 10.1016/j.neuroimage.2012.09.058; Fan Y, 2011, LECT NOTES COMPUT SC, V7012, P44, DOI 10.1007/978-3-642-24446-9_6; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Hastie T., 2009, ELEMENTS STAT LEARNI, Vsecond, pXXII, DOI DOI 10.1007/978-0-387-84858-7; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Liu X, 2013, NEUROIMAGE, V83, P148, DOI 10.1016/j.neuroimage.2013.06.033; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Rasmussen CE, 2010, J MACH LEARN RES, V11, P3011; Schuff N, 2012, NEUROBIOL AGING, V33, P845, DOI 10.1016/j.neurobiolaging.2010.07.012; Sluimer JD, 2008, NEUROLOGY, V70, P1836, DOI 10.1212/01.wnl.0000311446.61861.e3; Spulber G, 2013, J INTERN MED, V273, P396, DOI 10.1111/joim.12028; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Westman E, 2011, NEUROIMAGE, V58, P818, DOI 10.1016/j.neuroimage.2011.06.065; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Young J, 2013, NEUROIMAGE-CLIN, V2, P735, DOI 10.1016/j.nicl.2013.05.004	32	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105542	10.1371/journal.pone.0105542	http://dx.doi.org/10.1371/journal.pone.0105542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141298	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200097
J	Neuvonen, M; Manna, M; Mokkila, S; Javanainen, M; Rog, T; Liu, Z; Bittman, R; Vattulainen, I; Ikonen, E				Neuvonen, Maarit; Manna, Moutusi; Mokkila, Sini; Javanainen, Matti; Rog, Tomasz; Liu, Zheng; Bittman, Robert; Vattulainen, Ilpo; Ikonen, Elina			Enzymatic Oxidation of Cholesterol: Properties and Functional Effects of Cholestenone in Cell Membranes	PLOS ONE			English	Article							PLASMA-MEMBRANE; FLIP-FLOP; DYNAMICS; RAFTS; DOMAINS; CHOLESTANOL; TRAFFICKING	Bacterial cholesterol oxidase is commonly used as an experimental tool to reduce cellular cholesterol content. That the treatment also generates the poorly degradable metabolite 4-cholesten-3-one (cholestenone) has received less attention. Here, we investigated the membrane partitioning of cholestenone using simulations and cell biological experiments and assessed the functional effects of cholestenone in human cells. Atomistic simulations predicted that cholestenone reduces membrane order, undergoes faster flip-flop and desorbs more readily from membranes than cholesterol. In primary human fibroblasts, cholestenone was released from membranes to physiological extracellular acceptors more avidly than cholesterol, but without acceptors it remained in cells over a day. To address the functional effects of cholestenone, we studied fibroblast migration during wound healing. When cells were either cholesterol oxidase treated or part of cellular cholesterol was exchanged for cholestenone with cyclodextrin, cell migration during 22 h was markedly inhibited. Instead, when a similar fraction of cholesterol was removed using cyclodextrin, cells replenished their cholesterol content in 3 h and migrated similarly to control cells. Thus, cholesterol oxidation produces long-term functional effects in cells and these are in part due to the generated membrane active cholestenone.	[Neuvonen, Maarit; Ikonen, Elina] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Manna, Moutusi; Mokkila, Sini; Javanainen, Matti; Rog, Tomasz; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Liu, Zheng; Bittman, Robert] CUNY, Queens Coll, Dept Chem & Biochem, Flushing, NY 10021 USA; [Vattulainen, Ilpo] Univ Southern Denmark, Ctr Biomembrane Phys, MEMPHYS, Odense, Denmark; [Ikonen, Elina] Minerva Fdn, Helsinki, Finland	University of Helsinki; Tampere University; City University of New York (CUNY) System; Queens College NY (CUNY); University of Southern Denmark	Ikonen, E (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	elina.ikonen@helsinki.fi	Vattulainen, Ilpo T/G-4224-2014; Rog, Tomasz/ABE-3044-2020; Javanainen, Matti/GZA-9227-2022; Manna, Moutusi/GZL-7999-2022	Rog, Tomasz/0000-0001-6765-7013; Javanainen, Matti/0000-0003-4858-364X; Neuvonen, Maarit/0000-0002-7209-3029; Manna, Moutusi/0000-0001-9472-1594; Neuvonen, Mikko/0000-0002-7627-1638; Ikonen, Elina/0000-0001-8382-1135	Academy of Finland [257136, 218066, 131489, 135050]; Academy of Finland Center of Excellence program [272130]; European Research Council [CROWDED-PRO-LIPIDS]; National Institutes of Health [HL083187]; Sigrid Juselius Foundation; Finnish Medical Foundation; Emil Aaltonen Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence program(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Medical Foundation; Emil Aaltonen Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was financially supported by the Academy of Finland project funds (257136 to M.N., 218066, 131489, 135050 to E.I.) and Academy of Finland Center of Excellence program (272130 to E.I. and I.V.), The European Research Council (Advanced Grant CROWDED-PRO-LIPIDS to I.V.), National Institutes of Health grant (HL083187 to R.B.), Sigrid Juselius Foundation grant (to E.I.), Finnish Medical Foundation grant (to E.I.), and Emil Aaltonen Foundation grant (to M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MLS, 1996, J ORG CHEM, V61, P6587, DOI 10.1021/jo960361q; Anglin TC, 2009, BIOCHEMISTRY-US, V48, P10220, DOI 10.1021/bi901096j; Bennett WFD, 2009, J AM CHEM SOC, V131, P12714, DOI 10.1021/ja903529f; Bennett WFD, 2009, J AM CHEM SOC, V131, P1972, DOI 10.1021/ja808541r; Bjorkbom A, 2011, BBA-BIOMEMBRANES, V1808, P1179, DOI 10.1016/j.bbamem.2011.01.009; BJORKHEM I, 1974, BIOCHIM BIOPHYS ACTA, V337, P129, DOI 10.1016/0005-2760(74)90046-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruckner RJ, 2009, BIOPHYS J, V97, P3113, DOI 10.1016/j.bpj.2009.09.025; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cahuzac N, 2006, BLOOD, V107, P2384, DOI 10.1182/blood-2005-07-2883; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GRONBERG L, 1990, BIOCHEMISTRY-US, V29, P3173, DOI 10.1021/bi00465a003; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Jo S, 2010, J PHYS CHEM B, V114, P13342, DOI 10.1021/jp108166k; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Le Lay S, 2009, J LIPID RES, V50, P1609, DOI 10.1194/jlr.M800601-JLR200; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Meszaros P, 2011, BIOCHEM J, V437, P483, DOI 10.1042/BJ20110427; Murzyn K, 2001, BIOPHYS J, V81, P170, DOI 10.1016/S0006-3495(01)75689-5; Orlowski A, 2011, J PHYS CHEM B, V115, P13541, DOI 10.1021/jp207177p; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Parisio G, 2012, J AM CHEM SOC, V134, P12198, DOI 10.1021/ja304007t; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rhainds D, 2004, J CELL SCI, V117, P3095, DOI 10.1242/jcs.01182; Rog T, 2008, J PHYS CHEM B, V112, P1946, DOI 10.1021/jp075078h; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; SALEN G, 1994, J LIPID RES, V35, P1878; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Sapay N, 2009, SOFT MATTER, V5, P3295, DOI 10.1039/b902376c; SEELIG A, 1977, BIOCHEMISTRY-US, V16, P45, DOI 10.1021/bi00620a008; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Stepniewski M, 2012, J PHYS CHEM B, V116, P4889, DOI 10.1021/jp300899b; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Welf ES, 2012, J CELL BIOL, V197, P105, DOI 10.1083/jcb.201108152; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	50	44	45	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e103743	10.1371/journal.pone.0103743	http://dx.doi.org/10.1371/journal.pone.0103743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157633	Green Published, gold			2022-12-27	WOS:000341303200004
J	Kliper, E; Ben Assayag, E; Tarrasch, R; Artzi, M; Korczyn, AD; Shenhar-Tsarfaty, S; Aizenstein, O; Hallevi, H; Mike, A; Shopin, L; Bornstein, NM; Ben Bashat, D				Kliper, Efrat; Ben Assayag, Einor; Tarrasch, Ricardo; Artzi, Moran; Korczyn, Amos D.; Shenhar-Tsarfaty, Shani; Aizenstein, Orna; Hallevi, Hen; Mike, Anat; Shopin, Ludmila; Bornstein, Natan M.; Ben Bashat, Dafna			Cognitive State following Stroke: The Predominant Role of Preexisting White Matter Lesions	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; 1ST-EVER STROKE; ISCHEMIC-STROKE; DEMENTIA; BRAIN; IMPAIRMENT; LOCATION; HYPERINTENSITIES; INTEGRITY; ABNORMALITIES	Background and purpose: Stroke is a major cause of cognitive impairment and dementia in adults, however the role of the ischemic lesions themselves, on top of other risk factors known in the elderly, remains controversial. This study used structural equation modeling to determine the respective impact of the new ischemic lesions' volume, preexisting white matter lesions and white matter integrity on post stroke cognitive state. Methods: Consecutive first ever mild to moderate stroke or transient ischemic attack patients recruited into the ongoing prospective TABASCO study underwent magnetic resonance imaging scans within seven days of stroke onset and were cognitively assessed one year after the event using a computerized neuropsychological battery. The volumes of both ischemic lesions and preexisting white matter lesions and the integrity of the normal appearing white matter tissue were measured and their contribution to cognitive state was assessed using structural equation modeling path analysis taking into account demographic parameters. Two models were hypothesized, differing by the role of ischemic lesions' volume. Results: Structural equation modeling analysis of 142 patients confirmed the predominant role of white matter lesion volume (standardized path coefficient beta = -0.231) and normal appearing white matter integrity (beta = -0.176) on the global cognitive score, while ischemic lesions' volume showed no such effect (beta = 0.038). The model excluding the ischemic lesion presented better fit to the data (comparative fit index 0.9 versus 0.092). Conclusions: Mild to moderate stroke patients with preexisting white matter lesions are more vulnerable to cognitive impairment regardless of their new ischemic lesions. Thus, these patients can serve as a target group for studies on cognitive rehabilitation and neuro-protective therapies which may, in turn, slow their cognitive deterioration.	[Kliper, Efrat; Artzi, Moran; Aizenstein, Orna; Ben Bashat, Dafna] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, IL-69978 Tel Aviv, Israel; [Kliper, Efrat; Artzi, Moran; Korczyn, Amos D.; Bornstein, Natan M.; Ben Bashat, Dafna] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Kliper, Efrat; Ben Assayag, Einor; Shenhar-Tsarfaty, Shani; Hallevi, Hen; Mike, Anat; Shopin, Ludmila; Bornstein, Natan M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Tarrasch, Ricardo] Tel Aviv Univ, Jaime & Joan Constantiner Sch Educ, IL-69978 Tel Aviv, Israel; [Tarrasch, Ricardo; Ben Bashat, Dafna] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv University	Ben Bashat, D (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, IL-69978 Tel Aviv, Israel.	dafnab@tlvmc.gov.il	Korczyn, Amos D/C-3461-2017; Artzi, Moran/AAF-5167-2020; Tarrasch, Ricardo/H-9197-2013	Korczyn, Amos D/0000-0003-0125-2579; Tarrasch, Ricardo/0000-0003-1677-6615; Ben Bashat, Dafna/0000-0001-8396-1031; Shenhar-Tsarfaty, Shani/0000-0002-8268-1799	Chief Scientist Office, Ministry of Health, Israel [3000000-5062]; American Federation for Aging Research [RAG11482]	Chief Scientist Office, Ministry of Health, Israel; American Federation for Aging Research	This study is supported by grant 3000000-5062 from the Chief Scientist Office, Ministry of Health, Israel and grant RAG11482 from the American Federation for Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artzi M, 2013, EUR J RADIOL, V82, P1512, DOI 10.1016/j.ejrad.2013.05.029; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; Baune BT, 2009, STROKE, V40, P667, DOI 10.1161/STROKEAHA.108.534230; BELOOSESKY Y, 1995, AGE AGEING, V24, P515, DOI 10.1093/ageing/24.6.515; Ben Assayag E, 2012, INT J STROKE, V7, P341, DOI 10.1111/j.1747-4949.2011.00652.x; Bolandzadeh N, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-126; Bornstein NM, 1996, STROKE, V27, P904, DOI 10.1161/01.STR.27.5.904; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; de Groot JC, 2000, ANN NEUROL, V47, P145; de Groot M, 2013, STROKE, V44, P1037, DOI 10.1161/STROKEAHA.112.680223; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Dufouil C, 2009, STROKE, V40, P2219, DOI 10.1161/STROKEAHA.108.540633; ENGLUND E, 1988, BRAIN, V111, P1425, DOI 10.1093/brain/111.6.1425; Fillit HM, 2008, ALZHEIMERS DEMENT, V4, P14, DOI 10.1016/j.jalz.2007.09.008; Frisoni GB, 2007, NAT CLIN PRACT NEURO, V3, P620, DOI 10.1038/ncpneuro0638; Ganesan V, 1999, ARCH DIS CHILD, V81, P295, DOI 10.1136/adc.81.4.295; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hoffmann M, 2006, COGN BEHAV NEUROL, V19, P85, DOI 10.1097/01.wnn.0000213903.59827.50; Ihle-Hansen H, 2012, DEMENT GER COGN D EX, V2, P38, DOI 10.1159/000336817; Ivan CS, 2004, STROKE, V35, P1264, DOI 10.1161/01.STR.0000127810.92616.78; Jacobs HIL, 2013, HUM BRAIN MAPP, V34, P77, DOI 10.1002/hbm.21412; Kim SH, 2011, J NEUROIMAGING, V21, P317, DOI 10.1111/j.1552-6569.2010.00527.x; Leritz EC, 2014, HUM BRAIN MAPP, V35, P1085, DOI 10.1002/hbm.22236; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Leys D, 1999, EUR NEUROL, V42, P67, DOI 10.1159/000069414; Mailhard P, 2013, AM J NEURORADIOL, V34, P54, DOI 10.3174/ajnr.A3146; Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768; Makin SDJ, 2013, J NEUROL NEUROSUR PS, V84, P893, DOI 10.1136/jnnp-2012-303645; Mukherjee P, 2005, NEUROIMAG CLIN N AM, V15, P655, DOI 10.1016/j.nic.2005.08.010; Norman GR, 2003, PDQ STAT, P156; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; O'Sullivan M, 2010, STROKE, V41, pS154, DOI 10.1161/STROKEAHA.110.595314; Peek MK, 2000, AM J PHYS MED REHAB, V79, P301, DOI 10.1097/00002060-200005000-00014; Pendlebury ST, 2009, MATURITAS, V64, P165, DOI 10.1016/j.maturitas.2009.09.010; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Penke L, 2010, NEUROBIOL AGING, V31, P1656, DOI 10.1016/j.neurobiolaging.2009.10.019; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; Radanovic M, 2013, EXPERT REV NEUROTHER, V13, P483, DOI [10.1586/ERN.13.45, 10.1586/ern.13.45]; Richard E, 2010, STROKE, V41, P554, DOI 10.1161/STROKEAHA.109.571281; Ropele S, 2009, J MAGN RESON IMAGING, V29, P268, DOI 10.1002/jmri.21580; Rosenberg GA, 2009, STROKE, V40, pS20, DOI 10.1161/STROKEAHA.108.533133; Sachdev PS, 2006, DEMENT GERIATR COGN, V21, P275, DOI 10.1159/000091434; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P670, DOI 10.1111/j.1365-2990.2007.00890.x; Srikanth VK, 2006, STROKE, V37, P2479, DOI 10.1161/01.STR.0000239666.46828.d7; Srikanth VK, 2004, NEUROLOGY, V63, P785, DOI 10.1212/01.WNL.0000137042.01774.33; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165	54	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105461	10.1371/journal.pone.0105461	http://dx.doi.org/10.1371/journal.pone.0105461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153800	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200052
J	Lorente, L; Martin, MM; Abreu-Gonzalez, P; Sole-Violan, J; Ferreres, J; Labarta, L; Diaz, C; Gonzalez, O; Garcia, D; Jimenez, A; Borreguero-Leon, JM				Lorente, Leonardo; Martin, Maria M.; Abreu-Gonzalez, Pedro; Sole-Violan, Jordi; Ferreres, Jose; Labarta, Lorenzo; Diaz, Cesar; Gonzalez, Oswaldo; Garcia, Daida; Jimenez, Alejandro; Borreguero-Leon, Juan M.			Red Blood Cell Distribution Width during the First Week Is Associated with Severity and Mortality in Septic Patients	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; PROGNOSTIC MARKER; HEART-FAILURE; SEVERE SEPSIS; INDEPENDENT PREDICTOR; ERYTHROPOIESIS; INTERLEUKIN-6; DISEASE; LIVER; SERUM	Objective: Higher values of red blood cell distribution width (RDW) have been found in non-surviving than in surviving septic patients. However, it is unknown whether RDW during the first week of sepsis evolution is associated with sepsis severity and early mortality, oxidative stress and inflammation states, and these were the aims of the study. Methods: We performed a prospective, observational, multicenter study in six Spanish Intensive Care Units with 297 severe septic patients. We measured RDW, serum levels of malondialdehyde (MDA) to assess oxidative stress, and tumour necrosis factor (TNF)-alpha to assess inflammation at days 1, 4, and 8. The end-point was 30-day mortality. Results: We found higher RDW in non-surviving (n = 104) than in surviving (n = 193) septic patients at day 1 (p = 0.001), day 4 (p = 0.001), and day 8 (p = 0.002) of ICU admission. Cox regression analyses showed that RDW at day 1 (p<0.001), 4 (p = 0.005) and 8 (p = 0.03) were associated with 30-day mortality. Receiver operating characteristic curves showed that RDW at day 1 (p<0.001), 4 (p<0.001), and 8 (p<0.001) could be used to predict 30-day mortality. RDW showed a positive correlation with serum MDA levels at day 1 and day 4, with serum TNF-alpha levels at days 4 and 8, and with SOFA score at days 1, 4 and 8. Conclusions: The major findings of our study were that non-surviving septic patients showed persistently higher RDW during the first week of ICU stay than survivors, that RDW during the first week was associated with sepsis severity and mortality, that RDW during the first week could be used as biomarker of outcome in septic patients, and that there was an association between RDW, serum MDA levels, and serum TNF-alpha levels during the first week.	[Lorente, Leonardo; Gonzalez, Oswaldo] Hosp Univ Canarias, Intens Care Unit, Tenerife, Spain; [Martin, Maria M.; Garcia, Daida] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Tenerife, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Med, Dept Phisiol, Tenerife, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, Las Palmas Gran Canaria, Gran Canria, Spain; [Ferreres, Jose] Hosp Clin Univ Valencia, Intens Care Unit, Valencia, Spain; [Labarta, Lorenzo] Hosp San Jorge, Intens Care Unit, Huesca, Spain; [Diaz, Cesar] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Gran Canaria, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Tenerife, Spain; [Borreguero-Leon, Juan M.] Hosp Univ Canarias, Dept Lab, Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; Hospital Clinic Universitari de Valencia; Hospital Universidad San Jorge; Universidad de la Laguna; Universidad de la Laguna	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Tenerife, Spain.	lorentemartin@msn.com	Martín, María/HDL-9512-2022; Borreguero León, Juan María/ABQ-2161-2022; Abreu-Gonzalez, Pedro/AAC-7790-2020	Borreguero León, Juan María/0000-0001-7414-5278; Abreu-Gonzalez, Pedro/0000-0002-7553-1784	Instituto de Salud Carlos III (Madrid, Spain) [FIS-PI-10-01572, I3SNS-INT-11-063, I3SNS-INT-12-087]; Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government)	Supported, in part, by grants from Instituto de Salud Carlos III (FIS-PI-10-01572, I3SNS-INT-11-063 and I3SNS-INT-12-087) (Madrid, Spain) and co-financed with Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Braun E, 2011, CRIT CARE, V15, DOI 10.1186/cc10355; CALANDRA T, 1990, J INFECT DIS, V161, P982, DOI 10.1093/infdis/161.5.982; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Hampole CV, 2009, AM J CARDIOL, V104, P868, DOI 10.1016/j.amjcard.2009.05.016; Hu ZD, 2013, CLIN CHEM LAB MED, V51, P1403, DOI 10.1515/cclm-2012-0704; Jo YH, 2013, AM J EMERG MED, V31, P545, DOI 10.1016/j.ajem.2012.10.017; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; Kim J, 2012, RESUSCITATION, V83, P1248, DOI 10.1016/j.resuscitation.2012.01.038; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Ku NS, 2012, SHOCK, V38, P123, DOI 10.1097/SHK.0b013e31825e2a85; Lappe JM, 2011, CLIN CHIM ACTA, V412, P2094, DOI 10.1016/j.cca.2011.07.018; Lee JH, 2013, AM J EMERG MED, V31, P72, DOI 10.1016/j.ajem.2012.06.004; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Lorente L, 2013, CRIT CARE, V17, DOI 10.1186/cc13155; Lorente L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053741; Lou YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037644; OGILVIE AC, 1991, INTENS CARE MED, V17, P40, DOI 10.1007/BF01708408; Osadnik T, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-113; Panacek EA, 2004, CRIT CARE MED, V32, P2173, DOI 10.1097/01.CCM.0000145229.59014.6c; Pascual-Figal DA, 2009, EUR J HEART FAIL, V11, P840, DOI 10.1093/eurjhf/hfp109; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; PATEL RT, 1994, BRIT J SURG, V81, P1306, DOI 10.1002/bjs.1800810914; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Sangoi MB, 2011, INT J CARDIOL, V146, P278, DOI 10.1016/j.ijcard.2010.10.084; Scharte M, 2003, CRIT CARE MED, V31, pS651, DOI 10.1097/01.CCM.0000098036.90796.ED; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang FL, 2011, ANN MED, V43, P40, DOI 10.3109/07853890.2010.521766; Ye Z, 2011, AM J CARDIOL, V107, P1241, DOI 10.1016/j.amjcard.2010.12.023; Zorlu A, 2012, AM J CARDIOL, V109, P128, DOI 10.1016/j.amjcard.2011.08.015	37	54	61	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105436	10.1371/journal.pone.0105436	http://dx.doi.org/10.1371/journal.pone.0105436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153089	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200047
J	Meyer, KS; Soltwedel, T; Bergmann, M				Meyer, Kirstin S.; Soltwedel, Thomas; Bergmann, Melanie			High Biodiversity on a Deep-Water Reef in the Eastern Fram Strait	PLOS ONE			English	Article							ROCKY-REEF; COMMUNITY STRUCTURE; HERBIVOROUS INVERTEBRATES; MEGAFAUNAL ASSEMBLAGES; HABITAT STRUCTURE; SELF-RECRUITMENT; FISH; ABUNDANCE; GULF; CORALS	We report on the distribution and abundance of megafauna on a deep- water rocky reef (1796- 2373 m) in the Fram Strait, west of Svalbard. Biodiversity and population density are high, with a maximum average of 26.7 +/- 0.9 species m(-2) and 418.1 +/- 49.6 individuals m(-2) on the east side of the reef summit. These figures contrast with the surrounding abyssal plain fauna, with an average of only 18.1 +/- 1.4 species and 29.4 +/- 4.3 individuals m(-2) (mean +/- standard error). The east side of the reef summit, where the highest richness and density of fauna are found, faces into the predominant bottom current, which likely increases in speed to the summit and serves as a source of particulate food for the numerous suspension feeders present there. We conclude that the observed faunal distribution patterns could be the result of hydrodynamic patterns and food availability above and around the reef. To our knowledge, this study is the first to describe the distribution and diversity of benthic fauna on a rocky reef in deep water.	[Meyer, Kirstin S.] Oregon Inst Marine Biol, Charleston, OR USA; [Soltwedel, Thomas; Bergmann, Melanie] Alfred Wegener Inst, Helmholtz Zentrum Polar & Meeresforsch, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Meyer, KS (corresponding author), Oregon Inst Marine Biol, Charleston, OR USA.	kimeyer@alumni.nmu.edu	Soltwedel, Thomas/P-1852-2016; Bergmann, Melanie/H-3347-2015	Soltwedel, Thomas/0000-0002-8214-5937; Bergmann, Melanie/0000-0001-5212-9808; Meyer-Kaiser, Kirstin/0000-0003-2219-6086	Fulbright Study-Research grant	Fulbright Study-Research grant	K. Meyer was funded by a Fulbright Study-Research grant during the duration (July 2011-May 2012) of her tenure at the AWI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2001, MAR ECOL-P S Z N I, V22, P283, DOI 10.1046/j.1439-0485.2001.t01-1-01747.x; Bergmann M, 2011, DEEP-SEA RES PT I, V58, P711, DOI 10.1016/j.dsr.2011.03.007; Bergmann M, 2011, MAR BIOL RES, V7, P525, DOI 10.1080/17451000.2010.535834; Bergmann M, 2009, DEEP-SEA RES PT I, V56, P408, DOI 10.1016/j.dsr.2008.10.004; Brind'Amour A, 2014, CONT SHELF RES, V72, P1, DOI 10.1016/j.csr.2013.10.015; BURCHMORE JJ, 1985, B MAR SCI, V37, P70; COLIN PL, 1976, B MAR SCI, V26, P603; Connell SD, 2001, MAR ENVIRON RES, V52, P115, DOI 10.1016/S0141-1136(00)00266-X; FARROW GE, 1983, CAN J FISH AQUAT SCI, V40, P273, DOI 10.1139/f83-289; Feitoza BM, 2005, B MAR SCI, V76, P725; Garcia-Charton JA, 1998, MAR ECOL-P S Z N I, V19, P111; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Gorley C.K., 2006, GETTING STARTED PRIM; Heterier V, 2008, MAR ECOL PROG SER, V364, P67, DOI 10.3354/meps07487; HOLM S, 1979, SCAND J STAT, V6, P65; JONES GP, 1988, NEW ZEAL J MAR FRESH, V22, P445, DOI 10.1080/00288330.1988.9516315; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Leys SP, 2004, MAR ECOL PROG SER, V283, P133, DOI 10.3354/meps283133; Margalef R., 1968, PERSPECTIVES ECOLOGI; Meyer KS, 2013, BIOGEOSCIENCES, V10, P3479, DOI 10.5194/bg-10-3479-2013; Miller RJ, 2008, ECOLOGY, V89, P452, DOI 10.1890/06-1099.1; Mortensen PB, 2005, ERLANGEN EARTH C SER, P247, DOI 10.1007/3-540-27673-4_12; Mortensen PB, 2001, J MAR BIOL ASSOC UK, V81, P581, DOI 10.1017/S002531540100426X; MULLINEAUX LS, 1987, DEEP-SEA RES, V34, P165, DOI 10.1016/0198-0149(87)90080-X; Oigman-Pszczol SS, 2004, MAR ECOL-P S Z N I, V25, P173, DOI 10.1111/j.1439-0485.2004.00018.x; OJEDA FP, 1989, MAR ECOL PROG SER, V57, P147, DOI 10.3354/meps057147; Ontrup J., 2009, OCEANS 2009 EUROPE, V17, DOI [10.1109/OCEANSE.2009.5278332, DOI 10.1109/OCEANSE.2009.5278332]; Oschmann W., 1990, Senckenbergiana Maritima, V21, P55; PIELOU E C, 1969, P286; Quattrini AM, 2012, MAR BIOL, V159, P1079, DOI 10.1007/s00227-012-1888-7; Queric NV, 2007, MAR ECOL-EVOL PERSP, V28, P66, DOI 10.1111/j.1439-0485.2007.00177.x; Roberts DE, 2006, MAR ECOL PROG SER, V307, P143, DOI 10.3354/meps307143; Robillard MMR, 2010, J SHELLFISH RES, V29, P291, DOI 10.2983/035.029.0203; Rogers AD, 2008, SEAMOUNTS ECOLOGY FI; Ross SW, 2007, DEEP-SEA RES PT I, V54, P975, DOI 10.1016/j.dsr.2007.03.010; Ruitton S, 2000, ESTUAR COAST SHELF S, V50, P217, DOI 10.1006/ecss.1999.0546; Schoening T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038179; Schulz M, 2010, POLAR BIOL, V33, P1359, DOI 10.1007/s00300-010-0825-9; Shannon C.E., 1963, MATH THEORY COMMUNIC; Smith F, 1999, ECOLOGY, V80, P51, DOI 10.2307/176979; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; Swearer SE, 2002, B MAR SCI, V70, P251; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; THRESHER RE, 1986, B MAR SCI, V38, P253; Tissot BN, 2005, FISH B, V104, P167; Tuya F, 2004, MAR ECOL PROG SER, V278, P157, DOI 10.3354/meps278157; Vacelet J, 2002, CAH BIOL MAR, V43, P141; Vanderklift MA, 2004, MAR FRESHWATER RES, V55, P93, DOI 10.1071/MF03057; Wahl M, 2009, ECOL STUD-ANAL SYNTH, V206, P1, DOI 10.1007/b76710; WELLINGTON GM, 1982, ECOL MONOGR, V52, P223, DOI 10.2307/2937329	53	17	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105424	10.1371/journal.pone.0105424	http://dx.doi.org/10.1371/journal.pone.0105424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153985	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200046
J	Wu, JY; Zong, Y; Fei, XC; Chen, XS; Huang, O; He, JR; Chen, WG; Li, YF; Shen, KW; Zhu, L				Wu, Jiayi; Zong, Yu; Fei, Xiaochun; Chen, Xiaosong; Huang, Ou; He, Jianrong; Chen, Weiguo; Li, Yafen; Shen, Kunwei; Zhu, Li			Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; HEPATOCELLULAR-CARCINOMA; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; SUBTYPES; PROTEIN; ABERRATIONS; METASTASIS; INHIBITOR; GROWTH	Background: The chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like gene (CHD1L) is a recently identified oncogene localized at 1q21. CHD1L protein over-expression in primary hepatocellular carcinoma is correlated with enhanced apoptosis inhibition, reduced chemosensitivity and shortened patient survival. However, CHD1L protein status or mRNA expression in breast cancer and its clinical significance remain obscure. Material and Methods: In this study, immunohistochemical staining for CHD1L expression was performed on tissue microarrays containing 179 primary invasive breast cancers and 65 matched normal breast tissue specimens. Clinicopathological features were collected and compared between different CHD1L statuses. Kaplan-Meier curves were applied to estimate disease-free survival (DFS) and overall survival (OS). Cox regression was used to identify independent prognostic factors. Also, quantitative real-time polymerase chain reaction (QRT-PCR) was employed to evaluate the mRNA level expression of CHD1L in six breast cancer cell lines. Results: Presence of CHD1L over-expression was observed in 87 of the 179 patients (48.6%), which associated with a younger age (P = 0.011), higher grade (P = 0.004), higher Ki-67 index (P = 0.018) and HER2 over-expression/amplification (P = 0.037). After a median follow-up of 55 months, patients with presence of CHD1L over-expression had significantly poorer DFS (82.6% Vs 76.3%, P = 0.035), but not OS (87.0% Vs 94.9%, P = 0.439). In multivariate analysis, CHD1L status (HR = 2.169, [95% CI, 1.029-4.573], P = 0.042), triple negative subtype (HR = 2.809, [95% CI 1.086-7.264], P = 0.033) and HER2 positive subtype (HR = 5.221, [95% CI 1.788-15.240], P = 0.002) were identified as independent prognostic factors for DFS. In vitro study indicated that relative mRNA expression level of CHD1L was higher in breast cancer cell lines, especially in MDA-MB-231 and LM2-4175, when compared to normal breast epithelial cell line. Conclusions: Presence of CHD1L over-expression is probably associated with aggressive tumor biology in breast cancer. CHD1L status might be a novel prognostic biomarker for patients with breast cancer.	[Wu, Jiayi; Zong, Yu; Chen, Xiaosong; Huang, Ou; He, Jianrong; Chen, Weiguo; Li, Yafen; Shen, Kunwei; Zhu, Li] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Comprehens Breast Hlth Ctr, Shanghai 200030, Peoples R China; [Fei, Xiaochun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Dept Pathol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhu, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Comprehens Breast Hlth Ctr, Shanghai 200030, Peoples R China.	zhuli8@hotmail.com	吴, 家怡/GSI-7419-2022	Zhu, Li/0000-0002-9294-5727; Zong, Yu/0000-0001-9352-5997	Shanghai Natural Science Foundation [11ZR1422900]; National Natural Science Foundation of China [81102017]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Shanghai Natural Science Foundation 11ZR1422900 and National Natural Science Foundation of China (Young Investigators) 81102017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Bisaro B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3342; Chang J, 2002, CANCER LETT, V182, P193, DOI 10.1016/S0304-3835(02)00083-6; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen LL, 2011, GUT, V60, P534, DOI 10.1136/gut.2010.224071; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen LL, 2009, HEPATOLOGY, V50, P122, DOI 10.1002/hep.22933; Chen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006727; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Deng WB, 2009, CELL STEM CELL, V5, P349, DOI 10.1016/j.stem.2009.09.002; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Guan XY, 2000, GENE CHROMOSOME CANC, V29, P110; Gunther K, 2001, J PATHOL, V193, P40, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH745>3.0.CO;2-N; He WP, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-437; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Hyeon J, 2013, KOREAN J PATHOL, V47, P9, DOI [10.4132/KoreanJPathol.2013.47.1.9, 10.4132/KoreanJPathol.2014.48.2.91]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kusano N, 1999, HEPATOLOGY, V29, P1858, DOI 10.1002/hep.510290636; Laakso M, 2006, CLIN CANCER RES, V12, P4185, DOI 10.1158/1078-0432.CCR-06-0353; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Marchio A, 1997, GENE CHROMOSOME CANC, V18, P59, DOI 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Sakakura C, 1999, BRIT J CANCER, V80, P2034, DOI 10.1038/sj.bjc.6690638; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Thomas PA, 1999, CLIN CANCER RES, V5, P2698; Tsuji Katumi, 2010, BMC Cancer, V10, P15, DOI 10.1186/1471-2407-10-15; Wong N, 1999, AM J PATHOL, V154, P37, DOI 10.1016/S0002-9440(10)65248-0; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472	36	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e98673	10.1371/journal.pone.0098673	http://dx.doi.org/10.1371/journal.pone.0098673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153161	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200001
J	Blazquez-Medela, AM; Garcia-Sanchez, O; Blanco-Gozalo, V; Quiros, Y; Montero, MJ; Martinez-Salgado, C; Lopez-Novoa, JM; Lopez-Hernandez, FJ				Blazquez-Medela, Ana M.; Garcia-Sanchez, Omar; Blanco-Gozalo, Victor; Quiros, Yaremi; Montero, Maria J.; Martinez-Salgado, Carlos; Lopez-Novoa, Jose M.; Lopez-Hernandez, Francisco J.			Hypertension and Hyperglycemia Synergize to Cause Incipient Renal Tubular Alterations Resulting in Increased NGAL Urinary Excretion in Rats	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; CHRONIC KIDNEY-DISEASE; TNF RECEPTORS 1; PROXIMAL TUBULE; CARDIOVASCULAR RISK; MARKER; BIOMARKER; PROGRESSION; CKD; NEPHROPATHIES	Background: Hypertension and diabetes are the two leading causes of chronic kidney disease (CKD) eventually leading to end stage renal disease (ESRD) and the need of renal replacement therapy. Mortality among CKD and ESRD patients is high, mostly due to cardiovascular events. New early markers of risk are necessary to better anticipate the course of the disease, to detect the renal affection of additive risk factors, and to appropriately handle patients in a pre-emptive and personalized manner. Methods: Renal function and NGAL urinary excretion was monitored in rats with spontaneous (SHR) or L-NAME induced hypertension rendered hyperglycemic (or not as controls). Results: Combination of hypertension and hyperglycemia (but not each of these factors independently) causes an increased urinary excretion of neutrophil gelatinase-associated lipocalin (NGAL) in the rat, in the absence of signs of renal damage. Increased NGAL excretion is observed in diabetic animals with two independent models of hypertension. Elevated urinary NGAL results from a specific alteration in its tubular handling, rather than from an increase in its renal expression. In fact, when kidneys of hyperglycaemic-hypertensive rats are perfused in situ with Krebs-dextran solution containing exogenous NGAL, they excrete more NGAL in the urine than hypertensive rats. We also show that albuminuria is not capable of detecting the additive effect posed by the coexistence of these two risk factors. Conclusions: Our results suggest that accumulation of hypertension nd hyperglycemia induces an incipient and quite specific alteration in the tubular handling of NGAL resulting in its increased urinary excretion.	[Blanco-Gozalo, Victor; Martinez-Salgado, Carlos; Lopez-Hernandez, Francisco J.] Hosp Univ Salamanca, IECSCYL, Inst Invest Biomed Salamanca IBSAL, Unidad Invest, Salamanca, Spain; [Blazquez-Medela, Ana M.; Garcia-Sanchez, Omar; Blanco-Gozalo, Victor; Quiros, Yaremi; Montero, Maria J.; Martinez-Salgado, Carlos; Lopez-Novoa, Jose M.; Lopez-Hernandez, Francisco J.] Univ Salamanca, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain; [Blazquez-Medela, Ana M.; Garcia-Sanchez, Omar; Martinez-Salgado, Carlos; Lopez-Novoa, Jose M.; Lopez-Hernandez, Francisco J.] Fdn Inigo Alvarez Toledo, Inst Reina Sofia Invest Nefrol, Madrid, Spain; [Blanco-Gozalo, Victor; Quiros, Yaremi] BioinRen SL, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Lopez-Hernandez, FJ (corresponding author), Hosp Univ Salamanca, IECSCYL, Inst Invest Biomed Salamanca IBSAL, Unidad Invest, Salamanca, Spain.	flopezher@usal.es	Blázquez-Medela, Ana/K-3142-2014; Blázquez-Medela, Ana/ABC-1517-2021; Montero, María José MJ/C-3084-2018; Lopez-Novoa, Jose M/A-3672-2008; Lopez-Hernandez, Francisco J/A-5422-2016	Blázquez-Medela, Ana/0000-0003-3829-6997; Montero, María José MJ/0000-0003-2125-0378; Martinez-Salgado, Carlos/0000-0003-4641-6717; Garcia-Sanchez, Omar/0000-0002-5145-8455; Lopez-Hernandez, Francisco J/0000-0001-7778-7495	Junta de Castilla y Leon, Spain [HUS02B06, GRS80/A/06, GR-100]; Instituto de Salud Carlos III, Madrid, Spain [PI081900, PI11/02278, PS0901067, 06/0016]; Fundacion Renal Inigo Alvarez de Toledo, Madrid, Spain	Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Fundacion Renal Inigo Alvarez de Toledo, Madrid, Spain	This work was supported by grants from the Junta de Castilla y Leon (Consejeria de Educacion, HUS02B06; Consejeria de Sanidad, GRS80/A/06; and Excellence Group, GR-100), Spain; Instituto de Salud Carlos III (FIS, PI081900, PI11/02278, PS0901067; and RETIC 06/0016, RedinRen), Madrid, Spain; and Fundacion Renal Inigo Alvarez de Toledo, Madrid, Spain. AMB-M and OG-S were recipients of a fellowship from the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins RC, 2005, KIDNEY INT, V67, pS14, DOI 10.1111/j.1523-1755.2005.09403.x; Basi S, 2008, DIABETES CARE, V31, pS194, DOI 10.2337/dc08-s249; Bergeron M, 1996, AM J PHYSIOL-RENAL, V271, pF908, DOI 10.1152/ajprenal.1996.271.4.F908; Bolignano D, 2010, EUR J CLIN INVEST, V40, P273, DOI 10.1111/j.1365-2362.2010.02258.x; Bolignano D, 2009, KIDNEY BLOOD PRESS R, V32, P91, DOI 10.1159/000209379; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlson M, 2002, GUT, V50, P501, DOI 10.1136/gut.50.4.501; Carrero JJ, 2011, NAT REV NEPHROL, V7, P65, DOI 10.1038/nrneph.2010.177; Chaudhary K, 2010, CURR DIABETES REP, V10, P37, DOI 10.1007/s11892-009-0080-z; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; De Zeeuw D, 2005, KIDNEY INT, V68, pS25, DOI 10.1111/j.1523-1755.2005.09805.x; Devarajan P, 2008, SCAND J CLIN LAB INV, V68, P89, DOI 10.1080/00365510802150158; Devarajan P, 2010, BIOMARK MED, V4, P265, DOI [10.2217/bmm.10.12, 10.2217/BMM.10.12]; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gaspari F, 2010, NEPHRON CLIN PRACT, V115, pC154, DOI 10.1159/000312879; Gohda T, 2013, CURR DIABETES REP, V13, P560, DOI 10.1007/s11892-013-0385-9; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Grossman E, 2008, ADV CARDIOL, V45, P82, DOI 10.1159/000115189; Hryciw DH, 2004, CLIN EXP PHARMACOL P, V31, P372, DOI 10.1111/j.1440-1681.2004.04001.x; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Izumi Y, 2013, DIABETES RES CLIN PR, V99, P145, DOI 10.1016/j.diabres.2012.11.002; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Lebkowska U, 2009, TRANSPL P, V41, P154, DOI 10.1016/j.transproceed.2008.10.092; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; LOPEZNOVOA JM, 1986, AM J PHYSIOL, V250, pE545, DOI 10.1152/ajpendo.1986.250.5.E545; Malyszko J, 2008, RENAL FAILURE, V30, P625, DOI 10.1080/08860220802134607; Malyszko J, 2008, NEPHROLOGY, V13, P153, DOI 10.1111/j.1440-1797.2007.00899.x; Mancia G, 2005, ACTA DIABETOL, V42, pS17, DOI 10.1007/s00592-005-0177-z; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nagai J, 2001, AM J PHYSIOL-RENAL, V281, pF337, DOI 10.1152/ajprenal.2001.281.2.F337; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Quiros Y, 2010, KIDNEY INT, V78, P1006, DOI 10.1038/ki.2010.267; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Sahakyan K, 2010, AM HEART J, V159, P1074, DOI 10.1016/j.ahj.2010.03.023; SEEBER AM, 1982, CLIN SCI, V63, P217, DOI 10.1042/cs0630217; Soni SS, 2010, INT UROL NEPHROL, V42, P141, DOI 10.1007/s11255-009-9608-z; Szczech LA, 2004, KIDNEY INT, V66, pS3, DOI 10.1111/j.1523-1755.2004.09002.x; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; United States Renal Data Systems, USRDS 2007 ANN DAT R; *USRDS, 2009, 2009 ANN DAT REP ATL; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Wasilewska A, 2010, PEDIATR NEPHROL, V25, P889, DOI 10.1007/s00467-009-1397-1; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753	51	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105988	10.1371/journal.pone.0105988	http://dx.doi.org/10.1371/journal.pone.0105988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148248	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600105
J	Kovacevic, L; Tambets, K; Ilumae, AM; Kushniarevich, A; Yunusbayev, B; Solnik, A; Bego, T; Primorac, D; Skaro, V; Leskovac, A; Jakovski, Z; Drobnic, K; Tolk, HV; Kovacevic, S; Rudan, P; Metspalu, E; Marjanovic, D				Kovacevic, Lejla; Tambets, Kristiina; Ilumaee, Anne-Mai; Kushniarevich, Alena; Yunusbayev, Bayazit; Solnik, Anu; Bego, Tamer; Primorac, Dragan; Skaro, Vedrana; Leskovac, Andreja; Jakovski, Zlatko; Drobnic, Katja; Tolk, Helle-Viivi; Kovacevic, Sandra; Rudan, Pavao; Metspalu, Ene; Marjanovic, Damir			Standing at the Gateway to Europe - The Genetic Structure of Western Balkan Populations Based on Autosomal and Haploid Markers	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; Y-CHROMOSOME; MODERN HUMANS; SOUTHEASTERN EUROPE; MTDNA HAPLOGROUPS; HERITAGE; NEANDERTHALS; COLONIZATION; LINEAGES; BOSNIANS	Contemporary inhabitants of the Balkan Peninsula belong to several ethnic groups of diverse cultural background. In this study, three ethnic groups from Bosnia and Herzegovina - Bosniacs, Bosnian Croats and Bosnian Serbs - as well as the populations of Serbians, Croatians, Macedonians from the former Yugoslav Republic of Macedonia, Montenegrins and Kosovars have been characterized for the genetic variation of 660 000 genome-wide autosomal single nucleotide polymorphisms and for haploid markers. New autosomal data of the 70 individuals together with previously published data of 20 individuals from the populations of the Western Balkan region in a context of 695 samples of global range have been analysed. Comparison of the variation data of autosomal and haploid lineages of the studied Western Balkan populations reveals a concordance of the data in both sets and the genetic uniformity of the studied populations, especially of Western South-Slavic speakers. The genetic variation of Western Balkan populations reveals the continuity between the Middle East and Europe via the Balkan region and supports the scenario that one of the major routes of ancient gene flows and admixture went through the Balkan Peninsula.	[Kovacevic, Lejla; Tambets, Kristiina; Ilumaee, Anne-Mai; Kushniarevich, Alena; Yunusbayev, Bayazit; Solnik, Anu; Tolk, Helle-Viivi; Metspalu, Ene] Univ Tartu, Estonian Bioctr, Tartu, Estonia; [Kovacevic, Lejla; Tambets, Kristiina; Ilumaee, Anne-Mai; Kushniarevich, Alena; Yunusbayev, Bayazit; Solnik, Anu; Tolk, Helle-Viivi; Metspalu, Ene] Univ Tartu, Dept Evolutionary Biol, Tartu, Estonia; [Kovacevic, Lejla; Marjanovic, Damir] Inst Genet Engn & Biotechnol, Sarajevo, Bosnia & Herceg; [Kovacevic, Lejla; Yunusbayev, Bayazit] RAS, Ufa Res Ctr, Inst Biochem & Genet, Ufa, Bashkortostan, Russia; [Bego, Tamer] Univ Sarajevo, Fac Pharm, Sarajevo, Bosnia & Herceg; [Primorac, Dragan; Marjanovic, Damir] Univ Ctr Forens Sci, Split, Croatia; [Skaro, Vedrana] Genos Doo, Zagreb, Croatia; [Leskovac, Andreja] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade, Serbia; [Jakovski, Zlatko] Univ St Cyril & Methodius, Fac Med, Inst Forens Med Criminol & Med Deontol, Skopje, Macedonia; [Drobnic, Katja] Natl Forens Lab, Minist Interior, Ljubljana, Slovenia; [Kovacevic, Sandra] Forens Ctr, Police Directorate, Danilovgrad, Montenegro; [Rudan, Pavao] Croatian Acad Sci & Art, Zagreb, Croatia	Estonian Biocentre; University of Tartu; University of Tartu; University of Sarajevo; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; University of Sarajevo; University of Split; University of Belgrade; Saints Cyril & Methodius University of Skopje; Croatian Academy of Sciences & Arts	Kovacevic, L (corresponding author), Univ Tartu, Estonian Bioctr, Tartu, Estonia.	lejla_kova@yahoo.com	Leskovac, Andreja/H-4969-2016; Primorac, Dragan/I-6941-2017; Primorac, Dragan/GYJ-1505-2022; Primorac, Dragan/ABF-6238-2020; Tambets, Kristiina/M-2568-2019; Yunusbaev, Bayazit/T-5444-2019	Leskovac, Andreja/0000-0002-6293-5237; Tambets, Kristiina/0000-0002-8173-6380; Yunusbayev, Bayazit/0000-0002-6035-8763; Marjanovic, Damir/0000-0002-7472-4525; Ilumae, Anne-Mai/0000-0001-6920-1335; Skaro, Vedrana/0000-0002-8275-867X	European Union European Regional Development Fund through the Centre of Excellence in Genomics; Estonian Biocentre (EBC); University of Tartu; European Commission ECOGENE [205419]; Estonian Basic Research [SF 0270177s08]	European Union European Regional Development Fund through the Centre of Excellence in Genomics; Estonian Biocentre (EBC); University of Tartu; European Commission ECOGENE; Estonian Basic Research	This work was supported by the European Union European Regional Development Fund through the Centre of Excellence in Genomics, by the Estonian Biocentre (EBC) and the University of Tartu, by the European Commission grant 205419 ECOGENE to the EBC, and by the Estonian Basic Research Grant SF 0270177s08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Barac L, 2003, EUR J HUM GENET, V11, P535, DOI 10.1038/sj.ejhg.5200992; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Berg K, 2005, AM J HUM GENET, V77, P519; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Curta F, 2006, CAMB MEDIEV TEXTB, P1; Cvjetan S, 2004, COLLEGIUM ANTROPOL, V28, P193; Dolukhanov P. M., 2000, ROOTS PEOPLES LANGUA, P71; Durham ME, 1909, HIGH ALBANIA, P95; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foley R., 2001, ARCHAEOGENETICS DNA, P45; GEORGIEV V, 1966, SLAVON E EUR REV, V44, P285; Gnammankou D, 1988, AFRICAN SLAVE TRACE; Gray RD, 2011, PHILOS T R SOC B, V366, P1090, DOI 10.1098/rstb.2010.0378; Hoffecker JF, 2009, P NATL ACAD SCI USA, V106, P16040, DOI 10.1073/pnas.0903446106; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IMAMOVIC E, 1998, BOSNIA HERZEGOVINA O; JANKOVIC I, 2012, PALEOANTHROPOLOGY, P87, DOI DOI 10.4207/PA.2012.ART72; Jeran N, 2009, COLLEGIUM ANTROPOL, V33, P1323; Karavanic I, 1998, J HUM EVOL, V34, P223, DOI 10.1006/jhev.1997.0192; KARAVANIC I, 1995, J ANTHROPOL RES, V51, P9, DOI 10.1086/jar.51.1.3630370; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Malcolm N, 1998, KOSOVO SHORT HIST, P14; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Marjanovic D, 2005, ANN HUM GENET, V69, P757, DOI 10.1111/j.1529-8817.2005.00190.x; Markotic V, 1964, ARCHEOLOGY, P20; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Mellars P, 2006, EVOL ANTHROPOL, V15, P167, DOI 10.1002/evan.20103; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morley MW, 2011, QUATERNARY RES, V75, P683, DOI 10.1016/j.yqres.2011.02.005; Murphey R, 1999, OTTOMAN WARFARE 1500, P1; Paschou P, 2014, P NATL ACAD SCI USA, V111, P9211, DOI 10.1073/pnas.1320811111; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pereira L, 2004, INT CONGR SER, V1261, P416, DOI 10.1016/S0531-5131(03)01651-0; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Perle C., 2000, HUNTERS GOLDEN AGE M, P375; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Primorac D, 2011, CROAT MED J, V52, P225, DOI 10.3325/cmj.2011.52.225; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Saric J, 2009, PALEOLITHIC MESOLITH, VLVIII, P9; SAVLI J, 1996, VENETI 1 BUILDERS EU; Schevill F, 1922, HIST BALKAN PENINSUL, P59; SEDOV VV, 1979, ORIGIN EARLY HIST SL; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Stavros L, 2000, BALKANS 1453, P5; Stipicevic A, 1999, QUESTION ILLYRIAN AL; Tolk HV, 2000, COLLEGIUM ANTROPOL, V24, P267; Tolk HV, 2001, EUR J HUM GENET, V9, P717, DOI 10.1038/sj.ejhg.5200709; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varzari A, 2012, AM J HUM BIOL, V21, P326; Wachtel A.B., 2008, BALKANS WORLD HIST, P51; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkes John, 1992, THE ILLYRIANS; Yunusbayev B, 2014, COLD SPRING HARBOR L	68	37	37	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105090	10.1371/journal.pone.0105090	http://dx.doi.org/10.1371/journal.pone.0105090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148043	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600031
J	Sutliff, RL; Walp, ER; Kim, YH; Walker, LA; El-Ali, AM; Ma, J; Bonsall, R; Ramosevac, S; Eaton, DC; Verlander, JW; Hansen, L; Gleason, RL; Pham, TD; Hong, S; Pech, V; Wall, SM				Sutliff, Roy L.; Walp, Erik R.; Kim, Young Hee; Walker, Lori A.; El-Ali, Alexander M.; Ma, Jing; Bonsall, Robert; Ramosevac, Semra; Eaton, Douglas C.; Verlander, Jill W.; Hansen, Laura; Gleason, Rudolph L., Jr.; Pham, Truyen D.; Hong, Seongun; Pech, Vladimir; Wall, Susan M.			Contractile Force Is Enhanced in Aortas from Pendrin Null Mice Due to Stimulation of Angiotensin II-Dependent Signaling	PLOS ONE			English	Article							SMOOTH-MUSCLE; BLOOD-PRESSURE; PSYCHOPHYSIOLOGICAL INVESTIGATIONS; VASCULAR REACTIVITY; MYOCARDIAL-ISCHEMIA; ISOMETRIC FORCE; HEAVY-CHAIN; MOUSE; PROTEIN; MYOSIN	Pendrin is a Cl-/HCO3- exchanger expressed in the apical regions of renal intercalated cells. Following pendrin gene ablation, blood pressure falls, in part, from reduced renal NaCl absorption. We asked if pendrin is expressed in vascular tissue and if the lower blood pressure observed in pendrin null mice is accompanied by reduced vascular reactivity. Thus, the contractile responses to KCl and phenylephrine (PE) were examined in isometrically mounted thoracic aortas from wild-type and pendrin null mice. Although pendrin expression was not detected in the aorta, pendrin gene ablation changed contractile protein abundance and increased the maximal contractile response to PE when normalized to cross sectional area (CSA). However, the contractile sensitivity to this agent was unchanged. The increase in contractile force/cross sectional area observed in pendrin null mice was due to reduced cross sectional area of the aorta and not from increased contractile force per vessel. The pendrin-dependent increase in maximal contractile response was endothelium- and nitric oxide-independent and did not occur from changes in Ca2+ sensitivity or chronic changes in catecholamine production. However, application of 100 nM angiotensin II increased force/CSA more in aortas from pendrin null than from wild type mice. Moreover, angiotensin type 1 receptor inhibitor (candesartan) treatment in vivo eliminated the pendrin-dependent changes contractile protein abundance and changes in the contractile force/cross sectional area in response to PE. In conclusion, pendrin gene ablation increases aorta contractile force per cross sectional area in response to angiotensin II and PE due to stimulation of angiotensin type 1 receptor-dependent signaling. The angiotensin type 1 receptor-dependent increase in vascular reactivity may mitigate the fall in blood pressure observed with pendrin gene ablation.	[Sutliff, Roy L.; Walp, Erik R.; El-Ali, Alexander M.; Ma, Jing] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; [Sutliff, Roy L.; Walp, Erik R.; Kim, Young Hee; El-Ali, Alexander M.; Ma, Jing; Pham, Truyen D.; Hong, Seongun; Pech, Vladimir; Wall, Susan M.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Walker, Lori A.] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO USA; [Walker, Lori A.] Univ Colorado, Hlth Sci Ctr, Dept Cardiol, Aurora, CO USA; [Bonsall, Robert] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Ramosevac, Semra; Wall, Susan M.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Verlander, Jill W.] Univ Florida, Dept Med, Gainesville, FL USA; [Hansen, Laura; Gleason, Rudolph L., Jr.] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Emory University; Emory University; State University System of Florida; University of Florida; University System of Georgia; Georgia Institute of Technology	Wall, SM (corresponding author), Emory Univ, Dept Med, Atlanta, GA 30322 USA.	smwall@emory.edu	Walker, Lori/J-7098-2013; Verlander, Jill/I-5991-2015	Walker, Lori/0000-0003-2556-8076; Pech, Vladimir/0000-0002-1994-4277; Hansen, Laura/0000-0002-3936-9476	National Institute of Diabetes, Digestive and Kidney Diseases [46493, 37963]; National Heart, Lung and Blood Institute [070892]	National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institute of Diabetes, Digestive and Kidney Diseases grants 46493 (to S. M. Wall); 37963 (to D. C. Eaton); and National Heart, Lung and Blood Institute grant 070892 (to R. L. Sutliff). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BRUNER CA, 1992, HYPERTENSION, V20, P59, DOI 10.1161/01.HYP.20.1.59; Chamiot-Clerc P, 2001, HYPERTENSION, V37, P313, DOI 10.1161/01.HYP.37.2.313; Chipperfield AR, 2000, PROG BIOPHYS MOL BIO, V74, P175, DOI 10.1016/S0079-6107(00)00024-9; Eddinger TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC493, DOI 10.1152/ajpcell.00131.2007; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Goldberg AD, 1996, CIRCULATION, V94, P2402, DOI 10.1161/01.CIR.94.10.2402; GRIFFIN SA, 1991, HYPERTENSION, V17, P626, DOI 10.1161/01.HYP.17.5.626; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; IKEBE M, 1991, J BIOL CHEM, V266, P7030; Kaufmann PG, 1998, PSYCHOSOM MED, V60, P56, DOI 10.1097/00006842-199801000-00014; KILTS CD, 1984, J NEUROSCI METH, V11, P257, DOI 10.1016/0165-0270(84)90088-8; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Kim YH, 2007, AM J PHYSIOL-RENAL, V293, pF1314, DOI 10.1152/ajprenal.00155.2007; Kim YH, 2009, AM J PHYSIOL-RENAL, V297, pF1069, DOI 10.1152/ajprenal.90581.2008; Knauf F, 2001, P NATL ACAD SCI USA, V98, P9425, DOI 10.1073/pnas.141241098; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Lalli J, 1997, CIRC RES, V80, P506, DOI 10.1161/01.RES.80.4.506; LONGHURST PA, 1988, HYPERTENSION, V12, P133, DOI 10.1161/01.HYP.12.2.133; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; MAZE M, 1985, LIFE SCI, V37, P1571, DOI 10.1016/0024-3205(85)90475-8; MCMAHON EG, 1986, AM J PHYSIOL, V250, pC468, DOI 10.1152/ajpcell.1986.250.3.C468; MCMAHON EG, 1985, CIRC RES, V56, P427, DOI 10.1161/01.RES.56.3.427; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Pech V, 2010, J AM SOC NEPHROL, V21, P1928, DOI 10.1681/ASN.2009121257; Rajagopalan S, 1997, HYPERTENSION, V30, P29, DOI 10.1161/01.HYP.30.1.29; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Russell A, 2000, J PHARMACOL EXP THER, V294, P598; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Simon G, 2001, HYPERTENSION, V37, P255, DOI 10.1161/01.HYP.37.2.255; Stapleton Phoebe A, 2008, Pathophysiology, V15, P79, DOI 10.1016/j.pathophys.2008.04.007; Sutliff RL, 1999, ENDOCRINOLOGY, V140, P2077, DOI 10.1210/en.140.5.2077; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Tanaka M, 1999, BIOCHEM BIOPH RES CO, V258, P194, DOI 10.1006/bbrc.1999.0500; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; TURLA MB, 1991, CIRC RES, V68, P288, DOI 10.1161/01.RES.68.1.288; Verlander JW, 2006, AM J PHYSIOL-RENAL, V291, pF833, DOI 10.1152/ajprenal.00474.2005; Verlander JW, 2011, AM J PHYSIOL-RENAL, V301, pF1314, DOI 10.1152/ajprenal.00114.2011; Verlander JW, 2003, HYPERTENSION, V42, P356, DOI 10.1161/01.HYP.0000088321.67254.B7; Walker LA, 2001, J BIOL CHEM, V276, P24519, DOI 10.1074/jbc.M103560200; Wall SM, 2004, HYPERTENSION, V44, P982, DOI 10.1161/01.HYP.0000145863.96091.89; Wall SM, 2006, AM J PHYSIOL-RENAL, V290, pF409, DOI 10.1152/ajprenal.00309.2005; Wall SM, 2003, AM J PHYSIOL-RENAL, V284, pF229, DOI 10.1152/ajprenal.00147.2002; Wang D, 2006, J VASC RES, V43, P109, DOI 10.1159/000089969; Zhao GS, 2001, ENDOCRINOLOGY, V142, P623, DOI 10.1210/en.142.2.623; Zhou YB, 2003, AM J PHYSIOL-HEART C, V285, pH2797, DOI 10.1152/ajpheart.00466.2003	46	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105101	10.1371/journal.pone.0105101	http://dx.doi.org/10.1371/journal.pone.0105101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148130	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600032
J	Luo, YH; Ouyang, PB; Tian, J; Guo, XJ; Duan, XC				Luo, Yong-Heng; Ouyang, Ping-Bo; Tian, Jiao; Guo, Xiao-Jian; Duan, Xuan-Chu			Rosiglitazone Inhibits TGF-beta 1 Induced Activation of Human Tenon Fibroblasts via p38 Signal Pathway	PLOS ONE			English	Article							INDUCED MYOFIBROBLAST TRANSDIFFERENTIATION; POLYCYSTIC KIDNEY-DISEASE; HEPATIC STELLATE CELLS; TGF-BETA; KINASE INHIBITORS; GROWTH-FACTOR; FIBROSIS; RATS; MICE	Purpose: Transdifferentiation of human Tenon fibroblasts to myofibroblasts and subsequent deposition of extracellular matrix is a key step in the scarring after glaucoma filtration surgery. The p38 signaling pathway plays an important role in cell proliferation and differentiation, and its upstream regulators and downstream molecules are widely distributed in the eye. We aimed to investigate the role of p38 in the activation of Tenon fibroblasts and that of the anti-fibrotic mechanism of rosiglitazone in the modulation of the p38 signaling pathway. Methods: Cultured Tenon fibroblasts were stimulated with transforming growth factor (TGF)-beta 1. Activation of p38 was examined by western blot analysis. Rosiglitazone and blocking of the p38 signaling pathway by SB203580 were used to antagonize stimulation by TGF-beta 1. Fibroblast motility was examined by wound closure assay; alpha-smooth muscle actin, connective tissue growth factor, and collagen type I were determined by qPCR and western blot. Expression and localization of alpha-smooth muscle actin were determined by immunofluorescence staining. Results: Phosphorylated p38 was upregulated in fibroblasts stimulated with TGF-beta 1, and this effect was substantially inhibited by rosiglitazone. Proliferation and migration of fibroblasts were suppressed by rosiglitazone and SB203580. Expression of alpha-smooth muscle actin, connective tissue growth factor, and collagen type I were decreased at the mRNA and protein levels by rosiglitazone and SB203580. However, the inhibitory effect of SB203580 on transcription and protein expression was weaker than that of rosiglitazone. Similar phenomena were found on immunofluorescence microscopy of alpha-smooth muscle actin. Conclusions: The p38 signaling pathway mediates the TGF-beta 1-induced transdifferentiation of human Tenon fibroblasts to myofibroblasts. Rosiglitazone can exert anti-fibrotic activity by interfering with the TGF-beta/p38 signaling pathway and might be useful for modulating scar formation after glaucoma filtration surgery.	[Luo, Yong-Heng; Ouyang, Ping-Bo; Tian, Jiao; Guo, Xiao-Jian; Duan, Xuan-Chu] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China	Central South University	Duan, XC (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China.	duanxchu@126.com			National Natural Science Foundation of China [81170843, 81370913]; Science and Technology Program of Hunan Province [2011WK3044]; Postdoctoral Fund of central south university [140204]; Doctoral Site Fund of Ministry of Education of China [20120162110062]; Hunan Provincial Development and Reform Project Infrastructure Investment Plan (Hunan Province) [High-Tech 1060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Hunan Province; Postdoctoral Fund of central south university; Doctoral Site Fund of Ministry of Education of China(Ministry of Education, China); Hunan Provincial Development and Reform Project Infrastructure Investment Plan (Hunan Province)	Supported by National Natural Science Foundation of China Grant 81170843, 81370913, Hunan Provincial Development and Reform Project 2010 Infrastructure Investment Plan (Hunan Province, High-Tech 1060, 2010), 2011 Science and Technology Program of Hunan Province Grant 2011WK3044, Postdoctoral Fund of central south university 140204, Doctoral Site Fund of Ministry of Education of China 20120162110062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell R, 2008, BIOORG MED CHEM LETT, V18, P4428, DOI 10.1016/j.bmcl.2008.06.048; Asano T, 2012, J MED CHEM, V55, P7772, DOI 10.1021/jm3008008; Borkham-Kamphorst E, 2007, J HEPATOL, V46, P1064, DOI 10.1016/j.jhep.2007.01.029; Chang Y, 2009, J INT MED RES, V37, P727, DOI 10.1177/147323000903700316; Dai B, 2010, CLIN SCI, V119, P323, DOI 10.1042/CS20100113; Fan F, 2012, GRAEF ARCH CLIN EXP, V250, P1213, DOI 10.1007/s00417-011-1903-6; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kiyono T, 2007, EXPERT OPIN THER TAR, V11, P1623, DOI 10.1517/14728222.11.12.1623; Lama PJ, 2003, SURV OPHTHALMOL, V48, P314, DOI 10.1016/S0039-6257(03)00038-9; Laufer SA, 2008, J MED CHEM, V51, P2580, DOI 10.1021/jm701343f; Mac Ivan, 2003, Curr Opin Ophthalmol, V14, P91, DOI 10.1097/00055735-200304000-00007; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Nakamoto M, 2008, HYPERTENS RES, V31, P353, DOI 10.1291/hypres.31.353; Robertson JV, 2010, INVEST OPHTH VIS SCI, V51, P308, DOI 10.1167/iovs.09-3380; Saika Shizuya, 2009, Front Biosci (Schol Ed), V1, P376, DOI 10.2741/s32; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wrobleski ST, 2008, BIOORG MED CHEM LETT, V18, P2739, DOI 10.1016/j.bmcl.2008.02.067; Yamanaka O, 2007, MOL VIS, V13, P1730; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoshihara D, 2011, AM J PHYSIOL-RENAL, V300, pF465, DOI 10.1152/ajprenal.00460.2010; Yu J, 2010, INT J BIOCHEM CELL B, V42, P948, DOI 10.1016/j.biocel.2010.02.006; Zhao CY, 2006, BIOCHEM BIOPH RES CO, V350, P385, DOI 10.1016/j.bbrc.2006.09.069; Zhuo WL, 2008, BIOCHEM BIOPH RES CO, V369, P1098, DOI 10.1016/j.bbrc.2008.02.143	26	8	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105796	10.1371/journal.pone.0105796	http://dx.doi.org/10.1371/journal.pone.0105796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144187	Green Submitted, gold, Green Published			2022-12-27	WOS:000341106100121
J	Ma, N; Xu, ZQ; Mo, DP; Gao, F; Gao, K; Sun, X; Xu, XT; Liu, L; Song, LG; Wang, TJ; Zhao, XQ; Wang, YL; Wang, YJ; Miao, ZR				Ma, Ning; Xu, Ziqi; Mo, Dapeng; Gao, Feng; Gao, Kun; Sun, Xuan; Xu, Xiaotong; Liu, Lian; Song, Ligang; Wang, Tiejun; Zhao, Xingquan; Wang, Yilong; Wang, Yongjun; Miao, Zhongrong			Safety of Low-Dose Aspirin in Endovascular Treatment for Intracranial Atherosclerotic Stenosis	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ANGIOPLASTY; STROKE; CLOPIDOGREL; MANAGEMENT; SAMMPRIS; STANDARD; EVENTS	Objectives: To evaluate the safety of low-dose aspirin plus clopidogrel versus high-dose aspirin plus clopidogrel in prevention of vascular risk within 90 days of duration of dual antiplatelet therapy in patients treated with intracranial endovascular treatment. Methods: From January 2012 to December 2013, this prospective and observational study enrolled 370 patients with symptomatic intracranial atherosclerotic stenosis of >= 70% with poor collateral undergoing intracranial endovascular treatment. Antiplatelet therapy consists of aspirin, at a low-dose of 100 mg or high-dose of 300 mg daily; clopidogrel, at a dose of 75 mg daily for 5 days before endovascular treatment. The dual antiplatelet therapy continued for 90 days after intervention. The study endpoints include acute thrombosis, subacute thrombosis, stroke or death within 90 days after intervention. Results: Two hundred and seventy three patients received low-dose aspirin plus clopidogrel and 97 patients received high-dose aspirin plus clopidogrel before intracranial endovascular treatment. Within 90 days after intervention, there were 4 patients (1.5%) with acute thrombosis, 5 patients (1.8%) with subacute thrombosis, 17 patients (6.2%) with stroke, and 2 death (0.7%) in low-dose aspirin group, compared with no patient (0%) with acute thrombosis, 2 patient (2.1%) with subacute thrombosis, 6 patients (6.2%) with stroke, and 2 death (2.1%) in high-dose aspirin group, and there were no significant difference in all study endpoints between two groups. Conclusion: Low-dose aspirin plus clopidogrel is comparative in safety with high-dose aspirin plus clopidogrel within 90 days of duration of dual antiplatelet therapy in patients treated with intracranial endovascular treatment.	[Ma, Ning; Mo, Dapeng; Gao, Feng; Gao, Kun; Sun, Xuan; Xu, Xiaotong; Liu, Lian; Song, Ligang; Miao, Zhongrong] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Beijing, Peoples R China; [Zhao, Xingquan; Wang, Yilong; Wang, Yongjun] Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing, Peoples R China; [Xu, Ziqi] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Tiejun] Daxing Dist Hosp Beijing, Dept Neurol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Zhejiang University	Miao, ZR (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Beijing, Peoples R China.	zhongrongm@163.com			National Natural Science Foundation of China [81371290]; Beijing High-level Personnel Funds [2013-2-19]; Capital Medical University [13JL40]; Beijing Municipal Science and Technology Commission [D111107003111007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing High-level Personnel Funds; Capital Medical University; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	The following investigators have financial disclosure: Prof Z-R Miao - Contract grant sponsor from the National Natural Science Foundation of China (Contract grant number: 81371290) and from the Beijing High-level Personnel Funds (Contract grant number: 2013-2-19). Prof Ning Ma - Contract grant sponsor from the Clinical and Basic Medical Cooperation Project of Capital Medical University (Contract grant number: 13JL40). Prof X-Q Zhao - Contract grant sponsor from the Beijing Municipal Science and Technology Commission (Contract grant number: D111107003111007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chimowitz MI, 2013, STROKE, V44, P2664, DOI 10.1161/STROKEAHA.113.001290; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Derdeyn CP, 2013, NEUROSURGERY, V72, P777, DOI 10.1227/NEU.0b013e318286fdc8; Fiorella D, 2012, STROKE, V43, P2682, DOI 10.1161/STROKEAHA.112.661173; [高培毅 Gao Peiyi], 2003, [中华放射学杂志, Chinese Journal of Radiology], V37, P882; Higashida Randall, 2003, J Vasc Interv Radiol, V14, pS493; Hussain MS, 2012, J NEUROINTERV SURG, V4, P397, DOI 10.1136/neurintsurg-2012-010405; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Lutsep HL, 2004, STROKE, V35, P1388, DOI 10.1161/01.STR.0000128708.86762.d6; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Miao ZR, 2015, J NEUROINTERV SURG, V7, P331, DOI 10.1136/neurintsurg-2014-011109; Mori T, 1998, AM J NEURORADIOL, V19, P1525; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Riedel CH, 2009, STROKE, V40, P1310, DOI 10.1161/STROKEAHA.108.531400; Sanchez-Arjona MB, 2007, AM J NEURORADIOL, V28, P640; Schumacher HC, 2009, STROKE, V40, pE348, DOI 10.1161/STROKEAHA.108.527580; Topol EJ, 2003, CIRCULATION, V108, P399, DOI 10.1161/01.CIR.0000084501.48570.F6; Wada Tadashi, 2013, ISRN Cardiol, V2013, P518968, DOI 10.1155/2013/518968; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Yu SCH, 2013, HONG KONG MED J, V19, P69; Yu SCH, 2014, J NEUROINTERV SURG, V6, P212, DOI 10.1136/neurintsurg-2012-010593; Zaidat OO, 2014, J NEUROINTERV SURG, V6, P225, DOI 10.1136/neurintsurg-2013-010667	24	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105252	10.1371/journal.pone.0105252	http://dx.doi.org/10.1371/journal.pone.0105252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144449	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100045
J	Wang, YJ; Wang, H; Xu, KH; Ni, PX; Zhang, H; Ma, JM; Yang, HM; Xu, F				Wang, Yajing; Wang, Hui; Xu, Kunhan; Ni, Peixiang; Zhang, Huan; Ma, Jinmin; Yang, Huanming; Xu, Feng			A Survey of Overlooked Viral Infections in Biological Experiment Systems	PLOS ONE			English	Article							TUNGRO BACILLIFORM VIRUS; SHORT INTERFERING RNAS; METAGENOMICS; DISCOVERY; SEQUENCE; IMMUNITY; GENOME; ALIGNMENT; BACTERIA; CLONING	It is commonly accepted that there are many unknown viruses on the planet. For the known viruses, do we know their prevalence, even in our experimental systems? Here we report a virus survey using recently published small (s)RNA sequencing datasets. The sRNA reads were assembled and contigs were screened for virus homologues against the NCBI nucleotide (nt) database using the BLASTn program. To our surprise, approximately 30% (28 out of 94) of publications had highly scored viral sequences in their datasets. Among them, only two publications reported virus infections. Though viral vectors were used in some of the publications, virus sequences without any identifiable source appeared in more than 20 publications. By determining the distributions of viral reads and the antiviral RNA interference (RNAi) pathways using the sRNA profiles, we showed evidence that many of the viruses identified were indeed infecting and generated host RNAi responses. As virus infections affect many aspects of host molecular biology and metabolism, the presence and impact of viruses needs to be actively investigated in experimental systems.	[Wang, Yajing] Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin, Peoples R China; [Wang, Yajing; Zhang, Huan; Xu, Feng] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wang, Yajing; Zhang, Huan; Xu, Feng] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Wang, Hui] NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Wang, Hui; Ma, Jinmin; Yang, Huanming] Beijing Genome Inst, Shenzhen, Peoples R China; [Wang, Hui; Yang, Huanming] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Ni, Peixiang] BGI Tianjin, Airport Econ Area, Tianjin, Peoples R China; [Xu, Kunhan; Zhang, Huan; Xu, Feng] Tianjin Int Joint Acad Biotechnol & Med, Tianjin, Peoples R China; [Yang, Huanming] King Abdulaziz Univ, Prince Aljawhra Ctr Excellence Res Hereditary Dis, Jeddah 21413, Saudi Arabia; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China	Tianjin University Science & Technology; Nankai University; Nankai University; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Beijing Genomics Institute (BGI); University of Oxford; Beijing Genomics Institute (BGI); Tianjin International Joint Academy of Biomedicine; King Abdulaziz University	Wang, H (corresponding author), NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England.	huw@ceh.ac.uk; xufeng@nankai.edu.cn	Ma, Jinmin/L-8470-2019; Wang, Hui/E-6764-2012	Ma, Jinmin/0000-0002-7993-7001; 	Ministry of Science and Technology of the People's Republic of China [2011DFA33220]; Tianjin Municipal Science and Technology Commission [12ZCZDSY14500, 13JCYBJC20900]; NERC [NE/I000593/1, NE/L012863/1]; Natural Environment Research Council [NE/I000593/1, NE/L012863/1] Funding Source: researchfish	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Tianjin Municipal Science and Technology Commission; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Ministry of Science and Technology of the People's Republic of China Grant 2011DFA33220 (http://www.most.gov.cn/eng/), Tianjin Municipal Science and Technology Commission Grants 12ZCZDSY14500 and 13JCYBJC20900 (http://www.tstc.gov.cn/) and NERC Grant NE/I000593/1 and NE/L012863/1 (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamlan FS, 2013, J MICROBIOL METH, V92, P183, DOI 10.1016/j.mimet.2012.11.016; Alquezar-Planas DE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02468; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bibby K, 2013, TRENDS BIOTECHNOL, V31, P11, DOI 10.1016/j.tibtech.2013.01.016; Cheung AK, 2013, ARCH VIROL, V158, P2157, DOI 10.1007/s00705-013-1701-z; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2011, CURR OPIN VIROL, V1, P533, DOI 10.1016/j.coviro.2011.10.028; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Fancello L, 2012, VIROLOGY, V434, P162, DOI 10.1016/j.virol.2012.09.025; HAY JM, 1991, NUCLEIC ACIDS RES, V19, P2615, DOI 10.1093/nar/19.10.2615; Ho T, 2006, J VIROL METHODS, V136, P217, DOI 10.1016/j.jviromet.2006.05.016; Ho Thien X., 2008, V451, P229, DOI 10.1007/978-1-59745-102-4_16; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Kim Min-Soo, 2013, Genomics & Informatics, V11, P121, DOI 10.5808/GI.2013.11.3.121; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kunii M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-80; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Masembe C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-218; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Pallett DW, 2010, J VIROL METHODS, V168, P223, DOI 10.1016/j.jviromet.2010.06.003; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Van Borm S, 2013, VIRUS RES, V171, P186, DOI 10.1016/j.virusres.2012.11.017; van Rij RP, 2009, TRENDS MICROBIOL, V17, P163, DOI 10.1016/j.tim.2009.01.003; Walker A, 2010, NAT REV MICROBIOL, V8, P841, DOI 10.1038/nrmicro2476; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Willner D, 2013, BIOESSAYS, V35, P436, DOI 10.1002/bies.201200174; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105348	10.1371/journal.pone.0105348	http://dx.doi.org/10.1371/journal.pone.0105348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144530	Green Published, Green Accepted, gold			2022-12-27	WOS:000341106100056
J	Ye, FP; Zheng, Y; Wang, X; Tan, XL; Zhang, T; Xin, WW; Wang, J; Huang, Y; Fan, QS; Wang, JL				Ye, Fengping; Zheng, Ying; Wang, Xi; Tan, Xiaolong; Zhang, Tao; Xin, Wenwen; Wang, Jie; Huang, Yong; Fan, Quanshui; Wang, Jinglin			Recognition of Bungarus multicinctus Venom by a DNA Aptamer against beta-Bungarotoxin	PLOS ONE			English	Article							IN-VITRO SELECTION; RNA MOLECULES; SNAKE-VENOMS; IDENTIFICATION; BINDING; NEUROTOXIN; EVOLUTION; LIGANDS; KRAIT; NEED	Antibody-based technology is the main method for diagnosis and treatment of snake bite envenoming currently. However, the development of an antibody, polyclonal or monoclonal, is a complicated and costly procedure. Aptamers are single stranded oligonucleotides that recognize specific targets such as proteins and have shown great potential over the years as diagnostic and therapeutic agents. In contrast to antibodies, aptamers can be selected in vitro without immunization of animals, and synthesized chemically with extreme accuracy, low cost and high degree of purity. In this study we firstly report on the identification of DNA aptamers that bind to beta-bungarotoxin (beta-BuTx), a neurotoxin from the venom of Bungarus multicinctus. A plate-SELEX method was used for the selection of beta-BuTx specific aptamers. After 10 rounds of selection, four aptamer candidates were obtained, with the dissociation constant ranged from 65.9 nM to 995 nM measured by fluorescence spectroscopy. Competitive binding assays using both the fluorescently labeled and unlabeled aptamers revealed that the four aptamers bound to the same binding site of beta-BuTx. The best binder, beta B-1, bound specifically to beta-BuTx, but not to BSA, casein or alpha-Bungarotoxin. Moreover, electrophoretic mobility shift assay and enzyme-linked aptamer assay demonstrated that beta B-1 could discriminate B. multicinctus venom from other snake venoms tested. The results suggest that aptamer beta B-1 can serve as a useful tool for the design and development of drugs and diagnostic tests for beta-BuTx poisoning and B. multicinctus bites.	[Ye, Fengping; Zhang, Tao; Xin, Wenwen; Wang, Jinglin] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Ye, Fengping; Zheng, Ying; Wang, Xi; Tan, Xiaolong; Wang, Jie; Huang, Yong; Fan, Quanshui] Chengdu Mil Reg Ctr Dis Control & Prevent, Inst Mil Med, Kunming, Peoples R China		Fan, QS (corresponding author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	fqs168@126.com; wangjl6481@hotmail.com			Medical Science Foundation of Chengdu Military Region [C14048]	Medical Science Foundation of Chengdu Military Region	This work was supported by the Medical Science Foundation of Chengdu Military Region (C14048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Chan JCN, 1995, J TROP MED HYG, V98, P457; Chang CC, 1999, J BIOMED SCI, V6, P368, DOI 10.1159/000025412; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Chu Nai-Shin, 2005, J Hist Neurosci, V14, P138, DOI 10.1080/096470490881770; CHUANG LY, 1989, TOXICON, V27, P211, DOI 10.1016/0041-0101(89)90134-7; Cruz-Aguado JA, 2008, J AGR FOOD CHEM, V56, P10456, DOI 10.1021/jf801957h; de Roodt AR, 2003, COMP BIOCHEM PHYS C, V135, P469, DOI 10.1016/S1532-0456(03)00169-8; Dong LV, 2003, J IMMUNOL METHODS, V282, P13, DOI 10.1016/S0022-1759(03)00277-1; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gao JF, 2013, J IMMUNOL METHODS, V387, P211, DOI 10.1016/j.jim.2012.10.016; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; Ha TH, 2009, SE ASIAN J TROP MED, V40, P518; Hesselberth JR, 2000, J BIOL CHEM, V275, P4937, DOI 10.1074/jbc.275.7.4937; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hong P, 2012, SENSORS-BASEL, V12, P1181, DOI 10.3390/s120201181; Hu P, 2013, J AGR FOOD CHEM, V61, P3533, DOI 10.1021/jf400880r; Isbister GK, 2010, VACCINE, V28, P798, DOI 10.1016/j.vaccine.2009.10.055; Joeng CB, 2009, BIOORGAN MED CHEM, V17, P5380, DOI 10.1016/j.bmc.2009.06.044; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; KELLY RB, 1974, J NEUROBIOL, V5, P135, DOI 10.1002/neu.480050205; KONDO K, 1982, J BIOCHEM, V91, P1531, DOI 10.1093/oxfordjournals.jbchem.a133844; KWONG PD, 1995, STRUCTURE, V3, P1109, DOI 10.1016/S0969-2126(01)00246-5; Lalloo DG, 2003, J TOXICOL-CLIN TOXIC, V41, P277, DOI 10.1081/CLT-120021113; Lauridsen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041702; Lauridsen LH, 2012, NUCLEIC ACID THER, V22, P371, DOI 10.1089/nat.2012.0377; Levesque D, 2007, BIOCHEM J, V403, P129, DOI 10.1042/BJ20061216; Li W, 2007, ANALYST, V132, P107, DOI 10.1039/b614138b; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857; McKeague M, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/748913; Mendonsa SD, 2004, J AM CHEM SOC, V126, P20, DOI 10.1021/ja037832s; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Pe T, 1997, T ROY SOC TROP MED H, V91, P686, DOI 10.1016/S0035-9203(97)90524-1; Qin G., 1998, CHINA POISONOUS SNAK, P708; RYAN PC, 1991, J MOL BIOL, V221, P1257, DOI 10.1016/0022-2836(91)80125-E; Selvanayagam ZE, 1999, TOXICON, V37, P565, DOI 10.1016/S0041-0101(98)00203-7; SITTENFELD A, 1991, TOXICON, V29, P1213, DOI 10.1016/0041-0101(91)90194-V; STRONG PN, 1976, P NATL ACAD SCI USA, V73, P178, DOI 10.1073/pnas.73.1.178; Svobodova M, 2012, ANAL BIOANAL CHEM, V404, P835, DOI 10.1007/s00216-012-6183-4; Tan WH, 2013, CHEM REV, V113, P2842, DOI 10.1021/cr300468w; Tok JBH, 2008, CHEM COMMUN, P1883, DOI 10.1039/b717936g; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ueno E, 1996, TOXICON, V34, P1219, DOI 10.1016/S0041-0101(96)00113-4; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; World Health Organization, 2010, WHO GUIDELINES PRODU; Yan H, 2007, MOL CELL BIOCHEM, V306, P71, DOI 10.1007/s11010-007-9555-x	49	18	19	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105404	10.1371/journal.pone.0105404	http://dx.doi.org/10.1371/journal.pone.0105404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144237	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100062
J	Acharya, A; Vaniawala, S; Shah, P; Misra, RN; Wani, M; Mukhopadhyaya, PN				Acharya, Arpan; Vaniawala, Salil; Shah, Parth; Misra, Rabindra Nath; Wani, Minal; Mukhopadhyaya, Pratap N.			Development, Validation and Clinical Evaluation of a Low Cost In-House HIV-1 Drug Resistance Genotyping Assay for Indian Patients	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MUTATIONS; FAILURE; RECOMMENDATIONS; PERFORMANCE; PREVALENCE; DIAGNOSIS	Human Immunodeficiency Virus-1 (HIV-1) drug resistance genotyping assay is a part of clinical management of HIV-1 positive individuals under treatment with highly active antiretroviral therapy (HAART). Routine monitoring of drug resistance mutations in resource limited settings like India is not possible due to high cost of commercial drug resistance assays. In this study we developed an in-house, cost effective HIV-1 drug resistance genotyping assay for Indian patients and validated it against the US-FDA-approved ViroSeq HIV-1 drug resistance testing system. A reference panel of 20 clinical samples was used to develop and validate the assay against ViroSeq HIV-1 drug resistance testing system which was subsequently used to genotype a clinical panel of 225 samples. The Stanford HIV database was used to identify drug resistant mutations. The analytical sensitivity of the assay was 1000 HIV-1 RNA copies/ml of plasma sample while precision and reproducibility was 99.68 +/- 0.16% and 99.76 +/- 0.18% respectively. One hundred and one drug resistant mutations were detected by the in-house assay compared to 104 by ViroSeq system in the reference panel. The assay had 91.55% success rate in genotyping the clinical panel samples and was able to detect drug resistant mutations related to nucleoside reverse transcriptase inhibitor (NRTI), non-nucleoside reverse-transcriptase inhibitor (NNRTI) as well as protease inhibitor (PI) classes of antiretroviral drugs. It was found to be around 71.9% more cost effective compared to ViroSeq genotyping system. This evaluation of the assay on the clinical panel demonstrates its potential for monitoring clinical HIV-1 drug resistance mutations and population-based surveillance in resource limited settings like India.	[Acharya, Arpan; Wani, Minal] DY Patil Vidyapeeth, DY Patil Biotechnol & Bioinformat Inst, Dept Mol Biol, Pune, Maharashtra, India; [Vaniawala, Salil] SN Genelab, Dept Mol Diagnost, Surat, Gujarat, India; [Shah, Parth] Supratech Micropath Lab & Res Inst, Dept Mol Diagnost, Ahmadabad, Gujarat, India; [Misra, Rabindra Nath] DY Patil Vidyapeeth, Padmashree DY Patil Med Coll, Dept Microbiol, Pune, Maharashtra, India; [Misra, Rabindra Nath] DY Patil Vidyapeeth, Res Ctr, Pune, Maharashtra, India; [Mukhopadhyaya, Pratap N.] AISC, Interdisciplinary Sci Technol & Res Acad, Dept Microbiol, Pune, Maharashtra, India	Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Biotechnology & Bioinformatics Institute; Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Medical College, Hospital & Research Centre; Dr DY Patil Vidyapeeth Pune	Mukhopadhyaya, PN (corresponding author), AISC, Interdisciplinary Sci Technol & Res Acad, Dept Microbiol, Pune, Maharashtra, India.	pnm.istra@yahoo.com	Acharya, Arpan/AAH-5107-2019; Wani, Minal/Z-1791-2019	Wani, Minal/0000-0002-9695-0531; ACHARYA, ARPAN/0000-0003-2721-1062				Acharya A, 2013, CURR HIV RES, V11, P295, DOI 10.2174/1570162X113119990044; Aghokeng AF, 2011, J CLIN MICROBIOL, V49, P1635, DOI 10.1128/JCM.01478-10; Aitken SC, 2013, J CLIN MICROBIOL, V51, P1757, DOI 10.1128/JCM.00118-13; Aitken SC, 2012, J CLIN VIROL, V54, P21, DOI 10.1016/j.jcv.2012.01.010; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166; Bertognolio S, 2008, ANTIVIR THER, V13, P49; Chaturbhuj DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087441; Deshpande A, 2007, AIDS RES HUM RETROV, V23, P335, DOI 10.1089/aid.2006.0183; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Greengrass V., 2007, Journal of Chinese Clinical Medicine, V2, P469; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Korn K, 2009, J CLIN MICROBIOL, V47, P1238, DOI 10.1128/JCM.02204-08; Kumarasamy N, 2011, INDIAN J MED RES, V134, P787, DOI 10.4103/0971-5916.92626; Kumarasamy N, 2009, CLIN INFECT DIS, V49, P306, DOI 10.1086/600044; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Mehta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005819; National AIDS Control Programme, 2012, OP GUID ART SERV; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Parkin N, 2012, CLIN INFECT DIS, V54, pS273, DOI 10.1093/cid/cir982; Peeters M, 2003, AIDS, V17, P2547, DOI 10.1097/00002030-200312050-00002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saravanan S, 2009, J VIROL METHODS, V159, P211, DOI 10.1016/j.jviromet.2009.03.021; Sen S, 2007, AIDS RES HUM RETROV, V23, P1303, DOI 10.1089/aid.2007.0090; Shen CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025956; Sinha S, 2012, CURR HIV RES, V10, P532, DOI 10.2174/157016212802429785; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vidya M, 2009, ANTIVIR THER, V14, P1005, DOI 10.3851/IMP1411; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; WHO, 2009, 2009 HIV GEN ASS VAL; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105790	10.1371/journal.pone.0105790	http://dx.doi.org/10.1371/journal.pone.0105790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157501	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200065
J	Boeer, U; Buettner, FFR; Klingenberg, M; Antonopoulos, GC; Meyer, H; Haverich, A; Wilhelmi, M				Boeer, Ulrike; Buettner, Falk F. R.; Klingenberg, Melanie; Antonopoulos, Georgios C.; Meyer, Heiko; Haverich, Axel; Wilhelmi, Mathias			Immunogenicity of Intensively Decellularized Equine Carotid Arteries Is Conferred by the Extracellular Matrix Protein Collagen Type VI	PLOS ONE			English	Article							XENOGENEIC SCAFFOLD GENERATION; PEDIATRIC-PATIENTS; INDUCED ARTHRITIS; ANTIGEN REMOVAL; IMMUNE-RESPONSE; EARLY FAILURE; COMPONENTS; TISSUES	The limited biocompatibility of decellularized scaffolds is an ongoing challenge in tissue engineering. Here, we demonstrate the residual immunogenicity of an extensively decellularized equine carotid artery (dEAC(intens)) and identify the involved immunogenic components. EAC were submitted to an elaborated intensified decellularization protocol with SDS/sodium desoxycholate for 72 h using increased processing volumes (dEAC(intens)), and compared to dEAC(ord) prepared by an ordinary protocol (40 h, normal volumes). Matrix integrity was checked via correlative volumetric visualization which revealed only minor structural changes in the arterial wall. In dEAC(intens), a substantial depletion of cellular components was obvious for smooth muscle actin (100%), MHC I complexes (97.8%), alphaGal epitops (98.4% and 91.3%) and for DNA (final concentration of 0.34 +/- 0.16 ng/mg tissue). However, dEAC(intens) still evoked antibody formation in mice after immunization with dEAC(intens) extracts, although to a lower extent than dEAC(ord). Mouse plasma antibodies recognized a 140 kDa band which was revealed to contain collagen VI alpha1 and alpha2 chains via mass spectrometry of both 2D electrophoretically separated and immunoprecipitated proteins. Thus, even the complete removal of cellular proteins did not yield non-immunogenic dEAC as the extracellular matrix still conferred immunogenicity by collagen VI. However, as lower antibody levels were achieved by the intensified decellularization protocol, this seems to be a promising basis for further development.	[Boeer, Ulrike; Klingenberg, Melanie; Haverich, Axel; Wilhelmi, Mathias] GMP Model Lab Tissue Engn, Hannover, Germany; [Boeer, Ulrike; Klingenberg, Melanie; Meyer, Heiko; Haverich, Axel; Wilhelmi, Mathias] Hannover Med Sch, Div Cardiac Thoracic Transplantat & Vasc Surg, Hannover, Germany; [Buettner, Falk F. R.] Hannover Med Sch, Dept Cellular Chem, Hannover, Germany; [Antonopoulos, Georgios C.; Meyer, Heiko] Laser Zentrum Hannover EV, Biomed Opt Dept, Hannover, Germany	Hannover Medical School; Hannover Medical School	Boeer, U (corresponding author), GMP Model Lab Tissue Engn, Hannover, Germany.	boeer.ulrike@mh-hannover.de	Haverich, Axel/AAC-7552-2022		"Else Kroener-Fresenius foundation'', Germany [2012-A58]; Federal Ministry of Education and Research [13N12605]	"Else Kroener-Fresenius foundation'', Germany; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The work was funded by the "Else Kroener-Fresenius foundation'', Germany (project number 2012-A58). SLOT was funded by the Federal Ministry of Education and Research (project number 13N12605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Boer U, 2013, TISSUE ENG PT A, V19, P1829, DOI [10.1089/ten.tea.2012.0558, 10.1089/ten.TEA.2012.0558]; Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015; Buettner FFR, 2009, PROTEOMICS, V9, P2383, DOI 10.1002/pmic.200800439; CHUNG E, 1976, BIOCHEM BIOPH RES CO, V71, P1167, DOI 10.1016/0006-291X(76)90776-2; Cicha I, 2011, CARDIOVASC PATHOL, V20, P222, DOI 10.1016/j.carpath.2010.04.006; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Dingemans KP, 2000, ANAT REC, V258, P1; ENGEL J, 1985, ANN NY ACAD SCI, V460, P25, DOI 10.1111/j.1749-6632.1985.tb51154.x; Fitzgerald J, 2013, CONNECT TISSUE RES, V54, P345, DOI 10.3109/03008207.2013.822865; GAY S, 1988, ARCH DERMATOL RES, V280, P333, DOI 10.1007/BF00426610; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Koch C, 1996, APMIS, V104, P115, DOI 10.1111/j.1699-0463.1996.tb00696.x; Koenneker S, 2010, EUR J VASC ENDOVASC, V40, P810, DOI 10.1016/j.ejvs.2010.04.023; Lucchese Guglielmo, 2012, Front Biosci (Elite Ed), V4, P1843; Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Myers LK, 2004, AM J MED SCI, V327, P212, DOI 10.1097/00000441-200404000-00007; Myers LK, 2002, ARTHRITIS RHEUM-US, V46, P1086, DOI 10.1002/art.10163; Rabilloud T, 1999, METH MOL B, V112, P297; Ruffer A, 2010, EUR J CARDIO-THORAC, V38, P78, DOI 10.1016/j.ejcts.2010.01.044; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0; Takahashi H, 2013, ALLERGY; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028; Wong ML, 2013, ACTA BIOMATER, V9, P6492, DOI 10.1016/j.actbio.2012.12.034; Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099	31	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105964	10.1371/journal.pone.0105964	http://dx.doi.org/10.1371/journal.pone.0105964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157402	Green Submitted, gold, Green Published			2022-12-27	WOS:000341303200082
J	Nakajima, A; Negishi, N; Tsurui, H; Kadowaki-Ohtsuji, N; Maeda, K; Nanno, M; Yamaguchi, Y; Shimizu, N; Yagita, H; Okumura, K; Habu, S				Nakajima, Akihito; Negishi, Naoko; Tsurui, Hiromichi; Kadowaki-Ohtsuji, Naomi; Maeda, Keiko; Nanno, Masanobu; Yamaguchi, Yoshitaka; Shimizu, Nobuyoshi; Yagita, Hideo; Okumura, Ko; Habu, Sonoko			Commensal Bacteria Regulate Thymic Aire Expression	PLOS ONE			English	Article							EPITHELIAL-CELLS; T-CELLS; RECOGNITION; NOD1; DIFFERENTIATION; PEPTIDOGLYCAN; ESTABLISHMENT; MICROBIOTA; RECEPTORS	Commensal bacteria in gastrointestinal tracts are reported to function as an environmental factor to regulate intestinal inflammation and immune responses. However, it remains largely unknown whether such bacterial function exerts any effect on other immune organs distant from the intestine. In this study, the influence of commensal bacteria in the thymus, where T cell lineages develop into mature type to form proper repertoires, was investigated using germ-free (GF) mice and Nod1-deficient mice lacking an intracellular recognition receptor for certain bacterial components, in which a commensal bacterial effect is predicted to be less. In both mice, there was no significant difference in the numbers and subset ratios of thymocytes. Interestingly, however, autoimmune regulator (Aire) expression in thymic epithelial cells (TECs), main components of the thymic microenvironment, was decreased in comparison to specific pathogen-free (SPF) mice and Nod1 wild-type (WT) mice, respectively. In vitro analysis using a fetal thymus organ culture (FTOC) system showed that Aire expression in TECs was increased in the presence of a bacterial component or a bacterial product. These results suggest that through their products, commensal bacteria have the potential to have some effect on epithelial cells of the thymus in tissues distant from the intestine where they are originally harbored.	[Nakajima, Akihito; Negishi, Naoko; Yagita, Hideo; Okumura, Ko; Habu, Sonoko] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan; [Tsurui, Hiromichi; Kadowaki-Ohtsuji, Naomi] Juntendo Univ, Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; [Maeda, Keiko; Okumura, Ko] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 113, Japan; [Nanno, Masanobu] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 186, Japan; [Yamaguchi, Yoshitaka; Shimizu, Nobuyoshi] Keio Univ, Adv Res Ctr Genome Super Power, Tsukuba, Ibaraki, Japan	Juntendo University; Juntendo University; Juntendo University; Yakult Honsha Company, Limited; Keio University	Habu, S (corresponding author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan.	sonoko-h@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21390154, 23390260, 25860818]; Yakult -Bio-Science foundation; Grants-in-Aid for Scientific Research [25860818] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yakult -Bio-Science foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part a Grant-in-Aid for Scientific Research (B) (SH; 21390154), a Grant-in-Aid for Scientific Research (B) (KO; 23390260), and a Grant-in-Aid for Scientific Research Young Scientist (B) (AN; 25860818) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/e-grants/), and the Yakult -Bio-Science foundation (http://yakult-bioscience.or.jp/index.html) for AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hozumi K, 1998, EUR J IMMUNOL, V28, P1368, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1368::AID-IMMU1368&gt;3.0.CO;2-B; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	21	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105904	10.1371/journal.pone.0105904	http://dx.doi.org/10.1371/journal.pone.0105904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157574	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200075
J	Clerico, V; Masini, L; Boni, A; Meucci, S; Cecchini, M; Recchia, FA; Tredicucci, A; Bifone, A				Clerico, Vito; Masini, Luca; Boni, Adriano; Meucci, Sandro; Cecchini, Marco; Recchia, Fabio A.; Tredicucci, Alessandro; Bifone, Angelo			Water-Dispersible Three-Dimensional LC-Nanoresonators	PLOS ONE			English	Article							NEGATIVE-INDEX METAMATERIAL; SHAPE; NANOPARTICLES	Nanolithography techniques enable the fabrication of complex nanodevices that can be used for biosensing purposes. However, these devices are normally supported by a substrate and their use is limited to in vitro applications. Following a top-down procedure, we designed and fabricated composite inductance-capacitance (LC) nanoresonators that can be detached from their substrate and dispersed in water. The multimaterial composition of these resonators makes it possible to differentially functionalize different parts of the device to obtain stable aqueous suspensions and multi-sensing capabilities. For the first time, we demonstrate detection of these devices in an aqueous environment, and we show that they can be sensitized to their local environment and to chemical binding of specific molecular moieties. The possibility to optically probe the nanoresonator resonance in liquid dispersions paves the way to a variety of new applications, including injection into living organisms for in vivo sensing and imaging.	[Clerico, Vito; Recchia, Fabio A.] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Clerico, Vito; Masini, Luca; Boni, Adriano; Meucci, Sandro; Bifone, Angelo] Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, Pisa, Italy; [Masini, Luca; Meucci, Sandro; Cecchini, Marco; Tredicucci, Alessandro] CNR, Ist Nanosci, NEST, I-56100 Pisa, Italy; [Masini, Luca; Meucci, Sandro; Cecchini, Marco; Tredicucci, Alessandro] Scuola Normale Super Pisa, Pisa, Italy; [Recchia, Fabio A.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA	Scuola Superiore Sant'Anna; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Clerico, V (corresponding author), Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy.	v.clerico@sssup.it; Angelo.Bifone@iit.it	Tredicucci, Alessandro/M-6166-2015; Clericò, Vito/D-7988-2018; Clericò, Vito/AAQ-7426-2020	Tredicucci, Alessandro/0000-0003-3619-3011; Clericò, Vito/0000-0001-5364-6209; Clericò, Vito/0000-0001-6646-8309; Cecchini, Marco/0000-0002-9688-2356	European Research Council; NIH [P01 HL-74237, R01 HL108213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074237, R01HL108213] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the European Research Council through the advanced grant SouLMan. Fabio A. Recchia was supported by NIH grants P01 HL-74237 and R01 HL108213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameling R, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3530795; Andreone A, 2011, SELECTED TOPICS PHOT, P421; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Batt CA, 2007, SCIENCE, V316, P1579, DOI 10.1126/science.1140729; Cattoni A, 2011, NANO LETT, V11, P3557, DOI 10.1021/nl201004c; Chanda D, 2011, NAT NANOTECHNOL, V6, P402, DOI [10.1038/NNANO.2011.82, 10.1038/nnano.2011.82]; Crouse CA, 2010, ACS APPL MATER INTER, V2, P2560, DOI 10.1021/am100402z; Dicken MJ, 2009, OPT EXPRESS, V17, P18330, DOI 10.1364/OE.17.018330; Dolling G, 2007, OPT LETT, V32, P53, DOI 10.1364/OL.32.000053; Glangchai LC, 2008, J CONTROL RELEASE, V125, P263, DOI 10.1016/j.jconrel.2007.10.021; Guney DO, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.125129; Gutrath BS, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/22/225707; Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Hasan W, 2009, NANO LETT, V9, P1555, DOI 10.1021/nl803647n; Jaksic Z, 2007, J OPT A-PURE APPL OP, V9, pS377, DOI 10.1088/1464-4258/9/9/S16; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kim E, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801701; Kim YI, 2008, SENSOR ACTUAT A-PHYS, V143, P279, DOI 10.1016/j.sna.2007.11.014; Kumar S, 2007, NANO LETT, V7, P1338, DOI 10.1021/nl070365i; Lee J, 2008, ACCOUNTS CHEM RES, V41, P1762, DOI 10.1021/ar800126p; Lee SW, 2011, ACS NANO, V5, P897, DOI 10.1021/nn102041m; Lemoult F, 2013, NAT PHYS, V9, P55, DOI [10.1038/nphys2480, 10.1038/NPHYS2480]; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Mark AG, 2013, NAT MATER, V12, P802, DOI [10.1038/NMAT3685, 10.1038/nmat3685]; Miyamaru F, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3327830; Neuert G, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1899503; Padilla WJ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.041102; Paniagua-Dominguez R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01507; Pendry J, 2006, NAT MATER, V5, P599, DOI 10.1038/nmat1697; Prahl S, 1999, MOLAR EXTINCTION COE; Rheims J, 1997, MEAS SCI TECHNOL, V8, P601, DOI 10.1088/0957-0233/8/6/003; Rodriguez-Canto PJ, 2011, OPT EXPRESS, V19, P7664, DOI 10.1364/OE.19.007664; Rodriguez-Lorenzo L, 2012, NAT MATER, V11, P604, DOI [10.1038/NMAT3337, 10.1038/nmat3337]; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/nmat2630, 10.1038/NMAT2630]; Smith DR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195104; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Vos JG, 2003, INTERFACIAL SUPRAMOL, P88; Walther C, 2010, SCIENCE, V327, P1495, DOI 10.1126/science.1183167	39	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105474	10.1371/journal.pone.0105474	http://dx.doi.org/10.1371/journal.pone.0105474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153993	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200054
J	Sah, P; Dey, S				Sah, Pratha; Dey, Sutirth			Stabilizing Spatially-Structured Populations through Adaptive Limiter Control	PLOS ONE			English	Article							BIOLOGICAL POPULATIONS; CONTROLLING CHAOS; MIGRATION RATE; DYNAMICS; METAPOPULATIONS; DISPERSAL; MODELS; EXTINCTION; DROSOPHILA; SYNCHRONY	Stabilizing the dynamics of complex, non-linear systems is a major concern across several scientific disciplines including ecology and conservation biology. Unfortunately, most methods proposed to reduce the fluctuations in chaotic systems are not applicable to real, biological populations. This is because such methods typically require detailed knowledge of system specific parameters and the ability to manipulate them in real time; conditions often not met by most real populations. Moreover, real populations are often noisy and extinction-prone, which can sometimes render such methods ineffective. Here, we investigate a control strategy, which works by perturbing the population size, and is robust to reasonable amounts of noise and extinction probability. This strategy, called the Adaptive Limiter Control (ALC), has been previously shown to increase constancy and persistence of laboratory populations and metapopulations of Drosophila melanogaster. Here, we present a detailed numerical investigation of the effects of ALC on the fluctuations and persistence of metapopulations. We show that at high migration rates, application of ALC does not require a priori information about the population growth rates. We also show that ALC can stabilize metapopulations even when applied to as low as one-tenth of the total number of subpopulations. Moreover, ALC is effective even when the subpopulations have high extinction rates: conditions under which another control algorithm had previously failed to attain stability. Importantly, ALC not only reduces the fluctuation in metapopulation sizes, but also the global extinction probability. Finally, the method is robust to moderate levels of noise in the dynamics and the carrying capacity of the environment. These results, coupled with our earlier empirical findings, establish ALC to be a strong candidate for stabilizing real biological metapopulations.	[Sah, Pratha; Dey, Sutirth] Indian Inst Sci Educ & Res Pune, Div Biol, Populat Biol Lab, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Dey, S (corresponding author), Indian Inst Sci Educ & Res Pune, Div Biol, Populat Biol Lab, Pune, Maharashtra, India.	s.dey@iiserpune.ac.in	Sah, Pratha/H-5474-2019	Sah, Pratha/0000-0001-8936-5871	Extra-Mural Research Grant from Council of Scientific and Industrial Research, Govt. of India	Extra-Mural Research Grant from Council of Scientific and Industrial Research, Govt. of India	This study was supported by an Extra-Mural Research Grant from Council of Scientific and Industrial Research, Govt. of India and in-house funding by IISER-Pune. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrievskii BR, 2004, AUTOMAT REM CONTR+, V65, P505, DOI 10.1023/B:AURC.0000023528.59389.09; Andrievskii BR, 2003, AUTOMAT REM CONTR+, V64, P673, DOI 10.1023/A:1023684619933; Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; Ben Zion Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000643; Ben-Zion Y, 2011, THEOR BIOL, P1; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Brannstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2065, DOI 10.1098/rspb.2005.3185; CHEKE RA, 1993, ECOL ENTOMOL, V18, P109, DOI 10.1111/j.1365-2311.1993.tb01191.x; Corron NJ, 2000, PHYS REV LETT, V84, P3835, DOI 10.1103/PhysRevLett.84.3835; Dattani J, 2011, PHYS LETT A, V375, P3986, DOI 10.1016/j.physleta.2011.08.066; Denney NH, 2002, P ROY SOC B-BIOL SCI, V269, P2229, DOI 10.1098/rspb.2002.2138; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Dey S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01405; Dey S, 2008, J ANIM ECOL, V77, P670, DOI 10.1111/j.1365-2656.2008.01401.x; Dey S, 2006, SCIENCE, V314, DOI 10.1126/science.1131367; Dey S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000233; Doebeli M, 1997, B MATH BIOL, V59, P497, DOI 10.1016/S0092-8240(96)00097-3; Drake JM, 2009, ECOL LETT, V12, P772, DOI 10.1111/j.1461-0248.2009.01325.x; Earn DJD, 2000, SCIENCE, V290, P1360, DOI 10.1126/science.290.5495.1360; Franco D, 2013, J THEOR BIOL, V337, P161, DOI 10.1016/j.jtbi.2013.08.018; Franco D, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S021812741350003X; Fronhofer EA, 2012, ECOLOGY, V93, P1967, DOI 10.1890/11-1814.1; Fryxell JM, 2005, OIKOS, V111, P143, DOI 10.1111/j.0030-1299.2005.13840.x; Griffen BD, 2009, P ROY SOC B-BIOL SCI, V276, P4363, DOI 10.1098/rspb.2009.1153; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; GUEMEZ J, 1993, PHYS LETT A, V181, P29, DOI 10.1016/0375-9601(93)91119-P; GYLLENBERG M, 1993, MATH BIOSCI, V118, P25, DOI 10.1016/0025-5564(93)90032-6; Hanski I, 2002, OIKOS, V98, P87, DOI 10.1034/j.1600-0706.2002.980109.x; Hanski I., 1999, METAPOPULATION ECOLO; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Henson SM, 2001, SCIENCE, V294, P602, DOI 10.1126/science.1063358; Hilker F.M., 2005, BEITRAEGE I UMWELTSY; Hilker FM, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.052901; Ims RA, 2005, P ROY SOC B-BIOL SCI, V272, P913, DOI 10.1098/rspb.2004.3025; Ives AR, 2004, AM NAT, V163, P375, DOI 10.1086/381942; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Liz E, 2010, CHAOS, V20, DOI 10.1063/1.3432558; Matter SF, 2013, ECOL MODEL, V266, P68, DOI 10.1016/j.ecolmodel.2013.06.021; Matter SF, 2010, P ROY SOC B-BIOL SCI, V277, P729, DOI 10.1098/rspb.2009.1520; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MCCALLUM HI, 1992, J THEOR BIOL, V154, P277, DOI 10.1016/S0022-5193(05)80170-5; Parekh N, 1998, PHYS REV LETT, V81, P1401, DOI 10.1103/PhysRevLett.81.1401; Ponciano JM, 2005, APPL ENVIRON MICROB, V71, P2355, DOI 10.1128/AEM.71.5.2355-2364.2005; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Sah P, 2013, J THEOR BIOL, V320, P113, DOI 10.1016/j.jtbi.2012.12.014; Scholl E., 2008, HDB CHAOS CONTROL; Sheeba V, 1998, CURR SCI INDIA, V75, P1406; Sinha S., 1995, PHYS REV E, V51, P6239; Sole RV, 1999, B MATH BIOL, V61, P1187, DOI 10.1006/bulm.1999.0141; strom K. J. A, 2008, ADAPTIVE CONTROL, V2nd; Tung S, 2014, J THEOR BIOL, V356, P163, DOI 10.1016/j.jtbi.2014.04.036; Vogwill T, 2009, ECOL LETT, V12, P1194, DOI 10.1111/j.1461-0248.2009.01374.x; Wagner C, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.017201; Ylikarjula J, 2000, J THEOR BIOL, V207, P377, DOI 10.1006/jtbi.2000.2181; Zelinka I, 2005, HEURISTICA, V100	58	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105861	10.1371/journal.pone.0105861	http://dx.doi.org/10.1371/journal.pone.0105861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153073	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200087
J	Wolpaw, BJ; Mathews, C; Mtshizana, Y; Chopra, M; Hardie, D; Lurie, MN; De Azevedo, V; Jennings, K				Wolpaw, Benjamin J.; Mathews, Catherine; Mtshizana, Yolisa; Chopra, Mickey; Hardie, Diana; Lurie, Mark N.; De Azevedo, Virginia; Jennings, Karen			Patient Experiences following Acute HIV Infection Diagnosis and Counseling in South Africa	PLOS ONE			English	Article							TRANSMISSION; PREVENTION	Individuals in the acute stage of HIV infection (AHI) have an elevated potential to transmit HIV and play a critical role in the growth of the epidemic. Routine identification and counseling of individuals during AHI could decrease transmission behavior during this key period. However, diagnosis of AHI may present challenges distinct from those experienced through diagnosis of established HIV infection. A study was conducted in a public youth clinic outside of Cape Town, South Africa, to identify and counsel individuals with acute stage HIV infection. In-depth interviews were conducted with patients following diagnosis. After counseling, patients were accepting of the testing regimen used to diagnose AHI. They used the knowledge of having been recently infected to identify the source of their infection, but did not retain or place importance on information regarding the increased ability to transmit HIV during the acute stage. Future interventions directed at the reduction of HIV transmission following diagnosis with AHI will need to find ways of making this information more salient, possibly through more culturally meaningful educational approaches.	[Wolpaw, Benjamin J.; Mathews, Catherine; Mtshizana, Yolisa; Chopra, Mickey] S African MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Mathews, Catherine] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Hardie, Diana] Univ Cape Town, Dept Virol, ZA-7925 Cape Town, South Africa; [Lurie, Mark N.] Brown Univ, Sch Med, Dept Community Hlth, Providence, RI 02912 USA; [De Azevedo, Virginia; Jennings, Karen] Cape Town Municipal Hlth Directorate, Cape Town, South Africa	South African Medical Research Council; University of Cape Town; University of Cape Town; Brown University	Wolpaw, BJ (corresponding author), S African MRC, Hlth Syst Res Unit, Cape Town, South Africa.	ben.wolpaw@gmail.com	hardie, diana/R-6870-2019	Mathews, Catherine/0000-0001-5368-1127	Medical Research Council Health Systems Research Group; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020] Funding Source: NIH RePORTER	Medical Research Council Health Systems Research Group; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded internally by the Medical Research Council Health Systems Research Group, the research organization that employed several of the authors. The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Corneli A, 2014, AIDS BEHAV; Department of Social Services and Poverty Alleviation, 2006, POP REG UPD KHAYEL; Khayelitsha District Office Report, 2001, KHAYEL DISTR OFF REP; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Pilcher C. D., 2006, Current HIV/AIDS Reports, V3, P150, DOI 10.1007/s11904-006-0011-4; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Remien RH, 2009, AIDS BEHAV, V13, P1046, DOI 10.1007/s10461-009-9581-7; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Ulin PR, 2005, QUALITATIVE METHODS; West GR, 2007, AIDS EDUC PREV, V19, P275, DOI 10.1521/aeap.2007.19.4.275; Wolpaw BJ, 2011, SEX TRANSM INFECT, V87, P71, DOI 10.1136/sti.2009.041475; Zetola NM, 2007, INFECT DIS CLIN N AM, V21, P19, DOI 10.1016/j.idc.2007.01.008	14	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105459	10.1371/journal.pone.0105459	http://dx.doi.org/10.1371/journal.pone.0105459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153674	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200051
J	Zhang, PP; Frankel, LK; Bricker, TM				Zhang, Pengpeng; Frankel, Laurie K.; Bricker, Terry M.			Integration of Apo-alpha-Phycocyanin into Phycobilisomes and Its Association with FNRL in the Absence of the Phycocyanin alpha-Subunit Lyase (CpcF) in Synechocystis sp PCC 6803	PLOS ONE			English	Article							SYNECHOCOCCUS SP PCC-7002; FERREDOXIN-NADP(+) OXIDOREDUCTASE; THYLAKOID MEMBRANES; PHOTOSYSTEM-II; BILIN LYASE; PETH GENE; CHLOROPHYLL; ATTACHMENT; CYANOBACTERIA; CONSTRUCTION	Phycocyanin is an important component of the phycobilisome, which is the principal light-harvesting complex in cyanobacteria. The covalent attachment of the phycocyanobilin chromophore to phycocyanin is catalyzed by the enzyme phycocyanin lyase. The photosynthetic properties and phycobilisome assembly state were characterized in wild type and two mutants which lack holo-alpha-phycocyanin. Insertional inactivation of the phycocyanin alpha-subunit lyase (Delta cpcF mutant) prevents the ligation of phycocyanobilin to alpha-phycocyanin (CpcA), while disruption of the cpcB/A/C2/C1 operon in the CK mutant prevents synthesis of both apo-alpha-phycocyanin (apo-CpcA) and apo-beta-phycocyanin (apo-CpcB). Both mutants exhibited similar light saturation curves under white actinic light illumination conditions, indicating the phycobilisomes in the Delta cpcF mutant are not fully functional in excitation energy transfer. Under red actinic light illumination, wild type and both phycocyanin mutant strains exhibited similar light saturation characteristics. This indicates that all three strains contain functional allophycocyanin cores associated with their phycobilisomes. Analysis of the phycobilisome content of these strains indicated that, as expected, wild type exhibited normal phycobilisome assembly and the CK mutant assembled only the allophycocyanin core. However, the Delta cpcF mutant assembled phycobilisomes which, while much larger than the allophycocyanin core observed in the CK mutant, were significantly smaller than phycobilisomes observed in wild type. Interestingly, the phycobilisomes from the Delta cpcF mutant contained holo-CpcB and apo-CpcA. Additionally, we found that the large form of FNR (FNRL) accumulated to normal levels in wild type and the Delta cpcF mutant. In the CK mutant, however, significantly less FNRL accumulated. FNRL has been reported to associate with the phycocyanin rods in phycobilisomes via its N-terminal domain, which shares sequence homology with a phycocyanin linker polypeptide. We suggest that the assembly of apo-CpcA in the phycobilisomes of Delta cpcF can stabilize FNRL and modulate its function. These phycobilisomes, however, inefficiently transfer excitation energy to Photosystem II.	[Zhang, Pengpeng; Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-98ER20310]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Grant DE-FG02-98ER20310 provided by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy to TMB and LKF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AJLANI G, 1995, BBA-BIOENERGETICS, V1231, P189, DOI 10.1016/0005-2728(95)00086-X; Ajlani G, 1998, PLANT MOL BIOL, V37, P577, DOI 10.1023/A:1005924730298; Antal T, 2008, PHOTOSYNTH RES, V96, P217, DOI 10.1007/s11120-008-9301-6; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; Arteni A, 2009, BIOCHIM BIOPHYS ACTA, V1787, P222; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; Bolte K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-56; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FILLAT MF, 1993, PLANT MOL BIOL, V22, P725, DOI 10.1007/BF00047415; Gomez-Lojero C, 2003, BIOCHEMISTRY-US, V42, P13800, DOI 10.1021/bi0346998; Hu P, 2013, FEBS LETT, V587, P2340, DOI 10.1016/j.febslet.2013.05.040; Korn A, 2009, J BIOL CHEM, V284, P31789, DOI 10.1074/jbc.M109.024638; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Nakajima M, 2002, PLANT CELL PHYSIOL, V43, P484, DOI 10.1093/pcp/pcf058; Omairi-Nasser A, 2011, MOL MICROBIOL, V81, P1178, DOI 10.1111/j.1365-2958.2011.07739.x; Page LE, 2012, APPL ENVIRON MICROB, V78, P6349, DOI 10.1128/AEM.00499-12; PLANK T, 1995, J BACTERIOL, V177, P6804, DOI 10.1128/jb.177.23.6804-6809.1995; Rehman AU, 2013, BBA-BIOENERGETICS, V1827, P689, DOI 10.1016/j.bbabio.2013.02.016; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; SCHLUCHTER WM, 1992, BIOCHEMISTRY-US, V31, P3092, DOI 10.1021/bi00127a009; SCHLUCHTER WM, 1992, BIOCHEMISTRY-US, V31, P5952, DOI 10.1021/bi00140a037; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Szymanska R, 2011, PHYSIOL PLANTARUM, V141, P289, DOI 10.1111/j.1399-3054.2010.01434.x; Thomas JC, 2006, P NATL ACAD SCI USA, V103, P18368, DOI 10.1073/pnas.0607718103; Toole CM, 1998, MOL MICROBIOL, V30, P475, DOI 10.1046/j.1365-2958.1998.01082.x; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; van Thor JJ, 1999, EMBO J, V18, P4128, DOI 10.1093/emboj/18.15.4128; van Thor JJ, 2000, BBA-BIOENERGETICS, V1457, P129, DOI 10.1016/S0005-2728(00)00072-4; Watanabe M, 2014, P NATL ACAD SCI USA, V111, P2512, DOI 10.1073/pnas.1320599111; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zhang PP, 2012, PLANT CELL, V24, P1952, DOI 10.1105/tpc.111.094417; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	38	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105952	10.1371/journal.pone.0105952	http://dx.doi.org/10.1371/journal.pone.0105952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153076	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200095
J	de Fraga, R; Stow, AJ; Magnusson, WE; Lima, AP				de Fraga, Rafael; Stow, Adam J.; Magnusson, William E.; Lima, Albertina P.			The Costs of Evaluating Species Densities and Composition of Snakes to Assess Development Impacts in Amazonia	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; INVENTORIES; EFFICIENCY; PATTERNS; ECOLOGY; BIRDS; WIDTH	Studies leading to decision-making for environmental licensing often fail to provide accurate estimates of diversity. Measures of snake diversity are regularly obtained to assess development impacts in the rainforests of the Amazon Basin, but this taxonomic group may be subject to poor detection probabilities. Recently, the Brazilian government tried to standardize sampling designs by the implementation of a system (RAPELD) to quantify biological diversity using spatially-standardized sampling units. Consistency in sampling design allows the detection probabilities to be compared among taxa, and sampling effort and associated cost to be evaluated. The cost effectiveness of detecting snakes has received no attention in Amazonia. Here we tested the effects of reducing sampling effort on estimates of species densities and assemblage composition. We identified snakes in seven plot systems, each standardised with 14 plots. The 250 m long centre line of each plot followed an altitudinal contour. Surveys were repeated four times in each plot and detection probabilities were estimated for the 41 species encountered. Reducing the number of observations, or the size of the sampling modules, caused significant loss of information on species densities and local patterns of variation in assemblage composition. We estimated the cost to find a snake as $ 120 U.S., but general linear models indicated the possibility of identifying differences in assemblage composition for half the overall survey costs. Decisions to reduce sampling effort depend on the importance of lost information to target-issues, and may not be the preferred option if there is the potential for identifying individual snake species requiring specific conservation actions. However, in most studies of human disturbance on species assemblages, it is likely to be more cost-effective to focus on other groups of organisms with higher detection probabilities.	[de Fraga, Rafael] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Stow, Adam J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Magnusson, William E.; Lima, Albertina P.] Inst Nacl Pesquisas Amazonia Coordenacao Biodiver, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Macquarie University	de Fraga, R (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	r.defraga@gmail.com		Lima, Albertina Pimentel/0000-0003-4586-5633; Stow, Adam/0000-0002-6796-4854	Programa de Pesquisa em Biodiversidade (PPBio); National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Instituto Nacional de Pesquisas da Amazonia (INPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES	Programa de Pesquisa em Biodiversidade (PPBio); National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM); Instituto Nacional de Pesquisas da Amazonia (INPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Programa de Pesquisa em Biodiversidade (PPBio), the National Institute for Science, Technology and Innovation for Amazonian Biodiversity (INCT-CENBAM) and the Instituto Nacional de Pesquisas da Amazonia (INPA) have funded field work. The Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES provided a scholarship to R. de Fraga. The funders played a role in financing the construction of plot systems and data collection, but they had no direct involvement in those and other tasks (e.g. analysis, decision to publish, preparation of the manuscript).	Abrahao C, 2007, THESIS INPA UFAM MAN; ANGERMEIER PL, 1994, BIOSCIENCE, V44, P690, DOI 10.2307/1312512; [Anonymous], BIOTA NEOTROPICA; Austin MP, 2013, J VEG SCI, V24, P251, DOI 10.1111/j.1654-1103.2012.01467.x; Bassler C, 2014, J APPL ECOL, V51, P939, DOI 10.1111/1365-2664.12267; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Bernarde PS, 2012, BIOTA NEOTROP, V12, P154, DOI 10.1590/S1676-06032012000300018; Bibby CJ, 1999, OSTRICH, V70, P81, DOI 10.1080/00306525.1999.9639752; Bueno AS, 2012, ECOL APPL, V22, P722, DOI 10.1890/11-0789.1; BURBIDGE AA, 1991, NATURE CONSERVATION, P3; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Horbe AMC, 2013, ACTA AMAZON, V43, P489, DOI 10.1590/S0044-59672013000400011; Colwell RK, 2000, P NATL ACAD SCI USA, V97, P13470, DOI 10.1073/pnas.250497697; Danielsen F, 2003, ORYX, V37, P407, DOI 10.1017/S0030605303000735; DASILVA NJ, 1995, CONSERV BIOL, V9, P873, DOI 10.1046/j.1523-1739.1995.09040873.x; De Fraga Rafael, 2013, Copeia, V4, P684; de Fraga R, 2011, HERPETOL J, V21, P51; de Freitas CG, 2012, ACTA OECOL, V39, P128, DOI 10.1016/j.actao.2012.01.007; Ernst R, 2007, ENVIRON SCI ENG, P61; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; GENTRY AH, 1982, EVOL BIOL, V15, P1; Giradoux P, 2013, MISCELLANEOUS FUNCTI; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Hartel T, 2009, BIOLOGIA ACTA SCIENT, V17, P61; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Hinds WT, 1984, ENVIRON CONSERV, V11, P11; IUCN, 2013, IUCN RED LIST THREAT; JAMES FC, 1990, ANNU REV ECOL SYST, V21, P129, DOI 10.1146/annurev.es.21.110190.001021; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Magnusson WE, 2005, ESTATISTICA SEM MATE, P103; Magnusson WE, 2013, BIODIVERSITY INTEGRA; MARGULES CR, 1991, NATURE CONSERVATION; Mesquita PCMD, 2013, AN ACAD BRAS CIENC, V85, P1127, DOI 10.1590/S0001-37652013005000040; Oksanen J, 2010, R PACKAGE VERSION 1; Pansonato MP, 2013, BIOTROPICA, V45, P299, DOI 10.1111/btp.12008; Patrick DA, 2009, J HERPETOL, V43, P716, DOI 10.1670/08-288.1; Pawar S, 2003, BIOSCIENCE, V53, P861, DOI 10.1641/0006-3568(2003)053[0861:TCATMC]2.0.CO;2; de Souza JLP, 2009, PESQUI AGROPECU BRAS, V44, P940, DOI 10.1590/S0100-204X2009000800021; Souza Jorge Luiz Pereira, 2007, Acta Amaz., V37, P649, DOI 10.1590/S0044-59672007000400022; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Rojas-Ahumada DP, 2012, AUSTRAL ECOL, V37, P865, DOI 10.1111/j.1442-9993.2011.02330.x; Ruokolainen L, 2006, ANN BOT FENN, V43, P269; Santos EMR, 2008, BIOTROPICA, V40, P728, DOI 10.1111/j.1744-7429.2008.00425.x; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Steen DA, 2010, HERPETOL CONSERV BIO, V5, P183; Stork NE, 1995, GLOBAL BIODIVERSITY, P457; Stow AJ, 2012, WILDLIFE RES, V39, P290, DOI 10.1071/WR11150; Todd BD, 2008, CONSERV BIOL, V22, P753, DOI 10.1111/j.1523-1739.2008.00916.x	53	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105453	10.1371/journal.pone.0105453	http://dx.doi.org/10.1371/journal.pone.0105453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147930	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600048
J	Dempsey, SJ; Gese, EM; Kluever, BM				Dempsey, Steven J.; Gese, Eric M.; Kluever, Bryan M.			Finding a Fox: An Evaluation of Survey Methods to Estimate Abundance of a Small Desert Carnivore	PLOS ONE			English	Article							JOAQUIN KIT FOXES; GREAT-BASIN DESERT; VULPES-MACROTIS-MUTICA; SCAT DETECTION DOGS; HOME-RANGE SIZE; SWIFT FOXES; OCCUPANCY RATES; HABITAT USE; POPULATIONS; COYOTES	The status of many carnivore species is a growing concern for wildlife agencies, conservation organizations, and the general public. Historically, kit foxes (Vulpes macrotis) were classified as abundant and distributed in the desert and semi-arid regions of southwestern North America, but is now considered rare throughout its range. Survey methods have been evaluated for kit foxes, but often in populations where abundance is high and there is little consensus on which technique is best to monitor abundance. We conducted a 2-year study to evaluate four survey methods (scat deposition surveys, scent station surveys, spotlight survey, and trapping) for detecting kit foxes and measuring fox abundance. We determined the probability of detection for each method, and examined the correlation between the relative abundance as estimated by each survey method and the known minimum kit fox abundance as determined by radio-collared animals. All surveys were conducted on 15 5-km transects during the 3 biological seasons of the kit fox. Scat deposition surveys had both the highest detection probabilities (p = 0.88) and were most closely related to minimum known fox abundance (r(2) = 0.50, P = 0.001). The next best method for kit fox detection was the scent station survey (p = 0.73), which had the second highest correlation to fox abundance (r(2) = 0.46, P<0.001). For detecting kit foxes in a low density population we suggest using scat deposition transects during the breeding season. Scat deposition surveys have low costs, resilience to weather, low labor requirements, and pose no risk to the study animals. The breeding season was ideal for monitoring kit fox population size, as detections consisted of the resident population and had the highest detection probabilities. Using appropriate monitoring techniques will be critical for future conservation actions for this rare desert carnivore.	[Dempsey, Steven J.; Kluever, Bryan M.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Gese, Eric M.] Utah State Univ, USDA, Anim & Plant Hlth Inspect Serv, Wildlife Serv,Wildlife Res Ctr,Dept Wildland Reso, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University	Gese, EM (corresponding author), Utah State Univ, USDA, Anim & Plant Hlth Inspect Serv, Wildlife Serv,Wildlife Res Ctr,Dept Wildland Reso, Logan, UT 84322 USA.	eric.gese@usu.edu	Gese, Eric M/B-4578-2011		Department of Defense, United States Army Dugway Proving Ground, Environmental Programs, Dugway, Utah; United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, Utah State University, Logan, Utah; Quinney College of Natural Resources, Utah State University, Logan, Utah; Endangered Species Mitigation Fund of the Utah Department of Natural Resources, Division of Wildlife Resources, Salt Lake City, Utah	Department of Defense, United States Army Dugway Proving Ground, Environmental Programs, Dugway, Utah; United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, Utah State University, Logan, Utah; Quinney College of Natural Resources, Utah State University, Logan, Utah; Endangered Species Mitigation Fund of the Utah Department of Natural Resources, Division of Wildlife Resources, Salt Lake City, Utah	Funding and logistical support were provided by the Department of Defense, United States Army Dugway Proving Ground, Environmental Programs, Dugway, Utah, and the United States Department of Agriculture, Wildlife Services, National Wildlife Research Center, Utah State University, Logan, Utah. Additional funding was provided by the Quinney College of Natural Resources, Utah State University, Logan, Utah, and the Endangered Species Mitigation Fund of the Utah Department of Natural Resources, Division of Wildlife Resources, Salt Lake City, Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Arjo WM, 2007, WEST N AM NATURALIST, V67, P389, DOI 10.3398/1527-0904(2007)67[389:CIKFRI]2.0.CO;2; Arjo WM, 2003, CAN J ZOOL, V81, P96, DOI 10.1139/Z02-232; Beauvais GP, 2006, KIT FOX VULPES MACRO; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cypher BL, 2000, WILDLIFE MONOGR, P1; EBERHARDT LE, 1982, J WILDLIFE MANAGE, V46, P183, DOI 10.2307/3808421; EGOSCUE H. J., 1956, JOUR MAMMAL, V37, P351, DOI 10.2307/1376734; EGOSCUE HJ, 1962, ECOLOGY, V43, P481, DOI 10.2307/1933376; Finley DJ, 2005, J WILDLIFE MANAGE, V69, P861, DOI 10.2193/0022-541X(2005)069[0861:EOSFPS]2.0.CO;2; FITZGERALD JP, 1996, STATUS DISTRIBUTION; GESE EM, 1990, J WILDLIFE MANAGE, V54, P501, DOI 10.2307/3809665; Gese EM, 2001, CONSERV BIOL SER, V5, P372; GESE EM, 2004, CANIDS FOXES WOLVES, P273; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Harrison RL, 2002, AM MIDL NAT, V148, P320, DOI 10.1674/0003-0031(2002)148[0320:ACOPST]2.0.CO;2; Jacques CN, 2009, J MAMMAL, V90, P433, DOI 10.1644/07-MAMM-A-395.1; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Knowlton FF, 1984, FEASIBILITY ASSESSSI; Koopman ME, 2000, J MAMMAL, V81, P213, DOI 10.1644/1545-1542(2000)081<0213:DPOSJK>2.0.CO;2; Kozlowski AJ, 2008, AM MIDL NAT, V160, P191, DOI 10.1674/0003-0031(2008)160[191:NOARPB]2.0.CO;2; Kozlowski AJ, 2003, WILDLIFE SOC B, V31, P630; Kozlowski AJ, 2012, INT J ECOL, V2012, P1, DOI [10.1155/2012/629246, DOI 10.1155/2012/629246]; LINHART S B, 1975, Wildlife Society Bulletin, V3, P119; List R, 2003, J ZOOL, V259, P1, DOI 10.1017/S0952836902002959; Long RA, 2007, J WILDLIFE MANAGE, V71, P2007, DOI 10.2193/2006-230; Long RA, 2007, J WILDLIFE MANAGE, V71, P2018, DOI 10.2193/2006-292; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McGrew JC, 1976, MAMMALIAN SPECIES, V123, P1; Moehrenschlager A, 2007, J MAMMAL, V88, P1029, DOI 10.1644/06-MAMM-A-159R.1; Ralls K, 1997, J MAMMAL, V78, P65, DOI 10.2307/1382639; Ralls K, 2010, J WILDLIFE MANAGE, V74, P1457, DOI 10.2193/2009-401; ROUGHTON RD, 1982, J WILDLIFE MANAGE, V46, P217, DOI 10.2307/3808424; Ruette S, 2003, J APPL ECOL, V40, P32, DOI 10.1046/j.1365-2664.2003.00776.x; SCHALLER GB, 1996, CARNIVORE BEHAV ECOL, V2; Schauster ER, 2002, WILDLIFE SOC B, V30, P464; Schauster ER, 2002, CAN J ZOOL, V80, P307, DOI 10.1139/Z02-009; Smith DA, 2005, WILDLIFE SOC B, V33, P897, DOI 10.2193/0091-7648(2005)33[897:AOSDST]2.0.CO;2; Steiniger S, 2012, WILDLIFE SOC B, V36, P600, DOI 10.1002/wsb.168; SWIHART RK, 1985, ECOLOGY, V66, P1176, DOI 10.2307/1939170; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thacker R. K., 1995, COMP USE 4 TECHNIQUE; Utah Department of Natural Resources, 2011, UT SENS SPEC LIST; Warrick GD, 2001, WILDLIFE SOC B, V29, P827; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WHITE PJ, 1994, CAN J ZOOL, V72, P1831, DOI 10.1139/z94-247; White PJ, 1997, CAN J ZOOL, V75, P1982, DOI 10.1139/z97-830; WHITE PJ, 1993, J WILDLIFE MANAGE, V57, P861, DOI 10.2307/3809090; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; ZOELLICK BW, 1992, J MAMMAL, V73, P83, DOI 10.2307/1381868; Zoellick BW, 2002, WEST N AM NATURALIST, V62, P151	52	25	25	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105873	10.1371/journal.pone.0105873	http://dx.doi.org/10.1371/journal.pone.0105873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148102	Green Published, gold			2022-12-27	WOS:000341230600092
J	Guan, Z; Chen, YL; Yuan, Y; Song, J; Yang, DC; Xue, Y; He, YH				Guan, Zhi; Chen, Yan-Li; Yuan, Yi; Song, Jian; Yang, Da-Cheng; Xue, Yang; He, Yan-Hong			Earthworm Is a Versatile and Sustainable Biocatalyst for Organic Synthesis	PLOS ONE			English	Article								A crude extract of earthworms was used as an eco-friendly, environmentally benign, and easily accessible biocatalyst for various organic synthesis including the asymmetric direct aldol and Mannich reactions, Henry and Biginelli reactions, direct three-component aza-Diels-Alder reactions for the synthesis of isoquinuclidines, and domino reactions for the synthesis of coumarins. Most of these reactions have never before seen in nature, and moderate to good enantioselectivities in aldol and Mannich reactions were obtained with this earthworm catalyst. The products can be obtained in preparatively useful yields, and the procedure does not require any additional cofactors or special equipment. This work provides an example of a practical way to use sustainable catalysts from nature.	[Guan, Zhi; Chen, Yan-Li; Yuan, Yi; Song, Jian; Yang, Da-Cheng; Xue, Yang; He, Yan-Hong] Southwest Univ, Sch Chem & Chem Engn, Chongqing, Peoples R China	Southwest University - China	He, YH (corresponding author), Southwest Univ, Sch Chem & Chem Engn, Chongqing, Peoples R China.	heyh@swu.edu.cn	guan, zhi/R-9965-2016	He, Yan-Hong/0000-0002-6405-285X	National Natural Science Foundation of China [21276211]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No 21276211), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend M, 1998, ANGEW CHEM INT EDIT, V37, P1044, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1044::AID-ANIE1044>3.0.CO;2-E; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Boeris V, 2009, PROCESS BIOCHEM, V44, P1260, DOI 10.1016/j.procbio.2009.07.001; Bommarius AS, 2004, BIOCATALYSIS FUNDAME; Cordell GA, 2007, J NAT PROD, V70, P478, DOI 10.1021/np0680634; Faber K, 2018, BIOTRANSFORMATIONS O, P134, DOI 10.1007/978-3-319-61590-5; Ishihara K, 2006, BIOSCI BIOTECH BIOCH, V70, P3077, DOI 10.1271/bbb.60408; Ishii Y, 2009, Patent US, Patent No. [20090238891A1, 20090238891]; Johannes T, 2006, ENCY CHEM PROCESSING, DOI [10.1081/E-ECHP-120017565, DOI 10.1081/E-ECHP-120017565]; Kittelmann M, 2003, ADV SYNTH CATAL, V345, P825, DOI 10.1002/adsc.200303044; Leutbecher H, 2009, GREEN CHEM, V11, P676, DOI 10.1039/b822977e; Maruoka K, 2012, CHEM COMMUN, V48, P10703, DOI 10.1039/c2cc90327j; Messing R. A., 1975, IMMOBILIZED ENZYMES; Mirabal-Gallardo Y, 2013, TETRAHEDRON-ASYMMETR, V24, P440, DOI 10.1016/j.tetasy.2013.03.003; Nakajima N, 2005, BIOSCI BIOTECH BIOCH, V69, P2009, DOI 10.1271/bbb.69.2009; Nakajima N, 2003, J MOL CATAL B-ENZYM, V23, P191, DOI 10.1016/S1381-1177(03)00082-1; Pan R., 2010, APPL ENV SOIL SCI, DOI [10.1155/2010/294258, DOI 10.1155/2010/294258]; Toscano MD, 2007, ANGEW CHEM INT EDIT, V46, P3212, DOI 10.1002/anie.200604205	18	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105284	10.1371/journal.pone.0105284	http://dx.doi.org/10.1371/journal.pone.0105284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148527	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600041
J	Kuo, HC; Huang, YH; Chien, SC; Yu, HR; Hsieh, KS; Hsu, YW; Chang, WC				Kuo, Ho-Chang; Huang, Ying-Hsien; Chien, Shu-Chen; Yu, Hong-Ren; Hsieh, Kai-Sheng; Hsu, Yu-Wen; Chang, Wei-Chiao			Genetic Variants of CD209 Associated with Kawasaki Disease Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IMMUNOGLOBULIN TREATMENT FAILURE; DC-SIGN; EPIDEMIOLOGIC FEATURES; INFECTION; VIRUS; TUBERCULOSIS; POLYMORPHISM; DIAGNOSIS; IMMUNITY	Background: Kawasaki disease (KD) is a systemic vasculitis with unknown etiology mainly affecting children in Asian countries. Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN, CD209) in humans was showed to trigger an anti-inflammatory cascade and associated with KD susceptibility. This study was conducted to investigate the association between genetic polymorphisms of CD209 and the risk KD. Methods: A total of 948 subjects (381 KD and 567 controls) were recruited. Nine tagging SNPs (rs8112310, rs4804800, rs11465421, rs1544766, rs4804801, rs2287886, rs735239, rs735240, rs4804804) were selected for TaqMan allelic discrimination assay. Clinical phenotypes, coronary artery lesions (CAL) and intravenous immunoglobulin (IVIG) treatment outcomes were collected for analysis. Results: Significant associations were found between CD209 polymorphisms (rs4804800, rs2287886, rs735240) and the risk of KD. Haplotype analysis for CD209 polymorphisms showed that A/A/G haplotype (P = 0.0002, OR = 1.61) and G/A/G haplotype (P = 0.0365, OR = 1.52) had higher risk of KD as compared with G/G/A haplotype in rs2287886/rs735239/rs735240 pairwise allele analysis. There were no significant association in KD with regards to CAL formation and IVIG treatment responses. Conclusion: CD209 polymorphisms were responsible for the susceptibility of KD, but not CAL formation and IVIG treatment responsiveness.	[Kuo, Ho-Chang; Huang, Ying-Hsien; Yu, Hong-Ren; Hsieh, Kai-Sheng] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Huang, Ying-Hsien; Yu, Hong-Ren; Hsieh, Kai-Sheng] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Huang, Ying-Hsien; Yu, Hong-Ren; Hsieh, Kai-Sheng] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chien, Shu-Chen; Hsu, Yu-Wen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Hsu, Yu-Wen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogenom & Pharmacoprote, Taipei, Taiwan; [Chien, Shu-Chen] Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw	Kuo, Ho-Chang/AAQ-6644-2020; 于, 鴻仁/AAW-6827-2021	Kuo, Ho-Chang/0000-0002-3295-2984; 于, 鴻仁/0000-0003-1242-8760; Hsieh, Kai-Sheng/0000-0002-0294-9872; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council, Taiwan (NSC) [102-2314-B-182-053-MY3]; Taipei Medical University, Taiwan [TMU101-AE1-B14]; Chang Gung Memorial Hospital, Taiwan [CMRPG8C1081, CMRPG8B0211]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Taipei Medical University, Taiwan; Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by a grant from the National Science Council, Taiwan (NSC 102-2314-B-182-053-MY3), Taipei Medical University, Taiwan (Grant no. TMU101-AE1-B14) and grants from Chang Gung Memorial Hospital, Taiwan (CMRPG8C1081 and CMRPG8B0211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; de Witte L, 2006, J VIROL, V80, P3477, DOI 10.1128/JVI.80.7.3477-3486.2006; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; HR Yu, 2012, SCI WORLD J, V2012; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Koizumi Y, 2007, AIDS RES HUM RETROV, V23, P713, DOI 10.1089/aid.2006.0225; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2012, PEDIATR NEONATOL, V53, P4, DOI 10.1016/j.pedneo.2011.11.003; Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154; Kuo HC, 2011, J CLIN IMMUNOL, V31, P240, DOI 10.1007/s10875-010-9484-4; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Kuo Ho-Chang, 2007, Journal of Microbiology Immunology and Infection, V40, P395; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; Lidar M, 2009, AUTOIMMUNITY, V42, P432, DOI 10.1080/08916930802613210; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Mittal R, 2009, J IMMUNOL, V183, P6588, DOI 10.4049/jimmunol.0902029; Nakamura Y, 2008, J EPIDEMIOL, V18, P167, DOI 10.2188/jea.JE2008001; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Portman MA, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-32; Sarkar R., 2013, PLOS ONE, V8; SHULMAN ST, 1995, PEDIATR CLIN N AM, V42, P1205; Vannberg FO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001388; Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa; Yu HR, 2009, PEDIAT ALLERG IMM-UK, V20, P699, DOI 10.1111/j.1399-3038.2008.00844.x; Yu XJ, 2013, J MOL BIOL, V425, P1253, DOI 10.1016/j.jmb.2013.02.006; Zhou T, 2006, CELL MOL IMMUNOL, V3, P279	37	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105236	10.1371/journal.pone.0105236	http://dx.doi.org/10.1371/journal.pone.0105236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148534	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600035
J	Birol, M; Enchev, RI; Padilla, A; Stengel, F; Aebersold, R; Betzi, S; Yang, YS; Hoh, F; Peter, M; Dumas, C; Echalier, A				Birol, Melissa; Enchev, Radoslav Ivanov; Padilla, Andre; Stengel, Florian; Aebersold, Ruedi; Betzi, Stephane; Yang, Yinshan; Hoh, Francois; Peter, Matthias; Dumas, Christian; Echalier, Aude			Structural and Biochemical Characterization of the Cop9 Signalosome CSN5/CSN6 Heterodimer	PLOS ONE			English	Article							CROSS-LINKED PEPTIDES; ATOMIC STRUCTURES; CRYSTAL-STRUCTURE; H-1-NMR SPECTRA; PROTEIN; NEDD8; PROTEASOME; INSIGHTS; MODEL; ARCHITECTURE	The Cop9 signalosome complex (CSN) regulates the functional cycle of the major E3 ubiquitin ligase family, the cullin RING E3 ubiquitin ligases (CRLs). Activated CRLs are covalently modified by the ubiquitin-like protein Nedd8 (neural precursor cell expressed developmentally down-regulated protein 8). CSN serves an essential role in myriad cellular processes by reversing this modification through the isopeptidase activity of its CSN5 subunit. CSN5 alone is inactive due to an auto-inhibited conformation of its catalytic domain. Here we report the molecular basis of CSN5 catalytic domain activation and unravel a molecular hierarchy in CSN deneddylation activity. The association of CSN5 and CSN6 MPN (for Mpr1/Pad1 N-terminal) domains activates its isopeptidase activity. The CSN5/CSN6 module, however, is inefficient in CRL deneddylation, indicating a requirement of further elements in this reaction such as other CSN subunits. A hybrid molecular model of CSN5/CSN6 provides a structural framework to explain these functional observations. Docking this model into a published CSN electron density map and using distance constraints obtained from cross-linking coupled to mass-spectrometry, we find that the C-termini of the CSN subunits could form a helical bundle in the centre of the structure. They likely play a key scaffolding role in the spatial organization of CSN and precise positioning of the dimeric MPN catalytic core.	[Birol, Melissa; Padilla, Andre; Yang, Yinshan; Hoh, Francois; Dumas, Christian; Echalier, Aude] Univ Montpellier 2, Univ Montpellier 1, CNRS, UMR 5048,Ctr Biochim Struct, Montpellier, France; [Birol, Melissa; Padilla, Andre; Yang, Yinshan; Hoh, Francois; Dumas, Christian; Echalier, Aude] INSERM, U1054, Paris, France; [Enchev, Radoslav Ivanov; Peter, Matthias] Swiss Fed Inst Technol, Dept Biol, Inst Biochem, Zurich, Switzerland; [Stengel, Florian; Aebersold, Ruedi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland; [Betzi, Stephane] Aix Marseille Univ, UM105, Unite Mixte Rech UMR 7258,Inst Paoli Calmettes, INSERM,U1068,Ctr Rech Cancerol Marseille,Ctr Bioc, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Echalier, A (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	aude.echalier-glazer@cbs.cnrs.fr	Betzi, Stephane/AAC-6103-2022	Betzi, Stephane/0000-0001-5935-5058; Birol, Melissa/0000-0003-3397-8446; PADILLA, ANDRE/0000-0001-9702-4612; Peter, Matthias/0000-0002-2160-6824; hoh, francois/0000-0002-2905-7081; Stengel, Florian/0000-0003-1447-4509	Swiss National Science Foundation: European Research Council; ETH-Zurich; Marie Curie; Sir Henry Wellcome Fellow; Wellcome Trust [095951]; European Research Council [233226]; University Montpellier I; Centre national de la recherche scientifique; GEFLUC Languedoc Roussillon;  [CBS2/UM2]	Swiss National Science Foundation: European Research Council; ETH-Zurich(ETH Zurich); Marie Curie(European Commission); Sir Henry Wellcome Fellow; Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); University Montpellier I; Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); GEFLUC Languedoc Roussillon; 	Funding provided by Swiss National Science Foundation: European Research Council senior award: MP, ETH-Zurich: MP RA, Marie Curie: RIE, Sir Henry Wellcome Fellow: FS (Wellcome Trust Grant 095951), European Research Council advanced grant Proteomics v3.0 (233226): RA, CBS2/UM2 PhD studentship: MB, University Montpellier I: AE, Centre national de la recherche scientifique: AE and GEFLUC Languedoc Roussillon: AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Birol M., 2014, CURR PROTEIN PEPT SC; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Crow A, 2012, P NATL ACAD SCI USA, V109, pE1830, DOI 10.1073/pnas.1112107109; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Dobbins SE, 2008, P NATL ACAD SCI USA, V105, P10390, DOI 10.1073/pnas.0802496105; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Echalier A, 2013, P NATL ACAD SCI USA, V110, P1273, DOI 10.1073/pnas.1209345110; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; ENGLANDER SW, 1987, BIOCHEMISTRY-US, V26, P5953, DOI 10.1021/bi00393a001; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Gracy J, 2005, NUCLEIC ACIDS RES, V33, pW65, DOI 10.1093/nar/gki455; Hollup SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-52; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee JHW, 2013, J HYDRO-ENVIRON RES, V7, P227, DOI 10.1016/j.jher.2013.10.003; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Lingaraju GW, 2014, NATURE IN PRESS; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Malliavin TE, 1998, BIOINFORMATICS, V14, P624, DOI 10.1093/bioinformatics/14.7.624; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; O'Donoghue JE, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-8; Pathare GR, 2014, P NATL ACAD SCI US; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Rodrigues JPGLM, 2014, FEBS J, V281, P1988, DOI 10.1111/febs.12771; ROTH SM, 1992, BIOCHEMISTRY-US, V31, P1443, DOI 10.1021/bi00120a022; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sanches M, 2007, J MOL BIOL, V370, P846, DOI 10.1016/j.jmb.2007.04.084; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Shrestha RK, 2014, BIOCHEMISTRY; SKLENAR V, 1993, J BIOMOL NMR, V3, P721, DOI 10.1007/BF00198375; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Vashisth H, 2012, STRUCTURE, V20, P1453, DOI 10.1016/j.str.2012.08.007; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; WAND AJ, 1991, BIOPHYS J, V59, P1101, DOI 10.1016/S0006-3495(91)82325-6; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worden EJ, 2014, NAT STRUCT MOL BIOL; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Zhang H, 2012, FEBS LETT, V586, P1147, DOI 10.1016/j.febslet.2012.03.029	59	21	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105688	10.1371/journal.pone.0105688	http://dx.doi.org/10.1371/journal.pone.0105688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144743	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000341106100109
J	Fulara, A; Hernik, A; Nieznanska, H; Dzwolak, W				Fulara, Aleksandra; Hernik, Agnieszka; Nieznanska, Hanna; Dzwolak, Wojciech			Covalent Defects Restrict Supramolecular Self-Assembly of Homopolypeptides: Case Study of beta(2)-Fibrils of Poly-L-Glutamic Acid	PLOS ONE			English	Article							POLY(L-GLUTAMIC ACID); SIDE-CHAINS; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; POLYAMINO ACIDS; POLYPEPTIDES; COMPLEXES; OLIGOMERS; PROTEINS; FIBRILS	Poly-L-glutamic acid (PLGA) often serves as a model in studies on amyloid fibrils and conformational transitions in proteins, and as a precursor for synthetic biomaterials. Aggregation of PLGA chains and formation of amyloid-like fibrils was shown to continue on higher levels of superstructural self-assembly coinciding with the appearance of so-called beta(2)-sheet conformation manifesting in dramatic redshift of infrared amide I' band below 1600 cm(-1). This spectral hallmark has been attributed to network of bifurcated hydrogen bonds coupling C = O and N-D (N-H) groups of the main chains to glutamate side chains. However, other authors reported that, under essentially identical conditions, PLGA forms the conventional in terms of infrared characteristics beta(1)-sheet structure (exciton-split amide I' band with peaks at ca. 1616 and 1683 cm(-1)). Here we attempt to shed light on this discrepancy by studying the effect of increasing concentration of intentionally induced defects in PLGA on the tendency to form beta(1)/beta(2)-type aggregates using infrared spectroscopy. We have employed carbodiimide-mediated covalent modification of Glu side chains with n-butylamine (NBA), as well as electrostatics-driven inclusion of polylysine chains, as two different ways to trigger structural defects in PLGA. Our study depicts a clear correlation between concentration of defects in PLGA and increasing tendency to depart from the beta(2)-structure toward the one less demanding in terms of chemical uniformity of side chains: beta(1)-structure. The varying predisposition to form beta(1)- or beta(2)-type aggregates assessed by infrared absorption was compared with the degree of morphological order observed in electron microscopy images. Our results are discussed in the context of latent covalent defects in homopolypeptides (especially with side chains capable of hydrogen-bonding) that could obscure their actual propensities to adopt different conformations, and limit applications in the field of synthetic biomaterials.	[Fulara, Aleksandra; Hernik, Agnieszka; Dzwolak, Wojciech] Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, Warsaw, Poland; [Nieznanska, Hanna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	University of Warsaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Dzwolak, W (corresponding author), Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, Warsaw, Poland.	wdzwolak@chem.uw.edu.pl		Nieznanska, Hanna/0000-0001-7055-5018	National Science Centre of Poland [DEC-2011/03/B/ST4/03063]	National Science Centre of Poland(National Science Centre, Poland)	Support from the National Science Centre of Poland, contract grant number DEC-2011/03/B/ST4/03063 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackels L, 2009, VIB SPECTROSC, V50, P2, DOI 10.1016/j.vibspec.2008.07.004; APPEL P, 1965, BIOCHEMISTRY-US, V4, P1244, DOI 10.1021/bi00883a005; Babenko V, 2011, CHEM COMMUN, V47, P10686, DOI 10.1039/c1cc14230e; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; BLOUT ER, 1954, J AM CHEM SOC, V76, P4492, DOI 10.1021/ja01646a078; BLOUT ER, 1962, J AM CHEM SOC, V84, P3193, DOI 10.1021/ja00875a038; Chen LL, 2013, BIOMACROMOLECULES, V14, P4320, DOI 10.1021/bm401215w; Chi H, 2013, BIOMACROMOLECULES, V14, P3880, DOI 10.1021/bm401015f; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DOMARD A, 1980, MACROMOLECULES, V13, P898, DOI 10.1021/ma60076a026; DOTY P, 1957, J POLYM SCI, V23, P851, DOI 10.1002/pol.1957.1202310429; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fasman GD, 1967, POLYALPHA AMINO ACID; Fulara A, 2011, J PHYS CHEM B, V115, P11010, DOI 10.1021/jp206271e; Fulara A, 2010, J PHYS CHEM B, V114, P8278, DOI 10.1021/jp102440n; Itoh K, 2008, LANGMUIR, V24, P13426, DOI 10.1021/la8015832; ITOH K, 1976, BIOPOLYMERS, V15, P419, DOI 10.1002/bip.1976.360150302; Iwata H, 1998, BIOMATERIALS, V19, P1869, DOI 10.1016/S0142-9612(98)00095-7; Kessler J, 2014, J PHYS CHEM B, V118, P6937, DOI 10.1021/jp502178d; Krejtschi C, 2011, EUR BIOPHYS J BIOPHY, V40, P673, DOI 10.1007/s00249-011-0673-8; Li C, 2002, ADV DRUG DELIVER REV, V54, P695, DOI 10.1016/S0169-409X(02)00045-5; Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178; RINAUDO M, 1976, J AM CHEM SOC, V98, P6360, DOI 10.1021/ja00436a048; RINAUDO M, 1977, MACROMOLECULES, V10, P720, DOI 10.1021/ma60057a052; SELA M, 1956, J AM CHEM SOC, V78, P746, DOI 10.1021/ja01585a015; Shoji O, 2001, MACROMOLECULES, V34, P4270, DOI 10.1021/ma001984f; SONG SH, 1989, J AM CHEM SOC, V111, P4295, DOI 10.1021/ja00194a022; Tansey W, 2004, J CONTROL RELEASE, V94, P39, DOI 10.1016/j.jconrel.2003.09.005; Tian HY, 2014, J CONTROL RELEASE, V174, P117, DOI 10.1016/j.jconrel.2013.11.008; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Yamaoki Y, 2012, J PHYS CHEM B, V116, P5172, DOI 10.1021/jp2125685; YAN JF, 1968, J CHEM PHYS, V49, P2713, DOI 10.1063/1.1670476	33	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105660	10.1371/journal.pone.0105660	http://dx.doi.org/10.1371/journal.pone.0105660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144464	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100105
J	Goessens, A; Satyanarayana, B; Van der Stocken, T; Zuniga, MQ; Mohd-Lokman, H; Sulong, I; Dahdouh-Guebas, F				Goessens, Arnaud; Satyanarayana, Behara; Van der Stocken, Tom; Zuniga, Melissa Quispe; Mohd-Lokman, Husain; Sulong, Ibrahim; Dahdouh-Guebas, Farid			Is Matang Mangrove Forest in Malaysia Sustainably Rejuvenating after More than a Century of Conservation and Harvesting Management?	PLOS ONE			English	Article							STRUCTURAL DEVELOPMENT; COASTAL VEGETATION; GAZI BAY; BIOMASS; PRODUCTIVITY; ASSEMBLAGES; ALLOMETRY; ECOSYSTEM; TREE; REGENERATION	Matang Mangrove Forest Reserve (MMFR) in Peninsular Malaysia is under systematic management since 1902 and still considered as the best managed mangrove forest in the world. The present study on silvimetrics assessed the ongoing MMFR forest management, which includes a first thinning after 15 years, a second thinning after 20 years and clear-felling of 30-year old forest blocks, for its efficiency and productivity in comparison to natural mangroves. The estimated tree structural parameters (e.g. density, frequency) from three different-aged mangrove blocks of fifteen (MF15), twenty (MF20), and thirty (MF30) years old indicated that Bruguiera and Excoecaria spp. did not constitute a significant proportion of the vegetation (<5%), and hence the results focused majorly on Rhizophora apiculata. The density of R. apiculata at MF15, MF20 and MF30 was 4,331, 2,753 and 1,767 stems ha 21, respectively. In relation to ongoing practices of the artificial thinnings at MMFR, the present study suggests that the first thinning could be made earlier to limit the loss of exploitable wood due to natural thinning. In fact, the initial density at MF15 was expected to drop down from 6,726 to 1,858 trees ha 21 before the first thinning. Therefore the trees likely to qualify for natural thinning, though having a smaller stem diameter, should be exploited for domestic/commercial purposes at an earlier stage. The clear-felling block (MF30) with a maximum stem diameter of 30 cm was estimated to yield 372 t ha(-1) of the above-ground biomass and suggests that the mangrove management based on a 30-year rotation is appropriate for the MMFR. Since Matang is the only iconic site that practicing sustainable wood production, it could be an exemplary to other mangrove locations for their improved management.	[Goessens, Arnaud; Satyanarayana, Behara; Van der Stocken, Tom; Zuniga, Melissa Quispe; Dahdouh-Guebas, Farid] Univ Libre Bruxelles, Lab Syst Ecol & Resource Management, Brussels, Belgium; [Goessens, Arnaud; Satyanarayana, Behara; Mohd-Lokman, Husain; Sulong, Ibrahim] Univ Malaysia Terengganu UMT, Mangrove Res Unit MARU, Inst Oceanog & Environm INOS, Kuala Terengganu, Malaysia; [Satyanarayana, Behara; Van der Stocken, Tom; Zuniga, Melissa Quispe; Dahdouh-Guebas, Farid] Vrije Univ Brussel, Lab Plant Biol & Nat Management, Brussels, Belgium	Universite Libre de Bruxelles; Universiti Malaysia Terengganu; Vrije Universiteit Brussel	Satyanarayana, B (corresponding author), Univ Libre Bruxelles, Lab Syst Ecol & Resource Management, CPI 264-1, Brussels, Belgium.	satyam2149@gmail.com	Satyanarayana, Behara/F-7694-2013	Satyanarayana, Behara/0000-0003-4191-2607; Van der Stocken, Tom/0000-0002-1820-9123; DAHDOUH-GUEBAS, Farid/0000-0002-5906-8996; Quispe-Zuniga, Melissa Roxana/0000-0002-1624-1867	Interuniversity Council of the French Community of Belgium - University Commission for Development (CIUF-CUD); Belgian National Science Foundation [FNRS-MIS F. 4508.11]; Flemish Interuniversity Cooperation - University Development Cooperation (VLIR-UOS)	Interuniversity Council of the French Community of Belgium - University Commission for Development (CIUF-CUD); Belgian National Science Foundation; Flemish Interuniversity Cooperation - University Development Cooperation (VLIR-UOS)	The travel grant of AG was sponsored by the Interuniversity Council of the French Community of Belgium - University Commission for Development (CIUF-CUD). BS FDG were supported by the Belgian National Science Foundation (FNRS-MIS F.4508.11). TVdS MQZ were supported by the Flemish Interuniversity Cooperation - University Development Cooperation (VLIR-UOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2012, APPL ENERG, V91, P173, DOI 10.1016/j.apenergy.2011.08.028; Alfaro AC, 2006, ESTUAR COAST SHELF S, V66, P97, DOI 10.1016/j.ecss.2005.07.024; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Alongi DM, 1998, J EXP MAR BIOL ECOL, V225, P197, DOI 10.1016/S0022-0981(97)00223-2; Alongi DM, 2004, MAR GEOL, V208, P383, DOI 10.1016/j.margeo.2004.04.016; Alongi DM, 2003, MAR ENVIRON RES, V55, P313, DOI 10.1016/S0141-1136(02)00276-3; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; AMARASINGHE MD, 1992, HYDROBIOLOGIA, V247, P37, DOI 10.1007/BF00008203; Amir AA, 2012, FOREST ECOL MANAG, V269, P60, DOI 10.1016/j.foreco.2011.12.040; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2007, WORLDS MANGR 1980 20; [Anonymous], 1988, BIOL SYSTEM MANGROVE; [Anonymous], 2005, FUNDAMENTALS ECOLOGY; Ashton EC, 1999, HYDROBIOLOGIA, V413, P77, DOI 10.1023/A:1003842910811; Aung TT, 2011, WETL ECOL MANAG, V19, P195, DOI 10.1007/s11273-011-9211-9; Azahar M., 2003, WORKING PLAN MATANG, P320; Bayas JCL, 2011, P NATL ACAD SCI USA, V108, P18612, DOI 10.1073/pnas.1013516108; Bosire JO, 2008, AQUAT BOT, V89, P251, DOI 10.1016/j.aquabot.2008.03.010; Bosire JO, 2006, MAR ECOL PROG SER, V325, P85, DOI 10.3354/meps325085; Bosire JO, 2005, MAR ECOL PROG SER, V299, P149, DOI 10.3354/meps299149; Bosire JO, 2003, AQUAT BOT, V76, P267, DOI 10.1016/S0304-3770(03)00054-8; Cannicci S, 2008, AQUAT BOT, V89, P186, DOI 10.1016/j.aquabot.2008.01.009; Cannicci S, 2009, ESTUAR COAST SHELF S, V84, P305, DOI 10.1016/j.ecss.2009.04.021; Chapin III SF, 2009, PRINCIPLES ECOSYSTEM; Chong V. C., 2006, Aquatic Ecosystem Health & Management, V9, P249, DOI 10.1080/14634980600717084; Choudhury JK, 1997, P 11 WORLD FOR C, V6, P266; Cohen R, 2013, FOREST ECOL MANAG, V310, P968, DOI 10.1016/j.foreco.2013.09.047; Coronado-Molina C., 2004, Wetlands Ecology and Management, V12, P157, DOI 10.1023/B:WETL.0000034071.17156.c0; Cox G.W., 1996, LAB MANUAL GEN ECOLO; Cunha-Lignon M, 2011, J COASTAL RES, P349; Cunha-Lignon M, 2011, J COASTAL RES, P344; Curtis JT, 1959, VEGETATION WISCONSIN; Dahdouh-Guebas F, 2011, J EXP MAR BIOL ECOL, V399, P188, DOI 10.1016/j.jembe.2010.11.012; Dahdouh-Guebas F, 2006, FOREST ECOL MANAG, V228, P1, DOI 10.1016/j.foreco.2005.10.076; DAHDOUHGUEBAS F, 2002, MEDED ZITT K ACAD OV, V48, P487; Das S, 2013, ESTUAR COAST SHELF S, V134, P98, DOI 10.1016/j.ecss.2013.09.021; De Ryck DJR, 2012, AQUAT BOT, V103, P66, DOI 10.1016/j.aquabot.2012.06.005; Di Nitto D, 2008, MAR ECOL PROG SER, V356, P175, DOI 10.3354/meps07228; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; Ellison J.C., 2000, CLIMATE CHANGE S PAC, P289, DOI [DOI 10.1007/0-306-47981-8, 10.1007/0-306-47981-8_16]; EONG OJ, 1993, CHEMOSPHERE, V27, P1097, DOI 10.1016/0045-6535(93)90070-L; Feagin RA, 2010, CONSERV LETT, V3, P1, DOI 10.1111/j.1755-263X.2009.00087.x; Fontalvo-Herazo ML, 2011, WETL ECOL MANAG, V19, P397, DOI 10.1007/s11273-011-9224-4; Gates GM, 2011, FUNGAL ECOL, V4, P68, DOI 10.1016/j.funeco.2010.08.001; GONG WK, 1990, ESTUAR COAST SHELF S, V31, P519, DOI 10.1016/0272-7714(90)90010-O; Haron HA, 1981, WORKING PLAN 2 30 YE; JUPEM, 2004, HDB TID TABL; Kairo J., 2002, AMBIO, V31, P7, DOI DOI 10.1579/0044-7447-31.7.562; Kairo J. G., 2009, Journal of Sustainable Forestry, V28, P395, DOI 10.1080/10549810902791523; Kairo JG, 2009, AQUAT CONSERV, V19, pS63, DOI 10.1002/aqc.1046; Kairo JG, 2008, FOREST ECOL MANAG, V255, P2670, DOI 10.1016/j.foreco.2008.01.031; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; KHOON GW, 1995, HYDROBIOLOGIA, V295, P255, DOI 10.1007/BF00029132; KOMIYAMA A, 1987, J TROP ECOL, V3, P97, DOI 10.1017/S0266467400001826; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Krauss KW, 2008, AQUAT BOT, V89, P105, DOI 10.1016/j.aquabot.2007.12.014; Lee SY, 2014, GLOBAL ECOL BIOGEOGR, V23, P726, DOI 10.1111/geb.12155; MALL L P, 1991, Tropical Ecology, V32, P144; Mukherjee N, 2014, ECOLOGY EVO IN PRESS; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nfotabong Atheull A, 2013, ESTUAR COAST, V36, P1181, DOI DOI 10.1007/s12237-013-9638-8; Nfotabong-Atheull A, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-41; Okamura K, 2010, JARQ-JPN AGR RES Q, V44, P325, DOI 10.6090/jarq.44.325; Ong J.E., 1985, 7 YEARS PRODUCTIVITY, P213; Ong JE, 2004, FOREST ECOL MANAG, V188, P395, DOI 10.1016/j.foreco.2003.08.002; PUTZ FE, 1986, FOREST ECOL MANAG, V17, P211, DOI 10.1016/0378-1127(86)90113-1; Quispe Zuniga M., 2014, VLIZ SPECIAL PUBLICA, V67, P87; Roslan A., 2014, WORKING PLAN MATANG; Sangil C, 2014, J SEA RES, V85, P92, DOI 10.1016/j.seares.2013.10.009; Satyanarayana B, 2013, OCEAN COAST MANAGE, V71, P225, DOI 10.1016/j.ocecoaman.2012.10.008; Satyanarayana B, 2012, AMBIO, V41, P513, DOI 10.1007/s13280-012-0248-7; Satyanarayana B, 2011, MAR ECOL PROG SER, V443, P51, DOI 10.3354/meps09397; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; United Nations Environment Programme (UNEP), 2014, IMPORTANCE MANGROVES; Van der Stocken T, 2013, BIOGEOSCIENCES, V10, P3635, DOI 10.5194/bg-10-3635-2013; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; Wang G, 2013, FOREST ECOL MANAG, V310, P539, DOI 10.1016/j.foreco.2013.08.045; Zhang KQ, 2012, ESTUAR COAST SHELF S, V102, P11, DOI 10.1016/j.ecss.2012.02.021	80	71	72	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105069	10.1371/journal.pone.0105069	http://dx.doi.org/10.1371/journal.pone.0105069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144689	Green Published, gold			2022-12-27	WOS:000341106100038
J	Linder, N; Turkki, R; Walliander, M; Martensson, A; Diwan, V; Rahtu, E; Pietikainen, M; Lundin, M; Lundin, J				Linder, Nina; Turkki, Riku; Walliander, Margarita; Martensson, Andreas; Diwan, Vinod; Rahtu, Esa; Pietikainen, Matti; Lundin, Mikael; Lundin, Johan			A Malaria Diagnostic Tool Based on Computer Vision Screening and Visualization of Plasmodium falciparum Candidate Areas in Digitized Blood Smears	PLOS ONE			English	Article							MICROSCOPY; CLASSIFICATION; TANZANIA; IMPACT	Introduction: Microscopy is the gold standard for diagnosis of malaria, however, manual evaluation of blood films is highly dependent on skilled personnel in a time-consuming, error-prone and repetitive process. In this study we propose a method using computer vision detection and visualization of only the diagnostically most relevant sample regions in digitized blood smears. Methods: Giemsa-stained thin blood films with P. falciparum ring-stage trophozoites (n = 27) and uninfected controls (n = 20) were digitally scanned with an oil immersion objective (0.1 mm/pixel) to capture approximately 50,000 erythrocytes per sample. Parasite candidate regions were identified based on color and object size, followed by extraction of image features (local binary patterns, local contrast and Scale-invariant feature transform descriptors) used as input to a support vector machine classifier. The classifier was trained on digital slides from ten patients and validated on six samples. Results: The diagnostic accuracy was tested on 31 samples (19 infected and 12 controls). From each digitized area of a blood smear, a panel with the 128 most probable parasite candidate regions was generated. Two expert microscopists were asked to visually inspect the panel on a tablet computer and to judge whether the patient was infected with P. falciparum. The method achieved a diagnostic sensitivity and specificity of 95% and 100% as well as 90% and 100% for the two readers respectively using the diagnostic tool. Parasitemia was separately calculated by the automated system and the correlation coefficient between manual and automated parasitemia counts was 0.97. Conclusion: We developed a decision support system for detecting malaria parasites using a computer vision algorithm combined with visualization of sample areas with the highest probability of malaria infection. The system provides a novel method for blood smear screening with a significantly reduced need for visual examination and has a potential to increase the throughput in malaria diagnostics.	[Linder, Nina; Turkki, Riku; Walliander, Margarita; Lundin, Mikael; Lundin, Johan] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Martensson, Andreas; Diwan, Vinod; Lundin, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Rahtu, Esa; Pietikainen, Matti] Univ Oulu, Dept Comp Sci & Engn, Oulu, Finland	University of Helsinki; Karolinska Institutet; University of Oulu	Linder, N (corresponding author), Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland.	nina.linder@helsinki.fi	Lundin, Johan/AAC-8510-2020; Lundin, Johan/I-1843-2018	Lundin, Johan/0000-0002-2681-4139; Lundin, Johan/0000-0002-2681-4139; Linder, Nina/0000-0003-3930-0513; Turkki, Riku/0000-0002-8690-6983; Rahtu, Esa/0000-0001-8767-0864	Swedish Research Council; Sigrid Juselius Foundation; Finska Lakaresallskapet; Dorothea Olivia, Karl Walter and Jarl Walter Perklen Foundation; "European Advanced Translational Research Infra Structure in Medicine'' (EATRIS)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Dorothea Olivia, Karl Walter and Jarl Walter Perklen Foundation; "European Advanced Translational Research Infra Structure in Medicine'' (EATRIS)	The study was supported by the Swedish Research Council, Sigrid Juselius Foundation, Finska Lakaresallskapet, and the Dorothea Olivia, Karl Walter and Jarl Walter Perklen Foundation. In addition, this study has received funding from the "European Advanced Translational Research Infra Structure in Medicine'' (EATRIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; [Anonymous], 2009, MAL MICR QUAL ASS MA; Bain BJ, 2005, NEW ENGL J MED, V353, P498, DOI 10.1056/NEJMra043442; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Di Ruberto C, 2002, IMAGE VISION COMPUT, V20, P133, DOI 10.1016/S0262-8856(01)00092-0; Diaz G, 2009, J BIOMED INFORM, V42, P296, DOI 10.1016/j.jbi.2008.11.005; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Frean J, 2012, B WORLD HEALTH ORGAN, V90, P191, DOI 10.2471/BLT.11.091876; Garcia LS, 2000, LAB DIAGNOSIS BLOOD; Kaewkamnerd S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S18; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le MT, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-15; Linder E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000315; Linder E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002547; Linder N, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-22; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Maity M., 2012, INT J COMPUTER APPL, V52, P31, DOI [10.5120/8279-1906, DOI 10.5120/8279-1906]; Mavandadi S, 2012, LAB CHIP, V12, P4102, DOI 10.1039/c2lc40614d; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Ngasala B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-199; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; O'Meara WP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-118; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pang S, 2010, LAB CHIP, V10, P411, DOI 10.1039/b919004j; Prescott WR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-155; Purwar Y, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-364; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Tek FB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-153; Tek FB, 2010, COMPUT VIS IMAGE UND, V114, P21, DOI 10.1016/j.cviu.2009.08.003; Turkki R, 2013, DIAGNOSTIC PATHOL S1, pS30; Vedaldi A, 2010, VLFEAT OPEN PORTABLE, P1469; Vedaldi A, 2009, IEEE I CONF COMP VIS, P606, DOI 10.1109/ICCV.2009.5459183; Walliander M, 2013, DIAGNOSTIC PATHOLOGY, V8, pS37, DOI DOI 10.1186/1746-1596-8-S1-S37; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, BAS MAL MICR; WHO, 2010, GUID TREATM MAL, V2nd; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organisation, 2008, TASK SHIFT GLOB REC; Zhu HY, 2013, LAB CHIP, V13, P1282, DOI 10.1039/c3lc41408f	43	48	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104855	10.1371/journal.pone.0104855	http://dx.doi.org/10.1371/journal.pone.0104855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144549	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100026
J	Oth, T; Schnijderberg, MCA; Senden-Gijsbers, BLMG; Germeraad, WTV; Bos, GMJ; Vanderlocht, J				Oth, Tammy; Schnijderberg, Melanie C. A.; Senden-Gijsbers, Birgit L. M. G.; Germeraad, Wilfred T. V.; Bos, Gerard M. J.; Vanderlocht, Joris			Monitoring the Initiation and Kinetics of Human Dendritic Cell-Induced Polarization of Autologous Naive CD4(+) T Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR; CHROMATIN STATE; IFN-GAMMA; IN-VITRO; DIFFERENTIATION; TH1; ACTIVATION; EXPRESSION; TYPE-1	A crucial step in generating de novo immune responses is the polarization of naive cognate CD4(+) T cells by pathogen-triggered dendritic cells (DC). In the human setting, standardized DC-dependent systems are lacking to study molecular events during the initiation of a naive CD4(+) T cell response. We developed a TCR-restricted assay to compare different pathogen-triggered human DC for their capacities to instruct functional differentiation of autologous, naive CD4(+) T cells. We demonstrated that this methodology can be applied to compare differently matured DC in terms of kinetics, direction, and magnitude of the naive CD4(+) T cell response. Furthermore, we showed the applicability of this assay to study the T cell polarizing capacity of low-frequency blood-derived DC populations directly isolated ex vivo. This methodology for addressing APC-dependent instruction of naive CD4(+) T cells in a human autologous setting will provide researchers with a valuable tool to gain more insight into molecular mechanisms occurring in the early phase of T cell polarization. In addition, it may also allow the study of pharmacological agents on DC-dependent T cell polarization in the human system.	[Oth, Tammy; Schnijderberg, Melanie C. A.; Senden-Gijsbers, Birgit L. M. G.; Germeraad, Wilfred T. V.; Bos, Gerard M. J.] Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, Dept Internal Med, Div Hematol, Maastricht, Netherlands; [Vanderlocht, Joris] Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, Tissue Typing Lab, Dept Transplantat Immunol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Vanderlocht, J (corresponding author), Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, Tissue Typing Lab, Dept Transplantat Immunol, Maastricht, Netherlands.	joris.vanderlocht@mumc.nl			"Fonds National de la Recherche,'' Luxembourg [1039369]	"Fonds National de la Recherche,'' Luxembourg(Luxembourg National Research Fund)	This work was supported by the "Fonds National de la Recherche,'' Luxembourg (project 1039369; T.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Athie-Morales V, 2004, J IMMUNOL, V172, P61, DOI 10.4049/jimmunol.172.1.61; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bellanger AP, 2013, CLIN VACCINE IMMUNOL, V20, P1133, DOI 10.1128/CVI.00043-13; Blom L, 2013, J IMMUNOLOGICAL METH; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Bryant CE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120015; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; DELPRETE G, 1993, J IMMUNOL, V150, P353; Donnelly RP, 2010, CYTOKINE GROWTH F R, V21, P393, DOI 10.1016/j.cytogfr.2010.09.001; Dzopalic T, 2012, IMMUNOL RES, V52, P20, DOI 10.1007/s12026-012-8279-5; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Evans CM, 2013, BRIEF FUNCT GENOMICS, V12, P499, DOI 10.1093/bfgp/elt025; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Frasca L, 2008, J IMMUNOL, V180, P1471, DOI 10.4049/jimmunol.180.3.1471; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; Hayday AC, 2008, NAT IMMUNOL, V9, P575, DOI 10.1038/ni0608-575; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Josefowicz SZ, 2013, IMMUNOLOGY, V139, P299, DOI 10.1111/imm.12115; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; Lassmann H, 2004, TRENDS IMMUNOL, V25, P132, DOI 10.1016/j.it.2004.01.007; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; Lombardi V, 2009, J IMMUNOL, V182, P3372, DOI 10.4049/jimmunol.0801969; Luger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054879; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moser JM, 2010, J IMMUNOL METHODS, V353, P8, DOI 10.1016/j.jim.2009.11.006; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nembrini C, 2006, J IMMUNOL, V176, P7180, DOI 10.4049/jimmunol.176.12.7180; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Padovan E, 2007, TRENDS IMMUNOL, V28, P308, DOI 10.1016/j.it.2007.05.002; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Peters M, 2010, IMMUNOL CELL BIOL, V88, P537, DOI 10.1038/icb.2010.3; Placek K, 2009, J IMMUNOL, V183, P7743, DOI 10.4049/jimmunol.0803812; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; Rodriguez-Palmero M, 1999, EUR J IMMUNOL, V29, P3914; Rogge L, 1998, J IMMUNOL, V161, P6567; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Scott K, 2005, IMMUNOLOGY, V116, P245, DOI 10.1111/j.1365-2567.2005.02218.x; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tuomela S, 2012, BLOOD, V119, pE151, DOI 10.1182/blood-2012-01-407528; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Van Elssen CHMJ, 2010, EUR J IMMUNOL, V40, P3138, DOI 10.1002/eji.201040496; Vanderlocht J, 2010, INT J IMMUNOPATH PH, V23, P35, DOI 10.1177/039463201002300104; Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	67	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103725	10.1371/journal.pone.0103725	http://dx.doi.org/10.1371/journal.pone.0103725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144736	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100009
J	Sheardova, K; Laczo, J; Vyhnalek, M; Andel, R; Mokrisova, I; Vlcek, K; Amlerova, J; Hort, J				Sheardova, Katerina; Laczo, Jan; Vyhnalek, Martin; Andel, Ross; Mokrisova, Ivana; Vlcek, Kamil; Amlerova, Jana; Hort, Jakub			Famous Landmark Identification in Amnestic Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; EMOTION RECOGNITION; NATIONAL INSTITUTE; SEMANTIC MEMORY; FACE PERCEPTION; DEMENTIA; DEFICITS; RECOMMENDATIONS; CORTEX	Background: Identification of famous landmarks (FLI), famous faces (FFI) and recognition of facial emotions (FER) is affected early in the course of Alzheimer's disease (AD). FFI, FER and FLI may represent domain specific tasks relying on activation of distinct regions of the medial temporal lobe, which are affected successively during the course of AD. However, the data on FFI and FER in MCI are controversial and FLI domain remains almost unexplored. Objectives: To determine whether and how are these three specific domains impaired in head to head comparison of patients with amnestic MCI (aMCI) single domain (SD-aMCI) and multiple domain (MD-aMCI). We propose that FLI might be most reliable in differentiating SD-aMCI, which is considered to be an earlier stage of AD pathology spread out, from the controls. Patients and Methods: A total of 114 patients, 13 with single domain (SD-aMCI) and 30 with multiple domains (MD-aMCI), 29 with mild AD and 42 controls underwent standard neurological and neuropsychological evaluations as well as tests of FLI, FER and FFI. Results: Compared to the control group, AD subjects performed worse on FFI (p = 0.020), FER (p<0.001) and FLI (p<0.001), MD-aMCI group had significantly worse scores only on FLI (p = 0.002) and approached statistical significance on FER (0.053). SD-aMCI group performed significantly worse only on FLI (p = 0.028) compared to controls. Conclusions: Patients with SD-aMCI had an isolated impairment restricted to FLI, while patients with MD-aMCI showed impairment in FLI as well as in FER. Patients with mild dementia due to AD have more extensive impairment of higher visual perception. The results suggest that FLI testing may contribute to identification of patients at risk of AD. We hypothesize that clinical examination of all three domains might reflect the spread of the disease from transentorhinal cortex, over amygdala to fusiform gyrus.	[Sheardova, Katerina; Laczo, Jan; Vyhnalek, Martin; Andel, Ross; Mokrisova, Ivana; Hort, Jakub] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Laczo, Jan; Vyhnalek, Martin; Mokrisova, Ivana; Vlcek, Kamil; Amlerova, Jana; Hort, Jakub] Charles Univ Prague, Dept Neurol, Memory Clin, Fac Med 2, Prague, Czech Republic; [Laczo, Jan; Vyhnalek, Martin; Mokrisova, Ivana; Vlcek, Kamil; Amlerova, Jana; Hort, Jakub] Univ Hosp Motol, Prague, Czech Republic; [Andel, Ross] Univ S Florida, Sch Aging Studies, Tampa, FL USA; [Vlcek, Kamil] Acad Sci Czech Republ, Inst Physiol, Dept Neurophysiol Memory, Prague, Czech Republic	St Anne's University Hospital Brno (FNUSA-ICRC); Charles University Prague; Motol University Hospital; State University System of Florida; University of South Florida; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Laczo, J (corresponding author), St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic.	janlaczo@gmail.com	Hort, Jakub/M-4011-2016; Amlerova, Jana/AAD-9766-2020; Vlcek, Kamil/B-9620-2012; Vyhnalek, Martin/R-3515-2019	Hort, Jakub/0000-0002-1080-3726; Vlcek, Kamil/0000-0001-7152-3093; Vyhnalek, Martin/0000-0002-5976-4932; Sheardova, Katerina/0000-0002-7731-1996; Andel, Ross/0000-0003-4083-4790	European Union Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Grant Agency of Charles University [74308]; Ministry of Health, Czech Republic; Institutional Support of Laboratory Research Grant [2/2012 (699002)]; University Hospital Motol, Prague, Czech Republic [00064203]	European Union Regional Development Fund-Project FNUSA-ICRC; Grant Agency of Charles University; Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); Institutional Support of Laboratory Research Grant; University Hospital Motol, Prague, Czech Republic(Czech Republic Government)	Funding provided by the European Union Regional Development Fund-Project FNUSA-ICRC (CZ. 1.05/1.1.00/02.0123)-JH; Grant Agency of Charles University (74308)-IM; Ministry of Health, Czech Republic-conceptual development of research organization, University Hospital Motol, Prague, Czech Republic 00064203-JH; Institutional Support of Laboratory Research Grant No. 2/2012 (699002)-JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Ahmed S, 2008, CORTEX, V44, P746, DOI 10.1016/j.cortex.2007.02.002; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], ALZHEIMERS DIS; Baudic S, 2006, ARCH CLIN NEUROPSYCH, V21, P15, DOI 10.1016/j.acn.2005.07.002; Bechyne K, 2008, CESK SLOV NEUROL N, V71, P675; Bezdicek O, 2014, AGING NEUROPSYCHOL C, V21, P693, DOI 10.1080/13825585.2013.865699; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bucks RS, 2004, AGING MENT HEALTH, V8, P222, DOI 10.1080/13607860410001669750; Chan E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00304; Cheng PJ, 2010, CLIN NEUROPHYSIOL, V121, P1519, DOI 10.1016/j.clinph.2010.03.033; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Dubois B, 2004, LANCET NEUROL, V3, P246, DOI 10.1016/S1474-4422(04)00710-0; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dudas RB, 2005, NEUROPSYCHOLOGIA, V43, P1266, DOI 10.1016/j.neuropsychologia.2004.12.005; Ekman P., 1976, PICTURES FACIAL AFFE; Estevez-Gonzalez A, 2004, DEMENT GERIATR COGN, V17, P188, DOI 10.1159/000076355; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallo DA, 2006, NEUROPSYCHOLOGY, V20, P625, DOI 10.1037/0894-4105.20.6.625; Goodglass H., 1983, BOSTON NAMING TEST; Gorno-Tempini ML, 2001, BRAIN, V124, P2087, DOI 10.1093/brain/124.10.2087; Gorno-Tempini ML, 2001, J NEUROL NEUROSUR PS, V70, P397, DOI 10.1136/jnnp.70.3.397; Grabowski TJ, 2001, HUM BRAIN MAPP, V13, P199, DOI 10.1002/hbm.1033; Greene JDW, 1996, BRAIN, V119, P111, DOI 10.1093/brain/119.1.111; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; HODGES JR, 1995, NEUROPSYCHOLOGIA, V33, P441, DOI 10.1016/0028-3932(94)00127-B; HODGES JR, 1993, NEUROPSYCHOLOGIA, V31, P775, DOI 10.1016/0028-3932(93)90128-M; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; KERTESZ A, 1986, CAN J NEUROL SCI, V13, P415; Laczo J, 2009, BEHAV BRAIN RES, V202, P252, DOI 10.1016/j.bbr.2009.03.041; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lim TS, 2011, J NEUROL SCI, V309, P123, DOI 10.1016/j.jns.2011.07.001; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; McCade D, 2011, DEMENT GERIATR COGN, V32, P257, DOI 10.1159/000335009; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meyers J. E., 1995, REY COMPLEX FIGURE T; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Nedelska Z, 2012, P NATL ACAD SCI USA, V109, P2590, DOI 10.1073/pnas.1121588109; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Newsome RN, 2012, HIPPOCAMPUS, V22, P1990, DOI 10.1002/hipo.22071; Petersen RC, 2004, NEUROLOGY, V62, pA295; Petersen RC, 2003, MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER'S DISEASE, P15; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rosenbaum RS, 2005, J COGNITIVE NEUROSCI, V17, P446, DOI 10.1162/0898929053279496; Roudier M, 1998, J NEUROL SCI, V154, P151, DOI 10.1016/S0022-510X(97)00222-0; Sarazin M, 2007, NEUROLOGY, V69, P1859, DOI 10.1212/01.wnl.0000279336.36610.f7; Serra L, 2010, NEUROPSYCHOLOGY, V24, P316, DOI 10.1037/a0017654; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spoletini I, 2008, AM J GERIAT PSYCHIAT, V16, P389, DOI 10.1097/JGP.0b013e318165dbce; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Takahashi N, 2002, CORTEX, V38, P717, DOI 10.1016/S0010-9452(08)70039-X; Teipel SJ, 2007, BRAIN, V130, P1745, DOI 10.1093/brain/awm117; Teng E, 2007, DEMENT GERIATR COGN, V23, P271, DOI 10.1159/000100829; Thompson SA, 2002, NEUROPSYCHOLOGY, V16, P344, DOI 10.1037//0894-4105.16.3.344; Topinkova E, 2002, NEUROL PRAXI, V2, P232; Varjassyova A, 2013, J ALZHEIMERS DIS, V33, P273, DOI 10.3233/JAD-2012-120148; Vlcek K, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00089; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weiss EM, 2008, AM J GERIAT PSYCHIAT, V16, P974, DOI 10.1097/JGP.0b013e318186bd53; Westerberg CE, 2006, NEUROPSYCHOLOGY, V20, P193, DOI 10.1037/0894-4105.20.2.193; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Young AW, 1996, NEUROPSYCHOLOGIA, V34, P31, DOI 10.1016/0028-3932(95)00062-3	67	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105623	10.1371/journal.pone.0105623	http://dx.doi.org/10.1371/journal.pone.0105623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144755	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100100
J	Wang, P; Wu, TH; Zhang, Y				Wang, Ping; Wu, Tun-Hua; Zhang, Yong			Direct Observation of the Photodegradation of Anthracene and Pyrene Adsorbed onto Mangrove Leaves	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; FIBEROPTIC SENSOR; PAHS; PHOTOLYSIS; SURFACES; FLUORESCENCE; PLANT; IRRADIATION; RADIATION; PROFILES	An established synchronous fluorimetry method was used for in situ investigation of the photodegradation of pyrene (PYR) and anthracene (ANT) adsorbed onto fresh leaves of the seedlings of two mangrove species, Aegiceras corniculatum (L.) Blanco (Ac) and Kandelia obovata (Ko) in multicomponent mixtures (mixture of the ANT and PYR). Experimental results indicated that photodegradation was the main transformation pathway for both ANT and PYR in multicomponent mixtures. The amount of the PAHs volatilizing from the leaf surfaces and entering the inner leaf tissues was negligible. Over a certain period of irradiation time, the photodegradation of both PYR and ANT adsorbed onto the leaves of Ac and Ko followed first-order kinetics, with faster rates being observed on Ac leaves. In addition, the photodegradation rate of PYR on the leaves of the mangrove species in multicomponent mixtures was much slower than that of adsorbed ANT. Compared with the PAHs adsorbed as single component, the photodegradation rate of ANT adsorbed in multicomponent mixtures was slower, while that of PYR was faster. Moreover, the photodegradation of PYR and ANT dissolved in water in multicomponent mixtures was investigated for comparison. The photodegradation rate on leaves was much slower than in water. Therefore, the physical-chemical properties of the substrate may strongly influence the photodegradation rate of adsorbed PAHs.	[Wang, Ping] Wenzhou Med Univ, Sch Environm Sci & Publ Hlth, Wenzhou, Peoples R China; [Wang, Ping] Xiamen Univ, Key Lab Coastal & Wetland Ecosyst, Minist Educ, Xiamen, Peoples R China; [Wu, Tun-Hua] Wenzhou Med Univ, Sch Informat & Engn, Wenzhou, Peoples R China; [Zhang, Yong] Xiamen Univ, Coll Environm & Ecol, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Wenzhou Medical University; Xiamen University; Wenzhou Medical University; Xiamen University	Zhang, Y (corresponding author), Xiamen Univ, Coll Environm & Ecol, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	fruitful@xmu.edu.cn	张, 勇/G-3426-2010; Wu, Tunhua/L-9511-2019; Wang, Ping/I-8405-2019		National Natural Science Foundation of China [21177102, 21207103]; Public Benefit Project of Zhejiang Province [2012C31025]; Natural Science Foundation of Zhejiang Province [LY13H180012]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201222932]; Specialized Research Fund for the Doctoral Program of Higher Education [20130121130005]; Undergraduate Scientific and Technological Innovation project of Zhejiang Province [2013R413010]; WEL Visiting Fellowship Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Benefit Project of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Scientific Research Fund of Zhejiang Provincial Education Department; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Undergraduate Scientific and Technological Innovation project of Zhejiang Province; WEL Visiting Fellowship Program	The funding of our manuscript include National Natural Science Foundation of China (21177102, 21207103), Public Benefit Project of Zhejiang Province (2012C31025), Natural Science Foundation of Zhejiang Province (LY13H180012), Scientific Research Fund of Zhejiang Provincial Education Department (Y201222932), Specialized Research Fund for the Doctoral Program of Higher Education (20130121130005), Undergraduate Scientific and Technological Innovation project of Zhejiang Province (2013R413010) and WEL Visiting Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleh I, 2013, SCI TOTAL ENVIRON, V444, P565, DOI 10.1016/j.scitotenv.2012.12.021; Augusto S, 2010, ENVIRON POLLUT, V158, P483, DOI 10.1016/j.envpol.2009.08.016; Bamforth SM, 2005, J CHEM TECHNOL BIOT, V80, P723, DOI 10.1002/jctb.1276; Cai ZQ, 2006, J CLIN LAB ANAL, V25, P61; Chen L, 2011, J FLUORESC, V21, P765, DOI 10.1007/s10895-010-0769-z; Chen L, 2010, TALANTA, V83, P324, DOI 10.1016/j.talanta.2010.09.025; Collins C, 2006, ENVIRON SCI TECHNOL, V40, P45, DOI 10.1021/es0508166; Debestani R., 1995, J PHOTOCH PHOTOBIO A, V86, P231; Dittmar T, 2006, MAR CHEM, V102, P208, DOI 10.1016/j.marchem.2006.04.003; EHRHARDT M, 1991, FRESEN J ANAL CHEM, V339, P772, DOI 10.1007/BF00321742; Feilberg A, 2001, ENVIRON SCI TECHNOL, V35, P108, DOI 10.1021/es990834l; Henry KM, 2013, J COASTAL RES, V29, P1273, DOI 10.2112/JCOASTRES-D-12-00184.1; HUANG XD, 1993, ENVIRON TOXICOL CHEM, V12, P1067, DOI 10.1002/etc.5620120613; Kahan TF, 2007, J PHYS CHEM A, V111, P1277, DOI 10.1021/jp066660t; Ke L, 2002, MAR POLLUT BULL, V45, P339, DOI 10.1016/S0025-326X(02)00117-0; Kwon HO, 2014, SCI TOTAL ENVIRON, V470, P1494, DOI 10.1016/j.scitotenv.2013.08.031; Lehto KM, 2000, J PHOTOCH PHOTOBIO A, V136, P53, DOI 10.1016/S1010-6030(00)00321-X; LOW GKC, 1987, J CHROMATOGR, V392, P199, DOI 10.1016/S0021-9673(01)94266-9; Luiz FF, 2012, J COASTAL RES, V28, P156; Mallakin A, 2000, CHEMOSPHERE, V40, P1435, DOI 10.1016/S0045-6535(99)00331-8; NIESSNER R, 1991, ANAL CHIM ACTA, V255, P231, DOI 10.1016/0003-2670(91)80051-T; Niu JF, 2003, ENVIRON POLLUT, V123, P39, DOI 10.1016/S0269-7491(02)00362-7; PANNE U, 1993, SENSOR ACTUAT B-CHEM, V13, P288, DOI 10.1016/0925-4005(93)85383-L; Pongpiachan S, 2013, MAR POLLUT BULL, V76, P370, DOI 10.1016/j.marpolbul.2013.07.052; Reyes CA, 2000, ENVIRON SCI TECHNOL, V34, P415, DOI 10.1021/es9905391; Rogers KR, 1996, CHEMOSPHERE, V33, P1151, DOI 10.1016/0045-6535(96)00255-X; Schuler F, 1998, CHEMOSPHERE, V36, P21, DOI 10.1016/S0045-6535(97)00349-4; Sigman ME, 1996, J PHOTOCH PHOTOBIO A, V94, P149, DOI 10.1016/1010-6030(95)04099-4; SIMONICH SL, 1994, NATURE, V370, P49, DOI 10.1038/370049a0; Sojinu OS, 2013, INT J PHYTOREMEDIAT, V15, P439, DOI 10.1080/15226514.2012.716097; Tansel B, 2013, MAR POLLUT BULL, V73, P258, DOI 10.1016/j.marpolbul.2013.05.011; Wang DG, 2005, ATMOS ENVIRON, V39, P4583, DOI 10.1016/j.atmosenv.2005.04.008; Wang P, 2008, TALANTA, V76, P1177, DOI 10.1016/j.talanta.2008.05.021; Wang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084296; Wang P, 2012, MAR POLLUT BULL, V64, P1654, DOI 10.1016/j.marpolbul.2012.05.034; Wang P, 2012, J COASTAL RES, V28, P499, DOI 10.2112/JCOASTRES-D-11-00111.1; Wang Ping, 2010, Toxicological and Environmental Chemistry, V92, P1825, DOI 10.1080/02772248.2010.482833; Wang XT, 2013, SCI TOTAL ENVIRON, V447, P80, DOI 10.1016/j.scitotenv.2012.12.086; Wang Y, 2009, CHEMOSPHERE, V76, P999, DOI 10.1016/j.chemosphere.2009.04.010; Xiao X, 2015, ORAL LIT CONTINUUM C; Xu Z, 2004, THESIS DALIAN U TECH	41	3	3	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104903	10.1371/journal.pone.0104903	http://dx.doi.org/10.1371/journal.pone.0104903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144741	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100029
J	Baumann, MU; Schneider, H; Malek, A; Palta, V; Surbek, DV; Sager, R; Zamudio, S; Illsley, NP				Baumann, Marc U.; Schneider, Henning; Malek, Antoine; Palta, Vidya; Surbek, Daniel V.; Sager, Ruth; Zamudio, Stacy; Illsley, Nicholas P.			Regulation of Human Trophoblast GLUT1 Glucose Transporter by Insulin-Like Growth Factor I (IGF-I)	PLOS ONE			English	Article							MATERNAL NUTRIENT RESTRICTION; INTRAUTERINE GROWTH; HUMAN PLACENTA; AMINO-ACIDS; PROTEIN EXPRESSION; BINDING-PROTEINS; DOWN-REGULATION; FETAL-GROWTH; TERM; SYNCYTIOTROPHOBLAST	Glucose transport to the fetus across the placenta takes place via glucose transporters in the opposing faces of the barrier layer, the microvillous and basal membranes of the syncytiotrophoblast. While basal membrane content of the GLUT1 glucose transporter appears to be the rate-limiting step in transplacental transport, the factors regulating transporter expression and activity are largely unknown. In view of the many studies showing an association between IGF-I and fetal growth, we investigated the effects of IGF-I on placental glucose transport and GLUT1 transporter expression. Treatment of BeWo choriocarcinoma cells with IGF-I increased cellular GLUT1 protein. There was increased basolateral (but not microvillous) uptake of glucose and increased transepithelial transport of glucose across the BeWo monolayer. Primary syncytial cells treated with IGF-I also demonstrated an increase in GLUT1 protein. Term placental explants treated with IGF-I showed an increase in syncytial basal membrane GLUT1 but microvillous membrane GLUT1 was not affected. The placental dual perfusion model was used to assess the effects of fetally perfused IGF-I on transplacental glucose transport and syncytial GLUT1 content. In control perfusions there was a decrease in transplacental glucose transport over the course of the perfusion, whereas in tissues perfused with IGF-I through the fetal circulation there was no change. Syncytial basal membranes from IGF-I perfused tissues showed an increase in GLUT1 content. These results demonstrate that IGF-I, whether acting via microvillous or basal membrane receptors, increases the basal membrane content of GLUT1 and up-regulates basal membrane transport of glucose, leading to increased transepithelial glucose transport. These observations provide a partial explanation for the mechanism by which IGF-I controls nutrient supply in the regulation of fetal growth.	[Baumann, Marc U.; Schneider, Henning; Malek, Antoine; Surbek, Daniel V.; Sager, Ruth] Univ Bern, Inselspital, Dept Obstet & Gynecol, CH-3010 Bern, Switzerland; [Palta, Vidya] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Obstet, Newark, NJ 07103 USA; [Zamudio, Stacy; Illsley, Nicholas P.] Hackensack Univ, Med Ctr, Ctr Abnormal Placentat, Dept Obstet & Gynecol, Hackensack, NJ 07601 USA	University of Bern; University Hospital of Bern; Rutgers State University New Brunswick; Rutgers State University Medical Center; Hackensack University Medical Center	Illsley, NP (corresponding author), Hackensack Univ, Med Ctr, Ctr Abnormal Placentat, Dept Obstet & Gynecol, Hackensack, NJ 07601 USA.	NIllsley@hackensackUMC.org		Illsley, Nicholas/0000-0002-4336-2832; Surbek, Daniel/0000-0001-7705-1584	United States National Institutes of Health (NIH) [HD046982]; Swiss National Research Foundation [3200-061771.00]; Swiss National Science Foundation Grant (NCCR TransCure); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046982] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation Grant (NCCR TransCure); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by United States National Institutes of Health (NIH HD046982; NI, SZ), Swiss National Research Foundation Grant (3200-061771.00; HS) and Swiss National Science Foundation Grant (NCCR TransCure; MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin R, 2005, TRAFFIC, V6, P1196, DOI 10.1111/j.1600-0854.2005.00354.x; Bajoria R, 2002, J CLIN ENDOCR METAB, V87, P308, DOI 10.1210/jc.87.1.308; BARROS LF, 1995, PLACENTA, V16, P623, DOI 10.1016/0143-4004(95)90031-4; Baumann MU, 2007, AM J PHYSIOL-CELL PH, V293, pC477, DOI 10.1152/ajpcell.00075.2007; Bibee KP, 2011, REPROD SCI, V18, P20, DOI 10.1177/1933719110380276; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown K, 2011, PLACENTA, V32, P1041, DOI 10.1016/j.placenta.2011.09.014; Chellakooty M, 2004, J CLIN ENDOCR METAB, V89, P384, DOI 10.1210/jc.2003-030282; Cohran V, 1996, PLACENTA, V17, P313, DOI 10.1016/S0143-4004(96)90055-7; Cowley EA, 2005, AM J PHYSIOL-CELL PH, V288, pC891, DOI 10.1152/ajpcell.00134.2004; Davidson S, 2006, CLIN ENDOCRINOL, V65, P586, DOI 10.1111/j.1365-2265.2006.02632.x; Di Santo S, 2003, PLACENTA, V24, P882, DOI 10.1016/S0143-4004(03)00142-5; Fladeby C, 2003, BBA-MOL CELL RES, V1593, P201, DOI 10.1016/S0167-4889(02)00390-7; Gaither K, 1999, J CLIN ENDOCR METAB, V84, P695, DOI 10.1210/jc.84.2.695; Gatford KL, 2008, AM J PHYSIOL-ENDOC M, V295, pE170, DOI 10.1152/ajpendo.00047.2008; GRULLON K, 1995, PLACENTA, V16, P589, DOI 10.1016/0143-4004(95)90028-4; Heasman L, 2000, REPROD FERT DEVELOP, V12, P345, DOI 10.1071/RD00115; Hiden U, 2009, J ANAT, V215, P60, DOI 10.1111/j.1469-7580.2008.01035.x; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; JANSSON T, 1993, J CLIN ENDOCR METAB, V77, P1554, DOI 10.1210/jc.77.6.1554; Jansson T, 2001, AM J OBSTET GYNECOL, V184, P111, DOI 10.1067/mob.2001.108075; JANSSON T, 1990, PEDIATR RES, V28, P203, DOI 10.1203/00006450-199009000-00007; Jones HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074632; Kavitha JV, 2014, FASEB J, V28, P1294, DOI 10.1096/fj.13-242271; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Li T, 2003, CIRC RES, V93, P1202, DOI 10.1161/01.RES.0000104085.76261.02; Luo ZC, 2012, J CLIN ENDOCR METAB, V97, P1720, DOI 10.1210/jc.2011-3296; Magnusson-Olsson AL, 2006, J LIPID RES, V47, P2551, DOI 10.1194/jlr.M600098-JLR200; Masuyama H, 1996, J PERINAT MED, V24, P213, DOI 10.1515/jpme.1996.24.3.213; Matthews JC, 1999, PLACENTA, V20, P639, DOI 10.1053/plac.1999.0421; Olausson H, 2010, BRIT J NUTR, V104, P842, DOI 10.1017/S0007114510001224; OWENS JA, 1994, J ENDOCRINOL, V140, P5, DOI 10.1677/joe.0.1400005; Palmer ME, 1997, HUM REPROD, V12, P379, DOI 10.1093/humrep/12.2.379; Rebourcet R, 1998, BIOL REPROD, V58, P37, DOI 10.1095/biolreprod58.1.37; Russo VC, 2004, BRAIN RES, V1009, P40, DOI 10.1016/j.brainres.2004.02.042; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Schneider H, 2003, PLACENTA, V24, P27, DOI 10.1053/plac.2002.0869; Sferruzzi-Perri AN, 2011, J PHYSIOL-LONDON, V589, P7, DOI 10.1113/jphysiol.2010.198622; Sferruzzi-Perri AN, 2007, ENDOCRINOLOGY, V148, P4362, DOI 10.1210/en.2007-0411; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Vardhana PA, 2002, PLACENTA, V23, P653, DOI 10.1053/plac.2002.0857; Vatten LJ, 2002, PEDIATRICS, V109, P1131, DOI 10.1542/peds.109.6.1131; Verleysdonk S, 2004, NEUROCHEM RES, V29, P127, DOI 10.1023/B:NERE.0000010441.08234.ca; Wallborn T, 2010, J CLIN ENDOCR METAB, V95, P2316, DOI 10.1210/jc.2009-2404; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Williams SF, 2012, PLACENTA, V33, P31, DOI 10.1016/j.placenta.2011.09.021; Zamudio S, 2006, PLACENTA, V27, P49, DOI 10.1016/j.placenta.2004.12.010; Zamudio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008551	48	53	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106037	10.1371/journal.pone.0106037	http://dx.doi.org/10.1371/journal.pone.0106037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157747	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200086
J	Zhang, CQ; Chen, QD; Wang, YL; Zhao, XQ; Wang, CX; Liu, LP; Pu, YH; Zou, XY; Du, WL; Pan, YS; Li, ZX; Jing, J; Wang, DX; Luo, Y; Wong, KS; Wang, YJ				Zhang, Changqing; Chen, Qidong; Wang, Yilong; Zhao, Xingquan; Wang, Chunxue; Liu, Liping; Pu, Yuehua; Zou, Xinying; Du, Wanliang; Pan, Yuesong; Li, Zixiao; Jing, Jing; Wang, Dongxue; Luo, Yang; Wong, Ka Sing; Wang, Yongjun		Chinese IntraCranial AtheroScleros	Risk Factors of Dilated Virchow-Robin Spaces Are Different in Various Brain Regions	PLOS ONE			English	Article							SMALL VESSEL DISEASE; ENLARGED PERIVASCULAR SPACES; WHITE-MATTER; ISCHEMIC-STROKE; LACUNAR STROKE; DEMENTIA; MRI; SEVERITY; INFARCTS	Background and Purpose: Few studies have reported on the risk factors of dilated Virchow-Robin Spaces (dVRS) in large samples of ischemic stroke patients. Little evidence exists regarding the relationship between dVRS and etiologic subtype of ischemic stroke or lacune. We aimed to investigate the risk factors associated with the severity of dVRS in a large sample of ischemic stroke patients. Methods: We consecutively enrolled 1,090 patients who experienced an ischemic stroke within the past seven days and underwent a 3.0 T MRI scan in the Chinese IntraCranial AtheroSclerosis Study (ICAS). Clinical data and cranial MRI information of patients included age, sex, vascular risk factors, dVRS, leukoaraiosis, lacune, and etiologic subtype of ischemic stroke. Analyses were performed regarding the risk factors associated with the severity of dVRS by univariate analysis and multivariable ordinal logistic regression analysis. Results: Through multivariable ordinal logistic regression analysis, age, the severity of leukoaraiosis, lacune, admission National Institutes of Health Stroke Scale (NIHSS) <= 3, and the severity of dVRS in the white matter (WM) and hippocampus (Hip) were correlated with the severity of dVRS in basal ganglia (BG); male, history of hypertension, admission NIHSS <= 3, and the severity of dVRS in BG and Hip were correlated with the severity of dVRS in WM; female, the severity of leukoaraiosis, admission NIHSS >3, small artery occlusion subtype of ischemic stroke, and the severity of dVRS in BG and WM were correlated with the severity of dVRS in Hip. Conclusion: dVRS is an indicator of cerebral small vessel diseases such as leukoaraiosis and lacune. However, the risk factors of dVRS differ in various brain regions.	[Zhang, Changqing; Chen, Qidong; Wang, Yilong; Zhao, Xingquan; Wang, Chunxue; Liu, Liping; Pu, Yuehua; Zou, Xinying; Du, Wanliang; Pan, Yuesong; Li, Zixiao; Jing, Jing; Wang, Yongjun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Dongxue; Luo, Yang] Capital Med Univ, Beijing Tian Tan Hosp, Dept Nephrol, Beijing, Peoples R China; [Wong, Ka Sing] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Capital Medical University; Capital Medical University; Chinese University of Hong Kong; Prince of Wales Hospital	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	Pan, Yuesong/AAI-6303-2020; Wong, Ka Sing Lawrence/N-3434-2015; Luo, Yang/AAJ-3150-2021; liu, li/HGC-0900-2022	Pan, Yuesong/0000-0003-3082-6789; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Luo, Yang/0000-0002-1458-5519; 	Ministry of Science and Technology; Ministry of Health of the People's Republic of China; National S&T Major Project of China [2012ZX09303-005-001, 2011BAI08B02]; Beijing Municipal Science & Technology Commission [D111107003111007, Z131100002613005]; State Key Development Program of Basic Research of China [2009CB521905]; S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National S&T Major Project of China; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China); S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China, grant no. National S&T Major Project of China (2012ZX09303-005-001, 2011BAI08B02), Beijing Municipal Science & Technology Commission (D111107003111007, Z131100002613005), and State Key Development Program of Basic Research of China (2009CB521905) and, in part, by the S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1998, NEURORADIOLOGY, V40, P27, DOI 10.1007/s002340050533; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; BABIKIAN V, 1987, STROKE, V18, P2, DOI 10.1161/01.STR.18.1.2; Charidimou A, 2013, J NEUROL NEUROSUR PS, V84, P624, DOI 10.1136/jnnp-2012-304434; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FISHER CM, 1989, J NEUROL, V236, P65; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; FURUTA A, 1991, STROKE, V22, P442, DOI 10.1161/01.STR.22.4.442; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Kwee RM, 2007, RADIOGRAPHICS, V27, P1071, DOI 10.1148/rg.274065722; Leys D, 1999, EUR NEUROL, V42, P67, DOI 10.1159/000069414; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Patankar TF, 2005, AM J NEURORADIOL, V26, P1512; Potter GM, 2013, INT J STROKE; Pu YH, 2013, STROKE, V44, P2109, DOI 10.1161/STROKEAHA.113.001522; Revesz T, 2002, BRAIN PATHOL, V12, P343; Rosenberg GA, 2009, STROKE, V40, pS20, DOI 10.1161/STROKEAHA.108.533133; Rouhl RPW, 2008, J NEUROL, V255, P692, DOI 10.1007/s00415-008-0777-y; VANSWIETEN JC, 1991, BRAIN, V114, P761; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Wardlaw JM, 2009, ANN NEUROL, V65, P194, DOI 10.1002/ana.21549; Zhu YC, 2011, STROKE, V42, P1140, DOI 10.1161/STROKEAHA.110.600114; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	25	35	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105505	10.1371/journal.pone.0105505	http://dx.doi.org/10.1371/journal.pone.0105505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157843	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200033
J	Chaise, C; Lalmanach, AC; Marty, H; Soubies, SM; Croville, G; Loupias, J; Marc, D; Quere, P; Guerin, JL				Chaise, Coralie; Lalmanach, Anne-Christine; Marty, Helene; Soubies, Sebastien Mathieu; Croville, Guillaume; Loupias, Josyane; Marc, Daniel; Quere, Pascale; Guerin, Jean-Luc			Protection Patterns in Duck and Chicken after Homo- or Hetero-Subtypic Reinfections with H5 and H7 Low Pathogenicity Avian Influenza Viruses: A Comparative Study	PLOS ONE			English	Article							HETEROSUBTYPIC IMMUNITY; A VIRUSES; RIG-I; INFECTION; VACCINE; MALLARDS; GENES; HOST; H4N6; H3N8	Avian influenza viruses are circulating continuously in ducks, inducing a mostly asymptomatic infection, while chickens are accidental hosts highly susceptible to respiratory disease. This discrepancy might be due to a different host response to the virus between these two bird species and in particular to a different susceptibility to reinfection. In an attempt to address this question, we analyzed, in ducks and in chickens, the viral load in infected tissues and the humoral immune response after experimental primary and secondary challenge infections with either homologous or heterologous low pathogenicity avian influenza viruses (LPAIV). Following homologous reinfection, ducks were only partially protected against viral shedding in the lower intestine in conjunction with a moderate antibody response, whereas chickens were totally protected against viral shedding in the upper respiratory airways and developed a stronger antibody response. On the contrary, heterologous reinfection was not followed by a reduced viral excretion in the upper airways of chickens, while ducks were still partially protected from intestinal excretion of the virus, with no correlation to the antibody response. Our comparative study provides a comprehensive demonstration of the variation of viral tropism and control of the host humoral response to LPAIV between two different bird species with different degrees of susceptibility to avian influenza.	[Chaise, Coralie; Soubies, Sebastien Mathieu; Croville, Guillaume; Loupias, Josyane; Guerin, Jean-Luc] Univ Toulouse, Ecole Natl Vet Toulouse, Inst Natl Polytech Toulouse, Toulouse, France; [Chaise, Coralie; Soubies, Sebastien Mathieu; Croville, Guillaume; Loupias, Josyane; Guerin, Jean-Luc] INRA, Unite Mixte Rech Interact Hotes Agents Pathogene, F-31931 Toulouse, France; [Lalmanach, Anne-Christine; Marty, Helene; Marc, Daniel; Quere, Pascale] INRA, Unite Mixte Rech Infectiol & Sante Publ ISP 1282, F-37380 Nouzilly, France	Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; INRAE	Guerin, JL (corresponding author), Univ Toulouse, Ecole Natl Vet Toulouse, Inst Natl Polytech Toulouse, Toulouse, France.	jl.guerin@envt.fr	Quéré, Pascale/G-6590-2019; Croville, Guillaume/AAQ-6761-2021; Marc, Daniel/M-4296-2015	Quéré, Pascale/0000-0001-7763-3867; Croville, Guillaume/0000-0001-7577-2089; Marc, Daniel/0000-0003-3604-1958; Lalmanach, Anne-Christine/0000-0002-2666-4839; GUERIN, Jean-Luc/0000-0001-7770-4012; Soubies, Sebastien Mathieu/0000-0003-3065-3558	French Ministry of Agriculture, trough the "Fond National de Recherche sur l'Influenza Aviaire'' (FRIA)	French Ministry of Agriculture, trough the "Fond National de Recherche sur l'Influenza Aviaire'' (FRIA)	This work was granted by the French Ministry of Agriculture, trough the "Fond National de Recherche sur l'Influenza Aviaire'' (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando Y, 1996, IMMUNOLOGY, V89, P8, DOI 10.1046/j.1365-2567.1996.d01-703.x; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; Cornelissen JBWJ, 2012, AVIAN PATHOL, V41, P519, DOI 10.1080/03079457.2012.732691; Costa TP, 2010, AVIAN DIS, V54, P1286, DOI 10.1637/9480-072210-Reg.1; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Latorre-Margalef N, PLOS PATH, V9; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; Carranza-Flores JM, 2013, J VET SCI, V14, P487, DOI 10.4142/jvs.2013.14.4.487; Pepin KM, 2012, J GEN VIROL, V93, P2575, DOI 10.1099/vir.0.045427-0; Rebel JMJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-10; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Sasaki T, 2009, VACCINE, V27, P5174, DOI 10.1016/j.vaccine.2009.06.070; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Straight TM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-44; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; Swayne D. E., 2008, LAB MANUAL ISOLATION, P128; Swayne D.E., 2008, DIS POULTRY, P153; Vanderven HA, 2012, MOL IMMUNOL, V51, P316, DOI 10.1016/j.molimm.2012.03.034; Vergara-Alert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058692; Volmer C, 2011, J GEN VIROL, V92, P534, DOI 10.1099/vir.0.026443-0; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wibawa H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-117	29	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105189	10.1371/journal.pone.0105189	http://dx.doi.org/10.1371/journal.pone.0105189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153201	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200041
J	Le, AH; Bonachea, LA; Cargill, SL				Le, Anna H.; Bonachea, Luis A.; Cargill, Shelley L.			Meloxicam and Buprenorphine Treatment after Ovarian Transplantation Does Not Affect Estrous Cyclicity and Follicular Integrity in Aged CBA/J Mice	PLOS ONE			English	Article							VAGINAL CYTOLOGY; MOUSE OVARIES; FEMALE RATS; ANGIOGENESIS; GROWTH; CYCLE; MORPHINE; STRAINS; CELLS; INHIBITION	Angiogenesis, the formation of new blood vessels, is important for the survival of ovarian transplants and the restoration of ovarian functions. Without angiogenesis, transplanted ovarian tissue becomes more susceptible to tissue damage and necrosis. Administration of analgesics for pain management has been shown to decrease angiogenesis, which can influence transplant success especially in aged animals. Aging and the effects of hypoxia after transplantation decrease reproductive viability of the ovarian transplant; therefore, it is important to understand the additional effects of analgesics on aged animal models. The present study investigated the effects of two analgesics, buprenorphine, an opiate, and meloxicam, a non-steroidal anti-inflammatory drug (NSAID), on the reproductive indicators related to estrous cyclicity and follicular integrity after ovarian transplantation of young ovaries into aged CBA/J mice. These aged females did not show any different reproductive responses when treated with either buprenorphine or meloxicam. No significant differences were observed in estrous cycle length, the onset of estrous cycling, the regularity of estrous cycles, and the proportion of viable follicles and total number of follicles per ovarian sample across treatment groups.	[Le, Anna H.; Bonachea, Luis A.; Cargill, Shelley L.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA	California State University System; San Jose State University	Cargill, SL (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	shelley.cargill@sjsu.edu			California State University Research Funds; Junior Faculty Career Development Grant; John and Betty Davison Fellowship	California State University Research Funds; Junior Faculty Career Development Grant; John and Betty Davison Fellowship	This work was supported by: California State University Research Funds to SC; Junior Faculty Career Development Grant to SC; John and Betty Davison Fellowship to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, VET DRUG HDB; Arias P, 1996, BRAIN RES, V740, P234, DOI 10.1016/S0006-8993(96)00862-1; Basset DL, 1943, AM J ANAT, V73, P251, DOI 10.1002/aja.1000730206; Cargill SL, 2003, AGING CELL, V2, P185, DOI 10.1046/j.1474-9728.2003.00049.x; Cargill SL, 1999, BIOL REPROD, V61, P283, DOI 10.1095/biolreprod61.1.283; COOPER RL, 1980, BIOL REPROD, V23, P611, DOI 10.1095/biolreprod23.3.611; Dai X, 2010, EUR J PHARMACOL, V628, P42, DOI 10.1016/j.ejphar.2009.11.035; DISSEN GA, 1994, ENDOCRINOLOGY, V134, P1146, DOI 10.1210/en.134.3.1146; Fevold HI, 1931, AM J PHYSIOL, V97, P291, DOI 10.1152/ajplegacy.1931.97.2.291; Flecknell PA., 2009, LAB ANIMAL ANESTHESI, V3rd edition; Fujino Y, 1996, HUM REPROD, V11, P1480; FULLER JL, 1967, J HERED, V58, P135, DOI 10.1093/oxfordjournals.jhered.a107565; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; GOSDEN RG, 1975, J REPROD FERTIL, V42, P423, DOI 10.1530/jrf.0.0420423; Gunasena KT, 1997, HUM REPROD, V12, P101, DOI 10.1093/humrep/12.1.101; Gupta K, 2002, CANCER RES, V62, P4491; HARRIS M, 1949, J EXP ZOOL, V112, P131, DOI 10.1002/jez.1401120110; Hsiao PN, 2009, TOXICOLOGY, V256, P83, DOI 10.1016/j.tox.2008.11.015; Israely T, 2003, BIOL REPROD, V68, P2055, DOI 10.1095/biolreprod.102.011734; Jones MK, 1999, NAT MED, V5, P1418; KAMEI J, 1995, LIFE SCI, V56, pPL285, DOI 10.1016/0024-3205(95)00078-X; Kim SS, 2004, FERTIL STERIL, V82, P679, DOI 10.1016/j.fertnstert.2004.05.022; Lam CF, 2008, ANESTH ANALG, V107, P686, DOI 10.1213/ane.0b013e31817e6719; Liu HC, 2004, J NEUROIMMUNOL, V146, P13, DOI 10.1016/j.jneuroim.2003.09.016; Liu L, 2008, HUM REPROD, V23, P122, DOI 10.1093/humrep/dem348; Lohff JC, 2005, COMPARATIVE MED, V55, P523; Mason JB, 2009, J GERONTOL A-BIOL, V64, P1207, DOI 10.1093/gerona/glp134; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Nugent D, 1998, J REPROD FERTIL, V114, P341, DOI 10.1530/jrf.0.1140341; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450; Tarnawski AS, 2003, J MOL MED, V81, P627, DOI 10.1007/s00109-003-0479-y; Vane JR, 1996, SCAND J RHEUMATOL, P9; Wang YR, 2012, REPROD BIOMED ONLINE, V24, P646, DOI 10.1016/j.rbmo.2012.02.025; WHITTEN WK, 1956, J ENDOCRINOL, V13, P399, DOI 10.1677/joe.0.0130399; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zuniga J, 2003, BIOL RES, V36, P233, DOI 10.4067/S0716-97602003000200013	39	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106013	10.1371/journal.pone.0106013	http://dx.doi.org/10.1371/journal.pone.0106013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153315	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200105
J	Leskinen, MH; Hautaniemi, EJ; Tahvanainen, AM; Koskela, JK; Paallysaho, M; Tikkakoski, AJ; Kahonen, M; Koobi, T; Niemela, O; Mustonen, J; Porsti, IH				Leskinen, Miia H.; Hautaniemi, Elina J.; Tahvanainen, Anna M.; Koskela, Jenni K.; Paallysaho, Marika; Tikkakoski, Antti J.; Kahonen, Mika; Koobi, Tiit; Niemela, Onni; Mustonen, Jukka; Porsti, Ilkka H.			Daily Liquorice Consumption for Two Weeks Increases Augmentation Index and Central Systolic and Diastolic Blood Pressure	PLOS ONE			English	Article							CENTRAL AORTIC PRESSURE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID RECEPTOR; ARTERIAL STIFFNESS; GLYCYRRHIZIC ACID; LOWERING DRUGS; WAVE ANALYSIS; ALDOSTERONE; HYPERTENSION	Background: Liquorice ingestion often elevates blood pressure, but the detailed haemodynamic alterations are unknown. We studied haemodynamic changes induced by liquorice consumption in 20 subjects versus 30 controls with average blood pressures of 120/68 and 116/64 mmHg, respectively. Methods: Haemodynamic variables were measured in supine position before and after two weeks of liquorice consumption (daily glycyrrhizin dose 290-370 mg) with tonometric recording of radial blood pressure, pulse wave analysis, and whole-body impedance cardiography. Thirty age-matched healthy subjects maintaining their normal diet were studied as controls. Results: Two weeks of liquorice ingestion elevated peripheral and central systolic and diastolic blood pressure (by 7/4 and 8/4 mmHg, 95% confidence intervals [CI] 2-11/1-8 and 3-13/1-8, respectively, P<0.05), and increased extracellular volume by 0.5 litres (P<0.05 versus controls). Also augmentation index adjusted to heart rate 75/min (from 7% to 11%, 95% CI for change 0.3-7.5, P<0.05) and aortic pulse pressure (by 4 mmHg, 95% CI 1-7, P<0.05) were elevated indicating increased wave reflection from the periphery. In contrast, peripheral (-3/-0.3 mmHg) and central blood pressure (-2/-0.5 mmHg), aortic pulse pressure (-1 mmHg), and augmentation index adjusted to heart rate 75/min (from 9% to 7%) decreased numerically but not statistically significantly without changes in extracellular volume in the control group. Heart rate, systemic vascular resistance, cardiac output, and pulse wave velocity did not differ between the groups. Conclusions: Two weeks of daily liquorice consumption increased extracellular volume, amplified pressure wave reflection from the periphery, and elevated central systolic and diastolic blood pressure.	[Leskinen, Miia H.; Hautaniemi, Elina J.; Tahvanainen, Anna M.; Koskela, Jenni K.; Paallysaho, Marika; Tikkakoski, Antti J.; Kahonen, Mika; Niemela, Onni; Mustonen, Jukka; Porsti, Ilkka H.] Univ Tampere, Dept Internal Med, Sch Med, FIN-33101 Tampere, Finland; [Kahonen, Mika; Koobi, Tiit] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Niemela, Onni] Seinajoki Cent Hosp, Dept Lab Med, Seinajoki, Finland; [Niemela, Onni] Seinajoki Cent Hosp, Med Res Unit, Seinajoki, Finland; [Mustonen, Jukka; Porsti, Ilkka H.] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital; Seinajoki Central Hospital; Seinajoki Central Hospital; Tampere University; Tampere University Hospital	Hautaniemi, EJ (corresponding author), Univ Tampere, Dept Internal Med, Sch Med, FIN-33101 Tampere, Finland.	elina.hautaniemi@uta.fi		Kahonen, Mika/0000-0002-4510-7341	Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Paavo Nurmi Foundation; Pirkanmaa Regional Fund of the Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Astra Zeneca Plc.	Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paavo Nurmi Foundation; Pirkanmaa Regional Fund of the Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Astra Zeneca Plc.(AstraZeneca)	Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital, the Finnish Foundation for Cardiovascular Research, the Sigrid Juselius Foundation, the Paavo Nurmi Foundation, the Pirkanmaa Regional Fund of the Finnish Cultural Foundation, the Tampere Tuberculosis Foundation, and Astra Zeneca Plc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanini D, 2003, CRIT REV CL LAB SCI, V40, P295, DOI 10.1080/713609355; Blomberg K, 1993, FINNISH NATL FOOD AD, V10, P1; Chen CH, 1997, CIRCULATION, V95, P1827; CONN JW, 1968, J AMER MED ASSOC, V205, P492, DOI 10.1001/jama.205.7.492; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; EPSTEIN MT, 1977, BRIT MED J, V1, P209, DOI 10.1136/bmj.1.6055.209; FARESE RV, 1991, NEW ENGL J MED, V325, P1223, DOI 10.1056/NEJM199110243251706; Franklin SS, 1997, CIRCULATION, V96, P308; Frey FJ, 2004, CURR OPIN NEPHROL HY, V13, P451, DOI 10.1097/01.mnh.0000133976.32559.b0; Funder JW, 2010, PROG CARDIOVASC DIS, V52, P393, DOI 10.1016/j.pcad.2009.12.003; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; FUNDER JW, 1989, ENDOCRINOLOGY, V125, P2224, DOI 10.1210/endo-125-4-2224; Hatakeyama H, 1999, HYPERTENSION, V33, P1179, DOI 10.1161/01.HYP.33.5.1179; Hatakeyama H, 2000, KIDNEY INT, V57, P1352, DOI 10.1046/j.1523-1755.2000.00974.x; Hu YQ, 2006, AM J CLIN NUTR, V84, P70, DOI 10.1093/ajcn/84.1.70; Koobi T, 1997, INTENS CARE MED, V23, P1132, DOI 10.1007/s001340050469; Koskela JK, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-102; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Li YJ, 2011, J CHROMATOGR A, V1218, P8181, DOI 10.1016/j.chroma.2011.09.030; LOMBES M, 1995, CIRCULATION, V92, P175, DOI 10.1161/01.CIR.92.2.175; LUNDJOHANSEN P, 1991, HYPERTENSION, V18, pS54; Mahmud A, 2005, AM J HYPERTENS, V18, P50, DOI 10.1016/j.amjhyper.2004.08.026; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mynard JP, 2012, J HYPERTENS, V30, P734, DOI 10.1097/HJH.0b013e32834f9793; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Ploeger B, 2001, DRUG METAB REV, V33, P125, DOI 10.1081/DMR-100104400; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Schillaci G, 2011, J HYPERTENS, V29, P869, DOI 10.1097/HJH.0b013e328344da49; Sigurjonsdottir HA, 2003, J HUM HYPERTENS, V17, P125, DOI 10.1038/sj.jhh.1001504; Sigurjonsdottir HA, 2006, BLOOD PRESSURE, V15, P169, DOI 10.1080/08037050600593060; STEWART PM, 1987, LANCET, V2, P821; STORMER FC, 1993, FOOD CHEM TOXICOL, V31, P303, DOI 10.1016/0278-6915(93)90080-I; Sweetman, 2009, COMPLETE DRUG REFERE; Tahvanainen A, 2009, SCAND J CLIN LAB INV, V69, P128, DOI 10.1080/00365510802439098; Tahvanainen AM, 2012, J HYPERTENS, V30, P297, DOI 10.1097/HJH.0b013e32834e4b26; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; WALKER BR, 1992, CLIN SCI, V83, P171, DOI 10.1042/cs0830171; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496	41	12	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105607	10.1371/journal.pone.0105607	http://dx.doi.org/10.1371/journal.pone.0105607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153328	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200066
J	Luey, N; Toon, CW; Sioson, L; Clarkson, A; Watson, N; Cussigh, C; Kedziora, A; Pincott, S; Pillinger, S; Evans, J; Percy, J; Engel, A; Schnitzler, M; Gill, AJ				Luey, Nathan; Toon, Christopher W.; Sioson, Loretta; Clarkson, Adele; Watson, Nicole; Cussigh, Carmen; Kedziora, Andrew; Pincott, Stuart; Pillinger, Stephen; Evans, Justin; Percy, John; Engel, Alexander; Schnitzler, Margaret; Gill, Anthony J.			A Further Investigation of Combined Mismatch Repair and BRAFV600E Mutation Specific Immunohistochemistry as a Predictor of Overall Survival in Colorectal Carcinoma	PLOS ONE			English	Article							BRAF V600E MUTATION; LYNCH SYNDROME; THYROID-CARCINOMA; ANTIBODY; CANCER; ADENOCARCINOMA; VE1	Mutation specific immunohistochemistry (IHC) is a promising new technique to detect the presence of the BRAFV600E mutation in colorectal carcinoma (CRC). When performed in conjunction with mismatch repair (MMR) IHC, BRAFV600E IHC can help to further triage genetic testing for Lynch Syndrome. In a cohort of 1426 patients undergoing surgery from 2004 to 2009 we recently demonstrated that the combination of MMR and BRAFV600E IHC holds promise as a prognostic marker in CRC, particularly because of its ability to identify the poor prognosis MMR proficient (MMRp) BRAFV600E mutant subgroup. We attempted to validate combined MMR and BRAFV600E IHC as a prognostic indicator in a separate cohort comprising consecutive CRC patients undergoing surgery from 1998 to 2003. IHC was performed on a tissue microarray containing tissue from 1109 patients with CRC. The 5 year survivals stratified by staining patterns were: MMRd/BRAFwt 64%, MMRd/BRAFV600E 64%, MMRp/BRAFwt 60% and MMRp/BRAFV600E 53%. Using the poor prognosis MMRp/BRAFV600E phenotype as baseline, univariate Cox regression modelling demonstrated the following hazard ratios for death: MMRd/BRAFwt HR = 0.71 (95% CI = 0.40-1.27), p = 0.31; MMRd/BRAFV600E HR = 0.74 (95% CI = 0.51-1.07), p = 0.11 and MMRp/BRAFwt HR = 0.79 (95% CI = 0.60-1.04), p = 0.09. Although the findings did not reach statistical significance, this study supports the potential role of combined MMR and BRAF IHC as prognostic markers in CRC.	[Luey, Nathan; Toon, Christopher W.; Pincott, Stuart; Pillinger, Stephen; Evans, Justin; Percy, John; Engel, Alexander; Schnitzler, Margaret; Gill, Anthony J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Toon, Christopher W.; Sioson, Loretta; Clarkson, Adele; Watson, Nicole; Cussigh, Carmen; Kedziora, Andrew; Gill, Anthony J.] Royal N Shore Hosp, Kolling Inst Med Res, Canc Diag & Pathol Res Grp, St Leonards, NSW 2065, Australia; [Toon, Christopher W.; Clarkson, Adele] Histopath Pathol, N Ryde, NSW, Australia; [Toon, Christopher W.; Engel, Alexander; Gill, Anthony J.] Royal N Shore Hosp, Sydney Vital Translat Res Ctr, St Leonards, NSW 2065, Australia; [Engel, Alexander; Schnitzler, Margaret; Gill, Anthony J.] Royal N Shore Hosp, Dept Anat Pathol, St Leonards, NSW 2065, Australia; [Pincott, Stuart; Pillinger, Stephen; Evans, Justin; Percy, John] Royal N Shore Hosp, Dept Colorectal Surg, St Leonards, NSW 2065, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Royal North Shore Hospital; Royal North Shore Hospital	Gill, AJ (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	affgill@med.usyd.edu.au	Gill, Anthony J./M-5015-2019; Gill, Anthony/D-4215-2015	Gill, Anthony/0000-0002-9447-1967; Toon, Christopher/0000-0002-0750-918X; Pincott, Stuart/0000-0001-5333-0183	Cancer Institute NSW	Cancer Institute NSW	This study was supported by funding from the Cancer Institute NSW as part of a translational research centre grant and internally by the department of anatomical pathology Royal North Shore Hospital. No other funding support was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adackapara CA, 2013, HISTOPATHOLOGY, V63, P187, DOI 10.1111/his.12154; Affolter K, 2013, GENE CHROMOSOME CANC, V52, P748, DOI 10.1002/gcc.22070; Bullock M, 2012, ENDOCR-RELAT CANCER, V19, P779, DOI 10.1530/ERC-12-0239; Capper D, 2013, INT J CANCER, V133, P1624, DOI 10.1002/ijc.28183; Edge SB, 2009, AJCC CANC STAGING MA, V7; Hall G, 2010, PATHOLOGY, V42, P409, DOI 10.3109/00313025.2010.493871; Ilie MI, 2014, PATHOLOGY, V46, P311, DOI 10.1097/PAT.0000000000000113; Kuan SF, 2014, HUM PATHOL, V45, P464, DOI 10.1016/j.humpath.2013.10.026; Lasota J, 2014, AM J SURG PATHOL; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Nolan S, 2014, APPL IMMUNOHISTO M M, V22, pE8, DOI 10.1097/PAI.0000000000000026; Rossle M, 2013, VIRCHOWS ARCH, V463, P623, DOI 10.1007/s00428-013-1492-3; Routhier CA, 2013, HUM PATHOL, V44, P2563, DOI 10.1016/j.humpath.2013.06.018; Sajanti S, 2014, VIRCHOWS ARCH, V464, P637, DOI 10.1007/s00428-014-1555-0; Sinicrope FA, 2013, CANCER-AM CANCER SOC, V119, P2765, DOI 10.1002/cncr.28133; Thiel A, 2013, VIRCHOWS ARCH, V463, P613, DOI 10.1007/s00428-013-1470-9; Toon CW, 2014, MODERN PATHOL, V27, P644, DOI 10.1038/modpathol.2013.200; Toon CW, 2013, AM J SURG PATHOL, V37, P1592, DOI 10.1097/PAS.0b013e31828f233d	18	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106105	10.1371/journal.pone.0106105	http://dx.doi.org/10.1371/journal.pone.0106105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153715	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200116
J	Amgalan, B; Lee, H				Amgalan, Bayarbaatar; Lee, Hyunju			WMAXC: A Weighted Maximum Clique Method for Identifying Condition-Specific Sub-Network	PLOS ONE			English	Article							PROSTATE-CANCER; SIGNALING PATHWAY; UP-REGULATION; EXPRESSION; TRANSCRIPTION	Sub-networks can expose complex patterns in an entire bio-molecular network by extracting interactions that depend on temporal or condition-specific contexts. When genes interact with each other during cellular processes, they may form differential co-expression patterns with other genes across different cell states. The identification of condition-specific sub-networks is of great importance in investigating how a living cell adapts to environmental changes. In this work, we propose the weighted MAXimum clique (WMAXC) method to identify a condition-specific sub-network. WMAXC first proposes scoring functions that jointly measure condition-specific changes to both individual genes and gene-gene co-expressions. It then employs a weaker formula of a general maximum clique problem and relates the maximum scored clique of a weighted graph to the optimization of a quadratic objective function under sparsity constraints. We combine a continuous genetic algorithm and a projection procedure to obtain a single optimal sub-network that maximizes the objective function (scoring function) over the standard simplex (sparsity constraints). We applied the WMAXC method to both simulated data and real data sets of ovarian and prostate cancer. Compared with previous methods, WMAXC selected a large fraction of cancer-related genes, which were enriched in cancer-related pathways. The results demonstrated that our method efficiently captured a subset of genes relevant under the investigated condition.	[Amgalan, Bayarbaatar; Lee, Hyunju] Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST)	Lee, H (corresponding author), Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea.	hyunjulee@gist.ac.kr		Lee, Hyunju/0000-0003-2389-7183	Gwangju Institute of Science Technology; MSIP (The Ministry of Science, ICT and Future Planning), Korea; Microsoft Research, under IT/SW Creative research program [NIPA-2013-H0503-13-1019]	Gwangju Institute of Science Technology; MSIP (The Ministry of Science, ICT and Future Planning), Korea; Microsoft Research, under IT/SW Creative research program	This work was supported by the Systems biology infrastructure establishment grant provided by Gwangju Institute of Science & Technology in 2014, and by the MSIP (The Ministry of Science, ICT and Future Planning), Korea and Microsoft Research, under IT/SW Creative research program supervised by the NIPA (National IT Industry Promotion Agency) (NIPA-2013-H0503-13-1019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; Backes C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1227; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BREITLING R, 2004, BMC BIOINFORMATICS, V5; Chen L, 2012, NUCLEIC ACIDS RES, V41, pe42; Chen L, 2010, BIOINFORMATICS, V26, P1416, DOI 10.1093/bioinformatics/btq144; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; da Silva HB, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/920612; de Graeff P, 2008, BRIT J CANCER, V99, P341, DOI 10.1038/sj.bjc.6604471; Du D.Z., 1999, HDB COMBINATORIAL OP; Gioeli D, 1999, CANCER RES, V59, P279; Guo Z, 2007, BIOINFORMATICS, V23, P2121, DOI 10.1093/bioinformatics/btm294; Gupta S, 2007, CANCER RES, V70, P6735; Haupt R, 2004, PRACTICAL GENETIC AL, P51, DOI DOI 10.1002/0471671746.CH3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ideker T, 2003, BIOINFORMATICS, V18, ps233; Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Kyrillidis A., 2013, INT C MACH LEARN ICM, V28, P235; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Ma HS, 2011, BIOINFORMATICS, V27, P1290, DOI 10.1093/bioinformatics/btr136; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Maqungo M, 2011, NUCLEIC ACIDS RES, V39, pD980, DOI 10.1093/nar/gkq849; MICHELOT C, 1986, J OPTIMIZ THEORY APP, V50, P195, DOI 10.1007/BF00938486; MOTZKIN TS, 1965, CANADIAN J MATH, V17, P533, DOI 10.4153/CJM-1965-053-6; Nacu S, 2007, BIOINFORMATICS, V23, P850, DOI 10.1093/bioinformatics/btm019; Park J, NOTCH3 EXPRESSION RE; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qiu YQ, IET SYSTEMS BIOL, V3, P475; Rajagopalan D, 2005, BIOINFORMATICS, V21, P788, DOI 10.1093/bioinformatics/bti069; Resto VA, 2008, J BIOL CHEM, V283, P15816, DOI 10.1074/jbc.M708899200; Satoh F, 2001, INT J UROL, V8, pS28, DOI 10.1046/j.1442-2042.2001.00331.x; Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856; Songsiri J, 2011, AS S AUT CONTR VIETN; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Turan P, 1941, MAT FIZ LAPOK, V48, P435; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulitsky I, 2008, LECT N BIOINFORMAT, V4955, P347; Waaijenborg S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-315; Wang Q, 2010, PLOS ONE, pe10456; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu YM, 2004, CANCER RES, V64, P7311, DOI 10.1158/0008-5472.CAN-04-0972; Yamamura S, 2012, INT J CANCER, V130, P20, DOI 10.1002/ijc.25961	48	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104993	10.1371/journal.pone.0104993	http://dx.doi.org/10.1371/journal.pone.0104993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148538	gold, Green Published			2022-12-27	WOS:000341230600029
J	Arnaud-Haond, S; Moalic, Y; Barnabe, C; Ayala, FJ; Tibayrenc, M				Arnaud-Haond, Sophie; Moalic, Yann; Barnabe, Christian; Ayala, Francisco Jose; Tibayrenc, Michel			Discriminating Micropathogen Lineages and Their Reticulate Evolution through Graph Theory-Based Network Analysis: The Case of Trypanosoma cruzi, the Agent of Chagas Disease	PLOS ONE			English	Article							COMPARED VECTORIAL TRANSMISSIBILITY; CLONAL EVOLUTION; GENETIC EXCHANGE; POPULATION STRUCTURES; NUCLEOTIDE-SEQUENCES; NATURAL-POPULATIONS; PARASITIC PROTOZOA; RECOMBINATION; HYBRIDIZATION; PLASMODIUM	Micropathogens (viruses, bacteria, fungi, parasitic protozoa) share a common trait, which is partial clonality, with wide variance in the respective influence of clonality and sexual recombination on the dynamics and evolution of taxa. The discrimination of distinct lineages and the reconstruction of their phylogenetic history are key information to infer their biomedical properties. However, the phylogenetic picture is often clouded by occasional events of recombination across divergent lineages, limiting the relevance of classical phylogenetic analysis and dichotomic trees. We have applied a network analysis based on graph theory to illustrate the relationships among genotypes of Trypanosoma cruzi, the parasitic protozoan responsible for Chagas disease, to identify major lineages and to unravel their past history of divergence and possible recombination events. At the scale of T. cruzi subspecific diversity, graph theory-based networks applied to 22 isoenzyme loci (262 distinct Multi-Locus-Enzyme-Electrophoresis -MLEE) and 19 microsatellite loci (66 Multi-Locus-Genotypes -MLG) fully confirms the high clustering of genotypes into major lineages or "near-clades''. The release of the dichotomic constraint associated with phylogenetic reconstruction usually applied to Multilocus data allows identifying putative hybrids and their parental lineages. Reticulate topology suggests a slightly different history for some of the main "near-clades'', and a possibly more complex origin for the putative hybrids than hitherto proposed. Finally the sub-network of the near-clade T. cruzi I (28 MLG) shows a clustering subdivision into three differentiated lesser near-clades ("Russian doll pattern''), which confirms the hypothesis recently proposed by other investigators. The present study broadens and clarifies the hypotheses previously obtained from classical markers on the same sets of data, which demonstrates the added value of this approach. This underlines the potential of graph theory-based network analysis for describing the nature and relationships of major pathogens, thereby opening stimulating prospects to unravel the organization, dynamics and history of major micropathogen lineages.	[Arnaud-Haond, Sophie; Moalic, Yann] IFREMER, Dept Ecosyst Marins Exploites, F-34203 Sete, France; [Barnabe, Christian] INTERTRYP IRD CIRAD, Montpellier, France; [Ayala, Francisco Jose] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92717 USA; [Tibayrenc, Michel] IRD 224 CNRS 5290 UM1 UM2, MIVEGEC, Montpellier, France	Ifremer; CIRAD; Institut de Recherche pour le Developpement (IRD); University of California System; University of California Irvine; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Arnaud-Haond, S (corresponding author), IFREMER, Dept Ecosyst Marins Exploites, F-34203 Sete, France.	sarnaud@ifremer.fr	Moalic, Yann/G-6964-2015; Barnabé, Christian/R-2904-2016; Arnaud-Haond, Sophie/B-2479-2008; Tibayrenc, Michel/AAY-7494-2021	Moalic, Yann/0000-0001-7385-7484; Barnabé, Christian/0000-0003-1857-0741; Arnaud-Haond, Sophie/0000-0001-5814-8452; 	Clonix of the French National Agency for Research (ANR Clonix) [ANR-11-BSV7-007]	Clonix of the French National Agency for Research (ANR Clonix)(French National Research Agency (ANR))	This work was funded by the project Clonix of the French National Agency for Research (ANR Clonix (ANR-11-BSV7-007)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Avise JC, 2004, MOL MARKETS NATURAL; Awadalla P, 2003, NAT REV GENET, V4, P50, DOI 10.1038/nrg964; BarabuYSi A., 2003, LINKED EVERYTHING IS; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; Barnabe C, 2012, INFECT GENET EVOL, V12, P1879, DOI 10.1016/j.meegid.2012.08.018; Barton NH, 2010, PHILOS T R SOC B, V365, P2559, DOI 10.1098/rstb.2010.0106; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Batagelj V, 2002, LECT NOTES COMPUT SC, V2265, P477; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Breniere SF, 1998, ACTA TROP, V71, P269, DOI 10.1016/S0001-706X(98)00061-8; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; Burgos JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058967; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Conway DJ, 2000, INT J PARASITOL, V30, P1423, DOI 10.1016/S0020-7519(00)00126-0; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; de Lana M, 1998, EXP PARASITOL, V90, P20, DOI 10.1006/expr.1998.4304; de Lana M, 2000, EXP PARASITOL, V96, P61, DOI 10.1006/expr.2000.4552; de Meeus T, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P133, DOI 10.1016/B978-0-12-384890-1.00005-4; Dos Santos DA, 2012, SYST BIOL, V61, P240, DOI 10.1093/sysbio/syr098; ESTOUP A, 1995, GENETICS, V140, P679; Flores-Lopez CA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001272; Fortuna MA, 2009, P NATL ACAD SCI USA, V106, P19044, DOI 10.1073/pnas.0907704106; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Grigg ME, 2003, MICROBES INFECT, V5, P685, DOI 10.1016/S1286-4579(03)00088-1; Guhl F, 2011, ACTA TROP, V119, P1, DOI 10.1016/j.actatropica.2011.04.002; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; KIRKPATRICK M, 1989, NATURE, V339, P300, DOI 10.1038/339300a0; Kivela M, 2015, MOL ECOL RESOUR, V15, P117, DOI 10.1111/1755-0998.12290; Laurent JP, 1997, PARASITOLOGY, V114, P213, DOI 10.1017/S0031182096008414; Lauthier JJ, 2012, INFECT GENET EVOL, V12, P350, DOI 10.1016/j.meegid.2011.12.008; Lawrence JG, 2005, CURR OPIN MICROBIOL, V8, P572, DOI 10.1016/j.mib.2005.08.005; Lewis MD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001363; Lewis MD, 2009, INT J PARASITOL, V39, P1305, DOI 10.1016/j.ijpara.2009.04.001; Llewellyn MS, 2011, INT J PARASITOL, V41, P609, DOI 10.1016/j.ijpara.2010.12.004; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Martin DP, 2010, BACTERIAL POPULATION, P61; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MILES MA, 1978, NATURE, V272, P819, DOI 10.1038/272819a0; Moalic Y, 2012, SYST BIOL, V61, P127, DOI 10.1093/sysbio/syr088; Moalic Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-33; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ocana-Mayorga S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000915; Otto SP, 1998, TRENDS ECOL EVOL, V13, P145, DOI 10.1016/S0169-5347(97)01260-3; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; Pena SDJ, 2009, MEM I OSWALDO CRUZ, V104, P108, DOI 10.1590/S0074-02762009000900016; Pinto AD, 1998, PARASITOL RES, V84, P348, DOI 10.1007/s004360050409; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Revollo S, 1998, EXP PARASITOL, V89, P30, DOI 10.1006/expr.1998.4216; Rozenfeld AF, 2007, J R SOC INTERFACE, V4, P1093, DOI 10.1098/rsif.2007.0230; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; STAUFFER D, 1994, INTRO PERCOLATION TH; Subileau M, 2009, EXP PARASITOL, V122, P328, DOI 10.1016/j.exppara.2009.04.008; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Telleria J, 2010, P NATL ACAD SCI USA, V107, P20411, DOI 10.1073/pnas.1015496107; Tibayrenc M, 1998, INT J PARASITOL, V28, P85, DOI 10.1016/S0020-7519(97)00180-X; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; Tibayrenc M, 2013, TRENDS PARA IN PRESS; Tibayrenc M, 2012, P NATL ACAD SCI USA, V109, pE3305, DOI 10.1073/pnas.1212452109; Venegas J, 2009, PARASITOL RES, V105, P191, DOI 10.1007/s00436-009-1386-0; Watts DJ, 2004, ANNU REV SOCIOL, V30, P243, DOI 10.1146/annurev.soc.30.020404.104342; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Yeo M, 2011, PLOS NEGLECTED TROPI, V5; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	75	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e103213	10.1371/journal.pone.0103213	http://dx.doi.org/10.1371/journal.pone.0103213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148574	Green Published, gold			2022-12-27	WOS:000341230600005
J	Liu, YW; Beaucham, CC; Pearce, TA; Zhuang, ZQ				Liu, Yuewei; Beaucham, Catherine C.; Pearce, Terri A.; Zhuang, Ziqing			Assessment of Two Portable Real-Time Particle Monitors Used in Nanomaterial Workplace Exposure Evaluations	PLOS ONE			English	Article							POTENTIAL INHALATION EXPOSURE; ASSESSMENT TECHNIQUE NEAT; DIRECT-READING DUST; ENGINEERED NANOMATERIALS; NANOPARTICLES; FIELD; IDENTIFICATION; AGREEMENT; ULTRAFINE; HEALTH	Background: Nanoparticle emission assessment technique was developed to semi-quantitatively evaluate nanomaterial exposures and employs a combination of filter based samples and portable real-time particle monitors, including a condensation particle counter (CPC) and an optical particle counter (OPC), to detect nanomaterial releases. This laboratory study evaluated the results from CPC and OPC simultaneously measuring a polydisperse aerosol to assess their variability and accuracy. Methods and Results: Two CPCs and two OPCs were used to evaluate a polydisperse sodium chloride aerosol within an enclosed chamber. The measurement results for number concentration versus time were compared between paired particle monitors of the same type, and to results from the Scanning Mobility Particle Spectrometer (SMPS) which was widely used to measure concentration of size-specific particles. According to analyses by using the Bland-Altman method, the CPCs displayed a constant mean percent difference of 23.8% (95% agreement limits: -9.1 to 1.6%; range of 95% agreement limit: 10.7%) with the chamber particle concentration below its dynamic upper limit (100,000 particles per cubic centimeter). The mean percent difference increased from -3.4% to -12.0% (range of 95% agreement limits: 7.1%) with increasing particle concentrations that were above the dynamic upper limit. The OPC results showed the percent difference within 15% for measurements in particles with size ranges of 300 to 500 and 500 to 1000 regardless of the particle concentration. Compared with SMPS measurements, the CPC gave a mean percent difference of 22.9% (95% agreement limits: 10.5% to 35.2%); whereas the measurements from OPC were not comparable. Conclusions: This study demonstrated that CPC and OPC are useful for measuring nanoparticle exposures but the results from an individual monitor should be interpreted based upon the instrument's technical parameters. Future research should challenge these monitors with particles of different sizes, shapes, or composition, to determine measurement comparability and accuracy across various workplace nanomaterials.	[Liu, Yuewei] Hubei Ctr Dis Control & Prevent, Inst Hlth Surveillance Anal & Protect, Wuhan, Hubei, Peoples R China; [Liu, Yuewei; Zhuang, Ziqing] NIOSH, Natl Personal Protect Technol Lab, Pittsburgh, PA 15236 USA; [Beaucham, Catherine C.] NIOSH, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA; [Pearce, Terri A.] URS Corp, Pittsburgh, PA USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Zhuang, ZQ (corresponding author), NIOSH, Natl Personal Protect Technol Lab, Pittsburgh, PA 15236 USA.	zaz3@cdc.gov	Liu, Yuewei/J-5147-2019	Liu, Yuewei/0000-0001-5970-4262	Nanotechnology Research Center at the National Institute for Occupational Safety and Health	Nanotechnology Research Center at the National Institute for Occupational Safety and Health	The study was funded by the Nanotechnology Research Center at the National Institute for Occupational Safety and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Dr. Terri Pearce was a URS Corporation employee when this work was conducted. URS Corporation provided support in the form of salary for author Dr. Terri Pearce, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Asbach C, 2012, ANN OCCUP HYG, V56, P606, DOI 10.1093/annhyg/mes033; Bakand S, 2012, INHAL TOXICOL, V24, P125, DOI 10.3109/08958378.2010.642021; Biswas P, 2005, J AIR WASTE MANAGE, V55, P708, DOI 10.1080/10473289.2005.10464656; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brouwer D, 2010, TOXICOLOGY, V269, P120, DOI 10.1016/j.tox.2009.11.017; Evans DE, 2008, ANN OCCUP HYG, V52, P9, DOI 10.1093/annhyg/mem056; Maynard AD, 2005, J NANOPART RES, V7, P587, DOI 10.1007/s11051-005-6770-9; Maynard AD, 2007, NANOTOXICOLOGY, V1, P26, DOI 10.1080/17435390701314720; Methner M, 2010, J OCCUP ENVIRON HYG, V7, P163, DOI 10.1080/15459620903508066; Methner M, 2010, J OCCUP ENVIRON HYG, V7, P127, DOI 10.1080/15459620903476355; Middendorf PJ, 1999, AM IND HYG ASSOC J, V60, P502, DOI 10.1080/00028899908984471; Morawska L, 2003, ENV AEROSOL PHYS; National Institute for Occupational Safety and Health-NIOSH, 2007, PROGR SAF NAN WORKPL; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; Old L, 2008, J OCCUP ENVIRON HYG, V5, pD63, DOI 10.1080/15459620802059393; Peters TM, 2009, J OCCUP ENVIRON HYG, V6, P73, DOI 10.1080/15459620802590058; Peters TM, 2006, ANN OCCUP HYG, V50, P249, DOI 10.1093/annhyg/mei061; Schmoll Linda H, 2010, J Occup Environ Hyg, V7, P535, DOI 10.1080/15459624.2010.496072; Teikari M, 2003, AIHA J-J SCI OCCUP E, V64, P312, DOI 10.1202/484.1; Thorpe A, 2002, ANN OCCUP HYG, V46, P197, DOI 10.1093/annhyg/mef035; Thorpe A, 2007, ANN OCCUP HYG, V51, P97, DOI [10.1093/amhyg/mel032, 10.1093/annhyg/mel032]; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908	24	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105769	10.1371/journal.pone.0105769	http://dx.doi.org/10.1371/journal.pone.0105769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148239	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600081
J	Siddiqui, T; Lively, S; Ferreira, R; Wong, R; Schlichter, LC				Siddiqui, Tamjeed; Lively, Starlee; Ferreira, Roger; Wong, Raymond; Schlichter, Lyanne C.			Expression and Contributions of TRPM7 and KCa2.3/SK3 Channels to the Increased Migration and Invasion of Microglia in Anti-Inflammatory Activation States	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; PRO-INFLAMMATORY CYTOKINES; WHITE-MATTER INJURY; SMALL-CONDUCTANCE; POTASSIUM CHANNELS; NITRIC-OXIDE; CL-CHANNELS; SK3 CHANNEL; INTERLEUKIN-10; CELLS	Microglia rapidly respond to CNS injury and disease and can assume a spectrum of activation states. While changes in gene expression and production of inflammatory mediators have been extensively described after classical (LPS-induced) and alternative (IL4-induced) microglial activation, less is known about acquired de-activation in response to IL10. It is important to understand how microglial activation states affect their migration and invasion; crucial functions after injury and in the developing CNS. We reported that LPS-treated rat microglia migrate very poorly, while IL4-treated cells migrate and invade much better. Having discovered that the lamellum of migrating microglia contains a large ring of podosomes - microscopic structures that are thought to mediate adhesion, migration and invasion - we hypothesized that IL4 and IL10 would differentially affect podosome expression, gene induction, migration and invasion. Further, based on the enrichment of the KCa2.3/SK3 Ca2+-activated potassium channel in microglial podosomes, we predicted that it regulates migration and invasion. We found both similarities and differences in gene induction by IL4 and IL10 and, while both cytokines increased migration and invasion, only IL10 affected podosome expression. KCa2.3 currents were recorded in microglia under all three activation conditions and KCNN3 (KCa2.3) expression was similar. Surprisingly then, of three KCa2.3 inhibitors (apamin, tamapin, NS8593), only NS8593 abrogated the increased migration and invasion of IL4 and IL10-treated microglia (and invasion of unstimulated microglia). This discrepancy was explained by the observed block of TRPM7 currents in microglia by NS8593, which occurred under all three activation conditions. A similar inhibition of both migration and invasion was seen with a TRPM7 inhibitor (AA-861) that does not block KCa2.3 channels. Thus, we conclude that TRPM7 (not KCa2.3) contributes to the enhanced ability of microglia to migrate and invade when in anti-inflammatory states. This will be an important consideration in developing TRPM7 inhibitors for treating CNS injury.	[Siddiqui, Tamjeed; Lively, Starlee; Ferreira, Roger; Wong, Raymond; Schlichter, Lyanne C.] Univ Hlth Network, Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada; [Siddiqui, Tamjeed; Ferreira, Roger; Wong, Raymond; Schlichter, Lyanne C.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Schlichter, LC (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada.	schlicht@uhnres.utoronto.ca			Heart & Stroke Foundation (HSF), Ontario chapter (HSFO) [T6766, 00493]; Ontario Graduate Scholarship; HSF, Canada	Heart & Stroke Foundation (HSF), Ontario chapter (HSFO); Ontario Graduate Scholarship(Ontario Graduate Scholarship); HSF, Canada	This work was funded by grants from the Heart & Stroke Foundation (HSF), Ontario chapter (HSFO #T6766, #00493). Trainee salary support was provided by an Ontario Graduate Scholarship (RF) and a post-doctoral fellowship from HSF, Canada (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MM, 2005, NEUROSCIENTIST, V11, P116, DOI 10.1177/1073858404272966; Asrar S, 2013, CHANNELS, V7, P6, DOI 10.4161/chan.22824; Bae CYJ, 2013, ACTA PHARMACOL SIN, V34, P10, DOI 10.1038/aps.2012.94; Bates-Withers C, 2011, ADV EXP MED BIOL, V704, P173, DOI 10.1007/978-94-007-0265-3_9; Bouhy D, 2011, J NEUROSCI, V31, P16298, DOI 10.1523/JNEUROSCI.0047-11.2011; Cayabyab FS, 2000, EUR J NEUROSCI, V12, P1949, DOI 10.1046/j.1460-9568.2000.00083.x; Cayabyab FS, 2002, J BIOL CHEM, V277, P48130, DOI 10.1074/jbc.M208448200; Cayabyab FS, 2002, J BIOL CHEM, V277, P13673, DOI 10.1074/jbc.M108211200; Chantome A, 2013, CANCER RES, V73, P4852, DOI 10.1158/0008-5472.CAN-12-4572; Chantome A, 2009, EXP CELL RES, V315, P3620, DOI 10.1016/j.yexcr.2009.07.021; Chen HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011161; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chubanov V, 2012, BRIT J PHARMACOL, V166, P1357, DOI 10.1111/j.1476-5381.2012.01855.x; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Ferreira R, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fncel.2014.00183, 10.3389/fncel.2014.0018]; Ferreira R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062345; Foresti R, 2013, PHARMACOL RES, V76, P132, DOI 10.1016/j.phrs.2013.07.010; Fouda Abdelrahman Y, 2013, Exp Transl Stroke Med, V5, P12, DOI 10.1186/2040-7378-5-12; Girard S, 2013, GLIA, V61, P813, DOI 10.1002/glia.22478; Grunnet M, 2001, NEUROPHARMACOLOGY, V40, P879, DOI 10.1016/S0028-3908(01)00028-4; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jelassi B, 2011, ONCOGENE, V30, P2108, DOI 10.1038/onc.2010.593; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Koeberle PD, 2010, CHANNELS, V4, P337, DOI [10.4161/chan.4.5.12790, 10.1038/cdd.2009.113]; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kremlev SG, 2005, J NEUROIMMUNOL, V162, P71, DOI 10.1016/j.jneuroim.2005.01.010; Kuras Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043859; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Liebau S, 2007, J NEUROCHEM, V101, P1338, DOI 10.1111/j.1471-4159.2006.04437.x; Lim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081218; Lindenberg JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070237; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Liu BS, 2013, J NEUROIMMUNE PHARM, V8, P227, DOI 10.1007/s11481-012-9365-0; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Luo XG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-9; Mashimo H, 2008, INVEST OPHTH VIS SCI, V49, P5450, DOI 10.1167/iovs.08-1878; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Moxon-Emre I, 2010, J NEUROPATH EXP NEUR, V69, P1, DOI 10.1097/NEN.0b013e3181c3ce6c; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Newell EW, 2005, J PHYSIOL-LONDON, V567, P869, DOI 10.1113/jphysiol.2005.092056; Ohana L, 2009, CHANNELS, V3, P129, DOI 10.4161/chan.3.2.8609; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Park HS, 2014, KOREAN J PHYSIOL PHA, V18, P15, DOI 10.4196/kjpp.2014.18.1.15; Pedarzani P, 2002, J BIOL CHEM, V277, P46101, DOI 10.1074/JBC.m206465200; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Penner R., 2007, V179, P313; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Pla AF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00311; Potier M, 2011, BRIT J PHARMACOL, V162, P464, DOI 10.1111/j.1476-5381.2010.01044.x; Potier M, 2006, MOL CANCER THER, V5, P2946, DOI 10.1158/1535-7163.MCT-06-0194; Qian L, 2006, J PHARMACOL EXP THER, V319, P44, DOI 10.1124/jpet.106.106351; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schlichter LC, 1996, GLIA, V17, P225, DOI 10.1002/(SICI)1098-1136(199607)17:3<225::AID-GLIA5>3.0.CO;2-#; Schlichter LC, 2011, CHANNELS, V5, P128, DOI 10.4161/chan.5.2.14310; Schnitzler MMY, 2008, FASEB J, V22, P1540, DOI 10.1096/fj.07-9694com; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siddiqui TA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-250; Silva SL, 2012, NEUROPHARMACOLOGY, V62, P2398, DOI 10.1016/j.neuropharm.2012.02.002; Sivagnanam V, 2010, J NEUROIMMUNOL, V227, P111, DOI 10.1016/j.jneuroim.2010.06.021; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; Strobaek D, 2006, MOL PHARMACOL, V70, P1771, DOI 10.1124/mol.106.027110; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Szczepanik AM, 2001, J NEUROIMMUNOL, V113, P49, DOI 10.1016/S0165-5728(00)00404-5; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Vincent C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-190; Visser D, 2013, CELL CALCIUM, V54, P404, DOI 10.1016/j.ceca.2013.09.003; Wasserman JK, 2007, BRAIN RES, V1180, P140, DOI 10.1016/j.brainres.2007.08.058; Wasserman JK, 2008, EXP NEUROL, V214, P266, DOI 10.1016/j.expneurol.2008.08.010; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Won SY, 2013, J NEUROIMMUNOL, V265, P36, DOI 10.1016/j.jneuroim.2013.09.014; Yang MS, 2006, J IMMUNOL, V177, P1323, DOI 10.4049/jimmunol.177.2.1323; Zhao WH, 2006, J NEUROCHEM, V99, P1176, DOI 10.1111/j.1471-4159.2006.04172.x; Zhou W, 1998, J GEN PHYSIOL, V111, P781, DOI 10.1085/jgp.111.6.781	87	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106087	10.1371/journal.pone.0106087	http://dx.doi.org/10.1371/journal.pone.0106087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148577	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600113
J	Sorokowski, P; Koscinski, K; Sorokowska, A; Huanca, T				Sorokowski, Piotr; Koscinski, Krzysztof; Sorokowska, Agnieszka; Huanca, Tomas			Preference for Women's Body Mass and Waist-to-Hip Ratio in Tsimane' Men of the Bolivian Amazon: Biological and Cultural Determinants	PLOS ONE			English	Article							SEXUAL ATTRACTIVENESS; VARIABLE PREFERENCES; LEG LENGTH; FEMALE; JUDGMENTS; INDEX; SIZE; AMERINDIANS; PREDICTORS; PERCEPTION	The issue of cultural universality of waist-to-hip ratio (WHR) attractiveness in women is currently under debate. We tested men's preferences for female WHR in traditional society of Tsimane'(Native Amazonians) of the Bolivian rainforest (N = 66). Previous studies showed preferences for high WHR in traditional populations, but they did not control for the women's body mass. We used a method of stimulus creation that enabled us to overcome this problem. We found that WHR lower than the average WHR in the population is preferred independent of cultural conditions. Our participants preferred the silhouettes of low WHR, but high body mass index (BMI), which might suggest that previous results could be an artifact related to employed stimuli. We found also that preferences for female BMI are changeable and depend on environmental conditions and probably acculturation (distance from the city). Interestingly, the Tsimane' men did not associate female WHR with age, health, physical strength or fertility. This suggests that men do not have to be aware of the benefits associated with certain body proportions - an issue that requires further investigation.	[Sorokowski, Piotr; Sorokowska, Agnieszka] Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland; [Koscinski, Krzysztof] Adam Mickiewicz Univ, Inst Anthropol, Poznan, Poland; [Sorokowska, Agnieszka] Tech Univ Dresden, Ctr Smell & Taste, D-01062 Dresden, Germany; [Huanca, Tomas] Ctr Boliviano Invest & Desarrollo Socio Integral, San Borja, Bolivia	University of Wroclaw; Adam Mickiewicz University; Technische Universitat Dresden	Sorokowski, P (corresponding author), Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland.	sorokowskipiotr@yahoo.co.uk		Sorokowski, Piotr/0000-0001-9225-9965; Koscinski, Krzysztof/0000-0002-4748-903X; Sorokowska, Agnieszka/0000-0003-3999-8851	Polish Ministry of Science and Higher Education for science [IP 2011 051571]; Foundation for Polish Science START scholarship; National Science Centre ETIUDA [2013/08/T/HS6/00408]	Polish Ministry of Science and Higher Education for science; Foundation for Polish Science START scholarship; National Science Centre ETIUDA	The research was supported by funds of Polish Ministry of Science and Higher Education for science (research grant #IP 2011 051571 to P.S.; years 2012-2014) and Foundation for Polish Science START scholarship and National Science Centre ETIUDA (#2013/08/T/HS6/00408) scholarship to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JL, 1992, ETHOL SOCIOBIOL, V13, P197, DOI 10.1016/0162-3095(92)90033-Z; Apicella CL, 2004, EVOL HUM BEHAV, V25, P371, DOI 10.1016/j.evolhumbehav.2004.06.003; Bartali B, 2002, SOZ PRAVENTIV MED, V47, P336, DOI 10.1007/PL00012644; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Brewis AA, 2000, ECOL FOOD NUTR, V39, P105, DOI 10.1080/03670244.2000.9991609; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Brown WJ, 1998, INT J OBESITY, V22, P520, DOI 10.1038/sj.ijo.0800617; Bye E., 2012, INT J FASHION DESIGN, V5, P117, DOI DOI 10.1080/17543266.2011.649792; Byron E, 2003, THESIS U FLORIDA; Case A, 2010, DEMOGRAPHY, V47, pS65, DOI 10.1353/dem.2010.0007; Cassidy C M, 1991, Med Anthropol, V13, P181; Choi J., 1988, HOWARD J COMMUN, V1, P57; CUNNINGHAM MR, 1986, J PERS SOC PSYCHOL, V50, P925, DOI 10.1037/0022-3514.50.5.925; Dixson BJ, 2010, CURR ZOOL, V56, P175, DOI 10.1093/czoolo/56.2.175; Dixson BJ, 2007, ARCH SEX BEHAV, V36, P369, DOI 10.1007/s10508-006-9093-8; Dixson BJ, 2010, AM J PHYS ANTHROPOL, V141, P620, DOI 10.1002/ajpa.21181; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; Fan JT, 2004, P ROY SOC B-BIOL SCI, V271, P347, DOI 10.1098/rspb.2003.2613; Ford C.S., 1951, PATTERNSEXUAL BEHA; Frederick DA, 2007, PERS SOC PSYCHOL B, V33, P1167, DOI 10.1177/0146167207303022; FURNHAM A, 1983, PSYCHOL MED, V13, P829, DOI 10.1017/S0033291700051540; FURNHAM A, 1994, INT J EAT DISORDER, V15, P81, DOI 10.1002/1098-108X(199401)15:1&lt;81::AID-EAT2260150110&gt;3.0.CO;2-D; Furnham A, 1997, PERS INDIV DIFFER, V22, P539, DOI 10.1016/S0191-8869(96)00241-3; Godoy R, 2005, ANNU REV ANTHROPOL, V34, P121, DOI 10.1146/annurev.anthro.34.081804.120412; Godoy R, 1998, LAND ECON, V74, P162, DOI 10.2307/3147048; Godoy R, 2012, INDIANS MARKETS RAIN; Godoy R, 2005, ECON HUM BIOL, V3, P136, DOI 10.1016/j.ehb.2005.01.001; Godoy R, 2010, J ECON PSYCHOL, V31, P587, DOI 10.1016/j.joep.2010.04.001; Godoy RA, 2006, ECON HUM BIOL, V4, P184, DOI 10.1016/j.ehb.2005.11.001; Gray Peter B., 2013, EVOLUTION HUMAN SEXU; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Harrison K, 2003, SEX ROLES, V48, P255, DOI 10.1023/A:1022825421647; HORVATH T, 1981, ARCH SEX BEHAV, V10, P21, DOI 10.1007/BF01542671; Huanca Tomas, 2008, TSIMANE ORAL TRADITI; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; Karremans JC, 2010, EVOL HUM BEHAV, V31, P182, DOI 10.1016/j.evolhumbehav.2009.10.001; KIRSCHNER MA, 1991, INT J OBESITY, V15, P101; Komlos J, 1994, STATURE LIVING STAND; Koscinski K, 2014, ARCH SEX BEHAV, V43, P989, DOI 10.1007/s10508-013-0166-1; Koscinski K, 2013, BEHAV ECOL, V24, P914, DOI 10.1093/beheco/art016; Lassek WD, 2008, EVOL HUM BEHAV, V29, P26, DOI 10.1016/j.evolhumbehav.2007.07.005; Leonard WR, 2008, ECON HUM BIOL, V6, P299, DOI 10.1016/j.ehb.2008.04.001; Lipson SF, 1996, HUM REPROD, V11, P2090; Marlowe FW, 2001, PERS INDIV DIFFER, V30, P481, DOI 10.1016/S0191-8869(00)00039-8; McDade TW, 2005, AM J PHYS ANTHROPOL, V128, P906, DOI 10.1002/ajpa.20222; Nelson LD, 2005, PSYCHOL SCI, V16, P167, DOI 10.1111/j.0956-7976.2005.00798.x; Nube M, 1998, EUR J CLIN NUTR, V52, P136, DOI 10.1038/sj.ejcn.1600528; Pawlowski B, 2005, HUM NATURE-INT BIOS, V16, P164, DOI 10.1007/s12110-005-1002-7; Pawlowski B, 2003, P ROY SOC B-BIOL SCI, V270, P709, DOI 10.1098/rspb.2002.2294; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Pettijohn TF, 2004, PERS SOC PSYCHOL B, V30, P1186, DOI 10.1177/0146167204264078; Pisanski K, 2013, CROSS-CULT RES, V47, P162, DOI 10.1177/1069397112471806; Reyes-Garcia V, 2005, CURR ANTHROPOL, V46, P651, DOI 10.1086/432777; Rilling JK, 2009, EVOL HUM BEHAV, V30, P21, DOI 10.1016/j.evolhumbehav.2008.08.007; Ringhofer L, 2010, FISHING, FORAGING AND FARMING IN THE BOLIVIAN AMAZON, P1, DOI 10.1007/978-90-481-3487-8; Rozmus-Wrzesinska M, 2005, BIOL PSYCHOL, V68, P299, DOI 10.1016/j.biopsycho.2004.04.007; Sam DL, 2010, PERSPECT PSYCHOL SCI, V5, P472, DOI 10.1177/1745691610373075; Schutzwohl A, 2006, BIOL PSYCHOL, V71, P223, DOI 10.1016/j.biopsycho.2005.04.005; Singh D, 2004, J SEX RES, V41, P43, DOI 10.1080/00224490409552212; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; SINGH D, 1994, PERS INDIV DIFFER, V16, P123, DOI 10.1016/0191-8869(94)90116-3; SINGH D, 1995, HUM NATURE-INT BIOS, V6, P51, DOI 10.1007/BF02734135; Singh Devendra, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P81; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sorokowski P, 2008, EVOL HUM BEHAV, V29, P86, DOI 10.1016/j.evolhumbehav.2007.09.002; Sorokowski P, 2012, ARCH SEX BEHAV, V41, P1209, DOI 10.1007/s10508-012-9906-x; Sorokowski P, 2012, J CROSS CULT PSYCHOL, V43, P32, DOI 10.1177/0022022110395140; Sorokowski P, 2011, J CROSS CULT PSYCHOL, V42, P131, DOI 10.1177/0022022110392229; Southwell, 2004, ASIAN J COMMUN, V14, P81, DOI DOI 10.1080/01292980420001951512; Sugiyama LS, 2004, EVOL HUM BEHAV, V25, P51, DOI 10.1016/S1090-5138(03)00083-7; Swami V., 2006, J ARTIC SUPPORT NULL, V4, P17; Swami V, 2007, BODY IMAGE, V4, P219, DOI 10.1016/j.bodyim.2007.01.002; Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002; Swami V, 2006, BRIT J PSYCHOL, V97, P353, DOI 10.1348/000712605X80713; Tassinary LG, 1998, PSYCHOL SCI, V9, P150, DOI 10.1111/1467-9280.00029; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 1999, NATURE, V399, P215, DOI 10.1038/20345; Vallve Frederic, 2010, THESIS GEORGETOWN U; Wass P, 1997, HUM REPROD, V12, P2057, DOI 10.1093/humrep/12.9.2057; Wetsman A, 1999, EVOL HUM BEHAV, V20, P219, DOI 10.1016/S1090-5138(99)00007-0; World Health Organization, 2013, GLOB DAT BOD MAX IND; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002; Yu DW, 1998, NATURE, V396, P321, DOI 10.1038/24512; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484	85	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105468	10.1371/journal.pone.0105468	http://dx.doi.org/10.1371/journal.pone.0105468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25148034	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600049
J	Kallianpur, AR; Jia, PL; Ellis, RJ; Zhao, ZM; Bloss, C; Wen, WQ; Marra, CM; Hulgan, T; Simpson, DM; Morgello, S; McArthur, JC; Clifford, DB; Collier, AC; Gelman, BB; McCutchan, JA; Franklin, D; Samuels, DC; Rosario, D; Holzinger, E; Murdock, DG; Letendre, S; Grant, I				Kallianpur, Asha R.; Jia, Peilin; Ellis, Ronald J.; Zhao, Zhongming; Bloss, Cinnamon; Wen, Wanqing; Marra, Christina M.; Hulgan, Todd; Simpson, David M.; Morgello, Susan; McArthur, Justin C.; Clifford, David B.; Collier, Ann C.; Gelman, Benjamin B.; McCutchan, J. Allen; Franklin, Donald; Samuels, David C.; Rosario, Debralee; Holzinger, Emily; Murdock, Deborah G.; Letendre, Scott; Grant, Igor		CHARTER Study Grp	Genetic Variation in Iron Metabolism Is Associated with Neuropathic Pain and Pain Severity in HIV-Infected Patients on Antiretroviral Therapy	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; PERIPHERAL NEUROPATHY; SENSORY NEUROPATHY; MITOCHONDRIAL HAPLOGROUPS; OXIDATIVE STRESS; MODEL; MECHANISMS; PROTEIN; POLYNEUROPATHY; INTERFERENCE	HIV sensory neuropathy and distal neuropathic pain (DNP) are common, disabling complications associated with combination antiretroviral therapy (cART). We previously associated iron-regulatory genetic polymorphisms with a reduced risk of HIV sensory neuropathy during more neurotoxic types of cART. We here evaluated the impact of polymorphisms in 19 iron-regulatory genes on DNP in 560 HIV-infected subjects from a prospective, observational study, who underwent neurological examinations to ascertain peripheral neuropathy and structured interviews to ascertain DNP. Genotype-DNP associations were explored by logistic regression and permutation-based analytical methods. Among 559 evaluable subjects, 331 (59%) developed HIV-SN, and 168 (30%) reported DNP. Fifteen polymorphisms in 8 genes (p<0.05) and 5 variants in 4 genes (p<0.01) were nominally associated with DNP: polymorphisms in TF, TFRC, BMP6, ACO1, SLC11A2, and FXN conferred reduced risk (adjusted odds ratios [ORs] ranging from 0.2 to 0.7, all p<0.05); other variants in TF, CP, ACO1, BMP6, and B2M conferred increased risk (ORs ranging from 1.3 to 3.1, all p<0.05). Risks associated with some variants were statistically significant either in black or white subgroups but were consistent in direction. ACO1 rs2026739 remained significantly associated with DNP in whites (permutation p<0.0001) after correction for multiple tests. Several of the same iron-regulatory-gene polymorphisms, including ACO1 rs2026739, were also associated with severity of DNP (all p<0.05). Common polymorphisms in iron-management genes are associated with DNP and with DNP severity in HIV-infected persons receiving cART. Consistent risk estimates across population subgroups and persistence of the ACO1 rs2026739 association after adjustment for multiple testing suggest that genetic variation in iron-regulation and transport modulates susceptibility to DNP.	[Kallianpur, Asha R.] Cleveland Clin Fdn, Dept Genom Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Kallianpur, Asha R.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Ellis, Ronald J.] Univ Calif San Diego, Dept Neurol, San Diego, CA 92103 USA; [Bloss, Cinnamon] Scripps Translat Sci Inst, La Jolla, CA USA; [Bloss, Cinnamon] Scripps Hlth, La Jolla, CA USA; [Wen, Wanqing; Hulgan, Todd] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Marra, Christina M.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Simpson, David M.; Morgello, Susan] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [McArthur, Justin C.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Clifford, David B.] Washington Univ, Dept Neurol, St Louis, MO USA; [Collier, Ann C.] Univ Washington, Dept Med, Seattle, WA USA; [Gelman, Benjamin B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [McCutchan, J. Allen; Letendre, Scott] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Franklin, Donald; Rosario, Debralee] Univ Calif San Diego, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA; [Franklin, Donald; Rosario, Debralee] Univ Calif San Diego, CHARTER Ctr, San Diego, CA 92103 USA; [Samuels, David C.; Holzinger, Emily; Murdock, Deborah G.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Samuels, David C.; Holzinger, Emily; Murdock, Deborah G.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA; [Grant, Igor] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Vanderbilt University; University of California System; University of California San Diego; Scripps Research Institute; Vanderbilt University; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego	Kallianpur, AR (corresponding author), Cleveland Clin Fdn, Dept Genom Med, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	kalliaa@ccf.org	Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022; Hulgan, Todd/AAG-7491-2019; Letendre, Scott L./GLU-6874-2022; Hulgan, Todd/B-3947-2014; Ellis, Ronald/K-3543-2015	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Hulgan, Todd/0000-0002-3339-067X; Ellis, Ronald/0000-0003-4931-752X; Bloss, Cinnamon/0000-0003-1315-8387	National Institutes of Health [N01 MH22005, HHSN271201000036C, 1R01 MH 095621]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH075673, N01MH022005, R01MH095621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The co-authors of this manuscript have no pertinent financial disclosures. Funding support for this work was provided by the following grants: National Institutes of Health contracts N01 MH22005 and HHSN271201000036C from the National Institutes of Health (to CHARTER PI Igor Grant) and 1R01 MH 095621 (to PIs Asha Kallianpur and Todd Hulgan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova N, 2011, TRENDS PHARMACOL SCI, V32, P715, DOI 10.1016/j.tips.2011.07.007; Ayton S, 2014, FREE RADIC BIOL MED; Backonja M, 2010, ONCOLOGIST, V15, P24, DOI 10.1634/theoncologist.2009-S502; Belfer I, 2010, CURR PAIN HEADACHE R, V14, P203, DOI 10.1007/s11916-010-0110-1; Bentley AJ, 2007, CLIN J PAIN, V23, P62, DOI 10.1097/01.ajp.0000210948.11805.69; Boelaert JR, 1996, INFECT AGENT DIS, V5, P36; Bulaj ZJ, 1996, NEW ENGL J MED, V335, P1799, DOI 10.1056/NEJM199612123352403; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Cano A, 2006, J PAIN, V7, P459, DOI 10.1016/j.jpain.2006.01.445; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Chetty S, 2012, SAMJ S AFR MED J, V102, P312, DOI 10.7196/SAMJ.5472; Connor JR, 2011, BRAIN, V134, P959, DOI 10.1093/brain/awr012; Davis L, 2004, AIDS CARE, V16, P395, DOI 10.1080/09540120410001665394; Derry S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010111; Dowling P, 2009, J NUTR, V139, P2087, DOI 10.3945/jn.109.112557; Drakesmith H, 2005, P NATL ACAD SCI USA, V102, P11017, DOI 10.1073/pnas.0504823102; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Dubovy P, 2011, ANN ANAT, V193, P267, DOI 10.1016/j.aanat.2011.02.011; El Boghdady NA, 2012, CELL BIOCHEM FUNCT, V30, P328, DOI 10.1002/cbf.2808; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; Ellis RJ, 2008, ANN NEUROL, V64, P566, DOI 10.1002/ana.21484; Evans SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000551; Fellows RP, 2012, J INT NEUROPSYCH SOC, V18, P898, DOI 10.1017/S1355617712000707; Finberg KE, 2013, CURR OPIN HEMATOL, V20, P208, DOI 10.1097/MOH.0b013e32835f5a47; Foulkes T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000086; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Gemignani F, 2013, SLEEP MED, V14, P79, DOI 10.1016/j.sleep.2012.08.013; Gille G, 2011, J NEURAL TRANSM, V118, P349, DOI 10.1007/s00702-010-0503-7; Grady BJ, 2009, GENET EPIDEMIOL, V33, P788; Hao SL, 2013, CURR NEUROPHARMACOL, V11, P499, DOI 10.2174/1570159X11311050005; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hitchcock SA, 2008, SAMJ S AFR MED J, V98, P889; Holzinger ER, 2012, J NEUROVIROL, V18, P511, DOI 10.1007/s13365-012-0133-y; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Hulgan T, 2008, J INFECT DIS, V197, P858, DOI 10.1086/528697; Jia PL, 2012, J MED GENET, V49, P96, DOI 10.1136/jmedgenet-2011-100397; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; Joseph EK, 2006, PAIN, V121, P105, DOI 10.1016/j.pain.2005.12.010; Kallianpur AR, 2006, AIDS, V20, P1503, DOI 10.1097/01.aids.0000237366.56864.3c; Kallianpur AR, 2009, PHARMACOGENOMICS, V10, P623, DOI [10.2217/pgs.09.14, 10.2217/PGS.09.14]; Kamerman PR, 2012, J PERIPHER NERV SYST, V17, P19, DOI 10.1111/j.1529-8027.2012.00373.x; Keltner JR, 2012, PSYCHOSOMATICS, V53, P380, DOI 10.1016/j.psym.2012.05.002; Keltner JR, 2014, J NEUROVIROL; Keswani SC, 2006, J NEUROSCI, V26, P10299, DOI 10.1523/JNEUROSCI.3135-06.2006; Kranick Sarah M, 2012, Continuum (Minneap Minn), V18, P1319, DOI 10.1212/01.CON.0000423849.24900.ec; Kumar KR, 2011, SEMIN NEUROL, V31, P433, DOI 10.1055/s-0031-1299782; Lawless MW, 2007, TISSUE ANTIGENS, V70, P294, DOI 10.1111/j.1399-0039.2007.00895.x; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li JY, 2012, NEUROSCI LETT, V531, P52, DOI 10.1016/j.neulet.2012.10.014; Li XQ, 2003, J PAIN, V4, P101, DOI 10.1054/jpai.2003.18; Lorber Margalit, 2013, J Int Assoc Provid AIDS Care, V12, P378, DOI 10.1177/2325957413488189; Lucey BP, 2011, AIDS CARE, V23, P921, DOI 10.1080/09540121.2010.543883; Maag Rainer, 2006, Curr Pain Headache Rep, V10, P191, DOI 10.1007/s11916-006-0045-8; Max MB, 2008, NAT REV DRUG DISCOV, V7, P647, DOI 10.1038/nrd2595; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Mitchell RM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-6; Mitchell RM, 2011, NEUROBIOL AGING, V32, P1114, DOI 10.1016/j.neurobiolaging.2009.05.016; Moos T, 2011, MOL CELL NEUROSCI, V46, P607, DOI 10.1016/j.mcn.2010.12.013; Moos Torben, 2006, Semin Pediatr Neurol, V13, P149, DOI 10.1016/j.spen.2006.08.003; Oshinaike O, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/961510; Pahuja M, 2012, ANTIVIR THER, V17, P737, DOI 10.3851/IMP2087; Patton SM, 2011, EUR J NEUROL, V18, P1329, DOI 10.1111/j.1468-1331.2011.03397.x; Phillips TJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014433; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Robinson-Papp J, 2010, PAIN, V151, P732, DOI 10.1016/j.pain.2010.08.045; Ropele S, 2013, MAGN RESON MED; Sheftel AD, 2009, ANN MED, V41, P82, DOI 10.1080/07853890802322229; Staats KA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00249; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Tan ECTH, 2009, J SURG RES, V152, P84, DOI 10.1016/j.jss.2008.03.035; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P516, DOI 10.1161/ATVBAHA.111.237040; Thaisetthawatkul P, 2004, NEUROLOGY, V63, P1462; Tramullas M, 2010, J NEUROSCI, V30, P1502, DOI 10.1523/JNEUROSCI.2584-09.2010; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Wandner LD, 2012, J PAIN, V13, P220, DOI 10.1016/j.jpain.2011.10.014; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wu XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044622; Yan XS, 2013, J PHYSIOL-LONDON, V591, P2001, DOI 10.1113/jphysiol.2012.250522; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Zhang XL, 2013, BIOL CHEM, V394, P231, DOI 10.1515/hsz-2012-0217	85	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103123	10.1371/journal.pone.0103123	http://dx.doi.org/10.1371/journal.pone.0103123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144566	Green Published, gold			2022-12-27	WOS:000341106100006
J	Matsumoto, Y; Inden, M; Tamura, A; Hatano, R; Tsukita, S; Asano, S				Matsumoto, Yosuke; Inden, Masatoshi; Tamura, Atsushi; Hatano, Ryo; Tsukita, Sachiko; Asano, Shinji			Ezrin Mediates Neuritogenesis via Down-Regulation of RhoA Activity in Cultured Cortical Neurons	PLOS ONE			English	Article							RADIXIN-MOESIN PROTEINS; GROWTH CONE MORPHOLOGY; EZRIN/RADIXIN/MOESIN PROTEINS; AXON OUTGROWTH; ERM PROTEINS; KINASE; PHOSPHORYLATION; ACTIVATION; CELLS; ACTIN	Neuronal morphogenesis is implicated in neuronal function and development with rearrangement of cytoskeletal organization. Ezrin, a member of Ezrin/Radixin/Moesin (ERM) proteins links between membrane proteins and actin cytoskeleton, and contributes to maintenance of cellular function and morphology. In cultured hippocampal neurons, suppression of both radixin and moesin showed deficits in growth cone morphology and neurite extensions. Downregulation of ezrin using siRNA caused impairment of netrin-1-induced axon outgrowth in cultured cortical neurons. However, roles of ezrin in the neuronal morphogenesis of the cultured neurons have been poorly understood. In this report, we performed detailed studies on the roles of ezrin in the cultured cortical neurons prepared from the ezrin knockdown (Vil2(kd/kd)) mice embryo that showed a very small amount of ezrin expression compared with the wild-type (Vil2(+/+)) neurons. Ezrin was mainly expressed in cell body in the cultured cortical neurons. We demonstrated that the cultured cortical neurons prepared from the Vil2(kd/kd) mice embryo exhibited impairment of neuritogenesis. Moreover, we observed increased RhoA activity and phosphorylation of myosin light chain 2 (MLC2), as a downstream effector of RhoA in the Vil2(kd/kd) neurons. In addition, inhibition of Rho kinase and myosin II rescued the impairment of neuritogenesis in the Vil2(kd/kd) neurons. These data altogether suggest a novel role of ezrin in the neuritogenesis of the cultured cortical neurons through down-regulation of RhoA activity.	[Matsumoto, Yosuke; Hatano, Ryo; Asano, Shinji] Ritsumeikan Univ, Coll Pharmaceut Sci, Dept Mol Physiol, Kusatsu, Shiga, Japan; [Inden, Masatoshi] Gifu Pharmaceut Univ, Lab Med Therapeut & Mol Therapeut, Gifu, Japan; [Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Biol Sci Lab, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan	Ritsumeikan University; Gifu Pharmaceutical University; Osaka University; Osaka University	Asano, S (corresponding author), Ritsumeikan Univ, Coll Pharmaceut Sci, Dept Mol Physiol, Kusatsu, Shiga, Japan.	ashinji@ph.ritsumei.ac.jp		Asano, Shinji/0000-0003-1443-8970; Inden, Masatoshi/0000-0002-7480-4920	JSPS KAKENHI [24790097, 21590082, 24590104]; Grants-in-Aid for Scientific Research [26860058] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Number 24790097;(http://kaken.nii.ac.jp/d/p/24790097.en.html, MI), 21590082; (http://kaken.nii.ac.jp/d/p/21590082.en.html, SA), 24590104; (http://kaken.nii.ac.jp/d/p/24590104.en.html, SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Baeyens N, 2013, BIOCHEM BIOPH RES CO, V441, P579, DOI 10.1016/j.bbrc.2013.10.118; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Casaletto JB, 2011, P NATL ACAD SCI USA, V108, P11924, DOI 10.1073/pnas.1103418108; Castelo L, 1999, MOL BIOL CELL, V10, P1511, DOI 10.1091/mbc.10.5.1511; Christie KJ, 2013, NEUROSCIENCE, V247, P75, DOI 10.1016/j.neuroscience.2013.05.019; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DOTTI CG, 1988, J NEUROSCI, V8, P1454; EVERETT AW, 1990, J HISTOCHEM CYTOCHEM, V38, P1137, DOI 10.1177/38.8.2114439; Gallo G, 2008, DEV NEUROBIOL, V68, P926, DOI 10.1002/dneu.20631; Gimeno L, 2004, GENE EXPR PATTERNS, V4, P749, DOI 10.1016/j.modgep.2004.03.007; GonzalezAgosti C, 1996, CELL MOTIL CYTOSKEL, V34, P122, DOI 10.1002/(SICI)1097-0169(1996)34:2<122::AID-CM4>3.0.CO;2-D; GOSLIN K, 1989, J CELL BIOL, V109, P1621, DOI 10.1083/jcb.109.4.1621; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gronholm M, 2005, MOL CELL NEUROSCI, V28, P683, DOI 10.1016/j.mcn.2004.11.014; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hayashi K, 2007, DEV NEUROBIOL, V67, P655, DOI 10.1002/dneu.20363; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jeon S, 2002, J BIOL CHEM, V277, P16576, DOI 10.1074/jbc.M110380200; Johnson MW, 2002, ACTA NEUROPATHOL, V104, P188, DOI 10.1007/s00401-002-0540-x; Kim HS, 2010, J NEUROCHEM, V113, P1565, DOI 10.1111/j.1471-4159.2010.06713.x; Kobayashi Y, 2013, J BIOCHEM, V153, P389, DOI 10.1093/jb/mvt005; Kollins KM, 2009, DEV NEUROBIOL, V69, P279, DOI 10.1002/dneu.20704; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Marsick BM, 2012, J NEUROSCI, V32, P282, DOI 10.1523/JNEUROSCI.4794-11.2012; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Peris B, 2012, J NEUROCHEM, V121, P903, DOI 10.1111/j.1471-4159.2012.07733.x; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Schulz A, 2010, J NEUROSCI, V30, P10177, DOI 10.1523/JNEUROSCI.0840-10.2010; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Viesselmann C, 2011, JOVE-J VIS EXP, DOI 10.3791/2373	43	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105435	10.1371/journal.pone.0105435	http://dx.doi.org/10.1371/journal.pone.0105435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144196	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100071
J	McFerrin, HE; Olson, SD; Gutschow, MV; Semon, JA; Sullivan, DE; Prockop, DJ				McFerrin, Harris E.; Olson, Scott D.; Gutschow, Miriam V.; Semon, Julie A.; Sullivan, Deborah E.; Prockop, Darwin J.			Rapidly Self-Renewing Human Multipotent Marrow Stromal Cells (hMSC) Express Sialyl Lewis X and Actively Adhere to Arterial Endothelium in a Chick Embryo Model System	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-UTERO TRANSPLANTATION; LUNG CLEARANCE RATE; METASTATIC ABILITY; PROGENITOR CELLS; PROTEIN; VIVO; REPAIR; MSCS; MICROCIRCULATION	Background: There have been conflicting observations regarding the receptors utilized by human multipotent mesenchymal bone marrow stromal cells (hMSC) to adhere to endothelial cells (EC). To address the discrepancies, we performed experiments with cells prepared with a standardized, low-density protocol preserving a sub-population of small cells that are rapidly self-renewing. Methods: Sialyl Lewis X (SLeX) and alpha 4 integrin expression were determined by flow cytometry. Fucosyltransferase expression was determined by quantitative realtime RT-PCR. Cell adhesion assays were carried out with a panel of endothelial cells from arteries, veins and the microvasculature in vitro. In vivo experiments were performed to determine single cell interactions in the chick embryo chorioallantoic membrane (CAM). The CAM is a well-characterized respiratory organ allowing for time-lapse image acquisition of large numbers of cells treated with blocking antibodies against adhesion molecules expressed on hMSC. Results: hMSC expressed alpha 4 integrin, SLeX and fucosyltransferase 4 and adhered to human EC from arteries, veins and the microvasculature under static conditions in vitro. In vivo, hMSC rolled on and adhered to arterioles in the chick embryo CAM, whereas control melanoma cells embolized. Inhibition of alpha 4 integrin and/or SLeX with blocking antibodies reduced rolling and adhesion in arterioles and increased embolism of hMSC. Conclusions: The results demonstrated that rapidly self-renewing hMSC were retained in the CAM because they rolled on and adhered to respiratory arteriolar EC in an alpha 4 integrin- and SLeX-dependent manner. It is therefore important to select cells based on their cell adhesion receptor profile as well as size depending on the intended target of the cell and the injection route.	[McFerrin, Harris E.] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA; [Olson, Scott D.] Univ Texas Med Sch Houston, Program Regenerat Med, Houston, TX USA; [Gutschow, Miriam V.] Stanford Univ, Stanford Dept Bioengn, Stanford, CA 94305 USA; [McFerrin, Harris E.; Semon, Julie A.; Sullivan, Deborah E.] Tulane Univ, Sch Med, Ctr Stem Cell Res & Regenerat Med, New Orleans, LA 70112 USA; [McFerrin, Harris E.; Sullivan, Deborah E.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Prockop, Darwin J.] Scott & White Mem Hosp & Clin, Coll Med, Inst Regenerat Med, Texas A&M Hlth Sci Ctr, Temple, TX USA	Xavier University of Louisiana; University of Texas System; University of Texas Health Science Center Houston; Stanford University; Tulane University; Tulane University; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	McFerrin, HE (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA.	hmcferri@xula.edu		Olson, Scott/0000-0001-8032-3755	National Center for Research Resources [P20RR016456]; National Institute of General Medical Sciences [P20GM103424]; Louisiana Cancer Research Consortium; NIH-RCMI from the National Institute on Minority Health and Health Disparities [5G12RR026260]; National Institutes of Health [P40 RR 17447]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456, G12RR026260, P40RR017447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011050] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Louisiana Cancer Research Consortium; NIH-RCMI from the National Institute on Minority Health and Health Disparities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants from the National Center for Research Resources (P20RR016456), the National Institute of General Medical Sciences (P20GM103424), Louisiana Cancer Research Consortium and the NIH-RCMI grant #5G12RR026260 from the National Institute on Minority Health and Health Disparities (HEM) and P40 RR 17447 from the National Institutes of Health (DJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, CIRC RES, V95, P671, DOI 10.1161/01.RES.0000143421.27684.12; Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Bobek V, 2004, CLIN EXP METASTAS, V21, P347, DOI 10.1023/B:CLIN.0000046138.58210.31; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; CHAMBERS A F, 1990, In Vivo (Attiki), V4, P215; CHAMBERS AF, 1984, CANCER RES, V44, P3970; CHAMBERS AF, 1982, CANCER RES, V42, P4018; Chambers AF, 1998, CANCER METAST REV, V17, P263, DOI 10.1023/A:1006136428254; Chambers AF, 2000, BREAST CANCER RES, V2, P400, DOI 10.1186/bcr86; Chou SH, 2006, J ORTHOP RES, V24, P301, DOI 10.1002/jor.20047; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Dani Sergio U., 2002, Genetics and Molecular Research, V1, P167; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fu XM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-175; Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101; Gibbins JM, 2004, PLATELETS MEGAKARYOC; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Greenberg AW, 2000, BLOOD, V95, P478, DOI 10.1182/blood.V95.2.478; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Kerkela E, 2013, STEM CELL TRANSL MED, V2, P510, DOI 10.5966/sctm.2012-0187; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; KOOP S, 1995, CANCER RES, V55, P2520; Koop S, 1996, P NATL ACAD SCI USA, V93, P11080, DOI 10.1073/pnas.93.20.11080; Lee RH, 2006, BLOOD, V107, P2153, DOI 10.1182/blood-2005-07-2701; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; MACDONALD IC, 1992, MICROVASC RES, V44, P185, DOI 10.1016/0026-2862(92)90079-5; MASTELLER EL, 1995, J IMMUNOL, V155, P5550; McIntyre BAS, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-21; Nystedt J, 2013, STEM CELLS, V31, P317, DOI 10.1002/stem.1271; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Park HR, 1996, CANCER LETT, V106, P227, DOI 10.1016/0304-3835(96)04330-3; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Roth JM, 2006, AM J PATHOL, V168, P1576, DOI 10.2353/ajpath.2006.050176; Ruster B, 2006, BLOOD; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Sackstein R, 2006, NATURE; Sarkar D, 2011, BLOOD, V118, pE184, DOI 10.1182/blood-2010-10-311464; Sarkar D, 2011, METHODS MOL BIOL, V698, P505, DOI 10.1007/978-1-60761-999-4_35; Schlosser S, 2012, MICROVASC RES, V83, P267, DOI 10.1016/j.mvr.2012.02.011; SCHRAUFNAGEL DE, 1987, SCANNING MICROSCOPY, V1, P1733; Schueller M, 2005, ENTWICKLUNG GEEIGNET; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Semon JA, 2010, CELL TISSUE RES, V341, P147, DOI 10.1007/s00441-010-0994-4; Shi RZ, 2008, BIOCHEM BIOPH RES CO, V376, P247, DOI 10.1016/j.bbrc.2008.09.004; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; STEPP MA, 1994, CELL ADHES COMMUN, V2, P359, DOI 10.3109/15419069409014210; vanGolde J, 1996, PEDIATR RES, V40, P867, DOI 10.1203/00006450-199612000-00016; Von Luttichau I, 2005, STEM CELLS DEV, V14, P329, DOI 10.1089/scd.2005.14.329; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; YABLONKAREUVENI Z, 1989, DEV BIOL, V132, P230, DOI 10.1016/0012-1606(89)90219-4; Zijlstra A, 2002, CANCER RES, V62, P7083	59	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105411	10.1371/journal.pone.0105411	http://dx.doi.org/10.1371/journal.pone.0105411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144321	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100063
J	Pujades-Rodriguez, M; Timmis, A; Stogiannis, D; Rapsomaniki, E; Denaxas, S; Shah, A; Feder, G; Kivimaki, M; Hemingway, H				Pujades-Rodriguez, Mar; Timmis, Adam; Stogiannis, Dimitris; Rapsomaniki, Eleni; Denaxas, Spiros; Shah, Anoop; Feder, Gene; Kivimaki, Mika; Hemingway, Harry			Socioeconomic Deprivation and the Incidence of 12 Cardiovascular Diseases in 1.9 Million Women and Men: Implications for Risk Prediction and Prevention	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENERAL-PRACTICE; MYOCARDIAL-INFARCTION; OUTCOMES FRAMEWORK; MORTALITY; HEALTH; NEIGHBORHOOD; INEQUALITIES; METAANALYSIS; FAILURE	Background: Recent experimental evidence suggests that socioeconomic characteristics of neighbourhoods influence cardiovascular health, but observational studies which examine deprivation across a wide range of cardiovascular diseases (CVDs) are lacking. Methods: Record-linkage cohort study of 1.93 million people to examine the association between small-area socioeconomic deprivation and 12 CVDs. Health records covered primary care, hospital admissions, a myocardial infarction registry and cause-specific mortality in England (CALIBER). Patients were aged >= 30 years and were initially free of CVD. Cox proportional hazard models stratified by general practice were used. Findings: During a median follow-up of 5.5 years 114,859 people had one of 12 initial CVD presentations. In women the hazards of all CVDs except abdominal aortic aneurysm increased linearly with higher small-area socioeconomic deprivation (adjusted HR for most vs. least deprived ranged from 1.05, 95%CI 0.83-1.32 for abdominal aortic aneurysm to 1.55, 95%CI 1.42-1.70 for heart failure; I-2 = 81.9%, tau(2) = 0.01). In men heterogeneity was higher (HR ranged from 0.89, 95%CI 0.75-1.06 for cardiac arrest to 1.85, 95%CI 1.67-2.04 for peripheral arterial disease; I-2 = 96.0%, tau(2) = 0.06) and no association was observed with stable angina, sudden cardiac death, subarachnoid haemorrhage, transient ischaemic attack and abdominal aortic aneurysm. Lifetime risk difference between least and most deprived quintiles was most marked for peripheral arterial disease in women (4.3% least deprived, 5.8% most deprived) and men (4.6% least deprived, 7.8% in most deprived); but it was small or negligible for sudden cardiac death, transient ischaemic attack, abdominal aortic aneurysm and ischaemic and intracerebral haemorrhage, in both women and men. Conclusions: Associations of small-area socioeconomic deprivation with 12 types of CVDs were heterogeneous, and in men absent for several diseases. Findings suggest that policies to reduce deprivation may impact more strongly on heart failure and peripheral arterial disease, and might be more effective in women.	[Pujades-Rodriguez, Mar; Stogiannis, Dimitris; Rapsomaniki, Eleni; Denaxas, Spiros; Shah, Anoop; Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, London, England; [Pujades-Rodriguez, Mar; Stogiannis, Dimitris; Rapsomaniki, Eleni; Denaxas, Spiros; Shah, Anoop; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, London, England; [Timmis, Adam] Barts & London Queen Marys Sch Med & Dent, Natl Inst Hlth Res, Biomed Res Unit, London, England; [Feder, Gene] Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England; [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London; University of London; University College London; University of London; Queen Mary University London; University of Bristol; University of London; University College London	Pujades-Rodriguez, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	mar.pujades@ucl.ac.uk	Pujades-Rodriguez, Mar/T-1129-2018; Shah, Anoop Dinesh/D-4396-2014; Kivimaki, Mika/B-3607-2012; Hemingway, Harry/C-1219-2009	Pujades-Rodriguez, Mar/0000-0002-1375-1028; Shah, Anoop Dinesh/0000-0002-8907-5724; Kivimaki, Mika/0000-0002-4699-5627; Feder, Gene/0000-0002-7890-3926; Denaxas, Spiros/0000-0001-9612-7791; Hemingway, Harry/0000-0003-2279-0624	Welcome Trust [WT 086091/Z/08/Z]; United Kingdom National Institute for Health Research [RP-PG-0407-10314]; Farr Institute ofHealth Informatics Research at UCL Partners from the Medical Research Council [MR/K006584/1]; Arthritis Research United Kingdom; British Heart Foundation; Cancer Research United Kingdom; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust; Wellcome Trust Clinical Research Training Fellowship [0938/30/Z/10/Z]; Barts and the London Cardiovascular Biomedical Research Unit - National Institute for Health Research; MRC [K013351]; National Institute on Aging, National Institutes of Health; professorial fellowship from the ESRC; ESRC [ES/J023299/1, ES/L007517/1] Funding Source: UKRI; MRC [G0902393, MR/K013351/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1, ES/L007517/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1, G0902393, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish	Welcome Trust(Wellcome Trust); United Kingdom National Institute for Health Research(National Institute for Health Research (NIHR)); Farr Institute ofHealth Informatics Research at UCL Partners from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research United Kingdom(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research United Kingdom(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Clinical Research Training Fellowship(Wellcome Trust); Barts and the London Cardiovascular Biomedical Research Unit - National Institute for Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); professorial fellowship from the ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by grants from the Welcome Trust [WT 086091/Z/08/Z], the United Kingdom National Institute for Health Research (RP-PG-0407-10314), and by awards establishing the Farr Institute ofHealth Informatics Research at UCL Partners from the Medical Research Council (MR/K006584/1), in partnership with Arthritis Research United Kingdom, the British Heart Foundation, Cancer Research United Kingdom, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientific Office (Scottish Government Health Directorates), and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AS is supported by a Wellcome Trust Clinical Research Training Fellowship [0938/30/Z/10/Z], and AT by Barts and the London Cardiovascular Biomedical Research Unit funded by the National Institute for Health Research. MK is supported by the MRC (K013351), the National Institute on Aging, National Institutes of Health and a professorial fellowship from the ESRC. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR PHR P Programme or the Department of Health.	Albert MA, 2006, CIRCULATION, V114, P2619, DOI 10.1161/CIRCULATIONAHA.106.660043; Asaria P, 2012, INT J EPIDEMIOL, V41, P1737, DOI 10.1093/ije/dys151; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Badger SA, 2008, ANGIOLOGY, V59, P559, DOI 10.1177/0003319708321586; Bhattarai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029776; Boeckxstaens P, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-209; Breeze E, 2005, INT J EPIDEMIOL, V34, P276, DOI 10.1093/ije/dyh328; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Dixon A, 2012, EUR J PUBLIC HEALTH, V22, P9, DOI 10.1093/eurpub/ckq177; Dupre ME, 2012, ARCH INTERN MED, V172, P1731, DOI 10.1001/2013.jamainternmed.447; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Force SET, 2010, IMPR WAY WE MEET PRI; Ford I, 1995, J CLIN EPIDEMIOL, V48, P1441; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kroger K, 2009, VASC MED, V14, P289, DOI 10.1177/1358863X09102294; Ludwig J, 2012, SCIENCE, V337, P1505, DOI 10.1126/science.1224648; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Major JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015538; McLennan D., 2011, ENGLISH INDICES DEPR; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; Noble M, 2008, ENGLISH INDICES DEPR; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; O'Flaherty M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2613; Pearson AL, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-38; Pearson-Stuttard J, 2012, HEART, V98, P1573, DOI 10.1136/heartjnl-2012-302435; Ramsay SE, 2013, EUR HEART J; Rapsomaniki E, 2014, LANCET; Reinier K, 2006, RESUSCITATION, V70, P186, DOI 10.1016/j.resuscitation.2005.11.018; Roberts CB, 2010, AM J EPIDEMIOL, V172, P717, DOI 10.1093/aje/kwq193; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Roux AVD, 2001, ANN EPIDEMIOL, V11, P395, DOI 10.1016/S1047-2797(01)00221-6; Salomaa V, 2000, CIRCULATION, V101, P1913, DOI 10.1161/01.CIR.101.16.1913; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Stewart S, 2006, EUR J HEART FAIL, V8, P856, DOI 10.1016/j.ejheart.2006.02.008; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8; Tunstall-Pedoe H, 2006, HEART, V92, P307, DOI 10.1136/hrt.2005.077289; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	52	83	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104671	10.1371/journal.pone.0104671	http://dx.doi.org/10.1371/journal.pone.0104671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144739	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100019
J	Qu, LN; Cui, HG; Wu, GW; Zhou, JF; Su, JM; Wang, GP; Hong, N				Qu, Linning; Cui, Hongguang; Wu, Guanwei; Zhou, Jufang; Su, Jiaming; Wang, Guoping; Hong, Ni			Genetic Diversity and Molecular Evolution of Plum bark necrosis stem pitting-associated virus from China	PLOS ONE			English	Article							APRICOT-LATENT-VIRUS; STONE FRUIT-TREES; 1ST REPORT; RECOMBINATION EVENTS; CHERRY; INSIGHTS; SWEET; PCR	Plum bark necrosis stem pitting-associated virus (PBNSPaV), a member of the genus Ampelovirus in the family Closteroviridae, infects different Prunus species and has a worldwide distribution. Yet the population structure and genetic diversity of the virus is still unclear. In this study, sequence analyses of a partial heat shock protein 70 homolog (HSP70h) gene and coat protein (CP) gene of PBNSPaV isolates from seven Prunus species grown in China revealed a highly divergent Chinese PBNSPaV population, sharing nucleotide similarities of 73.1-100% with HSP70h gene, and 83.9-98.6% with CP gene. Phylogenetic analysis of HSP70h and CP sequences revealed segregation of global PBNSPaV isolates into four phylo-groups (I-IV), of which two newly identified groups, II and IV, solely comprised Chinese isolates. Complete genome sequences of three PBNSPaV isolates, Pch-WH-1 and Pch-GS-3 from peaches, and Plm-WH-3 from a plum tree, were determined. The three isolates showed overall nucleotide identities of 90.0% (Pch-GS-3) and 96.4% (Pch-WH-1) with the type isolate PL186, and the lowest identity of 70.2-71.2% with isolate Nanjing. For the first time, to the best of our knowledge, we report evidence of significant recombination in the HSP70h gene of PBNSPaV variant Pch2 by using five programs implemented in RDP3; in addition, five codon positions in its CP gene (3, 8, 44, 57, and 88) were identified that appeared to be under positive selection. Collectively, these results indicate a divergent Chinese PBNSPaV population. In addition, our findings provide a foundation for elucidating the epidemiological characteristics of virus population.	[Qu, Linning; Cui, Hongguang; Wu, Guanwei; Zhou, Jufang; Wang, Guoping; Hong, Ni] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Qu, Linning; Wang, Guoping; Hong, Ni] Huazhong Agr Univ, Natl Key Lab Agromicrobiol, Wuhan, Hubei, Peoples R China; [Su, Jiaming] Yantai Acad Agr Sci, Yantai Agr Sci & Technol Inst, Yantai, Shandong, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Wang, GP (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	gpwang@mail.hzau.edu.cn; whni@mail.hzau.edu.cn			 [nyhyzx-201203076-03];  [nyhyzx-200903004]	; 	This work was financially supported by the agricultural projects (nyhyzx-201203076-03 and nyhyzx-200903004) administered by the Chinese Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Leal R, 2011, PHYTOPATHOLOGY, V101, P1136, DOI 10.1094/PHYTO-01-11-0017; AGRIOS GN, 1971, PLANT DIS REP, V55, P1049; Al Rwahnih M, 2007, ARCH VIROL, V152, P2197, DOI 10.1007/s00705-007-1064-4; Amenduni T, 2005, J PLANT PATHOL, V87, P131; Boscia D, 2010, VIRUS VIRUS LIKE DIS, P177; Bouani A, 2004, J PLANT PATHOL, V86, P91; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; Cui HG, 2011, PLANT DIS, V95, P1483, DOI 10.1094/PDIS-07-11-0548; DiTerlizzi B, 1995, ACTA HORTIC, P115, DOI 10.17660/ActaHortic.1995.386.12; El Maghraby I, 2006, J PLANT PATHOL, V88, pS69; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Elena SF, 2011, MOL PLANT MICROBE IN, V24, P287, DOI 10.1094/MPMI-09-10-0214; English H, 1996, PHYTOPATHOLOGY, V86, P804; Farooq AU, 2013, VIRUS RES, V171, P15, DOI 10.1016/j.virusres.2012.10.014; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Garcia-Ibarra A, 2010, PLANT DIS, V94, P275, DOI 10.1094/PDIS-94-2-0275A; Ghanem-Sabanadzovic N. Abou, 2001, Journal of Plant Pathology, V83, P125; Hadidi A, 2012, VIRUS VIRUS LIKE DIS, P1; Karasev AV, 2000, ANNU REV PHYTOPATHOL, V38, P293, DOI 10.1146/annurev.phyto.38.1.293; Li R, 2008, J VIROL METHODS, V154, P48, DOI 10.1016/j.jviromet.2008.09.008; LOTT T. B., 1962, Canadian Plant Disease Survey, V42, P229; Mandic B, 2007, J PLANT PATHOL, V89, P103; Mandic B, 2005, J PLANT PATHOL, V87, P246; Marais A., 2014, PHYTOPATHOLOGY; Marini DB, 2002, PLANT DIS, V86, P415, DOI 10.1094/PDIS.2002.86.4.415; Martelli GP., 2012, VIRUS TAXONOMY, P987, DOI DOI 10.1016/B978-0-12-384684-6.00085-9; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Matic S, 2010, J PLANT PATHOL, V92, P759; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; MIRCETICH SM, 1977, PLANT DIS REP, V61, P931; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rubio L, 2001, J VIROL, V75, P8054, DOI 10.1128/JVI.75.17.8054-8062.2001; Sanchez-Navarro JA, 2005, EUR J PLANT PATHOL, V111, P77, DOI 10.1007/s10658-004-1422-y; SIMON AE, 1994, ANNU REV PHYTOPATHOL, V32, P337, DOI 10.1146/annurev.py.32.090194.002005; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; STOUFFER R F, 1969, Plant Disease Reporter, V53, P434; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Usta M., 2007, Bulletin OEPP, V37, P181, DOI 10.1111/j.1365-2338.2007.01058.x; UYEMOTO JK, 1995, PLANT DIS, V79, P366, DOI 10.1094/PD-79-0366; Vives MC, 2005, VIROLOGY, V331, P232, DOI 10.1016/j.virol.2004.10.037; Weng ZM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000917; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; ZHANG JY, 1994, J VIROL, V68, P2409, DOI 10.1128/JVI.68.4.2409-2414.1994; Zhang YP, 1998, PLANT DIS, V82, P871, DOI 10.1094/PDIS.1998.82.8.871	45	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105443	10.1371/journal.pone.0105443	http://dx.doi.org/10.1371/journal.pone.0105443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144238	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100072
J	Wang, F; Wang, YY; Li, J; You, X; Qiu, XH; Wang, YN; Gao, FG				Wang, Fang; Wang, Yan Yan; Li, Juan; You, Xiang; Qiu, Xin Hui; Wang, Yi Nan; Gao, Feng Guang			Increased Antigen Presentation but Impaired T Cells Priming after Upregulation of Interferon-Beta Induced by Lipopolysaccharides Is Mediated by Upregulation of B7H1 and GITRL	PLOS ONE			English	Article							DENDRITIC CELLS; I INTERFERON; ENDOTOXIN TOLERANCE; ADAPTIVE IMMUNITY; EXPRESSION; NICOTINE; FAMILY; LUNG; ACTIVATION; INFECTION	Dendritic cells are able to present Ag-derived peptides on MHC class I and II molecules and induce T cells priming. Lipopolysaccharides (LPS), an activator of Toll-like 4 receptor (TLR4) signaling, has been demonstrated to facilitate Ag-presentation, up-regulate surface molecules expression but impair T cells priming. In this study, we investigated the effect of LPS on nicotine-enhanced DCs-dependent T cells priming and the mechanisms of LPS orchestrating the immunosuppressive program. We could demonstrate that the treatment with LPS resulted in increased surface molecules expression, enhanced Ag-presentation, up-regulated release of TGF-beta, TNF-alpha, IL-6, and IFN-beta. Concomititantly, the upregulation of IFN-beta in DCs induces the up-regulation of coinhibitory molecules B7H1 and GITRL, which cause an impaired activation of naive Ag-specific T cells and the induction of T cell tolerance by enhancing B7H1-PD-1 interactions and promoting GITRL-GITL facilitated Treg generation, respectively. These data provide a mechanistic basis for the immunomodulatory action of IFN-beta which might open new possibilities in the development of therapeutic approaches aimed at the control of excessive immune response and persistent infection.	[Wang, Fang; Wang, Yan Yan; Li, Juan; You, Xiang; Qiu, Xin Hui; Wang, Yi Nan; Gao, Feng Guang] Xiamen Univ, Coll Med, Dept Immunol, Xiamen, Peoples R China; [Wang, Fang] NanYang Med Coll, Dept Basic Med Sci, Nanyang, Peoples R China	Xiamen University; Nanyang Medical College	Gao, FG (corresponding author), Xiamen Univ, Coll Med, Dept Immunol, Xiamen, Peoples R China.	gfengguang@xmu.edu.cn	Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022		State Key Laboratory of Oncogenes and Related Genes [90-14-05]; National Natural Science Foundation of China [81273203]	State Key Laboratory of Oncogenes and Related Genes; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the State Key Laboratory of Oncogenes and Related Genes (No. 90-14-05) and by grants from the National Natural Science Foundation of China (No. 81273203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; [Anonymous], 2011, CANCER-AM CANCER SOC, V117, P2357, DOI 10.1002/cncr.26212; Axtell RC, 2013, CLIN REV ALLERG IMMU, V44, P114, DOI 10.1007/s12016-011-8296-5; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen MY, 2012, J NEUROIMMUNOL, V242, P39, DOI 10.1016/j.jneuroim.2011.10.014; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Gao FG, 2007, CLIN CANCER RES, V13, P3706, DOI 10.1158/1078-0432.CCR-07-0028; Gao FG, 2011, J CLIN IMMUNOL, V31, P80, DOI 10.1007/s10875-010-9459-5; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Guo LL, 2012, BBA-MOL BASIS DIS, V1822, P852, DOI 10.1016/j.bbadis.2012.02.004; Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hu SX, 2012, MOL MED REP, V5, P1005, DOI 10.3892/mmr.2012.751; Jin HJ, 2013, J CLIN IMMUNOL, V33, P246, DOI 10.1007/s10875-012-9761-5; Klotz L, 2009, J IMMUNOL, V183, P129, DOI 10.4049/jimmunol.0804260; Kole A, 2013, J IMMUNOL, V191, P2771, DOI 10.4049/jimmunol.1301093; Krausz LT, 2007, THESCIENTIFICWORLDJO, V7, P533, DOI 10.1100/tsw.2007.106; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Ni XY, 2012, ONCOL REP, V28, P615, DOI 10.3892/or.2012.1822; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Pauls E, 2012, J BIOL CHEM, V287, P19216, DOI 10.1074/jbc.M112.345405; Schaer DA, 2013, CANCER IMMUNOL RES, V1, P320, DOI 10.1158/2326-6066.CIR-13-0086; Schaer DA, 2012, CURR OPIN IMMUNOL, V24, P217, DOI 10.1016/j.coi.2011.12.011; Schwandt T, 2012, EMBO J, V31, P201, DOI 10.1038/emboj.2011.380; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Siegfried A, 2013, J IMMUNOL, V191, P3913, DOI 10.4049/jimmunol.1203305; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Tournier JM, 2011, CURR OPIN ONCOL, V23, P83, DOI 10.1097/CCO.0b013e3283412ea1; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; van Olffen RW, 2009, J IMMUNOL, V182, P7490, DOI 10.4049/jimmunol.0802751; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Zaric SS, 2011, J BIOL CHEM, V286, P29492, DOI 10.1074/jbc.M111.252791; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	47	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105636	10.1371/journal.pone.0105636	http://dx.doi.org/10.1371/journal.pone.0105636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144375	Green Published, gold			2022-12-27	WOS:000341106100104
J	Yoon, JH; Won, JU; Lee, W; Jung, PK; Roh, J				Yoon, Jin-Ha; Won, Jong-Uk; Lee, Wanhyung; Jung, Pil Kyun; Roh, Jaehoon			Occupational Noise Annoyance Linked to Depressive Symptoms and Suicidal Ideation: A Result from Nationwide Survey of Korea	PLOS ONE			English	Article							ROAD-TRAFFIC NOISE; AIRCRAFT NOISE; EXPOSURE; HEALTH; RISK; PREVALENCE; DISORDERS	Background: Noise, or undesirable sound, is one of the most common environmental stressors, and it can cause various health effects. Beyond the auditory consequences of occupational noise exposure, extra-auditory effects such as psychological problems have also been found. The aim of the current study is to elucidate the association between occupational noise annoyance and psychological symptoms, including symptoms of depression and suicidal ideation. Methods: A total of 10,020 participants (5,410 men and 4,610 women) were included in the current analysis, using data from the fourth Korean National Health and Nutrition Examination Survey (KNHANES). Self-report questionnaires were used to assess noise annoyance levels, depressive symptoms, and suicidal ideation. Odds ratios (ORs) and 95% confidence intervals (95% CIs) for psychosocial symptoms were calculated using multiple logistic regression models. Results: Compared to the no noise annoyance group, ORs (95% CI) of the severe annoyance groups were 1.58 (1.12-2.23) and 1.76 (1.29-2.40) in men and 1.49 (1.05-2.11) and 1.41 (1.01-1.97) in women for depressive symptoms and suicidal ideation, respectively. The ORs (95% CI) for severe noise annoyance in those with less than five hours of sleep were 2.95 (1.46-5.96) and 2.05 (1.01-4.16) in men and women, respectively, compared with those with no noise annoyance and a sleep time of more than five hours. Conclusion: Our study shows that occupational noise annoyance is significantly related to mental health, including depressive symptoms and suicidal ideation after controlling for individual and socio-demographic characteristics even with gender stratification. However, prospective studies with quantified noise exposure assessment were needed to elucidate the causality on the association between noise annoyance and psychological symptoms.	[Yoon, Jin-Ha; Won, Jong-Uk; Lee, Wanhyung; Jung, Pil Kyun; Roh, Jaehoon] Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea; [Yoon, Jin-Ha; Won, Jong-Uk; Lee, Wanhyung; Jung, Pil Kyun; Roh, Jaehoon] Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea; [Yoon, Jin-Ha; Won, Jong-Uk; Lee, Wanhyung; Jung, Pil Kyun; Roh, Jaehoon] Yonsei Univ, Coll Med, Grad Sch Publ Hlth, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Roh, J (corresponding author), Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea.	jhroh@yuhs.ac	Lee, Wanhyung/M-8739-2016	Lee, Wanhyung/0000-0001-6408-7668; Won, Jong-Uk/0000-0002-9200-3297; Yoon, Jin-Ha/0000-0003-4198-2955				Barreto SM, 1997, INT J EPIDEMIOL, V26, P814, DOI 10.1093/ije/26.4.814; Carter JD, 2010, J AFFECT DISORDERS, V124, P202, DOI 10.1016/j.jad.2009.11.011; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Fields JM, 2001, J SOUND VIB, V242, P641, DOI 10.1006/jsvi.2000.3384; Hardoy MC, 2005, SOC PSYCH PSYCH EPID, V40, P24, DOI 10.1007/s00127-005-0837-x; Hiramatsu K, 1997, J SOUND VIB, V205, P451, DOI 10.1006/jsvi.1997.1011; Jakovjevic B, 2009, ENVIRON INT, V35, P552, DOI 10.1016/j.envint.2008.10.001; Jeon B, 2013, HEALTH POLICY, V113, P69, DOI 10.1016/j.healthpol.2013.05.007; KRYTER KD, 1990, PSYCHOL MED, V20, P395, DOI 10.1017/S0033291700017712; Lee J.H., 2010, HANYANG MED REV, V30, P326, DOI [10.7599/hmr.2010.30.4.326, DOI 10.7599/HMR.2010.30.4.326]; Magnusson S, 2010, PSYCHOL REP, V107, P157, DOI 10.2466/02.12.13.17.PR0.107.4.157-162; Naqvi F, 2012, PHARMACOL REP, V64, P64, DOI 10.1016/S1734-1140(12)70731-4; Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Nunes EV, 2006, ADDICTION, V101, P89, DOI 10.1111/j.1360-0443.2006.01585.x; Oh K, 2007, EPIDEMIOL HEALTH, V29, P139; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; Robbins TW, 1997, BIOL PSYCHOL, V45, P57, DOI 10.1016/S0301-0511(96)05222-2; Seidman MD, 2010, INT J ENV RES PUB HE, V7, P3730, DOI 10.3390/ijerph7103730; Stansfeld S, 1996, BMJ-BRIT MED J, V313, P266, DOI 10.1136/bmj.313.7052.266; Stansfeld S. A., 2000, Noise Health, V2, P1; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Stieglitz Rolf-Dieter, 2010, Ther Umsch, V67, P549, DOI 10.1024/0040-5930/a000093; Takeuchi A, 2014, IND HLTH; TARNOPOLSKY A, 1980, PSYCHOL MED, V10, P683, DOI 10.1017/S0033291700054982; van Kempen EEMM, 2002, ENVIRON HEALTH PERSP, V110, P307, DOI 10.1289/ehp.02110307	26	36	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105321	10.1371/journal.pone.0105321	http://dx.doi.org/10.1371/journal.pone.0105321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144292	Green Published, gold			2022-12-27	WOS:000341106100053
J	Jia, B; Xie, L; Zheng, Q; Yang, PF; Zhang, WJ; Ding, C; Qian, AR; Shang, P				Jia, Bin; Xie, Li; Zheng, Qi; Yang, Peng-fei; Zhang, Wei-ju; Ding, Chong; Qian, Ai-rong; Shang, Peng			A Hypomagnetic Field Aggravates Bone Loss Induced by Hindlimb Unloading in Rat Femurs	PLOS ONE			English	Article							STATIC MAGNETIC-FIELD; KAPPA-B LIGAND; OXIDATIVE STRESS; ZINC-DEFICIENCY; RECEPTOR ACTIVATOR; URINARY-EXCRETION; MINERAL DENSITY; IRON STATUS; IN-VITRO; MAGNESIUM	A hypomagnetic field is an extremely weak magnetic field-it is considerably weaker than the geomagnetic field. In deepspace exploration missions, such as those involving extended stays on the moon and interplanetary travel, astronauts will experience abnormal space environments involving hypomagnetic fields and microgravity. It is known that microgravity in space causes bone loss, which results in decreased bone mineral density. However, it is unclear whether hypomagnetic fields affect the skeletal system. In the present study, we aimed to investigate the complex effects of a hypomagnetic field and microgravity on bone loss. To study the effects of hypomagnetic fields on the femoral characteristics of rats in simulated weightlessness, we established a rat model of hindlimb unloading that was exposed to a hypomagnetic field. We used a geomagnetic field-shielding chamber to generate a hypomagnetic field of <300 nT. The results show that hypomagnetic fields can exacerbate bone mineral density loss and alter femoral biomechanical characteristics in hindlimb-unloaded rats. The underlying mechanism might involve changes in biological rhythms and the concentrations of trace elements due to the hypomagnetic field, which would result in the generation of oxidative stress responses in the rat. Excessive levels of reactive oxygen species would stimulate osteoblasts to secrete receptor activator of nuclear factor-kappa B ligand and promote the maturation and activation of osteoclasts and thus eventually cause bone resorption.	[Jia, Bin; Xie, Li; Zheng, Qi; Yang, Peng-fei; Zhang, Wei-ju; Ding, Chong; Qian, Ai-rong; Shang, Peng] Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China	Northwestern Polytechnical University	Shang, P (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China.	shangpeng@nwpu.edu.cn			National Basic Research Program of China [2011CB710903]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2011CB710903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaseth J, 2012, J TRACE ELEM MED BIO, V26, P149, DOI 10.1016/j.jtemb.2012.03.017; Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481; Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0; Amblard D, 2003, J BONE MINER RES, V18, P561, DOI 10.1359/jbmr.2003.18.3.561; Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010; ASASHIMA M, 1991, BIOELECTROMAGNETICS, V12, P215, DOI 10.1002/bem.2250120403; Aydin N, 2011, INT ORTHOP, V35, P135, DOI 10.1007/s00264-009-0932-9; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Belyavskaya NA, 2004, ADV SPACE RES-SERIES, V34, P1566, DOI 10.1016/j.asr.2004.01.021; Bjelakovic G, 2007, J Basic Clin Physiol Pharmacol, V18, P115; Blaber EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061372; Blanco-Rojo R, 2013, EUR J NUTR, V52, P695, DOI 10.1007/s00394-012-0375-8; BLISS VL, 1976, NATURE, V261, P411, DOI 10.1038/261411a0; Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022; COHEN L, 1981, ISRAEL J MED SCI, V17, P1123; DESPLANCHES D, 1987, J APPL PHYSIOL, V63, P558, DOI 10.1152/jappl.1987.63.2.558; Dubrov AP, 1989, GEOMAGNETIC FIELD LI; Eberle J, 1999, J TRACE ELEM MED BIO, V13, P21, DOI 10.1016/S0946-672X(99)80019-4; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Emkey RD, 2012, ENDOCRIN METAB CLIN, V41, P527, DOI 10.1016/j.ecl.2012.04.019; FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103; Feller DD, 1981, PHYSIOLOGIST S, V24, pS9; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FUSHIMI H, 1993, DIABETES RES CLIN PR, V20, P191, DOI 10.1016/0168-8227(93)90077-I; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Guggenbuhl P, 2008, METABOLISM, V57, P903, DOI 10.1016/j.metabol.2008.02.004; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hsu SH, 2010, CYTOTECHNOLOGY, V62, P143, DOI 10.1007/s10616-010-9271-3; [贾斌 Jia Bin], 2011, [航天医学与医学工程, Space Medicine & Medical Engineering], V24, P318; [贾斌 JIA Bin], 2009, [航天医学与医学工程, Space Medicine & Medical Engineering], V22, P308; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; KOPANEV V I, 1979, Biology Bulletin of the Academy of Sciences of the USSR, V6, P289; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; Langlais B, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002048; Leesungbok R, 2013, J ORAL IMPLANTOL, V39, P248, DOI 10.1563/AAID-JOI-D-11-00101; LEVINA RV, 1989, KOSM BIOL AVIAK MED+, V23, P45; Lumachi F, 2012, IN VIVO, V26, P1041; Maier JAM, 2012, CLIN SCI, V122, P397, DOI 10.1042/CS20110506; Mazur A, 2007, ARCH BIOCHEM BIOPHYS, V458, P48, DOI 10.1016/j.abb.2006.03.031; MCLAREN AM, 1992, ANN RHEUM DIS, V51, P648, DOI 10.1136/ard.51.5.648; Mo WC, 2012, PROG BIOCHEM BIOPHYS, V39, P835, DOI 10.3724/SP.J.1206.2011.00597; Mo WC, 2012, BIOELECTROMAGNETICS, V33, P238, DOI 10.1002/bem.20699; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Morey-Holton ER, 1998, BONE, V22, p83S, DOI 10.1016/S8756-3282(98)00019-2; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Orwoll ES, 2013, J BONE MINER RES, V28, P1243, DOI 10.1002/jbmr.1948; Puricelli Edela, 2006, Head Face Med, V2, P43, DOI 10.1186/1746-160X-2-43; Richardson IG, 2012, J SPACE WEATHER SPAC, V2, DOI 10.1051/swsc/2012003; Rico H, 2000, EUR J OBSTET GYN R B, V90, P97, DOI 10.1016/S0301-2115(99)00223-7; Rodionova NV, 2002, J GRAVITATIONAL PHYS, V9, P169; Rude RK, 2009, J AM COLL NUTR, V28, P131, DOI 10.1080/07315724.2009.10719764; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124; Sato H, 2010, J CLIN BIOCHEM NUTR, V47, P224, DOI 10.3164/jcbn.10-58; Smietana MJ, 2010, BIOCHEM BIOPH RES CO, V403, P149, DOI 10.1016/j.bbrc.2010.11.006; Song Y, 2009, J NUTR, V139, P1626, DOI 10.3945/jn.109.106369; Steinhilber F, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014193; Suwanjang W, 2013, J STEROID BIOCHEM, V138, P116, DOI 10.1016/j.jsbmb.2013.04.008; Tombarkiewicz B, 2008, ENVIRON TOXICOL PHAR, V26, P75, DOI 10.1016/j.etap.2008.02.003; Toxqui L, 2014, EUR J NUTR, V53, P441, DOI 10.1007/s00394-013-0544-4; Tsunakawa H, 2010, SPACE SCI REV, V154, P219, DOI 10.1007/s11214-010-9652-0; UEBELHART D, 1990, BONE MINER, V8, P87, DOI 10.1016/0169-6009(91)90143-N; Wang ZJ, 2013, J BONE MINER METAB, V31, P285, DOI 10.1007/s00774-012-0417-6; Warburton Darren E R, 2007, Vasc Health Risk Manag, V3, P673; Weinberg Eugene D, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P81; Weinstein RS, 2012, ENDOCRIN METAB CLIN, V41, P595, DOI 10.1016/j.ecl.2012.04.004; Weydahl A, 2001, BIOMED PHARMACOTHER, V55, p57S; Wilking M, 2013, ANTIOXID REDOX SIGN, V19, P192, DOI 10.1089/ars.2012.4889; Xu SZ, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/620984; Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205; Yan QC, 1998, MED ENG PHYS, V20, P397, DOI 10.1016/S1350-4533(98)00051-4; Yang P, 2009, AVIAT SPACE ENVIR MD, V80, P88, DOI 10.3357/ASEM.2368.2009; Yang Yurun, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P533; Zamoshchina T A, 2012, Aviakosm Ekolog Med, V46, P17; Zerath E, 1997, LIFE SCI, V61, P2397, DOI 10.1016/S0024-3205(97)00957-0; Zhang X, 2007, BIOELECTROMAGNETICS, V28, P155, DOI 10.1002/bem.20290; Zwart SR, 2013, AM J CLIN NUTR, V98, P217, DOI 10.3945/ajcn.112.056465	82	27	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105604	10.1371/journal.pone.0105604	http://dx.doi.org/10.1371/journal.pone.0105604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157571	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200039
J	Kumar, SN; Sreekala, SR; Chandrasekaran, D; Nambisan, B; Anto, RJ				Kumar, Sasidharan Nishanth; Sreekala, Sreerag Ravikumar; Chandrasekaran, Dileep; Nambisan, Bala; Anto, Ruby John			Biocontrol of Aspergillus Species on Peanut Kernels by Antifungal Diketopiperazine Producing Bacillus cereus Associated with Entomopathogenic Nematode	PLOS ONE			English	Article							POSTHARVEST BIOLOGICAL-CONTROL; CYCLIC DIPEPTIDES; ESSENTIAL OILS; FLAVUS; GROWTH; ACID; METABOLITES; INHIBITION; BACTERIA; PURIFICATION	The rhabditid entomopathogenic nematode associated Bacillus cereus and the antifungal compounds produced by this bacterium were evaluated for their activity in reducing postharvest decay of peanut kernels caused by Aspergillus species in in vitro and in vivo tests. The results showed that B. cereus had a significant effect on biocontrol effectiveness in in vitro and in vivo conditions. The antifungal compounds produced by the B. cereus were purified using silica gel column chromatography and their structure was elucidated using extensive spectral analyses. The compounds were identified as diketopiperazines (DKPs) [cyclo-(L-Pro-Gly), cyclo(L-Tyr-L-Tyr), cyclo-(L-Phe-Gly) and cyclo(4-hydroxy-L-Pro-L-Trp)]. The antifungal activities of diketopiperazines were studied against five Aspergillus species and best MIC of 2 mu g/ml was recorded against A. flavus by cyclo(4-hydroxy-L-Pro-L-Trp). To investigate the potential application of cyclo(4-hydroxy-L-Pro-L-Trp) to eliminate fungal spoilage in food and feed, peanut kernels was used as a food model system. White mycelia and dark/pale green spores of Aspergillus species were observed in the control peanut kernels after 2 days incubation. However the fungal growth was not observed in peanut kernels treated with cyclo(4-hydroxy-L-Pro-L-Trp). The cyclo(4-hydroxy-L-Pro-L-Trp) was nontoxic to two normal cell lines [fore skin (FS) normal fibroblast and African green monkey kidney (VERO)] up to 200 mu g/ml in MTT assay. Thus the cyclo(4-hydroxy-L-Pro-L-Trp) identified in this study may be a promising alternative to chemical preservatives as a potential biopreservative agent which prevent fungal growth in food and feed. To the best of our knowledge, this is the first report demonstrating that the entomopathogenic nematode associated B. cereus and cyclo(4-hydroxy-L-Pro-L-Trp) could be used as a biocontrol agents against postharvest fungal disease caused by Aspergillus species.	[Kumar, Sasidharan Nishanth; Sreekala, Sreerag Ravikumar; Nambisan, Bala] Cent Tuber Crops Res Inst, Div Crop Protect, Div Crop Utilizat, Thiruvananthapuram, Kerala, India; [Chandrasekaran, Dileep] SD Coll, Dept Bot, Alappuzha, India; [Anto, Ruby John] Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Integrated Canc Res Program, Thiruvananthapuram, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Tuber Crops Research Institute; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Nambisan, B (corresponding author), Cent Tuber Crops Res Inst, Div Crop Protect, Div Crop Utilizat, Thiruvananthapuram, Kerala, India.	balactcri@gmail.com			SRF	SRF	This was self financed work. The only funding received was the fellowship of SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide-Molina M, 2009, J CHROMATOGR A, V1216, P1115, DOI 10.1016/j.chroma.2008.12.049; [Anonymous], 2011, SCI MICROBIAL PATHOG; Anto RJ, 2003, J BIOL CHEM, V278, P25490, DOI 10.1074/jbc.M301790200; Bouchra C, 2003, J ETHNOPHARMACOL, V89, P165, DOI 10.1016/S0378-8741(03)00275-7; Cho KM, 2009, FOOD CONTROL, V20, P402, DOI 10.1016/j.foodcont.2008.07.010; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; Clinical and Laboratory Standards Institute [CLSI], 2010, M51A CLSI; CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI), 2012, REFERENCE METHOD BRO, V4th; CLSI, 2010, METHOD ANTIFUNGAL DI; Deepa I, 2010, J ROOT CROPS, V36, P227; Droby S, 2006, ACTA HORTIC, P45, DOI 10.17660/ActaHortic.2006.709.5; Duan JL, 2013, ANN MICROBIOL, V63, P1501, DOI 10.1007/s13213-013-0614-0; Dumdei EJ, 1997, AUST J CHEM, V50, P139, DOI 10.1071/C96111; Einholm AP, 2003, BIOCHEM J, V373, P723, DOI 10.1042/BJ20021880; Fan Q, 2001, POSTHARVEST BIOL TEC, V21, P341, DOI 10.1016/S0925-5214(00)00182-4; Fdhila F, 2003, J NAT PROD, V66, P1299, DOI 10.1021/np030233e; Gould M, 2008, BIOCONTROL SCI TECHN, V18, P1005, DOI 10.1080/09583150802478189; Hamdache A, 2011, J NAT PROD, V74, P893, DOI 10.1021/np100853e; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Holden MTG, 1999, MOL MICROBIOL, V33, P1254, DOI 10.1046/j.1365-2958.1999.01577.x; Holmes RA, 2008, APPL MICROBIOL BIOT, V78, P559, DOI 10.1007/s00253-008-1362-0; Horn BW, 2009, BIOCONTROL SCI TECHN, V19, P249, DOI 10.1080/09583150802696541; Huang HR, 2007, J NAT PROD, V70, P1696, DOI 10.1021/np0605891; Huang ZJ, 2010, CHEM NAT COMPD+, V46, P15, DOI 10.1007/s10600-010-9514-8; Jamali M, 2012, FOLIA MICROBIOL, V57, P27, DOI 10.1007/s12223-011-0090-5; JOHNSON JL, 1951, J AM CHEM SOC, V73, P2947, DOI 10.1021/ja01150a516; Kumar SN, 2013, MICROBIOL RES, V168, P278, DOI 10.1016/j.micres.2012.12.003; Kumar SN, 2012, J APPL MICROBIOL, V113, P914, DOI 10.1111/j.1365-2672.2012.05385.x; Li B, 2013, J ASIAN NAT PRODS RE, V12, P1146; Lin AQ, 2008, PHARMAZIE, V63, P323, DOI 10.1691/ph.2008.7700; Lopez-Malo A, 2007, FOOD CONTROL, V18, P1358, DOI 10.1016/j.foodcont.2006.04.010; Magnusson J, 2003, FEMS MICROBIOL LETT, V219, P129, DOI 10.1016/S0378-1097(02)01207-7; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Martins MB, 2007, TETRAHEDRON, V63, P9923, DOI 10.1016/j.tet.2007.04.105; Mohandas C, 2007, P NAT SEM ACH OPP PO, P195; Munoz R, 2010, BRAZ J MICROBIOL, V41, P1019, DOI 10.1590/S1517-838220100004000021; Nielsen PV, 2000, INT J FOOD MICROBIOL, V60, P219, DOI 10.1016/S0168-1605(00)00343-3; Nishanth Sasidharan Kumar, 2013, Archives of Phytopathology and Plant Protection, V46, P962, DOI 10.1080/03235408.2012.755800; Omidbeygi M, 2007, FOOD CONTROL, V18, P1518, DOI 10.1016/j.foodcont.2006.12.003; Pitt J. I., 1977, FUNGI FOOD SPOILAGE; PUSEY PL, 1984, PLANT DIS, V68, P753, DOI 10.1094/PD-69-753; Razzaghi-Abyaneh M, 2006, MYCOPATHOLOGIA, V161, P183, DOI 10.1007/s11046-005-0242-8; Shoda M, 2000, J BIOSCI BIOENG, V89, P515, DOI 10.1016/S1389-1723(00)80049-3; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Stierle AC, 1998, PNAS, V85, P8008; Stiles ME, 1996, ANTON LEEUW INT J G, V70, P331, DOI 10.1007/BF00395940; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; Ventura M, 2004, J CHROMATOGR A, V1048, P25, DOI 10.1016/j.chroma.2004.07.033; Wang YF, 2008, INT J FOOD MICROBIOL, V123, P234, DOI 10.1016/j.ijfoodmicro.2008.02.002; Yan PS, 2004, APPL ENVIRON MICROB, V70, P7466, DOI 10.1128/AEM.70.12.7466-7473.2004; Yang EJ, 2010, INT J FOOD MICROBIOL, V139, P56, DOI 10.1016/j.ijfoodmicro.2010.02.012; Zollner P, 2006, J CHROMATOGR A, V1136, P123, DOI 10.1016/j.chroma.2006.09.055	52	27	29	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106041	10.1371/journal.pone.0106041	http://dx.doi.org/10.1371/journal.pone.0106041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157831	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200087
J	Patro, CPK; Khan, AM; Tan, TW; Fu, XY				Patro, C. Pawan K.; Khan, Asif M.; Tan, Tin Wee; Fu, Xin-Yuan			STATdb: A Specialised Resource for the STATome	PLOS ONE			English	Article							COMMUNITY ANNOTATION; GENE FAMILY; DATABASE; PROTEIN; ROLES; JAKS	Signal transducers and activators of transcription (STAT) proteins are key signalling molecules in metazoans, implicated in various cellular processes. Increased research in the field has resulted in the accumulation of STAT sequence and structure data, which are scattered across various public databases, missing extensive functional annotations, and prone to effort redundancy because of the dearth of community sharing. Therefore, there is a need to integrate the existing sequence, structure and functional data into a central repository, one that is enriched with annotations and provides a platform for community contributions. Herein, we present STATdb (publicly available at http://statdb.bic.nus.edu.sg/), the first integrated resource for STAT sequences comprising 1540 records representing the known STATome, enriched with existing structural and functional information from various databases and literature and including manual annotations. STATdb provides advanced features for data visualization, analysis and prediction, and community contributions. A key feature is a meta-predictor to characterise STAT sequences based on a novel classification that integrates STAT domain architecture, lineage and function. A curation policy workflow has been devised for regulated and structured community contributions, with an update policy for the seamless integration of new data and annotations.	[Patro, C. Pawan K.; Tan, Tin Wee; Fu, Xin-Yuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore; [Khan, Asif M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD USA; [Khan, Asif M.] Perdana Univ, Grad Sch Med, Serdang, Selangor Darul, Malaysia; [Fu, Xin-Yuan] Natl Univ Singapore, Canc Sci Inst Singapore CSI, Singapore 117548, Singapore; [Fu, Xin-Yuan] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	National University of Singapore; Johns Hopkins University; Perdana University; National University of Singapore; Indiana University System; Indiana University-Purdue University Indianapolis	Tan, TW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore.	tinwee@bic.nus.edu.sg; bchfxy@nus.edu.sg	Khan, M. Asif/ABE-7839-2021; Khan, Mohammad Asif/F-4663-2010; Tan, Tin Wee/B-8963-2009	Khan, M. Asif/0000-0001-9202-279X; Khan, Mohammad Asif/0000-0001-9202-279X; Tan, Tin Wee/0000-0002-4062-2854	Office of the Deputy President (Research and Technology); Yong Loo Lin School of Medicine of the National University of Singapore (NUS); Ministry of Education of Singapore [MOE2010-T2-1-084]; NUS Research Scholarship	Office of the Deputy President (Research and Technology); Yong Loo Lin School of Medicine of the National University of Singapore (NUS)(National University of Singapore); Ministry of Education of Singapore(Ministry of Education, Singapore); NUS Research Scholarship(National University of Singapore)	XYF was supported by start-up funds from the Office of the Deputy President (Research and Technology) and the Yong Loo Lin School of Medicine of the National University of Singapore (NUS), and grants from Ministry of Education of Singapore (MOE2010-T2-1-084). CPKP was funded on an NUS Research Scholarship for part of this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; COPELAND NG, 1995, GENOMICS, V29, P225, DOI 10.1006/geno.1995.1235; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Daub J, 2008, RNA, V14, P2462, DOI 10.1261/rna.1200508; Decker T., 2012, JAK STAT SIGNALING B; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; Gaudet P, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq027; Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6; Huss JW, 2008, PLOS BIOL, V6, P1398, DOI 10.1371/journal.pbio.0060175; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kay RR, 1997, CURR BIOL, V7, pR723, DOI 10.1016/S0960-9822(06)00366-6; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lewis RS, 2004, GENE, V338, P65, DOI 10.1016/j.gene.2004.05.012; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mazumder R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-12; McIntosh BK, 2012, NUCLEIC ACIDS RES, V40, pD1270, DOI 10.1093/nar/gkr880; Mons B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r89; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stehr H, 2010, DATABASE, V2010; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tan TW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S13; Tan TW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S27; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veeramani A, 2006, 2006 INTERNATIONAL CONFERENCE ON BIOMEDICAL AND PHARMACEUTICAL ENGINEERING, VOLS 1 AND 2, P324; Wang Y, 2006, FASEB J, V20, P1641, DOI 10.1096/fj.06-6051com; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104597	10.1371/journal.pone.0104597	http://dx.doi.org/10.1371/journal.pone.0104597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157689	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200014
J	Qiao, GL; Le, Y; Li, J; Wang, LH; Shen, F				Qiao, Guoliang; Le, Yuan; Li, Jun; Wang, Lianghuan; Shen, Feng			Glycogen Synthase Kinase-3 beta Is Associated with the Prognosis of Hepatocellular Carcinoma and May Mediate the Influence of Type 2 Diabetes Mellitus on Hepatocellular Carcinoma	PLOS ONE			English	Article							CELL-SURVIVAL; INSULIN; CANCER; PHOSPHORYLATION; RISK; GLYCOGEN-SYNTHASE-KINASE-3-BETA; OVEREXPRESSION; PROLIFERATION; INACTIVATION; SUPPRESSION	Background: Although many studies have shown glycogen synthase kinase-3 beta(GSK-3 beta) was associated with type 2 diabetes mellitus(T2DM) and implicated with a wide range of cancers, the role of GSK-3 beta in hepatocellular carcinoma(HCC) and the correlation among GSK-3 beta, T2DM and HCC remains unclear. Our objectives were to identify the effect of p-Ser9-GSK-3 beta on the prognosis of patients with HCC and to learn more about the interaction among T2DM, GSK-3 beta and the prognosis of HCC. Methods: Firstly we used reverse transcriptase-PCR(RT-PCR) and western blotting to determine the expression levels of GSK-3 beta and p-Ser9-GSK-3 beta in human HCC samples. We then used immunohistochemical staining to evaluate the expression pattern of p-Ser9-GSK-3 beta in 178 patients with HCC after curative partial hepatectomy. Finally we statistically analyzed the association of p-Ser9-GSK-3 beta and T2DM with the prognosis of patients with HCC. Results: P-Ser9-GSK-3 beta was over-expressed in tumor tissues compared with their normal counterparts. Correlation and regression analysis indicated that the over-expression of p-Ser9-GSK-3 beta was significantly associated with T2DM, and the correlation coefficient was 0.259 (P = 0.001). Multivariate analysis showed that the over-expression of p-Ser9-GSK-3 beta(P<0.001) and T2DM(P = 0.008) were independently associated with poor prognosis of HCC, respectively. Further analysis demonstrated that these two variables are closely related with each other. Conclusion: The over-expression of p-Ser9-GSK-3 beta and T2DM are strongly correlated with worse surgical outcome of HCC. P-Ser9-GSK-3 beta may play a significant role in mediating the influence of T2DM on the prognosis of HCC.	[Qiao, Guoliang; Li, Jun; Shen, Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China; [Le, Yuan; Wang, Lianghuan] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Shen, F (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China.	shenfdfgd@163.com	Shen, Feng/GSD-2508-2022					Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Ban KC, 2003, CANCER LETT, V199, P201, DOI 10.1016/S0304-3835(03)00421-X; Bannasch P, 1997, J BIOENERG BIOMEMBR, V29, P303, DOI 10.1023/A:1022438528634; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Boissan M, 2005, AM J PATHOL, V167, P869, DOI 10.1016/S0002-9440(10)62058-5; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Desbois-Mouthon C, 2002, HEPATOLOGY, V36, P1528, DOI 10.1053/jhep.2002.37192; Duffy JP, 2008, CANCER J, V14, P100, DOI 10.1097/PPO.0b013e31816a5c1f; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Hassan MM, 2010, CANCER-AM CANCER SOC, V116, P1938, DOI 10.1002/cncr.24982; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huo TI, 2010, LIVER INT, V30, P198, DOI 10.1111/j.1478-3231.2009.02143.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kunnimalaiyaan M, 2007, MOL CANCER THER, V6, P1151, DOI 10.1158/1535-7163.MCT-06-0665; Lee JS, 2007, DIABETES RES CLIN PR, V77, pS49, DOI 10.1016/j.diabres.2007.01.033; Liao XB, 2003, MOL CANCER THER, V2, P1215; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Patel S, 2004, BIOCHEM SOC T, V32, P803, DOI 10.1042/BST0320803; Poon RTP, 2002, AM J GASTROENTEROL, V97, P1480, DOI 10.1016/S0002-9270(02)04148-5; Scharf JG, 2003, HORM METAB RES, V35, P685; Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Shau WY, 2012, ONCOLOGIST, V17, P856, DOI 10.1634/theoncologist.2012-0065; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tanaka S, 2002, SURGERY, V131, pS142, DOI 10.1067/msy.2002.119495; Wang K, 2010, HEPATOLOGY, V52, P164, DOI 10.1002/hep.23650; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	41	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105624	10.1371/journal.pone.0105624	http://dx.doi.org/10.1371/journal.pone.0105624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157753	gold, Green Submitted, Green Published			2022-12-27	WOS:000341303200041
J	Honsa, ES; Maresso, AW; Highlander, SK				Honsa, Erin S.; Maresso, Anthony W.; Highlander, Sarah K.			Molecular and Evolutionary Analysis of NEAr-Iron Transporter (NEAT) Domains	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; SURFACE PROTEIN; HEMOGLOBIN RECEPTOR; HEME-BINDING; SORTASE-B; ANTHRAX HEMOPHORE; CRYSTAL-STRUCTURE; AFFINITY BINDING; STRUCTURAL BASIS; EXTRACT HEME	Iron is essential for bacterial survival, being required for numerous biological processes. NEAr-iron Transporter (NEAT) domains have been studied in pathogenic Gram-positive bacteria to understand how their proteins obtain heme as an iron source during infection. While a 2002 study initially discovered and annotated the NEAT domain encoded by the genomes of several Gram-positive bacteria, there remains a scarcity of information regarding the conservation and distribution of NEAT domains throughout the bacterial kingdom, and whether these domains are restricted to pathogenic bacteria. This study aims to expand upon initial bioinformatics analysis of predicted NEAT domains, by exploring their evolution and conserved function. This information was used to identify new candidate domains in both pathogenic and nonpathogenic organisms. We also searched metagenomic datasets, specifically sequence from the Human Microbiome Project. Here, we report a comprehensive phylogenetic analysis of 343 NEAT domains, encoded by Gram-positive bacteria, mostly within the phylum Firmicutes, with the exception of Eggerthella sp. (Actinobacteria) and an unclassified Mollicutes bacterium (Tenericutes). No new NEAT sequences were identified in the HMP dataset. We detected specific groups of NEAT domains based on phylogeny of protein sequences, including a cluster of novel clostridial NEAT domains. We also identified environmental and soil organisms that encode putative NEAT proteins. Biochemical analysis of heme binding by a NEAT domain from a protein encoded by the soil-dwelling organism Paenibacillus polymyxa demonstrated that the domain is homologous in function to NEAT domains encoded by pathogenic bacteria. Together, this study provides the first global bioinformatics analysis and phylogenetic evidence that NEAT domains have a strong conservation of function, despite group-specific differences at the amino acid level. These findings will provide information useful for future projects concerning the structure and function of NEAT domains, particularly in pathogens where they have yet to be studied.	[Honsa, Erin S.; Maresso, Anthony W.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Highlander, Sarah K.] J Craig Venter Inst, La Jolla, CA 92037 USA	Baylor College of Medicine; J. Craig Venter Institute	Highlander, SK (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.	shighlan@jcvi.org		Highlander, Sarah/0000-0002-3800-4950	National Institutes of Health (NIH) [A1097167, A1069697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109465, R01AI097167] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sources of funding for this study were National Institutes of Health (NIH) grants A1097167 and A1069697 awarded to AWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; AKATOV AK, 1981, ZH MIKROB EPID IMMUN, P45; Akiyama Hisanori, 1998, Journal of Dermatology (Tokyo), V25, P563; ALFERY DD, 1979, CRIT CARE MED, V7, P176, DOI 10.1097/00003246-197904000-00007; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade MA, 2002, GENOME BIOL, V3; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Bahl H, 1997, FEMS MICROBIOL REV, V20, P47, DOI 10.1016/S0168-6445(97)00050-8; Balderas MA, 2012, J BACTERIOL, V194, P5513, DOI 10.1128/JB.00685-12; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Benevides-Matos N, 2008, J BACTERIOL, V190, P21, DOI 10.1128/JB.01389-07; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P99, DOI 10.1016/S0168-6445(97)00043-0; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brook I, 2007, ANAEROBE, V13, P171, DOI 10.1016/j.anaerobe.2007.08.004; Caillet-Saguy C, 2008, J BIOL CHEM, V283, P5960, DOI 10.1074/jbc.M703795200; Crosa JH., 2004, IRON TRANSPORT BACTE; Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; EALES C E, 1947, Aust J Sci, V10, P20; Ebert Tim, 2010, Human Antibodies, V19, P113, DOI 10.3233/HAB-2010-0235; Ekworomadu MT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fouet A, 1999, J APPL MICROBIOL, V87, P251, DOI 10.1046/j.1365-2672.1999.00882.x; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Haggag WM, 2008, J APPL MICROBIOL, V104, P961, DOI 10.1111/j.1365-2672.2007.03611.x; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Honsa ES, 2013, J BIOL CHEM, V288, P8479, DOI 10.1074/jbc.M112.430009; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Honsa ES, 2011, BIOMETALS, V24, P533, DOI 10.1007/s10534-011-9413-x; HUSS HH, 1980, APPL ENVIRON MICROB, V39, P764, DOI 10.1128/AEM.39.4.764-769.1980; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jeong H, 2011, J BACTERIOL, V193, P5026, DOI 10.1128/JB.05447-11; Jepkorir G, 2010, J AM CHEM SOC, V132, P9857, DOI 10.1021/ja103498z; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Lal S, 2012, ARCH MICROBIOL, V194, P345, DOI 10.1007/s00203-011-0763-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letoffe S, 2004, J BACTERIOL, V186, P4067, DOI 10.1128/JB.186.13.4067-4074.2004; LETOFFE S, 1994, J BACTERIOL, V176, P5372; Letoffe S, 1999, MOL MICROBIOL, V33, P546, DOI 10.1046/j.1365-2958.1999.01499.x; Li T, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-13; Ma MC, 2011, J BACTERIOL, V193, P311, DOI 10.1128/JB.01234-10; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; MARTIN MA, 1989, ANN INTERN MED, V110, P9, DOI 10.7326/0003-4819-110-1-9; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mey AR, 2001, MOL MICROBIOL, V42, P835, DOI 10.1046/j.1365-2958.2001.02683.x; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nagano N, 2008, J CLIN MICROBIOL, V46, P1545, DOI 10.1128/JCM.01895-07; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Noone M, 2002, J CLIN PATHOL, V55, P141, DOI 10.1136/jcp.55.2.141; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; RIGGS A, 1965, PHYSIOL REV, V45, P619, DOI 10.1152/physrev.1965.45.4.619; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Seki H, 2003, PEDIATR INT, V45, P86, DOI 10.1046/j.1442-200X.2003.01671.x; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Smith K.M., 1975, PORPHYRINS METALLOPO; Song YL, 2004, ANAEROBE, V10, P179, DOI 10.1016/j.anaerobe.2004.04.004; Spirig T, 2012, BIOMOL NMR ASSIGN, V6, P169, DOI 10.1007/s12104-011-9348-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Voet D, 2011, BIOCHEMISTRY-US, P323; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	95	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104794	10.1371/journal.pone.0104794	http://dx.doi.org/10.1371/journal.pone.0104794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153520	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200027
J	Li, C; Miao, HM; Wei, LB; Zhang, TD; Han, XH; Zhang, HY				Li, Chun; Miao, Hongmei; Wei, Libin; Zhang, Tide; Han, Xiuhua; Zhang, Haiyang			Association Mapping of Seed Oil and Protein Content in Sesamum indicum L. Using SSR Markers	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GERMPLASM COLLECTION; GENETIC DIVERSITY; BINDING PROTEIN; QUALITY TRAITS; SEQUENCE TAGS; ACID; IDENTIFICATION; EXPRESSION; TRANSPORTER	Sesame is an important oil crop for the high oil content and quality. The seed oil and protein contents are two important traits in sesame. To identify the molecular markers associated with the seed oil and protein contents in sesame, we systematically performed the association mapping among 369 worldwide germplasm accessions under 5 environments using 112 polymorphic SSR markers. The general linear model (GLM) was applied with the criteria of logP >= 3.0 and high stability under all 5 environments. Among the 369 sesame accessions, the oil content ranged from 27.89%-58.73% and the protein content ranged from 16.72%-27.79%. A significant negative correlation of the oil content with the protein content was found in the population. A total of 19 markers for oil content were detected with a R-2 value range from 4% to 29%; 24 markers for protein content were detected with a R-2 value range from 3% to 29%, of which 19 markers were associated with both traits. Moreover, partial markers were confirmed using mixed linear model (MLM) method, which suggested that the oil and protein contents are controlled mostly by major genes. Allele effect analysis showed that the allele associated with high oil content was always associated with low protein content, and vice versa. Of the 19 markers associated with oil content, 17 presented near the locations of the plant lipid pathway genes and 2 were located just next to a fatty acid elongation gene and a gene encoding Stearoyl-ACP Desaturase, respectively. The findings provided a valuable foundation for oil synthesis gene identification and molecular marker assistant selection (MAS) breeding in sesame.	[Li, Chun; Miao, Hongmei; Wei, Libin; Zhang, Tide; Han, Xiuhua; Zhang, Haiyang] Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China	Henan Academy of Agricultural Sciences	Zhang, HY (corresponding author), Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China.	zhy@hnagri.org.cn	Miao, Hongmei/AAQ-7525-2021	Li, Chun/0000-0002-9370-1775	China National "973'' Project [2011CB109304]; earmarked fund for the China Agriculture Research System [CARS-15]	China National "973'' Project(National Basic Research Program of China); earmarked fund for the China Agriculture Research System	This work was supported by China National "973'' Project (2011CB109304) and the earmarked fund for the China Agriculture Research System (CARS-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Anilakumar Kandangath Raghavan, 2010, Agriculturae Conspectus Scientificus, V75, P159; ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; BEDIGIAN D, 1986, ECON BOT, V40, P137, DOI 10.1007/BF02859136; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Brummer EC, 1997, CROP SCI, V37, P370, DOI 10.2135/cropsci1997.0011183X003700020011x; Chen G, 2010, EUPHYTICA, V175, P161, DOI 10.1007/s10681-010-0144-9; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Chen M, 2012, PLANT J, V69, P769, DOI 10.1111/j.1365-313X.2011.04829.x; Chen SiLong, 2009, Scientia Agricultura Sinica, V42, P3048; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Chun JA, 2003, PLANTA, V216, P874, DOI 10.1007/s00425-002-0940-0; Ecke W, 2010, THEOR APPL GENET, V120, P921, DOI 10.1007/s00122-009-1221-0; Eleuch L, 2008, J INTEGR PLANT BIOL, V50, P1004, DOI 10.1111/j.1744-7909.2008.00670.x; ELTINAY AH, 1976, J AM OIL CHEM SOC, V53, P648, DOI 10.1007/BF02586281; Engeseth NJ, 1996, ARCH BIOCHEM BIOPHYS, V331, P55, DOI 10.1006/abbi.1996.0282; Ersoz E.S., 2007, GENOMICS ASSISTED CR, P97, DOI DOI 10.1007/978-1-4020-6295-7_5; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Guo SX, 2011, THESIS SICHUAN AGR U; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Haselier A, 2010, PLANT PHYSIOL, V153, P1372, DOI 10.1104/pp.110.156422; He DaoHua, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P103; HEDRICK PW, 1987, GENETICS, V117, P331; Hobbs DH, 2004, PLANT PHYSIOL, V136, P3341, DOI 10.1104/pp.104.049486; Holland JB, 2002, PL BRED RE, V22, P9; Hwang EY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1; Jin UH, 2001, PLANT SCI, V161, P935, DOI 10.1016/S0168-9452(01)00489-7; JOHNSON LA, 1979, J AM OIL CHEM SOC, V56, P463, DOI 10.1007/BF02671542; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Ke T, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-180; Kim DH, 2002, PLANT BREEDING, V121, P259, DOI 10.1046/j.1439-0523.2002.00700.x; Kumar H, 2012, J CROP IMPROV, V26, P540, DOI 10.1080/15427528.2012.660563; Laurentin HE, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-10; Leduc V, 2006, ALLERGY, V61, P349, DOI 10.1111/j.1398-9995.2006.01013.x; Magni C, 2010, ANN ALLERG ASTHMA IM, V105, P458, DOI 10.1016/j.anai.2010.10.001; Miao H, 2014, INT PLANT ANIMAL GEN; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Monks DE, 1996, PLANT PHYSIOL, V110, P1197, DOI 10.1104/pp.110.4.1197; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Panikashvili D, 2011, NEW PHYTOL, V190, P113, DOI 10.1111/j.1469-8137.2010.03608.x; Pritchard JK, 2000, GENETICS, V155, P945; Quilichini TD, 2010, PLANT PHYSIOL, V154, P678, DOI 10.1104/pp.110.161968; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; Shi A, 2010, PLANT BREEDING, V129, P250, DOI 10.1111/j.1439-0523.2010.01766.x; Singkham N, 2010, J AGR FOOD CHEM, V58, P6257, DOI 10.1021/jf903728e; Stankiewicz M, 2001, WEED RES, V41, P287, DOI 10.1046/j.1365-3180.2001.00238.x; Suh MC, 2003, PLANT MOL BIOL, V52, P1107, DOI 10.1023/B:PLAN.0000004304.22770.e9; Tilton G, 2000, BIOCHEM SOC T, V28, P946, DOI 10.1042/BST0280946; Turhan H, 2010, BULG J AGRIC SCI, V16, P553; Uzun B, 2008, J AM OIL CHEM SOC, V85, P1135, DOI 10.1007/s11746-008-1304-0; Wei LB, 2009, GENES GENOM, V31, P199, DOI 10.1007/BF03191152; Wei WL, 2013, J INTEGR PLANT BIOL, V55, P745, DOI 10.1111/jipb.12049; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Weir BS., 1996, METHODS DISCRETE POP; Xing S, 2008, PLANT J, V53, P790, DOI 10.1111/j.1365-313X.2007.03375.x; Xue HW, 2000, PLANT MOL BIOL, V42, P757, DOI 10.1023/A:1006308909105; Yamaoka Y, 2011, PLANT J, V67, P648, DOI 10.1111/j.1365-313X.2011.04624.x; Yasuno R, 2002, FEBS LETT, V517, P110, DOI 10.1016/S0014-5793(02)02589-9; YERMANOS DM, 1972, J AM OIL CHEM SOC, V49, P20, DOI 10.1007/BF02545131; Yu JW, 2012, EUPHYTICA, V187, P191, DOI 10.1007/s10681-012-0630-3; Yue WenDi, 2012, Acta Agronomica Sinica, V38, P2286; Zhang HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-401; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang HY, 2013, 7 CHIN NAT OIL CROPS, P29; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhang Peng, 2007, Acta Agronomica Sinica, V33, P1696; Zhao JJ, 2010, GENOME, V53, P884, DOI 10.1139/G10-082; Zhao JY, 2006, THEOR APPL GENET, V113, P33, DOI 10.1007/s00122-006-0267-5; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85; Zou J, 2010, GENOME, V53, P908, DOI 10.1139/G10-075	75	25	32	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105757	10.1371/journal.pone.0105757	http://dx.doi.org/10.1371/journal.pone.0105757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153139	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200080
J	Libiakova, M; Flokova, K; Novak, O; Slovakova, L; Pavlovic, A				Libiakova, Michaela; Flokova, Kristyna; Novak, Ondrej; Slovakova, L'udmila; Pavlovic, Andrej			Abundance of Cysteine Endopeptidase Dionain in Digestive Fluid of Venus Flytrap (Dionaea muscipula Ellis) Is Regulated by Different Stimuli from Prey through Jasmonates	PLOS ONE			English	Article							SECRETORY CYCLE; TRAP CLOSURE; PHOTOSYNTHETIC EFFICIENCY; 12-OXO-PHYTODIENOIC ACID; ACTION-POTENTIALS; PITCHER FLUID; MECHANISM; PLANTS; GENES; ARABIDOPSIS	The trap of the carnivorous plant Venus flytrap (Dionaea muscipula) catches prey by very rapid closure of its modified leaves. After the rapid closure secures the prey, repeated mechanical stimulation of trigger hairs by struggling prey and the generation of action potentials (APs) result in secretion of digestive fluid. Once the prey's movement stops, the secretion is maintained by chemical stimuli released from digested prey. We investigated the effect of mechanical and chemical stimulation (NH4Cl, KH2PO4, further N(Cl) and P(K) stimulation) on enzyme activities in digestive fluid. Activities of beta-D-glucosidases and N-acetyl-beta-D-glucosaminidases were not detected. Acid phosphatase activity was higher in N(Cl) stimulated traps while proteolytic activity was higher in both chemically induced traps in comparison to mechanical stimulation. This is in accordance with higher abundance of recently described enzyme cysteine endopeptidase dionain in digestive fluid of chemically induced traps. Mechanical stimulation induced high levels of cis-12-oxophytodienoic acid (cis-OPDA) but jasmonic acid (JA) and its isoleucine conjugate (JA-Ile) accumulated to higher level after chemical stimulation. The concentration of indole-3-acetic acid (IAA), salicylic acid (SA) and abscisic acid (ABA) did not change significantly. The external application of JA bypassed the mechanical and chemical stimulation and induced a high abundance of dionain and proteolytic activity in digestive fluid. These results document the role of jasmonates in regulation of proteolytic activity in response to different stimuli from captured prey. The double trigger mechanism in protein digestion is proposed.	[Libiakova, Michaela; Slovakova, L'udmila; Pavlovic, Andrej] Comenius Univ, Fac Nat Sci, Dept Plant Physiol, Bratislava, Slovakia; [Flokova, Kristyna; Novak, Ondrej] Inst Expt Bot ASCR, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Olomouc, Czech Republic; [Flokova, Kristyna; Novak, Ondrej] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Pavlovic, Andrej] Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic	Comenius University Bratislava; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc	Pavlovic, A (corresponding author), Comenius Univ, Fac Nat Sci, Dept Plant Physiol, Bratislava, Slovakia.	pavlovic@fns.uniba.sk	NOVAK, Ondrej/F-7031-2014; PAVLOVIČ, Andrej/AAG-8027-2020; Floková, Kristýna/K-2888-2014	NOVAK, Ondrej/0000-0003-3452-0154; Flokova, Kristyna/0000-0002-5558-0669; Pavlovic, Andrej/0000-0003-4274-2099; Slovakova, Ludmila/0000-0001-6162-5037	Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 1/0520/12]; Ministry of Education Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0057]; National Program of Sustainability I [LO1204]; Internal Grant Agency of Palacky University [IGA_PrF_2014006]	Ministry of Education, Science, Research and Sport of the Slovak Republic; Ministry of Education Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); National Program of Sustainability I; Internal Grant Agency of Palacky University	This work was financially supported by the Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 1/0520/12], Ministry of Education Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0057] and grant LO1204 from the National Program of Sustainability I. The Internal Grant Agency of Palacky University [IGA_PrF_2014006] is also kindly acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFOLTER JM, 1975, AM MIDL NAT, V93, P443, DOI 10.2307/2424177; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; Ballare CL, 2011, TRENDS PLANT SCI, V16, P249, DOI 10.1016/j.tplants.2010.12.001; BALOTIN NM, 1962, SCIENCE, V138, P1338, DOI 10.1126/science.138.3547.1338; Brown WH, 1916, AM J BOT, V3, P68, DOI 10.2307/2435207; Burdon-Sanderson JI., 1873, P R SOC LOND, V21, P495, DOI DOI 10.1098/RSPL.1872.0092; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Darwin C., 1875, INSECTIVOROUS PLANTS; Dick CF, 2011, ENZYME RES, V2011; Eilenberg H, 2006, J EXP BOT, V57, P2775, DOI 10.1093/jxb/erl048; Ellison AM, 2006, PLANT BIOLOGY, V8, P740, DOI 10.1055/s-2006-923956; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Farnsworth EJ, 2008, J ECOL, V96, P213, DOI 10.1111/j.1365-2745.2007.01313.x; Fisahn J, 2004, PLANT CELL PHYSIOL, V45, P456, DOI 10.1093/pcp/pch054; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; Gibson TC, 2009, NEW PHYTOL, V183, P575, DOI 10.1111/j.1469-8137.2009.02935.x; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Hatano N, 2008, J PROTEOME RES, V7, P809, DOI 10.1021/pr700566d; Hatano N, 2012, J PROTEOMICS, V75, P4844, DOI 10.1016/j.jprot.2012.05.048; Hlavackova V, 2006, PLANTA, V225, P235, DOI 10.1007/s00425-006-0325-x; HODICK D, 1988, PLANTA, V174, P8, DOI 10.1007/BF00394867; HODICK D, 1989, PLANTA, V179, P32, DOI 10.1007/BF00395768; JAFFE MJ, 1973, PLANT PHYSIOL, V51, P17, DOI 10.1104/pp.51.1.17; Juniper B. E., 1989, CARNIVOROUS PLANTS; Krol E, 2006, BIOL PLANTARUM, V50, P411, DOI 10.1007/s10535-006-0058-5; Kruse J, 2014, OECOLOGIA, V174, P839, DOI 10.1007/s00442-013-2802-9; LICHTNER FT, 1977, AM J BOT, V64, P881, DOI 10.2307/2442381; Markin VS, 2008, PLANT SIGNAL BEHAV, V3, P778, DOI 10.4161/psb.3.10.6041; Matusikova I, 2005, PLANTA, V222, P1020, DOI 10.1007/s00425-005-0047-5; Mithofer A, 2014, PLANT BIOLOGY, V16, P982, DOI 10.1111/plb.12148; Mithofer A, 2011, PHYTOCHEMISTRY, V72, P1678, DOI 10.1016/j.phytochem.2010.11.024; Monshausen GB, 2013, J EXP BOT, V64, P4663, DOI 10.1093/jxb/ert204; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; Nakamura Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0228; Nishimura E, 2013, PLANTA, V238, P955, DOI 10.1007/s00425-013-1945-6; Paszota P, 2014, BBA-PROTEINS PROTEOM, V1844, P374, DOI 10.1016/j.bbapap.2013.11.009; Pavlovic A, 2014, ANN BOT-LONDON, V113, P69, DOI 10.1093/aob/mct254; Pavlovic A, 2011, PLANT CELL ENVIRON, V34, P1865, DOI 10.1111/j.1365-3040.2011.02382.x; Pavlovic A, 2011, J EXP BOT, V62, P1991, DOI 10.1093/jxb/erq404; Pavlovic A, 2010, ANN BOT-LONDON, V105, P37, DOI 10.1093/aob/mcp269; Pavlovic A, 2009, ANN BOT-LONDON, V104, P307, DOI 10.1093/aob/mcp121; ROBINS RI, 1980, NEW PHYTOL, V86, P401, DOI 10.1111/j.1469-8137.1980.tb01681.x; ROBINS RJ, 1980, NEW PHYTOL, V86, P313, DOI 10.1111/j.1469-8137.1980.tb00791.x; ROBINS RJ, 1976, PLANTA, V128, P263, DOI 10.1007/BF00393238; ROBINS RJ, 1980, NEW PHYTOL, V86, P297, DOI 10.1111/j.1469-8137.1980.tb00790.x; Rottloff S, 2011, J EXP BOT, V62, P4639, DOI 10.1093/jxb/err173; SCALA J, 1969, PLANT PHYSIOL, V44, P367, DOI 10.1104/pp.44.3.367; Scherzer S, 2013, CURR BIOL, V23, P1649, DOI 10.1016/j.cub.2013.07.028; Schulze W, 2001, J EXP BOT, V52, P1041, DOI 10.1093/jexbot/52.358.1041; Schulze WX, 2012, MOL CELL PROTEOMICS, V11, P1306, DOI 10.1074/mcp.M112.021006; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stelmach BA, 1999, PHYTOCHEMISTRY, V51, P187, DOI 10.1016/S0031-9422(99)00017-5; Stephenson P, 2006, INT J PLANT SCI, V167, P239, DOI 10.1086/499284; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Takahashi K, 2012, CARNIVOROUS PLANT NE, V41, P132; Takahashi K, 2009, CARNIV PL NEWSL, V38, P75; Takahashi K, 2011, BIOSCI BIOTECH BIOCH, V75, P346, DOI 10.1271/bbb.100546; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Ueda M, 2010, CHEMBIOCHEM, V11, P2378, DOI 10.1002/cbic.201000392; Volkov AG, 2008, PLANT PHYSIOL, V146, P694, DOI 10.1104/pp.107.108241; Volkov AG, 2007, PLANT SIGNAL BEHAV, V2, P139, DOI 10.4161/psb.2.3.4217; Volkov AG, 2013, J PLANT PHYSIOL, V170, P25, DOI 10.1016/j.jplph.2012.08.009; Volkov AG, 2011, J PLANT PHYSIOL, V168, P109, DOI 10.1016/j.jplph.2010.06.007; Volkov AG, 2009, BIOELECTROCHEMISTRY, V75, P142, DOI 10.1016/j.bioelechem.2009.03.005; Volkov AG, 2009, PLANT PHYSIOL, V149, P1661, DOI 10.1104/pp.108.134536; Wang L, 2008, PLANT PHYSIOL, V146, P904, DOI 10.1104/pp.107.109264; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; WILLIAMS SE, 1982, SCIENCE, V218, P1120, DOI 10.1126/science.218.4577.1120	72	42	43	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104424	10.1371/journal.pone.0104424	http://dx.doi.org/10.1371/journal.pone.0104424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153528	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200019
J	Pelland, NA; Sterling, JT; Lea, MA; Bond, NA; Ream, RR; Lee, CM; Eriksen, CC				Pelland, Noel A.; Sterling, Jeremy T.; Lea, Mary-Anne; Bond, Nicholas A.; Ream, Rolf R.; Lee, Craig M.; Eriksen, Charles C.			Fortuitous Encounters between Seagliders and Adult Female Northern Fur Seals (Callorhinus ursinus) off the Washington (USA) Coast: Upper Ocean Variability and Links to Top Predator Behavior	PLOS ONE			English	Article							CALIFORNIA CURRENT SYSTEM; OCEANOGRAPHIC FEATURES; MESOSCALE EDDIES; TRANSITION ZONE; PUP PRODUCTION; MIXED-LAYER; RIVER PLUME; EDDY; GULF; PACIFIC	Behavioral responses by top marine predators to oceanographic features such as eddies, river plumes, storms, and coastal topography suggest that biophysical interactions in these zones affect predators' prey, foraging behaviors, and potentially fitness. However, examining these pathways is challenged by the obstacles inherent in obtaining simultaneous observations of surface and subsurface environmental fields and predator behavior. In this study, migratory movements and, in some cases, diving behavior of 40 adult female northern fur seals (NFS; Callorhinus ursinus) were quantified across their range and compared to remotely-sensed environmental data in the Gulf of Alaska and California Current ecosystems, with a particular focus off the coast of Washington State (USA) - a known foraging ground for adult female NFS and where autonomous glider sampling allowed opportunistic comparison of seal behavior to subsurface biophysical measurements. The results show that in these ecosystems, adult female habitat utilization was concentrated near prominent coastal topographic, riverine, or inlet features and within 200 km of the continental shelf break. Seal dive depths, in most ecosystems, were moderated by surface light level (solar or lunar), mirroring known behaviors of diel vertically-migrating prey. However, seal dives differed in the California Current ecosystem due to a shift to more daytime diving concentrated at or below the surface mixed layer base. Seal movement models indicate behavioral responses to season, ecosystem, and surface wind speeds; individuals also responded to mesoscale eddies, jets, and the Columbia River plume. Foraging within small scale surface features is consistent with utilization of the inner coastal transition zone and habitats near coastal capes, which are known eddy and filament generation sites. These results contribute to our knowledge of NFS migratory patterns by demonstrating surface and subsurface behavioral responses to a spatially and temporally dynamic ocean environment, thus reflecting its influence on associated NFS prey species.	[Pelland, Noel A.; Lee, Craig M.; Eriksen, Charles C.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Sterling, Jeremy T.; Ream, Rolf R.] NOAA, Natl Marine Mammal Lab, Natl Oceanog & Atmospher Adm, Seattle, WA USA; [Lea, Mary-Anne] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Bond, Nicholas A.] Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98195 USA; [Lee, Craig M.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; University of Tasmania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pelland, NA (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	nap2@u.washington.edu	Lea, Mary-Anne/E-9054-2013	Lea, Mary-Anne/0000-0001-8318-9299	NOAA; North Pacific Research Board; National Cooperative Research Program of the NOAA Fisheries Office of Science and Technology; Joint Institute for the Study of the Atmosphere and Ocean at the University of Washington; National Science Foundation [OCE9911036, OCE0095414, OCE0526634]; National Oceanographic Partnership Program; Division Of Ocean Sciences [1129090] Funding Source: National Science Foundation	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); North Pacific Research Board; National Cooperative Research Program of the NOAA Fisheries Office of Science and Technology; Joint Institute for the Study of the Atmosphere and Ocean at the University of Washington; National Science Foundation(National Science Foundation (NSF)); National Oceanographic Partnership Program; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Northern fur seal tagging, monitoring, and analysis was funded by NOAA (www.noaa.gov), the North Pacific Research Board (www.nprb.org), the National Cooperative Research Program of the NOAA Fisheries Office of Science and Technology (www.st.nmfs.noaa.gov/cooperative-research/index), and the Joint Institute for the Study of the Atmosphere and Ocean at the University of Washington (jisao.washington.edu). Northern fur seal research was performed under National Marine Mammal Laboratory permits 782-1455 and 782-1708. Seaglider field work and analysis was supported by National Science Foundation (www.nsf.gov) grants OCE9911036, OCE0095414, and OCE0526634, with assistance in Seaglider development from the Office of Naval Research (www.onr.navy. mil) and National Oceanographic Partnership Program (www.nopp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2009, MAR ECOL PROG SER, V389, P271, DOI 10.3354/meps08153; Ainley DG, 2005, DEEP-SEA RES PT II, V52, P123, DOI 10.1016/j.dsr2.2004.08.016; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Allen SE, 2010, J GEOPHYS RES-OCEANS, V115, DOI [10.1029/2009JC00573, 10.1029/2009JC005731]; Alverson D. L., 1969, CAL COOP OCEAN FISH, V13, P24; APPENZELLER AR, 1992, CAN J FISH AQUAT SCI, V49, P2179, DOI 10.1139/f92-240; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; Baker JD, 2007, MAR ECOL PROG SER, V341, P243, DOI 10.3354/meps341243; Baker JD, 2012, MAR ECOL PROG SER, V469, P175, DOI 10.3354/meps09987; Banas NS, 2009, CONT SHELF RES, V29, P292, DOI 10.1016/j.csr.2008.03.011; BARTH JA, 1994, J GEOPHYS RES-OCEANS, V99, P16095, DOI 10.1029/94JC01270; Barth JA, 2005, DEEP-SEA RES PT II, V52, P5, DOI 10.1016/j.dsr2.2004.09.026; Barth JA, 2000, DEEP-SEA RES PT II, V47, P783, DOI 10.1016/S0967-0645(99)00127-7; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Berdeal IG, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000932; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Bigg M.A, 1990, CAN TECH REP FISH AQ, V1764; BIGG MA, 1986, FISH B-NOAA, V84, P383; Bigg MA, 1982, 25 ANN M N PAC FUR S; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boccaletti G, 2007, J PHYS OCEANOGR, V37, P2228, DOI 10.1175/JPO3101.1; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Carroll M, 2006, PERFORMANCE VERIFICA; Chaigneau A, 2009, PROG OCEANOGR, V83, P117, DOI 10.1016/j.pocean.2009.07.012; Chapman DG, 1961, FISH B, V63, P657; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Collins CA, 2003, DEEP-SEA RES PT II, V50, P2389, DOI 10.1016/S0967-0645(03)00134-6; Costa D.P., 1986, P79; Crawford WR, 2005, DEEP-SEA RES PT II, V52, P975, DOI 10.1016/j.dsr2.2005.02.011; Crawford WR, 2002, J OCEANOGR, V58, P703, DOI 10.1023/A:1022898424333; Dalton AJM, 2014, MAR MAMMAL SCI, V30, P994, DOI 10.1111/mms.12103; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; DeLong RL, 1991, PINNIPEDS EL NINO RE, P75; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dohan K, 2011, J PHYS OCEANOGR, V41, P42, DOI 10.1175/2010JPO4253.1; Eberhardt L.L., 1981, P197; Eriksen CC, 2001, IEEE J OCEANIC ENG, V26, P424, DOI 10.1109/48.972073; Feldman GC, 2013, OCEAN COLOR WEB SEA; Fong DA, 2001, J GEOPHYS RES-OCEANS, V106, P1067, DOI 10.1029/2000JC900134; Freeland HJ, 2005, PROG OCEANOGR, V64, P31, DOI 10.1016/j.pocean.2004.11.002; French DP, 1990, P 2 INT C MAR DEBR 2, P431, DOI [10.1051/0004-6361/201116485, DOI 10.1051/0004-6361/201116485]; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; Gentry R. L., 1986, FUR SEALS MATERNAL S, P61; Gentry RL, 1986, FUR SEALS MATERNAL S, P220; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; GOEBEL ME, 1991, FISH B-NOAA, V89, P171; HANEY JC, 1985, WILSON BULL, V97, P191; HAYWARD TL, 1990, J MAR RES, V48, P825, DOI 10.1357/002224090784988683; Henson SA, 2008, DEEP-SEA RES PT I, V55, P163, DOI 10.1016/j.dsr.2007.11.005; Hickey B.M., 1998, SEA, V11, P345; Hickey B. M., 1989, COASTAL OCEANOGRAPHY, P41, DOI DOI 10.1016/S0422-9894(08)70346-5; HOOPER C. L., 1895, P TRIBUNAL ARBITRATI, VVII, P228; Ichihara T., 1974, B FAR SEAS FISH RES, V11, P1; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kajimura H, 1984, SSRF779 NOAA NMFS; Kajimura H, 1982, THESIS U TOKYO TOKYO; Kajimura H, 1980, 23 ANN M N PAC SEA C; Kelly KA, 1998, J GEOPHYS RES-OCEANS, V103, P13067, DOI 10.1029/97JC03760; KENYON KW, 1953, J MAMMAL, V34, P86, DOI 10.2307/1375947; Kenyon KW, 1954, 12 US FISH WILD SERV; KOSRO PM, 1991, J GEOPHYS RES-OCEANS, V96, P14707, DOI 10.1029/91JC01210; Kuhn CE, 2014, J ANIM ECOL, V83, P1169, DOI 10.1111/1365-2656.12202; Kurian J, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006895; Ladd C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002710; Ladd C, 2007, DEEP-SEA RES PT I, V54, P487, DOI 10.1016/j.dsr.2007.01.006; Ladd C, 2009, DEEP-SEA RES PT II, V56, P2460, DOI 10.1016/j.dsr2.2009.02.007; Ladd C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029478; LANDER RH, 1979, FISH B-NOAA, V77, P311; LANDER RH, 1981, FISH RES, V1, P55, DOI 10.1016/0165-7836(81)90007-2; Lara-Lopez AL, 2012, J PLANKTON RES, V34, P828, DOI 10.1093/plankt/fbs016; LARGE WG, 1986, J PHYS OCEANOGR, V16, P1524, DOI 10.1175/1520-0485(1986)016<1524:UOTRTS>2.0.CO;2; Lea MA, 2010, MAR ECOL PROG SER, V419, P233, DOI 10.3354/meps08758; Lea MA, 2009, BIOL LETTERS, V5, P252, DOI 10.1098/rsbl.2008.0643; Li M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021911; Logerwell EA, 2001, FISH OCEANOGR, V10, P13, DOI 10.1046/j.1365-2419.2001.00152.x; Loughlin TR, 2003, FISH B-NOAA, V101, P566; Loughlin TR, 1999, DYNAMICS BERING SEA, P615; MacFadyen A, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004412; Mackas DL, 2005, DEEP-SEA RES PT II, V52, P1011, DOI 10.1016/j.dsr2.2005.02.008; Mahadevan A, 2008, SCIENCE, V320, DOI 10.1126/science.1152111; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marchesiello P, 2003, J PHYS OCEANOGR, V33, P753, DOI 10.1175/1520-0485(2003)33<753:ESADOT>2.0.CO;2; Melin SR, 2012, TALE 2 STOCKS STUDIE; Miller BS, 1980, 8001 U WASH FISH RES; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; Niggol K, 1959, PELAGIC SEAL INVESTI; NIILER PP, 1969, J GEOPHYS RES, V74, P7048, DOI 10.1029/JC074i028p07048; Nishimoto MM, 2002, MAR ECOL PROG SER, V241, P183, DOI 10.3354/meps241183; NMFS, 2007, CONS PLAN E PAC STOC; Nordstrom CA, 2013, DEEP-SEA RES PT II, V88-89, P78, DOI 10.1016/j.dsr2.2012.07.010; Okkonen SR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001342; Olesiuk PF, 2012, 2012040 CAN SCI ADV; PADUAN JD, 1993, J PHYS OCEANOGR, V23, P585, DOI 10.1175/1520-0485(1993)023<0585:SOVATI>2.0.CO;2; Pelland NA, 2013, J PHYS OCEANOGR, V43, P2025, DOI 10.1175/JPO-D-12-086.1; Perry MJ, 2008, LIMNOL OCEANOGR, V53, P2169, DOI 10.4319/lo.2008.53.5_part_2.2169; Peterson R, 1965, THESIS J HOPKINS U B; PHILANDER SGH, 1983, NATURE, V302, P295, DOI 10.1038/302295a0; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Ream RR, 2005, DEEP-SEA RES PT II, V52, P823, DOI 10.1016/j.dsr2.2004.12.021; Ream RR, 1999, FUR SEAL INVESTIGATI, P81; Rosen DAS, 2014, MAR MAMMAL SCI, V30, P1014, DOI 10.1111/mms.12097; Sackmann B., 2008, BIOGEOSCI DISCUSS, V5, P2839, DOI [10.5194/bgd-5-2839-2008, DOI 10.5194/BGD-5-2839-2008]; Sackmann B, 2007, THESIS U MAINE ORONO; SCHEFFER VICTOR B., 1950, CALIFORNIA FISH AND GAME, V36, P378; SCHUSTERMAN RJ, 1971, ANN NY ACAD SCI, V188, P37, DOI 10.1111/j.1749-6632.1971.tb13088.x; SHERMAN K, 1991, ECOL APPL, V1, P349, DOI 10.2307/1941896; SINCLAIR E, 1994, FISH B-NOAA, V92, P144; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Staniland IJ, 2008, ANIM BEHAV, V75, P1581, DOI 10.1016/j.anbehav.2007.10.012; Sterling J.T., 2009, NO SEAL FORAGING BEH; Sterling JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093068; Sterling JT, 2004, CAN J ZOOL, V82, P1621, DOI 10.1139/Z04-136; Strub PT, 2000, DEEP-SEA RES PT II, V47, P831, DOI 10.1016/S0967-0645(99)00129-0; Suga T, 2004, J PHYS OCEANOGR, V34, P3, DOI 10.1175/1520-0485(2004)034<0003:TNPCOW>2.0.CO;2; Towell RG, 2006, MAR MAMMAL SCI, V22, P486, DOI 10.1111/j.1748-7692.2006.00026.x; Towell RG, 2011, 2010 NO FUR SEA PUP; Trillmich F., 1991, Ecological Studies, V88, P66; Trillmich F., 1986, P168; Trillmich F., 1991, PINNIPEDS NINO, DOI DOI 10.1007/978-3-642-76398-4; TRITES A W, 1992, Aquatic Mammals, V18, P3; TRITES AW, 1991, CAN J ZOOL, V69, P2608, DOI 10.1139/z91-367; Trites AW, 1996, J ZOOL, V238, P459, DOI 10.1111/j.1469-7998.1996.tb05406.x; US Senate, 1896, SEAL LIF ROOK PRIB I; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Weise MJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027113; Whitney FA, 2005, DEEP-SEA RES PT II, V52, P681, DOI 10.1016/j.dsr2.2004.12.023; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; Yen PPW, 2006, DEEP-SEA RES PT II, V53, P399, DOI 10.1016/j.dsr2.2006.01.013; Yoda K, 2014, PROG OCEANOGR, V122, P54, DOI 10.1016/j.pocean.2013.12.002; YORK AE, 1981, CAN J FISH AQUAT SCI, V38, P84, DOI 10.1139/f81-011; York Anne E., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P317; Zeppelin TK, 2010, MAR ECOL PROG SER, V409, P241, DOI 10.3354/meps08624	140	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e101268	10.1371/journal.pone.0101268	http://dx.doi.org/10.1371/journal.pone.0101268			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153524	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200003
J	Sakamoto, S; Tsuruda, T; Hatakeyama, K; Imamura, T; Asada, Y; Kitamura, K				Sakamoto, Sumiharu; Tsuruda, Toshihiro; Hatakeyama, Kinta; Imamura, Takuroh; Asada, Yujiro; Kitamura, Kazuo			Impact of Age-Dependent Adventitia Inflammation on Structural Alteration of Abdominal Aorta in Hyperlipidemic Mice	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE ENTERPRISES; LYMPHOTOXIN-BETA-RECEPTOR; MAJOR SHAREHOLDERS; ATHEROSCLEROSIS; ARTERIAL; EXPRESSION; PROGRESSION; ACTIVATION; MECHANISMS; LESIONS	Background: The adventitia is suggested to contribute to vascular remodeling; however, the site-selective inflammatory responses in association with the development of atherosclerosis remain to be elucidated. Methods and Results: Wild-type or apolipoprotein E knockout male C57BL/6J background mice were fed standard chow for 16, 32, and 52 weeks, and the morphology of the aortic arch, descending aorta, and abdominal aorta was compared. Atheromatous plaque formation progressed with age, particularly in the aortic arch and abdominal aorta but not in the descending aorta. In addition, we found that the numbers of macrophages, T-lymphocytes, and microvessels, assessed by anti-F4/80, CD3, and CD31 antibodies, were higher in the adventitia of the abdominal aorta at 52 weeks. These numbers were positively correlated with plaque formation, but negatively correlated with elastin content, resulting in the enlargement of the total vessel area. In aortic tissues, interleukin-6 levels increased in the atheromatous plaque with age, whereas the level of regulated on activation, normal T cell expressed and secreted (RANTES) increased with age, and compared with other sites, it was particularly distributed in inflammatory cells in the adventitia of the abdominal aorta. Conclusion: This study suggests that adventitial inflammation contributes to the age-dependent structural alterations, and that the activation/inactivation of cytokines/chemokines is involved in the process.	[Sakamoto, Sumiharu; Tsuruda, Toshihiro; Kitamura, Kazuo] Miyazaki Univ, Fac Med, Dept Internal Med Circulatory & Body Fluid Regula, Miyazaki, Japan; [Hatakeyama, Kinta; Asada, Yujiro] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki, Japan; [Imamura, Takuroh] Koga Gen Hosp, Dept Internal Med, Miyazaki, Japan	University of Miyazaki; University of Miyazaki	Tsuruda, T (corresponding author), Miyazaki Univ, Fac Med, Dept Internal Med Circulatory & Body Fluid Regula, Miyazaki, Japan.	ttsuruda@med.miyazaki-u.ac.jp	Tsuruda, Toshihiro/AAX-1255-2020		Ministry of Education, Culture, Sport, Science and Technology, Japan [20590830]; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; SENSHIN Medical Research Foundation	Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This study was supported by Grant-in-Aid for Scientific Research (C) (20590830) from the Ministry of Education, Culture, Sport, Science and Technology, Japan; Grant-in-Aid for the Japan Cardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; SENSHIN Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler EP, 2003, IMMUNOL LETT, V90, P187, DOI 10.1016/j.imlet.2003.09.013; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Chiba T, 2003, ARTERIOSCL THROM VAS, V23, P1423, DOI 10.1161/01.ATV.0000085040.58340.36; DegliEsposti MA, 1997, J IMMUNOL, V158, P1756; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Gutterman DD, 1999, AM J PHYSIOL-HEART C, V277, pH1265, DOI 10.1152/ajpheart.1999.277.4.H1265; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; KUMAMOTO M, 1995, HUM PATHOL, V26, P450, DOI 10.1016/0046-8177(95)90148-5; Kuziel WA, 2003, ATHEROSCLEROSIS, V167, P25, DOI 10.1016/S0021-9150(02)00382-9; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Li GH, 2000, CIRCULATION, V101, P1362, DOI 10.1161/01.CIR.101.12.1362; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Malik N, 1996, J IMMUNOL, V156, P3952; Miles EA, 2008, ATHEROSCLEROSIS, V196, P298, DOI 10.1016/j.atherosclerosis.2006.11.002; Millonig G, 2002, ATHEROSCLEROSIS, V160, P441, DOI 10.1016/S0021-9150(01)00596-2; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Nakashima Y, 2002, VIRCHOWS ARCH, V441, P279, DOI 10.1007/s00428-002-0605-1; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Oviedo-Orta E, 2008, IMMUNOLOGY, V124, P42, DOI 10.1111/j.1365-2567.2007.02728.x; Padilla J, 2013, AM J PHYSIOL-REG I, V304, pR543, DOI 10.1152/ajpregu.00567.2012; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Quinones Marlon P, 2007, Atherosclerosis, V195, pe92, DOI 10.1016/j.atherosclerosis.2007.03.026; Richard JF, 2012, CLIN EXPT CARDIOLOGY, V12; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakamoto S, 2011, MAST CELL DENSITY DI, P55; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Sawabe M, 2010, GERIATR GERONTOL INT, V10, pS213, DOI 10.1111/j.1447-0594.2010.00603.x; SPINA M, 1983, ARTERIOSCLEROSIS, V3, P64, DOI 10.1161/01.ATV.3.1.64; Stopfer P, 2004, J IMMUNOL, V172, P7459, DOI 10.4049/jimmunol.172.12.7459; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; Tsuruda T, 2012, ARTERIOSCL THROM VAS, V32, P1410, DOI 10.1161/ATVBAHA.111.237065; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Yamashita A, 2008, HISTOL HISTOPATHOL, V23, P127, DOI 10.14670/HH-23.127; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	50	9	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105739	10.1371/journal.pone.0105739	http://dx.doi.org/10.1371/journal.pone.0105739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153991	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200078
J	Yildirim, MA; Coscia, M				Yildirim, Muhammed A.; Coscia, Michele			Using Random Walks to Generate Associations between Objects	PLOS ONE			English	Article							NETWORKS	Measuring similarities between objects based on their attributes has been an important problem in many disciplines. Object-attribute associations can be depicted as links on a bipartite graph. A similarity measure can be thought as a unipartite projection of this bipartite graph. The most widely used bipartite projection techniques make assumptions that are not often fulfilled in real life systems, or have the focus on the bipartite connections more than on the unipartite connections. Here, we define a new similarity measure that utilizes a practical procedure to extract unipartite graphs without making a priori assumptions about underlying distributions. Our similarity measure captures the relatedness between two objects via the likelihood of a random walker passing through these nodes sequentially on the bipartite graph. An important aspect of the method is that it is robust to heterogeneous bipartite structures and it controls for the transitivity similarity, avoiding the creation of unrealistic homogeneous degree distributions in the resulting unipartite graphs. We test this method using real world examples and compare the obtained results with alternative similarity measures, by validating the actual and orthogonal relations between the entities.	[Yildirim, Muhammed A.; Coscia, Michele] Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA	Harvard University	Yildirim, MA (corresponding author), Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA.	muhammed_yildirim@hks.harvard.edu	Yildirim, Muhammed/J-3695-2014; Coscia, Michele/AGJ-5531-2022	Yildirim, Muhammed/0000-0003-2826-1766; Coscia, Michele/0000-0001-5984-5137	National Science Foundation [1216028]; Division of Computing and Communication Foundations [1216028] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	MC was supported by the National Science Foundation (http://nsf.gov/) under Grant No. 1216028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Center OR, 2013, O NET VERS 17 0; Center OR, 2013, AB O NET; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Coscia M., 2013, J GLOBAL DEV, V3, P1; Feizi S, 2013, NAT BIOTECHNOL, V31, P726, DOI 10.1038/nbt.2635; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hausmann R., 2013, ATLAS EC COMPLEXITY, DOI DOI 10.7551/MITPRESS/9647.001.0001; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Lambiotte R, 2006, LECT NOTES COMPUT SC, V3993, P1114; Li MH, 2005, PHYSICA A, V350, P643, DOI 10.1016/j.physa.2004.11.039; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Ramasco JJ, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016122; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Ruggles S., 2010, INTEGRATED PUBLIC US, DOI DOI 10.18128/D010.V6.0; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yi Zhang, 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P81; Zhou T, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/58004; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	29	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104813	10.1371/journal.pone.0104813	http://dx.doi.org/10.1371/journal.pone.0104813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153830	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200029
J	Wennerstro, AB; Lothe, IMB; Sandhu, V; Kure, EH; Myklebost, O; Munthe, E				Wennerstro, Anna B.; Lothe, Inger Marie Bowitz; Sandhu, Vandana; Kure, Elin H.; Myklebost, Ola; Munthe, Else			Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines	PLOS ONE			English	Article							CANCER STEM-CELLS; MESENCHYMAL TRANSITION; SIDE POPULATION; TISSUE FACTOR; EXPRESSION; CARCINOMA; IDENTIFICATION; PROGNOSIS; SURVIVAL; MARKER	Pancreatic adenocarcinoma is one of the most lethal cancer types, currently lacking efficient treatment. The heterogeneous nature of these tumours are poorly represented by the classical pancreatic cell lines, which have been through strong clonal selection in vitro, and are often derived from metastases. Here, we describe the establishment of novel pancreatic adenocarcinoma models, xenografts and corresponding in vitro cell lines, from primary pancreatic tumours. The morphology, differentiation grade and gene expression pattern of the xenografts resemble the original tumours well. The cell lines were analysed for colony forming capacity, tumourigenicity and expression of known cancer cell surface markers and cancer stem-like characteristics. These primary cell models will be valuable tools for biological and preclinical studies for this devastating disease.	[Wennerstro, Anna B.; Myklebost, Ola; Munthe, Else] Oslo Univ Hosp, Norwegian Radium Hosp, Canc Stem Cell Innovat Ctr, Oslo, Norway; [Wennerstro, Anna B.; Myklebost, Ola; Munthe, Else] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Inst Canc Res, Oslo, Norway; [Lothe, Inger Marie Bowitz; Sandhu, Vandana; Kure, Elin H.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Lothe, Inger Marie Bowitz] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Sandhu, Vandana; Kure, Elin H.] Telemark Univ Coll, Dept Environm Hlth & Sci, Telemark, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University College of Southeast Norway	Munthe, E (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Canc Stem Cell Innovat Ctr, Oslo, Norway.	elsmun@rr-research.no	Munthe, Else/O-3576-2017; Myklebost, Ola/E-9335-2010	Munthe, Else/0000-0003-3859-1582; Myklebost, Ola/0000-0002-2866-3223; Wennerstrom, Anna Berit/0000-0001-8143-9944	Cancer Stem Cell Innovation Centre (CAST-SFI); HSO [2011090]	Cancer Stem Cell Innovation Centre (CAST-SFI); HSO	This work was financially supported by the Cancer Stem Cell Innovation Centre (CAST-SFI) and HSO (Grant nr. 2011090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Albores-Saavedra J, 2007, ANN DIAGN PATHOL, V11, P3, DOI 10.1016/j.anndiagpath.2006.06.008; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Flatmark K, 2004, TUMOR BIOL, V25, P31, DOI 10.1159/000077721; GEER RJ, 1993, AM J SURG, V165, P68, DOI 10.1016/S0002-9610(05)80406-4; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Khorana AA, 2007, CLIN CANCER RES, V13, P2870, DOI 10.1158/1078-0432.CCR-06-2351; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; KIMURA W, 1994, JPN J CANCER RES, V85, P161, DOI 10.1111/j.1349-7006.1994.tb02077.x; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Sobin L, 2009, TNM CLASSIFICATION M; Stratford EW, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-8; Tachezy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039018; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Virtanen C, 2002, P NATL ACAD SCI USA, V99, P12357, DOI 10.1073/pnas.192240599; Wang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057020; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Wasif N, 2010, ANN SURG ONCOL, V17, P2312, DOI 10.1245/s10434-010-1071-7; Westgaard A, 2008, BMC CANC, V8; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamada S, 2013, SURGERY, V154, P946, DOI 10.1016/j.surg.2013.05.004	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e103873	10.1371/journal.pone.0103873	http://dx.doi.org/10.1371/journal.pone.0103873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148029	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600007
J	Zhang, FS; Li, XW; Li, ZY; Xu, XS; Peng, B; Qin, XM; Du, GH				Zhang, Fusheng; Li, Xiaowei; Li, Zhenyu; Xu, Xiaoshuang; Peng, Bing; Qin, Xuemei; Du, Guanhua			UPLC/Q-TOF MS-Based Metabolomics and qRT-PCR in Enzyme Gene Screening with Key Role in Triterpenoid Saponin Biosynthesis of Polygala tenuifolia	PLOS ONE			English	Article							TIME RT-PCR; VALID REFERENCE GENES; BETA-AMYRIN; CHEMICAL-CONSTITUENTS; SUCROSE ESTERS; EXPRESSION; ROOTS; GLYCOSIDES; CYTOCHROME-P450; IDENTIFICATION	Background: The dried root of Polygala tenuifolia, named Radix Polygalae, is a well-known traditional Chinese medicine. Triterpenoid saponins are some of the most important components of Radix Polygalae extracts and are widely studied because of their valuable pharmacological properties. However, the relationship between gene expression and triterpenoid saponin biosynthesis in P. tenuifolia is unclear. Methodology/Findings: In this study, ultra-performance liquid chromatography (UPLC) coupled with quadrupole time-of-flight mass spectrometry (Q-TOF MS)-based metabolomic analysis was performed to identify and quantify the different chemical constituents of the roots, stems, leaves, and seeds of P. tenuifolia. A total of 22 marker compounds (VIP>1) were explored, and significant differences in all 7 triterpenoid saponins among the different tissues were found. We also observed an efficient reference gene GAPDH for different tissues in this plant and determined the expression level of some genes in the triterpenoid saponin biosynthetic pathway. Results showed that MVA pathway has more important functions in the triterpenoid saponin biosynthesis of P. tenuifolia. The expression levels of squalene synthase (SQS), squalene monooxygenase (SQE), and beta-amyrin synthase (beta-AS) were highly correlated with the peak area intensity of triterpenoid saponins compared with data from UPLC/Q-TOF MS-based metabolomic analysis. Conclusions/Significance: This finding suggested that a combination of UPLC/Q-TOF MS-based metabolomics and gene expression analysis can effectively elucidate the mechanism of triterpenoid saponin biosynthesis and can provide useful information on gene discovery. These findings can serve as a reference for using the overexpression of genes encoding for SQS, SQE, and/or beta-AS to increase the triterpenoid saponin production of P. tenuifolia.	[Zhang, Fusheng; Li, Xiaowei; Li, Zhenyu; Xu, Xiaoshuang; Qin, Xuemei; Du, Guanhua] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan, Shanxi, Peoples R China; [Li, Xiaowei; Xu, Xiaoshuang] Shanxi Univ, Coll Chem & Chem Engn, Taiyuan, Shanxi, Peoples R China; [Peng, Bing] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Beijing Inst Tradit Chinese Med, Beijing, Peoples R China; [Du, Guanhua] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China	Shanxi University; Shanxi University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Peng, B (corresponding author), Capital Med Univ, Beijing Hosp Tradit Chinese Med, Beijing Inst Tradit Chinese Med, Beijing, Peoples R China.	pengbing123@hotmail.com; dugh@imm.ac.cn	张, 福生/AAA-5858-2021	Du, Guanhua/0000-0002-6896-0847; Li, Xiaowei/0000-0002-0718-1938	National Natural Sciences Foundation of China [31100244]; National Science-technology Support Plan Projects [2011BA107B05]; Technological Innovation Projects in Shanxi [2013007]; Construction Plan for Basic Condition Platform of Shanxi [2014091022]; Shanxi Science and Technology Development Program [20140313010-1]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science-technology Support Plan Projects; Technological Innovation Projects in Shanxi; Construction Plan for Basic Condition Platform of Shanxi; Shanxi Science and Technology Development Program	This study (PONE-D-14-14501) was supported by the National Natural Sciences Foundation of China (Grant No. 31100244), the National Science-technology Support Plan Projects (Grant No. 2011BA107B05), the Technological Innovation Projects in Shanxi (Grant No. 2013007), the Construction Plan for Basic Condition Platform of Shanxi (Grant No. 2014091022), and the Shanxi Science and Technology Development Program (Grant No. 20140313010-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Arai M, 2011, J NAT MED-TOKYO, V65, P149, DOI 10.1007/s11418-010-0477-7; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Brent MR, 2008, NAT REV GENET, V9, P62, DOI 10.1038/nrg2220; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Carelli M, 2011, PLANT CELL, V23, P3070, DOI 10.1105/tpc.111.087312; Cheng MC, 2006, J NAT PROD, V69, P1305, DOI 10.1021/np060207r; Cheong MH, 2011, J ETHNOPHARMACOL, V137, P1402, DOI 10.1016/j.jep.2011.08.008; Choi JG, 2011, J ETHNOPHARMACOL, V134, P414, DOI 10.1016/j.jep.2010.12.030; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Han JY, 2010, PHYTOCHEMISTRY, V71, P36, DOI 10.1016/j.phytochem.2009.09.031; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; IKEYA Y, 1991, CHEM PHARM BULL, V39, P2600, DOI 10.1248/cpb.39.2600; Ikeya Y, 2004, BIOL PHARM BULL, V27, P1081, DOI 10.1248/bpb.27.1081; Jiang Y, 2005, CHEM PHARM BULL, V53, P1164, DOI 10.1248/cpb.53.1164; Jiang Y, 2005, J NAT PROD, V68, P875, DOI 10.1021/np050026+; Jiang Y, 2005, J LIQ CHROMATOGR R T, V28, P1583, DOI 10.1081/JLC-200058371; Jiang Y, 2002, PHYTOCHEMISTRY, V60, P813, DOI 10.1016/S0031-9422(02)00184-X; Kawashima K, 2004, BIOL PHARM BULL, V27, P1317, DOI 10.1248/bpb.27.1317; Kim TD, 2011, PLANT CELL PHYSIOL, V52, P125, DOI 10.1093/pcp/pcq179; Kumar S, 2013, PLANT MOL BIOL REP, V31, P569, DOI 10.1007/s11105-012-0524-5; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Li CJ, 2008, PLANTA MED, V74, P133, DOI 10.1055/s-2008-1034296; Li H, 2008, PHYTOTHER RES, V22, P159, DOI 10.1002/ptr.2262; Li XW, 2014, J PHARMACEUT BIOMED, V89, P42, DOI 10.1016/j.jpba.2013.10.023; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lin JT, 2009, J FOOD DRUG ANAL, V17, P116; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Ling Y, 2013, J PHARMACEUT BIOMED, V85, P1, DOI 10.1016/j.jpba.2013.06.011; Liu JY, 2007, J MASS SPECTROM, V42, P861, DOI 10.1002/jms.1210; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangas S, 2008, BIOTECHNOL LETT, V30, P1853, DOI 10.1007/s10529-008-9766-6; Meesapyodsuk D, 2007, PLANT PHYSIOL, V143, P959, DOI 10.1104/pp.106.088484; Miao WJ, 2013, J PHARMACEUT BIOMED, V72, P99, DOI 10.1016/j.jpba.2012.09.015; Miyase T, 1999, J NAT PROD, V62, P993, DOI 10.1021/np990084t; MIYASE T, 1991, CHEM PHARM BULL, V39, P3082, DOI 10.1248/cpb.39.3082; MIYASE T, 1992, CHEM PHARM BULL, V40, P2741, DOI 10.1248/cpb.40.2741; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; NDAMBA J, 1994, PHYTOCHEMISTRY, V35, P95, DOI 10.1016/S0031-9422(00)90515-6; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Sando T, 2008, BIOSCI BIOTECH BIOCH, V72, P2903, DOI 10.1271/bbb.80387; Seki H, 2008, P NATL ACAD SCI USA, V105, P14204, DOI 10.1073/pnas.0803876105; Seki H, 2011, PLANT CELL, V23, P4112, DOI 10.1105/tpc.110.082685; Shibuya M, 2006, FEBS J, V273, P948, DOI 10.1111/j.1742-4658.2006.05120.x; Shibuya M, 2010, FEBS LETT, V584, P2258, DOI 10.1016/j.febslet.2010.03.037; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tong W.Y, 2013, NAT PRODUCTS, P2733, DOI [10.1007/978-3-642-22144-6_122, DOI 10.1007/978-3-642-22144-6_122]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HL, 2006, CHEM PHARM BULL, V54, P1739, DOI 10.1248/cpb.54.1739; Wang YP, 2013, NEW PHYTOL, V198, P274, DOI 10.1111/nph.12137; WILLOW M, 1980, LIFE SCI, V26, P219, DOI 10.1016/0024-3205(80)90296-9; Woltedji D, 2012, J PROTEOME RES, V11, P4526, DOI 10.1021/pr300298w; Yang RL, 2013, PLANT CELL, V25, P71, DOI 10.1105/tpc.112.106716; Yao Y, 2010, PHARM BIOL, V48, P801, DOI 10.3109/13880200903280042; Zhou SJ, 2013, PHYTOCHEM ANALYSIS, V24, P527, DOI 10.1002/pca.2427	67	18	24	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105765	10.1371/journal.pone.0105765	http://dx.doi.org/10.1371/journal.pone.0105765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148032	Green Submitted, gold, Green Published			2022-12-27	WOS:000341230600079
J	Conrad, MD; Bigira, V; Kapisi, J; Muhindo, M; Kamya, MR; Havlir, DV; Dorsey, G; Rosenthal, PJ				Conrad, Melissa D.; Bigira, Victor; Kapisi, James; Muhindo, Mary; Kamya, Moses R.; Havlir, Diane V.; Dorsey, Grant; Rosenthal, Philip J.			Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children	PLOS ONE			English	Article							DIHYDROARTEMISININ-PIPERAQUINE; ARTEMETHER-LUMEFANTRINE; PARASITE CLEARANCE; MALARIA PARASITES; RANDOMIZED-TRIAL; WESTERN CAMBODIA	The emergence of resistance to artemisinin derivatives in Southeast Asia, manifested as delayed clearance of Plasmodium falciparum following treatment with artemisinins, is a major concern. Recently, the artemisinin resistance phenotype was attributed to mutations in portions of a P. falciparum gene (PF3D7_1343700) encoding kelch (K13) propeller domains, providing a molecular marker to monitor the spread of resistance. The P. falciparum cysteine protease falcipain-2 (FP2; PF3D7_1115700) has been shown to contribute to artemisinin action, as hemoglobin degradation is required for potent drug activity, and a stop mutation in the FP2 gene was identified in parasites selected for artemisinin resistance. Although delayed parasite clearance after artemisinin-based combination therapy (ACT) has not yet been noted in Uganda and ACTs remain highly efficacious, characterizing the diversity of these genes is important to assess the potential for resistance selection and to provide a baseline for future surveillance. We therefore sequenced the K13-propeller domain and FP2 gene in P. falciparum isolates from children previously treated with ACT in Uganda, including samples from 2006-7 (n = 49) and from 2010-12 (n = 175). Using 3D7 as the reference genome, we identified 5 non-synonymous polymorphisms in the K13-propeller domain (133 isolates) and 35 in FP2 (160 isolates); these did not include the polymorphisms recently associated with resistance after in vitro selection or identified in isolates from Asia. The prevalence of K13-propeller and FP2 polymorphisms did not increase over time, and was not associated with either time since prior receipt of an ACT or the persistence of parasites >= 2 days following treatment with an ACT. Thus, the K13-propeller and FP2 polymorphisms associated with artemisinin resistance are not prevalent in Uganda, and we did not see evidence for selection of polymorphisms in these genes.	[Conrad, Melissa D.; Havlir, Diane V.; Dorsey, Grant; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Bigira, Victor; Kapisi, James; Muhindo, Mary] Infect Dis Res Collaborat, Kampala, Uganda; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	University of California System; University of California San Francisco; Makerere University	Rosenthal, PJ (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	prosenthal@medsfgh.ucsf.edu	Conrad, Melissa/Q-8468-2019		National Institutes of Health [AI075045, HD059454, 1U19AI089674]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD059454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI075045, U19AI089674, R01AI075045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI075045 to PJR, HD059454 to DVH, and 1U19AI089674 to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J INFECT DIS; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Bigira V, PLOS MED IN PRESS; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eyase FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064299; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Maiga AW, 2012, AM J TROP MED HYG, V87, P23, DOI 10.4269/ajtmh.2012.12-0058; Mbogo GW, AM J TROP M IN PRESS; Miotto O, 2013, NAT GENET; Mita T, 2011, J INFECT DIS, V204, P1980, DOI 10.1093/infdis/jir664; Muhindo MK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-32; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Rosenthal PJ, 2013, MOL MICROBIOL, V89, P1025, DOI 10.1111/mmi.12349; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Wanzira H, 2014, CLIN INFECT DIS; Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Yeka A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002390; Zwang J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-114	22	107	110	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105690	10.1371/journal.pone.0105690	http://dx.doi.org/10.1371/journal.pone.0105690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144768	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100110
J	Manawadu, D; Choyi, J; Kalra, L				Manawadu, Dulka; Choyi, Jithesh; Kalra, Lalit			The Impact of Early Specialist Management on Outcomes of Patients with In-Hospital Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; COMPUTED-TOMOGRAPHY; REGISTRY	Delays in treatment of in-hospital stroke (IHS) adversely affect patient outcomes. We hypothesised that early referral and specialist management of IHS patients will improve outcomes at 90 days. Baseline characteristics, assessment delays, thrombolysis eligibility, 90-day functional outcomes and all-cause mortality were compared between IHS patients referred for specialist stroke management within 3 hours of symptom onset (early referrals) and later referrals. Patients were identified from a prospective stroke registry between January 2009 and December 2010. Inclusion criteria were primary admission with a non-stroke diagnosis, onset of new neurological deficits after admission and early ischaemic changes on CT or MR imaging. Eighty four (4.6%) of 1836 stroke patients had IHS (mean age 74 year; 51% male, median NIHSS score 10). There were no significant differences in baseline characteristics between 53 (63%) early and 31 (37%) late referrals. Thrombolysis was performed in 29 (76%) of the 37/78 (47%) potentially eligible patients; 7 patients were excluded because specialist referral was delayed beyond 4.5 hours despite symptom recognition within 3 hours of onset. Early referral improved functional outcomes (modified Rankin Scale 0-2 at 90 days 40% v 7%, p = 0.001) and was an independent predictor of mRS 0-2 at 90 days after adjusting for age, pre-morbid function, primary cause for hospital admission and stroke severity [OR 1.13 (95% C.I. = 1.10-1.27), p = 0.002]. Early referral and specialist management of IHS patients that includes thrombolysis is associated with better functional outcomes at 90 days.	[Manawadu, Dulka; Choyi, Jithesh; Kalra, Lalit] Kings Coll London, Dept Clin Neurosci, London, England; [Manawadu, Dulka] Kings Coll Hosp London, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Manawadu, D (corresponding author), Kings Coll London, Dept Clin Neurosci, London, England.	dulka.manawadu@nhs.net						Alvaro LC, 2008, NEUROLOGIA, V23, P4; Cumbler E, 2011, STROKE, V42, P207, DOI 10.1161/STROKEAHA.110.590265; Demchuk AM, 2005, STROKE, V36, P2110, DOI 10.1161/01.STR.0000181116.15426.58; Evans A, 2001, LANCET, V358, P1586, DOI 10.1016/S0140-6736(01)06652-1; Farooq MU, 2008, CEREBROVASC DIS, V25, P12, DOI 10.1159/000111494; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Kim EY, 2005, STROKE, V36, P2745, DOI 10.1161/01.STR.0000185720.03803.41; Kimura K, 2006, EUR NEUROL, V55, P155, DOI 10.1159/000093574; Masjuan J, 2008, STROKE, V39, P2614, DOI 10.1161/STROKEAHA.107.512848; Park HJ, 2009, EUR J NEUROL, V16, P582, DOI 10.1111/j.1468-1331.2009.02538.x; Stroke Unit Trialists' Collaboration Organised inpatient (stroke unit) care for stroke, 2007, COCHRANE DATABASE SY; Vera R, 2011, EUR J NEUROL, V18, P170, DOI 10.1111/j.1468-1331.2010.03105.x	13	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104758	10.1371/journal.pone.0104758	http://dx.doi.org/10.1371/journal.pone.0104758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144197	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100021
J	Takahashi, S; Tomita, J; Nishioka, K; Hisada, T; Nishijima, M				Takahashi, Shunsuke; Tomita, Junko; Nishioka, Kaori; Hisada, Takayoshi; Nishijima, Miyuki			Development of a Prokaryotic Universal Primer for Simultaneous Analysis of Bacteria and Archaea Using Next-Generation Sequencing	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; RIBOSOMAL-RNA GENE; MICROBIAL COMMUNITIES; RELATIVE ABUNDANCE; COPY NUMBER; GENOME SIZE; DIVERSITY; PCR; QUANTIFICATION; MISMATCH	For the analysis of microbial community structure based on 16S rDNA sequence diversity, sensitive and robust PCR amplification of 16S rDNA is a critical step. To obtain accurate microbial composition data, PCR amplification must be free of bias; however, amplifying all 16S rDNA species with equal efficiency from a sample containing a large variety of microorganisms remains challenging. Here, we designed a universal primer based on the V3-V4 hypervariable region of prokaryotic 16S rDNA for the simultaneous detection of Bacteria and Archaea in fecal samples from crossbred pigs (LandracexLarge whitexDuroc) using an Illumina MiSeq next-generation sequencer. In-silico analysis showed that the newly designed universal prokaryotic primers matched approximately 98.0% of Bacteria and 94.6% of Archaea rRNA gene sequences in the Ribosomal Database Project database. For each sequencing reaction performed with the prokaryotic universal primer, an average of 69,330 (+/- 20,482) reads were obtained, of which archaeal rRNA genes comprised approximately 1.2% to 3.2% of all prokaryotic reads. In addition, the detection frequency of Bacteria belonging to the phylum Verrucomicrobia, including members of the classes Verrucomicrobiae and Opitutae, was higher in the NGS analysis using the prokaryotic universal primer than that performed with the bacterial universal primer. Importantly, this new prokaryotic universal primer set had markedly lower bias than that of most previously designed universal primers. Our findings demonstrate that the prokaryotic universal primer set designed in the present study will permit the simultaneous detection of Bacteria and Archaea, and will therefore allow for a more comprehensive understanding of microbial community structures in environmental samples.	[Takahashi, Shunsuke; Tomita, Junko; Nishioka, Kaori; Hisada, Takayoshi; Nishijima, Miyuki] TechnoSuruga Lab Co Ltd, Shizuoka, Japan		Takahashi, S (corresponding author), TechnoSuruga Lab Co Ltd, Shizuoka, Japan.	shunsuke.takahashi@tecsrg.co.jp		Takahashi, Shunsuke/0000-0002-4186-8119				Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Han MQ, 2012, MAR BIOTECHNOL, V14, P701, DOI 10.1007/s10126-012-9436-5; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Ishii K, 2001, APPL ENVIRON MICROB, V67, P3753, DOI 10.1128/AEM.67.8.3753-3755.2001; Kiyohara M, 2012, BIOSCI BIOTECH BIOCH, V76, P48, DOI 10.1271/bbb.110424; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Liu FH, 2009, J APPL MICROBIOL, V106, P952, DOI 10.1111/j.1365-2672.2008.04064.x; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakayama J., 2007, Journal of Intestinal Microbiology, V21, P129; Nakayama J., 2010, Bioscience and Microflora, V29, P83; Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09; Patra AK, 2012, APPL ENVIRON MICROB, V78, P4271, DOI 10.1128/AEM.00309-12; Silva MCPE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051554; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Suchankova P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076431, 10.1371/journal.pone.0071284]; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tang C, 2013, APPL ENVIRON MICROB, V79, P1034, DOI 10.1128/AEM.02336-12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Winter C, 2013, ISME J, V7, P1507, DOI 10.1038/ismej.2013.56; Wrede C, 2012, ARCHAEA, V2012, DOI 10.1155/2012/596846; Wu JH, 2009, J MICROBIOL METH, V77, P267, DOI 10.1016/j.mimet.2009.03.001; Xu YJ, 2012, J CLIN MICROBIOL, V50, P3901, DOI 10.1128/JCM.01237-12; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465; Zumsteg A, 2012, MICROB ECOL, V63, P552, DOI 10.1007/s00248-011-9991-8	49	701	716	17	212	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105592	10.1371/journal.pone.0105592	http://dx.doi.org/10.1371/journal.pone.0105592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144201	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100091
J	Chang, CH; Wang, CZ; Chang, JK; Hsu, CY; Ho, ML				Chang, Chih-Hsiang; Wang, Chau-Zen; Chang, Je-Ken; Hsu, Che-Yu; Ho, Mei-Ling			The Susceptive Alendronate-Treatment Timing and Dosage for Osteogenesis Enhancement in Human Bone Marrow-Derived Stem Cells	PLOS ONE			English	Article							MEVALONATE PATHWAY; IN-VITRO; STROMAL CELLS; INHIBITION; DIFFERENTIATION; BISPHOSPHONATES; PROLIFERATION; FARNESYL; APOPTOSIS; PRENYLATION	Recent studies indicated that alendronate enhanced osteogenesis in osteoblasts and human bone marrow-derived stem cells. However, the time-and dose-dependent effects of Aln on ostegenic differentiation and cytotoxicity of hBMSCs remain undefined. In present study, we investigated the effective dose range and timing of hBMSCs. hBMSCs were treated with various Aln doses (1, 5 and 10 mu M) according to the following groups: group A was treated with Aln during the first five days of bone medium, groups B, C and D were treated during the first, second, and final five days of osteo-induction medium and group E was treated throughout the entire experiment. The mineralization level and cytotoxicity were measured by quantified Alizarin Red S staining and MTT assay. In addition, the reversal effects of farnesyl pyrophosphate and geranylgeranyl pyrophosphate replenishment in group B were also investigated. The results showed that Aln treatment in groups A, B and E enhanced hBMSC mineralization in a dose-dependent manner, and the most pronounced effects were observed in groups B and E. The higher dose of Aln simultaneously enhanced mineralization and caused cytotoxicity in groups B, C and E. Replenishment of FPP or GGPP resulted in partial or complete reverse of the Aln-induced mineralization respectively. Furthermore, the addition of FPP or GGPP also eliminated the Aln-induced cytotoxicity. We demonstrated that hBMSCs are susceptible to 5 mu M Aln during the initiation stage of osteogenic differentiation and that a 10 mu M dose is cytotoxic.	[Chang, Chih-Hsiang; Wang, Chau-Zen; Chang, Je-Ken; Hsu, Che-Yu; Ho, Mei-Ling] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chang, Je-Ken] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Orthopaed, Kaohsiung, Taiwan; [Chang, Je-Ken] Kaohsiung Municipal Tatung Hosp, Dept Orthopaed, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Ho, ML (corresponding author), Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan.	homelin@kmu.edu.tw		Ho, Mei-Ling/0000-0001-8064-8488	National Science Council [NSC 97-EC-17-A-17-S1-041, NSC 98-EC-17-A-17-S1-041, NSC 99-EC-17-A-17-S1-041, NSC 102-2325-B-037-003]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council: NSC 97-EC-17-A-17-S1-041, NSC 98-EC-17-A-17-S1-041, NSC 99-EC-17-A-17-S1-041, and NSC 102-2325-B-037-003. The funder's website is http://web1.most.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Duque G, 2011, BRIT J PHARMACOL, V162, P1109, DOI 10.1111/j.1476-5381.2010.01111.x; Ebert R, 2009, BONE, V44, P858, DOI 10.1016/j.bone.2009.01.009; Enjuanes A, 2010, ENDOCRINE, V37, P322, DOI 10.1007/s12020-009-9306-8; FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Jeong JA, 2007, PROTEOMICS, V7, P4181, DOI 10.1002/pmic.200700502; Keller RK, 1999, BIOCHEM BIOPH RES CO, V266, P560, DOI 10.1006/bbrc.1999.1849; Kim HK, 2009, CLIN ORTHOP RELAT R, V467, P3121, DOI 10.1007/s11999-008-0409-y; Komatsu K, 2013, J ENDOCRINOL, V219, P145, DOI 10.1530/JOE-13-0040; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Moreau MF, 2007, BIOCHEM PHARMACOL, V73, P718, DOI 10.1016/j.bcp.2006.09.031; Moreira MS, 2005, DENT TRAUMATOL, V21, P329, DOI 10.1111/j.1600-9657.2005.00370.x; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Muller S, 2005, ANTICANCER RES, V25, P2655; Orriss IR, 2009, J CELL BIOCHEM, V106, P109, DOI 10.1002/jcb.21983; Correia VDP, 2006, DENT TRAUMATOL, V22, P312, DOI 10.1111/j.1600-9657.2005.00434.x; Suri S, 2001, BONE, V29, P336, DOI 10.1016/S8756-3282(01)00589-0; Susa M, 2009, ANTICANCER RES, V29, P1879; Thompson K, 2006, MOL PHARMACOL, V69, P1624, DOI 10.1124/mol.105.020776; Toyras A, 2003, EUR J PHARM SCI, V19, P223, DOI 10.1016/S0928-0987(03)00108-8; von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059; Wang CZ, 2010, BIOMATERIALS, V31, P8674, DOI 10.1016/j.biomaterials.2010.07.096; Weivoda MM, 2012, BONE, V50, P467, DOI 10.1016/j.bone.2011.09.056; Weivoda MM, 2011, ENDOCRINOLOGY, V152, P3113, DOI 10.1210/en.2011-0016; Weivoda MM, 2011, J CELL BIOCHEM, V112, P1506, DOI 10.1002/jcb.23087; Xiong Y, 2009, J INT MED RES, V37, P407, DOI 10.1177/147323000903700216; Yoshida T, 2006, FEBS LETT, V580, P5203, DOI 10.1016/j.febslet.2006.08.060	34	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105705	10.1371/journal.pone.0105705	http://dx.doi.org/10.1371/journal.pone.0105705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157615	gold, Green Published, Green Submitted			2022-12-27	WOS:000341303200049
J	Han, ZY; Shen, FX; He, Y; Degos, V; Camus, M; Maze, M; Young, WL; Su, H				Han, Zhenying; Shen, Fanxia; He, Yue; Degos, Vincent; Camus, Marine; Maze, Mervyn; Young, William L.; Su, Hua			Activation of alpha-7 Nicotinic Acetylcholine Receptor Reduces Ischemic Stroke Injury through Reduction of Pro-Inflammatory Macrophages and Oxidative Stress	PLOS ONE			English	Article							GLUTAMATE NEUROTOXICITY; FOCAL ISCHEMIA; VAGUS NERVE; MOUSE; MICROGLIA; SENSORIMOTOR; INHIBITORS; RECOVERY; DISEASE; BRAIN	Activation of alpha-7 nicotinic acetylcholine receptor (alpha-7 nAchR) has a neuro-protective effect on ischemic and hemorrhagic stroke. However, the underlying mechanism is not completely understood. We hypothesized that alpha-7 nAchR agonist protects brain injury after ischemic stroke through reduction of pro-inflammatory macrophages (M1) and oxidative stress. C57BL/6 mice were treated with PHA568487 (PHA, alpha-7 nAchR agonist), methyllycaconitine (MLA, nAchR antagonist), or saline immediately and 24 hours after permanent occlusion of the distal middle cerebral artery (pMCAO). Behavior test, lesion volume, CD68(+), M1 (CD11b(+)/Iba1(+)) and M2 (CD206/Iba1(+)) microglia/macrophages, and phosphorylated p65 component of NF-kappa B in microglia/macrophages were quantified using histological stained sections. The expression of M1 and M2 marker genes, anti-oxidant genes and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase were quantified using real-time RT-PCR. Compared to the saline-treated mice, PHA mice had fewer behavior deficits 3 and 7 days after pMCAO, and smaller lesion volume, fewer CD68(+) and M1 macrophages, and more M2 macrophages 3 and 14 days after pMCAO, whereas MLA's effects were mostly the opposite in several analyses. PHA increased anti-oxidant genes and NADPH oxidase expression associated with decreased phosphorylation of NF-kappa B p65 in microglia/macrophages. Thus, reduction of inflammatory response and oxidative stress play roles in alpha-7 nAchR neuro-protective effect.	[Han, Zhenying; Shen, Fanxia; He, Yue; Degos, Vincent; Camus, Marine; Maze, Mervyn; Young, William L.; Su, Hua] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA; [Han, Zhenying] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China; [Degos, Vincent] Univ Paris 06, Hop La Pitie Salpetriere, Assistance Publi Hop Paris APHP, Paris, France; [Young, William L.] UMR INSERM 1141, Paris, France; [Young, William L.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Young, William L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; Tianjin Medical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Su, H (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA.	hua.su@ucsf.edu			National Institutes of Health [R01NS027713, R21NS070153, P01NS044155, R01 GM104194]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027713, R21NS070153, P01NS044155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health to HS (R01NS027713, R21NS070153, and P01NS044155), and to MM (R01 GM104194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2011, INTERN EMERG MED, V6, P119, DOI 10.1007/s11739-011-0675-7; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Degos V, 2013, ANESTHESIOLOGY, V118, P1362, DOI 10.1097/ALN.0b013e31828c23f8; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Duris K, 2011, STROKE, V42, P3530, DOI 10.1161/STROKEAHA.111.619965; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Fosbol EL, 2010, CIRC-CARDIOVASC QUAL, V3, P395, DOI 10.1161/CIRCOUTCOMES.109.861104; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Kahles T, 2012, CELL MOL LIFE SCI, V69, P2345, DOI 10.1007/s00018-012-1011-8; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Langdon KD, 2010, J CEREBR BLOOD F MET, V30, P1450, DOI 10.1038/jcbfm.2010.23; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Lightfoot AP, 2008, PROGR MED CHEM, V46, P131, DOI 10.1016/S0079-6468(07)00003-3; Lo EH, 2009, NAT MED, V15, P844, DOI 10.1038/nm0809-844; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pang L, 2001, STROKE, V32, P544, DOI 10.1161/01.STR.32.2.544; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Roumie CL, 2008, STROKE, V39, P2037, DOI 10.1161/STROKEAHA.107.508549; Roumie CL, 2009, PHARMACOEPIDEM DR S, V18, P1053, DOI 10.1002/pds.1820; Schilling M, 2005, EXP NEUROL, V196, P290, DOI 10.1016/j.expneurol.2005.08.004; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Takada-Takatori Y, 2006, NEUROPHARMACOLOGY, V51, P474, DOI 10.1016/j.neuropharm.2006.04.007; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Wang ZY, 2013, FREE RADICAL BIO MED, V65, P942, DOI 10.1016/j.freeradbiomed.2013.08.166; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	38	75	79	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105711	10.1371/journal.pone.0105711	http://dx.doi.org/10.1371/journal.pone.0105711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157794	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200050
J	Ramos, PS; Sardinha, A; Nardi, AE; Araujo, CG				Ramos, Plinio Santos; Sardinha, Aline; Nardi, Antonio Egidio; Araujo, Claudio Gil			Cardiorespiratory Optimal Point: A Submaximal Exercise Variable to Assess Panic Disorder Patients	PLOS ONE			English	Article							CHALLENGE TEST; PHYSICAL-EXERCISE; HYPERVENTILATION; RESPONSES; ANXIETY; ATTACKS; SENSITIVITY; DEPRESSION; CAPACITY; SUBTYPE	Panic disorder (PD) patients often report respiratory symptoms and tend to perform poorly during maximal cardiopulmonary exercise testing (CPX), at least partially, due to phobic anxiety. Thus, we hypothesized that a submaximal exercise variable, minimum VE/VO2 - hereafter named cardiorespiratory optimal point (COP) -, may be useful in their clinical assessment. Data from 2,338 subjects were retrospectively analyzed and 52 (2.2%) patients diagnosed with PD (PDG) (70% women; aged 48613 years). PD patients were compared with a healthy control group (CG) precisely matched to number of cases, age and gender profiles. PDG was further divided into two subgroups, based on having achieved a maximal or a submaximal CPX (unwilling to continue until exhaustion). We compared COP, VO2 max, maximum heart rate (HR max) between PDG and CG, and also COP between maximal and submaximal PD subgroups. COP was similar between PDG and CG (21.9 +/- 0.5 vs. 23.4 +/- 0.6; p = 0.07), as well as, for PD subgroups of maximal and submaximal CPX (22.0 +/- 0.5 vs. 21.6 +/- 1.3; p = 0.746). Additionally, PD patients completing a maximal CPX obtained VO2 max (mL.kg(-1).min(-1)) (32.9 +/- 1.57 vs 29.6 +/- 1.48; p = 0.145) and HR max (bpm) similar to controls (173 +/- 2.0 vs 168 +/- 2.7; p = 0.178). No adverse complications occurred during CPX. Although clinically safe, it is sometimes difficult to obtain a true maximal CPX in PD patients. Normalcy of cardiorespiratory interaction at submaximal effort as assessed by COP may contribute to reassure both patients and physicians that there is no physiological substrate for exercise-related respiratory symptoms often reported by PD patients.	[Ramos, Plinio Santos; Araujo, Claudio Gil] Exercise Med Clin CLINIMEX, Exercise Med Clin, Rio De Janeiro, Brazil; [Ramos, Plinio Santos] Matern Hosp Therezinha Jesus, Fac Med & Hlth Sci, SUPREMA, Juiz De Fora, MG, Brazil; [Sardinha, Aline; Nardi, Antonio Egidio] Univ Fed Rio de Janeiro, Natl Inst Translat Med, Inst Psychiat, Pan & Respirat Lab,INCT TM,CNPq, Rio De Janeiro, Brazil; [Araujo, Claudio Gil] Univ Fed Rio de Janeiro, Heart Inst Edson Saad, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Araujo, CG (corresponding author), Exercise Med Clin CLINIMEX, Exercise Med Clin, Rio De Janeiro, Brazil.	cgaraujo@iis.com.br	Sardinha, Aline/ABA-9528-2021; Ramos, Plinio/J-1291-2018; Ramos, Plinio/F-7453-2012; Sardinha, Aline/C-1529-2009; Araujo, Claudio Gil/A-7027-2008; Nardi, Antonio E/A-7335-2014	Sardinha, Aline/0000-0001-5934-771X; Ramos, Plinio/0000-0003-4035-3890; Ramos, Plinio/0000-0003-4035-3890; Sardinha, Aline/0000-0001-5934-771X; Araujo, Claudio Gil/0000-0001-6679-6695; Nardi, Antonio E/0000-0002-2152-4669	Fundacao de Amparo a Pesquisa do Rio de Janeiro - FAPERJ (Rio de Janeiro State Foundation for Scientifical Research); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for the Scientific and Technological Development and Instituto Nacional de Ciencia e Tecnologia - INCT-TM - Brazil	Fundacao de Amparo a Pesquisa do Rio de Janeiro - FAPERJ (Rio de Janeiro State Foundation for Scientifical Research); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for the Scientific and Technological Development and Instituto Nacional de Ciencia e Tecnologia - INCT-TM - Brazil	The experimental work was partially supported by Fundacao de Amparo a Pesquisa do Rio de Janeiro - FAPERJ (Rio de Janeiro State Foundation for Scientifical Research) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for the Scientific and Technological Development and Instituto Nacional de Ciencia e Tecnologia - INCT-TM - Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony MM, 2006, BEHAV RES THER, V44, P85, DOI 10.1016/j.brat.2004.12.005; APA, 2000, DIAGN STAT MAN MENT; Araújo Claudio Gil Soares de, 2005, Arq. Bras. Cardiol., V85, P45, DOI 10.1590/S0066-782X2005001400009; Biber B, 1999, AM J PSYCHIAT, V156, P739; Broocks A, 1997, NEUROPSYCHOBIOLOGY, V36, P182, DOI 10.1159/000119381; BYE PTP, 1983, ANNU REV PHYSIOL, V45, P439, DOI 10.1146/annurev.ph.45.030183.002255; Caldirola D, 2011, REV BRAS PSIQUIATR, V33, P385, DOI 10.1590/S1516-44462011000400013; CAMPBELL SC, 1982, J OCCUP ENVIRON MED, V24, P531; de Araujo C G, 1983, Arq Bras Cardiol, V41, P37; Freire RC, 2008, PSYCHIAT RES, V157, P307, DOI 10.1016/j.psychres.2007.07.015; Freire RC, 2012, REV BRAS PSIQUIATR, V34, pS32, DOI 10.1590/S1516-44462012000500004; Ho HP, 2004, PSYCHONEUROENDOCRINO, V29, P1138, DOI 10.1016/j.psyneuen.2004.01.005; Kelly MM, 2007, BEHAV THER, V38, P340, DOI 10.1016/j.beth.2006.10.007; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P415, DOI 10.1001/archpsyc.63.4.415; Kim YR, 2004, EUR NEUROPSYCHOPHARM, V14, P515, DOI 10.1016/j.euroneuro.2004.03.004; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; Martinsen EW, 1998, J ANXIETY DISORD, V12, P333, DOI 10.1016/S0887-6185(98)00018-8; Meyer T, 1998, INT J SPORTS MED, V19, P496, DOI 10.1055/s-2007-971951; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Muotri RW, 2014, REV BRAS PSIQUIATR, V36, P68, DOI 10.1590/1516-4446-2012-1012; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nardi AE, 1999, ARQ NEURO-PSIQUIAT, V57, P932, DOI 10.1590/S0004-282X1999000600006; Nardi AE, 2006, COMPR PSYCHIAT, V47, P209, DOI 10.1016/j.comppsych.2005.07.007; Nardi AE, 2004, PSYCHOPATHOLOGY, V37, P29, DOI 10.1159/000077017; Nardi AE, 2003, ARQ NEURO-PSIQUIAT, V61, P718, DOI 10.1590/S0004-282X2003000500003; Nardi AE, 2001, PSYCHIAT RES, V105, P57, DOI 10.1016/S0165-1781(01)00335-3; Nardi AE, 2009, RESP PHYSIOL NEUROBI, V167, P133, DOI 10.1016/j.resp.2008.07.011; Nathell L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-89; NIMH, 1999, FACTS PAN DIS; PERNA G, 1994, BIOL PSYCHIAT, V36, P601, DOI 10.1016/0006-3223(94)90071-X; Ramos PS, 2012, ARQ BRAS CARDIOL, V99, P988, DOI 10.1590/S0066-782X2012005000091; Ramos PS, 2010, ARQ BRAS CARDIOL, V95, P84; Ramos PS, 2013, REV BRAS ATIV FIS SA, V18, P585; Ricardo DR, 2005, CHEST, V127, P318, DOI 10.1378/chest.127.1.318; Sardinha Aline, 2011, J. bras. psiquiatr., V60, P227, DOI 10.1590/S0047-20852011000300013; Sardinha A, 2011, EXPERT REV CARDIOVAS, V9, P165, DOI [10.1586/erc.10.170, 10.1586/ERC.10.170]; Sardinha A, 2009, J BRAS PNEUMOL, V35, P698, DOI 10.1590/S1806-37132009000700012; Smits JAJ, 2008, DEPRESS ANXIETY, V25, P689, DOI 10.1002/da.20411; Meneghelo RS, 2010, Arq. Bras. Cardiol., V95, P1, DOI 10.1590/S0066-782X2010000800001; TAYLOR C B, 1987, American Journal of Cardiology, V60, p48J, DOI 10.1016/0002-9149(87)90683-7; Telch MJ, 2011, J ANXIETY DISORD, V25, P645, DOI 10.1016/j.janxdis.2011.02.005; von Leupoldt A, 2011, CHEST, V140, P730, DOI 10.1378/chest.10-2917; Whipp BJ, 1998, BRIT J SPORT MED, V32, P199, DOI 10.1136/bjsm.32.3.199; Zschucke Elisabeth, 2013, J Prev Med Public Health, V46 Suppl 1, pS12, DOI 10.3961/jpmph.2013.46.S.S12	44	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104932	10.1371/journal.pone.0104932	http://dx.doi.org/10.1371/journal.pone.0104932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JK	25157496	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200020
J	Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, AG; Calvez, V; Antinori, A; Ceccherini-Silberstein, F; Perno, CF; Santoro, MM				Armenia, Daniele; Soulie, Cathia; Di Carlo, Domenico; Fabeni, Lavinia; Gori, Caterina; Forbici, Federica; Svicher, Valentina; Bertoli, Ada; Sarmati, Loredana; Giuliani, Massimo; Latini, Alessandra; Boumis, Evangelo; Zaccarelli, Mauro; Bellagamba, Rita; Andreoni, Massimo; Marcelin, Anne-Genevieve; Calvez, Vincent; Antinori, Andrea; Ceccherini-Silberstein, Francesca; Perno, Carlo-Federico; Santoro, Maria Mercedes			A Very Low Geno2pheno False Positive Rate Is Associated with Poor Viro-Immunological Response in Drug-Naive Patients Starting a First-Line HAART	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; CD4 CELL COUNT; DISEASE PROGRESSION; CORECEPTOR TROPISM; TYPE-1 TROPISM; HIV-1-INFECTED PATIENTS; VIROLOGICAL RESPONSES; RESISTANCE MUTATIONS; CCR5 ANTAGONISTS	Background: We previously found that a very low geno2pheno false positive rate (FPR <= 2%) defines a viral population associated with low CD4 cell count and the highest amount of X4-quasispecies. In this study, we aimed at evaluating whether FPR <= 2% might impact on the viro-immunological response in HIV-1 infected patients starting a first-line HAART. Methods: The analysis was performed on 305 HIV-1 B subtype infected drug-naive patients who started their first-line HAART. Baseline FPR (%) values were stratified according to the following ranges: <= 2; 2-5; 5-10; 10-20; 20-60; >60. The impact of genotypically-inferred tropism on the time to achieve immunological reconstitution (a CD4 cell count gain from HAART initiation >= 150 cells/mm(3)) and on the time to achieve virological success (the first HIV-RNA measurement <50 copies/mL from HAART initiation) was evaluated by survival analyses. Results: Overall, at therapy start, 27% of patients had FPR <= 10 (6%, FPR <= 2; 7%, FPR 2-5; 14%, FPR 5-10). By 12 months of therapy the rate of immunological reconstitution was overall 75.5%, and it was significantly lower for FPR <= 2 (54.1%) in comparison to other FPR ranks (78.8%, FPR 2-5; 77.5%, FPR 5-10; 71.7%, FPR 10-20; 81.8%, FPR 20-60; 75.1%, FPR >60; p = 0.008). The overall proportion of patients achieving virological success was 95.5% by 12 months of therapy. Multivariable Cox analyses showed that patients having pre-HAART FPR <= 2% had a significant lower relative adjusted hazard [95% C. I.] both to achieve immunological reconstitution (0.37 [0.20-0.71], p = 0.003) and to achieve virological success (0.50 [0.26-0.94], p = 0.031) than those with pre-HAART FPR >60%. Conclusions: Beyond the genotypically-inferred tropism determination, FPR <= 2% predicts both a poor immunological reconstitution and a lower virological response in drug-naive patients who started their first-line therapy. This parameter could be useful to identify patients potentially with less chance of achieving adequate immunological reconstitution and virological undetectability.	[Armenia, Daniele; Di Carlo, Domenico; Svicher, Valentina; Bertoli, Ada; Ceccherini-Silberstein, Francesca; Perno, Carlo-Federico; Santoro, Maria Mercedes] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent] Univ Paris 06, Pierre Louis Inst Epidemiol & Publ Hlth, Unite Mixte Rech Sante UMR S 1136, Paris, France; [Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent] INSERM, Pierre Louis Inst Epidemiol & Publ Hlth, UMR S 1136, Paris, France; [Soulie, Cathia; Marcelin, Anne-Genevieve; Calvez, Vincent] Grp Hosp Pitie Salpetriere, AP HP, Virol Lab, F-75634 Paris, France; [Fabeni, Lavinia; Gori, Caterina; Forbici, Federica; Perno, Carlo-Federico] Ist Nazl Malattie Infett INMI Lazzaro Spallanzani, Antiviral Drug Monitoring Unit, Rome, Italy; [Bertoli, Ada; Perno, Carlo-Federico] Univ Hosp Tor Vergata, Rome, Italy; [Sarmati, Loredana; Andreoni, Massimo] Univ Hosp Tor Vergata, Infect Dis Unit, Rome, Italy; [Giuliani, Massimo; Latini, Alessandra] San Gallicano Hosp, Dept Infect Dermatol, Rome, Italy; [Boumis, Evangelo; Zaccarelli, Mauro; Bellagamba, Rita; Antinori, Andrea] Ist Nazl Malattie Infett INMI Lazzaro Spallanzani, Div Infect Dis, Rome, Italy	University of Rome Tor Vergata; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Santoro, MM (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy.	santormaria@gmail.com	FABENI, LAVINIA/J-6626-2016; Ceccherini-Silberstein, Francesca/K-4762-2016; Giuliani, Massimo/J-2788-2018; SOULIE, CATHIA/AIF-3965-2022; Di Maio, Velia Chiara/AGH-2628-2022; latini, alessandra/J-8186-2018; Armenia, Daniele/K-2009-2016; Antinori, Andrea/K-7125-2016; perno, carlo federico/O-1544-2016; Andreoni, Masimo/AAL-2214-2020; Zaccarelli, Mauro/GYV-1093-2022; SANTORO, MARIA/K-3250-2018; Marcelin, Anne-Genevieve/D-8272-2014; Forbici, Federica/B-6765-2017; gori, caterina/B-7836-2017	FABENI, LAVINIA/0000-0002-2975-8611; Giuliani, Massimo/0000-0002-4523-8261; Armenia, Daniele/0000-0002-3406-7014; Antinori, Andrea/0000-0003-2121-4684; SANTORO, MARIA/0000-0002-6228-1114; Marcelin, Anne-Genevieve/0000-0003-4808-8999; Forbici, Federica/0000-0002-3954-5679; BERTOLI, ADA/0000-0003-0663-2503; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; SVICHER, VALENTINA/0000-0002-2377-504X; Di Carlo, Domenico/0000-0002-8324-4873; Andreoni, Massimo/0000-0002-3205-9758; Latini, Alessandra/0000-0002-9421-6560; gori, caterina/0000-0002-6042-7570; PERNO, CARLO FEDERICO/0000-0002-0825-5388; sarmati, loredana/0000-0003-1452-0333	European Commission [223131]; European AIDS Treatment Network (NEAT) [LSHT/CT/2006/037570]; Italian Ministry of Health [CUP: E81J10000000001, 40H78]; AVIRALIA foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); European AIDS Treatment Network (NEAT); Italian Ministry of Health(Ministry of Health, Italy); AVIRALIA foundation	This work was financially supported by the European Commission Framework 7 Programme (CHAIN, the Collaborative HIV and Anti-HIV Drug Resistance Network, Integrated Project no. 223131), and by the European AIDS Treatment Network (NEAT, contract number LSHT/CT/2006/037570); Italian Ministry of Health (CUP: E81J10000000001, Ricerca Corrente and Progetto AIDS grant no. n. 40H78); and by an unrestricted grant from AVIRALIA foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-111; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Carrillo A, 1996, J VIROL, V70, P1301, DOI 10.1128/JVI.70.2.1301-1309.1996; Ceccherini-Silberstein F, 2005, J VIROL, V79, P10718, DOI 10.1128/JVI.79.16.10718-10729.2005; Charpentier C, 2013, J ANTIMICROB CHEMOTH, V68, P690, DOI 10.1093/jac/dks455; Coakley E, 2009, ANTIMICROB AGENTS CH, V53, P4686, DOI 10.1128/AAC.00229-09; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650; Feinberg MB, 2002, NAT MED, V8, P537, DOI 10.1038/nm0602-537a; Foca E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-153; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Goetz MB, 2009, JAIDS-J ACQ IMM DEF, V50, P259, DOI 10.1097/QAI.0b013e3181989a8b; Hu QX, 2000, J MOL BIOL, V302, P359, DOI 10.1006/jmbi.2000.4076; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Lee GQ, 2013, AIDS RES HUM RETROV, V29, P979, DOI [10.1089/aid.2012.0338, 10.1089/AID.2012.0338]; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; McGovern RA, 2013, J ANTIMICROB CHEMOTH, V68, P2007, DOI 10.1093/jac/dkt153; McGovern RA, 2012, JAIDS-J ACQ IMM DEF, V61, P279, DOI 10.1097/QAI.0b013e31826249cf; Moore DM, 2006, AIDS, V20, P371, DOI 10.1097/01.aids.0000196180.11293.9a; Moore RD, 2008, CLIN INFECT DIS, V47, P1102, DOI 10.1086/592115; Nozza S, 2012, J ANTIMICROB CHEMOTH, V67, P1224, DOI 10.1093/jac/dkr600; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014, GUIDELINES USE ANTIR; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Poveda E, 2012, AIDS REV, V14, P208; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Ross TM, 1998, P NATL ACAD SCI USA, V95, P7682, DOI 10.1073/pnas.95.13.7682; Ruelle J, 2009, J CLIN VIROL, V44, P297, DOI 10.1016/j.jcv.2009.01.004; Santoro MM, 2012, CLIN MICROBIOL INFEC, V18, pE289, DOI 10.1111/j.1469-0691.2012.03905.x; Santoro MM, 2013, ANTIVIR THER, V18, P867, DOI 10.3851/IMP2531; Seclen E, 2011, J INFECT DIS, V204, P139, DOI 10.1093/infdis/jir218; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/jac/dkq137; Sing T, 2007, ANTIVIR THER, V12, P1097; Sire JM, 2011, JAIDS-J ACQ IMM DEF, V56, P239, DOI 10.1097/QAI.0b013e3182099891; Soulie C, 2012, J MED VIROL, V84, P1853, DOI 10.1002/jmv.23362; Svicher V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053603; Svicher V, 2010, NEW MICROBIOL, V33, P195; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vandamme AM, 2011, AIDS REV, V13, P77; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Wirden M, 2011, J ANTIMICROB CHEMOTH, V66, P709, DOI 10.1093/jac/dkq544	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105853	10.1371/journal.pone.0105853	http://dx.doi.org/10.1371/journal.pone.0105853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153969	Green Published, gold			2022-12-27	WOS:000340952200086
J	Crichton, J; Hickman, M; Campbell, R; Heron, J; Horner, P; Macleod, J				Crichton, Joanna; Hickman, Matthew; Campbell, Rona; Heron, Jon; Horner, Paddy; Macleod, John			Prevalence of Chlamydia in Young Adulthood and Association with Life Course Socioeconomic Position: Birth Cohort Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; TRACHOMATIS GENITAL-INFECTION; POPULATION-BASED SURVEY; RISK; ATTITUDES; BEHAVIOR; BRITAIN; STYLES; WOMEN	Background: Few estimates are available of chlamydia prevalence in the general population. Existing studies have limited scope to explore potential selection bias or associations with socioeconomic position. Methods: We examined the prevalence of Chlamydia trachomatis infection and associations with life-course socioeconomic position in the Avon Longitudinal Study of Parents and Children in England. Chlamydia infection was measured through nucleic acid amplification test of urine specimens. Results: 4864 (51%) of those invited attended the clinic (mean age 17.8; SD 0.37 years). (60%) provided a urine specimen. Prevalence was 1.0% (95% CI 0.6 to 1.6) among participants reporting sexual activity. Risk of infection was strongly associated with life course social disadvantage and with recent sexual behaviour. After adjustment for other measures of disadvantage and for sexual behaviour the strongest risk factors for infection were lower maternal educational attainment (OR 9.1 (1.1, 76.7)) and lower participant educational attainment at age 11 (OR 5.0 (1.5, 16.5)). Both clinic attendance and agreement to test were lower amongst the disadvantaged. Adjustment for selective participation based on detailed information on non-participants approximately doubled prevalence estimates. Prevalence was higher in sexually active women (1.4% (0.7 to 2.4) than men (0.5% (0.1 to 1.3)). Conclusions: Chlamydia prevalence in this general population sample was low even after adjustment for selective participation in testing. These estimates of prevalence and patterns of association with socioeconomic position may both reflect recent screening efforts. Prevalence was higher amongst the disadvantaged who were also less likely to engage in testing. Our results reveal the importance of monitoring and addressing inequalities in screening programme participation and outcomes.	[Crichton, Joanna; Hickman, Matthew; Campbell, Rona; Heron, Jon; Horner, Paddy; Macleod, John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Bristol	Macleod, J (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	john.macleod@bristol.ac.uk	Hickman, Matthew/Y-2400-2019; Fazli, Ghazal/AAE-8320-2022; Heron, Jon/D-5884-2011	Hickman, Matthew/0000-0001-9864-459X; Heron, Jon/0000-0001-6199-5644; Horner, Paddy/0000-0003-0411-8332; Macleod, John/0000-0001-8202-1144	Wellcome Trust [092731]; Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation [MR/KO232331/1]; Cancer Research UK [MR/KO232331/1]; Economic and Social Research Council [MR/KO232331/1]; Medical Research Council [MR/KO232331/1]; Welsh Government [MR/KO232331/1]; Wellcome Trust under UK Clinical Research Collaboration [MR/KO232331/1]; UK Medical Research Council; University of Bristol; MRC [MR/K023233/1] Funding Source: UKRI; Economic and Social Research Council [1013622] Funding Source: researchfish; Medical Research Council [MC_PC_15018, MR/K023233/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Government; Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The work was undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence. Joint funding (MR/KO232331/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAC, 2013, ALSPAC DAT DICT; [Anonymous], 2013, FRAM SEX HLTH IMPR E; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Gottlieb SL, 2010, J INFECT DIS, V201, pS190, DOI 10.1086/652401; Gottlieb SL, 2010, J INFECT DIS, V201, pS156, DOI 10.1086/652396; Gotz HM, 2005, SEX TRANSM INFECT, V81, P24, DOI 10.1136/sti.2004.010181; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Horner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072001; Johnson SA, 2010, SEX TRANSM INFECT, V86, P217, DOI 10.1136/sti.2009.037283; Klausner JD, 2001, J INFECT DIS, V183, P1087, DOI 10.1086/319276; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; Low N, 2007, BMJ-BRIT MED J, V334, P725, DOI 10.1136/bmj.39154.378079.BE; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; Marmot M, 2010, FAIR SOC HLTH LIVES; McCadden A, 2005, SEX TRANSM DIS, V32, P387, DOI 10.1097/01.olq.0000162364.65643.08; McNulty CA, 2013, SEX TRANSM INFECT; Price MJ, 2013, EPIDEMIOL INFECT, P1; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Rubin DB, 2004, MULTIPLE IMPUTATION; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Sheringham J, 2013, SEX TRANSM INFECT, V89, P175, DOI 10.1136/sextrans-2011-050223; Sheringham J, 2011, SEX TRANSM DIS, V38, P677, DOI 10.1097/OLQ.0b013e31821597ca; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stein CR, 2008, ANN EPIDEMIOL, V18, P560, DOI 10.1016/j.annepidem.2008.03.002; Susser M, 2000, J EPIDEMIOL COMMUN H, V54, P882, DOI 10.1136/jech.54.12.882; Turner KME, 2013, SEX TRANSM INFECT, V89, P70, DOI 10.1136/sextrans-2012-050696; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Washbrook, 2008, UNDERSTANDING RELATI	33	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104943	10.1371/journal.pone.0104943	http://dx.doi.org/10.1371/journal.pone.0104943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153124	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200032
J	Zegeye, H; Rasheed, A; Makdis, F; Badebo, A; Ogbonnaya, FC				Zegeye, Habtemariam; Rasheed, Awais; Makdis, Farid; Badebo, Ayele; Ogbonnaya, Francis C.			Genome-Wide Association Mapping for Seedling and Adult Plant Resistance to Stripe Rust in Synthetic Hexaploid Wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; YELLOW RUST; LEAF RUST; LINKAGE DISEQUILIBRIUM; PUCCINIA-STRIIFORMIS; TRITICUM-TURGIDUM; GENETIC DIVERSITY; CHROMOSOMAL LOCATION; POPULATION-STRUCTURE; DURABLE RESISTANCE	Use of genetic diversity from related wild and domesticated species has made a significant contribution to improving wheat productivity. Synthetic hexaploid wheats (SHWs) exhibit natural genetic variation for resistance and/or tolerance to biotic and abiotic stresses. Stripe rust caused by (Puccinia striiformis f. sp. tritici; Pst), is an important disease of wheat worldwide. To characterise loci conferring resistance to stripe rust in SHWs, we conducted a genome-wide association study (GWAS) with a panel of 181 SHWs using the wheat 9K SNP iSelect array. The SHWs were evaluated for their response to the prevailing races of Pst at the seedling and adult plant stages, the latter in replicated field trials at two sites in Ethiopia in 2011. About 28% of the SHWs exhibited immunity at the seedling stage while 56% and 83% were resistant to Pst at the adult plant stage at Meraro and Arsi Robe, respectively. A total of 27 SNPs in nine genomic regions (1BS, 2AS, 2BL, 3BL, 3DL, 5A, 5BL, 6DS and 7A) were linked with resistance to Pst at the seedling stage, while 38 SNPs on 18 genomic regions were associated with resistance at the adult plant stage. Six genomic regions were commonly detected at both locations using a mixed linear model corrected for population structure, kinship relatedness and adjusted for false discovery rate (FDR). The loci on chromosome regions 1AS, 3DL, 6DS and 7AL appeared to be novel QTL; our results confirm that resynthesized wheat involving its progenitor species is a rich source of new stripe (yellow) rust resistance that may be useful in choosing SHWs and incorporating diverse yellow rust (YR) resistance loci into locally adapted wheat cultivars.	[Zegeye, Habtemariam; Badebo, Ayele] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Rasheed, Awais] Chinese Acad Agr Sci, Crop Sci Res Inst, Natl Wheat Improvement Ctr, Beijing 100193, Peoples R China; [Rasheed, Awais] Quaid I Azam Univ, Dept Plant Sci, Islamabad, Pakistan; [Makdis, Farid] Univ Aleppo, Fac Agr, Dept Field Crops, Aleppo, Syria; [Ogbonnaya, Francis C.] Int Ctr Agr Res Dry Areas, Aleppo, Syria; [Makdis, Farid; Ogbonnaya, Francis C.] Grains Res & Dev Corp, Res Program, Canberra, ACT, Australia	Ethiopian Institute of Agricultural Research (EIAR); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Quaid I Azam University; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Ogbonnaya, FC (corresponding author), Int Ctr Agr Res Dry Areas, POB 5466, Aleppo, Syria.	Francis.Ogbonnaya@grdc.com.au	Ogbonnaya, Francis C/C-5237-2014; Rasheed, Awais/A-1623-2010	Ogbonnaya, Francis C/0000-0002-8596-7362; Rasheed, Awais/0000-0003-2528-708X; Huluka, Ayele Badebo/0000-0001-6574-2724	Grains Research and Development Corporation (GRDC), Australia; International Centre for Agricultural Research in the Dryland Agriculture, Aleppo, Syria; Ethiopian Institute for Agricultural Research	Grains Research and Development Corporation (GRDC), Australia(Grains R&D Corp); International Centre for Agricultural Research in the Dryland Agriculture, Aleppo, Syria; Ethiopian Institute for Agricultural Research	The authors would like to thank Grains Research and Development Corporation (GRDC), Australia, International Centre for Agricultural Research in the Dryland Agriculture, Aleppo, Syria and Ethiopian Institute for Agricultural Research for providing financial support to carry out the research. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Qamar M, 2008, THEOR APPL GENET, V117, P1261, DOI 10.1007/s00122-008-0860-x; Ahmed S, 2014, AUSTRALAS PLANT PATH, V43, P109, DOI 10.1007/s13313-013-0237-8; Allen AM, 2013, PLANT BIOTECHNOL J, V11, P279, DOI 10.1111/pbi.12009; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; ANDERSON LH, 1993, J ANIM SCI, V71, P1566, DOI 10.2527/1993.7161566x; [Anonymous], 2014, ANN WHEAT NEWSL; Badebo A., 2005, ETHIOP J AGR SCI, V18, P129; Bariana HS, 2010, EUPHYTICA, V176, P251, DOI 10.1007/s10681-010-0240-x; Bariana HS, 2006, THEOR APPL GENET, V112, P1143, DOI 10.1007/s00122-006-0216-3; Boukhatem N, 2002, THEOR APPL GENET, V104, P111, DOI 10.1007/s001220200013; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Caldwell KS, 2004, GENETICS, V167, P941, DOI 10.1534/genetics.103.016303; Camus-Kulandaivelu L, 2007, CROP SCI, V47, P887, DOI 10.2135/cropsci2006.06.0366N; Carter AH, 2009, THEOR APPL GENET, V119, P1119, DOI 10.1007/s00122-009-1114-2; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Chao SM, 2009, MOL BREEDING, V23, P23, DOI 10.1007/s11032-008-9210-6; Chen X. M., 2002, Phytopathology, V92, pS14; Chen XM, 1996, PHYTOPATHOLOGY, V86, P1228, DOI 10.1094/Phyto-86-1228; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P375, DOI 10.1094/Phyto-85-375; COX TS, 1994, CROP SCI, V34, P958, DOI 10.2135/cropsci1994.0011183X003400020005x; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Dedryver F, 2009, PHYTOPATHOLOGY, V99, P968, DOI 10.1094/PHYTO-99-8-0968; Emebiri LC, 2010, MOL BREEDING, V26, P39, DOI 10.1007/s11032-009-9375-7; Emebiri LC, 2014, J SCI FOOD AGR, V94, P1422, DOI 10.1002/jsfa.6434; Eriksen L, 2004, THEOR APPL GENET, V108, P567, DOI [10.1007/s00122-003-1456-0, 10.1007/s00122-003-1573-9]; Flor HH, 1942, PHYTOPATHOLOGY, V32, P653; Fu YP, 2014, PLANT J, V78, P16, DOI [10.1111/tpj.12457, 10.1111/tpj.12355]; Guo J, 2013, PLANT PHYSIOL BIOCH, V71, P164, DOI 10.1016/j.plaphy.2013.07.009; Hadi Bux, 2012, Australian Journal of Crop Science, V6, P116; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Joukhadar R, 2013, MOL BREEDING, V32, P943, DOI 10.1007/s11032-013-9924-y; KEMA GHJ, 1992, EUPHYTICA, V63, P207; Khlestkina EK, 2007, EUPHYTICA, V153, P1, DOI 10.1007/s10681-006-9182-8; Knott DR, 1989, WHEAT RUSTS BREEEDIN; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Lan CX, 2010, PHYTOPATHOLOGY, V100, P313, DOI 10.1094/PHYTO-100-4-0313; Li CL, 2013, THEOR APPL GENET, V126, P2065, DOI 10.1007/s00122-013-2118-5; Li GQ, 2006, THEOR APPL GENET, V112, P1434, DOI 10.1007/s00122-006-0245-y; Li Q, 2011, THEOR APPL GENET, V122, P189, DOI 10.1007/s00122-010-1435-1; Lin F, 2008, THEOR APPL GENET, V116, P797, DOI 10.1007/s00122-008-0713-7; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lowe I, 2011, THEOR APPL GENET, V123, P143, DOI 10.1007/s00122-011-1573-0; Lu B. R., 2001, J GENET MOL GENET, V12, P190; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; MA H, 1995, EUPHYTICA, V83, P87, DOI 10.1007/BF01678034; MA H, 1995, EUPHYTICA, V82, P117, DOI 10.1007/BF00027057; Ma JX, 2001, EUPHYTICA, V120, P219, DOI 10.1023/A:1017510331721; Macharia KG, 2013, THESIS U MINNESOTA U; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Mallard S, 2005, THEOR APPL GENET, V110, P1401, DOI 10.1007/s00122-005-1954-3; Marais F, 2009, CROP SCI, V49, P871, DOI 10.2135/cropsci2008.06.0317; Marais GF, 2006, EUPHYTICA, V149, P373, DOI 10.1007/s10681-006-9092-9; Marais GF, 2005, PLANT BREEDING, V124, P538, DOI 10.1111/j.1439-0523.2005.01116.x; Marone D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-562; Marone D, 2012, MOL GENET GENOMICS, V287, P741, DOI 10.1007/s00438-012-0714-8; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; McIntosh RA, 2000, PLANT BREEDING, V119, P81, DOI 10.1046/j.1439-0523.2000.00449.x; McIntosh RA, 2011, THEOR APPL GENET, V123, P359, DOI 10.1007/s00122-011-1589-5; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Mulki MA, 2013, MOL BREEDING, V31, P299, DOI 10.1007/s11032-012-9790-z; Murphy LR, 2009, CROP SCI, V49, P1786, DOI 10.2135/cropsci2008.10.0621; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Ogbonnaya FC, 2008, AUST J AGR RES, V59, P421, DOI 10.1071/AR07227; Ogbonnaya FC, 2001, AUST J AGR RES, V52, P1367, DOI 10.1071/AR01031; Ogbonnaya FC, 2013, PL BRED RE, V37, P35; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rakshit S, 2012, J GENET, V91, P111, DOI 10.1007/s12041-012-0144-8; Rasheed A, 2014, BMC PLANT B IN PRESS; RAUPP WJ, 1993, J HERED, V84, P142, DOI 10.1093/oxfordjournals.jhered.a111300; Ren Y, 2012, THEOR APPL GENET, V125, P1211, DOI 10.1007/s00122-012-1907-6; RILEY R, 1968, NATURE, V217, P383, DOI 10.1038/217383a0; Rosewarne GM, 2008, THEOR APPL GENET, V116, P1027, DOI 10.1007/s00122-008-0736-0; Rosewarne GM, 2013, THEOR APPL GENET, V126, P2427, DOI 10.1007/s00122-013-2159-9; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Rosewarne GM, 2006, THEOR APPL GENET, V112, P500, DOI 10.1007/s00122-005-0153-6; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Sharma-Poudyal D, 2013, PLANT DIS, V97, P379, DOI 10.1094/PDIS-01-12-0078-RE; Singh R. P., 2000, Acta Phytopathologica et Entomologica Hungarica, V35, P133; Singh R. P., 2012, M CHALL YELL RUST CE, P25; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Singh RP, 2000, CROP SCI, V40, P1148, DOI 10.2135/cropsci2000.4041148x; Sohail Q, 2012, BREEDING SCI, V62, P38, DOI 10.1270/jsbbs.62.38; Solh M., 2012, GROWING THREAT STRIP; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun GL, 1997, THEOR APPL GENET, V95, P622, DOI 10.1007/s001220050604; Sun Q, 2002, PLANT BREEDING, V121, P539, DOI 10.1046/j.1439-0523.2002.00754.x; Tadesse W, 2014, CROP SCI, V54, P607, DOI 10.2135/cropsci2013.05.0289; Trethowan RM, 2008, CROP SCI, V48, P1255, DOI 10.2135/cropsci2007.08.0477; van Ginkel M, 2007, FIELD CROP RES, V104, P86, DOI 10.1016/j.fcr.2007.02.005; Vazquez MD, 2012, THEOR APPL GENET, V124, P1, DOI 10.1007/s00122-011-1681-x; Verslues PE, 2014, PLANT PHYSIOL, V164, P144, DOI 10.1104/pp.113.224014; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wang LF, 2002, EUPHYTICA, V124, P71, DOI 10.1023/A:1015689817857; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058969; Warburton ML, 2006, EUPHYTICA, V149, P289, DOI 10.1007/s10681-005-9077-0; Weir BS, 1996, SINAUER ASS SUNDERL; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; Wen WE, 2008, MOL BREEDING, V22, P507, DOI 10.1007/s11032-008-9194-2; WILCOXSON RD, 1975, ANN APPL BIOL, V80, P275, DOI 10.1111/j.1744-7348.1975.tb01633.x; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Yang WY, 2009, J GENET GENOMICS, V36, P539, DOI 10.1016/S1673-8527(08)60145-9; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zeller F. J., 1973, Proceedings of the fourth international wheat genetics symposium. Alien genetic material., P209; Zhang JJ, 2013, MOL BREEDING, V32, P771, DOI 10.1007/s11032-013-9905-1; Zhang P, 2009, THEOR APPL GENET, V120, P25, DOI 10.1007/s00122-009-1156-5; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao YS, 2013, J EXP BOT, V64, P4453, DOI 10.1093/jxb/ert259; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zwart RS, 2010, MOL BREEDING, V26, P107, DOI 10.1007/s11032-009-9381-9	117	129	136	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105593	10.1371/journal.pone.0105593	http://dx.doi.org/10.1371/journal.pone.0105593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153126	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200064
J	Carr, R; Borenstein, E				Carr, Rogan; Borenstein, Elhanan			Comparative Analysis of Functional Metagenomic Annotation and the Mappability of Short Reads	PLOS ONE			English	Article							MICROBIAL GENOMES; GUT MICROBIOME; SEQUENCES; BACTERIA; DATABASE; RECONSTRUCTION; PHYLOGENY; DIVERSITY; ALIGNMENT; TREE	To assess the functional capacities of microbial communities, including those inhabiting the human body, shotgun metagenomic reads are often aligned to a database of known genes. Such homology-based annotation practices critically rely on the assumption that short reads can map to orthologous genes of similar function. This assumption, however, and the various factors that impact short read annotation, have not been systematically evaluated. To address this challenge, we generated an extremely large database of simulated reads (totaling 15.9 Gb), spanning over 500,000 microbial genes and 170 curated genomes and including, for many genomes, every possible read of a given length. We annotated each read using common metagenomic protocols, fully characterizing the effect of read length, sequencing error, phylogeny, database coverage, and mapping parameters. We additionally rigorously quantified gene-, genome-, and protocol-specific annotation biases. Overall, our findings provide a first comprehensive evaluation of the capabilities and limitations of functional metagenomic annotation, providing crucial goal-specific best-practice guidelines to inform future metagenomic research.	[Carr, Rogan; Borenstein, Elhanan] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute	Borenstein, E (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	elbo@uw.edu			New Innovator Award [DP2 AT007802-01]; NIH [P30 DK089507]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [DP2AT007802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	New Innovator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by New Innovator Award DP2 AT007802-01 to EB and by NIH P30 DK089507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carr R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003292; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dalevi D, 2008, BIOINFORMATICS, V24, pI7, DOI 10.1093/bioinformatics/btn276; Davis C., 2013, J DATA MINING GENOM, V04, P1, DOI [10.4172/2153-0602.1000135, DOI 10.4172/2153-0602.1000135]; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Gevers D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002779; Greenblum S, 2013, CURR OPIN BIOTECH, V24, P810, DOI 10.1016/j.copbio.2013.04.001; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kelley DR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1067; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Liu Bo, 2011, BMC Proc, V5 Suppl 2, pS9, DOI 10.1186/1753-6561-5-S2-S9; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Oehmen CS, 2013, BIOINFORMATICS, V29, P797, DOI 10.1093/bioinformatics/btt013; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Treangen TJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r2; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Wright JJ, 2014, ISME J, V8, P455, DOI 10.1038/ismej.2013.152; Wu DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077033; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Xiong T, 2020, SENSOR ACTUAT B-CHEM, V304, DOI [10.1016/j.snb.2019.127310, 10.1126/scitranslmed.3009124]; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066; Zhang Q, 2012, BIOCOMPUT-PAC SYM, P259	56	40	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105776	10.1371/journal.pone.0105776	http://dx.doi.org/10.1371/journal.pone.0105776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148512	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600083
J	Duque-Ramos, A; Boeker, M; Jansen, L; Schulz, S; Iniesta, M; Fernandez-Breis, JT				Duque-Ramos, Astrid; Boeker, Martin; Jansen, Ludger; Schulz, Stefan; Iniesta, Miguela; Tomas Fernandez-Breis, Jesualdo			Evaluating the Good Ontology Design Guideline (GoodOD) with the Ontology Quality Requirements and Evaluation Method and Metrics (OQuaRE)	PLOS ONE			English	Article								Objective: To (1) evaluate the GoodOD guideline for ontology development by applying the OQuaRE evaluation method and metrics to the ontology artefacts that were produced by students in a randomized controlled trial, and (2) informally compare the OQuaRE evaluation method with gold standard and competency questions based evaluation methods, respectively. Background: In the last decades many methods for ontology construction and ontology evaluation have been proposed. However, none of them has become a standard and there is no empirical evidence of comparative evaluation of such methods. This paper brings together GoodOD and OQuaRE. GoodOD is a guideline for developing robust ontologies. It was previously evaluated in a randomized controlled trial employing metrics based on gold standard ontologies and competency questions as outcome parameters. OQuaRE is a method for ontology quality evaluation which adapts the SQuaRE standard for software product quality to ontologies and has been successfully used for evaluating the quality of ontologies. Methods: In this paper, we evaluate the effect of training in ontology construction based on the GoodOD guideline within the OQuaRE quality evaluation framework and compare the results with those obtained for the previous studies based on the same data. Results: Our results show a significant effect of the GoodOD training over developed ontologies by topics: (a) a highly significant effect was detected in three topics from the analysis of the ontologies of untrained and trained students; (b) both positive and negative training effects with respect to the gold standard were found for five topics. Conclusion: The GoodOD guideline had a significant effect over the quality of the ontologies developed. Our results show that GoodOD ontologies can be effectively evaluated using OQuaRE and that OQuaRE is able to provide additional useful information about the quality of the GoodOD ontologies.	[Duque-Ramos, Astrid; Tomas Fernandez-Breis, Jesualdo] Univ Murcia, Fac Informat, Dept Informat & Sistemas, Murcia, Spain; [Boeker, Martin] Univ Freiburg, Dept Med Biometry & Med Informat, D-79106 Freiburg, Germany; [Jansen, Ludger] Univ Munster, Dept Philosophy, Munster, Germany; [Schulz, Stefan] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Iniesta, Miguela] Univ Murcia, Dept Estat & Invest Operat, Murcia, Spain	University of Murcia; University of Freiburg; University of Munster; Medical University of Graz; University of Murcia	Duque-Ramos, A (corresponding author), Univ Murcia, Fac Informat, Dept Informat & Sistemas, Murcia, Spain.	astrid.duque@um.es	Boeker, Martin/N-3854-2016; Gkoutos, Georgios/AAS-9936-2020; Jansen, Ludger/AAE-9325-2020; Breis, Jesualdo Tomás Fernández/F-4269-2010	Boeker, Martin/0000-0003-2972-2042; Gkoutos, Georgios/0000-0002-2061-091X; Jansen, Ludger/0000-0002-0097-6359; Breis, Jesualdo Tomás Fernández/0000-0002-7558-2880; Duque Ramos, Astrid/0000-0001-6233-6384	Ministerio de Economia y Competitividad [TIN2010-21388-C02]; European Union through FEDER; Fundacion Seneca [15295/PI/10]; German Research Foundation (DFG)	Ministerio de Economia y Competitividad(Spanish Government); European Union through FEDER; Fundacion Seneca(Fundacion Seneca); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Ministerio de Economia y Competitividad through grant TIN2010-21388-C02, European Union through FEDER, and the Fundacion Seneca through grant 15295/PI/10. The GoodOD project was supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alani H, 2006, LECT NOTES COMPUT SC, V4273, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beisswanger E, 2008, APPL ONTOL, V3, P205, DOI 10.3233/AO-2008-0057; Boeker M, 2013, LECT NOTES INFORM, P1783; Boeker M, 2012, CEUR WORKSHOP P, V897; Boeker M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061425; Chidamber S., 1994, IEEE T SOFTWARE ENG, P467, DOI DOI 10.1109/32.295895; Corcho O., 2004, 1 IFIP C ART INT APP, P369, DOI DOI 10.1007/1-4020-8151-0_32; d'Aquin M, 2011, APPL ONTOL, V6, P165, DOI 10.3233/AO-2011-0093; David J, 2008, LECT NOTES COMPUT SC, V5318, P245, DOI 10.1007/978-3-540-88564-1_16; Sanchez-Vera MD, 2012, KNOWL-BASED SYST, V33, P152, DOI 10.1016/j.knosys.2012.03.010; Dellschaft K, 2006, LECT NOTES COMPUT SC, V4273, P228; Duque-Ramos A, 2013, EXPERT SYST APPL, V40, P2696, DOI 10.1016/j.eswa.2012.11.004; Duque-Ramos A, 2011, J RES PRACT INF TECH, V43, P159; Euzenat J, 2009, NEON LIFECYCLE SUPPO; Everitt B., 2011, INTRO APPL MULTIVARI, DOI [10.1007/978-1-4419-9650-3, DOI 10.1007/978-1-4419-9650-3]; Evermann J, 2010, INFORM SYST, V35, P391, DOI 10.1016/j.is.2008.09.001; Fox MS, 1997, MODELING; Fox MS, 1995, IJCAI 95; Gangemi A, 2006, LECT NOTES COMPUT SC, V4011, P140; Grewe N, 2012, 4 WORKHS ONT BIOM LI; Gruninger M, 1994, DESIGN EVALUATION ON; Guarino N, 2003, IN HAND I S, P151; Haining Yao, 2005, Journal of Computer Sciences, V1, P107, DOI 10.3844/jcssp.2005.107.113; Hepp M, 2008, LECT NOTES ARTIF INT, V5268, P329, DOI 10.1007/978-3-540-87696-0_29; International Organization for Standardization (ISO), 2005, 250002005 ISOIEC; LI W, 1993, J SYST SOFTWARE, V23, P111, DOI 10.1016/0164-1212(93)90077-B; Lopez MF, 1999, IEEE INTELL SYST APP, V14, P37, DOI 10.1109/5254.747904; Lozano-Tello A, 2004, J DATABASE MANAGE, V15, P1, DOI 10.4018/jdm.2004040101; Maedche A, 2002, LECT NOTES ARTIF INT, V2473, P251; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Neuhaus F, 2013, APPL ONTOL, V8, P179, DOI 10.3233/AO-130125; Obrst L., 2007, EVALUATION ONTOLOGIE, P139, DOI DOI 10.1007/978-0-387-48438-9_8; Rogers JE, 2006, METHOD INFORM MED, V45, P267; Sleeman D, 2006, WORKSH EV ONT; Stvilia Besiki, 2007, First Monday, V12; Tartir S, 2007, ICSC 2007: INTERNATIONAL CONFERENCE ON SEMANTIC COMPUTING, PROCEEDINGS, P185, DOI 10.1109/ICSC.2007.19; Tian Y, 2012, EXPERT SYST APPL, V39, P12522, DOI 10.1016/j.eswa.2012.04.061; Uschold M, 1996, KNOWL ENG REV, V11, P93, DOI 10.1017/S0269888900007797; Vrandecic D, 2010, THESIS I APPL INFORM; Vrandecic D, 2007, LECT NOTES COMPUT SC, V4519, P311	41	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104463	10.1371/journal.pone.0104463	http://dx.doi.org/10.1371/journal.pone.0104463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148262	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230600015
J	Hwang, CC; Nieh, S; Lai, CH; Tsai, CS; Chang, LC; Hua, CC; Chi, WY; Chien, HP; Wang, CW; Chan, SC; Hsieh, TY; Chen, JR				Hwang, Cheng-Cheng; Nieh, Shin; Lai, Chien-Hong; Tsai, Chien-Sheng; Chang, Liang-Che; Hua, Chung-Ching; Chi, Wen-Ying; Chien, Hui-Ping; Wang, Chih-Wei; Chan, Siu-Cheung; Hsieh, Tsan-Yu; Chen, Jim-Ray			A Retrospective Review of the Prognostic Value of ALDH-1, Bmi-1 and Nanog Stem Cell Markers in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; CHEMORADIOTHERAPY; HETEROGENEITY; METASTASIS; SURVIVAL; TARGET; BREAST	Stem cell markers are upregulated in various cancers and have potential as prognostic indicators. The objective of this study was to determine the expression of three stem cell markers, aldehyde dehydrogenase 1 (ALDH-1), B cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1), and Nanog, in esophageal squamous cell carcinoma (ESCC) tissues. Immunohistochemistry was used to measure the expression of ALDH-1, Bmi-1, and Nanog in ESCC tissues from 41 patients who received pre-operative chemoradiation. We evaluated the relationship between expression of these markers, and clinicopathological features, tumor regression grade (TRG), and 5-year overall survival (OS). There were no significant associations of ALDH-1 or Bmi-1 expression with age, gender, clinical stage, and treatments (p>0.05). However, patients with Nanog-positive tumors were significantly older than those whose tumors were Nanog-negative (p = 0.033). TRG after treatment was significantly associated with expression of ALDH-1 (p = 0.001), Bmi-1 (p = 0.004), and Nanog (p<0.001). Although OS was significantly better in patients with low TRGs (p = 0.001), there were no significant correlations between ALDH-1, Bmi-1, or Nanog with OS. Expression of ALDH-1, Bmi-1, and Nanog correlated with TRG, but not OS. Further large studies are necessary to fully elucidate the prognostic value of these stem cell markers for ESCC patients.	[Hwang, Cheng-Cheng; Chang, Liang-Che; Chi, Wen-Ying; Chien, Hui-Ping; Hsieh, Tsan-Yu; Chen, Jim-Ray] Chang Gung Mem Hosp, Dept Pathol, Keelung, Taiwan; [Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Nieh, Shin] Natl Def Med Ctr, Grad Inst Pathol, Taipei, Taiwan; [Nieh, Shin] Tri Serv Gen Hosp, Taipei, Taiwan; [Lai, Chien-Hong] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Keelung, Taiwan; [Tsai, Chien-Sheng] Chang Gung Mem Hosp, Dept Radiat Oncol, Keelung, Taiwan; [Hua, Chung-Ching] Chang Gung Mem Hosp, Div Pulm Crit Care & Sleep Med, Keelung, Taiwan; [Chan, Siu-Cheung] Chang Gung Mem Hosp, Dept Diagnost Radiol, Keelung, Taiwan; [Wang, Chih-Wei] Chang Gung Mem Hosp, Dept Anat Pathol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, JR (corresponding author), Chang Gung Mem Hosp, Dept Pathol, Keelung, Taiwan.	rrooyyaall@yahoo.com			Chang Gung Memorial Hospital, Keelung, Taiwan [CMRPG290391]	Chang Gung Memorial Hospital, Keelung, Taiwan(Chang Gung Memorial Hospital)	This study was supported by grant CMRPG290391 to C.-C. Hwang from Chang Gung Memorial Hospital, Keelung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Cao LX, 2011, J CELL BIOCHEM, V112, P2729, DOI 10.1002/jcb.23234; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Choy B, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-146; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Du YM, 2012, J CANCER RES CLIN, V138, P1759, DOI 10.1007/s00432-012-1253-8; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Gore RM, 1997, RADIOL CLIN N AM, V35, P243; Hang D, 2012, DIS ESOPHAGUS, V25, P638, DOI 10.1111/j.1442-2050.2011.01298.x; He XT, 2009, WORLD J GASTROENTERO, V15, P2389, DOI 10.3748/wjg.15.2389; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KASTAN MB, 1990, BLOOD, V75, P1947; Kelsen DP, 2008, PRINCIPLES PRACTICE; Li SH, 2012, J THORAC CARDIOV SUR, V144, P1352, DOI 10.1016/j.jtcvs.2012.06.049; Lin Y, 2013, J EPIDEMIOL; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056141; Liu WL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-467; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Nomura M, 2012, INT J RADIAT ONCOL, V82, P946, DOI 10.1016/j.ijrobp.2010.12.045; Oze I, 2012, JPN J CLIN ONCOL, V42, P63, DOI 10.1093/jjco/hyr170; Shimada H, 2003, SURGERY, V133, P24, DOI 10.1067/msy.2003.31; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Sudo T, 2012, ANN SURG ONCOL; Tu SM, 2002, LANCET ONCOL, V3, P508, DOI 10.1016/S1470-2045(02)00820-3; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wang Y, 2012, DIS ESOPHAGUS, V25, P560, DOI 10.1111/j.1442-2050.2011.01279.x; Wieder HA, 2004, J CLIN ONCOL, V22, P900, DOI 10.1200/JCO.2004.07.122	32	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105676	10.1371/journal.pone.0105676	http://dx.doi.org/10.1371/journal.pone.0105676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148045	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600067
J	Ianiri, G; Abhyankar, R; Kihara, A; Idnurm, A				Ianiri, Giuseppe; Abhyankar, Ritika; Kihara, Akio; Idnurm, Alexander			Phs1 and the Synthesis of Very Long Chain Fatty Acids Are Required for Ballistospore Formation	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-DIVISION; GENE-FUNCTION; ARABIDOPSIS; GENOME; YEASTS; DIFFERENTIATION; TRANSFORMATION; PROLIFERATION; PASTICCINO2	The production and dissemination of spores by members of the fungal kingdom is a major reason for the success of this eukaryotic lineage in colonizing most terrestrial ecosystems. Ballistospores are a type of spore produced by basidiomycete fungi, such as the mushrooms and plant pathogenic rusts. These spores are forcefully discharged through a unique liquid-drop fusion mechanism, enabling the aerosolization of these particles that can contribute to plant disease and human allergies. The genes responsible for this process are unknown due to technical challenges in studying many of the fungi that produce ballistospores. Here, we applied newly-developed techniques in a forward genetic screen to identify genes required for ballistospore formation or function in a tractable red yeast, a species of Sporobolomyces. One strain bearing a mutation in the PHS1 gene was identified as a mirror mutant. PHS1 encodes 3-hydroxyacyl-CoA dehydratase required for the third step in very long chain fatty acid biosynthesis. The Sporobolomyces PHS1 gene complements the essential functions of a S. cerevisiae phs1 mutant. The Sporobolomyces phs1 mutant strain has less dehydratase activity and a reduction in very long chain fatty acids compared to wild type. The mutant strain also exhibits sensitivity to cell wall stress agents and loss of shooting due to a delay in ballistospore formation, indicating that the role of Phs1 in spore dissemination may be primarily in cellular integrity.	[Ianiri, Giuseppe; Abhyankar, Ritika; Idnurm, Alexander] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; [Ianiri, Giuseppe] Univ Molise, Fac Agr, Dipartimento Agr Ambiente & Alimenti, Campobasso, Italy; [Abhyankar, Ritika] Pembroke Hill Sch, Kansas City, MO USA; [Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido 060, Japan; [Idnurm, Alexander] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia	University of Missouri System; University of Missouri Kansas City; University of Molise; Hokkaido University; University of Melbourne	Idnurm, A (corresponding author), Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA.	alexander.idnurm@unimelb.edu.au	Idnurm, Alexander/GPX-9055-2022; Idnurm, Alexander/AAC-9614-2019; Idnurm, Alexander/K-8558-2013; KIHARA, AKIO/A-3802-2012	Idnurm, Alexander/0000-0001-5995-7040; Idnurm, Alexander/0000-0001-5995-7040; KIHARA, AKIO/0000-0001-5889-0788; Ianiri, Giuseppe/0000-0002-3278-8678	Japan Society for the Promotion of Science (JSPS) [23370057]; University of Missouri Research Board, National Science Foundation [MCB-0920581]; National Institutes of Health (NIAID) [R21 AI094364]; Grants-in-Aid for Scientific Research [26251010] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094364] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Missouri Research Board, National Science Foundation; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a Grant-in-Aid for Scientific Research (B) (23370057) from the Japan Society for the Promotion of Science (JSPS), the University of Missouri Research Board, National Science Foundation (grant MCB-0920581) and National Institutes of Health (NIAID grant R21 AI094364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott EP, 2013, APPL MICROBIOL BIOT, V97, P283, DOI 10.1007/s00253-012-4561-7; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Bellec Y, 2002, PLANT J, V32, P713, DOI 10.1046/j.1365-313X.2002.01456.x; Boger P, 2000, PEST MANAG SCI, V56, P497; Brachmann CB, 1998, YEAST, V14, P115; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Buller AHR, 1909, RES FUNGI, VI; Buller ArthurHenryReginald., 1933, RES FUNGI, V5; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Faure JD, 1998, DEVELOPMENT, V125, P909; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; GREGORY PH, 1957, NATURE, V180, P330, DOI 10.1038/180330a0; Haberer G, 2002, DEV GENES EVOL, V212, P542, DOI 10.1007/s00427-002-0273-9; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Horner WE, 1998, ALLERGY, V53, P1114, DOI 10.1111/j.1398-9995.1998.tb03830.x; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Ianiri G, 2011, FUNGAL GENET BIOL, V48, P685, DOI 10.1016/j.fgb.2011.03.003; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Ingold C., 1971, MYCOLOGIA; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lin XP, 2014, FEMS YEAST RES, V14, P547, DOI 10.1111/1567-1364.12140; Liu YB, 2013, APPL MICROBIOL BIOT, V97, P719, DOI 10.1007/s00253-012-4223-9; MIOSGA T, 1994, YEAST, V10, P1481, DOI 10.1002/yea.320101112; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Noblin X, 2009, J EXP BIOL, V212, P2835, DOI 10.1242/jeb.029975; Nobusawa T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001531; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Pashley CH, 2012, FUNGAL BIOL-UK, V116, P214, DOI 10.1016/j.funbio.2011.11.004; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pringle A, 2005, MYCOLOGIA, V97, P866, DOI 10.3852/mycologia.97.4.866; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Stolze-Rybczynski JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004163; Takahashi H, 2001, Z NATURFORSCH C, V56, P781; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WEBSTER J, 1988, T BRIT MYCOL SOC, V91, P193, DOI 10.1016/S0007-1536(88)80205-5; YAMAZAKI M, 1983, J GEN APPL MICROBIOL, V29, P115, DOI 10.2323/jgam.29.115; Yazawa T, 2013, FEBS LETT, V587, P804, DOI 10.1016/j.febslet.2013.02.006; Yu L, 2006, MOL BIOL CELL, V17, P4736, DOI 10.1091/mbc.E06-04-0368	43	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105147	10.1371/journal.pone.0105147	http://dx.doi.org/10.1371/journal.pone.0105147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148260	Green Published, gold			2022-12-27	WOS:000341230600033
J	Lechtermann, C; Hauffa, BP; Herrmann, R; Schuendeln, MM; Gellhaus, A; Schmidt, M; Grasemann, C				Lechtermann, Carolin; Hauffa, Berthold P.; Herrmann, Ralf; Schuendeln, Michael M.; Gellhaus, Alexandra; Schmidt, Markus; Grasemann, Corinna			Maternal Vitamin D Status in Preeclampsia: Seasonal Changes Are Not Influenced by Placental Gene Expression of Vitamin D Metabolizing Enzymes	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; 1,25-DIHYDROXYVITAMIN-D; CALCIUM; METAANALYSIS; ASSOCIATION; CYP27B1	Preeclampsia, a hypertensive disorder in pregnancy develops in 2-8% of pregnancies worldwide. Winter season and vitamin D deficiency have been associated with its onset. Objective: To investigate the influence of season on maternal vitamin D status and placental vitamin D metabolism. Methods: 25-OH vitamin D and 1,25-(OH)(2) vitamin D were measured in maternal serum obtained during the winter or summer months from 63 pregnant women at delivery (43 healthy, 20 preeclampsia). In a subgroup, mRNA expression of CYP24A1 (24-hydroxylase), CYP27B1 (1 alpha-hydroxylase) and VDR (vitamin D receptor) were quantified by real time PCR in placental samples of 14 women with normal pregnancies and 13 with preeclampsia. Results: In patients with preeclampsia,25-OH vitamin D levels were lower, but differed significantly from controls only in summer (18.21 +/- 17.1 vs 49.2 +/- 29.2 ng/mL, P<0.001), whereas 1,25-(OH)(2) vitamin D levels were significantly lower only in winter (291 +/- 217 vs 612.3 +/- 455 pmol/mL, P<0.05). A two-factorial analysis of variance produced a statistically significant model (P<0.0001) with an effect of season (P<0.01) and preeclampsia (P = 0.01) on maternal 25-OH vitamin D levels, as well as a significant interaction between the two variables (P = 0.02). Placental gene expression of CYP24A1, CYP27B1, and VDR did not differ between groups or seasons. A negative correlation between placental gene expression of CYP24A1 and CYP27B1 was observed only in healthy controls (r = -0.81, P<0.0001). Summary: Patients with preeclampsia displayed lower vitamin D serum levels in response to seasonal changes. The regulation of placental CYP24A1, but not of the VDR or CYP27B1 might be altered in preeclampsia.	[Lechtermann, Carolin; Hauffa, Berthold P.; Herrmann, Ralf; Grasemann, Corinna] Univ Klinikum Essen, Kinderklin 2, Dept Pediat Endocrinol & Diabetol, Essen, Germany; [Lechtermann, Carolin; Hauffa, Berthold P.; Herrmann, Ralf; Schuendeln, Michael M.; Gellhaus, Alexandra; Grasemann, Corinna] Univ Duisburg Essen, Essen, Germany; [Herrmann, Ralf] Univ Klinikum Essen, Kinderklin 1, Dept Neonatol, Essen, Germany; [Schuendeln, Michael M.] Univ Klinikum Essen, Kinderklin 3, Dept Pediat Oncol & Hematol, Essen, Germany; [Gellhaus, Alexandra] Univ Klinikum Essen, Inst Mol Biol, Essen, Germany; [Schmidt, Markus] Klinikum Duisburg, Dept Gynecol & Obstet, Duisburg, Germany; [Schmidt, Markus] Univ Duisburg Essen, Duisburg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Grasemann, C (corresponding author), Univ Klinikum Essen, Kinderklin 2, Dept Pediat Endocrinol & Diabetol, Essen, Germany.	corinna.grasemann@uk-essen.de	Grasemann, Corinna/AAG-3861-2021; Schündeln, Michael M/W-3455-2018	Schündeln, Michael M/0000-0001-7495-9060; Grasemann, Corinna/0000-0003-1793-4603	IFORES stipend of the 'Faculty of Medicine, University of Duisburg-Essen'	IFORES stipend of the 'Faculty of Medicine, University of Duisburg-Essen'	CG and MS were supported by an IFORES stipend of the 'Faculty of Medicine, University of Duisburg-Essen'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; AUGUST P, 1992, AM J OBSTET GYNECOL, V166, P1295, DOI 10.1016/S0002-9378(11)90625-5; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Diaz L, 2002, J CLIN ENDOCR METAB, V87, P3876, DOI 10.1210/jc.87.8.3876; Fischer D, 2007, CLIN EXP OBSTET GYN, V34, P80; FROLICH A, 1992, EUR J OBSTET GYN R B, V47, P25, DOI 10.1016/0028-2243(92)90210-P; Gellhaus A, 2006, MOL HUM REPROD, V12, P389, DOI 10.1093/molehr/gal044; Halhali A, 2000, J CLIN ENDOCR METAB, V85, P1828, DOI 10.1210/jc.85.5.1828; Halhali A, 2013, J STEROID BIOCH MOL; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; LALAU JD, 1993, AM J HYPERTENS, V6, P522, DOI 10.1093/ajh/6.6.522; Liu NQ, 2013, ENDOCRINOLOGY, V154, P2270, DOI 10.1210/en.2012-2270; Ma R, 2012, AM J PHYSIOL-ENDOC M, V303, pE928, DOI 10.1152/ajpendo.00279.2012; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; SEKI K, 1991, AM J OBSTET GYNECOL, V164, P1248, DOI 10.1016/0002-9378(91)90694-M; Sharma S, 2009, BJOG-INT J OBSTET GY, V116, P1678, DOI 10.1111/j.1471-0528.2009.02285.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Tabesh M, 2013, J CLIN ENDOCR METAB, V98, P3165, DOI 10.1210/jc.2013-1257; TePoel MRW, 2011, J REPROD IMMUNOL, V89, P140, DOI 10.1016/j.jri.2011.01.020; Weisse K, 2013, ALLERGY, V68, P220, DOI 10.1111/all.12081	24	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105558	10.1371/journal.pone.0105558	http://dx.doi.org/10.1371/journal.pone.0105558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148115	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600056
J	Lee, SW; Geller, JT; Torok, T; Wu, CH; Singer, M; Reid, FC; Tarjan, DR; Hazen, TC; Arkin, AP; Hillson, NJ				Lee, Sangwon; Geller, Jil T.; Torok, Tamas; Wu, Cindy H.; Singer, Mary; Reid, Francine C.; Tarjan, Daniel R.; Hazen, Terry C.; Arkin, Adam P.; Hillson, Nathan J.			Characterization of Wastewater Treatment Plant Microbial Communities and the Effects of Carbon Sources on Diversity in Laboratory Models	PLOS ONE			English	Article							SYNTHETIC-BIOLOGY; SUBSTRATE-SPECIFICITY; PSEUDOMONAS-PUTIDA; BACTERIA; GENE; DEHALOGENASE; BIOCHEMISTRY; DATABASE; INSIGHT; ENZYMES	We are developing a laboratory-scale model to improve our understanding and capacity to assess the biological risks of genetically engineered bacteria and their genetic elements in the natural environment. Our hypothetical scenario concerns an industrial bioreactor failure resulting in the introduction of genetically engineered bacteria to a downstream municipal wastewater treatment plant (MWWTP). As the first step towards developing a model for this scenario, we sampled microbial communities from the aeration basin of a MWWTP at three seasonal time points. Having established a baseline for community composition, we investigated how the community changed when propagated in the laboratory, including cell culture media conditions that could provide selective pressure in future studies. Specifically, using PhyloChip 16S-rRNA-gene targeting microarrays, we compared the compositions of sampled communities to those of inocula propagated in the laboratory in simulated wastewater conditionally amended with various carbon sources (glucose, chloroacetate, D-threonine) or the ionic liquid 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl). Proteobacteria, Bacteroidetes, and Actinobacteria were predominant in both aeration basin and laboratory-cultured communities. Laboratory-cultured communities were enriched in gamma-Proteobacteria. Enterobacteriaceae, and Aeromonadaceae were enriched by glucose, Pseudomonadaceae by chloroacetate and D-threonine, and Burkholderiacea by high (50 mM) concentrations of chloroacetate. Microbial communities cultured with chloroacetate and D-threonine were more similar to sampled field communities than those cultured with glucose or [C2mim]Cl. Although observed relative richness in operational taxonomic units (OTUs) was lower for laboratory cultures than for field communities, both flask and reactor systems supported phylogenetically diverse communities. These results importantly provide a foundation for laboratory models of industrial bioreactor failure scenarios.	[Lee, Sangwon; Tarjan, Daniel R.; Arkin, Adam P.; Hillson, Nathan J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Geller, Jil T.; Torok, Tamas; Wu, Cindy H.; Singer, Mary; Reid, Francine C.; Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hillson, NJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	njhillson@lbl.gov	Hazen, Terry C/C-1076-2012; Arkin, Adam/M-9941-2019; Torok, Tamas/E-9450-2015; Arkin, Adam P/A-6751-2008	Hazen, Terry C/0000-0002-2536-9993; Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931	Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy(United States Department of Energy (DOE))	This work, performed in part at the Joint BioEnergy Institute, was supported by the Office of Science, Office of Biological and Environmental Research, of the United States Department of Energy (http://science.energy.gov/ber/) under Contract No. DE-AC02-05CH11231 to Lawrence Berkeley National Laboratory (to TCH, APA, and NJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Bokinsky G, 2011, P NATL ACAD SCI USA, V108, P19949, DOI 10.1073/pnas.1106958108; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Dana GV, 2012, NATURE, V483, P29, DOI 10.1038/483029a; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2005, FEMS MICROBIOL LETT, V245, P271, DOI 10.1016/j.femsle.2005.03.016; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Falk MW, 2013, WATER RES, V47, P7109, DOI 10.1016/j.watres.2013.08.040; Falk MW, 2009, WATER RES, V43, P842, DOI 10.1016/j.watres.2008.11.021; FETZNER S, 1994, MICROBIOL REV, V58, P641, DOI 10.1128/MMBR.58.4.641-685.1994; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Handley KM, 2012, FEMS MICROBIOL ECOL, V81, P188, DOI 10.1111/j.1574-6941.2012.01363.x; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hisano T, 1996, J BIOL CHEM, V271, P20322, DOI 10.1074/jbc.271.34.20322; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; JANSSEN DB, 1994, ANNU REV MICROBIOL, V48, P163, DOI 10.1146/annurev.mi.48.100194.001115; KAWASAKI H, 1994, BIOSCI BIOTECH BIOCH, V58, P160, DOI 10.1271/bbb.58.160; Kimura T, 1997, J AM CHEM SOC, V119, P11734, DOI 10.1021/ja9720422; Kurihara T, 2000, J MOL CATAL B-ENZYM, V10, P57, DOI 10.1016/S1381-1177(00)00108-9; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu JQ, 2000, APPL MICROBIOL BIOT, V54, P44, DOI 10.1007/s002539900301; McCune B, 2002, ANAL ECOLOGICAL COMM, DOI [10.1016/S0022-0981(03)00091-1, DOI 10.1016/S0022-0981(03)00091-1]; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Mielke PW, 2001, PERMUTATION METHODS, P9; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; Nakayama T, 2012, CHEM-EUR J, V18, P8392, DOI 10.1002/chem.201103369; Parnell JJ, 2010, BIODEGRADATION, V21, P147, DOI 10.1007/s10532-009-9289-4; Parsley LC, 2010, APPL ENVIRON MICROB, V76, P3753, DOI 10.1128/AEM.03080-09; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Probst AJ, 2013, ISME J, V7, P635, DOI 10.1038/ismej.2012.133; Ruegg TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4490; Secher C, 2013, BIODEGRADATION, V24, P549, DOI 10.1007/s10532-013-9625-6; Seo SW, 2013, BIOTECHNOL ADV, V31, P811, DOI 10.1016/j.biotechadv.2013.03.012; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Szczepanowski R, 2008, J BIOTECHNOL, V136, P54, DOI 10.1016/j.jbiotec.2008.03.020; Vyazmensky M, 1998, ENZYME MICROB TECH, V22, P323, DOI 10.1016/S0141-0229(97)00181-6; Wakasa Y, 2013, BIOTECHNOL J, V8, P1133, DOI 10.1002/biot.201300065; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; ZIMMERMAN GM, 1985, ECOLOGY, V66, P606, DOI 10.2307/1940409	41	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105689	10.1371/journal.pone.0105689	http://dx.doi.org/10.1371/journal.pone.0105689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148472	Green Published, gold			2022-12-27	WOS:000341230600070
J	Wang, G; Liu, J; Yang, N; Gao, X; Fan, H; Xu, Y; Yang, WY				Wang, Guang; Liu, Jia; Yang, Ning; Gao, Xia; Fan, Hui; Xu, Yuan; Yang, Wenying			MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HOMEOSTASIS MODEL ASSESSMENT; BLOOD-GLUCOSE FLUCTUATION; POLYCYSTIC-OVARY-SYNDROME; LIFE-STYLE INTERVENTION; INSULIN-RESISTANCE; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; GLYCEMIC CONTROL; LIPID PROFILE	Background: The data of MARCH (Metformin and AcaRbose in Chinese as the initial Hypoglycaemic treatment) trial demonstrated that acarbose and metformin have similar efficacy as initial therapy for hemoglobin A1c (HbA1c) reduction in Chinese patients with newly diagnosed type 2 diabetes. We investigated whether the therapeutic efficacy was diversified under different body mass index (BMI) status. Methods: All 784 subjects were divided into normal-weight group (BMI<24 kg/m(2)), overweight group (BMI 24-28 kg/m(2)) and obese group (BMI >= 28 kg/m(2)). Patients were assigned to 48 weeks of therapy with acarbose or metformin, respectively. The clinical trial registry number was ChiCTR-TRC-08000231. Results: The reduction of HbA1c levels and the proportion of patients with HbA1c of 6.5% or less were similar in the three groups after acarbose and metformin treatment. In overweight group, fasting blood glucose (FBG) after metformin treatment showed greater decline compared to acarbose group at 48 weeks [-1.73 (-1.99 to -1.46) vs. -1.37 (-1.61 to -1.12), P<0.05), however the decrease of 2 h post-challenge blood glucose (PBG) after acarbose treatment at 48 weeks was bigger compared to metformin group [-3.34 (-3.83 to -2.84) vs. -2.35 (-2.85 to -1.85), P<0.01]. Both acarbose and metformin treatment resulted in a significant decrease in waist circumference, hip circumference, weight and BMI in the three groups (all P<0.05). Conclusion: Acarbose and metformin decreased HbA1c levels similarly regardless of BMI status of Chinese type 2 diabetic patients. Acarbose and metformin resulted in a significant and modest improvement of anthropometric parametres in different BMI status. Thus, acarbose treatment may contribute a similar effect on plasma glucose control compared to metformin, even in obesity patients.	[Wang, Guang; Liu, Jia; Yang, Ning; Gao, Xia; Fan, Hui; Xu, Yuan] Capital Med Univ, Beijing Chaoyang Hosp Affiliated, Dept Endocrinol, Beijing, Peoples R China; [Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China	Capital Medical University; China-Japan Friendship Hospital	Xu, Y (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp Affiliated, Dept Endocrinol, Beijing, Peoples R China.	xuyuan3200@126.com; ywying_1010@163.com			Major National Basic Research Program of P. R. China [2011CB503904]; Chinese National Natural Science Foundation [81270369, 81070244, 30770873]; Beijing Natural Science Foundation [1142001]; Bayer Healthcare (China); Double Crane Phama	Major National Basic Research Program of P. R. China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Bayer Healthcare (China); Double Crane Phama	This work was supported by grants from the Major National Basic Research Program of P. R. China (No. 2011CB503904), the Chinese National Natural Science Foundation (No. 81270369, 81070244, 30770873), the Beijing Natural Science Foundation (No. 1142001) to Guang Wang, and the funding of Bayer Healthcare (China) and Double Crane Phama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghahosseini M, 2010, ARCH GYNECOL OBSTET, V282, P691, DOI 10.1007/s00404-010-1579-x; Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6; Azuma K, 2006, BIOCHEM BIOPH RES CO, V345, P688, DOI 10.1016/j.bbrc.2006.04.090; Bermudez V, 2008, AM J THER, V15, P409, DOI 10.1097/MJT.0b013e318160b909; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Fontbonne A, 1996, DIABETES CARE, V19, P920, DOI 10.2337/diacare.19.9.920; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Freeman JS, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.05.2672; Glueck CJ, 2001, METABOLISM, V50, P856, DOI 10.1053/meta.2001.24192; Grundy SM, 2013, J CLIN LIPIDOL, V7, P561, DOI 10.1016/j.jacl.2013.10.001; Hanefeld M, 2004, EUR HEART J, V25, P10, DOI 10.1016/S0195-668X(03)00468-8; Hanefeld M, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-20; He HB, 2012, J HYPERTENS, V30, P1430, DOI 10.1097/HJH.0b013e328353e249; Jensen MD, 2007, METABOLISM, V56, P68, DOI 10.1016/j.metabol.2006.08.022; Kaiser T, 2004, DIABETOLOGIA, V47, P575, DOI 10.1007/s00125-003-1318-y; Karamanos B, 2011, CURR MED RES OPIN, V27, P303, DOI 10.1185/03007995.2010.542081; Katsuki A, 2001, DIABETES CARE, V24, P362, DOI 10.2337/diacare.24.2.362; Kim SH, 2013, J CLIN ENDOCR METAB, V98, pE1716, DOI 10.1210/jc.2013-1166; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kohjima M, 2008, INT J MOL MED, V21, P507; Lamanna C, 2011, DIABETES OBES METAB, V13, P221, DOI 10.1111/j.1463-1326.2010.01349.x; Mannucci E, 2001, DIABETES CARE, V24, P489, DOI 10.2337/diacare.24.3.489; Meneghini LF, 2011, J CLIN ENDOCR METAB, V96, P3337, DOI 10.1210/jc.2011-1074; Miller M, 2008, AM J CARDIOL, V101, P1003, DOI 10.1016/j.amjcard.2007.11.046; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Monami M, 2012, ADV THER, V29, P736, DOI 10.1007/s12325-012-0045-5; Quintero-Castillo Daimarys, 2010, Endocrinol Nutr, V57, P262, DOI 10.1016/j.endonu.2010.04.001; Rosenbaum P, 2002, BRAZ J MED BIOL RES, V35, P877, DOI 10.1590/S0100-879X2002000800004; Salman ZK, 2013, EUR J PHARMACOL, V714, P448, DOI 10.1016/j.ejphar.2013.07.002; Uehara MH, 2001, DIABETES OBES METAB, V3, P319, DOI 10.1046/j.1463-1326.2001.00136.x; Verma S, 2000, J HYPERTENS, V18, P1445, DOI 10.1097/00004872-200018100-00012; Wenying Y, 2014, LANCET DIABETES ENDO, V2, P46; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yangfeng WU BZ, 2002, CHINESE J EPIDEMIOLO, V23, P5; Zhai J, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099788; Zhang W, 2013, CARDIOLOGY, V124, P11, DOI 10.1159/000345436; Zheng Z, 2012, DIABETES, V61, P217, DOI 10.2337/db11-0416	37	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105698	10.1371/journal.pone.0105698	http://dx.doi.org/10.1371/journal.pone.0105698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148570	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600071
J	Andraud, M; Casas, M; Pavio, N; Rose, N				Andraud, Mathieu; Casas, Maribel; Pavio, Nicole; Rose, Nicolas			Early-Life Hepatitis E Infection in Pigs: The Importance of Maternally-Derived Antibodies	PLOS ONE			English	Article							CLASSICAL SWINE FEVER; E VIRUS-INFECTION; BAYESIAN-ANALYSIS; VACCINE RESPONSES; IMMUNE-RESPONSE; EPIDEMIC MODELS; TRANSMISSION; PROTECTION; ANIMALS; INTERFERENCE	Passive immunity (PI), acquired through colostrum intake, is essential for piglet protection against pathogens. Maternally-derived antibodies (MDAs) can decrease the transmission of pathogens between individuals by reducing shedding from infected animals and/or susceptibility of naive animals. Only a limited number of studies, however, have been carried out to quantify the level of protection conferred by PI in terms of transmission. In the present study, an original modeling framework was designed to estimate parameters governing the transmission of infectious agents in the presence and absence of PI. This epidemiological model accounts for the distribution of PI duration and two different forces of infection depending on the serological status of animals after colostrum intake. A Bayesian approach (Metropolis-Hastings algorithm) was used for parameter estimation. The impact of PI on hepatitis E virus transmission in piglets was investigated using longitudinal serological data from six pig farms. A strong impact of PI was highlighted, the efficiency of transmission being on average 13 times lower in piglets with maternally-derived antibodies than in fully susceptible animals (range: 5-21). Median infection-free survival ages, based on herd-specific estimates, ranged between 8.7 and 13.8 weeks in all but one herd. Indeed, this herd exhibited a different profile with a relatively low prevalence of infected pigs (50% at slaughter age) despite the similar proportions of passively immune individuals after colostrum intake. These results suggest that the age at HEV infection is not strictly dependent upon the proportion of piglets with PI but is also linked to farm-specific husbandry (mingling of piglets after weaning) and hygiene practices. The original methodology developed here, using population-based longitudinal serological data, was able to demonstrate the relative impact of MDAs on the transmission of infectious agents.	[Andraud, Mathieu; Rose, Nicolas] Anses, Pig Epidemiol & Welf Unit, Lab Ploufragan Plouzane, Ploufragan, France; [Andraud, Mathieu; Rose, Nicolas] Univ Europeenne Bretagne, Rennes, France; [Pavio, Nicole] Anses, UMR Virol 1161, Lab Sante Anim, Maisons Alfort, France; [Pavio, Nicole] INRA, UMR Virol 1161, Maisons Alfort, France; [Pavio, Nicole] Univ Paris Est, UMR Virol 1161, Ecole Natl Vet Alfort, Maisons Alfort, France; [Casas, Maribel] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Casas, Maribel] Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ploufragan-Plouzane Niort Laboratory; Universite de Bretagne Occidentale; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA); Pompeu Fabra University; IRTA	Andraud, M (corresponding author), Anses, Pig Epidemiol & Welf Unit, Lab Ploufragan Plouzane, Ploufragan, France.	mathieu.andraud@anses.fr	Casas, Maribel/T-5643-2017; Andraud, Mathieu/AAD-5844-2022	Casas, Maribel/0000-0002-2112-6740; Andraud, Mathieu/0000-0003-2891-2901	French Research Agency (ANR) as part of the research project called "HEVECODYN'' [ANR-10-CESA-0010]	French Research Agency (ANR) as part of the research project called "HEVECODYN''(French National Research Agency (ANR))	This study was funded by the French Research Agency (ANR) as part of the research project called "HEVECODYN'' (ANR-10-CESA-0010; http://www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2[CODE] = ANR-10-CESA-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson M, 2013, VACCINE, V31, P500, DOI 10.1016/j.vaccine.2012.11.023; ANDERSON RM, 2004, INFECT DIS HUMANS DY; Andraud M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-102; Backer JA, 2012, EPIDEMICS-NETH, V4, P86, DOI 10.1016/j.epidem.2012.02.002; Barnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12; Bouma A, 1997, VACCINE, V15, P287, DOI 10.1016/S0264-410X(96)00179-X; Brinkhof MWG, 2013, VACCINE, V31, P1490, DOI 10.1016/j.vaccine.2013.01.011; Britton T, 2011, SCAND J STAT, V38, P578, DOI 10.1111/j.1467-9469.2010.00726.x; Casas M, 2011, VET MICROBIOL, V148, P27, DOI 10.1016/j.vetmic.2010.08.010; Cauchemez S, 2008, J R SOC INTERFACE, V5, P885, DOI 10.1098/rsif.2007.1292; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Courcoul A, 2010, P ROY SOC B-BIOL SCI, V277, P2857, DOI 10.1098/rspb.2010.0575; de Deus N, 2008, VET MICROBIOL, V132, P19, DOI 10.1016/j.vetmic.2008.04.036; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elbers ARW, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-103; Elderd BD, 2013, EPIDEMICS-NETH, V5, P146, DOI 10.1016/j.epidem.2013.07.001; Fernandez-Barredo S, 2006, J VET DIAGN INVEST, V18, P462, DOI 10.1177/104063870601800506; FRANCIS MJ, 1986, RES VET SCI, V41, P33, DOI 10.1016/S0034-5288(18)30568-X; Hassig M, 2007, VET REC, V160, P234, DOI 10.1136/vr.160.7.234; Jewell CP, 2009, BAYESIAN ANAL, V4, P465, DOI 10.1214/09-BA417; Kanai Y, 2010, J MED VIROL, V82, P69, DOI 10.1002/jmv.21647; KITCHING RP, 1995, BRIT VET J, V151, P379, DOI 10.1016/S0007-1935(95)80127-8; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Klinkenberg D, 2002, VACCINE, V20, P3005, DOI 10.1016/S0042-207X(02)00283-X; Lavielle M, 2007, J PHARMACOKINET PHAR, V34, P229, DOI 10.1007/s10928-006-9043-z; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; McBryde ES, 2006, B MATH BIOL, V68, P889, DOI 10.1007/s11538-005-9005-4; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; O'Neill PD, 2002, MATH BIOSCI, V180, P103, DOI 10.1016/S0025-5564(02)00109-8; Pastoret PP, 2007, J COMP PATHOL, V137, pS2, DOI 10.1016/j.jcpa.2007.04.003; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Peralta B, 2009, VET MICROBIOL, V137, P66, DOI 10.1016/j.vetmic.2009.01.006; Pluske J, 2003, WEANING THE PIG: CONCEPTS AND CONSEQUENCES, P15; Pravieux JJ, 2007, J COMP PATHOL, V137, pS32, DOI 10.1016/j.jcpa.2007.04.009; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Rose N, 2007, J COMP PATHOL, V136, P133, DOI 10.1016/j.jcpa.2007.01.006; Rose N, 2011, COMP IMMUNOL MICROB, V34, P419, DOI 10.1016/j.cimid.2011.07.003; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L; Snoeck E, 2010, CLIN PHARMACOL THER, V87, P706, DOI 10.1038/clpt.2010.35; Streftaris G, 2004, P ROY SOC B-BIOL SCI, V271, P1111, DOI 10.1098/rspb.2004.2715; Swain P, 2009, FISH SHELLFISH IMMUN, V27, P89, DOI 10.1016/j.fsi.2009.04.008; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Tomlinson A, 2012, VET IMMUNOL IMMUNOP, V148, P326, DOI 10.1016/j.vetimm.2012.04.024; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Vandeputte J, 2001, AM J VET RES, V62, P1805, DOI 10.2460/ajvr.2001.62.1805; Walachowski S, 2014, EPIDEMIOL INFECT, V142, P1934, DOI 10.1017/S0950268813003063; Ward LA, 1996, J INFECT DIS, V174, P276, DOI 10.1093/infdis/174.2.276	49	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105527	10.1371/journal.pone.0105527	http://dx.doi.org/10.1371/journal.pone.0105527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144763	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100080
J	Gatta, C; Russo, F; Russolillo, MG; Varricchio, E; Paolucci, M; Castaldo, L; Lucini, C; de Girolamo, P; Cozzi, B; Maruccio, L				Gatta, Claudia; Russo, Finizia; Russolillo, Maria Grazia; Varricchio, Ettore; Paolucci, Marina; Castaldo, Luciana; Lucini, Carla; de Girolamo, Paolo; Cozzi, Bruno; Maruccio, Lucianna			The Orexin System in the Enteric Nervous System of the Bottlenose Dolphin (Tursiops truncatus)	PLOS ONE			English	Article							MIGRATING MYOELECTRIC COMPLEX; GASTROINTESTINAL-TRACT; TYPE-2 RECEPTOR; EXPRESSION; RAT; SECRETION; LOCALIZATION; MOTILITY; BRAIN; BLOOD	This study provides a general approach to the presence and possible role of orexins and their receptors in the gut ( three gastric chambers and intestine) of confined environment bottlenose dolphin. The expression of prepro-orexin, orexin A and B and orexin 1 and 2 receptors were investigated by single immunostaining and western blot analysis. The co-localization of vasoactive intestinal peptide and orexin 1 receptor in the enteric nervous system was examined by double immunostaining. Also, orexin A concentration were measured in plasma samples to assess the possible diurnal variation of the plasma level of peptide in this species. Our results showed that the orexin system is widely distributed in bottlenose dolphin enteric nervous system of the all gastrointestinal tract examined. They are very peculiar and partially differs from that of terrestrial mammals. Orexin peptides and prepro-orexin were expressed in the main stomach, pyloric stomach and proximal intestine; while orexin receptors were expressed in the all examined tracts, with the exception of main stomach where found no evidence of orexin 2 receptor. Co-localization of vasoactive intestinal peptide and orexin 1 receptor were more evident in the pyloric stomach and proximal intestine. These data could suggest a possible role of orexin system on the contractility of bottlenose dolphin gastrointestinal districts. Finally, in agreement with several reports, bottlenose dolphin orexin A plasma level was higher in the morning during fasting. Our results emphasize some common features between bottlenose dolphin and terrestrial mammals. Certainly, further functional investigations may help to better explain the role of the orexin system in the energy balance of bottlenose dolphin and the complex interaction between feeding and digestive physiology.	[Gatta, Claudia; Castaldo, Luciana; Lucini, Carla; de Girolamo, Paolo; Maruccio, Lucianna] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, NA, Italy; [Russo, Finizia; Russolillo, Maria Grazia; Varricchio, Ettore; Paolucci, Marina] Univ Sannio, Dept Sci & Technol, Benevento, BN, Italy; [Cozzi, Bruno] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy	University of Naples Federico II; University of Sannio; University of Padua	Russo, F (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, NA, Italy.	finiziarusso@unisannio.it	Cozzi, Bruno/H-9618-2019; Varricchio, Ettore/GQZ-1929-2022; Lucini, Carla/E-6828-2013	Cozzi, Bruno/0000-0002-7531-7040; Varricchio, Ettore/0000-0001-6241-7096; Lucini, Carla/0000-0003-2216-6338; de girolamo, paolo/0000-0003-1557-4763; Paolucci, Marina/0000-0002-1784-3843				Ballarin C, 2011, OPEN NEUROENDOCRINOL, V500, P9; Barreiro ML, 2005, ENDOCRINOLOGY, V146, P5164, DOI 10.1210/en.2005-0455; Barros NB, 2008, ENCY MARINE MAMMALS, P311; Bulbul M, 2010, AUTON NEUROSCI-BASIC, V158, P24, DOI 10.1016/j.autneu.2010.05.009; Bulbul M, 2010, PEPTIDES, V31, P1099, DOI 10.1016/j.peptides.2010.03.007; Chaleek N, 2011, NEUROGASTROENT MOTIL, V24, P94; Dall'Aglio C, 2013, RES VET SCI, V95, P8, DOI 10.1016/j.rvsc.2013.02.001; Dall'Aglio C, 2008, EUR J HISTOCHEM, V52, P229; Dall'Aglio C, 2012, ACTA HISTOCHEM, V114, P74, DOI 10.1016/j.acthis.2011.02.006; Dall'Aglio C, 2009, RES VET SCI, V86, P189, DOI 10.1016/j.rvsc.2008.07.001; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Digby JE, 2006, J ENDOCRINOL, V191, P129, DOI 10.1677/joe.1.06886; Ehrstrom M, 2005, J CLIN ENDOCR METAB, V90, P2370, DOI 10.1210/jc.2004-1408; Facciolo RM, 2011, NEUROTOXICOL TERATOL, V33, P641, DOI 10.1016/j.ntt.2011.09.008; Flemstrom G, 2010, ACTA PHYSIOL, V198, P373, DOI 10.1111/j.1748-1716.2009.02067.x; Guimaraes JP, 2012, MICROSC RES TECHNIQ, V75, P737, DOI 10.1002/jemt.21119; HARRISON RJ, 1970, J ZOOL, V160, P377; Hellstrom PM, 1996, NEUROGASTROENT MOTIL, V8, P299, DOI 10.1111/j.1365-2982.1996.tb00268.x; Houser DS, 2010, J ACOUST SOC AM, V128, P1460, DOI 10.1121/1.3442572; Johren O, 2001, ENDOCRINOLOGY, V142, P3324, DOI 10.1210/en.142.8.3324; Kastin AJ, 1999, J PHARMACOL EXP THER, V289, P219; Kirchgessner AL, 1999, NEURON, V24, P941, DOI 10.1016/S0896-6273(00)81041-7; Kirchgessner AL, 2002, ENDOCR REV, V23, P1, DOI 10.1210/er.23.1.1; Kobashi M, 2002, NEUROSCI LETT, V332, P171, DOI 10.1016/S0304-3940(02)00958-8; Komaki G, 2001, EUR J ENDOCRINOL, V144, P645, DOI 10.1530/eje.0.1440645; Korczynski W, 2006, J PHYSIOL PHARMACOL, V57, P17; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; Kunii K, 1999, BRAIN RES, V842, P256, DOI 10.1016/S0006-8993(99)01884-3; Kuru M, 2000, NEUROREPORT, V11, P1977, DOI 10.1097/00001756-200006260-00034; Ljung T, 1999, ACTA PHYSIOL SCAND, V165, P225; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; MacDonald EE, 2010, GEN COMP ENDOCR, V169, P192, DOI 10.1016/j.ygcen.2010.09.014; Matsuda K, 2012, VITAM HORM, V89, P341, DOI 10.1016/B978-0-12-394623-2.00018-4; Miranda B, 2013, BRAIN RES, V1513, P34, DOI 10.1016/j.brainres.2013.03.036; Miyasaka K, 2002, PANCREAS, V25, P400, DOI 10.1097/00006676-200211000-00013; Nakabayashi M, 2003, MOL CELL ENDOCRINOL, V205, P43, DOI 10.1016/S0303-7207(03)00206-5; Nakayama S, 2011, J PHYSIOL-LONDON, V589, P5907, DOI 10.1113/jphysiol.2011.220962; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Naslund E, 2002, AM J PHYSIOL-GASTR L, V282, pG470, DOI 10.1152/ajpgi.00219.2001; Nowak KW, 2005, INT J MOL MED, V15, P969; Nozu T, 2011, NEUROSCI LETT, V498, P143, DOI 10.1016/j.neulet.2011.04.078; Okumura T, 2008, J GASTROENTEROL, V43, P652, DOI 10.1007/s00535-008-2218-1; Ouedraogo R, 2003, DIABETES, V52, P111, DOI 10.2337/diabetes.52.1.111; Panin M, 2012, GEN COMP ENDOCR, V177, P238, DOI 10.1016/j.ygcen.2012.04.012; Piper DC, 2000, EUR J NEUROSCI, V12, P726, DOI 10.1046/j.1460-9568.2000.00919.x; Randeva HS, 2001, J CLIN ENDOCR METAB, V86, P4808, DOI 10.1210/jc.86.10.4808; Reidenerg JS, 2007, ANAT REC, V290, P507, DOI 10.1002/ar.20541; Ridgway S, 2006, J EXP BIOL, V209, P2902, DOI 10.1242/jeb.02348; Russo F, 2008, ANAT REC, V291, P169, DOI 10.1002/ar.20641; Russo F, 2014, ACTA HISTOCHEM, V116, P286, DOI 10.1016/j.acthis.2013.04.012; Russo F, 2012, ANAT REC, V295, P1482, DOI 10.1002/ar.22532; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai Takeshi, 2006, CNS & Neurological Disorders-Drug Targets, V5, P313, DOI 10.2174/187152706777452218; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Tafuri S, 2009, REGUL PEPTIDES, V155, P1, DOI 10.1016/j.regpep.2009.03.010; Takahashi K, 2006, PEPTIDES, V27, P871, DOI 10.1016/j.peptides.2005.08.008; Venn-Watson Stephanie, 2013, Front Endocrinol (Lausanne), V4, P136, DOI 10.3389/fendo.2013.00136; Venn-Watson S, 2011, GEN COMP ENDOCR, V170, P193, DOI 10.1016/j.ygcen.2010.10.005; Worthy GAJ, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P791, DOI 10.1201/9781420041637.ch36; Yokobori E, 2011, PEPTIDES, V32, P1357, DOI 10.1016/j.peptides.2011.05.010	60	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105009	10.1371/journal.pone.0105009	http://dx.doi.org/10.1371/journal.pone.0105009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144456	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100035
J	Head, DA; Marsh, PD; Devine, DA				Head, David A.; Marsh, Phil D.; Devine, Deirdre A.			Non-Lethal Control of the Cariogenic Potential of an Agent-Based Model for Dental Plaque	PLOS ONE			English	Article							MICROBIAL COMMUNITIES INVITRO; STREPTOCOCCUS-MUTANS; POPULATION SHIFTS; ACID PRODUCTION; BIOFILMS; FLUORIDE; DIFFUSION; SANGUIS; PH; CARIES	Dental caries or tooth decay is a prevalent global disease whose causative agent is the oral biofilm known as plaque. According to the ecological plaque hypothesis, this biofilm becomes pathogenic when external challenges drive it towards a state with a high proportion of acid-producing bacteria. Determining which factors control biofilm composition is therefore desirable when developing novel clinical treatments to combat caries, but is also challenging due to the system complexity and the existence of multiple bacterial species performing similar functions. Here we employ agent-based mathematical modelling to simulate a biofilm consisting of two competing, distinct types of bacterial populations, each parameterised by their nutrient uptake and aciduricity, periodically subjected to an acid challenge resulting from the metabolism of dietary carbohydrates. It was found that one population was progressively eliminated from the system to give either a benign or a pathogenic biofilm, with a tipping point between these two fates depending on a multiplicity of factors relating to microbial physiology and biofilm geometry. Parameter sensitivity was quantified by individually varying the model parameters against putative experimental measures, suggesting non-lethal interventions that can favourably modulate biofilm composition. We discuss how the same parameter sensitivity data can be used to guide the design of validation experiments, and argue for the benefits of in silico modelling in providing an additional predictive capability upstream from in vitro experiments.	[Head, David A.] Univ Leeds, Sch Comp, Leeds, W Yorkshire, England; [Marsh, Phil D.] PHE Porton, Microbiol Serv, Salisbury, Wilts, England; [Marsh, Phil D.; Devine, Deirdre A.] Univ Leeds, Dept Oral Biol, Sch Dent, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Head, DA (corresponding author), Univ Leeds, Sch Comp, Leeds, W Yorkshire, England.	d.head@leeds.ac.uk	Head, David/E-8707-2010	Head, David/0000-0003-0216-6787	BHRC, University of Leeds	BHRC, University of Leeds	DAH was funded by the BHRC, University of Leeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison D.G., 2000, COMMUNITY STRUCTURE; [Anonymous], 2009, ORAL MICROBIOLOGY; BRADSHAW DJ, 1989, J DENT RES, V68, P1298, DOI 10.1177/00220345890680090101; BRADSHAW DJ, 1990, J DENT RES, V69, P436, DOI 10.1177/00220345900690020301; Bradshawa DJ, 2002, CARIES RES, V36, P81, DOI 10.1159/000057864; Chambless JD, 2007, BIOTECHNOL BIOENG, V97, P1573, DOI 10.1002/bit.21363; DAWES C, 1986, J DENT RES, V65, P89, DOI 10.1177/00220345860650021701; DAWES C, 1989, J DENT RES, V68, P1483, DOI 10.1177/00220345890680110301; DIBDIN GH, 1990, J DENT RES, V69, P1324, DOI 10.1177/00220345900690062001; Dibdin GH, 1998, CARIES RES, V32, P70, DOI 10.1159/000016432; Dibdin GH, 1992, BIOINFORMATICS, V8, P489; DIRKSEN TR, 1963, ARCH ORAL BIOL, V8, P91, DOI 10.1016/0003-9969(63)90046-3; EISENBERG AD, 1980, ARCH ORAL BIOL, V25, P133, DOI 10.1016/0003-9969(80)90089-8; Ellwood DC, 1982, PROPERTIES STREPTOCO; Ellwood DC, 1979, EFFECT GROWTH RATE G; Filoche S, 2010, J DENT RES, V89, P8, DOI 10.1177/0022034509351812; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Hamilton IR, 1979, EFFECT GROWTH RATE G; Hamilton IR, 1983, CARBOHYDRATE METABOL; HATA S, 1990, J DENT RES, V69, P1244, DOI 10.1177/00220345900690060401; He Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063750; Head DA, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032702; Hoeven JS, 1985, FEMS MICROBIOLOGY LE, V31, P373; Ilie O, 2012, J THEOR BIOL, V309, P159, DOI 10.1016/j.jtbi.2012.05.024; Kinniment SL, 1996, MICROBIOL-SGM, V142, P631, DOI 10.1099/13500872-142-3-631; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Laspidou CS, 2010, DESALINATION, V250, P390, DOI 10.1016/j.desal.2009.09.062; Lau PCY, 2009, BIOPHYS J, V96, P2935, DOI 10.1016/j.bpj.2008.12.3943; Liu JM, 2011, MICROBIOL-SGM, V157, P2433, DOI 10.1099/mic.0.048314-0; Marsh P D, 1994, Adv Dent Res, V8, P263; MARSH PD, 1989, J DENT RES, V68, P1151, DOI 10.1177/00220345890680070301; MARSH PD, 1985, J DENT RES, V64, P85, DOI 10.1177/00220345850640021501; Marsh PD, 1985, ENV REGULATION CARBO; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; MCDERMID AS, 1985, CARIES RES, V19, P64, DOI 10.1159/000260830; Metcalf D, 2006, J ANTIMICROB CHEMOTH, V58, P190, DOI 10.1093/jac/dkl205; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; PEARCE EIF, 1995, J DENT RES, V74, P691, DOI 10.1177/00220345950740021101; Phan TN, 2000, ARCH MICROBIOL, V174, P248, DOI 10.1007/s002030000202; Picioreanu C, 2004, APPL ENVIRON MICROB, V70, P3024, DOI 10.1128/AEM.70.5.3024-3040.2004; Rudge TJ, 2012, ACS SYNTH BIOL, V1, P345, DOI 10.1021/sb300031n; STRALFORS A, 1948, J DENT RES, V27, P587, DOI 10.1177/00220345480270050601; Tanzer JM, 2012, J DENT RES, V91, P513, DOI 10.1177/0022034512442894; Wang Q, 2010, SOLID STATE COMMUN, V150, P1009, DOI 10.1016/j.ssc.2010.01.021; Wolff D, 2013, CARIES RES, V47, P69, DOI 10.1159/000344022; Xavier JB, 2005, ENVIRON MICROBIOL, V7, P1085, DOI 10.1111/j.1462-2920.2005.00787.x; Xavier JB, 2007, P NATL ACAD SCI USA, V104, P876, DOI 10.1073/pnas.0607651104; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269	50	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105012	10.1371/journal.pone.0105012	http://dx.doi.org/10.1371/journal.pone.0105012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144538	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341106100036
J	Ishii, D; Matsuzawa, D; Matsuda, S; Tomizawa, H; Sutoh, C; Shimizu, E				Ishii, Daisuke; Matsuzawa, Daisuke; Matsuda, Shingo; Tomizawa, Haruna; Sutoh, Chihiro; Shimizu, Eiji			Methyl Donor-Deficient Diet during Development Can Affect Fear and Anxiety in Adulthood in C57BL/6J Mice	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DNA METHYLTRANSFERASES DNMT3A; MONOZYGOTIC TWINS DISCORDANT; NATIONAL COMORBIDITY SURVEY; REGULATES MEMORY FORMATION; EMBRYONIC STEM-CELLS; EPIGENETIC ALTERATIONS; LIFETIME PREVALENCE; UP-REGULATION; GENE	DNA methylation is one of the essential factors in the control of gene expression. Folic acid, methionine and choline (methyl donors)-all nutrients related to one-carbon metabolism-are known as important mediators of DNA methylation. A previous study has shown that long-term administration of a diet lacking in methyl donors caused global DNA hypermethylation in the brain (Pogribny et al., 2008). However, no study has investigated the effects of a diet lacking in methyl donors during the developmental period on emotional behaviors such as fear and anxiety-like behavior in association with gene expressions in the brain. In addition, it has not been elucidated whether a diet supplemented with methyl donors later in life can reverse these changes. Therefore, we examined the effects of methyl donor deficiency during the developmental period on fear memory acquisition/extinction and anxiety-like behavior, and the relevant gene expressions in the hippocampus in juvenile (6-wk) and adult (12-wk) mice. We found that juvenile mice fed a methyl-donor-deficient diet had impaired fear memory acquisition along with decreases in the gene expressions of Dnmt3a and Dnmt3b. In addition, reduced anxiety-like behavior with decreased gene expressions of Grin2b and Gabar2 was observed in both the methyl-donor-deficient group and the body-weight-matched food-restriction group. After being fed a diet supplemented with methyl donors ad libitum, adult mice reversed the alteration of gene expression of Dnmt3a, Dnmt3b, Grin2b and Gabar2, but anxiety-like behavior became elevated. In addition, impaired fear-memory formation was observed in the adult mice fed the methyl-donor-deficient diet during the developmental period. Our study suggested that developmental alterations in the one-carbon metabolic pathway in the brain could have effects on emotional behavior and memory formation that last into adulthood.	[Ishii, Daisuke; Matsuzawa, Daisuke; Matsuda, Shingo; Tomizawa, Haruna; Sutoh, Chihiro; Shimizu, Eiji] Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan; [Matsuzawa, Daisuke; Sutoh, Chihiro; Shimizu, Eiji] Chiba Univ, Grad Sch Med, Res Ctr Child Mental Dev, Chiba, Japan; [Matsuda, Shingo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan	Chiba University; Chiba University; National Center for Neurology & Psychiatry - Japan	Ishii, D (corresponding author), Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan.	dishii85@gmail.com	Shimizu, Eiji/K-4637-2017	Shimizu, Eiji/0000-0002-6741-9338; Sutoh, Chihiro/0000-0002-5191-8220	Japan Society for the Promotion of Science KAKENHI [24791196]; Grants-in-Aid for Scientific Research [26860912] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 24791196. DM received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bossenmeyer-Pourie C, 2010, AM J PATHOL, V176, P270, DOI 10.2353/ajpath.2010.090153; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Daval JL, 2009, P NATL ACAD SCI USA, V106, pE1, DOI 10.1073/pnas.0809217106; de Vries GJ, 2009, J TRAUMA STRESS, V22, P259, DOI 10.1002/jts.20429; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; Fuchikami M, 2010, PSYCHIAT INVEST, V7, P251, DOI 10.4306/pi.2010.7.4.251; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Genn RF, 2003, NEUROPSYCHOPHARMACOL, V28, P1257, DOI 10.1038/sj.npp.1300168; Gervin K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002454; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Gurba K.N., 2010, VANDERBILT REV NEURO, V2, P25; He S, 2010, J NEUROSCI, V30, P7910, DOI 10.1523/JNEUROSCI.6375-09.2010; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Inoue K, 2004, BIOL PSYCHIAT, V55, P1075, DOI 10.1016/j.biopsych.2004.01.026; Jacobson-Pick S, 2012, NEUROSCIENCE, V215, P114, DOI 10.1016/j.neuroscience.2012.04.038; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Javelot H, 2014, BEHAV BRAIN RES, V261, P8, DOI 10.1016/j.bbr.2013.11.047; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lalonde R, 2008, BRAIN RES, V1188, P122, DOI 10.1016/j.brainres.2007.10.068; Lei H, 1996, DEVELOPMENT, V122, P3195; Levay EA, 2007, PHYSIOL BEHAV, V92, P889, DOI 10.1016/j.physbeh.2007.06.018; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li SF, 2003, GYNECOL ONCOL, V90, P123, DOI 10.1016/S0090-8258(03)00194-X; Liu QC, 2011, TOXICOL LETT, V205, P235, DOI 10.1016/j.toxlet.2011.05.1039; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077; Qiang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008798; Regier DA, 1998, BRIT J PSYCHIAT, V173, P24, DOI 10.1192/S0007125000293483; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Rusiecki JA, 2012, EPIGENOMICS-UK, V4, P29, DOI [10.2217/EPI.11.116, 10.2217/epi.11.116]; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TURNER BM, 1991, J CELL SCI, V99, P13; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100	57	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105750	10.1371/journal.pone.0105750	http://dx.doi.org/10.1371/journal.pone.0105750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144567	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100116
J	Kashima, Y; Kanematsu, S; Asai, S; Kusada, M; Watanabe, S; Kawashima, T; Nakamura, T; Shimada, M; Goto, T; Nagaoka, S				Kashima, Yuri; Kanematsu, Satoshi; Asai, Saori; Kusada, Mio; Watanabe, Suzuyo; Kawashima, Takuji; Nakamura, Tadashi; Shimada, Masaya; Goto, Tsuyoshi; Nagaoka, Satoshi			Identification of a Novel Hypocholesterolemic Protein, Major Royal Jelly Protein 1, Derived from Royal Jelly	PLOS ONE			English	Article							PLASMA-CHOLESTEROL LEVELS; AMINO-ACID MIXTURES; MICELLAR SOLUBILITY; SERUM-CHOLESTEROL; DIETARY PROTEINS; SOY PROTEIN; IN-VITRO; ABSORPTION; RATS; METABOLISM	Royal jelly (RJ) intake lowers serum cholesterol levels in animals and humans, but the active component in RJ that lowers serum cholesterol level and its molecular mechanism are unclear. In this study, we set out to identify the bile acid-binding protein contained in RJ, because dietary bile acid-binding proteins including soybean protein and its peptide are effective in ameliorating hypercholesterolemia. Using a cholic acid-conjugated column, we separated some bile acid-binding proteins from RJ and identified the major RJ protein 1 (MRJP1), MRJP2, and MRJP3 as novel bile acid-binding proteins from RJ, based on matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Purified MRJP1, which is the most abundant protein of the bile acid-binding proteins in RJ, exhibited taurocholate-binding activity in vitro. The micellar solubility of cholesterol was significantly decreased in the presence of MRJP1 compared with casein in vitro. Liver bile acids levels were significantly increased, and cholesterol 7 alpha-hydroxylase (CYP7A1) mRNA and protein tended to increase by MRJP1 feeding compared with the control. CYP7A1 mRNA and protein levels were significantly increased by MRJP1 tryptic hydrolysate treatment compared with that of casein tryptic hydrolysate in hepatocytes. MRJP1 hypocholesterolemic effect has been investigated in rats. The cholesterol-lowering action induced by MRJP1 occurs because MRJP1 interacts with bile acids induces a significant increase in fecal bile acids excretion and a tendency to increase in fecal cholesterol excretion and also enhances the hepatic cholesterol catabolism. We have identified, for the first time, a novel hypocholesterolemic protein, MRJP1, in RJ. Interestingly, MRJP1 exhibits greater hypocholesterolemic activity than the medicine beta-sitosterol in rats.	[Kashima, Yuri; Kanematsu, Satoshi; Asai, Saori; Watanabe, Suzuyo; Kawashima, Takuji; Nakamura, Tadashi] Akitaya Honten Co Ltd, Kano, Gifu, Japan; [Kusada, Mio; Shimada, Masaya; Goto, Tsuyoshi; Nagaoka, Satoshi] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Yanagi, Gifu, Japan	Gifu University	Nagaoka, S (corresponding author), Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Yanagi, Gifu, Japan.	nagaoka@gifu-u.ac.jp	Goto, Tsuyoshi/AAY-2344-2020	Goto, Tsuyoshi/0000-0003-1283-147X	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by grants from the Seeds Validation Exploratory Research of Japan Science and Technology Agency, and High-risk Challenge of Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association of Official Analytical Chemists, 2016, OFFICIAL METHODS ANA; CARROLL KK, 1975, J FOOD SCI, V40, P18, DOI 10.1111/j.1365-2621.1975.tb03726.x; Cochran W.G., 1967, STAT METHODS; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Folin O, 1915, J BIOL CHEM, V22, P305; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Furusawa T, 2008, J PROTEOME RES, V7, P3194, DOI 10.1021/pr800061j; Guo H, 2007, J NUTR SCI VITAMINOL, V53, P345, DOI 10.3177/jnsv.53.345; Hasler CM, 2002, J NUTR, V132, P3772, DOI 10.1093/jn/132.12.3772; HAYTER AJ, 1984, ANN STAT, V12, P61, DOI 10.1214/aos/1176346392; HIROSE N, 1991, J LIPID RES, V32, P629; Hodge JE, 1962, METHODS CARBOHYDRATE, DOI DOI 10.1371/JOURNAL.PONE.0065418; Hosomi R, 2012, J MED FOOD, V15, P299, DOI 10.1089/jmf.2011.1620; HUFF JW, 1963, P SOC EXP BIOL MED, V114, P352; HUFF MW, 1980, J NUTR, V110, P1676, DOI 10.1093/jn/110.8.1676; IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2; IKEDA I, 1988, J LIPID RES, V29, P1573; IWAMI K, 1986, AGR BIOL CHEM TOKYO, V50, P1217, DOI 10.1080/00021369.1986.10867551; JACQUES H, 1986, ATHEROSCLEROSIS, V61, P89, DOI 10.1016/0021-9150(86)90067-5; Kamakura M, 2006, J PHARM PHARMACOL, V58, P1683, DOI 10.1211/jpp.58.12.0017; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; Li XA, 2013, J MED FOOD, V16, P96, DOI 10.1089/jmf.2012.2425; MAKINO S, 1988, AGR BIOL CHEM TOKYO, V52, P803; Mishima S, 2005, J ETHNOPHARMACOL, V101, P215, DOI 10.1016/j.jep.2005.04.012; Morikawa K, 2007, BIOCHEM BIOPH RES CO, V352, P697, DOI 10.1016/j.bbrc.2006.11.090; Moutsatsou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015594; Nagaoka S., 2006, Dietary fats and risk of chronic disease, P168; Nagaoka S, 1999, J NUTR, V129, P1725, DOI 10.1093/jn/129.9.1725; Nagaoka S, 2002, LIPIDS, V37, P267, DOI 10.1007/s11745-002-0890-6; NAGAOKA S, 1990, J NUTR, V120, P1134, DOI 10.1093/jn/120.10.1134; Nagaoka S, 2001, BIOCHEM BIOPH RES CO, V281, P11, DOI 10.1006/bbrc.2001.4298; Nagaoka S, 2005, J NUTR, V135, P2425, DOI 10.1093/jn/135.10.2425; Nagaoka S, 2010, BIOSCI BIOTECH BIOCH, V74, P1738, DOI 10.1271/bbb.100338; NAGATA Y, 1982, J NUTR, V112, P1614, DOI 10.1093/jn/112.8.1614; NAKAJIN S, 1982, Shoyakugaku Zasshi, V36, P65; Nuttall ME, 1998, ENDOCRINOLOGY, V139, P5224, DOI 10.1210/en.139.12.5224; Okamoto I, 2003, LIFE SCI, V73, P2029, DOI 10.1016/S0024-3205(03)00562-9; OLIVER MF, 1981, BRIT MED BULL, V37, P49, DOI 10.1093/oxfordjournals.bmb.a071675; Park Y, 2011, J NUTR, V141, P1424, DOI 10.3945/jn.111.138875; PATTINSON N, 1980, J CHROMATOGR, V187, P409, DOI 10.1016/S0021-9673(00)80473-2; Rosmilah M, 2008, TROP BIOMED, V25, P243; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; SPADY DK, 1995, J CLIN INVEST, V96, P700, DOI 10.1172/JCI118113; Spady DK, 1998, J BIOL CHEM, V273, P126, DOI 10.1074/jbc.273.1.126; Stein S, 2010, METABOLISM, V59, P33, DOI 10.1016/j.metabol.2009.07.003; SUGIYAMA K, 1986, J NUTR SCI VITAMINOL, V32, P413, DOI 10.3177/jnsv.32.413; Tamura S, 2009, PROTEOMICS, V9, P5534, DOI 10.1002/pmic.200900541; Tamura S, 2009, FOOD CHEM, V114, P1491, DOI 10.1016/j.foodchem.2008.11.058; Townsend GF, 1940, BIOCHEM J, V34, P1155, DOI 10.1042/bj0341155; VITTEK J, 1995, EXPERIENTIA, V51, P927, DOI 10.1007/BF01921742; WILSON MD, 1994, J LIPID RES, V35, P943	53	40	45	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105073	10.1371/journal.pone.0105073	http://dx.doi.org/10.1371/journal.pone.0105073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144734	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100039
J	Heimesaat, MM; Dunay, IR; Alutis, M; Fischer, A; Mohle, L; Gobel, UB; Kuhl, AA; Bereswill, S				Heimesaat, Markus M.; Dunay, Ildiko R.; Alutis, Marie; Fischer, Andre; Moehle, Luisa; Goebel, Ulf B.; Kuehl, Anja A.; Bereswill, Stefan			Nucleotide-Oligomerization-Domain-2 Affects Commensal Gut Microbiota Composition and Intracerebral Immunopathology in Acute Toxoplasma gondii Induced Murine Ileitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; KAPPA-B ACTIVATION; NOD-LIKE RECEPTORS; PERORAL INFECTION; ORAL INFECTION; EARLY SURVIVAL; MODEL; MICE; IMMUNITY	Background: Within one week following peroral high dose infection with Toxoplasma (T.) gondii, susceptible mice develop non-selflimiting acute ileitis due to an underlying Th1-type immunopathology. The role of the innate immune receptor nucleotide-oligomerization-domain-2 (NOD2) in mediating potential extra-intestinal inflammatory sequelae including the brain, however, has not been investigated so far. Methodology/Principal Findings: Following peroral infection with 100 cysts of T. gondii strain ME49, NOD2(-/-) mice displayed more severe ileitis and higher small intestinal parasitic loads as compared to wildtype (WT) mice. However, systemic (i. e. splenic) levels of pro-inflammatory cytokines such as TNF-a and IFN-gamma were lower in NOD2(-/-) mice versus WT controls at day 7 p. i. Given that the immunopathological outcome might be influenced by the intestinal microbiota composition, which is shaped by NOD2, we performed a quantitative survey of main intestinal bacterial groups by 16S rRNA analysis. Interestingly, Bifidobacteria were virtually absent in NOD2(-/-) but not WT mice, whereas differences in remaining bacterial species were rather subtle. Interestingly, more distinct intestinal inflammation was accompanied by higher bacterial translocation rates to extra-intestinal tissue sites such as liver, spleen, and kidneys in T. gondii infected NOD2 -/mice. Strikingly, intracerebral inflammatory foci could be observed as early as seven days following T. gondii infection irrespective of the genotype of animals, whereas NOD2(-/-) mice exhibited higher intracerebral parasitic loads, higher F4/80 positive macrophage and microglia numbers as well as higher IFN-gamma mRNA expression levels as compared to WT control animals. Conclusion/Significance: NOD2 signaling is involved in protection of mice from T. gondii induced acute ileitis. The parasiteinduced Th1-type immunopathology at intestinal as well as extra-intestinal sites including the brain is modulated in a NOD2-dependent manner.	[Heimesaat, Markus M.; Alutis, Marie; Fischer, Andre; Goebel, Ulf B.; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Dunay, Ildiko R.; Moehle, Luisa] Univ Magdeburg, Dept Microbiol & Hyg, D-39106 Magdeburg, Germany; [Kuehl, Anja A.] Charite, Dept Internal Med Rheumatol & Clin Immunol, Res Ctr ImmunoSci RCIS, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heimesaat, MM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de		Kuhl, Anja/0000-0003-2293-5387; Heimesaat, Markus/0000-0001-6399-651X; Mohle, Luisa/0000-0002-4535-9952	German Research Foundation (DFG) [SFB633, DU 1112/3-1, SFB854]; German Federal Ministry of Education and Research (BMBF) [TP 1.1, TP 8.2]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to UBG, SB and AF (SFB633, TP A7), MMH (SFB633, TP B6), MA (SFB633, IMMUCO), IRD (DFG DU 1112/3-1, SFB854) and from the German Federal Ministry of Education and Research (BMBF) to SB ("Lab in a hanky" projects TP 1.1 and TP 8.2). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Biswas A, 2012, J MOL MED, V90, P15, DOI 10.1007/s00109-011-0802-y; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Caetano BC, 2011, EUR J IMMUNOL, V41, P3627, DOI 10.1002/eji.201141876; Coudeyras S, 2010, CAN J MICROBIOL, V56, P611, DOI 10.1139/w10-052; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Dunay IR, 2009, ANTIMICROB AGENTS CH, V53, P4450, DOI 10.1128/AAC.00502-09; Dunay IR, 2004, ANTIMICROB AGENTS CH, V48, P4848, DOI 10.1128/AAC.48.12.4848-4854.2004; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Ge ZM, 2006, APPL ENVIRON MICROB, V72, P5100, DOI 10.1128/AEM.01934-05; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2011, EUR J MICROBIOL IMMU, V1, P302, DOI 10.1556/EuJMI.1.2011.4.6; Heimesaat MM, 2013, EUR J MICROBIOL IMMU, V3, P36, DOI 10.1556/EuJMI.3.2013.1.5; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2013, EUR J MICROBIOL IMMU, V3, P174, DOI 10.1556/EuJMI.3.2013.3.4; Heimesaat MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040758; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; MCLEOD R, 1989, J IMMUNOL, V143, P3031; MCLEOD R, 1989, J IMMUNOL, V142, P3247; Mohle L, 2014, EUR J MICROBIOL IMMU, V4, P65, DOI 10.1556/EuJMI.4.2014.1.6; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; O'Mahony D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-63; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Parlog A, 2014, DIS MODEL MECH, V7, P459, DOI 10.1242/dmm.014183; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Rubino SJ, 2012, CURR OPIN IMMUNOL, V24, P398, DOI 10.1016/j.coi.2012.04.010; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2010, GASTROENTEROLOGY, V139, P1816, DOI 10.1053/j.gastro.2010.10.036; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Struck D, 2012, EUR J MICROBIOL IMMU, V2, P249, DOI 10.1556/EuJMI.2.2012.3.11; Sydora BC, 2007, INFLAMM BOWEL DIS, V13, P947, DOI 10.1002/ibd.20155; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018	53	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105120	10.1371/journal.pone.0105120	http://dx.doi.org/10.1371/journal.pone.0105120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141224	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200052
J	Chung, SD; Liu, SP; Sheu, JJ; Lin, CC; Lin, HC; Chen, CH				Chung, Shiu-Dong; Liu, Shih-Ping; Sheu, Jau-Jiuan; Lin, Ching-Chun; Lin, Herng-Ching; Chen, Chao-Hung			Increased Healthcare Service Utilizations for Patients with Dementia: A Population-Based Study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; ALZHEIMERS-DISEASE; CLAIMS DATA; LONG-TERM; VASCULAR DEMENTIA; MANAGED CARE; COSTS; PREVALENCE; TAIWAN; ASSOCIATION	Background: The majority of previous studies investigating the health care utilization of people with dementia were conducted in Western societies. There is little information on the economic burden on the healthcare system attributable to dementia in Asian countries. This study thus investigated differences in utilization of healthcare services between subjects with and those without a diagnosis of dementia using Taiwan's National Health Insurance population-based database. Methods: This study comprised 5,666 subjects with a dementia diagnosis and 5,666 age- and gender-matched comparison subjects without a dementia diagnosis. We individually followed each subject for a 1-year period starting from their index date to evaluate their healthcare resource utilization. Healthcare resource utilization included the number of outpatient visits and inpatient days, and the mean costs of outpatient and inpatient treatments. In addition, we divided healthcare resource utilization into psychiatric and non-psychiatric services. Results: As for utilization of psychiatric services, subjects with a dementia diagnosis had significantly more outpatient visits (2.2 vs. 0.3, p<0.001) and significantly higher outpatient costs (US$124 vs. US$16, p<0.001) than comparison subjects. For non-psychiatric services, subjects with a dementia diagnosis also had significantly more outpatient visits (34.4 vs. 31.6, p< 0.001) and significantly higher outpatient costs (US$1754 vs. US$1322, p<0.001) than comparison subjects. For all healthcare services, subjects with a dementia diagnosis had significantly more outpatient visits (36.7 vs. 32.0, p<0.001) and significantly higher outpatient costs (US$1878 vs. US$1338, p<0.001) than comparison subjects. Furthermore, the total cost was about 2-fold greater for subjects with a dementia diagnosis than for comparison subjects (US$3997 vs. US$2409, p<0.001). Conclusions: We concluded that subjects who had received a clinical dementia diagnosis had significantly higher utilization of all healthcare services than comparison subjects.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan; [Chung, Shiu-Dong] Fu Jen Cathol Univ, Coll Med, Sch Med, Taipei, Taiwan; [Chung, Shiu-Dong; Liu, Shih-Ping; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Sheu, Jau-Jiuan] Taipei Med Univ Hosp, Dept Neurol, Taipei, Taiwan; [Sheu, Jau-Jiuan] Taipei Med Univ Hosp, Neurosci Res Ctr, Taipei, Taiwan; [Lin, Ching-Chun] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Chen, Chao-Hung] Mackay Mem Hosp, Dept Thorac Surg, Taiwa, Miyagi, Japan; [Chen, Chao-Hung] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan	Far Eastern Memorial Hospital; Fu Jen Catholic University; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Mackay Junior College of Medicine, Nursing & Management	Chen, CH (corresponding author), Mackay Mem Hosp, Dept Thorac Surg, Taiwa, Miyagi, Japan.	yichen@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Arling G, 2013, MED CARE, V51, P575, DOI 10.1097/MLR.0b013e31828d4d4a; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bickel H, 2000, GESUNDHEITSWESEN, V62, P211, DOI 10.1055/s-2000-10858; Chen TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-54; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Dementia Guideline Development Group, 2007, DEM NICE SCIE GUID S; Fick DM, 2005, J GERONTOL A-BIOL, V60, P748, DOI 10.1093/gerona/60.6.748; Frytak JR, 2008, ALZHEIMERS DEMENT, V4, P361, DOI 10.1016/j.jalz.2008.02.007; Gustavsson A, 2010, J NUTR HEALTH AGING, V14, P648, DOI 10.1007/s12603-010-0311-7; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Jonsson L, 2005, EUR J NEUROL, V12, P50, DOI 10.1111/j.1468-1331.2005.01190.x; Kane RL, 2000, ALZ DIS ASSOC DIS, V14, P187, DOI 10.1097/00002093-200010000-00001; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kunik ME, 2003, GERONTOLOGIST, V43, P86, DOI 10.1093/geront/43.1.86; Leicht H, 2011, ACTA PSYCHIAT SCAND, V124, P384, DOI 10.1111/j.1600-0447.2011.01741.x; Perkins P, 1997, NEUROLOGY, V49, P44, DOI 10.1212/WNL.49.1.44; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Schwarzkopf L, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-2; Schwarzkopf L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-165; Shrestha S, 2011, AM J ALZHEIMERS DIS, V26, P115, DOI 10.1177/1533317510394156; Sicras A, 2005, DEMENT GERIATR COGN, V19, P305, DOI 10.1159/000084556; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108; Ziegler U, 2009, GESUNDHEITSWESEN, V71, P281, DOI 10.1055/s-0028-1119384	27	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105789	10.1371/journal.pone.0105789	http://dx.doi.org/10.1371/journal.pone.0105789			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4JK	25157405	gold, Green Submitted, Green Published			2022-12-27	WOS:000341303200064
J	Kloepper, LN; Smith, AB; Nachtigall, PE; Buck, JR; Simmons, JA; Pacini, AF				Kloepper, Laura N.; Smith, Adam B.; Nachtigall, Paul E.; Buck, John R.; Simmons, James A.; Pacini, Aude F.			Cognitive Adaptation of Sonar Gain Control in the Bottlenose Dolphin	PLOS ONE			English	Article							FALSE KILLER WHALE; PORPOISES PHOCOENA-PHOCOENA; PERCEIVED ECHO AMPLITUDES; BIG BROWN BAT; ECHOLOCATING BATS; TURSIOPS-TRUNCATUS; PSEUDORCA-CRASSIDENS; EPTESICUS-FUSCUS; TARGET DETECTION; LAGENORHYNCHUS-ALBIROSTRIS	Echolocating animals adjust the transmit intensity and receive sensitivity of their sonar in order to regulate the sensation level of their echoes; this process is often termed automatic gain control. Gain control is considered not to be under the animal's cognitive control, but previous investigations studied animals ensonifying targets or hydrophone arrays at predictable distances. To test whether animals maintain gain control at a fixed level in uncertain conditions, we measured changes in signal intensity for a bottlenose dolphin (Tursiops truncatus) detecting a target at three target distances (2.5, 4 and 7 m) in two types of sessions: predictable and unpredictable. Predictable sessions presented the target at a constant distance; unpredictable sessions moved the target randomly between the three target positions. In the predictable sessions the dolphin demonstrated intensity distance compensation, increasing the emitted click intensity as the target distance increased. Additionally, as trials within sessions progressed, the animal adjusted its click intensity even from the first click in a click train, which is consistent with the animal expecting a target at a certain range. In the unpredictable sessions there was no significant difference of intensity with target distance until after the 7th click in a click train. Together, these results demonstrate that the bottlenose dolphin uses learning and expectation for sonar gain control.	[Kloepper, Laura N.; Simmons, James A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Kloepper, Laura N.; Buck, John R.] Univ Massachusetts, Dartmouth, MA USA; [Smith, Adam B.; Nachtigall, Paul E.; Pacini, Aude F.] Univ Hawaii, Dept Zool, Honolulu, HI 96822 USA	Brown University; University of Massachusetts System; University Massachusetts Dartmouth; University of Hawaii System	Kloepper, LN (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	laura_kloepper@brown.edu	Pacini, Aude/GYQ-6700-2022		National Science Foundation Postdoctoral Research Fellowship in Biology [DBI-120833]; Office of Naval Research grant [N00014-12-1-02-12]	National Science Foundation Postdoctoral Research Fellowship in Biology; Office of Naval Research grant(Office of Naval Research)	This was partially funded by the National Science Foundation Postdoctoral Research Fellowship in Biology DBI-120833 awarded to L.N.K. and an Office of Naval Research grant N00014-12-1-02-12 awarded to P.E.N. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie MA, 1998, J ACOUST SOC AM, V103, P1671, DOI 10.1121/1.421258; Atem ACG, 2009, BIOACOUSTICS, V19, P49, DOI 10.1080/09524622.2009.9753614; AU WWL, 1980, J ACOUST SOC AM, V68, P1077, DOI 10.1121/1.384993; AU WWL, 1974, J ACOUST SOC AM, V56, P1280, DOI 10.1121/1.1903419; AU WWL, 1981, J ACOUST SOC AM, V70, P687, DOI 10.1121/1.386931; AU WWL, 1988, J ACOUST SOC AM, V83, P662, DOI 10.1121/1.396161; AU WWL, 1983, J ACOUST SOC AM, V73, P1676, DOI 10.1121/1.389389; Au WWL, 2003, NATURE, V423, P861, DOI 10.1038/nature01727; Au WWL, 1990, SONAR DOLPHINS; Aubauer R, 2000, J ACOUST SOC AM, P1; Beedholm Kristian, 2007, Aquatic Mammals, V33, P69, DOI 10.1578/AM.33.1.2007.69; Boonman A, 2002, J EXP BIOL, V205, P2865; Brinklov S, 2010, BEHAV ECOL SOCIOBIOL, V64, P1867, DOI 10.1007/s00265-010-0998-9; Efron B, 1998, INTRO BOOTSTRAP; EVANS WE, 1967, ANIMAL SONAR SYSTEMS, P363; Fay R. R, 1994, COMP HEARING MAMMALS; Finneran JJ, 2013, J ACOUST SOC AM, V133, P1796, DOI 10.1121/1.4788997; Gorospe Kelvin D., 2011, Journal of Marine Biology, V2011, P1; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1120, DOI 10.1121/1.402639; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1133, DOI 10.1121/1.402640; Hiryu S, 2007, J ACOUST SOC AM, V121, P1749, DOI 10.1121/1.2431337; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Ibsen SD, 2007, J ACOUST SOC AM, V122, P2446, DOI 10.1121/1.2772213; Jensen FH, 2009, J EXP BIOL, V212, P1078, DOI 10.1242/jeb.025619; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; KICK SA, 1984, J NEUROSCI, V4, P2725; Kloepper LN, 2010, J EXP BIOL, V213, P3717, DOI 10.1242/jeb.042788; Kloepper LN, 2012, J EXP BIOL, V215, P1306, DOI 10.1242/jeb.066605; Kloepper LN, 2012, J ACOUST SOC AM, V131, P577, DOI 10.1121/1.3664076; Koblitz JC, 2010, J EXP BIOL, V213, P3263, DOI 10.1242/jeb.045450; LEATHERWOOD S, 1975, MAR FISH REV, V37, P10; Li SH, 2011, J EXP BIOL, V214, P2027, DOI 10.1242/jeb.053397; Linnenschmidt M, 2012, NATURWISSENSCHAFTEN, V99, P767, DOI 10.1007/s00114-012-0948-7; Linnenschmidt M, 2012, P ROY SOC B-BIOL SCI, V279, P2237, DOI 10.1098/rspb.2011.2465; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; McCormick JG, 1970, J ACOUST SOC AM, P1; Morozov BP, 1972, BIOFIZIKA, V17, P139; Muller MW, 2007, J ACOUST SOC AM, V122, P2255, DOI 10.1121/1.2769973; Nachtigall PE, 2008, J EXP BIOL, V211, P1714, DOI 10.1242/jeb.013862; Nachtigall PE, 2013, J EXP BIOL, V216, P3062, DOI 10.1242/jeb.085068; NEUWEILER G, 1990, PHYSIOL REV, V70, P615, DOI 10.1152/physrev.1990.70.3.615; Norum U, 2012, J EXP BIOL, V215, P3045, DOI 10.1242/jeb.069427; PENNER RH, 1988, ANIMAL SONAR PROCESS, P707; Posner MI, 1979, J EXPT ANAL BEHAV, V32, P363; Purves P E, 1966, WHALES DOLPHINS PORP, P321; Rasmussen MH, 2002, J ACOUST SOC AM, V111, P1122, DOI 10.1121/1.1433814; Schusterman R. J., 1980, ANIMAL SONAR SYSTEMS, P14; Schwartz CP, 2011, BEHAV BRAIN RES, V224, P358, DOI 10.1016/j.bbr.2011.06.023; SIMMONS JA, 1992, J ACOUST SOC AM, V91, P1150, DOI 10.1121/1.402641; SUGA N, 1975, J EXP BIOL, V62, P277; Supin AY, 2005, J ACOUST SOC AM, V117, P3928, DOI 10.1121/1.1914150; Supin AY, 2003, J ACOUST SOC AM, V113, P2408, DOI 10.1121/1.1561497; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; TAYLER C K, 1972, Annals of the Cape Provincial Museums Natural History, V9, P11; Tian B, 1997, J ACOUST SOC AM, V101, P2347, DOI 10.1121/1.418272; TURL CW, 1989, J ACOUST SOC AM, V86, P497, DOI 10.1121/1.398229; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Van Trees H.L., 2001, DETECTION ESTIMATION, P19; WURSIG B, 1979, FISH B-NOAA, V77, P399; [No title captured]	60	10	11	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105938	10.1371/journal.pone.0105938	http://dx.doi.org/10.1371/journal.pone.0105938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153530	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200091
J	Shang, DS; Li, CQ; Yao, QL; Yang, HX; Xu, YJ; Han, JW; Li, J; Su, F; Zhang, YP; Zhang, CL; Li, DG; Li, X				Shang, Desi; Li, Chunquan; Yao, Qianlan; Yang, Haixiu; Xu, Yanjun; Han, Junwei; Li, Jing; Su, Fei; Zhang, Yunpeng; Zhang, Chunlong; Li, Dongguo; Li, Xia			Prioritizing Candidate Disease Metabolites Based on Global Functional Relationships between Metabolites in the Context of Metabolic Pathways	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SYSTEMS BIOLOGY; D-GALACTOSE; PROSTATE; PROLIFERATION; GLUTAMATE; RISK; LINK	Identification of key metabolites for complex diseases is a challenging task in today's medicine and biology. A special disease is usually caused by the alteration of a series of functional related metabolites having a global influence on the metabolic network. Moreover, the metabolites in the same metabolic pathway are often associated with the same or similar disease. Based on these functional relationships between metabolites in the context of metabolic pathways, we here presented a pathway-based random walk method called PROFANCY for prioritization of candidate disease metabolites. Our strategy not only takes advantage of the global functional relationships between metabolites but also sufficiently exploits the functionally modular nature of metabolic networks. Our approach proved successful in prioritizing known metabolites for 71 diseases with an AUC value of 0.895. We also assessed the performance of PROFANCY on 16 disease classes and found that 4 classes achieved an AUC value over 0.95. To investigate the robustness of the PROFANCY, we repeated all the analyses in two metabolic networks and obtained similar results. Then we applied our approach to Alzheimer's disease (AD) and found that a top ranked candidate was potentially related to AD but had not been reported previously. Furthermore, our method was applicable to prioritize the metabolites from metabolomic profiles of prostate cancer. The PROFANCY could identify prostate cancer related-metabolites that are supported by literatures but not considered to be significantly differential by traditional differential analysis. We also developed a freely accessible web-based and R-based tool at http://bioinfo.hrbmu.edu.cn/PROFANCY.	[Shang, Desi; Li, Chunquan; Yao, Qianlan; Yang, Haixiu; Xu, Yanjun; Han, Junwei; Li, Jing; Su, Fei; Zhang, Yunpeng; Zhang, Chunlong; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Li, Chunquan] Harbin Med Univ, Sch Med Informat, Harbin, Peoples R China; [Li, Dongguo] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China	Harbin Medical University; Harbin Medical University; Capital Medical University	Li, DG (corresponding author), Capital Med Univ, Sch Biomed Engn, 10 You An Men Wai Xi Tou Tiao, Beijing, Peoples R China.	ldg213@ccmu.edu.cn; lixia@hrbmu.edu.cn	Han, Junwei/T-9849-2018; shang, desi/GOJ-9200-2022; li, xia/HHZ-7468-2022; Li, Chunquan/AAI-1072-2020	Han, Junwei/0000-0002-3276-0819; Li, Chunquan/0000-0002-4700-5496; qianlan, yao/0000-0003-0737-4147	Funds for Creative Research Groups of the National Natural Science Foundation of China [81121003]; National Program on Key Basic Research Project [2014CB910504]; National Natural Science Foundation of China [61170154, 61073136, 31200996]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307120027, 20102307110022]	Funds for Creative Research Groups of the National Natural Science Foundation of China; National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported in part by the Funds for Creative Research Groups of the National Natural Science Foundation of China (Grant No. 81121003), the National Program on Key Basic Research Project (Grant No. 2014CB910504), the National Natural Science Foundation of China (Grant Nos. 61170154, 61073136 and 31200996), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant Nos. 20102307120027 and 20102307110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r179; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Cottret L, 2010, NUCLEIC ACIDS RES, V38, pW132, DOI 10.1093/nar/gkq312; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fu YM, 2010, J CELL PHYSIOL, V224, P491, DOI 10.1002/jcp.22148; Giovannucci E, 1998, CANCER RES, V58, P442; Gu M, 2009, CANCER RES, V69, P9465, DOI 10.1158/0008-5472.CAN-09-2805; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hakim S, 2012, CURR TOP MICROBIOL, V362, P246, DOI 10.1007/978-94-007-5025-8_12; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Hassan GS, 2013, CHEM PHARM BULL, V61, P212, DOI 10.1248/cpb.c12-00881; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Hook G, 2011, J ALZHEIMERS DIS, V26, P387, DOI 10.3233/JAD-2011-110101; Hua XD, 2008, EXP NEUROL, V210, P709, DOI 10.1016/j.expneurol.2008.01.009; Hua XD, 2007, LIFE SCI, V80, P1897, DOI 10.1016/j.lfs.2007.02.030; Jamshidi N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100077; Joseloff E, 2013, PEDIAT PULMONOL; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Kitzmueller E, 2001, J NEURAL TRANSM-SUPP, P203; Kivipelto M, 2006, ACTA NEUROL SCAND, V114, P50, DOI 10.1111/j.1600-0404.2006.00685.x; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Koochekpour S, 2013, ASIAN J ANDROL, V15, P212, DOI 10.1038/aja.2012.145; Koochekpour S, 2012, CLIN CANCER RES, V18, P5888, DOI 10.1158/1078-0432.CCR-12-1308; Krysiak Robert, 2012, Wiad Lek, V65, P108; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee SI, 2008, J ANESTH, V22, P385, DOI 10.1007/s00540-008-0646-y; Levin YS, 2009, MAGN RESON MED, V62, P1091, DOI 10.1002/mrm.22120; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021131; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Michel TM, 2010, J ALZHEIMERS DIS, V19, P1295, DOI 10.3233/JAD-2010-1326; Mishur RJ, 2012, MASS SPECTROM REV, V31, P70, DOI 10.1002/mas.20338; Naj AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001130; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Picklo MJ, 2001, J NEUROPATH EXP NEUR, V60, P686, DOI 10.1093/jnen/60.7.686; Serkova NJ, 2008, PROSTATE, V68, P620, DOI 10.1002/pros.20727; SHERIF FM, 1995, CLIN BIOCHEM, V28, P145, DOI 10.1016/0009-9120(94)00074-6; Singh G, 1999, J CELL PHYSIOL, V180, P431, DOI 10.1002/(SICI)1097-4652(199909)180:3<431::AID-JCP14>3.0.CO;2-O; Singh RP, 2003, CARCINOGENESIS, V24, P555, DOI 10.1093/carcin/24.3.555; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stenman K, 2011, BIOMARK INSIGHTS, V6, P39, DOI 10.4137/BMI.S6794; SZABO S, 1989, TOXICOL PATHOL, V17, P317, DOI 10.1177/019262338901700208; Szabo Z, 2010, ONCOL REP, V23, P1233, DOI 10.3892/or_00000755; Taylor BS, 2008, MOL CELL PROTEOMICS, V7, P600, DOI 10.1074/mcp.M700263-MCP200; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Trock BJ, 2011, UROL ONCOL-SEMIN ORI, V29, P572, DOI 10.1016/j.urolonc.2011.08.002; Wilson ID, 2005, J CHROMATOGR B, V817, P67, DOI 10.1016/j.jchromb.2004.07.045; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004	55	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104934	10.1371/journal.pone.0104934	http://dx.doi.org/10.1371/journal.pone.0104934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153931	Green Submitted, gold, Green Published			2022-12-27	WOS:000340952200030
J	Souza-Talarico, JN; Plusquellec, P; Lupien, SJ; Fiocco, A; Suchecki, D				Souza-Talarico, Juliana N.; Plusquellec, Pierrich; Lupien, Sonia J.; Fiocco, Alexandra; Suchecki, Deborah			Cross-Country Differences in Basal and Stress-Induced Cortisol Secretion in Older Adults	PLOS ONE			English	Article							SALIVARY CORTISOL; SOCIOECONOMIC-STATUS; SOCIAL SUPPORT; RESPONSES; HEALTH; WORK; MEN; ATHEROSCLEROSIS; EPIDEMIOLOGY; MECHANISMS	Objectives: Several studies have emphasized the association between socioeconomic status (SES) and inadequate response of the biological stress system. However, other factors related to SES are rarely considered, such as cultural values, social norms, organization, language and communication skills, which raises the need to investigate cross-country differences in stress response. Although some studies have shown differences in cortisol levels between immigrants and natives, there is no cross-country evidence regarding cortisol levels in country-native elders. This is particularly important given the high prevalence of stress-related disorders across nations during aging. The current study examined basal diurnal and reactive cortisol levels in healthy older adults living in two different countries. Methods: Salivary cortisol of 260 older adults from Canada and Brazil were nalyzed. Diurnal cortisol was measured in saliva samples collected at home throughout two working days at awakening, 30 min after waking, 1400 h, 1600 h and before bedtime. Cortisol reactivity was assessed in response to the Trier Social Stress Test (TSST) in both populations. Results: Our results showed that even under similar health status, psychological and cognitive characteristics, Brazilian elders exhibited higher basal and stress-induced cortisol secretion compared to the Canadian participants. Conclusion: These findings suggest that country context may modulate cortisol secretion and could impact the population health.	[Souza-Talarico, Juliana N.] Univ Sao Paulo, Dept Med Surg Nursing, Sch Nursing, Sao Paulo, Brazil; [Souza-Talarico, Juliana N.; Suchecki, Deborah] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Plusquellec, Pierrich] Univ Montreal, Sch Psychoeduc, Montreal, PQ, Canada; [Plusquellec, Pierrich; Lupien, Sonia J.] Univ Montreal, Dept Psychiat, Ctr Studies Human Stress, Mental Hlth Inst,Montreal Res Ctr, Montreal, PQ H3C 3J7, Canada; [Fiocco, Alexandra] Ryerson Univ, Dept Psychol, Toronto, ON, Canada	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universite de Montreal; Universite de Montreal; Toronto Metropolitan University	Souza-Talarico, JN (corresponding author), Univ Sao Paulo, Dept Med Surg Nursing, Sao Paulo, Brazil.	junery@usp.br; pierrich.plusquellec@umontreal.ca	Suchecki, Deborah/B-9790-2014; Souza-Talarico, Juliana Nery/K-6133-2012; Suchecki, Deborah/B-7654-2012; Talarico, Juliana Souza/ABA-8650-2020	Souza-Talarico, Juliana Nery/0000-0001-8820-0725; Suchecki, Deborah/0000-0003-1697-8663; Talarico, Juliana Souza/0000-0001-8820-0725; Plusquellec, Pierrich/0000-0003-0378-2602; Fiocco, Alexandra/0000-0002-9353-476X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) in Brazil [2009/13911-6]; CIHR [165618, 232974]; Alzheimer's Society of Canada	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) in Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CIHR(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada	This study was funded by a grant (#2009/13911-6) from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) in Brazil, pilot project competition to Deborah Suchecki and by a grant from the CIHR (#165618) to S.J. Lupien, a grant from the Alzheimer's Society of Canada to S.J. Lupien, and a grant from the CIHR (#232974) to P. Plusquellec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad WIU, 2007, SOCIOL HEALTH ILL, V29, P795, DOI 10.1111/j.1467-9566.2007.01051.x; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Bennett GG, 2004, ETHNIC HEALTH, V9, P337, DOI 10.1080/1355785042000285366; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Burnard P, 2008, NURS EDUC TODAY, V28, P134, DOI 10.1016/j.nedt.2007.04.002; Champaneri S, 2012, METABOLISM, V61, P986, DOI 10.1016/j.metabol.2011.11.006; Cho HJ, 2009, BRIT J PSYCHIAT, V194, P117, DOI 10.1192/bjp.bp.108.051813; Clow A, 2004, STRESS, V7, P29, DOI 10.1080/10253890410001667205; Cohen S, 2006, PSYCHOSOM MED, V68, P41, DOI 10.1097/01.psy.0000195967.51768.ea; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Decker SA, 2000, HORM BEHAV, V38, P29, DOI 10.1006/hbeh.2000.1597; DeSantis AS, 2007, J ADOLESCENT HEALTH, V41, P3, DOI 10.1016/j.jadohealth.2007.03.006; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Eisenberger NI, 2007, NEUROIMAGE, V35, P1601, DOI 10.1016/j.neuroimage.2007.01.038; Eller NH, 2006, BIOL PSYCHOL, V73, P280, DOI 10.1016/j.biopsycho.2006.05.003; Fiocco AJ, 2007, PSYCHONEUROENDOCRINO, V32, P1158, DOI 10.1016/j.psyneuen.2007.08.008; Flinn MV, 2006, PSYCHOL INQ, V17, P118; Flinn MV, 1997, AM J PHYS ANTHROPOL, V102, P33; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia MC, 2008, ANN NY ACAD SCI, V1148, P504, DOI 10.1196/annals.1410.065; Guyatt GH, 2007, OPEN MED PEER REV IN, V1, P27; Hajat A, 2010, PSYCHONEUROENDOCRINO, V35, P932, DOI 10.1016/j.psyneuen.2009.12.009; Harrison G. Ainsworth, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P49, DOI 10.2114/jpa.20.49; Hofman MA, 2004, BIOL REV, V79, P61, DOI 10.1017/S1464793103006250; Kim HS, 2008, J PERS SOC PSYCHOL, V94, P32, DOI 10.1037/0022-3514.94.1.32; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kondo N, 2012, J EPIDEMIOL, V22, P2, DOI 10.2188/jea.JE20110116; Kudielka BM, 2003, PSYCHOSOM MED, V65, P313, DOI 10.1097/01.PSY.0000058374.50240.BF; Kudielka BM, 1998, J CLIN ENDOCR METAB, V83, P1756, DOI 10.1210/jc.83.5.1756; Kunz-Ebrecht SR, 2004, PSYCHONEUROENDOCRINO, V29, P516, DOI 10.1016/S0306-4530(03)00072-6; Levine S, 2005, PSYCHONEUROENDOCRINO, V30, P939, DOI 10.1016/j.psyneuen.2005.03.013; Li L, 2007, PSYCHONEUROENDOCRINO, V32, P824, DOI 10.1016/j.psyneuen.2007.05.014; Lupien S, 1993, REV NEUROPSYCHOL, V3, P3; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; Nyberg CH, 2012, PSYCHONEUROENDOCRINO, V37, P178, DOI 10.1016/j.psyneuen.2011.06.002; Pearlin LI, 2005, J HEALTH SOC BEHAV, V46, P205, DOI 10.1177/002214650504600206; Persike M, 2012, J YOUTH ADOLESCENCE, V41, P863, DOI 10.1007/s10964-011-9719-6; Pike RL, 2006, AM J HUM BIOL, V18, P729, DOI 10.1002/ajhb.20548; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Ranjit N, 2005, INT J EPIDEMIOL, V34, P1138, DOI 10.1093/ije/dyi120; Rosal MC, 2004, BEHAV MED, V30, P11, DOI 10.3200/BMED.30.1.11-22; Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Siegrist J, 2010, SOC SCI MED, V71, P298, DOI 10.1016/j.socscimed.2010.03.043; Steptoe A, 2003, PSYCHOSOM MED, V65, P461, DOI 10.1097/01.PSY.0000035717.78650.A1; Taylor SE, 2007, PSYCHOL SCI, V18, P831, DOI 10.1111/j.1467-9280.2007.01987.x; Tennison LR, 2010, INT J PSYCHOL, V45, P165, DOI 10.1080/00207590903452309; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Vermeer HJ, 2010, J APPL DEV PSYCHOL, V31, P339, DOI 10.1016/j.appdev.2010.05.001; Voltmer E, 2012, INT ARCH OCC ENV HEA, V85, P819, DOI 10.1007/s00420-011-0725-5; Wallerius S, 2003, J ENDOCRINOL INVEST, V26, P616, DOI 10.1007/BF03347017; WHO, 2012, WHO REC PREV TREATM, P48; *WHO, 2008, WORLD MAL REP 2008, P9; Wright CE, 2005, PSYCHONEUROENDOCRINO, V30, P582, DOI 10.1016/j.psyneuen.2005.01.007; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	57	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105968	10.1371/journal.pone.0105968	http://dx.doi.org/10.1371/journal.pone.0105968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153322	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200098
J	Wang, QD; Chen, GW; Wang, ZQ; Hu, CS; Hu, XQ; Fu, GY				Wang, Qiandong; Chen, Guowei; Wang, Zhaoquan; Hu, Chao S.; Hu, Xiaoqing; Fu, Genyue			Implicit Racial Attitudes Influence Perceived Emotional Intensity on Other-Race Faces	PLOS ONE			English	Article							FACIAL EXPRESSIONS; SOCIAL CATEGORIZATION; AMYGDALA RESPONSES; ASSOCIATION TEST; PREJUDICE; RECOGNITION; STEREOTYPES; PERCEPTION; AMERICANS; BLACK	An ability to accurately perceive and evaluate out-group members' emotions plays a critical role in intergroup interactions. Here we showed that Chinese participants' implicit attitudes toward White people bias their perception and judgment of emotional intensity of White people's facial expressions such as anger, fear and sadness. We found that Chinese participants held pro-Chinese/anti-White implicit biases that were assessed in an evaluative implicit association test (IAT). Moreover, their implicit biases positively predicted the perceived intensity of White people's angry, fearful and sad facial expressions but not for happy expressions. This study demonstrates that implicit racial attitudes can influence perception and judgment of a range of emotional expressions. Implications for intergroup interactions were discussed.	[Wang, Qiandong; Chen, Guowei; Wang, Zhaoquan; Fu, Genyue] Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China; [Hu, Chao S.] Univ Toronto, Appl Psychol & Human Dev Dept, Toronto, ON, Canada; [Hu, Xiaoqing] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA	Zhejiang Normal University; University of Toronto; Northwestern University	Fu, GY (corresponding author), Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China.	xhu@u.northwestern.edu; fugy@zjnu.edu.cn		Hu, Xiaoqing/0000-0001-8112-9700	National Natural Science Foundation of China [31070894]; Keith A. McLeod Scholarship from the Ontario Institute for Studies in Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Keith A. McLeod Scholarship from the Ontario Institute for Studies in Education	This research was funded by National Natural Science Foundation of China, No. 31070894 (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Keith A. McLeod Scholarship from the Ontario Institute for Studies in Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2006, MOTIV EMOTION, V30, P179, DOI 10.1007/s11031-006-9020-2; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Castelli L, 2009, DEV PSYCHOL, V45, P586, DOI 10.1037/a0014619; Crandall CS, 2002, J PERS SOC PSYCHOL, V82, P359, DOI 10.1037//0022-3514.82.3.359; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dasgupta N, 2000, J EXP SOC PSYCHOL, V36, P316, DOI 10.1006/jesp.1999.1418; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1996, MOTIV EMOTION, V20, P149, DOI 10.1007/BF02253869; Dunham Y, 2008, TRENDS COGN SCI, V12, P248, DOI 10.1016/j.tics.2008.04.006; Dunham Y, 2013, PSYCHOL SCI, V24, P860, DOI 10.1177/0956797612463081; Dunham Y, 2011, J EXP SOC PSYCHOL, V47, P668, DOI 10.1016/j.jesp.2011.01.003; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Gonsalkorale K, 2009, J EXP SOC PSYCHOL, V45, P161, DOI 10.1016/j.jesp.2008.07.022; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hugenberg K, 2005, EMOTION, V5, P267, DOI 10.1037/1528-3542.5.3.267; Hugenberg K, 2004, PSYCHOL SCI, V15, P342, DOI 10.1111/j.0956-7976.2004.00680.x; Hugenberg K, 2003, PSYCHOL SCI, V14, P640, DOI 10.1046/j.0956-7976.2003.psci_1478.x; Humphreys K, 2007, NEUROPSYCHOLOGIA, V45, P685, DOI 10.1016/j.neuropsychologia.2006.08.003; Hutchings PB, 2008, J EXP SOC PSYCHOL, V44, P1418, DOI 10.1016/j.jesp.2008.05.002; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lundqvist D., 1998, KAROLINSKA DIRECTED; McConnell AR, 2001, J EXP SOC PSYCHOL, V37, P435, DOI 10.1006/jesp.2000.1470; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Newheiser A-K, 2013, PREFERENCE HIGH STAT; Newheiser AK, 2012, J EXP SOC PSYCHOL, V48, P264, DOI 10.1016/j.jesp.2011.08.011; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Rosenthal MZ, 2011, PERSONALITY DISORDER, V2; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; TAJFEL H, 1970, SCI AM, V223, P96, DOI 10.1038/scientificamerican1170-96; Tan A, 2009, HOWARD J COMMUN, V20, P260, DOI 10.1080/10646170903065803; Trawalter S, 2008, J EXP SOC PSYCHOL, V44, P1322, DOI 10.1016/j.jesp.2008.03.006; VAUGHAN GM, 1981, SOC PSYCHOL QUART, V44, P37, DOI 10.2307/3033861; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Williams MA, 2005, NEUROIMAGE, V24, P417, DOI 10.1016/j.neuroimage.2004.08.017	44	7	8	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105946	10.1371/journal.pone.0105946	http://dx.doi.org/10.1371/journal.pone.0105946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153836	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200093
J	Cosgrove, C; Berger, CT; Kroy, DC; Cheney, PC; Ghebremichael, M; Aneja, J; Tomlinson, M; Kim, AY; Lauer, GM; Alter, G				Cosgrove, Cormac; Berger, Christoph T.; Kroy, Daniela C.; Cheney, Patrick C.; Ghebremichael, Musie; Aneja, Jasneet; Tomlinson, Michelle; Kim, Arthur Y.; Lauer, Georg M.; Alter, Galit			Chronic HCV Infection Affects the NK Cell Phenotype in the Blood More than in the Liver	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NATURAL-KILLER-CELLS; INHIBITORY RECEPTOR GENES; IG-LIKE RECEPTORS; T-CELLS; ACTIVATION; EXPRESSION; REPLICATION; RESPONSES; IMMUNITY	Although epidemiological and functional studies have implicated NK cells in protection and early clearance of HCV, the mechanism by which they may contribute to viral control is poorly understood, particularly at the site of infection, the liver. We hypothesized that a unique immunophenotypic/functional NK cell signature exists in the liver that may provide insights into the contribution of NK cells to viral control. Intrahepatic and blood NK cells were profiled from chronically infected HCV-positive and HCV-negative individuals. Baseline expression of activating and inhibitory receptors was assessed, as well as functional responses following stimulation through classic NK cell pathways. Independent of HCV infection, the liver was enriched for the immunoregulatory CD56(bright) NK cell population, which produced less IFN gamma and CD107a but comparable levels of MIP1 beta, and was immunophenotypically distinct from their blood counterparts. This profile was mostly unaltered in chronic HCV infection, though different expression levels of NKp46 and NKG2D were associated with different grades of fibrosis. In contrast to the liver, chronic HCV infection associated with an enrichment of CD161(low) perforin(high) NK cells in the blood correlated with increased AST and 2B4 expression. However, the association of relatively discrete changes in the NK cell phenotype in the liver with the fibrosis stage nevertheless suggests an important role for the NK response. Overall these data suggest that tissue localization has a more pervasive effect on NK cells than the presence of chronic viral infection, during which these cells might be mostly attuned to limiting immunopathology. It will be important to characterize NK cells during early HCV infection, when they should have a critical role in limiting infection.	[Cosgrove, Cormac; Berger, Christoph T.; Cheney, Patrick C.; Ghebremichael, Musie; Alter, Galit] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Kroy, Daniela C.; Aneja, Jasneet; Tomlinson, Michelle; Kim, Arthur Y.; Lauer, Georg M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kroy, Daniela C.] Rhein Westfal TH Aachen, Univ Hosp, D-52062 Aachen, Germany; [Kim, Arthur Y.; Lauer, Georg M.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Harvard University; Harvard Medical School	Alter, G (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.	galter@mgh.harvard.edu	Berger, Christoph T/I-6126-2019; Lauer, Georg/J-1467-2018	Berger, Christoph T/0000-0002-1730-8824; Lauer, Georg/0000-0002-9792-4271	National Institutes of Health [AI08230, AI066345]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the National Institutes of Health U19 #AI08230 and U19 #AI066345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Alter G, 2011, J HEPATOL, V55, P278, DOI 10.1016/j.jhep.2010.11.030; [Anonymous], 1925, J CLIN INVEST, V120, P1925, DOI [10.1172/JCI41264, DOI 10.1172/JCI41264]; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Burt BM, 2009, J IMMUNOL, V183, P1789, DOI 10.4049/jimmunol.0900541; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Carrega P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00347; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Farag MMS, 2011, CLIN EXP IMMUNOL, V165, P352, DOI 10.1111/j.1365-2249.2011.04431.x; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Fogli M, 2004, EUR J IMMUNOL, V34, P2313, DOI 10.1002/eji.200425251; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Glassner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54; Golden-Mason L, 2013, IMMUNOL REV, V255, P68, DOI 10.1111/imr.12090; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Kawarabayashi N, 2000, HEPATOLOGY, V32, P962, DOI 10.1053/jhep.2000.19362; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Khashab M, 2010, ENDOSCOPY, V42, P228, DOI 10.1055/s-0029-1243859; Klugewitz K, 2004, TRENDS IMMUNOL, V25, P590, DOI 10.1016/j.it.2004.09.006; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Kroy DC, 2014, GASTROENTEROLOGY, V146, P550, DOI 10.1053/j.gastro.2013.10.022; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lang PA, 2010, HEPATOLOGY, V52, P25, DOI 10.1002/hep.23640; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lauer GM, 2013, J INFECT DIS, V207, pS7, DOI 10.1093/infdis/jis762; Liang TJ, 2013, NAT MED, V19, P869, DOI 10.1038/nm.3183; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Nattermann J, 2006, GUT; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Parsons MS, 2014, J IMMUNOL, V192, P308, DOI 10.4049/jimmunol.1301247; Pelletier S, 2010, J HEPATOL, V53, P805, DOI 10.1016/j.jhep.2010.05.013; Pembroke T, 2014, GUT, V63, P515, DOI 10.1136/gutjnl-2013-304472; Romero V, 2008, MOL IMMUNOL, V45, P2429, DOI 10.1016/j.molimm.2008.01.002; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Stepp SE, 2000, IMMUNOL TODAY, V21, P254, DOI 10.1016/S0167-5699(00)01622-4; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Varchetta S, 2012, HEPATOLOGY, V56, P841, DOI 10.1002/hep.25723; Waggoner SN, 2012, NATURE, V481, P394, DOI [10.1038/nature10624, DOI 10.1038/nature10624]; Yamagiwa S, 2008, HEPATOL RES, V38, P664, DOI 10.1111/j.1872-034X.2008.00317.x; YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257	45	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105950	10.1371/journal.pone.0105950	http://dx.doi.org/10.1371/journal.pone.0105950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148254	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600099
J	Ebrahimi, M; Bull, CM				Ebrahimi, Mehregan; Bull, C. Michael			Short-Term Dispersal Response of an Endangered Australian Lizard Varies with Time of Year	PLOS ONE			English	Article							BLUE-TONGUE LIZARD; PYGMY BLUETONGUE LIZARDS; TILIQUA-ADELAIDENSIS; ANIMAL TRANSLOCATION; BREEDING DISPERSAL; ARTIFICIAL BURROWS; BIASED DISPERSAL; GENE FLOW; CONSERVATION; MOVEMENT	Dispersal is an important component in the demography of animal populations. Many animals show seasonal changes in their tendency to disperse, reflecting changes in resource availability, mating opportunities, or in population age structure at the time when new offspring enter the population. Understanding when and why dispersal occurs can be important for the management of endangered species. The pygmy bluetongue lizard is an endangered Australian species that occupies and defends single burrow refuges for extended periods of time, rarely moving far from the burrow entrance. However, previous pitfall trapping data have suggested movement of adult males in spring and of juveniles in autumn of each year. In the current study we compared behaviours of adult lizards each month, over the spring-summer activity period over two consecutive field seasons, to provide deeper understanding of the seasonal dispersal pattern. We released adult pygmy bluetongue lizards into a central area, provided with artificial burrows, within large enclosures, and monitored the behaviour and movements of the released lizards over a four day period. There was a consistent decline in time spent basking, amount of movement around burrow entrances, and rates of dispersal from the central release area from early spring to late summer. Results could be relevant to understanding and managing natural populations and for any translocation attempts of this endangered lizard species.	[Ebrahimi, Mehregan; Bull, C. Michael] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Ebrahimi, Mehregan] Shiraz Univ, Dept Biol, Shiraz, Fars Province, Iran	Flinders University South Australia; Shiraz University	Ebrahimi, M (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	mehregan.ebrahimi@flinders.edu.au	Ebrahimi, Mehregan/H-3614-2013	Ebrahimi, Mehregan/0000-0002-7140-047X; Ebrahimi, Mehregan/0000-0003-1897-9694; Bull, Michael/0000-0002-9350-5950	Australian Research Council [LP0883495]; SA Department of the Environment, Water and Natural Resources; Field Naturalists Society of SA; SA Museum; Northern and Yorke NRM Board; SA Murray-Darling NRM Board; Holsworth Wildlife Research Endowment; Sir Mark Mitchell Research Foundation; Ministry of Sciences, Research and Technology of Iran; Zoos SA	Australian Research Council(Australian Research Council); SA Department of the Environment, Water and Natural Resources; Field Naturalists Society of SA; SA Museum; Northern and Yorke NRM Board; SA Murray-Darling NRM Board; Holsworth Wildlife Research Endowment; Sir Mark Mitchell Research Foundation; Ministry of Sciences, Research and Technology of Iran; Zoos SA	There are no current external funding sources for this study. This research was supported by funding from the Australian Research Council: Linkage grant LP0883495 "Translocation as a conservation strategy for the Pygmy Bluetongue Lizard.'' Partner organizations who also provided funding to the same grant were Zoos SA (http://www.zoossa.com.au), the SA Department of the Environment, Water and Natural Resources (http://www.environment.sa.gov.au), the Field Naturalists Society of SA (http://www.fnssa.org.au), the SA Museum (http://www.samuseum.sa.gov.au), the Northern and Yorke NRM Board and the SA Murray-Darling NRM Board (http://www.naturalresources.sa.gov.au). Other research student grants were awarded to Mehregan Ebrahimi by the Holsworth Wildlife Research Endowment (http://www.anz.com.au/personal/private-banktrustees/trustees/granting/granting-programs/small-grants/) and the Sir Mark Mitchell Research Foundation (http://www.aetlimited.com.au). The Ministry of Sciences, Research and Technology of Iran (http://www.msrt.ir/) sponsored the PhD studies of Mehregan Ebrahimi. No individuals employed or contracted by any of the funders played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodinof CM, 2012, HERPETOLOGICA, V68, P160, DOI 10.1655/HERPETOLOGICA-D-11-00033.1; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; BRIGHT PW, 1994, J APPL ECOL, V31, P699, DOI 10.2307/2404160; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Ebrahimi M, 2013, J ARID ENV IN PRESS; Ebrahimi M, 2014, APPL ANIM BEHAV SCI, V156, P94, DOI 10.1016/j.applanim.2014.04.013; Ebrahimi M, 2013, AMPHIBIA-REPTILIA, V34, P31, DOI 10.1163/15685381-00002863; Ebrahimi Mehregan, 2012, Endangered Species Research, V18, P169, DOI 10.3354/esr00446; Ebrahimi M, 2012, WILDLIFE RES, V39, P295, DOI 10.1071/WR11155; Fellows HL, 2009, J ZOOL, V279, P156, DOI 10.1111/j.1469-7998.2009.00600.x; Fenner AL, 2011, J ZOOL, V283, P45, DOI 10.1111/j.1469-7998.2010.00742.x; Fenner AL, 2008, WILDLIFE RES, V35, P158, DOI 10.1071/WR07103; Fenner AL, 2008, COMP PARASITOL, V75, P69, DOI 10.1654/4316.1; Fenner AL, 2010, WILDLIFE RES, V37, P582, DOI 10.1071/WR10122; Fenner Aaron L., 2009, Herpetological Review, V40, P91; Fenner AL, 2014, HERPETOFAUN IN PRESS; Gandon Sylvain, 2001, P155; Gilliam JF, 2001, ECOLOGY, V82, P258, DOI 10.2307/2680101; Hanski I., 1999, METAPOPULATION ECOLO; Hardman B, 2006, BIOL CONSERV, V128, P403, DOI 10.1016/j.biocon.2005.10.006; HEDRICK PW, 1995, CONSERV BIOL, V9, P996, DOI 10.1046/j.1523-1739.1995.9050988.x-i1; Hutchinson Mark N., 1994, Transactions of the Royal Society of South Australia, V118, P217; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; Macdonald David W., 2001, P358; Milne T, 2003, J HERPETOL, V37, P762, DOI 10.1670/38-03N; Milne T, 2003, WILDLIFE RES, V30, P523, DOI 10.1071/WR02087; Milne T, 2002, J HERPETOL, V36, P110, DOI 10.2307/1565812; Olsson M, 2003, BIOL J LINN SOC, V79, P277, DOI 10.1046/j.1095-8312.2003.00116.x; Olsson M, 1997, BIOL J LINN SOC, V60, P243; Railsback SF, 1999, ECOL MODEL, V123, P73, DOI 10.1016/S0304-3800(99)00124-6; Rosatte R, 2002, ANN NY ACAD SCI, V969, P358, DOI 10.1111/j.1749-6632.2002.tb04405.x; Schaefer J, 2001, FRESHWATER BIOL, V46, P379, DOI 10.1046/j.1365-2427.2001.00685.x; Schofield JA, 2012, WILDLIFE RES, V39, P677, DOI 10.1071/WR12098; Scillitani L, 2013, J WILDLIFE MANAGE, V77, P761, DOI 10.1002/jwmg.517; Shier DM, 2006, CONSERV BIOL, V20, P1780, DOI 10.1111/j.1523-1739.2006.00512.x; Smith AL, 2009, WILDLIFE RES, V36, P466, DOI 10.1071/WR08171; Souter NJ, 2004, BIOL CONSERV, V116, P403, DOI 10.1016/S0006-3207(03)00232-5; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Tucker AD, 1998, BEHAV ECOL SOCIOBIOL, V44, P85, DOI 10.1007/s002650050519; Wallace M.P, 2000, BEHAV CONSERVATION, P300	42	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106002	10.1371/journal.pone.0106002	http://dx.doi.org/10.1371/journal.pone.0106002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147949	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600108
J	Patra, D; DeLassus, E; Liang, GS; Sandell, LJ				Patra, Debabrata; DeLassus, Elizabeth; Liang, Guosheng; Sandell, Linda J.			Cartilage-Specific Ablation of Site-1 Protease in Mice Results in the Endoplasmic Reticulum Entrapment of Type IIB Procollagen and Down-Regulation of Cholesterol and Lipid Homeostasis	PLOS ONE			English	Article							ASPARAGINE SYNTHETASE GENE; TRANSCRIPTION FACTOR; ER STRESS; TARGETED DISRUPTION; BONE-DEVELOPMENT; CELL-DEATH; PROTEOLYSIS; EXPRESSION; ATF6; ACTIVATION	The proprotein convertase site-1 protease (S1P) converts latent ER-membrane bound transcription factors SREBPs and ATF6 to their active forms. SREBPs are involved in cholesterol and fatty acid homeostasis whereas ATF6 is involved in unfolded protein response pathways (UPR). Cartilage-specific ablation of S1P in mice (S1P(cko)) results in abnormal cartilage devoid of type II collagen protein (Col II). S1P(cko) mice also lack endochondral bone development. To analyze S1P(cko) cartilage we performed double-labeled immunofluorescence studies for matrix proteins that demonstrated that type IIB procollagen is trapped inside the ER in S1P(cko) chondrocytes. This retention is specific to type IIB procollagen; other cartilage proteins such as type IIA procollagen, cartilage oligomeric matrix protein (COMP) and aggrecan are not affected. The S1P(cko) cartilage thus exhibits COMP-, aggrecan-, and type IIA procollagen-derived matrices but is characterized by the absence of a type IIB procollagen-derived matrix. To understand the molecular reason behind S1P(cko) phenotypes we performed genome-wide transcriptional profiling of cartilage isolated from S1P(cko) and wild type littermates. While the UPR pathways are unaffected, the SREBPs-directed cholesterol and fatty acid pathways are significantly down-regulated in S1P(cko) chondrocytes, with maximal down-regulation of the stearoyl-CoA desaturase-1 (Scd1) gene. However, mouse models that lack Scd1 or exhibit reduction in lipid homeostasis do not suffer from the ER retention of Col II or lack endochondral bone. These studies indicate an indispensable role for S1P in type IIB procollagen trafficking from the ER. This role appears not to be related to lipid pathways or other current known functions of S1P and is likely dependent on additional, yet unknown, S1P substrates in chondrocytes.	[Patra, Debabrata; DeLassus, Elizabeth; Sandell, Linda J.] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Sandell, Linda J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Liang, Guosheng] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas	Patra, D (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.	patrad@wudosis.wustl.edu			National Institutes of Health [RO1 AR050847, RO1 AR045550, HL020948, 1P30AR057235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045550, P30AR057235, R01AR050847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health RO1 AR050847 and RO1 AR045550 to L. J. Sandell and HL020948 to G. Liang and by a 1P30AR057235 to the Musculoskeletal Research Center at Washington University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Barbosa-Tessmann IP, 1999, J BIOL CHEM, V274, P31139, DOI 10.1074/jbc.274.44.31139; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Caplan AI, 1987, BONE MINERAL RES, P117; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Gartel AL, 2002, MOL CANCER THER, V1, P639; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Horton W. A., 1993, EXTRACELLULAR MATRIX, P73; Khan SU, 2008, CYTOTECHNOLOGY, V57, P207, DOI 10.1007/s10616-008-9157-9; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Li LX, 2011, J BIOL CHEM, V286, P17809, DOI 10.1074/jbc.M110.180893; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Long FX, 2001, DEVELOPMENT, V128, P5099; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okayasu M, 2012, J BIOL CHEM, V287, P19229, DOI 10.1074/jbc.M111.323600; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Patra D, 2014, MATRIX BIOL, V34, P154, DOI 10.1016/j.matbio.2013.10.014; Patra D, 2011, J BIOL CHEM, V286, P29227, DOI 10.1074/jbc.M110.208686; POOLE AR, 1991, CARTILAGE MOL ASPECT, P179; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Wu SF, 2004, J BIOL CHEM, V279, P4642, DOI 10.1074/jbc.M305518200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	55	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105674	10.1371/journal.pone.0105674	http://dx.doi.org/10.1371/journal.pone.0105674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147951	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600066
J	Rey, E; Barcelo, M; Cebrian, MJJ; Alvarez-Sanchez, A; Diaz-Rubio, M; Rocha, AL				Rey, Enrique; Barcelo, Marta; Jimenez Cebrian, Maria Jose; Alvarez-Sanchez, Angel; Diaz-Rubio, Manuel; Lopez Rocha, Alberto			A Nation-Wide Study of Prevalence and Risk Factors for Fecal Impaction in Nursing Homes	PLOS ONE			English	Article							QUALITY-OF-LIFE; CHRONIC CONSTIPATION; ELDERLY POPULATION; INCONTINENCE; HEALTH; QUESTIONNAIRE; DISORDERS	Background: There are no existing studies that provide data regarding the epidemiology of, and risk factors for, fecal impaction, either in the general population or in any sub-group of people. Objective: Estimate the prevalence of and factors associated with fecal impaction on a representative sample of the institutionalized elderly population. Design: Two-phase study. Phase 1: pilot study validating the methodology in which all residents of a single nursing home participated. Phase 2: national multi-center cross-sectional study. Setting: 34 randomly selected nursing homes. Measurements: The presence of fecal impaction and associated factors were evaluated using three different tools: data collected from medical records; a self-completion questionnaire filled out by the subjects or a proxy; and a rectal examination. Subjects: Older subjects living in nursing homes. Results: The prevalence of chronic constipation was 70.7% (95% CI: 67.3-74.1%), of which 95.9% of patients were properly diagnosed and 43.1% were properly controlled. The prevalence of FI according to patient history was 47.3% (43.6-51.0%) and 6.6% (4.7-8.5%) according to rectal examination. Controlled constipation (OR: 9.8 [5.2-18.4]) and uncontrolled constipation (OR: 37.21 [19.7-70.1]), the number of medications (OR: 1.2 [1.1-1.3]), reduced functional capacity (OR: 0.98 [0.97-0.99]) and the occasional use of NSAIDs were independent risk factors for fecal impaction. Conclusions: Constipation affects more than 70% of people living in nursing homes. Although it is properly diagnosed in more than 95% of cases, the disease is only controlled in less than 50%. Constipation, especially when not controlled, is the most significant risk factor leading to fecal impaction, which is prevalent in almost 50% of this population.	[Rey, Enrique; Barcelo, Marta; Alvarez-Sanchez, Angel; Diaz-Rubio, Manuel] Univ Complutense, Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Div Digest Dis, E-28040 Madrid, Spain; [Jimenez Cebrian, Maria Jose] Ctr Valdeluz, Madrid, Spain; [Jimenez Cebrian, Maria Jose; Lopez Rocha, Alberto] Spanish Soc Nursing Homes Phys, SEMER, Madrid, Spain	Complutense University of Madrid; Hospital Clinico San Carlos	Rey, E (corresponding author), Univ Complutense, Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Div Digest Dis, E-28040 Madrid, Spain.	rey.enrique.spain@gmail.com	SANCHEZ, ANGEL ALVAREZ/AAZ-8018-2020; Rey, Enrique/B-9492-2008	Rey, Enrique/0000-0002-5060-7105	Norgive Iberia	Norgive Iberia	This project was funded by an unrestricted grant from Norgive Iberia. The funders has no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-24; Bouras EP, 2009, GASTROENTEROL CLIN N, V38, P463, DOI 10.1016/j.gtc.2009.06.001; Chang JY, 2007, NEUROGASTROENT MOTIL, V19, P905, DOI 10.1111/j.1365-2982.2007.00974.x; Chassagne P, 1999, AM J MED, V106, P185, DOI 10.1016/S0002-9343(98)00407-0; Coyne KS, 2011, BJU INT, V107, P254, DOI 10.1111/j.1464-410X.2010.09446.x; Creason N, 2000, Nurs Diagn, V11, P15; De Lillo AR, 2000, AM J GASTROENTEROL, V95, P901, DOI 10.1016/S0002-9270(00)00718-8; Dennison C, 2005, PHARMACOECONOMICS, V23, P461, DOI 10.2165/00019053-200523050-00006; Equipo Portal Mayores, 2010, INF PORT MAYOR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank Lori, 2002, J Am Med Dir Assoc, V3, P215, DOI 10.1016/S1525-8610(04)70481-8; Gallagher P, 2009, BEST PRACT RES CL GA, V23, P875, DOI 10.1016/j.bpg.2009.09.001; Giannakouris K, 2010, REGIONAL POPULATION; Glia A, 1997, SCAND J GASTROENTERO, V32, P1083, DOI 10.3109/00365529709002985; GURLL N, 1975, DIS COLON RECTUM, V18, P507, DOI 10.1007/BF02587220; HARARI D, 1994, J AM GERIATR SOC, V42, P947, DOI 10.1111/j.1532-5415.1994.tb06585.x; Jones A, 2009, NATL NURSING HOME SU, V13; Kimberly Binaso-Stwalley, 2007, Director, V15, P20; KINNUNEN O, 1989, Z GERONTOL, V22, P321; Kinnunen O, 1991, Aging (Milano), V3, P161; Lal S, 1967, Am J Proctol, V18, P226; Lobo A, 1979, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V7, P189; MAHONEY F I, 1965, Md State Med J, V14, P61; Marfil C, 2005, J NUTR HEALTH AGING, V9, P185; Morgan DR, 2010, GASTROENTEROLOGY, V138, pS386; Morillas J, 2006, NUTR HOSP, V21, P650; OECD, 2011, HLTH GLANC 2011 OECD; OKEEFE EA, 1992, J GERONTOL, V47, pM116, DOI 10.1093/geronj/47.4.M116; PRIMROSE WR, 1987, AGE AGEING, V16, P25; Rao SSC, 2007, GASTROENTEROL CLIN N, V36, P687, DOI 10.1016/j.gtc.2007.07.013; Singh G, 2007, CLIN GASTROENTEROL H, V5, P1053, DOI 10.1016/j.cgh.2007.04.019; Starer P, 2000, ARCH GERONTOL GERIAT, V30, P47, DOI 10.1016/S0167-4943(99)00051-5; Talley Nicholas J, 2004, Rev Gastroenterol Disord, V4 Suppl 2, pS3; WIGZELL FW, 1969, GERONTOL CLIN, V11, P137, DOI 10.1159/000245227; WRENN K, 1989, NEW ENGL J MED, V321, P658	35	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105281	10.1371/journal.pone.0105281	http://dx.doi.org/10.1371/journal.pone.0105281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148393	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600040
J	Suzuki, K; Fukuda, T; Liao, YJ				Suzuki, Katsumi; Fukuda, Takeshi; Liao, Yingjie			Electrosprayed Molybdenum Trioxide Aqueous Solution and Its Application in Organic Photovoltaic Cells	PLOS ONE			English	Article							SOLUTION-PROCESSED MOO3; SOLAR-CELLS; HOLE-INJECTION; METAL-OXIDES; DEPOSITION; LAYER; FILMS; TRANSISTORS; EFFICIENCY	A molybdenum trioxide thin film with smooth surface and uniform thickness was successfully achieved by an electrospray deposition method using an aqueous solution with a drastically low concentration of 0.05 wt%. Previous papers demonstrated that an additive solvent technique is useful for depositing the thin film by the electrospray deposition, and the high vapor pressure and a low surface tension of an additive solvent were found to be important factors. As a result, the smooth molybdenum trioxide thin film was obtained when the acetonitrile was used as the additive solvent. Furthermore, the vapor pressure of acetone is much higher than that of aqueous solution, and this indicates that the acetone is easily evaporated after spraying from the glass capillary. By optimizing a concentration of acetone in the molybdenum aqueous solution, a minimum root mean square roughness of the MoO3 thin film became 3.7 nm. In addition, an organic photovoltaic cell was also demonstrated using the molybdenum trioxide as a hole transport layer. Highest photoconversion efficiency was 1.72%, a value comparable to that using conventional thermal evaporation process even though the aqueous solution was used for the solution process. The photovonversion efficiency was not an optimized value, and the higher value can be achieved by optimizing the coating condition of the active layer.	[Suzuki, Katsumi; Fukuda, Takeshi; Liao, Yingjie] Saitama Univ, Grad Sch Sci & Engn, Dept Funct Mat Sci, Saitama 3388570, Japan	Saitama University	Fukuda, T (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Dept Funct Mat Sci, Saitama 3388570, Japan.	fukuda@fms.saitama-u.ac.jp	Liao, Yingjie/L-8678-2013; Fukuda, Takeshi/G-8647-2011		JSPS KAKENHI [26420267]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number (26420267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2011, J APPL PHYS, V110, DOI 10.1063/1.3633519; Ali M, 2012, ORG ELECTRON, V13, P2130, DOI 10.1016/j.orgel.2012.06.016; Ameri T, 2013, ADV MATER, V25, P4245, DOI 10.1002/adma.201300623; Balendhran S, 2013, ADV FUNCT MATER, V23, P3952, DOI 10.1002/adfm.201300125; Bodnar E, 2013, J COLLOID INTERF SCI, V407, P536, DOI 10.1016/j.jcis.2013.06.013; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Fujita K, 2002, JPN J APPL PHYS 2, V41, pL70, DOI 10.1143/JJAP.41.L70; Fukuda T, 2013, PHYS STATUS SOLIDI-R, V7, P1055, DOI 10.1002/pssr.201308167; Fukuda T, 2012, PHYS STATUS SOLIDI A, V209, P2324, DOI 10.1002/pssa.201228242; Fukuda T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BK12; Fukuda T, 2011, THIN SOLID FILMS, V520, P600, DOI 10.1016/j.tsf.2011.07.048; Fukuda T, 2011, PHYS STATUS SOLIDI-R, V5, P229, DOI 10.1002/pssr.201105232; Fukuda T, 2009, THIN SOLID FILMS, V518, P575, DOI 10.1016/j.tsf.2009.07.020; Ganan-Calvo AM., 1994, J AEROSOL SCI, V25S, pS309, DOI [10.1016/0021-8502(94)90384-0, DOI 10.1016/0021-8502(94)90384-0]; Girotto C, 2011, ACS APPL MATER INTER, V3, P3244, DOI 10.1021/am200729k; Green MA, 2011, PROG PHOTOVOLTAICS, V19, P84, DOI 10.1002/pip.1088; Grimaldi IA, 2012, SYNTHETIC MET, V161, P2618, DOI 10.1016/j.synthmet.2011.08.004; Han S, 2009, ORG ELECTRON, V10, P791, DOI 10.1016/j.orgel.2009.03.016; Jaworek A, 2008, J ELECTROSTAT, V66, P197, DOI 10.1016/j.elstat.2007.10.001; Jaworek A, 2007, J MATER SCI, V42, P266, DOI 10.1007/s10853-006-0842-9; Jaworek A, 2014, J ELECTROSTAT, V72, P166, DOI 10.1016/j.elstat.2014.01.004; Ju J, 2009, ADV MATER, V21, P4343, DOI 10.1002/adma.200900444; Koishikawa Y, 2013, THIN SOLID FILMS, V545, P527, DOI 10.1016/j.tsf.2013.07.083; Krebs FC, 2004, SOL ENERG MAT SOL C, V83, P293, DOI 10.1016/j.solmat.2004.02.031; Ku BK, 2002, J AEROSOL SCI, V33, P1361, DOI 10.1016/S0021-8502(02)00075-7; Liao Y, 2014, THIN SOLID FILMS, V554, P132, DOI 10.1016/j.tsf.2013.08.019; Lim YF, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3021022; Meyer J, 2011, ADV MATER, V23, P70, DOI 10.1002/adma.201003065; Nakayama K, 2011, ADV MATER, V23, P1626, DOI 10.1002/adma.201004387; Nasu K, 2013, CHEM COMMUN, V49, P10385, DOI 10.1039/c3cc44179b; Ozden-Yenigun E, 2013, PHYS CHEM CHEM PHYS, V15, P17862, DOI 10.1039/c3cp53079e; Radacsi N, 2012, CRYST GROWTH DES, V12, P3514, DOI 10.1021/cg300285w; RAYLEIGH FRS, 1882, PHILOS MAG, V14, P184, DOI DOI 10.1080/14786448208628425; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Seo H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.024103; Steirer KX, 2009, SOL ENERG MAT SOL C, V93, P447, DOI 10.1016/j.solmat.2008.10.026; Steirer KX, 2009, THIN SOLID FILMS, V517, P2781, DOI 10.1016/j.tsf.2008.10.124; Takayama M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05DC15; Teichler A, 2013, J MATER CHEM C, V1, P1910, DOI 10.1039/c2tc00255h; Tekin E, 2008, SOFT MATTER, V4, P703, DOI 10.1039/b711984d; Tokito S, 1996, J PHYS D APPL PHYS, V29, P2750, DOI 10.1088/0022-3727/29/11/004; Torsi L, 2013, CHEM SOC REV, V42, P8612, DOI 10.1039/c3cs60127g; Tseng YC, 2012, SOL ENERG MAT SOL C, V99, P235, DOI 10.1016/j.solmat.2011.12.004; Walia S, 2013, PROG MATER SCI, V58, P1443, DOI 10.1016/j.pmatsci.2013.06.003; Xu MF, 2013, ORG ELECTRON, V14, P657, DOI 10.1016/j.orgel.2012.12.016; Yamauchi H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.01AB16; Zhao XY, 2014, SOL ENERG MAT SOL C, V121, P119, DOI 10.1016/j.solmat.2013.10.020	47	5	5	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106012	10.1371/journal.pone.0106012	http://dx.doi.org/10.1371/journal.pone.0106012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148047	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600109
J	Wuest, SC; Mexhitaj, I; Chai, NR; Romm, E; Scheffel, J; Xu, BY; Lane, K; Wu, TX; Bielekova, B				Wuest, Simone C.; Mexhitaj, Ina; Chai, Noo Ri; Romm, Elena; Scheffel, Joerg; Xu, Biying; Lane, Kelly; Wu, Tianxia; Bielekova, Bibiana			A Complex Role of Herpes Viruses in the Disease Process of Multiple Sclerosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID; T-CELLS; DEMYELINATING DISEASES; ISLET AUTOANTIBODIES; DACLIZUMAB; PROGRESSION; SERUM; RISK	Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system (CNS). Neither the antigenic target(s) nor the cell population(s) responsible for CNS tissue destruction in MS have been fully defined. The objective of this study was to simultaneously determine the antigen (Ag)-specificity and phenotype of un-manipulated intrathecal CD4(+) and CD8(+) T cells of patients with relapsing-remitting and progressive MS compared to subjects with other inflammatory neurological diseases. We applied a novel Ag-recognition assay based on co-cultures of freshly obtained cerebrospinal fluid T cells and autologous dendritic cells pre-loaded with complex candidate Ag's. We observed comparably low T cell responses to complex auto-Ag's including human myelin, brain homogenate, and cell lysates of apoptotically modified oligodendroglial and neuronal cells in all cohorts and both compartments. Conversely, we detected a strong intrathecal enrichment of Epstein-Barr virus- and human herpes virus 6-specific (but not cytomegalovirus-specific) reactivities of the Th1-phenotype throughout all patients. Qualitatively, the intrathecal enrichment of herpes virus reactivities was more pronounced in MS patients. This enrichment was completely reversed by long-term treatment with the IL-2 modulating antibody daclizumab, which strongly inhibits MS disease activity. Finally, we observed a striking discrepancy between diminished intrathecal T cell proliferation and enhanced cytokine production of herpes virus-specific T cells among progressive MS patients, consistent with the phenotype of terminally differentiated cells. The data suggest that intrathecal administration of novel therapeutic agents targeting immune cells outside of the proliferation cycle may be necessary to effectively eliminate intrathecal inflammation in progressive MS.	[Wuest, Simone C.; Mexhitaj, Ina; Chai, Noo Ri; Romm, Elena; Bielekova, Bibiana] NINDS, Neuroimmunol Dis Unit, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Scheffel, Joerg] NIAMSD, Mol Immunol Sect, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Xu, Biying; Lane, Kelly] NHLBI, Imaging Probe Dev Ctr, NIH, Bethesda, MD 20892 USA; [Wu, Tianxia] NINDS, Clin Neurosci Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bielekova, B (corresponding author), NINDS, Neuroimmunol Dis Unit, Neuroimmunol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	Bibi.Bielekova@nih.gov	Bielekova, Bibiana/V-1452-2017; Bielekova, Bibiana/AAA-8115-2020	Bielekova, Bibiana/0000-0002-0959-9430; Bielekova, Bibiana/0000-0002-0959-9430	NINDS intramural program; NINDS competitive fellowship; AbbVie Biotherapeutics and Biogen/IDEC [CRADA 2010-0039]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003055, ZIANS003056] Funding Source: NIH RePORTER	NINDS intramural program; NINDS competitive fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AbbVie Biotherapeutics and Biogen/IDEC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the NINDS intramural program, the NINDS competitive fellowship to S.C.W., and by AbbVie Biotherapeutics and Biogen/IDEC (CRADA# 2010-0039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour N, 2003, J NEUROIMMUNOL, V137, P197, DOI 10.1016/S0165-5728(03)00080-8; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Banwell B, 2008, ANN NEUROL, V63, P98, DOI 10.1002/ana.21244; BAXEVANIS CN, 1989, J NEUROIMMUNOL, V22, P23, DOI 10.1016/0165-5728(89)90005-2; Becker KJ, 2012, J NEUROCHEM, V123, P148, DOI 10.1111/j.1471-4159.2012.07953.x; Becker KJ, 2011, STROKE, V42, P2763, DOI 10.1161/STROKEAHA.111.619593; Bickham K, 2001, J CLIN INVEST, V107, P121, DOI 10.1172/JCI10209; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bielekova B, 2011, NEUROLOGY, V77, P1877, DOI 10.1212/WNL.0b013e318239f7ef; Bielekova B, 2004, J IMMUNOL, V172, P3893, DOI 10.4049/jimmunol.172.6.3893; Bielekova B, 2009, ARCH NEUROL-CHICAGO, V66, P483, DOI 10.1001/archneurol.2009.50; Buljevac D, 2005, J NEUROL NEUROSUR PS, V76, P1377, DOI 10.1136/jnnp.2004.048504; Castellazzi M, 2010, MULT SCLER J, V16, P883, DOI 10.1177/1352458510368051; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Derfuss T, 2005, J NEUROL, V252, P968, DOI 10.1007/s00415-005-0794-z; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Edwards LJ, 2013, AM J CLIN EXP IMMUNO, V2, P234; Hall JC, 2004, RHEUM DIS CLIN N AM, V30, P455, DOI 10.1016/j.rdc.2004.04.012; HAN S, 2014, J IMMUNOL; Hufner K, 2007, J NEUROVIROL, V13, P462, DOI 10.1080/13550280701447059; Hummel M, 2004, ANN INTERN MED, V140, P882, DOI 10.7326/0003-4819-140-11-200406010-00009; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Lunemann JD, 2007, CURR NEUROL NEUROSCI, V7, P253, DOI 10.1007/s11910-007-0038-y; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; MAIMONE D, 1991, J NEUROIMMUNOL, V32, P67, DOI 10.1016/0165-5728(91)90073-G; Ngono AE, 2012, CLIN IMMUNOL, V144, P117, DOI 10.1016/j.clim.2012.05.009; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Connor KC, 2003, J NEUROIMMUNOL, V136, P140, DOI 10.1016/S0165-5728(03)00002-X; OLSSON T, 1992, EUR J IMMUNOL, V22, P1083, DOI 10.1002/eji.1830220431; Peferoen LAN, 2010, BRAIN, V133, DOI 10.1093/brain/awp296; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Pohl D, 2010, J NEUROL, V257, P212, DOI 10.1007/s00415-009-5296-y; Reindl M, 2013, NAT REV NEUROL, V9, P455, DOI 10.1038/nrneurol.2013.118; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawtell NA, 2004, J VIROL, V78, P7784, DOI 10.1128/JVI.78.14.7784-7794.2004; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Soldan SS, 2001, ADV VIRUS RES, V56, P517, DOI 10.1016/S0065-3527(01)56037-6; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; TSUKADA N, 1991, J NEUROL SCI, V104, P230, DOI 10.1016/0022-510X(91)90315-X; Utz PJ, 2000, ARTHRITIS RES, V2, P101, DOI 10.1186/ar75; VILLEGAS E, 2011, DIAGN MICROBIOL INFE; Virtanen JO, 2011, J NEUROIMMUNOL, V237, P93, DOI 10.1016/j.jneuroim.2011.06.012; von Budingen HC, 2012, J CLIN INVEST, V122, P4533, DOI 10.1172/JCI63842; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	51	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105434	10.1371/journal.pone.0105434	http://dx.doi.org/10.1371/journal.pone.0105434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148387	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600046
J	Akbar, H; Hayat, K; ul Haq, N; Bajwa, UI				Akbar, Habib; Hayat, Khizar; ul Haq, Nuhman; Bajwa, Usama Ijaz			Bilateral Symmetry Detection on the Basis of Scale Invariant Feature Transform	PLOS ONE			English	Article								The automatic detection of bilateral symmetry is a challenging task in computer vision and pattern recognition. This paper presents an approach for the detection of bilateral symmetry in digital single object images. Our method relies on the extraction of Scale Invariant Feature Transform (SIFT) based feature points, which serves as the basis for the ascertainment of the centroid of the object; the latter being the origin under the Cartesian coordinate system to be converted to the polar coordinate system in order to facilitate the selection symmetric coordinate pairs. This is followed by comparing the gradient magnitude and orientation of the corresponding points to evaluate the amount of symmetry exhibited by each pair of points. The experimental results show that our approach draw the symmetry line accurately, provided that the observed centroid point is true.	[Akbar, Habib; Hayat, Khizar; ul Haq, Nuhman; Bajwa, Usama Ijaz] COMSATS Inst Informat Technol, Abbottabad, Pakistan; [Hayat, Khizar] Univ Nizwa, Coll Arts & Sci, Nizwa, Oman	COMSATS University Islamabad (CUI); University of Nizwa	Hayat, K (corresponding author), COMSATS Inst Informat Technol, Abbottabad, Pakistan.	khizarhayat@ciit.net.pk	Ul Haq, Nuhman/AGY-8616-2022; Hayat, Khizar/P-8954-2019	Bajwa, Usama/0000-0001-5755-1194; Hayat, Khizar/0000-0001-5216-6019				Davis LS, 1977, IEEE T SYST MAN CYB, V7; Keller Y, 2004, INT C PATT RECOG, P186, DOI 10.1109/ICPR.2004.1334499; Kootstra G., 2008, P BRIT MACH VIS C BM; KUEHNLE A, 1991, PATTERN RECOGN LETT, V12, P249, DOI 10.1016/0167-8655(91)90039-O; Lee S, 2012, IEEE T PATTERN ANAL, V34, P266, DOI 10.1109/TPAMI.2011.118; Li WH, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P4867, DOI 10.1109/IROS.2006.282442; Liu J, 2010, COMPUTER VISION ACCV, P102; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; LOWE DG, 2004, INT J COMPUTER VISIO; Loy G, 2003, IEEE T PATTERN ANAL, V25, P959, DOI 10.1109/TPAMI.2003.1217601; Loy G, 2006, LECT NOTES COMPUT SC, V3952, P508; Lu YX, 2009, FOUND TRENDS COMPUT, V5, P1, DOI 10.1561/0600000008; Mancas M, 2005, INT CONF ACOUST SPEE, P725; MAROLA G, 1989, IEEE T PATTERN ANAL, V11, P104, DOI 10.1109/34.23119; MASUDA T, 1993, PATTERN RECOGN, V26, P1245, DOI 10.1016/0031-3203(93)90209-F; Mitra S, 2007, STAT COMPUT, V17, P57, DOI 10.1007/s11222-006-9004-9; Park M., P 2008 IEEE 19 INT S, P1, DOI [10.1109/PIMRC.2008.4699890, DOI 10.1109/PIMRC.2008.4699890]; REISFELD D, 1995, INT J COMPUT VISION, V14, P119, DOI 10.1007/BF01418978; Sharvit D, 1998, IEEE WORKSHOP ON CONTENT-BASED ACCESS OF IMAGE AND VIDEO LIBRARIES - PROCEEDINGS, P56, DOI 10.1109/IVL.1998.694496; WH Li, 2005, P AUSTR C ROB AUT; Zabrodsky H., 1993, Proceedings. 1993 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.93CH3309-2), P678, DOI 10.1109/CVPR.1993.341031	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103561	10.1371/journal.pone.0103561	http://dx.doi.org/10.1371/journal.pone.0103561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144655	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100007
J	Dhal, PK; Barman, RK; Saha, S; Das, S				Dhal, Paltu Kumar; Barman, Ranjan Kumar; Saha, Sudipto; Das, Santasabuj			Dynamic Modularity of Host Protein Interaction Networks in Salmonella Typhi Infection	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; DILATED CARDIOMYOPATHY; COMPLEX NETWORKS; COEXPRESSION; CYTOSCAPE; REGULON; IDENTIFICATION; PROLIFERATION	Background: Salmonella Typhi is a human-restricted pathogen, which causes typhoid fever and remains a global health problem in the developing countries. Although previously reported host expression datasets had identified putative biomarkers and therapeutic targets of typhoid fever, the underlying molecular mechanism of pathogenesis remains incompletely understood. Methods: We used five gene expression datasets of human peripheral blood from patients suffering from S. Typhi or other bacteremic infections or non-infectious disease like leukemia. The expression datasets were merged into human protein interaction network (PIN) and the expression correlation between the hubs and their interacting proteins was measured by calculating Pearson Correlation Coefficient (PCC) values. The differences in the average PCC for each hub between the disease states and their respective controls were calculated for studied datasets. The individual hubs and their interactors with expression, PCC and average PCC values were treated as dynamic subnetworks. The hubs that showed unique trends of alterations specific to S. Typhi infection were identified. Results: We identified S. Typhi infection-specific dynamic subnetworks of the host, which involve 81 hubs and 1343 interactions. The major enriched GO biological process terms in the identified subnetworks were regulation of apoptosis and biological adhesions, while the enriched pathways include cytokine signalling in the immune system and downstream TCR signalling. The dynamic nature of the hubs CCR1, IRS2 and PRKCA with their interactors was studied in detail. The difference in the dynamics of the subnetworks specific to S. Typhi infection suggests a potential molecular model of typhoid fever. Conclusions: Hubs and their interactors of the S. Typhi infection-specific dynamic subnetworks carrying distinct PCC values compared with the non-typhoid and other disease conditions reveal new insight into the pathogenesis of S. Typhi.	[Dhal, Paltu Kumar; Barman, Ranjan Kumar; Das, Santasabuj] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata, W Bengal, India; [Das, Santasabuj] Natl Inst Cholera & Enter Dis, Div Clin Med, Kolkata, W Bengal, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Science & Technology (India); Bose Institute	Saha, S (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India.	ssaha4@jcbose.ac.in; dasss@icmr.org.in	Dhal, Paltu Kumar/AAA-2895-2022; Barman, Ranjan Kumar/GXZ-8073-2022; Saha, Sudipto/AAF-1034-2020	Dhal, Paltu Kumar/0000-0001-5790-3268; Barman, Ranjan Kumar/0000-0001-9901-3108; Saha, Sudipto/0000-0001-9433-8894	Indian Council of Medical Research (IRIS) [2013-1551G]; Department of Biotechnology [BT/RLF/Re-entry/11/2011]	Indian Council of Medical Research (IRIS)(Indian Council of Medical Research (ICMR)); Department of Biotechnology	This work was supported by Indian Council of Medical Research [extramural project (IRIS ID: 2013-1551G)]. SS thanks the Department of Biotechnology for Ramalingaswami fellowship (BT/RLF/Re-entry/11/2011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amundsen SS, 2010, GENES IMMUN, V11, P79, DOI 10.1038/gene.2009.67; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Bhardwaj Nitin, 2009, Journal of Bioinformatics and Computational Biology, V7, P1, DOI 10.1142/S0219720009003959; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Camargo A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001347; Camargo A, 2008, GENOMICS, V92, P404, DOI 10.1016/j.ygeno.2008.05.007; Charles RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006994; Cooke Fiona J, 2004, Travel Med Infect Dis, V2, P67, DOI 10.1016/j.tmaid.2004.04.005; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Ghosh S, 2011, P NATL ACAD SCI USA, V108, P3348, DOI 10.1073/pnas.1016180108; Giallourakis C, 2000, J BIOL CHEM, V275, P29275, DOI 10.1074/jbc.M002853200; Gingras SB, 2001, J STEROID BIOCHEM, V76, P213, DOI 10.1016/S0960-0760(00)00148-5; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; Gustin MP, 2008, PHYSIOL GENOMICS, V34, P34, DOI 10.1152/physiolgenomics.00008.2008; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Harrell F. E., 2006, HMISC HARRELL MISCEL; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Khoo SK, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-241; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lin CC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-138; Lutay N, 2013, J CLIN INVEST, V123, P2366, DOI 10.1172/JCI66451; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-99; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Pritykin Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003243; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheikh A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001419; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thompson LJ, 2009, P NATL ACAD SCI USA, V106, P22433, DOI 10.1073/pnas.0912386106; Uthe JJ, 2011, ANIM GENET, V42, P521, DOI 10.1111/j.1365-2052.2010.02171.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winter SE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001060; Winter SE, 2009, MOL MICROBIOL, V74, P175, DOI 10.1111/j.1365-2958.2009.06859.x; Wu C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-182; Wurster AL, 2002, MOL CELL BIOL, V22, P117, DOI 10.1128/MCB.22.1.117-126.2002; Xiaotu M, 2013, BRIEF BIOINFORM, V2013; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yeung KY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r48	51	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104911	10.1371/journal.pone.0104911	http://dx.doi.org/10.1371/journal.pone.0104911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144185	Green Submitted, gold, Green Published			2022-12-27	WOS:000341106100031
J	Jansson, EKH; Clemens, LE; Riess, O; Nguyen, HP				Jansson, Erik Karl Hakan; Clemens, Laura Emily; Riess, Olaf; Huu Phuc Nguyen			Reduced Motivation in the BACHD Rat Model of Huntington Disease Is Dependent on the Choice of Food Deprivation Strategy	PLOS ONE			English	Article							MONOSODIUM GLUTAMATE; MOUSE MODEL; WEIGHT-LOSS; HYPOTHALAMIC OBESITY; MUTANT HUNTINGTIN; NEUROPEPTIDE-Y; BODY-WEIGHT; MOTOR; LESIONS; LEPTIN	Huntington disease (HD) is an inherited neurodegenerative disease characterized by motor, cognitive, psychiatric and metabolic symptoms. Animal models of HD show phenotypes that can be divided into similar categories, with the metabolic phenotype of certain models being characterized by obesity. Although interesting in terms of modeling metabolic symptoms of HD, the obesity phenotype can be problematic as it might confound the results of certain behavioral tests. This concerns the assessment of cognitive function in particular, as tests for such phenotypes are often based on food depriving the animals and having them perform tasks for food rewards. The BACHD rat is a recently established animal model of HD, and in order to ensure that behavioral characterization of these rats is done in a reliable way, a basic understanding of their physiology is needed. Here, we show that BACHD rats are obese and suffer from discrete developmental deficits. When assessing the motivation to lever push for a food reward, BACHD rats were found to be less motivated than wild type rats, although this phenotype was dependent on the food deprivation strategy. Specifically, the phenotype was present when rats of both genotypes were deprived to 85% of their respective free-feeding body weight, but not when deprivation levels were adjusted in order to match the rats' apparent hunger levels. The study emphasizes the importance of considering metabolic abnormalities as a confounding factor when performing behavioral characterization of HD animal models.	[Huu Phuc Nguyen] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; Univ Tubingen, Ctr Rare Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Nguyen, HP (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany.	hoa.nguyen@med.uni-tuebingen.de	Nguyen, Huu Phuc/HDO-3462-2022	Nguyen, Huu Phuc/0000-0001-6139-788X; Clemensson, Erik/0000-0002-5158-6924	Medical Faculty of the University of Tuebingen; German Academic Exchange Program (DAAD) [54366469]; Deutsche Forschungsgemeinschaft; Tuebingen University	Medical Faculty of the University of Tuebingen; German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	The study was funded by yearly funds allocated to the Institute of Medical Genetics and Applied Genomics by the Medical Faculty of the University of Tuebingen, to maintain animals. Erik Jansson received a stipend from the German Academic Exchange Program (DAAD: https://www.daad.de/en/) under the Procope program, project number: 54366469. The authors also acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University for publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068584, 10.1371/journal.pone.0071633]; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2008, J NEUROL, V255, P1872, DOI 10.1007/s00415-009-0062-8; Bergen HT, 1998, ENDOCRINOLOGY, V139, P4483, DOI 10.1210/en.139.11.4483; Bradbury MJ, 2005, J PHARMACOL EXP THER, V313, P395, DOI 10.1124/jpet.104.076406; Chen W, 2013, N-S ARCH PHARMACOL, V386, P721, DOI 10.1007/s00210-013-0875-y; Clemens LE, 2014, GENES BRAIN BEHAV, V13, P305, DOI 10.1111/gbb.12093; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Eagle DM, 1999, BEHAV NEUROSCI, V113, P718, DOI 10.1037/0735-7044.113.4.718; Enkel T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00010; Fielding SA, 2012, BRAIN RES BULL, V88, P223, DOI 10.1016/j.brainresbull.2011.09.011; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Harrington DL, 2012, J NEUROL NEUROSUR PS, V83, P612, DOI 10.1136/jnnp-2011-301732; Hollopeter G, 1998, INT J OBESITY, V22, P506, DOI 10.1038/sj.ijo.0800615; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Kanoski SE, 2014, NEUROPSYCHOPHARMACOL, V39, P605, DOI 10.1038/npp.2013.235; Kirkwood SC, 2001, ARCH NEUROL-CHICAGO, V58, P273, DOI 10.1001/archneur.58.2.273; Kudwa AE, 2013, PLOS CURR, V30, P5; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lee JK, 2012, NEUROLOGY, V79, P668, DOI 10.1212/WNL.0b013e3182648b65; Lemiere J, 2004, J NEUROL, V251, P935, DOI 10.1007/s00415-004-0461-9; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Meyer C, 2012, MOVEMENT DISORD, V27, P118, DOI 10.1002/mds.23847; Morris MJ, 1998, REGUL PEPTIDES, V75-6, P441, DOI 10.1016/S0167-0115(98)00100-1; Naarding P, 2009, J NEUROPSYCH CLIN N, V21, P266, DOI 10.1176/appi.neuropsych.21.3.266; Nguyen GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064368; Oakeshott Stephen, 2012, PLoS Curr, V4, pe4f972cffe82c0, DOI 10.1371/4f972cffe82c0; Oakeshott Stephen, 2013, PLoS Curr, V5, DOI 10.1371/currents.hd.fe74c94bdd446a0470f6f905a30b5dd1; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Remmers F, 2008, PHYSIOL BEHAV, V95, P208, DOI 10.1016/j.physbeh.2008.05.021; Robbins AO, 2006, EUR J NEUROL, V13, pE7, DOI 10.1111/j.1468-1331.2006.01319.x; Roth JD, 2012, DIABETES OBES METAB, V14, P608, DOI 10.1111/j.1463-1326.2012.01570.x; SCALLET AC, 1986, BRAIN RES, V374, P380, DOI 10.1016/0006-8993(86)90434-8; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schmelzeis MC, 1996, BEHAV NEUROSCI, V110, P1049; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; SKJOLDAGER P, 1993, LEARN MOTIV, V24, P303, DOI 10.1006/lmot.1993.1019; TANAKA K, 1978, EXP NEUROL, V62, P191, DOI 10.1016/0014-4886(78)90050-X; Trueman RC, 2012, BRAIN RES BULL, V88, P261, DOI 10.1016/j.brainresbull.2011.03.015; Trueman RC, 2009, BEHAV BRAIN RES, V203, P215, DOI 10.1016/j.bbr.2009.05.006; Vaccarino AL, 2011, MOVEMENT DISORD, V26, P877, DOI 10.1002/mds.23574; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; WHISHAW IQ, 1988, PHYSIOL BEHAV, V43, P397, DOI 10.1016/0031-9384(88)90205-3; Youn J, 2012, BEHAV BRAIN RES, V226, P397, DOI 10.1016/j.bbr.2011.09.034; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	55	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105662	10.1371/journal.pone.0105662	http://dx.doi.org/10.1371/journal.pone.0105662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144554	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100106
J	de Rezende, LFM; Lopes, MR; Rey-Lopez, JP; Matsudo, VKR; Luiz, OD				Machado de Rezende, Leandro Fornias; Lopes, Mauricio Rodrigues; Rey-Lopez, Juan Pablo; Rodrigues Matsudo, Victor Keihan; Luiz, Olinda do Carmo			Sedentary Behavior and Health Outcomes: An Overview of Systematic Reviews	PLOS ONE			English	Review							TELEVISION VIEWING TIME; ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; CHILDHOOD OBESITY; LIFE-STYLE; CHILDREN; ADULTS; INDICATORS; ADOLESCENTS	Objective: 1) To synthesize the current observational evidence for the association between sedentary behavior and health outcomes using information from systematic reviews. 2) To assess the methodological quality of the systematic reviews found. Methodology/Principal Findings: Medline; Excerpta Medica (Embase); PsycINFO; and Web of Science were searched for reviews published up to September 2013. Additional publications were provided by Sedentary Behaviour Research Network members. The methodological quality of the systematic reviews was evaluated using recommended standard criteria from AMSTAR. For each review, improper use of causal language in the description of their main results/conclusion was evaluated. Altogether, 1,044 review titles were identified, 144 were read in their entirety, and 27 were included. Based on the systematic reviews with the best methodological quality, we found in children and adolescents, strong evidence of a relationship between time spent in sedentary behavior and obesity. Moreover, moderate evidence was observed for blood pressure and total cholesterol, self-esteem, social behavior problems, physical fitness and academic achievement. In adults, we found strong evidence of a relationship between sedentary behavior and all-cause mortality, fatal and non-fatal cardiovascular disease, type 2 diabetes and metabolic syndrome. In addition, there is moderate evidence for incidence rates of ovarian, colon and endometrial cancers. Conclusions: This overview based on the best available systematics reviews, shows that sedentary behavior may be an important determinant of health, independently of physical activity. However, the relationship is complex because it depends on the type of sedentary behavior and the age group studied. The relationship between sedentary behavior and many health outcomes remains uncertain; thus, further studies are warranted.	[Machado de Rezende, Leandro Fornias; Lopes, Mauricio Rodrigues; Rey-Lopez, Juan Pablo; Luiz, Olinda do Carmo] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; [Machado de Rezende, Leandro Fornias; Rodrigues Matsudo, Victor Keihan] Ctr Estudos Lab Aptidao Fis Sao Caetano do Sul, Sao Caetano do Sul, Brazil	Universidade de Sao Paulo	de Rezende, LFM (corresponding author), Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil.	lerezende@usp.br	Luiz, Olinda do Carmo/C-6075-2012; Rezende, Leandro F. M./C-1724-2012	Luiz, Olinda do Carmo/0000-0002-2596-3626; Rezende, Leandro F. M./0000-0002-7469-1399; Rey Lopez, Juan Pablo/0000-0002-7201-2006	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation) [2012/07314-8]; FAPESP, Sao Paulo Research Foundation [2012/057238]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP, Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study received financial support from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation; Grant no. 2012/07314-8). JPRL received financial support from the FAPESP, Sao Paulo Research Foundation: Grant no. 2012/057238. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Boyle T, 2012, AM J LIFESTYLE MED, V6, P204, DOI 10.1177/1559827612436932; Brown AW, 2013, AM J CLIN NUTR, V98, P1298, DOI 10.3945/ajcn.113.064410; Cerimele JM, 2013, GEN HOSP PSYCHIAT, V35, P16, DOI 10.1016/j.genhosppsych.2012.08.001; Chen SM, 2009, INT ARCH OCC ENV HEA, V82, P797, DOI 10.1007/s00420-009-0410-0; Chinapaw MJM, 2011, OBES REV, V12, pE621, DOI 10.1111/j.1467-789X.2011.00865.x; Costigan SA, 2013, J ADOLESCENT HEALTH, V52, P382, DOI 10.1016/j.jadohealth.2012.07.018; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Egger M, 1998, BRIT MED J, V316, P140; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Gabriel KKP, 2012, J PHYS ACT HEALTH, V9, pS11, DOI 10.1123/jpah.9.s1.s11; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoare E, 2014, OBES REV, V15, P40, DOI 10.1111/obr.12069; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028696; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; IARC Working Group on the Evaluation of Cancer-Preventive Agents, 2002, IARC HDB CANC PREV, V6; IJmker S, 2007, OCCUP ENVIRON MED, V64, P211, DOI 10.1136/oem.2006.026468; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LeBlanc AG, 2012, APPL PHYSIOL NUTR ME, V37, P753, DOI [10.1139/h2012-063, 10.1139/H2012-063]; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Leung MM, 2012, J OBES, V2012, DOI 10.1155/2012/685430; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; MacMillan F, 2014, PEDIATR DIABETES, V15, P175, DOI 10.1111/pedi.12060; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Mitrofan O, 2009, CHILD CARE HLTH DEV, V35, P5, DOI 10.1111/j.1365-2214.2008.00912.x; MORRIS JN, 1953, LANCET, V265, P1053; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Prentice-Dunn H, 2012, PSYCHOL HEALTH MED, V17, P255, DOI 10.1080/13548506.2011.608806; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Rossi CE, 2010, REV NUTR, V23, P607, DOI 10.1590/S1415-52732010000400011; Salmon J, 2011, AM J PREV MED, V41, P197, DOI 10.1016/j.amepre.2011.05.001; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Stubbe JH, 2007, PREV MED, V44, P148, DOI 10.1016/j.ypmed.2006.09.002; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; Teychenne M, 2013, AM J PREV MED, V45, P217, DOI 10.1016/j.amepre.2013.04.004; Teychenne M, 2011, INT J BEHAV MED, V17, P246, DOI 10.1007/s12529-010-9075-z; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; van Holten TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062080; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Velde SJT, 2012, OBES REV, V13, P56, DOI 10.1111/j.1467-789X.2011.00960.x; Waersted M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-79; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	56	510	528	18	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105620	10.1371/journal.pone.0105620	http://dx.doi.org/10.1371/journal.pone.0105620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144686	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100098
J	Wang, Y; Li, C; Duan, N; Li, B; Ding, XM; Yao, YF; Hu, J; Zhao, GP; Wang, J				Wang, Ying; Li, Chen; Duan, Na; Li, Bin; Ding, Xiao-Ming; Yao, Yu-Feng; Hu, Jun; Zhao, Guo-Ping; Wang, Jin			GInR Negatively Regulates the Transcription of the Alanine Dehydrogenase Encoding Gene ald in Amycolatopsis mediterranei U32 under Nitrogen Limited Conditions via Specific Binding to Its Major Transcription Initiation Site	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; STREPTOMYCES-COELICOLOR; MYCOBACTERIUM-SMEGMATIS; ESCHERICHIA-COLI; GLNR; METABOLISM; PROTEIN; IDENTIFICATION; ACTIVATION; EXPRESSION	Ammonium assimilation is catalyzed by two enzymatic pathways, i.e., glutamine synthetase/glutamate synthase (GS/GOGAT) and alanine dehydrogenase (AlaDH) in Amycolatopsis mediterranei U32. Under nitrogen-rich conditions, the AlaDH pathway is the major route for ammonium assimilation, while the GS/GOGAT pathway takes over when the extracellular nitrogen supply is limited. The global nitrogen regulator GlnR was previously characterized to activate the transcription of the GS encoding gene glnA in response to nitrogen limitation and is demonstrated in this study as a repressor for the transcription of the AlaDH encoding gene ald, whose regulation is consistent with the switch of the ammonium assimilation pathways from AlaDH to GS/GOGAT responding to nitrogen limitation. Three transcription initiation sites (TISs) of ald were determined with primer extension assay, among which transcription from aldP2 contributed the major transcripts under nitrogen-rich conditions but was repressed to an undetectable level in response to nitrogen limitation. Through DNase I footprinting assay, two separate regions were found to be protected by GlnR within ald promoter, within which three GlnR binding sites (a1, b1 sites in region I and a2 site in region II) were defined. Interestingly, the major TIS aldP2 is located in the middle of a2 site within region II. Therefore, one may easily conclude that GlnR represses the transcription of ald via specific binding to the GlnR binding sites, which obviously blocks the transcription initiation from aldP2 and therefore reduces ald transcripts.	[Wang, Ying; Zhao, Guo-Ping; Wang, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Wang, Ying; Li, Chen; Ding, Xiao-Ming; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol, Shanghai 200433, Peoples R China; [Duan, Na; Li, Bin; Hu, Jun] Chinese Acad Sci, Shanghai Inst Appl Phys, Phys Biol Lab, Shanghai, Peoples R China; [Yao, Yu-Feng] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Shanghai Jiao Tong University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Hu, J (corresponding author), Chinese Acad Sci, Shanghai Inst Appl Phys, Phys Biol Lab, Shanghai, Peoples R China.	hujun@sinap.ac.cn; gpzhao@sibs.ac.cn; cmg.wangjin@gmail.com	WANG, Jin/K-2085-2016; Wang, Jin/P-5458-2019	WANG, Jin/0000-0003-4008-9284; Wang, Jin/0000-0003-4008-9284; Zhao, Guo-Ping/0000-0002-7621-6620; Wang, Ying/0000-0003-2311-015X	National Natural Science Foundation of China [31121001]; National Basic Research Program of China [2012CB721102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	The work was supported by National Natural Science Foundation of China (31121001) and National Basic Research Program of China (2012CB721102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon J, 2008, J BACTERIOL, V190, P7108, DOI 10.1128/JB.00855-08; BENDER RA, 1991, MOL MICROBIOL, V5, P2575, DOI 10.1111/j.1365-2958.1991.tb01965.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Fink D, 2002, MOL MICROBIOL, V46, P331, DOI 10.1046/j.1365-2958.2002.03150.x; FISHER SH, 1989, J BACTERIOL, V171, P2372, DOI 10.1128/jb.171.5.2372-2377.1989; Jenkins VA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-301; Jenkins VA, 2012, FEMS MICROBIOL LETT, V330, P38, DOI 10.1111/j.1574-6968.2012.02530.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Lewis Richard A, 2011, BMC Res Notes, V4, P78, DOI 10.1186/1756-0500-4-78; Lin W, 2014, J BIOL CHEM, V289, P15413, DOI 10.1074/jbc.M113.543504; Lloyd G, 2001, ESSAYS BIOCHEM, V37, P17, DOI 10.1042/bse0370017; Mejia A, 1998, J ANTIBIOT, V51, P58, DOI 10.7164/antibiotics.51.58; Ni LY, 1984, ACTA MICROBIOL SIN, V24, P217; Pullan ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-175; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Semsey S, 2005, TRENDS BIOCHEM SCI, V30, P334, DOI 10.1016/j.tibs.2005.04.009; Shao ZH, 2009, IDENTIFICATION NITRA, P65; Tiffert Y, 2008, MOL MICROBIOL, V67, P861, DOI 10.1111/j.1365-2958.2007.06092.x; van Hijum SAFT, 2009, MICROBIOL MOL BIOL R, V73, P481, DOI 10.1128/MMBR.00037-08; Wang J, 2009, BIOCHEM BIOPH RES CO, V386, P77, DOI 10.1016/j.bbrc.2009.05.147; Wang Y, 2013, J BACTERIOL, V195, P2595, DOI 10.1128/JB.00182-13; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Yu H, 2007, ARCH MICROBIOL, V188, P89, DOI 10.1007/s00203-007-0228-7; Yu H, 2006, ACTA BIOCH BIOPH SIN, V38, P831, DOI 10.1111/j.1745-7270.2006.00238.x; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	28	6	7	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104811	10.1371/journal.pone.0104811	http://dx.doi.org/10.1371/journal.pone.0104811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144373	Green Submitted, gold, Green Published			2022-12-27	WOS:000341106100024
J	Zhang, PP; Liu, X; Wang, CB; Zhao, Y; Hua, F; Li, CF; Yang, RF; Zhou, L				Zhang, Pingping; Liu, Xiao; Wang, Chengbin; Zhao, Yong; Hua, Fei; Li, Chunfeng; Yang, Ruifu; Zhou, Lei			Evaluation of Up-Converting Phosphor Technology-Based Lateral Flow Strips for Rapid Detection of Bacillus anthracis Spore, Brucella spp., and Yersinia pestis	PLOS ONE			English	Article							QUANTITATIVE DETECTION; ASSAY; DIAGNOSIS; IMMUNOASSAY; ANTIBODIES; PLAGUE; REPORTERS; ANTIGEN; PCR	Bacillus anthracis, Brucella spp., and Yersinia pestis are zoonotic pathogens and biowarfare- or bioterrorism-associated agents that must be detected rapidly on-site from various samples (e.g., viscera and powders). An up-converting phosphor technology-based lateral flow (UPT-LF) strip was developed as a point-of-care testing (POCT) to satisfy the requirements of first-level emergency response. We developed UPT-LF POCT to quantitatively detect the three pathogens within 15 min. Sample and operation-error tolerances of the assay were comprehensively evaluated. The sensitivity of UPT-LF assay to bacterial detection reached 10(4) cfu.mL(-1) (100 cfu/test), with a linear quantitative range of 4 to 6 orders of magnitude. Results revealed that the UPT-LF assay exhibited a high specificity with the absence of false-positive results even at 10(9) cfu.mL(-1) of non-specific bacterial contamination. The assay could tolerate samples with a wide pH range (2 to 12), high ion strengths (>= 4 mol.L-1 of NaCl), high viscosities (>= 25 mg.mL(-1) of PEG20000 or >= 20% of glycerol), and high concentrations of bio-macromolecule (<= 200 mg.mL(-1) of bovine serum albumin or >= 80 mg.mL(-1) of casein). The influence of various types of powders and viscera (fresh and decomposed) on the performance of UPT-LF assay was determined. The operational error of liquid measurement exhibited few effects on sensitivity and specificity. The developed UPT-LF POCT assay is applicable under field conditions with excellent tolerance to sample complexity and operational error.	[Zhang, Pingping; Liu, Xiao; Zhao, Yong; Yang, Ruifu; Zhou, Lei] Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Liu, Xiao] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Wang, Chengbin; Li, Chunfeng] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Lab, Beijing, Peoples R China; [Hua, Fei] Taishan Med Univ, Dept Etiol, Tai An, Shandong, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Chongqing Medical University; Chinese People's Liberation Army General Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences	Yang, RF (corresponding author), Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; ammszhoulei@aliyun.com	Yang, Ruifu/A-2273-2011	Yang, Ruifu/0000-0003-3219-7269	National Natural Science Foundation of China [81000774]; National High Technology Research and Development Program of China [2013AA032205]; Major National Science and Technology Programs of China [2011ZX10004, 2012ZX1004801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major National Science and Technology Programs of China	This study was supported by the National Natural Science Foundation of China (Grant No. 81000774), the National High Technology Research and Development Program of China (Grant No. 2013AA032205) and the Major National Science and Technology Programs of China (Grant Nos. 2011ZX10004 and 2012ZX1004801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoako KK, 2012, J MICROBIOL METH, V90, P228, DOI 10.1016/j.mimet.2012.05.012; Begier EM, 2006, EMERG INFECT DIS, V12, P460, DOI 10.3201/eid1203.051051; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; Chanteau S, 2000, INT J MED MICROBIOL, V290, P279; Corstjens P, 2001, CLIN CHEM, V47, P1885; Corstjens PLAM, 2008, J CLIN MICROBIOL, V46, P171, DOI 10.1128/JCM.00877-07; Corstjens PLAM, 2011, CLIN BIOCHEM, V44, P1241, DOI 10.1016/j.clinbiochem.2011.06.983; Derzelle S, 2011, J MICROBIOL METH, V87, P195, DOI 10.1016/j.mimet.2011.08.005; Dichtwald S, 2008, BEST PRACT RES-CLIN, V22, P477, DOI 10.1016/j.bpa.2008.05.004; Garin-Bastuji B, 2006, SMALL RUMINANT RES, V62, P63, DOI 10.1016/j.smallrumres.2005.08.004; Genc O, 2011, J VET DIAGN INVEST, V23, P49, DOI 10.1177/104063871102300107; Gomes-Solecki MJC, 2005, CLIN DIAGN LAB IMMUN, V12, P339, DOI 10.1128/CDLI.12.2.339-346.2005; Hampl J, 2001, ANAL BIOCHEM, V288, P176, DOI 10.1006/abio.2000.4902; Hong WY, 2010, J MICROBIOL METH, V83, P133, DOI 10.1016/j.mimet.2010.08.005; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; Kuehn A, 2009, CLIN VACCINE IMMUNOL, V16, P1728, DOI 10.1128/CVI.00235-09; Li LP, 2009, DIAGN MICR INFEC DIS, V63, P165, DOI 10.1016/j.diagmicrobio.2008.10.020; Li Wei, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P761; Makino S, 2003, J MICROBIOL METH, V53, P141, DOI 10.1016/S0167-7012(03)00019-8; Niedbala RS, 2001, ANAL BIOCHEM, V293, P22, DOI 10.1006/abio.2001.5105; Nielsen K, 2007, VET MICROBIOL, V124, P173, DOI 10.1016/j.vetmic.2007.03.023; Nielsen K, 2007, J IMMUNOASS IMMUNOCH, V28, P61, DOI 10.1080/15321810601026125; Ongagna-Yhombi SY, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-74; Ouellette AL, 2009, ANAL CHEM, V81, P3216, DOI 10.1021/ac900475u; Porche Demetrius J, 2002, J Assoc Nurses AIDS Care, V13, P57, DOI 10.1177/105532902236783; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Qu Q, 2009, J MICROBIOL METH, V79, P121, DOI 10.1016/j.mimet.2009.07.015; Rao SS, 2010, BIOCHEM BIOPH RES CO, V395, P93, DOI 10.1016/j.bbrc.2010.03.145; Senior K, 2012, LANCET INFECT DIS, V12, P436, DOI 10.1016/S1473-3099(12)70128-7; Shott JP, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/651927; Simon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054947; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; Tamborrini M, 2010, CLIN VACCINE IMMUNOL, V17, P1446, DOI 10.1128/CVI.00205-10; Tuemmers C, 2013, REV CHIL INFECTOL, V30, P395, DOI 10.4067/S0716-10182013000400007; van Dam GJ, 2013, EXP PARASITOL, V135, P274, DOI 10.1016/j.exppara.2013.06.017; Wang DB, 2013, BIOSENS BIOELECTRON, V42, P661, DOI 10.1016/j.bios.2012.10.088; Yan ZQ, 2006, SENSOR ACTUAT B-CHEM, V119, P656, DOI 10.1016/j.snb.2006.01.029	38	34	41	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105305	10.1371/journal.pone.0105305	http://dx.doi.org/10.1371/journal.pone.0105305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144726	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100049
J	Barbosa, EJL; Glad, CAM; Nilsson, AG; Bosaeus, N; Nystrom, HF; Svensson, PA; Bengtsson, BA; Nilsson, S; Bosaeus, I; Boguszewski, CL; Johannsson, G				Barbosa, Edna J. L.; Glad, Camilla A. M.; Nilsson, Anna G.; Bosaeus, Niklas; Nystrom, Helena Filipsson; Svensson, Per-Arne; Bengtsson, Bengt-Ake; Nilsson, Staffan; Bosaeus, Ingvar; Boguszewski, Cesar Luiz; Johannsson, Gudmundur			Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CARDIOVASCULAR RISK-FACTORS; CHANNEL GAMMA-SUBUNIT; CL-COTRANSPORTER GENE; BIOIMPEDANCE SPECTROSCOPY; DOUBLE-BLIND; ENDOTHELIAL FUNCTION; GITELMANS-SYNDROME; BODY-COMPOSITION; RECEPTOR GENE	Objectives: Growth hormone deficiency (GHD) in adults is associated with decreased extracellular water volume (ECW). In response to GH replacement therapy (GHRT), ECW increases and blood pressure (BP) reduces or remains unchanged. Our primary aim was to study the association between polymorphisms in genes related to renal tubular function with ECW and BP before and 1 year after GHRT. The ECW measures using bioimpedance analysis (BIA) and bioimpedance spectroscopy (BIS) were validated against a reference method, the sodium bromide dilution method (Br-). Design and Methods: Using a candidate gene approach, fifteen single-nucleotide polymorphisms (SNPs) in nine genes with known impact on renal tubular function (AGT, SCNN1A, SCNN1G, SLC12A1, SLC12A3, KCNJ1, STK39, WNK1 and CASR) were genotyped and analyzed for associations with ECW and BP at baseline and with their changes after 1 year of GHRT in 311 adult GHD patients. ECW was measured with the Br-, BIA, and BIS. Results: Both BIA and BIS measurements demonstrated similar ECW results as the reference method. At baseline, after adjustment for sex and BMI, SNP rs2291340 in the SLC12A1 gene was associated with ECW volume in GHD patients (p = 0.039). None of the SNPs influenced the ECW response to GHRT. One SNP in the SLC12A3 gene (rs11643718; p = 0.024) and three SNPs in the SCNN1G gene [rs5723 (p = 0.02), rs5729 (p = 0.016) and rs13331086 (p = 0.035)] were associated with the inter-individual differences in BP levels at baseline. A polymorphism in the calcium-sensing receptor (CASR) gene (rs1965357) was associated with changes in systolic BP after GHRT (p = 0.036). None of these associations remained statistically significant when corrected for multiple testing. Conclusion: The BIA and BIS are as accurate as Br- to measure ECW in GHD adults before and during GHRT. Our study provides the first evidence that individual polymorphisms may have clinically relevant effects on ECW and BP in GHD adults.	[Barbosa, Edna J. L.; Glad, Camilla A. M.; Nilsson, Anna G.; Nystrom, Helena Filipsson; Bengtsson, Bengt-Ake; Johannsson, Gudmundur] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Endocrinol, Gothenburg, Sweden; [Barbosa, Edna J. L.; Boguszewski, Cesar Luiz] Univ Fed Parana, Hosp Clin, SEMPR, Serv Endocrinol & Metabol, BR-80060000 Curitiba, Parana, Brazil; [Glad, Camilla A. M.; Svensson, Per-Arne] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Ctr Cardiovasc & Metab Res, Inst Med,Dept Mol & Clin Med, Gothenburg, Sweden; [Nilsson, Staffan] Chalmers Univ Technol, Inst Math Sci, Dept Math Stat, S-41296 Gothenburg, Sweden; [Bosaeus, Niklas; Bosaeus, Ingvar] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Clin Nutr Unit, Gothenburg, Sweden	University of Gothenburg; Universidade Federal do Parana; University of Gothenburg; Chalmers University of Technology; Sahlgrenska University Hospital; University of Gothenburg	Johannsson, G (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Endocrinol, Gothenburg, Sweden.	gudmundur.johannsson@medic.gu.se	BOGUSZEWSKI, CESAR LUIZ/D-4603-2013; Boguszewski, Cesar Luiz/V-5661-2019; Svensson, Per-Arne/R-4626-2019; Nyström, Helena Filipsson/ABI-5659-2020	Boguszewski, Cesar Luiz/0000-0001-7285-7941; Nilsson, Staffan/0000-0003-4748-0446; Johannsson, Gudmundur/0000-0003-3484-8440; Svensson, Per-Arne/0000-0002-6731-806X	Swedish federal government under the LUA/ALF; NovoNordisk; Pfizer	Swedish federal government under the LUA/ALF; NovoNordisk(Novo Nordisk); Pfizer(Pfizer)	This project has received financial support from the Swedish federal government under the LUA/ALF agreement, NovoNordisk and Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boger RH, 1996, J CLIN INVEST, V98, P2706, DOI 10.1172/JCI119095; Busst CJ, 2011, HYPERTENSION, V58, P1073, DOI 10.1161/HYPERTENSIONAHA.111.176370; Busst CJ, 2007, HYPERTENSION, V50, P672, DOI 10.1161/HYPERTENSIONAHA.107.089128; Capaldo B, 2001, CIRCULATION, V103, P520, DOI 10.1161/01.CIR.103.4.520; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; CHIN E, 1992, ENDOCRINOLOGY, V131, P3061, DOI 10.1210/en.131.6.3061; DeLorenzo A, 1997, J APPL PHYSIOL, V82, P1542, DOI 10.1152/jappl.1997.82.5.1542; Dimke H, 2007, GROWTH HORM IGF RES, V17, P353, DOI 10.1016/j.ghir.2007.04.008; Dimke H, 2007, AM J PHYSIOL-RENAL, V292, pF723, DOI 10.1152/ajprenal.00276.2006; Evans LM, 2000, EUR J ENDOCRINOL, V142, P254, DOI 10.1530/eje.0.1420254; Hanisch Dorin, 2004, Anthropol Anz, V62, P51; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Iwai N, 2004, J HYPERTENS, V22, P1119, DOI 10.1097/00004872-200406000-00012; Jaffrin MY, 2009, MED BIOL ENG COMPUT, V47, P77, DOI 10.1007/s11517-008-0394-z; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Johannsson G, 2005, J CLIN ENDOCR METAB, V90, P3989, DOI 10.1210/jc.2005-0553; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P1743, DOI 10.1210/jc.87.4.1743; Jung JS, 2009, J CLIN ENDOCR METAB, V94, P1042, DOI 10.1210/jc.2008-1861; Koranyi J, 2006, EUR J ENDOCRINOL, V154, P545, DOI 10.1530/eje.1.02118; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x; Lin JL, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-9; Longobardi S, 2000, GROWTH HORM IGF RES, V10, P242, DOI 10.1054/ghir.2000.0160; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Matayoshi T, 2004, HYPERTENS RES, V27, P821, DOI 10.1291/hypres.27.821; Matsuo A, 2004, J HYPERTENS, V22, P2123, DOI 10.1097/00004872-200411000-00014; Matthie JR, 2005, J APPL PHYSIOL, V99, P780, DOI 10.1152/japplphysiol.00145.2005; Melander O, 2000, HYPERTENSION, V36, P389, DOI 10.1161/01.HYP.36.3.389; MILLER ME, 1989, AM J CLIN NUTR, V50, P168, DOI 10.1093/ajcn/50.1.168; Moller J, 1999, EUR J ENDOCRINOL, V140, P11, DOI 10.1530/eje.0.1400011; Pfeifer M, 1999, J CLIN ENDOCR METAB, V84, P453, DOI 10.1210/jc.84.2.453; Plank LD, 1998, APPL RADIAT ISOTOPES, V49, P481, DOI 10.1016/S0969-8043(97)00060-2; ROSEN T, 1993, CLIN ENDOCRINOL, V38, P63, DOI 10.1111/j.1365-2265.1993.tb00974.x; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P195, DOI 10.1530/acta.0.1290195; Rossoni G, 1999, J CARDIOVASC PHARM, V34, P454, DOI 10.1097/00005344-199909000-00021; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Silva AM, 2008, AM J CLIN NUTR, V88, P315, DOI 10.1093/ajcn/88.2.315; Silva AM, 2007, PHYSIOL MEAS, V28, P489, DOI 10.1088/0967-3334/28/5/004; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Smith JC, 2002, CLIN ENDOCRINOL, V56, P493, DOI 10.1046/j.1365-2265.2002.01514.x; SNEL YEM, 1995, ANN NUTR METAB, V39, P242, DOI 10.1159/000177869; Svensson J, 1997, CLIN ENDOCRINOL, V46, P579, DOI 10.1046/j.1365-2265.1997.1851001.x; Tanaka N, 2003, DIABETES, V52, P2848, DOI 10.2337/diabetes.52.11.2848; Tengvall M, 2010, PHYSIOL MEAS, V31, P59, DOI 10.1088/0967-3334/31/1/005; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; Tong QS, 2006, AM J PHYSIOL-RENAL, V290, pF821, DOI 10.1152/ajprenal.00312.2005; Turner ST, 2005, HYPERTENSION, V46, P758, DOI 10.1161/01.HYP.0000186240.81996.57; Vormfelde SV, 2007, CLIN PHARMACOL THER, V82, P300, DOI 10.1038/sj.clpt.6100131; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106	51	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105754	10.1371/journal.pone.0105754	http://dx.doi.org/10.1371/journal.pone.0105754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157616	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200058
J	Zhou, F; Zhang, L; Gao, L; Hao, YB; Zhao, XL; Liu, JM; Lu, J; Li, XW; Yang, Y; Chen, JG; Deng, Y				Zhou, Feng; Zhang, Li; Gao, Lei; Hao, Yibin; Zhao, Xianli; Liu, Jianmin; Lu, Jie; Li, Xiangwei; Yang, Yu; Chen, Junguo; Deng, Ying			Latent Tuberculosis Infection and Occupational Protection among Health Care Workers in Two Types of Public Hospitals in China	PLOS ONE			English	Article							RISK; DISEASE; ASSAY	Objective: To determine the impact factors of latent tuberculosis infection (LTBI) and the knowledge of TB prevention and treatment policy among health care workers (HCWs) in different types of hospitals and explore the strategies for improving TB prevention and control in medical institutions in China. Methods: A cross-sectional study was carried out to evaluate the risk of TB infection and personnel occupational protection among HCWs who directly engage in medical duties in one of two public hospitals. Each potential participant completed a structured questionnaire and performed a tuberculin skin test (TST). Factors associated with LTBI were identified by logistic regression analysis. Results: Seven hundred twelve HCWs completed questionnaires and 74.3% (n = 529) took the TST or had previous positive results. The TST-positive prevalence was 58.0% (n = 127) in the infectious disease hospital and 33.9% (n = 105) in the non-TB hospital. The duration of employment in the healthcare profession (6-10 years vs. <= 5 years [OR = 1.89; 95% CI = 1.10, 3.25] and >10 vs. <= 5[OR = 1.80; 95% CI = 1.20, 2.68]), type of hospital (OR = 2.40; 95% CI = 1.59, 3.62), and ever-employment in a HIV clinic or ward (OR = 1.87; 95% CI = 1.08, 3.26) were significantly associated with LTBI. The main reasons for an unwillingness to accept TST were previous positive TST results (70.2%) and concerns about skin reaction (31.9%). Conclusion: A high prevalence of TB infections was observed among HCWs working in high-risk settings and with long professional experiences in Henan Province in China. Comprehensive guidelines should be developed for different types of medical institutions to reduce TB transmission and ensure the health of HCWs.	[Zhou, Feng; Chen, Junguo] Third Mil Med Univ, Chongqing, Peoples R China; [Zhou, Feng; Zhang, Li; Deng, Ying] Beijing Res Ctr Prevent Med, Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Gao, Lei; Li, Xiangwei; Yang, Yu] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Gao, Lei; Li, Xiangwei; Yang, Yu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hao, Yibin] Zhengzhou Cent Hosp, Zhengzhou, Peoples R China; [Zhao, Xianli; Liu, Jianmin] Henan Prov Infect Dis Hosp, Zhengzhou, Peoples R China; [Lu, Jie] Zhengzhou Univ, Sch Publ Hlth, Zhengzhou 450052, Peoples R China	Army Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhengzhou University; Zhengzhou University	Chen, JG (corresponding author), Third Mil Med Univ, Chongqing, Peoples R China.	cqchenjunguo@sina.com; ydeng2014@sina.com		Yang, Yu/0000-0002-5611-8951	Institute of Pathogen Biology, Chinese Academy of Medical Science [IPB2011IPB104]	Institute of Pathogen Biology, Chinese Academy of Medical Science	This work was supported by the grants from the Institute of Pathogen Biology, Chinese Academy of Medical Science (IPB2011IPB104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC Ministry of Health of the People' Republic of China, 2008, GUID IMPL CHIN TUB C; Chai SJ, 2013, HEALTH POLICY PLANN, V28, P100, DOI 10.1093/heapol/czs029; Chinese Ministry of Health, 2013, ADM MEAS PREV CONTR; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Fennelly KP, 1999, INT J TUBERC LUNG D, V3, P363; Franco C, 2006, INT J TUBERC LUNG D, V10, P384; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010736; Harries AD, 1997, B WORLD HEALTH ORGAN, V75, P477; He GX, 2012, INT J TUBERC LUNG D, V16, P1485, DOI 10.5588/ijtld.12.0193; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kassim S, 2000, INT J TUBERC LUNG D, V4, P321; Kayanja HK, 2005, INT J TUBERC LUNG D, V9, P686; Li JM, 2006, CHINESE J PUBLIC HLT, V22, P488; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; National Technical Steering Group of the Epidemiological Sampling Survey for Tuberculosis, 2002, CHIN J TUBERC RESP D, V25, P5; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Sepkowitz KA, 1996, TUBERCLE LUNG DIS, V77, P81, DOI 10.1016/S0962-8479(96)90081-7; Wang Guo-jie, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P980; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2010, WHOHTMTB20107; Wrighton-Smith P, 2012, J OCCUP ENVIRON MED, V54, P806, DOI 10.1097/JOM.0b013e318254620f; Zahnow K, 1998, INFECT CONT HOSP EP, V19, P829; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066412; Zhou F, 2013, ZHONGGUO YU FANG YI, V14, P905	26	15	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104673	10.1371/journal.pone.0104673	http://dx.doi.org/10.1371/journal.pone.0104673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157814	gold, Green Published, Green Submitted			2022-12-27	WOS:000341303200015
J	Eutrope, J; Thierry, A; Lempp, F; Aupetit, L; Saad, S; Dodane, C; Bednarek, N; De Mare, L; Sibertin-Blanc, D; Nezelof, S; Rolland, AC				Eutrope, Julien; Thierry, Aurore; Lempp, Franziska; Aupetit, Laurence; Saad, Stephanie; Dodane, Catherine; Bednarek, Nathalie; De Mare, Laurence; Sibertin-Blanc, Daniel; Nezelof, Sylvie; Rolland, Anne-Catherine			Emotional Reactions of Mothers Facing Premature Births: Study of 100 Mother-Infant Dyads 32 Gestational Weeks	PLOS ONE			English	Article							PERINATAL PTSD QUESTIONNAIRE; POSTTRAUMATIC STRESS; POSTNATAL DEPRESSION; PRETERM BIRTH; LOW-RISK; PREDICTION; SYMPTOMS; DISTRESS; DELIVERY; PARENTS	Objectives: This current study has been conducted to clarify the relationship between the mother's post-traumatic reaction triggered by premature birth and the mother-infant interactions. In this article, the precocious maternal feelings are described. Methods: A multicenter prospective study was performed in three French hospitals. 100 dyads with 100 very premature infants and their mothers were recruited. Mothers completed, at two different times self-questionnaires of depression/anxiety, trauma and social support. The quality of interactions in the dyads was evaluated. Results: Thirty-nine percent of the mothers obtained a score at HADS suggesting a high risk of depression at the first visit and approximately one-third at visit two. Seventy-five percent of the mothers were at risk of suffering from an anxiety disorder at visit one and half remained so at visit two. A "depressed'' score at visits one and two correlated with a hospitalization for a threatened premature labor. We noted a high risk of trauma for 35% of the mothers and high interactional synchrony was observed for approximately two-thirds of the dyads. The mothers' psychological reactions such as depression and anxiety or postnatal depression correlate strongly with the presence of an initial trauma. At visit one and visit two, a high score of satisfaction concerning social support correlates negatively with presence of a trauma. A maternal risk of trauma is more frequent with a C-section delivery. Conclusions: Mothers' psychological reactions such as depression and anxiety correlate greatly with the presence of an initial trauma. The maternal traumatic reaction linked to premature birth does not correlate with the term at birth, but rather with the weight of the baby. Social support perceived by the mother is correlated with the absence of maternal trauma before returning home, and also seems to inhibit from depressive symptoms from the time of the infant's premature birth.	[Eutrope, Julien; Lempp, Franziska; Rolland, Anne-Catherine] CHU Reims, Hop Robert Debre, F-51092 Reims, France; [Thierry, Aurore] CHU Reims, Hop Robert Debre, Unite Aide Methodol, F-51092 Reims, France; [Aupetit, Laurence; De Mare, Laurence] Ctr Act Med Sociale Precoce, F-51100 Reims, France; [Saad, Stephanie; Sibertin-Blanc, Daniel] CHU Nancy, Ctr Psychotherap Nancy, Serv Pedopsychiat, F-54521 Laxou, France; [Dodane, Catherine; Nezelof, Sylvie] CHU Besancon, Hop St Jacques, Serv Psychiat Enfant & Adolescent, F-25030 Besancon, France; [Bednarek, Nathalie] CHU Reims, Hop Maison Blanche, F-51092 Reims, France	CHU de Reims; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Nancy; Universite de Franche-Comte; CHU Besancon; CHU de Reims	Eutrope, J (corresponding author), CHU Reims, Hop Robert Debre, F-51092 Reims, France.	jeutrope@chu-reims.fr		Rolland, Anne-Catherine/0000-0002-5013-2373; EUTROPE, Julien/0000-0001-7628-292X; Nezelof, Sylvie/0000-0001-9758-9648	Hospital Clinical Research Program of the French Ministry of Health [PHRC 2008]	Hospital Clinical Research Program of the French Ministry of Health	This study was supported by grants from the Hospital Clinical Research Program of the French Ministry of Health (PHRC 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, LANCET, V371, P1551, DOI DOI 10.1016/S0140-6736(08)60663-7; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Borghini A, 2009, NEUROPSYCHIAT ENFAN, V57, P385; Callahan JL, 2006, J PERINATOL, V26, P533, DOI 10.1038/sj.jp.7211562; Carter JD, 2005, ARCH DIS CHILD-FETAL, V90, P109, DOI 10.1136/adc.2003.031641; CENSULLO M, 1987, NURS RES, V36, P244; COHEN SE, 1983, CHILD DEV, V54, P1242; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Creedy DK, 2000, BIRTH-ISS PERINAT C, V27, P104, DOI 10.1046/j.1523-536x.2000.00104.x; Daltveit AK, 2008, OBSTET GYNECOL, V111, P1327, DOI 10.1097/AOG.0b013e3181744110; Davis L, 2003, EARLY HUM DEV, V73, P61, DOI 10.1016/S0378-3782(03)00073-2; De Muylder X, 1989, J REPROD INFANT PSYC, V7, P55; Drewett R, 2004, J CHILD PSYCHOL PSYC, V45, P359, DOI 10.1111/j.1469-7610.2004.00226.x; Druon C, 1996, ECOUTE BEBE PREMATUR; Feeley N, 2011, APPL NURS RES, V24, P114, DOI 10.1016/j.apnr.2009.04.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hamilton Brady E, 2006, Natl Vital Stat Rep, V55, P1; Hinz A, 2011, J PSYCHOSOM RES, V71, P74, DOI 10.1016/j.jpsychores.2011.01.005; HOLDEN JM, 1991, BIRTH-ISS PERINAT C, V18, P211, DOI 10.1111/j.1523-536X.1991.tb00104.x; Hynan MT, 2013, J PERINATOL, V33, P748, DOI 10.1038/jp.2013.72; Jakobsson M, 2008, BJOG-INT J OBSTET GY, V115, P38, DOI 10.1111/j.1471-0528.2007.01565.x; Kreisler L, 1976, ENFANT PREMATURE SA, P8; Langhoff-Roos J, 2006, BMJ-BRIT MED J, V332, P937, DOI 10.1136/bmj.38751.524132.2F; LEPINE JP, 1985, ANN MED-PSYCHOL, V143, P175; Martin Joyce A, 2006, Natl Vital Stat Rep, V55, P1; Miles MS, 2007, J DEV BEHAV PEDIATR, V28, P36, DOI 10.1097/01.DBP.0000257517.52459.7a; Muller-Nix C, 2004, EARLY HUM DEV, V79, P145, DOI 10.1016/j.earlhumdev.2004.05.002; Pavoine S, 2004, NEUROPSYCHIAT ENFAN, V52, P398, DOI DOI 10.1016/J.NEURENF.2004.06.002; Pierrehumbert B, 2004, ANN MED-PSYCHOL, V162, P711, DOI 10.1016/j.amp.2003.10.017; Pierrehumbert B, 2003, ARCH DIS CHILD-FETAL, V88, pF400, DOI 10.1136/fn.88.5.F400; Precelle F, 2004, NEUROPSYCHIAT ENFAN, V52, P279; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; SCHEINER AP, 1991, PEDIATRICS, V88, P1135; Sibertin-Blanc D, 2002, PSYCHIAT ENFANT, V2, P437; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Soet JE, 2003, BIRTH-ISS PERINAT C, V30, P36, DOI 10.1046/j.1523-536X.2003.00215.x; STARK AR, 2005, PEDIATRICS, V115, P1118; Tracy SK, 2007, BJOG-INT J OBSTET GY, V114, P731, DOI 10.1111/j.1471-0528.2007.01323.x; TRONICK E, 1980, MERRILL PALMER QUART, V26, P3; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	22	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104093	10.1371/journal.pone.0104093	http://dx.doi.org/10.1371/journal.pone.0104093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153825	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200013
J	Lim, KP; Chun, NAL; Ismail, SM; Abraham, MT; Yusoff, MN; Zain, RB; Ngeow, WC; Ponniah, S; Cheong, SC				Lim, Kue Peng; Chun, Nicole Ai Leng; Ismail, Siti Mazlipah; Abraham, Mannil Thomas; Yusoff, Mohd Nury; Zain, Rosnah Binti; Ngeow, Wei Cheong; Ponniah, Sathibalan; Cheong, Sok Ching			CD4(+)CD25(hi)CD127(low) Regulatory T Cells Are Increased in Oral Squamous Cell Carcinoma Patients	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-INFILTRATING LYMPHOCYTES; PERIPHERAL-CIRCULATION; INCREASED FREQUENCY; IMPROVED SURVIVAL; ADVANCED-STAGE; BREAST-CANCER; COLON-CANCER; NECK-CANCER; HEAD	Regulatory T cells (Tregs), a subset of CD4(+) T cells plays a pivotal role in regulating the immune system. An increase in Treg numbers enables cancer progression by dampening the immune system and allowing tumor cells to evade immune detection and destruction. An increase in Treg numbers and expression of inhibitory cytokines including TGF-beta and IL-10 are mechanisms by which Tregs exert their immune suppressive function. However, the presence of Tregs and inhibitory cytokines in oral cancer patients is still unclear. In this study, the presence of circulating Tregs in 39 oral cancer patients and 24 healthy donors was examined by studying the presence of the CD4(+)CD25(hi)CD127(low) cell population in their peripheral blood mononuclear cells using flow cytometry. Serum levels of TGF-beta and IL-10 were measured by ELISA. T cell subsets of OSCC patients were found to differ significantly from healthy donors where a decrease in CD8(+) cytotoxic T cells and an increase in Tregs (CD4(+)CD25(hi)CD127(low\)) were observed. Further, the ratio of CD8(+) T cells/Tregs was also decreased in patients compared to healthy donors. The presence of Tregs was accompanied by a decrease in IL-10 but not TGF-beta secretion in OSCC patients when compared to donors; in addition, the analysis also revealed that an increased presence of Tregs was accompanied by better patient survival. Amongst OSCC patients, smokers had significantly higher levels of TGF-beta. It is apparent that the immune system is compromised in OSCC patients and the characterization of the Treg subpopulation could form a basis for improving our understanding of the perturbations in the immune system that occur during OSCC tumorigenesis.	[Lim, Kue Peng; Chun, Nicole Ai Leng; Cheong, Sok Ching] Canc Res Initiat Fdn CARIF, Oral Canc Res Team, Subang Jaya, Selangor, Malaysia; [Chun, Nicole Ai Leng; Zain, Rosnah Binti] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia; [Ismail, Siti Mazlipah; Zain, Rosnah Binti; Ngeow, Wei Cheong; Cheong, Sok Ching] Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur, Malaysia; [Abraham, Mannil Thomas; Yusoff, Mohd Nury] Tengku Ampuan Rahimah Hosp, Dept Oral & Maxillofacial Surg, Klang, Malaysia; [Ponniah, Sathibalan] Uniformed Serv Univ Hlth Sci, Canc Vaccine Dev Program, Bethesda, MD 20814 USA	Universiti Malaya; Universiti Malaya; Uniformed Services University of the Health Sciences - USA	Cheong, SC (corresponding author), Canc Res Initiat Fdn CARIF, Oral Canc Res Team, 2nd Floor Outpatient Ctr, Subang Jaya, Selangor, Malaysia.	sokching.cheong@carif.com.my	Cheong, Ngeow Wei/A-2530-2009; Zain, Rosnah/B-8054-2010	Cheong, Ngeow Wei/0000-0003-4354-3518; 	University of Malaya Research Grant (UMRG) [RG289/11HTM]; Ministry of Science, Technology and Innovation (MOSTI) of Malaysia (e-Science Fund) [02-04-03-SF0011]; Cancer Research Initiatives Foundation (CARIF)	University of Malaya Research Grant (UMRG); Ministry of Science, Technology and Innovation (MOSTI) of Malaysia (e-Science Fund); Cancer Research Initiatives Foundation (CARIF)	This study was funded by the University of Malaya Research Grant (UMRG), RG289/11HTM, the Ministry of Science, Technology and Innovation (MOSTI) of Malaysia (e-Science Fund, 02-04-03-SF0011) and other sponsors of the Cancer Research Initiatives Foundation (CARIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamarneh O, 2011, HEAD NECK-J SCI SPEC, V33, P415, DOI 10.1002/hed.21464; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Cacev T, 2008, CARCINOGENESIS, V29, P1572, DOI 10.1093/carcin/bgn164; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Chan SL, 2012, CANCER-AM CANCER SOC, V118, P3984, DOI 10.1002/cncr.26726; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dhooge IJ, 1998, LARYNGOSCOPE, V108, P250, DOI 10.1097/00005537-199802000-00017; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Drennan S, 2013, IMMUNOLOGY, V140, P335, DOI 10.1111/imm.12144; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fox SB, 2007, PROSTATE, V67, P623, DOI 10.1002/pros.20538; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Fujieda S, 1999, CANCER LETT, V136, P1, DOI 10.1016/S0304-3835(98)00281-X; Gaiolla RD, 2011, ARCH PATHOL LAB MED, V135, P483, DOI 10.1043/2010-0060-OA.1; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gasparoto TH, 2010, CANCER IMMUNOL IMMUN, V59, P819, DOI 10.1007/s00262-009-0803-7; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gholamin M, 2009, WORLD J SURG, V33, P1439, DOI 10.1007/s00268-009-0070-y; Green VL, 2012, INT J ONCOL, V40, P833, DOI 10.3892/ijo.2011.1259; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatanaka H, 2000, ANN ONCOL, V11, P815, DOI 10.1023/A:1008375208574; Heckel MC, 2011, CELL IMMUNOL, V266, P143, DOI 10.1016/j.cellimm.2010.09.010; Hoffmann TK, 2007, HEAD NECK-J SCI SPEC, V29, P472, DOI 10.1002/hed.20533; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jordanova ES, 2008, CLIN CANCER RES, V14, P2028, DOI 10.1158/1078-0432.CCR-07-4554; Julie R, 2012, J CLIN ONCOLOGY OF S, V30; Kaskas NM, 2013, JAMA OTOLARYNGOLOGY; Katz LH, 2013, EXPERT OPIN THER TAR, V17, P743, DOI 10.1517/14728222.2013.782287; Kmieciak M, 2007, EUR J IMMUNOL, V37, P675, DOI 10.1002/eji.200636639; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kuss I, 2004, CLIN CANCER RES, V10, P3755, DOI 10.1158/1078-0432.CCR-04-0054; Laurent J, 2010, J IMMUNOTHER, V33, P723, DOI 10.1097/CJI.0b013e3181ea7e6e; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Liu Li, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P548, DOI 10.1007/s11596-006-0516-5; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Manjili MH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/641079; MASHBERG A, 1989, CA-CANCER J CLIN, V39, P67, DOI 10.3322/canjclin.39.2.67; Matsuura K, 2006, CANCER-AM CANCER SOC, V106, P1227, DOI 10.1002/cncr.21729; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Menetrier-Caux C, 2012, TARGET ONCOL, V7, P15, DOI 10.1007/s11523-012-0208-y; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Okita R, 2005, ONCOL REP, V14, P1269; Powell DJ, 2008, J IMMUNOTHER, V31, P189, DOI 10.1097/CJI.0b013e31815dc0e8; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reiman JM, 2007, SEMIN CANCER BIOL, V17, P275, DOI 10.1016/j.semcancer.2007.06.009; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schaefer C, 2005, BRIT J CANCER, V92, P913, DOI 10.1038/sj.bjc.6602407; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; SILVERMAN S, 1990, J AM DENT ASSOC, V120, P495, DOI 10.14219/jada.archive.1990.0082; Sparano A, 2004, OTOLARYNG HEAD NECK, V131, P573, DOI 10.1016/j.otohns.2004.03.016; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; van Monsjou HS, 2010, ORAL ONCOL, V46, P780, DOI 10.1016/j.oraloncology.2010.08.011; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	80	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103975	10.1371/journal.pone.0103975	http://dx.doi.org/10.1371/journal.pone.0103975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153698	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200012
J	Polakovicova, I; Draberova, L; Simicek, M; Draber, P				Polakovicova, Iva; Draberova, Lubica; Simicek, Michal; Draber, Petr			Multiple Regulatory Roles of the Mouse Transmembrane Adaptor Protein NTAL in Gene Transcription and Mast Cell Physiology	PLOS ONE			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; TYROSINE PHOSPHORYLATION; NEUTROPHIL CHEMOTAXIS; NEGATIVE REGULATION; CHOLESTEROL; ACTIVATION; DEGRANULATION; MIGRATION; MOLECULE	Non-T cell activation linker (NTAL; also called LAB or LAT2) is a transmembrane adaptor protein that is expressed in a subset of hematopoietic cells, including mast cells. There are conflicting reports on the role of NTAL in the high affinity immunoglobulin E receptor (FceRI) signaling. Studies carried out on mast cells derived from mice with NTAL knock out (KO) and wild type mice suggested that NTAL is a negative regulator of FceRI signaling, while experiments with RNAi-mediated NTAL knockdown (KD) in human mast cells and rat basophilic leukemia cells suggested its positive regulatory role. To determine whether different methodologies of NTAL ablation (KO vs KD) have different physiological consequences, we compared under well defined conditions FceRI-mediated signaling events in mouse bone marrow-derived mast cells (BMMCs) with NTAL KO or KD. BMMCs with both NTAL KO and KD exhibited enhanced degranulation, calcium mobilization, chemotaxis, tyrosine phosphorylation of LAT and ERK, and depolymerization of filamentous actin. These data provide clear evidence that NTAL is a negative regulator of FceRI activation events in murine BMMCs, independently of possible compensatory developmental alterations. To gain further insight into the role of NTAL in mast cells, we examined the transcriptome profiles of resting and antigen-activated NTAL KO, NTAL KD, and corresponding control BMMCs. Through this analysis we identified several genes that were differentially regulated in nonactivated and antigen-activated NTAL-deficient cells, when compared to the corresponding control cells. Some of the genes seem to be involved in regulation of cholesterol-dependent events in antigen-mediated chemotaxis. The combined data indicate multiple regulatory roles of NTAL in gene expression and mast cell physiology.	[Polakovicova, Iva; Draberova, Lubica; Simicek, Michal; Draber, Petr] Acad Sci Czech Republ, Inst Mol Genet, Dept Signal Transduct, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Draber, P (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Dept Signal Transduct, Prague, Czech Republic.	draberpe@img.cas.cz	Draber, Petr/E-1119-2018; Simicek, Michal/C-2514-2019; Polakovicova, Iva/AAF-6990-2019	Draber, Petr/0000-0002-3986-2025; Simicek, Michal/0000-0003-2388-2723; Polakovicova, Iva/0000-0002-4505-9896	Grant Agency of the Czech Republic [P302/12/G101, P302-14-09807S, P305-14-00703S]; Ministry of Education of the Czech Republic [LD12073 COST-CZ-MAST]; Academy of Sciences of the Czech Republic [RVO 68378050]; European Cooperation in Science and Technology [Action BM1007]; Faculty of Science, Charles University, Prague	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Faculty of Science, Charles University, Prague	This work was supported by project P302/12/G101, P302-14-09807S, and P305-14-00703S from the Grant Agency of the Czech Republic (URL: http://www.gacr.cz/); project LD12073 COST-CZ-MAST from Ministry of Education of the Czech Republic (URL: http://www.msmt.cz/); Institutional project RVO 68378050 from Academy of Sciences of the Czech Republic (URL: http://www.cas.cz/); and Action BM1007 from European Cooperation in Science and Technology (URL: http://www.cost.eu/). I. P. was supported in part by the Faculty of Science, Charles University, Prague (URL: http://www.natur.cuni.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Bugajev V, 2010, FEBS LETT, V584, P4949, DOI 10.1016/j.febslet.2010.08.045; Cavnar PJ, 2011, J CELL BIOL, V193, P465, DOI 10.1083/jcb.201010143; DASTYCH J, 1994, J IMMUNOL, V152, P213; Draber P, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00095; DRABEROVA L, 1995, ADV EXP MED BIOL, V371, P297; Draberova L, 2007, J IMMUNOL, V179, P5169, DOI 10.4049/jimmunol.179.8.5169; EISEMAN E, 1992, J BIOL CHEM, V267, P21027; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Fernandes AR, 2012, EUR J NEUROSCI, V35, P1344, DOI 10.1111/j.1460-9568.2012.08028.x; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Frigeri L, 1999, J IMMUNOL, V162, P2243; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Hajkova Z, 2011, J IMMUNOL, V186, P913, DOI 10.4049/jimmunol.1002074; Horakova H, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-41; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Ishizaki H, 2006, J IMMUNOL, V177, P8512, DOI 10.4049/jimmunol.177.12.8512; Iwaki S, 2008, CELL SIGNAL, V20, P195, DOI 10.1016/j.cellsig.2007.10.013; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kovarova M, 2006, J EXP MED, V203, P1161, DOI 10.1084/jem.20051701; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Lindquist JA, 2003, IMMUNOL REV, V191, P165, DOI 10.1034/j.1600-065X.2003.00007.x; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Nguyen DH, 2004, MECH AGEING DEV, V125, P641, DOI 10.1016/j.mad.2004.08.002; Nocka KH, 1997, BLOOD, V90, P3874, DOI 10.1182/blood.V90.10.3874; Orr SJ, 2011, J LEUKOCYTE BIOL, V89, P11, DOI 10.1189/jlb.0410221; Pagler TA, 2011, CIRC RES, V108, P194, DOI 10.1161/CIRCRESAHA.110.228619; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Pierini LM, 2003, J BIOL CHEM, V278, P10831, DOI 10.1074/jbc.M212386200; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; THOMPSON HL, 1993, CLIN EXP ALLERGY, V23, P270, DOI 10.1111/j.1365-2222.1993.tb00321.x; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; Tolar P, 2001, FOLIA BIOL-PRAGUE, V47, P215; Tolarova H, 2004, EUR J IMMUNOL, V34, P1627, DOI 10.1002/eji.200424991; Tumova M, 2010, EUR J IMMUNOL, V40, P3235, DOI 10.1002/eji.201040403; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Wang ZL, 2009, J BIOL CHEM, V284, P28599, DOI 10.1074/jbc.M109.047282; Wright J, 2008, PHYSIOL GENOMICS, V33, P341, DOI 10.1152/physiolgenomics.00024.2008; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325	50	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105539	10.1371/journal.pone.0105539	http://dx.doi.org/10.1371/journal.pone.0105539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153696	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200059
J	Alpay, K; Farshchian, M; Tuomela, J; Sandholm, J; Aittokallio, K; Siljamaki, E; Kallio, M; Kahari, VM; Hietanen, S				Alpay, Kemal; Farshchian, Mehdi; Tuomela, Johanna; Sandholm, Jouko; Aittokallio, Kaappo; Siljamaki, Elina; Kallio, Marko; Kahari, Veli-Matti; Hietanen, Sakari			Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; TYROSINE KINASE; IN-VITRO; PROSTATE-CANCER; MULTIDRUG-RESISTANCE; CELLULAR-RESPONSE; IMATINIB; DRUGS; P53; COMBINATION	Although c-Abl has increasingly emerged as a key player in the DNA damage response, its role in this context is far from clear. We studied the effect of inhibition of c-Abl kinase activity by imatinib with chemotherapy drugs and found a striking difference in cell survival after combined mitoxantrone (MX) and imatinib treatment compared to a panel of other chemotherapy drugs. The combinatory treatment induced apoptosis in HeLa cells and other cancer cell lines but not in primary fibroblasts. The difference in MX and doxorubicin was related to significant augmentation of DNA damage. Transcriptionally active p53 accumulated in cells in which human papillomavirus E6 normally degrades p53. The combination treatment resulted in caspase activation and apoptosis, but this effect did not depend on either p53 or p73 activity. Despite increased p53 activity, the cells arrested in G2 phase became defective in this checkpoint, allowing cell cycle progression. The effect after MX treatment depended partially on c-Abl: Short interfering RNA knockdown of c-Abl rendered HeLa cells less sensitive to MX. The effect of imatinib was decreased by c-Abl siRNA suggesting a role for catalytically inactive c-Abl in the death cascade. These findings indicate that MX has a unique cytotoxic effect when the kinase activity of c-Abl is inhibited. The treatment results in increased DNA damage and c-Abl-dependent apoptosis, which may offer new possibilities for potentiation of cancer chemotherapy.	[Alpay, Kemal; Aittokallio, Kaappo; Hietanen, Sakari] Univ Turku, Turku Univ Hosp, Med Res Lab, Dept Obstet & Gynecol, Turku, Finland; [Alpay, Kemal; Aittokallio, Kaappo; Hietanen, Sakari] Univ Turku, Turku Univ Hosp, Med Res Lab, Joint Clin Biochem Lab, Turku, Finland; [Farshchian, Mehdi; Siljamaki, Elina; Kahari, Veli-Matti] Univ Turku, Dept Dermatol, Turku, Finland; [Farshchian, Mehdi; Siljamaki, Elina; Kahari, Veli-Matti] Univ Turku, Med Res Lab, Turku, Finland; [Farshchian, Mehdi; Siljamaki, Elina; Kahari, Veli-Matti] Turku Univ Hosp, FIN-20520 Turku, Finland; [Tuomela, Johanna] Univ Turku, Dept Cell Biol & Anat, Turku, Finland; [Sandholm, Jouko] Univ Turku, Turku Ctr Biotechnol, Cell Imaging Core, Turku, Finland; [Sandholm, Jouko] Abo Akad Univ, Turku, Finland; [Kallio, Marko] VTT Hlth, VTT Tech Res Ctr Finland, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Abo Akademi University; VTT Technical Research Center Finland	Hietanen, S (corresponding author), Univ Turku, Turku Univ Hosp, Med Res Lab, Dept Obstet & Gynecol, Turku, Finland.	sakari.hietanen@utu.fi	Kahari, Veli-Matti/T-4925-2019; Hietanen, Sakari/AAD-2858-2021; Hietanen, Sakari/N-6849-2016; Kähäri, Veli-Matti/E-5144-2011	Kahari, Veli-Matti/0000-0003-2421-9368; Hietanen, Sakari/0000-0003-4734-4743; Hietanen, Sakari/0000-0003-4734-4743; Kähäri, Veli-Matti/0000-0003-2421-9368; Kallio, Marko/0000-0002-6345-1680; Tuomela, Johanna/0000-0003-4390-4563; Siljamaki, Elina/0000-0003-1709-8633; Alpay, Kemal/0000-0002-8129-2273; Sandholm, Jouko/0000-0003-0638-2444	Finnish Medical Society; Turku University Foundation and Cancer Society of South-Western Finland; Academy of Finland [137687, 268360]; Finnish Cancer Research Foundation; Sigrid Juselius Foundation; Turku University Hospital EVO [13336]; Cancer Foundation Finland sr [120097, 130107] Funding Source: researchfish	Finnish Medical Society; Turku University Foundation and Cancer Society of South-Western Finland; Academy of Finland(Academy of Finland); Finnish Cancer Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Hospital EVO; Cancer Foundation Finland sr	This study was financially supported by grants from Finnish Medical Society, Turku University Foundation and Cancer Society of South-Western Finland, the Academy of Finland (projects 137687 and 268360), the Finnish Cancer Research Foundation, Sigrid Juselius Foundation, Turku University Hospital EVO grant (project 13336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 1999, NATURE, V399, P809; Buchdunger E, 2002, EUR J CANCER, V38, pS28, DOI 10.1016/S0959-8049(02)80600-1; Chan AL, 2013, BIOCHEMISTRY-US, V52, P3119, DOI 10.1021/bi301710c; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Chen XA, 2006, MOL CELL, V22, P489, DOI 10.1016/j.molcel.2006.04.021; Choudhury A, 2009, MOL CANCER THER, V8, P203, DOI 10.1158/1535-7163.MCT-08-0959; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Fanta S, 2008, ONCOGENE, V27, P4380, DOI 10.1038/onc.2008.68; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hande KR, 2008, UPDATE CANC THERAPEU, V3, P13, DOI DOI 10.1016/J.UCT.2008.02.001; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Hietanen S, 1998, INT J CANCER, V78, P338, DOI 10.1002/(SICI)1097-0215(19981029)78:3<338::AID-IJC14>3.0.CO;2-2; Hietanen Sakari, 2009, P51, DOI 10.1007/978-1-4020-9597-9_3; Hoeijmakers JHJ, 2007, MECH AGEING DEV, V128, P460, DOI 10.1016/j.mad.2007.05.002; Houghton PJ, 2004, CANCER RES, V64, P2333, DOI 10.1158/0008-5472.CAN-03-3344; Huang DY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-35; Villar VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037735; Kerr JB, 2012, NAT MED, V18, P1170, DOI 10.1038/nm.2889; Kharbanda S, 1997, BBA-REV CANCER, V1333, pO1, DOI 10.1016/S0304-419X(97)00020-6; Koivusalo R, 2002, CANCER RES, V62, P7364; Koivusalo R, 2005, MOL PHARMACOL, V68, P372, DOI 10.1124/mol.105.011189; Koivusalo R, 2004, CANCER BIOL THER, V3, P1177, DOI 10.4161/cbt.3.11.1340; Kubler HR, 2005, PROSTATE, V63, P385, DOI 10.1002/pros.20201; Labib K, 2011, PHILOS T R SOC B, V366, P3554, DOI 10.1098/rstb.2011.0071; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Maiani E, 2011, BIOCHEM PHARMACOL, V82, P1269, DOI 10.1016/j.bcp.2011.07.001; Meltser V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.21; Morrow CS, 2006, MOL PHARMACOL, V69, P1499, DOI 10.1124/mol.105.017988; Nagar B, 2007, J NUTR, V137, p1518S, DOI 10.1093/jn/137.6.1518S; Pinto AC, 2011, CANCER CHEMOTH PHARM, V67, P275, DOI 10.1007/s00280-010-1315-z; Pinto AC, 2011, PROSTATE, V71, P81, DOI 10.1002/pros.21224; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Potter AJ, 2005, MUTAT RES-FUND MOL M, V572, P27, DOI 10.1016/j.mrfmmm.2004.11.018; Russell JS, 2003, CANCER RES, V63, P7377; Sims JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055509; Slupianek A, 2001, MOL CELL, V8, P795, DOI 10.1016/S1097-2765(01)00357-4; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Wang-Rodriguez J, 2006, LARYNGOSCOPE, V116, P1409, DOI 10.1097/01.mlg.0000225895.40732.52; White E, 1999, NATURE, V399, P734, DOI 10.1038/21539; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	45	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105526	10.1371/journal.pone.0105526	http://dx.doi.org/10.1371/journal.pone.0105526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148385	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600052
J	Iannella, N; Launey, T; Abbott, D; Tanaka, S				Iannella, Nicolangelo; Launey, Thomas; Abbott, Derek; Tanaka, Shigeru			A Nonlinear Cable Framework for Bidirectional Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; CALCIUM DYNAMICS; LATE-ASSOCIATIVITY; LATE MAINTENANCE; AREA CA1; MODEL; DEPRESSION; HIPPOCAMPUS; NEURONS	Finding the rules underlying how axons of cortical neurons form neural circuits and modify their corresponding synaptic strength is the still subject of intense research. Experiments have shown that internal calcium concentration, and both the precise timing and temporal order of pre and postsynaptic action potentials, are important constituents governing whether the strength of a synapse located on the dendrite is increased or decreased. In particular, previous investigations focusing on spike timing-dependent plasticity (STDP) have typically observed an asymmetric temporal window governing changes in synaptic efficacy. Such a temporal window emphasizes that if a presynaptic spike, arriving at the synaptic terminal, precedes the generation of a postsynaptic action potential, then the synapse is potentiated; however if the temporal order is reversed, then depression occurs. Furthermore, recent experimental studies have now demonstrated that the temporal window also depends on the dendritic location of the synapse. Specifically, it was shown that in distal regions of the apical dendrite, the magnitude of potentiation was smaller and the window for depression was broader, when compared to observations from the proximal region of the dendrite. To date, the underlying mechanism(s) for such a distance-dependent effect is (are) currently unknown. Here, using the ionic cable theory framework in conjunction with the standard calcium based plasticity model, we show for the first time that such distance-dependent inhomogeneities in the temporal learning window for STDP can be largely explained by both the spatial and active properties of the dendrite.	[Iannella, Nicolangelo; Abbott, Derek] Univ Adelaide SA, Ctr Biomed Engn CBME, Adelaide, SA, Australia; [Iannella, Nicolangelo; Abbott, Derek] Univ Adelaide SA, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Iannella, Nicolangelo] Univ South Australia, Inst Telecommun Res, Computat & Theoret Neurosci Lab, Mawson Lakes, SA, Australia; [Iannella, Nicolangelo; Launey, Thomas] Brain Sci Inst, RIKEN, Launey Res Unit, Saitama, Japan; [Tanaka, Shigeru] Univ Electrocommun, Fac Elect Commun, Tokyo, Japan	University of Adelaide; University of Adelaide; University of South Australia; RIKEN; University of Electro-Communications - Japan	Iannella, N (corresponding author), Univ Adelaide SA, Ctr Biomed Engn CBME, Adelaide, SA, Australia.	nicolangelo.iannella@gmail.com	Iannella, Nicolangelo/A-1026-2009; Abbott, Derek/E-8352-2011; Launey, Thomas/A-2605-2010	Iannella, Nicolangelo/0000-0002-1983-9071; Abbott, Derek/0000-0002-0945-2674; Launey, Thomas/0000-0001-9153-9260	RIKEN, Brain Science Institute; Australian Research Council (ARC) for support through an APD fellowship [DP1096083]	RIKEN, Brain Science Institute; Australian Research Council (ARC) for support through an APD fellowship(Australian Research Council)	The authors (NI and TL) wish to thank the support of the RIKEN, Brain Science Institute. NI further wishes to thank the Australian Research Council (ARC) for support through an APD fellowship DP1096083. Furthermore, the authors would like to express their gratitude to Prof SM Korogod for critically reading and providing useful feedback and suggestions which led to improvements to the original manuscript.	ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; BARRIONUEVO G, 1980, LIFE SCI, V27, P2385, DOI 10.1016/0024-3205(80)90509-3; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Debanne D, 1995, CAN J PHYSIOL PHARM, V73, P1295, DOI 10.1139/y95-185; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Evans J, 2005, MODELING NEUROSCIENC, P117; Evans JD, 2005, BIOL CYBERN, V92, P164, DOI 10.1007/s00422-004-0536-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Glenn L, 2005, MODELING NEUROSCIENC, P179; Gutman A, 2005, MODELING NEUROSCIENC, P145; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Iannella N, 2004, MATH BIOSCI, V188, P117, DOI 10.1016/j.mbs.2003.10.002; Iannella Nicolangelo, 2007, Journal of Integrative Neuroscience, V6, P241, DOI 10.1142/S0219635207001489; Iannella Nicolangelo, 2006, Journal of Integrative Neuroscience, V5, P249, DOI 10.1142/S0219635206001124; Isomura Y, 1999, J NEUROPHYSIOL, V82, P1993, DOI 10.1152/jn.1999.82.4.1993; Isomura Y, 2002, J NEUROPHYSIOL, V87, P1169, DOI 10.1152/jn.00536.2001; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kupferman R, 1997, BIOPHYS J, V72, P2430, DOI 10.1016/S0006-3495(97)78888-X; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larsson HP, 1997, BIOPHYS J, V72, P1193, DOI 10.1016/S0006-3495(97)78767-8; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; MOZRZYMAS JW, 1993, J THEOR BIOL, V162, P371, DOI 10.1006/jtbi.1993.1093; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; Poznanski Roman R., 2004, Journal of Integrative Neuroscience, V3, P267, DOI 10.1142/S0219635204000439; Poznanski RR, 2000, MATH BIOSCI, V166, P101, DOI 10.1016/S0025-5564(00)00031-6; Poznanski RR, 2000, MATH BIOSCI, V166, P123, DOI 10.1016/S0025-5564(00)00032-8; Poznanski RR, 2001, BIOPHYSICAL NEURAL N, P177; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; Rall W, 1964, NEURAL THEORY MODELI, P73; RALL WILFRID, 1962, BIOPHYS JOUR, V2, P145; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Rubin JE, 2005, J NEUROPHYSIOL, V93, P2600, DOI 10.1152/jn.00803.2004; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Sajikumar S, 2004, NEUROSCIENCE, V129, P503, DOI 10.1016/j.neuroscience.2004.08.014; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; Schutter E. D. E., 1998, METHODS NEURONAL MOD, P211; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Smolen P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000445; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Traub RD, 2003, J NEUROPHYSIOL, V89, P909, DOI 10.1152/jn.00573.2002; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Tsukada M, 2005, HIPPOCAMPUS, V15, P104, DOI 10.1002/hipo.20035; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V1; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	72	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e102601	10.1371/journal.pone.0102601	http://dx.doi.org/10.1371/journal.pone.0102601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148478	Green Published, gold, Green Accepted			2022-12-27	WOS:000341230600004
J	Xu, T; Pang, QY; Zhou, D; Zhang, AQ; Luo, SM; Wang, Y; Yan, XF				Xu, Tao; Pang, Qiuying; Zhou, Dong; Zhang, Aiqin; Luo, Shaman; Wang, Yang; Yan, Xiufeng			Proteomic Investigation into Betulinic Acid-Induced Apoptosis of Human Cervical Cancer HeLa Cells	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN-MELANOMA; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; ACTIVATION; INHIBITION; GROWTH; PHOSPHORYLATION; PROLIFERATION; CYTOTOXICITY	Betulinic acid is a pentacyclic triterpenoid that exhibits anticancer functions in human cancer cells. This study provides evidence that betulinic acid is highly effective against the human cervical cancer cell line HeLa by inducing dose- and time-dependent apoptosis. The apoptotic process was further investigated using a proteomics approach to reveal protein expression changes in HeLa cells following betulinic acid treatment. Proteomic analysis revealed that there were six up- and thirty down-regulated proteins in betulinic acid-induced HeLa cells, and these proteins were then subjected to functional pathway analysis using multiple analysis software. UDP-glucose 6-dehydrogenase, 6-phosphogluconate dehydrogenase decarboxylating, chain A Horf6-a novel human peroxidase enzyme that involved in redox process, was found to be down-regulated during the apoptosis process of the oxidative stress response pathway. Consistent with our results at the protein level, an increase in intracellular reactive oxygen species was observed in betulinic acid-treated cells. The proteins glucose-regulated protein and cargo-selection protein TIP47, which are involved in the endoplasmic reticulum pathway, were up-regulated by betulinic acid treatment. Meanwhile, 14-3-3 family proteins, including 14-3-3 beta and 14-3-3 epsilon, were down-regulated in response to betulinic acid treatment, which is consistent with the decrease in expression of the target genes 14-3-3 beta and 14-3-3 epsilon. Furthermore, it was found that the antiapoptotic bcl-2 gene was down-regulated while the proapoptotic bax gene was up-regulated after betulinic acid treatment in HeLa cells. These results suggest that betulinic acid induces apoptosis of HeLa cells by triggering both the endoplasmic reticulum pathway and the ROS-mediated mitochondrial pathway.	[Xu, Tao; Pang, Qiuying; Zhou, Dong; Zhang, Aiqin; Luo, Shaman; Wang, Yang; Yan, Xiufeng] Northeast Forestry Univ, Alkali Soil Nat Environm Sci Ctr, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Yan, XF (corresponding author), Northeast Forestry Univ, Alkali Soil Nat Environm Sci Ctr, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Harbin, Heilongjiang, Peoples R China.	xfyan@nefu.edu.cn		Yan, Xiufeng/0000-0001-5127-494X	Forestry Industry Research Special Fund for Public Welfare [201004069]; Fundamental Research Funds for the Central Universities [DL13EA02-03]	Forestry Industry Research Special Fund for Public Welfare; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was financially supported by the the Forestry Industry Research Special Fund for Public Welfare (201004069) and the Fundamental Research Funds for the Central Universities (DL13EA02-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Eiznhamer DA, 2004, IDRUGS, V7, P359; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 2000, MED PEDIATR ONCOL, V35, P616, DOI 10.1002/1096-911X(20001201)35:6<616::AID-MPO27>3.0.CO;2-N; Gheorgheosu D, 2014, ANTICANCER AGENTS ME; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hwang CC, 1998, BIOCHEMISTRY-US, V37, P12596, DOI 10.1021/bi980611s; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kessler JH, 2007, CANCER LETT, V251, P132, DOI 10.1016/j.canlet.2006.11.003; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Q, 2011, MOL CARCINOGEN, V50, P760, DOI 10.1002/mc.20673; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089962; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mullauer FB, 2011, ANTI-CANCER DRUG, V22, P223, DOI 10.1097/CAD.0b013e3283421035; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pandey MK, 2010, INT J CANCER, V127, P282, DOI 10.1002/ijc.25059; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379; Rabi T, 2008, MOL CARCINOGEN, V47, P964, DOI 10.1002/mc.20447; Rzeski W, 2006, N-S ARCH PHARMACOL, V374, P11, DOI 10.1007/s00210-006-0090-1; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Santos RC, 2011, BIOCHIMIE, V93, P1065, DOI 10.1016/j.biochi.2011.02.014; Santos RC, 2009, BIOORGAN MED CHEM, V17, P6241, DOI 10.1016/j.bmc.2009.07.050; Schettino M T, 2013, Minerva Ginecol, V65, P661; Selzer E, 2000, J INVEST DERMATOL, V114, P935, DOI 10.1046/j.1523-1747.2000.00972.x; Shen LM, 2009, SCI CHINA SER B, V52, P1814, DOI 10.1007/s11426-009-0272-z; Shen LM, 2009, CHEM-BIOL INTERACT, V181, P455, DOI 10.1016/j.cbi.2009.07.013; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Tan YM, 2003, CLIN CANCER RES, V9, P2866; Theo A, 2009, TOHOKU J EXP MED, V217, P93, DOI 10.1620/tjem.217.93; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Wang Y, 2006, PROTEOMICS, V6, P2422, DOI 10.1002/pmic.200500595; Wick W, 1999, J PHARMACOL EXP THER, V289, P1306; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Wong CC, 2008, J PROTEOME RES, V7, P2050, DOI 10.1021/pr800019k; Yang LJ, 2010, ACTA PHARMACOL SIN, V31, P66, DOI 10.1038/aps.2009.177; Yang XJ, 2008, INVEST OPHTH VIS SCI, V49, P2483, DOI 10.1167/iovs.07-1344; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	47	38	45	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105768	10.1371/journal.pone.0105768	http://dx.doi.org/10.1371/journal.pone.0105768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148076	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230600080
J	Yang, ZF; Zhao, PX; Wang, JW; Tong, LP; Cao, JY; Tian, Y; Yao, ZP; Wang, JB; Zhu, YR; Jia, YY; Wen, AD				Yang, Zhifu; Zhao, Peixi; Wang, Jingwen; Tong, Liping; Cao, Jinyi; Tian, Yun; Yao, Zhanpeng; Wang, Jingbo; Zhu, Yanrong; Jia, Yanyan; Wen, Aidong			DRUGS System Enhancing Adherence of Chinese Surgeons to Antibiotic Use Guidelines during Perioperative Period	PLOS ONE			English	Article							ANTIMICROBIAL PROPHYLAXIS; MANAGEMENT; DIAGNOSIS; UPDATE	Objective: Irrational use of antimicrobial agents for preventing postoperative SSIs is a common phenomenon in China, which results in more bacterial resistance, higher hospital infection rates, extra costs of antimicrobial agents. The aim of the study is to evaluate the effect of Drug Rational Usage Guidelines System (DRUGS) on the surgeon's prescription behavior of antimicrobial agents. Methods: 10 common surgical operations which included 1543 cases (where 778 cases using paper-based guidelines and 765 cases using DRUGS) were selected and their demographic and clinical data were collected. The selected operations include thyroid resection, breast mass resection, myomectomy, etc. The evaluation criteria were antibiotic administrative categories, the time of initial dose, duration of administration, length of stay, the costs of antibiotics, SSIs and drug adverse reactions(ADR). Results: The antimicrobial agents were mostly administrated within 0.5 h to 2 h before incision, 656 patients (85.75%) were intervened with DRUGS and 256 (32.90%) with paper-based guidelines according to the protocol. For the clean wounds incision, 547 patients (91.62%) were within 24 h of withdrawal antibiotics with using paper-based guidelines versus 91 (14.79%) with using DRUGS. A total of 19 kinds of antibiotics were used in the 1543 cases. The leading three on the list of frequency were piperacillin and sulbactam sodium, cefathiamidine and cefoperazone. While after the intervention, the list of frequency changed to cefazolin, cefathiamidine, cefoperazone. The average hospital stay was (7.00 +/- 4.31)d with paper-based guidelines and (2.54 +/- 1.57)d with DRUGS, respectively. The average cost of antibiotics was (sic)(3481.36 +/- 2584.46) with paper-based guidelines and (sic)(1693.39 +/- 1478.27) with DRUGS, respectively. However, there were no significant differences in the incidence of SSIs and ADR between two groups. Conclusion: In this study, the increased availability of antibiotic guidelines at the time of drug ordering, combined with DRUGS, was associated with an enhanced surgeon adherence to guidelines.	[Yang, Zhifu; Wang, Jingwen; Cao, Jinyi; Zhu, Yanrong; Jia, Yanyan; Wen, Aidong] Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Shaanxi, Peoples R China; [Zhao, Peixi; Tian, Yun] Shaanxi Prov Tumor Hosp, Dept Pharm, Xian, Shaanxi, Peoples R China; [Tong, Liping; Yao, Zhanpeng; Wang, Jingbo] Fourth Mil Med Univ, Xijing Hosp, Dept Med Affair, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Jia, YY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Shaanxi, Peoples R China.	jiayanyan-2004@hotmail.com; adwen@fmmu.edu.cn	wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022; Wen, Aidong/P-2654-2019	Wen, Aidong/0000-0002-4535-0501	National High Technology Research and Development Program of China [2012AA02A603]; Army Science and Technology Major Project in the 11th Five-year Plan [06D007]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Army Science and Technology Major Project in the 11th Five-year Plan	This study was conducted under contract by the National High Technology Research and Development Program of China (2012AA02A603) and the Army Science and Technology Major Project in the 11th Five-year Plan (06D007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrajati R, 2005, PHARM WORLD SCI, V27, P436, DOI 10.1007/s11096-005-5971-8; Ansari F, 2003, J ANTIMICROB CHEMOTH, V52, P842, DOI 10.1093/jac/dkg459; Ashraf M, 2009, INT J SURG, V7, P543, DOI 10.1016/j.ijsu.2009.08.012; BOOKER R, 2005, NURS STAND, V19, P54; Booker Rachel, 2005, Nurs Stand, V19, P43; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Bull AL, 2006, J HOSP INFECT, V63, P140, DOI 10.1016/j.jhin.2006.01.018; Bunn F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005360.pub3; Chueh H, 1997, ACAD MED, V72, P512, DOI 10.1097/00001888-199706000-00016; *ED BOARD CHIN J O, 2013, ZHONGHUA ER BI YAN H, V48, P180; FEDERSPIL P, 1991, HNO, V39, P371; Goins WP, 2010, OBSTET GYNECOL, V115, P1217, DOI 10.1097/AOG.0b013e3181dd916f; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Hu Xiang, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P113; Knox K, 2003, J HOSP INFECT, V53, P85, DOI 10.1053/jhin.2002.1350; Li YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054842; LUO Z, 2006, 4 KINDS PRESCRIPTION; Mahdaviazad Hamideh, 2011, J Infect Public Health, V4, P253, DOI 10.1016/j.jiph.2011.08.004; Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rodrigues Camilla, 2010, J Assoc Physicians India, V58 Suppl, P51; Saizy-Callaert S, 2003, J HOSP INFECT, V53, P177, DOI 10.1053/jhin.2002.1307; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P104, DOI 10.1136/jamia.1999.0060104; Shojania KG, 1998, J AM MED INFORM ASSN, V5, P554, DOI 10.1136/jamia.1998.0050554; Shojarna KG, 2001, EVID REP TECHNOL ASS, P1; Tourmousoglou CE, 2008, J ANTIMICROB CHEMOTH, V61, P214, DOI 10.1093/jac/dkm406; Tremolieres F, 2003, CLIN MICROBIOL INFEC, V9, P1162, DOI 10.1111/j.1469-0691.2003.00798.x; Westphal JF, 2011, PHARMACOEPIDEM DR S, V20, P162, DOI 10.1002/pds.2078; Yang ZP, 2012, LANCET, V379, pE13, DOI 10.1016/S0140-6736(11)60137-2; Young RP, 2012, ANN INTERN MED, V156, P68, DOI 10.7326/0003-4819-156-1-201201030-00021; Zielstorff RD, 1998, J AM MED INFORM ASSN, V5, P227, DOI 10.1136/jamia.1998.0050227	32	10	11	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e102226	10.1371/journal.pone.0102226	http://dx.doi.org/10.1371/journal.pone.0102226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148306	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600003
J	McPherson, MJ; Lopez-Gonzalez, M; Rankin, SK; Limb, CJ				McPherson, Malinda J.; Lopez-Gonzalez, Monica; Rankin, Summer K.; Limb, Charles J.			The Role of Emotion in Musical Improvisation: An Analysis of Structural Features	PLOS ONE			English	Article							AFFECTIVE CHARACTER; CUE UTILIZATION; PERCEPTION; MODE; EXPRESSION; ACCURACY; TEMPO; VOICE	One of the primary functions of music is to convey emotion, yet how music accomplishes this task remains unclear. For example, simple correlations between mode (major vs. minor) and emotion (happy vs. sad) do not adequately explain the enormous range, subtlety or complexity of musically induced emotions. In this study, we examined the structural features of unconstrained musical improvisations generated by jazz pianists in response to emotional cues. We hypothesized that musicians would not utilize any universal rules to convey emotions, but would instead combine heterogeneous musical elements together in order to depict positive and negative emotions. Our findings demonstrate a lack of simple correspondence between emotions and musical features of spontaneous musical improvisation. While improvisations in response to positive emotional cues were more likely to be in major keys, have faster tempos, faster key press velocities and more staccato notes when compared to negative improvisations, there was a wide distribution for each emotion with components that directly violated these primary associations. The finding that musicians often combine disparate features together in order to convey emotion during improvisation suggests that structural diversity may be an essential feature of the ability of music to express a wide range of emotion.	[McPherson, Malinda J.; Lopez-Gonzalez, Monica; Rankin, Summer K.; Limb, Charles J.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Lopez-Gonzalez, Monica; Limb, Charles J.] Johns Hopkins Univ, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	McPherson, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	mmcpherson@jhu.edu			Dana Foundation; Brain Science Institute of Johns Hopkins University School of Medicine; Department of Biomedical Engineering, Johns Hopkins University [T32-DC000023]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000023] Funding Source: NIH RePORTER	Dana Foundation; Brain Science Institute of Johns Hopkins University School of Medicine; Department of Biomedical Engineering, Johns Hopkins University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was funded by the Dana Foundation and the Brain Science Institute of Johns Hopkins University School of Medicine, as well as a Training Grant (T32-DC000023) from the Department of Biomedical Engineering, Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Baraldi FB, 2006, J NEW MUSIC RES, V35, P197, DOI 10.1080/09298210601045575; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Bowling DL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00464; Chapin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013812; Costa M, 2004, MUSIC PERCEPT, V22, P1, DOI 10.1525/mp.2004.22.1.1; COSTANZO FS, 1969, J COUNS PSYCHOL, V16, P267, DOI 10.1037/h0027355; Cross I., 2008, MUSIC SCI S1, V12, P147, DOI [DOI 10.1177/1029864908012001071, 10.1177/1029864908012001071]; Dalla Bella S, 2001, COGNITION, V80, pB1, DOI 10.1016/S0010-0277(00)00136-0; Denckla BF, 1997, DYNAMIC INTONATION S; DEXTER F, 1995, ANESTHESIOLOGY, V82, P896, DOI 10.1097/00000542-199504000-00012; Eerola T., 2004, MIDI TOOLBOX MATLAB; Eerola T, 2012, MUSIC PERCEPT, V30, P49, DOI [10.1525/MP.2012.30.1.49, 10.1525/mp.2012.30.3.307]; EKMAN P, 1992, PHILOS T ROY SOC B, V335, P63, DOI 10.1098/rstb.1992.0008; Gabrielsson A, 1995, PSYCHOMUSICOLOGY, V14; Gabrielsson A., 1996, PSYCHOL MUSIC, V24, P68, DOI DOI 10.1177/0305735696241007; Gagnon L, 2003, COGNITION EMOTION, V17, P25, DOI 10.1080/02699930302279; Goebl W, 2003, J ACOUST SOC AM, V114, P2273, DOI 10.1121/1.1605387; Halpern AR, 2008, MUSIC PERCEPT, V25, P181, DOI 10.1525/MP.2008.25.3.181; Hevner K, 1935, AM J PSYCHOL, V47, P103, DOI 10.2307/1416710; Huron D, 2010, ICMPC C SEATTL WASH; Huron D.B., 2006, SWEET ANTICIPATION M; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Juslin PN, 2003, ANN NY ACAD SCI, V1000, P279, DOI 10.1196/annals.1280.025; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Kamenetsky S.B., 1997, PSYCHOL MUSIC, V25, P149, DOI 10.1177/ 0305735697252005.; KASTNER MP, 1990, MUSIC PERCEPT, V8, P189; KRUMHANSL CL, 1990, MUSIC PERCEPT, V7, P309; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; Krumhansl CL, 1998, MUSIC PERCEPT, V16, P119; Krumhansl CL, 1986, MATH PSYCH M; Laukka P, 2000, INT J PSYCHOL, V35, P288; Laukka P., 2000, PSYCHOL MUSIC, V28, P181, DOI [10.1177/0305735600282007, DOI 10.1177/0305735600282007]; Livingstone SR, 2010, COMPUT MUSIC J, V34, P41, DOI 10.1162/comj.2010.34.1.41; McAdams S, 2004, MUSIC PERCEPT, V22, P265; MESQUITA B, 1992, PSYCHOL BULL, V112, P179, DOI 10.1037/0033-2909.112.2.179; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Paul B, 2010, EMPIR MUSICOL REV, V5, P27, DOI 10.18061/1811/46747; Rigg MG, 1940, J EXP PSYCHOL, V27, P566, DOI 10.1037/h0058652; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Scherer KR., 1981, SPEECH EVALUATION PS, V1, P460; Spencer H, 1928, ESSAYS ED KINDRED SU, Vxxi; Steblin Rita, 2002, HIST KEY CHARACTERIS; Tao Y., 2014, P NATL ACAD SCI; Timmers R, 2007, MUSIC PERCEPT, V25, P117, DOI 10.1525/MP.2007.25.2.117	45	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105144	10.1371/journal.pone.0105144	http://dx.doi.org/10.1371/journal.pone.0105144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AO1WL	25144200	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100041
J	Tan, RH; Devenney, E; Dobson-Stone, C; Kwok, JB; Hodges, JR; Kiernan, MC; Halliday, GM; Hornberger, M				Tan, Rachel H.; Devenney, Emma; Dobson-Stone, Carol; Kwok, John B.; Hodges, John R.; Kiernan, Matthew C.; Halliday, Glenda M.; Hornberger, Michael			Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ADDENBROOKES COGNITIVE EXAMINATION; MOTOR-NEURON DISEASE; BEHAVIORAL VARIANT; LOBAR DEGENERATION; BRAIN ATROPHY; FUNCTIONAL CONNECTIVITY; REPEAT EXPANSION; CORTICAL ATROPHY; WHOLE-BRAIN	Amyotrophic lateral sclerosis (ALS) and behavioural variant frontotemporal dementia (bvFTD) are multisystem neurodegenerative disorders that manifest overlapping cognitive, neuropsychiatric and motor features. The cerebellum has long been known to be crucial for intact motor function although emerging evidence over the past decade has attributed cognitive and neuropsychiatric processes to this structure. The current study set out i) to establish the integrity of cerebellar subregions in the amyotrophic lateral sclerosis-behavioural variant frontotemporal dementia spectrum (ALS-bvFTD) and ii) determine whether specific cerebellar atrophy regions are associated with cognitive, neuropsychiatric and motor symptoms in the patients. Seventy-eight patients diagnosed with ALS, ALS-bvFTD, behavioural variant frontotemporal dementia (bvFTD), most without C9ORF72 gene abnormalities, and healthy controls were investigated. Participants underwent cognitive, neuropsychiatric and functional evaluation as well as structural imaging using voxel-based morphometry (VBM) to examine the grey matter subregions of the cerebellar lobules, vermis and crus. VBM analyses revealed: i) significant grey matter atrophy in the cerebellum across the whole ALS-bvFTD continuum; ii) atrophy predominantly of the superior cerebellum and crus in bvFTD patients, atrophy of the inferior cerebellum and vermis in ALS patients, while ALS-bvFTD patients had both patterns of atrophy. Post-hoc covariance analyses revealed that cognitive and neuropsychiatric symptoms were particularly associated with atrophy of the crus and superior lobule, while motor symptoms were more associated with atrophy of the inferior lobules. Taken together, these findings indicate an important role of the cerebellum in the ALS-bvFTD disease spectrum, with all three clinical phenotypes demonstrating specific patterns of subregional atrophy that associated with different symptomology.	[Tan, Rachel H.; Devenney, Emma; Dobson-Stone, Carol; Kwok, John B.; Hodges, John R.; Kiernan, Matthew C.; Halliday, Glenda M.; Hornberger, Michael] Neurosci Res Australia, Randwick, NSW, Australia; [Tan, Rachel H.; Devenney, Emma; Dobson-Stone, Carol; Kwok, John B.; Hodges, John R.; Halliday, Glenda M.] Univ New S Wales, Sch Med Sci, Randwick, NSW, Australia; [Hodges, John R.; Hornberger, Michael] ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Kiernan, Matthew C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Hornberger, Michael] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of Cambridge	Hornberger, M (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	m.hornberger@neura.edu.au	Hornberger, Michael/C-9610-2011; Halliday, Glenda M/E-8555-2011; Kiernan, Matthew C/E-4460-2011	Hornberger, Michael/0000-0002-2214-3788; Halliday, Glenda M/0000-0003-0422-8398; Kwok, John/0000-0001-9574-6195; Tan, Rachel/0000-0002-0385-4090; Kiernan, Matthew/0000-0001-9054-026X; Dobson-Stone, Carol/0000-0002-2211-0257	Motor Neurone Disease Research Institute of Australia (MNDRIA); Mick Rodger Benalla MND Research Grant; Ian Potter Foundation; National Health Medical Research Council [630440]; Australian Research Council [DP110104202, FF0776229]; NHMRC Program Grant [1037746]	Motor Neurone Disease Research Institute of Australia (MNDRIA); Mick Rodger Benalla MND Research Grant; Ian Potter Foundation; National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia)	R. H. T. gratefully acknowledges funding support from Motor Neurone Disease Research Institute of Australia (MNDRIA), the Mick Rodger Benalla MND Research Grant and The Ian Potter Foundation. G. M. H. is a NHMRC Senior Principal Research Fellow (#630434). M. K. is supported by the National Health Medical Research Council #630440. J. R. H. and M. H. are supported by the Australian Research Council (DP110104202 to M. H. and FF0776229 to J. R. H.). This research was performed under Forefront, a collaborative research partnership in Australia funded by the NHMRC Program Grant (#1037746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MP, 2012, CORTEX, V48, P980, DOI 10.1016/j.cortex.2011.03.012; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Baillieux H, 2010, CORTEX, V46, P869, DOI 10.1016/j.cortex.2009.09.002; Bak TH, 2001, J NEUROL, V248, P260, DOI 10.1007/s004150170199; Balsters JH, 2011, J NEUROSCI, V31, P2305, DOI 10.1523/JNEUROSCI.4358-10.2011; Begeti F, 2013, J NEUROL, V260, P2777, DOI 10.1007/s00415-013-7061-5; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen ZY, 2010, AMYOTROPH LATERAL SC, V11, P549, DOI 10.3109/17482968.2010.516265; Clark CM, 2006, ARCH NEUROL-CHICAGO, V63, P489, DOI 10.1001/archneur.63.4.489; Dobson-Stone C, 2012, NEUROLOGY, V79, P995, DOI 10.1212/WNL.0b013e3182684634; Garibotto V, 2011, NEUROBIOL AGING, V32, P875, DOI 10.1016/j.neurobiolaging.2009.05.004; Giordano A, 2013, PARKINSONISM RELAT D, V19, P590, DOI 10.1016/j.parkreldis.2013.02.005; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hornberger M, 2012, HUM BRAIN MAPP; Irish M, 2013, NEUROIMAGE-CLIN, V2, P836, DOI 10.1016/j.nicl.2013.06.005; Irwin DJ, 2013, J NEUROL NEUROSUR PS, V84, P163, DOI 10.1136/jnnp-2012-303507; Josephs KA, 2006, ARCH NEUROL-CHICAGO, V63, P1632, DOI 10.1001/archneur.63.11.1632; Kanda T, 2008, EUR J NUCL MED MOL I, V35, P2227, DOI 10.1007/s00259-008-0871-5; Kassubek J, 2005, AMYOTROPH LATERAL SC, V6, P213, DOI 10.1080/14660820510038538; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Lauterbach EC, 2010, COGN BEHAV NEUROL, V23, P63, DOI 10.1097/WNN.0b013e3181cfb541; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Lillo P, 2010, ARCH NEUROL-CHICAGO, V67, P826, DOI 10.1001/archneurol.2010.146; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Mahoney CJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt144; McColgan P, 2012, MOVEMENT DISORD, V27, P1172, DOI 10.1002/mds.25084; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mioshi E, 2013, NEUROLOGY, V80, P1117, DOI 10.1212/WNL.0b013e31828869da; Mottolese C, 2013, BRAIN, V136, P330, DOI 10.1093/brain/aws186; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Halloran CJ, 2012, J CLIN EXP NEUROPSYC, V34, P35, DOI 10.1080/13803395.2011.614599; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Sbardella E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063250; Schmahmann JD, 2009, NEUROSCIENCE, V162, P852, DOI 10.1016/j.neuroscience.2009.06.023; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Senda J, 2011, AMYOTROPH LATERAL SC, V12, P59, DOI 10.3109/17482968.2010.517850; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Strong MJ, 2003, ANN NEUROL, V54, pS20, DOI 10.1002/ana.10574; Takada LT, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt141; Terpening Z, 2011, AUSTRALAS J AGEING, V30, P113, DOI 10.1111/j.1741-6612.2010.00446.x; Thivard L, 2007, J NEUROL NEUROSUR PS, V78, P889, DOI 10.1136/jnnp.2006.101758; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Villanueva R, 2012, PSYCHIAT RES, V198, P527, DOI 10.1016/j.psychres.2012.02.023; Wedderburn C, 2008, J NEUROL NEUROSUR PS, V79, P500, DOI 10.1136/jnnp.2007.122028; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Whitwell JL, 2009, BRAIN, V132, P2932, DOI 10.1093/brain/awp232; Whitwell JL, 2006, NEUROLOGY, V66, P102, DOI 10.1212/01.wnl.0000191395.69438.12; Yi Dong Seok, 2013, Dement. neuropsychol., V7, P75, DOI 10.1590/S1980-57642013DN70100012; Yoshida H, 2011, PSYCHIAT RES, V185, P211, DOI 10.1016/j.psychres.2009.06.012; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	72	69	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105632	10.1371/journal.pone.0105632	http://dx.doi.org/10.1371/journal.pone.0105632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144223	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000341106100102
J	Zheng, LH; Wu, LM; Yao, Y; Chen, WS; Bao, JR; Huang, W; Shi, R; Zhang, KJ; Zhang, S				Zheng, Li-hui; Wu, Ling-min; Yao, Yan; Chen, Wen-sheng; Bao, Jing-ru; Huang, Wen; Shi, Rui; Zhang, Kui-jun; Zhang, Shu			Impact of Body Mass Index on Plasma N-Terminal ProB-Type Natriuretic Peptides in Chinese Atrial Fibrillation Patients without Heart Failure	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; OBESITY; POPULATION; DISEASE; ADULTS; LEVEL; RISK; SIZE	Background: An inverse relationship between body mass index (BMI) and circulating levels of N-terminal proB-type natriuretic peptide (NT-proBNP) has been demonstrated in subjects with and without heart failure. Obesity also has been linked with increased incidence of atrial fibrillation (AF), but its influence on NT-proBNP concentrations in AF patients remains unclear. This study aimed to investigate the effect of BMI on NT-proBNP levels in AF patients without heart failure. Methods: A total of 239 consecutive patients with AF undergoing catheter ablation were evaluated. Levels of NT-proBNP and clinical characteristics were compared in overweight or obese (BMI >= 25 kg/m(2)) and normal weight (BMI<25 kg/m(2)) patients. Results: Of 239 patients, 129 (54%) were overweight or obese. Overweight or obese patients were younger, more likely to have a history of nonparoxysmal AF, hypertension, and diabetes mellitus. Levels of NT-proBNP were significantly lower in overweight or obese than in normal weight subjects (P<0.05). The relationship of obesity and decreased NT-proBNP levels persisted in subgroup of hypertension, both gender and both age levels (>= 65 yrs and <65 yrs). Multivariate linear regression identified BMI as an independent negative correlate of LogNT-proBNP level. Conclusions: An inverse relationship between BMI and plasma NT-proBNP concentrations have been demonstrated in AF patients without heart failure. Overweight or obese patients with AF appear to have lower NT-proBNP levels than normal weight patients.	[Zheng, Li-hui; Wu, Ling-min; Yao, Yan; Chen, Wen-sheng; Bao, Jing-ru; Huang, Wen; Shi, Rui; Zhang, Kui-jun; Zhang, Shu] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Clin EP Lab, Beijing 100730, Peoples R China; [Zheng, Li-hui; Wu, Ling-min; Yao, Yan; Chen, Wen-sheng; Bao, Jing-ru; Huang, Wen; Shi, Rui; Zhang, Kui-jun; Zhang, Shu] Chinese Acad Med Sci, Arrhythmia Ctr, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Zheng, Li-hui; Wu, Ling-min; Yao, Yan; Chen, Wen-sheng; Bao, Jing-ru; Huang, Wen; Shi, Rui; Zhang, Kui-jun; Zhang, Shu] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yao, Y (corresponding author), Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Clin EP Lab, Beijing 100730, Peoples R China.	ianyao@263.net.cn	Yao, Yan/AAL-3060-2020	Yao, Yan/0000-0002-4003-4323				Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Cortes R, 2008, AM J HYPERTENS, V21, P820, DOI 10.1038/ajh.2008.173; Das SR, 2005, CIRCULATION, V112, P2163, DOI 10.1161/CIRCULATIONAHA.105.555573; Deftereos S, 2011, HEART, V97, P914, DOI 10.1136/hrt.2010.214742; den Uijl DW, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.031; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; Gibson PH, 2009, AM HEART J, V158, P244, DOI 10.1016/j.ahj.2009.04.026; Hense HW, 1998, J AM COLL CARDIOL, V32, P451, DOI 10.1016/S0735-1097(98)00240-X; Hong SN, 2008, INT HEART J, V49, P403, DOI 10.1536/ihj.49.403; Karthikeyan G, 2009, J AM COLL CARDIOL, V54, P1599, DOI 10.1016/j.jacc.2009.06.028; Krauser DG, 2005, AM HEART J, V149, P744, DOI 10.1016/j.ahj.2004.07.010; Lorgis L, 2011, HEART, V97, P551, DOI 10.1136/hrt.2010.213041; Malavazos AE, 2006, CLIN CHEM, V52, P1211, DOI 10.1373/clinchem.2006.067736; Mollmann H, 2008, CIRC J, V72, P921, DOI 10.1253/circj.72.921; Patton KK, 2009, CIRCULATION, V120, P1768, DOI 10.1161/CIRCULATIONAHA.109.873265; Raymond I, 2003, HEART, V89, P745, DOI 10.1136/heart.89.7.745; Rivera M, 2005, EUR J HEART FAIL, V7, P1168, DOI 10.1016/j.ejheart.2005.04.003; Rutten FH, 2007, EUR J HEART FAIL, V9, P651, DOI 10.1016/j.ejheart.2007.01.010; Sarzani R, 1996, J ENDOCRINOL INVEST, V19, P581; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Sugisawa T, 2010, ENDOCR J, V57, P727, DOI 10.1507/endocrj.K10E-067; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Zhou ZQ, 2003, CHIN J INTERN MED CH, V43, P491	26	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105249	10.1371/journal.pone.0105249	http://dx.doi.org/10.1371/journal.pone.0105249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144363	Green Submitted, gold, Green Published			2022-12-27	WOS:000341106100044
J	Bruschi, DP; Lucas, EM; Garcia, PCA; Recco-Pimentel, SM				Bruschi, Daniel P.; Lucas, Elaine M.; Garcia, Paulo C. A.; Recco-Pimentel, Shirlei M.			Molecular and Morphological Evidence Reveals a New Species in the Phyllomedusa hypochondrialis Group (Hylidae, Phyllomedusinae) from the Atlantic Forest of the Highlands of Southern Brazil	PLOS ONE			English	Article							NUCLEOLUS ORGANIZER REGIONS; LATE QUATERNARY VEGETATION; ARAUCARIA FOREST; CYTOGENETIC ANALYSIS; TAXONOMIC STATUS; ANURA; CONSERVATION; DIVERSITY; FROGS; AMPHIBIA	The taxonomic status of a disjunctive population of Phyllomedusa from southern Brazil was diagnosed using molecular, chromosomal, and morphological approaches, which resulted in the recognition of a new species of the P. hypochondrialis group. Here, we describe P. rustica sp. n. from the Atlantic Forest biome, found in natural highland grassland formations on a plateau in the south of Brazil. Phylogenetic inferences placed P. rustica sp. n. in a subclade that includes P. rhodei + all the highland species of the clade. Chromosomal morphology is conservative, supporting the inference of homologies among the karyotypes of the species of this genus. Phyllomedusa rustica is apparently restricted to its type-locality, and we discuss the potential impact on the strategies applied to the conservation of the natural grassland formations found within the Brazilian Atlantic Forest biome in southern Brazil. We suggest that conservation strategies should be modified to guarantee the preservation of this species.	[Bruschi, Daniel P.; Recco-Pimentel, Shirlei M.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Estrutural & Func, Sao Paulo, Brazil; [Lucas, Elaine M.] Univ Comunitaria Regiao Chapeco UNOCHAPECO, Area Ciencias Exatas & Ambientais Mestrado Cienci, Chapeco, SC, Brazil; [Garcia, Paulo C. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Comunitaria Regional de Chapeco; Universidade Federal de Minas Gerais	Bruschi, DP (corresponding author), Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Estrutural & Func, Sao Paulo, Brazil.	daniel_bruschi@hotmail.com	Garcia, Paulo/A-9983-2010	Garcia, Paulo/0000-0002-4789-7033	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/11300-7, 2010/17464-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grants 2010/11300-7 and 2010/17464-1), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for DPB scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Baeta D, 2009, ZOOTAXA, P58, DOI 10.11646/zootaxa.2226.1.5; Barrio-Amoros CL, 2006, ZOOTAXA, P55, DOI 10.11646/zootaxa.1309.1.5; Barth A, 2013, GEN MOL RES, V12, P2400; Barth A, 2009, J HERPETOL, V43, P676, DOI 10.1670/08-210.1; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Behling H, 1997, QUATERNARY RES, V48, P348, DOI 10.1006/qres.1997.1932; Behling H, 2004, PALAEOGEOGR PALAEOCL, V203, P277, DOI 10.1016/S0031-0182(03)00687-4; Behling H, 1997, REV PALAEOBOT PALYNO, V97, P109, DOI 10.1016/S0034-6667(96)00065-6; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brandao RA, 2009, ZOOTAXA, P61, DOI 10.11646/zootaxa.2044.1.4; Bruschi DP, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-70; Bruschi DP, 2012, HEREDITAS, V149, P34, DOI 10.1111/j.1601-5223.2010.02236.x; CANNATELLA DC, 1982, COPEIA, P501, DOI 10.2307/1444649; Caramaschi U, 2007, B MUS NAC, V524, P1; Caramaschi Ulisses, 2006, Arquivos do Museu Nacional Rio de Janeiro, V64, P159; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Costa LP, 2000, BIOTROPICA, V32, P872; da Silva JMC, 2004, GLOBAL ECOL BIOGEOGR, V13, P85, DOI 10.1111/j.1466-882X.2004.00077.x; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Duellman William E., 2005, pi; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2011, J MORPHOL, V272, P354, DOI 10.1002/jmor.10919; Faivovich J, 2010, CLADISTICS, V26, P227, DOI 10.1111/j.1096-0031.2009.00287.x; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2013, MOL PHYLOGENET EVOL, V67, P445, DOI 10.1016/j.ympev.2013.02.009; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Fusinatto LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079504; Garcia PCA, 2003, HERPETOLOGICA, V59, P350, DOI 10.1655/01-54; GATESY J, 1993, MOL PHYLOGENET EVOL, V2, P152, DOI 10.1006/mpev.1993.1015; Gehara M, 2013, CONSERV GENET, V14, P973, DOI 10.1007/s10592-013-0488-5; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Giaretta Ariovaldo A., 2007, Zootaxa, V1614, P31; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Goloboff P.A., 2003, T N T TREE ANAL USIN; Green D. M, 1991, AMPHIBIAN CYTOGENETI, P431, DOI [DOI 10.1016/B978-0-12-297880-7.50021-4, 10.1016/B978-0-12-297880-7.50021-4]; Gruber SL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-75; Hall T, 1999, BIOEDIT; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; Jungfer KH, 2013, ZOOL SCR, V42, P351, DOI 10.1111/zsc.12015; KING M, 1976, CHROMOSOMA, V54, P75, DOI 10.1007/BF00331835; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Loyola RD, 2008, DIVERS DISTRIB, V14, P949, DOI 10.1111/j.1472-4642.2008.00508.x; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Lucas Elaine M., 2010, Check List, V6, P164; Maack V, 1981, GEOGRAFIA FISICA EST; McLeod DS, 2010, MOL PHYLOGENET EVOL, V56, P991, DOI 10.1016/j.ympev.2010.04.004; MEUNIERROTIVAL M, 1979, NUCLEIC ACIDS RES, V6, P2109, DOI 10.1093/nar/6.6.2109; Morand Mariana, 1997, Cuadernos de Herpetologia, V11, P31; MYERS C W, 1982, American Museum Novitates, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Napoli MF, 2005, HERPETOLOGICA, V61, P63, DOI 10.1655/03-41; Nylander J.A.A, 2004, MRMODELTEST V2; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Overbeck SCM, 2009, CAMPOS SULINOS CONSE; Paiva CR, 2010, ITAL J ZOOL, V77, P116, DOI 10.1080/11250000903187585; Pombal-Jr Jose P., 1992, Revista Brasileira de Biologia, V52, P217; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Tonini JFR, 2013, J ZOOL SYST EVOL RES, V51, P114, DOI 10.1111/jzs.12014; Rolland Jonathan, 2012, Biol Lett, V8, P692, DOI 10.1098/rsbl.2011.1024; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savage J. M., 1967, BEITR NEOTROP FAUNA, V5, P111, DOI DOI 10.1080/01650526709360400; SCHMID M, 1978, CHROMOSOMA, V66, P361, DOI 10.1007/BF00328536; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teixeira M, 2013, ZOOTAXA, V3702, P459, DOI 10.11646/zootaxa.3702.5.5; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo LF, 2010, J NAT HIST, V44, P1979, DOI 10.1080/00222931003624804; Viegas-Pequignot E, 1992, IN SITU HYBRIDIZATIO, P137	81	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105608	10.1371/journal.pone.0105608	http://dx.doi.org/10.1371/journal.pone.0105608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141279	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200115
J	Pham, TD				Pham, Tuan D.			Spatial Uncertainty Modeling of Fuzzy Information in Images for Pattern Classification	PLOS ONE			English	Article							INDICATOR KRIGING APPROACH; PROBABILITY-MEASURES; C-MEANS; RECOGNITION; TEXTURE; ENTROPY; SPACE	The modeling of the spatial distribution of image properties is important for many pattern recognition problems in science and engineering. Mathematical methods are needed to quantify the variability of this spatial distribution based on which a decision of classification can be made in an optimal sense. However, image properties are often subject to uncertainty due to both incomplete and imprecise information. This paper presents an integrated approach for estimating the spatial uncertainty of vagueness in images using the theory of geostatistics and the calculus of probability measures of fuzzy events. Such a model for the quantification of spatial uncertainty is utilized as a new image feature extraction method, based on which classifiers can be trained to perform the task of pattern recognition. Applications of the proposed algorithm to the classification of various types of image data suggest the usefulness of the proposed uncertainty modeling technique for texture feature extraction.	Univ Aizu, Ctr Adv Informat Sci & Technol, Aizu Res Cluster Med Engn & Informat, Aizu Wakamatsu, Fukushima, Japan	University of Aizu	Pham, TD (corresponding author), Univ Aizu, Ctr Adv Informat Sci & Technol, Aizu Res Cluster Med Engn & Informat, Aizu Wakamatsu, Fukushima, Japan.	tdpham@u-aizu.ac.jp			University of Aizu Special Grant; CRF Grant	University of Aizu Special Grant; CRF Grant	This work was funded by the FY2013 President of The University of Aizu Special Grant and FY2014 CRF Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asyali MH, 2005, BIOINFORMATICS, V21, P644, DOI 10.1093/bioinformatics/bti036; Bezdek J.C., 1992, FUZZY MODELS PATTERN; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; BHANDARI D, 1992, PATTERN RECOGN LETT, V13, P857, DOI 10.1016/0167-8655(92)90085-E; Caers J, 2011, MODELING UNCERTAINTY IN THE EARTH SCIENCES, P1, DOI 10.1002/9781119995920; Castanon CAB, 2007, PATTERN RECOGN, V40, P1899, DOI 10.1016/j.patcog.2006.12.006; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Cheng HD, 1998, PATTERN RECOGN, V31, P857, DOI 10.1016/S0031-3203(97)00113-1; Chi Z., 1996, FUZZY ALGORITHMS APP; Chiang JL, 2014, IEEE T GEOSCI REMOTE, V52, P4046, DOI 10.1109/TGRS.2013.2279118; Chica-Olmo M, 2000, COMPUT GEOSCI, V26, P373, DOI 10.1016/S0098-3004(99)00118-1; Chiles J.-P., 2012, GEOSTATISTICS MODELI; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cressie N. A. C., 2011, STAT SPATIO TEMPORAL; Davis J.C., 2002, STAT DATA ANAL GEOLO; DELUCA A, 1972, INFORM CONTROL, V20, P301, DOI 10.1016/S0019-9958(72)90199-4; Deutsch C.V., 2002, GEOSTATISTICAL RESER; Duda R.O., 2006, PATTERN CLASSIFICATI; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gonzalez-Rufino E, 2013, PATTERN RECOGN, V46, P2391, DOI 10.1016/j.patcog.2013.02.009; Hoshino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002479; Howson AG, 1976, HDB TERMS USED ALGEB; Iannaccone P.M., 1996, FRACTAL GEOMETRY BIO, V1; Isaaks EH, 1989, APPL GEOSTATISTICS; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Leuangthong O., 2008, SOLVED PROBLEMS GEOS; Liu J, 2012, PATTERN RECOGN, V45, P1759, DOI 10.1016/j.patcog.2011.11.001; Nguyen-Thanh N, 2013, PROCEEDINGS OF THE 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (CIBCB), P218, DOI 10.1109/CIBCB.2013.6595412; Nixon M., 2008, FEATURE EXTRACTION I; Nixon M., 2012, FEATURE EXTRACTION I; Oh W, 1999, IEEE T PATTERN ANAL, V21, P590, DOI 10.1109/34.777370; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Petrou M., 2003, IMAGE PROCESSING FUN; Pham T.D., 2003, P SPIE C APPL ART NE, V5015, P12; Pham TD, 2004, BIOINFORMATICS, V20, P2189, DOI 10.1093/bioinformatics/bth213; Pham TD, 2003, P SOC PHOTO-OPT INS, V5010, P20, DOI 10.1117/12.472840; Pham TD, 2003, PATTERN RECOGN, V36, P3023, DOI 10.1016/S0031-3203(03)00125-0; Pham TD, 2001, IEEE IMAGE PROC, P722, DOI 10.1109/ICIP.2001.959147; Pham TD, 2001, 10TH IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOLS 1-3, P69, DOI 10.1109/FUZZ.2001.1007249; Pham TD, 2000, INT J PATTERN RECOGN, V14, P1025, DOI 10.1142/S0218001400000659; Pham TD, 2014, INFORM SCIENCES, V270, P134, DOI 10.1016/j.ins.2014.02.102; Pham TD, 2014, PROC SPIE, V9069, DOI 10.1117/12.2050102; Pham TD, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-62; Pham TD, 2014, COMPUT METH PROG BIO, V113, P153, DOI 10.1016/j.cmpb.2013.09.019; Pham TD, 2011, IEEE T INF TECHNOL B, V15, P242, DOI 10.1109/TITB.2010.2081996; Plissiti ME, 2011, PATTERN RECOGN LETT, V32, P838, DOI 10.1016/j.patrec.2011.01.008; Sanchez-Brea LM, 2006, IEEE T IMAGE PROCESS, V15, P3131, DOI 10.1109/TIP.2006.877505; Singpurwalla ND, 2004, J AM STAT ASSOC, V99, P867, DOI 10.1198/016214504000001196; Szczepaniak P. S., 2000, FUZZY SYSTEMS MED; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Uchida S, 2013, DEV GROWTH DIFFER, V55, P523, DOI 10.1111/dgd.12054; VanderMeer F, 1996, INT J REMOTE SENS, V17, P1233, DOI 10.1080/01431169608949079; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094211; ZADEH LA, 1968, J MATH ANAL APPL, V23, P421, DOI 10.1016/0022-247X(68)90078-4; Zhang BL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-128	55	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105075	10.1371/journal.pone.0105075	http://dx.doi.org/10.1371/journal.pone.0105075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157744	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200023
J	Kent, ST; Shimbo, D; Huang, L; Diaz, KM; Kilgore, ML; Oparil, S; Muntner, P				Kent, Shia T.; Shimbo, Daichi; Huang, Lei; Diaz, Keith M.; Kilgore, Meredith L.; Oparil, Suzanne; Muntner, Paul			Antihypertensive Medication Classes Used among Medicare Beneficiaries Initiating Treatment in 2007-2010	PLOS ONE			English	Article							JOINT NATIONAL COMMITTEE; LIPID-LOWERING TREATMENT; NEWLY TREATED PATIENTS; HEART-ATTACK TRIAL; HYPERTENSION CONTROL; 7TH REPORT; PREVENTION; DISEASE; ADULTS; HEALTH	Background: After the 2003 publication of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines, there was a 5-10% increase in patients initiating antihypertensive medication with a thiazide-type diuretic, but most patients still did not initiate treatment with this class. There are few contemporary published data on antihypertensive medication classes filled by patients initiating treatment. Methods and Findings: We used the 5% random Medicare sample to study the initiation of antihypertensive medication between 2007 and 2010. Initiation was defined by the first antihypertensive medication fill preceded by 365 days with no antihypertensive medication fills. We restricted our analysis to beneficiaries >= 65 years who had two or more outpatient visits with a hypertension diagnosis and full Medicare fee-for-service coverage for the 365 days prior to initiation of antihypertensive medication. Between 2007 and 2010, 32,142 beneficiaries in the 5% Medicare sample initiated antihypertensive medication. Initiation with a thiazide-type diuretic decreased from 19.2% in 2007 to 17.9% in 2010. No other changes in medication classes initiated occurred over this period. Among those initiating antihypertensive medication in 2010, 31.3% filled angiotensin-converting enzyme inhibitors (ACE-Is), 26.9% filled beta blockers, 17.2% filled calcium channel blockers, and 14.4% filled angiotensin receptor blockers (ARBs). Initiation with >1 antihypertensive medication class decreased from 25.6% in 2007 to 24.1% in 2010. Patients initiated >1 antihypertensive medication class most commonly with a thiazide-type diuretic and either an ACE-I or ARB. Conclusion: These results suggest that JNC 7 had a limited long-term impact on the choice of antihypertensive medication class and provide baseline data prior to the publication of the 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).	[Kent, Shia T.; Huang, Lei; Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Shimbo, Daichi; Diaz, Keith M.] Columbia Univ, Dept Med, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY USA; [Kilgore, Meredith L.] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL USA; [Oparil, Suzanne; Muntner, Paul] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Columbia University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kent, ST (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	shia@uab.edu		Diaz, Keith/0000-0003-0190-0548	National Heart, Lung, and Blood Institute (NHLBI) [T32-HL007457-33]; NHLBI program [P01-HL047540]; NHLBI Diversity Supplement [P01-HL047540-19S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007457, P01HL047540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI Diversity Supplement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	STK was supported by a National Heart, Lung, and Blood Institute (NHLBI) training grant (T32-HL007457-33). DS was supported by an NHLBI program grant (P01-HL047540). KMD was supported by a NHLBI Diversity Supplement (P01-HL047540-19S1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Berndt ER, 2011, INT J ECON BUS, V18, P177, DOI 10.1080/13571516.2011.584423; Bien BY, 2010, J MANAGE CARE PHARM, V16, P671, DOI 10.18553/jmcp.2010.16.9.671; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Carson AP, 2011, HYPERTENSION, V57, P1101, DOI 10.1161/HYPERTENSIONAHA.110.168005; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Egan BM, 2012, HYPERTENSION, V59, P1124, DOI 10.1161/HYPERTENSIONAHA.112.194167; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2013, JAMA            1218; Krousel-Wood M, 2012, J CLIN HYPERTENS, V14, P277, DOI 10.1111/j.1751-7176.2012.00609.x; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Malacco E, 2003, BLOOD PRESSURE, V12, P160, DOI 10.1080/08037050310009545; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Muntner P, 2009, HYPERTENSION, V53, P617, DOI 10.1161/HYPERTENSIONAHA.108.120154; Player Marty S, 2006, J Clin Hypertens (Greenwich), V8, P860, DOI 10.1111/j.1524-6175.2006.05781.x; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Xie FG, 2005, AM J HYPERTENS, V18, P464, DOI 10.1016/j.amjhyper.2004.11.004; Yun HF, 2013, PHARMACOEPIDEM DR S, V22, P55, DOI 10.1002/pds.3361	23	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105888	10.1371/journal.pone.0105888	http://dx.doi.org/10.1371/journal.pone.0105888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153199	Green Published, gold			2022-12-27	WOS:000340952200089
J	Klumbies, E; Braeuer, D; Hoyer, J; Kirschbaum, C				Klumbies, Elisabeth; Braeuer, David; Hoyer, Juergen; Kirschbaum, Clemens			The Reaction to Social Stress in Social Phobia: Discordance between Physiological and Subjective Parameters	PLOS ONE			English	Article							SALIVARY CORTISOL-LEVELS; URINARY FREE CORTISOL; PSYCHOSOCIAL STRESS; ALPHA-AMYLASE; PSYCHOLOGICAL STRESSOR; ANXIETY SENSITIVITY; YOUNGER ADULTS; ELDERLY ADULTS; AXIS RESPONSE; HAIR CORTISOL	Background: Research on the biopsychological background of social phobia (SP) is scarce and inconsistent. We investigated endocrine and autonomic markers along with subjective responses to a standardized stress situation (Trier Social Stress Test, TSST) in SP patients and healthy controls (HC). Methods: We examined 88 patients with the primary diagnosis of SP as well as 78 age and sex comparable HCs with the TSST. Blood and saliva samples were obtained before and after the TSST for the assessment of salivary cortisol, plasma cortisol, salivary alpha-amylase (sAA), and prolactin. Heart rate (HR) and heart rate variability (HRV) were recorded continuously. Scalp-near hair samples were collected for the assessment of long-term cortisol secretion. The self-reported stress response was measured with different state and trait scales. Results: While self-reported anxiety was elevated in SP before, during, immediately after, and one week after the TSST, no significant differences in biological stress responses were observed between SP and HC. There was a trend for SP to show higher baseline stress markers. Also long-term cortisol deposition in hair remained unaltered. Conclusions: Our results suggest that the excessive self-reported stress in SP is not reflected by a respective biological stress response. Patients with SP apparently show neither an extreme form of focused fear reactivity nor excessive defensive impairment.	[Klumbies, Elisabeth; Kirschbaum, Clemens] Tech Univ Dresden, Inst Biopsychol, D-01062 Dresden, Germany; [Braeuer, David; Hoyer, Juergen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Klumbies, E (corresponding author), Tech Univ Dresden, Inst Biopsychol, D-01062 Dresden, Germany.	klumbies@biopsych.tu-dresden.de	Hoyer, Juergen/D-3619-2011; Hoyer, Juergen/AAP-6071-2020; Kirschbaum, Clemens/AAB-1752-2020	Hoyer, Juergen/0000-0002-1697-6732; Hoyer, Juergen/0000-0002-1697-6732; 	Deutsche Forschungsgemeinschaft [KI 537/26-1, HO1900/6-1]; Evangelisches Studienwerk eV Villigst	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evangelisches Studienwerk eV Villigst	This work was supported by grants from the Deutsche Forschungsgemeinschaft (KI 537/26-1 and HO1900/6-1) and a scholarship from Evangelisches Studienwerk eV Villigst to EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anderson ER, 2009, J ANXIETY DISORD, V23, P18, DOI 10.1016/j.janxdis.2008.03.011; Beaton EA, 2006, PERS INDIV DIFFER, V41, P1217, DOI 10.1016/j.paid.2006.02.020; BEATTY MJ, 1991, HUM COMMUN RES, V18, P147, DOI 10.1111/j.1468-2958.1991.tb00542.x; BEIDEL DC, 1985, BEHAV RES THER, V23, P109, DOI 10.1016/0005-7967(85)90019-1; Camm AJ, 1996, CIRCULATION, V93, P1043; Chong RY, 2008, PSYCHONEUROENDOCRINO, V33, P246, DOI 10.1016/j.psyneuen.2007.10.014; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Condren RM, 2002, PSYCHONEUROENDOCRINO, V27, P693, DOI 10.1016/S0306-4530(01)00070-1; Edelmann RJ, 2002, BRIT J CLIN PSYCHOL, V41, P1, DOI 10.1348/014466502163732; Fehm L, 2005, EUR NEUROPSYCHOPHARM, V15, P453, DOI 10.1016/j.euroneuro.2005.04.002; Fehm L, 2008, ANXIETY STRESS COPIN, V21, P129, DOI 10.1080/10615800701424672; Furlan PM, 2001, BIOL PSYCHIAT, V50, P254, DOI 10.1016/S0006-3223(00)01126-4; Fydrich T., 2002, DIAGNOSTISCHE VERFAH, P335; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P599, DOI 10.1016/j.psyneuen.2005.02.001; Gentle J. E., 2004, HDB COMPUTATIONAL ST; Gerlach AL, 2003, J ANXIETY DISORD, V17, P197, DOI 10.1016/S0887-6185(02)00197-4; Gerlach AL, 2001, J ABNORM PSYCHOL, V110, P247, DOI 10.1037/0021-843X.110.2.247; Gerra G, 2001, PSYCHONEUROENDOCRINO, V26, P91, DOI 10.1016/S0306-4530(00)00046-9; Grossman P, 2001, PSYCHOSOM MED, V63, P765, DOI 10.1097/00006842-200109000-00010; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Heiser NA, 2009, J ANXIETY DISORD, V23, P469, DOI 10.1016/j.janxdis.2008.10.002; Kessler RC, 2003, ACTA PSYCHIAT SCAND, V108, P19, DOI 10.1034/j.1600-0447.108.s417.2.x; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kramer M, 2012, J ABNORM CHILD PSYCH, V40, P95, DOI 10.1007/s10802-011-9548-9; Kudielka B. M., 2007, 10 YEARS RES TRIER S; Kudielka BM, 2004, INT J BEHAV MED, V11, P116, DOI 10.1207/s15327558ijbm1102_8; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4; Lang PJ, 2009, ANXIETY STRESS COPIN, V22, P5, DOI 10.1080/10615800802478247; Laux L., 1981, STATE TRAIT ANGSTINV; Lennartsson AK, 2011, PSYCHONEUROENDOCRINO, V36, P1530, DOI 10.1016/j.psyneuen.2011.04.007; LEVIN AP, 1993, J ANXIETY DISORD, V7, P207, DOI 10.1016/0887-6185(93)90003-4; Lorberbaum JP, 2004, NEUROREPORT, V15, P2701; Martel FL, 1999, DEPRESS ANXIETY, V10, P25, DOI 10.1002/(SICI)1520-6394(1999)10:1<25::AID-DA4>3.0.CO;2-O; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; POTTS NLS, 1991, J CLIN PSYCHIAT, V52, P41; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Roelofs K, 2009, BIOL PSYCHIAT, V65, P336, DOI 10.1016/j.biopsych.2008.08.022; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Ruscio AM, 2008, PSYCHOL MED, V38, P15, DOI 10.1017/S0033291707001699; Schmitz J, 2011, J CHILD PSYCHOL PSYC, V52, P1203, DOI 10.1111/j.1469-7610.2011.02417.x; Stalder T, 2012, PSYCHONEUROENDOCRINO, V37, P602, DOI 10.1016/j.psyneuen.2011.08.007; Stangier U., 2005, INT SKALEN F R PSYCH, P299; Steudte S, 2013, BIOL PSYCHIAT, V74, P639, DOI 10.1016/j.biopsych.2013.03.011; Steyer, 1997, MEHRDIMENSIONALE BEF; Strahler J, 2010, PSYCHOPHYSIOLOGY, V47, P587, DOI 10.1111/j.1469-8986.2009.00957.x; Thibodeau MA, 2012, J BEHAV THER EXP PSY, V43, P967, DOI 10.1016/j.jbtep.2012.03.001; UHDE TW, 1994, J AFFECT DISORDERS, V30, P155, DOI 10.1016/0165-0327(94)90076-0; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Veen JF, 2008, PSYCHONEUROENDOCRINO, V33, P1313, DOI 10.1016/j.psyneuen.2008.07.004; van West D, 2008, J AFFECT DISORDERS, V111, P281, DOI 10.1016/j.jad.2008.03.006; Wennig R, 2000, FORENSIC SCI INT, V107, P5, DOI 10.1016/S0379-0738(99)00146-2; WEYERS P, 1995, PERS INDIV DIFFER, V19, P853, DOI 10.1016/S0191-8869(95)00128-X; Wittchen H-U, 1997, INFORMATIONSMATERIAL; Wittchen HU., 1997, DIA X SCREENING VERF; Yoon KL, 2012, J ABNORM PSYCHOL, V121, P250, DOI 10.1037/a0025079	57	51	52	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105670	10.1371/journal.pone.0105670	http://dx.doi.org/10.1371/journal.pone.0105670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153526	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200067
J	Lopez, Y; Vandenbon, A; Nakai, K				Lopez, Yosvany; Vandenbon, Alexis; Nakai, Kenta			A Set of Structural Features Defines the Cis-Regulatory Modules of Antenna-Expressed Genes in Drosophila melanogaster	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; RNA-SEQ; PROTEIN; IDENTIFICATION; MOTIFS; DISCOVERY; PATTERNS; SEQUENCE; GENOMES; DNA	Unraveling the biological information within the regulatory region (RR) of genes has become one of the major focuses of current genomic research. It has been hypothesized that RRs of co-expressed genes share similar architecture, but to the best of our knowledge, no studies have simultaneously examined multiple structural features, such as positioning of cis-regulatory elements relative to transcription start sites and to each other, and the order and orientation of regulatory motifs, to accurately describe overall cis-regulatory structure. In our work we present an improved computational method that builds a feature collection based on all of these structural features. We demonstrate the utility of this approach by modeling the cis-regulatory modules of antenna-expressed genes in Drosophila melanogaster. Six potential antenna-related motifs were predicted initially, including three that appeared to be novel. A feature set was created with the predicted motifs, where a correlation-based filter was used to remove irrelevant features, and a genetic algorithm was designed to optimize the feature set. Finally, a set of eight highly informative structural features was obtained for the RRs of antenna-expressed genes, achieving an area under the curve of 0.841. We used these features to score all D. melanogaster RRs for potentially unknown antenna-expressed genes sharing a similar regulatory structure. Validation of our predictions with an independent RNA sequencing dataset showed that 76.7% of genes with high scoring RRs were expressed in antenna. In addition, we found that the structural features we identified are highly conserved in RRs of orthologs in other Drosophila sibling species. This approach to identify tissue-specific regulatory structures showed comparable performance to previous approaches, but also uncovered additional interesting features because it also considered the order and orientation of motifs.	[Lopez, Yosvany] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Chiba, Japan; [Lopez, Yosvany; Nakai, Kenta] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Tokyo, Japan; [Vandenbon, Alexis] Osaka Univ, Immunol Frontier Res Ctr, Osaka, Japan	University of Tokyo; University of Tokyo; Osaka University	Nakai, K (corresponding author), Univ Tokyo, Ctr Human Genome, Inst Med Sci, Tokyo, Japan.	knakai@ims.u-tokyo.ac.jp	Nakai, Kenta/B-7293-2009; Vandenbon, Alexis/A-8430-2017; Vandenbon, Alexis/N-4428-2019	Nakai, Kenta/0000-0002-8721-8883; Lopez, Yosvany/0000-0002-9550-0053	JSPS [25290067]; MEXT scholarship	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT scholarship	This work was partly supported by Grants-in-Aid for Scientific Research from JSPS (25290067). Yosvany Lopez thanks the support of the MEXT scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bajic VB, 2003, SILICO BIOL, V4, P1; Biryukova I, 2008, DEV BIOL, V323, P64, DOI 10.1016/j.ydbio.2008.08.014; Bodai L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040565; Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fujisawa K, 2009, COMP BIOCHEM PHYS B, V153, P29, DOI 10.1016/j.cbpb.2009.01.006; Fuller SB, 2014, P NATL ACAD SCI USA, V111, pE1182, DOI 10.1073/pnas.1323529111; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hatini V, 2013, DEV BIOL, V378, P38, DOI 10.1016/j.ydbio.2013.02.016; Hoeppner DJ, 2004, DEV BIOL, V274, P125, DOI 10.1016/j.ydbio.2004.06.022; Jeong MH, 2010, DEV DYNAM, V239, P1931, DOI 10.1002/dvdy.22322; Jory A, 2012, CELL REP, V2, P1014, DOI 10.1016/j.celrep.2012.09.010; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lopez Y, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S3-S10; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mitchell Melanie, 1998, INTRO GENETIC ALGORI; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Obayashi T, 2012, NUCLEIC ACIDS RES, V41, P1; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Pavesi G., 2001, BIOINFORMATICS, V17, pS207; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Shiao MS, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-42; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vandenbon A, 2010, NUCLEIC ACIDS RES, V38, P17, DOI 10.1093/nar/gkp866; Vandenbon A, 2008, GENOME INFORM SER, V21, P188; Yokoyama KD, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp423; Yu L., 2003, 20 INT C MACH LEARN; Zhao GY, 2007, GENOME RES, V17, P348, DOI 10.1101/gr.5989907; Zheng WW, 2013, INT J MOL SCI, V14, P14936, DOI 10.3390/ijms140714936	45	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104342	10.1371/journal.pone.0104342	http://dx.doi.org/10.1371/journal.pone.0104342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153327	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200018
J	Fornasero, LV; Del Papa, MF; Lopez, JL; Albicoro, FJ; Zabala, JM; Toniutti, MA; Pensiero, JF; Lagares, A				Viviana Fornasero, Laura; Florencia Del Papa, Maria; Luis Lopez, Jose; Javier Albicoro, Francisco; Marcelo Zabala, Juan; Antonieta Toniutti, Maria; Francisco Pensiero, Jose; Lagares, Antonio			Phenotypic, Molecular and Symbiotic Characterization of the Rhizobial Symbionts of Desmanthus paspalaceus (Lindm.) Burkart That Grow in the Province of Santa Fe, Argentina	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI; ILLINOIS BUNDLEFLOWER; NITROGEN-FIXATION; NODULE BACTERIA; STRAIN CB3126; ROOT-NODULES; SP NOV.; VIRGATUS; INOCULATION; QUEENSLAND	Desmanthus paspalaceus (Lindm.) Burkart belongs to the D. virgatus complex, subfamily Mimosoidae. The known potential as livestock fodder of several of these legumes prompted us to undertake a phenotypic, molecular, and symbiotic characterization of the D. paspalaceus symbionts in the Santa Fe province, Argentina. The rhizobia collected-containing isolates with different abiotic-stress tolerances-showed a remarkable genetic diversity by PCR fingerprinting, with 11 different amplification profiles present among 20 isolates. In selected isolates 16S-rDNA sequencing detected mesorhizobia (60%) and rhizobia (40%) within the collection, in contrast to the genus of the original inoculant strain CB3126-previously isolated from Leucaena leucocephala-that we typified here through its 16S rDNA as Sinorhizobium terangae. The results revealed the establishment by diverse bacterial genera -rhizobia, sinorhizobia, and mesorhizobia-of full N-2-fixing symbiotic associations with D. paspalaceus. This diversity was paralleled by the presence of at least two different nodC allelic variants. The identical nodC alleles of the Mesorhizobia sp. 10.L.4.2 and 10.L.5.3 notably failed to group within any of the currently described rhizo-/brady-/azorhizobial nodC clades. Interestingly, the nodC from S. terangae CB3126 clustered close to homologs from common bean nodulating rhizobia, but not with the nodC from S. terangae WSM1721 that nodulates Acacia. No previous data were available on nod-gene phylogeny for Desmanthus symbionts. A field assay indicated that inoculation of D. paspalaceus with the local Rhizobium sp. 10L.11.4 produced higher aerial-plant dry weights compared to S. teranga CB3126-inoculated plants. Neither the mesorhizobia 10.L.4.2 or 10.L.5.3 nor the rhizobium 10L.11.4 induced root nodules in L. leucocephala or P. vulgaris. The results show that some of the local isolates have remarkable tolerances to several abiotic stresses including acidity, salt, and temperature; while exhibiting prominent N-2 fixation; thus indicating suitability as candidates for inoculation of D. paspalaceus.	[Florencia Del Papa, Maria; Luis Lopez, Jose; Javier Albicoro, Francisco; Lagares, Antonio] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, IBBM Inst Biotecnol & Biol Mol,CONICET, La Plata, Buenos Aires, Argentina; [Viviana Fornasero, Laura; Marcelo Zabala, Juan; Antonieta Toniutti, Maria; Francisco Pensiero, Jose] Univ Nacl Litoral, Fac Ciencias Agr, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of the Littoral	Lagares, A (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, IBBM Inst Biotecnol & Biol Mol,CONICET, La Plata, Buenos Aires, Argentina.	lagares@biol.unlp.edu.ar	Del Papa, María Florencia/AAQ-3046-2021	Del Papa, María Florencia/0000-0003-0088-6756; Lopez Arcondo, Jose Luis/0000-0002-6942-7032; Albicoro, Francisco/0000-0001-5460-3534	National Science and Technology Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas-CONICET, Argentina); Ministry of Science Technology and Productive Innovation (Ministerio de Ciencia Tecnolologia e Innovacion Productiva-MinCyT, Argentina) [PICT 2008-0736, PICT 2012-1719]; Agencia de Promocion Cientifica y Tecnologica (ANPCyT-MinCyT, Argentina); CONICET	National Science and Technology Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas-CONICET, Argentina); Ministry of Science Technology and Productive Innovation (Ministerio de Ciencia Tecnolologia e Innovacion Productiva-MinCyT, Argentina); Agencia de Promocion Cientifica y Tecnologica (ANPCyT-MinCyT, Argentina); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by the National Science and Technology Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas-CONICET, Argentina), and the Ministry of Science Technology and Productive Innovation (Ministerio de Ciencia Tecnolologia e Innovacion Productiva-MinCyT, Argentina: grants PICT 2008-0736 and PICT 2012-1719 to AL). LVF and MAT were supported with a full-time position as Laboratory Instructors at the Facultad de Agronomia-Universidad Nacional del Litoral (UNL), Argentina. JLL and FA were supported by fellowships from the Agencia de Promocion Cientifica y Tecnologica (ANPCyT-MinCyT, Argentina) and CONICET, respectively. MFDP, JFP, and AL are Researchers at CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ON, 1981, LEGUMINOSAE SOURCE B, P227; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amarger N, 1997, INT J SYST BACTERIOL, V47, P996, DOI 10.1099/00207713-47-4-996; Bahnisch GA, 1998, TROP GRASSLANDS, V32, P13; Berge O, 2009, INT J SYST EVOL MICR, V59, P367, DOI 10.1099/ijs.0.000521-0; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Beyhaut E, 2006, CAN J PLANT SCI, V86, P919, DOI 10.4141/P05-097; Bhattacharyya R. N., 2000, Acta Microbiologica et Immunologica Hungarica, V47, P41; Boiero L, 2007, APPL MICROBIOL BIOT, V74, P874, DOI 10.1007/s00253-006-0731-9; Brandon NJ, 1998, TROP GRASSLANDS, V32, P20; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Burt R. L., 1993, Herbage Abstracts, V63, P401; DATE RA, 1991, TROP GRASSLANDS, V25, P47; Date RA, 1997, TROP GRASSLANDS, V31, P350; Datta C, 2000, MICROBIOL RES, V155, P123, DOI 10.1016/S0944-5013(00)80047-6; DAVIS PE, 1982, SOIL BIOL BIOCHEM, V14, P313, DOI 10.1016/0038-0717(82)90045-1; de Lajudie P, 1998, INT J SYST BACTERIOL, V48, P369, DOI 10.1099/00207713-48-2-369; DELAJUDIE P, 1994, INT J SYST BACTERIOL, V44, P715, DOI 10.1099/00207713-44-4-715; DOYLE JJ, 1994, ANNU REV ECOL SYST, V25, P325; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fischbach JA, 2005, AGRON J, V97, P895, DOI 10.2134/agronj2004.0139; GARDINER CP, 1995, TROP GRASSLANDS, V29, P183; Gardiner CP, 2004, P 4 INT CROP SCI C B; Ghosh S, 2008, DEUT VIER LIT GEIST, V82, P3; Hopkinson JM, 2004, TROP GRASSLANDS, V38, P1; Howard RA, 1988, DICOTYLEDONEAE; Jensen H., 1942, P LINN SOC N S W, V66, P98; Jones RM, 1997, TROP GRASSLANDS, V31, P315; Jones RM, 1998, TROP GRASSLANDS, V32, P145; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; Lewis G.P., 2005, LEGUMES WORLD, P187; Lin DX, 2009, INT J SYST EVOL MICR, V59, P1919, DOI 10.1099/ijs.0.006387-0; Liogier H.A., 1988, EDITORIAL U PUERTO R, V2, P481; Luckow M., 1993, Systematic Botany Monographs, V38, DOI 10.2307/25027822; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Ocumpaugh WR, 2004, CROP SCI, V44, P1860, DOI 10.2135/cropsci2004.1860; Rogel MA, 2011, SYST APPL MICROBIOL, V34, P96, DOI 10.1016/j.syapm.2010.11.015; Sambrook J., 2002, MOL CLONING LAB MANU; Sinsuwongwat S, 2002, SOIL SCI PLANT NUTR, V48, P719, DOI 10.1080/00380768.2002.10409262; Skerman PJ, 1988, TROPICAL FORAGE LEGU; Somasegaran P., 1994, HDB RHIZOBIA, DOI [10.1007/978-1-4613-8375-8, DOI 10.1007/978-1-4613-8375-8]; Spaepen S, 2009, FEMS MICROBIOL LETT, V291, P195, DOI 10.1111/j.1574-6968.2008.01453.x; Sprent J.I., 1990, NITROGEN FIXING ORGA; THOMPSON JA, 1991, EXPERT CONSULTATION, P113; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Vincent J. M., 1970, HANDBOOK, V15; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu LJ, 2011, FEMS MICROBIOL ECOL, V76, P439, DOI 10.1111/j.1574-6941.2011.01064.x; Xu J, 2012, APPL ENVIRON MICROB, V78, P8056, DOI 10.1128/AEM.01276-12; Zabala JM, 2008, TROP GRASSLANDS, V42, P229; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; Zamora Natera F, 2002, REV FITOTEC MEX, V25, P317; Zuckerkandl E., 1965, EVOLVING GENES PROTE; Zuloaga FO, 1999, DICOTYLEDONEAE MONOG	57	6	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104636	10.1371/journal.pone.0104636	http://dx.doi.org/10.1371/journal.pone.0104636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153989	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200022
J	Yamashiro, T; Miyara, T; Honda, O; Kamiya, H; Murata, K; Ohno, Y; Tomiyama, N; Moriya, H; Koyama, M; Noma, S; Kamiya, A; Tanaka, Y; Murayama, S				Yamashiro, Tsuneo; Miyara, Tetsuhiro; Honda, Osamu; Kamiya, Hisashi; Murata, Kiyoshi; Ohno, Yoshiharu; Tomiyama, Noriyuki; Moriya, Hiroshi; Koyama, Mitsuhiro; Noma, Satoshi; Kamiya, Ayano; Tanaka, Yuko; Murayama, Sadayuki		Investigators ACTIve Study Grp	Adaptive Iterative Dose Reduction Using Three Dimensional Processing (AIDR3D) Improves Chest CT Image Quality and Reduces Radiation Exposure	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; DUAL SOURCE CT; RECONSTRUCTION TECHNIQUE; COMPUTED-TOMOGRAPHY; INITIAL-EXPERIENCE; DIFFERENT KERNELS; 3D; SPACE; ANGIOGRAPHY; VOLTAGE	Objective: To assess the advantages of Adaptive Iterative Dose Reduction using Three Dimensional Processing (AIDR3D) for image quality improvement and dose reduction for chest computed tomography (CT). Methods: Institutional Review Boards approved this study and informed consent was obtained. Eighty-eight subjects underwent chest CT at five institutions using identical scanners and protocols. During a single visit, each subject was scanned using different tube currents: 240, 120, and 60 mA. Scan data were converted to images using AIDR3D and a conventional reconstruction mode (without AIDR3D). Using a 5-point scale from 1 (non-diagnostic) to 5 (excellent), three blinded observers independently evaluated image quality for three lung zones, four patterns of lung disease (nodule/mass, emphysema, bronchiolitis, and diffuse lung disease), and three mediastinal measurements (small structure visibility, streak artifacts, and shoulder artifacts). Differences in these scores were assessed by Scheffe's test. Results: At each tube current, scans using AIDR3D had higher scores than those without AIDR3D, which were significant for lung zones (p<0.0001) and all mediastinal measurements (p<0.01). For lung diseases, significant improvements with AIDR3D were frequently observed at 120 and 60 mA. Scans with AIDR3D at 120 mA had significantly higher scores than those without AIDR3D at 240 mA for lung zones and mediastinal streak artifacts (p<0.0001), and slightly higher or equal scores for all other measurements. Scans with AIDR3D at 60 mA were also judged superior or equivalent to those without AIDR3D at 120 mA. Conclusion: For chest CT, AIDR3D provides better image quality and can reduce radiation exposure by 50%.	[Yamashiro, Tsuneo; Miyara, Tetsuhiro; Kamiya, Hisashi; Kamiya, Ayano; Tanaka, Yuko; Murayama, Sadayuki] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Nishihara, Okinawa 90301, Japan; [Honda, Osamu; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka, Japan; [Murata, Kiyoshi] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga 52021, Japan; [Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan; [Moriya, Hiroshi] Ohara Gen Hosp, Dept Radiol, Fukushima, Japan; [Koyama, Mitsuhiro] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 569, Japan; [Noma, Satoshi] Tenri Hosp, Dept Radiol, Tenri, Nara 632, Japan; [Tanaka, Yuko] Fujieda Municipal Gen Hosp, Ctr Clin Training, Fujieda, Shizuoka, Japan	University of the Ryukyus; Osaka University; Shiga University of Medical Science; Kobe University; Osaka Medical College; Tenri Hospital	Yamashiro, T (corresponding author), Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Nishihara, Okinawa 90301, Japan.	clatsune@yahoo.co.jp	Ohno, Yoshiharu/AAE-2970-2020; Yamashiro, Tsuneo/H-6409-2019	Yamashiro, Tsuneo/0000-0002-1904-2548	Toshiba Medical Systems	Toshiba Medical Systems	Each participating institution has a research grant from Toshiba Medical Systems. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Chen MY, 2013, INT J CARDIOVAS IMAG, V29, P1167, DOI 10.1007/s10554-013-0190-1; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Eldevik K, 2010, RADIAT PROT DOSIM, V139, P430, DOI 10.1093/rpd/ncq063; Fleischmann D, 2011, EUR RADIOL, V21, P510, DOI 10.1007/s00330-011-2056-z; Funabashi N, 2013, INT J CARDIOL, V168, P601, DOI 10.1016/j.ijcard.2013.01.230; Higuchi K, 2013, RADIOL PHYS TECHNOL, V6, P299, DOI 10.1007/s12194-013-0200-y; Hu XH, 2011, CLIN RADIOL, V66, P1023, DOI 10.1016/j.crad.2011.04.008; Hwang HJ, 2012, KOREAN J RADIOL, V13, P711, DOI 10.3348/kjr.2012.13.6.711; Hwang HJ, 2012, KOREAN J RADIOL, V13, P720, DOI 10.3348/kjr.2012.13.6.720; Jang KJ, 2011, J KOREAN PHYS SOC, V58, P334, DOI 10.3938/jkps.58.334; Juri H, 2013, J COMPUT ASSIST TOMO, V37, P52, DOI 10.1097/RCT.0b013e3182742c0e; Katsura M, 2013, INVEST RADIOL, V48, P206, DOI 10.1097/RLI.0b013e31827efc3a; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Kim H, 2014, EUR J RADIO IN PRESS; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Leipsic J, 2010, AM J ROENTGENOL, V195, P1095, DOI 10.2214/AJR.09.4050; Li Q, 2013, CLIN RADIOL, V68, pE249, DOI 10.1016/j.crad.2012.12.009; Neroladaki A, 2013, EUR RADIOL, V23, P360, DOI 10.1007/s00330-012-2627-7; Nishio M, 2012, AM J ROENTGENOL, V199, P595, DOI 10.2214/AJR.11.8174; Ohno Y, 2012, AM J ROENTGENOL, V199, pW477, DOI 10.2214/AJR.11.8275; Pontana F, 2013, RADIOLOGY, V267, P609, DOI 10.1148/radiol.12120414; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Vardhanabhuti V, 2013, AM J ROENTGENOL, V200, P545, DOI 10.2214/AJR.12.9424; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y; Willemink MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058053; Yamada Y, 2012, EUR J RADIOL, V81, P4185, DOI 10.1016/j.ejrad.2012.07.013; Yamada Y, 2012, INVEST RADIOL, V47, P482, DOI 10.1097/RLI.0b013e3182562a89; Yanagawa M, 2012, EUR J RADIOL, V81, P2877, DOI 10.1016/j.ejrad.2011.09.011; Yanagawa M, 2010, ACAD RADIOL, V17, P1259, DOI 10.1016/j.acra.2010.05.014; Yang WJ, 2013, J COMPUT ASSIST TOMO, V37, P301, DOI 10.1097/RCT.0b013e31827b8c66	33	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105735	10.1371/journal.pone.0105735	http://dx.doi.org/10.1371/journal.pone.0105735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153797	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200076
J	Chang, CH; Tsai, MS; Lin, CL; Hou, JW; Wang, TH; Tsai, YA; Liao, KW; Mao, IF; Chen, ML				Chang, Chia-Huang; Tsai, Ming-Song; Lin, Ching-Ling; Hou, Jia-Woei; Wang, Tzu-Hao; Tsai, Yen-An; Liao, Kai-Wei; Mao, I-Fang; Chen, Mei-Lien			The Association between Nonylphenols and Sexual Hormones Levels among Pregnant Women: A Cohort Study in Taiwan	PLOS ONE			English	Article							BISPHENOL-A; GESTATIONAL EXPOSURE; ESTROGENIC ACTIVITY; NEGATIVE FEEDBACK; DRUG DISPOSITION; RAINBOW-TROUT; P-NONYLPHENOL; HUMAN URINE; MALE RATS; 4-NONYLPHENOL	Background: Nonylphenol (NP) has been proven as an endocrine disrupter and had the ability to interfere with the endocrine system. Though the health effects of NP on pregnant women and their fetuses are sustained, these negative associations related to the mechanisms of regulation for estrogen during pregnancy need to be further clarified. The objective of this study is to explore the association between maternal NP and hormonal levels, such as estradiol, testosterone, luteinizing hormone (LH) and follicle stimulating hormone (FSH), and progesterone. Methods: A pregnant women cohort was established in North Taiwan between March and December 2010. Maternal urine and blood samples from the first, second, and third trimesters of gestation were collected. Urinary NP concentration was measured by high-performance liquid chromatography coupled with fluorescent detection. A mixed-effects model using a generalised estimating equation (GEE) was applied to assess the associations between maternal NP concentration and plasma hormones throughout the three trimesters. Results: In total, 162 singleton pregnant women completed this study through delivery. The geometric mean of creatinine-adjusted urinary NP concentrations were 4.27, 4.21, and 4.10 mu g/g cre. in the first, second, and third trimesters respectively. A natural log-transformation of urinary NP concentrations were significantly associated with LH in the GEE model (beta= -20.23 mIU/ml, p<0.01). Conclusion: This perspective cohort study demonstrates that negative association occurs between maternal NP exposure and plasma LH levels. The estrogen-mimic effect of NP might influence the negative feedback on LH during pregnancy.	[Chang, Chia-Huang; Tsai, Yen-An; Liao, Kai-Wei; Chen, Mei-Lien] Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan; [Chang, Chia-Huang; Tsai, Ming-Song] Cathay Gen Hosp, Dept OBS & GYN, Taipei, Taiwan; [Tsai, Ming-Song] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Lin, Ching-Ling] Cathay Gen Hosp, Dept Endocrinol & Metab, Taipei, Taiwan; [Hou, Jia-Woei] Cathay Gen Hosp, Dept Pediat, Taipei, Taiwan; [Wang, Tzu-Hao] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Obstet & Gynecol,GMRCL, Taoyuan, Taiwan; [Mao, I-Fang] Chung Shan Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan	National Yang Ming Chiao Tung University; Cathay General Hospital; Fu Jen Catholic University; Cathay General Hospital; Cathay General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University	Chen, ML (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei 112, Taiwan.	mlchen7239@gmail.com	Liao, Kai-Wei/AAW-5992-2020	Liao, Kai-Wei/0000-0003-3842-416X	National Science Council of the Republic of China, Taiwan [NSC 99-2314-B-010-018-MY3, NSC 100-2314B-281-001-MY3]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by the National Science Council of the Republic of China, Taiwan, NSC 99-2314-B-010-018-MY3 and NSC 100-2314B-281-001-MY3. The funders had no role in study design, data collection and analysis, decision	Albrecht ED, 2010, INT J DEV BIOL, V54, P397, DOI 10.1387/ijdb.082758ea; Balakrishnan B, 2011, PLACENTA, V32, P788, DOI 10.1016/j.placenta.2011.07.014; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Chang CH, 2013, CHEMOSPHERE; Charles SM, 2014, J CLIN ENDOCR METAB; Chen HW, 2013, SCI TOTAL ENVIRON, V449, P20, DOI 10.1016/j.scitotenv.2013.01.038; Chen ML, 2008, CHEMOSPHERE, V73, pS239, DOI 10.1016/j.chemosphere.2007.04.091; Chen ML, 2009, CHEMOSPHERE, V76, P927, DOI 10.1016/j.chemosphere.2009.04.054; Chen ML, 2005, INT J ENVIRON AN CH, V85, P335, DOI 10.1080/03067310412331315575; Chen TC, 2009, J ENVIRON SCI HEAL A, V44, P1244, DOI 10.1080/10934520903139977; Coldham NG, 1998, DRUG METAB DISPOS, V26, P347; Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579; Cunningham FG, 2001, WILLIAMS OBSTET, V23rd; de Jager C, 1999, ANDROLOGIA, V31, P107, DOI 10.1046/j.1439-0272.1999.00246.x; EVAINBRION D, 1994, HORM RES, V42, P207, DOI 10.1159/000184195; Fan Qiyuan, 2001, Zhonghua Yufang Yixue Zazhi, V35, P344; Ferguson SA, 2000, NEUROTOXICOL TERATOL, V22, P583, DOI 10.1016/S0892-0362(00)00071-4; Fernandes AR, 2008, FOOD ADDIT CONTAM, V25, P364, DOI 10.1080/02652030701564548; Frederiksen MC, 2001, SEMIN PERINATOL, V25, P120, DOI 10.1053/sper.2001.24565; Fujimoto J, 2005, J STEROID BIOCHEM, V94, P67, DOI 10.1016/j.jsbmb.2004.12.030; Furuta M, 2006, NEUROENDOCRINOLOGY, V84, P14, DOI 10.1159/000096093; Gascon M, 2011, ENVIRON INT, V37, P605, DOI 10.1016/j.envint.2010.12.005; Guenther K, 2002, ENVIRON SCI TECHNOL, V36, P1676, DOI 10.1021/es010199v; Harris CA, 2001, ENVIRON SCI TECHNOL, V35, P2909, DOI 10.1021/es0002619; HIRANO M, 1976, TOHOKU J EXP MED, V118, P275, DOI 10.1620/tjem.118.275; Holdway DA, 2008, ENVIRON TOXICOL, V23, P253, DOI 10.1002/tox.20329; Hossaini A, 2001, REPROD TOXICOL, V15, P537, DOI 10.1016/S0890-6238(01)00155-1; Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205; Huang WR, 2010, FISH PHYSIOL BIOCHEM, V36, P237, DOI 10.1007/s10695-008-9280-8; Inoue K, 2001, FOOD ADDIT CONTAM, V18, P157, DOI 10.1080/02652030010018930; Iqbal J, 2009, ENDOCRINOLOGY, V150, P4213, DOI 10.1210/en.2009-0092; Isoherranen N, 2013, DRUG METAB DISPOS, V41, P256, DOI 10.1124/dmd.112.050245; Jarvela IY, 2012, PRENATAL DIAG, V32, P160, DOI 10.1002/pd.2921; Jie X, 2010, BIRTH DEFECTS RES B, V89, P418, DOI 10.1002/bdrb.20268; Kawaguchi M, 2005, J CHROMATOGR B, V820, P49, DOI 10.1016/j.jchromb.2005.03.019; Kimura N, 2006, J REPROD DEVELOP, V52, P789, DOI 10.1262/jrd.18007; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; LeBlanc GA, 2000, ENVIRON HEALTH PERSP, V108, P1133, DOI 10.2307/3434824; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lu J, 2008, CHEMOSPHERE, V71, P345, DOI 10.1016/j.chemosphere.2007.08.068; Lu YY, 2007, ENVIRON INT, V33, P903, DOI 10.1016/j.envint.2007.04.008; Mahoney MM, 2010, TOXICOL APPL PHARM, V247, P98, DOI 10.1016/j.taap.2010.05.017; Mao LH, 2004, ANAL CHIM ACTA, V522, P241, DOI 10.1016/j.aca.2004.04.071; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McCarthy MM, 2009, NEUROSCIENTIST, V15, P599, DOI 10.1177/1073858409340924; MITANI GM, 1987, CLIN PHARMACOKINET, V12, P253, DOI 10.2165/00003088-198712040-00002; Moller UK, 2013, OSTEOPOROSIS INT, V24, P1307, DOI 10.1007/s00198-012-2062-2; Muller S, 1998, ENVIRON TOXICOL PHAR, V5, P257, DOI 10.1016/S1382-6689(98)00009-X; Nagao T, 2001, REPROD TOXICOL, V15, P293, DOI 10.1016/S0890-6238(01)00123-X; Nagata C, 2006, CANCER CAUSE CONTROL, V17, P1107, DOI 10.1007/s10552-006-0044-4; OLEARY P, 1991, CLIN CHEM, V37, P667; Pan YP, 2009, CHEMOSPHERE, V76, P381, DOI 10.1016/j.chemosphere.2009.03.034; Ren LF, 1996, CHEM-BIOL INTERACT, V100, P67, DOI 10.1016/0009-2797(95)03686-5; Sayed AEH, 2012, ECOTOX ENVIRON SAFE, V78, P310, DOI 10.1016/j.ecoenv.2011.11.041; Shaw ND, 2010, J CLIN ENDOCR METAB, V95, P1955, DOI 10.1210/jc.2009-2108; Shue MF, 2010, ENVIRON MONIT ASSESS, V168, P91, DOI 10.1007/s10661-009-1093-4; Shue MF, 2009, WATER SCI TECHNOL, V59, P2055, DOI 10.2166/wst.2009.168; Soares A, 2008, ENVIRON INT, V34, P1033, DOI 10.1016/j.envint.2008.01.004; SOTO AM, 1991, ENVIRON HEALTH PERSP, V92, P167, DOI 10.1289/ehp.9192167; Takeda T, 2009, J PHARMACOL EXP THER, V329, P1091, DOI 10.1124/jpet.109.151282; Thomson BM, 2003, J ENVIRON MONITOR, V5, P229, DOI 10.1039/b211323f; Torgersen CKL, 2006, CRIT CARE NURS Q, V29, P2, DOI 10.1097/00002727-200601000-00002; Tsai MS, 2013, SCI TOTAL ENVIRON, V458, P367, DOI [10.1016/j.scitotenv.2013.04,039, 10.1016/j.scitotenv.2013.04.039]; Vonnahme KA, 2013, ANIM REPROD SCI, V141, P131, DOI 10.1016/j.anireprosci.2013.07.010; Wang CH, 2001, TAIWAN J PUBLIC HLTH, V20, pP202; Weissgerber TL, 2006, APPL PHYSIOL NUTR ME, V31, P1, DOI 10.1139/H05-003; Wilson CA, 2007, REPRODUCTION, V133, P331, DOI 10.1530/REP-06-0078; Wu JJ, 2010, TOXICOLOGY, V268, P1, DOI 10.1016/j.tox.2009.10.030; Yokota H, 2001, ENVIRON TOXICOL CHEM, V20, P2552, DOI [10.1897/1551-5028(2001)020&lt;2552:LCTONT&gt;2.0.CO;2, 10.1002/etc.5620201122]	69	8	8	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104245	10.1371/journal.pone.0104245	http://dx.doi.org/10.1371/journal.pone.0104245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148048	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230600013
J	Chylek, LA; Akimov, V; Dengjel, J; Rigbolt, KTG; Hu, B; Hlavacek, WS; Blagoev, B				Chylek, Lily A.; Akimov, Vyacheslav; Dengjel, Joern; Rigbolt, Kristoffer T. G.; Hu, Bin; Hlavacek, William S.; Blagoev, Blagoy			Phosphorylation Site Dynamics of Early T-cell Receptor Signaling	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; TERMINAL SRC KINASE; QUANTITATIVE PHOSPHOPROTEOMIC ANALYSIS; PROLINE-RICH SEQUENCE; TANDEM SH2 DOMAINS; ANTIGEN RECEPTOR; ADAPTER PROTEIN; PHOSPHOLIPASE C-GAMMA-1; BINDING-SPECIFICITY; CRYSTAL-STRUCTURE	In adaptive immune responses, T-cell receptor (TCR) signaling impacts multiple cellular processes and results in T-cell differentiation, proliferation, and cytokine production. Although individual protein-protein interactions and phosphorylation events have been studied extensively, we lack a systems-level understanding of how these components cooperate to control signaling dynamics, especially during the crucial first seconds of stimulation. Here, we used quantitative proteomics to characterize reshaping of the T-cell phosphoproteome in response to TCR/CD28 co-stimulation, and found that diverse dynamic patterns emerge within seconds. We detected phosphorylation dynamics as early as 5 s and observed widespread regulation of key TCR signaling proteins by 30 s. Development of a computational model pointed to the presence of novel regulatory mechanisms controlling phosphorylation of sites with central roles in TCR signaling. The model was used to generate predictions suggesting unexpected roles for the phosphatase PTPN6 (SHP-1) and shortcut recruitment of the actin regulator WAS. Predictions were validated experimentally. This integration of proteomics and modeling illustrates a novel, generalizable framework for solidifying quantitative understanding of a signaling network and for elucidating missing links.	[Chylek, Lily A.; Hu, Bin; Hlavacek, William S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Chylek, Lily A.; Hlavacek, William S.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Chylek, Lily A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Akimov, Vyacheslav; Blagoev, Blagoy] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark; [Dengjel, Joern; Rigbolt, Kristoffer T. G.] Univ Freiburg, ZBSA Ctr Biol Syst Anal, BIOSS Ctr Biol Signalling Studies, Freiburg Inst Adv Studies FRIAS,Med Ctr,Dept Derm, D-79106 Freiburg, Germany; [Hu, Bin; Hlavacek, William S.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Cornell University; University of Southern Denmark; University of Freiburg; University of New Mexico	Hlavacek, WS (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	wish@lanl.gov; bab@bmb.sdu.dk	Dengjel, Joern/AAI-3682-2020	Dengjel, Joern/0000-0002-9453-4614; Blagoev, Blagoy/0000-0002-3596-0066; Hu, Bin/0000-0002-0278-8466; Hlavacek, William/0000-0003-4383-8711	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [P50GM085273, R01GM076570]; US Department of Energy [DE-AC52-06NA25396]; Excellence Initiative of the German Federal and State Governments through the Freiburg Institute for Advanced Studies (FRIAS) in the School of Life Sciences-LifeNet; Center for Biological Signalling Studies (BIOSS); Danish Council for Independent Research/Natural Sciences; Lundbeck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273, R01GM076570] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy(United States Department of Energy (DOE)); Excellence Initiative of the German Federal and State Governments through the Freiburg Institute for Advanced Studies (FRIAS) in the School of Life Sciences-LifeNet; Center for Biological Signalling Studies (BIOSS); Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) grants P50GM085273 and R01GM076570; US Department of Energy Contract DE-AC52-06NA25396 through the Los Alamos Center for Nonlinear Studies and the Laboratory-directed Research and Development (LDRD) Program; the Excellence Initiative of the German Federal and State Governments through the Freiburg Institute for Advanced Studies (FRIAS) in the School of Life Sciences-LifeNet, and the Center for Biological Signalling Studies (BIOSS); the Danish Council for Independent Research/Natural Sciences; and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM N, 1990, MOL CELL BIOL, V10, P5197, DOI 10.1128/MCB.10.10.5197; Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x; ALARCON B, 1988, J BIOL CHEM, V263, P2953; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; AUGUST A, 1994, BIOCHEM BIOPH RES CO, V199, P1466, DOI 10.1006/bbrc.1994.1396; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; Banin S, 1999, MOL BIOL REP, V26, P173, DOI 10.1023/A:1006954206151; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barua D, 2012, J IMMUNOL, V189, P646, DOI 10.4049/jimmunol.1102003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Berkovitz L. D., 2012, NONLINEAR OPTIMAL CO; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Blundell MP, 2009, P NATL ACAD SCI USA, V106, P15738, DOI 10.1073/pnas.0904346106; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Borgeson G, 1998, GOLDEN AGE AM RACING; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Brodovitch A, 2013, J IMMUNOL, V191, P2064, DOI 10.4049/jimmunol.1300523; Brown K, 2004, J BIOL CHEM, V279, P18727, DOI 10.1074/jbc.M400031200; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Cao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046725; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chiang GG, 2001, J BIOL CHEM, V276, P23173, DOI 10.1074/jbc.M101219200; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Chylek LA, 2013, SYSTEMS BIOL INTEGRA, V1, P273; Chylek LA, 2014, SYSTEMS BIOL APPROAC; Chylek LA, 2014, WIRES SYST BIOL MED, V6, P13, DOI 10.1002/wsbm.1245; Chylek LA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004061; Chylek LA, 2011, MOL BIOSYST, V7, P2779, DOI 10.1039/c1mb05077j; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Colvin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-404; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danos V, 2007, LECT NOTES COMPUT SC, V4703, P17; Davidon WC, 1991, SIAM J OPTIMIZ, V1, P1, DOI 10.1137/0801001; de la Cruz J, 2011, J IMMUNOL, V186, P2282, DOI 10.4049/jimmunol.1003225; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; DENNIS EA, 1991, FASEB J, V5, P2068, DOI 10.1096/fasebj.5.7.1901288; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; DIANZANI U, 1992, J IMMUNOL, V148, P678; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Doro U, 1996, MOL CELL BIOL, V16, P4996; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Evren S, 2012, EXP HEMATOL, V40, P1055, DOI 10.1016/j.exphem.2012.08.007; Facchetti F, 1998, J PATHOL, V185, P99, DOI 10.1002/(SICI)1096-9896(199805)185:1<99::AID-PATH48>3.0.CO;2-L; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Faeder JR, 2003, J IMMUNOL, V170, P3769, DOI 10.4049/jimmunol.170.7.3769; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Fowler CC, 2010, J IMMUNOL, V185, P3256, DOI 10.4049/jimmunol.1001362; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Garcon F, 2004, EUR J IMMUNOL, V34, P1972, DOI 10.1002/eji.200324777; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Gibson S, 1996, J IMMUNOL, V156, P2716; Gibson S, 1996, J BIOL CHEM, V271, P7079, DOI 10.1074/jbc.271.12.7079; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gil D, 2001, J BIOL CHEM, V276, P11174, DOI 10.1074/jbc.M010114200; GILLILAND LK, 1992, J BIOL CHEM, V267, P13610; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Guirado M, 2002, BIOCHEM BIOPH RES CO, V291, P574, DOI 10.1006/bbrc.2002.6492; HARA T, 1985, J EXP MED, V161, P1513, DOI 10.1084/jem.161.6.1513; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Iwai LK, 2010, J PROTEOME RES, V9, P3135, DOI 10.1021/pr100035b; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Johnson DJ, 2013, J EXP MED, V210, P1419, DOI 10.1084/jem.20122239; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; JUNE CH, 1990, J IMMUNOL, V144, P1591; KENNEY D, 1986, BLOOD, V68, P1329; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Koretzky Gary A, 2009, Immune Netw, V9, P75, DOI 10.4110/in.2009.9.3.75; Krivine J, 2009, LECT NOTES COMPUT SC, V5643, P17; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lettau M, 2010, PROTEIN SCI, V19, P658, DOI 10.1002/pro.334; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Lock P, 1999, J BIOL CHEM, V274, P22775, DOI 10.1074/jbc.274.32.22775; Logue JS, 2012, GENE DEV, V26, P641, DOI 10.1101/gad.186965.112; LORENZ U, 1994, MOL CELL BIOL, V14, P1824, DOI 10.1128/MCB.14.3.1824; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; Malissen B, 2005, ADV IMMUNOL, V87, P1, DOI 10.1016/S0065-2776(05)87001-4; Marengere LEM, 1997, J IMMUNOL, V159, P3220; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; MOLINA IJ, 1992, J EXP MED, V176, P867, DOI 10.1084/jem.176.3.867; Moran O, 2008, BIOPHYS J, V94, P1766, DOI 10.1529/biophysj.107.116590; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Mukherjee S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003220; Mukhopadhyay H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003004; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Qi Q, 2007, SCI STKE, V2007, pe39; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rigbolt KTG, 2012, SEMIN CELL DEV BIOL, V23, P863, DOI 10.1016/j.semcdb.2012.05.006; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rigbolt KTG, 2011, MOL CELLULAR PROTEOM, V10, P1, DOI [10.1074/mcp.O1110.0075450, DOI 10.1074/MCP.O1110.0075450]; Risueno RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001747; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; RUDD CE, 1991, ADV EXP MED BIOL, V292, P85; Ruperez P, 2012, MOL CELL PROTEOMICS, V11, P171, DOI 10.1074/mcp.M112.017863; SABE H, 1992, MOL CELL BIOL, V12, P4706, DOI 10.1128/MCB.12.10.4706; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Seet BT, 2007, EMBO J, V26, P678, DOI 10.1038/sj.emboj.7601535; Sekar John A P, 2012, Methods Mol Biol, V880, P139, DOI 10.1007/978-1-61779-833-7_9; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Sneddon MW, 2011, NAT METHODS, V8, P177, DOI [10.1038/nmeth.1546, 10.1038/NMETH.1546]; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stover DR, 1996, J BIOL CHEM, V271, P12481, DOI 10.1074/jbc.271.21.12481; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; Tailor P, 2008, J IMMUNOL, V181, P243, DOI 10.4049/jimmunol.181.1.243; Takeuchi K, 2008, J MOL BIOL, V380, P704, DOI 10.1016/j.jmb.2008.05.037; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VEILLETTE A, 1990, ONCOGENE, V5, P1455; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; WATTS JD, 1992, J BIOL CHEM, V267, P901; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; WEISSMAN AM, 1989, EMBO J, V8, P3651, DOI 10.1002/j.1460-2075.1989.tb08539.x; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Wofsy C, 1997, J IMMUNOL, V159, P5984; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu H, 1995, ANN NY ACAD SCI, V766, P99, DOI 10.1111/j.1749-6632.1995.tb26655.x; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; Yang J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031910; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325	221	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104240	10.1371/journal.pone.0104240	http://dx.doi.org/10.1371/journal.pone.0104240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147952	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600012
J	Gnanapragassam, VS; Bork, K; Galuska, CE; Galuska, SP; Glanz, D; Nagasundaram, M; Bache, M; Vordermark, D; Kohla, G; Kannicht, C; Schauer, R; Horstkorte, R				Gnanapragassam, Vinayaga S.; Bork, Kaya; Galuska, Christina E.; Galuska, Sebastian P.; Glanz, Dagobert; Nagasundaram, Manimozhi; Bache, Matthias; Vordermark, Dirk; Kohla, Guido; Kannicht, Christoph; Schauer, Roland; Horstkorte, Ruediger			Sialic Acid Metabolic Engineering: A Potential Strategy for the Neuroblastoma Therapy	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; POLYSIALIC ACID; CANCER PROGRESSION; BREAST-CANCER; IN-VITRO; SYNCAM 1; SIALYLTRANSFERASE; POLYSIALYLATION; GLYCOPROTEINS; SIALYLATION	Background: Sialic acids (Sia) represent negative-charged terminal sugars on most glycoproteins and glycolipids on the cell surface of vertebrates. Aberrant expression of tumor associated sialylated carbohydrate epitopes significantly increases during onset of cancer. Since Sia contribute towards cell migration (= metastasis) and to chemo- and radiation resistance. Modulation of cellular Sia concentration and composition poses a challenge especially for neuroblastoma therapy, due to the high heterogeneity and therapeutic resistance of these cells. Here we propose that Metabolic Sia Engineering (MSE) is an effective strategy to reduce neuroblastoma progression and metastasis. Methods: Human neuroblastoma SH-SY5Y cells were treated with synthetic Sia precursors N-propanoyl mannosamine (ManNProp) or N-pentanoyl mannosamine (ManNPent). Total and Polysialic acids (PolySia) were investigated by high performance liquid chromatography. Cell surface polySia were examined by flow-cytometry. Sia precursors treated cells were examined for the migration, invasion and sensitivity towards anticancer drugs and radiation treatment. Results: Treatment of SH-SY5Y cells with ManNProp or ManNPent (referred as MSE) reduced their cell surface sialylation significantly. We found complete absence of polysialylation after treatment of SH-SY5Y cells with ManNPent. Loss of polysialylation results in a reduction of migration and invasion ability of these cells. Furthermore, radiation of Sia-engineered cells completely abolished their migration. In addition, MSE increases the cytotoxicity of anti-cancer drugs, such as 5-fluorouracil or cisplatin. Conclusions: Metabolic Sia Engineering (MSE) of neuroblastoma cells using modified Sia precursors reduces their sialylation, metastatic potential and increases their sensitivity towards radiation or chemotherapeutics. Therefore, MSE may serve as an effective method to treat neuroblastoma.	[Gnanapragassam, Vinayaga S.; Bork, Kaya; Glanz, Dagobert; Nagasundaram, Manimozhi; Horstkorte, Ruediger] Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Germany; [Galuska, Christina E.; Galuska, Sebastian P.] Univ Giessen, Fac Med, Inst Biochem, D-35390 Giessen, Germany; [Bache, Matthias; Vordermark, Dirk] Univ Hosp Halle, Clin Radiotherapy, Halle, Germany; [Kohla, Guido; Kannicht, Christoph] Octapharma R&D, Mol Biochem, Berlin, Germany; [Schauer, Roland] Univ Kiel, Inst Biochem, Kiel, Germany	Martin Luther University Halle Wittenberg; Justus Liebig University Giessen; Martin Luther University Halle Wittenberg; Octapharma; University of Kiel	Gnanapragassam, VS (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Germany.	vinayaga.gnanapragassam@medizin.uni-halle.de						Almaraz RT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017558; Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bork K, 2007, J NEUROCHEM, V103, P65, DOI 10.1111/j.1471-4159.2007.04711.x; Campbell CT, 2008, J MED CHEM, V51, P8135, DOI 10.1021/jm800873k; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; KOMMINOTH P, 1994, AM J SURG PATHOL, V18, P399, DOI 10.1097/00000478-199404000-00008; Lee M, 2008, MOL CANCER RES, V6, P1316, DOI 10.1158/1541-7786.MCR-07-2209; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Muhlenhoff M, 2013, NEUROCHEM RES, V38, P1134, DOI 10.1007/s11064-013-0979-2; Park JJ, 2013, GUT LIVER, V7, P629, DOI 10.5009/gnl.2013.7.6.629; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; REUTER G, 1994, METHOD ENZYMOL, V230, P168; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Tanaka F, 2001, CANCER RES, V61, P1666; Ulm C, 2013, CELL MOL LIFE SCI, V70, P3695, DOI 10.1007/s00018-013-1342-0; Valentiner U, 2011, INT J ONCOL, V39, P417, DOI 10.3892/ijo.2011.1038; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1099; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	33	18	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105403	10.1371/journal.pone.0105403	http://dx.doi.org/10.1371/journal.pone.0105403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148252	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600045
J	Jalava, K; Rintala, H; Ollgren, J; Maunula, L; Gomez-Alvarez, V; Revez, J; Palander, M; Antikainen, J; Kauppinen, A; Rasanen, P; Siponen, S; Nyholm, O; Kyyhkynen, A; Hakkarainen, S; Merentie, J; Parnanen, M; Loginov, R; Ryu, H; Kuusi, M; Siitonen, A; Miettinen, I; Domingo, JWS; Hanninen, ML; Pitkanen, T				Jalava, Katri; Rintala, Hanna; Ollgren, Jukka; Maunula, Leena; Gomez-Alvarez, Vicente; Revez, Joana; Palander, Marja; Antikainen, Jenni; Kauppinen, Ari; Rasanen, Pia; Siponen, Sallamaari; Nyholm, Outi; Kyyhkynen, Aino; Hakkarainen, Sirpa; Merentie, Juhani; Parnanen, Martti; Loginov, Raisa; Ryu, Hodon; Kuusi, Markku; Siitonen, Anja; Miettinen, Ilkka; Domingo, Jorge W. Santo; Hanninen, Marja-Liisa; Pitkanen, Tarja			Novel Microbiological and Spatial Statistical Methods to Improve Strength of Epidemiological Evidence in a Community-Wide Waterborne Outbreak	PLOS ONE			English	Article							REAL-TIME PCR; FIELD GEL-ELECTROPHORESIS; CAMPYLOBACTER-JEJUNI; DISTRIBUTION-SYSTEM; HUMAN SAPOVIRUSES; WASTE-WATER; RIVER WATER; DRINKING; GASTROENTERITIS; IDENTIFICATION	Failures in the drinking water distribution system cause gastrointestinal outbreaks with multiple pathogens. A water distribution pipe breakage caused a community-wide waterborne outbreak in Vuorela, Finland, July 2012. We investigated this outbreak with advanced epidemiological and microbiological methods. A total of 473/2931 inhabitants (16%) responded to a web-based questionnaire. Water and patient samples were subjected to analysis of multiple microbial targets, molecular typing and microbial community analysis. Spatial analysis on the water distribution network was done and we applied a spatial logistic regression model. The course of the illness was mild. Drinking untreated tap water from the defined outbreak area was significantly associated with illness (RR 5.6, 95% CI 1.9-16.4) increasing in a dose response manner. The closer a person lived to the water distribution breakage point, the higher the risk of becoming ill. Sapovirus, enterovirus, single Campylobacter jejuni and EHEC O157:H7 findings as well as virulence genes for EPEC, EAEC and EHEC pathogroups were detected by molecular or culture methods from the faecal samples of the patients. EPEC, EAEC and EHEC virulence genes and faecal indicator bacteria were also detected in water samples. Microbial community sequencing of contaminated tap water revealed abundance of Arcobacter species. The polyphasic approach improved the understanding of the source of the infections, and aided to define the extent and magnitude of this outbreak.	[Jalava, Katri; Ollgren, Jukka; Palander, Marja; Rasanen, Pia; Siponen, Sallamaari; Nyholm, Outi; Kyyhkynen, Aino; Kuusi, Markku; Siitonen, Anja] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Rintala, Hanna; Hakkarainen, Sirpa; Merentie, Juhani; Parnanen, Martti] Siilinjarvi Municipal, Siilinjarvi, Finland; [Maunula, Leena; Revez, Joana; Hanninen, Marja-Liisa] Univ Helsinki, Dept Food Hyg & Environm Hlth, Helskinki, Finland; [Gomez-Alvarez, Vicente; Ryu, Hodon; Domingo, Jorge W. Santo] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA; [Antikainen, Jenni; Loginov, Raisa] Helsinki Univ Hosp, Lab HUSLAB, Helsinki, Finland; [Kauppinen, Ari; Miettinen, Ilkka; Pitkanen, Tarja] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland	Finland National Institute for Health & Welfare; University of Helsinki; United States Environmental Protection Agency; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare	Jalava, K (corresponding author), Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland.	katri.jalava@thl.fi	Pitkänen, Tarja/D-1657-2014; Ryu, Hodon/HIA-0534-2022	Pitkänen, Tarja/0000-0002-7591-9148; Ryu, Hodon/0000-0002-6992-2519; Maunula, Leena/0000-0002-0841-5353; Kauppinen, Ari/0000-0001-7354-5595; Siponen, Sallamaari/0000-0002-9206-7979				[Anonymous], 2012, ISO93082A; [Anonymous], 1985, 7393 ISO; [Anonymous], 2002, 64612 ISOCD; [Anonymous], 2005, 164A NMKL; Antikainen J, 2009, EUR J CLIN MICROBIOL, V28, P899, DOI 10.1007/s10096-009-0720-x; Antikainen J, 2013, CLIN GASTROENTEROL H, V11, P1300, DOI 10.1016/j.cgh.2013.03.037; Bessong PO, 2009, J HEALTH POPUL NUTR, V27, P652; Bopp DJ, 2003, J CLIN MICROBIOL, V41, P174, DOI 10.1128/JCM.41.1.174-180.2003; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Cox MJ, 2013, HUM MOL GENET, V22, pR88, DOI 10.1093/hmg/ddt398; Dangendorf F, 2002, INT J HYG ENVIR HEAL, V205, P183, DOI 10.1078/1438-4639-00151; DEV VJ, 1991, LANCET, V337, P1412, DOI 10.1016/0140-6736(91)93092-N; Di Bella JM, 2013, J MICROBIOL METH, V95, P401, DOI 10.1016/j.mimet.2013.08.011; European U, 1998, OFFICIAL J EUROPEA L, V330, P32; Fong TT, 2007, ENVIRON HEALTH PERSP, V115, P856, DOI 10.1289/ehp.9430; Gubbels SM, 2012, SCAND J INFECT DIS, V44, P586, DOI 10.3109/00365548.2012.655773; Guy RA, 2003, APPL ENVIRON MICROB, V69, P5178, DOI 10.1128/AEM.69.9.5178-5185.2003; Harmon KM, 1996, LETT APPL MICROBIOL, V23, P241, DOI 10.1111/j.1472-765X.1996.tb00074.x; Hijnen WAM, 2009, ENVIRON SCI TECHNOL, V43, P4890, DOI 10.1021/es900037x; Hill VR, 2007, APPL ENVIRON MICROB, V73, P4218, DOI 10.1128/AEM.02713-06; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Houf K, 2000, FEMS MICROBIOL LETT, V193, P89, DOI 10.1111/j.1574-6968.2000.tb09407.x; ISO, 2006, ISO15553; Jakopanec I, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-128; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Jong B. de, 2008, Eurosurveillance, V13, P18847; Kauppinen A, 2014, J ENVIRON MANAGE, V133, P206, DOI 10.1016/j.jenvman.2013.12.008; Kauppinen A, 2012, J WATER HEALTH, V10, P406, DOI 10.2166/wh.2012.003; Kildare BJ, 2007, WATER RES, V41, P3701, DOI 10.1016/j.watres.2007.06.037; Kitajima M, 2010, APPL ENVIRON MICROB, V76, P2461, DOI 10.1128/AEM.02739-09; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Laine J, 2011, EPIDEMIOL INFECT, V139, P1105, DOI 10.1017/S0950268810002141; LAURSEN E, 1994, J EPIDEMIOL COMMUN H, V48, P453, DOI 10.1136/jech.48.5.453; Lautenschlager K, 2013, WATER RES, V47, P3015, DOI 10.1016/j.watres.2013.03.002; Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843; Martikainen P, 2007, SCAND J PUBLIC HEALT, V35, P212, DOI 10.1080/14034940600996563; Maurer AM, 2000, EPIDEMIOL INFECT, V125, P325, DOI 10.1017/S0950268899004495; Merga JY, 2011, APPL ENVIRON MICROB, V77, P1646, DOI 10.1128/AEM.01964-10; Miettinen I.T., 2006, 5 NORD DRINK WAT C 8; Miettinen IT, 2001, WATER SCI TECHNOL, V43, P67, DOI 10.2166/wst.2001.0713; Mikula C, 2010, EMERG INFECT DIS, V16, P1186, DOI 10.3201/eid1607.091789; Murray TY, 2013, WATER SCI TECHNOL, V67, P2776, DOI 10.2166/wst.2013.203; Nakari UM, 2011, FOODBORNE PATHOG DIS, V8, P1143, DOI 10.1089/fpd.2011.0882; Nenonen NP, 2012, APPL ENVIRON MICROB, V78, P1846, DOI 10.1128/AEM.07350-11; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Oxenford CJ, 2005, COMMUN DIS INTELL, V29, P379; Parshionikar SU, 2003, APPL ENVIRON MICROB, V69, P5263, DOI 10.1128/AEM.69.9.5263-5268.2003; Pinto AJ, 2012, ENVIRON SCI TECHNOL, V46, P8851, DOI 10.1021/es302042t; Pitkanen T, 2008, J WATER HEALTH, V6, P365, DOI 10.2166/wh.2008.050; Pitkanen T, 2013, ENVIRON SCI TECHNOL, V47, P13611, DOI 10.1021/es403489b; Pitkanen T, 2013, J MICROBIOL METH, V95, P39, DOI 10.1016/j.mimet.2013.06.008; Polaczyk AL, 2008, J MICROBIOL METH, V73, P92, DOI 10.1016/j.mimet.2008.02.014; Pradhan SK, 2013, J WATER HEALTH, V11, P581, DOI 10.2166/wh.2013.241; R Core Team R, 2013, R LANG ENV STAT COMP; Rasanen S, 2010, EPIDEMIOL INFECT, V138, P1227, DOI 10.1017/S0950268809991671; Reuter G, 2010, J CLIN MICROBIOL, V48, P363, DOI 10.1128/JCM.01279-09; Revez J, 2013, J FOOD PROTECT, V76, P1630, DOI 10.4315/0362-028X.JFP-13-083; Rhodes ER, 2011, J VIROL METHODS, V176, P38, DOI 10.1016/j.jviromet.2011.05.031; Richardson G, 2007, EPIDEMIOL INFECT, V135, P1151, DOI 10.1017/S0950268807007960; Riera-Montes M, 2011, EPIDEMIOL INFECT, V139, P1928, DOI 10.1017/S0950268810003146; Rimhanen-Finne R, 2010, SCAND J INFECT DIS, V42, P613, DOI 10.3109/00365541003774608; Ronnqvist M, 2013, J FOOD PROTECT, V76, P1421, DOI 10.4315/0362-028X.JFP-12-371; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siefring S, 2008, J WATER HEALTH, V6, P225, DOI 10.2166/wh.2008.022; Summa M, 2012, J CLIN VIROL, V53, P244, DOI 10.1016/j.jcv.2011.12.014; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ter Waarbeek HLG, 2010, J CLIN VIROL, V47, P268, DOI 10.1016/j.jcv.2009.12.002; Teunis P, 2005, EPIDEMIOL INFECT, V133, P583, DOI 10.1017/S0950268805003912; Tillett HE, 1998, EPIDEMIOL INFECT, V120, P37, DOI 10.1017/S0950268897008431; Toledo-Hernandez C, 2013, APPL ENVIRON MICROB, V79, P1689, DOI 10.1128/AEM.03070-12; Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Volken T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-167; Zacheus O, 2011, J WATER HEALTH, V9, P763, DOI 10.2166/wh.2011.021	79	30	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104713	10.1371/journal.pone.0104713	http://dx.doi.org/10.1371/journal.pone.0104713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147923	Green Submitted, gold, Green Published			2022-12-27	WOS:000341230600018
J	Maharani, A; Tampubolon, G				Maharani, Asri; Tampubolon, Gindo			Unmet Needs for Cardiovascular Care in Indonesia	PLOS ONE			English	Article							RISK-FACTORS; HEALTH-CARE; GLOBAL BURDEN; DISEASE; PREVENTION; PREDICTION; POVERTY; IMPACT; ADULTS; WOMEN	Background: In the past twenty years the heaviest burden of cardiovascular diseases has begun to shift from developed to developing countries. However, little is known about the real needs for cardiovascular care in these countries and how well those needs are being met. This study aims to investigate the prevalence and determinants of unmet needs for cardiovascular care based on objective assessment. Methods and Findings: Multilevel analysis is used to analyse the determinants of met needs and multilevel multiple imputation is applied to manage missing data. The 2008 Indonesian Family Life Survey (IFLS4) survey is the source of the household data used in this study, while district data is sourced from the Ministry of Health and Ministry of Finance. The data shows that nearly 70% of respondents with moderate to high cardiovascular risk failed to receive cardiovascular care. Higher income, possession of health insurance and residence in urban areas are significantly associated with met needs for cardiovascular care, while health facility density and physician density show no association with them. Conclusions: The prevalence of unmet needs for cardiovascular care is considerable in Indonesia. Inequality persists as a factor in meeting needs for cardiovascular care as the needs of people with higher incomes and those living in urban areas are more likely to be met. Alleviation of poverty, provision of health care insurance for the poor, and improvement in the quality of healthcare providers are recommended in order to meet this ever-increasing need.	[Maharani, Asri] Univ Brawijaya, Fac Med, Malang, Indonesia; [Maharani, Asri; Tampubolon, Gindo] Univ Manchester, Inst Social Change, Manchester, Lancs, England	Brawijaya University; University of Manchester	Maharani, A (corresponding author), Univ Brawijaya, Fac Med, Malang, Indonesia.	asri.maharani@postgrad.manchester.ac.uk	Maharani, Asri/U-7663-2017	Maharani, Asri/0000-0002-5931-8692				Aji B, 2013, INT J ENV RES PUB HE, V10, P2995, DOI 10.3390/ijerph10072995; Allin S., 2009, Eurohealth, V15, P7; [Anonymous], INT J VASC MED, DOI DOI 10.1155/2013/786801); Asparouhov T., 2010, SIMPLE 2 ORDER CHI S, P1; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Bank Indonesia, 2007, EXCH RAT T BANK IND; Carpenter JR, 2010, MULTILEVEL MULTIPLE; Castro-Leal F, 1999, WORLD BANK RES OBSER, V14, P49, DOI 10.1093/wbro/14.1.49; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; CUTLER DM, 1992, AM ECON REV, V82, P546; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Duncan C, 1996, SOC SCI MED, V42, P817, DOI 10.1016/0277-9536(95)00181-6; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Filmer D, 2000, WORLD BANK RES OBSER, V15, P199, DOI 10.1093/wbro/15.2.199; Ford ES, 1998, J WOMENS HEALTH, V7, P997, DOI 10.1089/jwh.1998.7.997; Garcia-Gomez P, 2014, INEQUITY LONG TERM C; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; Heo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051004; Herr M, 2013, EUROPEAN J PUBLIC HL, P1; Hong Wang, 2009, PRIVATE SECTOR HLTH; Hu P, 2013, RAND LABOR POPULATIO; Institute for Health Metrics and Evaluation, 2014, GLOB BURD DIS PATT; Joshi R, 2008, J AM COLL CARDIOL, V52, P1817, DOI 10.1016/j.jacc.2008.08.049; Litaker D, 2005, HEALTH POLICY, V73, P183, DOI 10.1016/j.healthpol.2004.11.010; Manning C, 2011, INDONESIA UPDATE SER, P1; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Ministry of Health Republic of Indonesia, 2008, IND HLTH PROF 2008; Organisation for Economic Co-operation and Development (OECD), 2013, STRUCT POL COUNTR NO; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Peterson LE, 2010, J RURAL HEALTH, V26, P373, DOI 10.1111/j.1748-0361.2010.00309.x; POTERBA JM, 1989, AM ECON REV, V79, P325; Rannan-Eliya RP, 2010, ESTIMATING OUT OF PO; Ricketts T, 1999, POPULATIONS PLACES R; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rokx C, 2010, DIR DEV, P1, DOI 10.1596/978-0-8213-8298-1; Tattersall MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044347; The World Bank, 2008, DAT GDP PER CAP COUN; The World Bank, 2008, DAT POP COUNTR; WHO, 2003, NEGL GLOB EP 3 GROW; World Bank, 2008, INV IND HLTH CHALL O; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zaidi S., 2002, GUIDELINES CONSTRUCT	46	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105831	10.1371/journal.pone.0105831	http://dx.doi.org/10.1371/journal.pone.0105831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25148389	Green Submitted, gold, Green Published			2022-12-27	WOS:000341230600088
J	Neveu, R; Neveu, D; Barsumian, F; Fouragnan, E; Carrier, E; Lai, M; Sultan, J; Nicolas, A; Coricelli, G				Neveu, Remi; Neveu, Dorine; Barsumian, Franck; Fouragnan, Elsa; Carrier, Edouard; Lai, Massimo; Sultan, Jocelyne; Nicolas, Alain; Coricelli, Giorgio			Improved Planning Abilities in Binge Eating	PLOS ONE			English	Article							FOOD; ANOREXIA; DISORDERS; ATTENTION; RISK; TIME	Objective: The role of planning in binge eating episodes is unknown. We investigated the characteristics of planning associated with food cues in binging patients. We studied planning based on backward reasoning, reasoning that determines a sequence of actions back to front from the final outcome. Method: A cross-sectional study was conducted with 20 healthy participants, 20 bulimia nervosa (BN), 22 restrictive (ANR) and 23 binging anorexia nervosa (ANB), without any concomitant impulsive disorder. In neutral/relaxing, binge food and stressful conditions, backward reasoning was assessed with the Race game, promotion of delayed large rewards with an intertemporal discounting task, attention with the Simon task, and repeating a dominant behavior with the Go/No-go task. Results: BN and to a lower extent ANB patients succeeded more at the Race game in food than in neutral condition. This difference discriminated binging from non-binging participants. Backward reasoning in the food condition was associated with lower approach behavior toward food in BN patients, and higher food avoidance in ANB patients. Enhanced backward reasoning in the food condition related to preferences for delayed large rewards in BN patients. In BN and ANB patients the enhanced success rate at the Race game in the food condition was associated with higher attention paid to binge food. Conclusion: These findings introduce a novel process underlying binges: planning based on backward reasoning is associated with binges. It likely aims to reduce craving for binge foods and extend binge refractory period in BN patients, and avoid binging in ANB patients. Shifts between these goals might explain shifts between eating disorder subtypes.	[Neveu, Remi; Barsumian, Franck; Coricelli, Giorgio] Univ Lyon 1, CNRS, Neurosci Res Ctr, INSERM,UMR5292,U1028,Team Olfact Coding Memory, F-69366 Lyon, France; [Neveu, Remi] Praxis, Ville La Grand, France; [Neveu, Dorine] Univ Montpellier I, Montpellier, France; [Neveu, Dorine] INSERM, U 1058, Montpellier, France; [Neveu, Dorine] CHU Montpellier, Dept Med Informat, Montpellier, France; [Fouragnan, Elsa] Univ Trento, Trento, Italy; [Carrier, Edouard] Clin St Vincent Paul, Lyon, France; [Lai, Massimo] Clin Lyon Lumiere, Meyzieu, France; [Sultan, Jocelyne] Clin Stella, Verargues, France; [Nicolas, Alain] Hop Vinatier, Bron, France; [Coricelli, Giorgio] Univ So Calif, Los Angeles, CA USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Trento; University of Southern California	Coricelli, G (corresponding author), Univ Lyon 1, CNRS, Neurosci Res Ctr, INSERM,UMR5292,U1028,Team Olfact Coding Memory, F-69366 Lyon, France.	giorgio.coricelli@usc.edu	NICOLAS, Alain/J-8514-2014	Fouragnan, Elsa/0000-0003-1485-0332	Institut du Comportement Alimentaire-Reseau TCA Rhone Alpes; Praxis; CNRS; CERMEP; University Montpellier 1	Institut du Comportement Alimentaire-Reseau TCA Rhone Alpes; Praxis; CNRS(Centre National de la Recherche Scientifique (CNRS)); CERMEP; University Montpellier 1	This work was supported by Institut du Comportement Alimentaire-Reseau TCA Rhone Alpes (http://www.reseau-tca-rhonealpes.fr/), Praxis, CNRS (http://crnl.univ-lyon1.fr/index.php/en), CERMEP (http://www.cermep.fr/) and University Montpellier 1 (http://www.univ-montp1.fr/). All Financial support was provided by the institutions to which authors are affiliated. These institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Sanchez N, 2009, SPAN J PSYCHOL, V12, P677, DOI 10.1017/S1138741600002043; American Psychiatric Association, 2006, Am J Psychiatry, V163, P4; [Anonymous], 2000, Am J Psychiatry, V157, P1; Bacaltchuk J, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003385; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Brand M, 2007, NEUROPSYCHOLOGY, V21, P742, DOI 10.1037/0894-4105.21.6.742; Brooks S, 2011, CLIN PSYCHOL REV, V31, P37, DOI 10.1016/j.cpr.2010.09.006; Burks SV, 2009, P NATL ACAD SCI USA, V106, P7745, DOI 10.1073/pnas.0812360106; Cepeda-Benito A, 2003, APPETITE, V40, P47, DOI 10.1016/S0195-6663(02)00145-9; Chiew KS, 2014, COGN AFFECT BEHAV NE; CRAFT JL, 1970, J EXP PSYCHOL, V83, P415, DOI 10.1037/h0028843; Cyders MA, 2011, CLIN PSYCHOL REV, V31, P965, DOI 10.1016/j.cpr.2011.06.001; Dreisbach G, 2006, BRAIN COGNITION, V60, P11, DOI 10.1016/j.bandc.2005.08.003; Drueke B, 2009, PSYCHOPHARMACOLOGY, V207, P213, DOI 10.1007/s00213-009-1649-6; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fairburn CG, 1993, BINGE EATING NATURE; Fairburn CG, 2008, COGNITIVE BEHAV THER; Fischer S, 2008, CLIN PSYCHOL REV, V28, P1413, DOI 10.1016/j.cpr.2008.09.001; Fowler L, 2006, PSYCHOL MED, V36, P517, DOI 10.1017/S0033291705006379; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Galimberti E, 2013, PSYCHIAT RES, V208, P238, DOI 10.1016/j.psychres.2012.10.001; Gaudreau P, 2011, ANXIETY STRESS COPIN; Gneezy U, 2010, J ECON BEHAV ORGAN, V75, P144, DOI 10.1016/j.jebo.2010.04.005; Green L, 1996, AM ZOOL, V36, P496; HADIGAN CM, 1989, AM J CLIN NUTR, V50, P759, DOI 10.1093/ajcn/50.4.759; Harrison A, 2010, PSYCHIAT RES, V177, P1, DOI 10.1016/j.psychres.2009.06.010; HETHERINGTON M, 1989, APPETITE, V12, P57, DOI 10.1016/0195-6663(89)90068-8; Kampov-Polevoy Alexey B, 2006, Eat Behav, V7, P181, DOI 10.1016/j.eatbeh.2005.09.005; Lager ACJ, 2012, INT J EPIDEMIOL, V41, P398, DOI 10.1093/ije/dyr139; Luger GF, 1998, ARTIFICIAL INTELLIGE; Madden S, 2009, MED J AUSTRALIA, V190, P410, DOI 10.5694/j.1326-5377.2009.tb02487.x; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Moreno S, 2009, APPETITE, V52, P588, DOI 10.1016/j.appet.2009.01.011; NEWMAN JP, 1985, J PERS SOC PSYCHOL, V48, P1316, DOI 10.1037/0022-3514.48.5.1316; Oberndorfer TA, 2013, AM J PSYCHIAT, V170, P1143, DOI 10.1176/appi.ajp.2013.11111745; Redish AD, 2007, ANN NY ACAD SCI, V1104, P324, DOI 10.1196/annals.1390.014; Savalei V, 2006, HDB MARKETING RES SA; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smyth JM, 2009, INT J EAT DISORDER, V42, P429, DOI 10.1002/eat.20623; Sobik L, 2005, APPETITE, V44, P253, DOI 10.1016/j.appet.2004.12.001; Spindler A, 2004, GEN HOSP PSYCHIAT, V26, P18, DOI 10.1016/j.genhosppsych.2003.07.001; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; Stice E, 2009, OXFORD HDB EATING DI, P148; Stickney MI, 1999, J BEHAV THER EXP PSY, V30, P177, DOI 10.1016/S0005-7916(99)00019-1; Stubbs RJ, 2004, PHYSIOL BEHAV, V81, P755, DOI 10.1016/j.physbeh.2004.04.027; Van den Eynde F, 2011, ACTA PSYCHIAT SCAND, V124, P120, DOI 10.1111/j.1600-0447.2011.01701.x; van Laar MW, 2002, PSYCHOPHARMACOLOGY, V162, P351, DOI 10.1007/s00213-002-1116-0; WALSH BT, 1989, ANN NY ACAD SCI, V575, P446	48	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105657	10.1371/journal.pone.0105657	http://dx.doi.org/10.1371/journal.pone.0105657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25148580	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000341230600065
J	Roxo, FF; Albert, JS; Silva, GSC; Zawadzki, CH; Foresti, F; Oliveira, C				Roxo, Fabio F.; Albert, James S.; Silva, Gabriel S. C.; Zawadzki, Claudio H.; Foresti, Fausto; Oliveira, Claudio			Molecular Phylogeny and Biogeographic History of the Armored Neotropical Catfish Subfamilies Hypoptopomatinae, Neoplecostominae and Otothyrinae (Siluriformes: Loricariidae)	PLOS ONE			English	Article							FRESH-WATER FISHES; GEOGRAPHIC RANGE; SOUTHERN BRAZIL; RIVER CAPTURE; EVOLUTION; EXTINCTION; DIVERSIFICATION; INFERENCE; GENUS; DISPERSAL	The main objectives of this study are estimate a species-dense, time-calibrated molecular phylogeny of Hypoptopomatinae, Neoplecostominae, and Otothyrinae, which together comprise a group of armoured catfishes that is widely distributed across South America, to place the origin of major clades in time and space, and to demonstrate the role of river capture on patterns of diversification in these taxa. We used maximum likelihood and Bayesian methods to estimate a time-calibrated phylogeny of 115 loricariid species, using three mitochondrial and one nuclear genes to generate a matrix of 4,500 base pairs, and used parametric biogeographic analyses to estimate ancestral geographic ranges and to infer the effects of river capture events on the geographic distributions of these taxa. Our analysis recovered Hypoptopomatinae, Neoplecostominae, and Otothyrinae as monophyletic with strong statistical support, and Neoplecostominae as more closely related to Otothyrinae than to Hypoptopomatinae. Our time-calibrated phylogeny and ancestral-area estimations indicate an origin of Hypoptopomatinae, Neoplecostominae, and Otothyrinae during the Lower Eocene in the Atlantic Coastal Drainages, from which it is possible to infer several dispersal events to adjacent river basins during the Neogene. In conclusion we infer a strong influence of river capture in: (1) the accumulation of modern clade species-richness values; (2) the formation of the modern basin-wide species assemblages, and (3) the presence of many low-diversity, early-branching lineages restricted to the Atlantic Coastal Drainages. We further infer the importance of headwater stream capture and marine transgressions in shaping patterns in the distributions of Hypoptopomatinae, Neoplecostominae and Otothyrinae throughout South America.	[Roxo, Fabio F.; Silva, Gabriel S. C.; Foresti, Fausto; Oliveira, Claudio] Univ Estadual Paulista, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil; [Albert, James S.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Zawadzki, Claudio H.] Univ Estadual Maringa, Nupelia, Maringa, PR, Brazil	Universidade Estadual Paulista; University of Louisiana Lafayette; Universidade Estadual de Maringa	Roxo, FF (corresponding author), Univ Estadual Paulista, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil.	roxoff@hotmail.com.br	Oliveira, Claudio/D-7713-2012; Zawadzki, Claudio H/X-2699-2018	Oliveira, Claudio/0000-0002-7010-8880; 	Brazilian agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/01610-9, 2012/01622-2]	Brazilian agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by the Brazilian agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, proc. 2010/01610-9 to FFR and proc. 2012/01622-2 to GSCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'saber AN, 1957, B PAULISTA GEOGRAFIA, V26, P38; Ab'Saber AN, 1998, GEOMORFOLOGIA BRASIL, P71; Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Albert J.S., 2010, NAT ED KNOWL, V3, P13; Albert JS, 2006, J S AM EARTH SCI, V21, P14, DOI 10.1016/j.jsames.2005.07.010; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P1; ALMEIDA Fernando F. M., 1998, REV BRAS GEOCIENC, V28, P135, DOI DOI 10.25249/0375-7536.1998135150; Armbruster JW, 2004, ZOOL J LINN SOC-LOND, V141, P1, DOI 10.1111/j.1096-3642.2004.00109.x; Armbruster JW, 1998, COPEIA, P663, DOI 10.2307/1447796; Arratia G, 1987, BONN ZOOL MONOGR, V24, P1, DOI DOI 10.1093/NAR/25.22.4692; Beheregaray LB, 2002, P ROY SOC B-BIOL SCI, V269, P65, DOI 10.1098/rspb.2001.1838; Bertuzzo E, 2009, WATER RESOUR RES, V45; Bishop P, 1995, PROG PHYS GEOG, V19, P449, DOI 10.1177/030913339501900402; Bizerril CRSF, 1994, ACTA BIOL LEOPOLDENS, V16, P51; Blakey R, 2006, PLATE TECTONICS CONT; Bloom DD, 2013, EVOLUTION, V67, P2040, DOI 10.1111/evo.12074; Bloom DD, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P137; Buckup PA, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P203; Carvalho TP, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P193; Chiachio MC, 2008, MOL PHYLOGENET EVOL, V49, P606, DOI 10.1016/j.ympev.2008.08.013; Cockerell TDA, 1925, SCIENCE, V62, P397, DOI 10.1126/science.62.1609.397-a; Covain R, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1462.1.1; Cox CB, 2005, BIOGEOGRAPHY ECOLOGI, P498; Cramer C.A., 2008, B FISH BIOL, V9, P51; Cramer CA, 2011, MOL PHYLOGENET EVOL, V59, P43, DOI 10.1016/j.ympev.2011.01.002; Silva José Francisco Pezzi da, 2004, Neotrop. ichthyol., V2, P55, DOI 10.1590/S1679-62252004000200002; de Pinna M. C. C., 1993, THESIS CITY U NEW YO; de Pinna Mario C.C., 1998, P279; do Amaral PG, 2012, QUATERN INT, V279, P120; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eigenmann C. H., 1891, Proceedings of the United States National Museum, Vxiv, P1; Eigenmann C.H., 1890, THESIS CALIFORNIA AC; Eigenmann Carl R., 1906, Popular Science Monthly, V68; Eschmeyer W. N. E., 2013, CATALOG FISHES; Eschmeyer WN, 2013, SPECIES FAMILY SUBFA; Fagan WF, 2002, ECOLOGY, V83, P3243, DOI 10.2307/3072074; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GOSLINE WA, 1947, ARQUIVOS MUSEU NACIO, V41, P79; Grande L., 1987, Journal of Vertebrate Paleontology, V7, P24; Grande L, 1998, J VERTEBR PALEONTOL, V18, P451, DOI 10.1080/02724634.1998.10011074; Grant EHC, 2007, ECOL LETT, V10, P165, DOI 10.1111/j.1461-0248.2006.01007.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hocutt CH, 1986, ZOOGEOGRAPHY FRESHWA; Howes G.J., 1983, Bulletin of the British Museum (Natural History) Zoology, V45, P309; Hubbell Stephen P., 2001, V32, pi; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISBRUCKER I.J.H., 1980, VERSLAGEN TECHNISCHE, V22, P1; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jordan DS, 1896, SCI SKETCHES; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langeani F., 1990, COMUN MUS CIENC PU Z, V3, P3; Lieberman B. S., 2008, Proceedings of the Royal Society of Victoria, V120, P51; Lima FCT, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P145; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Lopez-Fernandez H, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P105; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lucinda Paulo H. F., 2005, Neotrop. ichthyol., V3, P259, DOI 10.1590/S1679-62252005000200003; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; Lundberg John G., 1998, P13; Lundberg JG, 2007, P ACAD NAT SCI PHILA, V156, P39, DOI 10.1635/0097-3157(2007)156[39:DOARFT]2.0.CO;2; Malabarba LR, 2013, GUIA IDENTIFICACAO P; Marshall LG, 1997, J S AM EARTH SCI, V10, P49, DOI 10.1016/S0895-9811(97)00005-9; MAYDEN RL, 1988, SYST ZOOL, V37, P329, DOI 10.2307/2992197; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mo T, 1991, THESIS; Montoya-Burgos Juan-Ignacio, 1998, P363; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Nelson JA, 1999, J FISH BIOL, V54, P1069, DOI 10.1111/j.1095-8649.1999.tb00858.x; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Pearson N. E., 1937, Proceedings of the California Academy of Sciences, V23, P99; Pereira TL, 2013, J BIOGEOGR, V40, P905, DOI 10.1111/jbi.12044; Perez MHS, 2007, P ACAD NAT SCI PHILA, V156, P157, DOI 10.1635/0097-3157(2007)156[157:FCOTFD]2.0.CO;2; PITMAN WC, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P15; Ponte F.C., 1997, B GEOCIENCIAS PETROB, V11, P1; Pyron RA, 2013, TRENDS ECOL EVOL, V28, P729, DOI 10.1016/j.tree.2013.09.007; Rabosky DL, 2013, ANN REV ECOL EVOL SY, V44; Rambaut A, 2007, TREEANNOTATOR V1 7 5; Rambaut A, 2007, TRACERV1 5; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; REGAN C.T., 1904, T ZOOL SOC LONDON, V17, P191, DOI [DOI 10.1111/J.1096-3642.1904.TB00040.X, 10.1111/j.1096-3642.1904.tbOO040.x]; Reis R. E., 2013, International Zoo Yearbook, V47, P65, DOI 10.1111/izy.12000; Reis R. E., 2003, CLOFFSCA CHECK LIST; Reis RE, 2006, ZOOL J LINN SOC-LOND, V147, P277, DOI 10.1111/j.1096-3642.2006.00229.x; REIS RE, 1990, REV SUISSE ZOOL, V97, P729, DOI 10.5962/bhl.part.79760; Reis Roberto E., 1998, American Museum Novitates, V0, P1; Ribeiro AC, 2013, NEOTROP ICHTHYOL, V11, P319, DOI 10.1590/S1679-62252013000200010; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; Rosa RS, 2004, ECOLOGIA CONSERVACAO, P135; Roxo FF, 2012, ZOOTAXA, P33, DOI 10.11646/zootaxa.3390.1.3; Roxo FF, 2012, ECOL EVOL, V2, P2438, DOI 10.1002/ece3.368; Sabaj Mark H., 1999, Ichthyological Exploration of Freshwaters, V10, P217; SCHAEFER SA, 1991, ZOOL J LINN SOC-LOND, V102, P1, DOI 10.1111/j.1096-3642.1991.tb01535.x; Schaefer SA, 1987, NAT HIST MUS LOS ANG, V394, P1; Schaefer Scott A., 1998, P375; Scotese CR, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P9; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SMITH GR, 1981, ANNU REV ECOL SYST, V12, P163, DOI 10.1146/annurev.es.12.110181.001115; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vari Richard P., 1998, P1; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; VRBA ES, 1984, SYST ZOOL, V33, P318, DOI 10.2307/2413077; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waters JM, 2006, BIOL J LINN SOC, V88, P367, DOI 10.1111/j.1095-8312.2004.00622.x; Wilkinson MJ, 2006, J S AM EARTH SCI, V21, P151, DOI 10.1016/j.jsarnes.2005.08.002; Wilkinson MJ, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P162; Winemiller KO, 2008, J BIOGEOGR, V35, P1551, DOI 10.1111/j.1365-2699.2008.01917.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	124	79	82	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105564	10.1371/journal.pone.0105564	http://dx.doi.org/10.1371/journal.pone.0105564			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148406	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600058
J	Speth, RC; Carrera, EJ; Breton, C; Linares, A; Gonzalez-Reiley, L; Swindle, JD; Santos, KL; Schadock, I; Bader, M; Karamyan, VT				Speth, Robert C.; Carrera, Eduardo J.; Breton, Catalina; Linares, Andrea; Gonzalez-Reiley, Luz; Swindle, Jamala D.; Santos, Kira L.; Schadock, Ines; Bader, Michael; Karamyan, Vardan T.			Distribution of Non-AT(1), Non-AT(2) Binding of I-125-Sarcosine(1), Isoleucine(8) Angiotensin II in Neurolysin Knockout Mouse Brains	PLOS ONE			English	Article							RECEPTOR SUBTYPES; CONVERTING ENZYME; AT(2) RECEPTOR; RAT-BRAIN; PROLYL ENDOPEPTIDASE; TYPE-2 RECEPTOR; AT(1) RECEPTOR; UP-REGULATION; 3-7 FRAGMENT; SYSTEM	The recent identification of a novel binding site for angiotensin (Ang) II as the peptidase neurolysin (E.C. 3.4.24.16) has implications for the renin-angiotensin system (RAS). This report describes the distribution of specific binding of I-125-Sarcosine(1), Isoleucine(8) Ang II (I-125-SI Ang II) in neurolysin knockout mouse brains compared to wild-type mouse brains using quantitative receptor autoradiography. In the presence of p-chloromercuribenzoic acid (PCMB), which unmasks the novel binding site, widespread distribution of specific (3 mu M Ang II displaceable) I-125-SI Ang II binding in 32 mouse brain regions was observed. Highest levels of binding >700 fmol/g initial wet weight were seen in hypothalamic, thalamic and septal regions, while the lowest level of binding <300 fmol/g initial wet weight was in the mediolateralmedulla. I-125-SI Ang II binding was substantially higher by an average of 85% in wild-type mouse brains compared to neurolysin knockout brains, suggesting the presence of an additional non-AT(1), non-AT(2), non-neurolysin Ang II binding site in the mouse brain. Binding of I-125-SI Ang II to neurolysin in the presence of PCMB was highest in hypothalamic and ventral cortical brain regions, but broadly distributed across all regions surveyed. Non-AT(1), non-AT(2), non-neurolysin binding was also highest in the hypothalamus but had a different distribution than neurolysin. There was a significant reduction in AT(2) receptor binding in the neurolysin knockout brain and a trend towards decreased AT(1) receptor binding. In the neurolysin knockout brains, the size of the lateral ventricles was increased by 56% and the size of the mid forebrain (-22.72 to +1.48 relative to Bregma) was increased by 12%. These results confirm the identity of neurolysin as a novel Ang II binding site, suggesting that neurolysin may play a significant role in opposing the pathophysiological actions of the brain RAS and influencing brain morphology.	[Speth, Robert C.; Carrera, Eduardo J.; Breton, Catalina] Nova SE Univ, Dept Pharmaceut Sci, Ft Lauderdale, FL 33314 USA; [Speth, Robert C.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Carrera, Eduardo J.; Breton, Catalina; Linares, Andrea; Gonzalez-Reiley, Luz; Swindle, Jamala D.; Santos, Kira L.] Nova SE Univ, Farquhar Coll Arts & Sci, Ft Lauderdale, FL 33314 USA; [Santos, Kira L.] Univ Florida, Coll Dent, Gainesville, FL USA; [Schadock, Ines; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany; [Karamyan, Vardan T.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX USA; [Karamyan, Vardan T.] Texas Tech Univ, Hlth Sci Ctr, Ctr Blood Brain Barrier Res, Amarillo, TX USA	Nova Southeastern University; State University System of Florida; University of Florida; Nova Southeastern University; State University System of Florida; University of Florida; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Speth, RC (corresponding author), Nova SE Univ, Dept Pharmaceut Sci, Ft Lauderdale, FL 33314 USA.	rs1251@nova.edu	Bader, Michael/K-2124-2013	Bader, Michael/0000-0003-4780-4164; Schadock, Ines/0000-0002-6717-6276	 [HL-096357];  [HL-113905]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL096357, R15HL113905] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by HL-096357 https://www.nhlbi.nih.gov/ and HL-113905 https://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENELLI G, 1964, BRIT J PHARM CHEMOTH, V22, P211, DOI 10.1111/j.1476-5381.1964.tb01561.x; BRASZKO JJ, 1995, BRAIN RES BULL, V37, P627, DOI 10.1016/0361-9230(95)00056-K; BRASZKO JJ, 1991, BRAIN RES, V542, P49, DOI 10.1016/0006-8993(91)90996-9; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; BROWNLEES J, 1993, J NEUROCHEM, V60, P793, DOI 10.1111/j.1471-4159.1993.tb03223.x; Brunton L, 2011, GOODMAN GILMANS PHAR, P721; CAMPBELL DJ, 1987, J CLIN INVEST, V79, P1, DOI 10.1172/JCI112768; Cavalcanti DMLP, 2014, J BIOL CHEM, V289, P15426, DOI 10.1074/jbc.M113.539148; CHAUVEL EN, 1994, J MED CHEM, V37, P2950, DOI 10.1021/jm00044a016; Coleman CG, 2009, NEUROSCIENCE, V163, P129, DOI 10.1016/j.neuroscience.2009.06.032; Cote F, 1999, J BIOL CHEM, V274, P31686, DOI 10.1074/jbc.274.44.31686; Cunningham DF, 1998, INT J BIOCHEM CELL B, V30, P99, DOI 10.1016/S1357-2725(97)00076-9; DAHMS P, 1992, EUR J BIOCHEM, V208, P145, DOI 10.1111/j.1432-1033.1992.tb17168.x; Daubert DL, 1999, BRAIN RES, V816, P8, DOI 10.1016/S0006-8993(98)00930-5; DAVIS JO, 1962, J CLIN INVEST, V41, P378, DOI 10.1172/JCI104492; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Epstein A.N., 1978, FRONT NEUROENDOCRIN, VVolume 5, P101; FELDBERG W, 1964, J PHYSIOL-LONDON, V171, P98, DOI 10.1113/jphysiol.1964.sp007364; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Fleegal-DeMotta MA, 2009, J CEREBR BLOOD F MET, V29, P640, DOI 10.1038/jcbfm.2008.158; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GANTEN D, 1971, SCIENCE, V173, P64, DOI 10.1126/science.173.3991.64; Guimond MO, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/351758; Hauser W, 1998, EUR J PHARMACOL, V348, P101, DOI 10.1016/S0014-2999(98)00134-4; Jenkins TA, 1997, BRAIN RES, V748, P137, DOI 10.1016/S0006-8993(96)01276-0; JOHNSTON CI, 1990, DRUGS, V39, P21, DOI 10.2165/00003495-199000391-00005; Johren O, 1997, BRAIN RES, V757, P218, DOI 10.1016/S0006-8993(97)00220-5; Karamyan V, 2009, EXP BIOL M APR 2009; Karamyan VT, 2008, LIFE SCI, V83, P421, DOI 10.1016/j.lfs.2008.07.003; Karamyan VT, 2008, EUR J PHARMACOL, V590, P87, DOI 10.1016/j.ejphar.2008.05.035; Karamyan VT, 2007, REGUL PEPTIDES, V143, P15, DOI 10.1016/j.regpep.2007.03.006; Karamyan VT, 2007, BRAIN RES, V1143, P83, DOI 10.1016/j.brainres.2007.01.051; Karamyan VT, 2009, J PHARMACOL EXP THER, V331, P170, DOI 10.1124/jpet.109.157461; Karamyan VT, 2008, NEUROENDOCRINOLOGY, V88, P256, DOI 10.1159/000140635; KATO A, 1994, EUR J BIOCHEM, V221, P159, DOI 10.1111/j.1432-1033.1994.tb18725.x; KONO T, 1985, ENDOCRINOL JAPON, V32, P767; Kumar R, 2007, TRENDS ENDOCRIN MET, V18, P208, DOI 10.1016/j.tem.2007.05.001; LARAGH JH, 1960, JAMA-J AM MED ASSOC, V174, P234, DOI 10.1001/jama.1960.03030030014003; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; NAKAJIMA M, 1995, P NATL ACAD SCI USA, V92, P10663, DOI 10.1073/pnas.92.23.10663; OBERMULLER N, 1991, NEUROSCI LETT, V132, P11, DOI 10.1016/0304-3940(91)90420-X; ODYA CE, 1978, J BIOL CHEM, V253, P5927; OLeary RM, 1996, INT J BIOCHEM CELL B, V28, P441, DOI 10.1016/1357-2725(95)00154-9; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; Rashid M, 2014, J NEUROCHEM, V129, P179, DOI 10.1111/jnc.12513; Rashid M, 2010, J PHARMACOL EXP THER, V335, P754, DOI 10.1124/jpet.110.171439; Re RN, 2008, J CLIN PHARMACOL, V48, P344, DOI 10.1177/0091270007312155; Reinecke K, 2003, FASEB J, V17, P2094, DOI 10.1096/fj.02-1193fje; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; ROWE BP, 1990, EUR J PHARMACOL, V186, P339, DOI 10.1016/0014-2999(90)90457-H; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; SERIZAWA A, 1995, J BIOL CHEM, V270, P2092, DOI 10.1074/jbc.270.5.2092; SEVERS WB, 1966, J PHARMACOL EXP THER, V153, P530; SONG KF, 1991, CLIN EXP PHARMACOL P, V18, P93, DOI 10.1111/j.1440-1681.1991.tb01414.x; Speth RC, 2003, REGUL PEPTIDES, V115, P203, DOI 10.1016/S0167-0115(03)00172-1; Speth RC, 2001, METH MOLEC MED, V51, P275, DOI 10.1385/1-59259-087-X:275; Speth RC, 1999, AM J PHYSIOL-REG I, V277, pR904, DOI 10.1152/ajpregu.1999.277.3.R904; Steckelings UM, 2010, J RENIN-ANGIO-ALDO S, V11, P67, DOI 10.1177/1470320309347791; STRITTMATTER SM, 1984, P NATL ACAD SCI-BIOL, V81, P1599, DOI 10.1073/pnas.81.5.1599; TSUTSUMI K, 1991, J NEUROCHEM, V56, P348, DOI 10.1111/j.1471-4159.1991.tb02602.x; Unger T, 1999, J HYPERTENS, V17, P1775, DOI 10.1097/00004872-199917121-00001; Wangler NJ, 2012, J BIOL CHEM, V287, P114, DOI 10.1074/jbc.M111.273052; Wright JW, 2013, PFLUG ARCH EUR J PHY, V465, P133, DOI 10.1007/s00424-012-1102-2; YANG HYT, 1972, J NEUROCHEM, V19, P2443, DOI 10.1111/j.1471-4159.1972.tb01298.x; Zhang M, 2010, NEUROSCIENCE, V171, P852, DOI 10.1016/j.neuroscience.2010.09.029; ZIMMERMAN B. G., 1967, INT J NEUROPHARMACOL, V6, P27, DOI 10.1016/0028-3908(67)90039-1	69	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105762	10.1371/journal.pone.0105762	http://dx.doi.org/10.1371/journal.pone.0105762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147932	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000341230600078
J	Sasore, T; Kennedy, B				Sasore, Temitope; Kennedy, Breandan			Deciphering Combinations of PI3K/AKT/mTOR Pathway Drugs Augmenting Anti-Angiogenic Efficacy In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; RENAL-CELL CARCINOMA; MACULAR DEGENERATION; PHOSPHOINOSITIDE 3-KINASE; INTRAVITREAL INJECTION; VISUAL FUNCTION; ZEBRAFISH; EXPRESSION; VEGF	Ocular neovascularization is a common pathology associated with human eye diseases e.g. age-related macular degeneration and proliferative diabetic retinopathy. Blindness represents one of the most feared disabilities and remains a major burden to health-care systems. Current approaches to treat ocular neovascularisation include laser photocoagulation, photodynamic therapy and anti-VEGF therapies: Ranibizumab (Lucentis) and Aflibercept (Eylea). However, high clinical costs, frequent intraocular injections, and increased risk of infections are challenges related with these standards of care. Thus, there is a clinical need to develop more effective drugs that overcome these challenges. Here, we focus on an alternative approach by quantifying the in vivo anti-angiogenic efficacy of combinations of phosphatidylinositol-3-kinase (PI3K) pathway inhibitors. The PI3K/AKT/mTOR pathway is a complex signalling pathway involved in crucial cellular functions such as cell proliferation, migration and angiogenesis. RT-PCR confirms the expression of PI3K target genes (pik3ca, pik3r1, mtor and akt1) in zebrafish trunks from 6 hours post fertilisation (hpf) and in eyes from 2 days post fertilisation (dpf). Using both the zebrafish intersegmental vessel and hyaloid vessel assays to measure the in vivo anti-angiogenic efficacy of PI3K/Akt/mTOR pathway inhibitors, we identified 5 mu M combinations of i) NVP-BEZ235 (dual PI3K-mTOR inhibitor) + PI-103 (dual PI3K-mTOR inhibitor); or ii) LY-294002 (pan-PI3K inhibitor) + NVP-BEZ235; or iii) NVP-BEZ235 + rapamycin (mTOR inhibitor); or iv) LY-294002 + rapamycin as the most anti-angiogenic. Treatment of developing larvae from 2-5 dpf with 5 mu M NVP-BEZ235 plus PI-103 resulted in an essentially intact ocular morphology and visual behaviour, whereas other combinations severely disrupted the developing retinal morphology and visual function. In human ARPE19 retinal pigment epithelium cells, however, no significant difference in cell number was observed following treatment with the inhibitor combinations. Collectively, these results highlight the potential of combinations of PI3K/AKT/mTOR pathway inhibitors to safely and effectively treat ocular neovascularization.	[Sasore, Temitope; Kennedy, Breandan] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland	University College Dublin	Kennedy, B (corresponding author), Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland.	brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689	Irish Research Council; Marie Curie Actions- Industry-Academia Partnerships and Pathways (IAPP) [612218 (3D-NET)]	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Marie Curie Actions- Industry-Academia Partnerships and Pathways (IAPP)	This research was supported by an Irish Research Council postgraduate scholarship (TS) and a Marie Curie Actions- Industry-Academia Partnerships and Pathways (IAPP) grant #612218 (3D-NET) (BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Bowles DW, 2014, CLIN CANCER RES, V20, P1656, DOI 10.1158/1078-0432.CCR-13-2506; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Cai J, 2003, DIABETES, V52, P2959, DOI 10.2337/diabetes.52.12.2959; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Childs S, 2002, DEVELOPMENT, V129, P973; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Dalal M, 2013, GRAEF ARCH CLIN EXP, V251, P2705, DOI 10.1007/s00417-013-2375-7; Dejneka NS, 2004, MOL VIS, V10, P964; Dhakal S, 2013, INVEST OPHTHALMOL VI; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Frost, 2011, US RETINAL THERAPEUT; Gao GQ, 2002, DRUG DISCOV TODAY, V7, P171, DOI 10.1016/S1359-6446(01)02160-2; Georgopoulos M, 2009, BRIT J OPHTHALMOL, V93, P457, DOI 10.1136/bjo.2008.138479; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kidd KR, 2003, BRIT J PHARMACOL, V140, P585, DOI 10.1038/sj.bjp.0705496; Kilarski WW, 2012, ANGIOGENESIS, V15, P643, DOI 10.1007/s10456-012-9287-8; Kim SY, 2002, RETINA-J RET VIT DIS, V22, P464, DOI 10.1097/00006982-200208000-00011; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krishnadev N, 2011, GRAEF ARCH CLIN EXP, V249, P1627, DOI 10.1007/s00417-011-1694-9; Lang I, 2013, LANCET ONCOL, V14, P125, DOI 10.1016/S1470-2045(12)70566-1; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lien S., 2008, V181, P131; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; MEYER FA, 1990, ARTHRITIS RHEUM, V33, P1518, DOI 10.1002/art.1780331009; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2005, OPHTHAL SURG LAS IM, V36, P331, DOI 10.3928/1542-8877-20050701-14; Roulin D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-90; Sampat KM, 2010, CURR OPIN OPHTHALMOL, V21, P178, DOI 10.1097/ICU.0b013e328338679a; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Short BG, 2008, TOXICOL PATHOL, V36, P49, DOI 10.1177/0192623307310955; Stevens CB, 2012, INVEST OPHTHALMOL VI, P3960; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Werzowa J, 2011, J INVEST DERMATOL, V131, P495, DOI 10.1038/jid.2010.327; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-50; Yu WZ, 2008, OPHTHALMIC RES, V40, P19, DOI 10.1159/000111154; Zhao SL, 2001, MOL VIS, V7, P277	55	32	33	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105280	10.1371/journal.pone.0105280	http://dx.doi.org/10.1371/journal.pone.0105280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144531	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100046
J	Barbizan, R; Castro, MV; Barraviera, B; Ferreira, RS; Oliveira, ALR				Barbizan, Roberta; Castro, Mateus V.; Barraviera, Benedito; Ferreira, Rui S., Jr.; Oliveira, Alexandre L. R.			Influence of Delivery Method on Neuroprotection by Bone Marrow Mononuclear Cell Therapy following Ventral Root Reimplantation with Fibrin Sealant	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; PERIPHERAL-NERVE REGENERATION; DURISSUS-TERRIFICUS VENOM; NEUROTROPHIC FACTOR; MOTOR-NEURONS; FUNCTIONAL-EVALUATION; MOTONEURON SURVIVAL; SYNAPTIC PLASTICITY; AXONAL REGENERATION	The present work compared the local injection of mononuclear cells to the spinal cord lateral funiculus with the alternative approach of local delivery with fibrin sealant after ventral root avulsion (VRA) and reimplantation. For that, female adult Lewis rats were divided into the following groups: avulsion only, reimplantation with fibrin sealant; root repair with fibrin sealant associated with mononuclear cells; and repair with fibrin sealant and injected mononuclear cells. Cell therapy resulted in greater survival of spinal motoneurons up to four weeks post-surgery, especially when mononuclear cells were added to the fibrin glue. Injection of mononuclear cells to the lateral funiculus yield similar results to the reimplantation alone. Additionally, mononuclear cells added to the fibrin glue increased neurotrophic factor gene transcript levels in the spinal cord ventral horn. Regarding the motor recovery, evaluated by the functional peroneal index, as well as the paw print pressure, cell treated rats performed equally well as compared to reimplanted only animals, and significantly better than the avulsion only subjects. The results herein demonstrate that mononuclear cells therapy is neuroprotective by increasing levels of brain derived neurotrophic factor (BDNF) and glial derived neurotrophic factor (GDNF). Moreover, the use of fibrin sealant mononuclear cells delivery approach gave the best and more long lasting results.	[Barbizan, Roberta; Castro, Mateus V.; Oliveira, Alexandre L. R.] Univ Estadual Campinas, Dept Struct & Funct Biol, Lab Nerve Regenerat, Campinas, SP, Brazil; [Barraviera, Benedito; Ferreira, Rui S., Jr.] Univ Estadual Paulista, Sao Paulo State Univ, Ctr Study Venoms & Venomous Anim CEVAP, Botucatu, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual Paulista	Oliveira, ALR (corresponding author), Univ Estadual Campinas, Dept Struct & Funct Biol, Lab Nerve Regenerat, Campinas, SP, Brazil.	alroliv@unicamp.br	Barraviera, Benedito/C-6511-2012; Oliveira, Alexandre L. R./C-4436-2012; Ferreira, Rui Seabra/R-5920-2019; Oliveira, Alexandre/AAI-6815-2020; Ferreira, Rui Seabra/D-1285-2012; Castro, Mateus Vidigal de/CAA-2167-2022; Ferreira, Rui/D-1285-2012	Barraviera, Benedito/0000-0002-9855-5594; Oliveira, Alexandre L. R./0000-0003-4224-4575; Ferreira, Rui Seabra/0000-0001-6952-0512; Oliveira, Alexandre/0000-0003-4224-4575; Ferreira, Rui Seabra/0000-0001-6952-0512; Castro, Mateus Vidigal de/0000-0002-8895-652X; Ferreira, Rui/0000-0003-1856-2792	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil [2010/0986-5]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2010/00729-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The present work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil (2010/0986-5). Barbizan R. was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (process number: 2010/00729-2). This work was funded by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, J ANAT, V80, P37; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Barbizan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063260; Barros LC, 2011, J VENOM ANIM TOXINS, V17, P23, DOI 10.1590/S1678-91992011000100004; Barros LC, 2009, J TOXICOL ENV HEAL B, V12, P553, DOI 10.1080/10937400903442514; Brannstrom T, 1998, EXP BRAIN RES, V118, P1, DOI 10.1007/s002210050249; Bregman BS, 2002, PROG BRAIN RES, V137, P257; Carlstedt T, 2008, RESTOR NEUROL NEUROS, V26, P225; Carlstedt T, 2009, NEUROSURG CLIN N AM, V20, P39, DOI 10.1016/j.nec.2008.07.020; Chang HY, 2008, EXP NEUROL, V214, P117, DOI 10.1016/j.expneurol.2008.07.025; CULLHEIM S, 1989, NEUROSCIENCE, V29, P725, DOI 10.1016/0306-4522(89)90144-9; de Freitas HT, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-58; Dijkstra JR, 2000, J NEUROSCI METH, V96, P89, DOI 10.1016/S0165-0270(99)00174-0; Eggers R, 2010, EXP NEUROL, V223, P207, DOI 10.1016/j.expneurol.2009.07.021; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fernandes M, 2008, J NEUROSCI METH, V170, P16, DOI 10.1016/j.jneumeth.2007.12.009; Freria CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-240; Gasparotto VPO, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt467; Giuffre JL, 2010, J HAND SURG-AM, V35A, P678, DOI 10.1016/j.jhsa.2010.01.021; Goel RK, 2009, J CLIN NEUROSCI, V16, P1211, DOI 10.1016/j.jocn.2009.01.031; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Gubert F, 2013, STEM CELL RES, V10, P241, DOI 10.1016/j.scr.2012.11.009; Hoang TX, 2006, NEUROSCIENCE, V138, P1149, DOI 10.1016/j.neuroscience.2005.11.066; Ide C, 1996, NEUROSCI RES, V25, P101; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Lang EM, 2005, PLAST RECONSTR SURG, V115, P2042, DOI 10.1097/01.PRS.0000163328.51271.DD; Li LX, 1998, J COMP NEUROL, V396, P158; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes JD, 2011, MICROSC RES TECHNIQ, V74, P355, DOI 10.1002/jemt.20916; Mendell LM, 2001, J PHYSIOL-LONDON, V533, P91, DOI 10.1111/j.1469-7793.2001.0091b.x; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; NOVIKOV L, 1995, NEUROSCI LETT, V200, P45, DOI 10.1016/0304-3940(95)12078-I; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Oliveira ALR, 2000, NEUROSCI LETT, V293, P131, DOI 10.1016/S0304-3940(00)01506-8; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Penas C, 2009, J NEUROTRAUM, V26, P763, DOI [10.1089/neu.2008.0661, 10.1089/neu.2008-0661]; PRIVAT A, 1981, J NEUROPATH EXP NEUR, V40, P46; PURVES D, 1978, PHYSIOL REV, V58, P821, DOI 10.1152/physrev.1978.58.4.821; Hell RCR, 2009, NEUROBIOL DIS, V33, P290, DOI 10.1016/j.nbd.2008.10.017; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; Thatte MR, 2013, ANN INDIAN ACAD NEUR, V16, P26, DOI 10.4103/0972-2327.107686; Torres-Espin A, 2013, NEUROTHERAPEUTICS, V10, P354, DOI 10.1007/s13311-013-0178-5; Varejao ASP, 2001, J NEUROSCI METH, V108, P1, DOI 10.1016/S0165-0270(01)00378-8; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Yao L, 2012, MOL BIOL REP, V39, P569, DOI 10.1007/s11033-011-0772-8; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R	47	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105712	10.1371/journal.pone.0105712	http://dx.doi.org/10.1371/journal.pone.0105712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157845	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200051
J	Liang, TM; Yu, JF; Liu, C; Guo, L				Liang, Tingming; Yu, JiaFeng; Liu, Chang; Guo, Li			An Exploration of Evolution, Maturation, Expression and Function Relationships in Mir-23 similar to 27 similar to 24 Cluster	PLOS ONE			English	Article							MICRORNA EXPRESSION; RNA; BIOGENESIS; REVEALS; ADENYLATION; REPERTOIRE; COMPLEXITY; EVENTS	The study aims to explore the potential relationships of evolution, maturation, expression and function between homologous/clustered miRNAs. mir-23 similar to 27 similar to 24 gene cluster, including the two gene clusters (mir-23a and mir-23b) and the three miRNA gene families (mir-23, mir-27 and mir-24), was typically selected as an example. These related miRNAs show similar evolutionary patterns and various expression patterns. Most of them show consistent isomiR expression pattern, and the "switching" phenomenon can be found between different abundant isomiR species. These findings suggest that these sequence or location related miRNAs show the similar miRNA processing and maturation processes, and the robust selection of the most dominant isomiR exists in specific tissues. Functional analysis show that these miRNAs show similar distributions of enriched gene categories, suggesting the close functional prelateships via direct or indirect coordinate regulation in biological processes. The study reveals the close evolutionary, expression and functional relationships between related homologous/clustered miRNAs, which will further enrich miRNA studies and understand direct or indirect interactions between miRNAs.	[Liang, Tingming; Liu, Chang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Yu, JiaFeng] Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Funct Macromol Biophys, Dezhou, Shandong, Peoples R China; [Guo, Li] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Dezhou University; Nanjing Medical University	Guo, L (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	lguo@njmu.edu.cn	Liang, Tingming/ACL-6141-2022		National Basic Research Program of China (973 Program) [2012CB947600, 2013CB911600]; National Natural Science Foundation of China [31171137, 31271261, 61301251]; Program for New Century Excellent Talents in University by the Chinese Ministry of Education [NCET-11-0990]; Program for the Top Young Talents by the Organization Department of the CPC Central Committee; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); China Postdoctoral Science Foundation [2012M521100]; National Natural Science Foundation of Jiangsu [BK20130885]; Natural Science Foundation of the Jiangsu Higher Education Institutions [12KJB360001, 13KJB330003]; Jiangsu Planned Projects for Postdoctoral Research Funds [1201022B]; Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Chinese Ministry of Education; Program for the Top Young Talents by the Organization Department of the CPC Central Committee; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of Jiangsu; Natural Science Foundation of the Jiangsu Higher Education Institutions; Jiangsu Planned Projects for Postdoctoral Research Funds; Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program) (2012CB947600, 2013CB911600), the National Natural Science Foundation of China (31171137, 31271261, 61301251), the Program for New Century Excellent Talents in University by the Chinese Ministry of Education (NCET-11-0990), the Program for the Top Young Talents by the Organization Department of the CPC Central Committee, the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University), the China Postdoctoral Science Foundation funded project (No. 2012M521100), the National Natural Science Foundation of Jiangsu (No. BK20130885), the Natural Science Foundation of the Jiangsu Higher Education Institutions (No. 12KJB360001, 13KJB330003), the Jiangsu Planned Projects for Postdoctoral Research Funds (No. 1201022B), Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo L, 2013, MICRORNA NONCODING R, P127; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Guo L, 2012, MOL BIOL REP, V39, P6699, DOI 10.1007/s11033-012-1493-3; Guo L, 2012, MOL BIOL REP, V39, P2031, DOI 10.1007/s11033-011-0950-8; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Guo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007944; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jin LJ, 2013, CANCER RES, V73, P2884, DOI 10.1158/0008-5472.CAN-12-2162; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin ST, 2013, P NATL ACAD SCI USA, V110, P17468, DOI 10.1073/pnas.1317182110; Lu SF, 2009, NUCLEIC ACIDS RES, V37, P1878, DOI 10.1093/nar/gkp031; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sun T, 2012, PROSTATE, V72, P1093, DOI 10.1002/pros.22456; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang F, 2014, NUCLEIC ACIDS RES, V42, P442, DOI 10.1093/nar/gkt848; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhang Q, 2014, VIROLOGY, V450, P182, DOI 10.1016/j.virol.2013.12.020; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	51	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106223	10.1371/journal.pone.0106223	http://dx.doi.org/10.1371/journal.pone.0106223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157521	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200092
J	Rainer, TH; Yeung, HH; Gabbe, BJ; Yuen, KY; Ho, HF; Kam, CW; Chang, A; Poon, WS; Cameron, PA; Graham, CA				Rainer, Timothy H.; Yeung, Hiu Hung; Gabbe, Belinda J.; Yuen, Kai Y.; Ho, Hiu F.; Kam, Chak W.; Chang, Annice; Poon, Wai S.; Cameron, Peter A.; Graham, Colin A.			A Comparison of Functional Outcome in Patients Sustaining Major Trauma: A Multicentre, Prospective, International Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEAD-INJURY; HONG-KONG; CARE; POPULATION; AUSTRALIA; VICTORIA; REGISTRY; SYSTEMS; SCALES	Objectives: To compare 6 month and 12 month health status and functional outcomes between regional major trauma registries in Hong Kong and Victoria, Australia. Summary Background Data: Multicentres from trauma registries in Hong Kong and the Victorian State Trauma Registry (VSTR). Methods: Multicentre, prospective cohort study. Major trauma patients and aged >= 18 years were included. The main outcome measures were Extended Glasgow Outcome Scale (GOSE) functional outcome and risk-adjusted Short-Form 12 (SF-12) health status at 6 and 12 months after injury. Results: 261 cases from Hong Kong and 1955 cases from VSTR were included. Adjusting for age, sex, ISS, comorbid status, injury mechanism and GCS group, the odds of a better functional outcome for Hong Kong patients relative to Victorian patients at six months was 0.88 (95% CI: 0.66, 1.17), and at 12 months was 0.83 (95% CI: 0.60, 1.12). Adjusting for age, gender, ISS, GCS, injury mechanism and comorbid status, Hong Kong patients demonstrated comparable mean PCS-12 scores at 6-months (adjusted mean difference: 1.2, 95% CI: -1.2, 3.6) and 12-months (adjusted mean difference: -0.4, 95% CI: -3.2, 2.4) compared to Victorian patients. Keeping age, gender, ISS, GCS, injury mechanism and comorbid status, there was no difference in the MCS-12 scores of Hong Kong patients compared to Victorian patients at 6-months (adjusted mean difference: 0.4, 95% CI: -2.1, 2.8) or 12-months (adjusted mean difference: 1.8, 95% CI: -0.8, 4.5). Conclusion: The unadjusted analyses showed better outcomes for Victorian cases compared to Hong Kong but after adjusting for key confounders, there was no difference in 6-month or 12-month functional outcomes between the jurisdictions.	[Rainer, Timothy H.; Yeung, Hiu Hung; Yuen, Kai Y.; Graham, Colin A.] Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China; [Rainer, Timothy H.; Yeung, Hiu Hung; Graham, Colin A.] Prince Wales Hosp, Trauma & Emergency Ctr, Shatin, Hong Kong, Peoples R China; [Gabbe, Belinda J.; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Gabbe, Belinda J.] Swansea Univ, Coll Med, West Glamorgan, Wales; [Ho, Hiu F.; Chang, Annice] Queen Elizabeth Hosp, Dept Accid & Emergency, Kowloon, Hong Kong, Peoples R China; [Kam, Chak W.] Tuen Mun Hosp, Dept Accid & Emergency, Tuen Mun, Hong Kong, Peoples R China; [Poon, Wai S.] Chinese Univ Hong Kong, Dept Surg, Div Neurosurg, Shatin, Hong Kong, Peoples R China; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Monash University; Swansea University; Tuen Mun Hospital; Chinese University of Hong Kong; Florey Institute of Neuroscience & Mental Health	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China.	thrainer@cuhk.edu.hk	Graham, Colin A/B-4535-2013; Poon, Wai S/HGD-3084-2022; Rainer, Timothy/I-2591-2013; Yuen, Kai Yeung/J-9006-2015; Poon, Wai Sang/F-1558-2011	Graham, Colin A/0000-0002-4381-7470; Rainer, Timothy/0000-0003-3355-3237; Yuen, Kai Yeung/0000-0002-5093-2282; Gabbe, Belinda/0000-0001-7096-7688; Cameron, Peter/0000-0002-1443-557X; Yuen, Kwok-yung/0000-0002-2083-1552	Health and Health Services Research Grant Committee of Hong Kong Government [HHSRF 07080261]	Health and Health Services Research Grant Committee of Hong Kong Government	Funding the study has been conducted with the support of Health and Health Services Research Grant Committee of Hong Kong Government. Grant numbers: HHSRF 07080261. The URL of funder's website: http://rfs.fhb.gov.hk/grants/english/welcome/welcome.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bowling Ann, 1991, MEASURING HLTH REV Q, DOI 10.1046/j.1365-2648.1999.0951g.x; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brenneman RD, 1997, J TRAUMA, V42, P778; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cheng CH, 2008, ANN SURG, V247, P335, DOI 10.1097/SLA.0b013e31815ccc2e; Cheung NK, 2006, J TRAUMA, V61, P954, DOI 10.1097/01.ta.0000196573.02139.b4; Gabbe B, 2014, ANN SURG, P1; Gabbe BJ, 2007, AUST HEALTH REV, V31, P628, DOI 10.1071/AH070628; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; Garratt AN, 2002, BMJ-BRIT MED J, V324, P1417, DOI 10.1136/bmj.324.7351.1417; Graham CA, 2007, EUR J EMERG MED, V14, P35, DOI 10.1097/01.mej.0000224440.12612.62; Gruen RL, 2012, BRIT J SURG, V99, P97, DOI 10.1002/bjs.7754; Kiely JM, 2006, J TRAUMA, V61, P791, DOI 10.1097/01.ta.0000239360.29852.1d; Lam CL, 1999, HONG KONG PRACTITION, V21, P460; Lam CLK, 2005, J CLIN EPIDEMIOL, V58, P815, DOI 10.1016/j.jclinepi.2004.12.008; Leung GKK, 2011, J TRAUMA, V70, P1128, DOI 10.1097/TA.0b013e3181fd5d62; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Moi AL, 2006, J TRAUMA, V61, P961, DOI 10.1097/01.ta.0000195988.57939.9a; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Nijboer JMM, 2007, J TRAUMA, V63, P670, DOI 10.1097/01.ta.0000228890.65522.53; O'Mullane PA, 2009, MED J AUSTRALIA, V190, P129, DOI 10.5694/j.1326-5377.2009.tb02311.x; Rainer TH, 2014, INJURY, V45, P902, DOI 10.1016/j.injury.2013.11.006; Rainer TH, 2000, J EMERG MED, V7, P129; Sethi D, 2007, ANN EMERG MED, V49, P52, DOI 10.1016/j.annemergmed.2006.08.019; Tinkoff GH, 2007, J TRAUMA, V63, P121, DOI 10.1097/TA.0b013e3180686548; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	33	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e103396	10.1371/journal.pone.0103396	http://dx.doi.org/10.1371/journal.pone.0103396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157522	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000341303200002
J	Tokuda, S; Higashi, T; Furuse, M				Tokuda, Shinsaku; Higashi, Tomohito; Furuse, Mikio			ZO-1 Knockout by TALEN-Mediated Gene Targeting in MDCK Cells: Involvement of ZO-1 in the Regulation of Cytoskeleton and Cell Shape	PLOS ONE			English	Article							ZONULA OCCLUDENS-1 AND-2; TIGHT JUNCTION STRANDS; BELT-LIKE ADHERENS; EPITHELIAL-CELLS; BARRIER FUNCTION; ACTIN CYTOSKELETON; PROTEIN; EXPRESSION; OCCLUDIN; CLAUDINS	ZO-1, ZO-2 and ZO-3 are tight junction-associated scaffold proteins that bind to transmembrane proteins of tight junctions and the underlying cytoskeleton. ZO-1 is involved in the regulation of cytoskeletal organization, but its detailed molecular mechanism is less well understood. Gene knockout is an ideal method to investigate the functions of proteins that might have redundant functions such as ZO proteins, when compared with methods such as RNA interference-mediated suppression of gene expression. In this study we applied transcription activator-like effector nucleases (TALENs), a recently developed genome editing method for gene knockout, and established ZO-1 knockout clones in Madin-Darby canine kidney (MDCK) cells. ZO-1 knockout induced striking changes in myosin organization at cell-cell contacts and disrupted the localization of tight junction proteins; these findings were previously unseen in studies of ZO-1 knockdown by RNA interference. Rescue experiments revealed that trace ZO-1 expression reversed these changes while excessive ZO-1 expression induced an intensive zigzag shape of cell-cell junctions. These results suggest a role for ZO-1 in the regulation of cytoskeleton and shape of cell-cell junctions in MDCK cells and indicate the advantage of knockout analysis in cultured cells.	[Tokuda, Shinsaku; Higashi, Tomohito; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Biol, Kobe, Hyogo 657, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan	Kobe University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Furuse, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Biol, Kobe, Hyogo 657, Japan.	furuse@nips.ac.jp	Higashi, Tomohito/AHE-7942-2022	Furuse, Mikio/0000-0003-2847-8156; Higashi, Tomohito/0000-0001-5616-1477	Japan Society for the Promotion of Science [LS084, 26291043]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science: LS084 (M. F.). Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science: 26291043 (M. F.) The Global COE Program "Global Center for Education and Research in Integrative Membrane Biology'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (S. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijaz S, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-49; [Anonymous], [No title captured]; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Higashi T, 2013, J CELL SCI, V126, P966, DOI 10.1242/jcs.116442; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nakajima H, 2010, J CELL SCI, V123, P555, DOI 10.1242/jcs.057752; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320	41	46	47	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104994	10.1371/journal.pone.0104994	http://dx.doi.org/10.1371/journal.pone.0104994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157572	gold, Green Published, Green Submitted			2022-12-27	WOS:000341303200021
J	Wan, QQ; Xu, WX; Yan, JL; Yokota, H; Na, S				Wan, Qiaoqiao; Xu, Wenxiao; Yan, Jing-Long; Yokota, Hiroki; Na, Sungsoo			Distinctive Subcellular Inhibition of Cytokine-Induced Src by Salubrinal and Fluid Flow	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SIGNAL-TRANSDUCTION; SHEAR-STRESS; PLASMA-MEMBRANE; LIVING CELLS; EXPRESSION; ACTIVATION; CARTILAGE; KINASE; CHONDROCYTES	A non-receptor protein kinase Src plays a crucial role in fundamental cell functions such as proliferation, migration, and differentiation. While inhibition of Src is reported to contribute to chondrocyte homeostasis, its regulation at a subcellular level by chemical inhibitors and mechanical stimulation has not been fully understood. In response to inflammatory cytokines and stress to the endoplasmic reticulum (ER) that increase proteolytic activities in chondrocytes, we addressed two questions: Do cytokines such as interleukin 1 beta (IL1 beta) and tumor necrosis factor alpha (TNF alpha) induce location-dependent Src activation? Can cytokine-induced Src activation be suppressed by chemically alleviating ER stress or by applying fluid flow? Using live cell imaging with two Src biosensors (i.e., cytosolic, and plasma membrane-bound biosensors) for a fluorescence resonance energy transfer (FRET) technique, we determined cytosolic Src activity as well as membrane-bound Src activity in C28/I2 human chondrocytes. In response to TNF alpha and IL1 beta, both cytosolic and plasma membrane-bound Src proteins were activated, but activation in the cytosol occurred earlier than that in the plasma membrane. Treatment with salubrinal or guanabenz, two chemical agents that attenuate ER stress, significantly decreased cytokine-induced Src activities in the cytosol, but not in the plasma membrane. In contrast, fluid flow reduced Src activities in the plasma membrane, but not in the cytosol. Collectively, the results demonstrate that Src activity is differentially regulated by salubrinal/guanabenz and fluid flow in the cytosol and plasma membrane.	[Wan, Qiaoqiao; Yokota, Hiroki; Na, Sungsoo] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Xu, Wenxiao; Yan, Jing-Long] Harbin Med Univ, Clin Hosp 2, Dept Orthoped, Harbin, Peoples R China; [Yokota, Hiroki] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harbin Medical University; Indiana University System; Indiana University Bloomington	Na, S (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	sungna@iupui.edu	Wan, Qiaoqiao/N-6562-2017		IUPUI Biomechanics and Biomaterials Research Center; 100 Voices of Hope; NIH [AR065149, AR52144]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052144, R03AR065149] Funding Source: NIH RePORTER	IUPUI Biomechanics and Biomaterials Research Center; 100 Voices of Hope; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported in part by grants from the IUPUI Biomechanics and Biomaterials Research Center (SN), 100 Voices of Hope (HY), and NIH AR065149 (SN) and AR52144 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bursell L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2308; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Carames B, 2008, OSTEOARTHR CARTILAGE, V16, P715, DOI 10.1016/j.joca.2007.10.006; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; Chai DH, 2010, OSTEOARTHR CARTILAGE, V18, P249, DOI 10.1016/j.joca.2009.09.002; Chowdhury TT, 2006, BIOMECH MODEL MECHAN, V5, P192, DOI 10.1007/s10237-006-0032-3; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Hamamura K, 2013, OSTEOARTHR CARTILAGE, V21, P764, DOI 10.1016/j.joca.2013.02.657; Hamamura K, 2009, ARCH ORAL BIOL, V54, P279, DOI 10.1016/j.archoralbio.2008.11.003; Karginov AV, 2014, NAT CHEM BIOL, V10, P286, DOI [10.1038/NCHEMBIO.1477, 10.1038/nchembio.1477]; Lee IT, 2010, J CELL PHYSIOL, V224, P454, DOI 10.1002/jcp.22142; Loeser RF, 2002, BIORHEOLOGY, V39, P119; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Lu SY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000127; Madhavan S, 2006, OSTEOARTHR CARTILAGE, V14, P1023, DOI 10.1016/j.joca.2006.03.016; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Melchiorri C, 1998, ARTHRITIS RHEUM-US, V41, P2165, DOI 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.3.CO;2-F; Millward-Sadler SJ, 2004, ANN BIOMED ENG, V32, P435, DOI 10.1023/B:ABME.0000017538.72511.48; Moos V, 1999, J RHEUMATOL, V26, P870; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; NAWROTH PP, 1986, J EXP MED, V163, P1363, DOI 10.1084/jem.163.6.1363; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; PASQUALE EB, 1986, P NATL ACAD SCI USA, V83, P5507, DOI 10.1073/pnas.83.15.5507; Poh YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007886; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SCHLAEPFER DD, 1994, NATURE, V372, P786; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Smith MD, 1997, J RHEUMATOL, V24, P365; Smith RL, 1995, J ORTHOPAED RES, V13, P824, DOI 10.1002/jor.1100130604; Smith RL, 2004, CLIN ORTHOP RELAT R, pS89, DOI 10.1097/01.blo.0000143938.30681.9d; Sun HB, 2010, ANN NY ACAD SCI, V1211, P37, DOI 10.1111/j.1749-6632.2010.05808.x; Swaminathan R, 1996, BIOPHYS J, V71, P1140, DOI 10.1016/S0006-3495(96)79316-5; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Torzilli PA, 2011, CARTILAGE, V2, P364, DOI 10.1177/1947603511407484; Torzilli PA, 2010, OSTEOARTHR CARTILAGE, V18, P97, DOI 10.1016/j.joca.2009.07.012; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Wan QQ, 2013, CELL BIOL INT, V37, P568, DOI 10.1002/cbin.10072; Wan QQ, 2013, BIOCHEM BIOPH RES CO, V433, P502, DOI 10.1016/j.bbrc.2013.03.020; Wang P, 2013, FASEB J, V27, P4664, DOI 10.1096/fj.13-234542; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WEERNINK PAO, 1995, J BIOL CHEM, V270, P2264, DOI 10.1074/jbc.270.5.2264; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Yokota Hiroki, 2011, Curr Osteoporos Rep, V9, P237, DOI 10.1007/s11914-011-0067-y	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105699	10.1371/journal.pone.0105699	http://dx.doi.org/10.1371/journal.pone.0105699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157407	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200046
J	Yu, TF; Maestre-Reyna, M; Ko, CY; Ko, TP; Sun, YJ; Lin, TY; Shaw, JF; Wang, AHJ				Yu, Tsung-Fu; Maestre-Reyna, Manuel; Ko, Chia-Yun; Ko, Tzu-Ping; Sun, Yuh-Ju; Lin, Tsai-Yun; Shaw, Jei-Fu; Wang, Andrew H. -J.			Structural Insights of the ssDNA Binding Site in the Multifunctional Endonuclease AtBFN2 from Arabidopsis thaliana	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; PENICILLIUM-CITRINUM; NUCLEASE P1; CRYSTAL-STRUCTURES; BACILLUS-CEREUS; PHOSPHOLIPASE-C; RESOLUTION; MECHANISM; DNA; CRYSTALLOGRAPHY	The multi S1/P1 nuclease AtBFN2 (EC 3.1.30.1) encoded by the Arabidopsis thaliana At1g68290 gene is a glycoprotein that digests RNA, ssDNA, and dsDNA. AtBFN2 depends on three zinc ions for cleaving DNA and RNA at 3'-OH to yield 5'-nucleotides. In addition, AtBFN2's enzymatic activity is strongly glycan dependent. Plant Zn2+-dependent endonucleases present a unique fold, and belong to the Phospholipase C (PLC)/P1 nuclease superfamily. In this work, we present the first complete, ligand-free, AtBFN2 crystal structure, along with sulfate, phosphate and ssDNA co-crystal structures. With these, we were able to provide better insight into the glycan structure and possible enzymatic mechanism. In comparison with other nucleases, the AtBFN2/ligand-free and AtBFN2/PO4 models suggest a similar, previously proposed, catalytic mechanism. Our data also confirm that the phosphate and vanadate can inhibit the enzyme activity by occupying the active site. More importantly, the AtBFN2/A(5)T structure reveals a novel and conserved secondary binding site, which seems to be important for plant Zn2+-dependent endonucleases. Based on these findings, we propose a rational ssDNA binding model, in which the ssDNA wraps itself around the protein and the attached surface glycan, in turn, reinforces the binding complex.	[Yu, Tsung-Fu; Sun, Yuh-Ju; Lin, Tsai-Yun; Wang, Andrew H. -J.] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yu, Tsung-Fu; Maestre-Reyna, Manuel; Ko, Tzu-Ping; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Ko, Chia-Yun; Shaw, Jei-Fu; Wang, Andrew H. -J.] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Ko, Chia-Yun] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Shaw, Jei-Fu] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; I Shou University	Wang, AHJ (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	shawjf@isu.edu.tw; ahjwang@gate.sinica.edu.tw	Ko, Chia-Yun/J-9314-2013		Academia Sinica; Ministry of Science and Technology [NSC-101-2313-B-214-002-MY3, NSC-1033113-P-008-001, NSC-101-2319-B-001-003]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Academia Sinica, and Ministry of Science and Technology grants: NSC-101-2313-B-214-002-MY3 (to J.- F. Shaw), (NSC-1033113-P-008-001, and NSC-101-2319-B-001-003 (to A. H.- J. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAKRE SE, 1982, BIOCHEM J, V203, P799, DOI 10.1042/bj2030799; Aoyagi S, 1998, FEBS LETT, V429, P134, DOI 10.1016/S0014-5793(98)00563-8; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou TL, 2013, BIOCATAL AGRIC BIOTE, V2, P191, DOI 10.1016/j.bcab.2013.03.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farage-Barhom S, 2008, J EXP BOT, V59, P3247, DOI 10.1093/jxb/ern176; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FUJIMOTO M, 1974, AGR BIOL CHEM TOKYO, V38, P785, DOI 10.1080/00021369.1974.10861231; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; HOUGH E, 1989, NATURE, V338, P357, DOI 10.1038/338357a0; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ito J, 2002, PLANT CELL, V14, P3201, DOI 10.1105/tpc.006411; Ko CY, 2012, J AGR FOOD CHEM, V60, P5169, DOI 10.1021/jf300945c; Koval' T, 2013, ACTA CRYSTALLOGR D, V69, P213, DOI 10.1107/S0907444912043697; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; MAEKAWA K, 1991, EUR J BIOCHEM, V200, P651, DOI 10.1111/j.1432-1033.1991.tb16228.x; McCabe PF, 2000, PLANT MOL BIOL, V44, P359, DOI 10.1023/A:1026500810877; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; OLESON AE, 1980, ARCH BIOCHEM BIOPHYS, V204, P361, DOI 10.1016/0003-9861(80)90044-2; Oron A, 2003, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0804S02; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Amador MA, 2000, PLANT PHYSIOL, V122, P169, DOI 10.1104/pp.122.1.169; Podzimek T, 2011, PLANT SCI, V180, P343, DOI 10.1016/j.plantsci.2010.10.006; Romier C, 1998, PROTEINS, V32, P414, DOI 10.1002/(SICI)1097-0134(19980901)32:4<414::AID-PROT2>3.3.CO;2-5; Sugiyama M, 2000, PLANT MOL BIOL, V44, P387, DOI 10.1023/A:1026504911786; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Vogt V M, 1980, Methods Enzymol, V65, P248; VOLBEDA A, 1991, EMBO J, V10, P1607, DOI 10.1002/j.1460-2075.1991.tb07683.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang B, 2000, BIOCHEMISTRY-US, V39, P3533, DOI 10.1021/bi992376z; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181	34	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105821	10.1371/journal.pone.0105821	http://dx.doi.org/10.1371/journal.pone.0105821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157844	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200069
J	Buckley, MW; Arandjelovic, S; Trampont, PC; Kim, TS; Braciale, TJ; Ravichandran, KS				Buckley, Monica W.; Arandjelovic, Sanja; Trampont, Paul C.; Kim, Taeg S.; Braciale, Thomas J.; Ravichandran, Kodi S.			Unexpected Phenotype of Mice Lacking Shcbp1, a Protein Induced during T Cell Proliferation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; PRE-TCR; GENE-EXPRESSION; IN-VIVO; THYMOCYTE DIFFERENTIATION; CLINICAL-FEATURES; ACTIVATION; PATHOGENESIS; LEUKEMIA	T cell development and activation are highly regulated processes, and their proper execution is important for a competent immune system. Shc SH2-domain binding protein-1 (Shcbp1) is an evolutionarily conserved protein that binds to the adaptor protein ShcA. Studies in Drosophila and in cell lines have strongly linked Shcbp1 to cell proliferation, embryonic development, growth factor signaling, and tumorigenesis. Here we show that Shcbp1 expression is strikingly upregulated during the beta-selection checkpoint in thymocytes, and that its expression tightly correlates with proliferative stages of T cell development. To evaluate the role for Shcbp1 during thymic selection and T cell function in vivo, we generated mice with global and conditional deletion of Shcbp1. Surprisingly, the loss of Shcbp1 expression did not have an obvious effect during T cell development. However, in a mouse model of experimental autoimmune encephalomyelitis (EAE), which depends on CD4(+) T cell function and mimics multiple features of the human disease multiple sclerosis, Shcbp1 deficient mice had reduced disease severity and improved survival, and this effect was T cell intrinsic. These data suggest that despite the striking upregulation of Shcbp1 during T cell proliferation, loss of Shcbp1 does not directly affect T cell development, but regulates CD4(+) T cell effector function in vivo.	[Buckley, Monica W.; Arandjelovic, Sanja; Trampont, Paul C.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Buckley, Monica W.; Arandjelovic, Sanja; Trampont, Paul C.; Ravichandran, Kodi S.] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Buckley, Monica W.; Arandjelovic, Sanja; Trampont, Paul C.; Kim, Taeg S.; Braciale, Thomas J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.	Ravi@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410; Trampont, Paul/0000-0002-3643-8472	National Institute of General Medical Sciences [GM55761]; F30 Fellowship; MSTP program; T32 Immunology Training Grant; NATIONAL CANCER INSTITUTE [F30CA177173, P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, R01AI015608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055761, T32GM007267] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); F30 Fellowship; MSTP program; T32 Immunology Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of General Medical Sciences - GM55761 funding to Kodi S. Ravichandran. Support to MWB via a F30 Fellowship and the MSTP program and the T32 Immunology Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Asano E, 2013, J CELL SCI, V126, P3263, DOI 10.1242/jcs.124875; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Chen JF, 2012, GENE DEV, V26, P803, DOI 10.1101/gad.187641.112; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; CRIST WM, 1988, BLOOD, V72, P1891; Eckerle S, 2009, LEUKEMIA, V23, P2129, DOI 10.1038/leu.2009.161; Fink PJ, 2011, NAT REV IMMUNOL, V11, P544, DOI 10.1038/nri3028; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; GALLO P, 1989, J NEUROL SCI, V92, P9, DOI 10.1016/0022-510X(89)90171-8; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gold R, 2013, LANCET, V381, P2167, DOI 10.1016/S0140-6736(12)62190-4; Hardy WR, 2007, SCIENCE, V317, P251, DOI 10.1126/science.1140114; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Ito M, 2013, J VIROL, V87, P9633, DOI 10.1128/JVI.00714-13; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kreslavsky T, 2012, IMMUNITY, V37, P840, DOI 10.1016/j.immuni.2012.08.020; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lai KMV, 2000, GENE DEV, V14, P1132; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Matesanz F, 2004, J NEUROIMMUNOL, V148, P212, DOI 10.1016/j.jneuroim.2003.12.001; Matesanz F, 2001, J NEUROIMMUNOL, V119, P101, DOI 10.1016/S0165-5728(01)00354-X; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; McFarland KN, 2006, J NEUROSCI, V26, P7885, DOI 10.1523/JNEUROSCI.3524-05.2006; McNally JP, 2014, J IMMUNOL, V192, P73, DOI 10.4049/jimmunol.1301891; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Misslitz A, 2006, IMMUNOL REV, V209, P115, DOI 10.1111/j.0105-2896.2006.00351.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Montembault E, 2010, J CELL BIOL, V191, P1351, DOI 10.1083/jcb.201007060; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Petitto JM, 2000, NEUROSCI LETT, V285, P66, DOI 10.1016/S0304-3940(00)00996-4; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schmandt R, 1999, ONCOGENE, V18, P1867, DOI 10.1038/sj.onc.1202507; Schulze-Topphoff U, 2013, J EXP MED, V210, P1301, DOI 10.1084/jem.20121611; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tao HC, 2013, ASIAN PAC J CANCER P, V14, P5645, DOI 10.7314/APJCP.2013.14.10.5645; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Trampont P, 2006, MOL CELL BIOL, V26, P9035, DOI 10.1128/MCB.00988-06; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Trigueros C, 2003, EUR J IMMUNOL, V33, P1968, DOI 10.1002/eji.200323831; Truffinet V, 2007, J IMMUNOL, V179, P6033, DOI 10.4049/jimmunol.179.9.6033; Uckun FM, 1997, J CLIN ONCOL, V15, P2214, DOI 10.1200/JCO.1997.15.6.2214; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Zhang L, 2003, IMMUNOL REV, V191, P183, DOI 10.1034/j.1600-065X.2003.00025.x; Zhang L, 2002, NAT IMMUNOL, V3, P749, DOI 10.1038/ni820; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	69	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105576	10.1371/journal.pone.0105576	http://dx.doi.org/10.1371/journal.pone.0105576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153088	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200063
J	Glabska, H; Potworowski, J; Leski, S; Wojcik, DK				Glabska, Helena; Potworowski, Jan; Leski, Szymon; Wojcik, Daniel K.			Independent Components of Neural Activity Carry Information on Individual Populations	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; SOURCE DENSITY METHOD; ARTIFACTS; MODEL; 3D	Local field potential (LFP), the low-frequency part of the potential recorded extracellularly in the brain, reflects neural activity at the population level. The interpretation of LFP is complicated because it can mix activity from remote cells, on the order of millimeters from the electrode. To understand better the relation between the recordings and the local activity of cells we used a large-scale network thalamocortical model to compute simultaneous LFP, transmembrane currents, and spiking activity. We used this model to study the information contained in independent components obtained from the reconstructed Current Source Density (CSD), which smooths transmembrane currents, decomposed further with Independent Component Analysis (ICA). We found that the three most robust components matched well the activity of two dominating cell populations: superior pyramidal cells in layer 2/3 (rhythmic spiking) and tufted pyramids from layer 5 (intrinsically bursting). The pyramidal population from layer 2/3 could not be well described as a product of spatial profile and temporal activation, but by a sum of two such products which we recovered in two of the ICA components in our analysis, which correspond to the two first principal components of PCA decomposition of layer 2/3 population activity. At low noise one more cell population could be discerned but it is unlikely that it could be recovered in experiment given typical noise ranges.	[Glabska, Helena; Potworowski, Jan; Leski, Szymon; Wojcik, Daniel K.] M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Wojcik, DK (corresponding author), M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland.	d.wojcik@nencki.gov.pl	Leski, Szymon/A-8931-2008; Wojcik, Daniel/C-6334-2008	Wojcik, Daniel/0000-0003-0812-9872; Leski, Szymon/0000-0003-1764-1907	Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw [G35-7]; Polish Ministry of Regional Development [POIG.02.03.00-00-003/09, POIG.02.03.00-00-018/08]; Polish Ministry of Science and Higher Education [5428/B/P01/2010/39, IP2011similar to030971, 2948/7.PR/2013/2]	Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw; Polish Ministry of Regional Development; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Numerical simulations were in part performed in the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw, under grant G35-7. Research supported by the grants from the Polish Ministry of Regional Development, POIG.02.03.00-00-003/09, POIG.02.03.00-00-018/08, and from the Polish Ministry of Science and Higher Education: 5428/B/P01/2010/39, IP2011 similar to 030971,and 2948/7.PR/2013/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; DI S, 1990, J NEUROPHYSIOL, V63, P832, DOI 10.1152/jn.1990.63.4.832; Einevoll GT, 2007, J NEUROPHYSIOL, V97, P2174, DOI 10.1152/jn.00845.2006; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Einevoll GT, 2013, PRINCIPLES OF NEURAL CODING, P37; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Goto T, 2010, J NEUROPHYSIOL, V104, P3388, DOI 10.1152/jn.00122.2010; Gratiy Sergey L, 2011, Front Neuroinform, V5, P32, DOI 10.3389/fninf.2011.00032; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holt, 1998, THESIS CALTECH; Hunt MJ, 2011, J PSYCHOPHARMACOL, V25, P808, DOI 10.1177/0269881110362126; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; LAY DC, 1997, LINEAR ALGEBRA ITS A; Leski S, 2007, NEUROINFORMATICS, V5, P207, DOI 10.1007/s12021-007-9000-z; Leski S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003137; Leski S, 2011, NEUROINFORMATICS, V9, P401, DOI 10.1007/s12021-011-9111-4; Leski S, 2010, J COMPUT NEUROSCI, V29, P459, DOI 10.1007/s10827-009-0203-1; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Makarov VA, 2010, J COMPUT NEUROSCI, V29, P445, DOI 10.1007/s10827-009-0206-y; Makarova J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00077; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; Nelson MJ, 2013, J NEUROSCI, V33, P2821, DOI 10.1523/JNEUROSCI.3502-12.2013; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; Pitts W.H., 1952, CYBERNETICS, P159; Potworowski J, 2012, NEURAL COMPUT, V24, P541, DOI 10.1162/NECO_a_00236; Press W, 1989, NUMERICAL RECIPIES C; Reimann MW, 2013, NEURON, V79, P375, DOI 10.1016/j.neuron.2013.05.023; Stevens CF, 1966, NEUROPHYSIOLOGY PRIM; Stone J.V., 2004, INDEPENDENT COMPONEN; Stone JV, 2002, NEUROIMAGE, V15, P407, DOI 10.1006/nimg.2001.0986; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Wojcik DK, 2010, NEURAL COMPUT, V22, P48, DOI 10.1162/neco.2009.07-08-831	39	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105071	10.1371/journal.pone.0105071	http://dx.doi.org/10.1371/journal.pone.0105071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153730	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200036
J	Mohan, D; Angus, DC; Ricketts, D; Farris, C; Fischhoff, B; Rosengart, MR; Yealy, DM; Barnato, AE				Mohan, Deepika; Angus, Derek C.; Ricketts, Daniel; Farris, Coreen; Fischhoff, Baruch; Rosengart, Matthew R.; Yealy, Donald M.; Barnato, Amber E.			Assessing the Validity of Using Serious Game Technology to Analyze Physician Decision Making	PLOS ONE			English	Article							SUSTAINED INATTENTIONAL BLINDNESS; CLINICAL-PRACTICE GUIDELINES; TRAUMA CENTER CARE; STANDARDIZED PATIENTS; VIGNETTES; TRIAGE; ABSTRACTION; WORKLOAD; ACCESS	Background: Physician non-compliance with clinical practice guidelines remains a critical barrier to high quality care. Serious games (using gaming technology for serious purposes) have emerged as a method of studying physician decision making. However, little is known about their validity. Methods: We created a serious game and evaluated its construct validity. We used the decision context of trauma triage in the Emergency Department of non-trauma centers, given widely accepted guidelines that recommend the transfer of severely injured patients to trauma centers. We designed cases with the premise that the representativeness heuristic influences triage (i.e. physicians make transfer decisions based on archetypes of severely injured patients rather than guidelines). We randomized a convenience sample of emergency medicine physicians to a control or cognitive load arm, and compared performance (disposition decisions, number of orders entered, time spent per case). We hypothesized that cognitive load would increase the use of heuristics, increasing the transfer of representative cases and decreasing the transfer of non-representative cases. Findings: We recruited 209 physicians, of whom 168 (79%) began and 142 (68%) completed the task. Physicians transferred 31% of severely injured patients during the game, consistent with rates of transfer for severely injured patients in practice. They entered the same average number of orders in both arms (control (C): 10.9 [SD 4.8] vs. cognitive load (CL): 10.7 [SD 5.6], p = 0.74), despite spending less time per case in the control arm (C: 9.7 [SD 7.1] vs. CL: 11.7 [SD 6.7] minutes, p<0.01). Physicians were equally likely to transfer representative cases in the two arms (C: 45% vs. CL: 34%, p = 0.20), but were more likely to transfer non-representative cases in the control arm (C: 38% vs. CL: 26%, p = 0.03). Conclusions: We found that physicians made decisions consistent with actual practice, that we could manipulate cognitive load, and that load increased the use of heuristics, as predicted by cognitive theory.	[Mohan, Deepika; Angus, Derek C.; Ricketts, Daniel] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Farris, Coreen] RAND Corp, Pittsburgh, PA USA; [Fischhoff, Baruch] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Rosengart, Matthew R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Yealy, Donald M.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Barnato, Amber E.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RAND Corporation; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mohan, D (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	mohand@upmc.edu	Angus, Derek C/E-9671-2012; Fischhoff, Baruch/I-9859-2014	Fischhoff, Baruch/0000-0002-3030-6874	National Institute of General Medical Sciences [1K23 GM101292-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM101292] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences 1K23 GM101292-02 (DM). The funder had no role in study design, data collection, analysis, decision to publish, or preparation of manuscript.	[Anonymous], 2002, HEURISTICS BIASES PS; BARHILLEL M, 1980, ACTA PSYCHOL, V44, P211, DOI 10.1016/0001-6918(80)90046-3; BIRNBAUM MH, 1983, AM J PSYCHOL, V96, P85, DOI 10.2307/1422211; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Chui MA, 2012, J AM PHARM ASSOC, V52, pE153, DOI 10.1331/JAPhA.2012.11135; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dhami MK, 2004, PSYCHOL BULL, V130, P959, DOI 10.1037/0033-2909.130.6.959; Drew T, 2013, PSYCHOL SCI, V24, P1848, DOI 10.1177/0956797613479386; Flanagan PT, 2012, J AM COLL RADIOL, V9, P648, DOI 10.1016/j.jacr.2012.04.014; Gawron VJ, 2008, PERFORMANCE WORKLOAD; Gillard E, 2009, EXP PSYCHOL, V56, P92, DOI 10.1027/1618-3169.56.2.92; Gomez D, 2012, J TRAUMA ACUTE CARE, V73, P1288, DOI 10.1097/TA.0b013e318265cec2; Gomez D, 2012, SURGERY, V152, P179, DOI 10.1016/j.surg.2012.04.006; Graafland M, 2012, BRIT J SURG, V99, P1322, DOI 10.1002/bjs.8819; Hammond KR, 1996, PSYCHOL EGON BRUNSWI; HART SG, 1984, HUM FACTORS, V26, P545, DOI 10.1177/001872088402600506; Institute of Medicine, 2001, CROSS QUAL CHASM; Kahneman D, 2003, JUDGMENT UNCERTAINTY; KLAYMAN J, 1993, COGNITION, V49, P97, DOI 10.1016/0010-0277(93)90037-V; Lucet JC, 2011, INFECT CONT HOSP EP, V32, P1003, DOI 10.1086/661914; Ma J, 2013, PLOS ONE, V9; Mohan D, 2014, MED DECIS MAKING, V34, P242, DOI 10.1177/0272989X13508007; Mohan D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-103; Mohan D, 2011, ARCH SURG-CHICAGO, V146, P786, DOI 10.1001/archsurg.2011.43; Mohan D, 2010, ANN SURG, V251, P946, DOI 10.1097/SLA.0b013e3181d76cb5; Newgard CD, 2013, ACAD EMERG MED, V20, P911, DOI 10.1111/acem.12213; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Pronovost PJ, 2013, JAMA-J AM MED ASSOC, V310, P2501, DOI 10.1001/jama.2013.281334; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Shah AK, 2008, PSYCHOL BULL, V134, P207, DOI 10.1037/0033-2909.134.2.207; Shah R, 2010, OPHTHAL PHYSL OPT, V30, P209, DOI 10.1111/j.1475-1313.2010.00713.x; SIMON HA, 1979, AM ECON REV, V69, P493; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; STROSS JK, 1979, JAMA-J AM MED ASSOC, V241, P2622, DOI 10.1001/jama.241.24.2622; Zyda M, 2005, COMPUTER, V38, P25, DOI 10.1109/MC.2005.297	37	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105445	10.1371/journal.pone.0105445	http://dx.doi.org/10.1371/journal.pone.0105445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153149	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000340952200048
J	Vaezghasemi, M; Ohman, A; Eriksson, M; Hakimi, M; Weinehall, L; Kusnanto, H; Ng, N				Vaezghasemi, Masoud; Ohman, Ann; Eriksson, Malin; Hakimi, Mohammad; Weinehall, Lars; Kusnanto, Hari; Ng, Nawi			The Effect of Gender and Social Capital on the Dual Burden of Malnutrition: A Multilevel Study in Indonesia	PLOS ONE			English	Article							NUTRITION TRANSITION; SOCIOECONOMIC-STATUS; HEALTH; OBESITY; HOUSEHOLDS; OVERWEIGHT; COUNTRIES; PATTERNS	Introduction: The paradoxical phenomenon of the coexistence of overweight and underweight individuals in the same household, referred to as the "dual burden of malnutrition'', is a growing nutrition dilemma in low-and middle-income countries (LMICs). Aims: The objectives of this study were (i) to examine the extent of the dual burden of malnutrition across different provinces in Indonesia and (ii) to determine how gender, community social capital, place of residency and other socioeconomic factors affect the prevalence of the dual burden of malnutrition. Methods: The current study utilized data from the fourth wave of the Indonesian Family Life Survey (IFLS) conducted between November 2007 and April 2008. The dataset contains information from 12,048 households and 45,306 individuals of all ages. This study focused on households with individuals over two years old. To account for the multilevel nature of the data, a multilevel multiple logistic regression was conducted. Results: Approximately one-fifth of all households in Indonesia exhibited the dual burden of malnutrition, which was more prevalent among male-headed households, households with a high Socio-economic status (SES), and households in urban areas. Minimal variation in the dual burden of malnutrition was explained by the community level differences (<4%). Living in households with a higher SES resulted in higher odds of the dual burden of malnutrition but not among female-headed households and communities with the highest social capital. Conclusion: To improve household health and reduce the inequality across different SES groups, this study emphasizes the inclusion of women's empowerment and community social capital into intervention programs addressing the dual burden of malnutrition.	[Vaezghasemi, Masoud; Ohman, Ann; Eriksson, Malin; Weinehall, Lars; Ng, Nawi] Umea Univ, Dept Publ Hlth & Clin Med, Div Epidemiol & Global Hlth, Umea, Sweden; [Vaezghasemi, Masoud; Ohman, Ann; Eriksson, Malin; Weinehall, Lars; Ng, Nawi] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [Vaezghasemi, Masoud; Ohman, Ann] Umea Univ, Umea Ctr Gender Studies, Umea, Sweden; [Hakimi, Mohammad] Gadjah Mada Univ, Fac Med, Ctr Hlth & Nutr Res Lab, Yogyakarta, Indonesia; [Kusnanto, Hari] Gadjah Mada Univ, Fac Med, Ctr Environm Studies, Yogyakarta, Indonesia	Umea University; Umea University; Umea University; Gadjah Mada University; Gadjah Mada University	Vaezghasemi, M (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Div Epidemiol & Global Hlth, Umea, Sweden.	masoud.vaezghasemi@umu.se	Hakimi, Mohammad/GOV-6587-2022; Ng, Nawi/F-8373-2011	Ng, Nawi/0000-0003-0556-1483; Weinehall, Lars/0000-0003-3025-2690	Swedish International Development Cooperation Agency (Sida) [AKT-2010-048]	Swedish International Development Cooperation Agency (Sida)	The project has been funded through a grant from the Swedish International Development Cooperation Agency (Sida) (Grant number: AKT-2010-048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, FAO Food Nutr Pap, V84, P1; [Anonymous], 1983, WOMENS WORK WOMENS R; [Anonymous], 2008, DUAL BURDEN MALNUTRI; Buvinic M, 2012, ECON DEV CULT CHANGE, V45, P259; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Connell R., 2013, GENDER POWER SOC PER; Connell R. W., 1995, MASCULINITIES; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Doak C, 2002, PUBLIC HEALTH NUTR, V5, P215, DOI 10.1079/PHN2001296; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Doak CM, 2000, J NUTR, V130, P2965, DOI 10.1093/jn/130.12.2965; Eriksson M., 2010, SOCIAL CAPITAL HLTH; Garrett James L., 2005, Food and Nutrition Bulletin, V26, P209; GILLESPIE S, 2001, ATTACKING DOUBLE BUR; Harpham T, 2002, J TROP PEDIATRICS, V48, P128, DOI 10.1093/tropej/48.3.128; International IDEA Institute for Democracy and Electorial Assistance, 2000, GEND DEM IND ASS; Kim D, 2006, SOC SCI MED, V63, P1045, DOI 10.1016/j.socscimed.2006.02.017; Maluccio J.A., 1999, INTRAHOUSEHOLD ALLOC; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Miller DL, 2006, WORLD DEV, V34, P1084, DOI 10.1016/j.worlddev.2005.11.006; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Oddo VM, 2012, AM J CLIN NUTR, V95, P951, DOI 10.3945/ajcn.111.026070; Ohman A, 2008, SCAND J PUBLIC HEALT, V36, P449, DOI 10.1177/1403494808094242; Okin, 1989, JUSTICE GENDER FAMIL; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; PAPANEK H, 1988, ECON POLIT WEEKLY, V23, pWS73; Poortinga W, 2006, SOC SCI MED, V63, P255, DOI 10.1016/j.socscimed.2005.11.039; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Putnam R., 1993, AM PROSPECT, V13, P35, DOI DOI 10.1287/mnsc.1120.1644; Rae AN, 1999, AUST J AGR RESOUR EC, V43, P359, DOI 10.1111/1467-8489.00084; Roemling C, 2013, ECON HUM BIOL, V11, P563, DOI 10.1016/j.ehb.2013.07.001; Schuller T, 2000, SOCIAL CAPITAL CRITI, P1; Statistics Indonesia, 2012, TRENDS SEL SOC IND I; Strauss J., 2009, 4 WAVE INDONESIA FAM; The Asia Foundation ADB Canadian International Development Agency National Democratic Institute TWB, 2006, IND COUNTR GEND ASS; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029	40	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103849	10.1371/journal.pone.0103849	http://dx.doi.org/10.1371/journal.pone.0103849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153321	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200010
J	Brown, C; Lathia, N; Mascolo, C; Noulas, A; Blondel, V				Brown, Chloe; Lathia, Neal; Mascolo, Cecilia; Noulas, Anastasios; Blondel, Vincent			Group Colocation Behavior in Technological Social Networks	PLOS ONE			English	Article							HUMAN MOBILITY	We analyze two large datasets from technological networks with location and social data: user location records from an online location-based social networking service, and anonymized telecommunications data from a European cellphone operator, in order to investigate the differences between individual and group behavior with respect to physical location. We discover agreements between the two datasets: firstly, that individuals are more likely to meet with one friend at a place they have not visited before, but tend to meet at familiar locations when with a larger group. We also find that groups of individuals are more likely to meet at places that their other friends have visited, and that the type of a place strongly affects the propensity for groups to meet there. These differences between group and solo mobility has potential technological applications, for example, in venue recommendation in location-based social networks.	[Brown, Chloe; Lathia, Neal; Mascolo, Cecilia; Noulas, Anastasios] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Blondel, Vincent] Catholic Univ Louvain, Louvain Sch Engn, Louvain, Belgium	University of Cambridge; Universite Catholique Louvain	Brown, C (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	chloe.brown@cl.cam.ac.uk		Siegele-Brown, Chloe/0000-0002-9229-3351; Mascolo, Cecilia/0000-0001-9614-4380	Google Europe Fellowship in Mobile Computing; Google Fellowship; Engineering and Physical Sciences Research Council [EP/K019392, EP/I032673/1]; EPSRC [EP/I032673/1, EP/K019392/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K019392/1] Funding Source: researchfish	Google Europe Fellowship in Mobile Computing(Google Incorporated); Google Fellowship(Google Incorporated); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Chloe Brown is a recipient of the Google Europe Fellowship in Mobile Computing, and this research is supported in part by this Google Fellowship. We acknowledge the support of the Engineering and Physical Sciences Research Council through grants GALE (EP/K019392) and UBHAVE (EP/I032673/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom L., 2010, PROCEEDINGS OF THE 1, P61, DOI [10.1145/1772690.1772698, DOI 10.1145/1772690.1772698]; Calabrese F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020814; Chang J., 2011, P INT AAAI C WEB SOC, P74; Cheng Zhiyuan, 2011, ICWSM, P81; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; Cranshaw J, 2010, UBICOMP 2010: PROCEEDINGS OF THE 2010 ACM CONFERENCE ON UBIQUITOUS COMPUTING, P119; De Domenico M, 2013, PERVASIVE MOB COMPUT, V9, P798, DOI 10.1016/j.pmcj.2013.07.008; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; INGHAM AG, 1974, J EXP SOC PSYCHOL, V10, P371, DOI 10.1016/0022-1031(74)90033-X; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Mascolo C., 2011, 5 INT AAAI C WEBL SO, V5, P329; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939	16	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105816	10.1371/journal.pone.0105816	http://dx.doi.org/10.1371/journal.pone.0105816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148037	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600085
J	Joncourt, R; Eberle, AB; Rufener, SC; Muhlemann, O				Joncourt, Raphael; Eberle, Andrea B.; Rufener, Simone C.; Muehlemann, Oliver			Eukaryotic Initiation Factor 4G Suppresses Nonsense-Mediated mRNA Decay by Two Genetically Separable Mechanisms	PLOS ONE			English	Article							POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; TRANSLATION INITIATION; MAMMALIAN-CELLS; UPF1 PHOSPHORYLATION; CORE DOMAIN; IN-VIVO; COMPLEX; EIF4G; TERMINATION	Nonsense-mediated mRNA decay (NMD), which is best known for degrading mRNAs with premature termination codons (PTCs), is thought to be triggered by aberrant translation termination at stop codons located in an environment of the mRNP that is devoid of signals necessary for proper termination. In mammals, the cytoplasmic poly(A)-binding protein 1 (PABPC1) has been reported to promote correct termination and therewith antagonize NMD by interacting with the eukaryotic release factors 1 (eRF1) and 3 (eRF3). Using tethering assays in which proteins of interest are recruited as MS2 fusions to a NMD reporter transcript, we show that the three N-terminal RNA recognition motifs (RRMs) of PABPC1 are sufficient to antagonize NMD, while the eRF3-interacting C-terminal domain is dispensable. The RRM1-3 portion of PABPC1 interacts with eukaryotic initiation factor 4G (eIF4G) and tethering of eIF4G to the NMD reporter also suppresses NMD. We identified the interactions of the eIF4G N-terminus with PABPC1 and the eIF4G core domain with eIF3 as two genetically separable features that independently enable tethered eIF4G to inhibit NMD. Collectively, our results reveal a function of PABPC1, eIF4G and eIF3 in translation termination and NMD suppression, and they provide additional evidence for a tight coupling between translation termination and initiation.	[Joncourt, Raphael; Eberle, Andrea B.; Rufener, Simone C.; Muehlemann, Oliver] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Joncourt, Raphael; Rufener, Simone C.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	University of Bern; University of Bern	Muhlemann, O (corresponding author), Univ Bern, Dept Chem & Biochem, Bern, Switzerland.	oliver.muehlemann@dcb.unibe.ch		Rufener, Simone Carla/0000-0001-7477-2407; Muhlemann, Oliver/0000-0003-0657-1368	European Research Council [StG 207419]; Swiss National Science Foundation [31003A-127614, 31003A-143717]; canton of Bern	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); canton of Bern(Japanese Urological Association)	This work was supported by grants to OM from the European Research Council (http://erc.europa.eu/; StG 207419), the Swiss National Science Foundation (http://www.snf.ch; grants 31003A-127614 and 31003A-143717), and the canton of Bern (http://www.be.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; Beznoskova P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003962; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Bushell M, 2001, J BIOL CHEM, V276, P23922, DOI 10.1074/jbc.M100384200; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Choe J, 2012, J BIOL CHEM, V287, P18500, DOI 10.1074/jbc.M111.327528; Coldwell MJ, 2006, MOL CELL BIOL, V26, P8448, DOI 10.1128/MCB.01248-06; Coldwell MJ, 2004, J CELL SCI, V117, P2545, DOI 10.1242/jcs.01106; Cosson B, 2002, BIOL CELL, V94, P205, DOI 10.1016/S0248-4900(02)01194-2; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Durand S, 2013, NAT STRUCT MOL BIOL, V20, P702, DOI 10.1038/nsmb.2575; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Hurt JA, 2013, GENOME RES, V23, P1636, DOI 10.1101/gr.157354.113; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kervestin S, 2012, BIOCHIMIE, V94, P1560, DOI 10.1016/j.biochi.2011.12.021; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010169; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Loh B, 2013, GENE DEV, V27, P2125, DOI 10.1101/gad.226951.113; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; McIlwain DR, 2010, P NATL ACAD SCI USA, V107, P12186, DOI 10.1073/pnas.1007336107; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Moriarty PM, 1997, RNA, V3, P1369; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Muhlemann O, 2012, TRENDS GENET, V28, P70, DOI 10.1016/j.tig.2011.11.001; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; Nicholson P, 2012, CURR PROTOC CELL BIO; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Peixeiro I, 2012, NUCLEIC ACIDS RES, V40, P1160, DOI 10.1093/nar/gkr820; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Roy B, 2013, TRENDS GENET, V29, P691, DOI 10.1016/j.tig.2013.09.002; Roy G, 2002, MOL CELL BIOL, V22, P3769, DOI 10.1128/MCB.22.11.3769-3782.2002; Rufener SC, 2013, NAT STRUCT MOL BIOL, V20, P710, DOI 10.1038/nsmb.2576; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Welnowska E, 2009, J MOL BIOL, V394, P506, DOI 10.1016/j.jmb.2009.09.036; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Yepiskoposyan H, 2011, RNA, V17, P2108, DOI 10.1261/rna.030247.111; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826; Zund D, 2013, NAT STRUCT MOL BIOL, V20, P936, DOI 10.1038/nsmb.2635	80	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104391	10.1371/journal.pone.0104391	http://dx.doi.org/10.1371/journal.pone.0104391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148142	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600014
J	Newton, R; Wernisch, L				Newton, Richard; Wernisch, Lorenz			A Meta-Analysis of Multiple Matched Copy Number and Transcriptomics Data Sets for Inferring Gene Regulatory Relationships	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BREAST-CANCER CELLS; GASTRIC-CANCER; INTEGRATIVE ANALYSIS; EXPRESSION PROFILES; MICROARRAY ANALYSIS; MOLECULAR SUBTYPES; PROTEIN EXPRESSION; TARGET GENES; ABERRATIONS	Inferring gene regulatory relationships from observational data is challenging. Manipulation and intervention is often required to unravel causal relationships unambiguously. However, gene copy number changes, as they frequently occur in cancer cells, might be considered natural manipulation experiments on gene expression. An increasing number of data sets on matched array comparative genomic hybridisation and transcriptomics experiments from a variety of cancer pathologies are becoming publicly available. Here we explore the potential of a meta-analysis of thirty such data sets. The aim of our analysis was to assess the potential of in silico inference of trans-acting gene regulatory relationships from this type of data. We found sufficient correlation signal in the data to infer gene regulatory relationships, with interesting similarities between data sets. A number of genes had highly correlated copy number and expression changes in many of the data sets and we present predicted potential trans-acted regulatory relationships for each of these genes. The study also investigates to what extent heterogeneity between cell types and between pathologies determines the number of statistically significant predictions available from a meta-analysis of experiments.	[Newton, Richard; Wernisch, Lorenz] MRC, Biostat Unit, Cambridge CB2 2BW, England	MRC Biostatistics Unit	Newton, R (corresponding author), MRC, Biostat Unit, Cambridge CB2 2BW, England.	richard.newton@mrc-bsu.cam.ac.uk			UK Medical Research Council, Biostatistics Unit [U105260799]; MRC [MC_U105260799] Funding Source: UKRI; Medical Research Council [MC_U105260799] Funding Source: researchfish	UK Medical Research Council, Biostatistics Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the UK Medical Research Council, Biostatistics Unit (http://www.mrc-bsu.cam.ac.uk/), Unit Programme number U105260799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Anney RJL, 2008, AM J MED GENET B, V147B, P1369, DOI 10.1002/ajmg.b.30871; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Battaglia S, 2010, INT J CANCER, V126, P2511, DOI 10.1002/ijc.25181; Beck AH, 2010, ONCOGENE, V29, P845, DOI 10.1038/onc.2009.381; Bekhouche I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016950; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhattacharya N, 2012, ANN SURG ONCOL, P1; Bicciato S, 2009, NUCLEIC ACIDS RES, V37, P5057, DOI 10.1093/nar/gkp520; Both J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030907; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Braggio E, 2009, CANCER RES, V69, P3579, DOI 10.1158/0008-5472.CAN-08-3701; Bruning-Richardson A, 2011, BRIT J CANCER, V104, P1602, DOI 10.1038/bjc.2011.117; Carlson  M., 2014, ORG HS EG DB GENOME; Casola C, 2008, MOL BIOL EVOL, V25, P29, DOI 10.1093/molbev/msm221; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chaplet M, 2006, CELL CYCLE, V5, P2579, DOI 10.4161/cc.5.22.3471; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chin K, 2006, CANC CELL        DEC, P530; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Coco S, 2012, INT J CANCER, V131, P1591, DOI 10.1002/ijc.27432; Crowder RJ, 2009, CANCER RES, V69, P3955, DOI 10.1158/0008-5472.CAN-08-4450; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fabris S, 2007, GENE CHROMOSOME CANC, V46, P1109, DOI 10.1002/gcc.20494; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerloff A, 2011, ONCOL REP, V26, P1121, DOI 10.3892/or.2011.1409; Giallongo C, 2011, ACTA HAEMATOL-BASEL, V126, P205, DOI 10.1159/000329911; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Goh XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063780; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Huang N, 2012, BRIEF BIOINFORM, V13, P305, DOI 10.1093/bib/bbr056; Jarvinen AK, 2006, ONCOGENE, V25, P6997, DOI 10.1038/sj.onc.1209690; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Jiao X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-165; Jo YH, 2013, GENE, V517, P184, DOI 10.1016/j.gene.2012.12.088; Jones JO, 2003, J VIROL, V77, P1268, DOI 10.1128/JVI.77.2.1268-1280.2003; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Junnila S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-73; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Katuri V, 2005, ONCOGENE, V24, P8012, DOI 10.1038/sj.onc.1208946; Kaul D, 2010, CANCER BIOL THER, V9, P736, DOI 10.4161/cbt.9.9.11549; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim SS, 2006, BIOCHEM BIOPH RES CO, V344, P1216, DOI 10.1016/j.bbrc.2006.03.236; Kinyamu HK, 2008, MOL CARCINOGEN, V47, P845, DOI 10.1002/mc.20440; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Krebs AR, 2010, EMBO REP, V11, P541, DOI 10.1038/embor.2010.75; Kummar S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-25; La Rosa P, 2006, BIOINFORMATICS, V22, P2066, DOI 10.1093/bioinformatics/btl359; Lahti L, 2013, BRIEF BIOINFORM, V14, P27, DOI 10.1093/bib/bbs005; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; Larrinaga G, 2010, REGUL PEPTIDES, V163, P102, DOI 10.1016/j.regpep.2010.03.012; Lee H, 2008, BIOINFORMATICS, V24, P889, DOI 10.1093/bioinformatics/btn034; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Li SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-186; Lin MT, 2009, INT J CANCER, V125, P603, DOI 10.1002/ijc.24346; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Liu H., 2012, OPTIM METHOD SOFTW, V1, P1, DOI DOI 10.1128/GEN0MEA.00936-13; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Max Planck Institute for Molecular Genetics, 2014, CONSENSUSPATHDB REL; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Micci F, 2013, GENE CHROMOSOME CANC, V52, P551, DOI 10.1002/gcc.22053; Moreno-Baylach MJ, 2011, NEUROSIGNALS, V19, P97, DOI 10.1159/000326342; Muranen TA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3015; Myllykangas S, 2008, INT J CANCER, V123, P817, DOI 10.1002/ijc.23574; Myohanen TT, 2012, J HISTOCHEM CYTOCHEM, V60, P706, DOI 10.1369/0022155412453051; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Olson JE, 2010, BREAST CANCER RES TR, V119, P423, DOI 10.1007/s10549-009-0386-1; Ooi WF, 2012, GENE CHROMOSOME CANC, V51, P545, DOI 10.1002/gcc.21940; Ortiz-Estevez M, 2011, GENOMICS, V97, P86, DOI 10.1016/j.ygeno.2010.10.008; Parris TZ, 2010, CLIN CANCER RES, V16, P3860, DOI 10.1158/1078-0432.CCR-10-0889; Phillips JL, 2001, CANCER RES, V61, P8143; Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Richardson J, 2011, BREAST CANCER RES TR, V127, P639, DOI 10.1007/s10549-010-1019-4; Rodriguez-Paredes M, 2014, ONCOGENE, V33, P2807, DOI 10.1038/onc.2013.239; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Sabatier R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027656; Salari K, 2010, BIOINFORMATICS, V26, P414, DOI 10.1093/bioinformatics/btp702; Schafer M, 2009, BIOINFORMATICS, V25, P3228, DOI 10.1093/bioinformatics/btp592; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Soneson C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-191; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Sun ZF, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-35; Takai N, 2004, CURR CANCER DRUG TAR, V4, P511, DOI 10.2174/1568009043332871; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tieri P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032678; Toedt G, 2011, INT J CANCER, V128, P1095, DOI 10.1002/ijc.25448; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vainio P, 2012, PROSTATE, V72, P789, DOI 10.1002/pros.21487; van Wieringen WN, 2006, BIOINFORMATICS, V22, P1919, DOI 10.1093/bioinformatics/btl269; Vaughan Laura K., 2013, Frontiers in Genetics, V4, P38, DOI 10.3389/fgene.2013.00038; Venkatesh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054643; Wang XM, 2012, ASIAN PAC J CANCER P, V13, P1043, DOI 10.7314/APJCP.2012.13.3.1043; Wang Y, 2011, IRISH J MED SCI, V180, P865, DOI 10.1007/s11845-011-0714-4; Wang Y, 2012, ONCOL LETT, V3, P25, DOI 10.3892/ol.2011.428; Yang Dong-Xia, 2010, Chin J Cancer, V29, P396; Yang L, 2012, J POLYM RES, V19, P1; Yassin ER, 2010, LEUKEMIA, V24, P1001, DOI 10.1038/leu.2010.42; Yoo JY, 2012, MOL BIOL CELL, V23, P2943, DOI 10.1091/mbc.E11-11-0947; Yuan Y, 2011, IEEE ACM T COMPUT BI, V99; Zhou YM, 2012, BLOOD, V119, pE148, DOI 10.1182/blood-2011-10-388702	118	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105522	10.1371/journal.pone.0105522	http://dx.doi.org/10.1371/journal.pone.0105522			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148247	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600051
J	Wang, MD; Gomes, J; Cashman, NR; Little, J; Krewski, D				Wang, Ming-Dong; Gomes, James; Cashman, Neil R.; Little, Julian; Krewski, Daniel			Intermediate CAG Repeat Expansion in the ATXN2 Gene Is a Unique Genetic Risk Factor for ALS-A Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LENGTH POLYGLUTAMINE EXPANSIONS; SPINOCEREBELLAR ATAXIA TYPE-2; MOTOR-NEURON DISEASE; GGGGCC HEXANUCLEOTIDE REPEAT; C9ORF72 REPEAT; SCA2 LOCUS; MUTATIONS; PREVALENCE; POLYMORPHISMS	Amyotrophic lateral sclerosis (ALS) is a rare degenerative condition of the motor neurons. Over 10% of ALS cases are linked to monogenic mutations, with the remainder thought to be due to other risk factors, including environmental factors, genetic polymorphisms, and possibly gene-environmental interactions. We examined the association between ALS and an intermediate CAG repeat expansion in the ATXN2 gene using a meta-analytic approach. Observational studies were searched with relevant disease and gene terms from MEDLINE, EMBASE, and PsycINFO from January 2010 through to January 2014. All identified articles were screened using disease terms, gene terms, population information, and CAG repeat information according to PRISMA guidelines. The final list of 17 articles was further evaluated based on the study location, time period, and authors to exclude multiple usage of the same study populations: 13 relevant articles were retained for this study. The range 30-33 CAG repeats in the ATXN2 gene was most strongly associated with ALS. The meta-analysis revealed that the presence of an intermediate CAG repeat (30-33) in the ATXN2 gene was associated with an increased risk of ALS [odds ratio (OR) = 4.44, 95%CI: 2.91-6.76)] in Caucasian ALS patients. There was no significant difference in the association of this CAG intermediate repeat expansion in the ATXN2 gene between familial ALS cases (OR = 3.59, 1.58-8.17) and sporadic ALS cases (OR = 3.16, 1.88-5.32). These results indicate that the presence of intermediate CAG repeat expansion in the ATXN2 gene is a specific genetic risk factor for ALS, unlike monogenic mutations with an autosomal dominant transmission mode, which cause a more severe phenotype of ALS, with a higher prevalence in familial ALS.	[Wang, Ming-Dong; Gomes, James; Little, Julian; Krewski, Daniel] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Cashman, Neil R.] Univ British Columbia, Dept Med, Vancouver, BC, Canada	University of Ottawa; University of British Columbia	Wang, MD (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	myang015@uottawa.ca; jlittle@uottawa.ca; dkrewski@uottawa.ca	Little, Julian/AAR-6117-2020; Gomes, James/R-8363-2017	Little, Julian/0000-0001-5026-5531; Gomes, James/0000-0002-9818-5984	Public Health Agency of Canada under the National Population Health Study of Neurological Conditions in Canada	Public Health Agency of Canada under the National Population Health Study of Neurological Conditions in Canada	This work was supported by a contribution agreement with Public Health Agency of Canada to the University of Ottawa under the National Population Health Study of Neurological Conditions in Canada, for which D. Krewski served as Principal Investigator. D. Krewski holds the Natural Sciences and Engineering Research Council of Canada Chair in Risk Science at the University of Ottawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Ahmed A, 2011, NEUROL CLIN, V29, P689, DOI 10.1016/j.ncl.2011.06.001; Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; Alavi A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.07.016; ALS Online Genetics Database, 2014, ALS ONL GEN DAT WORL; Andersen PM, 1996, BRAIN, V119, P1153, DOI 10.1093/brain/119.4.1153; Baumer D, 2014, J ROY SOC MED, V107, P14, DOI 10.1177/0141076813511451; Beleza-Meireles A, 2009, AMYOTROPH LATERAL SC, V10, P1, DOI 10.1080/17482960802585469; Bonini NM, 2011, J MOL NEUROSCI, V45, P676, DOI 10.1007/s12031-011-9548-9; Braga-Neto P, 2011, ARQ NEURO-PSIQUIAT, V69, P405, DOI 10.1590/S0004-282X2011000300027; Chen XC, 2013, J GENET GENOMICS, V40, P543, DOI 10.1016/j.jgg.2013.08.003; Chen Y, 2011, NEUROBIOL AGING, V32, pe1, DOI DOI 10.1016/J.NEUR0BI0LAGING.2011.05.015; Choudhry S, 2001, HUM MOL GENET, V10, P2437, DOI 10.1093/hmg/10.21.2437; Conforti FL, 2012, NEUROLOGY, V79, P2315, DOI 10.1212/WNL.0b013e318278b618; Corrado L, 2011, HUM GENET, V130, P575, DOI 10.1007/s00439-011-1000-2; Costanzi-Porrini S, 2000, NEUROLOGY, V54, P491, DOI 10.1212/WNL.54.2.491; Cruts M, 2013, TRENDS NEUROSCI, V36, P450, DOI 10.1016/j.tins.2013.04.010; Daoud H, 2011, ARCH NEUROL-CHICAGO, V68, P739, DOI 10.1001/archneurol.2011.111; DeJesus-Hernandez M, 2013, PARKINSONISM RELAT D, V19, P198, DOI 10.1016/j.parkreldis.2012.09.013; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Drost J, 2013, J MOL NEUROSCI, V51, P68, DOI 10.1007/s12031-012-9949-4; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Farg MA, 2013, HUM MOL GENET, V22, P717, DOI 10.1093/hmg/dds479; Fernandez M, 2000, NEUROLOGY, V55, P569, DOI 10.1212/WNL.55.4.569; Garcia-Redondo A, 2013, HUM MUTAT, V34, P79, DOI 10.1002/humu.22211; Gellera C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.02.004; Geschwind DH, 1997, AM J HUM GENET, V60, P842; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Gispert S, 2012, NEUROBIOL DIS, V45, P356, DOI 10.1016/j.nbd.2011.08.021; Hart MP, 2012, ACTA NEUROPATHOL, V124, P221, DOI 10.1007/s00401-012-0985-5; Hart MP, 2012, J NEUROSCI, V32, P9133, DOI 10.1523/JNEUROSCI.0996-12.2012; Jiao B, 2014, NEUROBIOL AGING, V35; Johnson FO, 2009, NEUROTOXICOLOGY, V30, P761, DOI 10.1016/j.neuro.2009.07.010; JONES CT, 1993, LANCET, V342, P1050, DOI 10.1016/0140-6736(93)92905-9; Konno T, 2013, J NEUROL NEUROSUR PS, V84, P398, DOI 10.1136/jnnp-2012-302272; Laffita J, 2012, PARKINSONISM RELAT D, V18, pS187; Lahut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042956; Lambrechts D, 2009, J MED GENET, V46, P840, DOI 10.1136/jmg.2008.058222; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Lee T, 2011, NEUROLOGY, V76, P2062, DOI 10.1212/WNL.0b013e31821f4447; Lee T, 2011, HUM MOL GENET, V20, P1697, DOI 10.1093/hmg/ddr045; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lill CM, 2011, AMYOTROPH LATERAL SC, V12, P238, DOI 10.3109/17482968.2011.584629; Liu XD, 2013, J NEUROSURG-SPINE, V19, P2; Liu Y, 2014, MOL NEUROBIOL, V49, P386, DOI 10.1007/s12035-013-8528-1; Magana JJ, 2013, MOL NEUROBIOL, V47, P90, DOI 10.1007/s12035-012-8348-8; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Migliore L, 2009, MUTAT RES-FUND MOL M, V667, P82, DOI 10.1016/j.mrfmmm.2008.10.011; Laffita-Mesa JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070560; Laffita-Mesa JM, 2012, EUR J HUM GENET, V20, P41, DOI 10.1038/ejhg.2011.154; Mulligan VK, 2013, PROTEINS, V81, P1285, DOI 10.1002/prot.24285; Polymenidou M, 2012, BRAIN RES, V1462, P3, DOI 10.1016/j.brainres.2012.02.059; Qureshi AI, 1996, ARCH NEUROL-CHICAGO, V53, P987, DOI 10.1001/archneur.1996.00550100061015; Rademakers R, 2013, NAT REV NEUROL, V9, P63, DOI 10.1038/nrneurol.2012.276; Ramos EM, 2012, AMYOTROPH LATERAL SC, V13, P265, DOI 10.3109/17482968.2011.653573; Ramos EM, 2010, AM J MED GENET B, V153B, P524, DOI 10.1002/ajmg.b.31013; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Ross OA, 2011, HUM MOL GENET, V20, P3207, DOI 10.1093/hmg/ddr227; Smith BN, 2013, EUR J HUM GENET, V21, P102, DOI 10.1038/ejhg.2012.98; Soraru G, 2011, NEUROLOGY, V76, P2030, DOI 10.1212/WNL.0b013e31821e557a; Sutedja NA, 2007, ARCH NEUROL-CHICAGO, V64, P63, DOI 10.1001/archneur.64.1.63; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P302, DOI 10.3109/17482960802455416; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P295, DOI 10.3109/17482960802430799; Talman P, 2009, AMYOTROPH LATERAL SC, V10, P79, DOI 10.1080/17482960802195871; Tazen S, 2013, MOVEMENT DISORD, V28, pS241; Ticozzi N, 2011, ARCH ITAL BIOL, V149, P65, DOI 10.4449/aib.v149i1.1262; Tsai CP, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.05.002; Van Blitterswijk M, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.016; Van Damme P, 2011, NEUROLOGY, V76, P2066, DOI 10.1212/WNL.0b013e31821f445b; Van Langenhove T, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.025; van Rheenen W, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.07.020; Wills AM, 2009, NEUROLOGY, V73, P16, DOI 10.1212/WNL.0b013e3181a18674; Wingo TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027985; Yu ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017951; Zou ZY, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.11.018	81	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105534	10.1371/journal.pone.0105534	http://dx.doi.org/10.1371/journal.pone.0105534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148523	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600053
J	Jakobs, HH; Mikula, M; Havemeyer, A; Strzalkowska, A; Borowa-Chmielak, M; Dzwonek, A; Gajewska, M; Hennig, EE; Ostrowski, J; Clement, B				Jakobs, Heyka H.; Mikula, Michal; Havemeyer, Antje; Strzalkowska, Adriana; Borowa-Chmielak, Monika; Dzwonek, Artur; Gajewska, Marta; Hennig, Ewa E.; Ostrowski, Jerzy; Clement, Bernd			The N-Reductive System Composed of Mitochondrial Amidoxime Reducing Component (mARC), Cytochrome b5 (CYB5B) and Cytochrome b5 Reductase (CYB5R) Is Regulated by Fasting and High Fat Diet in Mice	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; PROTEIN; INVOLVEMENT; ENZYMES; B(5)	The mitochondrial amidoxime reducing component mARC is the fourth mammalian molybdenum enzyme. The protein is capable of reducing N-oxygenated structures, but requires cytochrome b5 and cytochrome b5 reductase for electron transfer to catalyze such reactions. It is well accepted that the enzyme is involved in N-reductive drug metabolism such as the activation of amidoxime prodrugs. However, the endogenous function of the protein is not fully understood. Among other functions, an involvement in lipogenesis is discussed. To study the potential involvement of the protein in energy metabolism, we tested whether the mARC protein and its partners are regulated due to fasting and high fat diet in mice. We used qRT-PCR for expression studies, Western Blot analysis to study protein levels and an N-reductive biotransformation assay to gain activity data. Indeed all proteins of the N-reductive system are regulated by fasting and its activity decreases. To study the potential impact of these changes on prodrug activation in vivo, another mice experiment was conducted. Model compound benzamidoxime was injected to mice that underwent fasting and the resulting metabolite of the N-reductive reaction, benzamidine, was determined. Albeit altered in vitro activity, no changes in the metabolite concentration in vivo were detectable and we can dispel concerns that fasting alters prodrug activation in animal models. With respect to high fat diet, changes in the mARC proteins occur that result in increased N-reductive activity. With this study we provide further evidence that the endogenous function of the mARC protein is linked with lipid metabolism.	[Jakobs, Heyka H.; Havemeyer, Antje; Clement, Bernd] Univ Kiel, Dept Pharmaceut & Med Chem, Kiel, Germany; [Mikula, Michal; Strzalkowska, Adriana; Borowa-Chmielak, Monika; Dzwonek, Artur; Gajewska, Marta; Hennig, Ewa E.; Ostrowski, Jerzy] Maria Sklodowska Curie Mem Canc Ctr, Dept Genet, Warsaw, Poland; [Mikula, Michal; Strzalkowska, Adriana; Borowa-Chmielak, Monika; Dzwonek, Artur; Gajewska, Marta; Hennig, Ewa E.; Ostrowski, Jerzy] Inst Oncol, Warsaw, Poland; [Hennig, Ewa E.; Ostrowski, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland	University of Kiel; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland	Clement, B (corresponding author), Univ Kiel, Dept Pharmaceut & Med Chem, Kiel, Germany.	bclement@pharmazie.uni-kiel.de	Hennig, Ewa E/N-6459-2013; Mikula, Michal/G-8276-2011	Hennig, Ewa E/0000-0002-6388-2237; Mikula, Michal/0000-0003-3447-7328; Ostrowski, Jerzy/0000-0003-1363-3766	Polish Ministry of Science and Higher Education [N N401 017436, N N401 532240]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by N N401 017436 and N N401 532240 grants from Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslibekyan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048663; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Froriep D, 2013, XENOBIOTICA, V43, P780, DOI 10.3109/00498254.2013.767481; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2010, DRUG METAB DISPOS, V38, P1917, DOI 10.1124/dmd.110.032813; Hennig EE, 2014, J CELL MOL MED, V18, P1762, DOI 10.1111/jcmm.12328; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Klein JM, 2012, J BIOL CHEM, V287, P42795, DOI 10.1074/jbc.M112.419424; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; Krompholz N, 2012, CHEM RES TOXICOL, V25, P2443, DOI 10.1021/tx300298m; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malhotra P, 2013, AM J PHYSIOL-GASTR L, V304, pG203, DOI 10.1152/ajpgi.00288.2012; Malik AN, 2007, BIOCHEM BIOPH RES CO, V357, P237, DOI 10.1016/j.bbrc.2007.03.132; Mikula M, 2011, FUNCT INTEGR GENOMIC, V11, P215, DOI 10.1007/s10142-010-0200-5; Nesteruk M, 2014, FUNCT INTEGR GENOMIC, V14, P245, DOI 10.1007/s10142-013-0342-3; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Newton BW, 2011, J PROTEOME RES, V10, P4692, DOI 10.1021/pr200491h; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Paton CM, 2009, ENDOCR REV, V31, P364; Plitzko B, 2013, J BIOL CHEM, V288, P20228, DOI 10.1074/jbc.M113.474916; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; Sparacino-Watkins CE, 2014, J BIOL CHEM, V289, P10345, DOI 10.1074/jbc.M114.555177; Stark AM, 2006, NEUROL RES, V28, P787, DOI 10.1179/016164106X110364; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	29	15	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105371	10.1371/journal.pone.0105371	http://dx.doi.org/10.1371/journal.pone.0105371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144769	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100060
J	Kuksis, M; Smith, PM; Ferguson, AV				Kuksis, Markus; Smith, Pauline M.; Ferguson, Alastair V.			Hydrogen Sulfide Regulates Cardiovascular Function by Influencing the Excitability of Subfornical Organ Neurons	PLOS ONE			English	Article							HYPERTENSION; H2S; INHIBITION; MECHANISM; CHANNELS; CYSTEINE; RELEASE; BRAIN; ACTS; TONE	Hydrogen sulfide (H2S), a gasotransmitter endogenously found in the central nervous system, has recently been suggested to act as a signalling molecule in the brain having beneficial effects on cardiovascular function. This study was thus undertaken to investigate the effect of NaHS (an H2S donor) in the subfornical organ (SFO), a central nervous system site important to blood pressure regulation. We used male Sprague-Dawley rats for both in vivo and in vitro experiments. We first used RT-PCR to confirm our previous microarray analyses showing that mRNAs for the enzymes required to produce H2S are expressed in the SFO. We then used microinjection techniques to investigate the physiological effects of NaHS in SFO, and found that NaHS microinjection (5 nmol) significantly increased blood pressure (mean AUC = 853.5 +/- 105.7 mmHg*s, n = 5). Further, we used patch-clamp electrophysiology and found that 97.8% (88 of 90) of neurons depolarized in response to NaHS. This response was found to be concentration dependent with an EC50 of 35.6 mu M. Coupled with the depolarized membrane potential, we observed an overall increase in neuronal excitability using an analysis of rheobase and action potential firing patterns. This study has provided the first evidence of NaHS and thus H2S actions and their cellular correlates in SFO, implicating this brain area as a site where H2S may act to control blood pressure.	[Kuksis, Markus; Smith, Pauline M.; Ferguson, Alastair V.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Ferguson, AV (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	avf@queensu.ca			Canadian Institutes for Health Research [12192]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research, Grant 12192 (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Ahmad FUD, 2012, RENAL FAILURE, V34, P203, DOI 10.3109/0886022X.2011.643365; Andersson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046917; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Bianca RDD, 2011, J PHARMACOL EXP THER, V337, P59, DOI 10.1124/jpet.110.176016; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Dai L, 2013, J PHYSIOL-LONDON, V591, P3421, DOI 10.1113/jphysiol.2013.254144; DeLeon ER, 2012, ANAL BIOCHEM, V421, P203, DOI 10.1016/j.ab.2011.10.016; Dombkowski RA, 2004, AM J PHYSIOL-REG I, V286, pR678, DOI 10.1152/ajpregu.00419.2003; Feng XM, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-4; Ferguson AV, 1997, NEUROENDOCRINOLOGY, V66, P409, DOI 10.1159/000127266; Fry M, 2007, PHYSIOL BEHAV, V91, P413, DOI 10.1016/j.physbeh.2007.04.003; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gan XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050102; Guo Q, 2011, J PHARMACOL EXP THER, V338, P458, DOI 10.1124/jpet.111.180711; Hendel MD, 2005, AM J PHYSIOL-HEART C, V288, pH680, DOI 10.1152/ajpheart.00823.2004; Hindmarch C, 2008, AM J PHYSIOL-REG I, V295, pR1914, DOI 10.1152/ajpregu.90560.2008; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; ISHIBASHI S, 1981, BRAIN RES BULL, V6, P135, DOI 10.1016/S0361-9230(81)80038-X; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Khademullah CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064495; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; KUO SM, 1983, BIOL NEONATE, V43, P23; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li Q, 2010, ANTIOXID REDOX SIGN, V12, P1179, DOI 10.1089/ars.2009.2926; Lob HE, 2013, HYPERTENSION, V61, P382, DOI 10.1161/HYPERTENSIONAHA.111.00546; Luo JL, 2011, J PAIN, V12, P600, DOI 10.1016/j.jpain.2010.11.005; MANGIAPANE ML, 1980, NEUROENDOCRINOLOGY, V31, P380, DOI 10.1159/000123107; Mani S, 2014, NITRIC OXIDE-BIOL CH, V41, P62, DOI 10.1016/j.niox.2014.02.006; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Paxinos G., 2004, J CHEM INF MODEL, V5th; Ren YS, 2011, CHINESE MED J-PEKING, V124, P3468, DOI 10.3760/cma.j.issn.0366-6999.2011.21.006; SAAVEDRA JM, 1986, CIRC RES, V58, P389, DOI 10.1161/01.RES.58.3.389; Sekiguchi F, 2014, BIOCHEM BIOPH RES CO, V445, P225, DOI 10.1016/j.bbrc.2014.01.185; Smith PM, 2007, J NEUROENDOCRINOL, V19, P7, DOI 10.1111/j.1365-2826.2006.01497.x; Smith PM, 2012, J NEUROENDOCRINOL, V24, P504, DOI 10.1111/j.1365-2826.2011.02257.x; Smith PM, 1997, NEUROENDOCRINOLOGY, V66, P130, DOI 10.1159/000127230; Streeter E, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00055; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Washburn DLS, 1999, NEUROSCIENCE, V93, P349, DOI 10.1016/S0306-4522(99)00125-6; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4	50	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105772	10.1371/journal.pone.0105772	http://dx.doi.org/10.1371/journal.pone.0105772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144759	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100120
J	Moroco, JA; Craigo, JK; Iacob, RE; Wales, TE; Engen, JR; Smithgall, TE				Moroco, Jamie A.; Craigo, Jodi K.; Iacob, Roxana E.; Wales, Thomas E.; Engen, John R.; Smithgall, Thomas E.			Differential Sensitivity of Src-Family Kinases to Activation by SH3 Domain Displacement	PLOS ONE			English	Article							HCK TYROSINE KINASE; FC-GAMMA-RI; C-SRC; CRYSTAL-STRUCTURE; ABL KINASE; PP60(C-SRC); AFFINITY; PROTEIN; PHOSPHORYLATION; IDENTIFICATION	Src-family kinases (SFKs) are non-receptor protein-tyrosine kinases involved in a variety of signaling pathways in virtually every cell type. The SFKs share a common negative regulatory mechanism that involves intramolecular interactions of the SH3 domain with the PPII helix formed by the SH2-kinase linker as well as the SH2 domain with a conserved phosphotyrosine residue in the C-terminal tail. Growing evidence suggests that individual SFKs may exhibit distinct activation mechanisms dictated by the relative strengths of these intramolecular interactions. To elucidate the role of the SH3:linker interaction in the regulation of individual SFKs, we used a synthetic SH3 domain-binding peptide (VSL12) to probe the sensitivity of downregulated c-Src, Hck, Lyn and Fyn to SH3-based activation in a kinetic kinase assay. All four SFKs responded to VSL12 binding with enhanced kinase activity, demonstrating a conserved role for SH3:linker interaction in the control of catalytic function. However, the sensitivity and extent of SH3-based activation varied over a wide range. In addition, autophosphorylation of the activation loops of c-Src and Hck did not override regulatory control by SH3: linker displacement, demonstrating that these modes of activation are independent. Our results show that despite the similarity of their downregulated conformations, individual Src-family members show diverse responses to activation by domain displacement which may reflect their adaptation to specific signaling environments in vivo.	[Moroco, Jamie A.; Craigo, Jodi K.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Craigo, Jodi K.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA USA; [Iacob, Roxana E.; Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northeastern University	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	tsmithga@pitt.edu		Engen, John R./0000-0002-6918-9476; Wales, Thomas E./0000-0001-6133-5689; Moroco, Jamie/0000-0001-8250-5923	National Institutes of Health [AI057083, AI102724]; Pittsburgh AIDS Research Training Program [T32 AI065380]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057083, R01AI102724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh AIDS Research Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants AI057083 and AI102724 (to TES) and the Pittsburgh AIDS Research Training Program (T32 AI065380 to JAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bhattacharjee A, 2011, J BIOL CHEM, V286, P36709, DOI 10.1074/jbc.M111.291492; Boerner RJ, 1995, BIOCHEMISTRY-US, V34, P16419, DOI 10.1021/bi00050a024; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Briggs SD, 2000, BIOCHEMISTRY-US, V39, P489, DOI 10.1021/bi992504j; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Charter NW, 2006, J BIOMOL SCREEN, V11, P390, DOI 10.1177/1087057106286829; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; DURDEN DL, 1995, J IMMUNOL, V154, P4039; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Kedzierska K, 2001, J LEUKOCYTE BIOL, V70, P322; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; LAM KS, 1995, INT J PEPT PROT RES, V45, P587; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Meyn MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000311; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Sancier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017237; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; WANG AVT, 1994, J EXP MED, V180, P1165, DOI 10.1084/jem.180.3.1165; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang X, 2014, ACS CHEM BIOL, V9, P139, DOI 10.1021/cb400249b	44	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105629	10.1371/journal.pone.0105629	http://dx.doi.org/10.1371/journal.pone.0105629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144189	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000341106100101
J	Malinska, H; Kahleova, H; Topolcan, O; Vrzalova, J; Oliyarnyk, O; Kazdova, L; Belinova, L; Hill, M; Pelikanova, T				Malinska, Hana; Kahleova, Hana; Topolcan, Ondrej; Vrzalova, Jindra; Oliyarnyk, Olena; Kazdova, Ludmila; Belinova, Lenka; Hill, Martin; Pelikanova, Terezie			Postprandial Oxidative Stress and Gastrointestinal Hormones: Is There a Link?	PLOS ONE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; TYPE-2 DIABETES-MELLITUS; INDUCED WEIGHT-LOSS; BETA-CELL FUNCTION; PANCREATIC-POLYPEPTIDE; GLUCOSE-TOLERANCE; INSULIN-SECRETION; BLOOD-GLUCOSE; GIP; GHRELIN	Background: Abnormal postprandial elevation of plasma glucose and lipids plays an important role in the pathogenesis of diabetes and strongly predicts cardiovascular mortality. In patients suffering from type 2 diabetes (T2D) postprandial state is associated with oxidative stress, cardiovascular risk and, probably, with impairment of both secretion and the effect of gastrointestinal peptides. Evaluating postprandial changes of gastrointestinal hormones together with changes in oxidative stress markers may help to understand the mechanisms behind the postprandial state in diabetes as well as suggest new preventive and therapeutical strategies. Methods: A standard meal test has been used for monitoring the postprandial concentrations of gastrointestinal hormones and oxidative stress markers in patients with T2D (n = 50) compared to healthy controls (n = 50). Blood samples were drawn 0, 30, 60, 120 and 180 minutes after the standard meal. Results: Both basal and postprandial plasma concentrations of glucose and insulin proved to be significantly higher in patients with T2D, whereas plasma concentrations of ghrelin showed significantly lower values during the whole meal test. In comparison with healthy controls, both basal and postprandial concentrations of almost all other gastrointestinal hormones and lipoperoxidation were significantly increased while ascorbic acid, reduced glutathione and superoxide dismutase activity were decreased in patients with T2D. A positive relationship was found between changes in GIP and those of glucose and immunoreactive insulin in diabetic patients (p<0.001 and p<0.001, respectively) and between changes in PYY and those of glucose (p<0.01). There was a positive correlation between changes in GIP and PYY and changes in ascorbic acid in patients with T2D (p<0.05 and p<0.001, respectively). Conclusion/Interpretation: Apart from a positive relationship of postprandial changes in GIP and PYY with changes in ascorbic acid, there was no direct link observed between gastrointestinal hormones and oxidative stress markers in diabetic patients.	[Malinska, Hana; Kahleova, Hana; Oliyarnyk, Olena; Kazdova, Ludmila; Belinova, Lenka; Pelikanova, Terezie] Inst Clin & Expt Med, Prague, Czech Republic; [Topolcan, Ondrej; Vrzalova, Jindra] Fac Hosp Pilsen, Plzen, Czech Republic; [Hill, Martin] Inst Endocrinol, Prague, Czech Republic; [Belinova, Lenka] Charles Univ Prague, Fac Med 1, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Institute of Endocrinology - Prague; Charles University Prague	Kahleova, H (corresponding author), Inst Clin & Expt Med, Prague, Czech Republic.	hana.kahleova@gmail.com; terezie.pelikanova@ikem.cz	Hill, Martin/G-7699-2019; Topolcan, Ondrej/K-7753-2017	Topolcan, Ondrej/0000-0001-6622-390X; Kahleova, Hana/0000-0003-0491-3993; Oliyarnyk, Olena/0000-0002-4912-6187; Hill, Martin/0000-0002-1705-0835; Windrichova, Jindra/0000-0003-0365-0968	Ministry of Health, Czech Republic, conceptual development of research organisation ("Institute for Clinical and Experimental Medicine - IKEM") [IN 00023001]; Internal Grant Agency of the Ministry of Health of the Czech Republic [NT/11238-4]; Grant Agency of Charles University - GAUK [702312]	Ministry of Health, Czech Republic, conceptual development of research organisation ("Institute for Clinical and Experimental Medicine - IKEM"); Internal Grant Agency of the Ministry of Health of the Czech Republic; Grant Agency of Charles University - GAUK	This work was supported by Ministry of Health, Czech Republic, conceptual development of research organisation ("Institute for Clinical and Experimental Medicine - IKEM, IN 00023001''), by the Internal Grant Agency of the Ministry of Health of the Czech Republic (NT/11238-4) and by the Grant Agency of Charles University - GAUK No 702312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alssema M, 2013, EUR J ENDOCRINOL, V169, P421, DOI 10.1530/EJE-13-0487; Anderson RA, 2006, DIABETIC MED, V23, P258, DOI 10.1111/j.1464-5491.2005.01767.x; Ashby D, 2007, PEPTIDES, V28, P198, DOI 10.1016/j.peptides.2006.10.019; Barazzoni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026224; Beisswenger PJ, 2001, DIABETES CARE, V24, P726, DOI 10.2337/diacare.24.4.726; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Ceriello A, 1998, DIABETES CARE, V21, P1529, DOI 10.2337/diacare.21.9.1529; Ceriello A, 2012, VASC PHARMACOL, V57, P133, DOI 10.1016/j.vph.2012.05.005; Ceriello A, 2011, DIABETES CARE, V34, P697, DOI 10.2337/dc10-1949; De Vriese C, 2010, NUTRITION, V26, P579, DOI 10.1016/j.nut.2009.09.013; Drucker DJ, 2010, DIABETES CARE, V33, P428, DOI 10.2337/dc09-1499; English PJ, 2007, DIABETES-METAB RES, V23, P299, DOI 10.1002/dmrr.681; Feinle-Bisset C, 2005, AM J PHYSIOL-ENDOC M, V289, pE948, DOI 10.1152/ajpendo.00220.2005; Flatt PR, 2008, DIABETIC MED, V25, P759, DOI 10.1111/j.1464-5491.2008.02455.x; Flatt Peter R, 2007, Diab Vasc Dis Res, V4, P151; Gault VA, 2005, DIABETES, V54, P2436, DOI 10.2337/diabetes.54.8.2436; Hamed EA, 2011, DIABETES RES CLIN PR, V94, P434, DOI 10.1016/j.diabres.2011.08.023; Holst JJ, 2011, DIABETES CARE, V34, pS251, DOI 10.2337/dc11-s227; Hou XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024815; Irwin N, 2009, DIABETOLOGIA, V52, P1724, DOI 10.1007/s00125-009-1422-8; Kahleova H, 2012, J DIABETES COMPLICAT, V26, P442, DOI 10.1016/j.jdiacomp.2012.05.003; Knop FK, 2007, REGUL PEPTIDES, V144, P123, DOI 10.1016/j.regpep.2007.07.002; Lutz TA, 2013, DIABETES OBES METAB, V15, P99, DOI 10.1111/j.1463-1326.2012.01670.x; Mather KJ, 2002, DIABETES-METAB RES, V18, P118, DOI 10.1002/dmrr.263; Meier JJ, 2005, DIABETOLOGIA, V48, P1872, DOI 10.1007/s00125-005-1863-7; Meier Juris J, 2006, Curr Diab Rep, V6, P194, DOI 10.1007/s11892-006-0034-7; Nakagawa K, 1997, ANAL BIOCHEM, V254, P31, DOI 10.1006/abio.1997.2372; PADH H, 1985, CELL BIOL INT REP, V9, P531, DOI 10.1016/0309-1651(85)90017-7; Ranganath LR, 2008, CLIN CHEM LAB MED, V46, P43, DOI 10.1515/CCLM.2008.008; Rigamonti AE, 2011, HORM METAB RES, V43, P569, DOI 10.1055/s-0031-1280783; Runchey SS, 2013, METABOLISM, V62, P188, DOI 10.1016/j.metabol.2012.07.006; Sampson MJ, 2002, DIABETES CARE, V25, P537, DOI 10.2337/diacare.25.3.537; Skrha J, 2010, PHYSIOL RES, V59, P749, DOI 10.33549/physiolres.931893; Small CJ, 2004, CNS NEUROL DISORD-DR, V3, P379, DOI 10.2174/1568007043336950; Solomon TPJ, 2010, DIABETES CARE, V33, P1561, DOI 10.2337/dc09-2021; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; Vilsboll T, 2004, DIABETOLOGIA, V47, P357, DOI 10.1007/s00125-004-1342-6; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; YOKODE M, 1988, J CLIN INVEST, V81, P720, DOI 10.1172/JCI113377	41	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e103565	10.1371/journal.pone.0103565	http://dx.doi.org/10.1371/journal.pone.0103565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141237	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200008
J	Zhu, X; Zhang, JF; Fan, WG; Gong, YG; Yan, JH; Yuan, ZD; Wu, L; Cui, HJ; Luo, HQ; Kong, QM; Tang, L; Leng, SL; Liao, YF; Fu, WM; Xiao, Q; Li, DP				Zhu, Xiao; Zhang, Jinfang; Fan, Wenguo; Gong, Yunguo; Yan, Jianhua; Yuan, Zhidong; Wu, Lang; Cui, Hongjing; Luo, Haiqing; Kong, Qingming; Tang, Li; Leng, Shuilong; Liao, Yufeng; Fu, Weiming; Xiao, Qin; Li, Dongpei			MAPKAP1 rs10118570 Polymorphism Is Associated with Anti-Infection and Anti-Hepatic Fibrogenesis in Schistosomiasis Japonica	PLOS ONE			English	Article							CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; CHROMOSOMAL INSTABILITY; 3' UTR; GRP78; CHINA; INFECTION; RISK; SUSCEPTIBILITY; INFLAMMATION	Chronic infection with Schistosoma japonicum is an important cause of hepatic fibrosis (HF). Human 9q33.3 is one of the most important loci for stress-related diseases. We examined the potential associations of 43 single-nucleotide polymorphisms (SNPs) with S. japonicum infection and HF in epidemic region in China. We identified a SNP (rs10118570 GG in mitogen-activated protein kinase associated protein 1, MAPKAP1) contributes to anti-infection (adjusted OR = 0.35) and anti-fibrogenesis (adjusted RR = 0.44) in the discovery study. Replicative and combined studies showed consistent protective quality for this genotype (replicative: adjusted OR = 0.37 for anti-infection, and adjusted RR = 0.40 for anti-fibrogenesis; Combined: adjusted OR = 0.45 for anti-infection, and adjusted RR = 0.42 for anti-fibrogenesis). Univariate and multivariate analysis in the discovery, replicative and combined studies, suggested that durations (years), splenomegaly, serum ALB and rs10118570 were independent predictors influencing the fibrogenesis. The analysis of gene-gene interaction showed rs10118570 functions independently. We conclude that MAPKAP1 may represent a novel anti-infection and anti-fibrogenesis genomic locus in chronic schistosomiasis japonica. And rs10118570 may be a potential biomarker and target for the treatment of this life-threatening ancient disease.	[Zhu, Xiao; Cui, Hongjing; Luo, Haiqing; Li, Dongpei] Guangdong Med Coll, Dept Clin Oncol, Guangdong Prov Key Lab Med Mol Diag, Zhanjiang Dongguan, Peoples R China; [Zhu, Xiao; Xiao, Qin] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ, Hong Kong Univ Sci & Technol,Med Ctr, Shenzhen, Peoples R China; [Zhang, Jinfang; Fu, Weiming] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Fan, Wenguo] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Gong, Yunguo] Univ Texas Houston, Sch Biomed Informat, Houston, TX USA; [Yan, Jianhua] A STAR NUS, Clin Imaging Res Ctr, Singapore, Singapore; [Yuan, Zhidong] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Peoples R China; [Wu, Lang] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN USA; [Kong, Qingming] Zhejiang Acad Med Sci, Immun & Biochem Res Lab, Hangzhou, Zhejiang, Peoples R China; [Tang, Li] Hubei Acad Prevent Med, Hubei Prov Ctr Dis Control & Prevent, Schistosomiasis Inst, Wuhan, Peoples R China; [Leng, Shuilong] Guangzhou Med Univ, Dept Human Anat, Guangzhou, Guangdong, Peoples R China; [Liao, Yufeng] Ningbo 2 Hosp, Dept Lab Med, Ningbo, Zhejiang, Peoples R China; [Fu, Weiming] Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China; [Li, Dongpei] Georgia Regents Univ, Dept Neurosci & Regenerat Med, Inst Mol Med & Genet, Augusta, GA USA	Guangdong Medical University; Hong Kong University of Science & Technology; Peking University; Chinese University of Hong Kong; Prince of Wales Hospital; Sun Yat Sen University; University of Texas System; University of Texas Health Science Center Houston; Hunan University of Science & Technology; Mayo Clinic; Zhejiang Academy of Medical Sciences; Guangzhou Medical University; Chinese Academy of Sciences; University System of Georgia; Augusta University	Zhu, X (corresponding author), Guangdong Med Coll, Dept Clin Oncol, Guangdong Prov Key Lab Med Mol Diag, Zhanjiang Dongguan, Peoples R China.	bioxzhu@yahoo.com; qin_xiao_sz@163.com; dliimmag@gmail.com	Wu, Lang/M-4053-2017		National Natural Science Foundation of China [81071697, 31100914, 30700436, 81271166, 81201831]; Natural Science Foundation of Guangdong Province [S2011040003694]; Research Project of Science and Information Technology of Guangzhou City Grant [2012J4100075, 12C22061657]; Research Project of Initial for Talent Research in Guangdong Medical College [XB1382, GZ1131-B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Research Project of Science and Information Technology of Guangzhou City Grant; Research Project of Initial for Talent Research in Guangdong Medical College	This work was supported by National Natural Science Foundation of China Grants 81071697, 31100914, 30700436, 81271166 and 81201831; Natural Science Foundation of Guangdong Province Grant S2011040003694; Research Project of Science and Information Technology of Guangzhou City Grant 2012J4100075, 12C22061657; Research Project of Initial for Talent Research in Guangdong Medical College XB1382, GZ1131-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ouf E, 2012, J INFECT DIS, V206, P562, DOI 10.1093/infdis/jis396; Antony JS, 2013, J INFECT DIS, V207, P1675, DOI 10.1093/infdis/jit081; BEWTRA M, 2009, GASTROENTEROLOGY, V136, P731; Bewtra Meenakshi, 2009, Gastroenterology, V136, P731, DOI 10.1053/j.gastro.2008.05.043; BORDA C E, 1971, Revista do Instituto de Medicina Tropical de Sao Paulo, V13, P71; Camacho-Lobato L, 1998, J HEPATOL, V29, P233, DOI 10.1016/S0168-8278(98)80008-1; Carneiro-Santos P, 2002, PARASITE IMMUNOL, V24, P493, DOI 10.1046/j.1365-3024.2002.00487.x; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; Coutinho HM, 2005, J INFECT DIS, V192, P528, DOI 10.1086/430929; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Ellis MK, 2009, PARASITOLOGY, V136, P699, DOI 10.1017/S003118200900612X; Fairfax KC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002490; FAUST EC, 1946, ANN INTERN MED, V25, P585, DOI 10.7326/0003-4819-25-4-585; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jenkins J., 1996, 2 INT WORKSH NIAM NI; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Knopp S, 2013, EXPERT REV ANTI INFE; Latif B, 2013, EMERG INFECT DIS, V19, P1340, DOI 10.3201/eid1908.121710; LI YS, 1991, T ROY SOC TROP MED H, V85, P623, DOI 10.1016/0035-9203(91)90370-E; Lu DB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001960; Lubeya M, 2010, LANCET, V376, P1645, DOI 10.1016/S0140-6736(10)62095-8; Makino C, 2006, GENES CELLS, V11, P1239, DOI 10.1111/j.1365-2443.2006.01016.x; Nair SS, 2011, HEPATOLOGY, V54, P285, DOI 10.1002/hep.24354; Poynard T, 2013, J HEPATOL, V58, P928, DOI 10.1016/j.jhep.2012.12.021; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Riley S, 2008, PLOS MED, V5, P70, DOI 10.1371/journal.pmed.0050018; ROSIN MP, 1994, CANCER RES, V54, pS1929; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Winder T, 2011, ANN ONCOL, V22, P2431, DOI 10.1093/annonc/mdq771; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Xiao Hui, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P288; Xiao Q, 2014, J THORAC ONCOL, V9, P1041, DOI 10.1097/JTO.0000000000000195; Yoshida T, 2010, INT J MOL MED, V25, P649, DOI 10.3892/ijmm_00000388; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhu X, 2013, CARCINOGENESIS, V34, P1273, DOI 10.1093/carcin/bgt061; Zhu X, 2012, CHEST, V142, P1691, DOI 10.1378/chest.12-1513; Zhu X, 2012, CHEST, V141, P1466, DOI 10.1378/chest.11-0469; Zhu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021997; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zhu X, 2010, HEPATO-GASTROENTEROL, V57, P1191; Zhu X, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-83; Zhu X, 2009, WORLD J GASTROENTERO, V15, P4958, DOI 10.3748/wjg.15.4958; Zhu X, 2009, INT J CANCER, V125, P1352, DOI 10.1002/ijc.24487	46	11	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105995	10.1371/journal.pone.0105995	http://dx.doi.org/10.1371/journal.pone.0105995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153992	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200102
J	Antunes, G; Sebastiao, AM; de Souza, FMS				Antunes, Gabriela; Sebastiao, Ana Maria; Simoes de Souza, Fabio Marques			Mechanisms of Regulation of Olfactory Transduction and Adaptation in the Olfactory Cilium	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; PROTEIN-COUPLED RECEPTORS; ACTIVATED CHLORIDE CHANNEL; LIGHT-CHAIN KINASE; C-TERMINAL DOMAIN; EF-HAND PROTEINS; SENSORY NEURONS; CA2+ BINDING; RESPONSE TERMINATION; CALCIUM-BINDING	Olfactory adaptation is a fundamental process for the functioning of the olfactory system, but the underlying mechanisms regulating its occurrence in intact olfactory sensory neurons (OSNs) are not fully understood. In this work, we have combined stochastic computational modeling and a systematic pharmacological study of different signaling pathways to investigate their impact during short-term adaptation (STA). We used odorant stimulation and electroolfactogram (EOG) recordings of the olfactory epithelium treated with pharmacological blockers to study the molecular mechanisms regulating the occurrence of adaptation in OSNs. EOG responses to paired-pulses of odorants showed that inhibition of phosphodiesterases (PDEs) and phosphatases enhanced the levels of STA in the olfactory epithelium, and this effect was mimicked by blocking vesicle exocytosis and reduced by blocking cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) and vesicle endocytosis. These results suggest that G-coupled receptors (GPCRs) cycling is involved with the occurrence of STA. To gain insights on the dynamical aspects of this process, we developed a stochastic computational model. The model consists of the olfactory transduction currents mediated by the cyclic nucleotide gated (CNG) channels and calcium ion (Ca2+)-activated chloride (CAC) channels, and the dynamics of their respective ligands, cAMP and Ca2+, and it simulates the EOG results obtained under different experimental conditions through changes in the amplitude and duration of cAMP and Ca2+ response, two second messengers implicated with STA occurrence. The model reproduced the experimental data for each pharmacological treatment and provided a mechanistic explanation for the action of GPCR cycling in the levels of second messengers modulating the levels of STA. All together, these experimental and theoretical results indicate the existence of a mechanism of regulation of STA by signaling pathways that control GPCR cycling and tune the levels of second messengers in OSNs, and not only by CNG channel desensitization as previously thought.	[Sebastiao, Ana Maria] Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, P-1699 Lisbon, Portugal; [Antunes, Gabriela; Sebastiao, Ana Maria; Simoes de Souza, Fabio Marques] Univ Lisbon, Inst Mol Med, Neurosci Unit, P-1699 Lisbon, Portugal; [Simoes de Souza, Fabio Marques] Fed Univ ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo, Brazil; [Antunes, Gabriela] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Psychol, Lab Neural Syst,Psychobiol Sect, Ribeirao Preto, Brazil	Universidade de Lisboa; Universidade de Lisboa; Universidade de Sao Paulo	de Souza, FMS (corresponding author), Univ Lisbon, Inst Mol Med, Neurosci Unit, P-1699 Lisbon, Portugal.	fabio.souza@ufabc.edu.br	de Souza, Fabio Simoes/B-8773-2015	de Souza, Fabio Simoes/0000-0001-8329-0311; Sebastiao, Ana M/0000-0001-9030-6115	European Union [PCOFUND-GA-2009-246542]; Foundation for Science and Technology of Portugal; Foundation for Science and Technology of Portugal [SFRH/BI/52112/2013]	European Union(European Commission); Foundation for Science and Technology of Portugal(Portuguese Foundation for Science and Technology); Foundation for Science and Technology of Portugal(Portuguese Foundation for Science and Technology)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. PCOFUND-GA-2009-246542 and from the Foundation for Science and Technology of Portugal. GA has received the fellowship SFRH/BI/52112/2013 of the Foundation for Science and Technology of Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEK GD, 1984, BRAIN RES, V310, P87, DOI 10.1016/0006-8993(84)90012-X; Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Antolin S, 2010, J GEN PHYSIOL, V135, P367, DOI 10.1085/jgp.200910337; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; Ben-Chaim Y, 2011, P NATL ACAD SCI USA, V108, P822, DOI 10.1073/pnas.1017983108; Benmerah A, 2013, CURR OPIN CELL BIOL, V25, P78, DOI 10.1016/j.ceb.2012.10.011; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bhandawat V, 2005, SCIENCE, V308, P1931, DOI 10.1126/science.1109886; Bhandawat V, 2010, P NATL ACAD SCI USA, V107, P18682, DOI 10.1073/pnas.1004571107; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Biekofsky RR, 2004, BIOCHEMISTRY-US, V43, P6554, DOI 10.1021/bi0497852; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Biel M, 2009, J BIOL CHEM, V284, P9017, DOI 10.1074/jbc.R800075200; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596; Bloodgood RA, 2012, MOL BIOL CELL, V23, P2407, DOI 10.1091/mbc.E12-01-0073; Boccaccio A, 2006, J GEN PHYSIOL, V128, P171, DOI 10.1085/jgp.200609555; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P11983, DOI 10.1073/pnas.89.24.11983; Boekhoff I, 1997, J BIOL CHEM, V272, P4606, DOI 10.1074/jbc.272.7.4606; BORISY FF, 1992, J NEUROSCI, V12, P915; Boschek CB, 2007, BIOCHEMISTRY-US, V46, P4580, DOI 10.1021/bi6025402; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; Castillo K, 2007, EUR J NEUROSCI, V26, P2524, DOI 10.1111/j.1460-9568.2007.05863.x; Castillo K, 2010, EUR J NEUROSCI, V32, P932, DOI 10.1111/j.1460-9568.2010.07393.x; Cenedese V, 2012, J GEN PHYSIOL, V139, P285, DOI 10.1085/jgp.201110764; Chen TC, 1998, LAB INVEST, V78, P165; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Cygnar K. D., 2010, J VIS EXP; Cygnar KD, 2012, J NEUROSCI, V32, P14557, DOI 10.1523/JNEUROSCI.0559-12.2012; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; DAVIDSON HW, 1992, J CELL BIOL, V116, P1343, DOI 10.1083/jcb.116.6.1343; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; De Palo G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01251; De Palo G, 2012, BIOPHYS J, V102, P2677, DOI 10.1016/j.bpj.2012.04.040; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dolzer J, 2008, CHEM SENSES, V33, P803, DOI 10.1093/chemse/bjn043; Dougherty DP, 2005, P NATL ACAD SCI USA, V102, P10415, DOI 10.1073/pnas.0504099102; Evenas J, 1998, BIOCHEMISTRY-US, V37, P13744, DOI 10.1021/bi9806448; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; Evenas J, 1997, BIOCHEMISTRY-US, V36, P3448, DOI 10.1021/bi9628275; Evenas J, 1999, J MOL BIOL, V289, P603, DOI 10.1006/jmbi.1999.2770; French DA, 2006, MATH COMPUT MODEL, V43, P945, DOI 10.1016/j.mcm.2005.11.010; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Ghossoub R, 2011, BIOL CELL, V103, P131, DOI 10.1042/BC20100128; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Griff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037148; HAIECH J, 1981, BIOCHEMISTRY-US, V20, P3890, DOI 10.1021/bi00516a035; Halnes G, 2009, J COMPUT NEUROSCI, V27, P471, DOI 10.1007/s10827-009-0162-6; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Katanosaka K, 2002, J BIOCHEM, V132, P301, DOI 10.1093/oxfordjournals.jbchem.a003224; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kent E, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-91; Kerr RA, 2008, SIAM J SCI COMPUT, V30, P3126, DOI 10.1137/070692017; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kleene SJ, 1997, BIOPHYS J, V73, P1110, DOI 10.1016/S0006-3495(97)78143-8; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Kleene SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005266; Klimmeck D, 2008, NEUROSCIENCE, V151, P901, DOI 10.1016/j.neuroscience.2007.11.023; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Kroner C, 1996, BBA-MOL CELL RES, V1312, P169, DOI 10.1016/0167-4889(96)00030-4; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Lagostena L, 2003, CHEM SENSES, V28, P705, DOI 10.1093/chemse/bjg063; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Li J, 1999, MOL PHARMACOL, V55, P883; LIDOW MS, 1984, J ULTRA MOL STRUCT R, V86, P18, DOI 10.1016/S0022-5320(84)90092-3; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LINSE S, 1991, J BIOL CHEM, V266, P8050; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; LOWE G, 1995, P NATL ACAD SCI USA, V92, P7864, DOI 10.1073/pnas.92.17.7864; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malmendal A, 1999, BIOCHEMISTRY-US, V38, P11844, DOI 10.1021/bi9909288; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; Mashukova A, 2006, J NEUROSCI, V26, P9902, DOI 10.1523/JNEUROSCI.2897-06.2006; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; MAUNE JF, 1992, BIOCHEMISTRY-US, V31, P7779, DOI 10.1021/bi00149a006; Mayer U, 2008, CHEM SENSES, V33, P145, DOI 10.1093/chemse/bjm073; MENCO B, 1992, MICROSC RES TECHNIQ, V22, P215; Menco BPM, 1997, CHEM SENSES, V22, P295, DOI 10.1093/chemse/22.3.295; MENCO BPM, 1980, CELL TISSUE RES, V207, P183; MENCO BPM, 1984, CELL TISSUE RES, V235, P225; MENINI A, 1995, NATURE, V373, P435, DOI 10.1038/373435a0; Menini A, 1999, CURR OPIN NEUROBIOL, V9, P419, DOI 10.1016/S0959-4388(99)80063-4; Nache V, 2005, J PHYSIOL-LONDON, V569, P91, DOI 10.1113/jphysiol.2005.092304; Nache V, 2008, BIOPHYS J, V95, P2750, DOI 10.1529/biophysj.108.129718; Nache V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003110; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; O'Donnell SE, 2011, PROTEINS, V79, P765, DOI 10.1002/prot.22917; OLWIN BB, 1984, J BIOL CHEM, V259, P949; OTTOSON D, 1955, Acta Physiol Scand Suppl, V35, P1; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; PERSAUD KC, 1988, BIOCHIM BIOPHYS ACTA, V944, P49, DOI 10.1016/0005-2736(88)90315-X; Poll F, 2011, J BIOL CHEM, V286, P32931, DOI 10.1074/jbc.M111.224899; Pun RYK, 2003, BIOPHYS J, V84, P3425, DOI 10.1016/S0006-3495(03)70064-2; Pyrski M, 2007, J COMP NEUROL, V501, P944, DOI 10.1002/cne.21290; Rankin ML, 1999, J NEUROCHEM, V72, P541, DOI 10.1046/j.1471-4159.1999.0720541.x; Reidl J, 2006, BIOPHYS J, V90, P1147, DOI 10.1529/biophysj.104.058545; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; RESTREPO D, 1993, J GEN PHYSIOL, V102, P907, DOI 10.1085/jgp.102.5.907; Saidu SP, 2009, CHEM SENSES, V34, P349, DOI 10.1093/chemse/bjp008; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; SCHNETKAMP PPM, 1991, ANN NY ACAD SCI, V639, P10, DOI 10.1111/j.1749-6632.1991.tb17285.x; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Shea MA, 1996, BIOCHEMISTRY-US, V35, P2943, DOI 10.1021/bi951934g; Simpson ML, 2009, WIRES NANOMED NANOBI, V1, P214, DOI 10.1002/wnan.22; Song Y, 2008, NEURON, V58, P374, DOI 10.1016/j.neuron.2008.02.029; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Suzuki N, 2004, CHEM SENSES, V29, P411, DOI 10.1093/chemse/bjh042; Suzuki N, 2002, CHEM SENSES, V27, P789, DOI 10.1093/chemse/27.9.789; Takeuchi H, 2002, J PHYSIOL-LONDON, V541, P825, DOI 10.1113/jphysiol.2002.016600; Tan RY, 1996, J BIOL CHEM, V271, P7479, DOI 10.1074/jbc.271.13.7479; TAREILUS E, 1995, BBA-MOL CELL RES, V1269, P129, DOI 10.1016/0167-4889(95)00105-2; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Ungerer N, 2011, BIOCHEMISTRY-US, V50, P3221, DOI 10.1021/bi200115m; Wachowiak M, 2011, NEURON, V71, P962, DOI 10.1016/j.neuron.2011.08.030; Waldeck C, 2009, J GEN PHYSIOL, V134, P397, DOI 10.1085/jgp.200910296; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; WILEMAN T, 1984, BIOCHEM J, V220, P665, DOI 10.1042/bj2200665; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	146	11	12	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105531	10.1371/journal.pone.0105531	http://dx.doi.org/10.1371/journal.pone.0105531			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144232	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100082
J	Derkarabetian, S; Hedin, M				Derkarabetian, Shahan; Hedin, Marshal			Integrative Taxonomy and Species Delimitation in Harvestmen: A Revision of the Western North American Genus Sclerobunus (Opiliones: Laniatores: Travunioidea)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; HIDDEN DIVERSITY; ARACHNIDA; DIVERSIFICATION; CYPHOPHTHALMI; INFERENCE; ROBUSTUS; TREES; CAVE	Alpha taxonomy, and specifically the delimitation of species, is becoming increasingly objective and integrative. The use of coalescent-based methods applied to genetic data is providing new tools for the discovery and delimitation of species. Here, we use an integrative approach via a combination of discovery-based multivariate morphological analyses to detect potential new species. These potential species are then used as a priori species in hypothesis-driven validation analyses with genetic data. This research focuses on the harvestmen genus Sclerobunus found throughout the mountainous regions of western North America. Based on our analyses, we conduct a revision of Sclerobunus resulting in synonymy of Cyptobunus with Sclerobunus including transfer of S. cavicolens comb. nov. and elevation of both subspecies of S. ungulatus: S. ungulatus comb. nov. and S. madhousensis comb. nov., stat. nov. The three subspecies of S. robustus are elevated, S. robustus, S. glorietus stat. nov., and S. idahoensis stat. nov. Additionally, five new species of Sclerobunus are described from New Mexico and Colorado, including S. jemez sp. nov., S. klomax sp. nov., S. skywalkeri sp. nov., S. speoventus sp. nov., and S. steinmanni sp. nov. Several of the newly described species are single-cave endemics, and our findings suggest that further exploration of western North American cave habitats will likely yield additional new species.	[Derkarabetian, Shahan; Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Derkarabetian, Shahan] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	California State University System; San Diego State University; University of California System; University of California Riverside	Derkarabetian, S (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	sderkarabetian@gmail.com			Cave Conservancy Foundation; Society of Systematic Biologists; American Arachnological Society	Cave Conservancy Foundation; Society of Systematic Biologists; American Arachnological Society	This research was funded by the Cave Conservancy Foundation (Doctoral Fellowship in Karst Studies), Society of Systematic Biologists (Graduate Student Research Award), and the American Arachnological Society (Vincent Roth Fund for Systematics Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Arthofer W, 2013, MOL ECOL, V22, P3850, DOI 10.1111/mec.12340; Banks N, 1901, AM NAT, V35, P669, DOI 10.1086/277984; Banks N., 1905, Entomological News Philadelphia, Vxvi, P251; Banks N, 1902, P ACAD NAT SCI PHILA, V53, P568; Banks N., 1894, CAN ENTOMOL, V26, P160; Banks N, 1893, T AM ENTOMOL SOC, V20, P149; Banks Nathan, 1911, Pomona College Journal of Entomology, V3; Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boyer SL, 2007, MOL ECOL, V16, P4999, DOI 10.1111/j.1365-294X.2007.03555.x; BRAGG P D, 1972, Journal of the Entomological Society of British Columbia, V69, P67; Bragg Philip D., 2009, Journal of the Entomological Society of British Columbia, V106, P29; Briggs T. S., 1971, Occasional Papers Calif Acad Sci, VNo. 90, P1; Briggs TS, 1974, J ARACHNOL, V1, P205; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; Camargo A, 2013, SPECIES PROBLEM ONGO; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; COKENDOLPHER JC, 1993, SOUTHWEST NAT, V38, P236, DOI 10.2307/3671428; Crosby C. R., 1924, Entomological News Philadelphia, V35, P104; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Derkarabetian S, 2011, MOL PHYLOGENET EVOL, V61, P844, DOI 10.1016/j.ympev.2011.08.004; Derkarabetian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010388; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; DUMITRESCU D, 1976, Travaux du Museum d'Histoire Naturelle "Grigore Antipa", V17, P17; Edgar A.L., 1990, P529; EKPA O, 1984, TETRAHEDRON LETT, V25, P1315, DOI 10.1016/S0040-4039(01)80145-3; Elliott WR, 2000, ECOSY WORLD, V30, P665; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Ezard THG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-175; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Giarla TC, 2014, MOL PHYLOGENET EVOL, V70, P137, DOI 10.1016/j.ympev.2013.09.019; Giribet Gonzalo, 2010, Bulletin of the Museum of Comparative Zoology, V160, P1, DOI 10.3099/0027-4100-160.1.1; Goodnight Clarence J., 1943, AMER MIDLAND NAT, V29, P643, DOI 10.2307/2421154; GOODNIGHT CLARENCE J., 1960, AMER MIDLAND NAE, V64, P34, DOI 10.2307/2422891; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Knowles L.L., 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701701091, DOI 10.1080/10635150701701091]; Kury Adriano B., 2003, Revista Iberica de Aracnologia Volumen Especial Monografico, V1, P1; Kury AB, 2013, ZOOTAXA, V3703, P27; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Near TJ, 2013, MOL PHYLOGENET EVOL, V66, P868, DOI 10.1016/j.ympev.2012.11.009; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Packard AS, 1877, B US GEOLOGICAL SURV, V3, P157; Packard AS, 1888, MEM NAT ACAD SCI; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paquin P, 2004, MOL ECOL, V13, P3239, DOI 10.1111/j.1365-294X.2004.02296.x; Parmakelis A, 2013, BIOL J LINN SOC, V110, P728, DOI 10.1111/bij.12170; Pearson PN, 2014, PALEOBIOLOGY, V40, P130, DOI 10.1666/13004; Rambla Maria, 1994, P215; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Richart CH, 2013, ZOOKEYS, DOI 10.3897/zookeys.311.2920; Roewer C. F., 1915, Archiv fuer Naturgeschichte Berlin, V80; Roewer C. F., 1923, WEBERKNECHTE ERDE SY; Rower CF, 1931, Z WISS ZOOL ABT A, V138, P137; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Seifert B, 2014, MYRMECOL NEWS, V19, P1; Shear W.A., 1977, Journal Arachnol, V3, P177; Shear William A., 2008, Zootaxa, V1809, P67; Simon E, 1879, ARACHNIDES FRANCE, V7; SIMON E., 1879, ANN SOC ENTOMOLOGIQU, V22, P183; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taylor SJ, 2008, 200825 INHS DIV BIOD; Welbourn W. Calvin, 1999, Journal of Caves and Karst Studies, V61, P93; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	77	36	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104982	10.1371/journal.pone.0104982	http://dx.doi.org/10.1371/journal.pone.0104982			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144370	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100034
J	Gole, HKA; Tharp, DL; Bowles, DK				Gole, Hope K. A.; Tharp, Darla L.; Bowles, Douglas K.			Upregulation of Intermediate-Conductance Ca2+-Activated K+ Channels (KCNN4) in Porcine Coronary Smooth Muscle Requires NADPH Oxidase 5 (NOX5)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; ANGIOTENSIN-II; POTASSIUM CHANNEL; SUPEROXIDE-PRODUCTION; NAD(P)H OXIDASE; MOLECULAR REGULATION; SIGNALING PATHWAYS; HYDROGEN-PEROXIDE; REDOX REGULATION	Aims: NADPH oxidase (NOX) is the primary source of reactive oxygen species (ROS) in vascular smooth muscle cells (SMC) and is proposed to play a key role in redox signaling involved in the pathogenesis of cardiovascular disease. Growth factors and cytokines stimulate coronary SMC (CSMC) phenotypic modulation, proliferation, and migration during atherosclerotic plaque development and restenosis. We previously demonstrated that increased expression and activity of intermediate-conductance Ca2+-activated K+ channels (KCNN4) is necessary for CSMC phenotypic modulation and progression of stenotic lesions. Therefore, the purpose of this study was to determine whether NOX is required for KCNN4 upregulation induced by mitogenic growth factors. Methods and Results: Dihydroethidium micro-fluorography in porcine CSMCs demonstrated that basic fibroblast growth factor (bFGF) increased superoxide production, which was blocked by the NOX inhibitor apocynin (Apo). Apo also blocked bFGF-induced increases in KCNN4 mRNA levels in both right coronary artery sections and CSMCs. Similarly, immunohistochemistry and whole cell voltage clamp showed bFGF-induced increases in CSMC KCNN4 protein expression and channel activity were abolished by Apo. Treatment with Apo also inhibited bFGF-induced increases in activator protein-1 promoter activity, as measured by luciferase activity assay. qRT-PCR demonstrated porcine coronary smooth muscle expression of NOX1, NOX2, NOX4, and NOX5 isoforms. Knockdown of NOX5 alone prevented both bFGF-induced upregulation of KCNN4 mRNA and CSMC migration. Conclusions: Our findings provide novel evidence that NOX5-derived ROS increase functional expression of KCNN4 through activator protein-1, providing another potential link between NOX, CSMC phenotypic modulation, and atherosclerosis.	[Gole, Hope K. A.; Tharp, Darla L.; Bowles, Douglas K.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA; [Bowles, Douglas K.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA; [Bowles, Douglas K.] Univ Missouri, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Bowles, DK (corresponding author), Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA.	BowlesD@missouri.edu	Gole, Hope/B-9196-2015	Gole, Hope/0000-0001-8550-0853; Bowles, Doug/0000-0003-2043-7368	National Institutes of Health [HL52490, RR18276]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR018276] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL052490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [HL52490, RR18276](http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Adhikari Neeta, 2006, Curr Atheroscler Rep, V8, P252, DOI 10.1007/s11883-006-0081-1; Aliev G., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P225; Ambasta RK, 2006, FREE RADICAL BIO MED, V41, P193, DOI 10.1016/j.freeradbiomed.2005.12.035; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; Bowles DK, 2004, AM J PHYSIOL-HEART C, V287, pH2091, DOI 10.1152/ajpheart.00258.2004; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Bowles DK, 1998, J APPL PHYSIOL, V84, P1225, DOI 10.1152/jappl.1998.84.4.1225; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Channon KM, 2002, ARTERIOSCL THROM VAS, V22, P1751, DOI 10.1161/01.ATV.0000042203.08210.17; Chen Gregory J, 2006, Recent Pat Cardiovasc Drug Discov, V1, P211, DOI 10.2174/157489006777442478; Cheong A, 2006, CELL CYCLE, V5, P129, DOI 10.4161/cc.5.2.2310; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Cui XL, 2010, BIOL REPROD, V82, P305, DOI 10.1095/biolreprod.109.080275; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; De Keulenaer GW, 2000, ARTERIOSCL THROM VAS, V20, P385, DOI 10.1161/01.ATV.20.2.385; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Dikalova AE, 2010, AM J PHYSIOL-HEART C, V299, pH673, DOI 10.1152/ajpheart.00242.2010; Fan CY, 2005, FEBS LETT, V579, P1301, DOI 10.1016/j.febslet.2005.01.021; Fike CD, 2008, AM J PHYSIOL-LUNG C, V295, pL881, DOI 10.1152/ajplung.00047.2008; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Griendling KK, 2006, ANTIOXID REDOX SIGN, V8, P1443, DOI 10.1089/ars.2006.8.1443; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; Harrison DG, 2002, J RENIN-ANGIO-ALDO S, V4, P51; Hayabuchi Y, 2006, J MOL CELL CARDIOL, V41, P972, DOI 10.1016/j.yjmcc.2006.07.010; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hu QH, 2000, J BIOL CHEM, V275, P15749, DOI 10.1074/jbc.M000381200; Hwang J, 2003, CIRC RES, V93, P1225, DOI 10.1161/01.RES.0000104087.29395.66; Hwang JN, 2005, AM J PHYSIOL-CELL PH, V288, pC899, DOI 10.1152/ajpcell.00474.2004; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kawahara T, 2008, MOL BIOL CELL, V19, P4020, DOI 10.1091/mbc.E07-12-1223; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kim SY, 2012, IMMUNOL CELL BIOL, V90, P441, DOI 10.1038/icb.2011.60; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Lapperre TS, 1999, FEBS LETT, V443, P235, DOI 10.1016/S0014-5793(98)01723-2; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Li JM, 2010, GENE THER, V17, P1279, DOI 10.1038/gt.2010.69; Li JM, 2002, CIRC RES, V90, P143, DOI 10.1161/hh0202.103615; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loppnow H, 2008, INNATE IMMUN-LONDON, V14, P63, DOI 10.1177/1753425908091246; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Manea A, 2012, FREE RADICAL BIO MED, V52, P1497, DOI 10.1016/j.freeradbiomed.2012.02.018; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Miller FJ, 2009, CIRC RES, V105, P209, DOI 10.1161/CIRCRESAHA.109.202986; Montezano AC, 2010, CIRC RES, V106, P1363, DOI 10.1161/CIRCRESAHA.109.216036; Munzel T, 2002, ARTERIOSCL THROM VAS, V22, P1761, DOI 10.1161/01.ATV.0000034022.11764.EC; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; San Martin A, 2007, FREE RADICAL BIO MED, V42, P1671, DOI 10.1016/j.freeradbiomed.2007.02.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Schulz E, 2008, J AM COLL CARDIOL, V52, P1810, DOI 10.1016/j.jacc.2008.08.040; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Sung HJ, 2005, ANN BIOMED ENG, V33, P1546, DOI 10.1007/s10439-005-7545-2; Szocs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Takac I, 2012, CURR HYPERTENS REP, V14, P70, DOI 10.1007/s11906-011-0238-3; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Terashima M, 2006, KOBE J MED SCI, V53, P107; Terashima M, 2009, CIRC-CARDIOVASC INTE, V2, P196, DOI 10.1161/CIRCINTERVENTIONS.108.799502; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Tharp D. L., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P1; Touyz RM, 2008, HYPERTENSION, V51, P172, DOI 10.1161/HYPERTENSIONAHA.107.103200; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trebak M, 2010, ANTIOXID REDOX SIGN, V12, P657, DOI 10.1089/ars.2009.2842; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Weber DS, 2005, AM J PHYSIOL-HEART C, V288, pH37, DOI 10.1152/ajpheart.00638.2004; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Yamakawa T, 2002, ARTERIOSCL THROM VAS, V22, P752, DOI 10.1161/01.ATV.0000015903.02749.71; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhan YM, 2002, ARTERIOSCL THROM VAS, V22, P82, DOI 10.1161/hq0102.101821	99	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105337	10.1371/journal.pone.0105337	http://dx.doi.org/10.1371/journal.pone.0105337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144362	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100054
J	Han, KA; Kang, HS; Lee, JW; Yoo, L; Im, E; Hong, A; Lee, YJ; Shin, WH; Chung, KC				Han, Kyung Ah; Kang, Hye Seon; Lee, Jee Won; Yoo, Lang; Im, Eunju; Hong, Ahyoung; Lee, Yun Ju; Shin, Woo Hyun; Chung, Kwang Chul			Histone Deacetylase 3 Promotes RCAN1 Stability and Nuclear Translocation	PLOS ONE			English	Article							SYNDROME CRITICAL REGION; REGULATES SUBCELLULAR-LOCALIZATION; DOWN-SYNDROME; PROTEASOMAL DEGRADATION; UBIQUITIN LIGASE; PROTEIN; ACETYLATION; CALCINEURIN; PHOSPHORYLATION; DSCR1	Regulator of calcineurin 1 (RCAN1; also referred as DSCR1 or MCIP1) is located in close proximity to a Down syndrome critical region of human chromosome 21. Although RCAN1 is an endogenous inhibitor of calcineurin signaling that controls lymphocyte activation, apoptosis, heart development, skeletal muscle differentiation, and cardiac function, it is not yet clear whether RCAN1 might be involved in other cellular activities. In this study, we explored the extra-functional roles of RCAN1 by searching for novel RCAN1-binding partners. Using a yeast two-hybrid assay, we found that RCAN1 (RCAN1-1S) interacts with histone deacetylase 3 (HDAC3) in mammalian cells. We also demonstrate that HDAC3 deacetylates RCAN1. In addition, HDAC3 increases RCAN1 protein stability by inhibiting its poly-ubiquitination. Furthermore, HDAC3 promotes RCAN1 nuclear translocation. These data suggest that HDAC3, a new binding regulator of RCAN1, affects the protein stability and intracellular localization of RCAN1.	[Han, Kyung Ah; Kang, Hye Seon; Lee, Jee Won; Yoo, Lang; Im, Eunju; Hong, Ahyoung; Lee, Yun Ju; Shin, Woo Hyun; Chung, Kwang Chul] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Chung, KC (corresponding author), Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Im, Eunju/GPJ-9628-2022; Im, Eunju/Y-2601-2018; rchnds, rchnds/D-7595-2016	Im, Eunju/0000-0002-7839-8878; Im, Eunju/0000-0002-7839-8878; 	Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare [H09C1311]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea [2007-0056092];  [NRF-2012R1A1A2021749];  [H11C1606];  [H14C0093]	Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea; ; ; 	This research was supported by grants from the Korea Healthcare Technology R&D Project (H09C1311 to KCC) through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, and from the National Research Foundation of Korea (NRF) (2007-0056092 to KCC) funded by the Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea. This work was also partially supported by grants (NRF-2012R1A1A2021749, H11C1606, and H14C0093 to KCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Asada S, 2008, INT J MOL MED, V22, P95; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Epstein C J, 1995, Prog Clin Biol Res, V393, P241; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Gay F, 2003, GENE DEV, V17, P717, DOI 10.1101/gad.1042403; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Ishfaq M, 2012, FEBS LETT, V586, P3236, DOI 10.1016/j.febslet.2012.06.042; Jeyakumar M, 2007, J BIOL CHEM, V282, P9312, DOI 10.1074/jbc.M609009200; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kim SS, 2012, BIOCHEM BIOPH RES CO, V418, P657, DOI 10.1016/j.bbrc.2012.01.071; Kim SS, 2010, GENES GENOM, V32, P578, DOI 10.1007/s13258-010-0109-3; Kishi T, 2007, P NATL ACAD SCI USA, V104, P17418, DOI 10.1073/pnas.0704951104; Lee JY, 2009, BBA-GEN SUBJECTS, V1790, P1673, DOI 10.1016/j.bbagen.2009.08.005; Lee JW, 2012, BIOCHEM BIOPH RES CO, V420, P404, DOI 10.1016/j.bbrc.2012.03.007; Lee J, 2008, J BIOL CHEM, V283, P3392, DOI 10.1074/jbc.M706707200; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; Marks Paul A, 2004, Novartis Found Symp, V259, P269; Moser MA, 2014, CHROMOSOMA, V123, P67, DOI 10.1007/s00412-013-0441-x; Nicolas E, 2001, NUCLEIC ACIDS RES, V29, P3131, DOI 10.1093/nar/29.15.3131; Noh EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048315; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Pfister SC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-24; Pickard A, 2010, J CELL SCI, V123, P3718, DOI 10.1242/jcs.068924; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Seo SR, 2008, FEBS LETT, V582, P1889, DOI 10.1016/j.febslet.2008.04.059; Takami Y, 2000, J BIOL CHEM, V275, P16191, DOI 10.1074/jbc.M908066199; Vidal-Laliena M, 2013, J BIOL CHEM, V288, P21096, DOI 10.1074/jbc.M113.458323; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105416	10.1371/journal.pone.0105416	http://dx.doi.org/10.1371/journal.pone.0105416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144594	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100066
J	Jonatan, D; Spence, JR; Method, AM; Kofron, M; Sinagoga, K; Haataja, L; Arvan, P; Deutsch, GH; Wells, JM				Jonatan, Diva; Spence, Jason R.; Method, Anna M.; Kofron, Matthew; Sinagoga, Katie; Haataja, Leena; Arvan, Peter; Deutsch, Gail H.; Wells, James M.			Sox17 Regulates Insulin Secretion in the Normal and Pathologic Mouse beta Cell	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; DISPROPORTIONATELY ELEVATED PROINSULIN; PROTEIN-KINASE-C; IMPAIRED GLUCOSE-TOLERANCE; TRANSCRIPTION FACTOR SOX4; ENDOPLASMIC-RETICULUM; SELECTIVE DELETION; EXOCRINE PANCREAS; REDUNDANT ROLES; KDEL RECEPTOR	SOX17 is a key transcriptional regulator that can act by regulating other transcription factors including HNF1 beta and FOXA2, which are known to regulate postnatal beta cell function. Given this, we investigated the role of SOX17 in the developing and postnatal pancreas and found a novel role for SOX17 in regulating insulin secretion. Deletion of the Sox17 gene in the pancreas (Sox17-paLOF) had no observable impact on pancreas development. However, Sox17-paLOF mice had higher islet proinsulin protein content, abnormal trafficking of proinsulin, and dilated secretory organelles suggesting that Sox17-paLOF adult mice are prediabetic. Consistant with this, Sox17-paLOF mice were more susceptible to aged-related and high fat diet-induced hyperglycemia and diabetes. Overexpression of Sox17 in mature beta cells using Ins2-rtTA driver mice resulted in precocious secretion of proinsulin. Transcriptionally, SOX17 appears to broadly regulate secretory networks since a 24-hour pulse of SOX17 expression resulted in global transcriptional changes in factors that regulate hormone transport and secretion. Lastly, transient SOX17 overexpression was able to reverse the insulin secretory defects observed in MODY4 animals and restored euglycemia. Together, these data demonstrate a critical new role for SOX17 in regulating insulin trafficking and secretion and that modulation of Sox17-regulated pathways might be used therapeutically to improve cell function in the context of diabetes.	[Jonatan, Diva; Method, Anna M.; Kofron, Matthew; Sinagoga, Katie; Wells, James M.] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Wells, James M.] Cincinnati Childrens Hosp, Med Ctr, Div Endocrinol, Cincinnati, OH USA; [Spence, Jason R.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA; [Spence, Jason R.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Spence, Jason R.] Univ Michigan, Sch Med, Ctr Organogenesis, Ann Arbor, MI USA; [Haataja, Leena; Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI USA; [Deutsch, Gail H.] Seattle Childrens Hosp, Seattle, WA USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Seattle Children's Hospital	Wells, JM (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	James.Wells@cchmc.org		Kofron, Matthew/0000-0001-6427-4148; Deutsch, Gail/0000-0002-0571-0285	NIH [R01DK080823, R01DK092456]; Cincinnati Digestive Disease Center Award [P30 DK0789392]; Clinical Translational Science Award [U54 RR025216]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080823, P30DK020572, R01DK092456, P30DK078392, R01DK048280] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Digestive Disease Center Award; Clinical Translational Science Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported from NIH grants R01DK080823, and R01DK092456. The authors also acknowledge core support from the Cincinnati Digestive Disease Center Award (P30 DK0789392) and the Clinical Translational Science Award (U54 RR025216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Arvan P, 2004, CELL BIOCHEM BIOPHYS, P169; Arvan P, 2004, TRAFFIC, V5, P53, DOI 10.1111/j.1600-0854.2004.00152.x; Basu A, 2012, DIABETES, V61, P270, DOI 10.2337/db11-1677; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Chen R, 2008, PEDIATRICS, V121, pE1541, DOI 10.1542/peds.2007-3543; Corada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3609; Dubois CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023131; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; GANESAN S, 1990, P NATL ACAD SCI USA, V87, P9893, DOI 10.1073/pnas.87.24.9893; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Goldsworthy M, 2008, DIABETES, V57, P2234, DOI 10.2337/db07-0337; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Hartling SG, 1997, EUR J ENDOCRINOL, V137, P490, DOI 10.1530/eje.0.1370490; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JOHNSON JH, 1990, SCIENCE, V250, P546, DOI 10.1126/science.2237405; Kahn SE, 1997, DIABETES, V46, P1725, DOI 10.2337/diabetes.46.11.1725; Kaimal V, 2011, METHODS MOL BIOL, V700, P241, DOI 10.1007/978-1-61737-954-3_16; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kanat M, 2012, DIABETES, V61, P447, DOI 10.2337/db11-0995; Ketola I, 2004, MOL CELL ENDOCRINOL, V226, P51, DOI 10.1016/j.mce.2004.06.007; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kobayashi M, 2012, AM J PHYSIOL-ENDOC M, V302, pE603, DOI 10.1152/ajpendo.00469.2011; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Lange AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005711; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; MAKO ME, 1977, AM J MED, V63, P865, DOI 10.1016/0002-9343(77)90538-1; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McDonald E, 2009, STEM CELLS DEV, V18, P1379, DOI 10.1089/scd.2009.0240; Mendez CF, 2003, J BIOL CHEM, V278, P44753, DOI 10.1074/jbc.M308664200; MILBURN JL, 1993, DIABETES METAB REV, V9, P231, DOI 10.1002/dmr.5610090306; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Okamoto M, 2012, J CELL SCI; ORCI L, 1990, P NATL ACAD SCI USA, V87, P9953, DOI 10.1073/pnas.87.24.9953; ORCI L, 1984, J CELL BIOL, V99, P2187, DOI 10.1083/jcb.99.6.2187; Park KS, 2006, DEV BIOL, V294, P192, DOI 10.1016/j.ydbio.2006.02.038; Regazzi R, 1996, J CELL SCI, V109, P2265; RODER ME, 1994, J CLIN ENDOCR METAB, V79, P1570, DOI 10.1210/jc.79.6.1570; Roder ME, 1998, J CLIN ENDOCR METAB, V83, P604, DOI 10.1210/jc.83.2.604; SAAD MF, 1990, J CLIN ENDOCR METAB, V70, P1247, DOI 10.1210/jcem-70-5-1247; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Sinner D, 2006, DEVELOPMENT, V133, P1955, DOI 10.1242/dev.02358; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Steiner P, 2004, J NEUROCHEM, V89, P569, DOI 10.1111/j.1471-4159.2004.02345.x; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; Wang L, 2004, ENDOCRINOLOGY, V145, P3941, DOI 10.1210/en.2004-0281; Wells JM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-4; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Yanh H, 2013, J CLIN INVEST, V123, P418, DOI 10.1172/JCI64547; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2; Zuber C, 2004, FASEB J, V18, P917, DOI 10.1096/fj.03-1210fje	73	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104675	10.1371/journal.pone.0104675	http://dx.doi.org/10.1371/journal.pone.0104675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144761	Green Submitted, gold, Green Published			2022-12-27	WOS:000341106100020
J	Mccoy, SI; Buzdugan, R; Ralph, LJ; Mushavi, A; Mahomva, A; Hakobyan, A; Watadzaushe, C; Dirawo, J; Cowan, FM; Padian, NS				McCoy, Sandra I.; Buzdugan, Raluca; Ralph, Lauren J.; Mushavi, Angela; Mahomva, Agnes; Hakobyan, Anna; Watadzaushe, Constancia; Dirawo, Jeffrey; Cowan, Frances M.; Padian, Nancy S.			Unmet Need for Family Planning, Contraceptive Failure, and Unintended Pregnancy among HIV-Infected and HIV-Uninfected Women in Zimbabwe	PLOS ONE			English	Article							TRANSMISSION; FERTILITY	Background: Prevention of unintended pregnancies among women living with HIV infection is a strategy recommended by the World Health Organization for prevention of mother-to-child transmission of HIV (PMTCT). We assessed pregnancy intentions and contraceptive use among HIV-positive and HIV-negative women with a recent pregnancy in Zimbabwe. Methods: We analyzed baseline data from the evaluation of Zimbabwe's Accelerated National PMTCT Program. Eligible women were randomly sampled from the catchment areas of 157 health facilities offering PMTCT services in five provinces. Eligible women were >= 16 years old and mothers of infants (alive or deceased) born 9 to 18 months prior to the interview. Participants were interviewed about their HIV status, intendedness of the birth, and contraceptive use. Results: Of 8,797 women, the mean age was 26.7 years, 92.8% were married or had a regular sexual partner, and they had an average of 2.7 lifetime births. Overall, 3,090 (35.1%) reported that their births were unintended; of these women, 1,477 (47.8%) and 1,613 (52.2%) were and were not using a contraceptive method prior to learning that they were pregnant, respectively. Twelve percent of women reported that they were HIV-positive at the time of the survey; women who reported that they were HIV-infected were significantly more likely to report that their pregnancy was unintended compared to women who reported that they were HIV-uninfected (44.9% vs. 33.8%, p<0.01). After adjustment for covariates, among women with unintended births, there was no association between self-reported HIV status and lack of contraception use prior to pregnancy. Conclusions: Unmet need for family planning and contraceptive failure contribute to unintended pregnancies among women in Zimbabwe. Both HIV-infected and HIV-uninfected women reported unintended pregnancies despite intending to avoid or delay pregnancy, highlighting the need for effective contraceptive methods that align with pregnancy intentions.	[McCoy, Sandra I.; Buzdugan, Raluca; Ralph, Lauren J.; Padian, Nancy S.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Mushavi, Angela] Minist Hlth & Child Care, Harare, Zimbabwe; [Mahomva, Agnes] Elizabeth Glaser Pediat AIDS Fdn, Harare, Zimbabwe; [Hakobyan, Anna] Childrens Investment Fund Fdn, London, England; [Watadzaushe, Constancia; Dirawo, Jeffrey; Cowan, Frances M.] Ctr Sexual Hlth & HIV Res, Harare, Zimbabwe; [Cowan, Frances M.] UCL, London, England	University of California System; University of California Berkeley; University of London; University College London	Mccoy, SI (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	smccoy@berkeley.edu		Cowan, Frances/0000-0003-3087-4422	Children's Investment Fund Foundation (CIFF); National Institute of Mental Health [K01MH094246]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH094246] Funding Source: NIH RePORTER	Children's Investment Fund Foundation (CIFF); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The evaluation of Zimbabwe's Accelerated National PMTCT Program was supported by the Children's Investment Fund Foundation (CIFF, www.ciff.org) in a grant to NSP. AH (from CIFF) contributed to the study and is included as a co-author. SIM is supported by Award Number K01MH094246 from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in data collection and analysis or the decision to publish. AH (from CIFF) participated in designing the impact evaluation and preparation of this manuscript.	AHPRA, 2012, 201112 ANN REP AHPR; [Anonymous], 2020, HIGH POSS COST COVID; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Brown S.S., 1995, BEST INTENTIONS UNIN; Buzdugan R, 2013, 7 IAS C HIV PATH TRE; Espey E, 2011, OBSTET GYNECOL, V117, P705, DOI 10.1097/AOG.0b013e31820ce2f0; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593; Grieser M, 2001, J S AFR STUD, V27, P225, DOI 10.1080/03057070120049949; Hayford SR, 2012, STUD FAMILY PLANN, V43, P191, DOI 10.1111/j.1728-4465.2012.00317.x; Hladik W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007691; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Inter-agency task team for prevention and treatment of HIV infection in preg-nant women m and their children, 2012, PREV HIV UN PREGN ST; Jhangri GS, 2012, J FAM PLAN REPROD H, V38, P23, DOI 10.1136/jfprhc-2011-0108; Koenig MA, 2006, POP STUD-J DEMOG, V60, P243, DOI 10.1080/00324720600895819; Kolenikov S, 2004, USE DISCRETE DATA PR; Kutner M., 2005, APPL LINEAR STAT MOD; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Petruney Tricia, 2008, Bull World Health Organ, V86, pb; Policar M., 2011, CONTRACEPTIVE TECHNO; Reynolds HW, 2008, SEX TRANSM INFECT, V84, pII49, DOI 10.1136/sti.2008.030049; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Reynolds HW, 2005, SEX TRANSM INFECT, V81, P184, DOI 10.1136/sti.2004.012013; Robinson Jennifer A, 2012, Infect Dis Obstet Gynecol, V2012, P890160, DOI 10.1155/2012/890160; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Schaan MM, 2012, AIDS CARE, V24, P1120, DOI 10.1080/09540121.2012.672814; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Singh S, 2012, ADDING IT COSTS BENE; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Trinitapoli J, 2011, AM SOCIOL REV, V76, P935, DOI 10.1177/0003122411427672; Trussell J, 2007, CONTRACEPTIVE TECHNO, P221; UNAIDS, 2012, REP GLOB AIDS EP; UNAIDS, 2010, REP GLOB AIDS EP; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2011; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; *WHO, 2009, RAP ADV US ANT DRUGS; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wilcher R, 2008, SEX TRANSM INFECT, V84, pII54, DOI 10.1136/sti.2008.030098; World Health Organization, 2011, WHO UNICEF EST NAT I; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2007, GUID GLOB SCAL UP PR; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Yamey G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4160; Zimbabwe Ministry of Health and Child Welfare, 2012, NAT SEX REPR HLTH PO; Zimbabwe National Family Planning Council (ZNFPC), ZIMB NAT FAM PLANN S; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	48	52	52	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105320	10.1371/journal.pone.0105320	http://dx.doi.org/10.1371/journal.pone.0105320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144229	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100052
J	Thierfelder, KM; von Baumgarten, L; Baumann, AB; Meinel, FG; Helck, AD; Opherk, C; Straube, A; Reiser, MF; Sommer, WH				Thierfelder, Kolja M.; von Baumgarten, Louisa; Baumann, Alena B.; Meinel, Felix G.; Helck, Andreas D.; Opherk, Christian; Straube, Andreas; Reiser, Maximilian F.; Sommer, Wieland H.			Penumbra Pattern Assessment in Acute Stroke Patients: Comparison of Quantitative and Non-Quantitative Methods in Whole Brain CT Perfusion	PLOS ONE			English	Article							EVALUATION TRIAL EPITHET; ACUTE ISCHEMIC-STROKE; COMBINED THROMBOLYSIS; IMAGING EVALUATION; EVOLUTION DEFUSE; MISMATCH; REPERFUSION; DIFFUSION; RECANALIZATION; SELECTION	Background and Purpose: While penumbra assessment has become an important part of the clinical decision making for acute stroke patients, there is a lack of studies measuring the reliability and reproducibility of defined assessment techniques in the clinical setting. Our aim was to determine reliability and reproducibility of different types of three-dimensional penumbra assessment methods in stroke patients who underwent whole brain CT perfusion imaging (WB-CTP). Materials and Methods: We included 29 patients with a confirmed MCA infarction who underwent initial WB-CTP with a scan coverage of 100 mm in the z-axis. Two blinded and experienced readers assessed the flow-volume-mismatch twice and in two quantitative ways: Performing a volumetric mismatch analysis using OsiriX imaging software (MMVOL) and visual estimation of mismatch (MMEST). Complementarily, the semiquantitative Alberta Stroke Programme Early CT Score for CT perfusion was used to define mismatch (MMASPECTS). A favorable penumbral pattern was defined by a mismatch of >= 30% in combination with a cerebral blood flow deficit of <= 90 ml and an MMASPECTS score of >= 1, respectively. Inter-and intrareader agreement was determined by Kappa-values and ICCs. Results: Overall, MMVOL showed considerably higher inter-/intrareader agreement (ICCs: 0.751/0.843) compared to MMEST (0.292/0.749). In the subgroup of large (>= 50 mL) perfusion deficits, inter-and intrareader agreement of MMVOL was excellent (ICCs: 0.961/0.942), while MMEST interreader agreement was poor (0.415) and intrareader agreement was good (0.919). With respect to penumbra classification, MMVOL showed the highest agreement (interreader agreement: 25 agreements/4 non-agreements/kappa: 0.595; intrareader agreement 27/2/0.833), followed by MMEST (22/7/0.471; 23/6/0.577), and MMASPECTS (18/11/0.133; 21/8/0.340). Conclusion: The evaluated approach of volumetric mismatch assessment is superior to pure visual and ASPECTS penumbra pattern assessment in WB-CTP and helps to precisely judge the extent of 3-dimensional mismatch in acute stroke patients.	[Thierfelder, Kolja M.; Baumann, Alena B.; Meinel, Felix G.; Helck, Andreas D.; Reiser, Maximilian F.; Sommer, Wieland H.] Ludwig Maximilians Univ Munich Hosp, Dept Clin Radiol, Munich, Germany; [von Baumgarten, Louisa; Opherk, Christian; Straube, Andreas] Ludwig Maximilians Univ Munich Hosp, Dept Neurol, Munich, Germany; [Opherk, Christian] Ludwig Maximilians Univ Munich Hosp, Inst Stroke & Dementia Res, Munich, Germany	University of Munich; University of Munich; University of Munich	Thierfelder, KM (corresponding author), Ludwig Maximilians Univ Munich Hosp, Dept Clin Radiol, Munich, Germany.	kolja.thierfelder@med.uni-muenchen.de	von Baumgarten, Louisa/A-4636-2016	Meinel, Felix/0000-0002-3201-1033; Baumann, Alena/0000-0002-2067-1616				Abels B, 2011, AM J NEURORADIOL, V32, P1632, DOI 10.3174/ajnr.A2576; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Bivard A., 2012, RADIOLOGY; Butcher KS, 2005, STROKE, V36, P1153, DOI 10.1161/01.STR.0000166181.86928.8b; Coutts SB, 2003, STROKE, V34, P1681, DOI 10.1161/01.STR.0000078840.96473.20; De Silva DA, 2009, STROKE, V40, P2872, DOI 10.1161/STROKEAHA.108.543595; Diekmann S, 2010, AM J NEURORADIOL, V31, P1003, DOI 10.3174/ajnr.A1971; Hesselmann V, 2012, AM J NEURORADIOL, V33, P336, DOI 10.3174/ajnr.A2746; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kim JT, 2009, CEREBROVASC DIS, V28, P259, DOI 10.1159/000228256; Lansberg MG, 2011, STROKE, V42, P1608, DOI 10.1161/STROKEAHA.110.609008; Lin K, 2009, NEURORADIOLOGY, V51, P17, DOI 10.1007/s00234-008-0454-y; Murayama K, 2009, RADIOLOGY, V250, P202, DOI 10.1148/radiol.2501071809; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; Parsons MW, 2008, INT J STROKE, V3, P41, DOI 10.1111/j.1747-4949.2008.00175.x; Parsons MW, 2005, ANN NEUROL, V58, P672, DOI 10.1002/ana.20638; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Sillanpaa N, 2011, CEREBROVASC DIS EXTR, V1, P6, DOI 10.1159/000324324; Thierfelder KM, 2013, NEURORADIOLOGY; van Seeters T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075615; Weir NU, 2006, NEUROLOGY, V67, P516, DOI 10.1212/01.wnl.0000228221.44334.73; Wintermark M, 2005, AM J NEURORADIOL, V26, P104	23	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105413	10.1371/journal.pone.0105413	http://dx.doi.org/10.1371/journal.pone.0105413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144396	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100064
J	Chen, R; Jiang, N; Jiang, QY; Sun, XJ; Wang, Y; Zhang, H; Hu, Z				Chen, Rui; Jiang, Nan; Jiang, Qiyan; Sun, Xianjun; Wang, Yong; Zhang, Hui; Hu, Zheng			Exploring MicroRNA-Like Small RNAs in the Filamentous Fungus Fusarium oxysporum	PLOS ONE			English	Article							PARALLEL ANALYSIS; GENE-EXPRESSION; MESSENGER-RNAS; MIRNA TARGETS; IDENTIFICATION; DNA; NEUROSPORA; ROLES; ACCUMULATION; METHYLATION	RNA silencing such as quelling and meiotic silencing by unpaired DNA (MSUD) and several other classes of special small RNAs have been discovered in filamentous fungi recently. More than four different mechanisms of microRNA-like RNAs (milRNAs) production have been illustrated in the model fungus Neurospora crassa including a dicer-independent pathway. To date, very little work focusing on small RNAs in fungi has been reported and no universal or particular characteristic of milRNAs were defined clearly. In this study, small RNA and degradome libraries were constructed and subsequently deep sequenced for investigating milRNAs and their potential cleavage targets on the genome level in the filamentous fungus F. oxysporum f. sp. lycopersici. As a result, there is no intersection of conserved miRNAs found by BLASTing against the miRBase. Further analysis showed that the small RNA population of F. oxysporum shared many common features with the small RNAs from N. crassa and other fungi. According to the known standards of miRNA prediction in plants and animals, milRNA candidates from 8 families (comprising 19 members) were screened out and identified. However, none of them could trigger target cleavage based on the degradome data. Moreover, most major signals of cleavage in transcripts could not match appropriate complementary small RNAs, suggesting that other predominant modes for milRNA-mediated gene regulation could exist in F. oxysporum. In addition, the PAREsnip program was utilized for comprehensive analysis and 3 families of small RNAs leading to transcript cleavage were experimentally validated. Altogether, our findings provided valuable information and important hints for better understanding the functions of the small RNAs and milRNAs in the fungal kingdom.	[Chen, Rui; Wang, Yong] Tianjin Acad Agr Sci, Tianjin Inst Agr Qual Standard & Testing Technol, Tianjin, Peoples R China; [Jiang, Qiyan; Sun, Xianjun; Zhang, Hui; Hu, Zheng] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Genet Resources & Improvement, Beijing 100193, Peoples R China; [Jiang, Nan] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Chen, R (corresponding author), Tianjin Acad Agr Sci, Tianjin Inst Agr Qual Standard & Testing Technol, Tianjin, Peoples R China.	chenrui.taas@gmail.com; huzheng@caas.cn	Sun, xianjun/AAG-1739-2020; 陈, 锐/AAA-2120-2020; JIANG, NAN/AHB-1945-2022		National Natural Science Foundation of China [31000356]; Presidential Foundation of the Tianjin Academy of Agricultural Sciences [13002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Presidential Foundation of the Tianjin Academy of Agricultural Sciences	This work was supported by National Natural Science Foundation of China (No. 31000356) and the Presidential Foundation of the Tianjin Academy of Agricultural Sciences (No. 13002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Albisetti M, 2004, INFECTION, V32, P364, DOI 10.1007/s15010-004-3135-8; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; CAMBARERI EB, 1991, GENETICS, V127, P699; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055252; Chen R, 2009, J INTEGR PLANT BIOL, V51, P1071, DOI 10.1111/j.1744-7909.2009.00887.x; Cogoni C, 1997, TRENDS PLANT SCI, V2, P438, DOI 10.1016/S1360-1385(97)90028-5; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; de Haro JP, 2009, EUKARYOT CELL, V8, P1486, DOI 10.1128/EC.00191-09; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Folkes L, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks277; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Gordon TR, 1997, ANNU REV PHYTOPATHOL, V35, P111, DOI 10.1146/annurev.phyto.35.1.111; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052734; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076288; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC., 2001, SCIENCE, V294, P858, DOI [DOI 10.1126/SCIENCE.1065062, 10.1126/science.1065062, DOI 10.1126/science.1065062]; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Laurie JD, 2008, CURR GENET, V53, P49, DOI 10.1007/s00294-007-0165-7; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; MARASAS WFO, 1984, TOXIGENIC FUSARIUM S; MATZKE MA, 1995, PLANT PHYSIOL, V107, P679, DOI 10.1104/pp.107.3.679; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nakayashiki H, 2008, CURR OPIN MICROBIOL, V11, P494, DOI 10.1016/j.mib.2008.10.001; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; O'Donnell K, 2004, J CLIN MICROBIOL, V42, P5109, DOI 10.1128/JCM.42.11.5109-5120.2004; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Richardson BC, 2014, NAT REV RHEUMATOL, V10, P72, DOI 10.1038/nrrheum.2013.211; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Yang QY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003227; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zhou Q, 2012, FUNGAL BIOL-UK, V116, P1156, DOI 10.1016/j.funbio.2012.09.001; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	61	55	75	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104956	10.1371/journal.pone.0104956	http://dx.doi.org/10.1371/journal.pone.0104956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141304	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200044
J	Hobson, C; Dortch, J; Baslanti, TO; Layon, DR; Roche, A; Rioux, A; Harman, JS; Fahy, B; Bihorac, A				Hobson, Charles; Dortch, John; Baslanti, Tezcan Ozrazgat; Layon, Daniel R.; Roche, Alina; Rioux, Alison; Harman, Jeffrey S.; Fahy, Brenda; Bihorac, Azra			Insurance Status Is Associated with Treatment Allocation and Outcomes after Subarachnoid Hemorrhage	PLOS ONE			English	Article							UNITED-STATES; PAYER STATUS; MYOCARDIAL-INFARCTION; CEREBRAL ANEURYSMS; OLDER PATIENTS; DISPARITIES; MORTALITY; CANCER; CARE; DISABILITIES	Objective: Subarachnoid hemorrhage (SAH) is a particularly devastating type of stroke which is responsible for one third of all stroke-related years of potential life lost before age 65. Surgical treatment has been shown to decrease both morbidity and mortality after subarachnoid hemorrhage. We hypothesized that payer status other than private insurance is associated with lower allocation to surgical treatment for patients with SAH and worse outcomes. Design: We examined the association between insurance type and surgical treatment allocation and outcomes for patients with SAH while adjusting for a wide range of patient and hospital factors. We analyzed the Nationwide Inpatient Sample hospital discharge database using survey procedures to produce weighted estimates representative of the United States population. Patients: We studied 21047 discharges, representing a weighted estimate of 102595 patients age 18 and above with a discharge diagnosis of SAH between 2003 and 2008. Measurements: Multivariable logistic and generalized linear regression analyses were used to assess for any associations between insurance status and surgery allocation and outcomes. Main Results: Despite the benefits of surgery 66% of SAH patients did not undergo surgical treatment to prevent rebleeding. Mortality was more than twice as likely for patients with no surgical treatment compared to those who received surgery. Medicare patients were significantly less likely to receive surgical treatment. Conclusions: Nearly two thirds of patients with SAH don't receive operative care, and Medicare patients were significantly less likely to receive surgical treatment than other patients. Bias against the elderly and those with chronic illness and disability may play a part in these findings. A system of regionalized care for patients presenting with SAH may reduce disparities and improve appropriate allocation to surgical care and deserves prospective study.	[Hobson, Charles] Malcom Randall VA Med Ctr, Dept Surg, Gainesville, FL USA; [Dortch, John; Baslanti, Tezcan Ozrazgat; Layon, Daniel R.; Roche, Alina; Rioux, Alison; Fahy, Brenda; Bihorac, Azra] Univ Florida, Dept Anesthesiol, Gainesville, FL 32603 USA; [Hobson, Charles; Harman, Jeffrey S.] Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bihorac, A (corresponding author), Univ Florida, Dept Anesthesiol, Gainesville, FL 32603 USA.	abihorac@anest.ufl.edu	Bihorac, Azra/Q-6500-2016	Bihorac, Azra/0000-0002-5745-2863; Fahy, Brenda/0000-0002-5248-5164	National Institutes of Health [K23GM087709]; Astute Medical, Inc.; Foundation for Anesthesia Education and Research Medical Student Research Fellowship; University of Florida University Scholars' fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM087709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astute Medical, Inc.; Foundation for Anesthesia Education and Research Medical Student Research Fellowship; University of Florida University Scholars' fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AB is supported by Award Number K23GM087709 from the National Institutes of Health and has received grant funding from Astute Medical, Inc. JD was supported by the Foundation for Anesthesia Education and Research Medical Student Research Fellowship. AR and AR were supported by the University of Florida University Scholars' fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2010, PAT SAF IND TECHN SP; Agency for Healthcare Research and Quality, 2008, HCUP NAT INP SAMP NI; Andaluz N, 2008, J NEUROSURG, V108, P1163, DOI 10.3171/JNS/2008/108/6/1163; Andersen R, 2005, MILBANK Q, V83; [Anonymous], 2005, HCUP METH SER REP 20; Babu MA, 2011, NEUROSURGERY, V69, P659, DOI 10.1227/NEU.0b013e31821bc667; Balsa AI, 2003, J HEALTH ECON, V22, P89, DOI 10.1016/S0167-6296(02)00098-X; Bardach NS, 2004, CIRCULATION, V109, P2207, DOI 10.1161/01.CIR.0000126433.12527.E6; BECKER G, 1994, J AGING STUD, V8, P271, DOI 10.1016/0890-4065(94)90004-3; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Brinjikji W, 2011, AM J NEURORADIOL, V32, P1071, DOI 10.3174/ajnr.A2453; Burgess DJ, 2004, J GEN INTERN MED, V19, P1154, DOI 10.1111/j.1525-1497.2004.30227.x; Canto JG, 2000, ARCH INTERN MED, V160, P817, DOI 10.1001/archinte.160.6.817; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cram P, 2008, MED CARE, V46, P467, DOI 10.1097/MLR.0b013e31816c43d9; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Downs A, 2004, REHABIL PSYCHOL, V49, P303, DOI 10.1037/0090-5550.49.4.303; Drum C., 2005, CALIFORNIAN J HLTH P, V3, P29, DOI 10.32398/cjhp.v3i3.647; Earnshaw VA, 2012, J HEALTH PSYCHOL, V17, P157, DOI 10.1177/1359105311414952; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Elixhauser A, 2005, CLIN CLASSIFICATIONS; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Ghebre RG, 2011, GYNECOL ONCOL, V121, P595, DOI 10.1016/j.ygyno.2011.02.005; Groth SS, 2013, ANN THORACIC SURG; Hanmer J, 2014, ANN INTERN MED, V160, P81, DOI 10.7326/M12-1977; Iezzoni LL, 2008, ARCH PHYS MED REHAB, V89, P595, DOI 10.1016/j.apmr.2007.09.042; Keith D, 2008, CLIN J AM SOC NEPHRO, V3, P463, DOI 10.2215/CJN.02220507; Khatri R, 2011, NEUROCRIT CARE, V15, P34, DOI 10.1007/s12028-010-9423-5; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; LaPar DJ, 2012, CIRCULATION, V126, pS132, DOI 10.1161/CIRCULATIONAHA.111.083782; Lavie CJ, 2011, CURR CARDIOVASC RISK, V5, P432, DOI 10.1007/s12170-011-0192-2; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Lee ES, 2006, ANAL COMPLEX SURVEY, pvii; McCarthy EP, 2006, ANN INTERN MED, V145, P637, DOI 10.7326/0003-4819-145-9-200611070-00005; McPhee J, 2009, J VASC SURG, V49, P817, DOI 10.1016/j.jvs.2008.11.002; Mills AM, 2012, COLORECTAL DIS; Momin EN, 2012, ARCH SURG-CHICAGO, V147, P1017, DOI 10.1001/archsurg.2012.1459; Muss HB, 2012, J CLIN ONCOL, V30, P2576, DOI 10.1200/JCO.2012.42.3780; Nathens AB, 2001, J TRAUMA, V50, P776, DOI 10.1097/00005373-200105000-00002; Norris K, 2008, J AM SOC NEPHROL, V19, P1261, DOI 10.1681/ASN.2008030276; Nuno M, 2012, NEUROCRIT CARE, V17, P312, DOI 10.1007/s12028-012-9740-y; Qureshi AI, 2011, J NEUROSURG, V114, P834, DOI 10.3171/2010.6.JNS091486; Shea AM, 2007, NEUROSURGERY, V61, P1131, DOI 10.1227/01.neu.0000306090.30517.ae; Smith GA, 2011, J NEUROSURG, V114, P1768, DOI 10.3171/2011.1.JNS101528; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; United States Bureau of Labor Statistics, 2013, CONS PRIC IND CALC	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105124	10.1371/journal.pone.0105124	http://dx.doi.org/10.1371/journal.pone.0105124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25141303	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200053
J	McKinnon, EA; Fraser, KC; Stanley, CQ; Stutchbury, BJM				McKinnon, Emily A.; Fraser, Kevin C.; Stanley, Calandra Q.; Stutchbury, Bridget J. M.			Tracking from the Tropics Reveals Behaviour of Juvenile Songbirds on Their First Spring Migration	PLOS ONE			English	Article							AMERICAN REDSTARTS; STOPOVER SITE; ARRIVAL DATE; AGE; BIRDS; ORIENTATION; WARBLERS; COMPETITION; PHENOLOGY; MOVEMENT	Juvenile songbirds on spring migration travel from tropical wintering sites to temperate breeding destinations thousands of kilometres away with no prior experience to guide them. We provide a first glimpse at the migration timing, routes, and stopover behaviour of juvenile wood thrushes (Hylocichla mustelina) on their inaugural spring migration by using miniaturized archival geolocators to track them from Central America to the U.S. and Canada. We found significant differences between the timing of juvenile migration and that of more experienced adults: juveniles not only departed later from tropical wintering sites relative to adults, they also became progressively later as they moved northward. The increasing delay was driven by more frequent short stops by juveniles along their migration route, particularly in the U.S. as they got closer to breeding sites. Surprisingly, juveniles were just as likely as adults to cross the Gulf of Mexico, an open-water crossing of 800-1000 km, and migration route at the Gulf was not significantly different for juveniles relative to adults. To determine if the later departure of juveniles was related to poor body condition in winter relative to adults, we examined percent lean body mass, fat scores, and pectoral muscle scores of juvenile versus adult birds at a wintering site in Belize. We found no age-related differences in body condition. Later migration timing of juveniles relative to adults could be an adaptive strategy (as opposed to condition-dependent) to avoid the high costs of fast migration and competition for breeding territories with experienced and larger adults. We did find significant differences in wing size between adults and juveniles, which could contribute to lower flight efficiency of juveniles and thus slower overall migration speed. We provide the first step toward understanding the "black box" of juvenile songbird migration by documenting their migration timing and en route performance.	[McKinnon, Emily A.; Fraser, Kevin C.; Stanley, Calandra Q.; Stutchbury, Bridget J. M.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	McKinnon, EA (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	emilymck@yorku.ca		McKinnon, Emily/0000-0003-3631-0644; Stanley, Calandra Q./0000-0003-1588-2248				ALATALO RV, 1984, IBIS, V126, P410, DOI 10.1111/j.1474-919X.1984.tb00264.x; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 2006, ARDEA, V94, P347; Arlt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082316; Bayly NJ, 2013, IBIS, V155, P271, DOI 10.1111/ibi.12029; Berthold P, 2001, AUK, V2nd; Berthold P, 1996, CONTROL BIRD MIGRATI; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bowlin MS, 2007, AUK, V124, P1388, DOI 10.1642/0004-8038(2007)124[1388:SWSAWP]2.0.CO;2; Bridge ES, 2013, J FIELD ORNITHOL, V84, P121, DOI 10.1111/jofo.12011; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Clausen KK, 2013, OECOLOGIA, V173, P1101, DOI 10.1007/s00442-013-2681-0; de la Hera I, 2014, IBIS, V156, P209, DOI 10.1111/ibi.12112; DeSante DF, 2009, MOSI MONITOREO SOBRE; FRANCIS CM, 1986, AUK, V103, P548; FRANCIS CM, 1990, J FIELD ORNITHOL, V61, P404; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; GOSLER AG, 1991, BIRD STUDY, V38, P1, DOI 10.1080/00063659109477061; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; Hake M, 2003, OIKOS, V103, P385, DOI 10.1034/j.1600-0706.2003.12145.x; Healy SD, 1996, BEHAV BRAIN RES, V81, P61, DOI 10.1016/S0166-4328(96)00044-7; Helm B, 2005, ANN NY ACAD SCI, V1046, P216, DOI 10.1196/annals.1343.019; HILL GE, 1989, ANIM BEHAV, V37, P665, DOI 10.1016/0003-3472(89)90045-6; Hockey PAR, 1998, J AVIAN BIOL, V29, P325, DOI 10.2307/3677117; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Lemke HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079209; Lindstrom A, 2011, CONDOR, V113, P129, DOI 10.1525/cond.2011.090171; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; Maggini I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031271; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; McKinney AM, 2012, ECOLOGY, V93, P1987, DOI 10.1890/12-0255.1; McKinnon Emily A., 2013, Animal Migration, V1, P31, DOI 10.2478/ami-2013-0001; McKinnon EA, 2013, AUK, V130, P211, DOI 10.1525/auk.2013.12226; Mellone U, 2013, J AVIAN BIOL, V44, P417, DOI 10.1111/j.1600-048X.2013.00139.x; Moore F, 2003, AVIAN MIGRATION, P281; MORTON ES, 1990, CONDOR, V92, P1040, DOI 10.2307/1368740; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Mukhin A, 2005, P ROY SOC B-BIOL SCI, V272, P1535, DOI 10.1098/rspb.2005.3120; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; Paxton KL, 2008, CONDOR, V110, P672, DOI 10.1525/cond.2008.8602; PERDECK AC, 1983, ARDEA, V71, P255; Pyle P, 1997, IDENTIFICATION GUIDE, VI; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Sandberg R, 1996, BEHAV ECOL SOCIOBIOL, V39, P1, DOI 10.1007/s002650050261; Saracco JF, 2010, ECOLOGY, V91, P1885, DOI 10.1890/09-0705.1; Sauer JR, 2012, N AM BREEDING BIRD S; Seewagen CL, 2013, BEHAV ECOL, V24, P634, DOI 10.1093/beheco/ars225; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Sirot E, 2014, J AVIAN BIOL, V45, P109, DOI 10.1111/j.1600-048X.2013.00184.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Stanley CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040688; Stewart RLM, 2002, WILSON BULL, V114, P264, DOI 10.1676/0043-5643(2002)114[0264:ARDTOS]2.0.CO;2; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Thorup K, 2010, INTEGR COMP BIOL, V50, P315, DOI 10.1093/icb/icq065; Townsend AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059467; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wiltschko R, 2003, AVIAN MIGRATION, P433; WINKER K, 1990, CONDOR, V92, P444, DOI 10.2307/1368241	63	54	55	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105605	10.1371/journal.pone.0105605	http://dx.doi.org/10.1371/journal.pone.0105605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141193	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200114
J	Kim, HT; Kim, KJ				Kim, Hyoung Tae; Kim, Ki-Joong			Chloroplast Genome Differences between Asian and American Equisetum arvense (Equisetaceae) and the Origin of the Hypervariable trnY-trnE Intergenic Spacer	PLOS ONE			English	Article							NORTH-AMERICAN; PLASTID GENOMES; EASTERN ASIA; PHYLOGENETIC-RELATIONSHIPS; FLORISTIC DISJUNCTION; SEQUENCE; EVOLUTION; FERN; REARRANGEMENTS; DISTRIBUTIONS	Comparative analyses of complete chloroplast (cp) DNA sequences within a species may provide clues to understand the population dynamics and colonization histories of plant species. Equisetum arvense (Equisetaceae) is a widely distributed fern species in northeastern Asia, Europe, and North America. The complete cp DNA sequences from Asian and American E. arvense individuals were compared in this study. The Asian E. arvense cp genome was 583 bp shorter than that of the American E. arvense. In total, 159 indels were observed between two individuals, most of which were concentrated on the hypervariable trnY-trnE intergenic spacer (IGS) in the large single-copy (LSC) region of the cp genome. This IGS region held a series of 19 bp repeating units. The numbers of the 19 bp repeat unit were responsible for 78% of the total length difference between the two cp genomes. Furthermore, only other closely related species of Equisetum also show the hypervariable nature of the trnY-trnE IGS. By contrast, only a single indel was observed in the gene coding regions: the ycf1 gene showed 24 bp differences between the two continental individuals due to a single tandem-repeat indel. A total of 165 single-nucleotide polymorphisms (SNPs) were recorded between the two cp genomes. Of these, 52 SNPs (31.5%) were distributed in coding regions, 13 SNPs (7.9%) were in introns, and 100 SNPs (60.6%) were in intergenic spacers (IGS). The overall difference between the Asian and American E. arvense cp genomes was 0.12%. Despite the relatively high genetic diversity between Asian and American E. arvense, the two populations are recognized as a single species based on their high morphological similarity. This indicated that the two regional populations have been in morphological stasis.	[Kim, Hyoung Tae; Kim, Ki-Joong] Korea Univ, Sch Life Sci & Biotechnol, Div Life Sci, Seoul, South Korea	Korea University	Kim, KJ (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Div Life Sci, Seoul, South Korea.	kimkj@korea.ac.kr		HyoungTae, Kim/0000-0002-2482-6064	Korea Research Foundation [KRF-2010-0011796]; KEITI [062-091-078, 416-111-005]; NIBR	Korea Research Foundation(National Research Foundation of Korea); KEITI; NIBR	This research was supported by a research grant (#KRF-2010-0011796) from the Korea Research Foundation and by research grants (#062-091-078, #416-111-005) from KEITI to Ki-Joong Kim. A Ph.D. fellowship to HTK was granted by the graduate student education program from NIBR (2012-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Cantrill DJ, 2005, NEW ZEAL J GEOL GEOP, V48, P537, DOI 10.1080/00288306.2005.9515132; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Des Marais DL, 2003, INT J PLANT SCI, V164, P737, DOI 10.1086/376817; DiMichele WA, 2005, NONMARINE PERMIAN, V30, P56; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Gao L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-64; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Grewe F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-8; Hauke R. L., 1963, NOVA HEDWIGIA S, V8, P1, DOI DOI 10.2307/1546980; HAUKE RL, 1978, NOVA HEDWIGIA, V30, P385; HIPKINS VD, 1995, CURR GENET, V27, P572, DOI 10.1007/BF00314450; HOEY MT, 1991, AM J BOT, V78, P938, DOI 10.2307/2445172; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; KATO M, 1993, J BIOGEOGR, V20, P265, DOI 10.2307/2845634; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelber KP, 1998, REV PALAEOBOT PALYNO, V100, P1, DOI 10.1016/S0034-6667(97)00061-4; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H. L., 1952, Transactions of the American Philosophical Society, Philadelphia, V42, P371, DOI 10.2307/1005654; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu JM, 2011, AM J BOT, V98, P1680, DOI 10.3732/ajb.1100125; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; McQueen DR, 1954, PHILOS T R SOC NZ, V82, P231; Morris GP, 2011, MOL ECOL, V20, P4938, DOI 10.1111/j.1365-294X.2011.05335.x; PALMER JD, 1986, METHOD ENZYMOL, V118, P167; Qiu YL, 1995, AM J BOT, V82, P1582, DOI 10.2307/2446187; Roper JM, 2007, AM FERN J, V97, P95, DOI 10.1640/0002-8444(2007)97[95:TCPGSO]2.0.CO;2; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; SCHAFFNER JOHN H., 1930, AMER FERN JOUR, V20, P89, DOI 10.2307/1543867; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; VEIT M, 1990, PHYTOCHEMISTRY, V29, P2555, DOI 10.1016/0031-9422(90)85187-K; Wall WA, 2010, MOL ECOL, V19, P4302, DOI 10.1111/j.1365-294X.2010.04793.x; Wang ZQ, 1996, REV PALAEOBOT PALYNO, V91, P121; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J, 2001, INT J PLANT SCI, V162, pS117, DOI 10.1086/322940; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59; Wolf PG, 2001, J BIOGEOGR, V28, P263, DOI 10.1046/j.1365-2699.2001.00531.x; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xiang QY, 2000, MOL PHYLOGENET EVOL, V15, P462, DOI 10.1006/mpev.2000.0766; Xiang QY, 1998, MOL PHYLOGENET EVOL, V10, P178, DOI 10.1006/mpev.1998.0524; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yi DK, 2012, MOL CELLS, V33, P497, DOI 10.1007/s10059-012-2281-6; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	62	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e103898	10.1371/journal.pone.0103898	http://dx.doi.org/10.1371/journal.pone.0103898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157804	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200005
J	Lamb, JJ; Hill, RE; Eaton-Rye, JJ; Hohmann-Marriott, MF				Lamb, Jacob J.; Hill, Ryan E.; Eaton-Rye, Julian J.; Hohmann-Marriott, Martin F.			Functional Role of PilA in Iron Acquisition in the Cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							CHLOROPHYLL-PROTEIN COMPLEX; TRANSFORMATION COMPETENCE; ISIAB OPERON; SP PCC-6803; MOTILITY; GENES; PHOTOSYNTHESIS; SIDEROPHORES; ORGANIZATION; TRANSPORT	Cyanobacteria require large quantities of iron to maintain their photosynthetic machinery; however, in most environments iron is present in the form of insoluble iron oxides. Whether cyanobacteria can utilize these sources of iron, and the potential molecular mechanisms involved remains to be defined. There is increasing evidence that pili can facilitate electron donation to extracellular electron acceptors, like iron oxides in non-photosynthetic bacteria. In these organisms, the donation of electrons to iron oxides is thought to be crucial for maintaining respiration in the absence of oxygen. Our study investigates if PilA1 (major pilin protein) may also provide a mechanism to convert insoluble ferric iron into soluble ferrous iron. Growth experiments supported by spectroscopic data of a strain deficient in pilA1 indicate that the presence of the pilA1 gene enhances the ability to grow on iron oxides. These observations suggest a novel function of PilA1 in cyanobacterial iron acquisition.	[Lamb, Jacob J.; Hohmann-Marriott, Martin F.] Norwegian Univ Sci & Technol, PhotoSynLab, Dept Biotechnol, N-7034 Trondheim, Norway; [Hill, Ryan E.; Eaton-Rye, Julian J.] Univ Otago, Dept Biochem, Dunedin, New Zealand	Norwegian University of Science & Technology (NTNU); University of Otago	Hohmann-Marriott, MF (corresponding author), Norwegian Univ Sci & Technol, PhotoSynLab, Dept Biotechnol, N-7034 Trondheim, Norway.	martin.hohmann-marriott@ntnu.no	Lamb, Jacob J./AAQ-4270-2020	Lamb, Jacob J./0000-0002-1019-6655; Eaton-Rye, Julian/0000-0003-4137-8838	New Zealand Foundation for Research and Technology; Norwegian University of Science and Technology, Trondheim, Norway	New Zealand Foundation for Research and Technology(New Zealand Foundation for Research, Science and Technology); Norwegian University of Science and Technology, Trondheim, Norway	This study was supported by a Postdoctoral Fellowship to MHM from the New Zealand Foundation for Research and Technology, succeeded by the Ministry of Business, Innovation and Employment; (http://www.msi.govt.nz/). Additional funding was provided through the PhD position awarded to JL by the Norwegian University of Science and Technology, Trondheim, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Badarau A, 2008, J BIOL CHEM, V283, P12520, DOI 10.1074/jbc.M709907200; Bhaya D, 1999, P NATL ACAD SCI USA, V96, P3188, DOI 10.1073/pnas.96.6.3188; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Eaton-Rye JJ, 2011, METHOD MOL BIOL, V684, P309; Ehrenreich IM, 2005, APPL ENVIRON MICROB, V71, P7401, DOI 10.1128/AEM.71.11.7401-7413.2005; FALK S, 1995, PHOTOSYNTH RES, V45, P51, DOI 10.1007/BF00032235; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fussenegger M, 1997, GENE, V192, P125, DOI 10.1016/S0378-1119(97)00038-3; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; GUIKEMA JA, 1983, PLANT PHYSIOL, V73, P250, DOI 10.1104/pp.73.2.250; Hopkinson BM, 2009, BIOMETALS, V22, P659, DOI 10.1007/s10534-009-9235-2; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P823, DOI 10.1093/pcp/pce106; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kranzler C, 2011, ENVIRON MICROBIOL, V13, P2990, DOI 10.1111/j.1462-2920.2011.02572.x; Kunert A, 2003, FEMS MICROBIOL LETT, V227, P255, DOI 10.1016/S0378-1097(03)00689-X; Lagarde D, 1999, FEBS LETT, V454, P247, DOI 10.1016/S0014-5793(99)00817-0; Lamb JJ, 2013, CURR MICROBIOL, V67, P123, DOI 10.1007/s00284-013-0340-7; Lamb JJ, 2012, PHOTOSYNTH RES, V114, P59, DOI 10.1007/s11120-012-9777-y; Legewie S, 2008, BIOPHYS J, V95, P3232, DOI 10.1529/biophysj.108.133819; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Maldonado MT, 2006, LIMNOL OCEANOGR, V51, P1729, DOI 10.4319/lo.2006.51.4.1729; MEYER TF, 1984, P NATL ACAD SCI-BIOL, V81, P6110, DOI 10.1073/pnas.81.19.6110; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Morris JN, 2014, NEW ZEAL J BOT, V52, P36, DOI 10.1080/0028825X.2013.846267; Murakami A, 1997, PHOTOSYNTH RES, V53, P141, DOI 10.1023/A:1005818317797; Nakasugi K, 2006, MICROBIOL-SGM, V152, P3623, DOI 10.1099/mic.0.29189-0; ODOM WR, 1993, PLANT MOL BIOL, V23, P1255, DOI 10.1007/BF00042358; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P1062, DOI 10.4319/lo.1983.28.6.1062; RIETHMAN HC, 1988, BIOCHIM BIOPHYS ACTA, V935, P141, DOI 10.1016/0005-2728(88)90211-3; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Singh AK, 2005, PHOTOSYNTH RES, V84, P65, DOI 10.1007/s11120-004-6429-x; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Vinnemeier J, 1998, FEMS MICROBIOL LETT, V169, P323, DOI 10.1111/j.1574-6968.1998.tb13336.x; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Yoshihara S, 2001, PLANT CELL PHYSIOL, V42, P63, DOI 10.1093/pcp/pce007	47	23	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105761	10.1371/journal.pone.0105761	http://dx.doi.org/10.1371/journal.pone.0105761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157828	gold, Green Published, Green Submitted			2022-12-27	WOS:000341303200060
J	Cai, DM; Jia, YM; Song, HG; Sui, SY; Lu, JY; Jiang, Z; Zhao, RQ				Cai, Demin; Jia, Yimin; Song, Haogang; Sui, Shiyan; Lu, Jingyu; Jiang, Zheng; Zhao, Ruqian			Betaine Supplementation in Maternal Diet Modulates the Epigenetic Regulation of Hepatic Gluconeogenic Genes in Neonatal Piglets	PLOS ONE			English	Article							GLOBAL DNA METHYLATION; GLUCOSE-PRODUCTION; METHIONINE METABOLISM; CHOLINE DEFICIENCY; FOLIC-ACID; PROTEIN; METHYLTRANSFERASE; HOMOCYSTEINE; LIVER; EXPRESSION	In this study, gestational sows were fed control or betaine-supplemented diets (3 g/kg) throughout the pregnancy, and the newborn piglets were used to elucidate whether maternal dietary betaine affected offspring hepatic gluconeogenic genes through epigenetic mechanisms. Neonatal piglets born to betaine-supplemented sows had significantly higher serum and hepatic betaine contents, together with significantly greater expression of methionine metabolic enzymes in the liver. Interestingly, significantly higher serum concentrations of lactic acid and glucogenic amino acids, including serine, glutamate, methionine and histidine, were detected in the piglets born to betaine-supplemented sows, which were coincident with higher hepatic glycogen content and PEPCK1 enzyme activity, as well as greater protein expression of gluconeogenic enzymes, pyruvate carboxylase (PC), cytoplasmic phosphoenolpyruvate carboxykinase (PEPCK1), mitochondrional phosphoenolpyruvate carboxykinase (PEPCK2) and fructose-1, 6-bisphosphatase (FBP1). Moreover, maternal betaine significantly changed the methylation status of both CpGs and histones on the promoter of gluconeogenic genes. The lower PEPCK1 mRNA was associated with DNA hypermethylation and more enriched repression histone mark H3K27me3, while the up-regulated PEPCK2 and FBP1 mRNA was associated with DNA hypomethylation and more enriched activation histone mark H3K4me3. Furthermore, the expression of two miRNAs predicted to target PC and 6 miRNAs predicted to target PEPCK1 was dramatically suppressed in the liver of piglets born to betaine-supplemented sows. Our results provide the first evidence that maternal betaine supplementation affects hepatic gluconeogenic genes expression in newborn piglets through enhanced hepatic methionine metabolism and epigenetic regulations, which involve DNA and histone methylations, and possibly miRNAs-mediated post-transcriptional mechanism.	[Cai, Demin; Jia, Yimin; Song, Haogang; Sui, Shiyan; Lu, Jingyu; Jiang, Zheng; Zhao, Ruqian] Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhao, RQ (corresponding author), Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	zhao.ruqian@gmail.com	Sui, Shiyan/AAW-7836-2021; Cai, Demin/AAT-7742-2021	Cai, Demin/0000-0003-0500-5292	National Basic Research Program of China [2012CB124703]; Special Fund for Agro-scientific Research in the Public Interest [201003011]; Fundamental Research Funds for the Central Universities [KYZ200913]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Innovation Project of Jiangsu Province Postgraduate Education [2013CXLX13_292]	National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions; Innovation Project of Jiangsu Province Postgraduate Education	This work was supported by the National Basic Research Program of China (2012CB124703), the Special Fund for Agro-scientific Research in the Public Interest (201003011), the Fundamental Research Funds for the Central Universities (KYZ200913), the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Innovation Project of Jiangsu Province Postgraduate Education (2013CXLX13_292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Altern Med Rev, V8, P193; Bennett LW, 2007, POULTRY SCI, V86, P2653, DOI 10.3382/ps.2007-00303; Burdge GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028282; Calvisi DF, 2007, INT J CANCER, V121, P2410, DOI 10.1002/ijc.22940; Cordero P, 2013, GENES NUTR, V8, P105, DOI 10.1007/s12263-012-0300-z; Corssmit EPM, 2001, METABOLISM, V50, P742, DOI 10.1053/meta.2001.24195; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Eklund M, 2005, NUTR RES REV, V18, P31, DOI 10.1079/NRR200493; FINKELSTEIN JD, 1983, J NUTR, V113, P519, DOI 10.1093/jn/113.3.519; Horowitz S, 2011, J BIOL CHEM, V286, P18658, DOI 10.1074/jbc.M111.232876; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Jackson MI, 2012, J BIOL CHEM, V287, P36455, DOI 10.1074/jbc.M112.412932; Jia YM, 2012, J NUTR, V142, P1659, DOI 10.3945/jn.112.160341; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kharbanda KK, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/962183; Kirsch SH, 2010, J CHROMATOGR B, V878, P3338, DOI 10.1016/j.jchromb.2010.10.016; KORNHAUSER D, 1970, PEDIATR RES, V4, P120, DOI 10.1203/00006450-197003000-00002; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; KUMAR S, 1980, NEUROCHEM RES, V5, P453, DOI 10.1007/BF00964233; Lee JK, 2013, BIOCHEM BIOPH RES CO, V438, P647, DOI 10.1016/j.bbrc.2013.07.128; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lillycrop KA, 2010, BRIT J NUTR, V103, P1711, DOI 10.1017/S0007114509993795; Liu XJ, 2011, EPIGENETICS-US, V6, P899, DOI 10.4161/epi.6.7.16005; Liu Y, 2012, J NUTR SCI VITAMINOL, V58, P69, DOI 10.3177/jnsv.58.69; Medici V, 2013, HEPATOLOGY, V57, P555, DOI 10.1002/hep.26047; Molloy AM, 2005, AM J CLIN NUTR, V82, P836, DOI 10.1093/ajcn/82.4.836; Mori S, 2010, BIOORGAN MED CHEM, V18, P8158, DOI 10.1016/j.bmc.2010.10.022; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Pan SF, 2013, BRIT J NUTR, V109, P1731, DOI 10.1017/S0007114512003728; PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7; Powell CL, 2010, TOXICOL SCI, V115, P131, DOI 10.1093/toxsci/kfq031; Ratriyanto A, 2009, ASIAN AUSTRAL J ANIM, V22, P1461, DOI 10.5713/ajas.2009.80659; ROSENSWE.NS, 1970, BIOCHIM BIOPHYS ACTA, V208, P373, DOI 10.1016/0304-4165(70)90209-6; Sangokoya C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003408; Sharma P, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-1; STORCH KJ, 1991, AM J CLIN NUTR, V54, P386, DOI 10.1093/ajcn/54.2.386; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Strakovsky RS, 2011, J PHYSIOL-LONDON, V589, P2707, DOI 10.1113/jphysiol.2010.203950; Surtees R, 1997, PEDIATR RES, V42, P577, DOI 10.1203/00006450-199711000-00004; van Poelje PD, 2011, HANDB EXP PHARMACOL, V203, P279, DOI 10.1007/978-3-642-17214-4_12; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Villamor E, 2012, PAEDIATR PERINAT EP, V26, P328, DOI 10.1111/j.1365-3016.2012.01264.x; Wagner T, 2012, NAT BIOTECHNOL, V30, P622, DOI 10.1038/nbt.2300; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9	48	45	52	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105504	10.1371/journal.pone.0105504	http://dx.doi.org/10.1371/journal.pone.0105504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153319	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200057
J	Chankaew, S; Isemura, T; Isobe, S; Kaga, A; Tomooka, N; Somta, P; Hirakawa, H; Shirasawa, K; Vaughan, DA; Srinives, P				Chankaew, Sompong; Isemura, Takehisa; Isobe, Sachiko; Kaga, Akito; Tomooka, Norihiko; Somta, Prakit; Hirakawa, Hideki; Shirasawa, Kenta; Vaughan, Duncan A.; Srinives, Peerasak			Detection of Genome Donor Species of Neglected Tetraploid Crop Vigna reflexo-pilosa (Creole Bean), and Genetic Structure of Diploid Species Based on Newly Developed EST-SSR Markers from Azuki Bean (Vigna angularis)	PLOS ONE			English	Article							SUBGENUS CERATOTROPIS; GENUS-VIGNA; MOLECULAR PHYLOGENY; LINKAGE MAP; WILLD. OHWI; DIVERSITY; ACCURACY; FABACEAE; THAILAND; REGIONS	Vigna reflexo-pilosa, which includes a neglected crop, is the only one tetraploid species in genus Vigna. The ancestral species that make up this allotetraploid species have not conclusively been identified, although previous studies suggested that a donor genome of V. reflexo-pilosa is V. trinervia. In this study, 1,429 azuki bean EST-SSR markers were developed of which 38 EST-SSR primer pairs that amplified one product in diploid species and two discrete products in tetraploid species were selected to analyze 268 accessions from eight taxa of seven Asian Vigna species including V. reflexo-pilosa var. glabra, V. reflexo-pilosa var. reflexo-pilosa, V. exilis, V. hirtella, V. minima, V. radiata var. sublobata, V. tenuicaulis and V. trinervia to identify genome donor of V. reflexo-pilosa. Since both diploid and tetraploid species were analyzed and each SSR primer pair detected two loci in the tetraploid species, we separated genomes of the tetraploid species into two different diploid types, viz. A and B. In total, 445 alleles were detected by 38 EST-SSR markers. The highest gene diversity was observed in V. hirtella. By assigning the discrete PCR products of V. reflexo-pilosa into two distinguished genomes, we were able to identify the two genome donor parents of creole bean. Phylogenetic and principal coordinate analyses suggested that V. hirtella is a species complex and may be composed of at least three distinct taxa. Both analyses also clearly demonstrated that V. trinervia and one taxon of V. hirtella are the genome donors of V. reflexo-pilosa. Gene diversity indicates that the evolution rate of EST-SSRs on genome B of creole bean might be faster than that on genome A. Species relationship among the Vigna species in relation to genetic data, morphology and geographical distribution are presented.	[Chankaew, Sompong] Kasetsart Univ, Fac Agr Kamphaeng Saen, Program Plant Breeding, Kamphaeng Saen, Nakhon Pathom, Thailand; [Isemura, Takehisa; Kaga, Akito; Tomooka, Norihiko; Vaughan, Duncan A.] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan; [Isobe, Sachiko; Hirakawa, Hideki; Shirasawa, Kenta] Kazusa DNA Res Inst, Chiba, Japan; [Somta, Prakit; Srinives, Peerasak] Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Agron, Kamphaeng Saen, Nakhon Pathom, Thailand	Kasetsart University; National Institute of Agrobiological Sciences - Japan; Kazusa DNA Research Institute; Kasetsart University	Tomooka, N (corresponding author), Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki, Japan.	tomooka@affrc.go.jp; agrpss@yahoo.com	Shirasawa, Kenta/L-9141-2019	Shirasawa, Kenta/0000-0001-7880-6221	Thailand Research Fund (TRF)	Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	The work was supported by the Thailand Research Fund (TRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; Chaitieng B, 2006, THEOR APPL GENET, V113, P1261, DOI 10.1007/s00122-006-0380-5; CHEN HK, 1989, THEOR APPL GENET, V78, P641, DOI 10.1007/BF00262558; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Doi K, 2002, GENETICA, V114, P129, DOI 10.1023/A:1015158408227; EGAWA Y, 1996, PHYLOGENETIC DIFFERE, P19; Egawa Y, 1990, COLLECTION MILLETS G, V6, P1; EGAWA Y, 1996, JIRCAS J, V3, P49; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han OK, 2005, THEOR APPL GENET, V111, P1278, DOI 10.1007/s00122-005-0046-8; Harlan JR, 1992, CROPS MAN, V2nd; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Isemura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041304; Isemura T, 2010, ANN BOT-LONDON, V106, P927, DOI 10.1093/aob/mcq188; Javadi F, 2011, ANN BOT-LONDON, V108, P367, DOI 10.1093/aob/mcr141; Kaewwongwal A, 2013, BOTANY, V91, P653, DOI 10.1139/cjb-2013-0029; Konarev AV, 2002, EUPHYTICA, V123, P165, DOI 10.1023/A:1014920309710; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; MARECHAL R, 1978, Boissiera, V28, P1; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Seehalak W, 2006, GENET RESOUR CROP EV, V53, P1043, DOI 10.1007/s10722-004-7939-2; Somta P, 2009, CONSERV GENET, V10, P1939, DOI 10.1007/s10592-009-9860-x; SWINDELL RE, 1973, J HERED, V64, P107, DOI 10.1093/oxfordjournals.jhered.a108350; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; TATEISHI Y, 1990, SERIES ENTOM, V46, P189; TATEISHI Y, 1985, THESIS TOHOKU U JAPA; Tomooka N., 2002, Kew Bulletin, V57, P613, DOI 10.2307/4110989; Tomooka N, 2002, GENET RESOUR CROP EV, V49, P521, DOI 10.1023/A:1020954800107; Tomooka N, 2005, ECOLOGICAL SURVEY CO, V21, P135; Tomooka N., 2002, ASIAN VIGNA GENUS VI; Tun YT, 2007, BREEDING SCI, V57, P271, DOI 10.1270/jsbbs.57.271; VERDCOURT B, 1970, Kew Bulletin, V24, P507, DOI 10.2307/4102859	37	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104990	10.1371/journal.pone.0104990	http://dx.doi.org/10.1371/journal.pone.0104990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153330	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200034
J	Chen, WG; Xiao, HB; Rizzo, AN; Zhang, W; Mai, YF; Ye, M				Chen, Weiguo; Xiao, Hongbing; Rizzo, Alicia N.; Zhang, Wei; Mai, Yifeng; Ye, Meng			Endothelial Nitric Oxide Synthase Dimerization Is Regulated by Heat Shock Protein 90 Rather than by Phosphorylation	PLOS ONE			English	Article							ENOS ACTIVATION; NO SYNTHASE; IN-VIVO; CELLS; TETRAHYDROBIOPTERIN; EXPRESSION; VEGF; DEPHOSPHORYLATION; DYSFUNCTION; INHIBITION	Endothelial nitric oxide synthase (eNOS) is a multifunctional enzyme with roles in diverse cellular processes including angiogenesis, tissue remodeling, and the maintenance of vascular tone. Monomeric and dimeric forms of eNOS exist in various tissues. The dimeric form of eNOS is considered the active form and the monomeric form is considered inactive. The activity of eNOS is also regulated by many other mechanisms, including amino acid phosphorylation and interactions with other proteins. However, the precise mechanisms regulating eNOS dimerization, phosphorylation, and activity remain incompletely characterized. We utilized purified eNOS and bovine aorta endothelial cells (BAECs) to investigate the mechanisms regulating eNOS degradation. Both eNOS monomer and dimer existed in purified bovine eNOS. Incubation of purified bovine eNOS with protein phosphatase 2A (PP2A) resulted in dephosphorylation at Serine 1179 (Ser1179) in both dimer and monomer and decrease in eNOS activity. However, the eNOS dimer: monomer ratio was unchanged. Similarly, protein phosphatase 1 (PP1) induced dephosphorylation of eNOS at Threonine 497 (Thr497), without altering the eNOS dimer: monomer ratio. Different from purified eNOS, in cultured BAECs eNOS existed predominantly as dimers. However, eNOS monomers accumulated following treatment with the proteasome inhibitor lactacystin. Additionally, treatment of BAECs with vascular endothelial growth factor (VEGF) resulted in phosphorylation of Ser1179 in eNOS dimers without altering the phosphorylation status of Thr497 in either form. Inhibition of heat shock protein 90 (Hsp90) or Hsp90 silencing destabilized eNOS dimers and was accompanied by dephosphorylation both of Ser1179 and Thr497. In conclusion, our study demonstrates that eNOS monomers, but not eNOS dimers, are degraded by ubiquitination. Additionally, the dimeric eNOS structure is the predominant condition for eNOS amino acid modification and activity regulation. Finally, destabilization of eNOS dimers not only results in eNOS degradation, but also causes changes in eNOS amino acid modifications that further affect eNOS activity.	[Chen, Weiguo; Zhang, Wei; Mai, Yifeng; Ye, Meng] Ningbo Univ, Sch Med, Affiliated Hosp, Dept Med, Ningbo 315211, Zhejiang, Peoples R China; [Chen, Weiguo; Xiao, Hongbing; Rizzo, Alicia N.; Zhang, Wei] Univ Illinois, Coll Med, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Rizzo, Alicia N.] Univ Illinois, Dept Pharmacol, Chicago, IL USA	Ningbo University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chen, WG (corresponding author), Ningbo Univ, Sch Med, Affiliated Hosp, Dept Med, Ningbo 315211, Zhejiang, Peoples R China.	chen_weiguo@hotmail.com		Rizzo, Alicia/0000-0001-9289-4635	National Natural Scientific Foundation of China [NSFC-81270133]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Scientific Foundation of China (NSFC-81270133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2002, STROKE, V33, P1071, DOI 10.1161/hs0402.105553; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Benson MA, 2013, J BIOL CHEM, V288, P29836, DOI 10.1074/jbc.M113.493023; Bhat TA, 2013, CANCER PREV RES, V6, P1128, DOI 10.1158/1940-6207.CAPR-13-0209; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; Chen YM, 2006, AM J PHYSIOL-LUNG C, V291, pL378, DOI 10.1152/ajplung.00424.2005; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Di Lorenzo A, 2013, J CELL SCI; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Garcia C, 2013, ENDOCRINE; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Gopalakrishnan B, 2012, JOVE-J VIS EXP, DOI 10.3791/2810; Govers R, 2003, LIFE SCI, V73, P2225, DOI 10.1016/S0024-3205(03)00644-1; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hatakeyama T, 2006, J PHYSIOL-LONDON, V574, P275, DOI 10.1113/jphysiol.2006.108175; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Komarov AM, 2000, FREE RADICAL BIO MED, V28, P739, DOI 10.1016/S0891-5849(00)00156-8; Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; Kupatt C, 2004, ARTERIOSCL THROM VAS, V24, P1435, DOI 10.1161/01.ATV.0000134300.87476.d1; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Persechini A, 2013, FEBS LETT, V587, P297, DOI 10.1016/j.febslet.2012.12.012; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Ramirez V, 2008, AM J PHYSIOL-RENAL, V295, pF1044, DOI 10.1152/ajprenal.90278.2008; Ruan L, 2013, VASC PHARMACOL, V59, P27, DOI 10.1016/j.vph.2013.05.004; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Scotland RS, 2002, CIRC RES, V90, P904, DOI 10.1161/01.RES.0000016506.04193.96; Sorenson J, 2005, STROKE, V36, P158, DOI 10.1161/01.STR.0000150489.47080.67; Stangl V, 2004, FASEB J, V18, P272, DOI 10.1096/fj.03-0054com; Taverne YJ, 1985, J APPL PHYSIOL, V112, P1644; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Venema RC, 1997, J BIOL CHEM, V272, P1276, DOI 10.1074/jbc.272.2.1276; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Zhang QJ, 2012, DIABETES, V61, P1848, DOI 10.2337/db11-1399	41	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105479	10.1371/journal.pone.0105479	http://dx.doi.org/10.1371/journal.pone.0105479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153129	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200056
J	Koike, H; Ouchi, R; Ueno, Y; Nakata, S; Obana, Y; Sekine, K; Zheng, YW; Takebe, T; Isono, K; Koseki, H; Taniguchi, H				Koike, Hiroyuki; Ouchi, Rie; Ueno, Yasuharu; Nakata, Susumu; Obana, Yuta; Sekine, Keisuke; Zheng, Yun-Wen; Takebe, Takanori; Isono, Kyoichi; Koseki, Haruhiko; Taniguchi, Hideki			Polycomb Group Protein Ezh2 Regulates Hepatic Progenitor Cell Proliferation and Differentiation in Murine Embryonic Liver	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; GROUP-COMPLEXES; SELF-RENEWAL; MAINTENANCE; EXPRESSION; CANCER; PLURIPOTENCY; METHYLATION; TRANSITION; IDENTITY	In embryonic liver, hepatic progenitor cells are actively proliferating and generate a fundamental cellular pool for establishing parenchymal components. However, the molecular basis for the expansion of the progenitors maintaining their immature state remains elusive. Polycomb group proteins regulate gene expression throughout the genome by modulating of chromatin structure and play crucial roles in development. Enhancer of zeste homolog 2 (Ezh2), a key component of polycomb group proteins, catalyzes tri-methylation of lysine 27 of histone H3 (H3K27me3), which trigger the gene suppression. In the present study, we investigated a role of Ezh2 in the regulation of the expanding hepatic progenitor population in vivo. We found that Ezh2 is highly expressed in the actively proliferating cells at the early developmental stage. Using a conditional knockout mouse model, we show that the deletion of the SET domain of Ezh2, which is responsible for catalytic induction of H3K27me3, results in significant reduction of the total liver size, absolute number of liver parenchymal cells, and hepatic progenitor cell population in size. A clonal colony assay in the hepatic progenitor cells directly isolated from in vivo fetal livers revealed that the bi-potent clonogenicity was significantly attenuated by the Ezh2 loss of function. Moreover, a marker expression based analysis and a global gene expression analysis showed that the knockout of Ezh2 inhibited differentiation to hepatocyte with reduced expression of a number of liver-function related genes. Taken together, our results indicate that Ezh2 is required for the hepatic progenitor expansion in vivo, which is essential for the functional maturation of embryonic liver, through its activity for catalyzing H3K27me3.	[Koike, Hiroyuki; Ouchi, Rie; Ueno, Yasuharu; Obana, Yuta; Sekine, Keisuke; Zheng, Yun-Wen; Takebe, Takanori; Taniguchi, Hideki] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Nakata, Susumu] Aichi Canc Ctr, Res Inst, Div Oncol Pathol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Takebe, Takanori; Taniguchi, Hideki] Yokohama City Univ, Adv Med Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Takebe, Takanori] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Isono, Kyoichi; Koseki, Haruhiko] RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Tsurumi Ku, Yokohama, Kanagawa, Japan	Yokohama City University; Aichi Cancer Center; Yokohama City University; Japan Science & Technology Agency (JST); RIKEN	Taniguchi, H (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan.	rtanigu@med.yokohama-cu.ac.jp	Koseki, Haruhiko/I-3825-2014; Koike, Hiroyuki/AAT-6065-2020; Koike, Hiroyuki/R-5103-2018; Zheng, Yun-Wen/R-2874-2019; Koike, Hiroyuki/AAZ-9941-2020	Koseki, Haruhiko/0000-0001-8424-5854; Koike, Hiroyuki/0000-0001-9934-6930; Koike, Hiroyuki/0000-0001-9934-6930; Zheng, Yun-Wen/0000-0001-9002-3190; Koike, Hiroyuki/0000-0001-9934-6930; Isono, Kyoichi/0000-0002-4609-8985; Sekine, Keisuke/0000-0001-5133-0876	Special Coordination Funds for Promoting Science [11800122]; Stategic Promotion of Innovative Research and Development (S-innovation) [62890004]; Japan Health Sciences Foundation of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [20591532, 21249071, 22390260, 23791490, 23791491, 24106510, 24689052, 25253079, 25461956]; Takeda Science Foundation; Yokohama Foundation for Advanced Medical Science; Japan Insulin Dependent Diabetes Mellitus (IDDM) network; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the MEXT; Centers for Clinical Application Research on Specific Disease/Organ of the MEXT; Pancreas Research Foundation of Japan	Special Coordination Funds for Promoting Science; Stategic Promotion of Innovative Research and Development (S-innovation); Japan Health Sciences Foundation of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yokohama Foundation for Advanced Medical Science; Japan Insulin Dependent Diabetes Mellitus (IDDM) network; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the MEXT; Centers for Clinical Application Research on Specific Disease/Organ of the MEXT; Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan)	This work was supported by grants from the Special Coordination Funds for Promoting Science (11800122), grants from Stategic Promotion of Innovative Research and Development (S-innovation, 62890004), the Grant-in-Aid for Scientific Research on Innovative Areas, and the Japan Health Sciences Foundation of the Japan Science and Technology Agency (JST). This work was also supported by the Grants-in-Aid No. 20591532, 21249071, 22390260, 23791490, 23791491, 24106510, 24689052, 25253079, and 25461956 of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; by the Specified Research Grant from Takeda Science Foundation; by a grant from Yokohama Foundation for Advanced Medical Science; and by a grant from Japan Insulin Dependent Diabetes Mellitus (IDDM) network. This work was partially supported by funding from Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the MEXT, by funding from Centers for Clinical Application Research on Specific Disease/Organ of the MEXT, and by the Grants-in-Aid for Pancreas Research 2013 from Pancreas Research Foundation of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chiba T, 2012, INT J CANCER, V130, P2557, DOI 10.1002/ijc.26264; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hirao A, 2004, CELL CYCLE, V3, P1481, DOI 10.4161/cc.3.12.1281; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Koike H, 2014, HEPATOLOGY; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mochizuki-Kashio M, 2011, BLOOD, V118, P6553, DOI 10.1182/blood-2011-03-340554; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349; Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; van Vlerken LE, 2013, STEM CELL TRANSL MED, V2, P43, DOI 10.5966/sctm.2012-0036; Yadirgi G, 2011, STEM CELLS, V29, P700, DOI 10.1002/stem.614; Yonemitsu Y, 2009, HUM PATHOL, V40, P1304, DOI 10.1016/j.humpath.2009.01.017	35	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104776	10.1371/journal.pone.0104776	http://dx.doi.org/10.1371/journal.pone.0104776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153170	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200025
J	Simon, T; Goldberg, A; Aharonson-Daniel, L; Leykin, D; Adini, B				Simon, Tomer; Goldberg, Avishay; Aharonson-Daniel, Limor; Leykin, Dmitry; Adini, Bruria			Twitter in the Cross Fire-The Use of Social Media in the Westgate Mall Terror Attack in Kenya	PLOS ONE			English	Article							COMMUNICATION; FACEBOOK; CRISIS	On September 2013 an attack on the Westgate mall in Kenya led to a four day siege, resulting in 67 fatalities and 175 wounded. During the crisis, Twitter became a crucial channel of communication between the government, emergency responders and the public, facilitating the emergency management of the event. The objectives of this paper are to present the main activities, use patterns and lessons learned from the use of the social media in the crisis. Using TwitterMate, a system developed to collect, store and analyze tweets, the main hashtags generated by the crowd and specific Twitter accounts of individuals, emergency responders and NGOs, were followed throughout the four day siege. A total of 67,849 tweets were collected and analyzed. Four main categories of hashtags were identified: geographical locations, terror attack, social support and organizations. The abundance of Twitter accounts providing official information made it difficult to synchronize and follow the flow of information. Many organizations posted simultaneously, by their manager and by the organization itself. Creating situational awareness was facilitated by information tweeted by the public. Threat assessment was updated through the information posted on social media. Security breaches led to the relay of sensitive data. At times, misinformation was only corrected after two days. Social media offer an accessible, widely available means for a bidirectional flow of information between the public and the authorities. In the crisis, all emergency responders used and leveraged social media networks for communicating both with the public and among themselves. A standard operating procedure should be developed to enable multiple responders to monitor, synchronize and integrate their social media feeds during emergencies. This will lead to better utilization and optimization of social media resources during crises, providing clear guidelines for communications and a hierarchy for dispersing information to the public and among responding organizations.	[Simon, Tomer; Aharonson-Daniel, Limor; Leykin, Dmitry; Adini, Bruria] Ben Gurion Univ Negev, Fac Hlth Sci, Recanati Sch Community Hlth Profess, Dept Emergency Med, IL-84105 Beer Sheva, Israel; [Simon, Tomer; Aharonson-Daniel, Limor; Leykin, Dmitry; Adini, Bruria] Ben Gurion Univ Negev, PREPARED Ctr Emergency Response Res, IL-84105 Beer Sheva, Israel; [Simon, Tomer] Ready Org Il Emergency Readiness & Preparedness I, Giv'atayim, Israel; [Goldberg, Avishay] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Hlth Syst Management, IL-84105 Beer Sheva, Israel; [Leykin, Dmitry] Tel Hai Acad Coll, Dept Psychol, Kiryat Shmona, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Tel Hai Academy College	Simon, T (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Recanati Sch Community Hlth Profess, Dept Emergency Med, IL-84105 Beer Sheva, Israel.	tomersi@asonot.org.il	Adini, Bruria/AAS-2434-2021; Aharonson-Daniel, Limor/F-1998-2012	Aharonson-Daniel, Limor/0000-0003-4585-6892				Abbasi A, 2010, ACM INT C CYB PHYS S; Adamopoulos P., 2013, 34 INT C INF SYST MI; [Anonymous], 2011, P 12 ANN INT DIG GOV; [Anonymous], 2013, NY TIMES; Bharosa N, 2010, INFORM SYST FRONT, V12, P49, DOI 10.1007/s10796-009-9174-z; Bird D, 2012, AUST J EMERG MANAG, V27, P27; Cameron MA, 2012, 21 INT C COMP WORLD; Cassa CA, 2013, PLOS CURRENTS, V2; Ciancarini P, 2013, 13 INT C IT ASS ART; Cohen WilliamW., 2010, P 4 INT C WEBL SOC M; Feldman R, 2013, COMMUN ACM, V56, P82, DOI 10.1145/2436256.2436274; Guy ME, 2013, INT J EMERG SERV, V2, P6, DOI 10.1108/IJES-07-2012-0033; Huang CM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-57; Kononenko O, 2012, 2012 IEEE S VIS LANG; Kryvasheyeu Y, 2014, CORR; Latonero M., 2011, INT J INFORM SYSTEMS, V3, P196, DOI [https://doi.org/10.4018/jiscrm.2011100101, DOI 10.4018/JISCRM.2011100101]; Liu B., 2012, SYNTHESIS LECT HUMAN, V5, P1, DOI DOI 10.2200/S00416ED1V01Y201204HLT016; Mastracci S.H., 2011, EMOTIONAL LABOR CRIS; Meehan Kevin, 2013, PERV COMP COMM WORKS; Mendoza M, 2010, 1 WORKSH SOC MED AN; Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591; Nagy A., 2012, P 9 INT ISCRAM C; Oh O, 2011, INFORM SYST FRONT, V13, P33, DOI 10.1007/s10796-010-9275-8; Pak A, 2010, P 7 INT C LANG RES E; Pena G., 2013, TWITTER ALERTS CRITI; Qu Y, 2010, P ACM 2011 C COMP SU; Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571; Saif H, 2012, 11 INT SEM WEB C; Saritha SK, 2013, INT J COMPUTERS TECH, V11, P2401; Seeger MW, 2006, J APPL COMMUN RES, V34, P232, DOI 10.1080/00909880600769944; Taylor M, 2012, AUST J EMERG MANAG, V27, P20; Tracy SJ, 1998, J APPL COMMUN RES, V26, P390, DOI 10.1080/00909889809365516; Vieweg S., 2010, P 28 INT C HUM FACT; Wray RJ, 2008, AM J PUBLIC HEALTH, V98, P2214, DOI 10.2105/AJPH.2006.107102; Yates D, 2011, INT J INFORM MANAGE, V31, P6, DOI 10.1016/j.ijinfomgt.2010.10.001	35	59	61	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104136	10.1371/journal.pone.0104136	http://dx.doi.org/10.1371/journal.pone.0104136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153889	Green Published, gold			2022-12-27	WOS:000340952200014
J	Zhou, P; An, Y; Wang, ZL; Du, HM; Huang, BR				Zhou, Peng; An, Yuan; Wang, Zhaolong; Du, Hongmei; Huang, Bingru			Characterization of Gene Expression Associated with Drought Avoidance and Tolerance Traits in a Perennial Grass Species	PLOS ONE			English	Article							RESPONSIVE GENES; CRYOPROTECTIVE ACTIVITY; TRANSCRIPTION FACTORS; DESICCATION-TOLERANT; PROLINE ACCUMULATION; STRESS TOLERANCE; IDENTIFICATION; PLANTS; BERMUDAGRASS; DIVERSITY	To understand molecular mechanisms of perennial grass adaptation to drought stress, genes associated with drought avoidance or tolerance traits were identified and their expression patterns were characterized in C4 hybrid bermudagrass [Cynodon dactylon (L.) Pers.xC. transvaalensis Burtt Davy, cv. Tifway] and common bermudagrass (C. dactylon, cv. C299). Plants of drought-tolerant 'Tifway' and drought-sensitive 'C299' were exposed to drought for 5 d (mild stress) and 10 d (severe stress) by withholding irrigation in a growth chamber. 'Tifway' maintained significantly lower electrolyte leakage and higher relative water content than 'C299' at both 5 and 10 d of drought stress. Four cDNA libraries via suppression subtractive hybridization analysis were constructed and identified 277 drought-responsive genes in the two genotypes at 5 and 10 d of drought stress, which were mainly classified into the functional categories of stress defense, metabolism, osmoregulation, membrane system, signal and regulator, structural protein, protein synthesis and degradation, and energy metabolism. Quantitative-PCR analysis confirmed the expression of 36 drought up-regulated genes that were more highly expressed in drought-tolerant 'Tifway' than drought-sensitive 'C299', including those for drought avoidance traits, such as cuticle wax formation (CER1 and sterol desaturase), for drought tolerance traits, such as dehydration-protective proteins (dehydrins, HVA-22-like protein) and oxidative stress defense (superoxide dismutase, dehydroascorbate reductase, 2-Cys peroxiredoxins), and for stress signaling (EREBP-4 like protein and WRKY transcription factor). The results suggest that the expression of genes for stress signaling, cuticle wax accumulation, antioxidant defense, and dehydration-protective protein accumulation could be critically important for warm-season perennial grass adaptation to long-term drought stress.	[Zhou, Peng; An, Yuan; Wang, Zhaolong; Du, Hongmei] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Zhou, Peng; Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Shanghai Jiao Tong University; Rutgers State University New Brunswick	Huang, BR (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	huang@aesop.rutgers.edu	Wang, Zhaolong/I-5598-2019	Wang, Zhaolong/0000-0001-5843-8687	Joint Research Fund for the Chinese Natural Science Foundation [31128016]; Chinese Natural Science Foundation Projects [31072071, 31272198]	Joint Research Fund for the Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Natural Science Foundation Projects	The authors wish to thank the Joint Research Fund for the Chinese Natural Science Foundation (Grant No. 31128016) and Chinese Natural Science Foundation Projects (Grant No. 31072071 and No. 31272198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; BADWEY JA, 1981, J BIOL CHEM, V256, P3479; Baier M, 1999, PLANT PHYSIOL, V119, P1407, DOI 10.1104/pp.119.4.1407; Blomstedt CK, 1998, AUST J PLANT PHYSIOL, V25, P937, DOI 10.1071/PP98113; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Bravo LA, 2003, PHYSIOL PLANTARUM, V118, P262, DOI 10.1034/j.1399-3054.2003.00060.x; Chen CH, 2009, J AM SOC HORTIC SCI, V134, P22, DOI 10.21273/JASHS.134.1.22; Chen D, 2008, ACTA PHYSIOL PLANT, V30, P183, DOI 10.1007/s11738-007-0107-5; Chen Z, 2006, PLANT PHYSIOL, V142, P775, DOI 10.1104/pp.106.085506; Clarke AK, 1999, ANN BOT-LONDON, V83, P593, DOI 10.1006/anbo.1999.0878; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Dastoor Z, 2001, J CELL SCI, V114, P1643; Davies WJ, 2002, NEW PHYTOL, V153, P449, DOI 10.1046/j.0028-646X.2001.00345.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gaff DF, 1997, AUST J PLANT PHYSIOL, V24, P617, DOI 10.1071/PP96073; Gorantla M, 2007, J EXP BOT, V58, P253, DOI 10.1093/jxb/erl213; Hancock JT, 2005, PLANT PHYSIOL BIOCH, V43, P828, DOI 10.1016/j.plaphy.2005.07.012; Hanna W., 1998, GOLF COURSE MANAGE, V66, P49; Hara M, 2001, J PLANT PHYSIOL, V158, P1333, DOI 10.1078/0176-1617-00600; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hincha DK, 2004, BIOCHEM J, V383, P277, DOI 10.1042/BJ20040746; Hu LX, 2010, J PLANT PHYSIOL, V167, P103, DOI 10.1016/j.jplph.2009.07.008; Hu LX, 2009, CROP SCI, V49, P1902, DOI 10.2135/cropsci2008.12.0697; Islam MA, 2009, PLANT MOL BIOL, V70, P443, DOI 10.1007/s11103-009-9483-0; Jewell MC, 2012, CROP SCI, V52, P879, DOI 10.2135/cropsci2011.09.0497; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Lai LB, 2002, PLANT PHYSIOL, V128, P140, DOI 10.1104/pp.010449; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mundree Sagadevan G., 2002, African Journal of Biotechnology, V1, P28; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Nilsen ET, 1996, FIELD CROP RES, P192; Oliver MJ, 2000, PLANT ECOL, V151, P85, DOI 10.1023/A:1026550808557; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; RoyChoudhury A, 2008, PLANT CELL REP, V27, P779, DOI 10.1007/s00299-007-0498-1; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Shen QX, 2001, PLANT MOL BIOL, V45, P327, DOI 10.1023/A:1006460231978; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Somssich I. E., 2006, Regulation of transcription in plants, P266; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; TALIAFERRO CM, 1995, CROP SCI, V35, P327, DOI 10.2135/cropsci1995.0011183X003500020006x; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Watt DA, 2003, J EXP BOT, V54, P1163, DOI 10.1093/jxb/erg128; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Wu YQ, 2007, CROP SCI, V47, P1985, DOI 10.2135/cropsci2007.01.0047; Xue GP, 2008, PLANT MOL BIOL, V67, P197, DOI 10.1007/s11103-008-9311-y; Yang JC, 2001, AGRON J, V93, P196, DOI 10.2134/agronj2001.931196x; Zhang Y, 2005, J EXP BOT, V56, P897, DOI 10.1093/jxb/eri082; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x	58	18	19	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103611	10.1371/journal.pone.0103611	http://dx.doi.org/10.1371/journal.pone.0103611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153119	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200008
J	Shimazu, T; Barjau, J; Sohtome, Y; Sodeoka, M; Shinkai, Y				Shimazu, Tadahiro; Barjau, Joaquin; Sohtome, Yoshihiro; Sodeoka, Mikiko; Shinkai, Yoichi			Selenium-Based S-Adenosylmethionine Analog Reveals the Mammalian Seven-Beta-Strand Methyltransferase METTL10 to Be an EF1A1 Lysine Methyltransferase	PLOS ONE			English	Article							BIOORTHOGONAL CHEMICAL REPORTERS; PROTEIN METHYLATION; HISTONE METHYLTRANSFERASE; IDENTIFICATION; RNA; REPLICATION; THINKING; HSP90; CELLS; YEAST	Lysine methylation has been extensively studied in histones, where it has been shown to provide specific epigenetic marks for the regulation of gene expression; however, the molecular mechanism and physiological function of lysine methylation in proteins other than histones remains to be fully addressed. To better understand the substrate diversity of lysine methylation, S-adenosylmethionine (SAM) derivatives with alkyne-moieties have been synthesized. A selenium-based SAM analog, propargylic Se-adenosyl-L-selenomethionine (ProSeAM), has a wide spectrum of reactivity against various lysine methyltransferases (KMTs) with sufficient stability to support enzymatic reactions in vitro. By using ProSeAM as a chemical probe for lysine methylation, we identified substrates for two seven-beta-strand KMTs, METTL21A and METTL10, on a proteomic scale in mammalian cells. METTL21A has been characterized as a heat shock protein (HSP)-70 methyltransferase. Mammalian METTL10 remains functionally uncharacterized, although its ortholog in yeast, See1, has been shown to methylate the translation elongation factor eEF1A. By using ProSeAM-mediated alkylation followed by purification and quantitative MS analysis, we confirmed that METTL21A labels HSP70 family proteins. Furthermore, we demonstrated that METTL10 also methylates the eukaryotic elongation factor EF1A1 in mammalian cells. Subsequent biochemical characterization revealed that METTL10 specifically trimethylates EF1A1 at lysine 318 and that siRNA-mediated knockdown of METTL10 decreases EF1A1 methylation levels in vivo. Thus, our study emphasizes the utility of the synthetic cofactor ProSeAM as a chemical probe for the identification of non-histone substrates of KMTs.	[Shimazu, Tadahiro; Shinkai, Yoichi] RIKEN, Cellular Memory Lab, Wako, Saitama, Japan; [Barjau, Joaquin; Sohtome, Yoshihiro; Sodeoka, Mikiko] RIKEN, Synthet Organ Chem Lab, Wako, Saitama, Japan	RIKEN; RIKEN	Shinkai, Y (corresponding author), RIKEN, Cellular Memory Lab, Wako, Saitama, Japan.	yshinkai@riken.jp	Shinkai, Yoichi/N-3909-2014; SHIMAZU, Tadahiro/ABC-3950-2020; Sodeoka, Mikiko/A-9952-2008; Sohtome, Yoshihiro/F-8010-2012	Shinkai, Yoichi/0000-0002-6051-2484; Sodeoka, Mikiko/0000-0002-1344-364X; Sohtome, Yoshihiro/0000-0002-9165-6720	RIKEN's Strategic Programs for R&D "Inter-disciplinary and beyond-/cross-hierarchy research to elucidate higher biological functions"	RIKEN's Strategic Programs for R&D "Inter-disciplinary and beyond-/cross-hierarchy research to elucidate higher biological functions"	This work was supported by a RIKEN's Strategic Programs for R&D "Inter-disciplinary and beyond-/cross-hierarchy research to elucidate higher biological functions.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Binda O, 2011, CHEMBIOCHEM, V12, P330, DOI 10.1002/cbic.201000433; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLUMENTHAL T, 1976, J BIOL CHEM, V251, P2740; Bothwell IR, 2012, J AM CHEM SOC, V134, P14905, DOI 10.1021/ja304782r; Brinton MA, 2001, ANN NY ACAD SCI, V951, P207; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carlson SM, 2014, NAT PROTOC, V9, P37, DOI 10.1038/nprot.2013.164; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Chang PV, 2009, ANGEW CHEM INT EDIT, V48, P4030, DOI 10.1002/anie.200806319; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; DEVER TE, 1989, J BIOL CHEM, V264, P20518; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Grosshans H, 2000, J STRUCT BIOL, V129, P288, DOI 10.1006/jsbi.2000.4226; Guo A, 2013, MOL CELLULAR PROTEOM; Hang HC, 2011, ACCOUNTS CHEM RES, V44, P699, DOI 10.1021/ar200063v; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Li ZH, 2014, VIROLOGY, V448, P43, DOI 10.1016/j.virol.2013.09.012; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Nishikiori M, 2006, J VIROL, V80, P8459, DOI 10.1128/JVI.00545-06; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tollervey JR, 2012, EPIGENETICS-US, V7, P823, DOI 10.4161/epi.21141; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Vermillion KL, 2014, J CELL BIOL, V204, P95, DOI 10.1083/jcb.201306071; Wang R, 2013, CURR OPIN CHEM BIOL, V17, P729, DOI 10.1016/j.cbpa.2013.08.007; Willnow S, 2012, CHEMBIOCHEM, V13, P1167, DOI 10.1002/cbic.201100781; Yang YY, 2010, J AM CHEM SOC, V132, P3640, DOI 10.1021/ja908871t	45	66	68	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105394	10.1371/journal.pone.0105394	http://dx.doi.org/10.1371/journal.pone.0105394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144183	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100061
J	Takei, H; Morishita, S; Araki, M; Edahiro, Y; Sunami, Y; Hironaka, Y; Noda, N; Sekiguchi, Y; Tsuneda, S; Ohsaka, A; Komatsu, N				Takei, Hiraku; Morishita, Soji; Araki, Marito; Edahiro, Yoko; Sunami, Yoshitaka; Hironaka, Yumi; Noda, Naohiro; Sekiguchi, Yuji; Tsuneda, Satoshi; Ohsaka, Akimichi; Komatsu, Norio			Detection of MPLW515L/K Mutations and Determination of Allele Frequencies with a Single-Tube PCR Assay	PLOS ONE			English	Article							CHRONIC MYELOPROLIFERATIVE DISORDERS; JAK2 V617F MUTATION; ESSENTIAL THROMBOCYTHEMIA; MARROW FIBROSIS; NEOPLASMS; MPL; MYELOFIBROSIS; BURDEN; PROBES	A gain-of-function mutation in the myeloproliferative leukemia virus (MPL) gene, which encodes the thrombopoietin receptor, has been identified in patients with essential thrombocythemia and primary myelofibrosis, subgroups of classic myeloproliferative neoplasms (MPNs). The presence of MPL gene mutations is a critical diagnostic criterion for these diseases. Here, we developed a rapid, simple, and cost-effective method of detecting two major MPL mutations, MPLW515L/K, in a single PCR assay; we termed this method DARMS (dual amplification refractory mutation system)-PCR. DARMS-PCR is designed to produce three different PCR products corresponding to MPLW515L, MPLW515K, and all MPL alleles. The amplicons are later detected and quantified using a capillary sequencer to determine the relative frequencies of the mutant and wild-type alleles. Applying DARMS-PCR to human specimens, we successfully identified MPL mutations in MPN patients, with the exception of patients bearing mutant allele frequencies below the detection limit (5%) of this method. The MPL mutant allele frequencies determined using DARMS-PCR correlated strongly with the values determined using deep sequencing. Thus, we demonstrated the potential of DARMS-PCR to detect MPL mutations and determine the allele frequencies in a timely and cost-effective manner.	[Takei, Hiraku; Edahiro, Yoko; Sunami, Yoshitaka; Hironaka, Yumi; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan; [Takei, Hiraku; Tsuneda, Satoshi] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Morishita, Soji; Araki, Marito; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo, Japan; [Noda, Naohiro; Sekiguchi, Yuji] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ibaraki, Japan	Juntendo University; Waseda University; Juntendo University; National Institute of Advanced Industrial Science & Technology (AIST)	Komatsu, N (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan.	komatsun@juntendo.ac.jp	NODA, Naohiro/M-2383-2018; Araki, Marito/T-4283-2019	NODA, Naohiro/0000-0001-7592-5495; Araki, Marito/0000-0002-3502-5000	Japan Society for the promotion of science (JSPS) KAKENHI [25860416]	Japan Society for the promotion of science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Society for the promotion of science (JSPS) (http://www.jsps.go.jp/english/e-grants/) KAKENHI grant #25860416 (SM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli E, 2005, LEUKEMIA, V19, P1847, DOI 10.1038/sj.leu.2403902; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Chaligne R, 2008, LEUKEMIA, V22, P1557, DOI 10.1038/leu.2008.137; Edahiro Y, 2014, INT J HEMATOL, V99, P625, DOI 10.1007/s12185-014-1567-1; Guglielmelli P, 2014, AM J HEMATOL; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Lee TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023396; Milosevic JD, 2013, INT J HEMATOL, V97, P183, DOI 10.1007/s12185-012-1235-2; Morishita S, 2011, LEUKEMIA RES, V35, P1632, DOI 10.1016/j.leukres.2011.06.016; Pancrazzi A, 2008, J MOL DIAGN, V10, P435, DOI 10.2353/jmoldx.2008.080015; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pietra D, 2011, HAEMATOL-HEMATOL J, V96, P607, DOI 10.3324/haematol.2010.034793; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Ruan GR, 2010, HEMATOL ONCOL, V28, P33, DOI 10.1002/hon.899; Rumi E, 2013, BLOOD, V121, P4388, DOI 10.1182/blood-2013-02-486050; Schnittger S, 2009, HAEMATOL-HEMATOL J, V94, P141, DOI 10.3324/haematol.13224; Skoda RC, 2010, BLOOD, V116, P1392, DOI 10.1182/blood-2010-06-287318; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Teofili L, 2010, HAEMATOL-HEMATOL J, V95, P65, DOI 10.3324/haematol.2009.007542; Vannucchi AM, 2006, LEUKEMIA, V20, P1055, DOI 10.1038/sj.leu.2404209	22	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104958	10.1371/journal.pone.0104958	http://dx.doi.org/10.1371/journal.pone.0104958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144224	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100032
J	Hornbak, M; Allin, KH; Jensen, ML; Lau, CJ; Witte, D; Jorgensen, ME; Sandbaek, A; Lauritzen, T; Andersson, A; Pedersen, O; Hansen, T				Hornbak, Malene; Allin, Kristine Hojgaard; Jensen, Majken Linnemann; Lau, Cathrine Juel; Witte, Daniel; Jorgensen, Marit Eika; Sandbaek, Annelli; Lauritzen, Torsten; Andersson, Asa; Pedersen, Oluf; Hansen, Torben			A Combined Analysis of 48 Type 2 Diabetes Genetic Risk Variants Shows No Discriminative Value to Predict Time to First Prescription of a Glucose Lowering Drug in Danish Patients with Screen Detected Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELL FUNCTION; INSULIN-RESISTANCE; PLASMA-GLUCOSE; FOLLOW-UP; MELLITUS; SCORE; ASSOCIATION; PROGRESSION; ONSET; COMPLICATIONS	Objective: To investigate the genetic influence of 48 type 2 diabetes susceptibility variants on disease progression measured as risk of early prescription redemption of glucose lowering drugs in screen-detected patients with type 2 diabetes. Methods: We studied type 2 diabetes progression in 1,480 patients with screen-detected type 2 diabetes from the ADDITION-Denmark study using information of redeemed prescriptions from the Register of Medicinal Products Statistics from 2001-2009 in Denmark. Patients were cluster randomized by general practitioners, who were randomized to treat type 2 diabetes according to either a conventional or a multifactorial intensive treatment algorithm. We investigated the genetic influence on diabetes progression by constructing a genetic risk score (GRS) of all 48 validated type 2 diabetes susceptibility variants, a GRS of 11 variants linked to beta-cell function and a GRS of 3 variants linked to insulin sensitivity and assessed the association between number of risk alleles and time from diagnosis until first redeemed prescription of either any glucose lowering drug or an insulin drug. Results: The GRS linked to insulin sensitivity only nominally increased the risk of an early prescription redemption with an insulin drug by 39% (HR [95% C.I.] = 1.39 [1.09-1.77], p = 0.009] in patients randomized to the intensive treatment group. Furthermore, the strongest univariate predictors of diabetes progression for the intensive treatment group (measured as time to first insulin) were younger age (HR [95% C.I.] = 0.96 [0.93-0.99]), increased BMI (1.05 [1.01-1.09]), increased HbA1c (1.50 [1.36-.66]), increased TG (1.24 [1.11-1.39]) and reduced fasting serum HDL (0.37 [0.17-0.80]) at baseline. Similar results were obtained for the conventional treatment group. Conclusion: Higher levels of HbA1c, fasting circulating levels of triglyceride, lower HDL, larger BMI and younger age are significant determinants of early pharmacological intervention in type 2 diabetes. However, known common type 2 diabetes-associated gene variants do not appear to significantly affect disease progression.	[Hornbak, Malene; Allin, Kristine Hojgaard; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Hornbak, Malene; Andersson, Asa] Univ Copenhagen, Fac Hlth & Med Sci, Sch Pharmaceut Sci, Copenhagen, Denmark; [Jensen, Majken Linnemann; Jorgensen, Marit Eika] Steno Diabet Ctr AS, Gentofte, Denmark; [Jensen, Majken Linnemann] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Sect Social & Clin Pharm, Copenhagen, Denmark; [Lau, Cathrine Juel] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Witte, Daniel] Ctr Hlth Studies, Publ Res Ctr Hlth, Strassen, Luxembourg; [Sandbaek, Annelli; Lauritzen, Torsten] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice Med, Aarhus, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Inst Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Inst Clin Res, Sect Mol Diabet & Metab, Odense, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Inst Mol Med, Odense, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; University of Copenhagen; Aarhus University; University of Copenhagen; Aarhus University; University of Southern Denmark; University of Southern Denmark	Hornbak, M (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark.	Malene.hornbak@sund.ku.dk	Pedersen, Oluf/AAG-8015-2020; Witte, Daniel/AAF-9535-2019; Witte, Daniel R/C-1722-2008; Allin, Kristine Højgaard/ABG-3463-2021; Pedersen, Oluf/Z-1731-2019	Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Pedersen, Oluf/0000-0002-3321-3972; Hornbak Landauro, Malene/0000-0003-4479-428X; /0000-0003-4360-7710; Jorgensen, Marit Eika/0000-0001-8356-5565; Juel Lau, Cathrine/0000-0001-5100-7518; Hansen, Torben/0000-0001-8748-3831; Allin, Kristine Hojgaard/0000-0002-6880-5759	Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp); Novo Nordisk Foundation Center for Basic Metabolic Research; Novo Nordisk Foundation; National Health Services; Danish Research Foundation; Novo Nordisk A/S; Novo Nordisk Scandinavia AB; ASTRA Denmark; Pfizer Denmark; GlaxoSmithKline Pharma Denmark; SERVIER Denmark A/S; HemoCue Denmark A/S	Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Health Services; Danish Research Foundation; Novo Nordisk A/S(Novo Nordisk); Novo Nordisk Scandinavia AB(Novo Nordisk); ASTRA Denmark; Pfizer Denmark(Pfizer); GlaxoSmithKline Pharma Denmark(GlaxoSmithKline); SERVIER Denmark A/S; HemoCue Denmark A/S	The study was supported by grants from The Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp; http://www.lucamp.org) and The Novo Nordisk Foundation Center for Basic Metabolic Research, which is an independent Research Center at the University of Copenhagen and is partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://metabol.ku.dk/). The ADDITION study in Denmark was supported by the National Health Services in the counties of Copenhagen, Aarhus, Ringkobing, Ribe and South Jutland, together with the Danish Research Foundation for General Practice, Danish Centre for Evaluation and Health Technology Assessment, the Diabetes Fund of the National Board of Health, the Danish Medical Research Council, the Aarhus University Research Foundation and the Novo Nordisk Foundation. The ADDITION trial has been given unrestricted grants from Novo Nordisk A/S, Novo Nordisk Scandinavia AB, ASTRA Denmark, Pfizer Denmark, GlaxoSmithKline Pharma Denmark, SERVIER Denmark A/S and HemoCue Denmark A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ali Mohammed K, 2012, MMWR Suppl, V61, P32; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Andersson EA, 2013, DIABETES, V62, P3610, DOI 10.2337/db13-0362; [Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 1999, GUIDELINE DANISH COL; [Anonymous], 1998, GUIDELINE DANISH COL; Che Ronglin, 2013, Frontiers in Genetics, V4, P138, DOI 10.3389/fgene.2013.00138; Christensen J, 2004, DIABETOLOGIA, V47, P1566, DOI 10.1007/s00125-004-1496-2; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337/dc06-1834; Cohen A, 2007, CURR MED RES OPIN, V23, P905, DOI 10.1185/030079907X182068; Cook MN, 2005, DIABETES CARE, V28, P995, DOI 10.2337/diacare.28.5.995; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Gong ZW, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/320482; Hayward RA, 1997, JAMA-J AM MED ASSOC, V278, P1663, DOI 10.1001/jama.278.20.1663; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Kahn SE, 2012, DIABETES OBES METAB, V14, P46, DOI 10.1111/j.1463-1326.2012.01650.x; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kristensen Jette Kolding, 2007, Prim Care Diabetes, V1, P159, DOI 10.1016/j.pcd.2007.07.007; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Lauritzen T, 2012, PRIM CARE DIABETES, V6, P193, DOI 10.1016/j.pcd.2012.04.005; LeRoith D, 2002, AM J MED, V113, p3S; Levy J, 1998, DIABETIC MED, V15, P290, DOI 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Meneilly GS, 1996, DIABETES CARE, V19, P1320, DOI 10.2337/diacare.19.12.1320; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Pani LN, 2008, DIABETES CARE, V31, P386, DOI 10.2337/dc07-1934; Ringborg A, 2010, DIABETES METAB, V36, P198, DOI 10.1016/j.diabet.2009.11.006; Robertson RP, 2009, TRENDS ENDOCRIN MET, V20, P388, DOI 10.1016/j.tem.2009.05.004; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Sandbaek A, 2005, DIABETIC MED, V22, P1173, DOI 10.1111/j.1464-5491.2005.01491.x; Scheen AJ, 2005, DIABETES METAB, V31, pS27; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Raalte DH, 2011, DIABETES RES CLIN PR, V93, pS37, DOI 10.1016/S0168-8227(11)70012-2; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace TM, 2002, DIABETIC MED, V19, P465; Watson RT, 2001, RECENT PROG HORM RES, V56, P175, DOI 10.1210/rp.56.1.175; WHO Collaborating Centre for Drug Statistics Methodology, 2014, INT LANG DRUG UT RES; Willems SM, 2011, CURR DIABETES REP, V11, P511, DOI 10.1007/s11892-011-0235-6; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001; Zhou AK, 2013, DIABETES CARE	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104837	10.1371/journal.pone.0104837	http://dx.doi.org/10.1371/journal.pone.0104837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157406	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200019
J	Anwar, N; Rouf, SF; Romling, U; Rhen, M				Anwar, Naeem; Rouf, Syed Fazle; Romling, Ute; Rhen, Mikael			Modulation of Biofilm-Formation in Salmonella enterica Serovar Typhimurium by the Periplasmic DsbA/DsbB Oxidoreductase System Requires the GGDEF-EAL Domain Protein STM3615	PLOS ONE			English	Article							CYCLIC-DI-GMP; ESCHERICHIA-COLI O157-H7; MULTICELLULAR BEHAVIOR; STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR DNA; GENE-EXPRESSION; NITRIC-OXIDE; AGGREGATIVE BEHAVIOR; MATRIX PRODUCTION; RDAR MORPHOTYPE	In Salmonella enterica serovar Typhimurium (S. Typhimurium), biofilm-formation is controlled by the cytoplasmic intracellular small-molecular second messenger cyclic 3', 5'-di-guanosine monophosphate (c-di-GMP) through the activities of GGDEF and EAL domain proteins. Here we describe that deleting either dsbA or dsbB, respectively encoding a periplasmic protein disulfide oxidase and a cytoplasmic membrane disulfide oxidoreductase, resulted in increased biofilm-formation on solid medium. This increased biofilm-formation, defined as a red, dry and rough (rdar) colony morphotype, paralleled with enhanced expression of the biofilm master regulator CsgD and the biofilm-associated fimbrial subunit CsgA. Deleting csgD in either dsb mutant abrogated the enhanced biofilm-formation. Likewise, overexpression of the c-di-GMP phosphodiesterase YhjH, or mutationally inactivating the CsgD activator EAL-domain protein YdiV, reduced biofilm-formation in either of the dsb mutants. Intriguingly, deleting the GGDEF-EAL domain protein gene STM3615 (yhjK), previously not connected to rdar morphotype development, also abrogated the escalated rdar morphotype formation in dsb mutant backgrounds. Enhanced biofilm-formation in dsb mutants was furthermore annulled by exposure to the protein disulfide catalyst copper chloride. When analyzed for the effect of exogenous reducing stress on biofilm-formation, both dsb mutants initially showed an escalated rdar morphotype development that later dissolved to reveal a smooth mucoid colony morphotype. From these results we conclude that biofilm-development in S. Typhimurium is affected by periplasmic protein disulphide bond status through CsgD, and discuss the involvement of selected GGDEF/EAL domain protein(s) as signaling mediators.	[Anwar, Naeem; Rouf, Syed Fazle; Romling, Ute; Rhen, Mikael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Anwar, Naeem] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan	Karolinska Institutet; Lahore University of Management Sciences	Rouf, SF (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Syed.rouf@gmail.com; mikael.rhen@ki.se	Anwar, Naeem/A-6945-2011	Anwar, Naeem/0000-0001-8638-2158; Romling, Ute/0000-0003-3812-6621	Vetenskapsradet (Swedish Research Council) [VR-2011-3379]	Vetenskapsradet (Swedish Research Council)(Swedish Research Council)	This study was supported by grants from Vetenskapsradet (Swedish Research Council) to MR with grant number VR-2011-3379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Ahmad I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028351; Ahmed I, 2013, THESIS KAROLINSKA I, P27; Anwar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064948; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; BUCHWALD DS, 1984, REV INFECT DIS, V6, P345; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Dinesh SD, 2003, CLIN MICROBIOL INFEC, V9, P1228, DOI 10.1111/j.1469-0691.2003.00793.x; EDELMAN R, 1986, REV INFECT DIS, V8, P329; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; Gast RK, 2013, J FOOD PROTECT, V76, P108, DOI 10.4315/0362-028X.JFP-12-268; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Gerstel U, 2006, FEMS MICROBIOL LETT, V261, P109, DOI 10.1111/j.1574-6968.2006.00332.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jansen A, 2011, ANN EPIDEMIOLOGICAL; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Kim YH, 2006, PROTEOMICS, V6, P6181, DOI 10.1002/pmic.200600320; Kolker S, 2012, CLIN MICROBIOL INFEC, V18, P167, DOI 10.1111/j.1469-0691.2011.03533.x; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee Y, 2008, FEMS MICROBIOL LETT, V278, P213, DOI 10.1111/j.1574-6968.2007.00993.x; Lee Y, 2009, FEMS MICROBIOL LETT, V297, P38, DOI 10.1111/j.1574-6968.2009.01650.x; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Lin DX, 2009, MICROBIOL-SGM, V155, P4014, DOI 10.1099/mic.0.032904-0; Lippa AM, 2012, J BACTERIOL, V194, P1457, DOI 10.1128/JB.06055-11; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Negrea A, 2009, J BACTERIOL, V191, P6918, DOI 10.1128/JB.00532-09; Ogasawara H, 2007, J BACTERIOL, V189, P4791, DOI 10.1128/JB.00319-07; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; Pang T, 1998, TRENDS MICROBIOL, V6, P131, DOI 10.1016/S0966-842X(98)01236-0; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 2003, INT J MED MICROBIOL, V293, P273, DOI 10.1078/1438-4221-00268; Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Romling U, 1999, FEMS MICROBIOL LETT, V180, P91; Romling U., 2003, MED IMPLICATIONS BIO, P231; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ruby T, 2012, FEMS MICROBIOL REV, V36, P600, DOI 10.1111/j.1574-6976.2012.00332.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sambrook J, 2001, MOL CLONING, V3; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Simm R, 2007, J BACTERIOL, V189, P3613, DOI 10.1128/JB.01719-06; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Suo YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048467; Tagliabue L, 2010, FEMS IMMUNOL MED MIC, V59, P477, DOI 10.1111/j.1574-695X.2010.00702.x; TINGE SA, 1990, J BACTERIOL, V172, P5266, DOI 10.1128/jb.172.9.5266-5277.1990; Vianney A, 2005, MICROBIOL-SGM, V151, P2487, DOI 10.1099/mic.0.27913-0; Wang SY, 2010, APPL ENVIRON MICROB, V76, P5013, DOI 10.1128/AEM.00823-10; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zakikhany K, 2010, MOL MICROBIOL, V77, P771, DOI 10.1111/j.1365-2958.2010.07247.x; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	86	25	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106095	10.1371/journal.pone.0106095	http://dx.doi.org/10.1371/journal.pone.0106095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153529	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200115
J	Ren, JY; Cone, A; Willmot, R; Jones, IM				Ren, Junyuan; Cone, Abigail; Willmot, Rebecca; Jones, Ian M.			Assembly of Recombinant Israeli Acute Paralysis Virus Capsids	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; VESICULAR DISEASE VIRUS; APIS-MELLIFERA; HONEY-BEE; VARROA-DESTRUCTOR; GENETIC-ANALYSIS; BACULOVIRUS; EXPRESSION; PROTEINS; PREVALENCE	The dicistrovirus Israeli Acute Paralysis Virus (IAPV) has been implicated in the worldwide decline of honey bees. Studies of IAPV and many other bee viruses in pure culture are restricted by available isolates and permissive cell culture. Here we show that coupling the IAPV major structural precursor protein ORF2 to its cognate 3C-like processing enzyme results in processing of the precursor to the individual structural proteins in a number of insect cell lines following expression by a recombinant baculovirus. The efficiency of expression is influenced by the level of IAPV 3C protein and moderation of its activity is required for optimal expression. The mature IAPV structural proteins assembled into empty capsids that migrated as particles on sucrose velocity gradients and showed typical dicistrovirus like morphology when examined by electron microscopy. Monoclonal antibodies raised to recombinant capsids were configured into a diagnostic test specific for the presence of IAPV. Recombinant capsids for each of the many bee viruses within the picornavirus family may provide virus specific reagents for the on-going investigation of the causes of honeybee loss.	[Ren, Junyuan; Cone, Abigail; Willmot, Rebecca; Jones, Ian M.] Univ Reading, Sch Biol Sci, Reading, Berks, England	University of Reading	Jones, IM (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	i.m.jones@rdg.ac.uk		Jones, Ian/0000-0002-7738-2516	UK Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/G02040X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G02040X/1] Funding Source: researchfish; Medical Research Council [979666] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC), www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2003, VIROLOGY, V308, P157, DOI 10.1016/S0042-6822(02)00141-1; Agirre J, 2011, VIROLOGY, V409, P91, DOI 10.1016/j.virol.2010.09.034; Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; Anderson D, 2008, SCIENCE, V319, P724, DOI 10.1126/science.319.5864.724c; Antunez K, 2012, RES VET SCI, V93, P1441, DOI 10.1016/j.rvsc.2012.03.006; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Blanchard P, 2008, J INVERTEBR PATHOL, V99, P348, DOI 10.1016/j.jip.2008.07.006; BRAUTIGAM S, 1993, VIROLOGY, V192, P512, DOI 10.1006/viro.1993.1067; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cornman RS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-154; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Dinman JD, 2012, ADV PROTEIN CHEM STR, V86, P129, DOI 10.1016/B978-0-12-386497-0.00004-9; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Ferris NP, 2010, J VIROL METHODS, V163, P477, DOI 10.1016/j.jviromet.2009.09.023; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Ghildyal R, 2009, J VIROL, V83, P7349, DOI 10.1128/JVI.01748-08; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Hunter WB, 2010, IN VITRO CELL DEV-AN, V46, P83, DOI 10.1007/s11626-009-9246-x; Kitagishi Y, 2011, IN VITRO CELL DEV-AN, V47, P451, DOI 10.1007/s11626-011-9431-6; Ko YJ, 2005, CLIN DIAGN LAB IMMUN, V12, P922, DOI 10.1128/CDLI.12.8.922-929.2005; Kojima Y, 2011, MICROB ECOL, V62, P895, DOI 10.1007/s00248-011-9947-z; Levy S, 2011, NATURE, V479, P164, DOI 10.1038/479164a; Li ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077354; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002273; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Oem JK, 2007, VACCINE, V25, P4112, DOI 10.1016/j.vaccine.2006.08.046; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Pengelley SC, 2006, PROTEIN EXPRES PURIF, V48, P173, DOI 10.1016/j.pep.2006.04.016; Porta Claudine, 2013, J Virol Methods, V187, P406, DOI 10.1016/j.jviromet.2012.11.011; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Reynaldi FJ, 2011, REV ARGENT MICROBIOL, V43, P84, DOI 10.1590/S0325-75412011000200003; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Squires G, 2013, ACTA CRYSTALLOGR D, V69, P1026, DOI 10.1107/S0907444913004617; Tate J, 1999, NAT STRUCT BIOL, V6, P765, DOI 10.1038/11543; Tomkies V, 2009, APIDOLOGIE, V40, P63, DOI 10.1051/apido:2008060; Valles SM, 2008, VIRUS RES, V136, P189, DOI 10.1016/j.virusres.2008.04.009; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; Xie L, 2009, SCI CHINA SER C, V52, P1186, DOI 10.1007/s11427-009-0151-z; Yang B, 2013, ECOL EVOL, V3, P298, DOI 10.1002/ece3.464; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	50	4	4	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105943	10.1371/journal.pone.0105943	http://dx.doi.org/10.1371/journal.pone.0105943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153716	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000340952200092
J	Tseng, SP; Tsai, WC; Liang, CY; Lin, YS; Huang, JW; Chang, CY; Tyan, YC; Lu, PL				Tseng, Sung-Pin; Tsai, Wan-Chi; Liang, Chih-Yuan; Lin, Yin-Shiou; Huang, Jun-Wei; Chang, Chung-Yu; Tyan, Yu-Chang; Lu, Po-Liang			The Contribution of Antibiotic Resistance Mechanisms in Clinical Burkholderia cepacia Complex Isolates: An Emphasis on Efflux Pump Activity	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; CENOCEPACIA; BACTEREMIA; GENE; IDENTIFICATION; VIETNAMIENSIS; EPIDEMIOLOGY; INTEGRONS	Due to the limited information of the contribution of various antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates, Antibiotic resistance mechanisms, including integron analysis, identification of quinolone resistance-determining region mutations, measurement of efflux pump activity, and sequence analysis of efflux pump regulators, were investigated in 66 clinical B. cepacia complex isolates. Species were identified via recA-RFLP and MALDI-TOF. Four genomovars were identified by recA-RFLP. B. cenocepacia (genomovar III) was the most prevalent genomovar (90.1%). Most isolates (60/66, 90.9%) were correctly identified by MALDI-TOF analysis. Clonal relatedness determined by PFGE analysis revealed 30 pulsotypes, including two major pulsotypes that comprised 22.7% and 18.2% of the isolates, respectively. Seventeen (25.8%) isolates harboured class 1 integron with various combinations of resistance genes. Among six levofloxacin-resistant isolates, five had single-base substitutions in the gyrA gene and three demonstrated efflux pump activities. Among the 42 isolates exhibiting resistance to at least one antimicrobial agent, 94.4% ceftazidime-resistant isolates (17/18) and 72.7% chloramphenicol-resistant isolates (16/22) demonstrated efflux pump activity. Quantitation of efflux pump RNA level and sequence analysis revealed that over-expression of the RND-3 efflux pump was attributable to specific mutations in the RND-3 efflux pump regulator gene. In conclusion, high-level expression of efflux pumps is prevalent in B. cepacia complex isolates. Mutations in the RND-3 efflux pump regulator gene are the major cause of efflux pump activity, resulting in the resistance to antibiotics in clinical B. cepacia complex isolates.	[Tseng, Sung-Pin; Tsai, Wan-Chi; Liang, Chih-Yuan; Lin, Yin-Shiou; Huang, Jun-Wei] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Tseng, Sung-Pin; Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Chang, Chung-Yu; Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lu, PL (corresponding author), Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.	d830166@cc.kmu.edu.tw	Lu, Po-Liang/D-4499-2009	Lu, Po-Liang/0000-0002-7423-6783; Tseng, sung-pin/0000-0001-8915-5268	Kaohsiung Medical University Research Foundation [KMU-Q102005]; NSYSU-KMU Joint Research Project, Taiwan [NSYSUKMU102-I004]	Kaohsiung Medical University Research Foundation; NSYSU-KMU Joint Research Project, Taiwan	This work was supported by KMU-Q102005 from Kaohsiung Medical University Research Foundation and NSYSUKMU102-I004 from the NSYSU-KMU Joint Research Project, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewoye L, 2002, J BACTERIOL, V184, P4308, DOI 10.1128/JB.184.15.4308-4312.2002; ARONOFF SC, 1988, ANTIMICROB AGENTS CH, V32, P1636, DOI 10.1128/AAC.32.11.1636; Bazzini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018902; BISSONNETTE L, 1992, J BACTERIOL, V174, P1248, DOI 10.1128/jb.174.4.1248-1257.1992; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Coenye T, 2011, ANTIMICROB AGENTS CH, V55, P1912, DOI 10.1128/AAC.01571-10; Crowley D, 2002, J APPL MICROBIOL, V92, P992, DOI 10.1046/j.1365-2672.2002.01612.x; Degand N, 2008, J CLIN MICROBIOL, V46, P3361, DOI 10.1128/JCM.00569-08; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Fehlner-Gardiner CC, 2002, FEMS MICROBIOL LETT, V215, P279, DOI 10.1111/j.1574-6968.2002.tb11403.x; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Guglierame P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-66; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Huang Chien-Hsien, 2001, Journal of Microbiology Immunology and Infection, V34, P215; Ku NS, 2011, SCAND J INFECT DIS, V43, P792, DOI 10.3109/00365548.2011.589076; Liao CH, 2011, DIAGN MICR INFEC DIS, V70, P260, DOI 10.1016/j.diagmicrobio.2011.01.008; LiPuma JJ, 2002, LANCET, V359, P2002, DOI 10.1016/S0140-6736(02)08836-0; Lu DCT, 1997, J FORMOS MED ASSOC, V96, P972; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P3165, DOI 10.1128/JCM.38.9.3165-3173.2000; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; MOORE RA, 1986, ANTIMICROB AGENTS CH, V30, P923, DOI 10.1128/AAC.30.6.923; Nair BM, 2004, J CLIN INVEST, V113, P464, DOI 10.1172/JCi200419710; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Perrin E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-164; Petrucca A, 2003, RES MICROBIOL, V154, P491, DOI 10.1016/S0923-2508(03)00145-1; Pope CF, 2008, ANTIMICROB AGENTS CH, V52, P1201, DOI 10.1128/AAC.00799-07; Ramirez MS, 2005, ANTIMICROB AGENTS CH, V49, P4418, DOI 10.1128/AAC.49.10.4418-4420.2005; Rushton L, 2013, ANTIMICROB AGENTS CH, V57, P2972, DOI 10.1128/AAC.00140-13; Sass A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-373; Siddiqui AH, 2001, INFECT CONT HOSP EP, V22, P419, DOI 10.1086/501927; Ramirez MS, 2010, ANTIMICROB AGENTS CH, V54, P699, DOI 10.1128/AAC.01392-08; Vettoretti L, 2009, ANTIMICROB AGENTS CH, V53, P1987, DOI 10.1128/AAC.01024-08; Yu WL, 1999, SCAND J INFECT DIS, V31, P293, DOI 10.1080/00365549950163608; Zhang Y, 2010, ANTIMICROB AGENTS CH, V54, P4772, DOI 10.1128/AAC.00009-10	38	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104986	10.1371/journal.pone.0104986	http://dx.doi.org/10.1371/journal.pone.0104986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153194	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200033
J	Wheat, JC; Krause, DS; Shin, TH; Chen, X; Wang, JF; Ding, DC; Yamin, R; Sweetser, DA				Wheat, Justin C.; Krause, Daniela S.; Shin, Thomas H.; Chen, Xi; Wang, Jianfeng; Ding, Dacheng; Yamin, Rae'e; Sweetser, David A.			The Corepressor Tle4 Is a Novel Regulator of Murine Hematopoiesis and Bone Development	PLOS ONE			English	Article							STEM-CELLS; TRANSCRIPTIONAL REPRESSION; B LYMPHOPOIESIS; PAX5 BSAP; GROUCHO; FAMILY; DIFFERENTIATION; PATHWAYS; PROTEIN; MICE	Hematopoiesis is a complex process that relies on various cell types, signaling pathways, transcription factors and a specific niche. The integration of these various components is of critical importance to normal blood development, as deregulation of these may lead to bone marrow failure or malignancy. Tle4, a transcriptional corepressor, acts as a tumor suppressor gene in a subset of acute myeloid leukemia, yet little is known about its function in normal and malignant hematopoiesis or in mammalian development. We report here that Tle4 knockout mice are runted and die at around four weeks with defects in bone development and BM aplasia. By two weeks of age, Tle4 knockout mice exhibit leukocytopenia, B cell lymphopenia, and significant reductions in hematopoietic stem and progenitor cells. Tle4 deficient hematopoietic stem cells are intrinsically defective in B lymphopoiesis and exhaust upon stress, such as serial transplantation. In the absence of Tle4 there is a profound decrease in bone mineralization. In addition, Tle4 knockout stromal cells are defective at maintaining wild-type hematopoietic stem cell function in vitro. In summary, we illustrate a novel and essential role for Tle4 in the extrinsic and intrinsic regulation of hematopoiesis and in bone development.	[Wheat, Justin C.; Shin, Thomas H.; Chen, Xi; Wang, Jianfeng; Ding, Dacheng; Yamin, Rae'e; Sweetser, David A.] Massachusetts Gen Hosp, Dept Pediat, Div Pediat Hematol Oncol, Boston, MA 02114 USA; [Wheat, Justin C.; Shin, Thomas H.; Chen, Xi; Wang, Jianfeng; Ding, Dacheng; Yamin, Rae'e; Sweetser, David A.] Massachusetts Gen Hosp, Div Med Genet, Boston, MA 02114 USA; [Krause, Daniela S.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Krause, Daniela S.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Krause, Daniela S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shin, Thomas H.] Boston Univ, Sch Med, Dept Mol & Translat Med, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University	Sweetser, DA (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Div Pediat Hematol Oncol, Boston, MA 02114 USA.	dsweetser@partners.org	Sweetser, David/ABB-9347-2021	Sweetser, David/0000-0002-1621-3284; Wheat, Justin/0000-0003-0018-4981	National Institutes of Health [K08 CA138916-02, R01 CA115772, T32 CA071345]; Hyundai Hope on Wheels; Mattina Proctor Foundation (75 Federal St, Boston, Massachusetts 02110); NATIONAL CANCER INSTITUTE [K08CA138916, R01CA115772, T32CA071345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels; Mattina Proctor Foundation (75 Federal St, Boston, Massachusetts 02110); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants K08 CA138916-02 (DSK), R01 CA115772 (DAS, JCW, XC, JW), and T32 CA071345 (JW) as well as funding by Hyundai Hope on Wheels (DAS; http://www.hyundaihopeonwheels.org) and the Mattina Proctor Foundation (DAS; 75 Federal St, Boston, Massachusetts 02110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Beagle B, 2010, DEV DYNAM, V239, P2795, DOI 10.1002/dvdy.22439; Brunquell C, 2012, MOL CANCER RES, V10, P1482, DOI 10.1158/1541-7786.MCR-12-0144; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Dayyani F, 2008, BLOOD, V111, P4338, DOI 10.1182/blood-2007-07-103291; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Krause DS, 2013, NAT MED IN PRESS; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Milili M, 2002, IMMUNOLOGY, V106, P447, DOI 10.1046/j.1365-2567.2002.01456.x; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nwajei Felix, 2013, Adv Hematol, V2013, P953982, DOI 10.1155/2013/953982; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Seo SW, 2011, J ORTHOP RES, V29, P1131, DOI 10.1002/jor.21318; Turki-Judeh W, 2012, CURR TOP DEV BIOL, V98, P65, DOI 10.1016/B978-0-12-386499-4.00003-3; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang WF, 2002, DEV DYNAM, V224, P79, DOI 10.1002/dvdy.10089; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	29	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105557	10.1371/journal.pone.0105557	http://dx.doi.org/10.1371/journal.pone.0105557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153823	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200060
J	Simpson, JL; Powell, H; Baines, KJ; Milne, D; Coxson, HO; Hansbro, PM; Gibson, PG				Simpson, Jodie L.; Powell, Heather; Baines, Katherine J.; Milne, David; Coxson, Harvey O.; Hansbro, Philip M.; Gibson, Peter G.			The Effect of Azithromycin in Adults with Stable Neutrophilic COPD: A Double Blind Randomised, Placebo Controlled Trial	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CYSTIC FIBROSIS BRONCHIECTASIS; LONG-TERM; AIRWAY INFLAMMATION; EXACERBATIONS; ASTHMA; ERYTHROMYCIN; MACROLIDES; DECLINE; CLARITHROMYCIN	Background: Chronic Obstructive Pulmonary Disease (COPD) is a progressive airway disease characterised by airway inflammation or bronchitis. Neutrophilic bronchitis is associated with both bacterial colonisation and lung decline and is common in exacerbations of COPD. Despite current available therapies to control inflammation, bronchitis remains common. This study tested the hypothesis that azithromycin treatment, as an add-on to medication, would significantly reduce airway neutrophil and neutrophils chemokine (CXCL8) levels, as well as load. We conducted a randomised, double-blind, placebo-controlled study in COPD participants with stable bronchitis. Methods: Eligible participants (n = 30) were randomised to azithromycin 250 mg daily or placebo for 12 weeks in to their standard respiratory medications. Sputum was induced at screening, randomisation and monthly for a 12 treatment period and processed for differential cell counts, CXCL8 and neutrophil elastase assessment. bacteriology was assessed in sputum samples at randomisation and the end of treatment visit. Severe exacerbations symptoms increased requiring unscheduled treatment were recorded during the 12 week treatment period and weeks following treatment. A sub-group of participants underwent chest computed tomography scans (n = 15). Results: Nine participants with neutrophilic bronchitis had a potentially pathogenic bacteria isolated and the bacterial load of all participants was 5.22 x 10(7) cfu/mL. Azithromycin treatment resulted in a non-significant sputum neutrophil proportion, CXCL8 levels and bacterial load. The mean severe exacerbation rate was 0.33 per 26 weeks in the azithromycin group compared to 0.93 exacerbations per person in the placebo group (incidence (95%CI): 0.37 (0.11,1.21), p = 0.062). For participants who underwent chest CT scans, no alterations were observed. Conclusions: In stable COPD with neutrophilic bronchitis, add-on azithromycin therapy showed a trend to reduced exacerbations sputum neutrophils, CXCL8 levels and bacterial load. Future studies with a larger sample size are warranted.	[Simpson, Jodie L.; Baines, Katherine J.; Hansbro, Philip M.; Gibson, Peter G.] Univ Newcastle, Fac Hlth & Med, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; [Simpson, Jodie L.; Baines, Katherine J.; Hansbro, Philip M.; Gibson, Peter G.] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia; [Powell, Heather; Gibson, Peter G.] Hunter New England Area Hlth Serv, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Milne, David] Auckland Dist Hlth Board, Auckland, New Zealand; [Coxson, Harvey O.] Univ British Columbia, Dept Radiol, Vancouver, BC V5Z 1M9, Canada; [Coxson, Harvey O.] Univ British Columbia, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Auckland District Health Board; University of British Columbia; University of British Columbia	Simpson, JL (corresponding author), Univ Newcastle, Fac Hlth & Med, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	jodie.simpson@newcastle.edu.au	Coxson, Harvey O/A-9861-2017; BAINES, KATHERINE JOANNE/G-7654-2013; SIMPSON, JODIE LOUISE/G-7639-2013; Hansbro, Phil/G-7486-2013; gibson, peter/G-6194-2014	Coxson, Harvey O/0000-0001-5750-9711; BAINES, KATHERINE JOANNE/0000-0002-4240-6581; SIMPSON, JODIE LOUISE/0000-0002-3626-680X; Hansbro, Phil/0000-0002-4741-3035; gibson, peter/0000-0001-5865-489X	National Health and Medical Research Council of Australia [455508]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the National Health and Medical Research Council of Australia through a project grant, ID 455508 2007-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; [Anonymous], 2013, GLOBAL STRATEGY MANA; Banerjee Dev, 2004, Treat Respir Med, V3, P59, DOI 10.2165/00151829-200403010-00007; BASELSKI VS, 1994, CLIN MICROBIOL REV, V7, P533, DOI 10.1128/CMR.7.4.533-558.1994; Basyigit I, 2004, ANN PHARMACOTHER, V38, P1400, DOI 10.1345/aph.1D634; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Charalambous BM, 2003, J CLIN MICROBIOL, V41, P5551, DOI 10.1128/JCM.41.12.5551-5556.2003; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Fujita K, 2000, EUR ARCH OTO-RHINO-L, V257, P199, DOI 10.1007/s004050050222; Gibson PG, 1998, AM J RESP CRIT CARE, V158, P36, DOI 10.1164/ajrccm.158.1.9705031; Hansbro PM, 2012, RESPIROLOGY, V17, P739, DOI 10.1111/j.1440-1843.2012.02186.x; He ZY, 2010, RESPIRATION, V80, P445, DOI 10.1159/000321374; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kadota J, 2005, INTERNAL MED, V44, P200, DOI 10.2169/internalmedicine.44.200; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; Marjanovic N, 2011, PHARMACOL RES, V63, P389, DOI 10.1016/j.phrs.2011.02.001; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Sato S, 2003, CHEST, V124, P1749, DOI 10.1378/chest.124.5.1749; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Serisier DJ, 2013, JAMA-J AM MED ASSOC, V309, P1260, DOI 10.1001/jama.2013.2290; Simpson JL, 2013, CLIN EXP ALLERGY, V43, P29, DOI 10.1111/j.1365-2222.2012.04075.x; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Simpson JL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/462934; Simpson JL, 2009, PHARMACOL THERAPEUT, V124, P86, DOI 10.1016/j.pharmthera.2009.06.004; Simpson JL, 2009, RESP MED, V103, P881, DOI 10.1016/j.rmed.2008.12.013; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; Verleden GM, 2006, AM J RESP CRIT CARE, V174, P566, DOI 10.1164/rccm.200601-071OC; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Wolter J, 2002, THORAX, V57, P212, DOI 10.1136/thorax.57.3.212; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; Yamaryo T, 2003, ANTIMICROB AGENTS CH, V47, P48, DOI 10.1128/AAC.47.1.48-53.2003; Yao GY, 2013, MACROLIDE THERAPY DE	36	59	61	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105609	10.1371/journal.pone.0105609	http://dx.doi.org/10.1371/journal.pone.0105609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148049	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600061
J	Jho, HJ; Kim, Y; Kong, KA; Kim, DH; Choi, JY; Nam, EJ; Choi, JY; Koh, S; Hwang, KO; Baek, SK; Park, EJ				Jho, Hyun Jung; Kim, Yeol; Kong, Kyung Ae; Kim, Dae Hyun; Choi, Jin Young; Nam, Eun Jeong; Choi, Jin Young; Koh, Sujin; Hwang, Kwan Ok; Baek, Sun Kyung; Park, Eun Jung			Knowledge, Practices, and Perceived Barriers Regarding Cancer Pain Management among Physicians and Nurses in Korea: A Nationwide Multicenter Survey	PLOS ONE			English	Article							HEALTH-CARE PROVIDERS; ATTITUDES; PREVALENCE; EDUCATION; DOCTORS; MODEL	Purpose: Medical professionals' practices and knowledge regarding cancer pain management have often been cited as inadequate. This study aimed to evaluate knowledge, practices and perceived barriers regarding cancer pain management among physicians and nurses in Korea. Methods: A nationwide questionnaire survey was administered to physicians and nurses involved in the care of cancer patients. Questionnaire items covered pain assessment and documentation practices, knowledge regarding cancer pain management, the perceived barriers to cancer pain control, and processes perceived as the major causes of delay in opioid administration. Results: A total of 333 questionnaires (149 physicians and 284 nurses) were analyzed. Nurses performed pain assessment and documentation more regularly than physicians did. Although physicians had better knowledge of pain management than did nurses, both groups lacked knowledge regarding the side effects and pharmacology of opioids. Physicians working in the palliative care ward and nurses who had received pain management education obtained higher scores on knowledge. Physicians perceived patients' reluctance to take opioids as a barrier to pain control, more so than did nurses, while nurses perceived patients' tendency to under-report of pain as a barrier, more so than did physicians. Physicians and nurses held different perceptions regarding major cause of delay during opioid administration. Conclusions: There were differences between physicians and nurses in knowledge and practices for cancer pain management. An effective educational strategy for cancer pain management is needed in order to improve medical professionals' knowledge and clinical practices.	[Jho, Hyun Jung; Choi, Jin Young; Park, Eun Jung] Natl Canc Ctr, Natl Canc Control Inst, Hosp & Palliat Care Branch, Goyang, South Korea; [Kim, Yeol] Natl Canc Ctr, Natl Canc Control Inst, Div Canc Management & Policy, Goyang, South Korea; [Kong, Kyung Ae] Ewha Womans Univ, Med Ctr, Clin Trial Ctr, Seoul, South Korea; [Kim, Dae Hyun] Natl Canc Ctr, Dept Pain & Anesthesiol, Goyang, South Korea; [Nam, Eun Jeong; Choi, Jin Young] Natl Canc Ctr, Dept Nursing, Goyang, South Korea; [Koh, Sujin] Ulsan Univ Hosp, Dept Hematol & Oncol, Ulsan, South Korea; [Hwang, Kwan Ok] Korean Hosp & Palliat Nurse Assoc, Taejon, South Korea; [Baek, Sun Kyung] Kyung Hee Univ, Med Ctr, Dept Med Oncol & Hematol, Seoul, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Ewha Womans University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); University of Ulsan; Ulsan University Hospital; Kyung Hee University	Kim, Y (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Div Canc Management & Policy, Goyang, South Korea.	drheat@ncc.re.kr			National Cancer Center [1032040-1]	National Cancer Center	This research was funded by National Cancer Center grant number 1032040-1. URL of funder http://ncc.re.kr/english/index.jsp. YK received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi M, 2007, EUR J ONCOL NURS, V11, P272, DOI 10.1016/j.ejon.2006.09.003; Bookbinder M, 1996, J PAIN SYMPTOM MANAG, V12, P334, DOI 10.1016/S0885-3924(96)00204-7; Breuer B, 2011, J CLIN ONCOL, V29, P4769, DOI 10.1200/JCO.2011.35.0561; Deandrea S, 2008, ANN ONCOL, V19, P1985, DOI 10.1093/annonc/mdn419; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Furstenberg CT, 1998, J PAIN SYMPTOM MANAG, V15, P335, DOI 10.1016/S0885-3924(98)00023-2; Gallagher R, 2004, Pain Res Manag, V9, P188; Ger LP, 2000, J PAIN SYMPTOM MANAG, V20, P335, DOI 10.1016/S0885-3924(00)00207-4; Gunnarsdottir S, 2002, PAIN, V99, P385, DOI 10.1016/S0304-3959(02)00243-9; International Associations for the Study of Pain, 2008, BARR CANC PAIN TREAT; Jeon YS, 2007, SUPPORT CARE CANCER, V15, P463, DOI 10.1007/s00520-006-0183-x; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kim HJ, 2012, ASIAN ONCOL NURS, V12, P147, DOI 10.5388/aon.2012.12.2.147; Kim MH, 2011, JPN J CLIN ONCOL, V41, P783, DOI 10.1093/jjco/hyr043; Lebovits AH, 1997, CLIN J PAIN, V13, P237, DOI 10.1097/00002508-199709000-00009; Lui LYY, 2008, J CLIN NURS, V17, P2014, DOI 10.1111/j.1365-2702.2007.02183.x; Meuser T, 2001, PAIN, V93, P247, DOI 10.1016/S0304-3959(01)00324-4; Pargeon KL, 1999, J PAIN SYMPTOM MANAG, V18, P358, DOI 10.1016/S0885-3924(99)00097-4; Sapir R, 1999, J PAIN SYMPTOM MANAG, V17, P266, DOI 10.1016/S0885-3924(98)00156-0; Su YJ, 2010, SUPPORT CARE CANCER, V18, P1455, DOI 10.1007/s00520-009-0768-2; Sun VCY, 2007, J PAIN SYMPTOM MANAG, V34, P359, DOI 10.1016/j.jpainsymman.2006.12.011; Visentin M, 2001, J PAIN SYMPTOM MANAG, V22, P925, DOI 10.1016/S0885-3924(01)00355-4; Weissman DE, 1996, J PAIN SYMPTOM MANAG, V12, P364, DOI 10.1016/S0885-3924(96)00185-6; WEISSMAN DE, 1995, J PAIN SYMPTOM MANAG, V10, P292, DOI 10.1016/0885-3924(95)00006-K; World Health Organization, 1996, CANC PAIN REL GUID O; Xue Ying, 2007, Clin J Oncol Nurs, V11, P687; Yun YH, 2003, J PAIN SYMPTOM MANAG, V25, P430, DOI 10.1016/S0885-3924(03)00103-9; 전명희, 2006, [The Journal of Korean Academic Society of Nursing Education, 한국간호교육학회지], V12, P115; 박현애, 2003, [Korean Journal of Adult Nursing, 성인간호학회지], V15, P205	29	44	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105900	10.1371/journal.pone.0105900	http://dx.doi.org/10.1371/journal.pone.0105900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144641	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100127
J	Wang, RR; Yang, QH; Luo, RH; Peng, YM; Dai, SX; Zhang, XJ; Chen, H; Cui, XQ; Liu, YJ; Huang, JF; Chang, JB; Zheng, YT				Wang, Rui-Rui; Yang, Qing-Hua; Luo, Rong-Hua; Peng, You-Mei; Dai, Shao-Xing; Zhang, Xing-Jie; Chen, Huan; Cui, Xue-Qing; Liu, Ya-Juan; Huang, Jing-Fei; Chang, Jun-Biao; Zheng, Yong-Tang			Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; QUANTITATIVE-ANALYSIS; ANTIVIRAL ACTIVITY; 3TC RESISTANCE; HIV TYPE-1; ANALOGS; REPLICATION; COMPLEX; PROTEIN; DESIGN	Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus. Here we reported the in vitro activity of azvudine against HIV-1 and HIV-2 when used alone or in combination with other antiretroviral drugs and its drug resistance features. Azvudine exerted highly potent inhibition on HIV-1 (EC(50)s ranging from 0.03 to 6.92 nM) and HIV-2 (EC(50)s ranging from 0.018 to 0.025 nM). It also showed synergism in combination with six approved anti-HIV drugs on both C8166 and PBMC. In combination assay, the concentrations of azvudine used were 1000 or 500 fold lower than other drugs. Azvudine also showed potent inhibition on NRTI-resistant strains (L74V and T69N). Although M184V caused 250 fold reduction in susceptibility, azvudine remained active at nanomolar range. In in vitro induced resistant assay, the frequency of M184I mutation increased with induction time which suggests M184I as the key mutation in azvudine treatment. As control, lamivudine treatment resulted in a higher frequency of M184I/V given the same induction time and higher occurrence of M184V was found. Molecular modeling analysis suggests that steric hindrance is more pronounced in mutant M184I than M184V due to the azido group of azvudine. The present data demonstrates the potential of azvudine as a complementary drug to current anti-HIV drugs. M184I should be the key mutation, however, azvudine still remains active on HIV-1(LAI-M184V) at nanomolar range.	[Wang, Rui-Rui; Luo, Rong-Hua; Zhang, Xing-Jie; Chen, Huan; Cui, Xue-Qing; Liu, Ya-Juan; Zheng, Yong-Tang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Wang, Rui-Rui; Luo, Rong-Hua; Zhang, Xing-Jie; Chen, Huan; Cui, Xue-Qing; Liu, Ya-Juan; Zheng, Yong-Tang] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Yang, Qing-Hua; Peng, You-Mei; Chang, Jun-Biao] Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou 450052, Henan, Peoples R China; [Zhang, Xing-Jie; Chen, Huan; Liu, Ya-Juan] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Dai, Shao-Xing; Huang, Jing-Fei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Cui, Xue-Qing] Dali Univ, Coll Pharm & Chem, Dali, Yunnan, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Zhengzhou University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Dali University	Chang, JB (corresponding author), Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou 450052, Henan, Peoples R China.	changjunbiao@zzu.edu.cn; zhengyt@mail.kiz.ac.cn	Dai, shaoxing/ABA-8699-2020	Dai, Shao-Xing/0000-0002-6919-2034	Twelfth Five-Year Key Scientific and Technological Program of China [2012ZX10001-006, 2012ZX10001-007, 2012ZX09103-101-022]; National Natural Science Foundation of China [21172202, 81001462, 81102483]; Yunnan Province [2010GA001, Y103951111]	Twelfth Five-Year Key Scientific and Technological Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province	This work was supported in part by grants from the Twelfth Five-Year Key Scientific and Technological Program of China (2012ZX10001-006, 2012ZX10001-007, 2012ZX09103-101-022), the National Natural Science Foundation of China (21172202, 81001462, 81102483), Yunnan Province (2010GA001, Y103951111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Peter L, 2010, Clin Med Rev Ther, V2, pa2004; Barnas D, 2010, ANTIVIR THER, V15, P437, DOI 10.3851/IMP1539; Boyer PL, 2012, J VIROL, V86, P5885, DOI 10.1128/JVI.06597-11; Chesney MA, 2006, JAIDS-J ACQ IMM DEF, V43, pS149, DOI 10.1097/01.qai.0000243112.91293.26; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cihlar T, 2008, ANTIMICROB AGENTS CH, V52, P655, DOI 10.1128/AAC.01215-07; Das K, 2012, NAT STRUCT MOL BIOL, V19, P253, DOI 10.1038/nsmb.2223; GU ZX, 1995, P NATL ACAD SCI USA, V92, P2760, DOI 10.1073/pnas.92.7.2760; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Kodama EI, 2001, ANTIMICROB AGENTS CH, V45, P1539, DOI 10.1128/AAC.45.5.1539-1546.2001; Lacombe K, 2010, J ANTIMICROB CHEMOTH, V65, P10, DOI 10.1093/jac/dkp414; Li L, 2010, AIDS RES HUM RETROV, V26, P711, DOI 10.1089/aid.2010.0001; Liu GJ, 2007, CELL MOL IMMUNOL, V4, P203; Lu XF, 2012, ANTIMICROB AGENTS CH, V56, P341, DOI 10.1128/AAC.05537-11; Murphy R L, 1999, AIDS Clin Care, V11, P47; Murphy RL, 1999, AIDS CLIN CARE, V11, P51; Murphy RL, 1999, AIDS CLIN CARE, V11, P53; Ntemgwa M, 2007, ANTIMICROB AGENTS CH, V51, P3861, DOI 10.1128/AAC.00646-07; Ohrui H, 2000, J MED CHEM, V43, P4516, DOI 10.1021/jm000209n; Pannecouque C, 2008, NAT PROTOC, V3, P427, DOI 10.1038/nprot.2007.517; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Rando RF, 2000, DRUG DISCOV TODAY, V5, P465, DOI 10.1016/S1359-6446(00)01558-0; Rezende LF, 1998, NUCLEIC ACIDS RES, V26, P3066, DOI 10.1093/nar/26.12.3066; Richman DD, 2001, ANTIVIR THER, V6, P83; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Scaglione F, 2012, INT J ANTIMICROB AG, V39, P458, DOI 10.1016/j.ijantimicag.2011.11.013; SCHINAZI RF, 1992, ANTIMICROB AGENTS CH, V36, P2423, DOI 10.1128/AAC.36.11.2423; Schrodinger, 2010, PYMOL MOL GRAPHICS S; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Smith DB, 2009, J MED CHEM, V52, P2971, DOI 10.1021/jm801595c; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; Tuccinardi T, 2010, J CHEM INF MODEL, V50, P1432, DOI 10.1021/ci100161z; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; WAINBERG MA, 1995, AIDS, V9, P351, DOI 10.1097/00002030-199509040-00006; Wang Q, 2011, EUR J MED CHEM, V46, P4178, DOI 10.1016/j.ejmech.2011.06.020; Wang QA, 2011, BIOCHEM PHARMACOL, V81, P848, DOI 10.1016/j.bcp.2011.01.001; Wang RR, 2009, BIOCHEM BIOPH RES CO, V382, P540, DOI 10.1016/j.bbrc.2009.03.057; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; Wu J, 2013, EUR J MED CHEM, V63, P739, DOI 10.1016/j.ejmech.2013.02.042; Yoder KE, 2008, J VIROL METHODS, V153, P253, DOI 10.1016/j.jviromet.2008.07.032; Zhang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081489; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zheng LY, 2012, ANTIVIR THER, V17, P679, DOI 10.3851/IMP2094; Zhou YB, 2012, ANTIVIR THER, V17, P1593, DOI 10.3851/IMP2292	46	41	48	47	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105617	10.1371/journal.pone.0105617	http://dx.doi.org/10.1371/journal.pone.0105617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144636	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100097
J	Ehlers, JP; Srivastava, SK; Feiler, D; Noonan, AI; Rollins, AM; Tao, YKK				Ehlers, Justis P.; Srivastava, Sunil K.; Feiler, Daniel; Noonan, Amanda I.; Rollins, Andrew M.; Tao, Yuankai K.			Integrative Advances for OCT-Guided Ophthalmic Surgery and Intraoperative OCT: Microscope Integration, Surgical Instrumentation, and Heads-Up Display Surgeon Feedback	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ANTERIOR SEGMENT; MEMBRANE; MANEUVERS; SPEED	Purpose: To demonstrate key integrative advances in microscope-integrated intraoperative optical coherence tomography (iOCT) technology that will facilitate adoption and utilization during ophthalmic surgery. Methods: We developed a second-generation prototype microscope-integrated iOCT system that interfaces directly with a standard ophthalmic surgical microscope. Novel features for improved design and functionality included improved profile and ergonomics, as well as a tunable lens system for optimized image quality and heads-up display (HUD) system for surgeon feedback. Novel material testing was performed for potential suitability for OCT-compatible instrumentation based on light scattering and transmission characteristics. Prototype surgical instruments were developed based on material testing and tested using the microscope-integrated iOCT system. Several surgical maneuvers were performed and imaged, and surgical motion visualization was evaluated with a unique scanning and image processing protocol. Results: High-resolution images were successfully obtained with the microscope-integrated iOCT system with HUD feedback. Six semi-transparent materials were characterized to determine their attenuation coefficients and scatter density with an 830 nm OCT light source. Based on these optical properties, polycarbonate was selected as a material substrate for prototype instrument construction. A surgical pick, retinal forceps, and corneal needle were constructed with semi-transparent materials. Excellent visualization of both the underlying tissues and surgical instrument were achieved on OCT cross-section. Using model eyes, various surgical maneuvers were visualized, including membrane peeling, vessel manipulation, cannulation of the subretinal space, subretinal intraocular foreign body removal, and corneal penetration. Conclusions: Significant iterative improvements in integrative technology related to iOCT and ophthalmic surgery are demonstrated.	[Ehlers, Justis P.; Srivastava, Sunil K.; Feiler, Daniel; Tao, Yuankai K.] Cleveland Clin, Cole Eye Inst, Ophthalm Imaging Ctr, Cleveland, OH 44106 USA; [Noonan, Amanda I.; Rollins, Andrew M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Tao, Yuankai K.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA; [Tao, Yuankai K.] Cleveland Clin, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ehlers, JP (corresponding author), Cleveland Clin, Cole Eye Inst, Ophthalm Imaging Ctr, Cleveland, OH 44106 USA.	ehlersj@ccf.org			National Institutes of Health/National Eye Institute [K23-EY022947-01A1, R01-EY023039-01]; Ohio Department of Development [TECH-13-059]; NATIONAL EYE INSTITUTE [K23EY022947, R01EY023039] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ohio Department of Development; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Institutes of Health/National Eye Institute (http://www.nei.nih.gov/) K23-EY022947-01A1 (JPE); Ohio Department of Development TECH-13-059 (http://development.ohio.gov/bs_thirdfrontier/ipp.htm) (JPE, SKS, YKT); National Institutes of Health/Natonal Eye Institute (http://www.nei.nih.gov/) R01-EY023039-01 (JPE, SKS, YKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balicki M, 2009, LECT NOTES COMPUT SC, V5761, P108, DOI 10.1007/978-3-642-04268-3_14; Binder S, 2011, RETINA-J RET VIT DIS, V31, P1332, DOI 10.1097/IAE.0b013e3182019c18; Chavala SH, 2009, OPHTHALMOLOGY, V116, P2448, DOI 10.1016/j.ophtha.2009.06.003; Chen TC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1715, DOI 10.1001/archopht.123.12.1715; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Dayani PN, 2009, RETINA-J RET VIT DIS, V29, P1457, DOI 10.1097/IAE.0b013e3181b266bc; De Benito-Llopis L, 2014, AM J OPHTHALMOL, V157, P334, DOI 10.1016/j.ajo.2013.10.001; Ehlers JP, 2014, BR J OPHTHA IN PRESS; Ehlers JP, 2014, CURRENT OPI IN PRESS; Ehlers JP, 2014, RETINA IN PRESS; Ehlers JP, 2013, RETINA; Ehlers JP, 2013, RETINA-J RET VIT DIS, V33, P1428, DOI 10.1097/IAE.0b013e31828396b7; Ehlers JP, 2013, RETINA-J RET VIT DIS, V33, P232, DOI 10.1097/IAE.0b013e31826e86f5; Ehlers JP, 2011, ARCH OPHTHALMOL-CHIC, V129, P1483, DOI 10.1001/archophthalmol.2011.316; Ehlers JP, 2011, INVEST OPHTH VIS SCI, V52, P3153, DOI 10.1167/iovs.10-6720; Faber DJ, 2004, OPT EXPRESS, V12, P4353, DOI 10.1364/OPEX.12.004353; Grulkowski I, 2012, BIOMED OPT EXPRESS, V3, P2733, DOI 10.1364/BOE.3.002733; Hahn P, 2013, RETINA-J RET VIT DIS, V33, P1328, DOI 10.1097/IAE.0b013e3182831293; Hahn P, 2013, GRAEF ARCH CLIN EXP, V251, P213, DOI 10.1007/s00417-012-2052-2; Han S, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2904664; Jian YF, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026002; Joos KM, 2013, BIOMED OPT EXPRESS, V4, P1342, DOI 10.1364/BOE.4.001342; Kadonosono K, 2000, ARCH OPHTHALMOL-CHIC, V118, P1116, DOI 10.1001/archopht.118.8.1116; Kang JU, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081403; Klein T, 2013, BIOMED OPT EXPRESS, V4, P1890, DOI 10.1364/BOE.4.001890; Knecht PB, 2010, AM J OPHTHALMOL, V150, P360, DOI 10.1016/j.ajo.2010.04.017; LaRocca F, 2013, BIOMED OPT EXPRESS, V4, P2307, DOI 10.1364/BOE.4.002307; Lee Lyndon B, 2011, Ophthalmic Surg Lasers Imaging, V42 Online, pe71, DOI 10.3928/15428877-20110804-05; Lu CD, 2014, BIOMED OPT EXPRESS, V5, P293, DOI 10.1364/BOE.5.000293; MACHEMER R, 1981, ARCH OPHTHALMOL-CHIC, V99, P152, DOI 10.1001/archopht.1981.03930010154023; MACHEMER R, 1978, AM J OPHTHALMOL, V85, P205, DOI 10.1016/S0002-9394(14)75949-5; PAREL JM, 1974, AM J OPHTHALMOL, V77, P6, DOI 10.1016/0002-9394(74)90598-4; Ray R, 2011, OPHTHALMOLOGY, V118, P2212, DOI 10.1016/j.ophtha.2011.04.012; Scorcia V, 2013, OPHTHALMOLOGY, V120, P471, DOI 10.1016/j.ophtha.2012.08.041; Song C, 2013, BIOMED OPT EXPRESS, V4, P1045, DOI 10.1364/BOE.4.001045; Steven P, 2013, JAMA OPHTHALMOL, V131, P1135, DOI 10.1001/jamaophthalmol.2013.4672; Tao YK, 2011, VISUALIZATION VITREO; Tao YKK, 2014, BIOMED OPT EXPRESS, V5, P1877, DOI 10.1364/BOE.5.001877; Tao YKK, 2010, OPT LETT, V35, P3315, DOI 10.1364/OL.35.003315; Xu D, 2013, INVEST OPHTH VIS SCI, V54, P163, DOI 10.1167/iovs.12-10246	40	85	88	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105224	10.1371/journal.pone.0105224	http://dx.doi.org/10.1371/journal.pone.0105224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141340	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200062
J	Salas, R; Bibiloni, MD; Ramos, E; Villarreal, JZ; Pons, A; Tur, JA; Sureda, A				Salas, Rogelio; del Mar Bibiloni, Maria; Ramos, Esteban; Villarreal, Jesus Z.; Pons, Antoni; Tur, Josep A.; Sureda, Antoni			Metabolic Syndrome Prevalence among Northern Mexican Adult Population	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; RISK-FACTORS; INSULIN-RESISTANCE; DIETARY PATTERNS; NATIONAL-HEALTH; SYNDROME DIFFER; WOMEN; PREVENTION; OBESITY; ASSOCIATION	Background and Aims: Dietary habits in the Mexican population have changed dramatically over the last few years, which are reflected in increased overweight and obesity prevalence. The aim was to examine the prevalence of metabolic syndrome (MetS) and associated risk factors in Northern Mexican adults aged >= 16 years. Methods and Results: The study was a population-based cross-sectional nutritional survey carried out in the State of Nuevo Leon, Mexico. The study included a sub-sample of 1,200 subjects aged 16 and over who took part in the State Survey of Nutrition and Health-Nuevo Leon 2011/2012. Anthropometric measurements, physical activity, blood pressure and fasting blood tests for biochemical analysis were obtained from all subjects. The prevalence of MetS in Mexican adults aged >= 16 years was 54.8%, reaching 73.8% in obese subjects. This prevalence was higher in women (60.4%) than in men (48.9%) and increased with age in both genders. Multivariate analyses showed no evident relation between MetS components and the level of physical activity. Conclusions: Obese adults, mainly women, are particularly at risk of developing MetS, with the associated implications for their health. The increasing prevalence of MetS highlights the need for developing strategies for its early detection and prevention.	[Salas, Rogelio; Ramos, Esteban] Autonomous Univ Nuevo Leon, Fac Publ Hlth Nutr, Monterrey, Mexico; [del Mar Bibiloni, Maria; Pons, Antoni; Tur, Josep A.; Sureda, Antoni] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain; [del Mar Bibiloni, Maria; Pons, Antoni; Tur, Josep A.; Sureda, Antoni] CIBERobn Physiopathol Obes & Nutr, Palma De Mallorca, Spain; [Villarreal, Jesus Z.] State Nuevo Leon, Dept Hlth, Monterrey, Mexico	Universidad Autonoma de Nuevo Leon; Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Tur, JA (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain.	pep.tur@uib.es	Gomila, Antonio Sureda/L-7191-2014; Bibiloni, Maria del Mar/H-9734-2015; Pons, Antoni/L-4844-2014; Sureda, Antoni/N-9588-2019; del Mar Bibiloni, Maria/M-3123-2014; Tur, Josep Antoni/F-5576-2014; Tur, Josep/AAE-5748-2020; , Antoni/AAB-5250-2019	Gomila, Antonio Sureda/0000-0003-2101-616X; Pons, Antoni/0000-0003-2447-3868; Sureda, Antoni/0000-0001-8656-6838; del Mar Bibiloni, Maria/0000-0001-8926-9206; Tur, Josep Antoni/0000-0002-6940-0761; Tur, Josep/0000-0002-6940-0761; , Antoni/0000-0001-8656-6838; /0000-0001-9835-1594	Department of Health, Government of the State of Nuevo Leon (Mexico): State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences) [11/01791]; Red Predimed [RETIC RD06/0045/1004]; CIBERobn [CB12/03/30038]; Balearic Islands Gov. [35/2011]; EU FEDER funds	Department of Health, Government of the State of Nuevo Leon (Mexico): State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences); Red Predimed; CIBERobn; Balearic Islands Gov.; EU FEDER funds(European Commission)	This work was supported by the Department of Health, Government of the State of Nuevo Leon (Mexico): State Survey of Nutrition and Health- Nuevo Leon 2011/2012 (EESN-NL 2011/2012). Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences, Projects 11/01791, Red Predimed-RETIC RD06/0045/1004, and CIBERobn CB12/03/30038). Grant of support to research groups no. 35/2011 (Balearic Islands Gov. and EU FEDER funds). The Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands, coming under the Centre Catala de la Nutricio (IEC) and Exernet Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Aguilar-Salinas CA, 2004, ARCH MED RES, V35, P76, DOI 10.1016/j.arcmed.2003.06.006; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Balkau B, 2002, DIABETES METAB, V28, P364; Barquera S, 2003, SALUD PUBLICA MEXICO, V45, pS530; Buckland G, 2008, PUBLIC HEALTH NUTR, V11, P1372, DOI 10.1017/S1368980008003492; Cuevas A, 2011, CURR OPIN ENDOCRINOL, V18, P134, DOI 10.1097/MED.0b013e3283449167; Denova-Gutierrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671; Denova-Gutierrez E, 2010, PUBLIC HEALTH NUTR, V13, P835, DOI 10.1017/S1368980009991145; Duclos M, 2007, SCI SPORT, V22, P129, DOI 10.1016/j.scispo.2007.06.001; Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gregory CO, 2009, BRIT J NUTR, V101, P1805, DOI 10.1017/S000711450813584X; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Gutierrez-Salmean G, 2012, CLIN INVEST ARTERIOS, V24, P204, DOI 10.1016/j.arteri.2011.11.002; Holme I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-154; Isordia-Salas I, 2012, EXP DIABETES RES, DOI 10.1155/2012/202540; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Ma X, 2013, EUR J CLIN NUTR, V67, P518, DOI 10.1038/ejcn.2013.24; Marquez-Sandoval F, 2011, PUBLIC HEALTH NUTR, V14, P1702, DOI 10.1017/S1368980010003320; Mattei J, 2011, AM J CLIN NUTR, V94, P869, DOI 10.3945/ajcn.111.013219; Meaney Alejandra, 2013, Arch. Cardiol. Méx., V83, P249, DOI 10.1016/j.acmx.2013.05.002; Mendez-Hernandez P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-276; Mirmiran P, 2008, NUTR METAB CARDIOVAS, V18, P567, DOI 10.1016/j.numecd.2007.06.002; Orantes CM, 2011, MEDICC REV, V13, P14, DOI 10.37757/MR2011V13.N4.5; Queen Saulette R, 2012, World J Cardiovasc Dis, V2, P50; Redinger Richard N, 2007, Gastroenterol Hepatol (N Y), V3, P856; Rojas R, 2010, SALUD PUBLICA MEXICO, V52, pS11, DOI 10.1590/s0036-36342010000700004; Rojas-Martinez R, 2012, SALUD PUBLICA MEXICO, V54, P7; Romieu I, 2012, PUBLIC HEALTH NUTR, V15, P116, DOI 10.1017/S1368980011001182; Spalding A, 2009, J CLIN HYPERTENS, V11, P755, DOI 10.1111/j.1751-7176.2009.00191.x; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Vella CA, 2011, J IMMIGR MINOR HEALT, V13, P119, DOI 10.1007/s10903-009-9299-7; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS72; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	38	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105581	10.1371/journal.pone.0105581	http://dx.doi.org/10.1371/journal.pone.0105581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141255	Green Submitted, gold, Green Published			2022-12-27	WOS:000342687200106
J	Liang, Z; Liu, LF; Chen, XP; Shi, XM; Guo, HY; Lin, K; Guo, JP; Shan, ZL; Wang, YT				Liang, Zhuo; Liu, Li-feng; Chen, Xin-pei; Shi, Xiang-min; Guo, Hong-yang; Lin, Kun; Guo, Jian-ping; Shan, Zhao-liang; Wang, Yu-tang			Establishment of a Model of Renal Impairment with Mild Renal Insufficiency Associated with Atrial Fibrillation in Canines	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SYMPATHETIC DENERVATION; ENDOTHELIAL DYSFUNCTION; ACTIVATION; MECHANISMS; SYSTEM	Background: Chronic kidney disease and occurrence of atrial fibrillation (AF) are closely related. No studies have examined whether renal impairment (RI) without severe renal dysfunction is associated with the occurrence of AF. Methods: Unilateral RI with mild renal insufficiency was induced in beagles by embolization of small branches of the renal artery in the left kidney for 2 weeks using gelatin sponge granules in the model group (n = 5). The sham group (n = 5) underwent the same procedure, except for embolization. Parameters associated with RI and renal function were tested, cardiac electrophysiological parameters, blood pressure, left ventricular pressure, and AF vulnerability were investigated. The activity of the sympathetic nervous system, renin-angiotensin-aldosterone system, inflammation, and oxidative stress were measured. Histological studies associated with atrial interstitial fibrosis were performed. Results: Embolization of small branches of the renal artery in the left kidney led to ischemic RI with mild renal insufficiency. The following changes occurred after embolization. Heart rate and P wave duration were increased. Blood pressure and left ventricular systolic pressure were elevated. The atrial effective refractory period and antegrade Wenckebach point were shortened. Episodes and duration of AF, as well as atrial and ventricular rate during AF were increased in the model group. Plasma levels of norepinephrine, renin, and aldosterone were increased, angiotensin II and aldosterone levels in atrial tissue were elevated, and atrial interstitial fibrosis was enhanced after 2 weeks of embolization in the model group. Conclusions: We successfully established a model of RI with mild renal insufficiency in a large animal. We found that RI with mild renal insufficiency was associated with AF in this model.	[Liang, Zhuo; Wang, Yu-tang] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [Liu, Li-feng; Chen, Xin-pei; Shi, Xiang-min; Guo, Hong-yang; Lin, Kun; Guo, Jian-ping; Shan, Zhao-liang] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Shan, ZL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China.	shanzl301@sina.com; wyt301@sina.com	Chen, Xinpei/AAO-1879-2021		National Natural Science Foundation of China [30570737, 81270308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30570737; 81270308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Brown SA, 2013, J VET EMERG CRIT CAR, V23, P115, DOI 10.1111/vec.12030; Chan CT, 2008, NEPHROL DIAL TRANSPL, V23, P3061, DOI 10.1093/ndt/gfn280; Chen LY, 2007, HEART RHYTHM, V4, pS1, DOI 10.1016/j.hrthm.2006.12.018; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Ewen S, 2013, CURR HYPERTENS REP, V15, P370, DOI 10.1007/s11906-013-0365-0; Fukunaga N, 2012, HEART RHYTHM, V9, P2023, DOI 10.1016/j.hrthm.2012.08.019; Grassi G, 2011, HYPERTENSION, V57, P846, DOI 10.1161/HYPERTENSIONAHA.110.164780; Guo YT, 2013, INT J CARDIOL, V168, P1502, DOI 10.1016/j.ijcard.2012.12.099; Hou YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078218; Kestenbaum B, 2007, CLIN J AM SOC NEPHRO, V2, P501, DOI 10.2215/CJN.04231206; Landray MJ, 2004, AM J KIDNEY DIS, V43, P244, DOI 10.1053/j.ajkd.2003.10.037; Linz D, 2013, HYPERTENSION, V62, P767, DOI 10.1161/HYPERTENSIONAHA.113.01728; Linz D, 2013, HYPERTENSION, V61, P225, DOI 10.1161/HYPERTENSIONAHA.111.00182; Linz D, 2012, HEART RHYTHM, V9, P2032, DOI 10.1016/j.hrthm.2012.08.024; Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965; Mayyas F, 2013, INT J CARDIOL, V168, P5135, DOI 10.1016/j.ijcard.2013.08.022; Naruse Y, 2011, HEART RHYTHM, V8, P335, DOI 10.1016/j.hrthm.2010.10.047; Park HW, 2012, CURR OPIN CARDIOL, V27, P24, DOI 10.1097/HCO.0b013e32834dc4e8; Redpath CJ, 2006, J MOL CELL CARDIOL, V40, P717, DOI 10.1016/j.yjmcc.2006.01.012; Sapoznikov D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078338; Savelieva I, 2011, EUROPACE, V13, P610, DOI 10.1093/europace/eur023; Schlaich MP, 2009, J AM SOC NEPHROL, V20, P933, DOI 10.1681/ASN.2008040402; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Wang Y, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-26; Watanabe T, 2007, J VET MED SCI, V69, P1015, DOI 10.1292/jvms.69.1015; Ye SH, 2002, AM J HYPERTENS, V15, P717, DOI 10.1016/S0895-7061(02)02959-X; Zhao QY, 2013, INT J CARDIOL, V168, P1672, DOI 10.1016/j.ijcard.2013.03.091; Zhao QY, 2012, J INTERV CARD ELECTR, V35, P119, DOI 10.1007/s10840-012-9717-y; Zimmerman D, 2012, NEPHROL DIAL TRANSPL, V27, P3816, DOI 10.1093/ndt/gfs416	32	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105974	10.1371/journal.pone.0105974	http://dx.doi.org/10.1371/journal.pone.0105974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157494	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200083
J	Allin, B; Knight, M; Johnson, P; Burge, D				Allin, Benjamin; Knight, Marian; Johnson, Paul; Burge, David		BAPS-CASS	Outcomes at One-Year Post Anastomosis from a National Cohort of Infants with Oesophageal Atresia	PLOS ONE			English	Article							TRACHEOESOPHAGEAL FISTULA; RISK-FACTORS; STRICTURE; CHILDREN; REPAIR; COMPLICATIONS; PREDICTION; EFFICACY	Background and Aims: We aimed to provide a contemporaneous assessment of outcomes at one-year post oesophageal atresia/tracheoesophageal fistula (OA-TOF) repair, focussing particularly on post-operative complications. It is generally accepted that oesophageal stricture is the most common complication and causes significant morbidity. We also aimed to assess the efficacy of prophylactic anti-reflux medication (PARM) in reducing stricture formation. Method: A prospective, multi-centre cohort study of all infants live-born with oesophageal atresia in the United Kingdom and Ireland in 2008/9 was performed, recording clinical management and outcomes at one year. The effect of PARM on stricture formation in infants with the type-c anomaly was assessed using logistic regression analysis. Results: 151 infants were live-born with oesophageal atresia in the defined reporting period, 126 of whom had the type-c anomaly. One-year follow-up information was returned for 105 infants (70%); the mortality rate was 8.6% (95% CI 4.7-14.3%). Post-operative complications included anastomotic leak (5.4%), recurrent fistula (3.3%) and oesophageal stricture (39%). Seventy-six (60%) of those with type-c anomaly were alive at one-year with returned follow-up, 57(75%) of whom had received PARM. Of these, 24 (42%) developed a stricture, compared to 4 (21%) of those who had not received PARM (adjusted odds ratio 2.60, 95% CI 0.71-9.46, p = 0.147). Conclusions: This study provides a benchmark for current outcomes and complication rates following OA-TOF repair, with oesophageal stricture causing significant morbidity. The use of PARM appeared ineffective in preventing strictures. This study creates enough doubt about the efficacy of PARM in preventing stricture formation to warrant further investigation of its use with a randomised controlled trial.	[Allin, Benjamin; Knight, Marian] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Allin, Benjamin; Johnson, Paul] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Dept Paediat Surg, Oxford, England; [Burge, David] Univ Hosp Southampton NHS Fdn Trust, Dept Paediat Surg, Southampton, Hants, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Southampton; University Hospital Southampton NHS Foundation Trust	Allin, B (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England.	benjaminallin@doctors.org.uk	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575	Newlife charity; National Institute for Health Research (NIHR) Professorship; National Institute for Health Research (NIHR); National Institute for Health Research [ACF-2012-13-012, NIHR-RP-011-032] Funding Source: researchfish	Newlife charity; National Institute for Health Research (NIHR) Professorship(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by Newlife charity. Marian Knight is funded by a National Institute for Health Research (NIHR) Professorship. This paper presents independent research partially funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshehri A, 2012, J PEDIATR SURG, V47, P881, DOI 10.1016/j.jpedsurg.2012.01.041; board Nc, 2012, EV COUNTS PLANN PAT; Burge DM, 2013, BRIT J SURG, V100, P515, DOI 10.1002/bjs.9019; Castilloux J, 2010, J PEDIATR-US, V156, P755, DOI 10.1016/j.jpeds.2009.11.038; CHITTMITTRAPAP S, 1990, J PEDIATR SURG, V25, P508, DOI 10.1016/0022-3468(90)90561-M; Fernando P, 2012, WORLD J GASTROENTERO, V18, P3662, DOI 10.3748/wjg.v18.i28.3662; Gross RE, 1952, ATRESIA OESOPHAGUS; Hagander L, 2012, EUR J PEDIATR SURG, V22, P139, DOI 10.1055/s-0032-1308698; Health Do, 2010, NHS OUTC FRAM 2011 1; Health Do, 2010, LIBERATING NHS TRANS; Hvid-Jensen F, 2011, SCAND J GASTROENTERO, V46, P1179, DOI 10.3109/00365521.2011.594084; Koivusalo A, 2009, DIS ESOPHAGUS, V22, P190, DOI 10.1111/j.1442-2050.2008.00902.x; Konkin DE, 2003, J PEDIATR SURG, V38, P1726, DOI 10.1016/j.jpedsurg.2003.08.039; Martin AJ, 2002, PEDIATRICS, V109, P1061, DOI 10.1542/peds.109.6.1061; MCKINNON LJ, 1990, J PEDIATR SURG, V25, P778; Owen A, 2010, J PEDIATR SURG, V45, P1808, DOI 10.1016/j.jpedsurg.2010.01.036; Pearson EG, 2010, J PEDIATR SURG, V45, P2356, DOI 10.1016/j.jpedsurg.2010.08.033; Ruigomez A, 2006, AM J GASTROENTEROL, V101, P2685, DOI 10.1111/j.1572-0241.2006.00828.x; Serhal L, 2010, J PEDIATR SURG, V45, P1459, DOI 10.1016/j.jpedsurg.2009.11.002; Skarsgard Erik D, 2006, Paediatr Child Health, V11, P15; Tennant PWG, LANCET, V375, P649; Terrin G, 2012, PEDIATRICS, V129, pE40, DOI 10.1542/peds.2011-0796; Uchida K, 2006, PEDIATR SURG INT, V22, P496, DOI 10.1007/s00383-006-1700-1; Van Biervliet S, 2001, J PEDIATR SURG, V36, P1416, DOI 10.1053/jpsu.2001.26388	24	57	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106149	10.1371/journal.pone.0106149	http://dx.doi.org/10.1371/journal.pone.0106149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153838	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200117
J	Bisio, A; Sciutti, A; Nori, F; Metta, G; Fadiga, L; Sandini, G; Pozzo, T				Bisio, Ambra; Sciutti, Alessandra; Nori, Francesco; Metta, Giorgio; Fadiga, Luciano; Sandini, Giulio; Pozzo, Thierry			Motor Contagion during Human-Human and Human-Robot Interaction	PLOS ONE			English	Article							PREMOTOR CORTEX; MOVEMENT; MIRROR; PERCEPTION; IMITATION; EXCITABILITY; RECOGNITION; MODULATION; MECHANISMS; INTENTION	Motor resonance mechanisms are known to affect humans' ability to interact with others, yielding the kind of "mutual understanding'' that is the basis of social interaction. However, it remains unclear how the partner's action features combine or compete to promote or prevent motor resonance during interaction. To clarify this point, the present study tested whether and how the nature of the visual stimulus and the properties of the observed actions influence observer's motor response, being motor contagion one of the behavioral manifestations of motor resonance. Participants observed a humanoid robot and a human agent move their hands into a pre-specified final position or put an object into a container at various velocities. Their movements, both in the object-and non-object-directed conditions, were characterized by either a smooth/curvilinear or a jerky/segmented trajectory. These trajectories were covered with biological or non-biological kinematics (the latter only by the humanoid robot). After action observation, participants were requested to either reach the indicated final position or to transport a similar object into another container. Results showed that motor contagion appeared for both the interactive partner except when the humanoid robot violated the biological laws of motion. These findings suggest that the observer may transiently match his/her own motor repertoire to that of the observed agent. This matching might mediate the activation of motor resonance, and modulate the spontaneity and the pleasantness of the interaction, whatever the nature of the communication partner.	[Bisio, Ambra; Sciutti, Alessandra; Nori, Francesco; Metta, Giorgio; Fadiga, Luciano; Sandini, Giulio; Pozzo, Thierry] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Metta, Giorgio] Ist Italiano Tecnol, iCub Unit, Genoa, Italy; [Fadiga, Luciano] Univ Ferrara, Dipartimento Sci Biomed & Terapie Avanzate, Sez Fisiol Umana, I-44100 Ferrara, Italy; [Pozzo, Thierry] INSERM, U1093, Dijon, France; [Pozzo, Thierry] Univ Bourgogne, Inst Univ France, UFR STAPS Dijon, F-21004 Dijon, France	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT; University of Ferrara; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut Universitaire de France; Universite de Bourgogne	Bisio, A (corresponding author), Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy.	ambra.bisio@gmail.com	Fadiga, Luciano/AAC-7404-2022; Sciutti, Alessandra/E-4291-2017; Bisio, Ambra/AAM-4979-2020; Bisio, Ambra/N-4309-2013	Sciutti, Alessandra/0000-0002-1056-3398; Bisio, Ambra/0000-0002-9385-1714; Sandini, Giulio/0000-0003-3324-985X; Pozzo, Thierry/0000-0002-0585-7965; fadiga, luciano/0000-0001-5691-5080	European projects ITALK [ICT-FP7-214668]	European projects ITALK	The work has been conducted in the framework of the European projects ITALK (Grant ICT-FP7-214668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONCOHEN S, 1995, BRIT J DEV PSYCHOL, V13, P379, DOI 10.1111/j.2044-835X.1995.tb00687.x; Bekkering H, 2000, Q J EXP PSYCHOL-A, V53, P153, DOI 10.1080/027249800390718; Bisio A, 2012, NEUROSCIENCE, V222, P58, DOI 10.1016/j.neuroscience.2012.07.017; Bisio A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013506; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Castiello U, 2002, ATTENTION PERFORM, V19, P315; Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; Cavallo A, 2011, COGN NEUROSCI-UK, V2, P83, DOI 10.1080/17588928.2010.533163; Cavallo A, 2012, CEREB CORTEX, V22, P710, DOI 10.1093/cercor/bhr157; Chaminade T, 2009, J PHYSIOL-PARIS, V103, P286, DOI 10.1016/j.jphysparis.2009.08.011; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cross ES, 2012, HUM BRAIN MAPP, V33, P2238, DOI 10.1002/hbm.21361; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gowen E, 2012, PSYCHOL RES-PSYCH FO, V76, P407, DOI 10.1007/s00426-011-0389-5; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jonas M, 2007, NEUROIMAGE, V36, pT44, DOI 10.1016/j.neuroimage.2007.03.028; Kilner J, 2007, SOC NEUROSCI-UK, V2, P158, DOI 10.1080/17470910701428190; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Kupferberg A, 2011, AI SOC, V26, P339, DOI 10.1007/s00146-010-0314-2; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Manera V, 2011, EXP BRAIN RES, V211, P547, DOI 10.1007/s00221-011-2649-4; Metta G, 2010, NEURAL NETWORKS, V23, P1125, DOI 10.1016/j.neunet.2010.08.010; Oberman LM, 2007, NEUROCOMPUTING, V70, P2194, DOI 10.1016/j.neucom.2006.02.024; Pozzo T, 2006, BEHAV BRAIN RES, V169, P75, DOI 10.1016/j.bbr.2005.12.005; Premack D, 1997, J COGNITIVE NEUROSCI, V9, P848, DOI 10.1162/jocn.1997.9.6.848; Press C, 2005, COGNITIVE BRAIN RES, V25, P632, DOI 10.1016/j.cogbrainres.2005.08.020; Press C, 2011, NEUROSCI BIOBEHAV R, V35, P1410, DOI 10.1016/j.neubiorev.2011.03.004; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1999, ARCH ITAL BIOL, V137, P85; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Sartori L, 2012, NEUROPSYCHOLOGIA, V50, P2341, DOI 10.1016/j.neuropsychologia.2012.06.002; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Sciutti A, INTERACT ST IN PRESS; Sciutti A, 2012, WORKSH 7 ACM IEEE IN; Sciutti A, 2012, INT J SOC ROBOT, V4, P223, DOI 10.1007/s12369-012-0143-1; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005; Tessari A, 2004, J EXP PSYCHOL HUMAN, V30, P1107, DOI 10.1037/0096-1523.30.6.1107; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Watanabe K, 2008, COGNITION, V106, P1514, DOI 10.1016/j.cognition.2007.06.001; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257; Wykowska Agnieszka, 2012, Social Robotics. 4th International Conference (ICSR 2012). Proceedings, P327, DOI 10.1007/978-3-642-34103-8_33	48	57	57	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106172	10.1371/journal.pone.0106172	http://dx.doi.org/10.1371/journal.pone.0106172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153990	Green Published, gold			2022-12-27	WOS:000340952200118
J	Cho, Y; Lee, DH; Lee, YB; Lee, M; Yoo, JJ; Choi, WM; Cho, YY; Paeng, JC; Kang, KW; Chung, JK; Yu, SJ; Lee, JH; Yoon, JH; Lee, HS; Kim, YJ				Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Lee, Minjong; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Paeng, Jin Chul; Kang, Keon Wook; Chung, June-Key; Yu, Su Jong; Lee, Jeong-Hoon; Yoon, Jung-Hwan; Lee, Hyo-Suk; Kim, Yoon Jun			Does F-18-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma?	PLOS ONE			English	Article							LIVER-TRANSPLANT CANDIDATES; EXTRAHEPATIC METASTASES; F-18-FLUORODEOXYGLUCOSE UPTAKE; PET; RECURRENCE; CT; FLUORINE-18-FLUORODEOXYGLUCOSE; MANAGEMENT; SORAFENIB; RESECTION	Background and Aim: The utility of fluorine-18 fluorodeoxyglucose (F-18-FDG) positron emission tomography-computed tomography (PET/CT) in initial staging of hepatocellular carcinoma (HCC) has yet to be fully explored. We assessed the usefulness of F-18-FDG PET/CT in initial staging of HCC. Methods: A total of 457 consecutive patients initially diagnosed with HCC at Seoul National University Hospital between 2006 and 2012 were evaluated retrospectively to assess the impact of F-18-FDG PET/CT on staging and compliancy with Milan criteria, relative to dynamic CT of liver and chest x-ray. Results: Seven among the 457 patients studied showed a shift in Barcelona Clinic Liver Cancer [BCLC] stage (A -> C: 6 patients; B -> C: 1 patient) and 5 patients who had originally met Milan criteria no longer qualified. F-18-FDG PET/CT had value in initial staging of early (stage A) or intermediate (stage B) HCC, as determined by dynamic CT of liver and BCLC or AJCC classifications, whereas BCLC stage 0 and stage C tumors were unchanged (P<0.001). F-18-FDG PET/CT disclosed additional metastases in patients with American Joint Committee on Cancer [AJCC] T2 (2.7%), T3a (5.3%), and T3b (4.8%) classifications. Conclusions: In initial staging of HCC, F-18-FDG PET/CT provided additional information, impacting the patients with BCLC (stages A and B) and AJCC (T2 and T3) classifications. Its use might be thus appropriate for these patient subsets, especially if hepatic resection or liver transplantation is planned.	[Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Lee, Minjong; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Yu, Su Jong; Lee, Jeong-Hoon; Yoon, Jung-Hwan; Lee, Hyo-Suk; Kim, Yoon Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Paeng, Jin Chul; Kang, Keon Wook; Chung, June-Key] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, YJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	yoonjun@snu.ac.kr	Kang, Keon Wook/J-1385-2012; Lee, Jeong-Hoon/Q-1055-2018	Kang, Keon Wook/0000-0003-2622-9017; Lee, Jeong-Hoon/0000-0002-0315-2080; Yu, Su Jong/0000-0001-8888-7977; , minjong/0000-0002-3159-5444; Lee, Yun Bin/0000-0002-3193-9745; Cho, Young Youn/0000-0002-9384-5357; Yoo, Jeong-Ju/0000-0002-7802-0381; Kim, Yoon Jun/0000-0001-9141-7773; Yoon, Jung-Hwan/0000-0002-9128-3610				[Anonymous], 2012, J HEPATOL, V56, P908; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Choi D, 2001, J COMPUT ASSIST TOMO, V25, P777, DOI 10.1097/00004728-200109000-00018; Choi GH, 2013, RADIOLOGY; Delbeke D, 1998, ARCH SURG-CHICAGO, V133, P510, DOI 10.1001/archsurg.133.5.510; Dierckx R, 2009, Q J NUCL MED MOL IM, V53, P336; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fartoux L, 2012, NUCL MED COMMUN, V33, P757, DOI 10.1097/MNM.0b013e328350fb9f; Haydon GH, 1996, EUR J GASTROEN HEPAT, V8, P856; Ho CL, 2003, J NUCL MED, V44, P213; HONDA H, 1992, GASTROINTEST RADIOL, V17, P245, DOI 10.1007/BF01888559; Iglehart JK, 2006, NEW ENGL J MED, V354, P2822, DOI 10.1056/NEJMhpr061219; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kim BK, 2011, CANCER-AM CANCER SOC, V117, P4779, DOI 10.1002/cncr.26099; Kim YK, 2010, LIVER TRANSPLANT, V16, P767, DOI 10.1002/lt.22069; Koneru B, 2005, ANN SURG, V241, P622, DOI 10.1097/01.sla.0000157267.27356.80; Lee JH, 2011, LIVER INT, V31, P1144, DOI 10.1111/j.1478-3231.2011.02541.x; Lee JD, 2004, EUR J NUCL MED MOL I, V31, P1621, DOI 10.1007/s00259-004-1602-1; Lee JY, 2009, CHICAGO REV, V54, P50; Lee SD, 2013, TRANSPL INT, V26, P50, DOI 10.1111/j.1432-2277.2012.01572.x; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; NAKASHIMA T, 1983, CANCER, V51, P863, DOI 10.1002/1097-0142(19830301)51:5<863::AID-CNCR2820510520>3.0.CO;2-D; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; OKAZUMI S, 1992, J NUCL MED, V33, P333; Rigo P, 1996, EUR J NUCL MED, V23, P1641, DOI 10.1007/BF01249629; Shiomi S, 2001, AM J GASTROENTEROL, V96, P1877, DOI 10.1016/S0002-9270(01)02451-0; Strauss LG, 1996, EUR J NUCL MED, V23, P1409, DOI 10.1007/BF01367602; Sugiyama M, 2004, J GASTROENTEROL, V39, P961, DOI 10.1007/s00535-004-1427-5; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Teefey SA, 2003, RADIOLOGY, V226, P533, DOI 10.1148/radiol.2262011980; Trojan J, 1999, AM J GASTROENTEROL, V94, P3314, DOI 10.1111/j.1572-0241.1999.01544.x; Yamamoto Y, 2008, J NUCL MED, V49, P1245, DOI 10.2967/jnumed.108.052639; Yoon KT, 2007, ONCOLOGY-BASEL, V72, P104, DOI 10.1159/000111715; YUKI K, 1990, CANCER-AM CANCER SOC, V66, P2174, DOI 10.1002/1097-0142(19901115)66:10<2174::AID-CNCR2820661022>3.0.CO;2-A	37	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105679	10.1371/journal.pone.0105679	http://dx.doi.org/10.1371/journal.pone.0105679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153834	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200069
J	Fuchs, B; Thurner, S				Fuchs, Benedikt; Thurner, Stefan			Behavioral and Network Origins of Wealth Inequality: Insights from a Virtual World	PLOS ONE			English	Article							POWER-LAW TAIL; STATISTICAL-MECHANICS; INCOME-DISTRIBUTION; SIZE DISTRIBUTION; SOCIAL NETWORKS; MODEL; DISTRIBUTIONS; EQUILIBRIUM	Almost universally, wealth is not distributed uniformly within societies or economies. Even though wealth data have been collected in various forms for centuries, the origins for the observed wealth-disparity and social inequality are not yet fully understood. Especially the impact and connections of human behavior on wealth could so far not be inferred from data. Here we study wealth data from the virtual economy of the massive multiplayer online game (MMOG) Pardus. This data not only contains every player's wealth at every point in time, but also all actions over a timespan of almost a decade. We find that wealth distributions in the virtual world are very similar to those in Western countries. In particular we find an approximate exponential distribution for low wealth levels and a power-law tail for high levels. The Gini index is found to be g=0.65, which is close to the indices of many Western countries. We find that wealth-increase rates depend on the time when players entered the game. Players that entered the game early on tend to have remarkably higher wealth-increase rates than those who joined later. Studying the players' positions within their social networks, we find that the local position in the trade network is most relevant for wealth. Wealthy people have high in-and out-degrees in the trade network, relatively low nearest-neighbor degrees, and low clustering coefficients. Wealthy players have many mutual friendships and are socially well respected by others, but spend more time on business than on socializing. Wealthy players have few personal enemies, but show animosity towards players that behave as public enemies. We find that players that are not organized within social groups are significantly poorer on average. We observe that "political'' status and wealth go hand in hand.	[Fuchs, Benedikt; Thurner, Stefan] Med Univ Vienna, Sect Sci Complex Syst, Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Thurner, Stefan] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	Medical University of Vienna; The Santa Fe Institute; International Institute for Applied Systems Analysis (IIASA)	Thurner, S (corresponding author), Med Univ Vienna, Sect Sci Complex Syst, Vienna, Austria.	stefan.thurner@meduniwien.ac.at			Austrian Science Fund FWF [P23378]; EU FP7 project CRISIS; Austrian Science Fund (FWF) [P 23378] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); EU FP7 project CRISIS; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors acknowledge support from the Austrian Science Fund FWF (http://www.fwf.ac.at/en/) P23378 and from EU FP7 project CRISIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Magd AY, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.057104; Activision Blizzard Inc, 2013, FORM 10 Q Q REP; ANGLE J, 1986, SOC FORCES, V65, P293, DOI 10.2307/2578675; Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; Banerjee A, 2006, PHYSICA A, V370, P54, DOI 10.1016/j.physa.2006.04.023; Banerjee A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/075032; Bouchaud JP, 2000, PHYSICA A, V282, P536, DOI 10.1016/S0378-4371(00)00205-3; Castronova E, 2008, 2355 CESIFO; Castronova E., 2001, GRUTER I WORKING PAP, V2; Castronova Edward, 2005, SYNTHETIC WORLDS BUS; Chakraborti A, 2000, EUR PHYS J B, V17, P167, DOI 10.1007/s100510070173; Champernowne DG, 1953, ECON J, V63, P318, DOI 10.2307/2227127; Chatterjee A, 2007, CURR SCI INDIA, V92, P1383; Childe VG, 1944, J R ANTHROPOL INST G, V74, P7, DOI 10.2307/2844291; Clementi F, 2008, PHYSICA A, V387, P3201, DOI 10.1016/j.physa.2008.01.109; Clementi F, 2007, EUR PHYS J B, V57, P187, DOI 10.1140/epjb/e2007-00120-9; Clementi F, 2005, PHYSICA A, V350, P427, DOI 10.1016/j.physa.2004.11.038; Coelho R, 2008, PHYSICA A, V387, P3847, DOI 10.1016/j.physa.2008.01.047; Davies JB, 2011, ECON J, V121, P223, DOI 10.1111/j.1468-0297.2010.02391.x; Di Matteo T, 2005, EUR PHYS J B, V47, P459, DOI 10.1140/epjb/e2005-00332-y; Di Matteo T, 2004, P INT SCH PHYS, V155, P435; Domeij D, 2002, REV ECON DYNAM, V5, P503, DOI 10.1006/redy.2002.0157; Dragulescu A, 2000, EUR PHYS J B, V17, P723, DOI 10.1007/s100510070114; Dragulescu A, 2001, PHYSICA A, V299, P213, DOI 10.1016/S0378-4371(01)00298-9; Engels F, 1883, AUSGEWAHLTE SCHRIFTE, V2, P156; Ernst & Young, 2013, WORLDW PERS TAX GUID; Ferrero JC, 2005, NEW ECON WINDOWS, P159, DOI 10.1007/88-470-0389-X_16; Gibrat R., 1931, INEGALITES EC; Gini C., 1912, REPRINTED 1955 MEMOR; Guo Y, 2012, J COMPUT INFORM SYST, V52, P18; Hartung J, 1999, STAT LEHRUND HDB ANG; Hegyi G, 2007, PHYSICA A, V380, P271, DOI 10.1016/j.physa.2007.02.094; HERSKOVITS M., 1952, EC ANTHR STUDY COMP; HERSKOVITS M., 1940, EC LIFE PRIMITIVE PE; HM Revenue & Customs, 2005, PERS WEALTH DISTR AD; Jagielski M, 2013, PHYSICA A, V392, P2130, DOI 10.1016/j.physa.2013.01.028; Jayadev A, 2008, PHYSICA A, V387, P270, DOI 10.1016/j.physa.2007.08.049; Kersley R, 2013, GLOBAL WEALTH REACHE; Klass OS, 2007, EUR PHYS J B, V55, P143, DOI 10.1140/epjb/e2006-00396-1; Klimek P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063008; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Levy S, 1998, WEALTHY PEOPLE FAT T, P30; Malaby Thomas, 2006, GAMES CULT, V1, P141, DOI DOI 10.1177/1555412006286688; Malthus T. R., 1820, PRINCIPLES POLITICAL, V1st; Marshall A., 1890, PRINCIPLES EC; Mill John Stuart, 1965, COLLECTED WORKS JS M, VII; Ning D, 2007, CHINESE PHYS LETT, V24, P2434, DOI 10.1088/0256-307X/24/8/076; Pareto, 1897, COURS EC POLITIQUE; Scafetta N, 2004, QUANT FINANC, V4, P353, DOI 10.1088/1469-7688/4/3/010; Silva AC, 2005, EUROPHYS LETT, V69, P304, DOI 10.1209/epl/i2004-10330-3; Sinha S, 2006, PHYSICA A, V359, P555, DOI 10.1016/j.physa.2005.02.092; Smith A., 1976, INQUIRY NATURE CAUSE; Souma W, 2001, FRACTALS, V9, P463, DOI 10.1142/S0218348X01000816; Statistics Sweden, 2010, NET WEALTH DIFF INT; Statistics Sweden, 2010, NUMB WOM MEN NET WEA; Steindl Josef., 1965, RANDOM PROCESSES GRO; Szell M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01214; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Szell M, 2010, SOC NETWORKS, V32, P313, DOI 10.1016/j.socnet.2010.06.001; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Thurner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029796	61	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103503	10.1371/journal.pone.0103503	http://dx.doi.org/10.1371/journal.pone.0103503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153072	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000340952200007
J	Israelsson, C; Kylberg, A; Bengtsson, H; Hillered, L; Ebendal, T				Israelsson, Charlotte; Kylberg, Annika; Bengtsson, Henrik; Hillered, Lars; Ebendal, Ted			Interacting Chemokine Signals Regulate Dendritic Cells in Acute Brain Injury	PLOS ONE			English	Article							IFN-GAMMA; MONOCYTES; MOUSE; BLOOD; MICE; CNS; HETEROGENEITY; MACROPHAGES; MECHANISMS; DISEASE	Brain trauma is known to activate inflammatory cells via various chemokine signals although their interactions remain to be characterized. Mice deficient in Ccl3, Ccr2 or Cxcl10 were compared with wildtype mice after controlled cortical impact injury. Expression of Ccl3 in wildtypes was rapidly upregulated in resident, regularly spaced reactive microglia. Ccl3-deficiency enhanced endothelial expression of platelet selectin and invasion of peripheral inflammatory cells. Appearance of Ccr2 transcripts, encoding the Ccl2 receptor, reflected invasion of lysozyme 2-expressing phagocytes and classical antigen-presenting dendritic cells expressing major histocompatibility complex class II. Ccr2 also directed clustered plasmacytoid dendritic cells positive for the T-cell attracting chemokine Cxcl10. A reduction in Ccr2 and dendritic cells was found in injured wildtype cortex after cyclophosphamide treatment resembling effects of Ccr2-deficiency. The findings demonstrate the feasibility to control inflammation in the injured brain by regulating chemokine-dependent pathways.	[Israelsson, Charlotte; Kylberg, Annika; Bengtsson, Henrik; Ebendal, Ted] Uppsala Univ, Biomed Ctr, Dept Neurosci, Uppsala, Sweden; [Hillered, Lars] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University; Uppsala University	Ebendal, T (corresponding author), Uppsala Univ, Biomed Ctr, Dept Neurosci, Uppsala, Sweden.	Ted.Ebendal@neuro.uu.se		Hillered, Lars/0000-0002-2808-9292	Swedish Research Council [K2010-62X-20383-04-3]; Swedish Brain Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation	This work was supported by The Swedish Research Council, K2010-62X-20383-04-3, http://www.vr.se/ (TE); and The Swedish Brain Foundation, http://www.hjarnfonden.se/ (TE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bendriss-Vermare N, 2005, J LEUKOCYTE BIOL, V78, P954, DOI 10.1189/jlb.0704383; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Colton CA, 2013, J NEUROIMMUNE PHARM, V8, P145, DOI 10.1007/s11481-012-9414-8; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Huyan XH, 2011, INT IMMUNOPHARMACOL, V11, P1293, DOI 10.1016/j.intimp.2011.04.011; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lasky-Su J, 2012, CLIN EXP ALLERGY, V42, P1724, DOI 10.1111/cea.12000; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Megiorni F, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-88; Megjugorac NJ, 2004, J LEUKOCYTE BIOL, V75, P504, DOI 10.1189/jlb.0603291; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Zhu WH, 2012, J NEUROIMMUNOL, V247, P81, DOI 10.1016/j.jneuroim.2012.03.018	47	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104754	10.1371/journal.pone.0104754	http://dx.doi.org/10.1371/journal.pone.0104754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153123	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200024
J	Menzler, J; Channappa, L; Zeck, G				Menzler, Jacob; Channappa, Lakshmi; Zeck, Guenther			Rhythmic Ganglion Cell Activity in Bleached and Blind Adult Mouse Retinas	PLOS ONE			English	Article							OSCILLATORY ACTIVITY; DEGENERATION RD1; NETWORK; RESPONSES; CHANNELS; MUTANT; MODEL	In retinitis pigmentosa - a degenerative disease which often leads to incurable blindness-the loss of photoreceptors deprives the retina from a continuous excitatory input, the so-called dark current. In rodent models of this disease this deprivation leads to oscillatory electrical activity in the remaining circuitry, which is reflected in the rhythmic spiking of retinal ganglion cells (RGCs). It remained unclear, however, if the rhythmic RGC activity is attributed to circuit alterations occurring during photoreceptor degeneration or if rhythmic activity is an intrinsic property of healthy retinal circuitry which is masked by the photoreceptor's dark current. Here we tested these hypotheses by inducing and analysing oscillatory activity in adult healthy (C57/Bl6) and blind mouse retinas (rd10 and rd1). Rhythmic RGC activity in healthy retinas was detected upon partial photoreceptor bleaching using an extracellular high-density multi-transistor-array. The mean fundamental spiking frequency in bleached retinas was 4.3 Hz; close to the RGC rhythm detected in blind rd10 mouse retinas (6.5 Hz). Crosscorrelation analysis of neighbouring wild-type and rd10 RGCs (separation distance <200 mu m) reveals synchrony among homologous RGC types and a constant phase shift (similar to 70 msec) among heterologous cell types (ON versus OFF). The rhythmic RGC spiking in these retinas is driven by a network of presynaptic neurons. The inhibition of glutamatergic ganglion cell input or the inhibition of gap junctional coupling abolished the rhythmic pattern. In rd10 and rd1 retinas the presynaptic network leads to local field potentials, whereas in bleached retinas additional pharmacological disinhibition is required to achieve detectable field potentials. Our results demonstrate that photoreceptor bleaching unmasks oscillatory activity in healthy retinas which shares many features with the functional phenotype detected in rd10 retinas. The quantitative physiological differences advance the understanding of the degeneration process and may guide future rescue strategies.	[Menzler, Jacob; Channappa, Lakshmi; Zeck, Guenther] Univ Tubingen, Nat & Med Sci Inst, Neurochip Res Grp, Reutlingen, Germany; [Menzler, Jacob] Helmholtz Zentrum Munchen, Deutsch Forschungszentrum Gesundheit & Umwelt, Neuherberg, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Zeck, G (corresponding author), Univ Tubingen, Nat & Med Sci Inst, Neurochip Res Grp, Reutlingen, Germany.	guenther.zeck@nmi.de	Zeck, Günther/H-7419-2013	Zeck, Günther/0000-0003-3998-9883	German Ministry for Research and Education (BMBF) [FKZ: 1312038]; Pro Retina Network of RP patients	German Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Pro Retina Network of RP patients	This study was supported by a grant of the German Ministry for Research and Education (BMBF, FKZ: 1312038) to LC and GZ and by a grant from the Pro Retina Network of RP patients to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CL, 2013, J NEUROPHYSIOL, V109, P1589, DOI 10.1152/jn.00786.2012; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cameron MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068882; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Choi H, 2014, J NEUROPHYSIOL, V112, P1491, DOI 10.1152/jn.00437.2014; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; FAIN GL, 1993, EXP EYE RES, V57, P335, DOI 10.1006/exer.1993.1132; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Goo YS, 2011, KOREAN J PHYSIOL PHA, V15, P415, DOI 10.4196/kjpp.2011.15.6.415; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lambacher A, 2011, APPL PHYS A-MATER, V102, P1, DOI 10.1007/s00339-010-6046-9; Luo DG, 2005, J GEN PHYSIOL, V126, P263, DOI 10.1085/jgp.200509342; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086253; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Petit-Jacquea J, 2005, J NEUROPHYSIOL, V94, P1770, DOI 10.1152/jn.00279.2005; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Reimann MW, 2013, NEURON, V79, P375, DOI 10.1016/j.neuron.2013.05.023; Soto F, 2012, J NEUROSCI, V32, P5426, DOI 10.1523/JNEUROSCI.0194-12.2012; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Stasheff SF, 2011, J NEUROPHYSIOL, V105, P3002, DOI 10.1152/jn.00704.2010; Toychiev AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077658; Trenholm S, 2012, J PHYSIOL-LONDON, V590, P2501, DOI 10.1113/jphysiol.2011.225060; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012; Ye JH, 2007, PHYSIOL MEAS, V28, P1079, DOI 10.1088/0967-3334/28/9/009; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; Zeck G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020810; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	34	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106047	10.1371/journal.pone.0106047	http://dx.doi.org/10.1371/journal.pone.0106047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153888	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200109
J	Navarro, JM; Gonzalez, K; Cisternas, B; Lopez, JA; Chaparro, OR; Segura, CJ; Cordova, M; Suarez-Isla, B; Fernandez-Reiriz, MJ; Labarta, U				Navarro, Jorge M.; Gonzalez, Katerina; Cisternas, Barbara; Lopez, Jorge A.; Chaparro, Oscar R.; Segura, Cristian J.; Cordova, Marco; Suarez-Isla, Benjamin; Fernandez-Reiriz, Maria J.; Labarta, Uxio			Contrasting Physiological Responses of Two Populations of the Razor Clam Tagelus dombeii with Different Histories of Exposure to Paralytic Shellfish Poisoning (PSP)	PLOS ONE			English	Article							DINOFLAGELLATE ALEXANDRIUM-TAMARENSE; MYTILUS-CHILENSIS; GYRODINIUM-AUREOLUM; FEEDING RESPONSE; MUSSEL; TOXINS; OYSTER; RESISTANCE; INGESTION; SELECTION	This study describes the physiological performance of two populations of the razor clam Tagelus dombeii from two geographic areas with different histories of exposure to paralytic shellfish poisoning (PSP) linked to the toxic dinoflagellate Alexandrium catenella. Clams from Melinka-Aysen, which are frequently exposed to PSP, were not affected by the presence of toxins in the diet. However, clams from Corral-Valdivia, which have never been exposed to PSP, exhibited significantly reduced filtration activity and absorption, affecting the energy allocated to scope for growth (SFG). Ammonia excretion and oxygen uptake were not affected significantly by the presence of A. catenella in the diet. Measurements of energy acquisition and expenditure were performed during a 12-day intoxication period. According to three-way repeated measure ANOVAs, the origin of the clams had a highly significant effect on all physiological variables, and the interaction between diet and origin was significant for the clearance and absorption rates and for the scope for growth. The scope for growth index showed similar positive values for both the toxic and non-toxic individuals from the Melinka-Aysen population. However, it was significantly reduced in individuals from Corral-Valdivia when exposed to the diet containing A. catenella. The absence of differences between the physiological response of the toxic and non-toxic clams from Melinka-Aysen may be related to the frequent presence of A. catenella in the environment, indicating that this bivalve does not suffer negative consequences from PSP. By contrast, A. catenella has a negative effect on the physiological performance, primarily on the energy gained from the environment, on T. dombeii from Corral-Valdivia. This study supports the hypothesis that the history of PSP exposure plays an important role in the physiological performance and fitness of filter feeding bivalves.	[Navarro, Jorge M.; Cisternas, Barbara; Lopez, Jorge A.; Chaparro, Oscar R.; Segura, Cristian J.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Gonzalez, Katerina] Univ Catolica Temuco, Escuela Acuicultura, Temuco, Chile; [Cordova, Marco; Suarez-Isla, Benjamin] Univ Chile, Fac Med, Lab Toxinas Marinas, Santiago 7, Chile; [Fernandez-Reiriz, Maria J.; Labarta, Uxio] CSIC, Inst Invest Marinas, Vigo, Spain	Universidad Austral de Chile; Universidad Catolica de Temuco; Universidad de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Navarro, JM (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	jnavarro@uach.cl	Fernandez-Reiriz, MJ/B-9014-2013; Labarta, Uxio/D-5644-2012; Navarro, Jorge/B-7928-2008; Chaparro, Oscar R/A-5070-2009	Navarro, Jorge/0000-0001-9920-190X; Cordova, Marco/0000-0002-8352-1340	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT-CHILE) [FONDECYT 1080127, FONDECYT 1120470]	Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT-CHILE)	This study was funded by the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT-CHILE), by research grants to JMN (FONDECYT 1080127 and FONDECYT 1120470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.M., 1989, P11; ANDERSON DM, 1994, MAR BIOL, V120, P467, DOI 10.1007/BF00680222; Bardouil M, 1996, OCEANOL ACTA, V19, P177; BARDOUIL M, 1993, J SHELLFISH RES, V12, P417; BAYNE BL, 1982, PHILOS T ROY SOC B, V297, P219, DOI 10.1098/rstb.1982.0039; BOALCH GT, 1979, J MAR BIOL ASSOC UK, V59, P515, DOI 10.1017/S0025315400042818; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; Bricelj VM, 2005, NATURE, V434, P763, DOI 10.1038/nature03415; BRICELJ VM, 1990, MAR ECOL PROG SER, V63, P177, DOI 10.3354/meps063177; Chen CY, 1998, TOXICON, V36, P515, DOI 10.1016/S0041-0101(97)00093-7; Clement A, 2002, 22 JORN CIENC MAR; Colin SP, 2007, HARMFUL ALGAE, V6, P875, DOI 10.1016/j.hal.2007.05.003; Colin SP, 2004, EVOL ECOL, V18, P355, DOI 10.1007/s10682-004-2369-3; Connell LB, 2007, MAR BIOL, V150, P1227, DOI 10.1007/s00227-006-0432-z; COUGHLAN J, 1969, MAR BIOL, V2, P356, DOI 10.1007/BF00355716; Dam HG, 2013, ANNU REV MAR SCI, V5, P349, DOI 10.1146/annurev-marine-121211-172229; Dupuy J. L., 1968, Proceedings of the National Shellfisheries Association, V58, P2; ELLIOTT JM, 1975, OECOLOGIA, V19, P195, DOI 10.1007/BF00345305; Fernandez-Reiriz MJ, 2013, HELGOLAND MAR RES, V67, P653, DOI 10.1007/s10152-013-0351-6; Gainey LF., 1988, J SHELLFISH RES, V7, P623; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guillard R.R.L., 1995, MANUAL HARMFUL MARIN, P45; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Lassus P, 2004, AQUAT LIVING RESOUR, V17, P207, DOI 10.1051/alr:2004012; Li SC, 2002, MAR ENVIRON RES, V53, P145, DOI 10.1016/S0141-1136(01)00117-9; MacQuarrie SP, 2008, MAR ECOL PROG SER, V366, P59, DOI 10.3354/meps07538; MacQuarrie SP, 2002, THESIS DALHOUSIE U H; MARSDEN ID, 1992, NEW ZEAL J MAR FRESH, V26, P371, DOI 10.1080/00288330.1992.9516530; McLusky D.S., 1981, ESTUARINE ECOSYSTEM, V2, P37; Molinet C, 2003, REV CHIL HIST NAT, V76, P681; Navarro JM, 2006, HARMFUL ALGAE, V5, P762, DOI 10.1016/j.hal.2006.04.001; NAVARRO JM, 1982, MAR BIOL, V67, P255, DOI 10.1007/BF00397666; Navarro JM, 2008, REV CHIL HIST NAT, V81, P41; Navarro JM, 2010, MAR BIOL, V157, P1967, DOI 10.1007/s00227-010-1465-x; Navarro Jorge M., 1994, Revista de Biologia Marina, V29, P57; Perez M, 1998, THESIS ESCUELA BIOL; Quinn GP, 2003, EXPT DESIGN DATA ANA; SHUMWAY SE, 1985, J EXP MAR BIOL ECOL, V91, P77, DOI 10.1016/0022-0981(85)90222-9; SHUMWAY SE, 1987, AQUAT TOXICOL, V10, P9, DOI 10.1016/0166-445X(87)90024-5; Smolowitz R, 1997, AQUACULT INT, V5, P291, DOI 10.1023/A:1018355905598; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; TANGEN K, 1977, SARSIA, V63, P123, DOI 10.1080/00364827.1977.10411330; Velez P, 2001, TOXICON, V39, P929, DOI 10.1016/S0041-0101(00)00230-0; Widdows J., 1985, P161; WIDDOWS J, 1978, J MAR BIOL ASSOC UK, V58, P125, DOI 10.1017/S0025315400024450; WIDDOWS J, 1979, J MAR BIOL ASSOC UK, V59, P522, DOI 10.1017/S0025315400042843; WIKFORS GH, 1993, DEV MAR BIO, V3, P447; Wildish D, 1998, AQUAT LIVING RESOUR, V11, P35, DOI 10.1016/S0990-7440(99)80029-1; Wilson JA, 1996, AQUACULTURE, V139, P63, DOI 10.1016/0044-8486(95)01159-5; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	50	21	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105794	10.1371/journal.pone.0105794	http://dx.doi.org/10.1371/journal.pone.0105794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153329	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200082
J	Seo, JA; Song, SW; Han, K; Lee, KJ; Kim, HN				Seo, Jin-A; Song, Sang-Wook; Han, Kyungdo; Lee, Kyung-Jin; Kim, Ha-Na			The Associations between Serum Zinc Levels and Metabolic Syndrome in the Korean Population: Findings from the 2010 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; SUPPLEMENTATION; GLUCOSE; CHOLESTEROL; PREVALENCE; MECHANISM; TRANSPORT; LIVER	The prevalence of metabolic syndrome has been increasing rapidly worldwide. The functions of zinc may have a potential association with metabolic syndrome, but such associations have not been investigated extensively. Therefore, we examined the relationship between serum zinc levels and metabolic syndrome or metabolic risk factors among South Korean adults >= 20 years of age. The analysis used data from the Korean National Health and Nutrition Examination Survey, a cross-sectional survey of Korean civilians, conducted from January to December 2010. A total of 1,926 participants were analyzed in this study. Serum zinc levels in men were negatively associated with elevated fasting glucose (adjusted odds ratio [aOR], 0.58; 95% confidence interval [CI], 0.36-0.93) and positively associated with elevated triglycerides (aOR, 1.47; 95% CI, 1.01-2.13). A difference in serum zinc levels was detected in women, depending on the number of metabolic syndrome components (p = 0.002). Furthermore, serum zinc levels showed a decreasing trend with increasing numbers of metabolic syndrome components in women with metabolic syndrome. These findings suggest that serum zinc levels might be associated with metabolic syndrome or metabolic risk factors. Further gender-specific studies are needed to evaluate the effect of dietary or supplemental zinc intake on metabolic syndrome.	[Seo, Jin-A; Song, Sang-Wook; Lee, Kyung-Jin; Kim, Ha-Na] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kim, HN (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Seoul, South Korea.	onef01@catholic.ac.kr						Abiaka C, 2003, J CLIN LAB ANAL, V17, P61, DOI 10.1002/jcla.10069; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arnaud J, 2012, NUTR METAB CARDIOVAS, V22, P517, DOI 10.1016/j.numecd.2010.09.005; Balasoiu M, 2014, ROM J MORPHOL EMBRYO, V55, P29; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chevalier CA, 2002, J RENAL NUTR, V12, P183, DOI 10.1053/jren.2002.33515; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Farvid MS, 2004, DIABETES RES CLIN PR, V65, P21, DOI 10.1016/j.diabres.2003.11.009; Foster M, 2010, ATHEROSCLEROSIS, V210, P344, DOI 10.1016/j.atherosclerosis.2009.11.038; Ghasemi A, 2014, ANN HUM BIOL, V41, P436, DOI 10.3109/03014460.2013.870228; Ghayour-Mobarhan M, 2009, J TRACE ELEM MED BIO, V23, P167, DOI 10.1016/j.jtemb.2009.03.006; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Gill H, 2005, AM J MED SCI, V330, P290, DOI 10.1097/00000441-200512000-00006; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Hambidge KM, 2010, AM J CLIN NUTR, V91, p1478S, DOI 10.3945/ajcn.2010.28674I; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Ilouz R, 2002, BIOCHEM BIOPH RES CO, V295, P102, DOI 10.1016/S0006-291X(02)00636-8; Islam MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061776; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Lowe NM, 2009, AM J CLIN NUTR, V89, p2040S, DOI 10.3945/ajcn.2009.27230G; Lowe NM, 2004, J NUTR, V134, P2178, DOI 10.1093/jn/134.9.2178; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Obeid O, 2008, BIOL TRACE ELEM RES, V123, P58, DOI 10.1007/s12011-008-8112-0; Otto MCD, 2012, J NUTR, V142, P526, DOI 10.3945/jn.111.149781; Partida-Hernandez G, 2006, BIOMED PHARMACOTHER, V60, P161, DOI 10.1016/j.biopha.2006.02.004; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Roozbeh J, 2009, RENAL FAILURE, V31, P798, DOI 10.3109/08860220903216055; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82; Tang XH, 2001, J NUTR, V131, P1414, DOI 10.1093/jn/131.5.1414; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vashum KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083944; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yu YH, 2012, NUTR RES, V32, P71, DOI 10.1016/j.nutres.2011.12.004; Zangger K, 2001, FASEB J, V15, P1303, DOI 10.1096/fj.00-0641fje	48	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105990	10.1371/journal.pone.0105990	http://dx.doi.org/10.1371/journal.pone.0105990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153887	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200101
J	Kim, JY; Goo, YK; Ji, SY; Shin, HI; Han, ET; Hong, Y; Chung, DI; Cho, SH; Lee, WJ				Kim, Jung-Yeon; Goo, Youn-Kyoung; Ji, So-Young; Shin, Hyun-Il; Han, Eun-Taek; Hong, Yeonchul; Chung, Dong-Il; Cho, Shin-Hyung; Lee, Won-Ja			Development and Efficacy of Real-Time PCR in the Diagnosis of Vivax Malaria Using Field Samples in the Republic of Korea	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PLASMODIUM-FALCIPARUM; ASSAY; MICROSCOPY; TESTS; IDENTIFICATION; AMPLIFICATION; ACCURACY; OVALE	The development of sensitive, rapid, and accurate diagnostic methods for vivax malaria is essential for the effective control of malaria in the Republic of Korea, where vivax malaria patients usually show low parasitemia. In this study, a TaqMan-based real-time polymerase chain reaction (PCR) method was established and compared with other PCR-based assays, including nested PCR, loop-mediated isothermal amplification, and multiplex PCR, using samples from febrile patients with suspected vivax malaria. The established real-time PCR had a high sensitivity (99.6%) and specificity (100%). Therefore, this sensitive, specific, rapid, and quantitative real-time PCR method could be used for the routine diagnosis of vivax malaria in the laboratory of the Korea National Institute of Health.	[Kim, Jung-Yeon; Goo, Youn-Kyoung; Ji, So-Young; Shin, Hyun-Il; Cho, Shin-Hyung; Lee, Won-Ja] Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, Osong, South Korea; [Goo, Youn-Kyoung; Hong, Yeonchul; Chung, Dong-Il] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Taegu, South Korea; [Han, Eun-Taek] Kangwon Natl Univ, Coll Med, Dept Parasitol, Chunchon, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Kyungpook National University; Kangwon National University	Lee, WJ (corresponding author), Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, Osong Saeng Myeong 2 Ro, Osong, South Korea.	leewonja@gmail.com			Korea National Institute of Health, Korea CDC [4847-311-210-13]	Korea National Institute of Health, Korea CDC	This work was supported by funding (4847-311-210-13) from the Korea National Institute of Health, Korea CDC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-175; Alemu A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-174; APMEN, 2013, EL MAL REP KOR; Barber BE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-8; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Berry A, 2005, Med Trop (Mars), V65, P176; Chen JH, 2010, ACTA TROP, V113, P61, DOI 10.1016/j.actatropica.2009.09.007; Chew CH, 2012, J CLIN MICROBIOL, V50, P4012, DOI 10.1128/JCM.06454-11; Coleman RE, 2002, AM J TROP MED HYG, V67, P141, DOI 10.4269/ajtmh.2002.67.141; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; Haanshuus CG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-26; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Han Eun-Taek, 2006, Korean Journal of Parasitology, V44, P285, DOI 10.3347/kjp.2006.44.4.285; Hwang SY, 2011, ACTA TROP, V120, P40, DOI 10.1016/j.actatropica.2011.05.006; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Kawamoto F, 1996, J CLIN MICROBIOL, V34, P2287, DOI 10.1128/JCM.34.9.2287-2289.1996; KIM J, 2013, NATL GEOGR, V224, P8; Krogstad DJ, 1996, EPIDEMIOL REV, V18, P77, DOI 10.1093/oxfordjournals.epirev.a017918; Kuamsab N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-190; Lee MA, 2002, J CLIN MICROBIOL, V40, P4343, DOI 10.1128/JCM.40.11.4343-4345.2002; Linard C, 2009, ECOHEALTH, V6, P135, DOI 10.1007/s10393-009-0236-y; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Rubio JM, 2001, J CLIN MICROBIOL, V39, P2736, DOI 10.1128/JCM.39.7.2736-2737.2001; Santana-Morales MA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-199; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; WHO, 2013, WHO MAL REP; WHO, 2012, REG ACT PLAN MAL CON; Zhong KJY, 1999, J CLIN MICROBIOL, V37, P339, DOI 10.1128/JCM.37.2.339-341.1999	30	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105871	10.1371/journal.pone.0105871	http://dx.doi.org/10.1371/journal.pone.0105871			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148038	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600091
J	Zhang, Y; Dai, SL; Hong, Y; Song, XB				Zhang, Yuan; Dai, Silan; Hong, Yan; Song, Xuebin			Application of Genomic SSR Locus Polymorphisms on the Identification and Classification of Chrysanthemum Cultivars in China	PLOS ONE			English	Article							POPULATION-STRUCTURE; RAPD ANALYSIS; MARKERS; DIVERSITY; INFERENCE; ORIGIN; NUMBER	The Chinese traditional chrysanthemum is a notable group of chrysanthemums (Chrysanthemum x morifolium Ramat.) in which the phenotypic characteristics richly vary. At present, there is a serious controversy regarding homonyms and synonyms within this group. Moreover, the current international chrysanthemum classification systems are not comprehensive enough to be used on Chinese traditional chrysanthemums. Thus, we first identified a broad collection of 480 Chinese traditional chrysanthemum cultivars using the unique DNA fingerprints and molecular identities that were established by 20 simple sequence repeat markers. Five loci, which distinguished all of the selected cultivars, were identified as the core loci to establish unique fingerprints and molecular identities with 19 denary digits for each cultivar. A cluster analysis based on Nei's genetic distance indicated that the selected cultivars were clustered according to their horticultural classification. Population structure analysis was subsequently performed with K values ranging from 2 to 14, and the most likely estimate for the population structure was ten subpopulations, which was nearly consistent with the clustering result. Principal component analysis was further performed to verify the classification results. On the basis of the Q-matrices of K = 10, a total of 19 traits were found to be associated with 42 markers. Taken together, these results can serve as starting points for the identification and classification of chrysanthemums based on the polymorphism of microsatellite markers, which is beneficial to promote the marker-assisted breeding and international communication of this marvelous crop.	[Zhang, Yuan; Dai, Silan; Hong, Yan; Song, Xuebin] Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China	Beijing Forestry University	Dai, SL (corresponding author), Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China.	silandai@sina.com			National Special Research Project for Forestry Public Affairs [200904050]; Important Research Project for Knowledge Innovation of Chinese Academy of Sciences [2A2011311211021]	National Special Research Project for Forestry Public Affairs; Important Research Project for Knowledge Innovation of Chinese Academy of Sciences	This study was supported by the National Special Research Project for Forestry Public Affairs (Grant No. 200904050) and the Important Research Project for Knowledge Innovation of Chinese Academy of Sciences (Grant No. 2A2011311211021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NO, 2006, FLOWER BREEDING AND GENETICS: ISSUES, CHALLENGES AND OPPORTUNITIES FOR THE 21ST CENTURY, P389; Barakat MN, 2010, AFR J AGR RES, V5, P748; Boran FE, 2009, EXPERT SYST APPL, V36, P11363, DOI 10.1016/j.eswa.2009.03.039; Braglia L, 2010, SCI HORTIC-AMSTERDAM, V123, P372, DOI 10.1016/j.scienta.2009.10.003; Chen JY., 2001, TAXONOMY FLOWER CULT; Colburn J.C., 1992, CAPILLARY ELECTROPHO; Dai SL, 1998, ACTA BOT SIN, V40, P1053; De Castro O, 2013, ANN BOT-LONDON, V112, P589, DOI 10.1093/aob/mct134; DOWRICK GJ, 1966, EUPHYTICA, V15, P32; DREWLOW LW, 1973, THEOR APPL GENET, V43, P1, DOI 10.1007/BF00277824; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Garibaldi A, 2009, Commun Agric Appl Biol Sci, V74, P651; Gawenda I, 2012, MOL BREEDING, V30, P305, DOI 10.1007/s11032-011-9620-8; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hong Yan, 2012, Acta Horticulturae Sinica, V39, P1330; Huang SC, 2000, BOT BULL ACAD SINICA, V41, P257; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kang EJ, 2013, HORTIC ENVIRON BIOTE, V54, P76, DOI 10.1007/s13580-013-0124-9; Klie M, 2013, MOL BREEDING, V32, P339, DOI 10.1007/s11032-013-9874-4; Lema-Ruminska J, 2004, PLANT BREEDING, V123, P290, DOI 10.1111/j.1439-0523.2004.00996.x; Li N, 2011, HUNAN AGR SCI, V8, P27; Li RenWei, 2012, Scientia Agricultura Sinica, V45, P1355; Li Y, 2012, NO HORT, V13, P127; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Martin C, 2002, EUPHYTICA, V127, P247, DOI 10.1023/A:1020215016347; Masuda Y., 2009, CHROMOSOME BOT, V4, P25; Mezmouk S, 2011, THEOR APPL GENET, V122, P1149, DOI 10.1007/s00122-010-1519-y; Ministry of Agriculture Forestry and Fisheries of Japan, 2012, CHRYS CHRYS MOR RAM; Ministry of Agriculture of the People's Republic of China, 2002, HDB DIST UN STAB TES; National Chrysanthemum Society of the United Kingdom, 2013, CHRYS CLASS; National Chrysanthemum Society of the United States of America, 2012, HDB CHRYS CLASS; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2001, GENETICS, V159, P699; Ruan CJ, 2009, MOL BREEDING, V24, P255, DOI 10.1007/s11032-009-9288-5; Sehrawat SK, 2003, ACTA HORTIC, P479, DOI 10.17660/ActaHortic.2003.624.66; Shao QS, 2010, BIOCHEM SYST ECOL, V38, P1160, DOI 10.1016/j.bse.2010.11.002; Torfi F, 2010, APPL SOFT COMPUT, V10, P520, DOI 10.1016/j.asoc.2009.08.021; Uysal H, 2010, GENET RESOUR CROP EV, V57, P1109, DOI 10.1007/s10722-010-9551-y; WOLFF K, 1995, THEOR APPL GENET, V91, P439, DOI 10.1007/BF00222971; Wolff K, 1996, EUPHYTICA, V89, P159, DOI 10.1007/BF00034601; Xie RJ, 2011, PLANT MOL BIOL REP, V29, P554, DOI 10.1007/s11105-010-0261-6; Yang WH, 2006, NEW PHYTOL, V171, P875, DOI 10.1111/j.1469-8137.2006.01779.x; Yuan JH, 2014, MOL ECOL, V23, P82, DOI 10.1111/mec.12567; Zhang F, 2012, SCI HORTIC-AMSTERDAM, V139, P39, DOI 10.1016/j.scienta.2012.03.002; Zhang F, 2011, MOL BREEDING, V27, P11, DOI 10.1007/s11032-010-9409-1; Zhang F, 2010, SCI HORTIC-AMSTERDAM, V125, P422, DOI 10.1016/j.scienta.2010.03.028; Zhang Y, 2014, J SYST EVOL IN PRESS; Zhang Y, 2013, J AM SOC HORTIC SCI, V138, P38, DOI 10.21273/JASHS.138.1.38; Zhang Y, 2013, J SYST EVOL, V51, P335, DOI 10.1111/j.1759-6831.2012.00235.x	52	27	31	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104856	10.1371/journal.pone.0104856	http://dx.doi.org/10.1371/journal.pone.0104856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148046	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600025
J	Kamel, W; Segerman, B; Punga, T; Akusjarvi, G				Kamel, Wael; Segerman, Bo; Punga, Tanel; Akusjarvi, Goran			Small RNA Sequence Analysis of Adenovirus VA RNA-Derived MiRNAs Reveals an Unexpected Serotype-Specific Difference in Structure and Abundance	PLOS ONE			English	Article							VIRUS-ASSOCIATED RNA; INDUCED SILENCING COMPLEX; MICRORNA BIOGENESIS; CELLS; INTERFERENCE; TRANSCRIPTION; RECOGNITION; TRANSLATION; EVOLUTION; INFECTION	Human adenoviruses (HAds) encode for one or two highly abundant virus-associated RNAs, designated VA RNAI and VA RNAII, which fold into stable hairpin structures resembling miRNA precursors. Here we show that the terminal stem of the VA RNAs originating from Ad4, Ad5, Ad11 and Ad37, all undergo Dicer dependent processing into virus-specific miRNAs (so-called mivaRNAs). We further show that the mivaRNA duplex is subjected to a highly asymmetric RISC loading with the 3'-strand from all VA RNAs being the favored strand, except for the Ad37 VA RNAII, where the 5'-mivaRNAII strand was preferentially assembled into RISC. Although the mivaRNA seed sequences are not fully conserved between the HAds a bioinformatics prediction approach suggests that a large fraction of the VA RNAII-, but not the VA RNAI-derived mivaRNAs still are able to target the same cellular genes. Using small RNA deep sequencing we demonstrate that the Dicer processing event in the terminal stem of the VA RNAs is not unique and generates 3'-mivaRNAs with a slight variation of the position of the 5'-terminal nucleotide in the RISC loaded guide strand. Also, we show that all analyzed VA RNAs, except Ad37 VA RNAI and Ad5 VA RNAII, utilize an alternative upstream A start site in addition to the classical +1 G start site. Further, the 5'-mivaRNAs with an A start appears to be preferentially incorporated into RISC. Although the majority of mivaRNA research has been done using Ad5 as the model system our analysis demonstrates that the mivaRNAs expressed in Ad11- and Ad37-infected cells are the most abundant mivaRNAs associated with Ago2-containing RISC. Collectively, our results show an unexpected variability in Dicer processing of the VA RNAs and a serotype-specific loading of mivaRNAs into Ago2-based RISC.	[Kamel, Wael; Punga, Tanel; Akusjarvi, Goran] Uppsala Univ, Sci Life Lab, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Segerman, Bo] Natl Vet Inst, S-75007 Uppsala, Sweden	Uppsala University; National Veterinary Institute SVA	Akusjarvi, G (corresponding author), Uppsala Univ, Sci Life Lab, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	goran.akusjarvi@imbim.uu.se	Kamel, Wael/AAD-4645-2022; Punga, Tanel/K-9844-2019	Kamel, Wael/0000-0002-7625-2648; Punga, Tanel/0000-0002-0561-367X	Swedish Cancer Society [13 0469, 12 0504]; Swedish Research Council [K2012-99X-21959-01-3, 2006-5038-36531-16]; Ake Wibergs Foundation [924563923]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wibergs Foundation	This study was supported by the Swedish Cancer Society (http://Cancerfonden.se; GA 13 0469, TP 12 0504), The Swedish Research Council (http://vr.se; TP K2012-99X-21959-01-3), The Swedish Research Council through a grant to the Uppsala RNA Research Centre (URRC) (http://urrc-linnaeuscentre.uu.se; GA and TP, 2006-5038-36531-16), and the Ake Wibergs Foundation (http://ake-wiberg.se; TP 924563923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Aparicio O, 2010, NUCLEIC ACIDS RES, V38, P750, DOI 10.1093/nar/gkp1028; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BHAT RA, 1984, NUCLEIC ACIDS RES, V12, P7377, DOI 10.1093/nar/12.19.7377; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; Enright AJ, 2004, GENOME BIOL, V5; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Furuse Y, 2013, VIROLOGY, V447, P140, DOI 10.1016/j.virol.2013.08.024; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Kamel W, 2013, NUCLEIC ACIDS RES, V41, P4802, DOI 10.1093/nar/gkt172; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Ma YL, 1996, J VIROL, V70, P5083, DOI 10.1128/JVI.70.8.5083-5099.1996; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; PHILIPSON L, 1961, VIROLOGY, V15, P263, DOI 10.1016/0042-6822(61)90357-9; Punga T, 2013, FUTURE VIROL, V8, P343, DOI 10.2217/FVL.13.19; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Sano M, 2006, FEBS LETT, V580, P1553, DOI 10.1016/j.febslet.2006.01.085; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; THIMMAPPAYA B, 1982, CELL, V31, P543, DOI 10.1016/0092-8674(82)90310-5; VENNSTROM B, 1978, NUCLEIC ACIDS RES, V5, P205, DOI 10.1093/nar/5.1.205; WARREN D, 1989, J INFECT DIS, V160, P938, DOI 10.1093/infdis/160.6.938; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Xu N, 2007, J VIROL, V81, P10540, DOI 10.1128/JVI.00885-07; Xu N, 2011, METHODS MOL BIOL, V721, P183, DOI 10.1007/978-1-61779-037-9_11; Xu N, 2009, NUCLEIC ACIDS RES, V37, P6950, DOI 10.1093/nar/gkp764; Zhao HX, 2013, VIROLOGY, V442, P148, DOI 10.1016/j.virol.2013.04.006	34	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105746	10.1371/journal.pone.0105746	http://dx.doi.org/10.1371/journal.pone.0105746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144466	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100115
J	Lien, HM; Tseng, CJ; Huang, CL; Lin, YT; Chen, CC; Lai, YY				Lien, Hsiu-Man; Tseng, Chin-Jui; Huang, Chao-Lu; Lin, Yu-Ting; Chen, Chia-Chang; Lai, Ya-Yun			Antimicrobial Activity of Antrodia camphorata Extracts against Oral Bacteria	PLOS ONE			English	Article							DENTAL-CARIES PREVENTION; KAPPA-B ACTIVATION; STREPTOCOCCUS-MUTANS; MEDICINES; MYCELIA; DAMAGE	Antrodia camphorata (A. camphorata) is a unique, endemic and extremely rare mushroom species native to Taiwan, and both crude extracts of and purified chemical compounds from A. camphorata have been reported to have a variety of significant beneficial effects, such as anti-tumor and anti-inflammatory activity. However, reports on the effects of A. camphorata against dental pathogens have been limited. Oral health is now recognized as important for overall general health, including conditions such as dental caries, periodontal disease and rheumatoid arthritis. Streptococcus mutans (S. mutans) and Porphyromonas gingivalis (P. gingivalis) are the most common bacteria associated with dental plaque and periodontopathic diseases, respectively. Thus, our study examined the ability of five various crude extracts of A. camphorata to inhibit the growth of dental bacteria and anti-adherence in vitro. Among the extracts, the ethanol, ethyl acetate and chloroform extracts exhibited the lowest MICs against P. gingivalis and S. mutans (MIC = 4 similar to 16 mu g/mL). The MIC of the aqueous extract was greater than 2048 mu g/mL against both P. gingivalis and S. mutans. In vitro adherence of S. mutans was significantly inhibited by the addition of either the ethyl acetate extract or chloroform extract (MIC = 16 similar to 24 mu g/mL), while the ethanol extract (MIC = 32 similar to 64 mu g/mL) exhibited moderate inhibitory activity. Based on the result of this study, the ethyl acetate and chloroform extracts of A. camphorata may be good candidates for oral hygiene agents to control dental caries and periodontopathic conditions.	[Lien, Hsiu-Man] Tunghai Univ, Dept Chem, Taichung 40704, Taiwan; [Tseng, Chin-Jui] Natl Chung Hsing Univ, Dept Chem, Taichung 40227, Taiwan; [Huang, Chao-Lu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lin, Yu-Ting] Natl Ilan Univ, Dept Food Sci, Ilan, Taiwan; [Chen, Chia-Chang] Feng Chia Univ, Sch Management Dept, Taichung 40724, Taiwan; [Lai, Ya-Yun] Natl Tainan Inst Nursing, Dept Appl Cosmetol, Tainan, Taiwan; [Chen, Chia-Chang] Yusheng Biotechnol Co Ltd, Taichung, Taiwan	Tunghai University; National Chung Hsing University; National Chung Hsing University; National Ilan University; Feng Chia University	Lai, YY (corresponding author), Natl Tainan Inst Nursing, Dept Appl Cosmetol, Tainan, Taiwan.	yayun819@gmail.com			Yusheng Biotechnology Co. Ltd.	Yusheng Biotechnology Co. Ltd.	The study is funded by Yusheng Biotechnology Co. Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlutti F, 2010, INT J IMMUNOPATH PH, V23, P1253, DOI 10.1177/039463201002300430; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Chen CC, 2007, J AGR FOOD CHEM, V55, P5007, DOI 10.1021/jf063484c; Chen YC, 2011, ACTA PHARMACOL SIN, V32, P904, DOI 10.1038/aps.2011.36; Chien SC, 2008, J AGR FOOD CHEM, V56, P7017, DOI 10.1021/jf801171x; GIBBONS RJ, 1974, INFECT IMMUN, V9, P481, DOI 10.1128/IAI.9.3.481-488.1974; HOMER KA, 1990, ARCH ORAL BIOL, V35, P421, DOI 10.1016/0003-9969(90)90203-M; Hseu YC, 2002, LIFE SCI, V71, P469, DOI 10.1016/S0024-3205(02)01686-7; Hseu YC, 2008, FOOD CHEM TOXICOL, V46, P2680, DOI 10.1016/j.fct.2008.04.036; Hseu YC, 2008, J ETHNOPHARMACOL, V118, P237, DOI 10.1016/j.jep.2008.04.004; Hseu YC, 2010, FOOD CHEM TOXICOL, V48, P2319, DOI 10.1016/j.fct.2010.05.066; KAKIUCHI N, 1986, CHEM PHARM BULL, V34, P720; Kang MS, 2008, J MICROBIOL, V46, P744, DOI 10.1007/s12275-008-0235-7; Lee YP, 2012, ANTICANCER RES, V32, P2727; LIEN HM, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEP020; Lu MC, 2009, ARCH TOXICOL, V83, P121, DOI 10.1007/s00204-008-0337-3; MCDONALD JL, 1978, J DENT RES, V57, P349, DOI 10.1177/00220345780570023501; NAMBA T, 1982, PLANTA MED, V44, P100, DOI 10.1055/s-2007-971412; Sheu F, 2009, J AGR FOOD CHEM, V57, P4130, DOI 10.1021/jf900469a; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Wong RWK, 2010, INT J ORAL MAX SURG, V39, P599, DOI 10.1016/j.ijom.2010.02.024; Woods R, 1971, Aust Dent J, V16, P116; Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10	23	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105286	10.1371/journal.pone.0105286	http://dx.doi.org/10.1371/journal.pone.0105286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144619	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100047
J	Mukai, T; Gallant, R; Ishida, S; Yoshitaka, T; Kittaka, M; Nishida, K; Fox, DA; Morita, Y; Ueki, Y				Mukai, Tomoyuki; Gallant, Richard; Ishida, Shu; Yoshitaka, Teruhito; Kittaka, Mizuho; Nishida, Keiichiro; Fox, David A.; Morita, Yoshitaka; Ueki, Yasuyoshi			SH3BP2 Gain-Of-Function Mutation Exacerbates Inflammation and Bone Loss in a Murine Collagen-Induced Arthritis Model	PLOS ONE			English	Article							ADAPTER PROTEIN 3BP2; COLONY-STIMULATING FACTOR; KAPPA-B LIGAND; T-CELLS; RHEUMATOID-ARTHRITIS; RECEPTOR ACTIVATOR; NUCLEAR-FACTOR; M-CSF; MICE; CHERUBISM	Objective: SH3BP2 is a signaling adapter protein which regulates immune and skeletal systems. Gain-of-function mutations in SH3BP2 cause cherubism, characterized by jawbone destruction. This study was aimed to examine the role of SH3BP2 in inflammatory bone loss using a collagen-induced arthritis (CIA) model. Methods: CIA was induced in wild-type (Sh3bp2(+/+)) and heterozygous P416R SH3BP2 cherubism mutant knock-in (Sh3bp2(KI/+)) mice, an SH3BP2 gain-of-function model. Severity of the arthritis was determined by assessing the paw swelling and histological analyses of the joints. Micro-CT analysis was used to determine the levels of bone loss. Inflammation and osteoclastogenesis in the joints were evaluated by quantitating the gene expression of inflammatory cytokines and osteoclast markers. Furthermore, involvement of the T- and B-cell responses was determined by draining lymph node cell culture and measurement of the serum anti-mouse type II collagen antibody levels, respectively. Finally, roles of the SH3BP2 mutation in macrophage activation and osteoclastogenesis were determined by evaluating the TNF-alpha production levels and osteoclast formation in bone marrow-derived M-CSF-dependent macrophage (BMM) cultures. Results: Sh3bp2(KI/+) mice exhibited more severe inflammation and bone loss, accompanying an increased number of osteoclasts. The mRNA levels for TNF-alpha and osteoclast marker genes were higher in the joints of Sh3bp2(KI/+) mice. Lymph node cell culture showed that lymphocyte proliferation and IFN-gamma and IL-17 production were comparable between Sh3bp(2+/+) and Sh3bp2(KI/+) cells. Serum anti-type II collagen antibody levels were comparable between Sh3bp(2+/+) and Sh3bp2(KI/+) mice. In vitro experiments showed that TNF-alpha production in Sh3bp2(KI/+) BMMs is elevated compared with Sh3bp(2+/+) BMMs and that RANKL-induced osteoclastogenesis is enhanced in Sh3bp2(KI/+) BMMs associated with increased NFATc1 nuclear localization. Conclusion: Gain-of-function of SH3BP2 augments inflammation and bone loss in the CIA model through increased macrophage activation and osteoclast formation. Therefore, modulation of the SH3BP2 expression may have therapeutic potential for the treatment of rheumatoid arthritis.	[Mukai, Tomoyuki; Gallant, Richard; Ishida, Shu; Yoshitaka, Teruhito; Kittaka, Mizuho; Ueki, Yasuyoshi] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 64110 USA; [Ishida, Shu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Inst Biomed & Hlth Sci, Dept Periodontal Med, Hiroshima, Japan; [Nishida, Keiichiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Okayama, Japan; [Nishida, Keiichiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Morphol, Okayama, Japan; [Fox, David A.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Morita, Yoshitaka] Kawasaki Med Sch, Dept Rheumatol, Kurashiki, Okayama, Japan	University of Missouri System; University of Missouri Kansas City; Hiroshima University; Okayama University; Okayama University; University of Michigan System; University of Michigan; Kawasaki Medical School	Ueki, Y (corresponding author), Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 64110 USA.	uekiy@umkc.edu	Mukai, Tomoyuki/AAP-5771-2021; Kittaka, Mizuho/AAT-7398-2021; NISHIDA, Keiichiro/B-2014-2011	Nishida, Keiichiro/0000-0003-1260-586X; Mukai, Tomoyuki/0000-0002-0103-1621	National Institute of Health [R01DE020835]; Japan Rheumatism Foundation; Kawasaki Medical School [25-83]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020835] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Rheumatism Foundation(Japan Rheumatism Foundation); Kawasaki Medical School; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants from the National Institute of Health (R01DE020835) to YU, the Japan Rheumatism Foundation (Rheumatology Traveling Fellowship) to TM, and Research Project Grants from Kawasaki Medical School (No. 25-83) to YM. The URLs of the funders' website are http://www.nih.gov/, http://www.rheuma-net.or.jp/rheuma/e-rheuma/e-index.htm, and http://www.kawasaki-m.ac.jp/med/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; BRUCE KW, 1953, ORAL SURG ORAL MED O, V6, P995, DOI 10.1016/0898-1221(53)90139-4; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; Chen G, 2012, J IMMUNOL, V189, P2138, DOI 10.4049/jimmunol.1103184; Chihara K, 2014, EXP CELL RES, V322, P99, DOI 10.1016/j.yexcr.2013.12.026; Cho YG, 2007, AUTOIMMUN REV, V7, P65, DOI 10.1016/j.autrev.2007.08.001; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Geusens P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3375; Gizinski AM, 2014, CURR OPIN RHEUMATOL, V26, P204, DOI 10.1097/BOR.0000000000000036; GOUGH AKS, 1994, LANCET, V344, P23, DOI 10.1016/S0140-6736(94)91049-9; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; GuezGuez A, 2010, J BIOL CHEM, V285, P20952, DOI 10.1074/jbc.M109.091124; Hatani T, 2008, CURR MED CHEM, V15, P549; Hutamekalin P, 2009, J IMMUNOL METHODS, V343, P49, DOI 10.1016/j.jim.2009.01.009; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Jevremovic D, 2001, J IMMUNOL, V166, P7219, DOI 10.4049/jimmunol.166.12.7219; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; Knevel R, 2013, ANN RHEUM DIS; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Levaot N, 2011, J CLIN INVEST, V121, P3244, DOI 10.1172/JCI45843; McClendon JL, 1962, ORAL SURG         S2, V15, P17; Morita Y, 2001, J CLIN INVEST, V107, P1275, DOI 10.1172/JCI11490; Mukai T, 2014, J BONE MINER RES, V29, P2618, DOI 10.1002/jbmr.2295; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakano K, 2007, RHEUMATOLOGY, V46, P597, DOI 10.1093/rheumatology/kel356; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Gradaigh D, 2004, ANN RHEUM DIS, V63, P354, DOI 10.1136/ard.2003.008458; Ogi K, 2011, GENES CELLS, V16, P951, DOI 10.1111/j.1365-2443.2011.01539.x; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Papadaki ME, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-S1-S6; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Proulx ST, 2007, ARTHRITIS RHEUM-US, V56, P4024, DOI 10.1002/art.23128; Proulx-Bonneau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021511; Qu XJ, 2005, BIOCHEMISTRY-US, V44, P3891, DOI 10.1021/bi048353o; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Rioja I, 2004, CLIN EXP IMMUNOL, V137, P65, DOI 10.1111/j.1365-2249.2004.02499.x; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; Southgate J, 1998, J CLIN PATHOL, V51, P831, DOI 10.1136/jcp.51.11.831; STUART JM, 1982, J CLIN INVEST, V69, P673, DOI 10.1172/JCI110495; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061045; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Tada Y, 1996, J IMMUNOL, V156, P4520; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Tanabe N, 2011, J BIOL CHEM, V286, P39871, DOI 10.1074/jbc.M111.295048; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721; van Staa TP, 2006, ARTHRITIS RHEUM-US, V54, P3104, DOI 10.1002/art.22117; Wang CCJ, 2010, BONE, V46, P1306, DOI 10.1016/j.bone.2010.01.380; WAYMAN JB, 1978, BRIT J ORAL SURG, V16, P47, DOI 10.1016/S0007-117X(78)80055-9; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang PT, 2006, ANN RHEUM DIS, V65, P1671, DOI 10.1136/ard.2006.054874; Yoshitaka T, 2014, J BONE MINER RES, V29, P1170, DOI 10.1002/jbmr.2125	68	15	39	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105518	10.1371/journal.pone.0105518	http://dx.doi.org/10.1371/journal.pone.0105518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144740	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100079
J	Sakai, F; Hosoya, T; Ono-Ohmachi, A; Ukibe, K; Ogawa, A; Moriya, T; Kadooka, Y; Shiozaki, T; Nakagawa, H; Nakayama, Y; Miyazaki, T				Sakai, Fumihiko; Hosoya, Tomohiro; Ono-Ohmachi, Aiko; Ukibe, Ken; Ogawa, Akihiro; Moriya, Tomohiro; Kadooka, Yukio; Shiozaki, Takuya; Nakagawa, Hisako; Nakayama, Yosuke; Miyazaki, Tadaaki			Lactobacillus gasseri SBT2055 Induces TGF-beta Expression in Dendritic Cells and Activates TLR2 Signal to Produce IgA in the Small Intestine	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; INDUCED CYTIDINE DEAMINASE; NAIVE B-CELLS; AUTOCRINE/PARACRINE TGF-BETA-1; IMMUNE-RESPONSE; ADIPOCYTE SIZE; MILK; BAFF; TACI; LYMPHOCYTES	Probiotic bacteria provide benefits in enhancing host immune responses and protecting against infection. Induction of IgA production by oral administration of probiotic bacteria in the intestine has been considered to be one reason for this beneficial effect, but the mechanisms of the effect are poorly understood. Lactobacillus gasseri SBT2055 (LG2055) is a probiotic bacterium with properties such as bile tolerance, ability to improve the intestinal environment, and it has preventive effects related to abdominal adiposity. In this study, we have found that oral administration of LG2055 induced IgA production and increased the rate of IgA(+) cell population in Peyer's patch and in the lamina propria of the mouse small intestine. The LG2055 markedly increased the amount of IgA in a co-culture of B cells and bone marrow derived dendritic cells (BMDC), and TLR2 signal is critical for it. In addition, it is demonstrated that LG2055 stimulates BMDC to promote the production of TGF-beta, BAFF, IL-6, and IL-10, all critical for IgA production from B cells. Combined stimulation of B cells with BAFF and LG2055 enhanced the induction of IgA production. Further, TGF-beta signal was shown to be critical for LG2055-induced IgA production in the B cell and BMDC co-culture system, but TGF-beta did not induce IgA production in a culture of only B cells stimulated with LG2055. Furthermore, TGF-beta was critical for the production of BAFF, IL-6, IL-10, and TGF-beta itself from LG2055-stimulated BMDC. These results demonstrate that TGF-beta was produced by BMDC stimulated with LG2055 and it has an autocrine/paracrine function essential for BMDC to induce the production of BAFF, IL-6, and IL-10.	[Sakai, Fumihiko; Hosoya, Tomohiro; Ono-Ohmachi, Aiko; Ukibe, Ken; Ogawa, Akihiro; Moriya, Tomohiro; Kadooka, Yukio] Megmilk Snow Brand Co Ltd, Milk Sci Res Inst, Kawagoe, Saitama, Japan; [Shiozaki, Takuya; Nakagawa, Hisako; Nakayama, Yosuke; Miyazaki, Tadaaki] Hokkaido Univ, Dept Probiot Immunol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University	Miyazaki, T (corresponding author), Hokkaido Univ, Dept Probiot Immunol, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan.	miyazaki@pop.med.hokudai.ac.jp	Ono-Ohmachi, A./ABE-9461-2021	Omachi, Aiko/0000-0002-8272-3071	Megmilk Snow Brand Co., Ltd.	Megmilk Snow Brand Co., Ltd.	This study was funded by Megmilk Snow Brand Co., Ltd. The funder provided support in the form of salaries for authors (Fumihiko Sakai, Tomohiro Hosoya, Aiko Ono-Ohmachi, Ken Ukibe, Akihiro Ogawa, Tomohiro Moriya, and Yukio Kadooka), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Belladonna ML, 2008, J IMMUNOL, V181, P5194, DOI 10.4049/jimmunol.181.8.5194; Bobr A, 2012, P NATL ACAD SCI USA, V109, P10492, DOI 10.1073/pnas.1119178109; Burt JR RW, 1999, TXB GASTROENTEROLOGY, P1995; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CONLEY ME, 1987, ANN INTERN MED, V106, P892, DOI 10.7326/0003-4819-106-6-892; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Dongarra ML, 2013, CURR ALLERGY ASTHM R, V13, P19, DOI 10.1007/s11882-012-0313-0; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2008, CURR OPIN IMMUNOL, V20, P170, DOI 10.1016/j.coi.2008.04.002; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fayette J, 1998, SCAND J IMMUNOL, V48, P563; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Feng T, 2010, J IMMUNOL, V185, P5915, DOI 10.4049/jimmunol.1001233; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Fujiwara S, 2001, J APPL MICROBIOL, V90, P343, DOI 10.1046/j.1365-2672.2001.01251.x; Galdeano CM, 2006, CLIN VACCINE IMMUNOL, V13, P219, DOI 10.1128/CVI.13.2.219-226.2006; group RoajFWw, 2002, GUID EV PROB FOOD; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; Harata G, 2009, MICROBIOL IMMUNOL, V53, P475, DOI 10.1111/j.1348-0421.2009.00146.x; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kadooka Y, 2012, J PEDIATR GASTR NUTR, V55, P66, DOI 10.1097/MPG.0b013e3182533a2b; Kajimoto O HH, 2002, JPN J LACTIC ACID BA, V13, P114; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kim HA, 2008, J LEUKOCYTE BIOL, V83, P1431, DOI 10.1189/jlb.1007676; Galdeano CM, 2009, J DAIRY RES, V76, P446, DOI 10.1017/S0022029909990021; Massacand JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002588; Matsuzaki T, 2007, J NUTR, V137, p798S, DOI 10.1093/jn/137.3.798S; MESTECKY J, 1986, CLIN IMMUNOL IMMUNOP, V40, P105, DOI 10.1016/0090-1229(86)90073-5; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Nakanishi Y, 2005, CYTOTECHNOLOGY, V47, P69, DOI 10.1007/s10616-005-3776-1; Ouwehand AC, 2007, J NUTR, V137, p794S, DOI 10.1093/jn/137.3.794S; Park JH, 2005, J FOOD PROTECT, V68, P571, DOI 10.4315/0362-028X-68.3.571; Park JH, 2002, CELL IMMUNOL, V219, P22, DOI 10.1016/S0008-8749(02)00579-8; Perdigon G, 2001, Curr Issues Intest Microbiol, V2, P27; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Sasaki M, 1996, MICROBIOL-UK, V142, P799, DOI 10.1099/00221287-142-4-799; Sashihara T, 2006, J DAIRY SCI, V89, P2846, DOI 10.3168/jds.S0022-0302(06)72557-7; Sato M, 2008, BRIT J NUTR, V99, P1013, DOI 10.1017/S0007114507839006; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Takahashi H, 2006, MICROBIOL IMMUNOL, V50, P867, DOI 10.1111/j.1348-0421.2006.tb03862.x; Takiguchi R., 1998, Journal of Intestinal Microbiology, V11, P117; Talham GL, 1999, INFECT IMMUN, V67, P1992; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Usman, 1999, J DAIRY SCI, V82, P243, DOI 10.3168/jds.S0022-0302(99)75229-X; Vinderola G, 2006, CYTOKINE, V36, P254, DOI 10.1016/j.cyto.2007.01.003; Yanagibashi T, 2009, BIOSCI BIOTECH BIOCH, V73, P372, DOI 10.1271/bbb.80612; Zan H, 1998, J IMMUNOL, V161, P5217	56	62	68	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105370	10.1371/journal.pone.0105370	http://dx.doi.org/10.1371/journal.pone.0105370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144744	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100059
J	Woo, JH; Wang, SM; Melhem, ER; Gee, JC; Cucchiara, A; McCluskey, L; Elman, L				Woo, John H.; Wang, Sumei; Melhem, Elias R.; Gee, James C.; Cucchiara, Andrew; McCluskey, Leo; Elman, Lauren			Linear Associations between Clinically Assessed Upper Motor Neuron Disease and Diffusion Tensor Imaging Metrics in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CORTICOSPINAL TRACT; MRI; REGISTRATION; TRACTOGRAPHY; INVOLVEMENT; ATLAS; TOOL	Objective: To assess the relationship between clinically assessed Upper Motor Neuron (UMN) disease in Amyotrophic Lateral Sclerosis (ALS) and local diffusion alterations measured in the brain corticospinal tract (CST) by a tractography-driven template-space region-of-interest (ROI) analysis of Diffusion Tensor Imaging (DTI). Methods: This cross-sectional study included 34 patients with ALS, on whom DTI was performed. Clinical measures were separately obtained including the Penn UMN Score, a summary metric based upon standard clinical methods. After normalizing all DTI data to a population-specific template, tractography was performed to determine a region-of-interest (ROI) outlining the CST, in which average Mean Diffusivity (MD) and Fractional Anisotropy (FA) were estimated. Linear regression analyses were used to investigate associations of DTI metrics (MD, FA) with clinical measures (Penn UMN Score, ALSFRS-R, duration-of-disease), along with age, sex, handedness, and El Escorial category as covariates. Results: For MD, the regression model was significant (p = 0.02), and the only significant predictors were the Penn UMN Score (p = 0.005) and age (p = 0.03). The FA regression model was also significant (p = 0.02); the only significant predictor was the Penn UMN Score (p = 0.003). Conclusions: Measured by the template-space ROI method, both MD and FA were linearly associated with the Penn UMN Score, supporting the hypothesis that DTI alterations reflect UMN pathology as assessed by the clinical examination.	[Woo, John H.; Wang, Sumei; Gee, James C.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cucchiara, Andrew] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [McCluskey, Leo; Elman, Lauren] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Woo, John H.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Melhem, Elias R.] Univ Maryland, Dept Radiol, Baltimore, MD 21201 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University System of Maryland; University of Maryland Baltimore	Woo, JH (corresponding author), Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	john.woo@uphs.upenn.edu			National Institutes of Health [NS063111, NS065347, DA022807, NS045839, AG032953]; Greater Philadelphia Chapter of the ALS Association; Philadelphia Veterans Affairs Medical Center; National Center for Advancing Translational Sciences (NCATS) of the NIH [UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063111, R01NS065347, P30NS045839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greater Philadelphia Chapter of the ALS Association; Philadelphia Veterans Affairs Medical Center(US Department of Veterans Affairs); National Center for Advancing Translational Sciences (NCATS) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors acknowledge the financial support of the following institutions: National Institutes of Health (NS063111, NS065347, DA022807, NS045839, AG032953), the Greater Philadelphia Chapter of the ALS Association, and the Philadelphia Veterans Affairs Medical Center. This project was also supported by Grant Number UL1TR000003 from the National Center for Advancing Translational Sciences (NCATS) of the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official view of NCATS or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Graham JM, 2004, NEUROLOGY, V63, P2111, DOI 10.1212/01.WNL.0000145766.03057.E7; Hong YH, 2004, J NEUROL SCI, V227, P73, DOI 10.1016/j.jns.2004.08.014; Iwata NK, 2011, BRAIN, V134, P2642, DOI 10.1093/brain/awr178; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Rose S, 2012, NEUROIMAGE, V59, P2661, DOI 10.1016/j.neuroimage.2011.08.054; Sage CA, 2007, NEUROIMAGE, V34, P486, DOI 10.1016/j.neuroimage.2006.09.025; Sage CA, 2009, HUM BRAIN MAPP, V30, P3657, DOI 10.1002/hbm.20794; Smith RA, 2004, AMYOTROPH LATERAL SC, V5, P99, DOI 10.1080/17434470410020058; Swash M, 2012, J NEUROL NEUROSUR PS, V83, P659, DOI 10.1136/jnnp-2012-302315; Toosy AT, 2003, J NEUROL NEUROSUR PS, V74, P1250, DOI 10.1136/jnnp.74.9.1250; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang SM, 2006, RADIOLOGY, V239, P831, DOI 10.1148/radiol.2393050573; Wang Y, 2011, NEUROIMAGE, V55, P1577, DOI 10.1016/j.neuroimage.2011.01.038; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang H, 2010, LECT NOTES COMPUT SC, V6204, P83, DOI 10.1007/978-3-642-14366-3_8	22	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105753	10.1371/journal.pone.0105753	http://dx.doi.org/10.1371/journal.pone.0105753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144708	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100118
J	Fuller, JC; Martinez, M; Wade, RC				Fuller, Jonathan C.; Martinez, Michael; Wade, Rebecca C.			On Calculation of the Electrostatic Potential of a Phosphatidylinositol Phosphate-Containing Phosphatidylcholine Lipid Membrane Accounting for Membrane Dynamics	PLOS ONE			English	Article							AMBER FORCE-FIELD; MOLECULAR-DYNAMICS; SIMULATIONS; CHARMM; BILAYERS; DOMAINS; RECOGNITION; VALIDATION; PROGRAM; ENERGY	Many signaling events require the binding of cytoplasmic proteins to cell membranes by recognition of specific charged lipids, such as phosphoinositol-phosphates. As a model for a protein-membrane binding site, we consider one charged phosphoinositol phosphate (PtdIns(3)P) embedded in a phosphatidylcholine bilayer. As the protein-membrane binding is driven by electrostatic interactions, continuum solvent models require an accurate representation of the electrostatic potential of the phosphoinositol phosphate-containing membrane. We computed and analyzed the electrostatic potentials of snapshots taken at regular intervals from molecular dynamics simulations of the bilayer. We observe considerable variation in the electrostatic potential of the bilayer both along a single simulation and between simulations performed with the GAFF or CHARMM c36 force fields. However, we find that the choice of GAFF or CHARMM c36 parameters has little effect on the electrostatic potential of a given configuration of the bilayer with a PtdIns(3)P embedded in it. From our results, we propose a remedian averaging method for calculating the electrostatic potential of a membrane system that is suitable for simulations of protein-membrane binding with a continuum solvent model.	[Fuller, Jonathan C.; Martinez, Michael; Wade, Rebecca C.] Heidelberg Inst Theoret Studies, Mol & Cellular Modeling Grp, Heidelberg, Germany; [Wade, Rebecca C.] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany	Heidelberg Institute for Theoretical Studies; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Fuller, JC (corresponding author), Heidelberg Inst Theoret Studies, Mol & Cellular Modeling Grp, Heidelberg, Germany.	jonathan.fuller@h-its.org; rebecca.wade@h-its.org	Wade, Rebecca/L-1489-2019	Wade, Rebecca/0000-0001-5951-8670; Fuller, Jonathan/0000-0001-8801-149X	Bundesministerium fur Bildung und Forschung (BMBF) Virtual Liver Network [0313076, 0313078C]; Klaus Tschira Foundation	Bundesministerium fur Bildung und Forschung (BMBF) Virtual Liver Network; Klaus Tschira Foundation	The authors gratefully acknowledge the financial support of the Bundesministerium fur Bildung und Forschung (BMBF) Virtual Liver Network (grant nos. 0313076 and 0313078C) and the Klaus Tschira Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Bockmann RA, 2003, BIOPHYS J, V85, P1647, DOI 10.1016/S0006-3495(03)74594-9; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Dickson CJ, 2012, SOFT MATTER, V8, P9617, DOI 10.1039/c2sm26007g; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Hatcher ER, 2009, J CHEM THEORY COMPUT, V5, P1315, DOI 10.1021/ct9000608; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jambeck JPM, 2013, J CHEM THEORY COMPUT, V9, P774, DOI 10.1021/ct300777p; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; Jojart B, 2007, J COMPUT CHEM, V28, P2051, DOI 10.1002/jcc.20748; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li Z, 2009, BIOPHYS J, V97, P155, DOI 10.1016/j.bpj.2009.04.037; Lumb CN, 2011, STRUCTURE, V19, P1338, DOI 10.1016/j.str.2011.04.010; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; LUTY BA, 1992, J COMPUT CHEM, V13, P1114, DOI 10.1002/jcc.540130911; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piggot TJ, 2012, J CHEM THEORY COMPUT, V8, P4593, DOI 10.1021/ct3003157; ROUSSEEUW PJ, 1990, J AM STAT ASSOC, V85, P97, DOI 10.2307/2289530; Skjevik AA, 2012, J PHYS CHEM B, V116, P11124, DOI 10.1021/jp3059992; Spaar A, 2009, BIOPHYS J, V96, P1721, DOI 10.1016/j.bpj.2008.11.052; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vanquelef E, 2010, RED SERVER; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	44	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104778	10.1371/journal.pone.0104778	http://dx.doi.org/10.1371/journal.pone.0104778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141217	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200034
J	Yuan, ZL; Chen, LQ				Yuan, Zhilin; Chen, Lianqing			The Role of Endophytic Fungal Individuals and Communities in the Decomposition of Pinus massoniana Needle Litter	PLOS ONE			English	Article							LEAF-LITTER; DIVERSITY; FOREST; PLANTATION; LEAVES; CHINA; SOIL; SEQUENCES; ENZYMES; GENES	The role of fungal endophytes (FEs) as "pioneer" decomposers has recently been recognized; however, the extent to which FEs contribute to litter loss is less well understood. The genetic and enzymatic bases of FE-mediated decomposition have also rarely been addressed. The effects of populations and individuals (with an emphasis on two dominant Lophodermium taxa) of FEs on needle-litter decomposition were assessed for Pinus massoniana, a ubiquitous pine in southern China. Data from in vivo (microcosm) experiments indicated that the percentage of litter-mass loss triggered by FEs was linearly correlated with incubation time and approached 60% after seven months. In vitro decomposition tests also confirmed that endophytic Lophodermium isolates caused 14-22% mass loss within two months. Qualitative analysis of exoenzymes (cellulase and laccase, important for lignocellulose degradation) revealed that almost all of the Lophodermium isolates showed moderate or strong positive reactions. Furthermore, partial sequences of beta-glucosidase (glycoside hydrolase family 3, GH3), laccase, and cellobiohydrolase (GH7) genes were amplified from Lophodermium isolates as "functional markers" to evaluate their potential for lignocellulolytic activity. Three different genes were detected, suggesting a flexible and delicate decomposition system rich in FEs. Our work highlights the possibility that the saprophytism and endophytism of FEs may be prerequisites to initiating rapid decomposition and thus may be key in Fes' contribution to litter decomposition, at least in the early stage. Potential indicators of the presence of core fungal decomposers are also briefly discussed.	[Yuan, Zhilin; Chen, Lianqing] Chinese Acad Forestry, Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Yuan, ZL (corresponding author), Chinese Acad Forestry, Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China.	zlyuanmycology@gmail.com		Yuan, Zhilin/0000-0002-5799-8401	National Natural Science Foundation of China [31100463]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been financially supported by the National Natural Science Foundation of China (No. 31100463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boberg JB, 2011, FUNGAL ECOL, V4, P110, DOI 10.1016/j.funeco.2010.09.002; Cox P, 2001, BIOL FERT SOILS, V33, P246, DOI 10.1007/s003740000315; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GRIFFITH GS, 1990, NEW PHYTOL, V116, P407, DOI 10.1111/j.1469-8137.1990.tb00526.x; He XB, 2012, ECOL RES, V27, P273, DOI 10.1007/s11284-011-0898-0; Hirose D, 2013, MYCOLOGIA, V105, P837, DOI 10.3852/12-385; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; Korkama-Rajala T, 2008, MICROB ECOL, V56, P76, DOI 10.1007/s00248-007-9326-y; Koukol O, 2012, FUNGAL DIVERS, V54, P69, DOI 10.1007/s13225-011-0112-2; Kumaresan V, 2002, FUNGAL DIVERS, V9, P81; Lacap DC, 2003, FUNGAL DIVERS, V12, P53; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; Lumyong S, 2002, CAN J MICROBIOL, V48, P1109, DOI 10.1139/W02-112; Lyons JI, 2003, MICROB ECOL, V45, P270, DOI 10.1007/s00248-002-1055-7; Mo JM, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008017; Muller MM, 2001, MOL ECOL, V10, P1801, DOI 10.1046/j.1365-294X.2001.01304.x; Nicholas KB., 1997, GENEDOC TOOL EDITING; Osono T, 2002, MYCOLOGIA, V94, P421, DOI 10.2307/3761776; Osono T, 2006, MYCOLOGIA, V98, P172, DOI 10.3852/mycologia.98.2.172; Osono T, 2009, APPLIED MYCOLOGY, P92, DOI 10.1079/9781845935344.0092; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; Purahong W, 2012, ANN FOREST SCI, V69, P659, DOI 10.1007/s13595-012-0210-7; Robl D, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-94; SIEBERCANAVESI F, 1993, NEW PHYTOL, V125, P149, DOI 10.1111/j.1469-8137.1993.tb03873.x; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Sun X, 2011, FUNGAL DIVERS, V47, P85, DOI 10.1007/s13225-010-0086-5; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wang CY, 2012, J PLANT ECOL, V5, P279, DOI 10.1093/jpe/rtr013; Weber CF, 2012, APPL ENVIRON MICROB, V78, P3950, DOI 10.1128/AEM.08018-11; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yuan ZL, 2011, FUNGAL BIOL-UK, V115, P197, DOI 10.1016/j.funbio.2010.11.002; Yuan ZL, 2015, MYCOSCIENCE, V56, P205, DOI 10.1016/j.myc.2014.06.004; Zifcakova L, 2011, FUNGAL ECOL, V4, P427, DOI 10.1016/j.funeco.2011.04.002	34	13	16	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105911	10.1371/journal.pone.0105911	http://dx.doi.org/10.1371/journal.pone.0105911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157631	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200076
J	Allman, D; Calzavara, L; Worthington, C; Tyndall, M; Adrien, A; Walters, M; White, S; Jones, MK				Allman, Dan; Calzavara, Liviana; Worthington, Catherine; Tyndall, Mark; Adrien, Alix; Walters, Melissa; White, Samantha; Jones, Marcella K.			Charitable Giving for HIV and AIDS: Results from a Canadian National Survey	PLOS ONE			English	Article							PHILANTHROPY; PREDICTORS; RESOURCES	Background: For the first time, a national survey of adults in Canada posed questions on charitable giving for HIV and AIDS. The objective of this analysis was to explore the behaviour and attitudes of this population in terms of charitable giving. Methods: In 2011, individuals in Canada 16 years of age or older were recruited for a survey from an online panel supplemented by random digit dial telephone interviewing. The margin of error was +/-2.1 percentage points (95%). Chisquare tests were used to detect bivariate associations. A multivariate logistic regression model was fit to compare those who had donated to HIV and AIDS in the past 12 months with those who had donated to other disease or illness charities. Results: 2,139 participated. 82.5% had donated to a charitable cause in the past 12 months. 22.2% had ever donated to HIV and AIDS, with 7.8% doing so in the past 12 months. Individuals who had donated to HIV and AIDS versus other disease or illness charities tended to be younger (p<0.05), single (p<0.005), more highly educated (p<0.001) and to self-identify as a member of a sexual minority group (p<0.001). Multivariate analysis revealed individuals who self-identified as a member of a sexual minority group were significantly much more likely to have donated to HIV and AIDS than to other disease or illness charities in the past 12 months (OR, 7.73; p<0.001; CI 4.32-13.88). Discussion: Despite a generally philanthropic orientation, relatively few respondents had ever been involved in charitable giving for HIV and AIDS. Those who had could be understood relationally as individuals at closer social proximity to HIV and AIDS such as members of sexual minority groups.	[Allman, Dan; Calzavara, Liviana; Walters, Melissa; White, Samantha] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Worthington, Catherine] Univ Victoria, Sch Publ Hlth & Social Policy, Victoria, BC, Canada; [Tyndall, Mark] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Adrien, Alix] McGill Univ, Fac Med, Montreal, PQ, Canada; [Jones, Marcella K.] Univ Toronto, Fac Med, Toronto, ON, Canada	University of Toronto; University of Victoria; University of Ottawa; McGill University; University of Toronto	Allman, D (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	dan.allman@utoronto.ca	Allman, Dan/B-5086-2012	Allman, Dan/0000-0001-5198-751X; Tyndall, Mark/0000-0003-4450-5679; Worthington, Catherine/0000-0003-3075-8229; Jones, Marcella/0000-0003-0609-1188	Canadian Institutes for Health Research (CIHR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was made possible through a generous donation from Andy Pringle and in-kind support from The CIHR Social Research Centre in HIV Prevention(SRC), which is funded by a grant from the Canadian Institutes for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KG, 2009, AM J SOCIOL, V114, P1129, DOI 10.1086/595945; [Anonymous], HIV AIDS EP UPD; Arumi A. M., 2005, CHARITABLE IMPULSE; Babbie E., 2012, PRACTICE SOCIAL RES; Batson CD., 1991, PSYCHOL INQ, V2, P107, DOI [10.1207/s15327965pli0202_1, DOI 10.1207/S15327965PLI0202_1]; Bekkers R, 2006, SOC PSYCHOL QUART, V69, P349, DOI 10.1177/019027250606900404; Bekkers R, 2011, VOLUNT SECT REV, V2, P337, DOI 10.1332/204080511X6087712; Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927; Bekkers R, 2011, QUAL QUANT, V45, P1369, DOI 10.1007/s11135-010-9341-9; Bennett R., 2003, INT J NONPROFIT VOLU, V8, P12, DOI [10.1002/nvsm.198, DOI 10.1002/NVSM.198]; Boyle J, 2009, SURVEY PRACTICE, V9; Breeze B, 2013, VOLUNT SECT REV, V4, P165, DOI 10.1332/204080513X667792; Burgoyne CB, 2005, J COMMUNITY APPL SOC, V15, P383, DOI 10.1002/casp.832; Calzavara L, 2012, HIV AIDS CANADA NATL; Canada Mortgage and Housing Corporation, 2013, HOUS INC WEALTH; Canadian Public Health Association, 2005, LEAD TOG CAN TAK ACT; Eckel C, 2007, SOUTH ECON J, V74, P388, DOI 10.2307/20111974; Einstein M., 2012, CORPORATE AM BLURS L; EKOS Research Associates, 2013, SEC RES BEST PRACT M; EKOS Research Associates Inc, 2006, HIV AIDS ATT T UNPUB; EKOS Research Associates Inc, 2003, HIV AIDS ATT S UNPUB; Eveland VB, 2007, INT J NONPROFIT VOLU, V12, P1, DOI 10.1002/nvsm.7; Fink A, 2008, CONDUCT SURVEYS STEP; Gabb J, 2008, RESEARCHING INTIMACY IN FAMILIES, P1, DOI 10.1057/9780230227668; Hall M., 2009, CARING CANADIANS INV; Hu SS, 2011, AM J EPIDEMIOL, V173, P703, DOI 10.1093/aje/kwq442; Human Resources and Skills Development Canada, 2013, LEAN ED ATT; Mathur A, 1996, PSYCHOL MARKET, V13, P107, DOI 10.1002/(SICI)1520-6793(199601)13:1<107::AID-MAR6>3.0.CO;2-K; Menard SW., 2008, HDB LONGITUDINAL RES; Merchant A, 2011, J BUS RES, V64, P610, DOI 10.1016/j.jbusres.2010.06.013; Ornstein M, 1989, AIDS CANADA KNOWLEDG, DOI North York; Phoenix Strategic Perspectives, 2012, SEC RES CELL PHON TE; Polonsky M.J., 2002, J NONPROFIT PUBLIC S, V10, P67, DOI [10.1300/J054v10n02_04, DOI 10.1300/J054V10N02_04]; Public Works and Government Services Canada, 2014, PUB OP RES NON UNPUB; Public Works and Government Services Canada, 2007, BEST PRACT PUBL OP R; Public Works and Government Services Canada, 2013, STAND COND GOV CAN P; Public Works and Government Services Canada, 2012, RESP RAT TEL OTH SUR; RADLEY A, 1995, HUM RELAT, V48, P685, DOI 10.1177/001872679504800605; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; SCHWARTZ RA, 1970, J POLIT ECON, V78, P1264, DOI 10.1086/259708; Small DA, 2008, J CONSUM RES, V35, P532, DOI 10.1086/527268; Statistics Canada, 2012, CAN POP 2011 AG SEX; Statistics Canada, 2013, CAN POP 2011 POP COU; van Leeuwen MHD, 2013, NONPROF VOLUNT SEC Q, V42, P219, DOI 10.1177/0899764012467084; Voigt LF, 2011, AM J EPIDEMIOL, V173, P118, DOI 10.1093/aje/kwq322; Wiepking P, 2012, VOLUNT SECT REV, V3, P217, DOI 10.1332/204080512X649379; Wiepking P, 2009, SOC FORCES, V87, P1973; Woodliffe, 2005, NONPROFIT MANAGEMENT, V16, P61, DOI [10.1002/nml.90, DOI 10.1002/NML.90]	48	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103184	10.1371/journal.pone.0103184	http://dx.doi.org/10.1371/journal.pone.0103184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153827	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200005
J	Grossmann, FF; Zumbrunn, T; Ciprian, S; Stephan, FP; Woy, N; Bingisser, R; Nickel, CH				Grossmann, Florian F.; Zumbrunn, Thomas; Ciprian, Sandro; Stephan, Frank-Peter; Woy, Natascha; Bingisser, Roland; Nickel, Christian H.			Undertriage in Older Emergency Department Patients - Tilting against Windmills?	PLOS ONE			English	Article							EARLY WARNING SCORE; SEVERITY INDEX; ELDERLY-PATIENTS; RISK PATIENTS; TRIAGE; ACCURACY; OUTCOMES	Objectives: The aim of this study was to investigate the long-term effect of a teaching intervention designed to reduce undertriage rates in older ED patients. Further, to test the hypothesis that non-adherence to the Emergency Severity Index (ESI) triage algorithm is associated with undertriage. Additionally, to detect patient related risk factors for undertriage. Methods: Pre-post-test design. The study sample consisted of all patients aged 65 years or older presenting to the ED of an urban tertiary and primary care center in the study periods. A teaching intervention designed to increase adherence to the triage algorithm. To assess, if the intervention resulted in an increase of factual knowledge, nurses took a test before and immediately after the teaching intervention. Undertriage rates were assessed one year after the intervention and compared to the pre-test period. Results: In the pre-test group 519 patients were included, and 394 in the post-test-group. Factual knowledge among triage nurses was high already before the teaching intervention. Prevalence of undertriaged patients before (22.5%) and one year after the intervention (24.2%) was not significantly different (x(2) = 0.248, df = 1, p = 0.619). Sex, age, mode of arrival, and type of complaint were not identified as independent risk factors for undertriage. However, undertriage rates increased with advancing age. Adherence to the ESI algorithm is associated with correct triage decisions. Conclusions: Undertriage of older ED patients remained unchanged over time. Reasons for undertriage seem to be more complex than anticipated. Therefore, additional contributing factors should be addressed.	[Grossmann, Florian F.; Ciprian, Sandro; Stephan, Frank-Peter; Woy, Natascha; Bingisser, Roland; Nickel, Christian H.] Univ Basel Hosp, Emergency Dept, CH-4031 Basel, Switzerland; [Zumbrunn, Thomas] Univ Basel Hosp, Clin Trial Unit, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Nickel, CH (corresponding author), Univ Basel Hosp, Emergency Dept, CH-4031 Basel, Switzerland.	christian.nickel@usb.ch	Grossmann, Florian/AAE-9175-2019; Grossmann, Florian F/E-7291-2017	Grossmann, Florian/0000-0001-7804-8870; Grossmann, Florian F/0000-0001-7804-8870				Andersson Anna-Karin, 2006, Nurs Crit Care, V11, P136, DOI 10.1111/j.1362-1017.2006.00162.x; Baumann MR, 2007, ANN EMERG MED, V49, P234, DOI 10.1016/j.annemergmed.2006.04.011; Egermayer P, 1998, THORAX, V53, P830, DOI 10.1136/thx.53.10.830; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gilboy N, 2011, IMLEMENTATION HDB; Grossmann FF, 2012, ANN EMERG MED, V60, P317, DOI 10.1016/j.annemergmed.2011.12.013; Grossmann FF, 2011, ANN EMERG MED, V57, P257, DOI 10.1016/j.annemergmed.2010.07.021; Hogan Jacqueline, 2006, Br J Nurs, V15, P489; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; Lim WS, 2001, EUR RESPIR J, V17, P200, DOI 10.1183/09031936.01.17202000; Nemec M, 2010, ACAD EMERG MED, V17, P284, DOI 10.1111/j.1553-2712.2009.00658.x; Nickel CH, 2009, SWISS MED WKLY, V139, P271, DOI smw-12620; Parkhe Meera, 2002, Emerg Med (Fremantle), V14, P50, DOI 10.1046/j.1442-2026.2002.00286.x; Pines JM, 2006, AM J EMERG MED, V24, P679, DOI 10.1016/j.ajem.2006.02.020; Platts-Mills TF, 2010, ACAD EMERG MED, V17, P238, DOI 10.1111/j.1553-2712.2010.00670.x; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; R Core Team, 2021, R LANGUAGE ENV STAT; Ruger JP, 2007, AM J EMERG MED, V25, P794, DOI 10.1016/j.ajem.2007.01.014; Rutschmann OT, 2005, SWISS MED WKLY, V135, P145; Subbe CP, 2003, ANAESTHESIA, V58, P797, DOI 10.1046/j.1365-2044.2003.03258.x; Tucker G, 2013, J EMERG NURS, V39, P309, DOI 10.1016/j.jen.2010.07.007; Yurkova I, 2011, J EMERG NURS, V37, P491, DOI 10.1016/j.jen.2011.01.016	22	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106203	10.1371/journal.pone.0106203	http://dx.doi.org/10.1371/journal.pone.0106203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153120	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200120
J	Kadoya, M; Koyama, H; Kanzaki, A; Kurajoh, M; Hatayama, M; Shiraishi, J; Okazaki, H; Shoji, T; Moriwaki, Y; Yamamoto, T; Inaba, M; Namba, M				Kadoya, Manabu; Koyama, Hidenori; Kanzaki, Akinori; Kurajoh, Masafumi; Hatayama, Miki; Shiraishi, Jun; Okazaki, Hirokazu; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Inaba, Masaaki; Namba, Mitsuyoshi			Plasma Brain-Derived Neurotrophic Factor and Reverse Dipping Pattern of Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; HYPERTENSIVE PATIENTS; CLINICAL-SIGNIFICANCE; BDNF; TIME; DYSFUNCTION; RESPONSES; DISEASE	Context: Basic studies have shown that brain-derived neurotrophic factor (BDNF) has critical roles in the survival, growth, maintenance, and death of central and peripheral neurons, while it is also involved in regulation of the autonomic nervous system. Furthermore, recent clinical studies have suggested potential role of plasma BDNF in the circulatory system. Objective: We investigated the mutual relationships among plasma BDNF, patterns of nocturnal blood pressure changes (dippers, non-dippers, extra-dippers, and reverse-dippers), and cardiac autonomic function as determined by heart rate variability (HRV). Design: This was a cross-sectional study of patients registered in the Hyogo Sleep Cardio-Autonomic Atherosclerosis (HSCAA) Study from October 2010 to November 2012. Patients: Two-hundred fifty patients with 1 or more cardiovascular risk factor(s) (obesity, smoking, presence of cardiovascular event history, hypertension, dyslipidemia, diabetes mellitus, chronic kidney disease) were enrolled. Results: Plasma BDNF levels (natural logarithm transformed) were significantly (p = 0.001) lower in reverse-dipper patients (7.18 +/- 0.69 pg/ml, mean +/- SD, n = 36) as compared to dippers (7.86 +/- 0.86 pg/ml, n = 100). Multiple logistic regression analysis showed that BDNF (odds ratios: 0.417, 95% confidence interval: 0.228-0.762, P = 0.004) was the sole factor significantly and independently associated with the reverse-dippers as compared with dippers. Furthermore, plasma BDNF level was significantly and positively correlated with the time-domain (SDNN, SDANN5, CVRR) and frequency-domain (LF) of HRV parameters. Finally, multiple logistic regression analyses showed that the relationship between plasma BDNF and the reverse-dippers was weakened, yet remained significant or borderline significant even after adjusting for HRV parameters. Conclusions: Low plasma BDNF was independently associated with patients showing a reverse-dipper pattern of nocturnal blood pressure, in which an imbalance of cardiac autonomic function may be partly involved.	[Kadoya, Manabu; Koyama, Hidenori; Kanzaki, Akinori; Kurajoh, Masafumi; Hatayama, Miki; Shiraishi, Jun; Okazaki, Hirokazu; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Namba, Mitsuyoshi] Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Nishinomiya, Hyogo 6638501, Japan; [Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Endocrinol Metab & Mol Med, Osaka 558, Japan	Hyogo College of Medicine; Osaka Metropolitan University	Koyama, H (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Nishinomiya, Hyogo 6638501, Japan.	hkoyama@hyo-med.ac.jp	Koyama, Hidenori/AAU-2346-2020	Koyama, Hidenori/0000-0001-7930-2228	Ministry of Education, Culture, Sports, Science and Technology of Japan [26461371]; Hyogo College of Medicine	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo College of Medicine	Grant-in-Aid for Scientific Research (26461371 to H. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A Grant-in-Aid for Promotion of Technological Seeds in Advanced Medicine, Hyogo College of Medicine (to T.Y.). A Grant-in-Aid for Graduate Students, Hyogo College of Medicine (to M. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Brady R, 1999, J NEUROSCI, V19, P2131; Camm AJ, 1996, EUR HEART J, V17, P354; Eissa MAH, 2001, BLOOD PRESS MONIT, V6, P21, DOI 10.1097/00126097-200102000-00004; Ejiri J, 2005, CIRCULATION, V112, P2114, DOI 10.1161/CIRCULATIONAHA.104.476903; Fujii H, 2013, J RENAL NUTR, V23, P340, DOI 10.1053/j.jrn.2012.12.008; Furmaga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034844; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Grassi G, 2008, HYPERTENSION, V52, P925, DOI 10.1161/HYPERTENSIONAHA.108.116368; Gray J, 2006, DANCING TIMES, V96, P55; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kario K, 2005, AM J HYPERTENS, V18, P149, DOI 10.1016/j.amjhyper.2004.09.007; Kario K, 1997, HYPERTENSION, V30, P1504, DOI 10.1161/01.HYP.30.6.1504; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Marosi K, 2014, TRENDS ENDOCRIN MET, V25, P89, DOI 10.1016/j.tem.2013.10.006; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mogensen UM, 2012, DIABETES, V61, P1822, DOI 10.2337/db11-1235; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; Okamoto LE, 2009, HYPERTENSION, V53, P363, DOI 10.1161/HYPERTENSIONAHA.108.124552; Orlov S, 2012, DIABETES CARE, V35, P809, DOI 10.2337/dc11-1652; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; PICKERING TG, 1990, CIRCULATION, V81, P700, DOI 10.1161/01.CIR.81.2.700; Rakugi H, 2012, HYPERTENS RES, V35, P552, DOI 10.1038/hr.2012.8; Sairaku A, 2013, SLEEP MED, V14, P622, DOI 10.1016/j.sleep.2013.04.003; Takagi T, 2006, HYPERTENS RES, V29, P977, DOI 10.1291/hypres.29.977; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Vermehren-Schmaedick A, 2013, J NEUROSCI RES, V91, P220, DOI 10.1002/jnr.23158; Wang H, 2002, NEUROSCIENCE, V112, P967, DOI 10.1016/S0306-4522(02)00085-4; Yamaguchi K, 2014, SLEEP MED, V15, P33, DOI 10.1016/j.sleep.2013.10.005; Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yoshida T, 2001, J NEUROL SCI, V184, P77, DOI 10.1016/S0022-510X(00)00505-0	41	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105977	10.1371/journal.pone.0105977	http://dx.doi.org/10.1371/journal.pone.0105977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153796	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200100
J	Packer, RMA; Shihab, NK; Torres, BBJ; Volk, HA				Packer, Rowena M. A.; Shihab, Nadia K.; Torres, Bruno B. J.; Volk, Holger A.			Clinical Risk Factors Associated with Anti-Epileptic Drug Responsiveness in Canine Epilepsy	PLOS ONE			English	Article							QUALITY-OF-LIFE; IDIOPATHIC EPILEPSY; LABRADOR RETRIEVERS; STATUS EPILEPTICUS; POTASSIUM-BROMIDE; DOGS; SEIZURE; REMISSION; PROGNOSIS; LEVETIRACETAM	The nature and occurrence of remission, and conversely, pharmacoresistance following epilepsy treatment is still not fully understood in human or veterinary medicine. As such, predicting which patients will have good or poor treatment outcomes is imprecise, impeding patient management. In the present study, we use a naturally occurring animal model of pharmacoresistant epilepsy to investigate clinical risk factors associated with treatment outcome. Dogs with idiopathic epilepsy, for which no underlying cause was identified, were treated at a canine epilepsy clinic and monitored following discharge from a small animal referral hospital. Clinical data was gained via standardised owner questionnaires and longitudinal follow up data was gained via telephone interview with the dogs' owners. At follow up, 14% of treated dogs were in seizure-free remission. Dogs that did not achieve remission were more likely to be male, and to have previously experienced cluster seizures. Seizure frequency or the total number of seizures prior to treatment were not significant predictors of pharmacoresistance, demonstrating that seizure density, that is, the temporal pattern of seizure activity, is a more influential predictor of pharmacoresistance. These results are in line with clinical studies of human epilepsy, and experimental rodent models of epilepsy, that patients experiencing episodes of high seizure density (cluster seizures), not just a high seizure frequency pre-treatment, are at an increased risk of drug-refractoriness. These data provide further evidence that the dog could be a useful naturally occurring epilepsy model in the study of pharmacoresistant epilepsy.	[Packer, Rowena M. A.; Shihab, Nadia K.; Volk, Holger A.] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Shihab, Nadia K.] Southern Counties Vet Specialists, Dept Neurol Neurosurg, Ringwood, Hants, England; [Torres, Bruno B. J.] Univ Fed Minas Gerais, Dept Vet Med & Surg, Belo Horizonte, MG, Brazil	University of London; University of London Royal Veterinary College; Universidade Federal de Minas Gerais	Volk, HA (corresponding author), Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England.	hvolk@rvc.ac.uk	Volk, Holger Andreas/B-9965-2011; Torres, Bruno Benetti Junta/AAX-9672-2020	Volk, Holger Andreas/0000-0002-7312-638X; Torres, Bruno Benetti Junta/0000-0002-6400-046X; Packer, Rowena/0000-0002-9988-9828				Andrew SE, 2008, VET CLIN N AM-SMALL, V38, P269, DOI 10.1016/j.cvsm.2007.11.007; Arrol L, 2012, VET REC, V170, P335, DOI 10.1136/vr.100316; Avanzini G, 2013, EPILEPSIA, V54, P14, DOI 10.1111/epi.12418; BEGHI E, 1992, EPILEPSIA, V33, P45; Berendt M, 2002, J VET INTERN MED, V16, P262, DOI 10.1892/0891-6640(2002)016&lt;0262:ACSOEI&gt;2.3.CO;2; Berendt M, 1999, ACTA NEUROL SCAND, V99, P276, DOI 10.1111/j.1600-0404.1999.tb00676.x; Berendt M, 2007, J VET INTERN MED, V21, P754, DOI 10.1892/0891-6640(2007)21[754:PDRFAL]2.0.CO;2; Berg AT, 1997, J CLIN NEUROPHYSIOL, V14, P102, DOI 10.1097/00004691-199703000-00003; BIELFELT SW, 1971, AM J VET RES, V32, P2039; Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Blumenfeld H, 2008, EPILEPSIA, V49, P400, DOI 10.1111/j.1528-1167.2007.01458.x; Bonnett LJ, 2014, J NEUROL NEUROSUR PS, V85, P603, DOI 10.1136/jnnp-2013-306040; Boothe DM, 2012, JAVMA-J AM VET MED A, V240, P1073, DOI 10.2460/javma.240.9.1073; Callaghan BC, 2007, ANN NEUROL, V62, P382, DOI 10.1002/ana.21166; Camfield C, 1996, NEUROLOGY, V46, P41, DOI 10.1212/WNL.46.1.41; Chang Y, 2006, J SMALL ANIM PRACT, V47, P574, DOI 10.1111/j.1748-5827.2006.00203.x; COCKERELL OC, 1995, LANCET, V346, P140, DOI 10.1016/S0140-6736(95)91208-8; Cockerell OC, 1997, EPILEPSIA, V38, P31, DOI 10.1111/j.1528-1157.1997.tb01075.x; Dewey CW, 2009, JAVMA-J AM VET MED A, V235, P1442, DOI 10.2460/javma.235.12.1442; Dewey CW, 2004, J AM ANIMAL HOSP ASS, V40; HAUSER WA, 1990, NEUROLOGY, V40, P9; Heynold Y, 1997, J SMALL ANIM PRACT, V38, P7, DOI 10.1111/j.1748-5827.1997.tb02977.x; Hulsmeyer V, 2010, J VET INTERN MED, V24, P171, DOI 10.1111/j.1939-1676.2009.0438.x; Kearsley-Fleet L, 2013, VET REC, V172, DOI 10.1136/vr.101133; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Loscher W, 2006, EPILEPSIA, V47, P1253, DOI 10.1111/j.1528-1167.2006.00607.x; Loscher W, 2010, EPILEPSIA, V51, P89, DOI 10.1111/j.1528-1167.2009.02183.x; LOSCHER W, 1985, ARZNEIMITTEL-FORSCH, V35, P82; MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.3.CO;2-L; Marson AG, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01920.x; Martle V, 2014, VET J, V199, P332, DOI 10.1016/j.tvjl.2013.09.055; Monteiro R, 2012, J SMALL ANIM PRACT, V53, P526, DOI 10.1111/j.1748-5827.2012.01251.x; Munana KR, 2012, J VET INTERN MED, V26, P1358, DOI 10.1111/j.1939-1676.2012.01006.x; Munana KR, 2012, J VET INTERN MED, V26, P341, DOI 10.1111/j.1939-1676.2011.00866.x; Musicco M, 1997, NEUROLOGY, V49, P991, DOI 10.1212/WNL.49.4.991; PLACENCIA M, 1993, EPILEPSY RES, V14, P237, DOI 10.1016/0920-1211(93)90048-C; Platt SR, 2006, VET REC, V159, P881; PODELL M, 1993, J VET INTERN MED, V7, P318, DOI 10.1111/j.1939-1676.1993.tb01025.x; Poochikian-Sarkissian S, 2008, CAN J NEUROL SCI, V35, P280, DOI 10.1017/S0317167100008842; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Ramey WL, 2013, CLIN NEUROL NEUROSUR, V115, P2411, DOI 10.1016/j.clineuro.2013.09.035; Regesta G, 1999, EPILEPSY RES, V34, P109, DOI 10.1016/S0920-1211(98)00106-5; REYNOLDS EH, 1983, LANCET, V2, P952; Saito M, 2001, J AM VET MED ASSOC, V219, P618, DOI 10.2460/javma.2001.219.618; Sander JWAS, 1996, J NEUROL NEUROSUR PS, V61, P433, DOI 10.1136/jnnp.61.5.433; SCHWARTZPORSCHE D, 1985, J VET PHARMACOL THER, V8, P113, DOI 10.1111/j.1365-2885.1985.tb00934.x; Short AD, 2011, VET REC, V169, P48, DOI 10.1136/vr.d1901; SILLANPAA M, 1993, EPILEPSIA, V34, P930, DOI 10.1111/j.1528-1157.1993.tb02114.x; Sillanpaa M, 2008, BRAIN, V131, P938, DOI 10.1093/brain/awn037; Trepanier LA, 1998, J AM VET MED ASSOC, V213, P1449; Volk HA, 2008, VET J, V176, P310, DOI 10.1016/j.tvjl.2007.03.002; von Klopmann T, 2007, J SMALL ANIM PRACT, V48, P134, DOI 10.1111/j.1748-5827.2006.00290.x; Weissl J, 2012, J VET INTERN MED, V26, P116, DOI 10.1111/j.1939-1676.2011.00853.x; Wessmann A, 2012, J VET INTERN MED, V26, P823	55	39	39	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106026	10.1371/journal.pone.0106026	http://dx.doi.org/10.1371/journal.pone.0106026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153799	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000340952200108
J	Bauerl, C; Collado, MC; Zuniga, M; Blas, E; Martinez, GP				Baeuerl, Christine; Carmen Collado, M.; Zuniga, Manuel; Blas, Enrique; Perez Martinez, Gaspar			Changes in Cecal Microbiota and Mucosal Gene Expression Revealed New Aspects of Epizootic Rabbit Enteropathy	PLOS ONE			English	Article							METHANOBREVIBACTER-SMITHII; AKKERMANSIA-MUCINIPHILA; INTESTINAL MICROBIOTA; GUT MICROBIOTA; ACID; RECOGNITION; DIVERSITY; ECOLOGY; ABILITY; TOXIN	Epizootic Rabbit Enteropathy (ERE) is a severe disease of unknown aetiology that mainly affects post-weaning animals. Its incidence can be prevented by antibiotic treatment suggesting that bacterial elements are crucial for the development of the disease. Microbial dynamics and host responses during the disease were studied. Cecal microbiota was characterized in three rabbit groups (ERE-affected, healthy and healthy pretreated with antibiotics), followed by transcriptional analysis of cytokines and mucins in the cecal mucosa and vermix by q-rtPCR. In healthy animals, cecal microbiota with or without antibiotic pretreatment was very similar and dominated by Alistipes and Ruminococcus. Proportions of both genera decreased in ERE rabbits whereas Bacteroides, Akkermansia and Rikenella increased, as well as Clostridium, gamma-Proteobacteria and other opportunistic and pathogenic species. The ERE group displayed remarkable dysbiosis and reduced taxonomic diversity. Transcription rate of mucins and inflammatory cytokines was very high in ERE rabbits, except IL-2, and its analysis revealed the existence of two clearly different gene expression patterns corresponding to Inflammatory and (mucin) Secretory Profiles. Furthermore, these profiles were associated to different bacterial species, suggesting that they may correspond to different stages of the disease. Other data obtained in this work reinforced the notion that ERE morbidity and mortality is possibly caused by an overgrowth of different pathogens in the gut of animals whose immune defence mechanisms seem not to be adequately responding.	[Baeuerl, Christine; Carmen Collado, M.; Zuniga, Manuel; Perez Martinez, Gaspar] CSIC, Inst Agroquim & Tecnol Alimentos, Spanish Natl Res Council, Dept Biotecnol,Lab Bacterias Lact & Probiot, E-46010 Valencia, Spain; [Blas, Enrique] Univ Politecn Valencia, Inst Anim Sci & Technol, Anim Nutr Res Grp, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universitat Politecnica de Valencia	Martinez, GP (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Spanish Natl Res Council, Dept Biotecnol,Lab Bacterias Lact & Probiot, Jaime Roig 11, E-46010 Valencia, Spain.	gaspar.perez@iata.csic.es	Zúñiga, Manuel/AAI-4370-2021; COLLADO, MARIA CARMEN/H-4924-2012; Zúñiga, Manuel/A-7519-2012; Martinez, Gaspar Perez/H-4167-2012; Bäuerl, Christine/A-4334-2017	COLLADO, MARIA CARMEN/0000-0002-6204-4864; Zúñiga, Manuel/0000-0003-1750-6975; Martinez, Gaspar Perez/0000-0003-3501-1626; Bäuerl, Christine/0000-0002-5226-9920; Blas, Enrique/0000-0002-4054-3929	Fun-C-Food from the Consolider-Ingenio programme [CSD2007-00063]; Spanish Ministry of Science and Innovation;  [AGL2010-22211];  [AGL2006-07596]	Fun-C-Food from the Consolider-Ingenio programme; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ; 	This work was supported by the grants AGL2010-22211, AGL2006-07596 and by the Fun-C-Food CSD2007-00063 project from the Consolider-Ingenio programme, both from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecia L, 2007, J APPL MICROBIOL, V103, P787, DOI 10.1111/j.1365-2672.2007.03309.x; Abecia L, 2005, FEMS MICROBIOL LETT, V244, P111, DOI 10.1016/j.femsle.2005.01.028; Abell GCJ, 2011, BRIT J NUTR, V105, P1480, DOI 10.1017/S0007114510005349; An C, 2013, APPL ENVIRON MICROB, V79, P860, DOI 10.1128/AEM.02354-12; Bangsgaard Bendtsen K.M., 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231.e46231; Berry D, 2013, BEST PRACT RES CL GA, V27, P47, DOI 10.1016/j.bpg.2013.03.005; BORRIELLO SP, 1983, J CLIN MICROBIOL, V17, P414, DOI 10.1128/JCM.17.3.414-418.1983; Carson CA, 2005, APPL ENVIRON MICROB, V71, P4945, DOI 10.1128/AEM.71.8.4945-4949.2005; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Combes S, 2011, FEMS MICROBIOL ECOL, V77, P680, DOI 10.1111/j.1574-6941.2011.01148.x; Comito D, 2012, INT J INFLAM, V687143, P20; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Dewree R, 2007, WORLD RABBIT SCI, V15, P91; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; From C, 2005, APPL ENVIRON MICROB, V71, P1178, DOI 10.1128/AEM.71.3.1178-1183.2005; Ganesh BP, 2013, PLOS ONE, V8; Hanifin CT, 2010, MAR DRUGS, V8, P577, DOI 10.3390/md8030577; Harcourt-Brown F, 2002, TXB RABBIT MED, P249; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hotchkiss CE, 1996, LAB ANIM SCI, V46, P174; Huybens N, 2013, VET J, V196, P109, DOI 10.1016/j.tvjl.2012.08.014; Huybens N, 2009, WORLD RABBIT SCI, V17, P185; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Lapthorne S, 2013, GUT MICROBES, V4, P212, DOI 10.4161/gmic.24372; LARSON G, 1988, J BIOL CHEM, V263, P10790; Lau SKP, 2004, DIAGN MICR INFEC DIS, V49, P255, DOI 10.1016/j.diagmicrobio.2004.04.012; Lebas F, 2001, CUNICULTURE, V28, P183; LELKES L, 1987, LAB ANIM SCI, V37, P757; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Licois D, 2005, VET RES, V36, P601, DOI 10.1051/vetres:2005021; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Marlier D, 2006, VET J, V172, P493, DOI 10.1016/j.tvjl.2005.07.011; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Michelland R, 2008, CHARACTERIZATION BAC, P1025; Monteils V, 2008, FEMS MICROBIOL ECOL, V66, P620, DOI 10.1111/j.1574-6941.2008.00611.x; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Rodriguez-Romero N, 2012, ANAEROBE, V18, P602, DOI 10.1016/j.anaerobe.2012.10.006; Rychlik JL, 2000, CURR MICROBIOL, V40, P176, DOI 10.1007/s002849910035; Sahl JW, 2012, INFECT IMMUN, V80, P1232, DOI 10.1128/IAI.06138-11; Scott KP, 2011, BIOCHEM SOC T, V39, P1073, DOI 10.1042/BST0391073; Sekirov I, 2009, J PHYSIOL-LONDON, V587, P4159, DOI 10.1113/jphysiol.2009.172742; SINKOVICS G, 1976, VET REC, V98, P151, DOI 10.1136/vr.98.8.151; Uehara A, 2006, J IMMUNOL, V177, P1796, DOI 10.4049/jimmunol.177.3.1796; Ufnar JA, 2006, J APPL MICROBIOL, V101, P44, DOI 10.1111/j.1365-2672.2006.02989.x; Wang J, 2010, TOXICON, V56, P640, DOI 10.1016/j.toxicon.2010.05.011; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	56	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105707	10.1371/journal.pone.0105707	http://dx.doi.org/10.1371/journal.pone.0105707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147938	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600072
J	Iniguez-Armijos, C; Leiva, A; Frede, HG; Hampel, H; Breuer, L				Iniguez-Armijos, Carlos; Leiva, Adrian; Frede, Hans-Georg; Hampel, Henrietta; Breuer, Lutz			Deforestation and Benthic Indicators: How Much Vegetation Cover Is Needed to Sustain Healthy Andean Streams?	PLOS ONE			English	Article							LAND-USE; ASSEMBLAGE STRUCTURE; WATER-QUALITY; IMPACTS; MACROINVERTEBRATES; BIODIVERSITY; COMMUNITIES; FOREST; ECOSYSTEMS; CATCHMENTS	Deforestation in the tropical Andes is affecting ecological conditions of streams, and determination of how much forest should be retained is a pressing task for conservation, restoration and management strategies. We calculated and analyzed eight benthic metrics (structural, compositional and water quality indices) and a physical-chemical composite index with gradients of vegetation cover to assess the effects of deforestation on macroinvertebrate communities and water quality of 23 streams in southern Ecuadorian Andes. Using a geographical information system (GIS), we quantified vegetation cover at three spatial scales: the entire catchment, the riparian buffer of 30 m width extending the entire stream length, and the local scale defined for a stream reach of 100 m in length and similar buffer width. Macroinvertebrate and water quality metrics had the strongest relationships with vegetation cover at catchment and riparian scales, while vegetation cover did not show any association with the macroinvertebrate metrics at local scale. At catchment scale, the water quality metrics indicate that ecological condition of Andean streams is good when vegetation cover is over 70%. Further, macroinvertebrate community assemblages were more diverse and related in catchments largely covered by native vegetation (>70%). Our results suggest that retaining an important quantity of native vegetation cover within the catchments and a linkage between headwater and riparian forests help to maintain and improve stream biodiversity and water quality in Andean streams affected by deforestation. This research proposes that a strong regulation focused to the management of riparian buffers can be successful when decision making is addressed to conservation/restoration of Andean catchments.	[Iniguez-Armijos, Carlos; Leiva, Adrian] UTPL, Dept Ciencias Nat, Secc Ecol, Loja, Ecuador; [Iniguez-Armijos, Carlos; Frede, Hans-Georg; Breuer, Lutz] Univ Giessen, Res Ctr Bio Syst Land Use & Nutr IFZ, Inst Landscape Ecol & Resources Management ILR, D-35390 Giessen, Germany; [Hampel, Henrietta] Univ Cuenca, Cuenca, Ecuador	Universidad Tecnica Particular de Loja; Justus Liebig University Giessen; Universidad de Cuenca	Iniguez-Armijos, C (corresponding author), UTPL, Dept Ciencias Nat, Secc Ecol, Loja, Ecuador.	cainiguez@utpl.edu.ec	Breuer, Lutz/C-6652-2013; Iñiguez Armijos, Carlos/I-8920-2014; Armijos, Carlos/HCJ-0327-2022	Breuer, Lutz/0000-0001-9720-1076; Iñiguez Armijos, Carlos/0000-0002-9787-3451; 	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador (SENACYT); DFG (Deutsche Forschungsgemeinschaft) [FR615/28-1/-2]; Universidad Tecnica Partucular de Loja (UTPL); Henrietta Hampel	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador (SENACYT); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Universidad Tecnica Partucular de Loja (UTPL); Henrietta Hampel	This research was funded through a scholarship of the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador (SENACYT), a DFG (Deutsche Forschungsgemeinschaft) grant (FR615/28-1/-2) and by the Universidad Tecnica Partucular de Loja (UTPL). The support from Henrietta Hampel was thanks to the PROMETEO Program of SENESCYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; American Public Health Association A., 1995, STANDARD METHODS EXA; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Bocard D., 2011, NUMERICAL ECOLOGY R; Bojsen BH, 2003, ARCH HYDROBIOL, V158, P317, DOI 10.1127/0003-9136/2003/0158-0317; Borbor-Cordova MJ, 2006, BIOGEOCHEMISTRY, V79, P135, DOI 10.1007/s10533-006-9009-7; Bucker A, 2010, FUND APPL LIMNOL, V177, P267, DOI 10.1127/1863-9135/2010/0177-0267; Buytaert W, 2011, GLOBAL ECOL BIOGEOGR, V20, P19, DOI 10.1111/j.1466-8238.2010.00585.x; Collier KJ, 2012, TECHNICAL REPORT; Couceiro SRM, 2007, HYDROBIOLOGIA, V575, P271, DOI 10.1007/s10750-006-0373-z; Crespo PJ, 2011, J HYDROL, V407, P164, DOI 10.1016/j.jhydrol.2011.07.021; Cummins KW, 2005, STUD NEOTROP FAUNA E, V40, P69, DOI 10.1080/01650520400025720; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; Death RG, 2010, FRESHWATER BIOL, V55, P1447, DOI 10.1111/j.1365-2427.2009.02233.x; Encalada AC, 2010, FRESHWATER BIOL, V55, P1719, DOI 10.1111/j.1365-2427.2010.02406.x; Environmental Protection Agency, 2013, NAT RIV STREAMS ASS; European Environment Agency, 2012, 8 EEA; Fernadez HR, 2001, GUIA DETERMINACION A; Gergel SE, 2002, AQUAT SCI, V64, P118, DOI 10.1007/s00027-002-8060-2; Gottlicher D, 2009, INT J REMOTE SENS, V30, P1867, DOI 10.1080/01431160802541531; Harden CP, 2006, GEOMORPHOLOGY, V79, P249, DOI 10.1016/j.geomorph.2006.06.021; Harding JS, 2006, HYDROBIOLOGIA, V568, P391, DOI 10.1007/s10750-006-0206-0; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Hauer F. Richard, 2007, P435, DOI 10.1016/B978-012332908-0.50028-0; Hladyz S, 2011, J APPL ECOL, V48, P443, DOI 10.1111/j.1365-2664.2010.01924.x; Iwata T, 2003, ECOL APPL, V13, P461, DOI 10.1890/1051-0761(2003)013[0461:IOPRDO]2.0.CO;2; Jacobsen D, 2004, FRESHWATER BIOL, V49, P1293, DOI 10.1111/j.1365-2427.2004.01274.x; Jacobsen D, 1998, ARCH HYDROBIOL, V142, P53; Jones JA, 2000, CONSERV BIOL, V14, P76, DOI 10.1046/j.1523-1739.2000.99083.x; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Miserendino ML, 2011, SCI TOTAL ENVIRON, V409, P612, DOI 10.1016/j.scitotenv.2010.10.034; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Lecerf A, 2005, OECOLOGIA, V146, P432, DOI 10.1007/s00442-005-0212-3; Lecerf A, 2010, FOREST ECOL MANAG, V259, P2433, DOI 10.1016/j.foreco.2010.03.022; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LENAT D R, 1988, Journal of the North American Benthological Society, V7, P222, DOI 10.2307/1467422; Lorion CM, 2009, FRESHWATER BIOL, V54, P165, DOI 10.1111/j.1365-2427.2008.02092.x; McClelland N.I., 1970, WATER SEWAGE WORKS, V117, P339, DOI DOI 10.1007/S13201-015-0318-7; Molina A, 2012, J HYDROL, V472, P25, DOI 10.1016/j.jhydrol.2012.09.012; Ordonez MV, 2011, INFLUENCIA USO SUELO; Parkyn SM, 2003, RESTOR ECOL, V11, P436, DOI 10.1046/j.1526-100X.2003.rec0260.x; Perrie A., 2012, GREATER WELLINGTON R; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rios SL, 2006, HYDROBIOLOGIA, V553, P153, DOI 10.1007/s10750-005-0868-z; Rios-Touma B, 2011, INT REV HYDROBIOL, V96, P667, DOI 10.1002/iroh.201111342; Roldan Perez G, 2003, BIOINDICACION CALIDA; Sarr DA, 2002, ENVIRON MANAGE, V30, P516, DOI 10.1007/s00267-002-2608-8; Shandas V, 2009, LANDSCAPE URBAN PLAN, V90, P66, DOI 10.1016/j.landurbplan.2008.10.016; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Sites RW, 2003, BIOTROPICA, V35, P226; Sponseller R, 2001, FRESHW BIOL; Stein H, 2008, ECOL ENG, V34, P267, DOI 10.1016/j.ecoleng.2007.06.010; Stewart JS, 2001, J AM WATER RESOUR AS, V37, P1475, DOI 10.1111/j.1752-1688.2001.tb03654.x; Suga CM, 2013, HYDROBIOLOGIA, V703, P203, DOI 10.1007/s10750-012-1360-1; Sutherland AB, 2002, FRESHWATER BIOL, V47, P1791, DOI 10.1046/j.1365-2427.2002.00927.x; Tarras-Wahlberg NH, 2001, SCI TOTAL ENVIRON, V278, P239, DOI 10.1016/S0048-9697(01)00655-6; Thies B, 2014, J LAND USE SCI, V9, P1, DOI 10.1080/1747423X.2012.718378; Tomanova S, 2006, HYDROBIOLOGIA, V556, P251, DOI 10.1007/s10750-005-1255-5; Torrachi S., 2013, AVANCES AN LISIS ESP, P275; Van Sickle J, 2004, ECOL APPL, V14, P368, DOI 10.1890/02-5009; Villamarin C, 2013, ECOL INDIC, V29, P79, DOI 10.1016/j.ecolind.2012.12.006; Wantzen KM, 2006, J N AM BENTHOL SOC, V25, P216, DOI 10.1899/0887-3593(2006)25[216:DPBISA]2.0.CO;2	64	46	47	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105869	10.1371/journal.pone.0105869	http://dx.doi.org/10.1371/journal.pone.0105869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147941	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600090
J	Speck, S; Courtiol, A; Junkes, C; Dathe, M; Muller, K; Schulze, M				Speck, Stephanie; Courtiol, Alexandre; Junkes, Christof; Dathe, Margitta; Mueller, Karin; Schulze, Martin			Cationic Synthetic Peptides: Assessment of Their Antimicrobial Potency in Liquid Preserved Boar Semen	PLOS ONE			English	Article							ARTIFICIAL-INSEMINATION; BACTERIA; ANTIBACTERIAL; ANTIBIOTICS; RESISTANCE; SYNERGY	Various semen extender formulas are in use to maintain sperm longevity and quality whilst acting against bacterial contamination in liquid sperm preservation. Aminoglycosides are commonly supplemented to aid in the control of bacteria. As bacterial resistance is increasing worldwide, antimicrobial peptides (AMPs) received lively interest as alternatives to overcome multi-drug resistant bacteria. We investigated, whether synthetic cationic AMPs might be a suitable alternative for conventional antibiotics in liquid boar sperm preservation. The antibacterial activity of two cyclic AMPs (c-WWW, c-WFW) and a helical magainin II amide analog (MK5E) was studied in vitro against two Gram-positive and eleven Gram-negative bacteria. Isolates included ATCC reference strains, multi-resistant E. coli and bacteria cultured from boar semen. Using broth microdilution, minimum inhibitory concentrations were determined for all AMPs. All AMPs revealed activity towards the majority of bacteria but not against Proteus spp. (all AMPs) and Staphylococcus aureus ATCC 29213 (MK5E). We could also demonstrate that c-WWW and c-WFW were effective against bacterial growth in liquid preserved boar semen in situ, especially when combined with a small amount of gentamicin. Our results suggest that albeit not offering a complete alternative to traditional antibiotics, the use of AMPs offers a promising solution to decrease the use of conventional antibiotics and thereby limit the selection of multi-resistant strains.	[Speck, Stephanie; Courtiol, Alexandre; Mueller, Karin] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Junkes, Christof; Dathe, Margitta] Leibniz Inst Mol Pharmacol, Berlin, Germany; [Schulze, Martin] Inst Reprod Farm Animals Schoenow EV, Bernau, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Speck, S (corresponding author), Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, D-04109 Leipzig, Germany.	stephanie.speck@vetmed.uni-leipzig.de	Schulze, Martin/AAR-3244-2020; Courtiol, Alexandre/O-3040-2017; 郑, 丽丽/HGE-2239-2022	Courtiol, Alexandre/0000-0003-0637-2959; 	AiF e.V. PRO INNO II [KF0376101MD6]; Leibniz Institute of Zoo and Wildlife Research	AiF e.V. PRO INNO II; Leibniz Institute of Zoo and Wildlife Research	The study was funded by AiF e.V. (www.aif.de) PRO INNO II Grant KF0376101MD6 and the Leibniz Institute of Zoo and Wildlife Research (www.izwberlin.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse GC, 2008, THERIOGENOLOGY, V70, P1317, DOI 10.1016/j.theriogenology.2008.07.010; Althouse GC, 2008, REPROD DOMEST ANIM, V43, P374, DOI 10.1111/j.1439-0531.2008.01187.x; Althouse GC, 2011, REPROD DOMEST ANIM, V46, P64, DOI 10.1111/j.1439-0531.2011.01863.x; Althouse GC, 2005, THERIOGENOLOGY, V63, P573, DOI 10.1016/j.theriogenology.2004.09.031; Althouse GC, 2000, THERIOGENOLOGY, V53, P1167, DOI 10.1016/S0093-691X(00)00261-2; Anantharaman A, 2010, ANTIMICROB AGENTS CH, V54, P1693, DOI 10.1128/AAC.01231-09; Arouri A, 2009, BBA-BIOMEMBRANES, V1788, P650, DOI 10.1016/j.bbamem.2008.11.022; Brunner E, 2002, NONPARAMETRIC ANAL L; Clinical and Laboratory Standards Institute (CLSI), 2008, PERF STAND ANT DISK, V28, pM31; DAGNALL GJR, 1986, THESIS ROYAL VET COL; Danowski K.M., 1989, THESIS TIERARZTLICHE; Dathe M, 2001, FEBS LETT, V501, P146, DOI 10.1016/S0014-5793(01)02648-5; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Junkes C, 2008, J PEPT SCI, V14, P535, DOI 10.1002/psc.940; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Kraus D, 2006, CURR TOP MICROBIOL, V306, P231; Maes D, 2008, THERIOGENOLOGY, V70, P1337, DOI 10.1016/j.theriogenology.2008.06.018; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Martin LOM, 2010, ANIM REPROD SCI, V120, P95, DOI 10.1016/j.anireprosci.2010.03.008; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Okazaki T, 2010, THERIOGENOLOGY, V74, P1691, DOI 10.1016/j.theriogenology.2010.05.019; R Core Team, 2021, R LANGUAGE ENV STAT; SONE M, 1982, VET REC, V111, P11, DOI 10.1136/vr.111.1.11; Theuretzbacher U, 2011, CURR OPIN PHARMACOL, V11, P433, DOI 10.1016/j.coph.2011.07.008; Wolska KI, 2012, POL J MICROBIOL, V61, P95, DOI 10.33073/pjm-2012-012; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	29	25	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105949	10.1371/journal.pone.0105949	http://dx.doi.org/10.1371/journal.pone.0105949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148109	Green Published, gold			2022-12-27	WOS:000341230600098
J	van de Wijgert, JHHM; Borgdorff, H; Verhelst, R; Crucitti, T; Francis, S; Verstraelen, H; Jespers, V				van de Wijgert, Janneke H. H. M.; Borgdorff, Hanneke; Verhelst, Rita; Crucitti, Tania; Francis, Suzanna; Verstraelen, Hans; Jespers, Vicky			The Vaginal Microbiota: What Have We Learned after a Decade of Molecular Characterization?	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; GARDNERELLA-VAGINALIS; LACTOBACILLUS-INERS; WOMEN; HIV; HEALTHY; COMMUNITIES; DIVERSITY; BIOFILM; FLORA	We conducted a systematic review of the Medline database (U.S. National Library of Medicine, National Institutes of Health, Bethesda, MD, U.S.A) to determine if consistent molecular vaginal microbiota (VMB) composition patterns can be discerned after a decade of molecular testing, and to evaluate demographic, behavioral and clinical determinants of VMB compositions. Studies were eligible when published between 1 January 2008 and 15 November 2013, and if at least one molecular technique (sequencing, PCR, DNA fingerprinting, or DNA hybridization) was used to characterize the VMB. Sixty three eligible studies were identified. These studies have now conclusively shown that lactobacilli-dominated VMB are associated with a healthy vaginal micro-environment and that bacterial vaginosis (BV) is best described as a polybacterial dysbiosis. The extent of dysbiosis correlates well with Nugent score and vaginal pH but not with the other Amsel criteria. Lactobacillus crispatus is more beneficial than L. iners. Longitudinal studies have shown that a L. crispatus-dominated VMB is more likely to shift to a L. iners-dominated or mixed lactobacilli VMB than to full dysbiosis. Data on VMB determinants are scarce and inconsistent, but dysbiosis is consistently associated with HIV, human papillomavirus (HPV), and Trichomonas vaginalis infection. In contrast, vaginal colonization with Candida spp. is more common in women with a lactobacilli-dominated VMB than in women with dysbiosis. Cervicovaginal mucosal immune responses to molecular VMB compositions have not yet been properly characterized. Molecular techniques have now become more affordable, and we make a case for incorporating them into larger epidemiological studies to address knowledge gaps in etiology and pathogenesis of dysbiosis, associations of different dysbiotic states with clinical outcomes, and to evaluate interventions aimed at restoring and maintaining a lactobacilli-dominated VMB.	[van de Wijgert, Janneke H. H. M.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Borgdorff, Hanneke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Borgdorff, Hanneke] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Verhelst, Rita] Ghent Univ Hosp, Int Ctr Reprod Hlth, Ghent, Belgium; [Crucitti, Tania; Jespers, Vicky] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Francis, Suzanna] London Sch Hyg & Trop Med, London WC1, England; [Verstraelen, Hans] Ghent Univ Hosp, Dept Obstet & Gynecol, Ghent, Belgium	University of Liverpool; University of Amsterdam; Academic Medical Center Amsterdam; Ghent University; Ghent University Hospital; Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine; Ghent University; Ghent University Hospital	van de Wijgert, JHHM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.	j.vandewijgert@liverpool.ac.uk	Verstraelen, Hans/AAA-8694-2019; Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AAH-1902-2021; Verstraelen, Hans/A-5602-2008	Verstraelen, Hans/0000-0002-4070-1587; Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; Francis, Suzanna Carter/0000-0002-3724-4813; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	Aids Fonds Netherlands [201102]; European Commission (CHAARM consortium); MRC [G1002369] Funding Source: UKRI; Medical Research Council [MR/K012126/1, G1002369] Funding Source: researchfish	Aids Fonds Netherlands; European Commission (CHAARM consortium)(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was part of projects funded by the Aids Fonds Netherlands (project number 201102) and the European Commission (CHAARM consortium). The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Biagi E, 2009, EUR J CLIN MICROBIOL, V28, P281, DOI 10.1007/s10096-008-0617-0; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Burton JP, 2002, J INFECT DIS, V186, P1770, DOI 10.1086/345761; Castro J, 2013, INT J MED SCI, V10, P1193, DOI 10.7150/ijms.6304; Cotter G, 2000, BRIT J BIOMED SCI, V57, P241; Damelin LH, 2011, J MED MICROBIOL, V60, P180, DOI 10.1099/jmm.0.024463-0; Martinez-Pena MD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-189; Datcu R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-480; Dols JAM, 2012, DIAGN CYTOPATHOL, V40, P472, DOI 10.1002/dc.21786; Dols JAM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.012; DONDERS GGG, 2002, BRIT J OBSTET GYNAEC, V109, P1, DOI 10.1111/j.1471-0528.2002.00432; Drell T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054379; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Frank DN, 2012, JAIDS-J ACQ IMM DEF, V60, P299, DOI 10.1097/QAI.0b013e31824e4bdb; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gao WJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-271; Gustafsson RJ, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-17; Haggerty CL, 2009, SEX TRANSM INFECT, V85, P242, DOI 10.1136/sti.2008.032821; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47; Hernandez-Rodriguez Cesar, 2011, Infect Dis Obstet Gynecol, V2011, P851485, DOI 10.1155/2011/851485; Hickey RJ, 2013, BJOG-INT J OBSTET GY, V120, P695, DOI 10.1111/1471-0528.12151; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Hummelen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026602; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Hyman RW, 2012, J ASSIST REPROD GEN, V29, P105, DOI 10.1007/s10815-011-9694-6; Jakobsson Tell, 2008, Ann Clin Microbiol Antimicrob, V7, P14, DOI 10.1186/1476-0711-7-14; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; Larsen B, 2001, CLIN INFECT DIS, V32, pE69, DOI 10.1086/318710; Lee JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063514; Li JR, 2012, REPROD SCI, V19, P235, DOI 10.1177/1933719111418379; Ling ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076589; Ling ZX, 2011, MICROB ECOL, V61, P704, DOI 10.1007/s00248-011-9813-z; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Lopes dos Santos Santiago G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028180; Machado A, 2013, INT J MOL SCI, V14, P12004, DOI 10.3390/ijms140612004; Macklaim JM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-12; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; Marrazzo JM, 2012, J INFECT DIS, V205, P1580, DOI 10.1093/infdis/jis242; Marrazzo JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011139; Martin David H, 2012, Trans Am Clin Climatol Assoc, V123, P242; Mitchell C, 2013, AIDS RES HUM RETROV, V29, P13, DOI [10.1089/aid.2012.0187, 10.1089/AID.2012.0187]; Mitchell Caroline, 2009, Infect Dis Obstet Gynecol, V2009, P236919, DOI 10.1155/2009/236919; Mitchell CM, 2012, OBSTET GYNECOL, V120, P1306, DOI [10.1097/AOG.0b013e31827075ac, http://10.1097/AOG.0b013e31827075ac]; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nikolaitchouk N, 2008, APMIS, V116, P263, DOI 10.1111/j.1600-0463.2008.00808.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Pendharkar S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-43; Pepin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025082; Persson R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-6; Petricevic L, 2012, EUR J OBSTET GYN R B, V160, P93, DOI 10.1016/j.ejogrb.2011.10.002; Pybus V, 1997, J INFECT DIS, V175, P406, DOI 10.1093/infdis/175.2.406; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shi Y, 2009, J OBSTET GYNAECOL RE, V35, P525, DOI 10.1111/j.1447-0756.2008.00971.x; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Sobel JD, 2011, OBSTET GYNECOL, V117, P850, DOI 10.1097/AOG.0b013e3182117c9e; Solt I, 2012, RAMBAM MAIMONIDES ME, V3, DOI 10.5041/RMMJ.10076; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Spear GT, 2011, APPL ENVIRON MICROB, V77, P378, DOI 10.1128/AEM.00973-10; Srinivasan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078633; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Taylor BD, 2013, SEX TRANSM DIS, V40, P117, DOI 10.1097/OLQ.0b013e31827c5a5b; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; van de Wijgert JHHM, 2013, AIDS, V27, P2141, DOI 10.1097/QAD.0b013e32836290b6; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Verstraelen H, 2011, ARCH GYNECOL OBSTET, V284, P95, DOI 10.1007/s00404-011-1861-6; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Wertz John, 2008, Interdiscip Perspect Infect Dis, V2008, P181253, DOI 10.1155/2008/181253; Yamamoto T, 2009, J PEDIATR ADOL GYNEC, V22, P11, DOI 10.1016/j.jpag.2008.01.073; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411; Yoshimura K, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.018; Zhang R, 2012, J MED MICROBIOL, V61, P729, DOI 10.1099/jmm.0.038687-0; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x; Zhou X, 2009, INFECT IMMUN, V77, P4130, DOI 10.1128/IAI.00436-09; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	98	256	266	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105998	10.1371/journal.pone.0105998	http://dx.doi.org/10.1371/journal.pone.0105998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148517	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000341230600107
J	Fan, YH; Chen, M; Meng, J; Yu, L; Tu, YF; Wan, L; Fang, K; Zhu, WL				Fan, Yuhua; Chen, Meng; Meng, Jia; Yu, Lei; Tu, Yingfeng; Wan, Lin; Fang, Kun; Zhu, Wenliang			Arsenic Trioxide and Resveratrol Show Synergistic Anti-Leukemia Activity and Neutralized Cardiotoxicity	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; OXIDATIVE STRESS; CELL-DEATH; CANCER-CELLS; QT INTERVAL; APOPTOSIS; AUTOPHAGY; DRUG; GENISTEIN; PATHWAY	Cardiotoxicity is an aggravating side effect of many clinical antineoplastic agents such as arsenic trioxide (As2O3), which is the first-line treatment for acute promyelocytic leukemia (APL). Clinically, drug combination strategies are widely applied for complex disease management. Here, an optimized, cardiac-friendly therapeutic strategy for APL was investigated using a combination of As2O3 and genistein or resveratrol. Potential combinations were explored with respect to their effects on mitochondrial membrane potential, reactive oxygen species, superoxide dismutase activity, autophagy, and apoptosis in both NB4 cells and neonatal rat left ventricular myocytes. All experiments consistently suggested that 5 mu M resveratrol remarkably alleviates As2O3-induced cardiotoxicity. To achieve an equivalent effect, a 10-fold dosage of genistein was required, thus highlighting the dose advantage of resveratrol, as poor bioavailability is a common concern for its clinical application. Co-administration of resveratrol substantially amplified the anticancer effect of As2O3 in NB4 cells. Furthermore, resveratrol exacerbated oxidative stress, mitochondrial damage, and apoptosis, thereby reflecting its full range of synergism with As2O3. Addition of 5 mM resveratrol to the single drug formula of As2O3 also further increased the expression of LC3, a marker of cellular autophagy activity, indicating an involvement of autophagy-mediated tumor cell death in the synergistic action. Our results suggest a possible application of an As2O3 and resveratrol combination to treat APL in order to achieve superior therapeutics effects and prevent cardiotoxicity.	[Fan, Yuhua; Yu, Lei; Fang, Kun] Harbin Med Univ Daqing, Coll Pharm, Daqing, Peoples R China; [Chen, Meng] Harbin Med Univ, Dept Resp Med, Hosp 4, Harbin, Peoples R China; [Meng, Jia] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Peoples R China; [Tu, Yingfeng] Harbin Med Univ, Dept Cardiol, Hosp 4, Harbin, Peoples R China; [Wan, Lin] Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Peoples R China; [Wan, Lin] Harbin Med Univ, Hosp 4, Key Lab Mol Imaging, Harbin, Peoples R China; [Zhu, Wenliang] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhu, WL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China.	wenzwl@yeah.net			National Natural Science Foundation of China [31301136]; Foundation of Health Department of Heilongjiang Province of China [2011-233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Health Department of Heilongjiang Province of China	This work was supported by National Natural Science Foundation of China (No. 31301136) and Foundation of Health Department of Heilongjiang Province of China (No. 2011-233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbey JT, 2003, J CLIN ONCOL, V21, P3609, DOI 10.1200/JCO.2003.10.009; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chu WF, 2012, CARDIOVASC RES, V96, P90, DOI 10.1093/cvr/cvs230; Drolet B, 2004, CIRCULATION, V109, P26, DOI 10.1161/01.CIR.0000109484.00668.CE; Ducas RA, 2011, J ROY COLL PHYS EDIN, V41, P117, DOI 10.4997/JRCPE.2011.204; Fan YH, 2013, CELL PHYSIOL BIOCHEM, V31, P80, DOI 10.1159/000343351; Fox E, 2008, BLOOD, V111, P566, DOI 10.1182/blood-2007-08-107839; Gao F, 2004, CELL RES, V14, P81, DOI 10.1038/sj.cr.7290206; Ghaffari SH, 2012, TUMOR BIOL, V33, P157, DOI 10.1007/s13277-011-0259-1; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Hirano S, 2003, ARCH TOXICOL, V77, P305, DOI 10.1007/s00204-003-0447-x; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Hwang JT, 2008, GENES NUTR, V2, P323, DOI 10.1007/s12263-007-0069-7; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Jiang SG, 2008, INT J ONCOL, V33, P103; Kanamori H, 2013, AM J PATHOL, V182, P701, DOI 10.1016/j.ajpath.2012.11.009; LANOTTE M, 1991, BLOOD, V77, P1080; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Li Yan, 2002, Cardiovasc Toxicol, V2, P63, DOI 10.1385/CT:2:1:63; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Manna P, 2008, ARCH TOXICOL, V82, P137, DOI 10.1007/s00204-007-0272-8; Mathews V, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.056; Mumford JL, 2007, ENVIRON HEALTH PERSP, V115, P690, DOI 10.1289/ehp.9686; Nadal-Serrano M, 2013, INT J BIOCHEM CELL B, V45, P2045, DOI 10.1016/j.biocel.2013.07.002; Nencioni A, 2013, HAEMATOLOGICA, V98, P1335, DOI 10.3324/haematol.2012.079061; Park SY, 2011, N-S ARCH PHARMACOL, V383, P191, DOI 10.1007/s00210-010-0594-6; Pereira GC, 2011, CURR PHARM DESIGN, V17, P2113; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Ravindranath MH, 2004, ADV EXP MED BIOL, V546, P121; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Sun WM, 2008, ADV EXP MED BIOL, V614, P179, DOI 10.1007/978-0-387-74911-2_21; Ullah MF, 2011, MOL NUTR FOOD RES, V55, P553, DOI 10.1002/mnfr.201000329; Vizzardi E, 2008, CARDIOVASC TOXICOL, V8, P41, DOI 10.1007/s12012-007-9009-4; Xuan WL, 2012, CRIT CARE MED, V40, P3026, DOI 10.1097/CCM.0b013e31825fd7da; Zhang WQ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/407839; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	39	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105890	10.1371/journal.pone.0105890	http://dx.doi.org/10.1371/journal.pone.0105890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144547	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100126
J	Nobrega, C; Nascimento-Ferreira, I; Onofre, I; Albuquerque, D; Deglon, N; de Almeida, LP				Nobrega, Clevio; Nascimento-Ferreira, Isabel; Onofre, Isabel; Albuquerque, David; Deglon, Nicole; de Almeida, Luis Pereira			RNA Interference Mitigates Motor and Neuropathological Deficits in a Cerebellar Mouse Model of Machado-Joseph Disease	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SCA3 TRANSGENIC MICE; SPINOCEREBELLAR ATAXIA; MUTANT ATAXIN-3; RAT MODEL; NUCLEAR-LOCALIZATION; CAG EXPANSIONS; KNOCKOUT MICE; PROTEIN; SYMPTOMS	Machado-Joseph disease or Spinocerebellar ataxia type 3 is a progressive fatal neurodegenerative disorder caused by the polyglutamine-expanded protein ataxin-3. Recent studies demonstrate that RNA interference is a promising approach for the treatment of Machado-Joseph disease. However, whether gene silencing at an early time-point is able to prevent the appearance of motor behavior deficits typical of the disease when initiated before onset of the disease had not been explored. Here, using a lentiviral-mediated allele-specific silencing of mutant ataxin-3 in an early pre-symptomatic cerebellar mouse model of Machado-Joseph disease we show that this strategy hampers the development of the motor and neuropathological phenotypic characteristics of the disease. At the histological level, the RNA-specific silencing of mutant ataxin-3 decreased formation of mutant ataxin-3 aggregates, preserved Purkinje cell morphology and expression of neuronal markers while reducing cell death. Importantly, gene silencing prevented the development of impairments in balance, motor coordination, gait and hyperactivity observed in control mice. These data support the therapeutic potential of RNA interference for Machado-Joseph disease and constitute a proof of principle of the beneficial effects of early allele-specific silencing for therapy of this disease.	[Nobrega, Clevio; Nascimento-Ferreira, Isabel; Onofre, Isabel; de Almeida, Luis Pereira] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Nascimento-Ferreira, Isabel; Onofre, Isabel; de Almeida, Luis Pereira] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Albuquerque, David] Univ Coimbra, Fac Sci & Technol, Coimbra, Portugal; [Deglon, Nicole] Univ Lausanne Hosp, Lab Cellular & Mol Neurotherapies, Dept Clin Neurosci, Lausanne, Switzerland	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	de Almeida, LP (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	luispa@cnc.uc.pt	Deglon, Nicole/A-2265-2012; de Almeida, Luis Pereira/A-4605-2009; de Almeida, Luis Pereira/O-8196-2019; Nobrega, Clévio/M-6047-2013; Albuquerque, David/S-5586-2017	Deglon, Nicole/0000-0003-4475-9476; de Almeida, Luis Pereira/0000-0001-5831-3307; de Almeida, Luis Pereira/0000-0001-5831-3307; Nobrega, Clévio/0000-0002-8312-5292; Albuquerque, David/0000-0001-8899-9020; Onofre, Isabel/0000-0002-4937-448X	Portuguese Foundation for Science and Technology; Programa Operacional Factores de Competitividade - COMPETE [PTDC/SAU-NEU/099307/2008, PTDC/SAU-FAR/116535/2010, PEst-C/SAU/LA0001/2013-2014]; Richard Chin and Lily Lock Machado-Joseph Research Fund; National Ataxia Foundation; Association Francaise pour les Myopathies (SB/NF) [15079CA]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Programa Operacional Factores de Competitividade - COMPETE; Richard Chin and Lily Lock Machado-Joseph Research Fund; National Ataxia Foundation; Association Francaise pour les Myopathies (SB/NF)(Association Francaise contre les Myopathies)	We thank the Portuguese Foundation for Science and Technology and FEDER funds by Programa Operacional Factores de Competitividade - COMPETE (PTDC/SAU-NEU/099307/2008, PTDC/SAU-FAR/116535/2010 and PEst-C/SAU/LA0001/2013-2014), the Richard Chin and Lily Lock Machado-Joseph Research Fund, the National Ataxia Foundation, and the Association Francaise pour les Myopathies (SB/NF/2010/2008 Number 15079CA) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2008, HUM MOL GENET, V17, P2071, DOI 10.1093/hmg/ddn106; Alves S, 2010, HUM MOL GENET, V19, P2380, DOI 10.1093/hmg/ddq111; Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Balemans MCM, 2010, BEHAV BRAIN RES, V208, P47, DOI 10.1016/j.bbr.2009.11.008; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Boy J, 2010, NEUROBIOL DIS, V37, P284, DOI 10.1016/j.nbd.2009.08.002; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chou AH, 2008, NEUROBIOL DIS, V31, P89, DOI 10.1016/j.nbd.2008.03.011; Costa MD, 2013, MOL THER, V21, P1898, DOI 10.1038/mt.2013.144; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; D'Abreu A, 2009, ACTA NEUROL SCAND, V119, P277, DOI 10.1111/j.1600-0404.2008.01092.x; D'Abreu A, 2010, PARKINSONISM RELAT D, V16, P2, DOI 10.1016/j.parkreldis.2009.08.012; de Almeida LP, 2002, J NEUROSCI, V22, P3473; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Friedland DR, 2006, J NEUROSCI METH, V150, P90, DOI 10.1016/j.jneumeth.2005.06.004; Gaspar C, 1996, HUM GENET, V98, P620, DOI 10.1007/s004390050270; Globas C, 2008, MOVEMENT DISORD, V23, P2232, DOI 10.1002/mds.22288; Goncalves N, 2013, ANN NEUROLOGY; Gonzalez-Alegre P, 2007, NAT CLIN PRACT NEURO, V3, P394, DOI 10.1038/ncpneuro0551; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Kalueff AV, 2007, BRAIN RES, V1169, P87, DOI 10.1016/j.brainres.2007.07.009; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Nobrega C, 2012, CEREBELLUM; Nobrega C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052396; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; RANUM LPW, 1995, AM J HUM GENET, V57, P603; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Rodrigues AJ, 2010, BBA-MOL CELL RES, V1803, P1154, DOI 10.1016/j.bbamcr.2010.07.004; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Rodriguez-Lebron E, 2013, MOL THER, V21, P1909, DOI 10.1038/mt.2013.152; Rodriguez-Lebron E, 2009, MOL THER, V17, P1563, DOI 10.1038/mt.2009.123; ROSENBERG RN, 1992, MOVEMENT DISORD, V7, P193, DOI 10.1002/mds.870070302; Schilling G, 2001, NEUROBIOL DIS, V8, P405, DOI 10.1006/nbdi.2001.0385; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Schols L, 1996, J NEUROL NEUROSUR PS, V61, P466, DOI 10.1136/jnnp.61.5.466; Simoes AT, 2012, BRAIN, V135, P2428, DOI 10.1093/brain/aws177; SUDARSKY L, 1995, CLIN NEUROSCI, V3, P17; Switonski PM, 2011, NEUROMOL MED, V13, P54, DOI 10.1007/s12017-010-8137-3; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; Taniwaki T, 1997, J NEUROL SCI, V145, P63, DOI 10.1016/S0022-510X(96)00242-0; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; VANDERSTAAY FJ, 1990, BEHAV GENET, V20, P51; Wullner U, 2005, ARCH NEUROL-CHICAGO, V62, P1280, DOI 10.1001/archneur.62.8.1280; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yen TC, 2000, J NUCL MED, V41, P994; Zawacki TM, 2002, MOVEMENT DISORD, V17, P1004, DOI 10.1002/mds.10033; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	55	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e100086	10.1371/journal.pone.0100086	http://dx.doi.org/10.1371/journal.pone.0100086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144231	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100002
J	Ou, WJ; Liu, X; Shen, Y; Li, JN; He, LB; Yuan, Y; Tan, XR; Liu, LS; Zhao, JB; Wang, XY				Ou, Wenjing; Liu, Xin; Shen, Yue; Li, Jiana; He, Lingbin; Yuan, Yuan; Tan, Xuerui; Liu, Lisheng; Zhao, Jingbo; Wang, Xingyu			Association of CVD Candidate Gene Polymorphisms with Ischemic Stroke and Cerebral Hemorrhage in Chinese Individuals	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; REPUBLIC-OF-CHINA; C677T POLYMORPHISM; BLOOD-PRESSURE; RISK-FACTOR; FUNCTIONAL SNP; CONFERS RISK; HYPERTENSION; ATHEROSCLEROSIS	Background: Contribution of cardiovascular disease related genetic risk factors for stroke are not clearly defined. We performed a genetic association study to assess the association of 56 previously characterized gene variants in 34 candidate genes from cardiovascular disease related biological pathways with ischemic stroke and cerebral hemorrhage in a Chinese population. Methods: There were 1280 stroke patients (1101 with ischemic stroke and 179 with cerebral hemorrhage) and 1380 controls in the study. The genotypes for 56 polymorphisms of 34 candidate genes were determined by the immobilized probe approach and the associations of gene polymorphisms with ischemic stroke and cerebral hemorrhage were performed by logistic regression under an allelic model. Results: After adjusting for age, sex, BMI and hypertension status by logistic regression analysis, we found that NPPA rs5063 was significantly associated with both ischemic stroke (odds ratio [OR] 0.69; 95% confidence interval [CI], 0.52 to 0.90; P = 0.006) and cerebral hemorrhage(OR = 0.39; 95%CI, 0.19 to 0.78; P = 0.007). In addition, MTHFR rs1801133 also was associated with cerebral hemorrhage (OR = 1.48; 95%CI, 1.16 to 1.89; P = 0.001) but not with ischemic stroke (OR = 1.08; 95%CI, 0.96 to 1.22; P = 0.210). After false discovery rate (FDR) correction, the association of NPPA rs5063 and MTHFR rs1801133 with cerebral hemorrhage remained significant. Conclusions: The NPPA rs5063 is associated with reduced risk for cerebral hemorrhage and MTHFR rs1801133 is associated with increased risk of cerebral hemorrhage in a Chinese population.	[Ou, Wenjing; Li, Jiana; Zhao, Jingbo] Harbin Med Univ, Sch Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang, Peoples R China; [He, Lingbin; Yuan, Yuan; Tan, Xuerui; Wang, Xingyu] Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China; [Liu, Xin; Shen, Yue; Liu, Lisheng; Wang, Xingyu] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China	Harbin Medical University; Shantou University; Chinese Hypertension League	Zhao, JB (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang, Peoples R China.	zhaojb168@sina.com; xngyuw@yahoo.com			Beijing Hypertension League Institute; National Infrastructure Program of Chinese Genetic Resources [2005DKA21300]	Beijing Hypertension League Institute; National Infrastructure Program of Chinese Genetic Resources	This study was supported by the Beijing Hypertension League Institute and National Infrastructure Program of Chinese Genetic Resources (2005DKA21300). F. Hoffmann-La Roche partly funded this study through an unrestricted educational grant. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN U, 1986, CLIN CHEM, V32, P241; Barcellos LF, 2004, ANN NEUROL, V55, P793, DOI 10.1002/ana.20092; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Conen D, 2007, HYPERTENSION, V50, P1114, DOI 10.1161/HYPERTENSIONAHA.107.097634; Cronin S, 2005, STROKE, V36, P1581, DOI 10.1161/01.STR.0000169946.31639.af; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Franco RF, 1998, THROMB HAEMOSTASIS, V79, P119, DOI 10.1055/s-0037-1614230; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; HE J, 1995, STROKE, V26, P2228; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kannel WB, 2008, JAMA-J AM MED ASSOC, V300, P2545, DOI 10.1001/jama.2008.759; Kohara K, 2003, STROKE, V34, P1130, DOI 10.1161/01.STR.0000069163.02611.B0; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Maack T, 1992, HDB PHYSL RENAL PHYS, P1577; Matsushita T, 2010, HUM MOL GENET, V19, P1137, DOI 10.1093/hmg/ddp582; Mazighi M, 2008, STROKE, V39, P1142, DOI 10.1161/STROKEAHA.107.496513; *NAT 8 5 CVD COLL, 1998, CHIN J PREVENT MED S, V32, P3; NEEDLEMAN P, 1986, NEW ENGL J MED, V314, P828; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Peck G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003691; Qian XQ, 2007, EUR J HUM GENET, V15, P1239, DOI 10.1038/sj.ejhg.5201914; Rubattu S, 1999, CIRCULATION, V100, P1722, DOI 10.1161/01.CIR.100.16.1722; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Sazci A, 2006, BRAIN RES BULL, V71, P45, DOI 10.1016/j.brainresbull.2006.07.014; SHI FL, 1989, STROKE, V20, P1581, DOI 10.1161/01.STR.20.11.1581; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Somarajan BI, 2011, J NEUROL SCI, V304, P67, DOI 10.1016/j.jns.2011.02.010; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Sun HX, 2013, J STROKE, V15, P109, DOI 10.5853/jos.2013.15.2.109; Tawakol A, 1997, CIRCULATION, V95, P1119; Wang XY, 2009, STROKE, V40, P683, DOI 10.1161/STROKEAHA.108.524587; Yang QD, 2004, CEREBROVASC DIS, V17, P303, DOI 10.1159/000077341; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C	42	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105516	10.1371/journal.pone.0105516	http://dx.doi.org/10.1371/journal.pone.0105516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144711	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100078
J	Ronchi, CL; Sbiera, S; Volante, M; Steinhauer, S; Scott-Wild, V; Altieri, B; Kroiss, M; Bala, M; Papotti, M; Deutschbein, T; Terzolo, M; Fassnacht, M; Allolio, B				Ronchi, Cristina L.; Sbiera, Silviu; Volante, Marco; Steinhauer, Sonja; Scott-Wild, Vanessa; Altieri, Barbara; Kroiss, Matthias; Bala, Margarita; Papotti, Mauro; Deutschbein, Timo; Terzolo, Massimo; Fassnacht, Martin; Allolio, Bruno			CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma	PLOS ONE			English	Article							TUMOR-SPECIFIC EXPRESSION; CYTOCHROME-P450 2W1; COLORECTAL-CANCER; PROGNOSIS; SURVIVAL; ANALOGS; ENZYME	Background: Adrenocortical tumors comprise frequent adenomas (ACA) and rare carcinomas (ACC). Human cytochrome P450 2W1 (CYP2W1) is highly expressed in some cancers holding the potential to activate certain drugs into tumor cytotoxins. Objective: To investigate the CYP2W1 expression in adrenal samples and its relationship with clinical outcome in ACC. Material and Methods: CYP2W1 expression was investigated by qRT-PCR in 13 normal adrenal glands, 32 ACA, 25 ACC, and 9 different non-adrenal normal tissue samples and by immunohistochemistry in 352 specimens (23 normal adrenal glands, 33 ACA, 239 ACC, 67 non-adrenal normal or neoplastic samples). Results: CYP2W1 mRNA expression was absent/low in normal non-adrenal tissues, but high in normal and neoplastic adrenal glands (all P<0.01 vs non-adrenal normal tissues). Accordingly, CYP2W1 immunoreactivity was absent/low (H-score 0-1) in 72% of non-adrenal normal tissues, but high (H-score 2-3) in 44% of non-adrenal cancers, in 65% of normal adrenal glands, in 62% of ACAs and in 50% of ACCs (all P<0.001 vs non-adrenal normal tissues), being significantly increased in steroid-secreting compared to non-secreting tumors. In ACC patients treated with mitotane only, high CYP2W1 immunoreactivity adjusted for ENSAT stage was associated with longer overall survival and time to progression (P<0.05 and P<0.01, respectively), and with a better response to therapy both as palliative (response/stable disease in 42% vs 6%, P<0.01) or adjuvant option (absence of disease recurrence in 69% vs 45%, P<0.01). Conclusion: CYP2W1 is highly expressed in both normal and neoplastic adrenal glands making it a promising tool for targeted therapy in ACC. Furthermore, CYP2W1 may represent a new predictive marker for the response to mitotane treatment.	[Ronchi, Cristina L.; Sbiera, Silviu; Steinhauer, Sonja; Altieri, Barbara; Bala, Margarita; Deutschbein, Timo; Fassnacht, Martin; Allolio, Bruno] Univ Wurzburg, Univ Hosp, Dept Internal Med 1, Endocrine & Diabet Unit, Wurzburg, Germany; [Volante, Marco; Papotti, Mauro] Univ Turin, Dept Oncol, San Luigi Hosp, Turin, Italy; [Scott-Wild, Vanessa] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Kroiss, Matthias; Fassnacht, Martin] Univ Wurzburg, Univ Hosp, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Terzolo, Massimo] Univ Turin, San Luigi Hosp, Div Internal Med 1, Turin, Italy	University of Wurzburg; University of Turin; University of Wurzburg; University of Wurzburg; University of Turin	Ronchi, CL (corresponding author), Univ Wurzburg, Univ Hosp, Dept Internal Med 1, Endocrine & Diabet Unit, Wurzburg, Germany.	Ronchi_C@ukw.de	Kroiss, Matthias/AAF-1624-2019; Fassnacht, Martin/N-9614-2019; Altieri, Barbara/GLT-3014-2022; Sbiera, Silviu/E-8128-2019; Kroiss, Matthias/B-4785-2014; Deutschbein, Timo/AAI-4662-2020; Terzolo, Massimo/D-5051-2015	Kroiss, Matthias/0000-0002-7628-3161; Fassnacht, Martin/0000-0001-6170-6398; Sbiera, Silviu/0000-0002-6271-5533; Kroiss, Matthias/0000-0002-7628-3161; VOLANTE, Marco/0000-0003-0719-105X; Terzolo, Massimo/0000-0002-4171-2851; Altieri, Barbara/0000-0003-2616-3249; Ronchi, Cristina/0000-0001-5020-2071	Wilhelm Sander Foundation [2012.095.1]; Deutsche Forschung Gesellschaft (DFG) [KR-4371/1-1, FA 466/4-1]; Italian Association for Cancer Research (AIRC) [IG/14820/2013]; German Research Foundation (DFG); University of Wuerzburg	Wilhelm Sander Foundation; Deutsche Forschung Gesellschaft (DFG)(German Research Foundation (DFG)); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by a grant from the Wilhelm Sander Foundation (grant number 2012.095.1 to BA). Additional funding was provided by the Deutsche Forschung Gesellschaft (DFG, KR-4371/1-1 to MK and FA 466/4-1 to MF) and also by a grant from the Italian Association for Cancer Research (AIRC, grant number IG/14820/2013 to MP). Publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886; Cai W, 1997, CANCER CHEMOTH PHARM, V39, P537, DOI 10.1007/s002800050610; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Edler D, 2009, EUR J CANCER, V45, P705, DOI 10.1016/j.ejca.2008.11.031; Else T, 2014, J CLIN ENDOCR METAB, V99, P455, DOI 10.1210/jc.2013-2856; Eun CY, 2010, TOX RESEARCH, V26, P171, DOI 10.5487/TR.2010.26.3.171; Fassnacht M, 2013, J CLIN ENDOCRINOL ME; Fassnacht M, 2012, NEW ENGL J MED, V366, P2189, DOI 10.1056/NEJMoa1200966; Fassnacht M, 2010, J CLIN ENDOCR METAB, V95, P4925, DOI 10.1210/jc.2010-0803; Fassnacht M, 2009, CANCER-AM CANCER SOC, V115, P243, DOI 10.1002/cncr.24030; Gomez A, 2007, PHARMACOGENOMICS, V8, P1315, DOI 10.2217/14622416.8.10.1315; Gomez A, 2010, MOL PHARMACOL, V78, P1004, DOI 10.1124/mol.110.067652; Karlgren M, 2006, BIOCHEM BIOPH RES CO, V341, P451, DOI 10.1016/j.bbrc.2005.12.200; Karlgren M, 2007, EXPERT OPIN THER TAR, V11, P61, DOI 10.1517/14728222.11.1.61; Li WH, 2009, J MOL GRAPH MODEL, V28, P170, DOI 10.1016/j.jmgm.2009.06.002; Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130; Molina-Ortiz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093261; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Nishida CR, 2010, MOL PHARMACOL, V78, P497, DOI 10.1124/mol.110.065045; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ronchi CL, 2014, EUR J ENDOCRINOL; Ronchi CL, 2012, NEOPLASIA, V14, P206, DOI 10.1593/neo.111758; Ronchi CL, 2009, ENDOCR-RELAT CANCER, V16, P907, DOI 10.1677/ERC-08-0224; Schteingart DE, 2012, ANTICANCER RES, V32, P2711; Sheldrake HM, 2013, J MED CHEM, V56, P6273, DOI 10.1021/jm4000209; Stenstedt K, 2014, ACTA ONCOL; Tan BS, 2011, MOL CANCER THER, V10, P1982, DOI 10.1158/1535-7163.MCT-11-0391; Travica S, 2013, CLIN CANCER RES, V19, P2952, DOI 10.1158/1078-0432.CCR-13-0238; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Volante M, 2012, CLIN CANCER RES, V18, P3452, DOI 10.1158/1078-0432.CCR-11-2692; Wu ZL, 2006, ARCH BIOCHEM BIOPHYS, V445, P138, DOI 10.1016/j.abb.2005.11.002; Xiao Y, 2012, J LIPID RES, V53, P1610, DOI 10.1194/jlr.M027185	34	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105855	10.1371/journal.pone.0105855	http://dx.doi.org/10.1371/journal.pone.0105855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144458	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100125
J	Zhou, HX; Ma, YZ; Liu, YL; Chen, Y; Zhou, CJ; Wu, SN; Shen, JP; Liang, CG				Zhou, Hong-Xia; Ma, Yu-Zhen; Liu, Ying-Lei; Chen, Ying; Zhou, Cheng-Jie; Wu, Sha-Na; Shen, Jiang-Peng; Liang, Cheng-Guang			Assessment of Mouse Germinal Vesicle Stage Oocyte Quality by Evaluating the Cumulus Layer, Zona Pellucida, and Perivitelline Space	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; MEIOTIC MATURATION; MAMMALIAN OVARY; COMPLEX; EMBRYO; CELLS; MORPHOLOGY; THICKNESS; IVF; COMMUNICATION	To improve the outcome of assisted reproductive technology (ART) for patients with ovulation problems, it is necessary to retrieve and select germinal vesicle (GV) stage oocytes with high developmental potential. Oocytes with high developmental potential are characterized by their ability to undergo proper maturation, fertilization, and embryo development. In this study, we analyzed morphological traits of GV stage mouse oocytes, including cumulus cell layer thickness, zona pellucida thickness, and perivitelline space width. Then, we assessed the corresponding developmental potential of each of these oocytes and found that it varies across the range measured for each morphological trait. Furthermore, by manipulating these morphological traits in vitro, we were able to determine the influence of morphological variation on oocyte developmental potential. Manually altering the thickness of the cumulus layer showed strong effects on the fertilization and embryo development potentials of oocytes, whereas manipulation of zona pellucida thickness effected the oocyte maturation potential. Our results provide a systematic detailed method for selecting GV stage oocytes based on a morphological assessment approach that would benefit for several downstream ART applications.	[Zhou, Hong-Xia; Liu, Ying-Lei; Chen, Ying; Zhou, Cheng-Jie; Wu, Sha-Na; Shen, Jiang-Peng; Liang, Cheng-Guang] Inner Mongolia Univ, Key Lab Natl Educ Minist Mammalian Reprod Biol &, Hohhot, Inner Mongolia, Peoples R China; [Ma, Yu-Zhen] Inner Mongolia Peoples Hosp, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University	Liang, CG (corresponding author), Inner Mongolia Univ, Key Lab Natl Educ Minist Mammalian Reprod Biol &, Hohhot, Inner Mongolia, Peoples R China.	liangchengguang@gmail.com	liang, chengguang/E-4837-2011	liang, chengguang/0000-0003-4407-7766; Zhou, Cheng-Jie/0000-0002-0575-5037	Open Major Basic Research Projects in Inner Mongolia [20102008]; National Natural Science Foundation of China [31160243, 31371454]; Program for New Century Excellent Talents in University [NCET-11-1014]; Inner Mongolia University [Z20100125]; Inner Mongolia Natural Science Foundation [20120516]	Open Major Basic Research Projects in Inner Mongolia; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Inner Mongolia University; Inner Mongolia Natural Science Foundation	This research was supported by: Open Major Basic Research Projects in Inner Mongolia (20102008) to CL, http://nsbr.nmkjt.gov.cn/index.aspx; The National Natural Science Foundation of China (31160243, 31371454) to CL, http://www.nsfc.gov.cn/; Program for New Century Excellent Talents in University (NCET-11-1014) to CL, http://www.moe.edu.cn/; Program of Higher Level Talents of Inner Mongolia University (Z20100125) to CL, http://www.imu.edu.cn/; Inner Mongolia Natural Science Foundation (20120516) to YM, http://nsbr.nmkjt.gov.cn/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong S, 2013, J ASSIST REPROD GEN, V30, P667, DOI 10.1007/s10815-013-9980-6; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Bao SQ, 2003, THERIOGENOLOGY, V59, P1231, DOI 10.1016/S0093-691X(02)01174-3; Chamayou S, 2006, REPROD BIOMED ONLINE, V13, P661, DOI 10.1016/S1472-6483(10)60656-6; Cheng Y, 2009, BIOL REPROD, V80, P464, DOI 10.1095/biolreprod.108.073593; Choi JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056158; DANDEKAR P, 1992, MOL REPROD DEV, V31, P135, DOI 10.1002/mrd.1080310208; DEAN J, 1992, J CLIN INVEST, V89, P1055, DOI 10.1172/JCI115684; Deb GK, 2012, J ANIM SCI, V90, P1798, DOI 10.2527/jas.2011-4340; Demant M, 2012, HUM REPROD, V27, P1096, DOI 10.1093/humrep/der453; Dunning KR, 2007, HUM REPROD, V22, P2842, DOI 10.1093/humrep/dem277; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Farhi J, 2002, J ASSIST REPROD GEN, V19, P545, DOI 10.1023/A:1021243530358; Fragouli E, 2014, HUM REPROD UPDATE, V20, P1, DOI 10.1093/humupd/dmt044; Gao SR, 2004, BIOL REPROD, V70, P1162, DOI 10.1095/biolreprod.103.024216; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; de Souza JMG, 2013, ANIM REPROD SCI, V138, P82, DOI 10.1016/j.anireprosci.2013.02.012; Goud PT, 1998, HUM REPROD, V13, P1638, DOI 10.1093/humrep/13.6.1638; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; HOWARD JG, 1993, BIOL REPROD, V49, P131, DOI 10.1095/biolreprod49.1.131; Huang HL, 2014, NEW ENGL J MED, V370, P1220, DOI 10.1056/NEJMoa1308851; Janssenswillen C, 1997, FERTIL STERIL, V67, P769, DOI 10.1016/S0015-0282(97)81381-7; Janvier A, 2011, J PEDIATR-US, V159, P409, DOI 10.1016/j.jpeds.2011.02.017; Lay KM, 2013, ANIM SCI J, V84, P8, DOI 10.1111/j.1740-0929.2012.01027.x; Li QL, 2008, MOL HUM REPROD, V14, P673, DOI 10.1093/molehr/gan064; Liang CG, 2009, HUM REPROD, V24, P2718, DOI 10.1093/humrep/dep286; Liu S, 2010, FERTIL STERIL, V93, P2202, DOI 10.1016/j.fertnstert.2009.01.062; Marco-Jimenez F, 2012, ANIM REPROD SCI, V132, P96, DOI 10.1016/j.anireprosci.2012.04.008; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201; Nawroth F, 2001, GYNECOL OBSTET INVES, V52, P55, DOI 10.1159/000052942; OKADA A, 1993, ANAT RECORD, V237, P518, DOI 10.1002/ar.1092370412; Gomes LMO, 2009, REV BRAS GINECOL OBS, V31, P230, DOI 10.1590/S0100-72032009000500005; Palmstierna M, 1998, J ASSIST REPROD GEN, V15, P70, DOI 10.1007/BF02766828; PIERCE KE, 1990, DEV BIOL, V141, P381, DOI 10.1016/0012-1606(90)90392-V; Rienzi L, 2008, FERTIL STERIL, V90, P1692, DOI 10.1016/j.fertnstert.2007.09.024; Rienzi L, 2011, HUM REPROD UPDATE, V17, P34, DOI 10.1093/humupd/dmq029; Shi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089409; Shimada M, 2013, AM J REPROD IMMUNOL, V69, P168, DOI 10.1111/aji.12024; SKUTELSKY E, 1992, HISTOCHEMISTRY, V98, P299, DOI 10.1007/BF00270013; Smolikova K, 2012, Endocr Regul, V46, P237; Sutton ML, 2003, HUM REPROD UPDATE, V9, P35, DOI 10.1093/humupd/dmg009; Ten J, 2007, REPROD BIOMED ONLINE, V14, P40, DOI 10.1016/S1472-6483(10)60762-6; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063173; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; Wassarman PM, 2012, INT J DEV BIOL, V56, P833, DOI 10.1387/ijdb.120136pw; Wassarman PM, 2009, J REPROD IMMUNOL, V83, P45, DOI 10.1016/j.jri.2009.06.259; Wassarman PM, 2002, MT SINAI J MED, V69, P148; Wasserman PM, 2013, CURR TOP DEV BIOL, V102, P243, DOI 10.1016/B978-0-12-416024-8.00009-X; Zhang AJ, 2012, J ASSIST REPROD GEN, V29, P313, DOI 10.1007/s10815-012-9712-3; ZHANG L, 1995, MOL REPROD DEV, V40, P338, DOI 10.1002/mrd.1080400310; Zhang Lun, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P810; Zou LP, 2013, J IMMUNOASS IMMUNOCH, V34, P134, DOI 10.1080/15321819.2012.690358	54	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105812	10.1371/journal.pone.0105812	http://dx.doi.org/10.1371/journal.pone.0105812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144310	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100123
J	Akada, J; Okuda, M; Hiramoto, N; Kitagawa, T; Zhang, XL; Kamei, S; Ito, A; Nakamura, M; Uchida, T; Hiwatani, T; Fukuda, Y; Nakazawa, T; Kuramitsu, Y; Nakamura, K				Akada, Junko; Okuda, Masumi; Hiramoto, Narumi; Kitagawa, Takao; Zhang, Xiulian; Kamei, Shuichi; Ito, Akane; Nakamura, Mikiko; Uchida, Tomohisa; Hiwatani, Tomoko; Fukuda, Yoshihiro; Nakazawa, Teruko; Kuramitsu, Yasuhiro; Nakamura, Kazuyuki			Proteomic Characterization of Helicobacter pylori CagA Antigen Recognized by Child Serum Antibodies and Its Epitope Mapping by Peptide Array	PLOS ONE			English	Article							STRAIN-SPECIFIC ANTIGEN; GASTRIC-CANCER; DUODENAL-ULCER; PROTEIN; IDENTIFICATION; INFECTION; CELLS; IMMUNOPROTEOMICS; CARCINOMA; DIAGNOSIS	Serum antibodies against pathogenic bacteria play immunologically protective roles, and can be utilized as diagnostic markers of infection. This study focused on Japanese child serum antibodies against Helicobacter pylori, a chronically-infected gastric bacterium which causes gastric cancer in adults. Serological diagnosis for H. pylori infection is well established for adults, but it needs to be improved for children. Serum samples from 24 children, 22 H. pylori (Hp)-positive and 2 Hp-negative children, were used to catalogue antigenic proteins of a Japanese strain CPY2052 by two-dimensional electrophoresis followed by immunoblot and LC-MS/MS analysis. In total, 24 proteins were identified as candidate antigen proteins. Among these, the major virulence factor, cytotoxin-associated gene A protein (CagA) was the most reactive antigen recognized by all the Hp-positive sera even from children under the age of 3 years. The major antigenic part of CagA was identified in the middle region, and two peptides containing CagA epitopes were identified using a newly developed peptide/protein-combined array chip method, modified from our previous protein chip method. Each of the epitopes was found to contain amino acid residue(s) unique to East Asian CagA. Epitope analysis of CagA indicated importance of the regional CagA antigens for serodiagnosis of H. pylori infection in children.	[Akada, Junko; Hiramoto, Narumi; Kitagawa, Takao; Zhang, Xiulian; Kuramitsu, Yasuhiro; Nakamura, Kazuyuki] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 755, Japan; [Okuda, Masumi; Fukuda, Yoshihiro] Hyogo Coll Med, Sasayama Med Ctr, Sasayama, Hyogo, Japan; [Okuda, Masumi; Fukuda, Yoshihiro] Hyogo Coll Med, Dept Gen Med & Community Hlth Sci, Nishinomiya, Hyogo 6638501, Japan; [Kamei, Shuichi; Ito, Akane] Toyo Kohan Co Ltd, Tech Res Lab, Yamaguchi, Japan; [Nakamura, Mikiko] Yamaguchi Univ, Innovat Ctr Univ Ind Publ Cooperat, Org Res Initiat, Ube, Yamaguchi 755, Japan; [Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Oita 87011, Japan; [Hiwatani, Tomoko] Wakayama Rosai Hosp, Wakayama, Japan; [Nakazawa, Teruko] Yamaguchi Univ, Grad Sch Med, Dept Microbiol & Immunol, Ube, Yamaguchi 755, Japan	Yamaguchi University; Hyogo College of Medicine; Hyogo College of Medicine; Yamaguchi University; Oita University; Yamaguchi University	Akada, J (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 755, Japan.	akadajk@yamaguchi-u.ac.jp; nakamura@yamaguchi-u.ac.jp			KAKEN-HI from JSPS of Japan [24590919]; Yamaguchi University Innovation Center Foundation grant [2010-03]; Yamaguchi University Yobimizu Project; Grants-in-Aid for Scientific Research [24590919] Funding Source: KAKEN	KAKEN-HI from JSPS of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamaguchi University Innovation Center Foundation grant; Yamaguchi University Yobimizu Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKEN-HI No. 24590919 from JSPS of Japan, by Yamaguchi University Innovation Center Foundation grant No. 2010-03, and partially by Yamaguchi University Yobimizu Project 2013, to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Akada J, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-33; Akada JK, 2010, DIS MODEL MECH, V3, P605, DOI 10.1242/dmm.004879; Arnold IC, 2011, J IMMUNOL, V186, P6165, DOI 10.4049/jimmunol.1003472; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Barabino A, 1999, J PEDIATR GASTR NUTR, V28, P116, DOI 10.1097/00005176-199901000-00027; Bumann D, 2004, PROTEOMICS, V4, P2843, DOI 10.1002/pmic.200400909; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Cardenas-Mondragon MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062850; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; de Angelis GL, 2007, DIGEST DIS, V25, P206, DOI 10.1159/000103886; Furuta Y, 2011, P NATL ACAD SCI USA, V108, P1501, DOI 10.1073/pnas.1012579108; Haas G, 2002, PROTEOMICS, V2, P313, DOI 10.1002/1615-9861(200203)2:3<313::AID-PROT313>3.0.CO;2-7; Hayashi T, 2012, CELL HOST MICROBE, V12, P20, DOI 10.1016/j.chom.2012.05.010; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; Ichihara T, 2006, J PROTEOME RES, V5, P2144, DOI 10.1021/pr0504889; Jungblut PR, 2000, MOL MICROBIOL, V36, P710, DOI 10.1046/j.1365-2958.2000.01896.x; Kido M, 2011, BIOCHEM BIOPH RES CO, V412, P266, DOI 10.1016/j.bbrc.2011.07.081; Kimmel B, 2000, INFECT IMMUN, V68, P915, DOI 10.1128/IAI.68.2.915-920.2000; Krah A, 2004, INT J CANCER, V108, P456, DOI 10.1002/ijc.11557; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Lin YF, 2007, MOL CELL PROTEOMICS, V6, P1018, DOI 10.1074/mcp.M700009-MCP200; Lin YF, 2006, MOL CELL PROTEOMICS, V5, P1484, DOI 10.1074/mcp.M600111-MCP200; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lock RA, 2002, HELICOBACTER, V7, P175, DOI 10.1046/j.1523-5378.2002.00078.x; Marchildon PA, 2003, J CLIN MICROBIOL, V41, P1480, DOI 10.1128/JCM.41.4.1480-1485.2003; McAtee CP, 1998, HELICOBACTER, V3, P163; Mini R, 2005, PROTEOMICS, V5, P777, DOI 10.1002/pmic.200401094; Mizuno S, 2010, DIGEST DIS SCI, V55, P3132, DOI 10.1007/s10620-010-1154-0; Moese S, 2001, PROTEOMICS, V1, P618, DOI 10.1002/1615-9861(200104)1:4<618::AID-PROT618>3.0.CO;2-C; Okuda M, 2005, CLIN DIAGN LAB IMMUN, V12, P1280, DOI 10.1128/CDLI.12.11.1280-1284.2005; Okuda M, 2004, AM J MED, V116, P209, DOI 10.1016/j.amjmed.2003.05.005; Okuda M, 2013, PEDIATR INT, V55, P337, DOI 10.1111/ped.12057; Ozturk A, 2007, SEIZURE-EUR J EPILEP, V16, P147, DOI 10.1016/j.seizure.2006.10.015; Price JV, 2012, NAT MED, V18, P1434, DOI 10.1038/nm.2913; Shiota S, 2010, FUTURE MICROBIOL, V5, P1885, DOI 10.2217/FMB.10.135; Tatemichi M, 2009, HELICOBACTER, V14, P231, DOI 10.1111/j.1523-5378.2009.00681.x; TSUDA M, 1993, MICROBIOL IMMUNOL, V37, P85, DOI 10.1111/j.1348-0421.1993.tb03184.x; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Wang YF, 2012, ANTICANCER RES, V32, P3219; Winkler Dirk F. H., 2008, V494, P47, DOI 10.1007/978-1-59745-419-3_4; Woon AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079367; Yahiro K, 1999, J BIOL CHEM, V274, P36693, DOI 10.1074/jbc.274.51.36693; Yamada K, 2012, HELICOBACTER, V17, P187, DOI 10.1111/j.1523-5378.2011.00930.x	46	14	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104611	10.1371/journal.pone.0104611	http://dx.doi.org/10.1371/journal.pone.0104611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141238	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200025
J	Liebherz, S; Rabung, S				Liebherz, Sarah; Rabung, Sven			Do Patients' Symptoms and Interpersonal Problems Improve in Psychotherapeutic Hospital Treatment in Germany? - A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							DAY CLINIC TREATMENT; DOSE-EFFECT RELATIONS; INPATIENT PSYCHOTHERAPY; FOLLOW-UP; BEHAVIOR-THERAPY; PSYCHOSOMATIC-MEDICINE; PERSONALITY-DISORDER; VALIDATION; ALEXITHYMIA; DIMENSIONS	Background: In Germany, inpatient psychotherapy plays a unique role in the treatment of patients with common mental disorders of higher severity. In addition to psychiatric inpatient services, psychotherapeutic hospital treatment and psychosomatic rehabilitation are offered as independent inpatient treatment options. This meta-analysis aims to provide systematic evidence for psychotherapeutic hospital treatment in Germany regarding its effects on symptomatic and interpersonal impairment. Methodology: Relevant papers were identified by electronic database search and hand search. Randomized controlled trials as well as naturalistic prospective studies (including post-therapy and follow-up assessments) evaluating psychotherapeutic hospital treatment of mentally ill adults in Germany were included. Outcomes were required to be quantified by either the Symptom-Checklist (SCL-90-R or short versions) or the Inventory of Interpersonal Problems (IIP-64 or short versions). Effect sizes (Hedges' g) were combined using random effect models. Principal Findings: Sixty-seven papers representing 59 studies fulfilled inclusion criteria. Meta-analysis yielded a medium within-group effect size for symptom change at discharge (g = 0.72; 95% CI 0.68-0.76), with a small reduction to follow-up (g = 0.61; 95% CI 0.55-0.68). Regarding interpersonal problems, a small effect size was found at discharge (g = 0.35; 95% CI 0.29-0.41), which increased to follow-up (g = 0.48; 95% CI 0.36-0.60). While higher impairment at intake was associated with a larger effect size in both measures, longer treatment duration was related to lower effect sizes in SCL GSI and to larger effect sizes in IIP Total. Conclusions: Psychotherapeutic hospital treatment may be considered an effective treatment. In accordance with Howard's phase model of psychotherapy outcome, the present study demonstrated that symptom distress changes more quickly and strongly than interpersonal problems. Preliminary analyses show impairment at intake and treatment duration to be the strongest outcome predictors. Further analyses regarding this relationship are required.	[Liebherz, Sarah; Rabung, Sven] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Rabung, Sven] Alpen Adria Univ Klagenfurt, Dept Psychol, Klagenfurt, Austria	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Klagenfurt	Liebherz, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	s.liebherz@uke.de	Rabung, Sven/G-3187-2013	Rabung, Sven/0000-0001-5883-3070	Kohler Stiftung im Stifterverband fur die deutsche Wissenschaft [S112/10104/09]	Kohler Stiftung im Stifterverband fur die deutsche Wissenschaft	This work was supported by the Kohler Stiftung im Stifterverband fur die deutsche Wissenschaft under Grant Number S112/10104/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligwekwe UG, 2005, INPATIENT TREATMENT; Barkham M, 1996, J CONSULT CLIN PSYCH, V64, P927, DOI 10.1037/0022-006X.64.5.927; Barkham M, 2006, J CONSULT CLIN PSYCH, V74, P160, DOI 10.1037/0022-006X.74.1.160; Bauer S, 2004, THESIS EBERHARD KARL; Benninghoven D, 2004, PSYCHOTHER PSYCH MED, V54, P9, DOI 10.1055/s-2003-812587; Beutel ME, 2004, Z KLIN PSYCHOL PSYCH, V52, P1; Bohart A.C., 2013, BERGIN GARFIELDS HDB, V6, P219, DOI DOI 10.1093/SCHBUL/SBP148; Borenstein M., 2009, INTRO METAANALYSIS; Cohen J.E., 1988, STAT POWER ANAL BEHA; Counsell C, 1997, ANN INTERN MED, V127, P380, DOI 10.7326/0003-4819-127-5-199709010-00008; Cuijpers P, 2011, CLIN PSYCHOL REV, V31, P353, DOI 10.1016/j.cpr.2011.01.002; Derogatis LR., 1977, SCL 90 ADM SCORING P; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deter HC, 2004, PSYCHOTHER PSYCH MED, V54, P161, DOI 10.1055/s-2003-814789; DGPPN BAK KBV AWMF AkdA, 2009, S3 LEITL NAT VERSORG; Dinger U, 2008, J CLIN PSYCHOL, V64, P344, DOI 10.1002/jclp.20443; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elliott R, 2006, PSYCHOL ASSESSMENT, V18, P359, DOI 10.1037/1040-3590.18.4.359; Falge-Kern A, 2007, VERHALTENSTHERAPIE, V17, P17, DOI 10.1159/000099657; Fassbinder E, 2007, PSYCHOTHER PSYCH MED, V57, P161, DOI 10.1055/s-2006-952015; Fenner E, 2004, GRUPPENPSYCHOTHER GR, V40, P340; Franz M, 2000, Z PSYCHOSOM MED PSYC, V46, P242, DOI 10.13109/zptm.2000.46.3.242; Fricke S, 2006, EUR PSYCHIAT, V21, P319, DOI 10.1016/j.eurpsy.2005.03.010; Geiser F, 2004, Z PSYCHOSOM MED PSYC, V50, P53; Grabe HJ, 2008, PSYCHOTHER PSYCHOSOM, V77, P189, DOI 10.1159/000119739; Grawe K., 1994, PSYCHOTHERAPIE WANDE; Gruhn U, 2006, THESIS F SCHILLER U; Haase M, 2008, PSYCHOTHER RES, V18, P615, DOI 10.1080/10503300802192158; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hess H, 1993, GRUPPENPSYCHOTHER GR, V29, P253; Hoflich A, 2005, THESIS J LIEBIG U GI; Hohagen F, 1998, BRIT J PSYCHIAT, V173, P71, DOI 10.1192/S0007125000297924; HOROWITZ LM, 1988, J CONSULT CLIN PSYCH, V56, P885, DOI 10.1037/0022-006X.56.6.885; HOWARD KI, 1993, J CONSULT CLIN PSYCH, V61, P678, DOI 10.1037/0022-006X.61.4.678; Huber D, 2009, Z PSYCHOSOM MED PSYC, V55, P189, DOI 10.13109/zptm.2009.55.2.189; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Janssen PL, 2007, MEDFUHRER PSYCHISCHE; Junge A, 1996, PSYCHOTHER PSYCH MED, V46, P430; Kech S, 2008, Z KL PSYCH PSYCHOTH, V37, P81, DOI 10.1026/1616-3443.37.2.81; Kirchmann H, 2009, PSYCHOTHER RES, V19, P234, DOI 10.1080/10503300902798367; Kosters M, 2006, GROUP DYN-THEOR RES, V10, P146, DOI 10.1037/1089-2699.10.2.146; Konig K, 1995, EINFUHRUNG STATIONAR; Konzag TA, 2006, PSYCHOTHERAPEUT, V51, P35, DOI 10.1007/s00278-005-0439-9; Konzag VTA, 2004, Z PSYCHOSOM MED PSYC, V50, P394; KOPTA SM, 1994, J CONSULT CLIN PSYCH, V62, P1009, DOI 10.1037/0022-006X.62.5.1009; Kruger C, 2004, FORSCHUNGSBERICHT EX; Kuhler T, 2000, WIRKFAKTOREN STATION, P74; Kunz R, 2009, SYSTEMATISCHE UBERSI; Kurth RA, 2005, PSYCHOTHER PSYCH MED, V55, P502, DOI 10.1055/s-2005-866943; Lambert MJ, 2001, J CONSULT CLIN PSYCH, V69, P159, DOI 10.1037//0022-006X.69.2.159; Leichsenring F, 2004, TRAUMAZENTRIERTE PSY, P334; Leichsenring F, 2006, PSYCHOTHER RES, V16, P594, DOI 10.1080/10503300600805217; Liebherz S, 2012, METAANALSE ZUSAMMENH; Liebherz S, 2010, BERICHTE EXTERNEN EV; Liebherz S, 2013, PSYCHOTHER PSYCH MED, V63, P355, DOI 10.1055/s-0033-1337909; Liebler A, 2004, GRUPPENPSYCHOTHER GR, V40, P1; Liedtke R, 2001, GRUPPENPSYCHOTHER GR, V37, P214; Liedtke R, 1993, GRUPPENPSYCHOTHER GR, V29, P249; Lipsey M. W., 2000, PRACTICAL METAANALAY; Lobo-Drost, 2003, BINDUNG PSYCHOTHERAP; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muhs A, 1993, GRUPPENPSYCHOTHER GR, V29, P259; Nickel R, 2005, PSYCHOTHER RES, V15, P483, DOI 10.1080/10503300500091660; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; Pedersen G, 2004, ACTA PSYCHIAT SCAND, V110, P215, DOI 10.1111/j.1600-0447.2004.00321.x; Peikert G, 2004, VERHALTENSTHERAPIE, V14, P253, DOI 10.1159/000082835; Peikert G, 2005, THESIS F SCHILLER U; Pohlmann K, 2009, Z PSYCHOSOM MED PSYC, V55, P180; Probst T, 2009, Z PSYCHOSOM MED PSYC, V55, P409, DOI 10.13109/zptm.2009.55.4.409; Rabung S, 2005, GRUPPENPSYCHOTHER GR, V41, P130; Rasting M, 2008, MIMIK PSYCHOTHERAPIE; Sack M, 1997, PSYCHOTHER PSYCH MED, V47, P149; Sack M, 2003, Z PSYCHOSOM MED PSYC, V49, P63; Salzer S, 2010, THESIS G AUGUST U GO; Sammet VI, 2004, Z PSYCHOSOM MED PSYC, V50, P376; Schauenburg H, 1999, PSYCHOTHER PSYCHOSOM, V68, P199, DOI 10.1159/000012333; Schauenburg H, 2005, PSYCHOTHER PSYCH MED, V55, P339, DOI 10.1055/s-2004-834750; Schauenburg H, 2007, KLINIKFUHRER STATION; Schellenberg K, 2004, GRUPPENPSYCHOTHER GR, V40, P248; Schepank H, 1988, STATIONARE PSYCHOTHE; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; Schneider G, 2006, Z PSYCHOSOM MED PSYC, V52, P259, DOI 10.13109/zptm.2006.52.3.259; Schneider W, 2001, PSYCHOTHER RES, V11, P153, DOI 10.1080/713663888; Schneider W, 1993, GRUPPENPSYCHOTHERAPI, V29, P270; Schon-Kliniken, 2009, DURCHL QUAL 2008; Schreiber-Willnow K, 2000, KORPER SELBST GRUPPE; Schreiber-Willnow K, 2002, STATIONARE GRUPPENPS, P147; Schulz H, 2002, PSYCHOTHERAPIE PSYCH, V52, pT1; Schulz H, 2011, KLIN PSYCHOL PSYCHOT, P361; Seidler GH, 1999, STATIONARE PSYCHOTHE; Simson U, 2006, PSYCHOTHER PSYCH MED, V56, P376, DOI 10.1055/s-2006-940127; Spitzer C, 2008, PSYCHODYN PSYCHOTHER, V7, P3; SPSS Inc, 2006, SPSS 15 0 COMM SYNT; Steffanowski A, 2007, METAANALYSE EFFEKTE; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stingl M, 2008, J PSYCHOSOM RES, V65, P173, DOI 10.1016/j.jpsychores.2008.01.010; Tran US, 2012, DIAGNOSTICA, V58, P75, DOI 10.1026/0012-1924/a000058; Tritt K, 2003, PSYCHOTHERAPIE, V8, P244; Tschuschke V, 1993, WIRKFAKTOREN STATION; Uhlmann C, 2008, VERHALTENSTHERAPIE, V18, P230, DOI 10.1159/000173107; Walte D, 2000, LEITLINIEN STATIONAR, P335; Wilson DB, 2011, METAANALYSIS MACROS; Wittchen H-U, 2011, KLIN PSYCHOL PSYCHOT, P449; Wittmann W., 2002, Z F R EVALUATION, V1, P39; Woller W, 2007, Z PSYCHOSOM MED PSYC, V53, P163; Zeeck A, 2006, Z PSYCHOSOM MED PSYC, V52, P190, DOI 10.13109/zptm.2006.52.2.190; Zeeck A, 2004, EUR EAT DISORD REV, V12, P79, DOI 10.1002/erv.535; Zeeck A, 2003, PSYCHOTHERAPEUT, V48, P420, DOI 10.1007/s00278-003-0311-8; Zeeck A, 2009, PSYCHOTHER PSYCH MED, V59, P354, DOI 10.1055/s-2008-1067542; Zeeck A, 2009, PSYCHOTHER PSYCHOSOM, V78, P152, DOI 10.1159/000206869; Ziegenrucker HC, 1996, GRUPPENPSYCHOTHER GR, V32, P22	112	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105329	10.1371/journal.pone.0105329	http://dx.doi.org/10.1371/journal.pone.0105329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25141289	Green Submitted, gold, Green Published			2022-12-27	WOS:000342687200071
J	Bordin, AI; Pillai, SD; Brake, C; Bagley, KB; Bourquin, JR; Coleman, M; Oliveira, FN; Mwangi, W; McMurray, DN; Love, CC; Felippe, MJB; Cohen, ND				Bordin, Angela I.; Pillai, Suresh D.; Brake, Courtney; Bagley, Kaytee B.; Bourquin, Jessica R.; Coleman, Michelle; Oliveira, Fabiano N.; Mwangi, Waithaka; McMurray, David N.; Love, Charles C.; Felippe, Maria Julia B.; Cohen, Noah D.			Immunogenicity of an Electron Beam Inactivated Rhodococcus equi Vaccine in Neonatal Foals	PLOS ONE			English	Article							VIRULENCE-ASSOCIATED PROTEIN; IMMUNOGLOBULIN-G; INFLUENZA-VIRUS; BRONCHOALVEOLAR LAVAGE; ADULT HORSES; PNEUMONIA; RESPONSES; IMMUNIZATION; IRRADIATION; EXPRESSION	Rhodococcus equi is an important pathogen of foals that causes severe pneumonia. To date, there is no licensed vaccine effective against R. equi pneumonia of foals. The objectives of our study were to develop an electron beam (eBeam) inactivated vaccine against R. equi and evaluate its immunogenicity. A dose of eBeam irradiation that inactivated replication of R. equi while maintaining outer cell wall integrity was identified. Enteral administration of eBeam inactivated R. equi increased interferon-gamma production by peripheral blood mononuclear cells in response to stimulation with virulent R. equi and generated naso-pharyngeal R. equi-specific IgA in newborn foals. Our results indicate that eBeam irradiated R. equi administered enterally produce cell-mediated and upper respiratory mucosal immune responses, in the face of passively transferred maternal antibodies, similar to those produced in response to enteral administration of live organisms (a strategy which previously has been documented to protect foals against intrabronchial infection with virulent R. equi). No evidence of adverse effects was noted among vaccinated foals.	[Bordin, Angela I.; Brake, Courtney; Bagley, Kaytee B.; Bourquin, Jessica R.; Coleman, Michelle; Cohen, Noah D.] Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, Equine Infect Dis Lab, College Stn, TX 77843 USA; [Pillai, Suresh D.] Texas A&M Univ, Natl Ctr Electon Beam Res, College Stn, TX USA; [Pillai, Suresh D.] Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA; [Pillai, Suresh D.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Oliveira, Fabiano N.] Antech Diagnost, College Stn, TX USA; [Mwangi, Waithaka] Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX USA; [McMurray, David N.] Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, Texas A&M Hlth Sci Ctr, College Stn, TX USA; [Love, Charles C.] Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Felippe, Maria Julia B.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Cornell University	Cohen, ND (corresponding author), Texas A&M Univ, Dept Large Anim Clin Sci, Coll Vet Med & Biomed Sci, Equine Infect Dis Lab, College Stn, TX 77843 USA.	ncohen@cvm.tamu.edu			Morris Animal Foundation [D13EQ-0001]; Link Equine Research Endowment, Texas AM University; Boehringer-Ingelheim; Zoetis	Morris Animal Foundation; Link Equine Research Endowment, Texas AM University; Boehringer-Ingelheim(Boehringer Ingelheim); Zoetis	This work was supported by the Morris Animal Foundation (D13EQ-0001). Additional funding was provided by the Link Equine Research Endowment, Texas A&M University. AIB was supported by a fellowship from Fort Dodge Animal Health/Pfizer Animal Health (now Zoetis). An unrestricted gift from Boehringer-Ingelheim to the Equine Infectious Disease Laboratory at Texas A&M University provided partial support to this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anosova NG, 2008, MUCOSAL IMMUNOL, V1, P59, DOI 10.1038/mi.2007.7; Baffa O, 2014, RADIAT ENVIRON BIOPH, V53, P233, DOI 10.1007/s00411-013-0509-2; Becu T, 1997, VET MICROBIOL, V56, P193, DOI 10.1016/S0378-1135(97)00088-6; Boyd NK, 2003, VET IMMUNOL IMMUNOP, V92, P75, DOI 10.1016/S0165-2427(03)00021-7; Brahmakshatriya V, 2009, AVIAN PATHOL, V38, P245, DOI 10.1080/03079450902912150; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; BROWN F, 1993, DEV BIOL STAND, V81, P103; Cabeza MC, 2010, FOOD MICROBIOL, V27, P777, DOI 10.1016/j.fm.2010.03.018; Cauchard J, 2004, VET MICROBIOL, V104, P73, DOI 10.1016/j.vetmic.2004.09.006; Chaffin MK, 2008, JAVMA-J AM VET MED A, V232, P1035, DOI 10.2460/javma.232.7.1035; CHIRINOTREJO JM, 1987, CAN J VET RES, V51, P444; Collie DDS, 1999, RES VET SCI, V67, P137, DOI 10.1053/rvsc.1999.0290; Darrah PA, 2000, INFECT IMMUN, V68, P3587, DOI 10.1128/IAI.68.6.3587-3593.2000; Demicheli MC, 2007, MYCOSES, V50, P397, DOI 10.1111/j.1439-0507.2007.01389.x; Dziedzic-Goclawska Anna, 2005, Cell and Tissue Banking, V6, P201, DOI 10.1007/s10561-005-0338-x; Fernandez-Bustamante A, 2012, RESP PHYSIOL NEUROBI, V183, P149, DOI 10.1016/j.resp.2012.06.015; Fiester S. E., 2012, INT J MICROBIOL, V2012; Flaminio MJBF, 1999, J VET INTERN MED, V13, P206, DOI 10.1892/0891-6640(1999)013&lt;0206:PBLSAI&gt;2.3.CO;2; GALAN JE, 1986, INFECT IMMUN, V54, P202, DOI 10.1128/IAI.54.1.202-206.1986; Gans HA, 1999, J IMMUNOL, V162, P5569; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; GARRISON RG, 1983, MICROBIOS, V36, P183; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Grasso EM, 2011, J FOOD PROTECT, V74, P115, DOI 10.4315/0362-028X.JFP-10-281; Grimm MB, 2007, AM J VET RES, V68, P63, DOI 10.2460/ajvr.68.1.63; Helfinstine SL, 2005, APPL ENVIRON MICROB, V71, P7029, DOI 10.1128/AEM.71.11.7029-7032.2005; Hines MT, 2001, VET IMMUNOL IMMUNOP, V79, P101, DOI 10.1016/S0165-2427(01)00258-6; Hooper-McGrevy KE, 2005, VACCINE, V23, P5760, DOI 10.1016/j.vaccine.2005.07.050; Hooper-McGrevy KE, 2003, CLIN DIAGN LAB IMMUN, V10, P345, DOI 10.1128/CDLI.10.3.345-351.2003; Horowitz ML, 2001, J VET INTERN MED, V15, P171, DOI 10.1892/0891-6640(2001)015&lt;0171:AOSMLD&gt;2.3.CO;2; Khan F.H., 2009, ELEMENTS IMMUNOLOGY; LAVOIE JP, 1989, AM J VET RES, V50, P466; Lewis MJ, 2008, MOL IMMUNOL, V45, P818, DOI 10.1016/j.molimm.2007.06.158; Lopez AM, 2008, VACCINE, V26, P998, DOI 10.1016/j.vaccine.2007.10.069; Lopez AM, 2003, VACCINE, V21, P3815, DOI 10.1016/S0264-410X(03)00329-3; Lopez AM, 2002, CLIN DIAGN LAB IMMUN, V9, P1270, DOI 10.1128/CDLI.9.6.1270-1276.2002; MADIGAN JE, 1991, J REPROD FERTIL, P571; Martens RJ, 1991, EQUINE VET J S, V12, P19; Mealey RH, 2007, VACCINE, V25, P7582, DOI 10.1016/j.vaccine.2007.07.055; Meijer WG, 2004, VET RES, V35, P383, DOI 10.1051/vetres:2004024; Molecular Probes Inc, 2004, PROD INF, P1; Murphy K., 2012, JANEWAYS IMMUNOBIOLO, P387; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; Nelson KM, 1998, VACCINE, V16, P1306, DOI 10.1016/S0264-410X(98)00009-7; Paillot R, 2013, VET MICROBIOL, V162, P396, DOI 10.1016/j.vetmic.2012.10.019; Pei Y, 2007, VET MICROBIOL, V125, P100, DOI 10.1016/j.vetmic.2007.05.007; Pillai S, 2007, ELECT PASTEURIZATION; Pillai SD, 2008, FOOD IRRADIATION, P375; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poon PWB, 2004, ADV EXP MED BIOL, V542, P101; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Prescott JF, 1997, AM J VET RES, V58, P356; Quan FS, 2012, VACCINE, V30, P180, DOI 10.1016/j.vaccine.2011.11.028; Rodriguez O, 2006, INT J FOOD MICROBIOL, V110, P117, DOI 10.1016/j.ijfoodmicro.2006.01.041; Sealy R, 2013, INT IMMUNOL, V25, P183, DOI 10.1093/intimm/dxs107; Sheoran AS, 2000, AM J VET RES, V61, P1099, DOI 10.2460/ajvr.2000.61.1099; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Smith PD, 2013, PRINCIPLES OF MUCOSAL IMMUNOLOGY, P1; Sommers C. H., 2006, FOOD IRR RES TECHN; Rivera CS, 2011, FOOD MICROBIOL, V28, P141, DOI 10.1016/j.fm.2010.09.008; TAKAI S, 1992, INFECT IMMUN, V60, P2995, DOI 10.1128/IAI.60.7.2995-2997.1992; Takai S, 1999, FEMS IMMUNOL MED MIC, V24, P1; Takai S, 1997, VET MICROBIOL, V56, P167, DOI 10.1016/S0378-1135(97)00085-0; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; Varga J, 1997, VET MICROBIOL, V56, P205, DOI 10.1016/S0378-1135(97)00089-8; WALTERS EH, 1991, THORAX, V46, P613, DOI 10.1136/thx.46.9.613; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014	67	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105367	10.1371/journal.pone.0105367	http://dx.doi.org/10.1371/journal.pone.0105367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153708	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200044
J	Meneghini, C; Leboffe, L; Bionducci, M; Fanali, G; Meli, M; Colombo, G; Fasano, M; Ascenzi, P; Mobilio, S				Meneghini, Carlo; Leboffe, Loris; Bionducci, Monica; Fanali, Gabriella; Meli, Massimiliano; Colombo, Giorgio; Fasano, Mauro; Ascenzi, Paolo; Mobilio, Settimio			The Five-To-Six-Coordination Transition of Ferric Human Serum Heme-Albumin Is Allosterically-Modulated by Ibuprofen and Warfarin: A Combined XAS and MD Study	PLOS ONE			English	Article							RAY-ABSORPTION SPECTROSCOPY; FREE-ENERGY CALCULATIONS; DRUG-BINDING; CRYSTALLOGRAPHIC ANALYSIS; MOLECULAR-DYNAMICS; NO DISSOCIATION; FINE-STRUCTURE; UCSF CHIMERA; PRE-EDGE; K-EDGE	Human serum albumin (HSA) is involved physiologically in heme scavenging; in turn, heme-albumin (HSA-heme-Fe) displays globin-like properties. Here, the allosteric effect of ibuprofen and warfarin on the local atomic structure around the ferric heme-Fe (heme-Fe(III)) atom of HSA-heme-Fe (HSA-heme-Fe(III)) has been probed by Fe-K edge X-ray absorption spectroscopy (XAS). The quantitative analysis of the Fe-K edge extended X-ray absorption fine structure (EXAFS) signals and modeling of the near edge (XANES) spectral features demonstrated that warfarin and ibuprofen binding modify the local structure of the heme-Fe(III). Combined XAS data analysis and targeted molecular dynamics (MD) simulations provided atomic resolution insights of protein structural rearrangements required to accommodate the heme-Fe(III) upon ibuprofen and warfarin binding. In the absence of drugs, the heme-Fe(III) atom is penta-coordinated having distorted 4+1 configuration made by the nitrogen atoms of the porphyrin ring and the oxygen phenoxy atom of the Tyr161 residue. MD simulations show that ibuprofen and warfarin association to the secondary fatty acid (FA) binding site 2 (FA2) induces a reorientation of domain I of HSA-heme-Fe(III), this leads to the redirection of the His146 residue providing an additional bond to the heme-Fe(III) atom, providing the 5+1 configuration. The comparison of Fe-K edge XANES spectra calculated using MD structures with those obtained experimentally confirms the reliability of the proposed structural model. As a whole, combining XAS and MD simulations it has been possible to provide a reliable model of the heme-Fe(III) atom coordination state and to understand the complex allosteric transition occurring in HSA-heme-Fe(III) upon ibuprofen and warfarin binding.	[Meneghini, Carlo; Leboffe, Loris; Bionducci, Monica; Mobilio, Settimio] Roma Tre Univ, Dept Sci, Rome, Italy; [Leboffe, Loris; Ascenzi, Paolo] Natl Inst Biostruct & Biosyst, Rome, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Theoret & Appl Sci, Biomed Res Div, Busto Arsizio, VA, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Ctr Neurosci, Busto Arsizio, VA, Italy; [Meli, Massimiliano; Colombo, Giorgio] CNR, Inst Mol Recognit Chem, Milan, Italy; [Ascenzi, Paolo] Roma Tre Univ, Interdept Lab Electron Microscopy, Rome, Italy	Italfarmaco; Roma Tre University; University of Insubria; University of Insubria; Consiglio Nazionale delle Ricerche (CNR); Roma Tre University	Ascenzi, P (corresponding author), Natl Inst Biostruct & Biosyst, Rome, Italy.	ascenzi@uniroma3.it	Meli, Massimiliano/AAY-8570-2020; Fasano, Mauro/A-7100-2008; Colombo, Giorgio/A-2730-2012; Leboffe, Loris/K-7838-2016; meneghini, carlo/F-7761-2013	Meli, Massimiliano/0000-0003-3304-6104; Fasano, Mauro/0000-0003-0628-5871; Colombo, Giorgio/0000-0002-1318-668X; Leboffe, Loris/0000-0001-8272-1896; meneghini, carlo/0000-0003-4846-8422	Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy (Universita Roma Tre, Roma, Italy) [CLAR 2012]; European Synchrotron Radiation Facility (ESRF, Grenoble, France) [MX1275]; AIRC (Associazione Italiana Ricerca sul Cancro) [IG.11775]; Flagship "INTEROMICS'' project - Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy [PB.P05]; National Research Council of Italy	Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy (Universita Roma Tre, Roma, Italy); European Synchrotron Radiation Facility (ESRF, Grenoble, France); AIRC (Associazione Italiana Ricerca sul Cancro); Flagship "INTEROMICS'' project - Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy; National Research Council of Italy	This work was supported by a grant from Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy (Universita Roma Tre, Roma, Italy; CLAR 2012 to P.A.). The EXAFS experiments have been supported by the European Synchrotron Radiation Facility (ESRF, Grenoble, France; exp. number MX1275). GC gratefully acknowledges AIRC (Associazione Italiana Ricerca sul Cancro) for support through the grant IG.11775 and the Flagship "INTEROMICS'' project (PB.P05) funded by Ministero dell'Istruzione, dell'Universitae della Ricerca of Italy and National Research Council of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Ascenzi P, 2008, BIOCHEM BIOPH RES CO, V369, P686, DOI 10.1016/j.bbrc.2008.02.077; Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V411, P185, DOI 10.1016/j.bbrc.2011.06.130; Ascenzi P, 2010, IUBMB LIFE, V62, P776, DOI 10.1002/iub.381; Ascenzi P, 2010, BIOPHYS CHEM, V148, P16, DOI 10.1016/j.bpc.2010.03.001; Ascenzi P, 2009, IUBMB LIFE, V61, P1118, DOI 10.1002/iub.263; Ascenzi P, 2009, J BIOL CHEM, V284, P31006, DOI 10.1074/jbc.M109.010736; Ascenzi P, 2009, BIOCHEM BIOPH RES CO, V387, P83, DOI 10.1016/j.bbrc.2009.06.117; Baroni S, 2001, EUR J BIOCHEM, V268, P6214, DOI 10.1046/j.0014-2956.2001.02569.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Besio R, 2010, EUR BIOPHYS J BIOPHY, V39, P935, DOI 10.1007/s00249-009-0459-4; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bocedi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058842; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Cabaret D, 2010, PHYS CHEM CHEM PHYS, V12, P5619, DOI 10.1039/b926499j; Curry S, 2002, VOX SANG, V83, P315, DOI 10.1111/j.1423-0410.2002.tb05326.x; Curry S, 2009, DRUG METAB PHARMACOK, V24, P342, DOI 10.2133/dmpk.24.342; D'Angelo P, 2004, BIOPHYS J, V86, P3882, DOI 10.1529/biophysj.103.034876; D'Angelo P, 2012, BIOCHEMISTRY-US, V51, P6068, DOI 10.1021/bi300233n; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Beer SBA, 2012, J CHEM INF MODEL, V52, P2139, DOI 10.1021/ci300243n; Della Longa S, 2003, BIOPHYS J, V85, P549, DOI 10.1016/S0006-3495(03)74499-3; di Masi A, 2011, FEBS J, V278, P654, DOI 10.1111/j.1742-4658.2010.07986.x; Fanali G, 2005, FEBS J, V272, P4672, DOI 10.1111/j.1742-4658.2005.04883.x; Fanali G, 2007, BIOPHYS CHEM, V129, P29, DOI 10.1016/j.bpc.2007.05.002; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fanali G, 2009, FEBS J, V276, P2241, DOI 10.1111/j.1742-4658.2009.06952.x; Fasano M, 2002, J INORG BIOCHEM, V91, P487, DOI 10.1016/S0162-0134(02)00473-7; Fasano M, 2001, J BIOL INORG CHEM, V6, P650, DOI 10.1007/s007750100242; Fasano M, 2007, IUBMB LIFE, V59, P436, DOI 10.1080/15216540701474523; Fitos I, 2002, CHIRALITY, V14, P442, DOI 10.1002/chir.10113; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Giuli G, 2011, AM MINERAL, V96, P631, DOI 10.2138/am.2011.3464; HEDIN L, 1971, J PHYS PART C SOLID, V4, P2064, DOI 10.1088/0022-3719/4/14/022; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9; Kaneko K, 2011, IUBMB LIFE, V63, P277, DOI 10.1002/iub.457; Koningsberger DC, 1988, XRAY ABSORPTION PRIN, P1; LEE PA, 1975, PHYS REV B, V11, P2795, DOI 10.1103/PhysRevB.11.2795; LEE PA, 1981, REV MOD PHYS, V53, P769, DOI 10.1103/RevModPhys.53.769; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Meneghini C, 2012, NUCL INSTRUM METH B, V285, P153, DOI 10.1016/j.nimb.2012.05.027; Meneghini C, 1998, BIOPHYS J, V75, P1953, DOI 10.1016/S0006-3495(98)77636-2; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; MOMENTEAU M, 1994, CHEM REV, V94, P659, DOI 10.1021/cr00027a006; Monesi C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174104; Nagy G, 2012, EUR BIOPHYS J BIOPHY, V41, P1065, DOI 10.1007/s00249-012-0865-x; Nicoletti FP, 2008, J AM CHEM SOC, V130, P11677, DOI 10.1021/ja800966t; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Peters Jr Th, 1996, ALL ALBUMIN BIOCH GE; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rich AM, 1998, J AM CHEM SOC, V120, P10827, DOI 10.1021/ja980253g; Roccatano D, 2008, CURR PROTEIN PEPT SC, V9, P407, DOI 10.2174/138920308785132686; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Silaghi-Dumitrescu R, 2007, BIOCHEM J, V403, P391, DOI 10.1042/BJ20061421; Smith LJ, 2006, PROTEINS, V65, P702, DOI 10.1002/prot.21141; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	68	26	26	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104231	10.1371/journal.pone.0104231	http://dx.doi.org/10.1371/journal.pone.0104231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153171	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200017
J	Simmons, DA; Knowles, JK; Belichenko, NP; Banerjee, G; Finkle, C; Massa, SM; Longo, FM				Simmons, Danielle A.; Knowles, Juliet K.; Belichenko, Nadia P.; Banerjee, Gargi; Finkle, Carly; Massa, Stephen M.; Longo, Frank M.			A Small Molecule p75(NTR) Ligand, LM11A-31, Reverses Cholinergic Neurite Dystrophy in Alzheimer's Disease Mouse Models with Mid- to Late-Stage Disease Progression	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; NERVE GROWTH-FACTOR; AMYLOID PRECURSOR PROTEIN; BASAL FOREBRAIN NEURONS; TRANSGENIC MICE; COGNITIVE IMPAIRMENT; BETA PROTEIN; EXPRESSION; BRAIN; DEFICITS	Degeneration of basal forebrain cholinergic neurons contributes significantly to the cognitive deficits associated with Alzheimer's disease (AD) and has been attributed to aberrant signaling through the neurotrophin receptor p75 (p75(NTR)). Thus, modulating p75(NTR) signaling is considered a promising therapeutic strategy for AD. Accordingly, our laboratory has developed small molecule p75(NTR) ligands that increase survival signaling and inhibit amyloid-beta-induced degenerative signaling in in vitro studies. Previous work found that a lead p75(NTR) ligand, LM11A-31, prevents degeneration of cholinergic neurites when given to an AD mouse model in the early stages of disease pathology. To extend its potential clinical applications, we sought to determine whether LM11A-31 could reverse cholinergic neurite atrophy when treatment begins in AD mouse models having mid-to late stages of pathology. Reversing pathology may have particular clinical relevance as most AD studies involve patients that are at an advanced pathological stage. In this study, LM11A-31 (50 or 75 mg/kg) was administered orally to two AD mouse models, Thy-1 hAPP(Lond/Swe) (APP(L/S)) and Tg2576, at age ranges during which marked AD-like pathology manifests. In mid-stage male APP(L/S) mice, LM11A-31 administered for 3 months starting at 6-8 months of age prevented and/or reversed atrophy of basal forebrain cholinergic neurites and cortical dystrophic neurites. Importantly, a 1 month LM11A-31 treatment given to male APP(L/S) mice (12-13 months old) with late-stage pathology reversed the degeneration of cholinergic neurites in basal forebrain, ameliorated cortical dystrophic neurites, and normalized increased basal forebrain levels of p75(NTR). Similar results were seen in female Tg2576 mice. These findings suggest that LM11A-31 can reduce and/or reverse fundamental AD pathologies in late-stage AD mice. Thus, targeting p75(NTR) is a promising approach to reducing AD-related degenerative processes that have progressed beyond early stages.	[Simmons, Danielle A.; Knowles, Juliet K.; Belichenko, Nadia P.; Banerjee, Gargi; Finkle, Carly; Longo, Frank M.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Knowles, Juliet K.; Longo, Frank M.] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA; [Massa, Stephen M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Massa, Stephen M.] Univ Calif San Francisco, Lab Computat Neurochem & Drug Discovery, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Longo, FM (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	longo@stanford.edu	Banerjee, Gargi/AAU-3081-2020	Banerjee, Gargi/0000-0003-0190-7782; Knowles, Juliet/0000-0002-9214-2991	Veteran's Administration;  [NIA UO1 AG032225];  [NINDS F30 NA051971]; NATIONAL INSTITUTE ON AGING [U01AG032225] Funding Source: NIH RePORTER	Veteran's Administration(US Department of Veterans Affairs); ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants NIA UO1 AG032225 (FML), NINDS F30 NA051971 (JKK) and the Veteran's Administration (SMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar A, 2006, INT J DEV NEUROSCI, V24, P133, DOI 10.1016/j.ijdevneu.2005.11.008; Apelt J, 2002, BRAIN RES, V953, P17, DOI 10.1016/S0006-8993(02)03262-6; BUELL SJ, 1981, BRAIN RES, V214, P23, DOI 10.1016/0006-8993(81)90436-4; Chakravarthy B, 2010, J ALZHEIMERS DIS, V19, P915, DOI 10.3233/JAD-2010-1288; Coulson EJ, 2009, NEUROSCIENTIST, V15, P317, DOI 10.1177/1073858408331376; Coulson EJ, 2000, CLIN EXP PHARMACOL P, V27, P537, DOI 10.1046/j.1440-1681.2000.03295.x; Coulson EJ, 2006, J NEUROCHEM, V98, P654, DOI 10.1111/j.1471-4159.2006.03905.x; Cuello AC, 2010, J MOL NEUROSCI, V40, P230, DOI 10.1007/s12031-009-9238-z; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Diarra Adama, 2009, Biochem Biophys Res Commun, V390, P352, DOI 10.1016/j.bbrc.2009.09.116; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Faizi M, 2012, BRAIN BEHAV, V2, P142, DOI 10.1002/brb3.41; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; German DC, 2003, J COMP NEUROL, V462, P371, DOI 10.1002/cne.10737; GIBBS RB, 1989, MOL BRAIN RES, V6, P275, DOI 10.1016/0169-328X(89)90073-9; Ginsberg SD, 2006, J NEUROCHEM, V97, P475, DOI 10.1111/j.1471-4159.2006.03764.x; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Havas D, 2011, J ALZHEIMERS DIS, V25, P231, DOI 10.3233/JAD-2011-101866; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu XY, 2002, EXP NEUROL, V178, P104, DOI 10.1006/exnr.2002.8018; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Jaffar S, 2000, EXP NEUROL, V170, P227, DOI 10.1006/exnr.2001.7710; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Knowles JK, 2013, NEUROBIOL AGING, V34, P2052, DOI 10.1016/j.neurobiolaging.2013.02.015; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; LAMOUR Y, 1982, NEUROSCI LETT, V34, P117, DOI 10.1016/0304-3940(82)90162-8; Longo FM, 2008, CNS NEUROL DISORD-DR, V7, P63, DOI 10.2174/187152708783885093; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; MUFSON EJ, 1992, P NATL ACAD SCI USA, V89, P569, DOI 10.1073/pnas.89.2.569; MUFSON EJ, 1992, BRAIN RES, V589, P115, DOI 10.1016/0006-8993(92)91169-F; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Perez RG, 1997, J NEUROSCI, V17, P9407; Perez SE, 2014, BIOL PSYCHIAT; Perez SE, 2007, NEUROBIOL DIS, V28, P3, DOI 10.1016/j.nbd.2007.06.015; Perez SE, 2011, NEUROBIOL DIS, V41, P338, DOI 10.1016/j.nbd.2010.10.002; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Yaar M, 2002, J BIOL CHEM, V277, P7720, DOI 10.1074/jbc.M110929200; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604; Yeo TT, 1997, J NEUROSCI, V17, P7594	56	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e102136	10.1371/journal.pone.0102136	http://dx.doi.org/10.1371/journal.pone.0102136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153701	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200004
J	Henninger, AMJ; Eliasson, B; Jenndahl, LE; Hammarstedt, A				Henninger, A. M. Josefin; Eliasson, Bjorn; Jenndahl, Lachmi E.; Hammarstedt, Ann			Adipocyte Hypertrophy, Inflammation and Fibrosis Characterize Subcutaneous Adipose Tissue of Healthy, Non-Obese Subjects Predisposed to Type 2 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; 1ST-DEGREE RELATIVES; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; GENE-EXPRESSION; OBESITY; FAT; DIFFERENTIATION; ADIPOGENESIS; MECHANISMS	Background: The adipose tissue is important for development of insulin resistance and type 2 diabetes and adipose tissue dysfunction has been proposed as an underlying cause. In the present study we investigated presence of adipocyte hypertrophy, and gene expression pattern of adipose tissue dysfunction in the subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes compared to matched control subjects with no known genetic predisposition for type 2 diabetes. Method: Seventeen healthy and non-obese subjects with known genetic predisposition for type 2 diabetes (first-degree relatives, FDRs) and 17 control subjects were recruited. The groups were matched for gender and BMI and had similar age. Glucose tolerance was determined by an oral glucose tolerance test and insulin sensitivity was calculated using HOMA-index. Blood samples were collected and subcutaneous abdominal adipose tissue biopsies obtained for gene expression analysis and adipocyte cell size measurement. Results: Our findings show that, in spite of similar age, BMI and percent body fat, FDRs displayed adipocyte hypertrophy, as well as higher waist/hip ratio, fasting insulin levels, HOMA-IR and serum triglycerides. Adipocyte hypertrophy in the FDR group, but not among controls, was associated with measures of impaired insulin sensitivity. The adipocyte hypertrophy was accompanied by increased inflammation and Wnt-signal activation. In addition, signs of tissue remodeling and fibrosis were observed indicating presence of early alterations associated with adipose tissue dysfunction in the FDRs. Conclusion: Genetic predisposition for type 2 diabetes is associated with impaired insulin sensitivity, adipocyte hypertrophy and other markers of adipose tissue dysfunction. A dysregulated subcutaneous adipose tissue may be a major susceptibility factor for later development of type 2 diabetes.	[Henninger, A. M. Josefin; Eliasson, Bjorn; Jenndahl, Lachmi E.; Hammarstedt, Ann] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden	University of Gothenburg	Hammarstedt, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden.	ann.hammarstedt@medic.gu.se	Eliasson, Bjorn/H-5783-2016	Eliasson, Bjorn/0000-0003-2569-4160	Magn Bergvall Foundation; Swedish Diabetes Association; Wilhelm and Martina Lundgren Foundation	Magn Bergvall Foundation; Swedish Diabetes Association; Wilhelm and Martina Lundgren Foundation	Magn Bergvall Foundation, Swedish Diabetes Association, Wilhelm and Martina Lundgren Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Arner P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018284; Bluher M, 2013, BEST PRACT RES CL EN, V27, P163, DOI 10.1016/j.beem.2013.02.005; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Ehrlund A, 2013, J CLIN ENDOCR METAB, V98, pE503, DOI 10.1210/jc.2012-3416; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; Kelley DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE941, DOI 10.1152/ajpendo.2000.278.5.E941; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Koska J, 2009, INT J OBESITY, V33, P842, DOI 10.1038/ijo.2009.106; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Marinou K, 2014, DIABETES CARE, V37, P821, DOI 10.2337/dc13-1353; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murdolo G, 2007, J CLIN ENDOCR METAB, V92, P2688, DOI 10.1210/jc.2006-2814; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pellme F, 2003, DIABETES, V52, P1182, DOI 10.2337/diabetes.52.5.1182; Pessin JE, 2012, J INVEST MED, V60, P1147, DOI 10.2310/JIM.0b013e318271fdb9; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Ruotsalainen E, 2006, DIABETES CARE, V29, P2714, DOI 10.2337/dc06-0147; Saltevo J, 2008, DIABETES-METAB RES, V24, P378, DOI 10.1002/dmrr.831; Schafer SA, 2011, DIABETES RES CLIN PR, V93, pS9, DOI 10.1016/S0168-8227(11)70008-0; Smith U, 2001, FASEB J, V15, P215, DOI 10.1096/fj.00-0020com; Snijder MB, 2003, OBES RES, V11, P104, DOI 10.1038/oby.2003.18; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Van Hul M, 2008, J THROMB HAEMOST, V6, P1198, DOI 10.1111/j.1538-7836.2008.02988.x; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang J, 2012, OBESITY, V20, P932, DOI 10.1038/oby.2011.371	46	75	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105262	10.1371/journal.pone.0105262	http://dx.doi.org/10.1371/journal.pone.0105262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148116	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600038
J	Jellinge, ME; Henriksen, DP; Hallas, P; Brabrand, M				Jellinge, Marlene Ersgaard; Henriksen, Daniel Pilsgaard; Hallas, Peter; Brabrand, Mikkel			Hypoalbuminemia Is a Strong Predictor of 30-Day All-Cause Mortality in Acutely Admitted Medical Patients: A Prospective, Observational, Cohort Study	PLOS ONE			English	Article							RISK	Objective: Emergency patients with hypoalbuminemia are known to have increased mortality. No previous studies have, however, assessed the predictive value of low albumin on mortality in unselected acutely admitted medical patients. We aimed at assessing the predictive power of hypoalbuminemia on 30-day all-cause mortality in a cohort of acutely admitted medical patients. Methods: We included all acutely admitted adult medical patients from the medical admission unit at a regional teaching hospital in Denmark. Data on mortality was extracted from the Danish Civil Register to ensure complete follow-up. Patients were divided into three groups according to their plasma albumin levels (0-34, 35-44 and >= 45 g/L) and mortality was identified for each group using Kaplan-Meier survival plot. Discriminatory power (ability to discriminate patients at increased risk of mortality) and calibration (precision of predictions) for hypoalbuminemia was determined. Results: We included 5,894 patients and albumin was available in 5,451 (92.5%). A total of 332 (5.6%) patients died within 30 days of admission. Median plasma albumin was 40 g/L (IQR 37-43). Crude 30-day mortality in patients with low albumin was 16.3% compared to 4.3% among patients with normal albumin (p<0.0001). Patients with low albumin were older and admitted for a longer period of time than patients with a normal albumin, while patients with high albumin had a lower 30-day mortality, were younger and were admitted for a shorter period. Multivariable logistic regression analyses confirmed the association of hypoalbuminemia with mortality (OR: 1.95 (95% CI: 1.31-2.90)). Discriminatory power was good (AUROC 0.73 (95% CI, 0.70-0.77)) and calibration acceptable. Conclusion: We found hypoalbuminemia to be associated with 30-day all-cause mortality in acutely admitted medical patients. Used as predictive tool for mortality, plasma albumin had acceptable discriminatory power and good calibration.	[Jellinge, Marlene Ersgaard] Sydvestjysk Sygehus Esbjerg, Dept Anesthesiol, Esbjerg, Denmark; [Henriksen, Daniel Pilsgaard] Univ Southern Denmark, Dept Clin Biochem & Pharmacol, Odense, Denmark; [Hallas, Peter] Rigshosp, Juliane Marie Centret, Dept Anesthesiol, DK-2100 Copenhagen, Denmark; [Brabrand, Mikkel] Sydvestjysk Sygehus Esbjerg, Dept Emergency Med, Esbjerg, Denmark; [Brabrand, Mikkel] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark	University of Southern Denmark; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Brabrand, M (corresponding author), Sydvestjysk Sygehus Esbjerg, Dept Emergency Med, Esbjerg, Denmark.	mbrabrand@health.sdu.dk	; Brabrand, Mikkel/F-7276-2011	Henriksen, Daniel Pilsgaard/0000-0003-1303-6195; Hallas, Peter/0000-0001-7659-9724; Brabrand, Mikkel/0000-0002-3340-8251				Brabrand M, 2013, BMJ OPEN, V3; Brabrand M, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Haller C, 2005, KIDNEY BLOOD PRESS R, V28, P307, DOI 10.1159/000090185; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Lyons O, 2010, EUR J INTERN MED, V21, P17, DOI 10.1016/j.ejim.2009.10.010; MARIK PE, 1993, HEART LUNG, V22, P166; Namendys-Silva SA, 2011, AM J HOSP PALLIAT ME, V28, P253, DOI 10.1177/1049909110384841; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Tal S, 2011, QJM-INT J MED, V104, P933, DOI 10.1093/qjmed/hcr093	12	88	91	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105983	10.1371/journal.pone.0105983	http://dx.doi.org/10.1371/journal.pone.0105983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148079	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600104
J	Reichwald, K; Jorgensen, TZ; Skov, S				Reichwald, Kirsten; Jorgensen, Tina Z.; Skov, Soren			TL1A Increases Expression of CD25, LFA-1, CD134 and CD154, and Induces IL-22 and GM-CSF Production from Effector CD4 T-Cells	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; CYTOKINE 1A TL1A; RHEUMATOID-ARTHRITIS; NK CELLS; OX40 CD134; ACTIVATION; IL-15; DR3; SUPPRESSION; MEMORY	Elevated levels of the cytokine TL1A is associated with several autoimmune diseases e.g. rheumatoid arthritis and inflammatory bowel disease. However, the exact role of TL1A remains elusive. In this study, we investigated the function of TL1A in a pro-inflammatory setting. We show that TL1A together with IL-12, IL-15 and IL-18 increases expression of the co-stimulatory molecules CD154 (CD40 ligand) and CD134 (OX40) on previously activated CD4(+) T cells. This indicates that TL1A functions as a co-stimulatory molecule, decreasing the activation threshold of T-cells. We have previously shown that TL1A co-stimulation strongly induces IL-6 in human healthy leukocytes. Interestingly, the cytokine-activated effector T-cells did not produce IL-6 in response to TL1A, indicating distinct effects of TL1A on different cell populations. We further show that this co-stimulation increases the expression of CD25 (IL-2R alpha) and CD11a (alpha-chain of LFA-1) on CD4 T-cells, likely governing increased IL-2/IL-15 sensitivity and cell-cell contact. Along with this, TL1A co-stimulation caused a specific induction of IL-22 and GM-CSF from the activated T-cells. These results substantially contribute to the explanation of TL1A's role in inflammation. Our results suggest that TL1A should be considered as a target for immunotherapeutic treatment of rheumatoid arthritis and inflammatory bowel disease.	[Reichwald, Kirsten; Jorgensen, Tina Z.; Skov, Soren] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Copenhagen, Denmark	University of Copenhagen	Reichwald, K (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Copenhagen, Denmark.	kirstenreichwald@gmail.com; sosk@sund.ku.dk		Jorgensen, Tina Zenia/0000-0003-3586-2332; Skov, Soren/0000-0003-0732-0026	University of Copenhagen	University of Copenhagen	This work was funded by a PhD scholarship granted by The University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RL, 2012, EUR J IMMUNOL, V42, P672, DOI 10.1002/eji.201142071; Bamias G, 2008, CLIN IMMUNOL, V129, P249, DOI 10.1016/j.clim.2008.07.014; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Bamias G, 2011, EXP DERMATOL, V20, P725, DOI 10.1111/j.1600-0625.2011.01304.x; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Boot EPJ, 2005, ARTHRITIS RES THER, V7, pR604, DOI 10.1186/ar1722; Boyman O, 2010, EUR J IMMUNOL, V40, P936, DOI 10.1002/eji.201040466; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hassan GS, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4153; Itsumi M, 2009, EUR J IMMUNOL, V39, P1784, DOI 10.1002/eji.200839106; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; Pan HF, 2013, CYTOKINE GROWTH F R, V24, P51, DOI 10.1016/j.cytogfr.2012.07.002; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004; Reichwald K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085793; Roeleveld DM, 2014, ANN RHEUM DIS, V73, pA9, DOI 10.1136/annrheumdis-2013-205124.21; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Salek-Ardakani S, 2006, VACCINE, V24, P872, DOI 10.1016/j.vaccine.2005.07.108; Skov S, 2000, J IMMUNOL, V164, P3500, DOI 10.4049/jimmunol.164.7.3500; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105627	10.1371/journal.pone.0105627	http://dx.doi.org/10.1371/journal.pone.0105627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148371	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600063
J	Zucchini, S; Marucci, G; Paradiso, B; Lanza, G; Roncon, P; Cifelli, P; Ferracin, M; Giulioni, M; Michelucci, R; Rubboli, G; Simonato, M				Zucchini, Silvia; Marucci, Gianluca; Paradiso, Beatrice; Lanza, Giovanni; Roncon, Paolo; Cifelli, Pierangelo; Ferracin, Manuela; Giulioni, Marco; Michelucci, Roberto; Rubboli, Guido; Simonato, Michele			Identification of miRNAs Differentially Expressed in Human Epilepsy with or without Granule Cell Pathology	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HIPPOCAMPAL SCLEROSIS; CLINICOPATHOLOGICAL CLASSIFICATION; CONSENSUS CLASSIFICATION; TASK-FORCE; MICRORNAS; DISPERSION; SYSTEM	The microRNAs (miRNAs) are small size non-coding RNAs that regulate expression of target mRNAs at post-transcriptional level. miRNAs differentially expressed under pathological conditions may help identifying mechanisms underlying the disease and may represent biomarkers with prognostic value. However, this kind of studies are difficult in the brain because of the cellular heterogeneity of the tissue and of the limited access to fresh tissue. Here, we focused on a pathology affecting specific cells in a subpopulation of epileptic brains (hippocampal granule cells), an approach that bypasses the above problems. All patients underwent surgery for intractable temporal lobe epilepsy and had hippocampal sclerosis associated with no granule cell pathology in half of the cases and with type-2 granule cell pathology (granule cell layer dispersion or bilamination) in the other half. The expression of more than 1000 miRNAs was examined in the laser-microdissected dentate granule cell layer. Twelve miRNAs were differentially expressed in the two groups. One of these, miR487a, was confirmed to be expressed at highly differential levels in an extended cohort of patients, using RT-qPCR. Bioinformatics searches and RT-qPCR verification identified ANTXR1 as a possible target of miR487a. ANTXR1 may be directly implicated in granule cell dispersion because it is an adhesion molecule that favors cell spreading. Thus, miR487a could be the first identified element of a miRNA signature that may be useful for prognostic evaluation of post-surgical epilepsy and may drive mechanistic studies leading to the identification of therapeutic targets.	[Zucchini, Silvia; Paradiso, Beatrice; Roncon, Paolo; Cifelli, Pierangelo; Simonato, Michele] Univ Ferrara, Dept Med Sci, Pharmacol Sect, I-44100 Ferrara, Italy; [Zucchini, Silvia; Paradiso, Beatrice; Roncon, Paolo; Cifelli, Pierangelo; Simonato, Michele] Univ Ferrara, Neurosci Ctr, I-44100 Ferrara, Italy; [Zucchini, Silvia; Paradiso, Beatrice; Roncon, Paolo; Simonato, Michele] Natl Inst Neurosci, Turin, Italy; [Zucchini, Silvia; Ferracin, Manuela; Simonato, Michele] Univ Ferrara, Lab Technol Adv Therapies LTTA, I-44100 Ferrara, Italy; [Marucci, Gianluca] Bellaria Hosp, Sect Pathol, Dept Biomed & NeuroMotor Sci DiBiNeM, Bologna, Italy; [Paradiso, Beatrice; Lanza, Giovanni] Univ Ferrara, Sect Pathol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Cifelli, Pierangelo] Ri MED Fdn, Palermo, Italy; [Ferracin, Manuela] Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Giulioni, Marco] Bellaria Hosp, Sect Neurosurg, IRCCS Inst Neurol Sci, Bologna, Italy; [Michelucci, Roberto; Rubboli, Guido] Bellaria Hosp, Neurol Sect, IRCCS Inst Neurol Sci, Bologna, Italy; [Rubboli, Guido] Epilepsihosp, Danish Epilepsy Ctr, Dianalund, Denmark	University of Ferrara; University of Ferrara; University of Ferrara; AUSL di Bologna; University of Ferrara; University of Ferrara; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)	Simonato, M (corresponding author), Univ Ferrara, Dept Med Sci, Pharmacol Sect, I-44100 Ferrara, Italy.	michele.simonato@unife.it	Ferracin, Manuela/K-2097-2016; Paradiso, Beatrice/AAL-2442-2020; Simonato, Michele/AIA-0028-2022; Marucci, Gianluca/F-1426-2019; Michelucci, Roberto/AAB-9074-2020; Paradiso, Beatrice/AAO-6555-2020; Lanza, Giovanni/K-6635-2016; cifelli, pierangelo/AAC-4700-2020	Ferracin, Manuela/0000-0002-1595-6887; Simonato, Michele/0000-0002-3586-2693; Marucci, Gianluca/0000-0003-4508-3359; Paradiso, Beatrice/0000-0002-4319-4832; Lanza, Giovanni/0000-0002-5362-1236; cifelli, pierangelo/0000-0002-7430-7641; Michelucci, Roberto/0000-0002-9655-7940	European Community [FP7] [285827, 602102]; Ri.MED foundation	European Community [FP7]; Ri.MED foundation	This work has been supported by grants from the European Community [FP7-PEOPLE-2011-IAPP project 285827 (EPIXCHANGE) and FP7-HEALTH project 602102 (EPITARGET), to MS], and from the Ri.MED foundation (to PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beveridge NJ, 2012, NEUROBIOL DIS, V46, P263, DOI 10.1016/j.nbd.2011.12.029; Blumcke I, 2007, ACTA NEUROPATHOL, V113, P235, DOI 10.1007/s00401-006-0187-0; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Blumcke I, 2009, ACTA NEUROPATHOL, V117, P535, DOI 10.1007/s00401-009-0512-5; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Chen DH, 2013, CANCER RES, V73, P5821, DOI 10.1158/0008-5472.CAN-13-1080; Neves RSD, 2013, CLIN NEUROPATHOL, V32, P24, DOI 10.5414/NP300509; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Engel J, 1993, SURG TREATMENT EPILE, P609; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Gu JS, 2010, EXP CELL RES, V316, P1946, DOI 10.1016/j.yexcr.2010.03.026; Gutwein LG, 2011, ANTICANCER RES, V31, P3417; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Marucci G, 2010, CLIN NEUROPATHOL, V29, P32; Maurer-Morelli CV, 2012, J NEUROSCI METH, V208, P44, DOI 10.1016/j.jneumeth.2012.04.020; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Peiro-Chova L, 2013, VIRCHOWS ARCH, V463, P765, DOI 10.1007/s00428-013-1485-2; Shizu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041291; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Thom M, 2010, EPILEPSIA, V51, P1801, DOI 10.1111/j.1528-1167.2010.02681.x; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; WYLER AR, 1992, J EPILEPSY, V5, P220, DOI 10.1016/S0896-6974(05)80120-3; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	31	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105521	10.1371/journal.pone.0105521	http://dx.doi.org/10.1371/journal.pone.0105521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148080	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600050
J	Brown, KA; Lambert, LJ; Brophy, JM; Nasmith, J; Rinfret, S; Segal, E; Kouz, S; Ross, D; Harvey, R; Maire, S; Boothroyd, LJ; Bogaty, P				Brown, Kevin A.; Lambert, Laurie J.; Brophy, James M.; Nasmith, James; Rinfret, Stephane; Segal, Eli; Kouz, Simon; Ross, Dave; Harvey, Richard; Maire, Sebastien; Boothroyd, Lucy J.; Bogaty, Peter			Impact of ECG Findings and Process-Of-Care Characteristics on the Likelihood of Not Receiving Reperfusion Therapy in Patients with ST-Elevation Myocardial Infarction: Results of a Field Evaluation	PLOS ONE			English	Article							BUNDLE-BRANCH BLOCK; SEGMENT-ELEVATION; NATIONAL-REGISTRY; UNITED-STATES; CHEST-PAIN; MANAGEMENT; OUTCOMES; ASSOCIATION; GUIDELINE; DIAGNOSIS	Background: Many patients with ST-elevation myocardial infarction (STEMI) do not receive reperfusion therapy and are known hospital characteristics associated with non-receipt of reperfusion therapy in patients with STEMI. Methods and Results: This systematic evaluation of STEMI care in 82 hospitals in Quebec included all patients with a discharge diagnosis of myocardial infarction, presenting with characteristic symptoms and an ECG showing STEMI as attested by at least one of two study cardiologists or left bundle branch block (LBBB). Excluding LBBB, an ECG was considered a definite STEMI diagnosis if both cardiologists scored 'certain STEMI' and ambiguous if one scored 'uncertain' or 'not STEMI'. Centers were classified according to accessibility to primary percutaneous coronary intervention (PPCI): 1) on-site PPCI; 2) routine transfer for PPCI; 3) varying mix of PPCI transfer and on-site fibrinolysis; and 4) routine on-site fibrinolysis. Of 3730 STEMI/LBBB patients, 812 (21.8%) did not receive reperfusion therapy. In multivariate analysis, likelihood of no reperfusion therapy was a function of PPCI accessibility (odds ratio [OR] for fibrinolysis versus PPCI centers = 3.1; 95% CI: 2.2-4.4), presence of LBBB (OR = 24.1; 95% CI: 17.8-32.9) and an ECG ambiguous for STEMI (OR = 4.1; 95% CI: 3.3-5.1). When the ECG was ambiguous, likelihood of no reperfusion therapy was highest in hospitals most distant from PPCI centers. Conclusions: ECG diagnostic ambiguity, LBBB and PPCI accessibility are important predictors of not receiving reperfusion therapy, suggesting opportunities for improving outcomes.	[Brown, Kevin A.; Lambert, Laurie J.; Boothroyd, Lucy J.; Bogaty, Peter] INESSS, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Nasmith, James] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Rinfret, Stephane; Bogaty, Peter] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Segal, Eli] Sir Mortimer B Davis Jewish Hosp, Montreal, PQ, Canada; [Segal, Eli; Ross, Dave] Corp Urgences Sante, Montreal, PQ, Canada; [Kouz, Simon] Ctr Hosp Reg Lanaudiere, Joliette, PQ, Canada; [Ross, Dave] Serv Prehosp Urgence Monteregie, Longueuil, PQ, Canada; [Ross, Dave] Hop Sacre Coeur, Dept Med Prehosp, Montreal, PQ H4J 1C5, Canada; [Harvey, Richard] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Maire, Sebastien] Univ Hotel Dieu Levis, Ctr Hosp, Levis, PQ, Canada	McGill University; St. Paul's Hospital; University of Saskatchewan; McGill University; Universite de Montreal; University of Sherbrooke	Lambert, LJ (corresponding author), INESSS, Montreal, PQ, Canada.	laurie.lambert@inesss.qc.ca	brophy, james/H-6673-2019; Segal, Eli/GPW-8146-2022	brophy, james/0000-0001-8049-6875; Brown, Kevin Antoine/0000-0002-1483-2188	Quebec Ministry of Health	Quebec Ministry of Health	This study was supported by an operating grant from the Quebec Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence d'evaluation des technologies et des modes d'intervention en sante (AETMIS), 2008, ETMIS, V4, P1; Alter DA, 2006, EUR HEART J, V27, P1539, DOI 10.1093/eurheartj/ehl066; [Anonymous], 2010, R LANG ENV STAT COMP; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Balzi D, 2008, INTERN EMERG MED, V3, P109, DOI 10.1007/s11739-008-0090-x; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; Cai QJ, 2013, AM HEART J, V166, P409, DOI 10.1016/j.ahj.2013.03.032; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eagle KA, 2008, EUR HEART J, V29, P609, DOI 10.1093/eurheartj/ehn069; Forman DE, 2010, AM J CARDIOL, V106, P1382, DOI 10.1016/j.amjcard.2010.07.008; Gharacholou SM, 2010, AM HEART J, V159, P757, DOI 10.1016/j.ahj.2010.02.009; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huynh T, 2006, CAN MED ASSOC J, V175, P1527, DOI 10.1503/cmaj.060359; Jollis JG, 2012, CIRCULATION, V126, P189, DOI 10.1161/CIRCULATIONAHA.111.068049; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lambert L, 2012, CAN J CARDIOL, V28, P162, DOI 10.1016/j.cjca.2011.10.005; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Lambert LJ, 2009, CIRC-CARDIOVASC QUAL, V2, pe40; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Neeland IJ, 2012, J AM COLL CARDIOL, V60, P96, DOI 10.1016/j.jacc.2012.02.054; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Rajagopal V, 2006, EUR HEART J, V27, P1513, DOI 10.1093/eurheartj/ehl007; Sgarbossa EB, 1996, NEW ENGL J MED, V334, P481, DOI 10.1056/NEJM199602223340801; Shlipak MG, 2000, J AM COLL CARDIOL, V36, P706, DOI 10.1016/S0735-1097(00)00789-0; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tricomi AJ, 2008, AM HEART J, V155, P471, DOI 10.1016/j.ahj.2007.10.023; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Tran V, 2011, AM J CARDIOL, V108, P1096, DOI 10.1016/j.amjcard.2011.06.008	30	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104874	10.1371/journal.pone.0104874	http://dx.doi.org/10.1371/journal.pone.0104874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144645	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100027
J	Gao, JJ; Wu, YM; Su, ZL; Barnie, PA; Jiao, ZJ; Bie, QL; Lu, LW; Wang, SJ; Xu, HX				Gao, Jingjing; Wu, Yumin; Su, Zhaoliang; Barnie, Prince Amoah; Jiao, Zhijun; Bie, Qingli; Lu, Liwei; Wang, Shengjun; Xu, Huaxi			Infiltration of Alternatively Activated Macrophages in Cancer Tissue Is Associated with MDSC and Th2 Polarization in Patients with Esophageal Cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; SUPPRESSOR-CELLS; SCAVENGER RECEPTOR; DENDRITIC CELLS; CROSS-TALK; EXPRESSION; MARKER	Myeloid derived suppressor cells (MDSCs) expand in cancer bearing hosts and contribute to tumor immune evasion. M2 macrophages constitute a major cellular component of cancer-related inflammation. However, the correlation between circulating MDSCs and infiltrating M2 macrophages in tumor tissues from patients with esophageal cancer (ECA), and its potential relationship with the polarization of Th2 cells remain unclear. In the present study, we showed the level of MDSCs in PBMC and Arg1 in plasma were significantly elevated in ECA patients, and the increased ratio of MDSC in PBMC was closely related to the expression of CD163 in cancer tissues. In addition, the ECA patients exhibited remarkable increases in the mRNA levels of IL-4 and GATA3, as well as the protein levels of IL-13 and IL-6, but IFN-gamma and IL-12 in peripheral blood were decreased. Our data indicate that the increased Th2 cytokines are associated with MDSCs and M2 macrophages polarization, and foster the infiltration of CD163(+)M2 macrophages in cancer tissues, which promote the formation of immunosuppressive microenvironment in ECA patients.	[Gao, Jingjing; Wu, Yumin; Su, Zhaoliang; Barnie, Prince Amoah; Bie, Qingli; Wang, Shengjun; Xu, Huaxi] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Immunol, Zhenjiang, Peoples R China; [Jiao, Zhijun] Jiangsu Univ, Affiliated Hosp, Dept Lab Med, Zhenjiang, Peoples R China; [Gao, Jingjing] Nanjing Med Univ, Suzhou Hosp, Dept Lab Med, Suzhou, Peoples R China; [Lu, Liwei] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lu, Liwei] Univ Hong Kong, Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China	Jiangsu University; Jiangsu University; Nanjing Medical University; University of Hong Kong; University of Hong Kong	Wang, SJ (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Dept Immunol, Zhenjiang, Peoples R China.	sjwjs@ujs.edu.cn; xuhx@ujs.edu.cn	SU, Zhaoliang/ABD-9062-2021; Lu, Liwei/C-4357-2009	SU, Zhaoliang/0000-0002-5998-5575; Lu, Liwei/0000-0002-8634-0967	National Natural Science Foundation of China [31270947, 31170849, 30972748]; Natural Science Foundation of Jiangsu Province [BK2011472]; Postdoctoral Foundation of China [2012M511705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Postdoctoral Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (31270947, 31170849 and 30972748, http://www.nsfc.gov.cn/), Natural Science Foundation of Jiangsu Province (BK2011472) and the Postdoctoral Foundation of China (2012M511705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Arantes Vitor, 2012, Rev. Col. Bras. Cir., V39, P534; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Cui YL, 2013, ASIAN PAC J CANCER P, V14, P1003, DOI 10.7314/APJCP.2013.14.2.1003; Delpisheh Ali, 2014, Gastroenterol Hepatol Bed Bench, V7, P101; Fujiwara Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/348539; Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ghosh AK, 2012, CANCER LETT, V324, P91, DOI 10.1016/j.canlet.2012.05.002; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gu M, 2012, ASIAN PAC J CANCER P, V13, P5587, DOI 10.7314/APJCP.2012.13.11.5587; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Hajian-Tilaki KO, 2001, BRIT J CANCER, V85, P1671, DOI 10.1054/bjoc.2001.2153; HOLNESS CL, 1993, BLOOD, V81, P1607; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Ma J, 2011, CANCER LETT, V301, P142, DOI 10.1016/j.canlet.2010.11.005; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Nguyen TDT, 2005, AM J SURG PATHOL, V29, P617, DOI 10.1097/01.pas.0000157940.80538.ec; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Teramoto K, 2013, J CANCER RES CLIN, V139, P861, DOI 10.1007/s00432-013-1394-4; Xu Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/949821; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	32	38	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104453	10.1371/journal.pone.0104453	http://dx.doi.org/10.1371/journal.pone.0104453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144454	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100015
J	He, YL; Gao, H; Li, XM; Zhao, YR				He, YingLi; Gao, Heng; Li, XiaoMei; Zhao, YingRen			Psychological Stress Exerts Effects on Pathogenesis of Hepatitis B via Type-1/Type-2 Cytokines Shift toward Type-2 Cytokine Response	PLOS ONE			English	Article							PSYCHOSOCIAL STRESS; LYMPHOCYTES; INFECTION; VERSION; SCALE; CELL; SEVERITY; HBSAG	Background: Psychological and physical stress has been demonstrated to have an impact on health through modulation of immune function. Despite high prevalence of stress among patients with hepatitis B virus (HBV) infection, little is known about whether and how stress exerts an effect on the course of hepatitis B. Methods: Eighty patients with chronic hepatitis B(CHB) completed the Perceived Stress Scale-10(PSS-10) and State-Trait Anxiety Inventory(STAI). Fresh whole blood was subject to flow cytometry for lymphocytes count. Plasma samples frozen at -80 degrees C were thawed for cytokines, alanine aminotransferase (ALT), and virus load. These patients were grouped into high or low perceived stress, state anxiety and trait anxiety groups according to the scale score. Sociodemographic, disease-specific characteristics, lymphocytes count and cytokines were compared. Results: Firstly, a negative association between ALT and stress (t = -4.308; p = .000), state anxiety (t = -3.085; p = .003) and trait anxiety (t = -4.925; p = .000) were found. As ALT is a surrogate marker of hepatocytes injury, and liver injury is a consequence of immune responses. Next, we tested the relationship between stress/anxiety and lymphocytes. No statistical significance were found with respect to counts of total T cells, CD4+ T cell, CD8+ T cell, NK cell, and B cell count between high and low stress group. Type-2 cytokine interleukin-10 (IL-10) level was significantly higher in high stress group relative to lower counterpart (t = 6.538; p = 0.000), and type-1 cytokine interferon-gamma (IFN-gamma) level shown a decreased tendency in high stress group (t = -1.702; p = 0.093). Finally, INF-gamma:IL-10 ratio displayed significant decrease in high perceived stress(t = -4.606; p = 0.000), state anxiety(t = -5.126; p = 0.000) and trait anxiety(t = -4.670; p = 0.000) groups relative to low counterparts. Conclusion: Our data show stress is not related to the lymphocyte cells count in CHB patients, however, stress induces a shift in the type-1/type-2 cytokine balance towards a type-2 response, which implicated a role of psychological stress in the course of HBV related immune-pathogenesis.	[He, YingLi; Zhao, YingRen] Xi An Jiao Tong Univ, Sch Med, Affiliated Teaching Hosp 1, Dept Infect Dis, Xian 710049, Shaanxi Provinc, Peoples R China; [Gao, Heng] Xian Municipal Hlth Coll, Xian, Shaanxi Provinc, Peoples R China; [Li, XiaoMei] Xi An Jiao Tong Univ, Sch Med, Dept Psychol & Nursing, Xian 710049, Shaanxi Provinc, Peoples R China; [He, YingLi; Zhao, YingRen] Xi An Jiao Tong Univ, Affiliated Hosp 1, Inst Hepatol, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zhao, YR (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Teaching Hosp 1, Dept Infect Dis, Xian 710049, Shaanxi Provinc, Peoples R China.	zhaoyingren@mail.xjtu.edu.cn			China National Natural Science Foundation [30700712]; Major National Science and Technology Projects for Infectious Diseases (China) [2008ZX10002-007, 2012ZX10002007]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major National Science and Technology Projects for Infectious Diseases (China)	This study was supported by grants from the China National Natural Science Foundation (No. 30700712) and The Major National Science and Technology Projects for Infectious Diseases (11th and 12th Five Year, China) (No. 2008ZX10002-007, No. 2012ZX10002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou E, 2011, INT J ENV RES PUB HE, V8, P3287, DOI 10.3390/ijerph8083287; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Atesci FC, 2005, PSYCHOSOMATICS, V46, P142, DOI 10.1176/appi.psy.46.2.142; Burns VE, 2002, PSYCHOSOM MED, V64, P287, DOI 10.1097/00006842-200203000-00012; Cao W, 2011, WORLD J GASTROENTERO, V17, P2191, DOI 10.3748/wjg.v17.i17.2191; Chaaya M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-111; Chen TY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-524; Chida Y, 2004, HEPATOLOGY, V39, P1131, DOI 10.1002/hep.20158; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Greeson JM, 2008, BRAIN BEHAV IMMUN, V22, P901, DOI 10.1016/j.bbi.2008.01.001; Hyodo N, 2003, HEPATOL RES, V27, P109, DOI 10.1016/S1386-6346(03)00199-2; Ioannou GN, 2013, HEPATOLOGY, V58, P839, DOI 10.1002/hep.26516; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Lee J, 2012, ASIA-PAC PSYCHIAT, V4, P108; Lee M, 1999, J KOREAN MED SCI, V14, P175, DOI 10.3346/jkms.1999.14.2.175; Loggi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065327; Luo Guang-han, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P147; M'Kada H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042418; MARINOS G, 1995, HEPATOLOGY, V22, P1040, DOI 10.1016/0270-9139(95)90607-X; Marshall GD, 1998, BRAIN BEHAV IMMUN, V12, P297, DOI 10.1006/brbi.1998.0537; Mimura C, 2004, INT J NURS STUD, V41, P379, DOI 10.1016/j.ijnurstu.2003.10.009; Nagano J, 2004, PSYCHOSOMATICS, V45, P100, DOI 10.1176/appi.psy.45.2.100; Niu YH, 2013, WORLD J GASTROENTERO, V19, P4146, DOI 10.3748/wjg.v19.i26.4146; Palumbo ML, 2010, J NEUROIMMUNOL, V218, P12, DOI 10.1016/j.jneuroim.2009.11.005; Pan LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035303; Remor E, 2006, SPAN J PSYCHOL, V9, P86, DOI 10.1017/S1138741600006004; Rico MA, 2001, HEPATOLOGY, V33, P295, DOI 10.1053/jhep.2001.21147; Szkaradkiewicz A, 2003, VIRUS RES, V97, P127, DOI 10.1016/j.virusres.2003.08.013; Vere CC, 2009, WORLD J GASTROENTERO, V15, P2980, DOI 10.3748/wjg.15.2980; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028610; Yang Y, 2013, J MED VIROL, V85, P1893, DOI 10.1002/jmv.23649; YingLi H, 2008, INT J INFECT DIS, V12, pE417, DOI 10.1016/j.ijid.2008.05.1099	32	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105530	10.1371/journal.pone.0105530	http://dx.doi.org/10.1371/journal.pone.0105530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144199	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100081
J	Langhorst, J; Frede, A; Knott, M; Pastille, E; Buer, J; Dobos, GJ; Westendorf, AM				Langhorst, Jost; Frede, Annika; Knott, Markus; Pastille, Eva; Buer, Jan; Dobos, Gustav J.; Westendorf, Astrid M.			Distinct Kinetics in the Frequency of Peripheral CD4(+) T Cells in Patients with Ulcerative Colitis Experiencing a Flare during Treatment with Mesalazine or with a Herbal Preparation of Myrrh, Chamomile, and Coffee Charcoal	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ALTERNATIVE MEDICINE USE; PHARMACOLOGICAL INVESTIGATIONS; 5-AMINOSALICYLIC ACID; ANTIINFLAMMATORY ACTIVITY; INTESTINAL INFLAMMATION; MAINTAINING REMISSION; BISABOLOL OXIDES; HEME OXYGENASE-1; NATIONAL-SURVEY	Background: We found the first evidence of the efficacy of a herbal treatment with myrrh, dry extract of chamomile flowers, and coffee charcoal for ulcerative colitis (UC). However, the impact of the herbal treatment on the CD4(+) T-cell compartment, which is essential for both the induction of UC and the maintenance of tolerance in the gut, is not well understood. Aim: To analyze the frequency and functional phenotype of CD4(+) T cells and of immune-suppressive CD4+CD25(high) regulatory T cells (Tregs) in healthy control subjects, patients with UC in remission, and patients with clinical flare of UC. Methods: Patients in clinical remission were treated with either mesalazine or the herbal preparation for 12 months. The frequencies of whole CD4(+) T cells, CD4(+)CD25(med) effector T cells, and Tregs and the expression of Foxp3 within the CD4(+)CD25(hig) Tregs were determined by flow cytometry at 6 time points. We determined the suppressive capability of Tregs from healthy control subjects and from patients in remission or clinical flare. Results: A total of 79 patients (42 women, 37 men; mean age, 48.5 years; 38 with clinical flare) and 5 healthy control subjects were included in the study. At baseline the frequencies of whole CD4(+) T cells, CD4(+)CD25(med) effector cells, and Tregs did not differ between the two treatment groups and the healthy control subjects. In addition, patients with UC in sustained clinical remission showed no alteration from baseline after 1, 3, 6, 9, or 12 months of either treatment. In contrast, CD4(+) T cells, CD4(+)CD25(med) effector T cells, and Tregs demonstrated distinctly different patterns at time points pre-flare and flare. The mesalazine group showed a continuous but not statistically significant increase from baseline to pre-flare and flare (p = ns). In the herbal treatment group, however, the percentage of the CD4(+) T cells was lower at pre-flare than at baseline. This decrease was completely reversed after flare, when a significant increase was seen (CD4(+)CD25(med) pre-flare/flare p = 0.0461; CD4(+)CD25(high) baseline/flare p = 0.0269 and pre-flare/flare p = 0.0032). In contrast, no changes in the expression of Foxp3 cells were detected within the subsets of CD4(+)CD25(high) regulatory T cells. Of note, no alterations were detected in the suppressive capability of CD4(+)CD25(high) regulatory T cells isolated from the peripheral blood of healthy donors, from patients in remission, or from patients with clinical flare. Conclusions: In patients with UC experiencing acute flare, the CD4(+) T compartment demonstrates a distinctly different pattern during treatment with myrrh, chamomile extract, and coffee charcoal than during treatment with mesalazine. These findings suggest an active repopulation of regulatory T cells during active disease.	[Langhorst, Jost] Univ Duisburg Essen, Kliniken Essen Mitte, Dept Integrat Gastroenterol, Essen, Germany; [Langhorst, Jost; Dobos, Gustav J.] Univ Duisburg Essen, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany; [Frede, Annika; Knott, Markus; Pastille, Eva; Buer, Jan; Westendorf, Astrid M.] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany	Kliniken Essen-Mitte; University of Duisburg Essen; Kliniken Essen-Mitte; University of Duisburg Essen; University of Duisburg Essen	Langhorst, J (corresponding author), Univ Duisburg Essen, Kliniken Essen Mitte, Dept Integrat Gastroenterol, Essen, Germany.	jost.langhorst@gmx.de	Knott, Markus/AAE-7076-2020; Westendorf, Astrid M./AAX-1937-2020	Buer, Jan/0000-0002-7602-1698; Frede, Annika/0000-0002-0075-6874	REPHA GmbH Biologische Arzneimittel, Hannover, Germany; IFORES program of the University of Duisburg-Essen, Germany	REPHA GmbH Biologische Arzneimittel, Hannover, Germany; IFORES program of the University of Duisburg-Essen, Germany	This study was performed as an independent sub-study of a drug trial comparing the efficacy of a herbal preparation of myrrh, dry extract of chamomile flowers and coffee charcoal to mesalamine as treatment for maintaining remission in ulcerative colitis which was funded in full by REPHA GmbH Biologische Arzneimittel, Hannover, Germany. The presented study was funded in part by the IFORES program of the University of Duisburg-Essen, Germany. No additional external or internal funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; ACHTERRATHTUCKERMANN U, 1980, PLANTA MED, V39, P38, DOI 10.1055/s-2008-1074901; Ammon HPT, 1992, KAMILLE PHARMAKOLOGI; Bhaskaran N, 2012, LIFE SCI, V90, P1027, DOI 10.1016/j.lfs.2012.05.019; Cheng YW, 2011, J PHARM PHARMACOL, V63, P1211, DOI 10.1111/j.2042-7158.2011.01329.x; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Della Loggia R, 1985, DTSCH APOTH ZTG S1, V125, P9; Dignass A, 2011, Z GASTROENTEROL, V49, P1276, DOI 10.1055/s-0031-1281666; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Dolara P, 2000, PLANTA MED, V66, P356, DOI 10.1055/s-2000-8532; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Ford AC, 2011, AM J GASTROENTEROL, V106, P601, DOI 10.1038/ajg.2011.67; Galvez J, 2003, INFLAMM BOWEL DIS, V9, P363, DOI 10.1097/00054725-200311000-00004; Ganguli SC, 2004, AM J GASTROENTEROL, V99, P319, DOI 10.1111/j.1572-0241.2004.04046.x; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hansen W, 2007, J IMMUNOL, V179, P8059, DOI 10.4049/jimmunol.179.12.8059; HAWKEY CJ, 1985, DIGEST DIS SCI, V30, P1161, DOI 10.1007/BF01314051; Hilsden RJ, 1998, AM J GASTROENTEROL, V93, P697; Hilsden RJ, 2003, AM J GASTROENTEROL, V98, P1563, DOI 10.1016/S0002-9270(03)00301-0; Hilsden RJ, 2011, INFLAMM BOWEL DIS, V17, P655, DOI 10.1002/ibd.21360; Himmel ME, 2012, IMMUNOLOGY, V136, P115, DOI 10.1111/j.1365-2567.2012.03572.x; ISAAC O, 1979, PLANTA MED, V35, P118, DOI 10.1055/s-0028-1097193; JAKOVLEV V, 1979, PLANTA MED, V35, P125, DOI 10.1055/s-0028-1097194; Janicke C., 2003, HDB PHYTOTHERAPIE IN; Kao J, 2010, J CLIN GASTROENTEROL, V44, P531, DOI 10.1097/MCG.0b013e3181db1a61; Kuhn A., 1939, SUDD APOTH ZTG, V79, P434; La Scaleia R, 2010, J PEDIATR GASTR NUTR, V51, P563, DOI 10.1097/MPG.0b013e3181e4d323; Langhorst J, 2005, INFLAMM BOWEL DIS, V11, P287, DOI 10.1097/01.MIB.0000160771.71328.6c; Langhorst J, 2013, ALIMENT PHARM THER, V38, P490, DOI 10.1111/apt.12397; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Langhorsta J, 2007, COMPLEMENT THER MED, V15, P30, DOI 10.1016/j.ctim.2006.03.008; Langmead L, 2002, INFLAMM BOWEL DIS, V8, P174, DOI 10.1097/00054725-200205000-00003; Li Z, 2010, INFLAMM BOWEL DIS, V16, P1299, DOI 10.1002/ibd.21229; Loggia R. della, 1990, Planta Medica, V56, P657, DOI 10.1055/s-2006-961313; MACDERMOTT RP, 1989, GASTROENTEROLOGY, V96, P442, DOI 10.1016/0016-5085(89)91569-2; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; NIELSEN OH, 1988, ALIMENT PHARM THERAP, V2, P203; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Rahimi R, 2009, DIGEST DIS SCI, V54, P471, DOI 10.1007/s10620-008-0368-x; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; SAFAYHI H, 1994, PLANTA MED, V60, P410, DOI 10.1055/s-2006-959520; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Simmonds NJ, 1999, ALIMENT PHARM THER, V13, P363; SIMMONDS NJ, 1993, GUT, V34, P865, DOI 10.1136/gut.34.7.865; Sutherland LR, 1997, INFLAMM BOWEL DIS, V3, P65, DOI 10.1002/ibd.3780030202; Takahashi M, 2006, DIGEST DIS SCI, V51, P677, DOI 10.1007/s10620-006-3191-2; TARIQ M, 1986, AGENTS ACTIONS, V17, P381, DOI 10.1007/BF01982655; TRAVIS SPL, 1994, PHARMACOL THERAPEUT, V63, P135, DOI 10.1016/0163-7258(94)90042-6; Veltkamp C, 2011, GUT, V60, P1345, DOI 10.1136/gut.2010.217117; Weizman AV, 2012, ALIMENT PHARM THER, V35, P342, DOI 10.1111/j.1365-2036.2011.04956.x; Westendorf AM, 2006, GASTROENTEROLOGY, V131, P510, DOI 10.1053/j.gastro.2006.05.015; Whittle BJR, 2010, PHARMACOL REP, V62, P548; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Zhu NQ, 2003, FLAVOUR FRAG J, V18, P282, DOI 10.1002/ffj.1193	55	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104257	10.1371/journal.pone.0104257	http://dx.doi.org/10.1371/journal.pone.0104257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144293	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100013
J	Nimeskern, L; Feldmann, EM; Kuo, W; Schwarz, S; Goldberg-Bockhorn, E; Durr, S; Muller, R; Rotter, N; Stok, KS				Nimeskern, Luc; Feldmann, Eva-Maria; Kuo, Willy; Schwarz, Silke; Goldberg-Bockhorn, Eva; Duerr, Susanne; Mueller, Ralph; Rotter, Nicole; Stok, Kathryn S.			Magnetic Resonance Imaging of the Ear for Patient-Specific Reconstructive Surgery	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; AURICULAR RECONSTRUCTION; IN-VITRO; REPRODUCIBILITY; FABRICATION; EXPERIENCE; MORPHOLOGY; MICROTIA; AURICLE; GRAFTS	Introduction: Like a fingerprint, ear shape is a unique personal feature that should be reconstructed with a high fidelity during reconstructive surgery. Ear cartilage tissue engineering (TE) advantageously offers the possibility to use novel 3D manufacturing techniques to reconstruct the ear, thus allowing for a detailed auricular shape. However it also requires detailed patient-specific images of the 3D cartilage structures of the patient's intact contralateral ear (if available). Therefore the aim of this study was to develop and evaluate an imaging strategy for acquiring patient-specific ear cartilage shape, with sufficient precision and accuracy for use in a clinical setting. Methods and Materials: Magnetic resonance imaging (MRI) was performed on 14 volunteer and six cadaveric auricles and manually segmented. Reproducibility of cartilage volume (Cg.V), surface (Cg.S) and thickness (Cg.Th) was assessed, to determine whether raters could repeatedly define the same volume of interest. Additionally, six cadaveric auricles were harvested, scanned and segmented using the same procedure, then dissected and scanned using high resolution micro-CT. Correlation between MR and micro-CT measurements was assessed to determine accuracy. Results: Good inter-and intra-rater reproducibility was observed (precision errors <4% for Cg.S and <9% for Cg.V and Cg.Th). Intraclass correlations were good for Cg.V and Cg.S (>0.82), but low for Cg.Th (<0.23) due to similar average Cg.Th between patients. However Pearson's coefficients showed that the ability to detect local cartilage shape variations is unaffected. Good correlation between clinical MRI and micro-CT (r>0.95) demonstrated high accuracy. Discussion and Conclusion: This study demonstrated that precision and accuracy of the proposed method was high enough to detect patient-specific variation in ear cartilage geometry. The present study provides a clinical strategy to access the necessary information required for the production of 3D ear scaffolds for TE purposes, including detailed patient-specific shape. Furthermore, the protocol is applicable in daily clinical practice with existing infrastructure.	[Nimeskern, Luc; Kuo, Willy; Mueller, Ralph; Stok, Kathryn S.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Feldmann, Eva-Maria; Schwarz, Silke; Rotter, Nicole] Univ Ulm, Med Ctr, Dept Otorhinolaryngol, D-89069 Ulm, Germany; [Goldberg-Bockhorn, Eva; Duerr, Susanne] Univ Ulm, Med Ctr, Dept Diagnost & Intervent Radiol, D-89069 Ulm, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Ulm University; Ulm University	Stok, KS (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	kas@ethz.ch	Müller, Ralph/A-1198-2008; Stok, Kathryn S/A-4871-2011; Stok, Kathryn/AAA-2667-2021	Müller, Ralph/0000-0002-5811-7725; Stok, Kathryn S/0000-0002-0522-4180; Stok, Kathryn/0000-0002-0522-4180; Rotter, Nicole/0000-0003-1537-8340; Kuo, Willy/0000-0002-0870-7997	Swiss National Science Foundation [NRP63]; ERANET/EuroNanoMed [EAREG-406340-131009/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERANET/EuroNanoMed	This study was supported by the Swiss National Science Foundation (NRP63) and ERANET/EuroNanoMed (EAREG-406340-131009/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Bauer JS, 2008, INVEST RADIOL, V43, P604, DOI 10.1097/RLI.0b013e31817e9ada; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BRENT B, 1992, PLAST RECONSTR SURG, V90, P355, DOI 10.1097/00006534-199209000-00001; Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc; Constantine KK, 2014, JAMA FACIAL PLAST SU; Coward TJ, 1999, INT J PROSTHODONT, V12, P20; Cummings AH, 2011, PATTERN RECOGN LETT, V32, P2053, DOI 10.1016/j.patrec.2011.08.020; Dinis P. Borges, 1998, Rhinology (Utrecht), V36, P32; Eckstein F, 2006, OSTEOARTHR CARTILAGE, V14, pA46, DOI 10.1016/j.joca.2006.02.026; Firmin F, 1998, SCAND J PLAST RECONS, V32, P35, DOI 10.1080/02844319850158930; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Golas AR, 2014, AESTHET PLAST SURG, V38, P207, DOI 10.1007/s00266-013-0255-5; Kamil SH, 2004, LARYNGOSCOPE, V114, P867, DOI 10.1097/00005537-200405000-00015; Kasrai L, 2014, PLAST RECONSTR SURG, V133, P652, DOI 10.1097/PRS.0000000000000063; Kludt NA, 2014, ANN PLAS SURG, V72, pS14, DOI 10.1097/SAP.0000000000000178; Kohler T, 2005, CALCIFIED TISSUE INT, V77, P281, DOI 10.1007/s00223-005-0039-2; Ledgerwood LG, 2014, JAMA FACIAL PLAST SU, V16, P153, DOI 10.1001/jamafacial.2013.2058; Liu Y, 2010, BIOMATERIALS, V31, P2176, DOI 10.1016/j.biomaterials.2009.11.080; Meijerman L, 2007, J FORENSIC SCI, V52, P286, DOI 10.1111/j.1556-4029.2006.00376.x; Mueller TL, 2009, BONE, V44, P364, DOI 10.1016/j.bone.2008.10.045; NAGATA S, 1993, PLAST RECONSTR SURG, V92, P187, DOI 10.1097/00006534-199308000-00001; Ohara K, 1997, PLAST RECONSTR SURG, V99, P1030, DOI 10.1097/00006534-199704000-00017; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506; Sforza C, 2009, FORENSIC SCI INT, V187, DOI 10.1016/j.forsciint.2009.02.019; Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5; Steffen Armin, 2008, Aesthet Surg J, V28, P404, DOI 10.1016/j.asj.2008.06.003; Stok KS, 2009, MICROSC RES TECHNIQ, V72, P650, DOI 10.1002/jemt.20713; Storck K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/373286; Trattnig S, 2000, INVEST RADIOL, V35, P595, DOI 10.1097/00004424-200010000-00006; Turgut G, 2009, J CRANIOFAC SURG, V20, P321, DOI 10.1097/SCS.0b013e3181992266; Walton RL, 2002, PLAST RECONSTR SURG, V110, P234, DOI 10.1097/00006534-200207000-00041; Xie L, 2009, OSTEOARTHR CARTILAGE, V17, P313, DOI 10.1016/j.joca.2008.07.015; Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627	35	11	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104975	10.1371/journal.pone.0104975	http://dx.doi.org/10.1371/journal.pone.0104975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144306	Green Published, gold			2022-12-27	WOS:000341106100033
J	Plecenikova, A; Slaninova, M; Riha, K				Plecenikova, Andrea; Slaninova, Miroslava; Riha, Karel			Characterization of DNA Repair Deficient Strains of Chlamydomonas reinhardtii Generated by Insertional Mutagenesis	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; NUCLEAR TRANSFORMATION; HUMAN CTIP; GENE; ARABIDOPSIS; GENOME; PLANTS; MECHANISMS; RESPONSES; DISRUPTION	While the mechanisms governing DNA damage response and repair are fundamentally conserved, cross-kingdom comparisons indicate that they differ in many aspects due to differences in life-styles and developmental strategies. In photosynthetic organisms these differences have not been fully explored because gene-discovery approaches are mainly based on homology searches with known DDR/DNA repair proteins. Here we performed a forward genetic screen in the green algae Chlamydomonas reinhardtii to identify genes deficient in DDR/DNA repair. We isolated five insertional mutants that were sensitive to various genotoxic insults and two of them exhibited altered efficiency of transgene integration. To identify genomic regions disrupted in these mutants, we established a novel adaptor-ligation strategy for the efficient recovery of the insertion flanking sites. Four mutants harbored deletions that involved known DNA repair factors, DNA Pol zeta, DNA Pol theta, SAE2/COM1, and two neighbouring genes encoding ERCC1 and RAD17. Deletion in the last mutant spanned two Chlamydomonas-specific genes with unknown function, demonstrating the utility of this approach for discovering novel factors involved in genome maintenance.	[Plecenikova, Andrea; Riha, Karel] Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst, A-1010 Vienna, Austria; [Plecenikova, Andrea; Slaninova, Miroslava] Comenius Univ, Dept Genet, Fac Nat Sci, Bratislava, Slovakia; [Riha, Karel] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Comenius University Bratislava; Masaryk University Brno	Riha, K (corresponding author), Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst, A-1010 Vienna, Austria.	karel.riha@gmi.oeaw.ac.at	Riha, Karel/P-9614-2018; Melicharkova, Andrea/G-4491-2016; Riha, Karel/A-7717-2008; Riha, Karel/AAM-4429-2021	Riha, Karel/0000-0002-6124-0118; Melicharkova, Andrea/0000-0003-4986-3774; Riha, Karel/0000-0002-6124-0118; Slaninova, Miroslava/0000-0001-9385-0343	Slovak Agency for Research and Development [SK-AT-0023-10, APVV-0661-10]; Comenius University [UK/63/2012]; Austrian Agency for International Cooperation (OeAD) [SK12/2011]; Austrian Science Fund (FWF) [Y418-B03]; Austrian Science Fund (FWF) [Y 418] Funding Source: researchfish	Slovak Agency for Research and Development(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Comenius University; Austrian Agency for International Cooperation (OeAD); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by grants from the Slovak Agency for Research and Development (SK-AT-0023-10; APVV-0661-10; www.apvv.sk), Comenius University (UK/63/2012), Austrian Agency for International Cooperation (OeAD, SK12/2011; www.oead.at), and Austrian Science Fund (FWF; Y418-B03; www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bray CM, 2005, NEW PHYTOL, V168, P511, DOI 10.1111/j.1469-8137.2005.01548.x; Cenkci B, 2003, J BIOL CHEM, V278, P22574, DOI 10.1074/jbc.M303249200; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; DAVIES AA, 1995, J BIOL CHEM, V270, P24638, DOI 10.1074/jbc.270.42.24638; De Muyt A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000654; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Doonan JH, 2010, NAT REV CANCER, V10, P793, DOI 10.1038/nrc2942; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Goff JP, 2009, RADIAT RES, V172, P165, DOI 10.1667/RR1598.1; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gutman BL, 2004, PLANT PHYSIOL, V135, P607, DOI 10.1104/pp.104.041491; Hefner E, 2003, J EXP BOT, V54, P669, DOI 10.1093/jxb/erg069; Heitzeberg F, 2004, PLANT J, V38, P954, DOI 10.1111/j.1365-313X.2004.02097.x; Helle F, 2012, CANCER GENE THER, V19, P299, DOI 10.1038/cgt.2012.1; Higgins GS, 2010, CANCER RES, V70, P2984, DOI 10.1158/0008-5472.CAN-09-4040; Inagaki S, 2006, PLANT CELL, V18, P879, DOI 10.1105/tpc.105.036798; Kazda A, 2012, GENE DEV, V26, P1703, DOI 10.1101/gad.194944.112; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kirik A, 2006, PLANT CELL, V18, P2431, DOI 10.1105/tpc.106.045088; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Liu J, 2010, PLANT J, V61, P36, DOI 10.1111/j.1365-313X.2009.04026.x; Mages W, 2007, PROTIST, V158, P435, DOI 10.1016/j.protis.2007.05.001; Mannuss A, 2012, BBA-GENE REGUL MECH, V1819, P154, DOI 10.1016/j.bbagrm.2011.08.003; Matsuo T, 2008, GENE DEV, V22, P918, DOI 10.1101/gad.1650408; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nagaria P, 2013, BBA-GEN SUBJECTS, V1830, P2345, DOI 10.1016/j.bbagen.2012.09.001; NELSON JAE, 1995, MOL CELL BIOL, V15, P5762; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Plecenikova A, 2013, PROTIST, V164, P570, DOI 10.1016/j.protis.2013.05.004; Prinz S, 1997, GENETICS, V146, P781; PURTON S, 1995, EUR J PHYCOL, V30, P141, DOI 10.1080/09670269500650901; Riha K, 2001, SCIENCE, V291, P1797, DOI 10.1126/science.1057110; Sakamoto A, 2003, PLANT CELL, V15, P2042, DOI 10.1105/tpc.012369; Sambrook J., 2001, MOL CLONING LAB MANU; Sarkar N, 2005, EUKARYOT CELL, V4, P262, DOI 10.1128/EC.4.2.262-273.2005; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaefer DG, 2001, CURR OPIN PLANT BIOL, V4, P143, DOI 10.1016/S1369-5266(00)00150-3; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shen X, 2006, J BIOL CHEM, V281, P13869, DOI 10.1074/jbc.C600071200; Singh SK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-443; SODEINDE OA, 1993, P NATL ACAD SCI USA, V90, P9199, DOI 10.1073/pnas.90.19.9199; Takeda S, 2004, GENE DEV, V18, P782, DOI 10.1101/gad.295404; Timofejeva L, 2013, G3-GENES GENOM GENET, V3, P231, DOI 10.1534/g3.112.004465; Tuncay H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074763; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Ulm R, 2001, GENE DEV, V15, P699, DOI 10.1101/gad.192601; Vlcek D, 2008, CURR GENET, V53, P1, DOI 10.1007/s00294-007-0163-9; Waterworth WM, 2011, NEW PHYTOL, V192, P805, DOI 10.1111/j.1469-8137.2011.03926.x; Wu F, 2004, CANCER RES, V64, P8029, DOI 10.1158/0008-5472.CAN-03-3942; Yoshiyama K, 2009, P NATL ACAD SCI USA, V106, P12843, DOI 10.1073/pnas.0810304106; Zorin B, 2005, EUKARYOT CELL, V4, P1264, DOI 10.1128/EC.4.7.1264-1272.2005; Zorin B, 2009, GENE, V432, P91, DOI 10.1016/j.gene.2008.11.028	58	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105482	10.1371/journal.pone.0105482	http://dx.doi.org/10.1371/journal.pone.0105482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144319	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100073
J	Berglin, L; Bergquist, A; Johansson, H; Glaumann, H; Jorns, C; Lunemann, S; Wedemeyer, H; Ellis, EC; Bjorkstrom, NK				Berglin, Lena; Bergquist, Annika; Johansson, Helene; Glaumann, Hans; Jorns, Carl; Lunemann, Sebastian; Wedemeyer, Heiner; Ellis, Ewa C.; Bjorkstrom, Niklas K.			In Situ Characterization of Intrahepatic Non-Parenchymal Cells in PSC Reveals Phenotypic Patterns Associated with Disease Severity	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; LIVER; PATHOGENESIS; LYMPHOCYTES; STIMULATION; CALDESMON	Liver-infiltrating T cells have been implicated in the pathogenesis of primary sclerosing cholangitis (PSC), however little information is available about changes in other cellular compartments in the liver during PSC. This study aimed to characterize non-parenchymal intrahepatic cells in PSC livers and to find associations between phenotypes and disease severity. Using immunohistochemistry, followed by automated image analysis and quantification and a principal component analysis, we have studied non-parenchymal intrahepatic cells in PSC-patient livers (n = 17) and controls (n = 17). We observed a significant increase of T cells in the PSC patients, localized to the fibrotic areas. MAIT cells, normally present at high numbers in the liver, were not increased to the same extent. PSC patients had lower expression of MHC class I than controls. However, the levels of NKp46+ NK cells were similar between patients and controls, nevertheless, NKp46 was identified as a phenotypic marker that distinguished PSC patients with mild from those with severe fibrosis. Beyond that, a group of PSC patients had lost expression of Caldesmon and this was associated with more extensive bile duct proliferation and higher numbers of T cells. Our data reveals phenotypic patterns in PSC patients associated with disease severity.	[Berglin, Lena; Bergquist, Annika; Bjorkstrom, Niklas K.] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Liver Immunol Lab,Unit Gastroenterol & Hepatol, Stockholm, Sweden; [Johansson, Helene; Ellis, Ewa C.] Karolinska Inst, Karolinska Univ Hosp, Div Transplantat Surg, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Glaumann, Hans] Karolinska Univ Hosp, Dept Med Clin Pathol & Cytol, Stockholm, Sweden; [Lunemann, Sebastian; Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Bjorkstrom, Niklas K.] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Ctr Infect Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Hannover Medical School; Karolinska Institutet; Karolinska University Hospital	Bjorkstrom, NK (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Med, Liver Immunol Lab,Unit Gastroenterol & Hepatol, Stockholm, Sweden.	niklas.bjorkstrom@ki.se	Björkström, Niklas/N-2919-2017; Jorns, Carl/AAE-6925-2021; Ellis, Ewa C S/D-5370-2014	Björkström, Niklas/0000-0002-0967-076X; Jorns, Carl/0000-0001-7727-8113; Ellis, Ewa C S/0000-0002-3057-5337; Johansson, Helene/0000-0001-5519-0401; Bergquist, Annika/0000-0002-3858-6241	Swedish Cancer Society; Karolinska Institutet; Swedish Society for Medical Research; Alex and Eva Wallstrom Foundation; Cancer Research Foundations of Radiumhemmet; Swedish Society of Medicine; Jeansson Foundation; Bengt Ihre Foundation; Groschinsky Foundation; Hedlunds Foundation; Mag-tarmfonden; Magnus Bergvall Foundation; Nanna Svartz Foundation; Julin Foundation; Novo Nordisk Fonden [NNF14OC0009347] Funding Source: researchfish	Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet); Swedish Society for Medical Research; Alex and Eva Wallstrom Foundation; Cancer Research Foundations of Radiumhemmet; Swedish Society of Medicine; Jeansson Foundation; Bengt Ihre Foundation; Groschinsky Foundation; Hedlunds Foundation; Mag-tarmfonden; Magnus Bergvall Foundation; Nanna Svartz Foundation; Julin Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was funded by the the Swedish Cancer Society, the Karolinska Institutet, the Swedish Society for Medical Research, the Alex and Eva Wallstrom Foundation, the Cancer Research Foundations of Radiumhemmet, the Swedish Society of Medicine, the Jeansson Foundation, the Bengt Ihre Foundation, the Groschinsky Foundation, the Hedlunds Foundation, Mag-tarmfonden, Magnus Bergvall Foundation, the Nanna Svartz Foundation, and the Julin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CALMUS Y, 1991, BIOCHIMIE, V73, P1335, DOI 10.1016/0300-9084(91)90098-L; Cerbonil C, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00508; Chapman R, 2008, WORLD J GASTROENTERO, V14, P3350, DOI 10.3748/wjg.14.3350; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Deng M, 2007, CELL MOTIL CYTOSKEL, V64, P951, DOI 10.1002/cm.20236; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Eksteen B, 2004, J EXP MED, V200, P1511, DOI 10.1084/jem.20041035; Fabris L, 2011, SEMIN LIVER DIS, V31, P11, DOI 10.1055/s-0031-1272832; Glassner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54; Grant AJ, 2002, LANCET, V359, P150, DOI 10.1016/S0140-6736(02)07374-9; Grant AJ, 2001, HEPATOLOGY, V33, P1065, DOI 10.1053/jhep.2001.24231; HATA K, 1992, HEPATOLOGY, V15, P816, DOI 10.1002/hep.1840150512; Katt J, 2013, HEPATOLOGY, V58, P1084, DOI 10.1002/hep.26447; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Numaguchi Yasushi, 2003, Angiogenesis, V6, P55, DOI 10.1023/A:1025821517679; Parekh A, 2009, J UROLOGY, V182, P1210, DOI 10.1016/j.juro.2009.05.002; Pollheimer MJ, 2011, BEST PRACT RES CL GA, V25, P727, DOI 10.1016/j.bpg.2011.10.009; Ponsioen CY, 1999, EUR J GASTROEN HEPAT, V11, P769, DOI 10.1097/00042737-199907000-00015; SAEKI R, 1995, J GASTROENTEROL, V30, P739, DOI 10.1007/BF02349640; Seidel D, 2014, HEPATOLOGY, V59, P601, DOI 10.1002/hep.26702; SI L, 1984, J CLIN IMMUNOL, V4, P262, DOI 10.1007/BF00915293; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0	24	14	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105375	10.1371/journal.pone.0105375	http://dx.doi.org/10.1371/journal.pone.0105375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141347	gold, Green Submitted, Green Published			2022-12-27	WOS:000342687200080
J	Enserink, R; Lugner, A; Suijkerbuijk, A; Bruijning-Verhagen, P; Smit, HA; van Pelt, W				Enserink, Remko; Lugner, Anna; Suijkerbuijk, Anita; Bruijning-Verhagen, Patricia; Smit, Henriette A.; van Pelt, Wilfrid			Gastrointestinal and Respiratory Illness in Children That Do and Do Not Attend Child Day Care Centers: A Cost-of-Illness Study	PLOS ONE			English	Article							INFECTIOUS-DISEASE; YOUNG-CHILDREN; EAR INFECTIONS; GASTROENTERITIS; NETHERLANDS; RISK; HEALTH; ARRANGEMENTS; AGE; HOSPITALIZATION	Background: Gastrointestinal and respiratory diseases are major causes of morbidity for young children, particularly for those children attending child day care centers (DCCs). Although both diseases are presumed to cause considerable societal costs for care and treatment of illness, the extent of these costs, and the difference of these costs between children that do and do not attend such centers, is largely unknown. Objective: Estimate the societal costs for care and treatment of episodes of gastroenteritis (GE) and influenza-like illness (ILI) experienced by Dutch children that attend a DCC, compared to children that do not attend a DCC. Methods: A web-based monthly survey was conducted among households with children aged 0-48 months from October 2012 to October 2013. Households filled-in a questionnaire on the incidence of GE and ILI episodes experienced by their child during the past 4 weeks, on the costs related to care and treatment of these episodes, and on DCC arrangements. Costs and incidence were adjusted for socioeconomic characteristics including education level, nationality and monthly income of parents, number of children in the household, gender and age of the child and month of survey conduct. Results: Children attending a DCC experienced higher rates of GE (aIRR 1.4 [95% CI: 1.2-1.9]) and ILI (aIRR: 1.4 [95% CI: 1.2-1.6]) compared to children not attending a DCC. The societal costs for care and treatment of an episode of GE and ILI experienced by a DCC-attending child were estimated at (sic)215.45 [(sic)115.69-(sic)315.02] and (sic)196.32 [(sic)161.58-(sic)232.74] respectively, twice as high as for a non-DCC-attending child. The DCC-attributable economic burden of GE and ILI for the Netherlands was estimated at (sic)25 million and (sic)72 million per year. Conclusions: Although children attending a DCC experience only slightly higher rates of GE and ILI compared to children not attending a DCC, the costs involved per episode are substantially higher.	[Enserink, Remko; Lugner, Anna; Bruijning-Verhagen, Patricia; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Bruijning-Verhagen, Patricia; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Suijkerbuijk, Anita] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Enserink, R (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	remko.enserink@rivm.nl	Bruijning-Verhagen, Patricia C.J.L./E-4134-2015	Bruijning-Verhagen, Patricia C.J.L./0000-0003-4105-9669				ALEXANDER CS, 1990, AM J EPIDEMIOL, V131, P124, DOI 10.1093/oxfordjournals.aje.a115465; ANDERSON LJ, 1988, PEDIATRICS, V82, P300; ARNOLD C, 1993, AM J EPIDEMIOL, V138, P333, DOI 10.1093/oxfordjournals.aje.a116863; Augustine JM, 2013, J HLTH SOCIAL BEHAV; Ball, 2002, INFLUENCE ATTENDANCE; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Ball TM, 2002, ARCH PEDIAT ADOL MED, V156, P121, DOI 10.1001/archpedi.156.2.121; Beijers R, 2011, EARLY HUM DEV, V87, P9, DOI 10.1016/j.earlhumdev.2010.09.003; Belotti F, 2015, STATA J, V15, P3, DOI 10.1177/1536867X1501500102; Bloomfield SF, 2006, CLIN EXP ALLERGY, V36, P402, DOI 10.1111/j.1365-2222.2006.02463.x; Bradley RH, 2003, ARCH PEDIAT ADOL MED, V157, P196, DOI 10.1001/archpedi.157.2.196; Bradley RH, 2001, ARCH PEDIAT ADOL MED, V155, P481, DOI 10.1001/archpedi.155.4.481; Brady MT, 2005, AM J INFECT CONTROL, V33, P276, DOI 10.1016/j.ajic.2004.11.007; COLLET JP, 1994, PEDIATRICS, V94, P997; Cordell RL, 1999, ARCH PEDIAT ADOL MED, V153, P275; Cordell RL, 1997, PEDIATRICS, V100, P850, DOI 10.1542/peds.100.5.850; Cote SM, 2010, ARCH PEDIAT ADOL MED, V164, P1132, DOI 10.1001/archpediatrics.2010.216; de Meer G, 2005, ALLERGY, V60, P619, DOI 10.1111/j.1398-9995.2005.00746.x; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; de Wit MAS, 2001, EMERG INFECT DIS, V7, P82, DOI 10.3201/eid0701.010113; Donker GA, 2012, CONTINUOUS MORBIDITY; Dunder T, 2007, ARCH PEDIAT ADOL MED, V161, P972, DOI 10.1001/archpedi.161.10.972; Enserink R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089496; Enserink R, 2013, PEDIATR INFECT DIS J, V32, pE334, DOI 10.1097/INF.0b013e318290601e; Friesema IHM, 2012, EUR J CLIN MICROBIOL, V31, P1895, DOI 10.1007/s10096-011-1518-1; Giaquinto C, 2007, J INFECT DIS, V195, pS36, DOI 10.1086/516716; Groot W, 1993, KINDEROPVANG NEDERLA; Haby MM, 2000, PEDIATR PULM, V30, P377, DOI 10.1002/1099-0496(200011)30:5<377::AID-PPUL3>3.3.CO;2-V; HARDY AM, 1993, AM J PUBLIC HEALTH, V83, P1321, DOI 10.2105/AJPH.83.9.1321; HASKINS R, 1986, PEDIATRICS, V77, P951; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Hildesheim ME, 1999, PAEDIATR PERINAT EP, V13, P466; HURWITZ ES, 1991, PEDIATRICS, V87, P62; JB O, 2008, GUIDELINES COST RES; JOHANSEN AS, 1988, AM J PUBLIC HEALTH, V78, P1175, DOI 10.2105/AJPH.78.9.1175; Kamper-Jorgensen M, 2006, PEDIATRICS, V118, P1439, DOI 10.1542/peds.2006-0373; Kamper-Jorgensen M, 2008, PEDIATRICS, V122, pE1168, DOI 10.1542/peds.2008-1757; Koningstein M ea, 2013, MVNA C COP DENM; Lambert Stephen, 2004, Commun Dis Intell Q Rep, V28, P510; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Mangen MJJ, 2010, VACCINE, V28, P2624, DOI 10.1016/j.vaccine.2010.01.014; Mangen MJ, 2013, 330331007 RIVM; McCutcheon H, 1996, AUST NZ J PUBL HEAL, V20, P49, DOI 10.1111/j.1467-842X.1996.tb01335.x; Nafstad P, 1999, PEDIATRICS, V103, P753, DOI 10.1542/peds.103.4.753; Nesti MMM, 2007, J PEDIAT-BRAZIL, V83, P299, DOI [10.2223/JPED.1649, 10.1590/S0021-75572007000500004]; RASMUSSEN F, 1990, ACTA PAEDIATR SCAND, V79, P838, DOI 10.1111/j.1651-2227.1990.tb11563.x; Rijksoverheid, 2014, WELK VORM KIND ZIJN; Shope TR, 2014, PEDIATR REV, V35, P182, DOI 10.1542/pir.35-5-182; Silverstein M, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e371; Szajewska H, 2014, J PEDIATR GASTR NUTR, V58, P531, DOI 10.1097/MPG.0000000000000320; van de Pol AC, 2013, INT J PEDIATR OTORHI, V77, P906, DOI 10.1016/j.ijporl.2013.03.003; van den Brandhof WE, 2004, EPIDEMIOL INFECT, V132, P211, DOI 10.1017/S0950268803001559; Wald ER, 1991, FREQUENCY SEVERITY I, P509	53	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104940	10.1371/journal.pone.0104940	http://dx.doi.org/10.1371/journal.pone.0104940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AQ3JB	25141226	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200043
J	Djiane, A; Zaessinger, S; Babaoglan, AB; Bray, SJ				Djiane, Alexandre; Zaessinger, Sophie; Babaoglan, A. Burcu; Bray, Sarah J.			Notch Inhibits Yorkie Activity in Drosophila Wing Discs	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; SPLIT COMPLEX GENES; ORGAN SIZE CONTROL; CELL-PROLIFERATION; PROMOTES APOPTOSIS; REGULATORY NETWORK; TEAD/TEF FAMILY; VESTIGIAL GENE; TISSUE-GROWTH; SELF-RENEWAL	During development, tissues and organs must coordinate growth and patterning so they reach the right size and shape. During larval stages, a dramatic increase in size and cell number of Drosophila wing imaginal discs is controlled by the action of several signaling pathways. Complex cross-talk between these pathways also pattern these discs to specify different regions with different fates and growth potentials. We show that the Notch signaling pathway is both required and sufficient to inhibit the activity of Yorkie (Yki), the Salvador/Warts/Hippo (SWH) pathway terminal transcription activator, but only in the central regions of the wing disc, where the TEAD factor and Yki partner Scalloped (Sd) is expressed. We show that this cross-talk between the Notch and SWH pathways is mediated, at least in part, by the Notch target and Sd partner Vestigial (Vg). We propose that, by altering the ratios between Yki, Sd and Vg, Notch pathway activation restricts the effects of Yki mediated transcription, therefore contributing to define a zone of low proliferation in the central wing discs.	[Djiane, Alexandre; Babaoglan, A. Burcu; Bray, Sarah J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Djiane, Alexandre; Zaessinger, Sophie] IRCM, Montpellier, France; [Djiane, Alexandre; Zaessinger, Sophie] INSERM, U896, Montpellier, France; [Djiane, Alexandre; Zaessinger, Sophie] Univ Montpellier I, Montpellier, France; [Djiane, Alexandre; Zaessinger, Sophie] Inst Reg Canc Montpellier, Montpellier, France	University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Djiane, A (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	alexandre.djiane@inserm.fr		Bray, Sarah/0000-0002-1642-599X; Djiane, Alexandre/0000-0001-6210-2713	Wellcome Trust [WT083576MA]; ATIP-Avenir grant; MRC programme grant [G0800034]; MRC [G0800034, MR/L007177/1] Funding Source: UKRI; Medical Research Council [G0800034, MR/L007177/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ATIP-Avenir grant(French National Research Agency (ANR)); MRC programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from the Wellcome Trust to AD and SJB (WT083576MA). AD is supported by an ATIP-Avenir grant. SJB is supported by a MRC programme grant (G0800034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaoglan AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075632; Baena-Lopez LA, 2012, CURR OPIN CELL BIOL, V24, P166, DOI 10.1016/j.ceb.2011.12.010; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Baonza A, 2000, P NATL ACAD SCI USA, V97, P2609, DOI 10.1073/pnas.040576497; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; deCelis JF, 1996, DEVELOPMENT, V122, P2719; deCelis JF, 1996, DEVELOPMENT, V122, P359; Djiane A, 2013, EMBO J, V32, P60, DOI 10.1038/emboj.2012.326; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Go MJ, 1998, DEVELOPMENT, V125, P2031; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Graves HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037615; Guo T, 2013, CELL RES, V23, P1201, DOI 10.1038/cr.2013.120; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Halder G, 2001, DEVELOPMENT, V128, P3295; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Heitzler P, 1996, DEVELOPMENT, V122, P161; Herranz H, 2008, EMBO J, V27, P1633, DOI 10.1038/emboj.2008.84; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Klein T, 1999, DEVELOPMENT, V126, P913; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Nagel AC, 2001, MECH DEVELOP, V109, P241, DOI 10.1016/S0925-4773(01)00539-1; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Rafel N, 2008, DEVELOPMENT, V135, P3995, DOI 10.1242/dev.027789; San Juan BP, 2012, BIOL OPEN, V1, P667, DOI 10.1242/bio.20121172; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zacharioudaki E, 2012, DEVELOPMENT, V139, P1258, DOI 10.1242/dev.071779; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Ziosi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001140	53	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106211	10.1371/journal.pone.0106211	http://dx.doi.org/10.1371/journal.pone.0106211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157415	gold, Green Published, Green Submitted			2022-12-27	WOS:000341303200091
J	Radhakrishnan, EK; Bava, SV; Narayanan, SS; Nath, LR; Thulasidasan, AKT; Soniya, EV; Anto, RJ				Radhakrishnan, E. K.; Bava, Smitha V.; Narayanan, Sai Shyam; Nath, Lekshmi R.; Thulasidasan, Arun Kumar T.; Soniya, Eppurathu Vasudevan; Anto, Ruby John			[6]-Gingerol Induces Caspase-Dependent Apoptosis and Prevents PMA-Induced Proliferation in Colon Cancer Cells by Inhibiting MAPK/AP-1 Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-C; FACTOR-KAPPA-B; IN-VITRO; EPITHELIAL-CELLS; CARCINOMA CELLS; PHORBOL ESTER; DOWN-REGULATION; ACTIVATION; EXPRESSION; GINGER	We report mechanism-based evidence for the anticancer and chemopreventive efficacy of [6]-gingerol, the major active principle of the medicinal plant, Ginger (Zingiber officinale), in colon cancer cells. The compound was evaluated in two human colon cancer cell lines for its cytotoxic effect and the most sensitive cell line, SW-480, was selected for the mechanistic evaluation of its anticancer and chemopreventive efficacy. The non-toxic nature of [6]-gingerol was confirmed by viability assays on rapidly dividing normal mouse colon cells. [6]-gingerol inhibited cell proliferation and induced apoptosis as evidenced by externalization of phosphatidyl serine in SW-480, while the normal colon cells were unaffected. Sensitivity to [6]-gingerol in SW-480 cells was associated with activation of caspases 8, 9, 3 & 7 and cleavage of PARP, which attests induction of apoptotic cell death. Mechanistically, [6]-gingerol down-regulated Phorbol Myristate Acetate (PMA) induced phosphorylation of ERK1/2 and JNK MAP kinases and activation of AP-1 transcription factor, but had only little effects on phosphorylation of p38 MAP kinase and activation of NF-kappa B. Additionally, it complemented the inhibitors of either ERK1/ 2 or JNK MAP kinase in bringing down the PMA-induced cell proliferation in SW-480 cells. We report the inhibition of ERK1/2/JNK/AP-1 pathway as a possible mechanism behind the anticancer as well as chemopreventive efficacy of [6]-gingerol against colon cancer.	[Radhakrishnan, E. K.; Soniya, Eppurathu Vasudevan] Rajiv Gandhi Ctr Biotechnol, Div Plant Mol Biol, Thiruvananthapuram, Kerala, India; [Bava, Smitha V.; Narayanan, Sai Shyam; Nath, Lekshmi R.; Thulasidasan, Arun Kumar T.; Anto, Ruby John] Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Soniya, EV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Div Plant Mol Biol, Thiruvananthapuram, Kerala, India.	evsoniya@rgcb.res.in; rjanto@rgcb.res.in						Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Ashida Reiko, 2005, Inflammopharmacology, V13, P113, DOI 10.1163/156856005774423935; AZZI A, 1992, EUR J BIOCHEM, V208, P547, DOI 10.1111/j.1432-1033.1992.tb17219.x; Baliga MS, 2011, CRIT REV FOOD SCI, V51, P499, DOI 10.1080/10408391003698669; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bava SV, 2011, INT J BIOCHEM CELL B, V43, P331, DOI 10.1016/j.biocel.2010.09.011; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Bode AM, 2001, CANCER RES, V61, P850; Brown AC, 2009, PHYTOTHER RES, V23, P640, DOI 10.1002/ptr.2677; Bubici C, 2006, HISTOL HISTOPATHOL, V21, P69, DOI 10.14670/HH-21.69; Chakraborty D, 2012, EUR J PHARMACOL, V694, P20, DOI 10.1016/j.ejphar.2012.08.001; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Cho HJ, 2007, CARCINOGENESIS, V28, P1104, DOI 10.1093/carcin/bgl217; Collett GP, 2004, CARCINOGENESIS, V25, P2183, DOI 10.1093/carcin/bgh233; Cordero-Herrera I, 2013, NUTR CANCER, V65, P718, DOI 10.1080/01635581.2013.795981; Debruyne PR, 2001, MUTAT RES-FUND MOL M, V480, P359, DOI 10.1016/S0027-5107(01)00195-6; Han HH, 2010, MOL CANCER RES, V8, P1477, DOI 10.1158/1541-7786.MCR-10-0114; Heider I, 2004, ONCOL RES, V14, P475, DOI 10.3727/0965040042380496; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; Jiang SZ, 2008, BIOPHARM DRUG DISPOS, V29, P529, DOI 10.1002/bdd.638; Ju SA, 2012, INT J CANCER, V130, P2618, DOI 10.1002/ijc.26316; Kim SO, 2005, ONCOGENE, V24, P2558, DOI 10.1038/sj.onc.1208446; Krell J, 2012, LANCET ONCOL, V13, P235, DOI 10.1016/S1470-2045(12)70097-9; Kudinov Y, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-4; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lee E, 1998, CANCER LETT, V134, P163, DOI 10.1016/S0304-3835(98)00253-5; Lee HS, 2008, J NUTR BIOCHEM, V19, P313, DOI 10.1016/j.jnutbio.2007.05.008; Lee SH, 2008, MOL CARCINOGEN, V47, P197, DOI 10.1002/mc.20374; Lin CB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/326096; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Masur K, 2001, MOL BIOL CELL, V12, P1973, DOI 10.1091/mbc.12.7.1973; Mayer RJ, 2009, NEW ENGL J MED, V360, P623, DOI 10.1056/NEJMe0809343; Meyer E, 2005, CANCER RES, V65, P4261, DOI 10.1158/0008-5472.CAN-04-2908; Miao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057226; Mowla S, 2011, BIOCHEM J, V433, P145, DOI 10.1042/BJ20100886; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Park KK, 1998, CANCER LETT, V129, P139, DOI 10.1016/S0304-3835(98)00081-0; Park KA, 2007, CARCINOGENESIS, V28, P71, DOI 10.1093/carcin/bgl094; Park YJ, 2006, YONSEI MED J, V47, P688, DOI 10.3349/ymj.2006.47.5.688; Puliyappadamba VT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-220; Rhode Jennifer, 2007, BMC Complement Altern Med, V7, P44, DOI 10.1186/1472-6882-7-44; Rickard KL, 1999, CARCINOGENESIS, V20, P977, DOI 10.1093/carcin/20.6.977; Seo EY, 2011, J GINSENG RES, V35, P315, DOI 10.5142/jgr.2011.35.3.315; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shukla Y, 2007, MOL NUTR FOOD RES, V51, P1492, DOI 10.1002/mnfr.200700197; Shukla Y, 2007, FOOD CHEM TOXICOL, V45, P683, DOI 10.1016/j.fct.2006.11.002; Surh YJ, 1998, MUTAT RES-FUND MOL M, V402, P259, DOI 10.1016/S0027-5107(97)00305-9; Vaiopoulos AG, 2010, INT J BIOCHEM CELL B, V42, P1061, DOI 10.1016/j.biocel.2010.03.018; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Weng CJ, 2012, MOL NUTR FOOD RES, V56, P1304, DOI 10.1002/mnfr.201200173; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yang G, 2010, CHEM-BIOL INTERACT, V185, P12, DOI 10.1016/j.cbi.2010.02.017; Yu R, 2001, MOL PHARMACOL, V60, P217, DOI 10.1124/mol.60.1.217; Yu YK, 2011, AAPS J, V13, P417, DOI 10.1208/s12248-011-9286-5; Zick SM, 2008, CANCER EPIDEM BIOMAR, V17, P1930, DOI 10.1158/1055-9965.EPI-07-2934	58	76	79	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104401	10.1371/journal.pone.0104401	http://dx.doi.org/10.1371/journal.pone.0104401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157570	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200012
J	Reitz, T; Rossberg, A; Barkleit, A; Selenska-Pobell, S; Merroun, ML				Reitz, Thomas; Rossberg, Andre; Barkleit, Astrid; Selenska-Pobell, Sonja; Merroun, Mohamed L.			Decrease of U(VI) Immobilization Capability of the Facultative Anaerobic Strain Paenibacillus sp JG-TB8 under Anoxic Conditions Due to Strongly Reduced Phosphatase Activity	PLOS ONE			English	Article							INDUCED FLUORESCENCE SPECTROSCOPY; URANIUM(VI) COMPLEXES; SULFOLOBUS-ACIDOCALDARIUS; BACILLUS-SUBTILIS; RADIOACTIVE-WASTE; ACID-PHOSPHATASE; HEAVY-METALS; SP-NOV; BIOMINERALIZATION; REDUCTION	Interactions of a facultative anaerobic bacterial isolate named Paenibacillus sp. JG-TB8 with U(VI) were studied under oxic and anoxic conditions in order to assess the influence of the oxygen-dependent cell metabolism on microbial uranium mobilization and immobilization. We demonstrated that aerobically and anaerobically grown cells of Paenibacillus sp. JG-TB8 accumulate uranium from aqueous solutions under acidic conditions (pH 2 to 6), under oxic and anoxic conditions. A combination of spectroscopic and microscopic methods revealed that the speciation of U(VI) associated with the cells of the strain depend on the pH as well as on the aeration conditions. At pH 2 and pH 3, uranium was exclusively bound by organic phosphate groups provided by cellular components, independently on the aeration conditions. At higher pH values, a part (pH 4.5) or the total amount (pH 6) of the dissolved uranium was precipitated under oxic conditions in a meta-autunite-like uranyl phosphate mineral phase without supplying an additional organic phosphate substrate. In contrast to that, under anoxic conditions no mineral formation was observed at pH 4.5 and pH 6, which was clearly assigned to decreased orthophosphate release by the cells. This in turn was caused by a suppression of the indigenous phosphatase activity of the strain. The results demonstrate that changes in the metabolism of facultative anaerobic microorganisms caused by the presence or absence of oxygen can decisively influence U(VI) biomineralization.	[Reitz, Thomas; Rossberg, Andre; Barkleit, Astrid; Selenska-Pobell, Sonja] Helmholtz Ctr Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany; [Reitz, Thomas] Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Merroun, Mohamed L.] Univ Granada, Dept Microbiol, Granada, Spain	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Granada	Reitz, T (corresponding author), Helmholtz Ctr Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany.	thomas.reitz@ufz.de	Barkleit, Astrid/N-3827-2017; ESRF, ROBL: The Rossendorf Beamline at/A-2586-2011; Reitz, Thomas/AFP-6355-2022; Merroun, Mohamed L./L-4514-2014	Barkleit, Astrid/0000-0003-3241-3443; ESRF, ROBL: The Rossendorf Beamline at/0000-0002-6608-5428; Merroun, Mohamed L./0000-0003-4553-5976	Ministerio de Ciencia e Innovacion, Spain [CGL2009-09760, CGL2012-36505]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially funded by the grants CGL2009-09760 and CGL2012-36505 (Ministerio de Ciencia e Innovacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearne JF, 1997, PHYS TODAY, V50, P24, DOI 10.1063/1.881763; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Atlas RM., 2004, HDB MICROBIOLOGICAL; Baik MH, 2004, RADIOCHIM ACTA, V92, P663, DOI 10.1524/ract.92.9.663.54980; Barkleit A, 2008, DALTON T, P2879, DOI 10.1039/b715669c; Barkleit A, 2009, DALTON T, P5379, DOI 10.1039/b818702a; Barnett MO, 2000, SOIL SCI SOC AM J, V64, P908, DOI 10.2136/sssaj2000.643908x; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Beazley MJ, 2007, ENVIRON SCI TECHNOL, V41, P5701, DOI 10.1021/es070567g; Beazley MJ, 2011, GEOCHIM COSMOCHIM AC, V75, P5648, DOI 10.1016/j.gca.2011.07.006; Beazley MJ, 2009, GEOMICROBIOL J, V26, P431, DOI 10.1080/01490450903060780; Boswell CD, 1999, MICROBIOL-UK, V145, P1711, DOI 10.1099/13500872-145-7-1711; Burns PC, 1997, CAN MINERAL, V35, P1551; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; DASSA E, 1982, J BIOL CHEM, V257, P6669; Deuerling E, 1997, MOL MICROBIOL, V23, P921, DOI 10.1046/j.1365-2958.1997.2721636.x; EKMAN P, 1993, ANAL BIOCHEM, V214, P138, DOI 10.1006/abio.1993.1468; Elo S, 2001, INT J SYST EVOL MICR, V51, P535, DOI 10.1099/00207713-51-2-535; Fanghanel T., 2003, UPDATE CHEM THERMODY; Fowle DA, 2000, ENVIRON SCI TECHNOL, V34, P3737, DOI 10.1021/es991356h; Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999; Geipel G, 2000, RADIOCHIM ACTA, V88, P757, DOI 10.1524/ract.2000.88.9-11.757; Geissler A, 2009, GEOBIOLOGY, V7, P282, DOI 10.1111/j.1472-4669.2009.00199.x; Goel R, 1998, WATER RES, V32, P2081, DOI 10.1016/S0043-1354(97)00425-9; Hennig C, 2001, RADIOCHIM ACTA, V89, P625, DOI 10.1524/ract.2001.89.10.625; Hudson EA, 1996, PHYS REV B, V54, P156, DOI 10.1103/PhysRevB.54.156; Jroundi F, 2007, GEOMICROBIOL J, V24, P441, DOI 10.1080/01490450701437651; Koban A, 2007, J INORG BIOCHEM, V101, P750, DOI 10.1016/j.jinorgbio.2007.01.001; Koban A, 2004, RADIOCHIM ACTA, V92, P903, DOI 10.1524/ract.92.12.903.55114; Koban A, 2004, POLYHEDRON, V23, P1793, DOI 10.1016/j.poly.2004.04.022; Kurosawa N, 2000, CURR MICROBIOL, V40, P57, DOI 10.1007/s002849910011; Liu CX, 2002, BIOTECHNOL BIOENG, V80, P637, DOI 10.1002/bit.10430; Lloyd JR, 2002, INTERACTIONS MICROOR; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Lucks C, 2012, INORG CHEM, V51, P12288, DOI 10.1021/ic301565p; MACASKIE LE, 1994, FEMS MICROBIOL REV, V14, P351, DOI 10.1016/0168-6445(94)90053-1; MACASKIE LE, 1992, SCIENCE, V257, P782, DOI 10.1126/science.1496397; MACASKIE LE, 1994, FEMS MICROBIOL LETT, V121, P141, DOI 10.1111/j.1574-6968.1994.tb07090.x; Markich Scott J, 2002, ScientificWorldJournal, V2, P707; Matz W, 1999, J SYNCHROTRON RADIAT, V6, P1076, DOI 10.1107/S0909049599010663; Merroun M, 2003, RADIOCHIM ACTA, V91, P583, DOI 10.1524/ract.91.10.583.22477; Merroun ML, 2003, BIOMETALS, V16, P331, DOI 10.1023/A:1020612600726; Merroun ML, 2011, J HAZARD MATER, V197, P1, DOI 10.1016/j.jhazmat.2011.09.049; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Murphy WM, 1999, REV MINERAL <D>, V38, P221; Nakano MM, 1997, J BACTERIOL, V179, P6749, DOI 10.1128/jb.179.21.6749-6755.1997; Nedelkova M, 2007, FEMS MICROBIOL ECOL, V59, P694, DOI 10.1111/j.1574-6941.2006.00261.x; Pedersen K, 2005, J NUCL RADIOCHEM SCI, V6, P11; PORSCHEN RK, 1974, APPL MICROBIOL, V27, P744, DOI 10.1128/AEM.27.4.744-747.1974; Powers LG, 2002, FEMS MICROBIOL ECOL, V41, P115, DOI 10.1111/j.1574-6941.2002.tb00972.x; Reitz T, 2011, RADIOCHIM ACTA, V99, P543, DOI 10.1524/ract.2011.1848; Reitz T, 2010, RADIOCHIM ACTA, V98, P249, DOI 10.1524/ract.2010.1716; Renninger N, 2004, APPL ENVIRON MICROB, V70, P7404, DOI 10.1128/AEM.70.12.7404-7412.2004; Renshaw JC, 2007, CR CHIM, V10, P1067, DOI 10.1016/j.crci.2007.02.013; Salome KR, 2013, GEOCHIM COSMOCHIM AC, V106, P344, DOI 10.1016/j.gca.2012.12.037; Sar P, 2001, J CHEM TECHNOL BIOT, V76, P1286, DOI 10.1002/jctb.517; SATTA G, 1979, J CLIN PATHOL, V32, P391, DOI 10.1136/jcp.32.4.391; Sivaswamy V, 2011, BIOTECHNOL BIOENG, V108, P264, DOI 10.1002/bit.22956; Suzuki Y, 2004, RADIOCHIM ACTA, V92, P11, DOI 10.1524/ract.92.1.11.25404; Vogel M, 2010, SCI TOTAL ENVIRON, V409, P384, DOI 10.1016/j.scitotenv.2010.10.011; Wall JD, 2006, ANNU REV MICROBIOL, V60, P149, DOI 10.1146/annurev.micro.59.030804.121357; Wolery TJ, 1992, EQ3 6 SOFTWARE PACKA	64	15	16	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e102447	10.1371/journal.pone.0102447	http://dx.doi.org/10.1371/journal.pone.0102447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157416	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200001
J	Yu, QX; Sheng, LL; Yang, M; Zhu, M; Huang, XL; Li, QF				Yu, Qingxiong; Sheng, Lingling; Yang, Mei; Zhu, Ming; Huang, Xiaolu; Li, Qingfeng			Tanshinon IIA Injection Accelerates Tissue Expansion by Reducing the Formation of the Fibrous Capsule	PLOS ONE			English	Article							FOREIGN-BODY RESPONSE; IMPLANTS; REGENERATION	The tissue expansion technique has been applied to obtain new skin tissue to repair large defects in clinical practice. The implantation of tissue expander could initiate a host response to foreign body (FBR), which leads to fibrotic encapsulation around the expander and prolongs the period of tissue expansion. Tanshinon IIA (Tan IIA) has been shown to have anti-inflammation and immunoregulation effect. The rat tissue expansion model was used in this study to observe whether Tan IIA injection systematically could inhibit the FBR to reduce fibrous capsule formation and accelerate the process of tissue expansion. Forty-eight rats were randomly divided into the Tan IIA group and control group with 24 rats in each group. The expansion was conducted twice a week to maintain a capsule pressure of 60 mmHg. The expansion volume and expanded area were measured. The expanded tissue in the two groups was harvested, and histological staining was performed; proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and interleukin-1 beta (IL-1 beta) and transforming growth factor-beta (TGF-beta) were examined. The expansion volume and the expanded area in the Tan IIA group were greater than that of the control group. The thickness of the fibrous capsule in the Tan IIA group was reduced with no influence on the normal skin regeneration. Decreased infiltration of macrophages, lower level of TNF-alpha, IL-6, IL-1 beta and TGF-beta, less proliferating myofibroblasts and enhanced neovascularization were observed in the Tan IIA group. Our findings indicated that the Tan IIA injection reduced the formation of the fibrous capsule and accelerated the process of tissue expansion by inhibiting the FBR.	[Yu, Qingxiong; Sheng, Lingling; Zhu, Ming; Huang, Xiaolu; Li, Qingfeng] Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China; [Yang, Mei] So Illinois Univ, Div Plast Surg, Springfield, IL USA	Shanghai Jiao Tong University; Southern Illinois University System; Southern Illinois University	Li, QF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China.	dr.liqingfeng@yahoo.com			National Key Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [2012BAI11B03]; Shanghai Jiaotong University School of Medicine Doctoral Innovation Foundation [BXJ201230]	National Key Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China; Shanghai Jiaotong University School of Medicine Doctoral Innovation Foundation	This study was supported by the National Key Project of Scientific and Technical Supporting Programs funded by the Ministry of Science & Technology of China (no. 2012BAI11B03) and Shanghai Jiaotong University School of Medicine Doctoral Innovation Foundation (BXJ201230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozkurt A, 2008, BURNS, V34, P1113, DOI 10.1016/j.burns.2008.05.008; Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; HEPPLESTON AG, 1967, NATURE, V214, P521, DOI 10.1038/214521a0; Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962; Joseph J, 2010, J MATER SCI-MATER M, V21, P1665, DOI 10.1007/s10856-010-4015-7; LAITUNG JKG, 1987, ANN PLAS SURG, V19, P208, DOI 10.1097/00000637-198709000-00005; LEE P, 1985, PLAST RECONSTR SURG, V76, P604, DOI 10.1097/00006534-198510000-00023; Li AG, 2007, J BIOMED MATER RES A, V82A, P498, DOI 10.1002/jbm.a.31168; Li JH, 2011, RESP PHYSIOL NEUROBI, V176, P39, DOI 10.1016/j.resp.2011.01.005; MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805; Poeppl N, 2007, AESTHET PLAST SURG, V31, P133, DOI 10.1007/s00266-006-0091-y; Prantl L, 2007, PLAST RECONSTR SURG, V120, P275, DOI 10.1097/01.prs.0000264398.85652.9a; Raposio E, 1999, BRIT J PLAST SURG, V52, P194, DOI 10.1054/bjps.1998.3096; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; Ruiz-de-Erenchun R, 2005, PLAST RECONSTR SURG, V116, P1370, DOI 10.1097/01.prs.0000181694.07661.0d; SCHMIDT SC, 1991, PLAST RECONSTR SURG, V87, P10, DOI 10.1097/00006534-199101000-00003; Sheng LL, 2014, MOL MED REP, V9, P872, DOI 10.3892/mmr.2013.1881; Sheng LL, 2013, WOUND REPAIR REGEN, V21, P746, DOI 10.1111/wrr.12080; Sheng LL, 2013, J PLAST RECONSTR AES, V66, P551, DOI 10.1016/j.bjps.2012.11.008; Siggelkow W, 2003, BIOMATERIALS, V24, P1101, DOI 10.1016/S0142-9612(02)00429-5; Tang Y, 2004, PLAST RECONSTR SURG, V114, P1166, DOI 10.1097/01.prs.0000135854.48570.76; Tavazzani F, 2005, J BIOMED MATER RES A, V72A, P161, DOI 10.1002/jbm.a.30181; Wu WY, 2013, BRIT J PHARMACOL, V169, P1058, DOI 10.1111/bph.12185; Xu SW, 2013, EXPERT OPIN THER PAT, V23, P149, DOI 10.1517/13543776.2013.743995; Yang M, 2011, ANN SURG, V253, P202, DOI 10.1097/SLA.0b013e3181f9ba1ah; Yin S, 2010, TISSUE ENG PT A, V16, P1633, DOI 10.1089/ten.TEA.2009.0570; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]	29	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105756	10.1371/journal.pone.0105756	http://dx.doi.org/10.1371/journal.pone.0105756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157742	Green Submitted, gold, Green Published			2022-12-27	WOS:000341303200059
J	Choi, H; Chakraborty, S; Liu, RH; Gellman, SH; Weisshaar, JC				Choi, Heejun; Chakraborty, Saswata; Liu, Runhui; Gellman, Samuel H.; Weisshaar, James C.			Medium Effects on Minimum Inhibitory Concentrations of Nylon-3 Polymers against E-coli	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE ACTION; REAL-TIME ATTACK; ANTIBACTERIAL; MECHANISMS; COPOLYMERS; DESIGN; MIMICS	Minimum inhibitory concentrations (MICs) against E. coli were measured for three nylon-3 polymers using Luria-Bertani broth (LB), brain-heart infusion broth (BHI), and a chemically defined complete medium (EZRDM). The polymers differ in the ratio of hydrophobic to cationic subunits. The cationic homopolymer is inert against E. coli in BHI and LB, but becomes highly potent in EZRDM. A mixed hydrophobic/cationic polymer with a hydrophobic t-butylbenzoyl group at its N-terminus is effective in BHI, but becomes more effective in EZRDM. Supplementation of EZRDM with the tryptic digest of casein (often found in LB) recapitulates the LB and BHI behavior. Additional evidence suggests that polyanionic peptides present in LB and BHI may form electrostatic complexes with cationic polymers, decreasing activity by diminishing binding to the anionic lipopolysaccharide layer of E. coli. In contrast, two natural antimicrobial peptides show no medium effects. Thus, the use of a chemically defined medium helps to reveal factors that influence antimicrobial potency of cationic polymers and functional differences between these polymers and evolved antimicrobial peptides.	[Choi, Heejun; Chakraborty, Saswata; Liu, Runhui; Gellman, Samuel H.; Weisshaar, James C.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Gellman, Samuel H.; Weisshaar, James C.] Univ Wisconsin, Mol Biophys Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gellman, SH (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	gellman@chem.wisc.edu; weisshaar@chem.wisc.edu		Choi, Heejun/0000-0002-1337-3813	National Institute of General Medical Sciences of the National Institutes of Health [R01GM094510, R01GM093265]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094510, R01GM093265] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health, Grant # R01GM094510 (JCW as PI) and R01GM093265 (JCW and SHG as co-PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BC, 2007, BIOMACROMOLECULES, V8, P2995, DOI 10.1021/bm7004627; Bakshi S, 2011, BIOPHYS J, V101, P2535, DOI 10.1016/j.bpj.2011.10.013; Barns KJ, 2013, BBA-BIOMEMBRANES, V1828, P1511, DOI 10.1016/j.bbamem.2013.02.011; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bryan L., 1984, ANTIMICROBIAL DRUG R; Chakraborty S, 2013, ACS MACRO LETT, V2, P753, DOI 10.1021/mz400239r; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Godballe T, 2011, CHEM BIOL DRUG DES, V77, P107, DOI 10.1111/j.1747-0285.2010.01067.x; Goodson B, 1999, ANTIMICROB AGENTS CH, V43, P1429, DOI 10.1128/AAC.43.6.1429; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hiraki J, 2003, REGUL TOXICOL PHARM, V37, P328, DOI 10.1016/S0273-2300(03)00029-1; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kuroda K, 2013, WIRES NANOMED NANOBI, V5, P49, DOI 10.1002/wnan.1199; Lewenza S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00021; Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004; Mowery BP, 2009, J AM CHEM SOC, V131, P9735, DOI 10.1021/ja901613g; Munk JK, 2013, J PEPT SCI, V19, P669, DOI 10.1002/psc.2548; Patch JA, 2003, J AM CHEM SOC, V125, P12092, DOI 10.1021/ja037320d; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Rangarajan N, 2013, BIOCHEMISTRY-US, V52, P6584, DOI 10.1021/bi400785j; Sambhy V, 2008, ANGEW CHEM INT EDIT, V47, P1250, DOI 10.1002/anie.200702287; Schwab U, 1999, ANTIMICROB AGENTS CH, V43, P1435, DOI 10.1128/AAC.43.6.1435; Sellenet PH, 2007, BIOMACROMOLECULES, V8, P19, DOI 10.1021/bm0605513; SHIMA S, 1984, J ANTIBIOT, V37, P1449, DOI 10.7164/antibiotics.37.1449; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Takahashi H, 2013, MACROMOL BIOSCI, V13, P1285, DOI 10.1002/mabi.201300126; Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wesolowski D, 2013, P NATL ACAD SCI USA, V110, P8686, DOI 10.1073/pnas.1306911110; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao X., 2013, PLOS ONE, V8	38	31	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104500	10.1371/journal.pone.0104500	http://dx.doi.org/10.1371/journal.pone.0104500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153714	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200020
J	Latini, A; Tomellini, M; Lazzarini, L; Bertoni, G; Gazzoli, D; Bossa, L; Gozzi, D				Latini, Alessandro; Tomellini, Massimo; Lazzarini, Laura; Bertoni, Giovanni; Gazzoli, Delia; Bossa, Luigi; Gozzi, Daniele			High Temperature Stability of Onion-Like Carbon vs Highly Oriented Pyrolytic Graphite	PLOS ONE			English	Article							TRANSFORMATIONS; THERMODYNAMICS	The thermodynamic stability of onion-like carbon (OLC) nanostructures with respect to highly oriented pyrolytic graphite (HOPG) was determined in the interval 765-1030 K by the electromotive force (emf) measurements of solid electrolyte galvanic cell: (Low) Pt|Cr3C2,CrF2,OLC|CaF(2)s.c.|Cr3C2,CrF2,HOPG|Pt (High). The free energy change of transformation HOPG = OLC was found positive below 920.6 K crossing the zero value at this temperature. Its trend with temperature was well described by a 3rd degree polynomial. The unexpected too high values of (partial derivative Delta H-r(T)/partial derivative T)(P) = Delta C-p(T) jointly to the HR-TEM, STEM and EELS evidences that showed OLC completely embedded in rigid cages made of a Cr3C2/CrF2 matrix, suggested that carbon in the electrodes experienced different internal pressures. This was confirmed by the evaluation under constant volume of dP/dT by the alpha/kappa ratio for OLC (0.5 MPa K-1) and HOPG (8 Pa K-1) where alpha and kappa are the isobaric thermal expansion and isothermal compressibility coefficients, respectively. The temperature dependency of the pressure was derived and utilized to calculate the enthalpy and entropy changes as function of temperature and pressure. The highest value of the internal pressure experienced by OLC was calculated to be about 7 GPa at the highest temperature. At 920.6 K, Delta H-r and Delta S-r values are 95.8 kJ mol(-1) and 104.1 JK(-1) mol(-1), respectively. The surface contributions to the energetic of the system were evaluated and they were found negligible compared with the bulk terms. As a consequence of the high internal pressure, the values of the enthalpy and entropy changes were mainly attributed to the formation of carbon defects in OLC considered as multishell fullerenes. The change of the carbon defect fraction is reported as a function of temperature.	[Latini, Alessandro; Gazzoli, Delia; Bossa, Luigi; Gozzi, Daniele] Univ Roma La Sapienza, Dipartimento Chim, I-00185 Rome, Italy; [Tomellini, Massimo] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Rome, Italy; [Lazzarini, Laura; Bertoni, Giovanni] CNR, IMEM, I-43100 Parma, Italy	Sapienza University Rome; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Materiali per l'Elettronica ed il Magnetismo (IMEM-CNR)	Gozzi, D (corresponding author), Univ Roma La Sapienza, Dipartimento Chim, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	daniele.gozzi@uniroma1.it	Gazzoli, Delia/AAX-7403-2020; Gozzi, Daniele/M-6356-2014; lazzarini, Laura/AAE-7796-2021; Bertoni, Giovanni/J-4710-2012; lazzarini, laura/B-7009-2015	Gazzoli, Delia/0000-0001-9850-1855; Gozzi, Daniele/0000-0002-4190-2022; Bertoni, Giovanni/0000-0001-6424-9102; lazzarini, laura/0000-0001-5346-4026; Latini, Alessandro/0000-0002-3205-4826	PRIN Project [2009N4BJ4J]; "Acquisizione di medie e grandi attrezzature scientifiche" Universita di Roma La Sapienza [C26G10KKK5]	PRIN Project(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); "Acquisizione di medie e grandi attrezzature scientifiche" Universita di Roma La Sapienza	This work was partially financed through the PRIN 2009 Project no. 2009N4BJ4J and "Acquisizione di medie e grandi attrezzature scientifiche 2010" Universita di Roma La Sapienza, no. C26G10KKK5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GLUSHKO THERMOCENTER; Banhart F, 1997, CHEM PHYS LETT, V269, P349, DOI 10.1016/S0009-2614(97)00269-8; Banhart F, 1996, NATURE, V382, P433, DOI 10.1038/382433a0; Barnard AS, 2006, DIAM RELAT MATER, V15, P285, DOI 10.1016/j.diamond.2005.05.007; BERNHOLC J, 1994, COMP MATER SCI, V2, P547, DOI 10.1016/0927-0256(94)90086-8; Chao J, 2008, APPL PHYS LETT, V92; Colonna F, 2011, CARBON, V49, P364, DOI 10.1016/j.carbon.2010.09.029; Dubitsky GA, 2011, RUSS CHEM B+, V60, P413, DOI 10.1007/s11172-011-0065-3; Girifalco LA, 2000, PHYS REV B, V62, P13104, DOI 10.1103/PhysRevB.62.13104; GIRIFALCO LA, 1995, PHYS REV B, V52, P9910, DOI 10.1103/PhysRevB.52.9910; Gozzi D, 2007, J AM CHEM SOC, V129, P10269, DOI 10.1021/ja072120d; Gozzi D, 2009, J AM CHEM SOC, V131, P12474, DOI 10.1021/ja904294z; Gozzi D, 2009, J PHYS CHEM C, V113, P45, DOI 10.1021/jp806102f; Jiang Q, 2006, CARBON, V44, P79, DOI 10.1016/j.carbon.2005.07.014; Klotz IM, 2008, CHEM THERMODYN, P200; KUZNETSOV VL, 1995, MATER RES SOC SYMP P, V359, P105, DOI 10.1557/PROC-359-105; Latini A, 2011, J PHYS CHEM C, V115, P11023, DOI 10.1021/jp203149v; Lee RKF, 2012, J MATH CHEM, V50, P1289, DOI 10.1007/s10910-011-9970-9; Mutaftschiev B., 2001, ATOMISTIC NATURE CRY; Sano N, 2002, J APPL PHYS, V92, P2783, DOI 10.1063/1.1498884; Scabarozi TH, 2009, J APPL PHYS, V105, DOI 10.1063/1.3021465; Shenderova OA, 2002, CRIT REV SOLID STATE, V27, P227, DOI 10.1080/10408430208500497; SHUTTLEWORTH R, 1950, P PHYS SOC LOND A, V63, P444, DOI 10.1088/0370-1298/63/5/302; Sun L, 2006, APPL PHYS LETT, V88; Tang AC, 1995, PHYS REV B, V52, P17435, DOI 10.1103/PhysRevB.52.17435; TOMANEK D, 1993, PHYS REV B, V48, P15461, DOI 10.1103/PhysRevB.48.15461; Welz S, 2006, J MATER PROCESS TECH, V179, P11, DOI 10.1016/j.jmatprotec.2006.03.103; Zaiser M, 1997, PHYS REV LETT, V79, P3680, DOI 10.1103/PhysRevLett.79.3680	28	6	7	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105788	10.1371/journal.pone.0105788	http://dx.doi.org/10.1371/journal.pone.0105788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153181	Green Submitted, gold, Green Published			2022-12-27	WOS:000340952200081
J	Li, SG; Hu, T; Beran, MA; Li, S				Li, Shengai; Hu, Tracy; Beran, Maria A.; Li, Sheng			Habituation to Experimentally Induced Electrical Pain during Voluntary-Breathing Controlled Electrical Stimulation (BreEStim)	PLOS ONE			English	Article							SPINAL-CORD-INJURY; PRIMARY SOMATOSENSORY CORTEX; CEREBRAL-BLOOD-FLOW; CINGULATE CORTEX; VOLITIONAL INSPIRATION; PERIAQUEDUCTAL GRAY; NERVE-STIMULATION; BRAIN ACTIVATION; FUNCTIONAL MRI; INSULAR CORTEX	Objective: Painful peripheral electrical stimulation to acupuncture points was found to cause sensitization if delivered randomly (EStim), but induced habituation if triggered by voluntary breathing (BreEStim). The objective was to systematically compare the effectiveness of BreEStim and EStim and to investigate the possible mechanisms mediating the habituation effect of BreEStim. Methods: Eleven pain-free, healthy subjects (6 males, 5 females) participated in the study. Each subject received the BreEStim and EStim treatments in a random order at least three days apart. Both treatments consisted of 120 painful but tolerable stimuli to the ulnar nerve at the elbow on the dominant arm. BreEStim was triggered by voluntary breathing while EStim was delivered randomly. Electrical sensation threshold (EST) and electrical pain threshold (EPT) were measured from the thenar and hypothenar eminences on both hands at pre-intervention and 10-minutes post-intervention. Results: There was no difference in the pre-intervention baseline measurement of EST and EPT between BreEStim and EStim. BreEStim increased EPT in all tested sites on both hands, while EStim increased EPT in the dominant hypothenar eminence distal to the stimulating site and had no effect on EPT in other sites. There was no difference in the intensity of electrical stimulation between EStim and BreEStim. Conclusion: Our findings support the important role human voluntary breathing plays in the systemic habituation effect of BreEStim to peripheral painful electrical stimulation.	[Li, Shengai; Hu, Tracy; Beran, Maria A.; Li, Sheng] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Li, Shengai; Hu, Tracy; Beran, Maria A.; Li, Sheng] TIRR Mem Hermann Res Ctr, Neurorehabil Res Lab, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Li, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	sheng.li@uth.tmc.edu	Li, Sheng/ABC-5392-2021		NIH grant [NIH/NINDS R01NS060774]; Mission Connect, a program of TIRR Foundation [013-109]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060774] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mission Connect, a program of TIRR Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by an NIH grant (NIH/NINDS R01NS060774) and a research grant (013-109) from Mission Connect, a program of TIRR Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; Budh CN, 2005, SPINAL CORD, V43, P85, DOI 10.1038/sj.sc.3101680; Budh CN, 2004, COMPLEMENT THER MED, V12, P189, DOI 10.1016/j.ctim.2004.10.003; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91, DOI 10.1113/jphysiol.1991.sp018824; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; Evans KC, 2009, NEUROIMAGE, V47, P961, DOI 10.1016/j.neuroimage.2009.05.025; Evans KC, 1999, J PHYSIOL-LONDON, V520, P383, DOI 10.1111/j.1469-7793.1999.00383.x; Fink GR, 1995, J PHYSIOL-LONDON, V489, P663, DOI 10.1113/jphysiol.1995.sp021081; Finnerup NB, 2001, PAIN CLIN UPDATES, V9, P1; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Freund W, 2011, CLIN J PAIN, V27, P796, DOI 10.1097/AJP.0b013e31821d9063; Gaytan SP, 1998, BRAIN RES BULL, V47, P625, DOI 10.1016/S0361-9230(98)00125-7; Green AL, 2007, J PHYSIOL-LONDON, V578, P605, DOI 10.1113/jphysiol.2006.122549; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; Hahn A, 2013, NEUROIMAGE, V82, P336, DOI 10.1016/j.neuroimage.2013.06.010; Hanamori T, 1998, BRAIN RES, V785, P97, DOI 10.1016/S0006-8993(97)01392-9; Haouzi P, 2006, RESP PHYSIOL NEUROBI, V152, P169, DOI 10.1016/j.resp.2005.08.004; Ikeda ER, 2009, J STRENGTH COND RES, V23, P127, DOI 10.1519/JSC.0b013e31818eb256; Jensen MP, 2007, NEUROLOGY, V68, P1178, DOI 10.1212/01.wnl.0000259085.61898.9e; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; Kotze A, 2008, ANAEST INTENS CARE M, V9, P29, DOI 10.1016/j.mpaic.2007.10.008; LaBuda CJ, 2005, NEUROSCIENCE, V136, P311, DOI 10.1016/j.neuroscience.2005.07.010; LaGraize SC, 2006, EXP NEUROL, V197, P22, DOI 10.1016/j.expneurol.2005.05.008; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Li S, 2006, MUSCLE NERVE, V34, P651, DOI 10.1002/mus.20592; Li S, 2013, JOVE-J VIS EXP, DOI 10.3791/50077; Li S, 2012, MOTOR CONTROL, V16, P493, DOI 10.1123/mcj.16.4.493; Li Sheng, 2012, J Pain Res, V5, P71, DOI 10.2147/JPR.S31036; Li S, 2011, J NEUROPHYSIOL, V105, P512, DOI 10.1152/jn.00946.2010; Li SG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070282, 10.1371/journal.pone.0070461]; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Macey KE, 2004, J APPL PHYSIOL, V97, P1897, DOI 10.1152/japplphysiol.00359.2004; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; MASKILL D, 1991, J PHYSIOL-LONDON, V443, P105, DOI 10.1113/jphysiol.1991.sp018825; Mazzone SB, 2007, AM J RESP CRIT CARE, V176, P327, DOI 10.1164/rccm.200612-1856OC; Murphy D, 2001, SPINAL CORD, V39, P44, DOI 10.1038/sj.sc.3101094; Nickel FT, 2014, EUR J PAIN, V18, P56, DOI 10.1002/j.1532-2149.2013.00339.x; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Plow EB, 2012, J PAIN, V13, P411, DOI 10.1016/j.jpain.2012.02.001; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85, DOI 10.1113/jphysiol.1993.sp019503; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; Sluka KA, 2003, J PAIN, V4, P109, DOI 10.1054/jpai.2003.434; Smejkal V, 1999, PHYSIOL RES, V48, P21; Smejkal V, 2000, PHYSIOL RES, V49, P659; Stehberg J, 2009, EUR J NEUROSCI, V29, P964, DOI 10.1111/j.1460-9568.2009.06634.x; Stormer S, 1997, SPINAL CORD, V35, P446, DOI 10.1038/sj.sc.3100411; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; von Leupoidt A, 2009, AM J RESP CRIT CARE, V180, P232, DOI 10.1164/rccm.200902-0300OC; Zautra AJ, 2010, PAIN, V149, P12, DOI 10.1016/j.pain.2009.10.001; Zeidan F, 2011, J NEUROSCI, V31, P5540, DOI 10.1523/JNEUROSCI.5791-10.2011	53	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104729	10.1371/journal.pone.0104729	http://dx.doi.org/10.1371/journal.pone.0104729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153077	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200023
J	Zhang, HW; Gao, L; Zhang, JL; Li, WH; Yang, M; Zhang, H; Gao, CH; He, ZG				Zhang, Haiwei; Gao, Long; Zhang, Jiaoling; Li, Weihui; Yang, Min; Zhang, Hua; Gao, Chunhui; He, Zheng-Guo			A Novel marRAB Operon Contributes to the Rifampicin Resistance in Mycobacterium smegmatis	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; DRUG-RESISTANCE; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; REGULATOR; REPRESSOR; EFFLUX; TUBERCULOSIS; EXPRESSION	The multiple-antibiotic resistance regulator (MarR) plays an important role in modulating bacterial antibiotic resistance. However, the regulatory model of the marRAB operon in mycobacteria remains to be characterized. Here we report that a MarR, encoded by Ms6508, and its marRAB operon specifically contribute to rifampicin (RIF) resistance in Mycobacterium smegmatis. We show that the MarR recognizes a conserved 21-bp palindromic motif and negatively regulates the expression of two ABC transporters in the operon, encoded by Ms6509-6510. Unlike other known drug efflux pumps, overexpression of these two ABC transporters unexpectedly increased RIF sensitivity and deletion of these two genes increased mycobacterial resistance to the antibiotic. No change can be detected for the sensitivity of recombinant mycobacterial strains to three other anti-TB drugs. Furthermore, HPLC experiments suggested that Ms6509-Ms6510 could pump RIF into the mycobacterial cells. These findings indicated that the mycobacterial MarR functions as a repressor and constitutively inhibits the expression of the marRAB operon, which specifically contributes to RIF resistance in M. smegmatis. Therefore, our data suggest a new regulatory mechanism of RIF resistance and also provide the new insight into the regulatory model of a marRAB operon in mycobacteria.	[Zhang, Haiwei; Gao, Long; Zhang, Jiaoling; Li, Weihui; Yang, Min; Zhang, Hua; Gao, Chunhui; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014; Gao, Chun-Hui/B-3667-2016; Gao, Chun-Hui/B-4111-2008	Gao, Chun-Hui/0000-0002-1445-7939; Gao, Chun-Hui/0000-0002-1445-7939; Yang, Min/0000-0003-2924-5717	973 Program [2012CB518800]; National Natural Science Foundation of China [31025002, 31121004]; Hubei Chutian Scholar Program; Chang Jiang Scholars Program	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Chutian Scholar Program; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by 973 Program (2012CB518800), the National Natural Science Foundation of China (31025002 and 31121004), Hubei Chutian Scholar Program and Chang Jiang Scholars Program (to Z-G He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Li XZ, 1999, CAN J MICROBIOL, V45, P18, DOI 10.1139/cjm-45-1-18; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247; Panchagnula R, 1999, J PHARMACEUT BIOMED, V18, P1013, DOI 10.1016/S0731-7085(98)00112-5; Quan SW, 1997, ANTIMICROB AGENTS CH, V41, P2456, DOI 10.1128/AAC.41.11.2456; Radhakrishnan A, 2014, J BIOL CHEM, V289, P16526, DOI 10.1074/jbc.M113.538959; Rodrigues L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-35; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; SEOANE AS, 1995, J BACTERIOL, V177, P3414, DOI 10.1128/jb.177.12.3414-3419.1995; Srikumar R, 2000, J BACTERIOL, V182, P1410, DOI 10.1128/JB.182.5.1410-1414.2000; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672	30	7	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106016	10.1371/journal.pone.0106016	http://dx.doi.org/10.1371/journal.pone.0106016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153492	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200106
J	Adler, LA; Clemow, DB; Williams, DW; Durell, TM				Adler, Lenard A.; Clemow, David B.; Williams, David W.; Durell, Todd M.			Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; LISDEXAMFETAMINE DIMESYLATE; IMPAIRMENT; DEFICITS; CHILDREN; MEDICATION; RATINGS	Objective: To evaluate the effect of atomoxetine treatment on executive functions in young adults with attention-deficit/hyperactivity disorder (ADHD). Methods: In this Phase 4, multi-center, double-blind, placebo-controlled trial, young adults (18-30 years) with ADHD were randomized to receive atomoxetine (20-50 mg BID, N = 220) or placebo (N = 225) for 12 weeks. The Behavior Rating Inventory of Executive Function-Adult (BRIEF-A) consists of 75 self-report items within 9 nonoverlapping clinical scales measuring various aspects of executive functioning. Mean changes from baseline to 12-week endpoint on the BRIEF-A were analyzed using an ANCOVA model (terms: baseline score, treatment, and investigator). Results: At baseline, there were no significant treatment group differences in the percentage of patients with BRIEF-A composite or index T-scores >= 60 (p > .5), with over 92% of patients having composite scores >= 60 (>= 60 deemed clinically meaningful for these analyses). At endpoint, statistically significantly greater mean reductions were seen in the atomoxetine versus placebo group for the BRIEF-A Global Executive Composite (GEC), Behavioral Regulation Index (BRI), and Metacognitive Index (MI) scores, as well as the Inhibit, Self-Monitor, Working Memory, Plan/Organize and Task Monitor subscale scores (p < .05), with decreases in scores signifying improvements in executive functioning. Changes in the BRIEF-A Initiate (p = .051), Organization of Materials (p = .051), Shift (p = .090), and Emotional Control (p = .219) subscale scores were not statistically significant. In addition, the validity scales: Inconsistency (p = .644), Infrequency (p = .097), and Negativity (p = .456) were not statistically significant, showing scale validity. Conclusion: Statistically significantly greater improvement in executive function was observed in young adults with ADHD in the atomoxetine versus placebo group as measured by changes in the BRIEF-A scales.	[Adler, Lenard A.] NYU, Dept Psychiat, New York, NY 10016 USA; [Adler, Lenard A.] NYU, Dept Child & Adolescent Psychiat, New York, NY USA; [Clemow, David B.] Lilly USA LLC, Indianapolis, IN 46221 USA; [Williams, David W.] InVentiv Hlth Clin, Indianapolis, IN USA	New York University; New York University; Lilly USA LLC	Clemow, DB (corresponding author), Lilly USA LLC, Indianapolis, IN 46221 USA.	davidclemow@lilly.com			Lilly USA, LLC	Lilly USA, LLC(Eli Lilly)	This research was funded by Lilly USA, LLC, who contributed to study design, data collection and analysis, decision to publish, and manuscript preparation (http://www.lilly.com).	Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; Adler LA, 2008, J ATTEN DISORD, V11, P711, DOI 10.1177/1087054707308503; Adler LA, 2013, J CLIN PSYCHIAT, V74, P694, DOI 10.4088/JCP.12m08144; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2013, STRATT AT; [Anonymous], 2012, VYV PACK INS; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Barkley R.A, 2006, ATTENTION DEFICIT HY, V3rd; Barkley RA, 2011, DEV NEUROPSYCHOL, V36, P137, DOI 10.1080/87565641.2010.549877; Barkley RA, 2010, ARCH CLIN NEUROPSYCH, V25, P157, DOI 10.1093/arclin/acq014; Biederman J, 2008, J CLIN PSYCHIAT, V69, P1150, DOI 10.4088/JCP.v69n0715; Biederman J, 2011, EUR NEUROPSYCHOPHARM, V21, P508, DOI 10.1016/j.euroneuro.2010.11.005; Biederman J, 2008, J ATTEN DISORD, V12, P92, DOI 10.1177/1087054707305111; Biederman J, 2006, AM J PSYCHIAT, V163, P1730, DOI 10.1176/appi.ajp.163.10.1730; Brown TE, 2001, BROWN ATTENTION DEFI, P5; Brown TE, 2011, J ATTEN DISORD, V15, P130, DOI 10.1177/1087054709356165; Brown Thomas E, 2008, Curr Psychiatry Rep, V10, P407, DOI 10.1007/s11920-008-0065-7; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Durell TM, 2013, J CLIN PSYCHOPHARM, V33, P45, DOI 10.1097/JCP.0b013e31827d8a23; Faraone SV, 2000, BIOL PSYCHIAT, V48, P9, DOI 10.1016/S0006-3223(00)00889-1; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Gehring K, 2012, J NEURO-ONCOL, V107, P165, DOI 10.1007/s11060-011-0723-1; Isquith, 2006, BEHAV RATING INVENTO; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Michelson D, 2003, BIOL PSYCHIAT, V53, P112, DOI 10.1016/S0006-3223(02)01671-2; Morrow SA, 2013, J NEUROL, V260, P489, DOI 10.1007/s00415-012-6663-7; Qiu AQ, 2009, AM J PSYCHIAT, V166, P74, DOI 10.1176/appi.ajp.2008.08030426; ROGENESS GA, 1992, J AM ACAD CHILD PSY, V31, P765, DOI 10.1097/00004583-199209000-00001; Roth RM., 2005, BRIEF A BEHAV RATING; Saylor KE, 2002, J CLIN PSYCHIAT, V63, P23; Stahl S., 2008, STAHLS ESSENTIAL PSY; Yudofsky SC, 2002, TXB NEUROPSYCHIATRY, P71	35	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104175	10.1371/journal.pone.0104175	http://dx.doi.org/10.1371/journal.pone.0104175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148243	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600009
J	Decaro, N; Martella, V; Desario, C; Lanave, G; Circella, E; Cavalli, A; Elia, G; Camero, M; Buonavoglia, C				Decaro, Nicola; Martella, Vito; Desario, Costantina; Lanave, Gianvito; Circella, Elena; Cavalli, Alessandra; Elia, Gabriella; Camero, Michele; Buonavoglia, Canio			Genomic Characterization of a Circovirus Associated with Fatal Hemorrhagic Enteritis in Dog, Italy	PLOS ONE			English	Article							CANINE PARVOVIRUS TYPE-2; TIME PCR ASSAY; PORCINE CIRCOVIRUS; DIARRHEIC DOGS; QUANTITATION; SEQUENCE; VIRUS; FECES; RNA; KOBUVIRUSES	Dog circovirus (DogCV) was identified in an outbreak of enteritis in pups in Italy. The disease was observed in 6 young dachshunds pups of a litter from a breeding kennel and caused the death of 2 dogs. Upon full-genome analysis, the virus detected in one of the dead pups (strain Bari/411-13) was closely related to DogCVs that have been recently isolated in the USA. The present study, if corroborated by further reports, could represent a useful contribution to the knowledge of the pathogenic potential of DogCV and its association with enteritis in dogs.	[Decaro, Nicola; Martella, Vito; Desario, Costantina; Lanave, Gianvito; Circella, Elena; Cavalli, Alessandra; Elia, Gabriella; Camero, Michele; Buonavoglia, Canio] Univ Bari, Dept Vet Med, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Decaro, N (corresponding author), Univ Bari, Dept Vet Med, Bari, Italy.	nicola.decaro@uniba.it	Decaro, Nicola/K-2560-2018; Decaro, Nicola/AAB-8820-2019; Martella, Vito/K-3146-2016; Lanave, Gianvito/J-2375-2018; Decaro, Nicola/ABB-1426-2021; Elia, Gabriella/K-5286-2018	Decaro, Nicola/0000-0001-6348-7969; Martella, Vito/0000-0002-5740-6947; Lanave, Gianvito/0000-0003-4614-677X; Elia, Gabriella/0000-0001-7469-2175; Camero, Michele/0000-0003-0026-8325	Italian Ministry of Health, Ricerca corrente [IZS VE 21/09 RC]	Italian Ministry of Health, Ricerca corrente(Ministry of Health, Italy)	This work was supported by grants from the Italian Ministry of Health, Ricerca corrente 2009, project IZS VE 21/09 RC "Definizione di una procedura validata per la selezione di cani per programmi di Interventi Assistiti dagli Animali (IAA)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINN L N, 1970, Infection and Immunity, V1, P503; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Decaro N, 2005, J VIROL METHODS, V130, P72, DOI 10.1016/j.jviromet.2005.06.005; Decaro N, 2005, VET MICROBIOL, V105, P19, DOI 10.1016/j.vetmic.2004.09.018; Decaro N, 2004, J VIROL METHODS, V119, P145, DOI 10.1016/j.jviromet.2004.03.012; Decaro N, 2002, MICROBIOLOGICA, V25, P291; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; Decaro N, 2008, VET CLIN N AM-SMALL, V38, P799, DOI 10.1016/j.cvsm.2008.02.006; Decaro N, 2006, J VIROL METHODS, V133, P92, DOI 10.1016/j.jviromet.2005.10.026; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Decaro N, 2010, J VIROL METHODS, V169, P176, DOI 10.1016/j.jviromet.2010.07.021; Di Martino B, 2013, VET MICROBIOL, V166, P246, DOI 10.1016/j.vetmic.2013.05.007; Elia G, 2006, J VIROL METHODS, V136, P171, DOI 10.1016/j.jviromet.2006.05.004; EUGSTER AK, 1979, VET MED SM ANIM CLIN, V74, P817; Gouvea V, 1999, J CLIN MICROBIOL, V32, P1338; Hu RL, 2001, VET RES COMMUN, V25, P77, DOI 10.1023/A:1006417203856; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; Kapoor A, 2012, J VIROL, V86, P7018, DOI 10.1128/JVI.00791-12; KOKUBU T, 1993, J VET MED SCI, V55, P453, DOI 10.1292/jvms.55.453; Leary TP, 2002, J CLIN MICROBIOL, V40, P1368, DOI 10.1128/JCM.40.4.1368-1375.2002; Li LL, 2013, EMERG INFECT DIS, V19, P534, DOI 10.3201/eid1904.121390; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Martella V, 2012, J CLIN MICROBIOL, V50, P1066, DOI 10.1128/JCM.05018-11; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; MOCHIZUKI M, 1993, VET REC, V132, P221, DOI 10.1136/vr.132.9.221; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Reuter G, 2009, ARCH VIROL, V154, P101, DOI 10.1007/s00705-008-0288-2; Segales J, 2013, VET MICROBIOL, V165, P13, DOI 10.1016/j.vetmic.2012.12.033; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TISCHER I, 1987, ARCH VIROL, V96, P39, DOI 10.1007/BF01310989; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11	34	62	70	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105909	10.1371/journal.pone.0105909	http://dx.doi.org/10.1371/journal.pone.0105909			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147946	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600096
J	Fang, M; Fu, WX; Jiang, D; Zhang, Q; Sun, DX; Ding, XD; Liu, JF				Fang, Ming; Fu, Weixuan; Jiang, Dan; Zhang, Qin; Sun, Dongxiao; Ding, Xiangdong; Liu, Jianfeng			A Multiple-SNP Approach for Genome-Wide Association Study of Milk Production Traits in Chinese Holstein Cattle	PLOS ONE			English	Article							BAYESIAN LASSO; ALGORITHM; PREDICTION; REGRESSION	The multiple-SNP analysis has been studied by many researchers, in which the effects of multiple SNPs are simultaneously estimated and tested in a multiple linear regression. The multiple-SNP association analysis usually has higher power and lower false-positive rate for detecting causative SNP(s) than single marker analysis (SMA). Several methods have been proposed to simultaneously estimate and test multiple SNP effects. In this research, a fast method called MEML (Mixed model based Expectation-Maximization Lasso algorithm) was developed for simultaneously estimate of multiple SNP effects. An improved Lasso prior was assigned to SNP effects which were estimated by searching the maximum joint posterior mode. The residual polygenic effect was included in the model to absorb many tiny SNP effects, which is treated as missing data in our EM algorithm. A series of simulation experiments were conducted to validate the proposed method, and the results showed that compared with SMMA, the new method can dramatically decrease the false-positive rate. The new method was also applied to the 50k SNP-panel dataset for genome-wide association study of milk production traits in Chinese Holstein cattle. Totally, 39 significant SNPs and their nearby 25 genes were found. The number of significant SNPs is remarkably fewer than that by SMMA which found 105 significant SNPs. Among 39 significant SNPs, 8 were also found by SMMA and several well-known QTLs or genes were confirmed again; furthermore, we also got some positional candidate gene with potential function of effecting milk production traits. These novel findings in our research should be valuable for further investigation.	[Fang, Ming; Fu, Weixuan; Zhang, Qin; Sun, Dongxiao; Ding, Xiangdong; Liu, Jianfeng] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Beijing 100094, Peoples R China; [Fang, Ming; Jiang, Dan] Heilongjiang Bayi Agr Univ, Life Sci Coll, Daqing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Heilongjiang Bayi Agricultural University	Fang, M (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Beijing 100094, Peoples R China.	fangming618@126.com; qzhang@cau.edu.cn; sundx@cau.edu.cn			National Natural Science Foundation of China [31001001]; Program for New Century Excellent Talents In Heilongjiang Provincial University [1253-NCET-001]; National Science and Technology Programs of China [2011BAD28B02, 2012BAD12B01, 2013AA102504]; Beijing Dairy Industry Innovation Team; Beijing Research and Technology program [D121100003312001]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents In Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); National Science and Technology Programs of China; Beijing Dairy Industry Innovation Team; Beijing Research and Technology program; Program for Changjiang Scholar and Innovation Research Team in University	This work was supported by the the National Natural Science Foundation of China (Grant No. 31001001), Program for New Century Excellent Talents In Heilongjiang Provincial University (Grant No. 1253-NCET-001), National Science and Technology Programs of China (2011BAD28B02, 2012BAD12B01, 2013AA102504), Beijing Dairy Industry Innovation Team, Beijing Research and Technology program (D121100003312001) and Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Duan Q, 2012, ANIM GENET, V43, P115, DOI 10.1111/j.1365-2052.2011.02224.x; Fang M, 2012, THEOR APPL GENET, V124, P1315, DOI 10.1007/s00122-012-1789-7; Golik M, 2011, J DAIRY SCI, V94, P2092, DOI 10.3168/jds.2010-3655; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Logsdon BA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-53; Lu BZ, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1924448; Lund M. S., 2009, BMC P S1, V3, pS1, DOI DOI 10.1186/1753-6561-3-S1-S1; Meuwissen THE, 2001, GENETICS, V157, P1819; Mutshinda CM, 2010, GENETICS, V186, P1067, DOI 10.1534/genetics.110.119586; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Xu S, 2010, HEREDITY, V105, P483, DOI 10.1038/hdy.2009.180; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	17	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e99544	10.1371/journal.pone.0099544	http://dx.doi.org/10.1371/journal.pone.0099544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148050	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600001
J	Jung, GS; Jeon, JH; Jung, YA; Choi, YK; Kim, HS; Kim, JG; Park, KG; Kim, MK; Lee, IK				Jung, Gwon-Soo; Jeon, Jae-Han; Jung, Yun-A; Choi, Yeon-Kyung; Kim, Hye-Soon; Kim, Jung-Guk; Park, Keun-Gyu; Kim, Mi-Kyung; Lee, In-Kyu			Clusterin/Apolipoprotein J Attenuates Angiotensin II-Induced Renal Fibrosis	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR-BETA; TUBULOINTERSTITIAL FIBROSIS; KIDNEY-DISEASE; TGF-BETA; DIABETIC-NEPHROPATHY; URETERAL OBSTRUCTION; DELAYED TREATMENT; OXIDATIVE STRESS; UP-REGULATION	The blockade of angiotensin II (Ang II) is a major therapeutic strategy for diabetic nephropathy. The main roles of Ang II in renal disease are mediated via the Ang type 1 receptor (AT1R). Upregulation of clusterin/apolipoprotein J has been reported in nephropathy models, suggesting it has a protective role in nephropathogenesis. Here, we studied how clusterin acts against Ang II-induced renal fibrosis. Levels of AT1R and fibrotic markers in clusterin-/- mice and Ang II infused rats transfected with an adenovirus encoding clusterin were evaluated by immunoblot analysis, real time RT-PCR, and immunohistochemical staining. The effect of clusterin on renal fibrosis was evaluated in NRK-52E cells, a cultured renal tubular epithelial cell line, using immunoblot analysis and real time RT-PCR. Nuclear localization of NF-kappa B was evaluated using immunofluorecence and co-immunoprecipitation. Renal fibrosis and expression of AT1R was higher in the kidneys of clusterin-/- mice than in those of wild-type mice. Furthermore, loss of clusterin accelerated Ang II-stimulated renal fibrosis and AT1R expression. Overexpression of clusterin in proximal tubular epithelial cells decreased the levels of Ang II-stimulated fibrotic markers and AT1R. Moreover, intrarenal delivery of clusterin attenuated Ang II-mediated expression of fibrotic markers and AT1R in rats. Fluorescence microscopy and co-immunoprecipitation in conjunction with western blot revealed that clusterin inhibited Ang II-stimulated nuclear localization of p-NF-kappa B via a direct physical interaction and subsequently decreased the AT1R level in proximal tubular epithelial cells. These data suggest that clusterin attenuates Ang II-induced renal fibrosis by inhibition of NF-kappa B activation and subsequent downregulation of AT1R. This study raises the possibility that clusterin could be used as a therapeutic target for Ang II-induced renal diseases.	[Jung, Gwon-Soo; Jeon, Jae-Han; Choi, Yeon-Kyung; Kim, Jung-Guk; Park, Keun-Gyu; Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Taegu, South Korea; [Jung, Yun-A; Kim, Hye-Soon; Kim, Mi-Kyung] Keimyung Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Taegu, South Korea	Kyungpook National University; Keimyung University	Kim, MK (corresponding author), Keimyung Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Taegu, South Korea.	mdkmk@dsmc.or.kr; leei@knu.ac.kr	Lee, In-Kyu/AAR-6374-2021		National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2010-0019514, 2012R1A2A2A01043867, NRF-2012R1A1A1010047, NRF-2013R1A1A3007064]; Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea [A111345]; Korean Diabetes Association Grant; Korea Science and Engineering Foundation (KOSEF) - Korea government (MEST) [2006-2005412]	National Research Foundation of Korea (NRF) - Ministry of Education; Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea; Korean Diabetes Association Grant; Korea Science and Engineering Foundation (KOSEF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorea Science and Engineering FoundationKorean Government)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2010-0019514, 2012R1A2A2A01043867, NRF-2012R1A1A1010047, NRF-2013R1A1A3007064), a grant from the Korea Health Technology R & D Project, Ministry of Health & Welfare, Republic of Korea (A111345), the Korean Diabetes Association Grant (2011) and by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (NO. 2006-2005412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; Brewster UC, 2004, AM J MED, V116, P263, DOI 10.1016/j.amjmed.2003.09.034; Calero M, 2005, SUB CELL BIOCHEM, V38, P273; Chuang LY, 2001, NEPHROLOGY, V6, P165, DOI 10.1046/j.1440-1797.2001.00043.x; Chung ACK, 2010, J AM SOC NEPHROL, V21, P249, DOI 10.1681/ASN.2009010018; Cooper ME, 2001, DIABETOLOGIA, V44, P1957, DOI 10.1007/s001250100000; Cowling RT, 2002, J BIOL CHEM, V277, P5719, DOI 10.1074/jbc.M107515200; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Gilmore TD, 1996, ONCOGENE, V13, P1367; Griffin KA, 2006, CLIN J AM SOC NEPHRO, V1, P1054, DOI 10.2215/CJN.02231205; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Ishidoya S, 1996, KIDNEY INT, V49, P1110, DOI 10.1038/ki.1996.161; ISHIDOYA S, 1995, KIDNEY INT, V47, P1285, DOI 10.1038/ki.1995.183; Jung GS, 2012, J AM SOC NEPHROL, V23, P73, DOI 10.1681/ASN.2011010048; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Lan HY, 2012, SEMIN NEPHROL, V32, P236, DOI 10.1016/j.semnephrol.2012.04.002; Lavoz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040490; Lee FTH, 2004, J AM SOC NEPHROL, V15, P2139, DOI 10.1097/01.ASN.0000135055.61833.A8; LEE SK, 1993, NEPHROL DIAL TRANSPL, V8, P1338; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; Okada H, 2004, BIOCHEM BIOPH RES CO, V314, P403, DOI 10.1016/j.bbrc.2003.12.105; Peters H, 1998, KIDNEY INT, V54, P1570, DOI 10.1046/j.1523-1755.1998.00164.x; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Ruiz-Ortega M, 2002, KIDNEY INT, V62, pS12, DOI 10.1046/j.1523-1755.62.s82.4.x; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Ruiz-Ortega M, 2000, CIRC RES, V86, P1266, DOI 10.1161/01.RES.86.12.1266; RuizOrtega M, 1997, KIDNEY INT, V52, P1497, DOI 10.1038/ki.1997.480; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Vaziri ND, 2007, J PHARMACOL EXP THER, V323, P85, DOI 10.1124/jpet.107.123638; Wolf G, 2000, NEPHROL DIAL TRANSPL, V15, P61, DOI 10.1093/ndt/15.suppl_6.61; Wolf G, 1998, MINER ELECTROL METAB, V24, P174, DOI 10.1159/000057367; WOLF G, 1993, J AM SOC NEPHROL, V3, P1531; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Yamada K, 2001, KIDNEY INT, V59, P137, DOI 10.1046/j.1523-1755.2001.00474.x; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Zhou XY, 2005, CURR OPIN CARDIOL, V20, P290	44	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105635	10.1371/journal.pone.0105635	http://dx.doi.org/10.1371/journal.pone.0105635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148511	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600064
J	Luo, HX; Wu, Q; Ye, XY; Xiong, Y; Zhu, JY; Xu, JY; Diao, YR; Zhang, D; Wang, MS; Qiu, JH; Miao, JT; Zhang, W; Wan, J				Luo, Hongxue; Wu, Qi; Ye, Xiaoyang; Xiong, Yi; Zhu, Jinyong; Xu, Junyu; Diao, Yarui; Zhang, Duo; Wang, Maosheng; Qiu, Jinhua; Miao, Jianting; Zhang, Wei; Wan, Jun			Genome-Wide Analysis of miRNA Signature in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							SIGNALING ALTERATION; MICRORNA TARGETS; MTOR; EXPRESSION; GENES; NEURODEGENERATION; DEPOSITION; SEQUENCES; PATHOLOGY; PATHWAYS	Alzheimer's disease (AD) is the most common cause of dementia. One of the pathological hallmarks of AD is amyloid beta (A beta) deposition. MicroRNAs (miRNAs) are small non-coding RNAs whose expression levels change significantly during neuronal pathogenesis and may be used as diagnostic markers. Some miRNAs are important in AD development by targeting genes responsible for A beta metabolism. However, a systematic assessment of the miRNA expression profile induced by A beta-mediated neuronal pathogenesis is still lacking. In the present study, we examined miRNA expression profile by using the APPswe/PS1 Delta E9 mouse model of AD. Two sibling pairs of mice were examined, showing 30 and 24 miRNAs with significantly altered expression levels from each paired control, respectively. Nine known miRNAs were common in both groups. Prediction of putative target genes and functional annotation implied that these altered miRNAs affect many target genes mainly involved in PI3K/Akt signaling pathway. This study provides a general profile of miRNAs regulated by A beta-associated signal pathways, which is helpful to understand the mechanism of A beta-induced neuronal dysfunction in AD development.	[Luo, Hongxue; Wu, Qi; Ye, Xiaoyang; Xiong, Yi; Zhu, Jinyong; Xu, Junyu; Zhang, Wei; Wan, Jun] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Shenzhen Key Lab Neuronal Struct Biol, Biomed Res Inst,Med Ctr, Shenzhen, Guangdong, Peoples R China; [Diao, Yarui] Ludwig Inst Canc Res, La Jolla, CA USA; [Zhang, Duo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Wang, Maosheng; Qiu, Jinhua] GaoZhou Peoples Hosp, Gao Zhou, Guangdong, Peoples R China; [Miao, Jianting] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Shanxi Province, Peoples R China; [Wan, Jun] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Ludwig Institute for Cancer Research; University of California System; University of California Los Angeles; Air Force Military Medical University; Hong Kong University of Science & Technology	Zhang, W (corresponding author), Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Shenzhen Key Lab Neuronal Struct Biol, Biomed Res Inst,Med Ctr, Shenzhen, Guangdong, Peoples R China.	zhangweispace@gmail.com; wanj@ust.hk	Ye, Xiaoyang/ABF-1682-2020	Wan, Jun/0000-0001-7308-0150	National Natural Scientific Foundation of China [81000465, 81171017]; Innovation Science and Technology Commission of Shenzhen Municipality for Basic Research Grant [JC201005260206A, JCYJ20120616153316095]; Peacock Plan Research Grant [KQC201105300001A]; Distinguished Young Scholars Grant [JC201005260218A]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Science and Technology Commission of Shenzhen Municipality for Basic Research Grant; Peacock Plan Research Grant; Distinguished Young Scholars Grant	This work was supported by the National Natural Scientific Foundation of China (Grant No. 81000465 and 81171017); and by Innovation Science and Technology Commission of Shenzhen Municipality for Basic Research Grants (Grant No. JC201005260206A, JCYJ20120616153316095), Peacock Plan Research Grant (Grant No. KQC201105300001A), Distinguished Young Scholars Grant (JC201005260218A). The funders had no contribution in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Chano T, 2007, BRAIN RES, V1168, P97, DOI 10.1016/j.brainres.2007.06.075; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Guo XB, 2010, BIOCHEM BIOPH RES CO, V398, P1, DOI 10.1016/j.bbrc.2010.05.082; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2007, SCIENCE, V317, P1179, DOI 10.1126/science.1148530; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Oddo Salvatore, 2012, Front Biosci (Schol Ed), V4, P941; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Phillips M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019567; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Satoh J, 2009, DIS MARKERS, V27, P239, DOI [10.1155/2009/618619, 10.3233/DMA-2009-0670]; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wu XF, 2010, BIOCHEM BIOPH RES CO, V393, P514, DOI 10.1016/j.bbrc.2010.02.038; Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003; Zhang Chun-zhi, 2009, Zhonghua Zhong Liu Za Zhi, V31, P721; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054111	48	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e101725	10.1371/journal.pone.0101725	http://dx.doi.org/10.1371/journal.pone.0101725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148207	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600002
J	Barth, MB; Moritz, RFA; Kraus, FB				Barth, Matthias Benjamin; Moritz, Robin Frederik Alexander; Kraus, Frank Bernhard			The Evolution of Extreme Polyandry in Social Insects: Insights from Army Ants	PLOS ONE			English	Article							GENETIC DIVERSITY; PATERNITY SKEW; MICROSATELLITE MARKERS; SPERM COMPETITION; MULTIPLE QUEENS; HYMENOPTERA; PATTERNS; BEHAVIOR; DNA; STATISTICS	The unique nomadic life-history pattern of army ants (army ant adaptive syndrome), including obligate colony fission and strongly male-biased sex-ratios, makes army ants prone to heavily reduced effective population sizes (N-e). Excessive multiple mating by queens (polyandry) has been suggested to compensate these negative effects by increasing genetic variance in colonies and populations. However, the combined effects and evolutionary consequences of polyandry and army ant life history on genetic colony and population structure have only been studied in a few selected species. Here we provide new genetic data on paternity frequencies, colony structure and paternity skew for the five Neotropical army ants Eciton mexicanum, E. vagans, Labidus coecus, L. praedator and Nomamyrmex esenbeckii; and compare those data among a total of nine army ant species (including literature data). The number of effective matings per queen ranged from about 6 up to 25 in our tested species, and we show that such extreme polyandry is in two ways highly adaptive. First, given the detected low intracolonial relatedness and population differentiation extreme polyandry may counteract inbreeding and low N-e. Second, as indicated by a negative correlation of paternity frequency and paternity skew, queens maximize intracolonial genotypic variance by increasingly equalizing paternity shares with higher numbers of sires. Thus, extreme polyandry is not only an integral part of the army ant syndrome, but generally adaptive in social insects by improving genetic variance, even at the high end spectrum of mating frequencies.	[Barth, Matthias Benjamin; Moritz, Robin Frederik Alexander; Kraus, Frank Bernhard] Univ Halle Wittenberg, Dept Zool, Inst Biol, D-06108 Halle, Saale, Germany; [Barth, Matthias Benjamin] Senckenberg Nat Hist Collect Dresden, Museum Zool, DNA Lab, Dresden, Germany; [Moritz, Robin Frederik Alexander] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Kraus, Frank Bernhard] Univ Hosp Halle, Dept Lab Med, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Pretoria; Martin Luther University Halle Wittenberg	Barth, MB (corresponding author), Univ Halle Wittenberg, Dept Zool, Inst Biol, D-06108 Halle, Saale, Germany.	benjamin.barth@zoologie.uni-halle.de	Kraus, Bernhard/B-8172-2011; Moritz, Robin FA/K-6053-2012	Kraus, Bernhard/0000-0003-4354-9952; Moritz, Robin FA/0000-0003-0791-887X; Barth, Benjamin/0000-0003-3459-2174	Saxony Anhalt; Mexican-European grant MUTUAL [FONCICYT 94293]	Saxony Anhalt; Mexican-European grant MUTUAL	This work was supported by the Graduate Scholarship of Saxony Anhalt (http://www.uni-halle.de/forschung/service/wissenschaftlicher_nachwuchs/gradfoerd_lsa/#anchor1071166), Mexican-European grant MUTUAL (FONCICYT 94293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; Barth MB, 2013, POPUL ECOL, V55, P523, DOI 10.1007/s10144-013-0383-4; Berghoff SM, 2008, J EVOLUTION BIOL, V21, P1125, DOI 10.1111/j.1420-9101.2008.01531.x; Boomsma Jacobus J., 2009, P3; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; Boomsma JJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P85, DOI 10.1007/s002650050415; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; BULMER MG, 1983, J THEOR BIOL, V100, P329, DOI 10.1016/0022-5193(83)90356-9; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; COLE BJ, 1983, BEHAV ECOL SOCIOBIOL, V12, P191, DOI 10.1007/BF00290771; Crozier RH, 2001, ANN ZOOL FENN, V38, P267; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; Denny AJ, 2004, MOL ECOL NOTES, V4, P234, DOI 10.1111/j.1471-8286.2004.00627.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Evison SEF, 2011, NATURWISSENSCHAFTEN, V98, P643, DOI 10.1007/s00114-011-0810-3; Franck P, 2002, ANIM BEHAV, V64, P503, DOI 10.1006/anbe.2002.3078; Franks N. R., 1983, Tropical rain forest; ecology and management, P151; FRANKS NR, 1985, FORTS ZOOL, V31, P91; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fuchs S, 1999, BEHAV ECOL SOCIOBIOL, V45, P269, DOI 10.1007/s002650050561; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goulson Dave, 2009, Glasgow Naturalist, V25, P31; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Holman L, 2011, MOL ECOL, V20, P5092, DOI 10.1111/j.1365-294X.2011.05338.x; Hughes WOH, 2008, J EVOLUTION BIOL, V21, P1090, DOI 10.1111/j.1420-9101.2008.01532.x; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Jaffe R, 2014, SOCIOBIOLOGY, V61, P1; Jaffe R, 2007, BIOL LETTERS, V3, P513, DOI 10.1098/rsbl.2007.0257; Jaffe R, 2014, NATURWISSENSCHAFTEN, V101, P261, DOI 10.1007/s00114-014-1149-3; Jaffe R, 2012, EVOLUTION, V66, P3778, DOI 10.1111/j.1558-5646.2012.01721.x; Jaffe R, 2009, POPUL ECOL, V51, P227, DOI 10.1007/s10144-008-0133-1; Kaspari M, 2003, EVOL ECOL RES, V5, P933; Kaspari M, 2011, J ANIM ECOL, V80, P818, DOI 10.1111/j.1365-2656.2011.01826.x; KELLER L, 1994, EVOLUTION, V48, P694, DOI [10.2307/2410479, 10.1111/j.1558-5646.1994.tb01354.x]; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kraus FB, 2011, BEHAV GENET, V41, P323, DOI 10.1007/s10519-010-9382-9; Kraus FB, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P413, DOI 10.1007/978-3-642-02624-9_14; Kraus FB, 2005, INSECT SOC, V52, P1, DOI 10.1007/s00040-004-0766-9; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; Kronauer DJC, 2007, CURR BIOL, V17, pR753, DOI 10.1016/j.cub.2007.06.057; Kronauer DJC, 2007, EVOLUTION, V61, P413, DOI 10.1111/j.1558-5646.2007.00040.x; Kronauer DJC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-20; Kronauer DJC, 2011, MOL ECOL, V20, P420, DOI 10.1111/j.1365-294X.2010.04945.x; Kronauer DJC, 2009, MYRMECOL NEWS, V12, P51; Kronauer DJC, 2004, MOL ECOL NOTES, V4, P289, DOI 10.1111/j.1471-8286.2004.00645.x; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Moilanen A, 2004, MOL ECOL NOTES, V4, P795, DOI 10.1111/j.1471-8286.2004.00779.x; MORITZ RFA, 1995, BEHAV ECOL SOCIOBIOL, V37, P357, DOI 10.1007/BF00174141; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2003, MOL ECOL, V12, P3157, DOI 10.1046/j.1365-294X.2003.01994.x; Nonacs P, 2007, J EVOLUTION BIOL, V20, P2253, DOI 10.1111/j.1420-9101.2007.01418.x; Nonacs P, 2003, ANIM BEHAV, V65, P615, DOI 10.1006/anbe.2003.2096; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; OHTA T, 1971, GENET RES, V18, P277, DOI 10.1017/S0016672300012684; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Packer L, 2001, CONSERV ECOL, V5; PAGE RE, 1989, NATURE, V338, P576, DOI 10.1038/338576a0; PAGE RE, 1982, AM NAT, V119, P263, DOI 10.1086/283907; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; PAMILO P, 1993, HEREDITY, V70, P472, DOI 10.1038/hdy.1993.69; Pamilo P, 1996, OIKOS, V75, P533, DOI 10.2307/3545895; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pearcy M, 2009, INSECT SOC, V56, P94, DOI 10.1007/s00040-008-1043-0; Powell S, 2004, INSECT SOC, V51, P342, DOI 10.1007/s00040-004-0752-2; Powell S, 2006, FUNCT ECOL, V20, P1105, DOI 10.1111/j.1365-2435.2006.01184.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; RETTENMEYER C W, 1978, Journal of the Kansas Entomological Society, V51, P581; RETTENMEYER CARL W., 1963, UNIV KANSAS SCI BULL, V44, P281; Schluns H, 2005, APIDOLOGIE, V36, P201, DOI 10.1051/apido:2005006; Schmid-Hempel P., 1998, Parasites in social insects.; Schneirla T. C., 1971, ARMY ANTS STUDY SOCI; Seppa Perttu, 2008, Myrmecological News, V11, P161; Simmons L. W., 2001, MG BEH ECOL; Starr C.K., 1984, P427; StatSoft Inc, 2008, STATISTICA DAT AN SO; Sundstrom L, 2000, P ROY SOC B-BIOL SCI, V267, P1439, DOI 10.1098/rspb.2000.1161; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Watkins JF., 1976, IDENTIFICATION DISTR; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zayed A, 2004, HEREDITY, V93, P627, DOI 10.1038/sj.hdy.6800588	87	15	16	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105621	10.1371/journal.pone.0105621	http://dx.doi.org/10.1371/journal.pone.0105621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144731	Green Submitted, gold, Green Published			2022-12-27	WOS:000341106100099
J	Kashi, VP; Ortega, SB; Karandikar, NJ				Kashi, Venkatesh P.; Ortega, Sterling B.; Karandikar, Nitin J.			Neuroantigen-Specific Autoregulatory CD8+T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function	PLOS ONE			English	Article							CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS LESIONS; CUTTING EDGE; CEREBROSPINAL-FLUID; CROSS-PRESENTATION; CLONAL EXPANSIONS; IMMUNE-RESPONSES; B-CELLS	Experimental autoimmune encephalomyelitis (EAE) is a well-established murine model of multiple sclerosis, an immune-mediated demyelinating disorder of the central nervous system (CNS). We have previously shown that CNS-specific CD8+ T cells (CNS-CD8+) ameliorate EAE, at least in part through modulation of CNS-specific CD4+ T cell responses. In this study, we show that CNS-CD8+ also modulate the function of CD11c+ dendritic cells (DC), but not other APCs such as CD11b+ monocytes or B220+ B cells. DC from mice receiving either myelin oligodendrocyte glycoprotein-specific CD8+ (MOG-CD8+) or proteolipid protein-specific CD8+ (PLP-CD8+) T cells were rendered inefficient in priming T cell responses from naive CD4+ T cells (OT-II) or supporting recall responses from CNS-specific CD4+ T cells. CNS-CD8+ did not alter DC subset distribution or MHC class II and CD86 expression, suggesting that DC maturation was not affected. However, the cytokine profile of DC from CNS-CD8+ recipients showed lower IL-12 and higher IL-10 production. These functions were not modulated in the absence of immunization with CD8-cognate antigen, suggesting an antigen-specific mechanism likely requiring CNS-CD8-DC interaction. Interestingly, blockade of IL-10 in vitro rescued CD4+ proliferation and in vivo expression of IL-10 was necessary for the suppression of EAE by MOG-CD8+. These studies demonstrate a complex interplay between CNS-specific CD8+ T cells, DC and pathogenic CD4+ T cells, with important implications for therapeutic interventions in this disease.	[Kashi, Venkatesh P.; Ortega, Sterling B.; Karandikar, Nitin J.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Karandikar, NJ (corresponding author), Univ Iowa Hlth Care, Dept Pathol, Iowa City, IA 52242 USA.	nitin-karandikar@uiowa.edu		Karandikar, Nitin/0000-0002-6867-6950; Ortega, Sterling/0000-0003-3542-9555	National Institutes of Health (NIH) [K24 AI079272, NIH R01 AI092106]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092106, K24AI079272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS051837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) K24 AI079272 and NIH R01 AI092106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Anderson AC, 2012, J IMMUNOL, V188, P2084, DOI 10.4049/jimmunol.1102186; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Bailey-Bucktrout SL, 2008, J IMMUNOL, V180, P6457, DOI 10.4049/jimmunol.180.10.6457; Baughman EJ, 2011, J AUTOIMMUN, V36, P115, DOI 10.1016/j.jaut.2010.12.003; Bettini M, 2009, J NEUROIMMUNOL, V213, P60, DOI 10.1016/j.jneuroim.2009.05.017; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Demangel C, 2002, EUR J IMMUNOL, V32, P994, DOI 10.1002/1521-4141(200204)32:4<994::AID-IMMU994>3.3.CO;2-Y; Deshpande P, 2007, J IMMUNOL, V178, P6695, DOI 10.4049/jimmunol.178.11.6695; Ford ML, 2005, EUR J IMMUNOL, V35, P76, DOI 10.1002/eji.200425660; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Gonzalez P, 2009, J NEUROPATH EXP NEUR, V68, P391, DOI 10.1097/NEN.0b013e31819dca30; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681; Huseby ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00064; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Ji QY, 2007, ANN NY ACAD SCI, V1103, P157, DOI 10.1196/annals.1394.017; Ji QY, 2013, NAT IMMUNOL, V14, P254, DOI 10.1038/ni.2513; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Jurewicz A, 1998, J IMMUNOL, V160, P3056; Kala M, 2010, EXP NEUROL, V221, P136, DOI 10.1016/j.expneurol.2009.10.015; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Lee YH, 2008, J IMMUNOL, V180, P825, DOI 10.4049/jimmunol.180.2.825; Leech MD, 2013, J IMMUNOL, V190, P881, DOI 10.4049/jimmunol.1202925; Lewis KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007401; Linker RA, 2005, NEUROBIOL DIS, V19, P218, DOI 10.1016/j.nbd.2004.12.017; Mangalam AK, 2012, J AUTOIMMUN, V38, P344, DOI 10.1016/j.jaut.2012.02.004; Mars LT, 2007, J IMMUNOL, V179, P5090, DOI 10.4049/jimmunol.179.8.5090; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miller SD, 2007, ANN NY ACAD SCI, V1103, P179, DOI 10.1196/annals.1394.023; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Na SY, 2008, BRAIN, V131, P2353, DOI 10.1093/brain/awn148; Najafian N, 2003, J CLIN INVEST, V112, P1037, DOI 10.1172/JCI200317935; Ortega SB, 2013, J IMMUNOL, V191, P117, DOI 10.4049/jimmunol.1300452; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saxena A, 2008, J IMMUNOL, V181, P1617, DOI 10.4049/jimmunol.181.3.1617; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Segura E, 2013, J EXP MED, V210, P1035, DOI 10.1084/jem.20121103; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Sinha S, 2014, IMMUNOL RES; Skulina C, 2004, P NATL ACAD SCI USA, V101, P2428, DOI 10.1073/pnas.0308689100; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; WOODROOFE MN, 1986, J NEUROL SCI, V74, P135, DOI 10.1016/0022-510X(86)90100-0; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025; York NR, 2010, J AUTOIMMUN, V35, P33, DOI 10.1016/j.jaut.2010.01.003; Zhou H, 2014, EUR J IMMUNOL; Zozulya AL, 2008, HUM IMMUNOL, V69, P797, DOI 10.1016/j.humimm.2008.07.014	58	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105763	10.1371/journal.pone.0105763	http://dx.doi.org/10.1371/journal.pone.0105763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144738	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100119
J	Schafer, JL; Just, MG				Schafer, Jennifer L.; Just, Michael G.			Size Dependency of Post-Disturbance Recovery of Multi-Stemmed Resprouting Trees	PLOS ONE			English	Article							LONGLEAF PINE SAVANNAS; SOUTHEASTERN UNITED-STATES; SHRUB ERICA-AUSTRALIS; HEIGHT GROWTH; GRASSLAND COMMUNITIES; WOODY-PLANTS; QUERCUS-ILEX; FIRE REGIMES; VEGETATION; PERSISTENCE	In frequently burned ecosystems, many plants persist by repeated resprouting from basal or belowground buds. This strategy requires that plants reach a balance between biomass loss and recovery, which depends on the shape of the relationship between pre- and post-fire size. Previous analyses of this relationship, however, have focused on the size of the largest stem, which ignores the importance of the multi-stem growth habit that is common in pyrogenic ecosystems. We hypothesized that the presence of multiple stems causes a substantial shift in the relationship between pre- and post-fire size and in the relationship between pre-fire size and size recovery. We measured the height and basal diameter, then calculated volume and biomass, of all stems of six tree species before and nine months after complete removal of aboveground biomass via coppicing. The number of resprouts was correlated with the original number of stems for four species. For all species, the relationship between pre-coppicing and resprout size fit a positive curvilinear function, and the shape of this curve did not differ for maximum and total stem size. Smaller individuals recovered a larger proportion of their pre-coppicing size than larger individuals, but the shape of the size recovery curves were the same regardless of whether the analysis was performed with all stems or only the largest stem. Our results indicate that measuring only the largest stem of multi-stemmed individuals is sufficient to assess the ability of individuals to recover after complete loss of aboveground biomass and persist under frequent burning.	[Schafer, Jennifer L.; Just, Michael G.] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Schafer, JL (corresponding author), William Jewell Coll, Dept Biol, Liberty, MO 64068 USA.	schaferj@william.jewell.edu	Just, Michael G/N-1279-2013	Just, Michael G/0000-0003-2493-9269	US Army Engineer Research and Development Center [W9132T-11-2-0007]; North Carolina State University [W9132T-11-2-0007]	US Army Engineer Research and Development Center(United States Department of DefenseUnited States Army); North Carolina State University	This research was supported by a cooperative agreement between the US Army Engineer Research and Development Center and North Carolina State University (W9132T-11-2-0007 to W. Hoffmann). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Bonfil C, 2004, J VEG SCI, V15, P423, DOI 10.1658/1100-9233(2004)015[0423:TRODIT]2.0.CO;2; BOWEN BJ, 1993, ANN BOT-LONDON, V72, P7, DOI 10.1006/anbo.1993.1075; Canadell J, 1998, FUNCT ECOL, V12, P31, DOI 10.1046/j.1365-2435.1998.00154.x; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Cruz A, 2003, NEW PHYTOL, V157, P251, DOI 10.1046/j.1469-8137.2003.00668.x; Cruz A, 2002, J VEG SCI, V13, P641, DOI 10.1111/j.1654-1103.2002.tb02092.x; Dacy EC, 2009, RANGELAND ECOL MANAG, V62, P179, DOI 10.2111/08-125.1; DAVIES SJ, 1991, AUST J BOT, V39, P459, DOI 10.1071/BT9910459; Drewa PB, 2006, APPL VEG SCI, V9, P27, DOI 10.1111/j.1654-109X.2006.tb00653.x; Drewa PB, 2002, ECOLOGY, V83, P755, DOI 10.1890/0012-9658(2002)083[0755:FEOROS]2.0.CO;2; El Omari B, 2003, PLANT SOIL, V252, P349, DOI 10.1023/A:1024792206369; Falster DS, 2005, OIKOS, V111, P57, DOI 10.1111/j.0030-1299.2005.13383.x; Fang XW, 2013, TREE PHYSIOL, V33, P275, DOI 10.1093/treephys/tpt006; Fill JM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00044.1; Fowler C, 2007, HUM ECOL REV, V14, P165; Frost CC, 1995, FIRE WETLANDS MANAGE, V19, P39; Goorman R, 2011, PLANT ECOL, V212, P2023, DOI 10.1007/s11258-011-9967-2; Grady JM, 2012, ECOLOGY, V93, P2052, DOI 10.1890/12-0354.1; Hermann JM, 2012, PLANT ECOL, V213, P1757, DOI 10.1007/s11258-012-0131-4; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hmielowski TL, 2014, PLANT ECOL, V215, P1221, DOI 10.1007/s11258-014-0380-5; Hoffmann W.A., 2002, CERRADOS BRAZIL ECOL, P159, DOI DOI 10.7312/OLIV12042-008; Hoffmann WA, 2003, FOREST ECOL MANAG, V180, P273, DOI 10.1016/S0378-1127(02)00566-2; Kabeya D, 2005, ANN BOT-LONDON, V96, P479, DOI 10.1093/aob/mci200; Kennedy LM, 2008, BIOTROPICA, V40, P412, DOI 10.1111/j.1744-7429.2007.00394.x; KING DA, 1986, ECOLOGY, V67, P980, DOI 10.2307/1939821; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; Konstantinidis P, 2006, FOREST ECOL MANAG, V225, P359, DOI 10.1016/j.foreco.2006.01.011; Kozovits AR, 2005, NEW PHYTOL, V167, P181, DOI 10.1111/j.1469-8137.2005.01391.x; Krall JS, 2014, BIOL INVASIONS, V16, P1055, DOI 10.1007/s10530-013-0557-1; Lashley MA, 2014, ECOL INDIC, V38, P212, DOI 10.1016/j.ecolind.2013.11.006; LLORET F, 1993, J VEG SCI, V4, P367, DOI 10.2307/3235595; Maguire AJ, 2011, FIRE ECOL, V7, P12, DOI 10.4996/fireecology.0703012; MALANSON GP, 1988, J ECOL, V76, P351, DOI 10.2307/2260598; Masaka K, 2000, ANN BOT-LONDON, V85, P137, DOI 10.1006/anbo.1999.1007; Moreira B, 2012, OIKOS, V121, P1577, DOI 10.1111/j.1600-0706.2011.20258.x; MORENO JM, 1991, OECOLOGIA, V85, P429, DOI 10.1007/BF00320621; Niklas KJ, 2007, TREE PHYSIOL, V27, P433, DOI 10.1093/treephys/27.3.433; Niklas KJ, 2006, ANN BOT-LONDON, V97, P155, DOI 10.1093/aob/mcj021; Niklas KJ, 2005, AM J BOT, V92, P1256, DOI 10.3732/ajb.92.8.1256; Noble JC, 2001, AUST J BOT, V49, P31, DOI 10.1071/BT00046; Olano JM, 2006, NEW PHYTOL, V170, P99, DOI 10.1111/j.1469-8137.2005.01634.x; OLSON MS, 1995, VEGETATIO, V119, P101, DOI 10.1007/BF00045593; Paula S, 2009, BOTANY, V87, P253, DOI 10.1139/B08-134; Robertson KM, 2014, OECOLOGIA, V174, P765, DOI 10.1007/s00442-013-2823-4; Robertson KM, 2009, SOUTH J APPL FOR, V33, P121, DOI 10.1093/sjaf/33.3.121; Schafale MP, 1990, CLASSIFICATION NATUR, P321; Schafer JL, 2014, AM MIDL NAT IN PRESS; Schafer JL, 2010, THESIS U FLORIDA GAI, P257; Schutz AEN, 2009, OECOLOGIA, V160, P235, DOI 10.1007/s00442-009-1293-1; Sorrie BA, 2006, CASTANEA, V71, P129, DOI 10.2179/05-02.1; Stambaugh MC, 2011, J VEG SCI, V22, P1094, DOI 10.1111/j.1654-1103.2011.01322.x; *USDA, 2007, SOIL SURV GEOGR SSUR; Vesk PA, 2004, J ECOL, V92, P310, DOI 10.1111/j.0022-0477.2004.00871.x; WALDROP TA, 1992, FOREST ECOL MANAG, V47, P195, DOI 10.1016/0378-1127(92)90274-D	57	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105600	10.1371/journal.pone.0105600	http://dx.doi.org/10.1371/journal.pone.0105600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144236	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100092
J	Chapman, LAC; Shipley, RJ; Whiteley, JP; Ellis, MJ; Byrne, HM; Waters, SL				Chapman, Lloyd A. C.; Shipley, Rebecca J.; Whiteley, Jonathan P.; Ellis, Marianne J.; Byrne, Helen M.; Waters, Sarah L.			Optimising Cell Aggregate Expansion in a Perfused Hollow Fibre Bioreactor via Mathematical Modelling	PLOS ONE			English	Article							3-DIMENSIONAL BONE TISSUE; SHEAR-STRESS; MICROCHANNEL BIOREACTOR; NUTRIENT TRANSPORT; MASS-TRANSPORT; CULTURE; PROLIFERATION; GROWTH; SCAFFOLD; SIMULATION	The need for efficient and controlled expansion of cell populations is paramount in tissue engineering. Hollow fibre bioreactors (HFBs) have the potential to meet this need, but only with improved understanding of how operating conditions and cell seeding strategy affect cell proliferation in the bioreactor. This study is designed to assess the effects of two key operating parameters (the flow rate of culture medium into the fibre lumen and the fluid pressure imposed at the lumen outlet), together with the cell seeding distribution, on cell population growth in a single-fibre HFB. This is achieved using mathematical modelling and numerical methods to simulate the growth of cell aggregates along the outer surface of the fibre in response to the local oxygen concentration and fluid shear stress. The oxygen delivery to the cell aggregates and the fluid shear stress increase as the flow rate and pressure imposed at the lumen outlet are increased. Although the increased oxygen delivery promotes growth, the higher fluid shear stress can lead to cell death. For a given cell type and initial aggregate distribution, the operating parameters that give the most rapid overall growth can be identified from simulations. For example, when aggregates of rat cardiomyocytes that can tolerate shear stresses of up to 0.05 Pa are evenly distributed along the fibre, the inlet flow rate and outlet pressure that maximise the overall growth rate are predicted to be in the ranges 2.75 x 10(-5)m(2) s(-1) to 3 x 10(-5)m(2) s(-1) (equivalent to 2.07 ml min(-1) to 2.26 ml min(-1)) and 1.077 x 10(5) Pa to 1.083 x 10(5) Pa (or 15.6 psi to 15.7 psi) respectively. The combined effects of the seeding distribution and flow on the growth are also investigated and the optimal conditions for growth found to depend on the shear tolerance and oxygen demands of the cells.	[Chapman, Lloyd A. C.; Byrne, Helen M.; Waters, Sarah L.] Univ Oxford, Math Inst, Oxford, England; [Shipley, Rebecca J.] UCL, Dept Mech Engn, London, England; [Chapman, Lloyd A. C.; Whiteley, Jonathan P.; Byrne, Helen M.] Univ Oxford, Dept Comp Sci, Oxford, England; [Ellis, Marianne J.] Univ Bath, Dept Chem Engn, Bath BA2 7AY, Avon, England	University of Oxford; University of London; University College London; University of Oxford; University of Bath	Waters, SL (corresponding author), Univ Oxford, Math Inst, Oxford, England.	waters@maths.ox.ac.uk		Waters, Sarah/0000-0001-5285-0523; Ellis, Marianne/0000-0003-4155-0853; Chapman, Lloyd/0000-0001-7727-7102; Shipley, Rebecca/0000-0002-2818-6228; Byrne, Helen/0000-0003-1771-5910	EPSRC Life Sciences Interface Doctoral Training Centre from the University of Oxford [EP/F500394/1]; King Abdullah University of Science and Technology, Saudi Arabia [KUK-C1-013-04]; EPSRC through an Advanced Research Fellowship; EPSRC [EP/D070635/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D070635/2] Funding Source: researchfish	EPSRC Life Sciences Interface Doctoral Training Centre from the University of Oxford(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); King Abdullah University of Science and Technology, Saudi Arabia(King Abdullah University of Science & Technology); EPSRC through an Advanced Research Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work is primarily supported by an EPSRC Life Sciences Interface Doctoral Training Centre grant from the University of Oxford (EP/F500394/1). HMB is supported by King Abdullah University of Science and Technology, Saudi Arabia (Award No. KUK-C1-013-04). SLW is funded by the EPSRC through an Advanced Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brayfield CA, 2008, THESIS U PITTSBURGH; Brotherton JD, 1996, BIOTECHNOL PROGR, V12, P575, DOI 10.1021/bp960002g; Elert G, 2011, DENSITY PHYS HYPERTE; Ellis MJ, 2007, BIOTECHNOL BIOENG, V96, P177, DOI 10.1002/bit.21093; Korin N, 2007, LAB CHIP, V7, P611, DOI 10.1039/b702392h; Ladoux B, 2009, NAT PHYS, V5, P377, DOI 10.1038/nphys1281; Landman KA, 2007, B MATH BIOL, V69, P2405, DOI 10.1007/s11538-007-9225-x; Lemon G, 2006, J MATH BIOL, V52, P571, DOI 10.1007/s00285-005-0363-1; Lu HF, 2005, TISSUE ENG, V11, P1667, DOI 10.1089/ten.2005.11.1667; McCoy RJ, 2010, TISSUE ENG PART B-RE, V16, P587, DOI [10.1089/ten.teb.2010.0370, 10.1089/ten.TEB.2010.0370]; MCELWAIN DLS, 1977, MATH BIOSCI, V35, P267, DOI 10.1016/0025-5564(77)90028-1; Meneghello G, 2009, J MEMBRANE SCI, V344, P55, DOI 10.1016/j.memsci.2009.07.034; Mohebbi-Kalhori D, 2012, J ARTIF ORGANS, V15, P250, DOI 10.1007/s10047-012-0649-1; O'Dea RD, 2010, MATH MED BIOL, V27, P95, DOI 10.1093/imammb/dqp003; O'Dea RD, 2013, COMPUTATIONAL MODELI, P229; Pearson NC, 2014, MATH MED BIOL, V31, P393, DOI 10.1093/imammb/dqt015; Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004; Rodrigues CAV, 2011, BIOTECHNOL ADV, V29, P815, DOI 10.1016/j.biotechadv.2011.06.009; Saxby L, 1998, BRIT J OPHTHALMOL, V82, P945, DOI 10.1136/bjo.82.8.945; Shakeel M, 2013, MATH MED BIOL, V30, P21, DOI 10.1093/imammb/dqr022; Shipley RJ, 2010, BIOTECHNOL BIOENG, V107, P382, DOI 10.1002/bit.22815; Shipley RJ, 2012, MATH MED BIOL, V29, P329, DOI 10.1093/imammb/dqr025; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; THARAKAN JP, 1986, BIOTECHNOL BIOENG, V28, P329, DOI 10.1002/bit.260280305; Treloar KK, 2014, J THEOR BIOL, V356, P71, DOI 10.1016/j.jtbi.2014.04.026; Ye H, 2006, J MEMBRANE SCI, V272, P169, DOI 10.1016/j.memsci.2005.07.040; Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I; Zeng Y, 2006, J BIOMECH ENG-T ASME, V128, P185, DOI 10.1115/1.2170118; Zhao F, 2005, BIOTECHNOL PROGR, V21, P1269, DOI 10.1021/bp0500664; Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184	31	17	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105813	10.1371/journal.pone.0105813	http://dx.doi.org/10.1371/journal.pone.0105813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157635	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000341303200067
J	Zhuang, Q; Di, ZR; Wu, JS				Zhuang, Qian; Di, Zengru; Wu, Jinshan			Stability of Mixed-Strategy-Based Iterative Logit Quantal Response Dynamics in Game Theory	PLOS ONE			English	Article							NASH EQUILIBRIUM; FICTITIOUS PLAY	Using the Logit quantal response form as the response function in each step, the original definition of static quantal response equilibrium (QRE) is extended into an iterative evolution process. QREs remain as the fixed points of the dynamic process. However, depending on whether such fixed points are the long-term solutions of the dynamic process, they can be classified into stable (SQREs) and unstable (USQREs) equilibriums. This extension resembles the extension from static Nash equilibriums (NEs) to evolutionary stable solutions in the framework of evolutionary game theory. The relation between SQREs and other solution concepts of games, including NEs and QREs, is discussed. Using experimental data from other published papers, we perform a preliminary comparison between SQREs, NEs, QREs and the observed behavioral outcomes of those experiments. For certain games, we determine that SQREs have better predictive power than QREs and NEs.	[Zhuang, Qian; Di, Zengru; Wu, Jinshan] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Zhuang, Qian] Nanjing Agr Univ, Coll Informat Sci & Technol, Nanjing, Jiangsu, Peoples R China	Beijing Normal University; Nanjing Agricultural University	Wu, JS (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	jinshanw@bnu.edu.cn	Wu, Jinshan/C-1203-2010	Wu, Jinshan/0000-0001-5014-385X	Fundamental Research Funds for the Central Universities, China	Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This paper was supported by the Fundamental Research Funds for the Central Universities, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos-Ferrer C, 2010, GAME ECON BEHAV, V68, P413, DOI 10.1016/j.geb.2009.08.004; AUMANN RJ, 1987, ECONOMETRICA, V55, P1, DOI 10.2307/1911154; Baron R, 2002, J EVOL ECON, V12, P563, DOI 10.1007/s00191-002-0135-7; Berger U, 2005, J ECON THEORY, V120, P139, DOI 10.1016/j.jet.2004.02.003; Borgers T, 1997, J ECON THEORY, V77, P1, DOI 10.1006/jeth.1997.2319; Brown G., 1951, ACT ANAL PROD ALLOCA, P374; Chen HC, 1997, GAME ECON BEHAV, V18, P32, DOI 10.1006/game.1997.0514; Dixit A., 2009, GAMES STRATEGY, V3rd; Erev I, 2007, ECON THEOR, V33, P29, DOI 10.1007/s00199-007-0214-y; FUDENBERG D, 1993, GAME ECON BEHAV, V5, P320, DOI 10.1006/game.1993.1021; Fudenberg D., 1998, MIT PRESS SERIES EC; Fudenberg D, 2009, ANNU REV ECON, V1, P385, DOI 10.1146/annurev.economics.050708.142930; Goeree JK, 2004, GAME ECON BEHAV, V46, P365, DOI 10.1016/S0899-8256(03)00145-3; Goeree JK, 2001, AM ECON REV, V91, P1402, DOI 10.1257/aer.91.5.1402; Haile PA, 2008, AM ECON REV, V98, P180, DOI 10.1257/aer.98.1.180; Harsanyi J. C., 1988, GEN THEORY EQUILIBRI; Hofbauer J, 1996, J ECON THEORY, V71, P558, DOI 10.1006/jeth.1996.0133; Holt CA, 2004, P NATL ACAD SCI USA, V101, P3999, DOI 10.1073/pnas.0308738101; Hommes CH, 2012, GAME ECON BEHAV, V74, P434, DOI 10.1016/j.geb.2011.05.014; Hopkins E, 2002, ECONOMETRICA, V70, P2141, DOI 10.1111/j.1468-0262.2002.00436.x; JORDAN JS, 1993, GAME ECON BEHAV, V5, P368, DOI 10.1006/game.1993.1022; Konno T, 2011, EXACT SOLUTION SPATI; Krishna V, 1998, MATH OPER RES, V23, P479, DOI 10.1287/moor.23.2.479; McKelvey R. D., 1998, Experimental Economics, V1, P9, DOI 10.1023/A:1009905800005; Mckelvey R. D., 1996, JAPANESE EC REV, V47, P186; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Morgan J, 2002, GAME ECON BEHAV, V40, P123, DOI 10.1006/game.2001.0905; Myerson Roger., 1978, INT J GAME THEORY, V7, P73, DOI DOI 10.1007/BF01753236; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; OCHS J, 1995, GAME ECON BEHAV, V10, P202, DOI 10.1006/game.1995.1030; Sabourian H, 2007, FDN FORMAL SCI 5; Samuelson L., 1998, EVOLUTIONARY GAMES E; Strogatz SH., 1994, NONLINEAR DYNAMICS C, V1; Weibull J W, 1997, EVOLUTIONARY GAME TH; Wolpert DH, 2006, UND COM SYS, P262; Wu J, 2004, ARXIVQUANTPH0404159; Xu B, 2012, PHYS LETT A, V376, P1318, DOI 10.1016/j.physleta.2012.02.047	38	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105391	10.1371/journal.pone.0105391	http://dx.doi.org/10.1371/journal.pone.0105391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157502	gold, Green Submitted, Green Published			2022-12-27	WOS:000341303200029
J	Costa, KM; Maciel, IS; Kist, LW; Campos, MM; Bogo, MR				Costa, Kesiane M.; Maciel, Izaque S.; Kist, Luiza W.; Campos, Maria M.; Bogo, Mauricio R.			Pharmacological Inhibition of CXCR2 Chemokine Receptors Modulates Paraquat-Induced Intoxication in Rats	PLOS ONE			English	Article							PARKINSONS-DISEASE; NITRIC-OXIDE; HEMORRHAGIC CYSTITIS; LIPID-PEROXIDATION; MOUSE-BRAIN; CELL-DEATH; ADULT RATS; IN-VIVO; EXPRESSION; MODEL	Paraquat (PQ) is an agrochemical agent commonly used worldwide, which is allied to potential risks of intoxication. This herbicide induces the formation of reactive oxygen species (ROS) that ends up compromising various organs, particularly the lungs and the brain. This study evaluated the deleterious effects of paraquat on the central nervous system (CNS) and peripherally, with special attempts to assess the putative protective effects of the selective CXCR2 receptor antagonist SB225002 on these parameters. PQ-toxicity was induced in male Wistar rats, in a total dose of 50 mg/kg, and control animals received saline solution at the same schedule of administration. Separate groups of animals were treated with the selective CXCR2 antagonist SB225002 (1 or 3 mg/kg), administered 30 min before each paraquat injection. The major changes found in paraquat-treated animals were: decreased body weight and hypothermia, nociception behavior, impairment of locomotor and gait capabilities, enhanced TNF-alpha and IL-1 beta expression in the striatum, and cell migration to the lungs and blood. Some of these parameters were reversed when the antagonist SB225002 was administered, including recovery of physiological parameters, decreased nociception, improvement of gait abnormalities, modulation of striatal TNF-alpha and IL-1 beta expression, and decrease of neutrophil migration to the lungs and blood. Taken together, our results demonstrate that damage to the central and peripheral systems elicited by paraquat can be prevented by the pharmacological inhibition of CXCR2 chemokine receptors. The experimental evidence presented herein extends the comprehension on the toxicodynamic aspects of paraquat, and opens new avenues to treat intoxication induced by this herbicide.	[Costa, Kesiane M.; Maciel, Izaque S.; Kist, Luiza W.; Campos, Maria M.; Bogo, Mauricio R.] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil; [Kist, Luiza W.; Bogo, Mauricio R.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biosci, Lab Genom & Mol Biol, Porto Alegre, RS, Brazil; [Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Inst Pharmacol & Toxicol, Porto Alegre, RS, Brazil; [Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Fac Dent, Porto Alegre, RS, Brazil; [Bogo, Mauricio R.] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Cellular & Mol Biol, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Bogo, MR (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil.	mbogo@pucrs.br	de Sousa Maciel, Izaque/AAD-9693-2020; Maciel, Izaque/I-1038-2014; Kist, Luiza Wilges/J-3786-2013; Campos, Maria Martha M/J-8829-2015; Bogo, Mauricio R/D-7537-2013	de Sousa Maciel, Izaque/0000-0001-6597-5288; Kist, Luiza Wilges/0000-0001-6358-9367; Campos, Maria Martha M/0000-0002-1153-3633; Bogo, Mauricio R/0000-0002-5728-9576; Campos, Maria/0000-0001-7738-9892	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); DECIT/SCTIEMS through CNPq; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [Proc. FAPERGS 10/0036-5 - PRONEX]; FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS'' (PUCRSINFRA) [01.11.0014-00]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DECIT/SCTIEMS through CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS'' (PUCRSINFRA)	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), DECIT/SCTIEMS through CNPq and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) (Proc. FAPERGS 10/0036-5 - PRONEX), and FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS'' (PUCRSINFRA) # 01.11.0014-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073562; Bacon KB, 2000, J NEUROIMMUNOL, V104, P92, DOI 10.1016/S0165-5728(99)00266-0; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Carvalho MM, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-14; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chanyachukul T, 2004, TOXICOL LETT, V150, P259, DOI 10.1016/j.toxlet.2004.02.007; Cho JH, 2005, VASC PHARMACOL, V42, P171, DOI 10.1016/j.vph.2005.01.001; Choi WS, 2010, J NEUROPATH EXP NEUR, V69, P511, DOI 10.1097/NEN.0b013e3181db8100; Cicchetti F, 2005, NEUROBIOL DIS, V20, P360, DOI 10.1016/j.nbd.2005.03.018; Corasaniti MT, 1998, PHARMACOL TOXICOL, V83, P1, DOI 10.1111/j.1600-0773.1998.tb01434.x; Czerniczyniec A, 2011, FREE RADICAL BIO MED, V51, P1428, DOI 10.1016/j.freeradbiomed.2011.06.034; Day BJ, 1999, P NATL ACAD SCI USA, V96, P12760, DOI 10.1073/pnas.96.22.12760; DELLON ES, 1991, PLAST RECONSTR SURG, V88, P686, DOI 10.1097/00006534-199110000-00020; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Dinis-Oliveira RJ, 2006, TOXICOLOGY, V227, P73, DOI 10.1016/j.tox.2006.07.025; Dinis-Oliveira RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007149; Dornelles FN, 2014, BRIT J PHARMACOL, V171, P452, DOI 10.1111/bph.12467; Fareed M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069755; Gupta SP, 2010, NEUROCHEM RES, V35, P1206, DOI 10.1007/s11064-010-0176-5; Hanafy S, 2012, J PHARM PHARM SCI, V15, P361, DOI 10.18433/J30300; Hayashi A, 2013, NEUROMOL MED, V15, P238, DOI 10.1007/s12017-012-8214-x; HOLLAND HC, 1968, ACTA PSYCHOL, V28, P293, DOI 10.1016/0001-6918(68)90020-6; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Hsieh YW, 2013, PEDIATR EMERG CARE, V29, P487, DOI 10.1097/PEC.0b013e31828a347e; Kang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078160; Kang MJ, 2010, TOXICOL LETT, V195, P127, DOI 10.1016/j.toxlet.2010.03.011; Kireev RA, 2012, J SURG RES, V178, P922, DOI 10.1016/j.jss.2012.04.060; KORNBRUST DJ, 1980, TOXICOL APPL PHARM, V53, P323, DOI 10.1016/0041-008X(80)90433-0; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Litteljohn D, 2008, EUR J NEUROSCI, V28, P707, DOI 10.1111/j.1460-9568.2008.06371.x; Mainwaring G, 2006, TOXICOLOGY, V225, P157, DOI 10.1016/j.tox.2006.05.017; Manjavachi MN, 2010, EUR J PAIN, V14, P23, DOI 10.1016/j.ejpain.2009.01.007; Martins JP, 2012, BRIT J PHARMACOL, V165, P183, DOI 10.1111/j.1476-5381.2011.01535.x; Mitra S, 2006, BBA-MOL BASIS DIS, V1762, P732, DOI 10.1016/j.bbadis.2006.06.011; Mitra S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-163; Moretto A, 2013, TOXICOLOGY, V307, P24, DOI 10.1016/j.tox.2012.11.021; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nasser MW, 2007, J BIOL CHEM, V282, P6906, DOI 10.1074/jbc.M610289200; Nguyen D, 2001, DEV BRAIN RES, V128, P77, DOI 10.1016/S0165-3806(01)00128-6; Paolillo N, 2011, INT J IMMUNOPATH PH, V24, P861, DOI 10.1177/039463201102400405; Pereira VM, 2012, NEUROTOXICOLOGY, V33, P469, DOI 10.1016/j.neuro.2012.03.005; Pilny Anthony A., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P523, DOI 10.1016/j.cvex.2008.04.001; Popivanova BK, 2003, BRAIN RES, V970, P195, DOI 10.1016/S0006-8993(03)02343-6; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Richter F, 2008, BRAIN RES, V1188, P148, DOI 10.1016/j.brainres.2007.09.083; ROSE MS, 1976, BIOCHEM PHARMACOL, V25, P419, DOI 10.1016/0006-2952(76)90344-0; Santos AA, 2010, N-S ARCH PHARMACOL, V382, P399, DOI 10.1007/s00210-010-0555-0; Satomi Yoshihide, 2004, J Toxicol Sci, V29, P91, DOI 10.2131/jts.29.91; Singh LP, 2012, EXP NEUROL, V238, P79, DOI 10.1016/j.expneurol.2012.08.009; Smith P, 1975, J Clin Pathol Suppl (R Coll Pathol), V9, P81, DOI 10.1136/jcp.28.Suppl_9.81; Souza DG, 2000, EUR J PHARMACOL, V403, P121, DOI 10.1016/S0014-2999(00)00574-4; Thrash Bessy, 2007, Proc West Pharmacol Soc, V50, P31; Tomita M, 2007, TOXICOLOGY, V231, P200, DOI 10.1016/j.tox.2006.12.005; Vaculin S, 2010, NEUROSCI LETT, V477, P82, DOI 10.1016/j.neulet.2010.04.037; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Venkatesan N, 1999, LIFE SCI, V66, pPL21, DOI 10.1016/S0024-3205(99)00576-7; WALLACE JE, 1980, J GERONTOL, V35, P364, DOI 10.1093/geronj/35.3.364; Wantuch C, 2007, NEUROSCI LETT, V421, P250, DOI 10.1016/j.neulet.2007.05.043; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Zhang ZJ, 2013, PAIN, V154, P2185, DOI 10.1016/j.pain.2013.07.002; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	64	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105740	10.1371/journal.pone.0105740	http://dx.doi.org/10.1371/journal.pone.0105740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153082	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200079
J	Knipping, K; Simons, PJ; Buelens-Sleumer, LS; Cox, L; den Hartog, M; de Jong, N; Teshima, R; Garssen, J; Boon, L; Knippels, LMJ				Knipping, Karen; Simons, Peter J.; Buelens-Sleumer, Laura S.; Cox, Linda; den Hartog, Marcel; de Jong, Niels; Teshima, Reiko; Garssen, Johan; Boon, Louis; Knippels, Leon M. J.			Development of beta-Lactoglobulin-Specific Chimeric Human IgE kappa Monoclonal Antibodies for In Vitro Safety Assessment of Whey Hydrolysates	PLOS ONE			English	Article							COWS MILK ALLERGY; INFANT FORMULAS; SERUM IGE; CELL DEGRANULATION; BINDING EPITOPES; CROSS-LINKING; MAST-CELLS; PREVENTION; FOOD; ALLERGENICITY	Background: Cow's milk-derived whey hydrolysates are nutritional substitutes for allergic infants. Safety or residual allergenicity assessment of these whey hydrolysates is crucial. Currently, rat basophilic leukemia RBL-2H3 cells expressing the human IgE receptor alpha-chain (huFc epsilon RI alpha-RBL-2H3), sensitized with serum IgE from cow's milk allergic children, are being employed to assess in vitro residual allergenicity of these whey hydrolysates. However, limited availability and inter-lot variation of these allergic sera impede standardization of whey hydrolysate safety testing in degranulation assays. Objective: An oligoclonal pool of chimeric human (chu)IgE antibodies against bovine beta-lactoglobulin (a major allergen in whey) was generated to increase sensitivity, specificity, and reproducibility of existing degranulation assays. Methods: Mice were immunized with bovine beta-lactoglobulin, and subsequently the variable domains of dissimilar anti-blactoglobulin mouse IgG antibodies were cloned and sequenced. Six chimeric antibodies were generated comprising mouse variable domains and human constant IgE/kappa domains. Results: After sensitization with this pool of anti-beta-lactoglobulin chuIgEs, huFc epsilon RI alpha-expressing RBL-2H3 cells demonstrated degranulation upon cross-linking with whey, native 18 kDa beta-lactoglobulin, and 5-10 kDa whey hydrolysates, whereas a 3 kDa whey hydrolysate and cow's milk powder (mainly casein) showed no degranulation. In parallel, allergic serum IgEs were less sensitive. In addition, our pool anti-beta-lactoglobulin chuIgEs recognized multiple allergenic immunodominant regions on beta-lactoglobulin, which were also recognized by serum IgEs from cow's milk allergic children. Conclusion: Usage of our 'unlimited' source and well-defined pool of beta-lactoglobulin-specific recombinant chuIgEs to sensitize huFc epsilon RI alpha on RBL-2H3 cells showed to be a relevant and sensitive alternative for serum IgEs from cow's milk allergic patients to assess safety of whey-based non-allergic hydrolyzed formula.	[Knipping, Karen; Buelens-Sleumer, Laura S.; Garssen, Johan; Knippels, Leon M. J.] Nutricia Res BV, Utrecht, Netherlands; [Knipping, Karen; Garssen, Johan; Knippels, Leon M. J.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Simons, Peter J.; Cox, Linda; den Hartog, Marcel; de Jong, Niels; Boon, Louis] Bioceros Holding BV, Utrecht, Netherlands; [Teshima, Reiko] Natl Inst Hlth Sci, Div Foods, Tokyo, Japan	Danone Nutricia; Utrecht University; Bioceros B.V.; National Institute of Health Sciences - Japan	Knipping, K (corresponding author), Nutricia Res BV, Utrecht, Netherlands.	karen.knipping@danone.com; p.simons@bioceros.com	garssen, johan/I-7159-2016; Boon, Laurence/HCI-3629-2022	Boon, Louis/0000-0002-0937-9171	Agentschap NL within the SLIM (SneLler van Innovatie naar Mens) project [PID 101063]	Agentschap NL within the SLIM (SneLler van Innovatie naar Mens) project	This study is financially supported by Agentschap NL within the SLIM (SneLler van Innovatie naar Mens) project in frame of 'Pieken in de Delta' (PID 101063) to improve fast implementation of alternatives for animal testing. Funding received by KK, PS, LBS, LC, MdH, NdJ, JG, LB and LK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan YH, 2002, J PAEDIATR CHILD H, V38, P84, DOI 10.1046/j.1440-1754.2002.00725.x; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Cocco RR, 2007, CLIN EXP ALLERGY, V37, P831, DOI 10.1111/j.1365-2222.2007.02712.x; Dibbern DA, 2003, J IMMUNOL METHODS, V274, P37, DOI 10.1016/S0022-1759(02)00369-1; Fritsche R, 2003, TOXICOL LETT, V140, P303, DOI 10.1016/S0378-4274(03)00026-2; Halken S, 2000, PEDIATR ALLERGY IMMU, V11, P149, DOI 10.1034/j.1399-3038.2000.00081.x; Hays T, 2005, ARCH PEDIAT ADOL MED, V159, P810, DOI 10.1001/archpedi.159.9.810; Howard G., 2006, MAKING USING ANTIBOD; HUDSON MJ, 1995, EUR J CLIN NUTR, V49, pS64; Jarvinen KM, 2001, INT ARCH ALLERGY IMM, V126, P111, DOI 10.1159/000049501; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Knipping K, 2014, ACTA PAEDIATR, V103, P766, DOI 10.1111/apa.12651; Knipping K, 2012, INT ARCH ALLERGY IMM, V159, P263, DOI 10.1159/000338007; Knol EF, 2006, MOL NUTR FOOD RES, V50, P620, DOI 10.1002/mnfr.200500272; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Ladics GS, 2008, REGUL TOXICOL PHARM, V51, P288, DOI 10.1016/j.yrtph.2008.04.012; LINKOLOPPONEN S, 1985, ANAL BIOCHEM, V148, P50, DOI 10.1016/0003-2697(85)90626-8; Marchand F, 2003, ALLERGY, V58, P1037, DOI 10.1034/j.1398-9995.2003.00251.x; Meza-Nieto MA, 2007, J DAIRY SCI, V90, P582, DOI 10.3168/jds.S0022-0302(07)71541-2; Monaci L, 2006, EUR FOOD RES TECHNOL, V223, P149, DOI 10.1007/s00217-005-0178-8; Nakamura R, 2010, ALLERGY, V65, P1266, DOI 10.1111/j.1398-9995.2010.02363.x; Nakamura R, 2012, ALLERGOL INT, V61, P431, DOI 10.2332/allergolint.11-OA-0407; Rouvinen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009037; Takagi K, 2003, BIOL PHARM BULL, V26, P252, DOI 10.1248/bpb.26.252; van Esch BCAM, 2013, TOXICOL LETT, V220, P95, DOI 10.1016/j.toxlet.2013.04.008; van Esch BCAM, 2011, TOXICOL LETT, V201, P264, DOI 10.1016/j.toxlet.2011.01.010; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; Wada Naruhito, 1997, Allergology International, V46, P173, DOI 10.2332/allergolint.46.173; ZEIGER RS, 1995, J ALLERGY CLIN IMMUN, V95, P1179, DOI 10.1016/S0091-6749(95)70074-9	29	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106025	10.1371/journal.pone.0106025	http://dx.doi.org/10.1371/journal.pone.0106025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153680	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200107
J	Kong, XZ; Zhen, ZL; Li, XT; Lu, HH; Wang, RS; Liu, L; He, Y; Zang, YF; Liu, J				Kong, Xiang-zhen; Zhen, Zonglei; Li, Xueting; Lu, Huan-hua; Wang, Ruosi; Liu, Ling; He, Yong; Zang, Yufeng; Liu, Jia			Individual Differences in Impulsivity Predict Head Motion during Magnetic Resonance Imaging	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; FUNCTIONAL CONNECTIVITY MRI; FRONTAL-CORTEX; FMRI; CHILDREN; BEHAVIOR; ADHD; DYSFUNCTION; ACTIVATION; NETWORK	Magnetic resonance imaging (MRI) provides valuable data for understanding the human mind and brain disorders, but in-scanner head motion introduces systematic and spurious biases. For example, differences in MRI measures (e.g., network strength, white matter integrity) between patient and control groups may be due to the differences in their head motion. To determine whether head motion is an important variable in itself, or just simply a confounding variable, we explored individual differences in psychological traits that may predispose some people to move more than others during an MRI scan. In the first two studies, we demonstrated in both children (N = 245) and adults (N = 581) that head motion, estimated from resting-state functional MRI and diffusion tensor imaging, was reliably correlated with impulsivity scores. Further, the difference in head motion between children with attention deficit hyperactivity disorder (ADHD) and typically developing children was largely due to differences in impulsivity. Finally, in the third study, we confirmed the observation that the regression approach, which aims to deal with motion issues by regressing out motion in the group analysis, would underestimate the effect of interest. Taken together, the present findings provide empirical evidence that links in-scanner head motion to psychological traits.	[Kong, Xiang-zhen; Zhen, Zonglei; Li, Xueting; Lu, Huan-hua; Wang, Ruosi; Liu, Ling; He, Yong] Beijing Normal Univ, McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Kong, Xiang-zhen; Zhen, Zonglei; Li, Xueting; Lu, Huan-hua; Wang, Ruosi; Liu, Ling; He, Yong] Beijing Normal Univ, McGovern Inst Brain Res, IDG, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Kong, Xiang-zhen; Zhen, Zonglei; Li, Xueting; Lu, Huan-hua; Liu, Ling; He, Yong; Liu, Jia] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Zang, Yufeng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University; Hangzhou Normal University	Liu, J (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn	Wang, Ruosi/AAB-4624-2022; He, Yong/Q-5756-2018; ZANG, Yu-Feng/J-1558-2012; He, Yong/C-2161-2009; Zhen, Zonglei/GPG-1239-2022	Wang, Ruosi/0000-0002-0341-5020; ZANG, Yu-Feng/0000-0003-1833-8010; Liu, Jia/0000-0003-0383-0934; He, Yong/0000-0002-7039-2850; Kong, Xiangzhen/0000-0002-0805-1350	National Natural Science Foundation of China [31230031, 91132703, 31221003, 30800295]; National Basic Research Program of China [2010CB833903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (31230031, 91132703, 31221003 and 30800295) and the National Basic Research Program of China (2010CB833903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cho SS, 2013, BRAIN TOPOGR, V26, P479, DOI 10.1007/s10548-012-0270-x; Deen Ben, 2012, Nature, V491, pS20; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Dvorak RD, 2013, AGGRESSIVE BEHAV, V39, P222, DOI 10.1002/ab.21474; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; Kong XZ, 2014, PEERJ, V2, DOI 10.7717/peerj.366; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Lucantonio F, 2012, NAT NEUROSCI, V15, P358, DOI 10.1038/nn.3014; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Murphy K, 2013, RESTING STATE FMRI C; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PAULSEN K, 1980, J ABNORM CHILD PSYCH, V8, P269, DOI 10.1007/BF00919070; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reynolds B, 2008, EXP CLIN PSYCHOPHARM, V16, P124, DOI 10.1037/1064-1297.16.2.124; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Tijssen RHN, 2009, HUM BRAIN MAPP, V30, P2641, DOI 10.1002/hbm.20695; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Worsley K.J., 2001, FUNCTIONAL MRI INTRO, P25; Wylie GR, 2014, HUM BRAIN MAPP, V35, P1, DOI 10.1002/hbm.22150; Yan CG, 2013, NEUROIMAGE; Yendiki A, 2013, NEUROIMAGE; Yoo SS, 2005, NEUROSCI RES, V53, P84, DOI 10.1016/j.neures.2005.06.004; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng L-L, 2014, P NATL ACAD SCI US; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	41	63	63	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104989	10.1371/journal.pone.0104989	http://dx.doi.org/10.1371/journal.pone.0104989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148416	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600028
J	Ohara, M; Takahashi, H; Lee, MTM; Wen, MS; Lee, TH; Chuang, HP; Luo, CH; Arima, A; Onozuka, A; Nagai, R; Shiomi, M; Mihara, K; Morita, T; Chen, YT				Ohara, Minami; Takahashi, Harumi; Lee, Ming Ta Michael; Wen, Ming-Shien; Lee, Tsong-Hai; Chuang, Hui-Ping; Luo, Chen-Hui; Arima, Aki; Onozuka, Akiko; Nagai, Rui; Shiomi, Mari; Mihara, Kiyoshi; Morita, Takashi; Chen, Yuan-Tsong			Determinants of the Over-Anticoagulation Response during Warfarin Initiation Therapy in Asian Patients Based on Population Pharmacokinetic-Pharmacodynamic Analyses	PLOS ONE			English	Article							NORMALIZED RATIO CONTROL; CLINICAL CLASSIFICATION SCHEMES; ATRIAL-FIBRILLATION; HEMORRHAGIC COMPLICATIONS; NATIONAL REGISTRY; PREDICTING STROKE; VKORC1 GENOTYPES; CYP2C9; RISK; VALIDATION	To clarify pharmacokinetic-pharmacodynamic (PK-PD) factors associated with the over-anticoagulation response in Asians during warfarin induction therapy, population PK-PD analyses were conducted in an attempt to predict the time-courses of the plasma S-warfarin concentration, Cp(S), and coagulation and anti-coagulation (INR) responses. In 99 Chinese patients we analyzed the relationships between dose and Cp(S) to estimate the clearance of S-warfarin, CL(S), and that between Cp(S) and the normal prothrombin concentration (NPT) as a coagulation marker for estimation of IC50. We also analyzed the non-linear relationship between NPT inhibition and the increase in INR to derive the non-linear index lambda. Population analyses accurately predicted the time-courses of Cp(S), NPT and INR. Multivariate analysis showed that CYP2C9*3 mutation and body surface area were predictors of CL(S), that VKORC1 and CYP4F2 polymorphisms were predictors of IC50, and that baseline NPT was a predictor of lambda. CL(S) and lambda were significantly lower in patients with INR >= 4 than in those with INR, 4 (190 mL/h vs 265 mL/h, P<0.01 and 3.2 vs 3.7, P<0.01, respectively). Finally, logistic regression analysis revealed that CL(S), ALT and hypertension contributed significantly to INR >= 4. All these results indicate that factors associated with the reduced metabolic activity of warfarin represented by CL(S), might be critical determinants of the over-anticoagulation response during warfarin initiation in Asians.	[Ohara, Minami; Takahashi, Harumi; Luo, Chen-Hui; Arima, Aki; Onozuka, Akiko; Nagai, Rui; Shiomi, Mari] Meiji Pharmaceut Univ, Dept Biopharmaceut, Tokyo, Japan; [Lee, Ming Ta Michael] RIKEN, Ctr Integrat Med Sci, Lab Int Alliance Genom Res, Kanagawa, Japan; [Wen, Ming-Shien; Lee, Tsong-Hai] Chang Gung Mem Hosp, Dept Med, Taoyuan, Taiwan; [Wen, Ming-Shien; Lee, Tsong-Hai] Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Wen, Ming-Shien; Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Ming Ta Michael; Chuang, Hui-Ping; Chen, Yuan-Tsong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Mihara, Kiyoshi] Musashino Univ, Fac Pharm, Ctr Clin Pharm, Tokyo, Japan; [Morita, Takashi] Juntendo Univ, Sch Med, Tokyo 113, Japan	Meiji Pharmaceutical University; RIKEN; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Academia Sinica - Taiwan; Juntendo University	Takahashi, H (corresponding author), Meiji Pharmaceut Univ, Dept Biopharmaceut, Tokyo, Japan.	harumit@my-pharm.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI C) [20590548]; Department of Health, Taiwan [DOH101-TD-PB-111-TM005]	Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI C)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Department of Health, Taiwan	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI C, 20590548) and the Department of Health, Taiwan (DOH101-TD-PB-111-TM005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal SL, 1994, NONMEM USERS GUIDES; Bristol-Myers Squibb, COUM WARF SOD TABL C; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Danese E, 2012, CLIN PHARMACOL THER, V92, P746, DOI 10.1038/clpt.2012.184; Donze J, 2012, AM J MED, V125, P1095, DOI 10.1016/j.amjmed.2012.04.005; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Hamberg AK, 2007, CLIN PHARMACOL THER, V81, P529, DOI 10.1038/sj.clpt.6100084; Ichimura Y, 2012, CLIN PHARMACOKINET, V51, P799, DOI 10.1007/s40262-012-0009-6; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; JUSKO WJ, 1994, CLIN PHARMACOL THER, V56, P406, DOI 10.1038/clpt.1994.155; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Lee MTM, 2009, PHARMACOGENOMICS, V10, P1905, DOI [10.2217/pgs.09.106, 10.2217/PGS.09.106]; Li C, 2009, BLOOD, V113, P3925, DOI 10.1182/blood-2008-09-176859; Limdi NA, 2009, BLOOD CELL MOL DIS, V43, P119, DOI 10.1016/j.bcmd.2009.01.019; Limdi N, 2008, CLIN PHARMACOL THER, V83, P312, DOI 10.1038/sj.clpt.6100290; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Loewen P, 2011, ANN HEMATOL, V90, P1191, DOI 10.1007/s00277-011-1267-3; Lund K, 2012, BRIT J HAEMATOL, V158, P256, DOI 10.1111/j.1365-2141.2012.09150.x; Ma C, 2012, INT J HEMATOL, V96, P719, DOI 10.1007/s12185-012-1205-8; Parke J, 1999, COMPUT METH PROG BIO, V59, P19, DOI 10.1016/S0169-2607(98)00098-4; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Tait RC, 1998, BRIT J HAEMATOL, V101, P450; Takahashi H, 2003, CLIN PHARMACOL THER, V73, P253, DOI 10.1067/mcp.2003.26a; Takahashi H, 1997, J CHROMATOGR B, V701, P71, DOI 10.1016/S0378-4347(97)00346-0; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wen MS, 2008, CLIN PHARMACOL THER, V84, P83, DOI 10.1038/sj.clpt.6100453; Yamada D, 1999, THROMB RES, V94, P221, DOI 10.1016/S0049-3848(98)00212-6	34	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105891	10.1371/journal.pone.0105891	http://dx.doi.org/10.1371/journal.pone.0105891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148255	Green Published, gold			2022-12-27	WOS:000341230600093
J	Schmidt, D; Kollan, C; Fatkenheuer, G; Schulter, E; Stellbrink, HJ; Noah, C; Jensen, BEO; Stoll, M; Bogner, JR; Eberle, J; Meixenberger, K; Kuecherer, C; Hamouda, O; Bartmeyer, B				Schmidt, Daniel; Kollan, Christian; Faetkenheuer, Gerd; Schuelter, Eugen; Stellbrink, Hans-Juergen; Noah, Christian; Jensen, Bjoern-Erik Ole; Stoll, Matthias; Bogner, Johannes R.; Eberle, Josef; Meixenberger, Karolin; Kuecherer, Claudia; Hamouda, Osamah; Bartmeyer, Barbara		Clinsurv-HIV Drug Resistance Study	Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany	PLOS ONE			English	Article							INFECTED PATIENTS; MUTATIONS; PREVALENCE; TRANSMISSION; ASSOCIATION; INHIBITORS	Objective: We assessed trends in the proportion of transmitted (TDR) and acquired (ADR) HIV drug resistance and associated mutations between 2001 and 2011 in the German ClinSurv-HIV Drug Resistance Study. Method: The German ClinSurv-HIV Drug Resistance Study is a subset of the German ClinSurv-HIV Cohort. For the ClinSurv-HIV Drug Resistance Study all available sequences isolated from patients in five study centres of the long term observational ClinSurv-HIV Cohort were included. TDR was estimated using the first viral sequence of antiretroviral treatment (ART) naive patients. One HIV sequence/patient/year of ART experienced patients was considered to estimate the proportion of ADR. Trends in the proportion of HIV drug resistance were calculated by logistic regression. Results: 9,528 patients were included into the analysis. HIV-sequences of antiretroviral naive and treatment experienced patients were available from 34% (3,267/9,528) of patients. The proportion of TDR over time was stable at 10.4% (95% CI 9.1-11.8; p (for trend) = 0.6; 2001-2011). The proportion of ADR among all treated patients was 16%, whereas it was high among those with available HIV genotypic resistance test (64%; 1,310/2,049 sequences; 95% CI 62-66) but declined significantly over time (OR 0.8; 95% CI 0.77-0.83; p (for trend)<0.001; 2001-2011). Viral load monitoring subsequent to resistance testing was performed in the majority of treated patients (96%) and most of them (67%) were treated successfully. Conclusions: The proportion of TDR was stable in this study population. ADR declined significantly over time. This decline might have been influenced by broader resistance testing, resistance test guided therapy and the availability of more therapeutic options and not by a decline in the proportion of TDR within the study population.	[Schmidt, Daniel; Kollan, Christian; Hamouda, Osamah; Bartmeyer, Barbara] Robert Koch Inst, HIV AIDS, Dept Infect Dis Epidemiol, Berlin, Germany; [Faetkenheuer, Gerd; Schuelter, Eugen] Univ Cologne, Clin Internal Med, D-50931 Cologne, Germany; [Stellbrink, Hans-Juergen] ICH Study Ctr, Hamburg, Germany; [Noah, Christian] Lab Lademannbogen, Hamburg, Germany; [Jensen, Bjoern-Erik Ole] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Stoll, Matthias] Hannover Med Sch, Infect Dis Unit, Clin Immunol & Rheumatol, Hannover, Germany; [Bogner, Johannes R.] Univ Hosp Munich, Dept Infect Dis, Munich, Germany; [Eberle, Josef] Univ Munich, Inst Virol, Max Von Pettenkofer Inst, Munich, Germany; [Meixenberger, Karolin; Kuecherer, Claudia] Robert Koch Inst, HIV & Other Retroviruses, Dept Infect Dis, Berlin, Germany	Robert Koch Institute; University of Cologne; Heinrich Heine University Dusseldorf; Hannover Medical School; University of Munich; University of Munich; Robert Koch Institute	Bartmeyer, B (corresponding author), Robert Koch Inst, HIV AIDS, Dept Infect Dis Epidemiol, Berlin, Germany.	Gunsenheimer-BartmeyerB@rki.de	Jensen, Björn/HIK-2559-2022		Collaborative HIV and Anti-HIV Drug Resistance Network CHAIN; 7th Framework of the European Commission; Laboratory Lademannbogen	Collaborative HIV and Anti-HIV Drug Resistance Network CHAIN; 7th Framework of the European Commission; Laboratory Lademannbogen	The study received grants from the Collaborative HIV and Anti-HIV Drug Resistance Network CHAIN, 7th Framework of the European Commission, http://www.chain-hiv.eu/. Laboratory Lademannbogen provided support in the form of a salary for author CN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Batzing-Feigenbaum J, 2011, HIV MED, V12, P269, DOI 10.1111/j.1468-1293.2010.00879.x; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Betancor G, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-68; Bezemer D, 2004, AIDS, V18, P1571, DOI 10.1097/01.aids.0000131357.52457.33; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; BUB-Richtlinien/Anlage A, 2004, BUNDESANZEIGER; Burns S, 2007, AIDS, V21, P1035, DOI 10.1097/QAD.0b013e3280b07761; Costagliola D, 2007, JAIDS-J ACQ IMM DEF, V46, P12; De Luca A, 2013, J INFECT DIS, V207, P1216, DOI 10.1093/infdis/jit017; De Mendoza C, 2007, AIDS RES HUM RETROV, V23, P879, DOI 10.1089/aid.2005.0072; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Dolling D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5253; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Jones Joyce, 2007, Top HIV Med, V15, P48; Kauf TL, 2012, PATIENT PREFER ADHER, V6, P155, DOI 10.2147/PPA.S28482; Knyphausen FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095956; Llibre JM, 2011, AIDS, V25, P1683, DOI 10.1097/QAD.0b013e3283499cd9; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Oette M, 2007, DEUT MED WOCHENSCHR, V132, P977, DOI 10.1055/s-2007-979365; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Sagir A, 2007, J ANTIMICROB CHEMOTH, V60, P843, DOI 10.1093/jac/dkm274; Tejerina F, 2011, AIDS REV, V13, P227	26	21	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104474	10.1371/journal.pone.0104474	http://dx.doi.org/10.1371/journal.pone.0104474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148412	gold, Green Published			2022-12-27	WOS:000341230600016
J	Tahara, T; Shibata, T; Okubo, M; Sumi, K; Ishizuka, T; Nakamura, M; Nagasaka, M; Nakagawa, Y; Ohmiya, N; Arisawa, T; Hirata, I				Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Sumi, Kazuya; Ishizuka, Takamitsu; Nakamura, Masakatsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Arisawa, Tomiyasu; Hirata, Ichiro			Change in DNA Methylation Patterns of SLC6A4 Gene in the Gastric Mucosa in Functional Dyspepsia	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; SEROTONIN TRANSPORTER GENE; PSYCHOSOCIAL FACTORS; POLYMORPHISM; POPULATION; GENOTYPE	Background: The neurochemical serotonin (5-HT) is an important signaling molecule in the gastrointestinal motor and sensory functions. A key regulator of 5-HT levels is the transmembrane serotonin transporter (5-HTT; SLC6A4) that governs the reuptake of 5-HT. Recent studies have indicated 5-HTT expression may be regulated by epigenetic mechanisms. We investigated DNA methylation status of SLC6A4 gene in the gastric mucosa from functional dyspepsia (FD) because of their potential role in dyspeptic symptoms. Methods: Endoscopic gastric biopsies were obtained from 78 subjects with no upper abdominal symptoms and 79 patients with FD. Bisulfite Pyrosequencing was carried out to determine the methylation status of promoter CpG islands (PCGIs), promoter non-CpG islands (PNCGIs) and gene body non-CpG islands (NPNCGIs) in the SLC6A4 gene. Gene expression was examined by real-time PCR. Results: In overall, methylation level of PCGIs was significantly lower in FD compared to control subjects (p = 0.04). On the other hand, methylation level of NPNCGIs was significantly higher in FD compared to control subjects (p = 0.03). Lower methylation level in PNCGIs was highlighted in the patients with PDS (p = 0.01), while higher methylation level in NPNCGIs was more prominent in the patients with EPS (p = 0.017). Methylation levels of PCGIs and PNCGIs were inversely correlated, while methylation levels of NPNCGIs was positively correlated with SLC6A4 mRNA levels in FD patients. Conclusions: Our data suggest that change in DNA methylation pattern of SLC6A4 in the gastric mucosa may have a role for developing FD. A role of epigenetics for developing FD needs to be further evaluated.	[Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Sumi, Kazuya; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Hirata, Ichiro] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 47011, Japan; [Nakamura, Masakatsu; Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Uchinada, Ishikawa 92002, Japan	Fujita Health University; Kanazawa Medical University	Tahara, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 47011, Japan.	tomomiccyu@yahoo.co.jp	Sumi, Kazuya/AFN-4425-2022	Sumi, Kazuya/0000-0002-5484-8504				Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Coffin B, 1991, GASTROENTEROLOGY; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701, DOI 10.1016/S0016-5085(88)80017-9; DROSSMAN DA, 1990, GASTROEN CLIN BIOL, V14, pC49; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Holtmann G, 2004, GASTROENTEROLOGY, V126, P971, DOI 10.1053/j.gastro.2004.01.006; Holtmann G, 1998, GUT, V42, P501, DOI 10.1136/gut.42.4.501; Locke GR, 1998, BAILLIERE CLIN GASTR, V12, P435; Pata C, 2002, AM J GASTROENTEROL, V97, P1780; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Stanghellini V, 1996, GASTROENTEROLOGY, V110, P1036, DOI 10.1053/gast.1996.v110.pm8612991; Tack J, 1998, GASTROENTEROLOGY, V115, P1346, DOI 10.1016/S0016-5085(98)70012-5; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Tahara T, 2012, EXPERT REV MOL DIAGN, V12, P489, DOI [10.1586/erm.12.38, 10.1586/ERM.12.38]; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P1259; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Toyoshima F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-88; Turker MS, 1999, SEMIN CANCER BIOL, V9, P329, DOI 10.1006/scbi.1999.0133; Yeo A, 2004, GUT, V53, P1452, DOI 10.1136/gut.2003.035451	22	6	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105565	10.1371/journal.pone.0105565	http://dx.doi.org/10.1371/journal.pone.0105565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148529	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600059
J	Akinyemiju, TF; McDonald, JA; Tsui, J; Greenlee, H				Akinyemiju, Tomi F.; McDonald, Jasmine A.; Tsui, Jennifer; Greenlee, Heather			Adherence to Cancer Prevention Guidelines in 18 African Countries	PLOS ONE			English	Article							RESEARCH FUND/AMERICAN INSTITUTE; LIFE-STYLE FACTORS; RISK-FACTORS; PROSTATE-CANCER; SOCIOECONOMIC-STATUS; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; HEALTH; MORTALITY; WORLD	Background: Cancer rates in Africa are projected to double by 2030 due to aging and increased exposure to cancer risk factors, including modifiable risk factors. We assessed adherence to 5 modifiable cancer risk factors across 18 African countries. Methods: Data on adults 18 years and older were obtained from the 2002-2004 World Health Survey. Adherence to current World Cancer Research Fund guidelines on smoking, alcohol, body weight, physical activity, and nutrition was assessed. Adherence scores ranged from 0 (no guideline met) to 5 (all guidelines met). Determinants of adherence were assessed using multivariable linear regression adjusted for individual and country level characteristics. Results: Across all countries, adherence to the guidelines among adults was high for smoking (72%-99%) and alcohol (85%-100%), but low for body weight (1.8%-78%), physical activity (3.4%-84%) and nutrition (1.4%-61%). Overall adherence score ranged from 2.32 in Mali to 3.72 in Comoros. In multivariable models, residing in low versus high SES households was associated with reduced adherence by 0.24 and 0.21 points for men and women respectively after adjusting for age, gender, education, and marital status (p<0.001). Every % increase in GDP spent on health was associated with increased adherence by 0.03 in men and 0.09 in women (p<0.001). Conclusions: The wide variation in adherence to cancer prevention guidelines observed across countries and between population sub-groups suggests the need for targeted public health efforts to improve behaviors related to body weight, physical activity and nutrition.	[Akinyemiju, Tomi F.; McDonald, Jasmine A.; Tsui, Jennifer; Greenlee, Heather] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Greenlee, Heather] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University	Akinyemiju, TF (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	ofa2107@columbia.edu	McDonald, Jasmine/L-4249-2019; Tsui, Jennifer/ABE-3743-2020	McDonald, Jasmine/0000-0002-8270-8074; 	National Cancer Institute [2-R25-CA-09529, 5T32CA09529, K23CA141052]; NATIONAL CANCER INSTITUTE [K23CA141052, T32CA009529] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was financially supported by the National Cancer Institute's R25 Cancer Training Grant 2-R25-CA-09529 (TA and JT), 5T32CA09529 (JAM), and K23CA141052 (HG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji J, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P11; Akinyemiju TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048834; American Cancer Society, 2011, CANC FACTS FIG 2011; Arab L, 2013, NUTR CANCER, V65, P633, DOI 10.1080/01635581.2013.789540; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Blakely T, 2005, B WORLD HEALTH ORGAN, V83, P118; Catsburg C, 2014, INT J CANC; Centers for Disease Control and Prevention, 2009, BEH RISK FACT SURV S; Farag M, 2013, INT J HEALTH CARE FI, V13, P33, DOI 10.1007/s10754-012-9120-3; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Hastert TA, 2013, CANC EPIDEMIOL BIOMA; Hastert TA, 2014, CANCER CAUSE CONTROL, V25, P541, DOI 10.1007/s10552-014-0358-6; Health and Social Science Information Center, 2011, HLTH SURV ENGL 2011; Inoue-Choi M, 2013, J CLIN ONCOL, V31, P1758, DOI 10.1200/JCO.2012.45.4462; Inoue-Choi M, 2013, CANCER EPIDEM BIOMAR, V22, P792, DOI 10.1158/1055-9965.EPI-13-0054; International Agency for Research on Cancer, 2013, GLOBOCAN CANC STAT; International Agency for Research on Cancer, 2008, WORLD CANC REPORT 20; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Manthalu G, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-6; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Nelson NJ, 2012, J NATL CANCER I, V104, P574, DOI 10.1093/jnci/djs213; Nilsen TIL, 2000, BRIT J CANCER, V82, P1358; Putnam SD, 2000, ANN EPIDEMIOL, V10, P361, DOI 10.1016/S1047-2797(00)00057-0; Rasool S, 2013, TUMOUR BIOL; Romaguera D, 2012, AM J CLIN NUTR, V96, P150, DOI 10.3945/ajcn.111.031674; Rosato V, 2013, EUR J CANC PREV; Swift R, 2011, HEALTH ECON, V20, P306, DOI 10.1002/hec.1590; Tehranifar P, 2009, CANCER EPIDEM BIOMAR, V18, P2701, DOI 10.1158/1055-9965.EPI-09-0305; The World Bank, 2013, INDICATORS; Thomson CA, 2014, CANCER PREV RES, V7, P42, DOI 10.1158/1940-6207.CAPR-13-0258; Vergnaud AC, 2013, AM J CLIN NUTR, V97, P1107, DOI 10.3945/ajcn.112.049569; Vossenaar M, 2010, NUTRITION, V26, P40, DOI 10.1016/j.nut.2009.04.007; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2013, WHO WORLD HLTH SURV; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105209	10.1371/journal.pone.0105209	http://dx.doi.org/10.1371/journal.pone.0105209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144291	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100043
J	Gilabert, M; Launay, S; Ginestier, C; Bertucci, F; Audebert, S; Pophillat, M; Toiron, Y; Baudelet, E; Finetti, P; Noguchi, T; Sobol, H; Birnbaum, D; Borg, JP; Charafe-Jauffret, E; Goncalves, A				Gilabert, Marine; Launay, Simon; Ginestier, Christophe; Bertucci, Francois; Audebert, Stephane; Pophillat, Mathieu; Toiron, Yves; Baudelet, Emilie; Finetti, Pascal; Noguchi, Tetsuro; Sobol, Hagay; Birnbaum, Daniel; Borg, Jean-Paul; Charafe-Jauffret, Emmanuelle; Goncalves, Anthony			Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib	PLOS ONE			English	Article							DRUG-RESISTANCE; TUMORS; EXPRESSION; CARCINOMA; GRADE	Background: Breast cancer stem cells (BCSCs) have been recognized as playing a major role in various aspects of breast cancer biology. To identify specific biomarkers of BCSCs, we have performed comparative proteomics of BCSC-enriched and mature cancer cell populations from the human breast cancer cell line (BCL), BrCA-MZ-01. Methods: ALDEFLUOR assay was used to sort BCSC-enriched (ALDH+) and mature cancer (ALDH-) cell populations. Total proteins were extracted from both fractions and subjected to 2-Dimensional Difference In-Gel Electrophoresis (2-D DIGE). Differentially-expressed spots were excised and proteins were gel-extracted, digested and identified using MALDI-TOF MS. Results: 2-D DIGE identified poly(ADP-ribose) polymerase 1 (PARP1) as overexpressed in ALDH+ cells from BrCA-MZ-01. This observation was confirmed by western blot and extended to four additional human BCLs. ALDH+ cells from BRCA1-mutated HCC1937, which had the highest level of PARP1 overexpression, displayed resistance to olaparib, a specific PARP1 inhibitor. Conclusion: An unbiased proteomic approach identified PARP1 as upregulated in ALDH+, BCSC-enriched cells from various human BCLs, which may contribute to clinical resistance to PARP inhibitors.	[Gilabert, Marine; Audebert, Stephane; Pophillat, Mathieu; Toiron, Yves; Baudelet, Emilie; Borg, Jean-Paul; Goncalves, Anthony] Inst Paoli Calmettes, Dept Mol Pharmacol, Marseille, France; [Gilabert, Marine; Launay, Simon; Bertucci, Francois; Goncalves, Anthony] Inst Paoli Calmettes, Dept Med Oncol, Marseille, France; [Charafe-Jauffret, Emmanuelle] Inst Paoli Calmettes, Dept Biopathol, Marseille, France; [Launay, Simon; Ginestier, Christophe; Bertucci, Francois; Finetti, Pascal; Birnbaum, Daniel; Charafe-Jauffret, Emmanuelle] Inst Paoli Calmettes, Dept Mol Oncol, Marseille, France; [Noguchi, Tetsuro; Sobol, Hagay] Inst Paoli Calmettes, Dept Canc Genet, Marseille, France; [Gilabert, Marine; Bertucci, Francois; Sobol, Hagay; Borg, Jean-Paul; Charafe-Jauffret, Emmanuelle; Goncalves, Anthony] Aix Marseille Univ, Marseille, France; [Gilabert, Marine; Ginestier, Christophe; Bertucci, Francois; Audebert, Stephane; Pophillat, Mathieu; Toiron, Yves; Baudelet, Emilie; Finetti, Pascal; Birnbaum, Daniel; Borg, Jean-Paul; Charafe-Jauffret, Emmanuelle; Goncalves, Anthony] CNRS, INSERM, Ctr Rech Cancerol Marseille, U1068,U7258, Marseille, France	UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Goncalves, A (corresponding author), Inst Paoli Calmettes, Dept Mol Pharmacol, Marseille, France.	goncalvesa@ipc.unicancer.fr	Ginestier, Christophe/M-8828-2017; Borg, Jean-Paul/AAX-8096-2020; Charafe-Jauffret, emmanuelle/P-6009-2017; Finetti, Pascal/O-8669-2017	Ginestier, Christophe/0000-0002-7477-3837; Borg, Jean-Paul/0000-0001-8418-3382; Charafe-Jauffret, emmanuelle/0000-0002-0286-1299; Finetti, Pascal/0000-0002-2674-3123; Bertucci, Francois/0000-0002-0157-0959; Audebert, Stephane/0000-0002-9409-2588	SIRIC program [INCa-DGOS-Inserm 6038]; Sanofi-Aventis; Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale (FRM)	SIRIC program; Sanofi-Aventis(Sanofi-Aventis); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by SIRIC program (INCa-DGOS-Inserm 6038) and Sanofi-Aventis. MG was supported by a grant from "Association pour la Recherche sur le Cancer (ARC)''. SL was supported by a grant from "Fondation pour la Recherche Medicale (FRM)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goncalves A, 2008, MOL CELL PROTEOMICS, V7, P1420, DOI 10.1074/mcp.M700487-MCP200; Goncalves A, 2011, BREAST CANCER RES TR, V127, P273, DOI 10.1007/s10549-010-1199-y; Guo W, 1999, CLIN CANCER RES, V5, P621; Hassanein M, 2013, PATHOBIOLOGY, V80, P219, DOI 10.1159/000339432; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kelly RJ, 2012, ONCOLOGIST, V17, P512, DOI 10.1634/theoncologist.2012-0080; Mobus VJ, 1998, INT J CANCER, V77, P415, DOI 10.1002/(SICI)1097-0215(19980729)77:3<415::AID-IJC18>3.0.CO;2-6; O'Shaughnessy J, 2011, J CLIN ONCOL S, V29; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; von Minckwitz G, 2011, J CLIN ONCOL, V29, P2150, DOI 10.1200/JCO.2010.31.9079; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153	23	40	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104302	10.1371/journal.pone.0104302	http://dx.doi.org/10.1371/journal.pone.0104302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144364	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100014
J	Kremb, S; Helfer, M; Kraus, B; Wolff, H; Wild, C; Schneider, M; Voolstra, CR; Brack-Werner, R				Kremb, Stephan; Helfer, Markus; Kraus, Birgit; Wolff, Horst; Wild, Christian; Schneider, Martha; Voolstra, Christian R.; Brack-Werner, Ruth			Aqueous Extracts of the Marine Brown Alga Lobophora variegata Inhibit HIV-1 Infection at the Level of Virus Entry into Cells	PLOS ONE			English	Article							POLYSACCHARIDES; REPLICATION; GRIFFITHSIN	In recent years, marine algae have emerged as a rich and promising source of molecules with potent activities against various human pathogens. The widely distributed brown alga Lobophora variegata that is often associated with tropical coral reefs exerts strong antibacterial and antiprotozoal effects, but so far has not been associated with specific anti-viral activities. This study investigated potential HIV-1 inhibitory activity of L. variegata collected from different geographical regions, using a cell-based full replication HIV-1 reporter assay. Aqueous L. variegata extracts showed strong inhibitory effects on several HIV-1 strains, including drug-resistant and primary HIV-1 isolates, and protected even primary cells (PBMC) from HIV-1-infection. Anti-viral potency was related to ecological factors and showed clear differences depending on light exposition or epiphyte growth. Assays addressing early events of the HIV-1 replication cycle indicated that L. variegata extracts inhibited entry of HIV-1 into cells at a pre-fusion step possibly by impeding mobility of virus particles. Further characterization of the aqueous extract demonstrated that even high doses had only moderate effects on viability of cultured and primary cells (PBMCs). Imaging-based techniques revealed extract effects on the plasma membrane and actin filaments as well as induction of apoptosis at concentrations exceeding EC50 of anti-HIV-1 activity by more than 400 fold. In summary, we show for the first time that L. variegata extracts inhibit HIV-1 entry, thereby suggesting this alga as promising source for the development of novel HIV-1 inhibitors.	[Kremb, Stephan; Voolstra, Christian R.] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Kremb, Stephan; Helfer, Markus; Schneider, Martha; Brack-Werner, Ruth] Helmholtz Zentrum Muenchen, Inst Virol, Neuherberg, Germany; [Kraus, Birgit] Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany; [Wolff, Horst] Carl Zeiss Microscopy GmbH, Gottingen, Germany; [Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany; [Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	King Abdullah University of Science & Technology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; Carl Zeiss AG; Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen	Kremb, S (corresponding author), KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia.	StephanGeorg.Kremb@kaust.edu.sa	Brack-Werner, Ruth/M-4615-2014; Kraus, Birgit/AAM-2985-2020; Voolstra, Christian R/H-7158-2014	Brack-Werner, Ruth/0000-0002-8651-9318; Voolstra, Christian R/0000-0003-4555-3795	Helmholtz Zentrum Munich; King Abdullah University of Science and Technology	Helmholtz Zentrum Munich; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This study was jointly funded by the Helmholtz Zentrum Munich (www.helmholtz-muenchen.de) and the King Abdullah University of Science and Technology (www.kaust.edu.sa). The research vessel "Aldebaran'' was provided by "ALDEBARAN Marine Research and Broadcast'' (aldebaran.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre KB, 2011, J VIROL, V85, P9039, DOI 10.1128/JVI.02675-10; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Cantillo-Ciau Z, 2010, MAR DRUGS, V8, P1292, DOI 10.3390/md8041292; Chung HY, 2003, J AGR FOOD CHEM, V51, P2619, DOI 10.1021/jf026082n; Cirne-Santos CC, 2006, PLANTA MED, V72, P295, DOI 10.1055/s-2005-916209; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Freile-Pelegrin Y, 2008, FITOTERAPIA, V79, P374, DOI 10.1016/j.fitote.2008.02.006; Helfer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087487; Huskens D, 2012, MAR DRUGS, V10, P1476, DOI 10.3390/md10071476; Jiang ZD, 1999, BIOORG MED CHEM LETT, V9, P2003, DOI 10.1016/S0960-894X(99)00337-6; Kabamba-Mukadi B, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-15; Karsten U, 2009, BOT MAR, V52, P639, DOI 10.1515/BOT.2009.077; Koppensteiner H, 2012, J VIROL, V86, P2826, DOI 10.1128/JVI.05915-11; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Kremb S, 2010, ANTIMICROB AGENTS CH, V54, P5257, DOI 10.1128/AAC.00515-10; Kubanek J, 2003, P NATL ACAD SCI USA, V100, P6916, DOI 10.1073/pnas.1131855100; Medeiros VP, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1018, DOI 10.1134/S0006297908090095; Moo-Puc R, 2008, J ETHNOPHARMACOL, V120, P92, DOI 10.1016/j.jep.2008.07.035; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Morrow KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044859; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Paiva AAD, 2011, INT IMMUNOPHARMACOL, V11, P1241, DOI 10.1016/j.intimp.2011.04.003; Siqueira RCL, 2011, PHARM BIOL, V49, P167, DOI 10.3109/13880209.2010.505605; Suarez A.M., 2005, REV INVEST MAR, V26, P93; Teas J, 2004, MED HYPOTHESES, V62, P507, DOI 10.1016/j.mehy.2003.10.005; Teas J, 2012, J APPL PHYCOL, V24, P575, DOI 10.1007/s10811-011-9766-0; Trinchero J, 2009, PHYTOTHER RES, V23, P707, DOI 10.1002/ptr.2723; Wiencke C, 2012, ECOLOGICAL STUDIES, V219; Witvrouw M, 1997, GEN PHARMACOL-VASC S, V29, P497, DOI 10.1016/S0306-3623(96)00563-0; Wolkerstorfer A, 2009, ANTIVIR RES, V83, P171, DOI 10.1016/j.antiviral.2009.04.012	30	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103895	10.1371/journal.pone.0103895	http://dx.doi.org/10.1371/journal.pone.0103895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144758	Green Published, gold			2022-12-27	WOS:000341106100010
J	Martins, AES; Lucena-Silva, N; Garcia, RG; Welkovic, S; Barbosa, A; Menezes, MLB; Tenorio, T; Maruza, M; Ximenes, RAA				Silva Martins, Albert Eduardo; Lucena-Silva, Norma; Garcia, Renan Gomes; Welkovic, Stefan; Barbosa, Aureliana; Bezerra Menezes, Maria Luiza; Tenorio, Terezinha; Maruza, Magda; Ximenes, Ricardo A. A.			Prognostic Evaluation of DNA Index in HIV-HPV Co-Infected Women Cervical Samples Attending in Reference Centers for HIV-AIDS in Recife	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; POSITIVE WOMEN; FLOW-CYTOMETRY; PREVALENCE; PLOIDY; RISK; PROGRESSION; ANEUPLOIDY; DYSPLASIA	Introduction: Persistence of cervical infection caused by human papillomavirus (HPV) types with high oncogenic risk may lead to cervical intraepithelial neoplasia (CIN). The aim of the present study was to evaluate whether, in HIV-positive women, the presence of aneuploidy in cervical cell samples is associated with presence and evolution of CIN. Methods: The present study had two stages. In the first stage, comprising a cross-sectional study, the association between the presence of aneuploidy seen via flow cytometry and sociodemographic characteristics, habits and characteristics relating to HPV and HIV infection was analyzed. In the second stage, comprising a cohort study, it was investigated whether aneuploidy was predictive of CIN evolution. Results: No association was observed between the presence of aneuploidy and HPV infection, or between its presence and alterations seen in oncotic cytological analysis. On the other hand, aneuploidy was associated with the presence of CIN (p = 0.030) in histological analysis and with nonuse of antiretroviral therapy (p = 0.001). Most of the HIV-positive women (234/272) presented normal CD4+ T lymphocyte counts (greater than 350 cells/mm(3)) and showed a greater aneuploidy regression rate (77.5%) than a progression rate (23.9%) over a follow-up of up to two years. Conclusion: Although there was an association between the presence of cervical tissue lesions and the DNA index, the latter was not predictive of progression of the cervical lesion. This suggests that progression of the cervical lesion to cancer in HIV-positive women may also be changed through improvement of the immunological state enabled by using antiretroviral therapy.	[Silva Martins, Albert Eduardo; Lucena-Silva, Norma; Garcia, Renan Gomes] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Imunogenet, Recife, PE, Brazil; [Silva Martins, Albert Eduardo; Lucena-Silva, Norma] Hosp IMIP, Dept Oncol Pediat, Lab Biol Mol, Recife, PE, Brazil; [Welkovic, Stefan; Barbosa, Aureliana; Bezerra Menezes, Maria Luiza] Univ Pernambuco, Dept Materno Infantil, Recife, PE, Brazil; [Welkovic, Stefan; Barbosa, Aureliana; Bezerra Menezes, Maria Luiza] Univ Pernambuco, Ctr Integrado Saude Amaury Medeiro CISAM UPE, Recife, PE, Brazil; [Tenorio, Terezinha] Univ Fed Pernambuco, Dept Materno Infantil, Recife, PE, Brazil; [Maruza, Magda] Hosp Correia Picanco, Secretaria Saude Pernambuco, Recife, PE, Brazil; [Ximenes, Ricardo A. A.] Univ Fed Pernambuco UFPE, Dept Trop Med, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Martins, AES (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Imunogenet, Recife, PE, Brazil.	aesmartins@hotmail.com	Lucena-Silva, Norma/AAH-9437-2019	Garcia Gomes, Renan/0000-0003-4950-7614	Program for Technological Development in Tools for Health-PDTISFIOCRUZ; FACEPE [APQ-IBPG-1802-4]; CNPq [150572/2011-5]; Brazilian Health Ministry [322/2005]	Program for Technological Development in Tools for Health-PDTISFIOCRUZ; FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Health Ministry	The Program for Technological Development in Tools for Health-PDTISFIOCRUZ gave financial support for gene sequencing. A. E. S. M was a Ph.D. student supported by FACEPE (APQ-IBPG-1802-4). N.L.S. is the recipient of a postdoctoral fellowship from CNPq (grant # 150572/2011-5). This work was supported by Brazilian Health Ministry (Grant #322/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165; Brandao VDRAB, 2009, MEM I OSWALDO CRUZ, V104, P755, DOI 10.1590/S0074-02762009000500016; Anton M, 1997, CANCER DETECT PREV, V21, P242; Bollmann R, 2005, CANCER, V105, P1; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Chhavi, 2010, BIOSCI TRENDS, V4, P103; Dabic MM, 2008, ACTA OBSTET GYN SCAN, V87, P366, DOI 10.1080/00016340801936560; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doeberitz MV, 2009, ARCH MED RES, V40, P435, DOI 10.1016/j.arcmed.2009.06.002; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; El-Sayed SS, 2004, CAN J GASTROENTEROL, V18, P87, DOI 10.1155/2004/638136; Entiauspe LG, 2010, REV SOC BRAS MED TRO, V43, P260, DOI 10.1590/S0037-86822010000300009; Firnhaber C, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17382; Garbuglia AR, 2012, J CLIN VIROL, V54, P141, DOI 10.1016/j.jcv.2012.02.013; Garnett TO, 2006, ARCH VIROL, V151, P2321, DOI 10.1007/s00705-006-0821-0; Gillet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045201; Heilmann Volker, 2002, Curr Womens Health Rep, V2, P27; Klaes R, 1999, CANCER RES, V59, P6132; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/eri.11.21, 10.1586/ERI.11.21]; LOOK AT, 1985, BLOOD, V65, P1079; MacLeod IJ, 2011, J MED VIROL, V83, P1689, DOI 10.1002/jmv.22178; Mangili G, 2008, ANN ONCOL, V19, P1278, DOI 10.1093/annonc/mdn041; Massad LS, 2001, GYNECOL ONCOL, V82, P516, DOI 10.1006/gyno.2001.6323; Melsheimer P, 2004, CLIN CANCER RES, V10, P3059, DOI 10.1158/1078-0432.CCR-03-0565; Melsheimer P, 2001, CYTOMETRY, V46, P166, DOI 10.1002/cyto.1101; Naucler P, 2011, J GEN VIROL, V92, P2784, DOI 10.1099/vir.0.034298-0; Palefsky J, 2006, Adv Dent Res, V19, P99; Schneider ML, 1998, ATLAS DIAGNOSTICO DI; Sharma Surendra K, 2011, Indian J Med Res, V134, P866, DOI 10.4103/0971-5916.92632; Singh M, 2008, J CANCER EPIDEMIOL, V2008, DOI 10.1155/2008/298495; Sociedade Brasileira de Patologia do Trato Genital Inferior e Colposcopia (SBPTGIC), 2003, B INF DIR SBPTGIC, V5, P5; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104801	10.1371/journal.pone.0104801	http://dx.doi.org/10.1371/journal.pone.0104801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144309	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100023
J	Moreira, X; Abdala-Roberts, L; Parra-Tabla, V; Mooney, KA				Moreira, Xoaquin; Abdala-Roberts, Luis; Parra-Tabla, Victor; Mooney, Kailen A.			Positive Effects of Plant Genotypic and Species Diversity on Anti-Herbivore Defenses in a Tropical Tree Species	PLOS ONE			English	Article							GENETIC DIVERSITY; ASSOCIATIONAL RESISTANCE; TRADE-OFFS; MAHOGANY; COMMUNITY; DAMAGE; COMPLEMENTARITY; POPULATIONS; SEEDLINGS; RICHNESS	Despite increasing evidence that plant intra-and inter-specific diversity increases primary productivity, and that such effect may in turn cascade up to influence herbivores, there is little information about plant diversity effects on plant anti-herbivore defenses, the relative importance of different sources of plant diversity, and the mechanisms for such effects. For example, increased plant growth at high diversity may lead to reduced investment in defenses via growth-defense trade-offs. Alternatively, positive effects of plant diversity on plant growth may lead to increased herbivore abundance which in turn leads to a greater investment in plant defenses. The magnitude of trait variation underlying diversity effects is usually greater among species than among genotypes within a given species, so plant species diversity effects on resource use by producers as well as on higher trophic levels should be stronger than genotypic diversity effects. Here we compared the relative importance of plant genotypic and species diversity on anti-herbivore defenses and whether such effects are mediated indirectly via diversity effects on plant growth and/or herbivore damage. To this end, we performed a large-scale field experiment where we manipulated genotypic diversity of big-leaf mahogany (Swietenia macrophylla) and tree species diversity, and measured effects on mahogany growth, damage by the stem-boring specialist caterpillar Hypsipyla grandella, and defensive traits (polyphenolics and condensed tannins in stem and leaves). We found that both forms of plant diversity had positive effects on stem (but not leaf) defenses. However, neither source of diversity influenced mahogany growth, and diversity effects on defenses were not mediated by either growth-defense trade-offs or changes in stem-borer damage. Although the mechanism(s) of diversity effects on plant defenses are yet to be determined, our study is one of the few to test for and show producer diversity effects on plant chemical defenses.	[Moreira, Xoaquin; Abdala-Roberts, Luis; Mooney, Kailen A.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Parra-Tabla, Victor] Univ Autonoma Yucatan, Dept Ecol Trop, Merida, Yucatan, Mexico	University of California System; University of California Irvine; Universidad Autonoma de Yucatan	Moreira, X (corresponding author), Univ Neuchatel, Inst Biol, Lab Evolut Entomol, CH-2000 Neuchatel, Switzerland.	xmoreira1@gmail.com	Moreira, Xoaquín/J-9427-2018; Parra-Tabla, Victor/H-7320-2015	Moreira, Xoaquín/0000-0003-0166-838X; 	UC MEXUS-CONACyT [UCM-101443, UCM-55592]; CONACyT [128856]; Postdoctoral Fulbright/Spanish Ministry of Education grant program; GAANN fellowship; UC MEXUS-CONACyT scholarship	UC MEXUS-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Postdoctoral Fulbright/Spanish Ministry of Education grant program; GAANN fellowship(US Department of Education); UC MEXUS-CONACyT scholarship	This research was supported by a UC MEXUS-CONACyT grant for UC postdocs to XM (UCM-101443), a CONACyT grant to VPT (128856) and a UC MEXUS-CONACyT collaborative grant to all the authors (UCM-55592). XM received financial support from Postdoctoral Fulbright/Spanish Ministry of Education grant program. LAR was funded by a GAANN fellowship and a UC MEXUS-CONACyT scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Roberts L, 2014, BIOTROPICA IN PRESS; [Anonymous], 2005, ARBOLES TROPICALES M; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; CICY (Centro de Investigacion Cientifica de Yucatan A.C.), 2020, FLOR DIG PEN YUC; Close D, 2003, ECOLOGY, V84, P2952, DOI 10.1890/02-0531; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Crawford KM, 2013, ECOLOGY, V94, P1025, DOI 10.1890/12-1468.1; Crawford KM, 2012, J ECOL, V100, P1512, DOI 10.1111/j.1365-2745.2012.02016.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Fridley JD, 2010, ECOLOGY, V91, P2272, DOI 10.1890/09-1240.1; Gillies ACM, 1999, HEREDITY, V83, P722, DOI 10.1038/sj.hdy.6886260; Grijpma P, 1973, IICA MISCELLANEOUS P, V1, P3; Grogan J, 2003, ECOL STU AN, V159, P193; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hamback PA, 2000, ECOLOGY, V81, P1784, DOI 10.1890/0012-9658(2000)081[1784:ARIDTP]2.0.CO;2; Heil M, 2002, NATURWISSENSCHAFTEN, V89, P519, DOI 10.1007/s00114-002-0366-3; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Karban R, 2014, ECOL LETT, V17, P44, DOI 10.1111/ele.12205; Kareiva P., 1983, P259; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Lang AC, 2014, J APPL ECOL, V51, P224, DOI 10.1111/1365-2664.12157; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loveless MD, 2003, ECOL STU AN, V159, P9; Mayhew JE, 1998, SILVICULTURA MAHOGAN; McArt SH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0639; Mcart SH, 2012, OECOLOGIA, V168, P1013, DOI 10.1007/s00442-011-2150-6; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; Moreira X, 2014, ECOL LETT, V17, P537, DOI 10.1111/ele.12253; Moreira X, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0133; Moreira X, 2012, P ROY SOC B-BIOL SCI, V279, P4464, DOI 10.1098/rspb.2012.0893; Moreira X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034006; Mraja A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028055; Nair KSS, 2007, TROPICAL FOREST INSECT PESTS: ECOLOGY, IMPACT, AND MANAGEMENT, P1, DOI 10.1017/CBO9780511542695; Newton A. C., 1999, Agricultural and Forest Entomology, V1, P11; Norghauer JM, 2008, J ECOL, V96, P103, DOI 10.1111/j.1365-2745.2007.01325.x; Norghauer JM, 2010, OECOLOGIA, V162, P405, DOI 10.1007/s00442-009-1476-9; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Otway SJ, 2005, J ANIM ECOL, V74, P234, DOI 10.1111/j.1365-2656.2005.00913.x; Parker JD, 2010, ECOL LETT, V13, P553, DOI 10.1111/j.1461-0248.2010.01452.x; Perez-Flores J., 2012, American Journal of Plant Sciences, V3, P988, DOI 10.4236/ajps.2012.37117; PORTER L J, 1986, Phytochemistry (Oxford), V25, P223; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roscher C, 2011, PLANT BIOLOGY, V13, P134, DOI 10.1111/j.1438-8677.2010.00338.x; Salminen JP, 2011, FUNCT ECOL, V25, P325, DOI 10.1111/j.1365-2435.2010.01826.x; Sampedro L, 2011, J ECOL, V99, P818, DOI 10.1111/j.1365-2745.2011.01814.x; Scherber C, 2006, OECOLOGIA, V147, P489, DOI 10.1007/s00442-005-0281-3; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Taveras R, 2004, AGR FOREST ENTOMOL, V6, P89, DOI 10.1111/j.1461-9555.2004.00205.x; Tilman D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P21; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Van Der Putten WH, 2003, ECOLOGY, V84, P2269, DOI 10.1890/02-0284; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7	59	51	52	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105438	10.1371/journal.pone.0105438	http://dx.doi.org/10.1371/journal.pone.0105438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141305	Green Published, gold			2022-12-27	WOS:000342687200089
J	Zhang, CL; Ren, HJ; Liu, MM; Li, XG; Sun, DL; Li, N; Ming, L				Zhang, Chun Li; Ren, Hui Jun; Liu, Meng Meng; Li, Xiao Gai; Sun, De Li; Li, Nan; Ming, Liang			Modulation of Intestinal Epithelial Cell Proliferation, Migration, and Differentiation In Vitro by Astragalus Polysaccharides	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE; RESTITUTION; PROTEIN; GROWTH; RATS; POLYAMINES; EXPRESSION; IMMUNITY; MUCOSA; MODEL	Previous studies have shown that Astragalus polysaccharides (APS) can be used to treat general gastrointestinal disturbances including intestinal mucosal injury. However, the mechanism by which APS mediate this effect is unclear. In the present study, the effects of APS on proliferation, migration, and differentiation of intestinal epithelial cells (IEC-6) were assessed using an in vitro wounding model and colorimetric thiazolyl blue (MTT) assays. The effect of APS on IEC-6 cell differentiation was observed using a light microscope and scanning electron microscope, and the expression of differentiation-specific markers of IEC-6 cells, such as cytokeratin 18 (CK18), alkaline phosphatase (ALP), tight junction protein ZO-2, and sucrase-isomaltase (SI), was determined by immunofluorescence assay (IFA) and real-time PCR. In addition, APS-induced signaling pathways in IEC-6 cells were characterized. Our results indicated that APS significantly enhance migration and proliferation of IEC-6 cells in vitro. APS-treated IEC-6 cells have numerous microvilli on their apical surface and also highly express CK18, ALP, ZO-2, and SI. Moreover, APS-treated IEC-6 cells, in which the activity and expression level of ornithine decarboxylase (ODC) were significantly elevated, also exhibited an increase in cellular putrescine, whereas no significant increase in TGF-beta levels was observed. These findings suggest that APS may enhance intestinal epithelial cell proliferation, migration, and differentiation in vitro by stimulating ODC gene expression and activity and putrescine production, independent of TGF-beta. Exogenous administration of APS may provide a new approach for modulating intestinal epithelial wound restitution in vivo.	[Zhang, Chun Li; Sun, De Li] Peoples Hosp Zhengzhou, Dept Gen Surg, Zhengzhou, Peoples R China; [Ren, Hui Jun; Li, Xiao Gai; Li, Nan] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Zhengzhou 450052, Peoples R China; [Liu, Meng Meng] Third Peoples Hosp Zhengzhou, Dept Pathol, Zhengzhou, Peoples R China	Zhengzhou University	Ming, L (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Zhengzhou 450052, Peoples R China.	mingliang@zzu.edu.cn						BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen AQ, 2009, ANIM REPROD SCI, V115, P39, DOI 10.1016/j.anireprosci.2008.10.022; Cheng YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027437; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Dalloul RA, 2006, POULTRY SCI, V85, P446, DOI 10.1093/ps/85.3.446; Dang SS, 2009, WORLD J GASTROENTERO, V15, P5669, DOI 10.3748/wjg.15.5669; DIGNASS AU, 1994, GASTROENTEROLOGY, V106, P1254, DOI 10.1016/0016-5085(94)90017-5; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; GROBLEWSKI GE, 1992, AM J PHYSIOL, V263, pG742, DOI 10.1152/ajpgi.1992.263.5.G742; Guo FC, 2004, POULTRY SCI, V83, P175, DOI 10.1093/ps/83.2.175; Hei ZQ, 2005, WORLD J GASTROENTERO, V11, P4986, DOI 10.3748/wjg.v11.i32.4986; Hikita C, 2000, J CELL BIOL, V151, P1235, DOI 10.1083/jcb.151.6.1235; Huang XY, 2008, INT J BIOL MACROMOL, V42, P166, DOI 10.1016/j.ijbiomac.2007.10.019; Hwang S, 2012, J BIOL CHEM, V287, P22227, DOI 10.1074/jbc.M112.367979; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Lange I, 2014, J MOL BIOL, V426, P332, DOI 10.1016/j.jmb.2013.09.037; Li RJ, 2007, BIOL PHARM BULL, V30, P470, DOI 10.1248/bpb.30.470; Li SG, 2007, INT IMMUNOPHARMACOL, V7, P23, DOI 10.1016/j.intimp.2006.08.016; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; Paclik D, 2008, INFLAMM BOWEL DIS, V14, P1366, DOI 10.1002/ibd.20499; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rao JN, 2002, AM J PHYSIOL-CELL PH, V282, pC885, DOI 10.1152/ajpcell.00361.2001; Ray RM, 2012, J BIOL CHEM, V287, P3674, DOI 10.1074/jbc.M111.232561; Ren HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027010; Samal K, 2013, INT J CANCER, V133, P1323, DOI 10.1002/ijc.28139; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song HP, 2014, J ETHNOPHARMACOL, V152, P163, DOI 10.1016/j.jep.2013.12.049; Stettler M, 2001, ANTIMICROB AGENTS CH, V45, P2256, DOI 10.1128/AAC.45.8.2256-2262.2001; Sturm A, 1999, GASTROENTEROLOGY, V117, P368, DOI 10.1053/gast.1999.0029900368; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; WANG JY, 1991, GASTROENTEROLOGY, V100, P333, DOI 10.1016/0016-5085(91)90200-5; Wargovich MJ, 2001, J NUTR, V131, p3034S, DOI 10.1093/jn/131.11.3034S; Wu F, 2009, FASEB J, V23, P565, DOI 10.1096/fj.08-115121; Xu DJ, 2008, MOLECULES, V13, P2408, DOI 10.3390/molecules13102408; Yamada Y, 2013, DIGEST DIS SCI, V58, P1207, DOI 10.1007/s10620-012-2515-7; Zhao P, 2008, TOXICOL LETT, V182, P29, DOI 10.1016/j.toxlet.2008.08.002	40	29	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e106674	10.1371/journal.pone.0106674	http://dx.doi.org/10.1371/journal.pone.0106674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157577	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200093
J	Flaquer, A; Baumbach, C; Kriebel, J; Meitinger, T; Peters, A; Waldenberger, M; Grallert, H; Strauch, K				Flaquer, Antonia; Baumbach, Clemens; Kriebel, Jennifer; Meitinger, Thomas; Peters, Annette; Waldenberger, Melanie; Grallert, Harald; Strauch, Konstantin			Mitochondrial Genetic Variants Identified to Be Associated with BMI in Adults	PLOS ONE			English	Article							BODY-MASS INDEX; OXIDATIVE STRESS; COMMON VARIANTS; GENOME; METAANALYSIS; LOCI; POLYMORPHISMS; OXIDASE; OBESITY; IMPACT	It has been suggested that mitochondrial dysfunction plays a role in metabolic disorders including obesity, diabetes, and hypertension. The fact that mitochondrial defects can be accumulated over time as a normal part of aging may explain why some individuals can eat all sorts of foods and remain at normal weight while they are young. However, around the fourth decade of life there is a trend towards "middle-age spread'' with weight gain and the body's decreasing ability to metabolize calories efficiently. To test the hypothesis that mitochondrial variants are associated with BMI in adults, we analyzed a total number of 984 mitochondrial single nucleotide polymorphisms (mtSNPs) in a sample of 6,528 individuals participating in the KORA studies. To assess mtSNP association while taking heteroplasmy into account we used the raw signal intensity values measured on the microarray and applied linear regression. Significant results were obtained for 2 mtSNPs located in the Cytochrome c oxidase subunit genes (MT-CO1: P-adjusted = 0.0140 and MT-CO3: P-adjusted = 0.0286) and 3 mtSNPs located in the NADH dehydrogenase subunit genes (MT-ND1, MT-ND2 and MT-ND4L: P-adjusted = 0.0286). Polymorphisms located in the MT-CO3 and MT-ND4L genes have not been associated with BMI or related phenotypes in the past. Our results highlight the importance of the mitochondrial genome among the factors that contribute to the risk of high BMI. Focusing on mitochondrial variants may lead to further insights regarding effects of existing medications, or even to the development of innovative treatments.	[Flaquer, Antonia; Baumbach, Clemens; Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Neuherberg, Germany; [Flaquer, Antonia; Baumbach, Clemens; Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Kriebel, Jennifer; Peters, Annette; Waldenberger, Melanie; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Peters, Annette; Waldenberger, Melanie; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Flaquer, A (corresponding author), Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Neuherberg, Germany.	antonia.flaquer@lmu.de	Grallert, Harald/B-3424-2013; Waldenberger, Melanie/B-5355-2014; Kriebel, Jennifer/N-4782-2017; Peters, Annette/A-6117-2011; Meitinger, Thomas/O-1318-2015	Waldenberger, Melanie/0000-0003-0583-5093; Kriebel, Jennifer/0000-0003-4270-018X; Peters, Annette/0000-0001-6645-0985; Meitinger, Thomas/0000-0002-8838-8403	Helmholtz Zentrum Munchen - German Research Center for Environmental Health; State of Bavaria; KORA research within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); State of Bavaria; KORA research within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health which is founded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; BRADY LJ, 1985, BIOCHEM J, V231, P439, DOI 10.1042/bj2310439; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Flaquer A, 2014, MITOCHONDRION, V14, P49, DOI 10.1016/j.mito.2013.11.002; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hipkiss AR, 2010, ADV CLIN CHEM, V50, P123, DOI 10.1016/S0065-2423(10)50007-6; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Johannsen DL, 2012, J CLIN ENDOCR METAB, V97, P242, DOI 10.1210/jc.2011-1798; KATYARE SS, 1978, ARCH BIOCHEM BIOPHYS, V188, P15, DOI 10.1016/0003-9861(78)90349-1; Knoll N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094882; Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee SH, 2012, LIVEST SCI, V146, P160, DOI 10.1016/j.livsci.2012.03.003; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liu CY, 2012, HYPERTENSION, V60, P949, DOI 10.1161/HYPERTENSIONAHA.112.196519; Macgregor S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl136; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nardelli C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/631082; Nube M, 1998, EUR J CLIN NUTR, V52, P136, DOI 10.1038/sj.ejcn.1600528; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Peterson Courtney M, 2012, J Aging Res, V2012, P194821, DOI 10.1155/2012/194821; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; R Core Team, 2021, R LANGUAGE ENV STAT; RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1; Rahkonen O, 1998, J PUBLIC HEALTH POL, V19, P88, DOI 10.2307/3343091; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Sankhla M, 2012, CLIN LAB, V58, P385; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Smyth GK, 2010, P ADJUST PART R PACK; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Welon Z, 2002, AM J HUM BIOL, V14, P693, DOI 10.1002/ajhb.10079; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; World Health Organization, 2010, INT STAT CLASS DIS H; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a; Yang HC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-196; Yang TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021595	51	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105116	10.1371/journal.pone.0105116	http://dx.doi.org/10.1371/journal.pone.0105116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153900	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200038
J	Mechelmans, DJ; Irvine, M; Banca, P; Porter, L; Mitchell, S; Mole, TB; Lapa, TR; Harrison, NA; Potenza, MN; Voon, V				Mechelmans, Daisy J.; Irvine, Michael; Banca, Paula; Porter, Laura; Mitchell, Simon; Mole, Tom B.; Lapa, Tatyana R.; Harrison, Neil A.; Potenza, Marc N.; Voon, Valerie			Enhanced Attentional Bias towards Sexually Explicit Cues in Individuals with and without Compulsive Sexual Behaviours	PLOS ONE			English	Article							IMPULSE-CONTROL DISORDERS; TIME-COURSE; PSYCHIATRIC-INPATIENTS; HYPERSEXUAL DISORDER; ABSTINENT ALCOHOLICS; NONEROTIC STIMULI; VISUAL-ATTENTION; EYE-MOVEMENTS; TRAIT ANXIETY; SMOKING CUES	Compulsive sexual behaviour (CSB) is relatively common and has been associated with significant distress and psychosocial impairments. CSB has been conceptualized as either an impulse control disorder or a non-substance 'behavioural' addiction. Substance use disorders are commonly associated with attentional biases to drug cues which are believed to reflect processes of incentive salience. Here we assess male CSB subjects compared to age-matched male healthy controls using a dot probe task to assess attentional bias to sexually explicit cues. We show that compared to healthy volunteers, CSB subjects have enhanced attentional bias to explicit cues but not neutral cues particularly for early stimuli latency. Our findings suggest enhanced attentional bias to explicit cues possibly related to an early orienting attentional response. This finding dovetails with our recent observation that sexually explicit videos were associated with greater activity in a neural network similar to that observed in drug-cue-reactivity studies. Greater desire or wanting rather than liking was further associated with activity in this neural network. These studies together provide support for an incentive motivation theory of addiction underlying the aberrant response towards sexual cues in CSB.	[Mechelmans, Daisy J.; Irvine, Michael; Banca, Paula; Porter, Laura; Mitchell, Simon; Mole, Tom B.; Lapa, Tatyana R.; Voon, Valerie] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; [Voon, Valerie] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 2QQ, England; [Mitchell, Simon; Mole, Tom B.; Voon, Valerie] Cambridgeshire & Peterborough Fdn Trust, Cambridge, England; [Harrison, Neil A.] Brighton & Sussex Med Sch, Dept Psychiat, Brighton, E Sussex, England; [Potenza, Marc N.] Yale Univ, Dept Psychiat, Neurobiol & Child Study Ctr, New Haven, CT 06520 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Brighton; University of Sussex; Yale University	Voon, V (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England.	vv247@cam.ac.uk	Banca, Paula/G-8330-2017; Voon, Valerie/O-7038-2017; Mole, Tom/P-7588-2015	Banca, Paula/0000-0001-7617-3635; Voon, Valerie/0000-0001-6790-1776; Mole, Tom/0000-0001-8732-8188; Harrison, Neil/0000-0002-9584-3769	Wellcome Trust fellowship grant [093705/Z/10/Z]; National Institutes of Health [P20 DA027844, R01 DA018647]; Connecticut State Department of Mental Health and Addiction Services; Connecticut Mental Health Center; Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming; Medical Research Council [G0001354, G0001354B, G1000183B] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA027844, R01DA018647] Funding Source: NIH RePORTER	Wellcome Trust fellowship grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut State Department of Mental Health and Addiction Services; Connecticut Mental Health Center; Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was mostly funded by a grant from the Wellcome Trust fellowship grant (093705/Z/10/Z). Dr. Potenza was supported in part by grants P20 DA027844 and R01 DA018647 from the National Institutes of Health; the Connecticut State Department of Mental Health and Addiction Services; the Connecticut Mental Health Center; and a Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bradley BP, 2003, PSYCHOL ADDICT BEHAV, V17, P66, DOI 10.1037/0893-164X.17.1.66; Carnes P. J., 2001, SHADOWS NET BREAKING; Chanon VW, 2010, PSYCHOPHARMACOLOGY, V212, P309, DOI 10.1007/s00213-010-1953-1; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Cousijn J, 2013, ADDICT BEHAV, V38, P2825, DOI 10.1016/j.addbeh.2013.08.011; Cox WM, 2006, PSYCHOL BULL, V132, P443, DOI 10.1037/0033-2909.132.3.443; Delmonico DL, 2003, SEXUAL RELATIONSHIP, V18; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Ersche KD, 2010, ARCH GEN PSYCHIAT, V67, P632, DOI 10.1001/archgenpsychiatry.2010.60; Field M., 2006, ATTENTIONAL BIASES D; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Fineberg NA, 2014, CNS SPECTRUMS, V19, P69, DOI 10.1017/S1092852913000801; Fong Timothy W, 2006, Psychiatry (Edgmont), V3, P51; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Franken IHA, 2003, PSYCHOPHARMACOLOGY, V170, P205, DOI 10.1007/s00213-003-1542-7; Fromberger P, 2012, ARCH SEX BEHAV, V41, P919, DOI 10.1007/s10508-011-9816-3; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386; Grant JE, 2005, AM J PSYCHIAT, V162, P2184, DOI 10.1176/appi.ajp.162.11.2184; Grant JE, 2007, J CLIN PSYCHIAT, V68, P1584, DOI 10.4088/JCP.v68n1018; Hartston HJ, 1999, NEUROPSYCHOLOGY, V13, P447, DOI 10.1037/0894-4105.13.3.447; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Kafka MP, 2010, ARCH SEX BEHAV, V39, P377, DOI 10.1007/s10508-009-9574-7; Klein AA, 2007, BEHAV RES THER, V45, P169, DOI 10.1016/j.brat.2005.12.012; Kor A, 2013, SEX ADDICT COMPULSIV, V20; Koster EHW, 2005, BEHAV RES THER, V43, P1087, DOI 10.1016/j.brat.2004.08.004; Kuhn S, 2011, EUR J NEUROSCI, V33, P1318, DOI 10.1111/j.1460-9568.2010.07590.x; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; Lykins AD, 2006, ARCH SEX BEHAV, V35, P569, DOI 10.1007/s10508-006-9065-z; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Meerkerk GJ, 2009, CYBERPSYCHOL BEHAV, V12, P1, DOI 10.1089/cpb.2008.0181; Mogg K, 1997, BEHAV RES THER, V35, P297, DOI 10.1016/S0005-7967(96)00109-X; Mogg K, 2005, PSYCHOPHARMACOLOGY, V180, P333, DOI 10.1007/s00213-005-2158-x; Mogg K, 2003, ADDICTION, V98, P825, DOI 10.1046/j.1360-0443.2003.00392.x; Mogg K, 2000, PERS INDIV DIFFER, V28, P1063, DOI 10.1016/S0191-8869(99)00157-9; Nelson HE., 1982, NATL ADULT READING T; Noel X, 2006, ALCOHOL CLIN EXP RES, V30, P1871, DOI 10.1111/j.1530-0277.2006.00224.x; Odlaug B.L., 2010, PRIM CARE COMPANION, V12; Odlaug BL, 2013, ANN CLIN PSYCHIATRY, V25, P193; Oliver JA, 2012, EXP CLIN PSYCHOPHARM, V20, P489, DOI 10.1037/a0029519; Petry NM, 2013, ADDICTION, V108, P1186, DOI 10.1111/add.12162; Potenza MN, 2014, BIOL PSYCHIAT, V75, P94, DOI 10.1016/j.biopsych.2013.11.010; Prause N, 2008, ARCH SEX BEHAV, V37, P934, DOI 10.1007/s10508-007-9236-6; Reid RC, 2012, J SEX MED, V9, P2868, DOI 10.1111/j.1743-6109.2012.02936.x; Robbins Steven J, 2004, Behav Cogn Neurosci Rev, V3, P243, DOI 10.1177/1534582305275423; Roberts GMP, 2013, PSYCHIAT RES-NEUROIM, V213, P122, DOI 10.1016/j.pscychresns.2013.03.011; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rosse RB, 1997, J NEUROPSYCH CLIN N, V9, P91; Ryan F, 2002, ADDICT BEHAV, V27, P471, DOI 10.1016/S0306-4603(01)00183-6; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stormark KM, 1997, ADDICT BEHAV, V22, P509, DOI 10.1016/S0306-4603(96)00051-2; Theeuwes J, 2002, PERCEPT PSYCHOPHYS, V64, P764, DOI 10.3758/BF03194743; van Hemel-Ruiter MLE, 2013, PSYCHOL ADDICT BEHAV, V27, P142, DOI 10.1037/a0028271; Vollstadt-Klein S, 2012, ADDICT BIOL, V17, P807, DOI 10.1111/j.1369-1600.2011.00352.x; Voon V, PLOS ONE IN PRESS; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	62	61	62	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105476	10.1371/journal.pone.0105476	http://dx.doi.org/10.1371/journal.pone.0105476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153083	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000340952200055
J	Sui, ZW; Wen, B; Gao, ZM; Chen, QJ				Sui, Zhiwei; Wen, Bo; Gao, Zhimin; Chen, Quanjiao			Fusion-Related Host Proteins Are Actively Regulated by NA during Influenza Infection as Revealed by Quantitative Proteomics Analysis	PLOS ONE			English	Article							LAMININ RECEPTOR; DIFFERENTIAL EXPRESSION; VIRUS-INFECTION; CELLS; ENZYMES; LIFE	Three recombinant influenza A viruses with different neuraminidases (NAs) in the background of A/PR/8/34 (PR8), named rPR8-H5N1NA, rPR8-H9N2NA, and rPR8-H1N1NA, derived from H5N1, H9N2, H1N1 (swine) viruses, respectively, were constructed. We performed a quantitative proteomics analysis to investigate differential protein expression in Madin-Darby canine kidney (MDCK) cells infected with recombinant and wild-type influenza viruses to determine whether NA replacement would alter host cell gene expression. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-TOF MS) and two-dimensional gel electrophoresis (2-DE), we identified 12 up-regulated and 49 down-regulated protein spots, including cytoskeletal proteins, molecular biosynthesis proteins, ubiquitin-proteasome pathway proteins, and heat shock proteins. The most significant changes in infected cells were observed for molecular biosynthesis proteins. We found more differentially expressed protein spots in cells infected with rPR8-H5N1NA or rPR8-H9N2NA viruses than cells infected with wild-type virus. Many of those proteins are postulated to be involved in cell-cell fusion, but the full mechanism remains to be explored. Meanwhile, our data demonstrate that the wild-type virus has evolutionary advantages over recombinant viruses.	[Gao, Zhimin; Chen, Quanjiao] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Sui, Zhiwei] Natl Inst Metrol, Beijing, Peoples R China; [Wen, Bo] BGI Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; National Institute of Metrology China; Beijing Genomics Institute (BGI)	Chen, QJ (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	chenqj@wh.iov.cn	Wen, Bo/I-1259-2019	Wen, Bo/0000-0003-2261-3150	National Natural Science Foundation of China [31070141, 31100132]; National Science and Technology Support Program [2013BAK12B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program	This work was supported by grants from National Natural Science Foundation of China (31070141, 31100132) and National Science and Technology Support Program (NO. 2013BAK12B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Baas T, 2006, J VIROL, V80, P10813, DOI 10.1128/JVI.00851-06; Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Chen QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054334; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Jamieson KV, 2011, J MOL BIOL, V405, P24, DOI 10.1016/j.jmb.2010.10.028; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Osaki H, 2013, LEUKEMIA, V27, P1461, DOI 10.1038/leu.2013.42; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zou W, 2010, J PROTEOME RES, V9, P3789, DOI 10.1021/pr100080x	18	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105947	10.1371/journal.pone.0105947	http://dx.doi.org/10.1371/journal.pone.0105947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153908	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200094
J	Brantley, ST; Bissett, SN; Young, DR; Wolner, CWV; Moore, LJ				Brantley, Steven T.; Bissett, Spencer N.; Young, Donald R.; Wolner, Catherine W. V.; Moore, Laura J.			Barrier Island Morphology and Sediment Characteristics Affect the Recovery of Dune Building Grasses following Storm-Induced Overwash	PLOS ONE			English	Article							COASTAL; PLANT; ZONATION; STABILITY; SALINITY; DYNAMICS; BIOMASS; BURIAL; SCALE; SAND	Barrier islands are complex and dynamic systems that provide critical ecosystem services to coastal populations. Stability of these systems is threatened by rising sea level and the potential for coastal storms to increase in frequency and intensity. Recovery of dune-building grasses following storms is an important process that promotes topographic heterogeneity and long-term stability of barrier islands, yet factors that drive dune recovery are poorly understood. We examined vegetation recovery in overwash zones on two geomorphically distinct (undisturbed vs. frequently overwashed) barrier islands on the Virginia coast, USA. We hypothesized that vegetation recovery in overwash zones would be driven primarily by environmental characteristics, especially elevation and beach width. We sampled species composition and environmental characteristics along a continuum of disturbance from active overwash zones to relict overwash zones and in adjacent undisturbed environments. We compared species assemblages along the disturbance chronosequence and between islands and we analyzed species composition data and environmental measurements with Canonical Correspondence Analysis to link community composition with environmental characteristics. Recovering and geomorphically stable dunes were dominated by Ammophila breviligulata Fernaud (Poaceae) on both islands while active overwash zones were dominated by Spartina patens (Aiton) Muhl. (Poaceae) on the frequently disturbed island and bare sand on the less disturbed island. Species composition was associated with environmental characteristics only on the frequently disturbed island (p = 0.005) where A. breviligulata was associated with higher elevation and greater beach width. Spartina patens, the second most abundant species, was associated with larger sediment grain size and greater sediment size distribution. On the less frequently disturbed island, time since disturbance was the only factor that affected community composition. Thus, factors driving the abundance of dune-building grasses and subsequent recovery of dunes varied between the two geomorphically distinct islands.	[Brantley, Steven T.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55455 USA; [Bissett, Spencer N.; Young, Donald R.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Wolner, Catherine W. V.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Moore, Laura J.] Univ N Carolina, Dept Geol Sci, Chapel Hill, NC USA	University of Minnesota System; University of Minnesota Twin Cities; Virginia Commonwealth University; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Brantley, ST (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55455 USA.	sbrantle@umn.edu		Brantley, Steven/0000-0002-1780-3366	United States Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute for Climatic Change Research at Tulane University [DE-FC02-06ER64298]; Geological Society of America; Virginia Coast Reserve Long-Term Ecological Research (VCR-LTER) [DEB-0080381]; Direct For Biological Sciences [1237733] Funding Source: National Science Foundation	United States Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute for Climatic Change Research at Tulane University; Geological Society of America; Virginia Coast Reserve Long-Term Ecological Research (VCR-LTER); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the United States Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute for Climatic Change Research at Tulane University (http://www.tulane.edu/similar to NICCR/) grant number DE-FC02-06ER64298 to LJM and DRY. The Geological Society of America and the Virginia Coast Reserve Long-Term Ecological Research (VCR-LTER) program provided additional support through grant number DEB-0080381 to LJM and DRY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTNESS MD, 1991, ECOLOGY, V72, P125, DOI 10.2307/1938908; BOYCE SG, 1954, ECOL MONOGR, V24, P29, DOI 10.2307/1943510; Cahoon DR, 2006, ESTUAR COAST, V29, P889, DOI 10.1007/BF02798648; CLARK JS, 1990, REV AQUAT SCI, V2, P509; da Silva GM, 2008, EARTH SURF PROC LAND, V33, P1557, DOI 10.1002/esp.1633; Day FP, 2001, J TORREY BOT SOC, V128, P197, DOI 10.2307/3088711; Dilustro JJ, 1997, AM MIDL NAT, V137, P27, DOI 10.2307/2426752; Duncan W. H., 1987, SEASIDE PLANTS GULF; EHRENFELD JG, 1990, REV AQUAT SCI, V2, P437; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Emanuel KA, 2013, P NATL ACAD SCI USA, V110, P12219, DOI 10.1073/pnas.1301293110; FAHRIG L, 1993, J COASTAL RES, V9, P403; Feagin RA, 2010, J COASTAL RES, V26, P987, DOI 10.2112/09-1185.1; Fenu G, 2013, FOLIA GEOBOT, V48, P493, DOI 10.1007/s12224-012-9141-1; Godfrey P. J., 1979, BARRIER ISLANDS, P99; Gornish ES, 2010, GLOBAL CHANGE BIOL, V16, P2668, DOI 10.1111/j.1365-2486.2009.02144.x; Houle G, 2008, ECOSCIENCE, V15, P113, DOI 10.2980/1195-6860(2008)15[113:PSRAID]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; LEATHERMAN SP, 1987, SEDIMENT GEOL, V52, P183, DOI 10.1016/0037-0738(87)90061-3; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; MAUN MA, 1984, J ECOL, V72, P827, DOI 10.2307/2259534; MAUN MA, 1994, VEGETATIO, V111, P59; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Miller TE, 2010, PLANT ECOL, V206, P97, DOI 10.1007/s11258-009-9626-z; Molina JA, 2003, PHYTOCOENOLOGIA, V33, P475, DOI 10.1127/0340-269X/2003/0033-0475; Morton RA, 2005, J COASTAL RES, V21, P704, DOI 10.2112/04-0230.1; Oosting HJ, 1942, ECOLOGY, V23, P131, DOI 10.2307/1931081; Oster DJ, 2012, THESIS U VIRGINIA; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; Radford AE, 1968, MANUAL VASCULAR FLOR; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Sallenger AH, 2000, J COASTAL RES, V16, P890; Seabloom EW, 2013, GLOBAL CHANGE BIOL, V19, P824, DOI 10.1111/gcb.12078; Snyder RA, 2002, J COASTAL RES, V18, P530; Stallins JA, 2005, ECOL COMPLEX, V2, P410, DOI 10.1016/j.ecocom.2005.04.011; Stallins JA, 2003, ANN ASSOC AM GEOGR, V93, P13, DOI 10.1111/1467-8306.93102; Uva RH., 1997, WEEDS NE, P408; VANDERVALK AG, 1974, CAN J BOT, V52, P1057, DOI 10.1139/b74-135; Wilson JB, 1999, ECOL LETT, V2, P233; Wolner CWV, 2013, GEOMORPHOLOGY, V199, P115, DOI 10.1016/j.geomorph.2013.03.035; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; Young DR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00186.1; YOUNG DR, 1995, AM J BOT, V82, P638, DOI 10.2307/2445422; YOUNG DR, 1994, CAN J BOT, V72, P1365, DOI 10.1139/b94-167	45	36	36	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104747	10.1371/journal.pone.0104747	http://dx.doi.org/10.1371/journal.pone.0104747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148028	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600019
J	Budde, H; Kolb, S; Tejedor, LS; Wulf, G; Reichardt, HM; Riggert, J; Legler, TJ				Budde, Holger; Kolb, Susanne; Tejedor, Laura Salinas; Wulf, Gerald; Reichardt, Holger M.; Riggert, Joachim; Legler, Tobias J.			Modified Extracorporeal Photopheresis with Cells from a Healthy Donor for Acute Graft-versus-Host Disease in a Mouse Model	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; PERIPHERAL-BLOOD; APOPTOTIC CELLS; PHOTOCHEMOTHERAPY; DEATH; MECHANISMS; INDUCTION; IMMUNITY; FOCUS	Background: Graft-versus-host disease (GvHD) is a major challenge after hematopoietic stem cell transplantation but treatment options for patients are still limited. In many cases first-line treatment with glucocorticoids is not successful. Among second-line therapies the extracorporeal photopheresis (ECP) is frequently performed, due to induction of selective tolerance instead of general immunosuppression. However, for some patients with severe acute GvHD the leukapheresis step of the ECP procedure is physically exhausting and limits the number of ECP cycles. Methods: We hypothesized that leukocytes from healthy cell donors could be used as a replacement for ECP leukocytes gained from the GvHD patient. For this purpose we used a well established mouse model of acute GvHD. The ECP therapy was based on cells with the genetic background of the initial donor of the stem cell transplantation. As a precondition we developed a protocol representing conventional ECP in mice equivalent to clinical used ECP setup. Results: We could demonstrate that conventional, clinically derived ECP setup is able to alleviate acute GvHD. By using leukocytes obtained from healthy mice with the bone marrow donor's genetic background we could not observe a statistically significant therapeutic effect. Conclusions: Conventional human ECP setup is effective in the mouse model of severe acute GvHD. In addition we could not prove that ECP cells from healthy mice with bone marrow donor's genetic background are as effective as ECP cells derived from GvHD mice. Based on our findings, new questions arise for further studies, in which the cellular characteristics for ECP mediated immune tolerance are a matter of investigation.	[Budde, Holger; Kolb, Susanne; Tejedor, Laura Salinas; Riggert, Joachim; Legler, Tobias J.] Univ Med Ctr Gottingen, Dept Transfus Med, Gottingen, Germany; [Wulf, Gerald] Univ Med Ctr Gottingen, Dept Hematol & Oncol, Gottingen, Germany; [Reichardt, Holger M.] Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Budde, H (corresponding author), Univ Med Ctr Gottingen, Dept Transfus Med, Gottingen, Germany.	holger.budde@med.uni-goettingen.de	Reichardt, Holger/AAF-3048-2020	Reichardt, Holger/0000-0003-4647-057X	Deutsche Jose Carreras Leukamie Stiftung e.V [DJCLS R 12/34]	Deutsche Jose Carreras Leukamie Stiftung e.V	This work was supported by grants from the Deutsche Jose Carreras Leukamie Stiftung e.V. to H.B. (grant number: DJCLS R 12/34, http://www.carreras-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; Bladon J, 2006, J DERMATOL SCI, V43, P85, DOI 10.1016/j.jdermsci.2006.05.004; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Capitini CM, 2011, BIOL BLOOD MARROW TR, V17, P790, DOI 10.1016/j.bbmt.2010.12.712; Devine SM, 2011, BIOL BLOOD MARROW TR, V17, P1343, DOI 10.1016/j.bbmt.2011.02.002; Edelson RL, 2014, TRANSFUS APHER SCI, V50, P322, DOI 10.1016/j.transci.2013.07.031; GASPARRO FP, 1989, YALE J BIOL MED, V62, P579; Gatza E, 2008, BLOOD, V112, P1515, DOI 10.1182/blood-2007-11-125542; Greinix HT, 2006, BONE MARROW TRANSPL, V38, P265, DOI 10.1038/sj.bmt.1705440; Greinix HT, 2010, BIOL BLOOD MARROW TR, V16, P1747, DOI 10.1016/j.bbmt.2010.06.012; Greinix HT, 2000, BLOOD, V96, P2426; Hart JW, 2013, THER ADV HEMATOL, V4, P320, DOI 10.1177/2040620713490316; Heshmati F, 2003, TRANSFUS APHER SCI, V29, P61, DOI 10.1016/S1473-0502(03)00103-4; KORNGOLD R, 1978, J EXP MED, V148, P1687; Li HW, 2012, NAT REV IMMUNOL, V12, P403, DOI 10.1038/nri3226; Maeda A, 2008, J IMMUNOL, V181, P5956, DOI 10.4049/jimmunol.181.9.5956; Marshall SR, 2006, NAT CLIN PRACT ONCOL, V3, P302, DOI 10.1038/ncponc0511; Merlin E, 2010, BONE MARROW TRANSPL, V45, P963, DOI 10.1038/bmt.2009.271; Pasquini Marcelo C, 2010, Clin Transpl, P87; Perfetti P, 2008, BONE MARROW TRANSPL, V42, P609, DOI 10.1038/bmt.2008.221; Reddy P, 2009, MOUSE MODELS GRAFT V, DOI [10.3824/stem-book.1.36.1, DOI 10.3824/STEM-BOOK.1.36.1.]; Reddy P, 2008, BIOL BLOOD MARROW TR, V14, P129, DOI 10.1016/j.bbmt.2007.10.021; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Suchin KR, 1999, J AM ACAD DERMATOL, V41, P980, DOI 10.1016/S0190-9622(99)70257-4; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Tischner D, 2011, J IMMUNOL, V187, P4509, DOI 10.4049/jimmunol.1100911; Wolf CE, 2005, VOX SANG, V88, P249, DOI 10.1111/j.1423-0410.2005.00562.x; Wolf D, 2012, BLOOD, V119, P16, DOI 10.1182/blood-2011-08-339465; Wolff D, 2009, CURR PHARM DESIGN, V15, P1974, DOI 10.2174/138161209788453158; Xia CQ, 2009, CURR OPIN ORGAN TRAN, V14, P338, DOI 10.1097/MOT.0b013e32832ce943	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105896	10.1371/journal.pone.0105896	http://dx.doi.org/10.1371/journal.pone.0105896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148404	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600094
J	Daume, M; Plagens, A; Randau, L				Daume, Michael; Plagens, Andre; Randau, Lennart			DNA Binding Properties of the Small Cascade Subunit Csa5	PLOS ONE			English	Article							ADAPTIVE BACTERIAL IMMUNITY; IN-VITRO RECONSTITUTION; CRISPR-CAS SYSTEMS; ESCHERICHIA-COLI; RNA; COMPLEX; INTERFERENCE; DEGRADATION; PROKARYOTES; DEFENSE	CRISPR-Cas systems provide immunity against viral attacks in archaeal and bacterial cells. Type I systems employ a Cas protein complex termed Cascade, which utilizes small CRISPR RNAs to detect and degrade the exogenic DNA. A small sequence motif, the PAM, marks the foreign substrates. Previously, a recombinant type I-A Cascade complex from the archaeon Thermoproteus tenax was shown to target and degrade DNA in vitro, dependent on a native PAM sequence. Here, we present the biochemical analysis of the small subunit, Csa5, of this Cascade complex. T. tenax Csa5 preferentially bound ssDNA and mutants that showed decreased ssDNA-binding and reduced Cascade-mediated DNA cleavage were identified. Csa5 oligomerization prevented DNA binding. Specific recognition of the PAM sequence was not observed. Phylogenetic analyses identified Csa5 as a universal member of type I-A systems and revealed three distinct groups. A potential role of Csa5 in R-loop stabilization is discussed.	[Daume, Michael; Plagens, Andre; Randau, Lennart] Max Planck Inst Terr Microbiol, Prokaryot Small RNA Biol, D-35043 Marburg, Germany	Max Planck Society	Randau, L (corresponding author), Max Planck Inst Terr Microbiol, Prokaryot Small RNA Biol, D-35043 Marburg, Germany.	lennart.randau@mpi-marburg.mpg.de		Randau, Lennart/0000-0002-2780-2076	Deutsche Forschungsgemeinschaft (DFG) [FOR1680]; Max-Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG (dfg. de), FOR1680) and the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kiro R, 2013, BIOCHEM SOC T, V41, P1412, DOI 10.1042/BST20130109; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nam KH, 2012, FEBS LETT, V586, P3956, DOI 10.1016/j.febslet.2012.09.041; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Pande VS, 1998, P NATL ACAD SCI USA, V95, P1490, DOI 10.1073/pnas.95.4.1490; Plagens A, 2014, NUCLEIC ACIDS RES, V42, P5125, DOI 10.1093/nar/gku120; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Reeks J, 2013, RNA BIOL, V10, P762, DOI 10.4161/rna.23854; Richter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049549; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105716	10.1371/journal.pone.0105716	http://dx.doi.org/10.1371/journal.pone.0105716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148031	Green Submitted, gold, Green Published			2022-12-27	WOS:000341230600073
J	Elemraid, MA; Muller, M; Spencer, DA; Rushton, SP; Gorton, R; Thomas, MF; Eastham, KM; Hampton, F; Gennery, AR; Clark, JE				Elemraid, Mohamed A.; Muller, Michelle; Spencer, David A.; Rushton, Stephen P.; Gorton, Russell; Thomas, Matthew F.; Eastham, Katherine M.; Hampton, Fiona; Gennery, Andrew R.; Clark, Julia E.		North East England Paediat Resp In	Accuracy of the Interpretation of Chest Radiographs for the Diagnosis of Paediatric Pneumonia	PLOS ONE			English	Article								Introduction: World Health Organization (WHO) radiological classification remains an important entry criterion in epidemiological studies of pneumonia in children. We report inter-observer variability in the interpretation of 169 chest radiographs in children suspected of having pneumonia. Methods: An 18-month prospective aetiological study of pneumonia was undertaken in Northern England. Chest radiographs were performed on eligible children aged <= 16 years with clinical features of pneumonia. The initial radiology report was compared with a subsequent assessment by a consultant cardiothoracic radiologist. Chest radiographic changes were categorised according to the WHO classification. Results: There was significant disagreement (22%) between the first and second reports (kappa = 0.70, P<0.001), notably in those aged <5 years (26%, kappa = 0.66, P<0.001). The most frequent sources of disagreement were the reporting of patchy and perihilar changes. Conclusion: This substantial inter-observer variability highlights the need for experts from different countries to create a consensus to review the radiological definition of pneumonia in children.	[Elemraid, Mohamed A.; Gennery, Andrew R.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Paediat Infect Dis & Immunol, Newcastle Upon Tyne, Tyne & Wear, England; [Elemraid, Mohamed A.; Gennery, Andrew R.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Muller, Michelle] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Radiol, Newcastle Upon Tyne, Tyne & Wear, England; [Spencer, David A.; Thomas, Matthew F.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Resp Paediat, Newcastle Upon Tyne, Tyne & Wear, England; [Rushton, Stephen P.; Thomas, Matthew F.] Newcastle Univ, Sch Biol, Biol Clin & Environm Syst Modelling Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gorton, Russell] Publ Hlth England North East, Reg Epidemiol Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Eastham, Katherine M.] Sunderland Royal Hosp, Dept Paediat, Sunderland, England; [Hampton, Fiona] James Cook Univ Hosp, Dept Paediat, Middlesbrough, Cleveland, England; [Clark, Julia E.] Royal Childrens Hosp, Dept Paediat Infect Dis, Brisbane, Qld, Australia	Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Sunderland Royal Hospital; James Cook University Hospital; Royal Children's Hospital Brisbane	Elemraid, MA (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Paediat Infect Dis & Immunol, Newcastle Upon Tyne, Tyne & Wear, England.	elemraid@doctors.org.uk	Clark, Julia/A-8214-2012	Clark, Julia/0000-0001-7746-0599	Pfizer Vaccines UK [0887X1-4479]	Pfizer Vaccines UK	The authors declare that this study was supported by a grant (No: 0887X1-4479) from Pfizer Vaccines UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Shimol S, 2012, EUR J PEDIATR, V171, P369, DOI 10.1007/s00431-011-1543-1; Berlin L, 2007, AM J ROENTGENOL, V188, P1173, DOI 10.2214/AJR.06.1270; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Elemraid MA, 2013, EUR RESPIR J, V42, P1595, DOI 10.1183/09031936.00199112; Esayag Yaacov, 2010, Am J Med, V123, DOI 10.1016/j.amjmed.2009.09.012; GARLAND LH, 1959, AMER J ROENTGENOL RA, V82, P25; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Johnson J, 2010, EMERG RADIOL, V17, P285, DOI 10.1007/s10140-009-0854-2; Klein EJ, 1999, PEDIATR EMERG CARE, V15, P245; Loy CT, 2004, JAMA-J AM MED ASSOC, V292, P1602, DOI 10.1001/jama.292.13.1602; Madhi SA, 2007, VACCINE, V25, P2413, DOI 10.1016/j.vaccine.2006.09.010; Neuman MI, 2012, J HOSP MED, V7, P294, DOI 10.1002/jhm.955; Patterson HS, 2005, RADIOLOGY, V235, P5, DOI 10.1148/radiol.2351020759; Puumalainen T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-95; RENFREW DL, 1992, RADIOLOGY, V183, P145, DOI 10.1148/radiology.183.1.1549661; STICKLER GB, 1984, CLIN PEDIATR, V23, P398, DOI 10.1177/000992288402300707; SWENSSON RG, 1982, INVEST RADIOL, V17, P145, DOI 10.1097/00004424-198203000-00006; Swingler GH, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001268.PUB3; Tudor GR, 1997, CLIN RADIOL, V52, P235, DOI 10.1016/S0009-9260(97)80280-2; WHO, 2001, WHOFCHCAH0101; World Health Organization, 2001, WHOVB0135; Xavier-Souza G, 2013, PEDIATR PULM, V48, P464, DOI 10.1002/ppul.22644	25	53	55	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106051	10.1371/journal.pone.0106051	http://dx.doi.org/10.1371/journal.pone.0106051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148361	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600111
J	Pacheco-Arjona, JR; Ramirez-Prado, JH				Ramon Pacheco-Arjona, Jose; Humberto Ramirez-Prado, Jorge			Large-Scale Phylogenetic Classification of Fungal Chitin Synthases and Identification of a Putative Cell-Wall Metabolism Gene Cluster in Aspergillus Genomes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES-CEREVISIAE; PROTEIN EVOLUTION; PROBE LEVEL; CLASS-VII; YEAST; CONSERVATION; KINESIN-1; FUMIGATUS; COOPERATE	The cell wall is a protective and versatile structure distributed in all fungi. The component responsible for its rigidity is chitin, a product of chitin synthase (Chsp) enzymes. There are seven classes of chitin synthase genes (CHS) and the amount and type encoded in fungal genomes varies considerably from one species to another. Previous Chsp sequence analyses focused on their study as individual units, regardless of genomic context. The identification of blocks of conserved genes between genomes can provide important clues about the interactions and localization of chitin synthases. On the present study, we carried out an in silico search of all putative Chsp encoded in 54 full fungal genomes, encompassing 21 orders from five phyla. Phylogenetic studies of these Chsp were able to confidently classify 347 out of the 369 Chsp identified (94%). Patterns in the distribution of Chsp related to taxonomy were identified, the most prominent being related to the type of fungal growth. More importantly, a synteny analysis for genomic blocks centered on class IV Chsp (the most abundant and widely distributed Chsp class) identified a putative cell wall metabolism gene cluster in members of the genus Aspergillus, the first such association reported for any fungal genome.	[Ramon Pacheco-Arjona, Jose; Humberto Ramirez-Prado, Jorge] Ctr Invest Cient Yucatan, Unidad Biotecnol, AC, Merida, Yucatan, Mexico	Centro de Investigacion Cientifica de Yucatan	Ramirez-Prado, JH (corresponding author), Ctr Invest Cient Yucatan, Unidad Biotecnol, AC, Merida, Yucatan, Mexico.	jhramirez@cicy.mx	Pacheco-Arjona, Ramon/F-3635-2019; Ramirez-Prado, Jorge H/A-3012-2011	Pacheco-Arjona, Ramon/0000-0001-9067-5316; Ramirez-Prado, Jorge H/0000-0003-2780-5223	Mexico National Science and Technology Council CONACYT [CB-2008 107114]; CONACYT Ph. D. scholarship	Mexico National Science and Technology Council CONACYT; CONACYT Ph. D. scholarship	This work was supported by funds from Mexico National Science and Technology Council CONACYT grant CB-2008 107114 to JHR-P as well as a CONACYT Ph. D. scholarship to JRP-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Brown SS, 1997, CURR OPIN CELL BIOL, V9, P44, DOI 10.1016/S0955-0674(97)80150-0; Chen NS, 2006, GENOME RES, V16, P606, DOI 10.1101/gr.4515306; Choquer M, 2004, EUR J BIOCHEM, V271, P2153, DOI 10.1111/j.1432-1033.2004.04135.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Goodson HV, 1996, J CELL BIOL, V133, P1277, DOI 10.1083/jcb.133.6.1277; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hane JK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r45; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Jacob F, 1960, CR HEBD ACAD SCI, V250; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jukes TH, 1969, EVOLUTION PROTEIN MO; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Mahabhashyam Brudno, 2005, GENOME RES, V15, P330; Mandel MA, 2006, FUNGAL GENET BIOL, V43, P775, DOI 10.1016/j.fgb.2006.05.005; McGary KL, 2013, P NATL ACAD SCI USA, V110, P11481, DOI 10.1073/pnas.1304461110; Mellado E, 1996, FEMS MICROBIOL LETT, V143, P69, DOI 10.1111/j.1574-6968.1996.tb08463.x; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; Nei M., 2000, MOL EVOLUTION PHYLOG; Nino-Vega GA, 2004, MED MYCOL, V42, P51, DOI 10.1080/1369378031000153811; Odenbach D, 2009, MOL PLANT PATHOL, V10, P81, DOI 10.1111/j.1364-3703.2008.00515.x; Osmond BC, 1999, P NATL ACAD SCI USA, V96, P11206, DOI 10.1073/pnas.96.20.11206; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruiz-Herrera Jose, 2002, FEMS Yeast Research, V1, P247, DOI 10.1016/S1567-1356(01)00049-6; Ruiz-Herrera J, 2010, FEMS YEAST RES, V10, P225, DOI 10.1111/j.1567-1364.2009.00589.x; Santiago-Sotelo P, 2012, BIOTECHNIQUES, V53, P299, DOI [10.2144/0000113953, 10.2144/000113953]; Schuchardt I, 2005, MOL BIOL CELL, V16, P5191, DOI 10.1091/mbc.E05-04-0272; Schuster M, 2012, EMBO J, V31, P214, DOI 10.1038/emboj.2011.361; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Tamura K, 2011, MEGA5 MOL EVOLUTIONA; Teparic R, 2004, MICROBIOL-SGM, V150, P3145, DOI 10.1099/mic.0.27296-0; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Trilla JA, 1997, YEAST, V13, P795, DOI 10.1002/(SICI)1097-0061(199707)13:9<795::AID-YEA139>3.3.CO;2-C; Wang H., 2009, BMC EVOLUTIONARY BIO, P9; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	50	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104920	10.1371/journal.pone.0104920	http://dx.doi.org/10.1371/journal.pone.0104920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148134	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600026
J	Zhou, JL; Zhong, RQ; Ye, ZH				Zhou, Jianli; Zhong, Ruiqin; Ye, Zheng-Hua			Arabidopsis NAC Domain Proteins, VND1 to VND5, Are Transcriptional Regulators of Secondary Wall Biosynthesis in Vessels	PLOS ONE			English	Article							CELL-WALL; WOOD FORMATION; DIRECT TARGET; POPLAR; GENES; SND1; MYB46; XYLEM; RICE; NST1	One of the most prominent features of xylem conducting cells is the deposition of secondary walls. In Arabidopsis, secondary wall biosynthesis in the xylem conducting cells, vessels, has been shown to be regulated by two VASCULAR-RELATED NAC-DOMAIN (VND) genes, VND6 and VND7. In this report, we have investigated the roles of five additional Arabidopsis VND genes, VND1 to VND5, in regulating secondary wall biosynthesis in vessels. The VND1 to VND5 genes were shown to be specifically expressed in vessels but not in interfascicular fibers in stems. The expression of VND4 and VND5 was also seen specifically in vessels in the secondary xylem of the root-hypocotyl region. When overexpressed, VND1 to VND5 were able to activate the expression of secondary wall-associated transcription factors and genes involved in secondary wall biosynthesis and programmed cell death. As a result, many normally parenchymatous cells in leaves and stems acquired thickened secondary walls in the VND1 to VND5 overexpressors. In contrast, dominant repression of VND3 function resulted in reduced secondary wall thickening in vessels and a collapsed vessel phenotype. In addition, VND1 to VND5 were shown to be capable of rescuing the secondary wall defects in the fibers of the snd1 nst1 double mutant when expressed under the SND1 promoter. Furthermore, transactivation analysis revealed that VND1 to VND5 could activate expression of the GUS reporter gene driven by the secondary wall NAC binding element (SNBE). Together, these results demonstrate that VND1 to VND5 possess functions similar to that of the SND1 secondary wall NAC and are transcriptional regulators of secondary wall biosynthesis in vessels.	[Zhou, Jianli; Zhong, Ruiqin; Ye, Zheng-Hua] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Ye, ZH (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	zhye@plantbio.uga.edu			United States Department of Agriculture National Institute of Food and Agriculture [2010-65116-20468]; National Science Foundation [ISO-1051900]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the United States Department of Agriculture National Institute of Food and Agriculture (AFRI Plant Biology program (#2010-65116-20468)) and the National Science Foundation (ISO-1051900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avci U, 2008, PLANT J, V56, P303, DOI 10.1111/j.1365-313X.2008.03592.x; Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Burk DH, 2006, J INTEGR PLANT BIOL, V48, P85, DOI 10.1111/j.1744-7909.2006.00202.x; Gampala SSL, 2001, J BIOL CHEM, V276, P9855, DOI 10.1074/jbc.M009168200; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Handakumbura PP, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00074; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; HUGHES J, 1975, STAIN TECHNOL, V50, P319, DOI 10.3109/10520297509117082; Ko JH, 2009, PLANT J, V60, P649, DOI 10.1111/j.1365-313X.2009.03989.x; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1659, DOI 10.1093/pcp/pcm155; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; Mauseth J., 1988, PLANT ANATOMY; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Ye ZH, 2002, INT REV CYTOL, V220, P225; Yoshida K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00383; Zhang J, 2014, CURR OPIN PLANT BIOL, V17, P56, DOI 10.1016/j.pbi.2013.11.003; Zhao QA, 2010, PLANT J, V63, P100, DOI 10.1111/j.1365-313X.2010.04223.x; Zhong RQ, 1997, PLANT CELL, V9, P2159, DOI 10.1105/tpc.9.12.2159; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069219; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007; Zhong RQ, 2010, PLANT PHYSIOL, V152, P1044, DOI 10.1104/pp.109.148270; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	46	47	61	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105726	10.1371/journal.pone.0105726	http://dx.doi.org/10.1371/journal.pone.0105726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148240	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230600075
J	Zhou, YF; Zhang, DG; Chen, YT; Zhou, S; Pan, SH; Huang, YC; Ba-Thein, W				Zhou, Yunfang; Zhang, Dangui; Chen, Youting; Zhou, Sha; Pan, Shuhua; Huang, Yuanchun; Ba-Thein, William			Healthcare-Associated Infections and Shanghai Clinicians: A Multicenter Cross-Sectional Study	PLOS ONE			English	Article							ISOLATION PRECAUTIONS; STANDARD PRECAUTIONS; CONTROL KNOWLEDGE; WORKERS; ATTITUDE; CHINA	Literature about healthcare-associated infection (HCAI) in China is scarce. A cross-sectional anonymous survey was conducted on 647 clinicians (199 physicians and 448 nurses) from six Shanghai hospitals (grades A-C) to investigate their cognizance, knowledge, attitude, self-reported practice, and risks regarding HCAI with emphasis on precautions. The mean overall score of HCAI knowledge was 40.89 +/- 11.4 (mean +/- SD; range, 13 similar to 72) out of 100 for physicians and 43.48 +/- 9.9 (10 similar to 70) for nurses. The respondents generally received high scores in hand hygiene, HCAI core concept, and healthcare worker safety but low scores in HCAI pathogen identification and isolation precautions. There were substantial variations in the knowledge scores of various demographic groups across individual hospitals and within hospital grades (ps<0.05). Within-hospital comparisons showed that the nurses were better than physicians particularly in hand hygiene knowledge in 4 hospitals (ps<0.05). Multiple linear regression analysis showed that longer work experience was inversely and independently associated with the overall and categorical knowledge of nurses, whereas independent associations between older age or higher education and categorical knowledge were noted for physicians. The respondents' self-reported practices and adherence to standard precautions were less than satisfactory. This multi-center study reports a high level of cognizance, patchy knowledge, suboptimal adherence to infection control precautions, and self-protective attitudes among the practicing clinicians regarding HCAI, with potential safety risk to patients and healthcare providers. Providing quality learning resources, enforcing knowledge-informed practice, and promoting a healthcare safety culture are recommended as interventions. Future studies are warranted for social and behavioral aspects of healthcare safety with emphasis on infection control.	[Zhou, Yunfang; Chen, Youting; Zhou, Sha; Pan, Shuhua] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr Affiliated, Coll Med, Dept Infect Dis, Shanghai 200030, Peoples R China; [Zhang, Dangui] Shantou Univ, Affiliated Hosp 2, Coll Med, Res Ctr Translat Med, Shantou, Guangdong, Peoples R China; [Huang, Yuanchun] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Clin Microbiol, Shantou, Guangdong, Peoples R China; [Ba-Thein, William] Shantou Univ, Coll Med, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China; [Ba-Thein, William] Shantou Univ, Coll Med, Shantou Oxford Clin Res Unit, Shantou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Shantou University; Shantou University; Shantou University; Shantou University	Ba-Thein, W (corresponding author), Shantou Univ, Coll Med, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China.	wbathein@stu.edu.cn	Zhang, Dangui/CAE-9930-2022		Li Ka Shing Foundation-University of Oxford Global Health Programme [B9RSRT0-14]	Li Ka Shing Foundation-University of Oxford Global Health Programme	This study was supported by the Li Ka Shing Foundation-University of Oxford Global Health Programme (grant no. B9RSRT0-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GUIDELINE ISOLATION; Askarian M, 2006, INFECT CONT HOSP EP, V27, P868, DOI 10.1086/506411; Butsashvili M, 2010, J INFECT DEV COUNTR, V4, P329, DOI 10.3855/jidc.526; Charani E, 2013, CLIN INFECT DIS, V57, P188, DOI 10.1093/cid/cit212; China TMoHotPsRo, 2006, REG HAI MAN; Ferguson KJ, 2004, J GEN INTERN MED, V19, P726, DOI 10.1111/j.1525-1497.2004.20424.x; Ghabrah TM, 2007, SCAND J INFECT DIS, V39, P1018, DOI 10.1080/00365540701466173; Huang YC, 2013, J INFECT DEV COUNTR, V7, P144, DOI 10.3855/jidc.3099; Jain M, 2010, MED ORAL PATOL ORAL, V15, pE957, DOI 10.4317/medoral.15.e957; Liu CJ, 2014, BMJ QUAL SAF, V23, P556, DOI 10.1136/bmjqs-2013-002172; Luo Y, 2010, INT J INFECT DIS, V14, pE1106, DOI 10.1016/j.ijid.2009.03.037; Ng TC, 2009, INFECT CONT HOSP EP, V30, P292, DOI 10.1086/595690; Ong MS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-72; Parmeggiani C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-35; Paudyal P, 2008, AM J INFECT CONTROL, V36, P595, DOI 10.1016/j.ajic.2007.10.026; Regina C, 2002, INT J NURS STUD, V39, P157, DOI 10.1016/S0020-7489(01)00021-9; Sax H, 2005, INFECT CONT HOSP EP, V26, P298, DOI 10.1086/502543; Tao LL, 2011, INT J INFECT DIS, V15, pE774, DOI 10.1016/j.ijid.2011.06.009; World Health Organization, 2011, BURD HLTH CAR ASS IN; Xie DS, 2010, J HOSP INFECT, V76, P150, DOI 10.1016/j.jhin.2010.04.003; YeYuan GJ, 2009, XINHUA NEWS; Zhang QL, 2010, AM J INFECT CONTROL, V38, P473, DOI 10.1016/j.ajic.2009.12.010	22	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105838	10.1371/journal.pone.0105838	http://dx.doi.org/10.1371/journal.pone.0105838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148526	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600089
J	Chen, DP; Wang, Y; Zhou, XY; Wang, YL; Xu, JR				Chen, Daipeng; Wang, Yang; Zhou, Xiaoying; Wang, Yulin; Xu, Jin-Rong			The Sch9 Kinase Regulates Conidium Size, Stress Responses, and Pathogenesis in Fusarium graminearum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE SCH9; MAGNAPORTHE-GRISEA; GIBBERELLA-ZEAE; FISSION YEAST; CELL-GROWTH; HEAD-BLIGHT; MAP KINASE; GENE; VIRULENCE; WHEAT	Fusarium head blight caused by Fusarium graminearum is an important disease of wheat and barley worldwide. In a previous study on functional characterization of the F. graminearum kinome, one protein kinase gene important for virulence is orthologous to SCH9 that is functionally related to the cAMP-PKA and TOR pathways in the budding yeast. In this study, we further characterized the functions of FgSCH9 in F. graminearum and its ortholog in Magnaporthe oryzae. The Delta Fgsch9 mutant was slightly reduced in growth rate but significantly reduced in conidiation, DON production, and virulence on wheat heads and corn silks. It had increased tolerance to elevated temperatures but became hypersensitive to oxidative, hyperosmotic, cell wall, and membrane stresses. The Delta Fgsch9 deletion also had conidium morphology defects and produced smaller conidia. These results suggest that FgSCH9 is important for stress responses, DON production, conidiogenesis, and pathogenesis in F. graminearum. In the rice blast fungus Magnaporthe oryzae, the Delta Mosch9 mutant also was defective in conidiogenesis and pathogenesis. Interestingly, it also produced smaller conidia and appressoria. Taken together, our data indicate that the SCH9 kinase gene may have a conserved role in regulating conidium size and plant infection in phytopathogenic ascomycetes.	[Chen, Daipeng; Wang, Yang; Wang, Yulin; Xu, Jin-Rong] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Zhou, Xiaoying; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xu, JR (corresponding author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	jinrong@purdue.edu			National Major Project of Breeding for New Transgenic Organisms [2012ZX08009003]; National Basic Research Program of China [2012CB114002, 2013CB127703]	National Major Project of Breeding for New Transgenic Organisms; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Major Project of Breeding for New Transgenic Organisms (2012ZX08009003) and the National Basic Research Program of China (2012CB114002; 2013CB127703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Boddu J, 2006, MOL PLANT MICROBE IN, V19, P407, DOI 10.1094/MPMI-19-0407; Bormann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091135; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Desjardins AE, 2003, ANNU REV PHYTOPATHOL, V41, P177, DOI 10.1146/annurev.phyto.41.011703.115501; Ding SL, 2009, EUKARYOT CELL, V8, P867, DOI 10.1128/EC.00048-09; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fujita M, 1998, CURR GENET, V33, P248, DOI 10.1007/s002940050333; Gale LR, 2002, PHYTOPATHOLOGY, V92, P1315, DOI 10.1094/PHYTO.2002.92.12.1315; Geyskens I, 2000, NATO SCI S A LIF SCI, V316, P117; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Harris LJ, 1999, PLANT DIS, V83, P954, DOI 10.1094/PDIS.1999.83.10.954; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Hu S, 2014, MOL PLANT M IN PRESS, V27; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; JIN M, 1995, GENETICS, V140, P457; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Li GT, 2012, CURR OPIN MICROBIOL, V15, P678, DOI 10.1016/j.mib.2012.09.004; Liu W, 2010, FEMS YEAST RES, V10, P462, DOI 10.1111/j.1567-1364.2010.00617.x; Liu X, 2014, MICROBIOL-SGM, V160, P692, DOI 10.1099/mic.0.075333-0; Menke J, 2012, MOL PLANT MICROBE IN, V25, P1408, DOI 10.1094/MPMI-04-12-0081-R; Min K, 2012, FEMS MICROBIOL LETT, V334, P66, DOI 10.1111/j.1574-6968.2012.02620.x; Motoyama T, 2008, CURR GENET, V54, P185, DOI 10.1007/s00294-008-0211-0; Park G, 2006, PLANT CELL, V18, P2822, DOI 10.1105/tpc.105.038422; Pascual-Ahuir A, 2007, EMBO J, V26, P3098, DOI 10.1038/sj.emboj.7601756; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Seong K, 2006, FUNGAL GENET BIOL, V43, P34, DOI 10.1016/j.fgb.2005.10.002; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Swinnen E, 2014, FEMS YEAST RES, V14, P17, DOI 10.1111/1567-1364.12097; Nguyen TV, 2012, MOL PLANT MICROBE IN, V25, P1142, DOI 10.1094/MPMI-02-12-0047-R; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Voigt CA, 2005, PLANT J, V42, P364, DOI 10.1111/j.1365-313X.2005.02377.x; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038324; Wang P, 2004, CURR GENET, V46, P247, DOI 10.1007/s00294-004-0529-1; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Yu F, 2014, NEW PHYTOLO IN PRESS; Zhang AL, 2011, FEBS LETT, V585, P3026, DOI 10.1016/j.febslet.2011.08.023; Zhang XW, 2012, PLANT CELL, V24, P5159, DOI 10.1105/tpc.112.105957; Zhao X., 2004, FUNGAL GENETICS REPO, V51, P17; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zhao XH, 2007, MOL MICROBIOL, V63, P881, DOI 10.1111/j.1365-2958.2006.05548.x; Zheng DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049495; Zheng Q, 2013, PLOS ONE, V8; Zheng Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066980; Zhou XY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002911; Zhou XY, 2011, MOL MICROBIOL, V80, P33, DOI 10.1111/j.1365-2958.2011.07556.x; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	63	30	31	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105811	10.1371/journal.pone.0105811	http://dx.doi.org/10.1371/journal.pone.0105811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144230	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100122
J	Korir, JC; Nyakoe, NK; Awinda, G; Waitumbi, JN				Korir, Jackson C.; Nyakoe, Nancy K.; Awinda, George; Waitumbi, John N.			Complement Activation by Merozoite Antigens of Plasmodium falciparum	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; IMMUNE-COMPLEXES; INFECTED ERYTHROCYTES; MALARIA PARASITES; CEREBRAL MALARIA; CHILDREN; PROTEINS; POLYMORPHISMS; COMPONENT; INVASION	Background: Complement (C) is a crucial part of the innate immune system and becomes over activated during malaria, resulting in depletion of C components, especially those for lectin pathway (LP), thereby compromising the host's innate defense. In this study, involvement of P. falciparum antigens in C activation was investigated. Methods: A highly synchronous culture of the Dd2 clone of P. falciparum was established in a serum free medium. Supernatants harvested from rings, trophozoites and schizonts at various parasite densities were tested for ability to activate C by quantifying amount of C3b deposited on erythrocytes (E). Uninfected sham culture was used as control. Remnants of each C pathway were determined using Wieslab complement System Screenkit (Euro-diagnostica, Sweden). To identify MBL binding antigens of LP, culture supernatants were added to MBL sepharose columns and trapped antigens eluted with increasing concentrations of EDTA (10 mM, 50 mM and 100 mM) and then desalted before being tested for ability to activate C. The EDTA eluate with highest activity was run on a polyacrylamide gel and silver stained proteins analyzed by mass spectroscopy. Results: Antigens released by P. falciparum growing in culture activated C leading to C3b deposition on E. Maximal activation at 7% parasitemia was associated with schizont stage (36.7%) compared to 22% for rings, 21% for trophozoites and 3% for sham culture. All the three pathways of C were activated, with highest activation being for the alternative pathway (only 6% of C activation potential remained), 65% for classiical and 43% for the LP. Seven MBL binding merozoite proteins were identified by mass spectrometry in the 50 mM EDTA eluate. Conclusions: MBL binding merozoite adhesins with ability to activate C pathway were identified. The survival advantage for such pronounced C activation is unclear, but opsonisation could facilitate recognition and invasion of E.	[Korir, Jackson C.] Masinde Muliro Univ Sci & Technol, Kakamega, Kenya; [Nyakoe, Nancy K.; Awinda, George; Waitumbi, John N.] Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya	Kenya Medical Research Institute	Waitumbi, JN (corresponding author), Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya.	John.Waitumbi@usamru-k.org	Korir, Jackson Cheruiyot/AAG-7764-2021	Korir, Jackson Cheruiyot/0000-0003-3264-3054	D43 Training Grant, Forgaty International Training Center, of NIH	D43 Training Grant, Forgaty International Training Center, of NIH	This work was supported by D43 Training Grant, Forgaty International Training Center, of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM C, 1981, INFECT IMMUN, V31, P530, DOI 10.1128/IAI.31.2.530-535.1981; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Brunner J, 2012, RHEUMATOL INT, V32, P1815, DOI 10.1007/s00296-011-1973-0; Garred P, 2003, J INFECT DIS, V188, P1394, DOI 10.1086/379044; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2003, INFECT IMMUN, V71, P5245, DOI 10.1128/IAI.71.9.5245-5253.2003; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; GREENWOOD BM, 1974, CLIN EXP IMMUNOL, V18, P267; Gunalan K, 2011, INFECT IMMUN, V79, P3421, DOI 10.1128/IAI.00201-11; KACA W, 1995, BBA-GEN SUBJECTS, V1245, P49, DOI 10.1016/0304-4165(95)00077-O; Kilpatrick DC, 1997, TRANSFUSION MED, V7, P289, DOI 10.1046/j.1365-3148.1997.d01-40.x; Klabunde J, 2002, PARASITOL RES, V88, P113, DOI 10.1007/s00436-001-0518-y; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Luty AJF, 1998, J INFECT DIS, V178, P1221, DOI 10.1086/515690; Mibei EK, 2008, PARASITE IMMUNOL, V30, P334, DOI 10.1111/j.1365-3024.2008.01030.x; Mibei EK, 2005, AM J TROP MED HYG, V72, P593, DOI 10.4269/ajtmh.2005.72.593; NEVA FA, 1974, J CLIN INVEST, V54, P451, DOI 10.1172/JCI107781; Nyakoe NK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-7; Ocarnpo M, 2004, PARASITOL INT, V53, P77, DOI 10.1016/j.parint.2003.11.004; Pawluczkowycz AW, 2007, J IMMUNOL, V179, P5543, DOI 10.4049/jimmunol.179.8.5543; Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437; Roestenberg M, 2007, T ROY SOC TROP MED H, V101, P643, DOI 10.1016/j.trstmh.2007.02.023; Sahar T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017102; Salvesen B, 2009, MOL IMMUNOL, V46, P1620, DOI 10.1016/j.molimm.2009.02.028; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P355, DOI 10.1128/CMR.15.3.355-364.2002; STANLEY HA, 1984, MOL IMMUNOL, V21, P145, DOI 10.1016/0161-5890(84)90129-9; TAYLOR RP, 1991, CLIN IMMUNOL IMMUNOP, V61, P143, DOI 10.1016/S0090-1229(05)80020-0; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2009, CELL MICROBIOL, V11, P1671, DOI 10.1111/j.1462-5822.2009.01358.x; Wenisch C, 1997, CLIN IMMUNOL IMMUNOP, V85, P166, DOI 10.1006/clin.1997.4417	33	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105093	10.1371/journal.pone.0105093	http://dx.doi.org/10.1371/journal.pone.0105093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144772	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100040
J	Krock, BL; Perkins, BD				Krock, Bryan L.; Perkins, Brian D.			The Par-PrkC Polarity Complex Is Required for Cilia Growth in Zebrafish Photoreceptors	PLOS ONE			English	Article							RETROGRADE INTRAFLAGELLAR TRANSPORT; SENSORY OUTER SEGMENT; VERTEBRATE PHOTORECEPTORS; EPITHELIAL POLARITY; CELL POLARITY; KINESIN-II; REVEALS MULTIPLE; KUPFFERS VESICLE; CRUMBS COMPLEX; MOSAIC EYES	Specification and development of the apical membrane in epithelial cells requires the function of polarity proteins, including Pard3 and an atypical protein kinase C (PrkC). Many epithelial cells possess microtubule-based organelles, known as cilia, that project from their apical surface and the membrane surrounding the cilium is contiguous with the apical cell membrane. Although cilia formation in cultured cells required Pard3, the in vivo requirement for Pard3 in cilia development remains unknown. The vertebrate photoreceptor outer segment represents a highly specialized cilia structure in which to identify factors necessary for apical and ciliary membrane formation. Pard3 and PrkC localized to distinct domains within vertebrate photoreceptors. Using partial morpholino knockdown, photo-morpholinos, and pharmacological approaches, the function of Pard3 and PrkC were found to be required for the formation of both the apical and ciliary membrane of vertebrate photoreceptors. Inhibition of Pard3 or PrkC activity significantly reduced the size of photoreceptor outer segments and resulted in mislocalization of rhodopsin. Suppression of Pard3 or PrkC also led to a reduction in cilia size and cilia number in Kupffer's Vesicle, which resulted in left-right asymmetry defects. Thus, the Par-PrkC complex functions in cilia formation in vivo and this likely reflects a general role in specifying non-ciliary and ciliary compartments of the apical domain.	[Krock, Bryan L.; Perkins, Brian D.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Perkins, Brian D.] Cleveland Clin Fdn, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44195 USA	Texas A&M University System; Texas A&M University College Station; Cleveland Clinic Foundation	Perkins, BD (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	perkinb2@ccf.org		Perkins, Brian/0000-0002-9348-6542	National Institutes of Health [EY017037]; Doris and Jules Stein Professorship from the Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY017037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris and Jules Stein Professorship from the Research to Prevent Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by a grant from the National Institutes of Health (EY017037) and from a Doris and Jules Stein Professorship from the Research to Prevent Blindness to BDP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Bloodgood RA, 2010, J CELL SCI, V123, P505, DOI 10.1242/jcs.066308; BOISVIEUXULRICH E, 1989, BIOL CELL, V67, P67, DOI 10.1111/j.1768-322X.1989.tb03011.x; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Cui S, 2007, MOL CELL NEUROSCI, V34, P431, DOI 10.1016/j.mcn.2006.11.016; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Fadool JM, 1999, INVEST OPHTH VIS SCI, V40, P1251; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Hong E, 2010, DEV BIOL, V341, P335, DOI 10.1016/j.ydbio.2010.01.034; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hsu YC, 2006, DEVELOPMENT, V133, P4849, DOI 10.1242/dev.02685; Hsu YC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-60; Hu QC, 2011, CYTOSKELETON, V68, P313, DOI 10.1002/cm.20514; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Jensen AM, 2001, DEVELOPMENT, V128, P95; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Krahn MP, 2010, J CELL BIOL, V190, P751, DOI 10.1083/jcb.201006029; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; Krock BL, 2009, INVEST OPHTH VIS SCI, V50, P5463, DOI 10.1167/iovs.09-3828; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Lunt S, 2009, DEV DYN IN PRESS; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; NAGLE BW, 1986, INVEST OPHTH VIS SCI, V27, P689; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Pocha SM, 2011, J CELL BIOL, V195, P827, DOI 10.1083/jcb.201105144; Pruliere G, 2011, MOL BIOL CELL, V22, P2042, DOI 10.1091/mbc.E10-10-0844; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; Standaert ML, 1999, J BIOL CHEM, V274, P14074, DOI 10.1074/jbc.274.20.14074; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Tallafuss A, 2012, DEVELOPMENT, V139, P1691, DOI 10.1242/dev.072702; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; Wei XY, 2002, NAT GENET, V31, P150, DOI 10.1038/ng883; Westerfield M, 1995, ZEBRAFISH BOOK	70	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104661	10.1371/journal.pone.0104661	http://dx.doi.org/10.1371/journal.pone.0104661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144710	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100018
J	Lee, Y; Song, YS; Fang, CH; So, BI; Park, JY; Joo, HW; Park, IH; Shen, GY; Shin, JH; Kim, H; Ahn, YH; Kim, KS				Lee, Yonggu; Song, Yi-Sun; Fang, Cheng-Hu; So, Byung-Im; Park, Jun-Young; Joo, Hyun-Woo; Park, In-Hwa; Shen, Guang-Yin; Shin, Jeong-Hun; Kim, Hyuck; Ahn, You-Heon; Kim, Kyung-Soo			Anti-Obesity Effects of Granulocyte-Colony Stimulating Factor in Otsuka-Long-Evans-Tokushima Fatty Rats	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; UNCOUPLING PROTEIN-1 UCP1; TYPE-2 DIABETES-MELLITUS; TUMOR-NECROSIS-FACTOR; BROWN ADIPOSE-TISSUE; FACTOR G-CSF; BODY-WEIGHT; FOOD-INTAKE; ENERGY-EXPENDITURE; INSULIN-RESISTANCE	Granulocyte-colony stimulating factor (G-CSF) has molecular structures and intracellular signaling pathways that are similar to those of leptin and ciliary neurotropic factor (CNTF). It also has immune-modulatory properties. Given that leptin and CNTF play important roles in energy homeostasis and that obesity is an inflammatory condition in adipose tissue, we hypothesized that G-CSF could also play a role in energy homeostasis. We treated 12 38-week-old male Otsuka-Long-Evans-Tokushima fatty rats (OLETF, diabetic) and 12 age-matched male Long-Evans-Tokushima rats (LETO, healthy) with 200 mu g/day G-CSF or saline for 5 consecutive days. Body weight reduction was greater in G-CSF-treated OLETF (G-CSF/OLETF) than saline-treated OLETF (saline/OLETF) following 8 weeks of treatment (-6.9 +/- 1.6% vs. -3.1 +/- 2.2%, p<0.05). G-CSF treatment had no effect on body weight in LETO or on food intake in either OLETF or LETO. Body fat in G-CSF/OLETF was more reduced than in saline/OLETF (-32.2 +/- 3.1% vs. -20.8 +/- 6.2%, p<0.05). Energy expenditure was higher in G-CSF/OLETF from 4 weeks after the treatments than in saline/OLETF. Serum levels of cholesterol, triglyceride, interleukin-6 and tumor necrosis factor-a were lower in G-CSF/OLETF than in saline/OLETF. Uncoupling protein-1 (UCP-1) expression in brown adipose tissue (BAT) was higher in G-CSF/OLETF than in saline/OLETF, but was unaffected in LETO. Immunofluorescence staining and PCR results revealed that G-CSF receptors were expressed in BAT. In vitro experiments using brown adipocyte primary culture revealed that G-CSF enhanced UCP-1 expression from mature brown adipocytes via p38 mitogen-activated protein kinase pathway. In conclusion, G-CSF treatment reduced body weight and increased energy expenditure in a diabetic model, and enhanced UCP-1 expression and decreased inflammatory cytokine levels may be associated with the effects of G-CSF treatment.	[Lee, Yonggu; Shin, Jeong-Hun; Kim, Kyung-Soo] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133791, South Korea; [Song, Yi-Sun; So, Byung-Im; Park, Jun-Young; Joo, Hyun-Woo; Park, In-Hwa; Shen, Guang-Yin; Kim, Kyung-Soo] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Fang, Cheng-Hu] Yanbian Univ, Div Cardiol, Yanji, Peoples R China; [Kim, Hyuck] Hanyang Univ Hosp, Dept Thorac Surg, Seoul, South Korea; [Ahn, You-Heon] Hanyang Univ Hosp, Dept Endocrinol, Seoul, South Korea; [Lee, Yonggu] Sung Ae Hosp, Dept Cardiol, Seoul, South Korea	Hanyang University; Hanyang University; Yanbian University; Hanyang University; Hanyang University Hospital; Hanyang University; Hanyang University Hospital	Kim, KS (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133791, South Korea.	kskim@hanyang.ac.kr	Shin, Jeong Hun/O-1273-2019; Lee, Yonggu/Q-3832-2018	Shin, Jeong Hun/0000-0002-6718-9763; Lee, Yonggu/0000-0002-3757-3692				Beretta E, 2002, PEPTIDES, V23, P975, DOI 10.1016/S0196-9781(02)00021-9; Bi S, 2007, AM J PHYSIOL-REG I, V293, pR55, DOI 10.1152/ajpregu.00002.2007; Bluher S, 2004, DIABETES, V53, P2787, DOI 10.2337/diabetes.53.11.2787; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Brondani LD, 2012, ARQ BRAS ENDOCRINOL, V56, P215, DOI 10.1590/S0004-27302012000400001; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Choi HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072340; Couvreur O, 2012, AM J PHYSIOL-ENDOC M, V302, pE458, DOI 10.1152/ajpendo.00388.2011; Crowe S, 2008, ENDOCRINOLOGY, V149, P2546, DOI 10.1210/en.2007-1447; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Hidaka S, 2002, FASEB J, V16, P509, DOI 10.1096/fj.01-0164com; Hong EG, 2002, J KOREAN MED SCI, V17, P34, DOI 10.3346/jkms.2002.17.1.34; Huising MO, 2006, J ENDOCRINOL, V189, P1, DOI 10.1677/joe.1.06591; Hwa JJ, 1997, AM J PHYSIOL-REG I, V272, pR1204, DOI 10.1152/ajpregu.1997.272.4.R1204; Janoschek R, 2006, P NATL ACAD SCI USA, V103, P10707, DOI 10.1073/pnas.0600425103; Jia JJ, 2010, MOL BIOL REP, V37, P1513, DOI 10.1007/s11033-009-9550-2; Jung H, 2009, BIOCHEM BIOPH RES CO, V383, P252, DOI 10.1016/j.bbrc.2009.04.001; Kanemoto N, 1998, MAMM GENOME, V9, P419, DOI 10.1007/s003359900789; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Knapp S, 2004, J INFECT DIS, V189, P1506, DOI 10.1086/382962; Lim YH, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-92; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Marino VJ, 2008, J CELL BIOCHEM, V103, P1512, DOI 10.1002/jcb.21542; Markelic M, 2011, EUR J HISTOCHEM, V55, P187, DOI 10.4081/ejh.2011.e34; Moran TH, 2006, PHILOS T R SOC B, V361, P1211, DOI 10.1098/rstb.2006.1857; Moschen AR, 2010, GUT, V59, P1259, DOI 10.1136/gut.2010.214577; Nishiki S, 2004, AM J PHYSIOL-CELL PH, V286, pC1302, DOI 10.1152/ajpcell.00387.2003; Ott V, 2002, J ENDOCRINOL, V173, pR1, DOI 10.1677/joe.0.173R001; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Porras A, 1997, FEBS LETT, V416, P324, DOI 10.1016/S0014-5793(97)01204-0; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Scarpace PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE226, DOI 10.1152/ajpendo.1997.273.1.E226; Schroeder M, 2009, AM J PHYSIOL-REG I, V297, pR1749, DOI 10.1152/ajpregu.00461.2009; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; So BI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077048; Song YS, 2013, ANN HEPATOL, V12, P115, DOI 10.1016/S1665-2681(19)31393-6; STORLIEN LH, 1986, AM J PHYSIOL, V251, pE576, DOI 10.1152/ajpendo.1986.251.5.E576; Suzuki H, 2013, J GASTROENTEROL, V48, P574, DOI 10.1007/s00535-013-0787-0; TANAKA H, 1991, DRUG METAB DISPOS, V19, P200; Valladares A, 2001, FEBS LETT, V493, P6, DOI 10.1016/S0014-5793(01)02264-5; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; White UA, 2011, CURR PHARM DESIGN, V17, P340	49	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105603	10.1371/journal.pone.0105603	http://dx.doi.org/10.1371/journal.pone.0105603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144367	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100094
J	Saletti, PG; Maior, RS; Hori, E; de Almeida, RM; Nishijo, H; Tomaz, C				Saletti, Patricia G.; Maior, Rafael S.; Hori, Etsuro; de Almeida, Ricardo Miyasaka; Nishijo, Hisao; Tomaz, Carlos			Whole-Body Prepulse Inhibition Protocol to Test Sensorymotor Gating Mechanisms in Monkeys	PLOS ONE			English	Article							PRIMATE SUPERIOR COLLICULUS; FEAR-POTENTIATED STARTLE; SACCADIC EYE-MOVEMENTS; SENSORIMOTOR INTEGRATION; THREAT RESPONSIVENESS; INFERIOR COLLICULUS; RHESUS-MONKEYS; HABITUATION; DEFICITS; SCHIZOPHRENIA	Prepulse inhibition (PPI) is the decrease of startle reflex amplitude when a slight stimulus is previously generated. This paradigm may provide valuable information about sensorimotor gating functionality. Here we aimed at determining the inhibited and uninhibited startle response of capuchin monkeys (Sapajus spp.), and to evaluate the role of the superior colliculus in PPI. Capuchin monkeys were tested in a whole-body protocol, to determine the best startle amplitude and interstimuli interval. Additionally we tested two subjects with bilateral superior colliculus damage in this protocol. Results show that 115 dB auditory pulse has induced the best startle response. In contrast to reports in other species, no habituation to the auditory stimuli was observed here in capuchins. Also, startle reflex inhibition was optimal after 120 msec interstimuli interval. Finally, there was a downward tendency of percentage inhibition in superior colliculus-lesioned monkeys. Our data provides the possibility of further studies with whole-body protocol in capuchin monkeys and reinforces the importance of the superior colliculus in PPI.	[Saletti, Patricia G.; Maior, Rafael S.; Tomaz, Carlos] Univ Brasilia, Ctr Primate, Brasilia, DF, Brazil; [Saletti, Patricia G.; Maior, Rafael S.; Tomaz, Carlos] Univ Brasilia, Dept Physiol Sci, Inst Biol, Lab Neurosci & Behav, Brasilia, DF, Brazil; [Hori, Etsuro; Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [de Almeida, Ricardo Miyasaka] Univ Brasilia, Fac Agron & Vet Med, Large Anim Teaching Hosp, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; University of Toyama; Universidade de Brasilia	Tomaz, C (corresponding author), Univ Brasilia, Ctr Primate, Brasilia, DF, Brazil.	ctomaz@unb.br	Tomaz, Carlos A B/F-8626-2012; Tomaz, Carlos/AAU-1524-2020; de Almeida, Ricardo Miyasaka/F-5437-2010; Maior, Rafael S./F-3994-2012	Tomaz, Carlos/0000-0001-7341-0922; de Almeida, Ricardo Miyasaka/0000-0002-2858-3637; Maior, Rafael S./0000-0001-7219-8675	JSPS Asian Core Program; Ministry of Education, Science, Sports, and Culture [25290005]; Research Support Foundation, FAP-DF, Brazil [2010/00154-0]; CAPES; CNPq	JSPS Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Support Foundation, FAP-DF, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported in part by the JSPS Asian Core Program and the Ministry of Education, Science, Sports, and Culture, Grant-in-Aid for Scientific Research (B) (25290005); and Research Support Foundation, FAP-DF, Brazil (2010/00154-0). PGS was recipient of a doctoral fellowship from CAPES and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballmaier M, 2007, NEUROPSYCHOPHARMACOL, V32, P2098, DOI 10.1038/sj.npp.1301344; Bell AH, 2005, J NEUROPHYSIOL, V93, P3659, DOI 10.1152/jn.01214.2004; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Brandao ML, 2003, EUR J PHARMACOL, V463, P225, DOI 10.1016/S0014-2999(03)01284-6; Coimbra NC, 2006, EXP NEUROL, V197, P93, DOI 10.1016/j.expneurol.2005.08.022; CYNADER M, 1972, J NEUROPHYSIOL, V35, P187, DOI 10.1152/jn.1972.35.2.187; Doubell TP, 2003, J NEUROSCI, V23, P6596; Feifel D, 1999, J PHARMACOL EXP THER, V288, P710; Fendt M, 1999, BRAIN RES, V833, P81, DOI 10.1016/S0006-8993(99)01525-5; FENDT M, 1994, NEUROREPORT, V5, P1725, DOI 10.1097/00001756-199409080-00009; Gacsalyi I, 2013, NEUROPHARMACOLOGY, V64, P254, DOI 10.1016/j.neuropharm.2012.07.017; GEYER MA, 1987, SCHIZOPHRENIA BULL, V13, P643, DOI 10.1093/schbul/13.4.643; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Harting JK, 2000, BRAIN RES, V881, P244, DOI 10.1016/S0006-8993(00)02849-3; HOFFMAN HS, 1980, PSYCHOL REV, V87, P175, DOI 10.1037/0033-295X.87.2.175; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Isa T, 2002, CURR OPIN NEUROBIOL, V12, P668, DOI 10.1016/S0959-4388(02)00387-2; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Lane ST, 2013, INT J PSYCHOPHYSIOL, V88, P55, DOI 10.1016/j.ijpsycho.2013.01.010; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Li L, 1998, PHYSIOL BEHAV, V65, P133, DOI 10.1016/S0031-9384(98)00143-7; Linn GS, 2003, PSYCHOPHARMACOLOGY, V169, P234, DOI 10.1007/s00213-003-1533-8; Linn GS, 2001, NEUROREPORT, V12, P117, DOI 10.1097/00001756-200101220-00031; Maior RS, 2012, REV NEUROSCIENCE, V23, P697, DOI 10.1515/revneuro-2012-0055; Maior RS, 2011, NEUROSCI LETT, V504, P257, DOI 10.1016/j.neulet.2011.09.042; Manocha S. L., 1968, STEREOTAXIC ATLAS BR; Maravita A, 2008, NEUROREPORT, V19, P271, DOI 10.1097/WNR.0b013e3282f4f04e; Northmore OPM, 1988, EXP BRAIN RES, V73, P595; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; RIGDON GC, 1991, DRUG DEVELOP RES, V23, P91, DOI 10.1002/ddr.430230110; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; Stein BE, 1976, J NEUROPHYSIOL, V39, P410; SWERDLOW NR, 1993, PHARMACOL BIOCHEM BE, V44, P741, DOI 10.1016/0091-3057(93)90193-W; Thompson RF, 2009, NEUROBIOL LEARN MEM, V92, P127, DOI 10.1016/j.nlm.2008.07.011; Williams LE, 2013, SCHIZOPHR RES, V151, P124, DOI 10.1016/j.schres.2013.10.017; Winslow JT, 2007, BIOL PSYCHIAT, V61, P389, DOI 10.1016/j.biopsych.2006.03.012; Winslow JT, 2002, BIOL PSYCHIAT, V51, P859, DOI 10.1016/S0006-3223(02)01345-8; Yeomans JS, 2006, NEUROSCIENCE, V142, P921, DOI 10.1016/j.neuroscience.2006.06.025	44	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105551	10.1371/journal.pone.0105551	http://dx.doi.org/10.1371/journal.pone.0105551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144368	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100084
J	Soderstjerna, E; Bauer, P; Cedervall, T; Abdshill, H; Johansson, F; Johansson, UE				Soderstjerna, Erika; Bauer, Patrik; Cedervall, Tommy; Abdshill, Hodan; Johansson, Fredrik; Johansson, Ulrica Englund			Silver and Gold Nanoparticles Exposure to In Vitro Cultured Retina - Studies on Nanoparticle Internalization, Apoptosis, Oxidative Stress, Glial- and Microglial Activity	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; ORGANOTYPIC CULTURES; MOUSE RETINA; CELLS; DEGENERATION; RATS; VIVO; NEURONS; SYSTEM; TRANSLOCATION	The complex network of neuronal cells in the retina makes it a potential target of neuronal toxicity - a risk factor for visual loss. With growing use of nanoparticles (NPs) in commercial and medical applications, including ophthalmology, there is a need for reliable models for early prediction of NP toxicity in the eye and retina. Metal NPs, such as gold and silver, gain much of attention in the ophthalmology community due to their potential to cross the barriers of the eye. Here, NP uptake and signs of toxicity were investigated after exposure to 20 and 80 nm Ag- and AuNPs, using an in vitro tissue culture model of the mouse retina. The model offers long-term preservation of retinal cell types, numbers and morphology and is a controlled system for delivery of NPs, using serum-free defined culture medium. AgNO3-treatment was used as control for toxicity caused by silver ions. These end-points were studied; gross morphological organization, glial activity, microglial activity, level of apoptosis and oxidative stress, which are all well described as signs of insult to neural tissue. TEM analysis demonstrated cellular- and nuclear uptake of all NP types in all neuronal layers of the retina. Htx-eosin staining showed morphological disruption of the normal complex layered retinal structure, vacuole formation and pyknotic cells after exposure to all Ag- and AuNPs. Significantly higher numbers of apoptotic cells as well as an increased number of oxidative stressed cells demonstrated NP-related neuronal toxicity. NPs also caused increased glial staining and microglial cell activation, typical hallmarks of neural tissue insult. This study demonstrates that low concentrations of 20 and 80 nm sized Ag- and AuNPs have adverse effects on the retina, using an organotypic retina culture model. Our results motivate careful assessment of candidate NP, metallic or-non-metallic, to be used in neural systems for therapeutic approaches.	[Soderstjerna, Erika; Abdshill, Hodan; Johansson, Ulrica Englund] Lund Univ, Dept Ophthalmol, Inst Clin Sci, Lund, Sweden; [Bauer, Patrik; Johansson, Fredrik] Lund Univ, Dept Biol, Sect Funct Zool, Lund, Sweden; [Cedervall, Tommy] Lund Univ, Lund, Sweden	Lund University; Lund University; Lund University	Johansson, UE (corresponding author), Lund Univ, Dept Ophthalmol, Inst Clin Sci, Lund, Sweden.	ulrica.englund_johansson@med.lu.se	Johansson, Fredrik/M-4554-2014; Cedervall, Tommy/AAT-9766-2021	Johansson, Fredrik/0000-0002-7813-8822; Cedervall, Tommy/0000-0003-2255-8446	Crafoord Foundation; VELUX stiftung; Clas Groschinskys Foundation; Kronprinsessan Margaretas Arbetsnamnd for synskadade (KMA); Magnus Bergvall Foundation; Greta and Johans Kock Foundation; Signhild Engqvist Foundation; Royal Physiographic Society in Lund; Nanometer Consortium at Lund University	Crafoord Foundation; VELUX stiftung; Clas Groschinskys Foundation; Kronprinsessan Margaretas Arbetsnamnd for synskadade (KMA); Magnus Bergvall Foundation; Greta and Johans Kock Foundation; Signhild Engqvist Foundation; Royal Physiographic Society in Lund; Nanometer Consortium at Lund University	This work was supported by grants from the Crafoord Foundation, VELUX stiftung, Clas Groschinskys Foundation, Kronprinsessan Margaretas Arbetsnamnd for synskadade (KMA), Magnus Bergvall Foundation, Greta and Johans Kock Foundation, Signhild Engqvist Foundation, The Royal Physiographic Society in Lund and the Nanometer Consortium at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Bassett EA, 2012, TRENDS NEUROSCI, V35, P565, DOI 10.1016/j.tins.2012.05.004; Bhatt L, 2010, MOL VIS, V16, P283; Bull ND, 2011, INVEST OPHTH VIS SCI, V52, P3309, DOI 10.1167/iovs.10-6873; Buyukhatipoglu K, 2011, J BIOMED MATER RES A, V96A, P186, DOI 10.1002/jbm.a.32972; Caffe AR, 2001, J CHEM NEUROANAT, V22, P263; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Chen JM, 2006, TOXICOLOGY, V222, P195, DOI 10.1016/j.tox.2006.02.016; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cortese-Krott MM, 2009, FREE RADICAL BIO MED, V47, P1570, DOI 10.1016/j.freeradbiomed.2009.08.023; Diebold Y, 2010, PROG RETIN EYE RES, V29, P596, DOI 10.1016/j.preteyeres.2010.08.002; Drexler B, 2010, CURR MED CHEM, V17, P4538, DOI 10.2174/092986710794183042; Dziendzikowska K, 2012, J APPL TOXICOL, V32, P920, DOI 10.1002/jat.2758; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Englund-Johansson U, 2010, EXP EYE RES, V90, P292, DOI 10.1016/j.exer.2009.11.005; Farjo KM, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-21; GAHWILER BH, 1988, TRENDS NEUROSCI, V11, P484, DOI 10.1016/0166-2236(88)90007-0; Gramowski A, 2010, ENVIRON HEALTH PERSP, V118, P1363, DOI 10.1289/ehp.0901661; Grottone GT, 2013, CURR EYE RES; GUERIN CJ, 1990, INVEST OPHTH VIS SCI, V31, P1474; Guo DD, 2013, J NANOSCI NANOTECHNO, V13, P3769, DOI 10.1166/jnn.2013.7169; Gurunathan S, 2009, BIOMATERIALS, V30, P6341, DOI 10.1016/j.biomaterials.2009.08.008; Haase A, 2012, TOXICOL SCI, V126, P457, DOI 10.1093/toxsci/kfs003; Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001; Hakansson Gisela, 2010, J Ocul Biol Dis Infor, V3, P20, DOI 10.1007/s12177-010-9050-6; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hussain SM, 2006, TOXICOL SCI, V92, P456, DOI 10.1093/toxsci/kfl020; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Ji JH, 2007, INHAL TOXICOL, V19, P857, DOI 10.1080/08958370701432108; Jo DH, 2014, NANOMEDICINE; Jo SH, 2011, INT J MOL SCI, V12, P1359, DOI 10.3390/ijms12021359; Kalishwaralal K, 2010, J CONTROL RELEASE, V145, P76, DOI 10.1016/j.jconrel.2010.03.022; Karthikeyan B, 2010, EXP EYE RES, V91, P769, DOI 10.1016/j.exer.2010.09.003; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Kim JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/50/505101; Kim JH, 2011, BIOMATERIALS, V32, P1865, DOI 10.1016/j.biomaterials.2010.11.030; Kim S, 2013, J APPL TOXICOL, V33, P78, DOI 10.1002/jat.2792; Kompella UB, 2010, THER DELIV, V1, P435, DOI 10.4155/TDE.10.40; Kreyling WG, 2006, J AEROSOL MED, V19, P74, DOI 10.1089/jam.2006.19.74; Kreyling Wolfgang G, 2009, Inhal Toxicol, V21 Suppl 1, P55, DOI 10.1080/08958370902942517; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lavik E, 2011, EYE, V25, P578, DOI 10.1038/eye.2011.82; Li F, 2012, KENYON REV, V34, P6; Liu ZW, 2011, ENVIRON TOXICOL, V26, P552, DOI 10.1002/tox.20586; Liu ZW, 2009, TOXICOLOGY, V264, P179, DOI 10.1016/j.tox.2009.08.005; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; Mertsch K, 2001, J COMP NEUROL, V431, P217; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Ning T, 2004, VISION RES, V44, P3307, DOI 10.1016/j.visres.2004.07.041; Oberdorster G, 2009, J NANOSCI NANOTECHNO, V9, P4996, DOI 10.1166/jnn.2009.GR02; Ogilvie JM, 1999, J NEUROSCI METH, V87, P57; Olson JL, 2013, J NANOMATER MOL NANO, V2, DOI [10.4172/2324-8777.1000111, DOI 10.4172/2324-8777.1000111]; Panariti A, 2012, NANOTECHNOL SCI APPL, V5, P87, DOI 10.2147/NSA.S25515; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Prediger RDS, 2012, NEUROTOX RES, V21, P90, DOI 10.1007/s12640-011-9281-8; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ramirez-Lee MA, 2013, TOXICOL LETT; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ryu JK, 2002, GLIA, V38, P15, DOI 10.1002/glia.10047; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Schleh C, 2012, NANOTOXICOLOGY, V6, P36, DOI 10.3109/17435390.2011.552811; Sintubin L, 2012, BIOTECHNOL BIOENG, V109, P2422, DOI 10.1002/bit.24570; Soderstjerna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058211; Soenen SJ, 2012, ACS NANO, V6, P5767, DOI 10.1021/nn301714n; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Suen WLL, 2013, J CONTROL RELEASE, V167, P21, DOI 10.1016/j.jconrel.2013.01.004; Tsai GY, 2009, CLIN EXP OPHTHALMOL, V37, P223, DOI 10.1111/j.1442-9071.2009.02000.x; Wang JY, 2009, NEUROTOXICOLOGY, V30, P926, DOI 10.1016/j.neuro.2009.09.005; Wang SW, 2002, METHODS, V28, P448, DOI 10.1016/S1046-2023(02)00264-5; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Xue Y, 2012, TOXICOL LETT, V214, P91, DOI 10.1016/j.toxlet.2012.08.009; Zou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028720	77	68	71	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105359	10.1371/journal.pone.0105359	http://dx.doi.org/10.1371/journal.pone.0105359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144684	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100058
J	Wang, HG; van Eeuwijk, FA				Wang, Huange; van Eeuwijk, Fred A.			A New Method to Infer Causal Phenotype Networks Using QTL and Phenotypic Information	PLOS ONE			English	Article							MULTI-TRAIT; ACCUMULATION; MODELS; LOCI	In the context of genetics and breeding research on multiple phenotypic traits, reconstructing the directional or causal structure between phenotypic traits is a prerequisite for quantifying the effects of genetic interventions on the traits. Current approaches mainly exploit the genetic effects at quantitative trait loci (QTLs) to learn about causal relationships among phenotypic traits. A requirement for using these approaches is that at least one unique QTL has been identified for each trait studied. However, in practice, especially for molecular phenotypes such as metabolites, this prerequisite is often not met due to limited sample sizes, high noise levels and small QTL effects. Here, we present a novel heuristic search algorithm called the QTL+phenotype supervised orientation (QPSO) algorithm to infer causal directions for edges in undirected phenotype networks. The two main advantages of this algorithm are: first, it does not require QTLs for each and every trait; second, it takes into account associated phenotypic interactions in addition to detected QTLs when orienting undirected edges between traits. We evaluate and compare the performance of QPSO with another state-of-the-art approach, the QTL-directed dependency graph (QDG) algorithm. Simulation results show that our method has broader applicability and leads to more accurate overall orientations. We also illustrate our method with a real-life example involving 24 metabolites and a few major QTLs measured on an association panel of 93 tomato cultivars. Matlab source code implementing the proposed algorithm is freely available upon request.	[Wang, Huange; van Eeuwijk, Fred A.] Wageningen Univ, Dept Plant Sci, NL-6700 AP Wageningen, Netherlands; [van Eeuwijk, Fred A.] Ctr BioSyst Genom, Wageningen, Netherlands; [van Eeuwijk, Fred A.] Netherlands Metabol Ctr, Leiden, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	Wang, HG (corresponding author), Wageningen Univ, Dept Plant Sci, NL-6700 AP Wageningen, Netherlands.	hw428@cam.ac.uk			Centre for BioSystems Genomics (CBSG); Netherlands Metabolomics Centre (NMC), The Netherlands Genomics Initiative/The Netherlands Organization for Scientific Research; CBSG	Centre for BioSystems Genomics (CBSG); Netherlands Metabolomics Centre (NMC), The Netherlands Genomics Initiative/The Netherlands Organization for Scientific Research; CBSG	This work was supported by the Centre for BioSystems Genomics (CBSG) and the Netherlands Metabolomics Centre (NMC), which are part of The Netherlands Genomics Initiative/The Netherlands Organization for Scientific Research. CBSG financed the collection of the tomato volatile data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimi NA, 2013, THEOR APPL GENET, V126, P2597, DOI 10.1007/s00122-013-2160-3; Aten JE, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-34; Baldermann S, 2010, J EXP BOT, V61, P2967, DOI 10.1093/jxb/erq123; Blair RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002458; Calus MPL, 2011, GENETICS SELECTION E, V43; Chickering DM, 1996, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P150; Gagneur J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-406; Gao HY, 2008, J INTEGR PLANT BIOL, V50, P991, DOI 10.1111/j.1744-7909.2008.00685.x; Gavai AK, 2009, METABOLOMICS, V5, P419, DOI 10.1007/s11306-009-0166-2; Hill CB, 2013, PLANT PHYSIOL, V162, P1266, DOI 10.1104/pp.113.217851; Hodges AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009513; Iyer SP, 2013, NEUROIMAGE, V75, P165, DOI 10.1016/j.neuroimage.2013.02.054; Jansen RC, 2009, CURR OPIN PLANT BIOL, V12, P241, DOI 10.1016/j.pbi.2009.01.003; JIANG CJ, 1995, GENETICS, V140, P1111; Joosen RVL, 2013, PLANT PHYSIOL, V162, P553, DOI 10.1104/pp.113.216176; Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21; Li RH, 2006, PLOS GENET, V2, P1046, DOI 10.1371/journal.pgen.0020114; Li Y, 2010, TRENDS GENET, V26, P493, DOI 10.1016/j.tig.2010.09.002; Logsdon BA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001014; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Mahdi R, 2013, J MACH LEARN RES, V14, P1563; Malosetti M, 2008, EUPHYTICA, V161, P241, DOI 10.1007/s10681-007-9594-0; Mathieu S, 2009, J EXP BOT, V60, P325, DOI 10.1093/jxb/ern294; Neto EC, 2008, GENETICS, V179, P1089, DOI 10.1534/genetics.107.085167; Neto EC, 2010, ANN APPL STAT, V4, P320, DOI 10.1214/09-AOAS288; Rambla J. L, 2014, J EXPT BOT; Roessner-Tunali U, 2003, PLANT PHYSIOL, V133, P84, DOI 10.1104/pp.103.023572; Rosa GJM, 2011, GENETICS SELECTION E, V43; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shenoy P. P, 2006, INFERENCE HYBRID BAY, P428; Spirtes P., 2000, CAUSATION PREDICTION; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Ursem R, 2008, EUPHYTICA, V161, P181, DOI 10.1007/s10681-008-9672-y; Valente BD, 2013, GENETICS, V194, P561, DOI 10.1534/genetics.113.151209; Verma T, 1990, EQUIVALENCE SYNTHESI, P220; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391	37	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e103997	10.1371/journal.pone.0103997	http://dx.doi.org/10.1371/journal.pone.0103997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144184	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100011
J	Yu, H; Zeng, JP; Liang, XM; Wang, WF; Zhou, YB; Sun, YD; Liu, SL; Li, WJ; Chen, CY; Jia, JH				Yu, Han; Zeng, Jiping; Liang, Xiuming; Wang, Wenfu; Zhou, Yabin; Sun, Yundong; Liu, Shili; Li, Wenjuan; Chen, Chunyan; Jia, Jihui			Helicobacter pylori Promotes Epithelial-Mesenchymal Transition in Gastric Cancer by Downregulating Programmed Cell Death Protein 4 (PDCD4)	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PDCD4; E-CADHERIN; EXPRESSION; CAGA; GENE; TUMORIGENESIS; TRANSCRIPTION; MICRORNA-21; PROGRESSION; METASTASIS	Helicobacter pylori, a Gram-negative, microaerophilic bacterium found in the stomach, is assumed to be associated with carcinogenesis, invasion and metastasis in digestive diseases. Cytotoxin-associated gene A (CagA) is an oncogenic protein of H. pylori that is encoded by a Cag pathogenicity island related to the development of gastric cancer. The epithelial-mesenchymal transition (EMT) is the main biological event in invasion or metastasis of epithelial cells. H. pylori may promote EMT in human gastric cancer cell lines, but the specific mechanisms are still obscure. We explored the underlying molecular mechanism of EMT induced by H. pylori CagA in gastric cancer. In our article, we detected gastric cancer specimens and adjacent non-cancerous specimens by immunohistochemistry and found increased expression of the EMT-related regulatory protein TWIST1 and the mesenchymal marker vimentin in cancer tissues, while programmed cell death factor 4 (PDCD4) and the epithelial marker E-cadherin expression decreased in cancer specimens. These changes were associated with degree of tissue malignancy. In addition, PDCD4 and TWIST1 levels were related. In gastric cancer cells cocultured with CagA expression plasmid, CagA activated TWIST1 and vimentin expression, and inhibited E-cadherin expression by downregulating PDCD4. CagA also promoted mobility of gastric cancer cells by regulating PDCD4. Thus, H. pylori CagA induced EMT in gastric cancer cells, which reveals a new signaling pathway of EMT in gastric cancer cell lines.	[Yu, Han; Zeng, Jiping; Liang, Xiuming; Wang, Wenfu; Zhou, Yabin; Sun, Yundong; Liu, Shili; Li, Wenjuan; Chen, Chunyan; Jia, Jihui] Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250100, Peoples R China; [Zeng, Jiping] Shandong Univ, Sch Med, Dept Biochem, Jinan 250100, Peoples R China	Shandong University; Shandong University	Jia, JH (corresponding author), Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250100, Peoples R China.	jiajihui@sdu.edu.cn			National Basic Research Program of China (973 Program) [2012CB911202]; National Natural Science Foundation of China [81171536, 81371781, 81272654, 81372680, 81170514]; Medical Science and Technology Development Program of Shandong [2013WS0209]; Independent Innovation Foundation of Shandong University [2012TS106]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Development Program of Shandong; Independent Innovation Foundation of Shandong University	This work was supported by the National Basic Research Program of China (no. 973 Program 2012CB911202), the National Natural Science Foundation of China (nos: 81171536, 81371781, 81272654, 81372680 and 81170514), the Medical Science and Technology Development Program of Shandong (no. 2013WS0209) and the Independent Innovation Foundation of Shandong University (no. 2012TS106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Azzoni L, 1998, J IMMUNOL, V161, P3493; Buti L, 2011, P NATL ACAD SCI USA, V108, P9238, DOI 10.1073/pnas.1106200108; Chan AOO, 2006, WORLD J GASTROENTERO, V12, P199, DOI 10.3748/wjg.v12.i2.199; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; KUIPERS EJ, 1995, ALIMENT PHARM THERAP, V9, P59; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Li J, 2010, BMC EVOL BIOL, V10, DOI [10.1186/1471-2148-10-68, 10.1186/1471-2407-10-354]; Liu YC, 2005, WORLD J GASTROENTERO, V11, P5174; Ma G, 2013, TUMOR BIOL, V34, P3879, DOI 10.1007/s13277-013-0975-9; Motoyama K, 2010, INT J ONCOL, V36, P1089, DOI 10.3892/ijo_00000590; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pinzani M, 2011, J HEPATOL, V55, P459, DOI 10.1016/j.jhep.2011.02.001; Resende C, 2011, HELICOBACTER, V16, P38, DOI 10.1111/j.1523-5378.2011.00879.x; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Sohn SH, 2011, ENVIRON TOXICOL PHAR, V32, P382, DOI 10.1016/j.etap.2011.08.006; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vikhreva P N, 2010, Mol Gen Mikrobiol Virusol, P3; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang Q, 2013, EUR J CANCER, V49, P1761, DOI 10.1016/j.ejca.2012.12.014; Watanabe T, 2014, INT J CANCER, V134, P2373, DOI 10.1002/ijc.28582; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yao Q, 2011, INT J CANCER, V128, P1783, DOI 10.1002/ijc.25506; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794	42	38	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105306	10.1371/journal.pone.0105306	http://dx.doi.org/10.1371/journal.pone.0105306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144746	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100050
J	Li, L; Wang, BT; Feng, S; Li, JN; Wu, CM; Wang, Y; Ruan, XC; Zeng, MH				Li, Lin; Wang, Binting; Feng, Shuai; Li, Jinnian; Wu, Congming; Wang, Ying; Ruan, Xiangchun; Zeng, Minghua			Prevalence and Characteristics of Extended-Spectrum beta-Lactamase and Plasmid-Mediated Fluoroquinolone Resistance Genes in Escherichia coli Isolated from Chickens in Anhui Province, China	PLOS ONE			English	Article							QUINOLONE RESISTANCE; ANTIMICROBIAL RESISTANCE; CTX-M; ENTEROBACTERIACEAE; COMMUNITY; ANIMALS; ESBLS; EPIDEMIOLOGY; EMERGENCE; THREAT	The aim of this study was to characterize the prevalence of extended-spectrum beta-lactamase (ESBL) genes and plasmidmediated fluoroquinolone resistance (PMQR) determinants in 202 Escherichia coli isolates from chickens in Anhui Province, China, and to determine whether ESBL and PMQR genes co-localized in the isolates. Antimicrobial susceptibility for 12 antimicrobials was determined by broth microdilution. Polymerase chain reactions (PCRs), DNA sequencing, and pulsed field gel electrophoresis (PFGE) were employed to characterize the molecular basis for beta-lactam and fluoroquinolone resistance. High rates of antimicrobial resistance were observed, 147 out of the 202 (72.8%) isolates were resistant to at least 6 antimicrobial agents and 28 (13.9%) of the isolates were resistant to at least 10 antimicrobials. The prevalence of bla(CTX-M), bla(TEM-1) and bla(TEM-206) genes was 19.8%, 24.3% and 11.9%, respectively. Seventy-five out of the 202 (37.1%) isolates possessed a plasmid-mediated quinolone resistance determinant in the form of qnrS (n = 21); this determinant occurred occasionally in combination with aac(6')-1b-cr (n = 65). Coexistence of ESBL and/or PMQR genes was identified in 31 of the isolates. Two E. coli isolates carried bla(TEM-1), bla(CTX-M) and qnrS, while two others carried bla(CTX-M), qnrS and aac(6')-1b-cr. In addition, bla(TEM-1), qnrS and aac(6')-1b-cr were co-located in two other E. coli isolates. PFGE analysis showed that these isolates were not clonally related and were genetically diverse. To the best of our knowledge, this study is the first to describe detection of TEM-206-producing E. coli in farmed chickens, and the presence of bla(TEM-206), qnrS and aac(6')-1b-cr in one of the isolates.	[Li, Lin; Wang, Binting; Feng, Shuai; Wang, Ying; Ruan, Xiangchun; Zeng, Minghua] Anhui Agr Univ, Coll Anim Sci & Technol, Pharmacol & Toxicol Lab, Hefei, Peoples R China; [Li, Jinnian] Anhui Agr Univ, Coll Anim Sci & Technol, Microbiol & Immunol Lab, Hefei, Peoples R China; [Wu, Congming] China Agr Univ, Coll Vet Med, Beijing Key Lab Detect Technol Anim Derived Food, Beijing 100094, Peoples R China	Anhui Agricultural University; Anhui Agricultural University; China Agricultural University	Zeng, MH (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Pharmacol & Toxicol Lab, Hefei, Peoples R China.	zmhzmh@ahau.edu.cn	li, lijinnian/HDO-3498-2022; Zeng, Ming/GXF-3628-2022	Zeng, Ming/0000-0003-2836-9240	Anhui University Provincial Natural Science Research Project [KJ2012A111]; National Natural Science Foundation of China [31201957]; Annual disciplinary and academic degree construction projects [XKXWD2013006]; Special Fund for Agro-Scientific Research in the Public Interest [201203040]	Anhui University Provincial Natural Science Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Annual disciplinary and academic degree construction projects; Special Fund for Agro-Scientific Research in the Public Interest	This work was supported by grants from the Anhui University Provincial Natural Science Research Project (KJ2012A111), National Natural Science Foundation of China (31201957), Annual disciplinary and academic degree construction projects in 2013 (XKXWD2013006), and Special Fund for Agro-Scientific Research in the Public Interest (201203040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin C, 2009, J ANTIMICROB CHEMOTH, V63, P1205, DOI 10.1093/jac/dkp108; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; *CLIN LAB STAND I, 2011, M100S21 CLSI; Dai L, 2008, FEMS MICROBIOL LETT, V286, P178, DOI 10.1111/j.1574-6968.2008.01272.x; Drugdova Z, 2013, BIOLOGIA, V68, P11, DOI 10.2478/s11756-012-0142-6; Fortini D, 2011, J ANTIMICROB CHEMOTH, V66, P1269, DOI 10.1093/jac/dkr085; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Li L, 2010, VET MICROBIOL, V144, P505, DOI 10.1016/j.vetmic.2010.02.005; Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Luo YP, 2011, INT J ANTIMICROB AG, V37, P352, DOI 10.1016/j.ijantimicag.2010.12.018; Mustak HK, 2012, ANKARA UNIV VET FAK, V59, P255, DOI 10.1501/Vetfak_0000002535; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rodriguez-Bano J, 2004, J CLIN MICROBIOL, V42, P1089, DOI 10.1128/JCM.42.3.1089-1094.2004; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Wang Y, 2012, VET MICROBIOL, V159, P53, DOI 10.1016/j.vetmic.2012.03.009; Xia LN, 2010, FOODBORNE PATHOG DIS, V7, P207, DOI 10.1089/fpd.2009.0378; Yang T, 2014, VET MICROBIOL, V170, P89, DOI 10.1016/j.vetmic.2014.01.019; Yuan L, 2009, J MED MICROBIOL, V58, P1449, DOI 10.1099/jmm.0.012229-0; Yue L, 2008, VET MICROBIOL, V132, P414, DOI 10.1016/j.vetmic.2008.05.009; Zhou TL, 2011, JPN J INFECT DIS, V64, P55	25	21	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104356	10.1371/journal.pone.0104356	http://dx.doi.org/10.1371/journal.pone.0104356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141348	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200017
J	Schurch, R; Gruter, C				Schuerch, Roger; Grueter, Christoph			Dancing Bees Improve Colony Foraging Success as Long-Term Benefits Outweigh Short-Term Costs	PLOS ONE			English	Article							SOCIAL-LEARNING STRATEGIES; COLLECTIVE DECISION-MAKING; HONEY-BEES; APIS-MELLIFERA; WAGGLE DANCE; INFORMATION; COMMUNICATION; FORAGERS; INSIGHTS; BEHAVIOR	Waggle dancing bees provide nestmates with spatial information about high quality resources. Surprisingly, attempts to quantify the benefits of this encoded spatial information have failed to find positive effects on colony foraging success under many ecological circumstances. Experimental designs have often involved measuring the foraging success of colonies that were repeatedly switched between oriented dances versus disoriented dances (i.e. communicating vectors versus not communicating vectors). However, if recruited bees continue to visit profitable food sources for more than one day, this procedure would lead to confounded results because of the long-term effects of successful recruitment events. Using agent-based simulations, we found that spatial information was beneficial in almost all ecological situations. Contrary to common belief, the benefits of recruitment increased with environmental stability because benefits can accumulate over time to outweigh the short-term costs of recruitment. Furthermore, we found that in simulations mimicking previous experiments, the benefits of communication were considerably underestimated (at low food density) or not detected at all (at medium and high densities). Our results suggest that the benefits of waggle dance communication are currently underestimated and that different experimental designs, which account for potential long-term benefits, are needed to measure empirically how spatial information affects colony foraging success.	[Schuerch, Roger] Univ Sussex, Sch Life Sci, Lab Apiculture & Social Insects, Falmer, England; [Grueter, Christoph] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	University of Sussex; Universidade de Sao Paulo	Schurch, R (corresponding author), Univ Sussex, Sch Life Sci, Lab Apiculture & Social Insects, Falmer, England.	R.Schuerch@sussex.ac.uk	Schurch, Roger/J-8744-2019	Schurch, Roger/0000-0001-9075-8912; Gruter, Christoph/0000-0001-5553-5465	Swiss National Science Foundation [PA00P3_139731]; Brazilian National Council for Scientific and Technological Development (CNPq) [400664/2012-7]; Ambizione fellowship from the Swiss National Science Foundation [PZ00P3_142628/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ambizione fellowship from the Swiss National Science Foundation	RS was funded by the Swiss National Science Foundation (Grant PA00P3_139731). CG was funded by a Science without Borders fellowship from the Brazilian National Council for Scientific and Technological Development (CNPq, Process-number: 400664/2012-7) and an Ambizione fellowship from the Swiss National Science Foundation (PZ00P3_142628/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Toufailia H, 2013, ETHOLOGY, V119, P1096, DOI 10.1111/eth.12170; Anderson C, 1999, AM NAT, V154, P521, DOI 10.1086/303255; Anderson C, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P31; [Anonymous], 1971, INSECT SOC; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Beekman M, 2005, J COMP PHYSIOL A, V191, P1107, DOI 10.1007/s00359-005-0034-0; Beekman M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1259, DOI 10.1007/s00265-008-0554-z; Beekman M, 2008, BEHAV ECOL, V19, P255, DOI 10.1093/beheco/arm117; Beekman M, 2007, BEHAV ECOL SOCIOBIOL, V61, P985, DOI 10.1007/s00265-006-0331-9; BELING INGEBORG, 1929, ZEITSCHR VERGLEICH PHYSIOL, V9, P259, DOI 10.1007/BF00340159; Biesmeijer J, 2005, BEHAV ECOL SOCIOBIOL, V59, P133, DOI 10.1007/s00265-005-0019-6; BOCH R, 1956, Z VERGL PHYSIOL, V38, P136, DOI 10.1007/BF00338624; BOGDANY FJ, 1978, BEHAV ECOL SOCIOBIOL, V3, P323, DOI 10.1007/BF00303198; Butler CG, 1943, J EXP BIOL, V20, P65; Collett M, 2009, CURR BIOL, V19, pR1103, DOI 10.1016/j.cub.2009.10.004; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; Couvillon MJ, 2012, INSECT SOC, V59, P297, DOI 10.1007/s00040-012-0224-z; Couvillon MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093495; De Marco RJ, 2003, J COMP PHYSIOL A, V189, P125, DOI 10.1007/s00359-002-0382-y; Dechaume-Moncharmont FX, 2005, P ROY SOC B-BIOL SCI, V272, P1689, DOI 10.1098/rspb.2005.3137; Donaldson-Matasci MC, 2013, ANIM BEHAV, V85, P585, DOI 10.1016/j.anbehav.2012.12.020; Donaldson-Matasci MC, 2012, BEHAV ECOL SOCIOBIOL, V66, P583, DOI 10.1007/s00265-011-1306-z; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Dornhaus A, 2006, BEHAV ECOL, V17, P336, DOI 10.1093/beheco/arj036; ESCH H, 1970, Z VERGL PHYSIOL, V68, P175, DOI 10.1007/BF00297693; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Farina WM., 2012, C GALIZIA, DOI [10.1007/978-94-007-2099-2_8, DOI 10.1007/978-94-007-2099-2_8]; Frisch K. v., 1946, OESTERREICH ZOOL ZEITSCHR [ VIENNA], V1, P1; GENTRY A H, 1974, Biotropica, V6, P64, DOI 10.2307/2989698; Gilley DC, 2012, APIDOLOGIE, V43, P85, DOI 10.1007/s13592-011-0080-2; GOULD JL, 1970, SCIENCE, V169, P544, DOI 10.1126/science.169.3945.544; GOULD JL, 1976, Q REV BIOL, V51, P211, DOI 10.1086/409309; Granovskiy B, 2012, BEHAV ECOL, V23, P588, DOI 10.1093/beheco/ars002; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gruter C, 2008, P R SOC B, V275, P1321, DOI 10.1098/rspb.2008.0186; Gruter C, 2014, TRENDS ECOL EVOL, V29, P177, DOI 10.1016/j.tree.2014.01.004; Gruter C, 2013, ANIM BEHAV, V85, P1443, DOI 10.1016/j.anbehav.2013.03.041; Gruter C, 2011, ANIM BEHAV, V81, P949, DOI 10.1016/j.anbehav.2011.01.014; Gruter C, 2010, CURR BIOL, V20, pR683, DOI 10.1016/j.cub.2010.06.052; Gruter C, 2009, TRENDS ECOL EVOL, V24, P242, DOI 10.1016/j.tree.2008.12.007; Holldobler B., 2009, SUPERORGANISM; Jarau S, 2009, CONTEMP TOP ENTOMOL, P1, DOI 10.1201/9781420075618; JOHNSON DL, 1967, ANIM BEHAV, V15, P487, DOI 10.1016/0003-3472(67)90048-6; Kleber E., 1935, Zeitschrift fuer Vergleichende Physiologie Berlin, V22, P221, DOI 10.1007/BF00586500; Liang ZZS, 2012, SCIENCE, V335, P1225, DOI 10.1126/science.1213962; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; LINDAUER M, 1949, Z VERGL PHYSIOL, V31, P348, DOI 10.1007/BF00297951; MAUTZ D, 1971, Z VERGL PHYSIOL, V72, P197, DOI 10.1007/BF00297822; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Moore D, 2001, J INSECT PHYSIOL, V47, P843, DOI 10.1016/S0022-1910(01)00057-9; Moore D, 2011, J COMP PHYSIOL A, V197, P641, DOI 10.1007/s00359-011-0624-y; Moore D, 2009, J COMP PHYSIOL A, V195, P741, DOI 10.1007/s00359-009-0450-7; Naeger NL, 2011, J EXP BIOL, V214, P979, DOI 10.1242/jeb.053421; NUNEZ JA, 1966, Z VERGL PHYSIOL, V53, P142; Okada R, 2012, ACTA BIOL HUNG, V63, P75, DOI 10.1556/ABiol.63.2012.Suppl.2.8; Park WO, 1926, J ECON ENTOMOL, V19, P656, DOI 10.1093/jee/19.4.656; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; R Core Team, 2021, R LANGUAGE ENV STAT; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Rendell L, 2011, PHILOS T R SOC B, V366, P1118, DOI 10.1098/rstb.2010.0376; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Reynolds AM, 2009, BEHAV ECOL SOCIOBIOL, V64, P115, DOI 10.1007/s00265-009-0826-2; RIBBANDS CR, 1949, J ANIM ECOL, V18, P47, DOI 10.2307/1581; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1988, BEHAV ECOL SOCIOBIOL, V22, P229, DOI 10.1007/BF00299837; SEELEY TD, 1986, BEHAV ECOL SOCIOBIOL, V19, P343, DOI 10.1007/BF00295707; SEELEY TD, 1983, AM SCI, V71, P264; SEELEY TD, 1992, BEHAV ECOL SOCIOBIOL, V30, P59, DOI 10.1007/BF00168595; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Seeley TD, 2012, HONEYBEE NEUROBIOLOG, P77; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Tanner DA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1891, DOI 10.1007/s00265-008-0619-z; Tautz J, 1996, J EXP BIOL, V199, P1375; TOWNE W F, 1988, Journal of Insect Behavior, V1, P129, DOI 10.1007/BF01052234; Van Nest BN, 2012, BEHAV ECOL, V23, P649, DOI 10.1093/beheco/ars010; Venables WN., 2002, MODERN APPL STAT S 4; Vogel S., 1983, Encyclopedia of plant physiology, New Series, Volume 12C. Physiological plant ecology III, P559; von Frisch K, 1923, SODERABDRUCK ZOOLOGI, P1186; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wenner AM., 1990, ANATOMY CONTROVERSY, DOI [10.7312/wenn90330, DOI 10.7312/WENN90330]; Wilms W, 1996, STUD NEOTROP FAUNA E, V31, P137, DOI 10.1076/snfe.31.3.137.13336; Wray MK, 2012, BEHAV ECOL, V23, P125, DOI 10.1093/beheco/arr165	87	32	32	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104660	10.1371/journal.pone.0104660	http://dx.doi.org/10.1371/journal.pone.0104660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141306	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200026
J	Artegoitia, VM; Middleton, JL; Harte, FM; Campagna, SR; de Veth, MJ				Artegoitia, Virginia M.; Middleton, Jesse L.; Harte, Federico M.; Campagna, Shawn R.; de Veth, Michael J.			Choline and Choline Metabolite Patterns and Associations in Blood and Milk during Lactation in Dairy Cows	PLOS ONE			English	Article							RUMEN-PROTECTED CHOLINE; ESSENTIAL NUTRIENT; PHOSPHATIDYLCHOLINE; BIOSYNTHESIS; PHOSPHOLIPIDS; SECRETION; ESTERS; ACID	Milk and dairy products are an important source of choline, a nutrient essential for human health. Infant formula derived from bovine milk contains a number of metabolic forms of choline, all contribute to the growth and development of the newborn. At present, little is known about the factors that influence the concentrations of choline metabolites in milk. The objectives of this study were to characterize and then evaluate associations for choline and its metabolites in blood and milk through the first 37 weeks of lactation in the dairy cow. Milk and blood samples from twelve Holstein cows were collected in early, mid and late lactation and analyzed for acetylcholine, free choline, betaine, glycerophosphocholine, lysophosphatidylcholine, phosphatidylcholine, phosphocholine and sphingomyelin using hydrophilic interaction liquid chromatography-tandem mass spectrometry, and quantified using stable isotope-labeled internal standards. Total choline concentration in plasma, which was almost entirely phosphatidylcholine, increased 10-times from early to late lactation (1305 to 13,535 mu mol/L). In milk, phosphocholine was the main metabolite in early lactation (492 mu mol/L), which is a similar concentration to that found in human milk, however, phosphocholine concentration decreased exponentially through lactation to 43 mu mol/L in late lactation. In contrast, phosphatidylcholine was the main metabolite in mid and late lactation (188 mu mol/L and 659 mu mol/L, respectively), with the increase through lactation positively correlated with phosphatidylcholine in plasma (R-2 = 0.78). Unlike previously reported with human milk we found no correlation between plasma free choline concentration and milk choline metabolites. The changes in pattern of phosphocholine and phosphatidylcholine in milk through lactation observed in the bovine suggests that it is possible to manufacture infant formula that more closely matches these metabolites profile in human milk.	[Artegoitia, Virginia M.; Harte, Federico M.] Univ Tennessee, Dept Food Sci & Technol, Knoxville, TN 37901 USA; [Middleton, Jesse L.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37901 USA; [de Veth, Michael J.] Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA; [de Veth, Michael J.] Balchem Corp, New Hampton, NY USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	de Veth, MJ (corresponding author), Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA.	mdeveth@utk.edu	Harte, Federico M/N-4283-2015	Harte, Federico/0000-0001-6822-0083	University of Tennessee Agricultural Experiment Station and Balchem Corporation, New Hampton, NY	University of Tennessee Agricultural Experiment Station and Balchem Corporation, New Hampton, NY	This research was supported by The University of Tennessee Agricultural Experiment Station and Balchem Corporation, New Hampton, NY (http://www.balchem.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi A, 2006, CAN J ANIM SCI, V86, P207, DOI 10.4141/A05-061; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Caudill MA, 2010, J AM DIET ASSOC, V110, P1198, DOI 10.1016/j.jada.2010.05.009; CHAO CK, 1988, BIOCHEM J, V254, P33, DOI 10.1042/bj2540033; Cheng WL, 1996, J NUTR BIOCHEM, V7, P457, DOI 10.1016/0955-2863(96)00079-4; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Committee on the Evaluation of the Addition of Ingredients New to Infant Formula, 2004, INF FORM EV SAF NEW; da Costa KA, 2011, AM J CLIN NUTR, V93, P968, DOI 10.3945/ajcn.110.011064; Davenport C, 2013, HUM HEALT HANDB, P335, DOI 10.3920/978-90-8686-764-6_17; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Deuchler KN, 1998, J DAIRY SCI, V81, P238, DOI 10.3168/jds.S0022-0302(98)75571-7; Donovan SM, 1997, J NUTR BIOCHEM, V8, P603, DOI 10.1016/S0955-2863(97)00115-0; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; Garrow TA, 2007, HDB VITAMINS, P459; Goselink RMA, 2013, J DAIRY SCI, V96, P1102, DOI 10.3168/jds.2012-5396; Holmes HC, 2000, EUR J PEDIATR, V159, P198, DOI 10.1007/s004310050050; HolmesMcNary MQ, 1996, AM J CLIN NUTR, V64, P572, DOI 10.1093/ajcn/64.4.572; Ilcol YO, 2005, J NUTR BIOCHEM, V16, P489, DOI 10.1016/j.jnutbio.2005.01.011; Klein MS, 2012, J PROTEOME RES, V11, P1373, DOI 10.1021/pr201017n; LEHUEROU I, 1992, DIGEST DIS SCI, V37, P40, DOI 10.1007/BF01308340; LEHUEROULURON I, 1992, J NUTR, V122, P1434, DOI 10.1093/jn/122.7.1434; Lopez C, 2008, J AGR FOOD CHEM, V56, P5226, DOI 10.1021/jf7036104; National Research Council (NRC), 2001, NUTR REQ DAIR CATTL; NEILL AR, 1979, BIOCHEM J, V180, P559, DOI 10.1042/bj1800559; Pinotti L, 2003, J VET MED A, V50, P18, DOI 10.1046/j.1439-0442.2003.00502.x; Pinotti L, 2002, NUTR RES REV, V15, P315, DOI 10.1079/NRR200247; Pitkin RM., 2000, DIETARY REFERENCE IN; Pynn CJ, 2011, J LIPID RES, V52, P399, DOI 10.1194/jlr.d011916; RAPHAEL BC, 1973, J DAIRY SCI, V56, P1025, DOI 10.3168/jds.S0022-0302(73)85300-7; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; ROBINSON BS, 1987, BIOCHEM J, V244, P367, DOI 10.1042/bj2440367; SHARMA BK, 1989, J DAIRY SCI, V72, P2772, DOI 10.3168/jds.S0022-0302(89)79421-2; Xiong YP, 2012, J CHROMATOGR B, V911, P170, DOI 10.1016/j.jchromb.2012.10.038; YAO ZM, 1988, J BIOL CHEM, V263, P2998; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeisel SH, 2003, J NUTR, V133, P1302; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; ZEISEL SH, 1990, J NUTR BIOCHEM, V1, P332, DOI 10.1016/0955-2863(90)90001-2; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x; Zhao YY, 2011, J CHROMATOGR A, V1218, P5470, DOI 10.1016/j.chroma.2011.06.025; Zom RLG, 2011, J DAIRY SCI, V94, P4016, DOI 10.3168/jds.2011-4233	42	46	48	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e103412	10.1371/journal.pone.0103412	http://dx.doi.org/10.1371/journal.pone.0103412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157578	Green Published, gold			2022-12-27	WOS:000341303200003
J	Wang, YK; Chu, P; Yang, Q; Chang, SX; Chen, JM; Hu, ML; Guan, RZ				Wang, Yankun; Chu, Pu; Yang, Qing; Chang, Shengxin; Chen, Jianmei; Hu, Maolong; Guan, Rongzhan			Complete Mitochondrial Genome of Eruca sativa Mill. (Garden Rocket)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CYTOPLASMIC MALE-STERILITY; RAPHANUS-SATIVUS; BRASSICA-NAPUS; GENE; DNA; DIVERGENCE; EVOLUTION; CONTAINS; L.	Eruca sativa (Cruciferae family) is an ancient crop of great economic and agronomic importance. Here, the complete mitochondrial genome of Eruca sativa was sequenced and annotated. The circular molecule is 247 696 bp long, with a G+C content of 45.07%, containing 33 protein-coding genes, three rRNA genes, and 18 tRNA genes. The Eruca sativa mitochondrial genome may be divided into six master circles and four subgenomic molecules via three pairwise large repeats, resulting in a more dynamic structure of the Eruca sativa mtDNA compared with other cruciferous mitotypes. Comparison with the Brassica napus MtDNA revealed that most of the genes with known function are conserved between these two mitotypes except for the ccmFN2 and rrn18 genes, and 27 point mutations were scattered in the 14 protein-coding genes. Evolutionary relationships analysis suggested that Eruca sativa is more closely related to the Brassica species and to Raphanus sativus than to Arabidopsis thaliana.	[Wang, Yankun; Chu, Pu; Yang, Qing; Chang, Shengxin; Chen, Jianmei; Guan, Rongzhan] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Hu, Maolong] Jiangsu Acad Agr Sci, Inst Econ Crop, Nanjing, Jiangsu, Peoples R China; [Guan, Rongzhan] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University	Guan, RZ (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	guanrz@njau.edu.cn	Chang, Scott X/G-2029-2011	Guan, Rongzhan/0000-0001-9177-6610	National Natural Science Foundation of China [31270386, 31301352, 31101174]; National Key Technology R & D Program, in China [2010BAD01B02, 2011BAD13B09]; Open Research Fund of State Key Laboratory of State Key Laboratory of Crop Genetics and Germplasm Enhancement [ZW2011006]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Fund for Independent innovation of Agricultural Science and Technology in Jiangsu province [CX (11) 1026]; Science and Technology Support Program of Jiangsu Province [BE2012327]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R & D Program, in China(National Key Technology R&D Program); Open Research Fund of State Key Laboratory of State Key Laboratory of Crop Genetics and Germplasm Enhancement; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Special Fund for Independent innovation of Agricultural Science and Technology in Jiangsu province; Science and Technology Support Program of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (No. 31270386, 31301352 and 31101174), the National Key Technology R & D Program (No. 2010BAD01B02 and 2011BAD13B09) in China, the Open Research Fund of State Key Laboratory of State Key Laboratory of Crop Genetics and Germplasm Enhancement(ZW2011006), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Special Fund for Independent innovation of Agricultural Science and Technology in Jiangsu province (Nos. CX (11) 1026), and the Science and Technology Support Program of Jiangsu Province (BE2012327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Anjum NA, 2012, PLANT FAMILY BRASSIC, P1, DOI DOI 10.1007/978-94-007-3913-0_1; Arrieta-Montiel MP, 2011, ADVAN PL BIO, V1, P65; Arrieta-Montiel MP, 2009, GENETICS, V183, P1261, DOI 10.1534/genetics.109.108514; ASHRAF M, 1994, BIOL PLANTARUM, V36, P255, DOI 10.1007/BF02921095; Chang SX, 2013, J GENET GENOMICS, V40, P117, DOI 10.1016/j.jgg.2013.01.003; Chang SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056502; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Chen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017662; Diamond M, 2011, ADVAN PL BIO, V1, P439; Fahleson J, 1997, PLANT SCI, V123, P133, DOI 10.1016/S0168-9452(96)04575-X; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Goremykin VV, 2012, PLANT J, V71, P615, DOI 10.1111/j.1365-313X.2012.05014.x; GRABAU EA, 1985, PLANT MOL BIOL, V5, P119, DOI 10.1007/BF00020094; GRAY MW, 1982, CAN J BIOCHEM CELL B, V60, P157, DOI 10.1139/o82-022; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Huang S, 2011, ADVAN PL BIO, V1, P207; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LAKSHMIKUMARAN M, 1994, PLANT MOL BIOL, V24, P915, DOI 10.1007/BF00014445; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Park JY, 2013, THEOR APPL GENET, V126, P1763, DOI 10.1007/s00122-013-2090-0; Pellny TK, 2008, PLANT J, V54, P976, DOI 10.1111/j.1365-313X.2008.03472.x; Rayapuram N, 2008, J BIOL CHEM, V283, P25200, DOI 10.1074/jbc.M802621200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandhu APS, 2007, P NATL ACAD SCI USA, V104, P1766, DOI 10.1073/pnas.0609344104; Sastry E. V. D., 2003, Agricultural Reviews, V24, P235; Slater SM, 2013, BIOTECHNOLOGY NEGLEC, P203; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tanaka Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-352; Tsunoda S., 1980, Brassica crops and wild allies. Biology and breeding., P109; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wang J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-675; Woloszynska M, 2010, J EXP BOT, V61, P657, DOI 10.1093/jxb/erp361; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	44	5	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105748	10.1371/journal.pone.0105748	http://dx.doi.org/10.1371/journal.pone.0105748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157569	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200057
J	Liu, CK; Tan, XY; Luo, JC; Liu, HW; Hu, M; Yue, W				Liu, ChangKui; Tan, XinYing; Luo, JinChao; Liu, HuaWei; Hu, Min; Yue, Wen			Reconstruction of Beagle Hemi-Mandibular Defects with Allogenic Mandibular Scaffolds and Autologous Mesenchymal Stem Cells	PLOS ONE			English	Article							SIMULTANEOUS IMPLANT PLACEMENT; RETRIEVED HUMAN ALLOGRAFTS; TISSUE-ENGINEERED BONE; FIBRIN GLUE; OSTEOGENESIS; GRAFT	Objective: Massive bone allografts are frequently used in orthopedic reconstructive surgery, but carry a high failure rate of approximately 25%. We tested whether treatment of graft with mesenchymal stem cells (MSCs) can increase the integration of massive allografts (hemi-mandible) in a large animal model. Methods: Thirty beagle dogs received surgical left-sided hemi-mandibular defects, and then divided into two equal groups. Bony defects of the control group were reconstructed using allografts only. Those of the experimental group were reconstructed using allogenic mandibular scaffold-loaded autologous MSCs. Beagles from each group were killed at4 (n = 4), 12 (n = 4), 24 (n = 4) or 48 weeks (n = 3) postoperatively. CT and micro-CT scans, histological analyses and the bone mineral density (BMD) of transplants were used to evaluate defect reconstruction outcomes. Results: Gross and CT examinations showed that the autologous bone grafts had healed in both groups. At 48 weeks, the allogenic mandibular scaffolds of the experimental group had been completely replaced by new bone, which has a smaller surface area to that of the original allogenic scaffold, whereas the scaffold in control dogs remained the same size as the original allogenic scaffold throughout. At 12 weeks, the BMD of the experimental group was significantly higher than the control group (p<0.05), and all micro-architectural parameters were significantly different between groups (p<0.05). Histological analyses showed almost all transplanted allogeneic bone was replaced by new bone, principally fibrous ossification, in the experimental group, which differed from the control group where little new bone formed. Conclusions: Our study demonstrated the feasibility of MSC-loaded allogenic mandibular scaffolds for the reconstruction of hemi-mandibular defects. Further studies are needed to test whether these results can be surpassed by the use of allogenic mandibular scaffolds loaded with a combination of MSCs and osteoinductive growth factors.	[Liu, ChangKui; Tan, XinYing; Luo, JinChao; Liu, HuaWei; Hu, Min] Gen Hosp PLA, Dept Stomatol, Beijing, Peoples R China; [Yue, Wen] Beijing Inst Transfus Med, Dept Stem Cell, Beijing, Peoples R China; [Yue, Wen] Beijing Inst Transfus Med, Regenerat Med Lab, Beijing, Peoples R China; [Liu, ChangKui] 451th Hosp Peoples Librat Army, Dept Stomatol, Xian, Peoples R China	Chinese People's Liberation Army General Hospital	Hu, M (corresponding author), Gen Hosp PLA, Dept Stomatol, Beijing, Peoples R China.	humin48@vip.163.com; wenyue26@yahoo.com			Beijing Municipal Commission of Science and Technology [D131100003013001]; Beijing Natural Science Foundation of China [7112124]	Beijing Municipal Commission of Science and Technology; Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was Supported by the Beijing Municipal Commission of Science and Technology (D131100003013001) and Beijing Natural Science Foundation of China (7112124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Caldroa P, 1995, Chir Organi Mov, V80, P191; Chen FL, 2002, J ORAL MAXIL SURG, V60, P1155, DOI 10.1053/joms.2002.34991; Donati D, 2000, CLIN ORTHOP RELAT R, P186; Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001; ENNEKING WF, 1991, J BONE JOINT SURG AM, V73A, P1123, DOI 10.2106/00004623-199173080-00002; Goh BT, 2008, INT J ORAL MAX SURG, V37, P597, DOI 10.1016/j.ijom.2008.03.002; Hasegawa N, 2006, J PERIODONTOL, V77, P1003, DOI 10.1902/jop.2006.050341; Isogai N, 2000, PLAST RECONSTR SURG, V105, P953, DOI 10.1097/00006534-200003000-00019; Ito K, 2006, CLIN ORAL IMPLAN RES, V17, P579, DOI 10.1111/j.1600-0501.2006.01246.x; Lee LT, 2008, J CHIN MED ASSOC, V71, P66, DOI 10.1016/S1726-4901(08)70077-7; Marshall R, 1979, P NATL ACAD SCI USA, VSci76, P1828; Street J, 2000, CLIN ORTHOP RELAT R, P224, DOI 10.1097/00003086-200009000-00033; Ueda M, 2005, INT J PERIODONT REST, V25, P129; URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828	15	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105733	10.1371/journal.pone.0105733	http://dx.doi.org/10.1371/journal.pone.0105733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153673	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200075
J	Cuneo, NR; Gandolfo, MA; Zamaloa, MC; Hermsen, E				Cuneo, N. Ruben; Gandolfo, Maria A.; Zamaloa, Maria C.; Hermsen, Elizabeth			Late Cretaceous Aquatic Plant World in Patagonia, Argentina	PLOS ONE			English	Article							COLONIA FORMATION; HETEROSPOROUS FERN; SP-NOV.; FOSSIL; EVOLUTION; SPORES; SOUTH; NELUMBONACEAE; MARSILEACEAE; VEGETATION	In this contribution, we describe latest Cretaceous aquatic plant communities from the La Colonia Formation, Patagonia, Argentina, based on their taxonomic components and paleoecological attributes. The La Colonia Formation is a geological unit deposited during a Maastrichtian-Danian transgressive episode of the South Atlantic Ocean. This event resulted in the deposition of a series of fine-grained sediments associated with lagoon systems occurring along irregular coastal plains in northern Patagonia. These deposits preserved a diverse biota, including aquatic and terrestrial plants and animals. The aquatic macrophytes can be broadly divided into two groups: free-floating and rooted, the latter with emergent or floating leaves. Free-floating macrophytes include ferns in Salviniaceae (Azolla and Paleoazolla) and a monocot (Araceae). Floating microphytes include green algae (Botryoccocus, Pediastrum and Zygnemataceae). Among the rooted components, marsileaceous water ferns (including Regnellidium and an extinct form) and the eudicot angiosperm Nelumbo (Nelumbonaceae) are the dominant groups. Terrestrial plants occurring in the vegetation surrounding the lagoons include monocots (palms and Typhaceae), ferns with affinities to Dicksoniaceae, conifers, and dicots. A reconstruction of the aquatic plant paleocommuniy is provided based on the distribution of the fossils along a freshwater horizon within the La Colonia Formation. This contribution constitutes the first reconstruction of a Cretaceous aquatic habitat for southern South America.	[Cuneo, N. Ruben] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Gandolfo, Maria A.] Cornell Univ, Sch Integrat Plant Sci, LH Bailey Hortorium Plant Biol Sect, Ithaca, NY USA; [Zamaloa, Maria C.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Hermsen, Elizabeth] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Cornell University; University of Buenos Aires; University System of Ohio; Ohio University	Cuneo, NR (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina.	rcuneo@mef.org.ar		Hermsen, Elizabeth/0000-0003-2666-4385	Philosophical Society Franklin Award; United States National Science Foundation [DEB-0918932]; National Science Foundation [DEB-0919071]; CONICET [12410]; Agencia Nacional Promicion Ciencia y Tecnologia PICT [1696]; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation; Division Of Environmental Biology [0830020] Funding Source: National Science Foundation	Philosophical Society Franklin Award; United States National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional Promicion Ciencia y Tecnologia PICT; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding provided by Philosophical Society Franklin Award and United States National Science Foundation DEB-0918932 to MAG; National Science Foundation DEB-0919071 and CONICET 12410 to NRC; Agencia Nacional Promicion Ciencia y Tecnologia PICT 1696 to MCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino Adriana Maria, 2000, Geodiversitas, V22, P247; Alonso Paz E, 2002, MUSEOS NACL HIST NAT, V125, P1; Archangelsky A, 1999, AM J BOT, V86, P1200, DOI 10.2307/2656984; Ardolino A., 1987, 10 C GEOL ARG TUC AC CONGRESO GEOLOGICO A, V3, P193; Ardolino AA, 1996, DIRECCION NACL SERVI; Barreda VD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052455; BATTEN D J, 1988, Cretaceous Research, V9, P337, DOI 10.1016/0195-6671(88)90007-9; Batten D.J., 1996, PALYNOLOGY PRINCIPLE, V1, P191; BATTEN D.J., 1996, PALYNOLOGY PRINCIPLE, V1, P205; Batten DJ, 1990, AM ASS STRAT PALYN C, V24; Benson RBJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031838; Blanc-Louvel C., 1984, ILERDA, V45, P83; Bonaparte JF, 1985, NAT GEOG RES, V1, P263; BOYD R, 1992, SEDIMENT GEOL, V80, P139, DOI 10.1016/0037-0738(92)90037-R; Cambon G, 1997, GRANA, V36, P105, DOI 10.1080/00173139709362596; Cattaneo A, 2003, EARTH-SCI REV, V62, P187, DOI 10.1016/S0012-8252(02)00134-4; Chambers PA, 2008, HYDROBIOLOGIA, V595, P9, DOI 10.1007/s10750-007-9154-6; Coiffard C, 2013, TAXON, V62, P141, DOI 10.1002/tax.621012; COLLINSON ME, 1988, PALAEOGEOGR PALAEOCL, V62, P317, DOI 10.1016/0031-0182(88)90060-0; Collinson ME, 2001, POLLEN SPORES SYST A, V44, P119; Cook C.D.K., 1990, AQUATIC PLANT BOOK; Cook CD., 1996, AQUATIC PLANT BOOK; CROW GE, 1993, AQUAT BOT, V44, P229, DOI 10.1016/0304-3770(93)90072-5; Cruickshank Arthur R. I., 1997, Annals of the South African Museum, V105, P207; Cuneo NR, 2013, INT J PLANT SCI, V174, P340, DOI 10.1086/668811; DALRYMPLE RW, 1992, J SEDIMENT PETROL, V62, P1130, DOI 10.1306/D4267A69-2B26-11D7-8648000102C1865D; DETTMANN ME, 1992, CRETACEOUS RES, V13, P207, DOI 10.1016/0195-6671(92)90001-7; Dransfield J., 2008, GENERA PALMARUM THE; Estrada-Ruiz E, 2011, SYST BOT, V36, P337, DOI 10.1600/036364411X569525; FINLAYSON M, 1985, AUST J BOT, V33, P101, DOI 10.1071/BT9850101; Fiori CCL, 2009, AM FERN J, V99, P207, DOI 10.1640/0002-8444-99.3.207; FLYNN KM, 1995, OECOLOGIA, V103, P63, DOI 10.1007/BF00328426; Franzese J, 2003, J S AM EARTH SCI, V16, P81, DOI 10.1016/S0895-9811(03)00020-8; Gallego J, REV PALAEOB IN PRESS; Gandolfo MA, 2004, P NATL ACAD SCI USA, V101, P8056, DOI 10.1073/pnas.0402473101; Gandolfo MA, 2005, REV PALAEOBOT PALYNO, V133, P169, DOI 10.1016/j.revpalbo.2004.09.007; Gandolfo MA, 2014, BOL SOC GEOL MEX, V66, P11, DOI 10.18268/BSGM2014v66n1a2; Gandolfo MA, 2009, INT J PLANT SCI, V170, P419, DOI 10.1086/595290; Gasparini Z, 2001, J S AM EARTH SCI, V14, P51, DOI 10.1016/S0895-9811(01)00012-8; Gasparini Zulma, 2000, Revista Espanola de Paleontologia, V15, P23; Golovneva Lena B., 2000, Acta Palaeobotanica, V40, P139; GRACE JB, 1986, CAN J PLANT SCI, V66, P361, DOI 10.4141/cjps86-051; Gupta KM, 1962, BOT MONOGR, V2, P1; Hayes M.O., 1979, BARIER ISLANDS MEXIC; Hermsen EJ, 2014, PLANT SYST EVOL, V300, P369, DOI 10.1007/s00606-013-0886-7; Heusser CJ, 1996, ARCTIC ALPINE RES, V28, P148, DOI 10.2307/1551754; Hofmann CC, 2002, REV PALAEOBOT PALYNO, V119, P191, DOI 10.1016/S0034-6667(01)00141-5; HORNE JC, 1978, AAPG BULL, V62, P2379; Iglesias A, 2011, BIOL J LINN SOC, V103, P409, DOI 10.1111/j.1095-8312.2011.01657.x; Janauer Georg A., 2001, Journal of Limnology, V60, P33; JOHNSON D. M., 1986, SYSTEMATIC BOT MONOG, V11, P1, DOI DOI 10.2307/25027626; Kielan-Jaworowska Z, 2007, ACTA PALAEONTOL POL, V52, P257; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; Kovach W.L., 1989, PALYNOLOGY, V13, P247277, DOI [10.1080/01916122.1989.9989362, DOI 10.1080/01916122.1989.9989362]; Kramer K.U., 1990, FAMILIES GENERA VASC, P180; Kramer K. U., 1990, FAMILIES GENERA VASC, V1; Krassilov V.A., 1995, PALEONTOL J+, V29, P119; Krassilov VA, 2010, B GEOSCI, V85, P95, DOI 10.3140/bull.geosci.1150; Kvacek J, 2004, REV PALAEOBOT PALYNO, V128, P323, DOI 10.1016/S0034-6667(03)00154-4; KVACEK Z, 1995, AQUAT BOT, V50, P49, DOI 10.1016/0304-3770(94)00442-O; Lacoul P, 2006, ENVIRON REV, V14, P89, DOI 10.1139/a06-001; Lawver DR, 2011, ANN CARNEGIE MUS, V80, P35, DOI 10.2992/007.080.0104; Li Y, 2014, PALAEOGEOGR PALAEOCL, V399, P284, DOI 10.1016/j.palaeo.2014.01.022; Lupia R, 2000, INT J PLANT SCI, V161, P975, DOI 10.1086/317567; MAHABALE TS, 1968, REV PALAEOBOT PALYNO, V7, P285, DOI 10.1016/0034-6667(68)90034-1; MAI DH, 1985, FLORA, V176, P449, DOI 10.1016/S0367-2530(17)30141-X; Malumian N, 2011, BIOL J LINN SOC, V103, P269, DOI 10.1111/j.1095-8312.2011.01649.x; Martin-Closas C., 2003, Geologica Acta, V1, P315; McIver EE, 1993, PALAEONTOGR CAN, V10, P101; Metzgar JS, 2007, INT J PLANT SCI, V168, P1045, DOI 10.1086/519007; Mohr BAR, 2000, INT J PLANT SCI, V161, pS155, DOI 10.1086/317580; Nanez Carolina, 2008, Revista Espanola de Paleontologia, V23, P273; O'Gorman JP, 2013, ALCHERINGA, V37, P259, DOI 10.1080/03115518.2013.745250; O'Gorman JP, 2013, ALCHERINGA, V37, P163, DOI 10.1080/03115518.2013.736788; Pascual Rosendo, 2000, Geodiversitas, V22, P395; PUNT W, 1975, REV PALAEOBOT PALYNO, V19, pNE75, DOI 10.1016/0034-6667(75)90060-3; Rai AK, 2000, SYMBIOSIS, V29, P249; Rai V, 1999, PLANT SOIL, V206, P79, DOI 10.1023/A:1004340005693; Reading H.G., 1996, SEDIMENTARY ENV PROC, V3rd edn, P154; Reinson G E, 1992, FACIES MODELS RESPON, P179; ROTHWELL GW, 1994, AM J BOT, V81, P479, DOI 10.2307/2445498; Rougier GW, 2009, ACTA PALAEONTOL POL, V54, P195, DOI 10.4202/app.2006.0026; SANDERS JE, 1975, GEOL SOC AM BULL, V86, P65, DOI 10.1130/0016-7606(1975)86<65:EOSRAI>2.0.CO;2; Saulich A.H., 2007, SEASONAL DEV AQUATIC; SAUNDERS RMK, 1993, PLANT SYST EVOL, V184, P175, DOI 10.1007/BF00937434; Scasso RA, 2012, CRETACEOUS RES, V36, P37, DOI 10.1016/j.cretres.2012.02.002; Schneider H, 2002, INT J PLANT SCI, V163, P485, DOI 10.1086/340736; Schneller J.J., 1990, FAMILIES GENERA VASC, P57; SCHULTZ ALARICH R., 1949, LILLOA, V17, P139; Schuyler AE, 1984, BARTONIA, V50, P8; Scremin-Dias E, 2003, TROPICAL BIOL CONSER, V1; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; STAMP L. D., 1921, GEOLOGICAL MAGAZINE, V58, P108; Sterli J, 2011, PALAEONTOLOGY, V54, P63, DOI 10.1111/j.1475-4983.2010.01002.x; Stockey RA, 1997, AM J BOT, V84, P355, DOI 10.2307/2446009; Stockey RA, 2007, AM J BOT, V94, P609, DOI 10.3732/ajb.94.4.609; SWIFT DJP, 1968, J GEOL, V76, P444, DOI 10.1086/627342; THIERET JW, 1982, J ARNOLD ARBORETUM, V63, P341; Thieret JW, 1996, HARVARD PAPERS BOT, V8, P27; Thomaz SM, 2008, TROPICAL BIOL CONSER, V4; Tryon A.F., 2012, SPORES PTERIDOPHYTA; Tryon R. M., 1982, FERNS ALLIED PLANTS; Vajda V, 2013, CRETACEOUS RES, V46, P114, DOI 10.1016/j.cretres.2013.08.010; VAN GEEL B., 1996, PALYNOLOGY PRINCIPLE, V1; Guler MV, 2014, AMEGHINIANA, V51, P141, DOI 10.5710/AMGH.15.02.2014.949; Volkheimer W., 2007, REV ESPA NOLA MICROP, V39, P117; Wang H, 2006, INT J PLANT SCI, V167, P385, DOI 10.1086/499502; Wang Xin, 2012, Palaeoworld, V21, P193, DOI 10.1016/j.palwor.2012.10.002; Williamson PS., 1993, FAMILIES GENERA VASC, VII, P470; Yamada T, 2002, INT J PLANT SCI, V163, P715, DOI 10.1086/342036; Zamaloa Maria Del Carmen, 1996, Ameghiniana, V33, P179; Zamaloa MD, 2005, J PALEOLIMNOL, V34, P433, DOI 10.1007/s10933-005-5804-8; Zippi Pierre A., 1998, Micropaleontology (New York), V44, P1, DOI 10.2307/1485998	113	27	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104749	10.1371/journal.pone.0104749	http://dx.doi.org/10.1371/journal.pone.0104749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148081	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600020
J	Dugue, GP; Lorincz, ML; Lottem, E; Audero, E; Matias, S; Correia, PA; Lena, C; Mainen, ZF				Dugue, Guillaume P.; Loerincz, Magor L.; Lottem, Eran; Audero, Enrica; Matias, Sara; Correia, Patricia A.; Lena, Clement; Mainen, Zachary F.			Optogenetic Recruitment of Dorsal Raphe Serotonergic Neurons Acutely Decreases Mechanosensory Responsivity in Behaving Mice	PLOS ONE			English	Article							NOCICEPTIVE RESPONSES; MECHANICAL ALLODYNIA; LATERAL GENICULATE; NEUROPATHIC PAIN; NUCLEUS; MODULATION; GLUTAMATE; RAT; RECEPTORS; MODELS	The inhibition of sensory responsivity is considered a core serotonin function, yet this hypothesis lacks direct support due to methodological obstacles. We adapted an optogenetic approach to induce acute, robust and specific firing of dorsal raphe serotonergic neurons. In vitro, the responsiveness of individual dorsal raphe serotonergic neurons to trains of light pulses varied with frequency and intensity as well as between cells, and the photostimulation protocol was therefore adjusted to maximize their overall output rate. In vivo, the photoactivation of dorsal raphe serotonergic neurons gave rise to a prominent light-evoked field response that displayed some sensitivity to a 5-HT1A agonist, consistent with autoreceptor inhibition of raphe neurons. In behaving mice, the photostimulation of dorsal raphe serotonergic neurons produced a rapid and reversible decrease in the animals' responses to plantar stimulation, providing a new level of evidence that serotonin gates sensory-driven responses.	[Dugue, Guillaume P.; Loerincz, Magor L.; Lottem, Eran; Audero, Enrica; Matias, Sara; Correia, Patricia A.; Mainen, Zachary F.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Dugue, Guillaume P.; Lena, Clement] CNRS, INSERM, Inst Biol Ecole Normale Super, UMR8197,U1024, Paris, France; [Loerincz, Magor L.] Univ Szeged, Dept Physiol, MTA SZTE Res Grp Cort Microcircuits, Szeged, Hungary	Fundacao Champalimaud; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Szeged University	Dugue, GP (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.	gdugue@biologie.ens.fr; zmainen@neuro.fchampalimaud.org	Lőrincz, Magor L/C-7746-2012; Matias, Sara/GSE-3006-2022; Léna, Clément/T-8458-2018; Léna, Clément/P-6929-2019; , clement/ADN-8076-2022; Léna, Clément/ABE-4862-2021	Lőrincz, Magor L/0000-0001-5240-1904; Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Correia, Patricia/0000-0002-2136-4757; Matias, Sara/0000-0002-7432-6754; Mainen, Zachary/0000-0001-7913-9109	European Research Council [250334]; Intra-European Marie Curie postdoctoral fellowship [220098]; Human Frontier Science Programme postdoctoral fellowship [LT001009/2010L, LT000881/2011L]; Agence Nationale pour la Recherche grant [11-BSV4-028]	European Research Council(European Research Council (ERC)European Commission); Intra-European Marie Curie postdoctoral fellowship; Human Frontier Science Programme postdoctoral fellowship; Agence Nationale pour la Recherche grant(French National Research Agency (ANR))	This work was supported by an European Research Council grant to ZM (No 250334), an Intra-European Marie Curie postdoctoral fellowship to GD (No 220098), a Human Frontier Science Programme postdoctoral fellowship to MLL (No LT001009/2010L), a Human Frontier Science Programme postdoctoral fellowship to EL (No LT000881/2011L) and an Agence Nationale pour la Recherche grant to CL (Sensocode 11-BSV4-028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; ANDERSEN E, 1982, INT J NEUROSCI, V17, P151, DOI 10.3109/00207458208985917; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Bromberg-Martin ES, 2010, J NEUROSCI, V30, P6262, DOI 10.1523/JNEUROSCI.0015-10.2010; Challis C, 2013, J NEUROSCI, V33, P13978, DOI 10.1523/JNEUROSCI.2383-13.2013; Chen CF, 2003, J NEUROSCI, V23, P3130; Choi IS, 2012, BRIT J PHARMACOL, V167, P356, DOI 10.1111/j.1476-5381.2012.01964.x; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; DAVIS M, 1980, SCIENCE, V209, P521, DOI 10.1126/science.7394520; FARDIN V, 1984, BRAIN RES, V306, P105, DOI 10.1016/0006-8993(84)90360-3; FORNAL CA, 1994, J PHARMACOL EXP THER, V270, P1345; Fornal CA, 1996, BRAIN RES, V716, P123, DOI 10.1016/0006-8993(96)00006-6; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gras C, 2002, J NEUROSCI, V22, P5442; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Ikeda T, 2009, NEUROSCI RES, V63, P42, DOI 10.1016/j.neures.2008.10.002; Ito H, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-59; IWAYAMA K, 1989, Neurological Research, V11, P105; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Katsuyama S, 2013, BIOMED RES-TOKYO, V34, P105, DOI 10.2220/biomedres.34.105; KAYAMA Y, 1989, BRAIN RES, V489, P1, DOI 10.1016/0006-8993(89)90002-4; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Miyazaki K, 2011, J NEUROSCI, V31, P469, DOI 10.1523/JNEUROSCI.3714-10.2011; Ohmura Y, 2014, INT J NEUROPSYCHOPH, P1; Petzold GC, 2009, NAT NEUROSCI, V12, P784, DOI 10.1038/nn.2335; QIAO JT, 1988, PAIN, V34, P65, DOI 10.1016/0304-3959(88)90183-2; REYESVAZQUEZ C, 1989, BRAIN RES BULL, V23, P405, DOI 10.1016/0361-9230(89)90181-0; Riad M, 2001, J NEUROSCI, V21, P8378, DOI 10.1523/JNEUROSCI.21-21-08378.2001; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Rothermel M, 2013, J NEUROSCI, V33, P15195, DOI 10.1523/JNEUROSCI.1618-13.2013; Trudeau LE, 2004, J PSYCHIATR NEUROSCI, V29, P296; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; WALLETSCHEK H, 1982, PHYSIOL BEHAV, V28, P697, DOI 10.1016/0031-9384(82)90054-3; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; WATERHOUSE BD, 1990, BRAIN RES, V514, P276, DOI 10.1016/0006-8993(90)91422-D; Xu WJ, 2013, NEUROSCIENCE, V238, P252, DOI 10.1016/j.neuroscience.2013.02.036; Yokogawa T, 2012, J NEUROSCI, V32, P15205, DOI 10.1523/JNEUROSCI.1019-12.2012; YOSHIDA M, 1984, BRAIN RES, V290, P95, DOI 10.1016/0006-8993(84)90739-X	41	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105941	10.1371/journal.pone.0105941	http://dx.doi.org/10.1371/journal.pone.0105941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148042	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600097
J	Liu, ZX; Zhao, ZW				Liu, Zhenxing; Zhao, Zhangwu			Effects of Light Interruption on Sleep and Viability of Drosophila melanogaster	PLOS ONE			English	Article							DIFFERENTIAL ROLES; CIRCADIAN CLOCK; CRYPTOCHROME; PHOTORECEPTOR; DISORDERS; GENETICS; MUTATION; CRY	Light is a very important regulator of the daily sleep rhythm. Here, we investigate the influence of nocturnal light stimulation on Drosophila sleep. Results showed that total daytime sleep was reduced due to a decrease in daytime sleep episode duration caused by discontinuous light stimulation, but sleep was not strongly impacted at nighttime although the discontinuous light stimulation occurred during the scotophase. During a subsequent recovery period without light interruption, the sleep quality of nighttime sleep was improved and of daytime sleep reduced, indicating flies have a persistent response to nocturnal light stimulation. Further studies showed that the discontinuous light stimulation damped the daily rhythm of a circadian light-sensitive protein cryptochrome both at the mRNA and protein levels, which subsequently caused disappearance of circadian rhythm of the core oscillator timeless and decrease of TIMLESS protein at nighttime. These data indicate that the nocturnal light interruption plays an important role in sleep through core proteins CRYTOCHROME and TIMLESS, Moreover, interruption of sleep further impacted reproduction and viability.	[Liu, Zhenxing; Zhao, Zhangwu] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China	China Agricultural University	Zhao, ZW (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	zhaozw@cau.edu.cn	Liu, Zhenxing/U-2062-2019; Liu, Zhenxing/HCH-6877-2022; liu, zhenxing/GWC-9542-2022	liu, zhenxing/0000-0001-8236-1931	National Basic Research Program from Ministry of Science and Technology of the People's Republic of China ("973" Program) [2012CB114100]; National Natural Science Foundation of China [31272371]	National Basic Research Program from Ministry of Science and Technology of the People's Republic of China ("973" Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program from Ministry of Science and Technology of the People's Republic of China ("973" Program Grant number 2012CB114100) and the National Natural Science Foundation of China (Grant number 31272371) to Z. Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; ANGUS J, 1974, BEHAV GENET, V4, P317, DOI 10.1007/BF01066153; Antoch MP, 2008, CELL CYCLE, V7, P1197, DOI 10.4161/cc.7.9.5886; Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Benguria A, 1996, J BIOTECHNOL, V47, P191, DOI 10.1016/0168-1656(96)01407-1; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Busza J, 2004, AIDS CARE, V16, P507, DOI 10.1080/09540120410001683457; Catterson JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012062; Caylak E, 2009, AM J MED GENET A, V149A, P2612, DOI 10.1002/ajmg.a.33087; Cermakian N, 2003, BRAIN RES REV, V42, P204, DOI 10.1016/S0165-0173(03)00171-1; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Helfand SL, 2003, ANNU REV GENET, V37, P329, DOI 10.1146/annurev.genet.37.040103.095211; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Klarsfeld A, 1998, J BIOL RHYTHM, V13, P471, DOI 10.1177/074873098129000309; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kumar S, 2012, GENE DEV, V26, P1224, DOI 10.1101/gad.186338.111; LEBOURG E, 1992, GERONTOLOGY, V38, P65; Nishinokubi Izumi, 2006, J Circadian Rhythms, V4, P4, DOI 10.1186/1740-3391-4-4; Rakshit K, 2013, AGING CELL, V12, P752, DOI 10.1111/acel.12100; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Sakai T, 2006, J NEUROBIOL, V66, P821, DOI 10.1002/neu.20262; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sloane PD, 2007, J AM GERIATR SOC, V55, P1524, DOI 10.1111/j.1532-5415.2007.01358.x; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Swanson LM, 2011, J SLEEP RES, V20, P487, DOI 10.1111/j.1365-2869.2010.00890.x; Torres G, 1998, SYNAPSE, V29, P148, DOI 10.1002/(SICI)1098-2396(199806)29:2<148::AID-SYN6>3.0.CO;2-7; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323	39	11	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105678	10.1371/journal.pone.0105678	http://dx.doi.org/10.1371/journal.pone.0105678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148297	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600069
J	Towns, AM; Eyi, SM; van Andel, T				Towns, Alexandra M.; Eyi, Sandra Mengue; van Andel, Tinde			Traditional Medicine and Childcare in Western Africa: Mothers' Knowledge, Folk Illnesses, and Patterns of Healthcare-Seeking Behavior	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; SUB-SAHARAN AFRICA; MORTALITY; MALARIA; MANAGEMENT; DIARRHEA	Background: In spite of the strong role of traditional medicine in childcare in the pluralistic healthcare system in Western Africa, little information is known on mothers' domestic plant knowledge. Identifying local perspectives and treatments of children's illnesses, including folk illnesses, is essential to having a comprehensive understanding of how mothers make healthcare treatment decisions. We aimed to identify which infant illnesses Beninese and Gabonese mothers knew to treat with medicinal plants and for which illnesses they sought biomedical care or traditional healers. Methods: We conducted 81 questionnaires with mothers in Benin and Gabon and made 800 botanical specimens of cited medicinal plants. We calculated the number of species cited per illness and the proportion of participants knowledgeable on at least one herbal remedy per illness. Using qualitative data, we described folk illnesses in each country and summarized responses on preferences for each of the three healthcare options. Results: Participants from both countries were most knowledgeable on plants to treat respiratory illnesses, malaria, diarrhea, and intestinal ailments. Mothers also frequently mentioned the use of plants to encourage children to walk early, monitor the closure of fontanels, and apply herbal enemas. Major folk illnesses were atita and ka in Benin and la rate and fesses rouges in Gabon. Traditional healers were reported to have specialized knowledge of cultural bound illnesses. Malaria was frequently cited as an illness for which mothers would directly seek biomedical treatment. Conclusion: Mothers largely saw the three systems as complementary, seamlessly switching between different healing options until a remedy was found. Folk illnesses were found to give insight into local treatments and may reveal important neglected diseases. Due to high reported levels of knowledge on treating top statistical causes of infant mortality and folk illnesses, mothers' medicinal plant knowledge should be included in the analysis of healthcare-seeking behavior for childcare.	[Towns, Alexandra M.; van Andel, Tinde] Leiden Univ, Naturalis Biodivers Ctr, Leiden, Netherlands; [Eyi, Sandra Mengue] Ctr Natl Rech Sci & Technol, Libreville, Gabon	Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center	Towns, AM (corresponding author), Leiden Univ, Naturalis Biodivers Ctr, Leiden, Netherlands.	alexandra.towns@naturalis.nl		Towns, Alexandra/0000-0002-1886-9447	Netherlands Organization for Scientific Research (NWO) [864.09.00]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was funded by the Netherlands Organization for Scientific Research (NWO), Vidi grant nr. 864.09.00 (http://www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi SS, 2013, ACTA TROP, V127, P46, DOI 10.1016/j.actatropica.2013.03.010; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bland RM, 2004, TROP MED INT HEALTH, V9, P118, DOI 10.1046/j.1365-3156.2003.01148.x; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; DEZOYSA I, 1984, SOC SCI MED, V19, P727, DOI 10.1016/0277-9536(84)90245-4; Etkin NL, 1998, CONTEXT MED DEV COUN, P299; Friend-du Preez N, 2013, SOC SCI MED, V92, P43, DOI 10.1016/j.socscimed.2013.05.014; Geissler PW, 2002, J ETHNOPHARMACOL, V83, P39, DOI 10.1016/S0378-8741(02)00191-5; Gottlieb A, 2004, AFTERLIFE IS WE COME, P1; GREEN EC, 1985, SOC SCI MED, V20, P277, DOI 10.1016/0277-9536(85)90242-4; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Helman CG, 2007, CULTURE HLTH ILLNESS, P266; Kay M A, 1993, Med Anthropol, V15, P137; Kiesler J, 2003, AM FAM PHYSICIAN, V67, P2547; Langwick SA, 2008, AM ETHNOL, V35, P428, DOI 10.1111/j.1548-1425.2008.00044.x; Makani J, 2007, ANN TROP MED PARASIT, V101, P3, DOI 10.1179/136485907X154638; Martin, 2004, ETHNOBOTANY METHODS; Mathez-Stiefel SL, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-26; McDade TW, 2007, P NATL ACAD SCI USA, V104, P6134, DOI 10.1073/pnas.0609123104; Meier ER, 2012, DRUGS, V72, P895, DOI 10.2165/11632890-000000000-00000; Miller EM, 2011, SOC SCI MED, V73, P1266, DOI 10.1016/j.socscimed.2011.07.009; Mogensen HO, 2000, CULT MED PSYCHIAT, V24, P331, DOI 10.1023/A:1005615619241; Montgomery CM, 2006, TROP MED INT HEALTH, V11, P1661, DOI 10.1111/j.1365-3156.2006.01719.x; Nsungwa-Sabiiti J, 2004, TROP MED INT HEALTH, V9, P1191, DOI 10.1111/j.1365-3156.2004.01319.x; Nyamongo IK, 2002, SOC SCI MED, V54, P377, DOI 10.1016/S0277-9536(01)00036-3; Pearce TO, 1993, KNOWLEDGE POWER PRAC, P150; Pfeiffer Jeanine M., 2005, Journal of Ethnobiology, V25, P240, DOI 10.2993/0278-0771(2005)25[240:ACAEVI]2.0.CO;2; Quinlan MB, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-9; Reyes-Garcia V, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-32; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Ryan GW, 1998, SOC SCI MED, V46, P209, DOI 10.1016/S0277-9536(97)00151-2; Straus L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-556; Tanner S, 2011, SOC SCI MED, V72, P701, DOI 10.1016/j.socscimed.2010.12.012; Towns AM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-113; Vandebroek I, 2013, J ETHNOPHARMACOL, V148, P746, DOI 10.1016/j.jep.2013.05.039; vanderGeest S, 1997, TROP MED INT HEALTH, V2, P903, DOI 10.1046/j.1365-3156.1997.d01-410.x; World Health Organization, TRAD MED	38	25	25	0	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105972	10.1371/journal.pone.0105972	http://dx.doi.org/10.1371/journal.pone.0105972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LL	25147924	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600102
J	Schroeter, ER; Egerton, VM; Ibiricu, LM; Lacovara, KJ				Schroeter, Elena R.; Egerton, Victoria M.; Ibiricu, Lucio M.; Lacovara, Kenneth J.			Lamniform Shark Teeth from the Late Cretaceous of Southernmost South America (Santa Cruz Province, Argentina)	PLOS ONE			English	Article							CARCHARHINUS-LEUCAS; GEARLE SILTSTONE; ASSEMBLAGE; TAXONOMY; DINOSAUR; BASIN	Here we report multiple lamniform shark teeth recovered from fluvial sediments in the (Campanian-Maastrichtian) Cerro Fortaleza Formation, Santa Cruz Province, Argentina. This small tooth assemblage is compared to various lamniform sharks possessing similar dental morphologies, including Archaeolamna, Cretalamna, Dwardius, Dallasiella, and Cretodus. Although the teeth share numerous morphological features with the genus Archaeolamna, including a developed neck that maintains a relatively consistent width along the base of the crown, the small sample size and incomplete nature of these specimens precludes definitive taxonomic assignment. Regardless, the discovery of selachian teeth unique from those previously described for the region broadens the known diversity of Late Cretaceous South American sharks. Additionally, the discovery of the teeth in fluvial sandstone may indicate a euryhaline paleobiology in the lamniform taxon or taxa represented by this tooth assemblage.	[Schroeter, Elena R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Egerton, Victoria M.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Ibiricu, Lucio M.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Lab Paleontol, Puerto Madryn, Chubut, Argentina; [Lacovara, Kenneth J.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Drexel University; University of Manchester; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Drexel University	Lacovara, KJ (corresponding author), Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA.	lacovara@drexel.edu		Schroeter, Elena/0000-0003-4314-2976; Egerton, Victoria/0000-0002-0739-6533	Betz Fund for Environmental Science, Drexel University; National Science Foundation [DGE 1002809]	Betz Fund for Environmental Science, Drexel University; National Science Foundation(National Science Foundation (NSF))	This work was funded by the Betz Fund for Environmental Science, Drexel University, and a National Science Foundation Graduate Research Fellowship award (DGE 1002809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1972, GEOLOGIA REGIONAL AR; Arbe H.A., 2002, GEOLOG A RECURSOS NA, P103; Arbe H.A., 1984, ACT 9 C GEOL ARG, P124; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Beavan NR, 1999, J PALEONTOL, V73, P494, DOI 10.1017/S0022336000028006; Becker MA, 2000, LETHAIA, V33, P103; Biddle J.P., 1993, Service Geologique de Belgique Professional Paper, V264, P191; Bogan Sergio, 2010, Pap. Avulsos Zool. (São Paulo), V50, P175, DOI 10.1590/S0031-10492010001200001; Cappetta H., 1975, Palaeontographica Abt A, V151, P1; Cappetta H., 1987, CHONDRICHTHYES; CASE G R, 1987, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V197, P1; Case G.R., 1978, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V160, P176; Cook TD, 2011, J VERTEBR PALEONTOL, V31, P8, DOI 10.1080/02724634.2011.539968; Cook TD, 2008, CAN J EARTH SCI, V45, P1185, DOI 10.1139/E08-064; Cumbaa Stephen L., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P139; DAVis J. W., 1890, SCI T ROYAL DUBLIN S, V4, P363; Egerton VM, 2013, GONDWANA RES, V23, P268, DOI 10.1016/j.gr.2012.08.010; Ezcurra MD, 2010, ZOOTAXA, P1; Feruglio E., 1938, Physis Buenos Aires, V12, P293; Feruglio E, 1944, B ACAD NACL CIENCIAS, V37, P3; Herman J., 1977, MEMOIRES SERVIR LESP, V15, P1; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Kennedy WJ, 2008, BULL INST R SC N B-S, V78, P117; Kent B. W., 1994, FOSSIL SHARKS CHESAP; Kraemer P.E., 1997, Revista de la Asociacion Geologica Argentina, V52, P333; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Macellari C., 1989, J S AM EARTH SCI, V2, P223, DOI [DOI 10.1016/0895-9811(89)90031-X, 10.1016/0895-9811(89)90031-X]; Marenssi SA, 2003, Rev. Asoc. Geol. Argent., V58, P403; Novas FE, 2002, ACT 15 C GEOL ARG, V315, P1; O'Gorman JP, 2010, AMEGHINIANA, V47, P447, DOI 10.5710/AMGH.v47i4.3; Riccardi A., 1980, S GEOLOGIA REGIONAL, V2, P1173; Schwimmer DR, 2002, J VERTEBR PALEONTOL, V22, P704, DOI 10.1671/0272-4634(2002)022[0704:RTAAGR]2.0.CO;2; Shimada K, 2002, J MORPHOL, V251, P38, DOI 10.1002/jmor.1073; Shimada K., 2008, FORT HAYS STUDIES, V2, P89; Shimada K, 2007, J VERTEBR PALEONTOL, V27, P584, DOI 10.1671/0272-4634(2007)27[584:SADAOL]2.0.CO;2; SIVERSON M, 1992, PALAEONTOLOGY, V35, P519; Siverson M, 1996, PALAEONTOLOGY, V39, P813; Siverson M, 1999, T ROY SOC EDIN-EARTH, V90, P49, DOI 10.1017/S0263593300002509; Siverson M, 1997, J VERTEBR PALEONTOL, V17, P453, DOI 10.1080/02724634.1997.10010995; Siverson M, ACTA PALAEO IN PRESS; THORSON TB, 1973, PHYSIOL ZOOL, V46, P29, DOI 10.1086/physzool.46.1.30152514; Underwood CJ, 2010, PALAEONTOLOGY, V53, P903, DOI 10.1111/j.1475-4983.2010.00969.x; Varela AN, 2012, SEDIMENT GEOL, V271, P67, DOI 10.1016/j.sedgeo.2012.06.006; Vullo R, 2004, CR PALEVOL, V4, P95; Welton B.J., 1993, COLLECTORS GUIDE FOS; Woodward A. S., 1894, Proceedings of the Geologists' Association, Vxiii, P190; Wosnick N, 2013, COMP BIOCHEM PHYS A, V166, P36, DOI 10.1016/j.cbpa.2013.05.002; [No title captured]	48	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104800	10.1371/journal.pone.0104800	http://dx.doi.org/10.1371/journal.pone.0104800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141301	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200035
J	Chung, RY; Kim, JH; Yip, BH; Wong, SYS; Wong, MCS; Chung, VCH; Griffiths, SM				Chung, Roger Y.; Kim, Jean H.; Yip, Benjamin H.; Wong, Samuel Y. S.; Wong, Martin C. S.; Chung, Vincent C. H.; Griffiths, Sian M.			Alcohol Tax Policy and Related Mortality. An Age-Period-Cohort Analysis of a Rapidly Developed Chinese Population, 1981-2010	PLOS ONE			English	Article							DRINKING BEHAVIOR; CONSUMPTION; PATTERNS; TRENDS; RISK; ADULTS; ONSET	To delineate the temporal dynamics between alcohol tax policy changes and related health outcomes, this study examined the age, period and cohort effects on alcohol-related mortality in relation to changes in government alcohol policies. We used the age-period-cohort modeling to analyze retrospective mortality data over 30 years from 1981 to 2010 in a rapidly developed Chinese population, Hong Kong. Alcohol-related mortality from 1) chronic causes, 2) acute causes, 3) all (chronic+acute) causes and 4) causes 100% attributable to alcohol, as defined according to the Alcohol-Related Disease Impact (ARDI) criteria developed by the US Centers for Disease Control and Prevention, were examined. The findings illustrated the possible effects of alcohol policy changes on adult alcohol-related mortality. The age-standardized mortality trends were generally in decline, with fluctuations that coincided with the timing of the alcohol policy changes. The age-period-cohort analyses demonstrated possible temporal dynamics between alcohol policy changes and alcohol-related mortality through the period effects, and also generational impact of alcohol policy changes through the cohort effects. Based on the illustrated association between the dramatic increase of alcohol imports in the mid-1980s and the increased alcohol-related mortality risk of the generations coming of age of majority at that time, attention should be paid to generations coming of drinking age during the 2007-2008 duty reduction.	[Chung, Roger Y.; Kim, Jean H.; Yip, Benjamin H.; Wong, Samuel Y. S.; Wong, Martin C. S.; Chung, Vincent C. H.; Griffiths, Sian M.] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Yip, BH (corresponding author), Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	benyip@cuhk.edu.hk	Yip, Benjamin/AAC-7845-2019; WONG, Samuel Yeung Shan/D-7311-2013; Wong, Martin/L-4568-2014; Chung, Vincent CH/K-2447-2013; Chung, Roger Y. N./B-7288-2016	Yip, Benjamin/0000-0002-4749-7611; WONG, Samuel Yeung Shan/0000-0003-0934-6385; Wong, Martin/0000-0001-7706-9370; Chung, Vincent CH/0000-0002-5947-4492; /0000-0002-5799-5913				AHMAD O, 2001, 31 GPE WHO; Aristei D, 2008, EMPIR ECON, V35, P29, DOI 10.1007/s00181-007-0142-5; CASE R A, 1956, Br J Prev Soc Med, V10, P172; CASE R A, 1956, Br J Prev Soc Med, V10, P159; CHI I, 1988, J STUD ALCOHOL, V49, P21, DOI 10.15288/jsa.1988.49.21; CHI I, 1989, J STUD ALCOHOL, V50, P15, DOI 10.15288/jsa.1989.50.15; CHOU SP, 1992, BRIT J ADDICT, V87, P1199; Chung RY, 2012, EPIDEMIOL INFECT, V140, P1904, DOI 10.1017/S0950268811002469; Chung RY, 2010, AM J EPIDEMIOL, V171, P345, DOI 10.1093/aje/kwp378; Chung VCH, 2013, ALCOHOL ALCOHOLISM, V48, P720, DOI 10.1093/alcalc/agt065; COLLINS JJ, 1982, DEMOGRAPHY, V19, P409, DOI 10.2307/2060979; Corrao G, 1997, INT J EPIDEMIOL, V26, P100, DOI 10.1093/ije/26.1.100; Department of Health, 2011, ACT PLAN RED ALC REL; Donnan SPB, 1988, HONG KONG MED J, V41, P16; Duff Cameron, 2011, J Ethn Subst Abuse, V10, P2, DOI 10.1080/15332640.2011.547791; Fienberg S.E., 1985, COHORT ANAL SOCIAL R, DOI DOI 10.1007/978-1-4613-8536-3; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Hong Kong Government Financial Secretary, 2008, HONG KONG BUDG REP 2; Hong Kong Government Financial Secretary, 2001, HONG KONG BUDG REP 2; Hong Kong Government Financial Secretary, 2007, HONG KONG BUDG REP 2; Hong Kong Transport Department, FIGUREA1 TREND ROAD; Kerr WC, 2004, ADDICTION, V99, P1111, DOI 10.1111/j.1360-0443.2004.00820.x; Kerr WC, 2013, ADDICTION, V108, P1038, DOI 10.1111/j.1360-0443.2012.04055.x; Kim JH, 2008, ALCOHOL ALCOHOLISM, V43, P360, DOI 10.1093/alcalc/agm181; Kim JH, 2010, ACCIDENT ANAL PREV, V42, P994, DOI 10.1016/j.aap.2009.12.001; Kohn C, 2014, TRAFFIC INJ PREV, V15, P119, DOI 10.1080/15389588.2013.803221; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Levenson MR, 1998, J STUD ALCOHOL, V59, P712, DOI 10.15288/jsa.1998.59.712; Mannheim K., 1952, ESSAYS SOCIOL KNOW; Mason W., 1985, COHORT ANAL SOCIAL R, P1, DOI DOI 10.1007/978-1-4613-8536-3; Moore AA, 2005, AM J PUBLIC HEALTH, V95, P458, DOI 10.2105/AJPH.2003.019471; Pitkanen T, 2005, ADDICTION, V100, P652, DOI 10.1111/j.1360-0443.2005.01053.x; Pun VC, 2013, J EPIDEMIOL COMMUN H, V67, P514, DOI 10.1136/jech-2012-201859; Ramstedt M, 2001, ADDICTION, V96, pS19; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rosen M, 2006, ADDICTION, V101, P835, DOI 10.1111/j.1360-0443.2006.01421.x; Shahpar C, 1999, AM J EPIDEMIOL, V150, P1213; Siliquini R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-526; Tarone RE, 1996, AM J EPIDEMIOL, V143, P85; Treasury Branch Financial Services and the Treasury Bureau Government of the Hong Kong Special Administrative Region, 2004, DUT ALC BEV CONS DOC; Tse G. M. K., 2000, Hong Kong Medical Journal, V6, P190; US Centers for Disease Control and Prevention, ALC PUBL HLTH ALC RE; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Wong IOL, 2010, J EPIDEMIOL COMMUN H, V64, P596, DOI 10.1136/jech.2008.080788; Young B, 1996, HK J PAEDIAT NEW SER, V1, P207	45	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e99906	10.1371/journal.pone.0099906	http://dx.doi.org/10.1371/journal.pone.0099906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153324	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200002
J	Daigle, RM; Metaxas, A; deYoung, B				Daigle, Remi M.; Metaxas, Anna; deYoung, Brad			Fine-Scale Distribution and Spatial Variability of Benthic Invertebrate Larvae in an Open Coastal Embayment in Nova Scotia, Canada	PLOS ONE			English	Article							SUPPLY-SIDE ECOLOGY; VERTICAL-DISTRIBUTION; PLACOPECTEN-MAGELLANICUS; THERMAL STRATIFICATION; TRANSPORT; DISPERSAL; BEHAVIOR; PATTERNS; AUTOCORRELATION; PHYTOPLANKTON	This study quantified the fine-scale (0.5 km) of variability in the horizontal distributions of benthic invertebrate larvae and related this variability to that in physical and biological variables, such as density, temperature, salinity, fluorescence and current velocity. Larvae were sampled in contiguous 500-m transects along two perpendicular 10-km transects with a 200-mu m plankton ring net (0.75-m diameter) in St. George's Bay, Nova Scotia, Canada, in Aug 2009. Temperature, conductivity, pressure and fluorescence were measured with a CTD cast at each station, and currents were measured with an Acoustic Doppler Current Profiler moored at the intersection of the 2 transects. Gastropod, bivalve and, to a lesser extent, bryozoan larvae had very similar spatial distributions, but the distribution of decapod larvae had a different pattern. These findings suggest that taxonomic groups with functionally similar larvae have similar dispersive properties such as distribution and spatial variability, while the opposite is true for groups with functionally dissimilar larvae. The spatial variability in larval distributions was anisotropic and matched the temporal/spatial variability in the current velocity. We postulate that in a system with no strong oceanographic features, the scale of spatially coherent physical forcing (e.g. tidal periodicity) can regulate the formation or maintenance of larval patches; however, swimming ability may modulate it.	[Daigle, Remi M.; Metaxas, Anna] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [deYoung, Brad] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada	Dalhousie University; Memorial University Newfoundland	Daigle, RM (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.	daigleremi@gmail.com	Daigle, Remi M/H-3160-2019	Daigle, Remi M/0000-0001-8832-4189	NSERC (Natural Sciences and Engineering Research Council of Canada) [222932, 200291]; Strategic Network - Canadian Healthy Oceans Network (CHONe) [290606]; NSERC; Dalhousie University	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Strategic Network - Canadian Healthy Oceans Network (CHONe); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie University	Funding for this study was provided by NSERC (Natural Sciences and Engineering Research Council of Canada) grants to A.M. and B.deY.: Discovery (A.M.: 222932, B.deY.: 200291) and the Strategic Network (290606) - Canadian Healthy Oceans Network (CHONe). Funding to R.D. was through a NSERC CGS M and PGS D, as well as Graduate Scholarships and President Awards from Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; CHIA FS, 1984, CAN J ZOOL, V62, P1205, DOI 10.1139/z84-176; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Daigle RM, 2014, MAR ECOL PROG SER, V503, P139, DOI 10.3354/meps10734; Daigle RM, 2012, J EXP MAR BIOL ECOL, V438, P14, DOI 10.1016/j.jembe.2012.09.004; Daigle RM, 2011, J EXP MAR BIOL ECOL, V409, P89, DOI 10.1016/j.jembe.2011.08.008; DiBacco C, 2001, MAR ECOL PROG SER, V217, P191, DOI 10.3354/meps217191; DiBacco C, 2011, MAR ECOL PROG SER, V433, P131, DOI 10.3354/meps09186; Epstein AW, 2001, DEEP-SEA RES PT II, V48, P395, DOI 10.1016/S0967-0645(00)00086-2; Folt CL, 1999, TRENDS ECOL EVOL, V14, P300, DOI 10.1016/S0169-5347(99)01616-X; Forward RB, 2003, B MAR SCI, V72, P347; Fuchs HL, 2007, LIMNOL OCEANOGR, V52, P1156, DOI 10.4319/lo.2007.52.3.1156; Fujimura AG, 2014, LIMNOL OCEANOGR, V59, P1434, DOI 10.4319/lo.2014.59.4.1434; Gallager SM, 1996, MAR BIOL, V124, P679, DOI 10.1007/BF00351049; GROSBERG RK, 1992, TRENDS ECOL EVOL, V7, P130, DOI 10.1016/0169-5347(92)90148-5; Higgins FA, 2012, J THERM BIOL, V37, P83, DOI 10.1016/j.jtherbio.2011.11.004; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; JILLETT J B, 1976, New Zealand Journal of Marine and Freshwater Research, V10, P543; Legendre P., 2012, NUMERICAL ECOLOGY; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lloyd MJ, 2012, MAR ECOL PROG SER, V469, P37, DOI 10.3354/meps09983; MACKAS DL, 1984, LIMNOL OCEANOGR, V29, P451, DOI 10.4319/lo.1984.29.3.0451; Manuel JL, 1997, J PLANKTON RES, V19, P1929, DOI 10.1093/plankt/19.12.1929; Martin AP, 2003, PROG OCEANOGR, V57, P125, DOI 10.1016/S0079-6611(03)00085-5; Menge BA, 2009, ECOL MONOGR, V79, P379, DOI 10.1890/08-2086.1; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Miller SH, 2013, MAR ECOL PROG SER, V476, P301, DOI 10.3354/meps10150; Oksanen J., 2008, COMMUNITY ECOLOGY PA, V190, P254, DOI 10.4135/9781412971874.n145; Okubo A, 1977, SPATIAL PATTERN PLAN, P21; OKUBO A, 2001, DIFFUSION ECOLOGICAL; OLSON RR, 1985, ECOLOGY, V66, P30, DOI 10.2307/1941304; OMORI M, 1982, MAR BIOL, V72, P193, DOI 10.1007/BF00396920; PINEDA J, 1991, SCIENCE, V253, P548, DOI 10.1126/science.253.5019.548; Poulin E, 2002, LIMNOL OCEANOGR, V47, P1248, DOI 10.4319/lo.2002.47.4.1248; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ryland JS, 1977, BIOL BRYOZOANS, P441; SHANKS AL, 1995, J EXP MAR BIOL ECOL, V186, P1, DOI 10.1016/0022-0981(94)00144-3; Shanks AL, 2005, MAR ECOL PROG SER, V302, P1, DOI 10.3354/meps302001; Shanks AL, 2002, J PLANKTON RES, V24, P391, DOI 10.1093/plankt/24.4.391; Shanks AL, 2000, LIMNOL OCEANOGR; Shanks AL, 2009, BIOL BULL-US, V216, P373; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Steele JH, 1976, ECOLOGY SEAS; Tamaki A, 2010, ESTUAR COAST SHELF S, V86, P125, DOI 10.1016/j.ecss.2009.11.005; Tapia FJ, 2007, MAR ECOL PROG SER, V342, P177, DOI 10.3354/meps342177; Team RC, 2012, R LANG ENV STAT COMP; TREMBLAY MJ, 1990, MAR ECOL PROG SER, V61, P1, DOI 10.3354/meps061001; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Vazquez E, 2007, MAR ECOL PROG SER, V338, P119, DOI 10.3354/meps338119; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Young Craig M., 1995, P249; Zar JH, 1999, BIOSTATISTICAL ANAL	52	3	3	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106178	10.1371/journal.pone.0106178	http://dx.doi.org/10.1371/journal.pone.0106178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153075	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200119
J	Morgado, L; Lourenco, S; Londer, YY; Schiffer, M; Pokkuluri, PR; Salgueiro, CA				Morgado, Leonor; Lourenco, Silvia; Londer, Yuri Y.; Schiffer, Marianne; Pokkuluri, P. Raj; Salgueiro, Carlos A.			Dissecting the Functional Role of Key Residues in Triheme Cytochrome PpcA: A Path to Rational Design of G-sulfurreducens Strains with Enhanced Electron Transfer Capabilities	PLOS ONE			English	Article							C-TYPE CYTOCHROME; GEOBACTER-SULFURREDUCENS; THERMODYNAMIC CHARACTERIZATION; C(7); FAMILY; PHYSIOLOGY; REDUCTION; PROTEINS; PROTEOME; CENTERS	PpcA is the most abundant member of a family of five triheme cytochromes c(7) in the bacterium Geobacter sulfurreducens (Gs) and is the most likely carrier of electrons destined for outer surface during respiration on solid metal oxides, a process that requires extracellular electron transfer. This cytochrome has the highest content of lysine residues (24%) among the family, and it was suggested to be involved in e(-)/H+ energy transduction processes. In the present work, we investigated the functional role of lysine residues strategically located in the vicinity of each heme group. Each lysine was replaced by glutamine or glutamic acid to evaluate the effects of a neutral or negatively charged residue in each position. The results showed that replacing Lys(9) (located near heme IV), Lys(18) (near heme I) or Lys(22) (between hemes I and III) has essentially no effect on the redox properties of the heme groups and are probably involved in redox partner recognition. On the other hand, Lys(43) (near heme IV), Lys(52) (between hemes III and IV) and Lys(60) (near heme III) are crucial in the regulation of the functional mechanism of PpcA, namely in the selection of microstates that allow the protein to establish preferential e(-)/H+ transfer pathways. The results showed that the preferred e(-)/H+ transfer pathways are only established when heme III is the last heme to oxidize, a feature reinforced by a higher difference between its reduction potential and that of its predecessor in the order of oxidation. We also showed that K43 and K52 mutants keep the mechanistic features of PpcA by establishing preferential e(-)/H+ transfer pathways at lower reduction potential values than the wild-type protein, a property that can enable rational design of Gs strains with optimized extracellular electron transfer capabilities.	[Morgado, Leonor; Lourenco, Silvia; Salgueiro, Carlos A.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Requimte,CQFB, Caparica, Portugal; [Londer, Yuri Y.; Schiffer, Marianne; Pokkuluri, P. Raj] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	Universidade Nova de Lisboa; United States Department of Energy (DOE); Argonne National Laboratory	Salgueiro, CA (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Requimte,CQFB, Caparica, Portugal.	csalgueiro@fct.unl.pt	Salgueiro, Carlos/A-4522-2013; Morgado, Leonor/D-7387-2013	Salgueiro, Carlos/0000-0003-1136-809X; Morgado, Leonor/0000-0002-3760-5180	Fundacao para a Cieancia e a Tecnologia (FCT), Portugal [PEst-C/EQB/LA0006/2013]; Fundacao para a Cieancia e a Tecnologia [RECI/BBB-BQB/0230/2012]; division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy program [DE-AC02-06CH11357];  [PTDC/BBB-BEP/0753/2012]	Fundacao para a Cieancia e a Tecnologia (FCT), Portugal; Fundacao para a Cieancia e a Tecnologia; division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy program; 	This work was supported by project grant PTDC/BBB-BEP/0753/2012 (to CAS) and the strategic grant PEst-C/EQB/LA0006/2013 (to REQUIMTE Laboratorio Associado) from Fundacao para a Cieancia e a Tecnologia (FCT), Portugal. The NMR spectrometers are part of The National NMR Facility, supported by Fundacao para a Cieancia e a Tecnologia (RECI/BBB-BQB/0230/2012). PRP is partially supported by the division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy program under contract no. DE-AC02-06CH11357 (URL:http://www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-109; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Dantas JM, 2012, J BIOL INORG CHEM, V17, P11, DOI 10.1007/s00775-011-0821-8; Ding YHR, 2006, BBA-PROTEINS PROTEOM, V1764, P1198, DOI 10.1016/j.bbapap.2006.04.017; Ding YHR, 2008, BBA-PROTEINS PROTEOM, V1784, P1935, DOI 10.1016/j.bbapap.2008.06.011; Goddard T., 2007, SPARKY 3 114; Lloyd JR, 2003, BIOCHEM J, V369, P153, DOI 10.1042/BJ20020597; Londer YY, 2002, BBA-BIOENERGETICS, V1554, P202, DOI 10.1016/S0005-2728(02)00244-X; Louro RO, 2004, FEBS LETT, V576, P77, DOI 10.1016/j.febslet.2004.08.066; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Morgado L, 2008, BBA-BIOENERGETICS, V1777, P1157, DOI 10.1016/j.bbabio.2008.04.043; Morgado L, 2007, BIOCHEM BIOPH RES CO, V360, P194, DOI 10.1016/j.bbrc.2007.06.026; Morgado L, 2013, BIOSCIENCE REP, V33, P11, DOI 10.1042/BSR20120086; Morgado L, 2012, BIOINORG CHEM APPL, V2012, DOI 10.1155/2012/298739; Morgado L, 2012, BIOCHEM J, V441, P179, DOI 10.1042/BJ20111103; Morgado L, 2011, BIOMOL NMR ASSIGN, V5, P113, DOI 10.1007/s12104-010-9280-3; Morgado L, 2010, BIOPHYS J, V99, P293, DOI 10.1016/j.bpj.2010.04.017; Moss G P, 1988, Eur J Biochem, V178, P277, DOI 10.1111/j.1432-1033.1988.tb14453.x; Pessanha M, 2004, BIOCHEMISTRY-US, V43, P9909, DOI 10.1021/bi0492859; Pessanha M, 2006, BIOCHEMISTRY-US, V45, P13910, DOI 10.1021/bi061394v; Pokkuluri PR, 2010, BBA-BIOENERGETICS, V1797, P222, DOI 10.1016/j.bbabio.2009.10.007; Pokkuluri PR, 2004, BIOCHEMISTRY-US, V43, P849, DOI 10.1021/bi0301439; SALGUEIRO CA, 1992, FEBS LETT, V314, P155, DOI 10.1016/0014-5793(92)80963-H; SANTOS H, 1984, EUR J BIOCHEM, V141, P283, DOI 10.1111/j.1432-1033.1984.tb08190.x; Shelobolina ES, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-16; Speers AM, 2012, APPL ENVIRON MICROB, V78, P437, DOI 10.1128/AEM.06782-11; Turner DL, 1996, EUR J BIOCHEM, V241, P723, DOI 10.1111/j.1432-1033.1996.00723.x; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105566	10.1371/journal.pone.0105566	http://dx.doi.org/10.1371/journal.pone.0105566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153891	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200061
J	Stormo, C; Kringen, MK; Lyle, R; Olstad, OK; Sachse, D; Berg, JP; Piehler, AP				Stormo, Camilla; Kringen, Marianne K.; Lyle, Robert; Olstad, Ole Kristoffer; Sachse, Daniel; Berg, Jens P.; Piehler, Armin P.			RNA-Sequencing Analysis of HepG2 Cells Treated with Atorvastatin	PLOS ONE			English	Article							RANDOMIZED CONTROLLED TRIAL; STATIN-INDUCED MYOPATHY; GENE-EXPRESSION; DIFFERENTIAL GENE; C2C12 MYOTUBES; SEQ; CHOLESTEROL; SIMVASTATIN; MICROARRAY; QUANTIFICATION	The cholesterol-lowering drug atorvastatin is among the most prescribed drug in the world. Alternative splicing in a number of genes has been reported to be associated with variable statin response. RNA-seq has proven to be a powerful technique for genome-wide splice variant analysis. In the present study, we sought to investigate atorvastatin responsive splice variants in HepG2 cells using RNA-seq analysis to identify novel candidate genes implicated in cholesterol homeostasis and in the statin response. HepG2 cells were treated with 10 mu M atorvastatin for 24 hours. RNA-seq and exon array analyses were performed. The validation of selected genes was performed using Taqman gene expression assays. RNA-seq analysis identified 121 genes and 98 specific splice variants, of which four were minor splice variants to be differentially expressed, 11 were genes with potential changes in their splicing patterns (SYCP3, ZNF195, ZNF674, MYD88, WHSC1, KIF16B, ZNF92, AGER, FCHO1, SLC6A12 and AKAP9), and one was a gene (RAP1GAP) with differential promoter usage. The IL21R transcript was detected to be differentially expressed via RNA-seq and RT-qPCR, but not in the exon array. In conclusion, several novel candidate genes that are affected by atorvastatin treatment were identified in this study. Further studies are needed to determine the biological significance of the atorvastatin responsive splice variants that have been uniquely identified using RNA-seq.	[Stormo, Camilla; Olstad, Ole Kristoffer; Berg, Jens P.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Kringen, Marianne K.] Oslo Univ Hosp, Dept Pharmacol, Oslo, Norway; [Lyle, Robert] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Lyle, Robert] Univ Oslo, Oslo, Norway; [Sachse, Daniel; Berg, Jens P.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Piehler, Armin P.] Furst Med Lab, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Stormo, C (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.	camilla.stormo@medisin.uio.no	Berg, Jens P/G-1455-2012	Berg, Jens P/0000-0003-0157-5888; Sachse, Daniel/0000-0002-3121-1236	Division of Diagnostics and Intervention, Oslo University Hospital, Norway; Blix Family Foundation; Sigrid Wolmar Fund for Heart and Lung Diseases; Research Council of Norway; Southeastern Regional Health Authorities	Division of Diagnostics and Intervention, Oslo University Hospital, Norway; Blix Family Foundation; Sigrid Wolmar Fund for Heart and Lung Diseases; Research Council of Norway(Research Council of Norway); Southeastern Regional Health Authorities	This work was funded by the Division of Diagnostics and Intervention, Oslo University Hospital, Norway and by grants from The Blix Family Foundation and Sigrid Wolmar Fund for Heart and Lung Diseases. The sequencing service was provided by the Norwegian Sequencing Centre (www.sequencing.uio.no) a national technology platform supported by the Research Council of Norway and the Southeastern Regional Health Authorities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerma M, 2008, BLOOD COAGUL FIBRIN, V19, P709, DOI 10.1097/MBC.0b013e32830b2891; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao Y, 2012, INT J MOL MED, V30, P765, DOI 10.3892/ijmm.2012.1054; Gelissen IC, 2012, PHARMACOGENOMICS, V13, P1223, DOI [10.2217/PGS.12.107, 10.2217/pgs.12.107]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerber R, 2004, ANAL BIOCHEM, V329, P28, DOI 10.1016/j.ab.2004.03.023; Kohro T, 2009, J ATHEROSCLER THROMB, V16, P30, DOI 10.5551/jat.E812; Kulseth MA, 2010, J HUM GENET, V55, P676, DOI 10.1038/jhg.2010.87; Leszczynska A, 2011, ACTA BIOCHIM POL, V58, P635; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Maeda A, 2010, ATHEROSCLEROSIS, V208, P112, DOI 10.1016/j.atherosclerosis.2009.07.033; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Medina MW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003058; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; Medina MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019420; Morikawa S, 2005, J ATHEROSCLER THROMB, V12, P121, DOI 10.5551/jat.12.121; Morikawa Shigeru, 2004, J Atheroscler Thromb, V11, P62; Mullen PJ, 2010, BIOCHEM PHARMACOL, V79, P1200, DOI 10.1016/j.bcp.2009.12.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollack JR, 2009, METHODS MOL BIOL, V556, P1, DOI 10.1007/978-1-60327-192-9_1; R Core Team, 2012, R LANG ENV STAT COMP; Raghavachari N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-28; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Skottheim IB, 2008, EUR J PHARM SCI, V33, P317, DOI 10.1016/j.ejps.2007.12.009; Stormo C, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-29; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2011, BIOMED PHARMACOTHER, V65, P118, DOI 10.1016/j.biopha.2010.12.005; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yu JG, 2009, J ATHEROSCLER THROMB, V16, P21, DOI 10.5551/jat.E551; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124	41	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105836	10.1371/journal.pone.0105836	http://dx.doi.org/10.1371/journal.pone.0105836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153832	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200085
J	Wei, P; Xu, LD; Li, CD; Sun, FD; Chen, L; Tan, TW; Luo, SZ				Wei, Peng; Xu, Lida; Li, Cheng-Dong; Sun, Fu-De; Chen, Long; Tan, Tianwei; Luo, Shi-Zhong			Molecular Dynamic Simulation of the Self-Assembly of DAP12-NKG2C Activating Immunoreceptor Complex	PLOS ONE			English	Article							HELIX-HELIX INTERACTIONS; COARSE-GRAINED MODEL; FORCE-FIELD; MEMBRANE-PROTEINS; IMMUNE RECEPTORS; CELL RECEPTORS; DAP12; ASSOCIATION; NKG2-C; DOMAIN	The DAP12-NKG2C activating immunoreceptor complex is one of the multisubunit transmembrane protein complexes in which ligand-binding receptor chains assemble with dimeric signal-transducing modules through non-covalent associations in their transmembrane (TM) domains. In this work, both coarse grained and atomistic molecular dynamic simulation methods were applied to investigate the self-assembly dynamics of the transmembrane domains of the DAP12-NKG2C activating immunoreceptor complex. Through simulating the dynamics of DAP12-NKG2C TM heterotrimer and point mutations, we demonstrated that a five-polar-residue motif including: 2 Asps and 2 Thrs in DAP12 dimer, as well as 1 Lys in NKG2C TM plays an important role in the assembly structure of the DAP12-NKG2C TM heterotrimer. Furthermore, we provided clear evidences to exclude the possibility that another NKG2C could stably associate with the DAP12-NKG2C heterotrimer. Based on the simulation results, we proposed a revised model for the self-assembly of DAP12-NKG2C activating immunoreceptor complex, along with a plausible explanation for the association of only one NKG2C with a DAP12 dimer.	[Wei, Peng; Xu, Lida; Li, Cheng-Dong; Sun, Fu-De; Chen, Long; Tan, Tianwei; Luo, Shi-Zhong] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China	Beijing University of Chemical Technology	Luo, SZ (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing 100029, Peoples R China.	luosz@mail.buct.edu.cn	Chen, Long/AAM-9688-2021; xu, li/GNH-3667-2022		National Basic Research Program of China (973 program) [2013CB910700]; National Natural Science Foundation of China [21002007, 21372026]; Beijing NOVA Programme [Z131102000413010]; CHEMCLOUDCOMPUTING	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVA Programme(Beijing Municipal Science & Technology Commission); CHEMCLOUDCOMPUTING	This work was supported by the National Basic Research Program of China (973 program) (2013CB910700), the National Natural Science Foundation of China (Nos. 21002007, and 21372026), and Beijing NOVA Programme (Z131102000413010). This work is partly supported by CHEMCLOUDCOMPUTING. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Braun R, 2004, BIOPHYS J, V87, P754, DOI 10.1529/biophysj.104.040279; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Cantoni C, 1998, EUR J IMMUNOL, V28, P327, DOI 10.1002/(SICI)1521-4141(199801)28:01<327::AID-IMMU327>3.0.CO;2-O; Cheng X, 2012, BIOPHYS J, V102, pL27, DOI 10.1016/j.bpj.2012.03.002; Chng CP, 2011, PROTEINS, V79, P2203, DOI 10.1002/prot.23044; Cuthbertson JM, 2006, BIOCHEMISTRY-US, V45, P14298, DOI 10.1021/bi0610911; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Drolle E, 2013, BBA-BIOMEMBRANES, V1828, P2247, DOI 10.1016/j.bbamem.2013.05.015; Feng JW, 2006, PLOS BIOL, V4, P768, DOI 10.1371/journal.pbio.0040142; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holdbrook DA, 2013, BBA-BIOMEMBRANES, V1828, P715, DOI 10.1016/j.bbamem.2012.09.002; Houchins JP, 1997, J IMMUNOL, V158, P3603; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lazetic S, 1996, J IMMUNOL, V157, P4741; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2010, PHYS CHEM CHEM PHYS, V12, P2254, DOI 10.1039/b915293h; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nielsen SO, 2004, J PHYS-CONDENS MAT, V16, pR481, DOI 10.1088/0953-8984/16/15/R03; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Psachoulia E, 2008, BIOCHEMISTRY-US, V47, P10503, DOI 10.1021/bi800678t; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sharma S, 2013, J AM CHEM SOC, V135, P2188, DOI 10.1021/ja308413e; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Sun H, 2013, J PHYS CHEM B, V117, P4789, DOI 10.1021/jp312375g; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Wee CL, 2010, BIOPHYS J, V98, P1558, DOI 10.1016/j.bpj.2009.12.4321; Wei P, 2013, BIOPHYS J, V104, P1435, DOI 10.1016/j.bpj.2013.01.054	40	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105560	10.1371/journal.pone.0105560	http://dx.doi.org/10.1371/journal.pone.0105560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148259	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600057
J	Bevivino, A; Paganin, P; Bacci, G; Florio, A; Pellicer, MS; Papaleo, MC; Mengoni, A; Ledda, L; Fani, R; Benedetti, A; Dalmastri, C				Bevivino, Annamaria; Paganin, Patrizia; Bacci, Giovanni; Florio, Alessandro; Pellicer, Maite Sampedro; Papaleo, Maria Cristiana; Mengoni, Alessio; Ledda, Luigi; Fani, Renato; Benedetti, Anna; Dalmastri, Claudia			Soil Bacterial Community Response to Differences in Agricultural Management along with Seasonal Changes in a Mediterranean Region	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; MICROBIAL BIOMASS; ORGANIC-CARBON; LAND-USE; BIODIVERSITY HOTSPOTS; DIVERSITY; RATIOS; IDENTIFICATION; RHIZOSPHERE	Land-use change is considered likely to be one of main drivers of biodiversity changes in grassland ecosystems. To gain insight into the impact of land use on the underlying soil bacterial communities, we aimed at determining the effects of agricultural management, along with seasonal variations, on soil bacterial community in a Mediterranean ecosystem where different land-use and plant cover types led to the creation of a soil and vegetation gradient. A set of soils subjected to different anthropogenic impact in a typical Mediterranean landscape, dominated by Quercus suber L., was examined in spring and autumn: a natural cork-oak forest, a pasture, a managed meadow, and two vineyards (ploughed and grass covered). Land uses affected the chemical and structural composition of the most stabilised fractions of soil organic matter and reduced soil C stocks and labile organic matter at both sampling season. A significant effect of land uses on bacterial community structure as well as an interaction effect between land uses and season was revealed by the EP index. Cluster analysis of culture-dependent DGGE patterns showed a different seasonal distribution of soil bacterial populations with subgroups associated to different land uses, in agreement with culture-independent T-RFLP results. Soils subjected to low human inputs (cork-oak forest and pasture) showed a more stable bacterial community than those with high human input (vineyards and managed meadow). Phylogenetic analysis revealed the predominance of Proteobacteria, Actinobacteria, Bacteroidetes, and Firmicutes phyla with differences in class composition across the site, suggesting that the microbial composition changes in response to land uses. Taken altogether, our data suggest that soil bacterial communities were seasonally distinct and exhibited compositional shifts that tracked with changes in land use and soil management. These findings may contribute to future searches for bacterial bio-indicators of soil health and sustainable productivity.	[Bevivino, Annamaria; Paganin, Patrizia; Pellicer, Maite Sampedro; Dalmastri, Claudia] ENEA Italian Natl Agcy New Technol Energy & Susta, Casaccia Res Ctr, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy; [Bacci, Giovanni; Florio, Alessandro; Benedetti, Anna] Consiglio Ric & Sperimentaz Agr, Res Ctr Soil Plant Syst, Rome, Italy; [Bacci, Giovanni; Papaleo, Maria Cristiana; Mengoni, Alessio; Fani, Renato] Univ Florence, Dept Biol, Lab Microbial & Mol Evolut, Florence, Italy; [Ledda, Luigi] Univ Sassari, Dipartimento Agr, I-07100 Sassari, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Florence; University of Sassari	Bevivino, A (corresponding author), ENEA Italian Natl Agcy New Technol Energy & Susta, Casaccia Res Ctr, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy.	annamaria.bevivino@enea.it	Ledda, Luigi/AAY-6332-2021; florio, alessandro/I-6066-2019; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Mengoni, Alessio/G-5336-2013; Bevivino, Annamaria/F-4060-2015; Paganin, Patrizia/AAB-9735-2022; Dalmastri, Claudia/AAD-1627-2021; Ledda, Luigi/E-2649-2012	Mengoni, Alessio/0000-0002-1265-8251; Paganin, Patrizia/0000-0002-8993-6651; Ledda, Luigi/0000-0001-5337-5701; Bevivino, Annamaria/0000-0003-4277-7048; Bacci, Giovanni/0000-0003-4406-7816; Florio, Alessandro/0000-0001-6814-8675	MIUR; MIUR (Research Department of Italian Government) [191]	MIUR(Ministry of Education, Universities and Research (MIUR)); MIUR (Research Department of Italian Government)(Ministry of Education, Universities and Research (MIUR))	This research was funded by MIUR (Integrated Special Fund for Research - FISR) in the frame of the Italian National Project SOILSINK "Climate change and agro-forestry systems, impacts on soil carbon sink and microbial diversity'', and partially supported by MIUR (Research Department of Italian Government) in the framework of the Agreement Program ENEA-CNR (Articolo 2, comma 44, Legge 23.12.2009 n. 191 - Legge Finanziaria 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; ANDERSON TH, 1993, SOIL BIOL BIOCHEM, V25, P393, DOI 10.1016/0038-0717(93)90140-7; [Anonymous], 1999, BIOL WILDLIFE MEDITE; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1, DOI [10.1002/mrd.1080010210, DOI 10.1002/MRD.1080010210]; Bacchetta G., 2004, Fitosociologia (Pavia), V41, P29; Bachetta G., 2009, Fitosociologia (Pavia), V46, P3; BADALUCCO L, 1992, BIOL FERT SOILS, V14, P76, DOI 10.1007/BF00336254; Bagella S., 2011, FITOSOCIOLOGIA, V48, P47; Benedetti A, 2005, SOIL QUALITY, P63; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; CIAVATTA C, 1990, J CHROMATOGR, V509, P141, DOI 10.1016/S0021-9673(01)93248-0; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Council of the European Communities, 1992, OFFICIAL J EUROPEAN, V35, P7, DOI DOI 10.1017/CB09780511610851.039; Council of the European Communities, 2001, OFF J EUR COMMUNIT L, V250, P1; Cremonesi L, 1997, BIOTECHNIQUES, V22, P326, DOI 10.2144/97222rr01; DELEIJ FAAM, 1994, MICROB ECOL, V27, P81, DOI 10.1007/BF00170116; DiCello F, 1997, RES MICROBIOL, V148, P237, DOI 10.1016/S0923-2508(97)85244-8; Dilly O, 1998, BIOL FERT SOILS, V27, P374, DOI 10.1007/s003740050446; Doran JW, 1998, SOIL TILL RES, V49, P3, DOI 10.1016/S0167-1987(98)00150-0; Duineveld BM, 2001, APPL ENVIRON MICROB, V67, P172, DOI 10.1128/AEM.67.1.172-178.2001; Edenborn SL, 2007, SOIL BIOL BIOCHEM, V39, P1570, DOI 10.1016/j.soilbio.2007.01.007; El Fantroussi S, 1999, APPL ENVIRON MICROB, V65, P982; Ellis RJ, 2003, APPL ENVIRON MICROB, V69, P3223, DOI 10.1128/AEM.69.6.3223-3230.2003; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Francaviglia R, 2014, AGR ECOSYST ENVIRON, V183, P86, DOI 10.1016/j.agee.2013.10.026; Francaviglia R, 2012, AGR SYST, V112, P48, DOI 10.1016/j.agsy.2012.07.001; Franzluebbers AJ, 2000, SOIL BIOL BIOCHEM, V32, P469, DOI 10.1016/S0038-0717(99)00176-5; Garland J., 1999, P 8 INT S MICROBIAL, P1; Girvan MS, 2005, ENVIRON MICROBIOL, V7, P301, DOI 10.1111/j.1462-2920.2005.00695.x; Goncalves P, 2012, AGROFOREST SYST, V85, P383, DOI 10.1007/s10457-011-9439-7; GRIFONI A, 1995, FEMS MICROBIOL LETT, V127, P85, DOI 10.1111/j.1574-6968.1995.tb07454.x; Haider K., 1992, SOIL BIOCH, V7, P55; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Lagomarsino A, 2011, BIOL FERT SOILS, V47, P283, DOI 10.1007/s00374-010-0530-4; Lai R, 2014, TURK J AGRIC FOR, V38, P62, DOI 10.3906/tar-1303-82; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Mengoni A, 2005, MICROB ECOL, V50, P375, DOI 10.1007/s00248-004-0222-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Oades JM, 1995, DAHL WS ENV, V16, P293; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Pastorelli R, 2011, APPL SOIL ECOL, V49, P46, DOI 10.1016/j.apsoil.2011.07.002; Pinzari F, 1999, J MICROBIOL METH, V36, P21, DOI 10.1016/S0167-7012(99)00007-X; Puddu G, 2012, AGROFOREST SYST, V85, P319, DOI 10.1007/s10457-011-9443-y; Riffaldi R, 1996, BIOL FERT SOILS, V22, P293, DOI 10.1007/BF00334572; Salis L., 2010, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P181; Seddaiu G, 2013, AGR ECOSYST ENVIRON, V167, P1, DOI 10.1016/j.agee.2013.01.002; SEQUI P, 1986, AGROCHIMICA, V30, P175; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Soil Survey Staff, 2006, KEYS SOIL TAXONOMY, V10; Soltani A. A., 2010, Journal of Agricultural Science (Toronto), V2, P106; Springer U KJ, J PLANT NUTR SOIL SC, V64, P1; Stevenson F. J., 1999, Cycles of soil: carbon, nitrogen, phosphorus, sulfur, micronutrients., ppp; STOTZKY G., 1962, Plant and Soil, V16, P1, DOI 10.1007/BF01378154; Tiedje JM, 1999, APPL SOIL ECOL, V13, P109, DOI 10.1016/S0929-1393(99)00026-8; Trabelsi D, 2009, ANN MICROBIOL, V59, P25, DOI 10.1007/BF03175594; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Weon HY, 2008, INT J SYST EVOL MICR, V58, P470, DOI 10.1099/ijs.0.65295-0; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	70	69	73	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105515	10.1371/journal.pone.0105515	http://dx.doi.org/10.1371/journal.pone.0105515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144665	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100077
J	Cai, HY; Jiang, HL; Krumholz, LR; Yang, Z				Cai, Haiyuan; Jiang, Helong; Krumholz, Lee R.; Yang, Zhen			Bacterial Community Composition of Size-Fractioned Aggregates within the Phycosphere of Cyanobacterial Blooms in a Eutrophic Freshwater Lake	PLOS ONE			English	Article							MICROCYSTIS-AERUGINOSA; HETEROTROPHIC BACTERIA; LEGIONELLA-PNEUMOPHILA; MICROBIAL COMMUNITY; TAIHU LAKE; SP-NOV.; DIVERSITY; DYNAMICS; GENUS; RECLASSIFICATION	Bacterial community composition of different sized aggregates within the Microcystis cyanobacterial phycosphere were determined during summer and fall in Lake Taihu, a eutrophic lake in eastern China. Bloom samples taken in August and September represent healthy bloom biomass, whereas samples from October represent decomposing bloom biomass. To improve our understanding of the complex interior structure in the phycosphere, bloom samples were separated into large (>100 mu m), medium (10-100 mu m) and small (0.2-10 mu m) size aggregates. Species richness and library coverage indicated that pyrosequencing recovered a large bacterial diversity. The community of each size aggregate was highly organized, indicating highly specific conditions within the Microcystis phycosphere. While the communities of medium and small-size aggregates clustered together in August and September samples, large-and medium-size aggregate communities in the October sample were grouped together and distinct from small-size aggregate community. Pronounced changes in the absolute and relative percentages of the dominant genus from the two most important phyla Proteobacteria and Bacteroidetes were observed among the various size aggregates. Bacterial species on large and small-size aggregates likely have the ability to degrade high and low molecular weight compounds, respectively. Thus, there exists a spatial differentiation of bacterial taxa within the phycosphere, possibly operating in sequence and synergy to catalyze the turnover of complex organic matters.	[Cai, Haiyuan; Jiang, Helong; Yang, Zhen] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Krumholz, Lee R.] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Oklahoma System; University of Oklahoma - Norman	Jiang, HL (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	hljiang@niglas.ac.cn	Cai, Haiyuan/ABJ-7799-2022; Jiang, Helong/H-2709-2015	Jiang, He-Long/0000-0001-5528-423X; Cai, Haiyuan/0000-0003-4105-2790	National Natural Science Foundation of China [31100021, 51079139]; Innovation program of the Chinese Academy of Science [KZCX2-EW-314]; Natural Science Foundation of Jiangsu Province of China [Bk2011875]; 135 project of Nanjing Institute of Geography and Limnology, CAS [NIGLAS2012135008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation program of the Chinese Academy of Science(Knowledge Innovation Program of the Chinese Academy of Sciences); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); 135 project of Nanjing Institute of Geography and Limnology, CAS	National Natural Science Foundation of China (31100021 and 51079139), Innovation program of the Chinese Academy of Science (KZCX2-EW-314), Natural Science Foundation of Jiangsu Province of China (Bk2011875), and the 135 project of Nanjing Institute of Geography and Limnology, CAS (No. NIGLAS2012135008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach LA, 2001, INT J SYST EVOL MICR, V51, P527, DOI 10.1099/00207713-51-2-527; Asai R, 2001, ANAL LETT, V34, P2521, DOI 10.1081/AL-100107533; BERENDT RF, 1981, INFECT IMMUN, V32, P690, DOI 10.1128/IAI.32.2.690-692.1981; Berg KA, 2011, J WATER HEALTH, V9, P670, DOI 10.2166/wh.2011.206; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; Brune A, 2002, INT J SYST EVOL MICR, V52, P441, DOI 10.1099/00207713-52-2-441; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Cai HY, 2010, APPL ENVIRON MICROB, V76, P2955, DOI 10.1128/AEM.02868-09; CAIOLA MG, 1984, J PHYCOL, V20, P471, DOI 10.1111/j.0022-3646.1984.00471.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carey CC, 2012, WATER RES, V46, P1394, DOI 10.1016/j.watres.2011.12.016; Chin KJ, 2002, APPL ENVIRON MICROB, V68, P2089, DOI 10.1128/AEM.68.4.2089-2092.2002; Coman C, 2011, ANTON LEEUW INT J G, V99, P271, DOI 10.1007/s10482-010-9486-5; Davidov Y, 2004, INT J SYST EVOL MICR, V54, P1439, DOI 10.1099/ijs.0.02978-0; Detkova E N, 2009, Mikrobiologiia, V78, P310; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Eiler A, 2006, FRESHWATER BIOL, V51, P298, DOI 10.1111/j.1365-2427.2005.01493.x; Gallego V, 2005, INT J SYST EVOL MICR, V55, P281, DOI 10.1099/ijs.0.63319-0; GOVORUKHINA NI, 1991, INT J SYST BACTERIOL, V41, P158, DOI 10.1099/00207713-41-1-158; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Havens KE, 2007, CYANOBACTERIAL HARMF, V619, P675; Holt J., 1994, BERGEYS MANUAL DETER; Jasti S, 2005, APPL ENVIRON MICROB, V71, P3483, DOI 10.1128/AEM.71.7.3483-3494.2005; JENKINS O, 1987, INT J SYST BACTERIOL, V37, P446, DOI 10.1099/00207713-37-4-446; Jin X., 1990, STANDARD METHODS OBS; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Li HB, 2011, WATER RES, V45, P1702, DOI 10.1016/j.watres.2010.11.011; Madigan M.T., 2006, BROCK BIOL MICROORGA; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nelson CE, 2012, ENVIRON MICROBIOL, V14, P1500, DOI 10.1111/j.1462-2920.2012.02738.x; Oliver R. L., 2000, ECOLOGY CYANOBACTERI, P149, DOI [10.1007/0-306-46855-7_6, DOI 10.1007/0-306-46855-7_6]; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Pope PB, 2008, FEMS MICROBIOL ECOL, V64, P9, DOI 10.1111/j.1574-6941.2008.00448.x; Qu FS, 2012, WATER RES, V46, P1490, DOI 10.1016/j.watres.2011.11.051; Riemann L, 2001, MICROB ECOL, V42, P274, DOI 10.1007/s00248-001-0018-8; Salcher MM, 2011, ISME J, V5, P1242, DOI 10.1038/ismej.2011.8; Sapp M, 2007, MICROB ECOL, V53, P683, DOI 10.1007/s00248-006-9162-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen H, 2011, FRESHWATER BIOL, V56, P1065, DOI 10.1111/j.1365-2427.2010.02551.x; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; TISON DL, 1980, APPL ENVIRON MICROB, V39, P456, DOI 10.1128/AEM.39.2.456-459.1980; Turner AM, 2010, ECOL APPL, V20, P2089, DOI 10.1890/10-0208.1; Wang HJ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006864; Wang XY, 2013, WATER RES, V47, P5659, DOI 10.1016/j.watres.2013.06.040; Wiegand C, 2005, TOXICOL APPL PHARM, V203, P201, DOI 10.1016/j.taap.2004.11.002; Worm J, 1998, AQUAT MICROB ECOL, V14, P19, DOI 10.3354/ame014019; Wu QL, 2007, ENVIRON MICROBIOL, V9, P2765, DOI 10.1111/j.1462-2920.2007.01388.x; Xing P, 2011, ISME J, V5, P792, DOI 10.1038/ismej.2010.176; Xu HC, 2013, WATER RES, V47, P2005, DOI 10.1016/j.watres.2013.01.019	53	44	50	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e102879	10.1371/journal.pone.0102879	http://dx.doi.org/10.1371/journal.pone.0102879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144467	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100005
J	Kigozi, G; Musoke, R; Watya, S; Kighoma, N; Nkale, J; Nakafeero, M; Namuguzi, D; Serwada, D; Nalugoda, F; Sewankambo, N; Wawer, MJ; Gray, RH				Kigozi, Godfrey; Musoke, Richard; Watya, Stephen; Kighoma, Nehemia; Nkale, James; Nakafeero, Mary; Namuguzi, Dan; Serwada, David; Nalugoda, Fred; Sewankambo, Nelson; Wawer, Maria Joan; Gray, Ronald Henry			The Safety and Acceptance of the PrePex Device for Non-Surgical Adult Male Circumcision in Rakai, Uganda. A Non-Randomized Observational Study	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; HIV PREVENTION; RANDOMIZED-TRIAL; SCALE-UP; EFFICACY; MEN	Objectives: To assess the safety and acceptance of the PrePex device for medical male circumcision (MMC) in rural Uganda. Methods: In an observational study, HIV-uninfected, uncircumcised men aged 18 and older who requested elective MMC were informed about the PrePex and dorsal slit methods and offered a free choice of their preferred procedure. 100 men received PrePex to assess preliminary safety (aim 1). An additional 329 men, 250 chose PrePex and 79 chose Dorsal slit, were enrolled following approval by the Safety Monitoring Committee (aim 2). Men were followed up at 7 days to assess adverse events (AEs) and to remove the PrePex device. Wound healing was assessed at 4 weeks, with subsequent weekly follow up until completed healing. Results: The PrePex device was contraindicated in 5.7% of men due to a tight prepuce or phimosis/adhesions. Among 429 enrolled men 350 (82.0%) got the PrePex device and 79 (18.0%) the dorsal slit procedure. 250 of 329 men (76.0%) who were invited to choose between the 2 procedures chose Prepex. There were 9 AEs (2.6%) with the PrePex, of which 5 (1.4%) were severe complications, 4 due to patient self-removal of the device leading to edema and urinary obstruction requiring emergency surgical circumcision, and one due to wound dehiscence following device removal. 71.8% of men reported an unpleasant odor prior to PrePex removal. Cumulative rates of completed wound healing with the PrePex were 56.7% at week 4, 84.8% week 5, 97.6% week 6 and 98.6% week 7, compared to 98.7% at week 4 with dorsal slit (p<0.0001). Conclusion: The PrePex device was well accepted, but healing was slower than with dorsal slit surgery. Severe complications, primarily following PrePex self-removal, required rapid access to emergency surgical facilities. The need to return for removal and delayed healing may increase Program cost and client burden.	[Kigozi, Godfrey; Musoke, Richard; Watya, Stephen; Kighoma, Nehemia; Nkale, James; Nakafeero, Mary; Serwada, David; Nalugoda, Fred; Sewankambo, Nelson; Wawer, Maria Joan; Gray, Ronald Henry] Rakai Hlth Sci Program, Entebbe, Uganda; [Namuguzi, Dan] Mulago Hosp, Dept Urol, Kampala, Uganda; [Serwada, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Wawer, Maria Joan; Gray, Ronald Henry] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Sewankambo, Nelson] Makerere Univ, Coll Hlth Sci, Kampala, Uganda	Rakai Health Sciences Program; Mulago National Referral Hospital; Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University	Kigozi, G (corresponding author), Rakai Hlth Sci Program, Entebbe, Uganda.	gkigozi@rhsp.org		Musoke, Richard/0000-0002-2566-4191; Nakafeero, Mary/0000-0003-2943-0744; Sewankambo, Nelson/0000-0001-9362-053X	Division of AIDS (DAIDS) of the US National Institutes of Health (NIH) [UO1 AI075115-0451]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075115] Funding Source: NIH RePORTER	Division of AIDS (DAIDS) of the US National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grant UO1 AI075115-0451 from the Division of AIDS (DAIDS) of the US National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kigozi G, 2013, JAIDS-J ACQ IMM DEF, V63, P617, DOI 10.1097/QAI.0b013e3182968dda; Masson P, 2010, NAT REV UROL, V7, P638, DOI 10.1038/nrurol.2010.167; McIntyre JA, 2011, JAIDS-J ACQ IMM DEF, V58, P506, DOI 10.1097/QAI.0b013e318237af5d; Mutabazi V, 2013, JAIDS-J ACQ IMM DEF, V63, P315, DOI 10.1097/QAI.0b013e31828e6412; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Obiero W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053380; Plank RM, 2013, JAIDS-J ACQ IMM DEF, V62, pE131, DOI 10.1097/QAI.0b013e318285d449; [UNAIDS WHO], 2007, NEW DAT MAL CIRC HIV; UNAIDS World Health Organization, 2010, PROGR MAL CIRC SCAL; World Health Organization, 2013, WHO TECHN ADV GROUP	15	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e100008	10.1371/journal.pone.0100008	http://dx.doi.org/10.1371/journal.pone.0100008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144194	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100001
J	Lindenberg, KS; Weydt, P; Muller, HP; Bornstedt, A; Ludolph, AC; Landwehrmeyer, GB; Rottbauer, W; Kassubek, J; Rasche, V				Lindenberg, Katrin S.; Weydt, Patrick; Mueller, Hans-Peter; Bornstedt, Axel; Ludolph, Albert C.; Landwehrmeyer, G. Bernhard; Rottbauer, Wolfgang; Kassubek, Jan; Rasche, Volker			Two-Point Magnitude MRI for Rapid Mapping of Brown Adipose Tissue and Its Application to the R6/2 Mouse Model of Huntington Disease	PLOS ONE			English	Article							TRANSGENIC MOUSE; ADULT HUMANS; WATER; FAT; MICE; PROTON; NMR; IDENTIFICATION; PGC-1-ALPHA	The recent discovery of active brown fat in human adults has led to renewed interest in the role of this key metabolic tissue. This is particularly true for neurodegenerative conditions like Huntington disease (HD), an adult-onset heritable disorder with a prominent energy deficit phenotype. Current methods for imaging brown adipose tissue (BAT) are in limited use because they are equipment-wise demanding and often prohibitively expensive. This prompted us to explore how a standard MRI set-up can be modified to visualize BAT in situ by taking advantage of its characteristic fat/water content ratio to differentiate it from surrounding white fat. We present a modified MRI protocol for use on an 11.7 T small animal MRI scanner to visualize and quantify BAT in wild-type and disease model laboratory mice. In this application study using the R6/2 transgenic mouse model of HD we demonstrate a significantly reduced BAT volume in HD mice vs. matched controls (n = 5 per group). This finding provides a plausible structural explanation for the previously described temperature phenotype of HD mice and underscores the significance of peripheral tissue pathology for the HD phenotype. On a more general level, the results demonstrate the feasibility of MR-based BAT imaging in rodents and open the path towards transferring this imaging approach to human patients. Future studies are needed to determine if this method can be used to track disease progression in HD and other disease entities associated with BAT abnormalities, including metabolic conditions such as obesity, cachexia, and diabetes.	[Lindenberg, Katrin S.; Weydt, Patrick; Mueller, Hans-Peter; Ludolph, Albert C.; Landwehrmeyer, G. Bernhard; Kassubek, Jan] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Bornstedt, Axel; Rottbauer, Wolfgang; Rasche, Volker] Univ Ulm, Dept Internal Med 2, D-89069 Ulm, Germany; [Rasche, Volker] Univ Ulm, Core Facil Small Anim Imaging, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Rasche, V (corresponding author), Univ Ulm, Dept Internal Med 2, Robert Koch Str 8, D-89069 Ulm, Germany.	volker.rasche@uni-ulm.de	Rasche, Volker/P-6523-2016; Kassubek, Jan/GPX-0910-2022; Weydt, Patrick/F-5114-2015; Kassubek, Jan/F-2774-2015; Landwehrmeyer, Georg Bernhard/AHB-4443-2022; Kassubek, Jan/O-1740-2019	Rasche, Volker/0000-0001-8844-3583; Kassubek, Jan/0000-0002-7106-9270; Weydt, Patrick/0000-0003-2344-5662; Kassubek, Jan/0000-0002-7106-9270; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Kassubek, Jan/0000-0002-7106-9270	European Huntington's Disease Network (EHDN) [414]	European Huntington's Disease Network (EHDN)	Funding provided by European Huntington's Disease Network (EHDN) seed fund 414, http://www.eurohd.net/html/network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauwens M, 2014, EUR J NUCL MED MOL I, V41, P776, DOI 10.1007/s00259-013-2611-8; Bley TA, 2010, J MAGN RESON IMAGING, V31, P4, DOI 10.1002/jmri.21895; Branca RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074206; Branca RT, 2011, MAGN RESON MED, V65, P313, DOI 10.1002/mrm.22622; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chen YI, 2012, OBESITY, V20, P1519, DOI 10.1038/oby.2012.22; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; Hamilton G, 2011, J MAGN RESON IMAGING, V34, P468, DOI 10.1002/jmri.22623; Ho DJ, 2010, EXP NEUROL, V225, P74, DOI 10.1016/j.expneurol.2010.05.006; Hu HH, 2013, NMR BIOMED, V26, P1609, DOI 10.1002/nbm.3025; Hu HCH, 2013, J MAGN RESON IMAGING, V38, P885, DOI 10.1002/jmri.24053; Hu HH, 2010, J MAGN RESON IMAGING, V31, P1195, DOI 10.1002/jmri.22162; Hu HH, 2012, MAGN RESON MED, V68, P378, DOI 10.1002/mrm.24369; Jahnke W, 2004, CELL MOL LIFE SCI, V61, P580, DOI 10.1007/s00018-003-3382-3; Johri A, 2012, HUM MOL GENET, V21, P1124, DOI 10.1093/hmg/ddr541; Khanna A, 2012, MAGN RESON MED, V68, P1285, DOI 10.1002/mrm.24118; Lee P, 2013, ENDOCR REV, V34, P413, DOI 10.1210/er.2012-1081; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lindauer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067783; Lunati E, 1999, J LIPID RES, V40, P1395; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marion D, 2013, MOL CELL PROTEOMICS, V12, P3006, DOI 10.1074/mcp.O113.030239; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Rasmussen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077907; Rona-Voros K, 2010, CURR DRUG TARGETS, V11, P1262, DOI 10.2174/1389450111007011262; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wijers SLJ, 2010, OBESITY, V18, P1092, DOI 10.1038/oby.2010.74; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	42	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105556	10.1371/journal.pone.0105556	http://dx.doi.org/10.1371/journal.pone.0105556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144457	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100085
J	Yao, LB; Li, CH; Ge, XL; Wang, HD; Xu, KS; Zhang, AQ; Dong, JH				Yao, Libin; Li, Chonghui; Ge, Xinlan; Wang, Hongdong; Xu, Kesen; Zhang, Aiqun; Dong, Jiahong			Establishment of a Rat Model of Portal Vein Ligation Combined with In Situ Splitting	PLOS ONE			English	Article							POSTOPERATIVE LIVER-FAILURE; MAJOR HEPATECTOMY; HEPATOCELLULAR-CARCINOMA; HEPATIC RESECTION; ALPPS APPROACH; EMBOLIZATION; REGENERATION; RESECTABILITY; HYPERTROPHY; INCREASE	Background: Portal vein ligation (PVL) combined with in situ splitting (ISS) has been shown to induce remarkable liver regeneration in patients. The purpose of this study was to establish a model of PVL+ISS in rats for exploring the possible mechanisms of liver regeneration using these techniques. Materials and Methods: Rats were randomly assigned to three experimental groups: selective PVL, selective PVL+ISS and sham operation. The hepatic regeneration rate (HRR), Ki-67, liver biochemical determinations and histopathology were assessed at 24, 48, and 72 h and 7 days after the operation. The microcirculation of the median lobes before and after ISS was examined by laser speckle contrast imaging. Meanwhile, cytokines such as TNF-alpha, IL-6, HGF and HSP70 in regenerating liver lobes at 24 h was investigated by RT-PCR and ELISA. Results: The HRR of PVL+ISS was much higher than that of the PVL at 72 h and 7 days after surgery (p<0.01). The expression of Ki-67 in hepatocytes in the regenerating liver lobe was stronger in the PVL+ISS group than in the PVL group at 48 and 72 h (p<0.01). There was a significant reduction in microcirculation blood perfusion of the left median lobe before and after ISS. Liver biochemical determinations and histopathology demonstrated more severe hepatocyte injury in the PVL+ISS group. Both the mRNA levels of TNF-alpha and IL-6 and the protein levels of TNF-alpha, IL-6 and HGF in regenerating liver lobes were higher in the PVL+ISS than the PVL alone. Conclusions: The higher HRR in the PVL+ISS compared with the PVL confirmed that we had successfully established a PVL+ISS model in rats. The possible mechanisms included the reduced microcirculation blood perfusion of the left median lobe and up-regulation of cytokines in the regenerating lobes after ISS.	[Yao, Libin; Wang, Hongdong; Xu, Kesen; Dong, Jiahong] Shandong Univ, Qilu Hosp, Dept Hepatobiliary Surg, Jinan 250100, Shandong, Peoples R China; [Li, Chonghui; Ge, Xinlan; Zhang, Aiqun; Dong, Jiahong] Chinese Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Beijing, Peoples R China	Shandong University; Chinese People's Liberation Army General Hospital	Dong, JH (corresponding author), Shandong Univ, Qilu Hosp, Dept Hepatobiliary Surg, Jinan 250100, Shandong, Peoples R China.	dongjh301@163.com		Yao, Libin/0000-0001-8274-2857	National Key Technology R&D Program of China [2012BAI06B01]; National Natural Science Foundation of China [81271738]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Technology R&D Program of China (2012BAI06B01) and the Project of the National Natural Science Foundation of China (81271738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2010, J SURG ONCOL, V102, P960, DOI 10.1002/jso.21654; Abulkhir A, 2008, ANN SURG, V247, P49, DOI 10.1097/SLA.0b013e31815f6e5b; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; de Santibanes E, 2012, ANN SURG, V255, P415, DOI 10.1097/SLA.0b013e318248577d; Fujiyoshi M, 2011, J HEPATO-BIL-PAN SCI, V18, P13, DOI 10.1007/s00534-010-0304-2; Jaeck D, 2004, ANN SURG, V240, P1037, DOI 10.1097/01.sla.0000145965.86383.89; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kishi Y, 2009, T M AM SURG ASS, V127, P171; Liu H, 2009, AM J SURG, V197, P686, DOI [10.1016/j.amjsurg.2008.04.006, 10.1016/j.amjsurg.2008.04.022]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado MA, 2013, ANN SURG ONCOL, V20, P1491, DOI 10.1245/s10434-013-2920-y; MAKUUCHI M, 1990, SURGERY, V107, P521; McGuire PG, 2010, J SURG RES, V164, pE201, DOI 10.1016/j.jss.2010.07.059; Neumann UP, 2013, BRIT J SURG, V100, P310, DOI 10.1002/bjs.9050; Pahlavan PS, 2006, J SURG RES, V134, P238, DOI 10.1016/j.jss.2005.12.011; Ribero D, 2007, BRIT J SURG, V94, P1386, DOI 10.1002/bjs.5836; Ribero D, 2008, ANN SURG ONCOL, V15, P986, DOI 10.1245/s10434-007-9731-y; Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; Seyama Y, 2007, WORLD J GASTROENTERO, V13, P1505, DOI 10.3748/wjg.v13.i10.1505; Shirabe K, 1999, J AM COLL SURGEONS, V188, P304, DOI 10.1016/S1072-7515(98)00301-9; Sturesson C, 2013, MICROVASC RES, V87, P34, DOI 10.1016/j.mvr.2013.01.004; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tschuor C, 2013, EJSO-EUR J SURG ONC, V39, P1230, DOI 10.1016/j.ejso.2013.08.009; Vetelainen R, 2006, J VASC INTERV RADIOL, V17, P1181, DOI 10.1097/01.RVI.0000228460.48294.2E	24	29	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105511	10.1371/journal.pone.0105511	http://dx.doi.org/10.1371/journal.pone.0105511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144490	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100075
J	Feng, L; Wang, JM; Cao, BR; Zhang, Y; Wu, B; Di, XB; Jiang, W; An, N; Lu, D; Gao, SH; Zhao, YD; Chen, ZL; Mao, YS; Gao, YN; Zhou, DS; Jen, J; Liu, XH; Zhang, YP; Li, X; Zhang, KT; He, J; Cheng, SJ				Feng, Lin; Wang, Jiamei; Cao, Bangrong; Zhang, Yi; Wu, Bo; Di, Xuebing; Jiang, Wei; An, Ning; Lu, Dan; Gao, Suhong; Zhao, Yuda; Chen, Zhaoli; Mao, Yousheng; Gao, Yanning; Zhou, Deshan; Jen, Jin; Liu, Xiaohong; Zhang, Yunping; Li, Xia; Zhang, Kaitai; He, Jie; Cheng, Shujun			Gene Expression Profiling in Human Lung Development: An Abundant Resource for Lung Adenocarcinoma Prognosis	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; COLORECTAL-CANCER; PREDICT SURVIVAL; EMBRYONIC COLON; SIGNATURE; MOUSE; VALIDATION; PROLIFERATION; PERSPECTIVE	A tumor can be viewed as a special "organ" that undergoes aberrant and poorly regulated organogenesis. Progress in cancer prognosis and therapy might be facilitated by re-examining distinctive processes that operate during normal development, to elucidate the intrinsic features of cancer that are significantly obscured by its heterogeneity. The global gene expression signatures of 44 human lung tissues at four development stages from Asian descent and 69 lung adenocarcinoma (ADC) tissue samples from ethnic Chinese patients were profiled using microarrays. All of the genes were classified into 27 distinct groups based on their expression patterns (named as PTN1 to PTN27) during the developmental process. In lung ADC, genes whose expression levels decreased steadily during lung development (genes in PTN1) generally had their expression reactivated, while those with uniformly increasing expression levels (genes in PTN27) had their expression suppressed. The genes in PTN1 contain many n-gene signatures that are of prognostic value for lung ADC. The prognostic relevance of a 12-gene demonstrator for patient survival was characterized in five cohorts of healthy and ADC patients [ADC_CICAMS (n = 69, p = 0.007), ADC_PNAS (n = 125, p = 0.0063), ADC_GSE13213 (n = 117, p = 0.0027), ADC_GSE8894 (n = 62, p = 0.01), and ADC_NCI (n = 282, p = 0.045)] and in four groups of stage I patients [ADC_CICAMS (n = 22, p = 0.017), ADC_PNAS (n = 76, p = 0.018), ADC_GSE13213 (n = 79, p = 0.02), and ADC_qPCR (n = 62, p = 0.006)]. In conclusion, by comparison of gene expression profiles during human lung developmental process and lung ADC progression, we revealed that the genes with a uniformly decreasing expression pattern during lung development are of enormous prognostic value for lung ADC.	[Feng, Lin; Cao, Bangrong; Di, Xuebing; An, Ning; Lu, Dan; Gao, Yanning; Zhang, Kaitai; Cheng, Shujun] Peking Union Med Coll, Canc Hosp & Inst, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Feng, Lin; Cao, Bangrong; Di, Xuebing; An, Ning; Lu, Dan; Zhao, Yuda; Chen, Zhaoli; Mao, Yousheng; Gao, Yanning; Zhang, Kaitai; He, Jie; Cheng, Shujun] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wang, Jiamei; Gao, Suhong; Liu, Xiaohong; Zhang, Yunping] Maternal & Child Hlth Care Hosp Haidian, Dept Obstet & Gynaecol, Beijing, Peoples R China; [Zhang, Yi] Capital Med Univ, Xuanwu Hosp, Dept Thorac Surg, Beijing, Peoples R China; [Wu, Bo; Zhou, Deshan] Capital Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Beijing, Peoples R China; [Jiang, Wei; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Zhao, Yuda; Chen, Zhaoli; Mao, Yousheng; He, Jie] Peking Union Med Coll, Canc Hosp & Inst, Dept Thorac Surg, Beijing 100021, Peoples R China; [Jen, Jin] Mayo Clin, Med Genome Facil, Rochester, MN USA; [Jen, Jin] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University; Capital Medical University; Harbin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Mayo Clinic; Mayo Clinic	Zhang, KT (corresponding author), Peking Union Med Coll, Canc Hosp & Inst, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	zhangkt@cicams.ac.cn; prof.hejie@263.net; chengshj@263.net.cn	, 曹邦荣/AAN-3604-2020; Mao, Yousheng/T-7200-2018	Cao, Bangrong/0000-0002-3865-3563; Mao, Yousheng/0000-0003-1120-241X	National High Technology Research and Development Program of China [2012AA02A502, 2014AA020602]; Capital Citizen Health Project [Z111107067311018]; National Natural Science Foundation of China [81201592]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Capital Citizen Health Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (2012AA02A502 and 2014AA020602) received by YG and SC, respectively; and the Capital Citizen Health Project (Z111107067311018) received by SC; and the National Natural Science Foundation of China (81201592) received by LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, GLOB CANC FACTS FIG; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Frangogiannis NG, 2012, TRANSL RES, V159, P197, DOI 10.1016/j.trsl.2012.01.023; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; He K, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-41; Hu M, 2005, CANCER RES, V65, P8715, DOI 10.1158/0008-5472.CAN-05-0700; Iwamoto T, 2010, GENOME MED, V2, DOI 10.1186/gm202; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kim SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-147; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Naxerova K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r108; Peacock CD, 2008, J CLIN ONCOL, V26, P2883, DOI 10.1200/JCO.2007.15.2702; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Silvia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-200; Starmans MHW, 2008, BRIT J CANCER, V99, P1884, DOI 10.1038/sj.bjc.6604746; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Yi H, 2010, FASEB J, V24, P3341, DOI 10.1096/fj.10-158782	39	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105639	10.1371/journal.pone.0105639	http://dx.doi.org/10.1371/journal.pone.0105639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141350	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200116
J	Kozomara, A; Hunt, S; Ninova, M; Griffiths-Jones, S; Ronshaugen, M				Kozomara, Ana; Hunt, Suzanne; Ninova, Maria; Griffiths-Jones, Sam; Ronshaugen, Matthew			Target Repression Induced by Endogenous microRNAs: Large Differences, Small Effects	PLOS ONE			English	Article							SMALL RNAS; RECOGNITION; EXPRESSION; SIRNAS; MIRNAS; ENCODES; TISSUE; ROLES	MicroRNAs are small RNAs that regulate protein levels. It is commonly assumed that the expression level of a microRNA is directly correlated with its repressive activity - that is, highly expressed microRNAs will repress their target mRNAs more. Here we investigate the quantitative relationship between endogenous microRNA expression and repression for 32 mature microRNAs in Drosophila melanogaster S2 cells. In general, we find that more abundant microRNAs repress their targets to a greater degree. However, the relationship between expression and repression is nonlinear, such that a 10-fold greater microRNA concentration produces only a 10% increase in target repression. The expression/repression relationship is the same for both dominant guide microRNAs and minor mature products (so-called passenger strands/microRNA* sequences). However, we find examples of microRNAs whose cellular concentrations differ by several orders of magnitude, yet induce similar repression of target mRNAs. Likewise, microRNAs with similar expression can have very different repressive abilities. We show that the association of microRNAs with Argonaute proteins does not explain this variation in repression. The observed relationship is consistent with the limiting step in target repression being the association of the microRNA/RISC complex with the target site. These findings argue that modest changes in cellular microRNA concentration will have minor effects on repression of targets.	[Kozomara, Ana; Hunt, Suzanne; Ninova, Maria; Griffiths-Jones, Sam; Ronshaugen, Matthew] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Griffiths-Jones, S (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	sam.griffiths-jones@manchester.ac.uk; matthew.ronshaugen@manchester.ac.uk	Ninova, Maria/AAG-9476-2021; Griffiths-Jones, Sam/H-2998-2014	Ninova, Maria/0000-0001-5051-5502; Griffiths-Jones, Sam/0000-0001-6043-807X; Ronshaugen, Matthew/0000-0001-5326-5924	Biotechnology and Biological Sciences Research Council [BB/G022623/1, BB/H017801/1]; Wellcome Trust; BBSRC [BB/G022623/1, BB/H017801/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council [BB/G022623/1 to AK, SGJ; BB/H017801/1 SH, MR] http://bbsrc.ac.uk/home/home.aspx Wellcome Trust (PhD studentship to MN] http://www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; HE L, 2004, NAT REV GENET, V5, P522; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kadri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029217; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC., 2001, SCIENCE, V294, P858, DOI [DOI 10.1126/SCIENCE.1065062, 10.1126/science.1065062, DOI 10.1126/science.1065062]; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Marco A, 2012, BIOINFORMATICS, V28, P318, DOI 10.1093/bioinformatics/btr686; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051	59	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104286	10.1371/journal.pone.0104286	http://dx.doi.org/10.1371/journal.pone.0104286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141277	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200016
J	Srimani, JK; Yao, G; Neu, J; Tanouchi, Y; Lee, TJ; You, LC				Srimani, Jaydeep K.; Yao, Guang; Neu, John; Tanouchi, Yu; Lee, Tae Jun; You, Lingchong			Linear Population Allocation by Bistable Switches in Response to Transient Stimulation	PLOS ONE			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; FEEDBACK; SYSTEMS; PROTEIN; MODULATE; DENSITY; GROWTH; MODEL; ACTS	Many cellular decision processes, including proliferation, differentiation, and phenotypic switching, are controlled by bistable signaling networks. In response to transient or intermediate input signals, these networks allocate a population fraction to each of two distinct states (e.g. OFF and ON). While extensive studies have been carried out to analyze various bistable networks, they are primarily focused on responses of bistable networks to sustained input signals. In this work, we investigate the response characteristics of bistable networks to transient signals, using both theoretical analysis and numerical simulation. We find that bistable systems exhibit a common property: for input signals with short durations, the fraction of switching cells increases linearly with the signal duration, allowing the population to integrate transient signals to tune its response. We propose that this allocation algorithm can be an optimal response strategy for certain cellular decisions in which excessive switching results in lower population fitness.	[Srimani, Jaydeep K.; Neu, John; Tanouchi, Yu; Lee, Tae Jun; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Yao, Guang] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Duke University; University of Arizona	You, LC (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	you@duke.edu		, Guang/0000-0003-0167-777X	National Science Foundation [CBET-0953202]; National Institutes of Health [1R01GM098642]; North Carolina Biotech Center [2012-MRG-1102]; DuPont Young Professorship; David and Lucile Packard Fellowship; American Cancer Society [IRG7400l34]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106107, R01GM098642] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotech Center; DuPont Young Professorship; David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Science Foundation (LY, CBET-0953202); National Institutes of Health (LY, 1R01GM098642); North Carolina Biotech Center (LY, 2012-MRG-1102); DuPont Young Professorship (LY); David and Lucile Packard Fellowship (LY); American Cancer Society (GY, IRG7400l34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Arvanitis DN, 2010, MOL CELL BIOL, V30, P2508, DOI 10.1128/MCB.01620-09; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Choi MH, 1998, PHYS REV E, V57, P6335, DOI 10.1103/PhysRevE.57.6335; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; CONTOIS DE, 1959, J GEN MICROBIOL, V21, P40, DOI 10.1099/00221287-21-1-40; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Diaz, 2011, FRONTIERS MICROBIOLO; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Galan Jorge E., 1999, Science (Washington D C), V284, P1322, DOI 10.1126/science.284.5418.1322; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Greber D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn443; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; JUNG P, 1989, Z PHYS B CON MAT, V76, P521, DOI 10.1007/BF01307904; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Lee TJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000488; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Menke NB, 2010, WOUND REPAIR REGEN, V18, P105, DOI 10.1111/j.1524-475X.2009.00549.x; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Munsky B, 2010, IET SYST BIOL, V4, P356, DOI 10.1049/iet-syb.2010.0013; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; NEVINS JR, 1992, SCIENCE, V258, P424; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Pace V, 2010, CELL STRESS CHAPERON, V15, P13, DOI 10.1007/s12192-009-0118-9; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tanouchi Y, 2012, MOL SYSTEMS BIOL, V8, P1; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Wong JV, 2011, MOL CELL, V41, P275, DOI 10.1016/j.molcel.2011.01.014; Xu SW, 2012, RHEUMATOLOGY, V51, P2146, DOI 10.1093/rheumatology/kes234; Yao G, 2011, MOL SYSTEMS BIOL, V7, P1; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zeng Q, 2012, MOL PLANT MICROBE IN, V25, P37, DOI 10.1094/MPMI-05-11-0105; ZHOU T, 1990, PHYS REV A, V42, P3161, DOI 10.1103/PhysRevA.42.3161	51	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105408	10.1371/journal.pone.0105408	http://dx.doi.org/10.1371/journal.pone.0105408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141235	Green Submitted, Green Published, gold			2022-12-27	WOS:000342687200088
J	Chen, MF; Li, Y; Liu, H; Fu, X; Yu, YX; Yu, GQ; Wang, C; Bao, FF; Liany, H; Wang, ZZ; Shi, ZX; Zhang, DZ; Zhou, GZ; Liu, JJ; Zhang, FR				Chen, Mingfei; Li, Yi; Liu, Hong; Fu, Xi'an; Yu, Yiongxiang; Yu, Gongqi; Wang, Chuan; Bao, Fangfang; Liany, Herty; Wang, Zhenzhen; Shi, Zhongxiang; Zhang, Dizhan; Zhou, Guizhi; Liu, Jianjun; Zhang, Furen			Analysis of POFUT1 Gene Mutation in a Chinese Family with Dowling-Degos Disease	PLOS ONE			English	Article								Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by reticular pigmented anomaly mainly affecting flexures. Though KRT5 has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, POFUT1 and POGLUT1 were recently identified and confirmed to be additional pathogenic genes of DDD. To identify other DDD causative genes, we performed genome-wide linkage and exome sequencing analyses in a multiplex Chinese DDD family, in which the KRT5 mutation was absent. Only a novel 1-bp deletion (c.246+5delG) in POFUT1 was found. No other novel mutation or this deletion was detected in POFUT1 in a second DDD family and a sporadic DDD case by Sanger Sequencing. The result shows the genetic-heterogeneity and complexity of DDD and will contribute to the further understanding of DDD genotype/phenotype correlations and to the pathogenesis of this disease.	[Chen, Mingfei] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Chen, Mingfei] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Chen, Mingfei; Liu, Hong; Fu, Xi'an; Yu, Yiongxiang; Yu, Gongqi; Wang, Chuan; Bao, Fangfang; Wang, Zhenzhen; Zhou, Guizhi; Zhang, Furen] Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China; [Li, Yi; Liany, Herty; Liu, Jianjun] Genome Inst Singapore, Dept Human Genet, Singapore, Singapore; [Shi, Zhongxiang; Zhang, Dizhan; Zhang, Furen] Shandong Prov Hosp Skin Dis, Jinan, Shandong, Peoples R China; [Chen, Mingfei; Liu, Hong; Fu, Xi'an; Yu, Yiongxiang; Yu, Gongqi; Wang, Chuan; Bao, Fangfang; Wang, Zhenzhen; Zhang, Furen] Shandong Prov Key Lab Dermatovenereol, Jinan, Shandong, Peoples R China; [Shi, Zhongxiang; Zhang, Dizhan; Zhou, Guizhi; Zhang, Furen] Shandong Prov Med Ctr Dermatovenereol, Jinan, Shandong, Peoples R China	Anhui Medical University; Anhui Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhang, FR (corresponding author), Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China.	zhangfuren@hotmail.com	Liu, Jianjun/AAK-4989-2020	Liu, Jianjun/0000-0002-3255-3019	Natural Science Foundation of Shandong Province [ZR2011HQ003, ZR2011HQ037]; Project of Taishan scholar; Project of clinical center for Dermatology and Venereology of Shandong Province; Project of Research Foundation of Shandong Provincial Institute of Dermatology and Venereology [2008-7]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Project of Taishan scholar; Project of clinical center for Dermatology and Venereology of Shandong Province; Project of Research Foundation of Shandong Provincial Institute of Dermatology and Venereology	This work was supported by Natural Science Foundation of Shandong Province (ZR2011HQ003, ZR2011HQ037), to FZ; Project of Taishan scholar (2008-), to FZ; Project of clinical center for Dermatology and Venereology of Shandong Province (2010-), to FZ; and Project of Research Foundation of Shandong Provincial Institute of Dermatology and Venereology (2008-7), to FZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Asahina A, 2007, ACTA DERM-VENEREOL, V87, P556, DOI 10.2340/00015555-0313; Basmanav FB, 2014, AM J HUM GENET, V94, P135, DOI 10.1016/j.ajhg.2013.12.003; Betz RC, 2006, AM J HUM GENET, V78, P510, DOI 10.1086/500850; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; DEGOS R, 1954, Ann Dermatol Syphiligr (Paris), V81, P147; Dowling G B, 1938, Proc R Soc Med, V31, P1147; Eng L, 2004, HUM MUTAT, V23, P67, DOI 10.1002/humu.10295; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2013, AM J HUM GENET, V92, P1014, DOI 10.1016/j.ajhg.2013.05.016; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087250; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; REBORA A, 1984, BRIT J DERMATOL, V110, P627; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Yang J, 2013, MOL NEUROBIOL, V47, P957, DOI 10.1007/s12035-012-8392-4; Yao D, 2011, BLOOD, V117, P5652, DOI 10.1182/blood-2010-12-326074	18	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e104496	10.1371/journal.pone.0104496	http://dx.doi.org/10.1371/journal.pone.0104496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157627	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200013
J	Lambert, JE; Fellner, V; McKenney, E; Hartstone-Rose, A				Lambert, Joanna E.; Fellner, Vivek; McKenney, Erin; Hartstone-Rose, Adam			Binturong (Arctictis binturong) and Kinkajou (Potos flavus) Digestive Strategy: Implications for Interpreting Frugivory in Carnivora and Primates	PLOS ONE			English	Article							IN-VITRO FERMENTATION; DIETARY FIBER; GASTROINTESTINAL-TRACT; SEED DISPERSAL; SPIDER MONKEYS; FECAL INOCULUM; GUT PASSAGE; TRADE-OFFS; FOOD; ENERGY	Exclusive frugivory is rare. As a food resource, fruit is temporally and spatially patchy, low in protein, and variable in terms of energy yield from different carbohydrate types. Here, we evaluate the digestive physiology of two frugivorous Carnivora species (Potos flavus, Arctictis binturong) that converge with primates in a diversity of ecological and anatomical traits related to fruit consumption. We conducted feeding trials to determine mean digestive retention times (MRT) on captive animals at the Carnivore Preservation Trust (now Carolina Tiger Rescue), Pittsboro, NC. Fecal samples were collected on study subjects for in vitro analysis to determine methane, pH, and short chain fatty acid profiles; fiber was assayed using standard neutral detergent (NDF) and acid detergent (ADF) fiber methods. Results indicate that both carnivoran species have rapid digestive passage for mammals that consume a predominantly plant-based diet: A. binturong MRT = 6.5 hrs (0.3); P. flavus MRT = 2.5 hrs (1.6). In vitro experiments revealed no fermentation of structural polysaccharides - methane levels did not shift from 0 h to either 24 or 48 hours and no short chain fatty acids were detected. In both species, however, pH declined from one incubation period to another suggesting acidification and bacterial activity of microbes using soluble carbohydrates. A comparison with primates indicates that the study species are most similar in digestive retention times to Ateles - the most frugivorous anthropoid primate taxon.	[Lambert, Joanna E.] Univ Texas San Antonio, Dept Anthropol, San Antonio, TX 78249 USA; N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; [McKenney, Erin] Duke Univ, Dept Biol, Durham, NC USA; [Hartstone-Rose, Adam] Univ S Carolina, Dept Cell Biol & Anat, Columbia, SC 29208 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of North Carolina; North Carolina State University; Duke University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Lambert, JE (corresponding author), Univ Texas San Antonio, Dept Anthropol, San Antonio, TX 78249 USA.	joanna.lambert@utsa.edu	Hartstone-Rose, Adam/AAU-3332-2020; Hartstone-Rose, Adam/I-3503-2016	Hartstone-Rose, Adam/0000-0001-5307-5573; Fellner, Vivek/0000-0001-6498-7666; McKenney, Erin/0000-0001-9874-1146	University of Texas at San Antonio	University of Texas at San Antonio	The University of Texas at San Antonio provided financial support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFIK D, 1995, ECOLOGY, V76, P2247, DOI 10.2307/1941699; [Anonymous], 1999, WALKERS MAMMALS WORL; AOAC, 1995, OFF METH AN AOAC INT; Bjornhag G, 1989, Acta Vet Scand Suppl, V86, P204; Blaine KP, 2012, INTEGR ZOOL, V7, P183, DOI 10.1111/j.1749-4877.2012.00282.x; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P1, DOI 10.1017/CBO9780511542343; BRYANT MP, 1953, J DAIRY SCI, V36, P205, DOI 10.3168/jds.S0022-0302(53)91482-9; Campbell JL, 2002, J NUTR, V132, P3073, DOI 10.1093/jn/131.10.3073; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; CLEMENS E, 1980, COMP BIOCHEM PHYS A, V66, P529, DOI 10.1016/0300-9629(80)90204-2; Colon CP, 2013, RAFFLES B ZOOL, V61, P417; Delorme M, 1999, J COMP PHYSIOL B, V169, P123, DOI 10.1007/s003600050202; Depauw S, 2013, J ANIM PHYSIOL AN N, V97, P146, DOI 10.1111/j.1439-0396.2011.01252.x; Di Fiore A, 2010, PRIMATES PERSPECTIVE, P155; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; Djossa Bruno A., 2008, Ecotropica (Bonn), V14, P37; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Edwards MS, 1999, ZOO BIOL, V18, P537, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;537::AID-ZOO8&gt;3.0.CO;2-F; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Foley WJ, 2000, J COMP PHYSIOL B, V170, P345, DOI 10.1007/s003600000109; FORD L S, 1988, Mammalian Species, P1, DOI 10.2307/3504086; Ganzhorn JU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008253; Graae BJ, 2003, ARCT ANTARCT ALP RES, V36, P468; Hanya G, 2006, PRIMATES, V47, P275, DOI 10.1007/s10329-005-0176-2; IZHAKI I, 1989, OIKOS, V54, P23, DOI 10.2307/3565893; Janson C. H., 1999, PRIMATE COMMUNITIES; Julien-Laferriere D, 1999, J ZOOL, V247, P71, DOI 10.1111/j.1469-7998.1999.tb00194.x; JULIENLAFERRIERE D, 1993, J TROP ECOL, V9, P19, DOI 10.1017/S0266467400006908; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; KARASOV WH, 1992, AM J PHYSIOL, V263, pR496, DOI 10.1152/ajpregu.1992.263.3.R496; KARASOV WH, 1990, PHYSIOL ZOOL, V63, P1248, DOI 10.1086/physzool.63.6.30152643; Karasov WH, 2013, COMPR PHYSIOL, V3, P741, DOI 10.1002/cphy.c110054; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kay Robin N. B., 1994, P229; Kays RW, 1995, BIOTROPICA, V27, P530, DOI 10.2307/2388969; Kays RW, 1999, J MAMMAL, V80, P589, DOI 10.2307/1383303; Kleiman DV, 1997, WILD MAMMALS CAPTIVI; Koenig A, 1998, BEHAV ECOL SOCIOBIOL, V42, P225, DOI 10.1007/s002650050434; Kortlucke S. M., 1973, OCCASIONAL PAPERS MU, V17, P1; Lambert F, 1990, PRIMATES, V17, P1; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.0.CO;2-C; Lambert JE, 1999, AM J PHYS ANTHROPOL, V109, P365, DOI 10.1002/(SICI)1096-8644(199907)109:3&lt;365::AID-AJPA6&gt;3.0.CO;2-Q; Lambert JE, 2002, INT J PRIMATOL, V23, P1169, DOI 10.1023/A:1021166502098; Lambert JE, 2001, PRIMATES PERSPECTIVE, P512; Lambert JE, 2002, GUENONS DIVERSITY AD, P303; Lambert JE, 2012, INT J PRIMATOL, V33, P263, DOI 10.1007/s10764-011-9559-y; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; MAISELS F, 1993, FOLIA PRIMATOL, V61, P35, DOI 10.1159/000156725; Martin R.D., 1985, P61; MASON VC, 1969, J AGR SCI, V73, P99, DOI 10.1017/S0021859600024175; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1995, J MAMMAL, V76, P206, DOI 10.2307/1382329; MILTON K, 1988, J NUTR, V118, P1082, DOI 10.1093/jn/118.9.1082; MILTON K, 1983, COMP BIOCHEM PHYS A, V74, P29, DOI 10.1016/0300-9629(83)90706-5; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Milton K, 1984, ADAPTATIONS FORAGING; MULLER E, 1978, ARCH INT PHYSIOL BIO, V86, P153, DOI 10.3109/13813457809069892; MULLER EF, 1983, Z SAUGETIERKD, V48, P217; Overdorff DJ, 1995, CREATURES OF THE DARK, P61; Pocock RI, 1921, P ZOOL SOC LOND, V1921, P389; Remis MJ, 2004, INT J PRIMATOL, V25, P825, DOI 10.1023/B:IJOP.0000029124.04610.c7; Rothman JM, 2012, INT J PRIMATOL, V33, P542, DOI 10.1007/s10764-011-9568-x; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Russo SE, 2004, ECOL LETT, V7, P1058, DOI 10.1111/j.1461-0248.2004.00668.x; Schwab C, 2011, CANADIAN J MICROBIOL, V57; Sela DA, 2010, BIFIDOBACTERIA: GENOMICS AND MOLECULAR ASPECTS, P45; Stephens CE, 1995, COMP PHYSL VETEBRATE; Sunvold GD, 1995, J ANIM SCI, V73, P3639; VanSoest PJ, 1996, ZOO BIOL, V15, P455, DOI 10.1002/(SICI)1098-2361(1996)15:5<455::AID-ZOO3>3.0.CO;2-A; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Warner A. C. I., 1981, Nutrition Abstracts and Reviews, B, V51, P789; Watts DP, 2012, AM J PRIMATOL, V74, P114, DOI 10.1002/ajp.21016; WRANGHAM RW, 1991, PHILOS T ROY SOC B, V334, P171, DOI 10.1098/rstb.1991.0106	76	18	18	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105415	10.1371/journal.pone.0105415	http://dx.doi.org/10.1371/journal.pone.0105415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157614	Green Submitted, gold, Green Published			2022-12-27	WOS:000341303200031
J	Holmberg, K; Bowman, TD; Haustein, S; Peters, I				Holmberg, Kim; Bowman, Timothy D.; Haustein, Stefanie; Peters, Isabella			Astrophysicists' Conversational Connections on Twitter	PLOS ONE			English	Article								Because Twitter and other social media are increasingly used for analyses based on altmetrics, this research sought to understand what contexts, affordance use, and social activities influence the tweeting behavior of astrophysicists. Thus, the presented study has been guided by three research questions that consider the influence of astrophysicists' activities (i.e., publishing and tweeting frequency) and of their tweet construction and affordance use (i.e. use of hashtags, language, and emotions) on the conversational connections they have on Twitter. We found that astrophysicists communicate with a variety of user types (e.g. colleagues, science communicators, other researchers, and educators) and that in the ego networks of the astrophysicists clear groups consisting of users with different professional roles can be distinguished. Interestingly, the analysis of noun phrases and hashtags showed that when the astrophysicists address the different groups of very different professional composition they use very similar terminology, but that they do not talk to each other (i.e. mentioning other user names in tweets). The results also showed that in those areas of the ego networks that tweeted more the sentiment of the tweets tended to be closer to neutral, connecting frequent tweeting with information sharing activities rather than conversations or expressing opinions.	[Holmberg, Kim] Wolverhampton Univ, Sch Math & Comp, Wolverhampton WV1 1DJ, W Midlands, England; [Holmberg, Kim] Abo Akad Univ, Turku, Finland; [Bowman, Timothy D.] Indiana Univ, Dept Informat & Lib Sci, Bloomington, IN USA; [Bowman, Timothy D.; Haustein, Stefanie] Univ Montreal, Ecole Bibliothecon & Sci Informat, Montreal, PQ, Canada; [Peters, Isabella] ZBW Leibniz Informat Ctr Econ, Kiel, Germany; [Peters, Isabella] Univ Kiel, Kiel, Germany	University of Wolverhampton; Abo Akademi University; Indiana University System; Indiana University Bloomington; Universite de Montreal; Deutsche Zentralbibliothek fur Wirtschaftswissenschaften (ZBW); University of Kiel	Holmberg, K (corresponding author), Wolverhampton Univ, Sch Math & Comp, Wolverhampton WV1 1DJ, W Midlands, England.	kim.holmberg@abo.fi	Haustein, Stefanie/AAH-3636-2020; Bowman, Timothy D/M-3792-2015; Holmberg, Kim/A-6840-2010; Haustein, Stefanie/C-6748-2011; Peters, Isabella/C-9891-2012; Peters, Isabella/R-4109-2019	Haustein, Stefanie/0000-0003-0157-1430; Bowman, Timothy D/0000-0003-0247-4771; Holmberg, Kim/0000-0002-4185-9298; Haustein, Stefanie/0000-0003-0157-1430; Peters, Isabella/0000-0001-5840-0806; Peters, Isabella/0000-0001-5840-0806	Arts and Humanities Research Council/Economic and Social Research Council/Joint Information Systems Committee (United Kingdom); Social Sciences and Humanities Research Council (Canada); National Science Foundation (United States) [1208804]	Arts and Humanities Research Council/Economic and Social Research Council/Joint Information Systems Committee (United Kingdom)(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Social Sciences and Humanities Research Council (Canada)(Social Sciences and Humanities Research Council of Canada (SSHRC)); National Science Foundation (United States)(National Science Foundation (NSF))	This research was part of the international Digging into Data program (funded by Arts and Humanities Research Council/Economic and Social Research Council/Joint Information Systems Committee (United Kingdom), Social Sciences and Humanities Research Council (Canada), and the National Science Foundation (United States; grant #1208804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar A., 2012, NAACL HLT 2012 2012, P597; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bifet A, 2010, LECT NOTES ARTIF INT, V6332, P1, DOI 10.1007/978-3-642-16184-1_1; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blood Rebecca, 2002, WEBLOG HDB PRACTICAL; Bonetta L, 2007, CELL, V129, P443, DOI 10.1016/j.cell.2007.04.032; Bowman TD, 2013, MAPPING DH HETEROGEN; Brenner J., 2013, 72 ONLINE ADULTS SOC; Bruns A, 2012, J TECHNOL HUMAN SERV, V30, P160, DOI 10.1080/15228835.2012.744249; Chretien KC, 2011, JAMA-J AM MED ASSOC, V305, P566, DOI 10.1001/jama.2011.68; Christian C., 2012, ORG PEOPLE STRATEGIE, V1, P183; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Groth P., 2010, STUDYING SCI DISCOUR; Gruzd A, 2011, AM BEHAV SCI, V55, P1294, DOI 10.1177/0002764211409378; Harwood N, 2009, J PRAGMATICS, V41, P497, DOI 10.1016/j.pragma.2008.06.001; Haustein S, 2014, ACM WEB SCI C 2014 W, DOI [10.6084/m9.figshare.1041514, DOI 10.6084/M9.FIGSHARE.1041514]; Haustein S, IT INFORM T IN PRESS; Haustein S, 2014, SCIENTOMETRICS, V101, P1145, DOI 10.1007/s11192-013-1221-3; Haustein S, 2014, ASLIB J INFORM MANAG, V66, P279, DOI 10.1108/AJIM-09-2013-0081; Haustein S, 2014, J ASSOC INF SCI TECH, V65, P656, DOI 10.1002/asi.23101; Holmberg Kim, 2014, Scientometrics, V101, P1027, DOI 10.1007/s11192-014-1229-3; Honeycutt C., 2009, P 2009 42 HAW INT C, P1, DOI [10.1109/HICSS.2009.89, DOI 10.1109/HICSS.2009.89]; Jansen BJ, 2009, J AM SOC INF SCI TEC, V60, P2169, DOI 10.1002/asi.21149; Kohler T., 2014, NUTZUNG SOCIAL MEDIA; Kouper I, 2010, JCOM-J SCI COMMUN, V9; Lambiotte R., 2014, IEEE T NETW SCI ENG, V1, P76, DOI [10.1109/TNSE.2015.2391998, DOI 10.1109/TNSE.2015.2391998]; Martin S, 2011, PROC SPIE, V7868, DOI 10.1117/12.871402; Moran M, 2011, TEACHING LEARNING SH; Niset MC, 2009, COMMUNICATING SCI NE, P40; Ponte D, 2011, SERIALS REV, V37, P149, DOI 10.1016/j.serrev.2011.06.002; Priem J, 2011, METR 2011 S INF SCIE; Priem J., 2010, P AM SOC INFORM SCI, V47, P1, DOI DOI 10.1002/MEET.14504701201; Priem J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048753; Rowlands I, 2011, LEARN PUBL, V24, P183, DOI 10.1087/20110306; Shuai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047523; Small H, 2011, SCIENTOMETRICS, V87, P373, DOI 10.1007/s11192-011-0349-2; Stieglitz S., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P3500, DOI 10.1109/HICSS.2012.476; Stieglitz S, 2011, 22 AUSTR C INF SYST; Thelwall M, HEART SOUL IN PRESS; Thelwall M, 2009, SYNTHESIS LECT INFOR, DOI [10.2200/S00176ED1V01Y200903ICR004, DOI 10.2200/S00176ED1V01Y200903ICR004]; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; van Eck NJ, 2010, SCIENTOMETRICS, V82, P581, DOI 10.1007/s11192-010-0173-0; Veltri GA, 2013, PUBLIC UNDERST SCI, V22, P832, DOI 10.1177/0963662512463510; Verlic M, 2008, COMP MED SY, P138, DOI 10.1109/CBMS.2008.135; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weller K., 2011, CEUR WORKSHOP P, P1; ZHAO D, 2009, ACM 2009 INT C SUPP	48	33	33	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106086	10.1371/journal.pone.0106086	http://dx.doi.org/10.1371/journal.pone.0106086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153196	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200113
J	Li, T; Pantazes, RJ; Maranas, CD				Li, Tong; Pantazes, Robert J.; Maranas, Costas D.			OptMAVEn - A New Framework for the de novo Design of Antibody Variable Region Models Targeting Specific Antigen Epitopes	PLOS ONE			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; COMPUTATIONAL PROTEIN DESIGN; RECEPTOR-BINDING SITE; NEUTRALIZING ANTIBODIES; AFFINITY MATURATION; STRUCTURAL BASIS; HIV-1 VACCINE; MOLECULES; SEQUENCE; DOCKING	Antibody-based therapeutics provides novel and efficacious treatments for a number of diseases. Traditional experimental approaches for designing therapeutic antibodies rely on raising antibodies against a target antigen in an immunized animal or directed evolution of antibodies with low affinity for the desired antigen. However, these methods remain time consuming, cannot target a specific epitope and do not lead to broad design principles informing other studies. Computational design methods can overcome some of these limitations by using biophysics models to rationally select antibody parts that maximize affinity for a target antigen epitope. This has been addressed to some extend by OptCDR for the design of complementary determining regions. Here, we extend this earlier contribution by addressing the de novo design of a model of the entire antibody variable region against a given antigen epitope while safeguarding for immunogenicity (Optimal Method for Antibody Variable region Engineering, OptMAVEn). OptMAVEn simulates in silico the in vivo steps of antibody generation and evolution, and is capable of capturing the critical structural features responsible for affinity maturation of antibodies. In addition, a humanization procedure was developed and incorporated into OptMAVEn to minimize the potential immunogenicity of the designed antibody models. As case studies, OptMAVEn was applied to design models of neutralizing antibodies targeting influenza hemagglutinin and HIV gp120. For both HA and gp120, novel computational antibody models with numerous interactions with their target epitopes were generated. The observed rates of mutations and types of amino acid changes during in silico affinity maturation are consistent with what has been observed during in vivo affinity maturation. The results demonstrate that OptMAVEn can efficiently generate diverse computational antibody models with both optimized binding affinity to antigens and reduced immunogenicity.	[Li, Tong; Pantazes, Robert J.; Maranas, Costas D.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Maranas, CD (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398; Pantazes, Robert/0000-0002-0994-007X	National Science Foundation [CBET-1133040]; Div Of Chem, Bioeng, Env, & Transp Sys [1133040] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation CBET-1133040 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinandan KR, 2007, J MOL BIOL, V369, P852, DOI 10.1016/j.jmb.2007.02.100; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; BOULIANNE GL, 1984, NATURE, V312, P643, DOI 10.1038/312643a0; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Burkovitz A, 2014, FEBS J, V281, P306, DOI 10.1111/febs.12597; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Ehrenmann Francois, 2011, Cold Spring Harb Protoc, V2011, P726, DOI 10.1101/pdb.prot5635; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gao SH, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-55; Hoess RH, 2001, CHEM REV, V101, P3205, DOI 10.1021/cr000056b; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; ILOG, 2013, ILOG CPLEX 12 4 US M; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jaramillo A, 2005, BIOPHYS J, V88, P156, DOI 10.1529/biophysj.104.042044; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; JESPERS LS, 1994, BIO-TECHNOL, V12, P899, DOI 10.1038/nbt0994-899; Krawczyk K, 2013, PROTEIN ENG DES SEL, V26, P621, DOI 10.1093/protein/gzt043; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lazar GA, 2007, MOL IMMUNOL, V44, P1986, DOI 10.1016/j.molimm.2006.09.029; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P633, DOI 10.1101/pdb.ip85; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P643, DOI 10.1101/pdb.ip86; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Li T, 2013, PROTEIN PEPT LETT; Li T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092870; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Livesay DR, 2004, PROTEIN ENG DES SEL, V17, P463, DOI 10.1093/protein/gzh058; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Pantazes RJ, 2010, PROTEIN ENG DES SEL, V23, P849, DOI 10.1093/protein/gzq061; Pantazes RJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-168; Parker AS, 2013, J COMPUT BIOL, V20, P152, DOI 10.1089/cmb.2012.0251; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Saraf MC, 2006, BIOPHYS J, V90, P4167, DOI 10.1529/biophysj.105.079277; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Schneider G, 2013, NOVO MOL DESIGN, P480; Sciretti D, 2009, PROTEINS, V74, P176, DOI 10.1002/prot.22145; Sellers BD, 2010, PROTEINS, V78, P2490, DOI 10.1002/prot.22757; Simonelli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055561; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Willis JR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003045; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Yu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033340; Zhang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080636; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	66	42	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105954	10.1371/journal.pone.0105954	http://dx.doi.org/10.1371/journal.pone.0105954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153121	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200096
J	Tseng, P; Pushkarsky, I; Di Carlo, D				Tseng, Peter; Pushkarsky, Ivan; Di Carlo, Dino			Metallization and Biopatterning on Ultra-Flexible Substrates via Dextran Sacrificial Layers	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; THIN-FILMS; POLY(DIMETHYLSILOXANE); CELLS; ELECTRONICS; SURFACE; FORCES; FABRICATION; SILICON; ARRAYS	Micro-patterning tools adopted from the semiconductor industry have mostly been optimized to pattern features onto rigid silicon and glass substrates, however, recently the need to pattern on soft substrates has been identified in simulating cellular environments or developing flexible biosensors. We present a simple method of introducing a variety of patterned materials and structures into ultra-flexible polydimethylsiloxane (PDMS) layers (elastic moduli down to 3 kPa) utilizing water-soluble dextran sacrificial thin films. Dextran films provided a stable template for photolithography, metal deposition, particle adsorption, and protein stamping. These materials and structures (including dextran itself) were then readily transferrable to an elastomer surface following PDMS (10 to 70: 1 base to crosslinker ratios) curing over the patterned dextran layer and after sacrificial etch of the dextran in water. We demonstrate that this simple and straightforward approach can controllably manipulate surface wetting and protein adsorption characteristics of PDMS, covalently link protein patterns for stable cell patterning, generate composite structures of epoxy or particles for study of cell mechanical response, and stably integrate certain metals with use of vinyl molecular adhesives. This method is compatible over the complete moduli range of PDMS, and potentially generalizable over a host of additional micro- and nano-structures and materials.	[Tseng, Peter; Pushkarsky, Ivan; Di Carlo, Dino] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Di Carlo, D (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	dicarlo@ucla.edu		Tseng, Peter/0000-0001-6598-1661	NIH New Innovator Award [1DP2OD007113]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007113] Funding Source: NIH RePORTER	NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work received support from a NIH New Innovator Award (#1DP2OD007113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrega T, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/5/055025; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Befahy S, 2010, LANGMUIR, V26, P3372, DOI 10.1021/la903154y; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Farrell M, 2010, COLLOID SURFACE B, V81, P468, DOI 10.1016/j.colsurfb.2010.07.059; Gou HL, 2010, ACS APPL MATER INTER, V2, P1324, DOI 10.1021/am100196z; Gray DS, 2004, ADV MATER, V16, P393, DOI 10.1002/adma.200306107; Guo L, 2010, SMALL, V6, P2847, DOI 10.1002/smll.201001456; Gutierrez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023807; Heyries KA, 2007, LANGMUIR, V23, P4523, DOI 10.1021/la070018o; Horsfall AB, 2004, IEEE T DEVICE MAT RE, V4, P482, DOI 10.1109/TDMR.2004.829389; Hung PJ, 2004, APPL PHYS LETT, V85, P6051, DOI 10.1063/1.1835553; Iwadate Y, 2008, J CELL SCI, V121, P1314, DOI 10.1242/jcs.021576; Iwadate Y, 2008, BIOTECHNIQUES, V44, P739, DOI 10.2144/000112752; Karlsson JM, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/8/085009; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Kim DH, 2008, ADV MATER, V20, P4887, DOI 10.1002/adma.200801788; Kishi K, 2000, J POLYM SCI POL CHEM, V38, P804; Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+; Lee KS, 2009, LAB CHIP, V9, P1618, DOI 10.1039/b820924c; Lee KJ, 2005, ADV FUNCT MATER, V15, P557, DOI 10.1002/adfm.200400189; Lim KS, 2006, LAB CHIP, V6, P578, DOI 10.1039/b514755g; Linder V, 2005, SMALL, V1, P730, DOI 10.1002/smll.200400159; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Moon MW, 2007, P NATL ACAD SCI USA, V104, P1130, DOI 10.1073/pnas.0610654104; Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o; Park JY, 2010, SOFT MATTER, V6, P677, DOI 10.1039/b916603c; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Tseng P, 2014, ADV MATER, V26, P1242, DOI 10.1002/adma.201304607; Tseng P, 2012, NAT METHODS, V9, P1113, DOI [10.1038/NMETH.2210, 10.1038/nmeth.2210]; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yoon J, 2008, NAT MATER, V7, P907, DOI 10.1038/nmat2287; Yu HY, 2012, ACTA BIOMATER, V8, P1267, DOI 10.1016/j.actbio.2011.09.006; Yu L, 2009, LAB CHIP, V9, P1243, DOI 10.1039/b816018j	39	22	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106091	10.1371/journal.pone.0106091	http://dx.doi.org/10.1371/journal.pone.0106091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153326	Green Submitted, gold, Green Published			2022-12-27	WOS:000340952200114
J	Wes, PD; Easton, A; Corradi, J; Barten, DM; Devidze, N; DeCarr, LB; Truong, A; He, AQ; Barrezueta, NX; Polson, C; Bourin, C; Flynn, ME; Keenan, S; Lidge, R; Meredith, J; Natale, J; Sankaranarayanan, S; Cadelina, GW; Albright, CF; Cacace, AM				Wes, Paul D.; Easton, Amy; Corradi, John; Barten, Donna M.; Devidze, Nino; DeCarr, Lynn B.; Amy Truong; He, Aiqing; Barrezueta, Nestor X.; Polson, Craig; Bourin, Clotilde; Flynn, Marianne E.; Keenan, Stefanie; Lidge, Regina; Meredith, Jere; Natale, Joanne; Sankaranarayanan, Sethu; Cadelina, Greg W.; Albright, Charlie F.; Cacace, Angela M.			Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RTG4510 MOUSE MODEL; FRONTOTEMPORAL DEMENTIA; IDENTIFIES VARIANTS; INDUCED DEFICITS; IMPROVES MEMORY; TAUOPATHY; MICE; DOXYCYCLINE; CLU	Filamentous inclusions of the microtubule-associated protein, tau, define a variety of neurodegenerative diseases known as tauopathies, including Alzheimer's disease (AD). To better understand the role of tau-mediated effects on pathophysiology and global central nervous system function, we extensively characterized gene expression, pathology and behavior of the rTg4510 mouse model, which overexpresses a mutant form of human tau that causes Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). We found that the most predominantly altered gene expression pathways in rTg4510 mice were in inflammatory processes. These results closely matched the causal immune function and microglial gene-regulatory network recently identified in AD. We identified additional gene expression changes by laser microdissecting specific regions of the hippocampus, which highlighted alterations in neuronal network activity. Expression of inflammatory genes and markers of neuronal activity changed as a function of age in rTg4510 mice and coincided with behavioral deficits. Inflammatory changes were tau-dependent, as they were reversed by suppression of the tau transgene. Our results suggest that the alterations in microglial phenotypes that appear to contribute to the pathogenesis of Alzheimer's disease may be driven by tau dysfunction, in addition to the direct effects of beta-amyloid.	[Wes, Paul D.; Easton, Amy; Barten, Donna M.; Devidze, Nino; DeCarr, Lynn B.; Barrezueta, Nestor X.; Polson, Craig; Bourin, Clotilde; Flynn, Marianne E.; Keenan, Stefanie; Lidge, Regina; Meredith, Jere; Natale, Joanne; Sankaranarayanan, Sethu; Cadelina, Greg W.; Albright, Charlie F.; Cacace, Angela M.] Bristol Myers Squibb Co, Dept Neurosci, Wallingford, CT 06492 USA; [Corradi, John; Amy Truong; He, Aiqing] Bristol Myers Squibb Co, Dept Appl Genom, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb	Cacace, AM (corresponding author), Bristol Myers Squibb Co, Dept Neurosci, 5 Res Pkwy, Wallingford, CT 06492 USA.	angela.cacace@bms.com		Corradi, John/0000-0003-3456-4974	Bristol-Myers Squibb internal RD budget	Bristol-Myers Squibb internal RD budget	The Bristol-Myers Squibb internal R&D budget provided all sources of funding. The funders had no rolein the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badrakalimuthu V.R., 2012, ADV PSYCHIAT TREATME, V18, P119, DOI DOI 10.1192/APT.BP.110.008458; Bailey RM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-8; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brouwers N, 2011, MOL PSYCHIAT; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Crimins JL, 2011, ACTA NEUROPATHOL, V122, P551, DOI 10.1007/s00401-011-0877-0; Dodart JC, 1997, NEUROREPORT, V8, P1173, DOI 10.1097/00001756-199703240-00023; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Duncan RS, 2005, EXP BIOL MED, V230, P527, DOI 10.1177/153537020523000803; Dunlop DD, 2000, STAT DATA ANAL ELEME; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Forabosco P, 2013, NEUROBIOL AGING, V34, P2699, DOI 10.1016/j.neurobiolaging.2013.05.001; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Gandy S, 2013, NEURON, V78, P575, DOI 10.1016/j.neuron.2013.05.007; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Han HJ, 2012, J NEUROSCI, V32, P10574, DOI 10.1523/JNEUROSCI.0893-12.2012; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kopeikina KJ, 2013, J COMP NEUROL, V521, P1334, DOI 10.1002/cne.23234; Krakauer T, 2003, ANTIMICROB AGENTS CH, V47, P3630, DOI 10.1128/AAC.47.11.3630-3633.2003; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2011, CURR OPIN GENET DEV, V21, P295, DOI 10.1016/j.gde.2011.02.002; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P345, DOI 10.1016/j.neubiorev.2010.02.004; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee VMY, 2005, BBA-MOL BASIS DIS, V1739, P251, DOI 10.1016/j.bbadis.2004.06.014; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu W, 2004, NEUROLOGY, V62, P742, DOI 10.1212/01.WNL.0000113729.77161.C9; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; McKinney BC, 2008, GENES BRAIN BEHAV, V7, P203, DOI 10.1111/j.1601-183X.2007.00339.x; Milano S, 1997, ANTIMICROB AGENTS CH, V41, P117, DOI 10.1128/AAC.41.1.117; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Myers AJ, 2013, J ALZHEIMERS DIS, V33, pS15, DOI 10.3233/JAD-2012-129013; Nash KR, 2013, NEUROBIOL AGING, V34, P1540, DOI 10.1016/j.neurobiolaging.2012.12.011; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sahara N, 2013, J ALZHEIMERS DIS, V33, P249, DOI 10.3233/JAD-2012-121093; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selenica ML, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt241; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Solomon A, 2000, INVEST OPHTH VIS SCI, V41, P2544; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Teri L, 1999, J GERONTOL A-BIOL, V54, pM348, DOI 10.1093/gerona/54.7.M348; Yi CJ, 2011, NEUROCHEM RES, V36, P1984, DOI 10.1007/s11064-011-0522-2; Yue M, 2011, NEUROBIOL AGING, V32, P590, DOI 10.1016/j.neurobiolaging.2009.04.006; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	63	76	76	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106050	10.1371/journal.pone.0106050	http://dx.doi.org/10.1371/journal.pone.0106050			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153994	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200110
J	Biswas, MK; Xu, Q; Mayer, C; Deng, XX				Biswas, Manosh Kumar; Xu, Qiang; Mayer, Christoph; Deng, Xiuxin			Genome Wide Characterization of Short Tandem Repeat Markers in Sweet Orange (Citrus sinensis)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; BAC-END SEQUENCES; SSR MARKERS; MICROSATELLITE MARKERS; TRANSFERABILITY; DNA; INSTABILITY; LENGTH; PLANTS; DIVERSITY	Sweet orange (Citrus sinensis) is one of the major cultivated and most-consumed citrus species. With the goal of enhancing the genomic resources in citrus, we surveyed, developed and characterized microsatellite markers in the approximate to 347 Mb sequence assembly of the sweet orange genome. A total of 50,846 SSRs were identified with a frequency of 146.4 SSRs/Mbp. Dinucleotide repeats are the most frequent repeat class and the highest density of SSRs was found in chromosome 4. SSRs are non-randomly distributed in the genome and most of the SSRs (62.02%) are located in the intergenic regions. We found that AT-rich SSRs are more frequent than GC-rich SSRs. A total number of 21,248 SSR primers were successfully developed, which represents 89 SSR markers per Mb of the genome. A subset of 950 developed SSR primer pairs were synthesized and tested by wet lab experiments on a set of 16 citrus accessions. In total we identified 534 (56.21%) polymorphic SSR markers that will be useful in citrus improvement. The number of amplified alleles ranges from 2 to 12 with an average of 4 alleles per marker and an average PIC value of 0.75. The newly developed sweet orange primer sequences, their in silico PCR products, exact position in the genome assembly and putative function are made publicly available. We present the largest number of SSR markers ever developed for a citrus species. Almost two thirds of the markers are transferable to 16 citrus relatives and may be used for constructing a high density linkage map. In addition, they are valuable for marker-assisted selection studies, population structure analyses and comparative genomic studies of C. sinensis with other citrus related species. Altogether, these markers provide a significant contribution to the citrus research community.	[Biswas, Manosh Kumar; Xu, Qiang; Deng, Xiuxin] Huazhong Agr Univ, Minist Educ MOE, Key Lab Hort Plant Biol, Wuhan, Hubei, Peoples R China; [Mayer, Christoph] Forschungs Museum Alexander Koenig, Bonn, Germany	Huazhong Agricultural University; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Deng, XX (corresponding author), Huazhong Agr Univ, Minist Educ MOE, Key Lab Hort Plant Biol, Wuhan, Hubei, Peoples R China.	xxdeng@mail.hzau.edu.cn	Mayer, Christoph/AAD-6696-2019	Mayer, Christoph/0000-0001-5104-6621; Xiuxin, Deng/0000-0003-4490-4514	Ministry of Science & Technology of China [2011CB100600]; National Natural Science Foundation of China [31330066]	Ministry of Science & Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Ministry of Science & Technology of China (No. 2011CB100600) and the National Natural Science Foundation of China (No. 31330066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Biswas MK, 2012, MOL BIOL REP, V39, P5373, DOI 10.1007/s11033-011-1338-5; Biswas MK, 2011, SCI HORTIC-AMSTERDAM, V129, P798, DOI 10.1016/j.scienta.2011.06.015; Biswas MK, 2010, SCI HORTIC-AMSTERDAM, V124, P254, DOI 10.1016/j.scienta.2009.12.013; Bohra A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-56; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-386; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Cheng YunJiang, 2003, Plant Molecular Biology Reporter, V21, p177a, DOI 10.1007/BF02774246; da Maia LC, 2009, GENET MOL BIOL, V32, P822, DOI 10.1590/S1415-47572009005000091; Duval A, 2002, ANN GENET-PARIS, V45, P71, DOI 10.1016/S0003-3995(02)01115-2; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Hong CP, 2007, MOL CELLS, V23, P349; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Kuntal H, 2012, BIOINFORMATION, V8, P255, DOI 10.6026/97320630008255; Labbe J, 2011, CURR GENET, V57, P75, DOI 10.1007/s00294-010-0328-9; Li Bin, 2004, Genomics Proteomics & Bioinformatics, V2, P24; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; Murat C, 2011, FUNGAL GENET BIOL, V48, P592, DOI 10.1016/j.fgb.2010.10.007; Ollitrault F, 2010, AM J BOT, V97, pE124, DOI 10.3732/ajb.1000280; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Ruiz C, 2000, EUPHYTICA, V112, P89, DOI 10.1023/A:1003992719598; Shama S, 1996, EUR J BIOCHEM, V236, P383, DOI 10.1111/j.1432-1033.1996.00383.x; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Vassileva V, 2002, CANCER RES, V62, P4095; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weng Y, 2007, INSECT MOL BIOL, V16, P613, DOI 10.1111/j.1365-2583.2007.00757.x; Wierdl M, 1997, GENETICS, V146, P769; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]; Zhang LY, 2005, THEOR APPL GENET, V111, P677, DOI 10.1007/s00122-005-2041-5; Zhao H, 2011, J INTEGR PLANT BIOL, V53, P232, DOI 10.1111/j.1744-7909.2010.01026.x	40	36	40	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104182	10.1371/journal.pone.0104182	http://dx.doi.org/10.1371/journal.pone.0104182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148383	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600010
J	Lan, AP; Zhang, J; Xiao, ZC; Peng, XG; Qi, YF; Du, J				Lan, Aiping; Zhang, Jing; Xiao, Zhicheng; Peng, Xiaogang; Qi, Yongfen; Du, Jie			Akt2 Is Involved in Loss of Epithelial Cells and Renal Fibrosis following Unilateral Ureteral Obstruction	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; INTERSTITIAL FIBROSIS; MECHANISMS; PROGRESSION; ORIGIN	Obstructive nephropathy is an aggressive form of chronic kidney disease (CKD), which is characterized by an epithelial-to-mesenchymal transition (EMT) and interstitial fibrosis. However, the molecular mechanisms of EMT and fibrosis are complex and not fully understood. In this study, we investigated the contribution of Akt2 to experimental renal EMT and fibrosis using the well-established model of unilateral ureteral obstruction (UUO). We found that Akt2 and phosphor (p)-Akt protein levels were increased in the obstructed kidneys. UUO induced activation of transforming growth factor-beta 1 (TGF-beta 1) signaling. Importantly, knockout of Akt2 suppressed UUO-induced EMT, kidney fibrosis, increased GSK3 beta activity, and decreased expression of Snail and beta-catenin. Inhibition of GSK3 beta with LiCl (the inhibitor of GSK3 beta) increased the expression of Snail and beta-catenin in cultured kidney epithelial cells. Our findings suggest that Akt2 partially contributes to interstitial fibrosis following UUO and that inhibition of this signaling pathway may provide a novel approach of prevent progression of renal fibrosis.	[Lan, Aiping; Zhang, Jing; Xiao, Zhicheng; Peng, Xiaogang; Qi, Yongfen; Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Inst Heart Lung & Blood Vessel Dis,Minist Educ, Beijing, Peoples R China	Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Key Lab Remodeling Related Cardiovasc Dis, Inst Heart Lung & Blood Vessel Dis,Minist Educ, Beijing, Peoples R China.	jdu@bcm.edu	lan, A/HHZ-6588-2022		National Science Foundation of China Grant EMT [31090363]; Chinese Ministry of Science and Technology [2009CB522205]	National Science Foundation of China Grant EMT; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This study was supported by National Science Foundation of China Grant EMT grant 31090363, and Chinese Ministry of Science and Technology Grants 2009CB522205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Carew RM, 2010, AM J PHYSIOL-RENAL, V298, P1263; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Duffield JS, 2011, KIDNEY INT, V79, P494, DOI 10.1038/ki.2010.338; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mishra Prajna, 2010, J Mol Signal, V5, P9, DOI 10.1186/1750-2187-5-9; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Villagrasa P, 2012, ONCOGENE, V31, P4022, DOI 10.1038/onc.2011.562; White BD, 2007, CURR BIOL, V17, pR923, DOI 10.1016/j.cub.2007.08.062	25	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105451	10.1371/journal.pone.0105451	http://dx.doi.org/10.1371/journal.pone.0105451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148525	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600047
J	Nibouche, S; Fartek, B; Mississipi, S; Delatte, H; Reynaud, B; Costet, L				Nibouche, Samuel; Fartek, Benjamin; Mississipi, Stelly; Delatte, Helene; Reynaud, Bernard; Costet, Laurent			Low Genetic Diversity in Melanaphis sacchari Aphid Populations at the Worldwide Scale	PLOS ONE			English	Article							YELLOW-LEAF-VIRUS; INSECTA HEMIPTERA APHIDIDAE; SEXUAL REPRODUCTION; SITOBION-AVENAE; COTTON APHID; SUGARCANE; MITOCHONDRIAL; RESISTANCE; PLANT; SUPERCLONES	Numerous studies have examined the genetic diversity and genetic structure of invading species, with contrasting results concerning the relative roles of genetic diversity and phenotypic plasticity in the success of introduced populations. Increasing evidence shows that asexual lineages of aphids are able to occupy a wide geographical and ecological range of habitats despite low genetic diversity. The anholocyclic aphid Melanaphis sacchari is a pest of sugarcane and sorghum which originated in the old world, was introduced into the Americas, and is now distributed worldwide. Our purpose was to assess the genetic diversity and structuring of populations of this species according to host and locality. We used 10 microsatellite markers to genotype 1333 individuals (57 samples, 42 localities, 15 countries) collected mainly on sugarcane or sorghum. Five multilocus lineages (MLL) were defined, grouping multilocus genotypes (MLG) differing by only a few mutations or scoring errors. Analysis of a 658 bp sequence of mitochondrial COI gene on 96 individuals revealed five haplotypes, with a mean divergence of only 0.19 %. The distribution of MLL appeared to be strongly influenced by geography but not by host plant. Each of the five MLL grouped individuals from (A) Africa, (B) Australia, (C) South America, the Caribbean and the Indian Ocean including East Africa, (D) USA, and (E) China. The MLL A and C, with a wide geographic distribution, matched the definition of superclone. Among aphids, M. sacchari has one of the lowest known rates of genetic diversity for such a wide geographical distribution.	[Nibouche, Samuel; Fartek, Benjamin; Mississipi, Stelly; Delatte, Helene; Reynaud, Bernard; Costet, Laurent] Cirad, UMR PVBMT, Saint Pierre, La Reunion, France; [Fartek, Benjamin] Univ La Reunion, UMR PVBMT, Saint Pierre, La Reunion, France	CIRAD; University of La Reunion	Nibouche, S (corresponding author), Cirad, UMR PVBMT, Saint Pierre, La Reunion, France.	samuel.nibouche@cirad.fr	Costet, Laurent/AAQ-1579-2020; Costet, Laurent/C-2281-2011; Nibouche, Samuel/C-1964-2008	Costet, Laurent/0000-0003-3199-2885; Nibouche, Samuel/0000-0003-2675-1382	CIRAD; Conseil Regional de La Reunion; European Union: European regional development fund (ERDF)	CIRAD; Conseil Regional de La Reunion; European Union: European regional development fund (ERDF)	This work was funded by CIRAD, by the Conseil Regional de La Reunion and by the European Union: European regional development fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar W, 2011, ANN ENTOMOL SOC AM, V104, P699, DOI 10.1603/AN11020; Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Andris M, 2010, MOL ECOL RESOUR, V10, P1106, DOI 10.1111/j.1755-0998.2010.02916.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Biomatters, 2012, GEN VERS 5 6 6; Blackman R.L., 2000, APHIDS WORLD CROPS I; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Blackman RL, 1990, WORLD PERSPECTIVES B, P197; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; CAILLAUD CM, 1995, B ENTOMOL RES, V85, P189, DOI 10.1017/S000748530003426X; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Chen YZ, 2013, PEST MANAG SCI, V69, P938, DOI 10.1002/ps.3455; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dogimont C, 2010, CR BIOL, V333, P566, DOI 10.1016/j.crvi.2010.04.003; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Fartek B, 2012, ENTOMOL EXP APPL, V144, P270, DOI 10.1111/j.1570-7458.2012.01286.x; Figueroa CC, 2005, HEREDITY, V95, P24, DOI 10.1038/sj.hdy.6800662; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Foottit RG, 2012, PAC SCI, V66, P1, DOI 10.2984/66.1.1; Goncalves MC, 2012, FUNCT PLANT SCI BIOT, V6, P108; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; HALL DG, 1988, FLA ENTOMOL, V71, P138, DOI 10.2307/3495361; Hall DG, 1987, J AM SOC SUGAR CANE, V7, P26; Harrison JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017524; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2008, MOL CELLS, V25, P510; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lehrer AT, 2009, J GEN PLANT PATHOL, V75, P288, DOI 10.1007/s10327-009-0172-2; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lombaert E, 2009, ENTOMOL EXP APPL, V133, P46, DOI 10.1111/j.1570-7458.2009.00904.x; Loxdale HD, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P535, DOI 10.1007/978-90-481-2770-2_25; Loxdale HD, 2008, MITT DEUT GES ALLGEM, V16, P437; Mead FW, 1978, COOPERATIVE PLANT PE; Mondor EB, 2007, BIOL INVASIONS, V9, P87, DOI 10.1007/s10530-006-9010-z; Nei M., 2000, MOL EVOLUTION PHYLOG; Piffaretti J, 2013, MOL ECOL, V22, P3916, DOI 10.1111/mec.12371; Rassaby L, 2003, EUR J PLANT PATHOL, V109, P459, DOI 10.1023/A:1024211823306; Raymond M, 2004, GENEPOP WEB V 3 4; Razmjou J, 2010, ENTOMOL EXP APPL, V134, P191, DOI 10.1111/j.1570-7458.2009.00951.x; Rebijith KB, 2013, B ENTOMOL RES, V103, P601, DOI 10.1017/S0007485313000278; Remaudiere Georges, 1997, P1; Rott P., 2008, Sugar Cane International, V26, P18; Schenck S, 2000, PLANT DIS, V84, P1085, DOI 10.1094/PDIS.2000.84.10.1085; Singh BU, 2004, CROP PROT, V23, P739, DOI 10.1016/j.cropro.2004.01.004; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Thomas S, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-47; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vorburger C, 2003, MOL ECOL, V12, P3493, DOI 10.1046/j.1365-294X.2003.01998.x; Vrijenhoek RC, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P99, DOI 10.1007/978-90-481-2770-2_6; Wang FM, 2013, MOL BREEDING, V31, P777, DOI 10.1007/s11032-012-9832-6; Ward SM, 2008, INVAS PLANT SCI MANA, V1, P98, DOI 10.1614/IPSM-07-022.1; White WH, 2001, FLA ENTOMOL, V84, P435, DOI 10.2307/3496505; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; Zimmerman EC, 1948, INSECTS HAWAII	61	41	42	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106067	10.1371/journal.pone.0106067	http://dx.doi.org/10.1371/journal.pone.0106067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148510	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600112
J	Gambarotta, G; Ronchi, G; Friard, O; Galletta, P; Perroteau, I; Geuna, S				Gambarotta, Giovanna; Ronchi, Giulia; Friard, Olivier; Galletta, Pantaleo; Perroteau, Isabelle; Geuna, Stefano			Identification and Validation of Suitable Housekeeping Genes for Normalizing Quantitative Real-Time PCR Assays in Injured Peripheral Nerves	PLOS ONE			English	Article							WALLERIAN DEGENERATION; SCHWANN-CELLS	Injury to the peripheral nerve induces dramatic changes in terms of cellular composition that are reflected on RNA quality and quantity, making messenger RNA expression analysis very complex. Several commonly used housekeeping genes are regulated following peripheral nerve injury and are thus not suitable for quantitative real-time PCR normalization; moreover, the presence of pseudogenes in some of them impairs their use. To deal with this problem, we have developed a new method to identify new stable housekeeping genes based on publicly available microarray data on normal and injured nerves. Four new candidate stable genes were identified and validated by quantitative real-time PCR analysis on nerves during the different phases after nerve injury: nerve degeneration, regeneration and remyelination. The stability measure of these genes was calculated with both NormFinder and geNorm algorithms and compared with six commonly used housekeeping genes. This procedure allowed us to identify two new and highly stable genes that can be employed for normalizing injured peripheral nerve data: ANKRD27 and RICTOR. Besides providing a tool for peripheral nerve research, our study also describes a simple and cheap procedure that can be used to identify suitable housekeeping genes in other tissues and organs.	[Gambarotta, Giovanna; Ronchi, Giulia; Galletta, Pantaleo; Perroteau, Isabelle; Geuna, Stefano] Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy; [Gambarotta, Giovanna; Perroteau, Isabelle; Geuna, Stefano] Univ Turin, NIT, Orbassano, Italy; [Ronchi, Giulia; Geuna, Stefano] Univ Turin, Neurosci Inst Cavalieri Ottolenghi Fdn NICO, Orbassano, Italy; [Friard, Olivier] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Turin	Gambarotta, G (corresponding author), Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy.	giovanna.gambarotta@unito.it	Ronchi, Giulia/J-4785-2018; Gambarotta, Giovanna/I-8473-2012; Friard, Olivier/ABG-2435-2021	Ronchi, Giulia/0000-0002-4795-7024; Gambarotta, Giovanna/0000-0002-8380-5925; Friard, Olivier/0000-0002-0374-9872; Geuna, Stefano/0000-0002-6962-831X; Perroteau, Isabelle/0000-0001-9797-2276	European Community [278612]; MIUR; Compagnia di San Paolo	European Community(European Commission); MIUR(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo(Compagnia di San Paolo)	The research leading to this paper has received funding from the European Community's Seventh Framework Programme (FP7-HEALTH-2011) under grant agreement no. 278612 (BIOHYBRID), from MIUR and from Compagnia di San Paolo (MOVAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barrette B, 2010, BRAIN BEHAV IMMUN, V24, P1254, DOI 10.1016/j.bbi.2010.07.249; BRADLEY W G, 1970, Experimental Neurology, V26, P275, DOI 10.1016/0014-4886(70)90125-1; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; LUBINSKA L, 1982, BRAIN RES, V233, P227, DOI 10.1016/0006-8993(82)91199-4; Ren SW, 2010, MOL VIS, V16, P1076; Ronchi G, 2009, J NEUROSCI METH, V179, P51, DOI 10.1016/j.jneumeth.2009.01.011; SCHLAEPFER WW, 1977, BRAIN RES, V136, P1, DOI 10.1016/0006-8993(77)90126-3; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIAL JD, 1958, J BIOPHYS BIOCHEM CY, V4, P551, DOI 10.1083/jcb.4.5.551	17	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105601	10.1371/journal.pone.0105601	http://dx.doi.org/10.1371/journal.pone.0105601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144298	Green Submitted, gold, Green Published			2022-12-27	WOS:000341106100093
J	Chen, ZX; Li, C; Xu, YN; Li, YJ; Yang, H; Rao, L				Chen, Zhongxiu; Li, Chen; Xu, Yuanning; Li, Yajiao; Yang, Hao; Rao, Li			Circulating Level of miR-378 Predicts Left Ventricular Hypertrophy in Patients with Aortic Stenosis	PLOS ONE			English	Article							VALVULAR HEART-DISEASE; CARDIAC-HYPERTROPHY; VALVE STENOSIS; POTENTIAL BIOMARKERS; GENE-EXPRESSION; MICRORNAS; REPRESSION; RECOMMENDATIONS; PROLIFERATION; MASS	Aims: Excessively high left ventricle mass is an independent predictor of adverse prognosis. MicroRNAs (miRs) play crucial roles in the regulation of left ventricle hypertrophy (LVH). However, few circulating miRs have been established as predictors of LVH in aortic stenosis (AS) patients. In this study, we aimed to investigate whether circulating levels of miR-1, miR-133, and miR-378 predict LVH in patients with AS. Methods and Results: One-hundred twelve patients with moderate to severe AS and 40 healthy controls were included in the study. Levels of miR-1, miR-133, and miR-378 in the plasma were measured by qPCR. Compared with healthy controls, AS patients had significantly lower circulating levels of miR-1, miR-133, and miR-378. AS patients with LVH had significantly lower miR-378 but not miR-1 and miR-133 compared with those without LVH. Linear regression analysis showed circulating miR-378 had strong correlation with left ventricular mass index (r = 0.283, p = 0.002) and logistic regression showed that lower miR-378 was an independent predictor for LVH in patients with AS (p = 0.037, OR 4.110, 95% CI 1.086 to 15.558). Conclusion: Circulating levels of miR-1, miR-133 and miR-378 were decreased in AS patients, and miR-378 predicts LVH independent of the pressure gradient. Further prospective investigations are needed to elucidate whether these circulating miRs affect clinical outcome.	[Chen, Zhongxiu; Li, Chen; Xu, Yuanning; Li, Yajiao; Yang, Hao; Rao, Li] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China	Sichuan University	Rao, L (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China.	lrlz1989@163.com			Natural Science Foundation of China [81300169, 81270289]; Science & Technology Pillar Program of Sichuan Province [2013SZ0082]; Doctoral Fund of Ministry of Education of China [20110181110011]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Pillar Program of Sichuan Province; Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This study was funded by the grant from Natural Science Foundation of China (grant number: 81300169, 81270289), Science & Technology Pillar Program of Sichuan Province (grant number: 2013SZ0082), and Doctoral Fund of Ministry of Education of China (grant number: 20110181110011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Baggish AL, 2014, J APPL PHYSIOL, V116, P522, DOI 10.1152/japplphysiol.01141.2013; Bagnall RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044744; Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JH, 2012, J MOL CELL CARDIOL, V52, P949, DOI 10.1016/j.yjmcc.2012.01.012; Cioffi G, 2011, HEART, V97, P301, DOI 10.1136/hrt.2010.192997; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cramariuc D, 2010, HEART, V96, P106, DOI 10.1136/hrt.2009.172569; Dong DL, 2010, HYPERTENSION, V55, P946, DOI 10.1161/HYPERTENSIONAHA.109.139519; Dweck MR, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-50; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Garcia R, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000211; HE L, 2004, NAT REV GENET, V5, P522; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Kupari M, 2005, EUR HEART J, V26, P1790, DOI 10.1093/eurheartj/ehi290; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Mureddu GF, 2009, J HYPERTENS, V27, P642, DOI 10.1097/HJH.0b013e32831cec98; Nagalingam RS, 2013, J BIOL CHEM, V288, P11216, DOI 10.1074/jbc.M112.442384; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Owens DS, 2010, AM J CARDIOL, V105, P701, DOI 10.1016/j.amjcard.2009.10.071; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Villar AV, 2011, HEART, V97, P1132, DOI 10.1136/hrt.2010.220418; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Zanutto S, 2014, BRIT J CANCER, V110, P1001, DOI 10.1038/bjc.2013.819	39	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105702	10.1371/journal.pone.0105702	http://dx.doi.org/10.1371/journal.pone.0105702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157568	Green Published, Green Submitted, gold			2022-12-27	WOS:000341303200048
J	Cao, HH; Zheng, CP; Wang, SH; Wu, JY; Shen, JH; Xu, XE; Fu, JH; Wu, ZY; Li, EM; Xu, LY				Cao, Hui-Hui; Zheng, Chun-Peng; Wang, Shao-Hong; Wu, Jian-Yi; Shen, Jin-Hui; Xu, Xiu-E; Fu, Jun-Hui; Wu, Zhi-Yong; Li, En-Min; Xu, Li-Yan			A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis	PLOS ONE			English	Article							EXPRESSION SIGNATURE; FASCIN; OVEREXPRESSION; PROGRESSION; BIOMARKERS; CETUXIMAB; SURVIVAL; GROWTH; RISK; EGFR	Background: Esophageal squamous cell carcinoma (ESCC) has the highest mortality rates in China. The 5-year survival rate of ESCC remains dismal despite improvements in treatments such as surgical resection and adjuvant chemoradiation, and current clinical staging approaches are limited in their ability to effectively stratify patients for treatment options. The aim of the present study, therefore, was to develop an immunohistochemistry-based prognostic model to improve clinical risk assessment for patients with ESCC. Methods: We developed a molecular prognostic model based on the combined expression of axis of epidermal growth factor receptor (EGFR), phosphorylated Specificity protein 1 (p-Sp1), and Fascin proteins. The presence of this prognostic model and associated clinical outcomes were analyzed for 130 formalin-fixed, paraffin-embedded esophageal curative resection specimens (generation dataset) and validated using an independent cohort of 185 specimens (validation dataset). Results: The expression of these three genes at the protein level was used to build a molecular prognostic model that was highly predictive of ESCC survival in both generation and validation datasets (P = 0.001). Regression analysis showed that this molecular prognostic model was strongly and independently predictive of overall survival (hazard ratio = 2.358 [95% CI, 1.391-3.996], P = 0.001 in generation dataset; hazard ratio = 1.990 [95% CI, 1.256-3.154], P = 0.003 in validation dataset). Furthermore, the predictive ability of these 3 biomarkers in combination was more robust than that of each individual biomarker. Conclusions: This technically simple immunohistochemistry-based molecular model accurately predicts ESCC patient survival and thus could serve as a complement to current clinical risk stratification approaches.	[Cao, Hui-Hui; Wu, Jian-Yi; Xu, Xiu-E; Li, En-Min; Xu, Li-Yan] Shantou Univ, Coll Med, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou, Guangdong, Peoples R China; [Cao, Hui-Hui; Xu, Xiu-E; Xu, Li-Yan] Shantou Univ Med Coll, Inst Oncol Pathol, Shantou, Guangdong, Peoples R China; [Wu, Jian-Yi; Li, En-Min] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Shantou, Guangdong, Peoples R China; [Zheng, Chun-Peng; Shen, Jin-Hui; Fu, Jun-Hui; Wu, Zhi-Yong] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Dept Surg Oncol, Shantou, Guangdong, Peoples R China; [Wang, Shao-Hong] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Dept Pathol, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Sun Yat Sen University; Sun Yat Sen University	Li, EM (corresponding author), Shantou Univ, Coll Med, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou, Guangdong, Peoples R China.	nmli@stu.edu.cn; lyxu@stu.edu.cn	xu, li/GNH-3667-2022		National Research Program (973 Program) [2012CB526600]; National High Technology Research and Development Program of China [2012AA02A503, 2012AA02A209]; Natural Science Foundation of China-GuangDong Joint Fund [U0932001, U1301227]	National Research Program (973 Program); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China-GuangDong Joint Fund	This work was supported by grants from the National Research Program (973 Program No. 2012CB526600), the National High Technology Research and Development Program of China (No. 2012AA02A503 and No. 2012AA02A209), and the Natural Science Foundation of China-GuangDong Joint Fund (No. U0932001 and No. U1301227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ONCOLOGY WILLISTON P, V21; Benowitz S, 2008, J NATL CANCER I, V100, P916, DOI 10.1093/jnci/djn228; Bilous M, 2003, MODERN PATHOL, V16, P173, DOI 10.1097/01.MP.0000052102.90815.82; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chen YS, 2012, CANCER SCI, V103, P1979, DOI 10.1111/j.1349-7006.2012.02393.x; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Garcia I, 2012, CLIN CANCER RES, V18, P2012, DOI 10.1158/1078-0432.CCR-11-2483; Gonzaga IM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-569; Gou HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062175; Grothey A, 2000, BRIT J CANCER, V83, P870, DOI 10.1054/bjoc.2000.1395; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; Heinemann V, 2009, CANCER TREAT REV, V35, P262, DOI 10.1016/j.ctrv.2008.11.005; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; Kadara H, 2011, CLIN CANCER RES, V17, P1490, DOI 10.1158/1078-0432.CCR-10-2703; Krikelis D, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-1; Li LW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-52; Lu XF, 2010, CELL MOL LIFE SCI, V67, P3313, DOI 10.1007/s00018-010-0382-y; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sun LL, 2013, ACTA HISTOCHEM, V115, P56, DOI 10.1016/j.acthis.2012.04.001; Sveen A, 2012, CLIN CANCER RES, V18, P6001, DOI 10.1158/1078-0432.CCR-11-3302; Tan VY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-52; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Xu QX, 2012, J HISTOCHEM CYTOCHEM, V60, P457, DOI 10.1369/0022155412443542; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Zhang H, 2006, J CLIN PATHOL, V59, P958, DOI 10.1136/jcp.2005.032730; ZHAO Q, 2010, HEALTH TECHNOL ASSES, V14, P979, DOI DOI 10.1369/JHC.2010.955765; Zhu H, 2013, AM J CANCER RES, V3, P230	32	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106007	10.1371/journal.pone.0106007	http://dx.doi.org/10.1371/journal.pone.0106007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153136	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200104
J	Haack, N; Dublin, P; Rose, CR				Haack, Nicole; Dublin, Pavel; Rose, Christine R.			Dysbalance of Astrocyte Calcium under Hyperammonemic Conditions	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACUTE LIVER-FAILURE; ACUTE AMMONIA INTOXICATION; CULTURED RAT ASTROCYTES; HEPATIC-ENCEPHALOPATHY; BRAIN EDEMA; GLIAL-CELLS; IN-VIVO; HIPPOCAMPAL ASTROCYTES; PORTACAVAL ANASTOMOSIS	Increased brain ammonium (NH4+/NH3) plays a central role in the manifestation of hepatic encephalopathy (HE), a complex syndrome associated with neurological and psychiatric alterations, which is primarily a disorder of astrocytes. Here, we analysed the influence of NH4+/NH3 on the calcium concentration of astrocytes in situ and studied the underlying mechanisms of NH4+/NH3-evoked calcium changes, employing fluorescence imaging with Fura-2 in acute tissue slices derived from different regions of the mouse brain. In the hippocampal stratum radiatum, perfusion with 5 mM NH4+/NH3 for 30 minutes caused a transient calcium increase in about 40% of astrocytes lasting about 10 minutes. Furthermore, the vast majority of astrocytes (similar to 90%) experienced a persistent calcium increase by similar to 50 nM. This persistent increase was already evoked at concentrations of 1-2 mM NH4+/NH3, developed within 10-20 minutes and was maintained as long as the NH4+/NH3 was present. Qualitatively similar changes were observed in astrocytes of different neocortical regions as well as in cerebellar Bergmann glia. Inhibition of glutamine synthetase resulted in significantly larger calcium increases in response to NH4+/NH3, indicating that glutamine accumulation was not a primary cause. Calcium increases were not mimicked by changes in intracellular pH. Pharmacological inhibition of voltage-gated sodium channels, sodium-potassium-chloride-cotransporters (NKCC), the reverse mode of sodium/calcium exchange (NCX), AMPA-or mGluR5-receptors did not dampen NH4+/NH3-induced calcium increases. They were, however, significantly reduced by inhibition of NMDA receptors and depletion of intracellular calcium stores. Taken together, our measurements show that sustained exposure to NH4+/NH3 causes a sustained increase in intracellular calcium in astrocytes in situ, which is partly dependent on NMDA receptor activation and on release of calcium from intracellular stores. Our study furthermore suggests that dysbalance of astrocyte calcium homeostasis under hyperammonemic conditions is a widespread phenomenon, which might contribute to the disturbance of neurotransmission during HE.	[Haack, Nicole; Dublin, Pavel; Rose, Christine R.] Univ Dusseldorf, Inst Neurobiol, Fac Math & Nat Sci, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Rose, CR (corresponding author), Univ Dusseldorf, Inst Neurobiol, Fac Math & Nat Sci, Dusseldorf, Germany.	rose@uni-duesseldorf.de			DFG (German Research Foundation) [575]	DFG (German Research Foundation)(German Research Foundation (DFG))	The study was supported by a grant of the DFG (German Research Foundation) to CRR (Collaborative Research Center 575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Albrecht J, 2010, BIOCHEM PHARMACOL, V80, P1303, DOI 10.1016/j.bcp.2010.07.024; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Beck A, 2004, CELL CALCIUM, V35, P47, DOI 10.1016/S0143-4160(03)00171-4; Bender AS, 1998, J NEUROSCI RES, V54, P673, DOI 10.1002/(SICI)1097-4547(19981201)54:5<673::AID-JNR12>3.3.CO;2-G; Bezzi P, 2001, Prog Brain Res, V132, P255; BLEI AT, 1994, HEPATOLOGY, V19, P1437, DOI 10.1002/hep.1840190619; Butterworth RF, 2010, NEUROCHEM INT, V57, P383, DOI 10.1016/j.neuint.2010.03.012; Cauli O, 2009, METAB BRAIN DIS, V24, P69, DOI 10.1007/s11011-008-9115-4; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Chepkova AN, 2006, NEUROBIOL DIS, V23, P512, DOI 10.1016/j.nbd.2006.04.006; Dadsetan S, 2013, J CEREBR BLOOD F MET, V33, P1235, DOI 10.1038/jcbfm.2013.73; DEKNEGT RJ, 1994, J HEPATOL, V20, P19, DOI 10.1016/S0168-8278(05)80462-3; Desjardins P, 2012, NEUROCHEM INT, V60, P690, DOI 10.1016/j.neuint.2012.02.001; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; GANZ R, 1989, METAB BRAIN DIS, V4, P213, DOI 10.1007/BF01000297; Gorg B, 2013, ARCH BIOCHEM BIOPHYS, V536, P158, DOI 10.1016/j.abb.2013.03.010; Gorg B, 2010, GLIA, V58, P691, DOI 10.1002/glia.20955; Golovina VA, 1996, GLIA, V16, P296; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hermenegildo C, 2000, HEPATOLOGY, V31, P709, DOI 10.1002/hep.510310322; HINDFELT B, 1977, J CLIN INVEST, V59, P386, DOI 10.1172/JCI108651; INESI G, 1994, J MEMBRANE BIOL, V141, P1; Jayakumar AR, 2009, J NEUROCHEM, V109, P252, DOI 10.1111/j.1471-4159.2009.05842.x; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Kafitz KW, 2008, J NEUROSCI METH, V169, P84, DOI 10.1016/j.jneumeth.2007.11.022; Kang J, 2010, NEUROSCIENCE, V169, P1601, DOI 10.1016/j.neuroscience.2010.06.020; Kelly T, 2010, J NEUROCHEM, V115, P1123, DOI 10.1111/j.1471-4159.2010.07009.x; Kelly T, 2009, GLIA, V57, P921, DOI 10.1002/glia.20817; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; KOSENKO E, 1993, BIOCHIM BIOPHYS ACTA, V1180, P321, DOI 10.1016/0925-4439(93)90057-8; Lalo U, 2011, BBA-MOL CELL RES, V1813, P992, DOI 10.1016/j.bbamcr.2010.09.007; Latour I, 2001, HIPPOCAMPUS, V11, P132, DOI 10.1002/hipo.1031; LAVOIE J, 1987, J NEUROCHEM, V49, P692, DOI 10.1111/j.1471-4159.1987.tb00949.x; Lemberg A, 2009, ANN HEPATOL, V8, P95, DOI 10.1016/S1665-2681(19)31785-5; Llansola M, 2007, METAB BRAIN DIS, V22, P321, DOI 10.1007/s11011-007-9067-0; MANS AM, 1979, J NEUROCHEM, V32, P285, DOI 10.1111/j.1471-4159.1979.tb00350.x; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Matthias K, 2003, J NEUROSCI, V23, P1750; Meier SD, 2008, GLIA, V56, P1127, DOI 10.1002/glia.20684; Michalak A, 1996, HEPATOLOGY, V24, P908, DOI 10.1002/hep.510240425; Monfort P, 2007, EUR J NEUROSCI, V25, P2103, DOI 10.1111/j.1460-9568.2007.05444.x; Munoz MD, 2000, NEUROCHEM RES, V25, P437, DOI 10.1023/A:1007547622844; Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883; Nedergaard M, 2010, CELL CALCIUM, V47, P101, DOI 10.1016/j.ceca.2009.12.011; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohara K, 2009, NEUROSCI LETT, V462, P109, DOI 10.1016/j.neulet.2009.06.090; Palomero-Gallagher N, 2013, ARCH BIOCHEM BIOPHYS, V536, P109, DOI 10.1016/j.abb.2013.02.010; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Rao KVR, 2012, NEUROCHEM INT, V61, P575, DOI 10.1016/j.neuint.2012.01.012; Rao KVR, 2001, METAB BRAIN DIS, V16, P67, DOI 10.1023/A:1011666612822; Rodrigo R, 2009, NEUROCHEM INT, V55, P113, DOI 10.1016/j.neuint.2009.01.007; Rose C, 2006, J NEUROCHEM, V97, P11, DOI 10.1111/j.1471-4159.2006.03796.x; Rose C, 2005, J BIOL CHEM, V280, P20937, DOI 10.1074/jbc.M412448200; Rose CR, 2013, GLIA, V61, P1191, DOI 10.1002/glia.22492; Schliess F, 2002, FASEB J, V16, P739, DOI 10.1096/fj.01-0862fje; Sergeeva OA, 2013, ARCH BIOCHEM BIOPHYS, V536, P122, DOI 10.1016/j.abb.2013.04.005; Stephan J, 2012, GLIA, V60, P965, DOI 10.1002/glia.22328; SWAIN M, 1992, HEPATOLOGY, V15, P449, DOI 10.1002/hep.1840150316; SWAIN MS, 1991, AM J PHYSIOL, V261, pR1491, DOI 10.1152/ajpregu.1991.261.6.R1491; THOMAS RC, 1984, J PHYSIOL-LONDON, V354, P3; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; TRABER PG, 1987, HEPATOLOGY, V7, P1272, DOI 10.1002/hep.1840070616; Vaquero J, 2007, NEUROL RES, V29, P683, DOI 10.1179/016164107X240099; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; WATANABE A, 1984, BIOCHEM MED METAB B, V32, P225, DOI 10.1016/0006-2944(84)90076-0; Wen SP, 2013, ARCH BIOCHEM BIOPHYS, V536, P183, DOI 10.1016/j.abb.2013.04.008; WillardMack CL, 1996, NEUROSCIENCE, V71, P589, DOI 10.1016/0306-4522(95)00462-9	74	29	29	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105832	10.1371/journal.pone.0105832	http://dx.doi.org/10.1371/journal.pone.0105832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153709	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200084
J	Ji, WJ; Shi, Z; Huang, JY; Li, S				Ji Wenjun; Shi Zhou; Huang Jingyi; Li Shuo			In Situ Measurement of Some Soil Properties in Paddy Soil Using Visible and Near-Infrared Spectroscopy	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE; CHEMICAL-PROPERTIES; CLAY CONTENT; ONLINE; PHOSPHORUS; PREDICTION; NITROGEN; SPECTRA; MODEL	In situ measurements with visible and near-infrared spectroscopy (vis-NIR) provide an efficient way for acquiring soil information of paddy soils in the short time gap between the harvest and following rotation. The aim of this study was to evaluate its feasibility to predict a series of soil properties including organic matter (OM), organic carbon (OC), total nitrogen (TN), available nitrogen (AN), available phosphorus (AP), available potassium (AK) and pH of paddy soils in Zhejiang province, China. Firstly, the linear partial least squares regression (PLSR) was performed on the in situ spectra and the predictions were compared to those with laboratory-based recorded spectra. Then, the non-linear least-square support vector machine (LS-SVM) algorithm was carried out aiming to extract more useful information from the in situ spectra and improve predictions. Results show that in terms of OC, OM, TN, AN and pH, (i) the predictions were worse using in situ spectra compared to laboratory-based spectra with PLSR algorithm (ii) the prediction accuracy using LS-SVM (R-2>0.75, RPD>1.90) was obviously improved with in situ vis-NIR spectra compared to PLSR algorithm, and comparable or even better than results generated using laboratory-based spectra with PLSR; (iii) in terms of AP and AK, poor predictions were obtained with in situ spectra (R-2<0.5, RPD<1.50) either using PLSR or LS-SVM. The results highlight the use of LS-SVM for in situ vis-NIR spectroscopic estimation of soil properties of paddy soils.	[Ji Wenjun; Shi Zhou; Li Shuo] Zhejiang Univ, Inst Agr Remote Sensing & Informat Technol, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Huang Jingyi] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2033, Australia; [Shi Zhou] Zhejiang Univ, Zhejiang Prov Key Lab Subtrop Soil & Plant Nutr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; University of New South Wales Sydney; Zhejiang University	Shi, Z (corresponding author), Zhejiang Univ, Inst Agr Remote Sensing & Informat Technol, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	shizhou@zju.edu.cn	Huang, Jingyi/ABI-5860-2020; shi, Zhou/A-2283-2015; Huang, Jingyi/B-5541-2015; shi, Zhou/M-7845-2019	Huang, Jingyi/0000-0002-1209-9699; shi, Zhou/0000-0003-3914-5402; Huang, Jingyi/0000-0002-1209-9699; shi, Zhou/0000-0003-3914-5402	National High Technology Research and Development Program of China [2013AA102301]; National Natural Science Foundation of China [41271234]; Zhejiang Provincial Science and Technology Project of China [2011C13010]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Science and Technology Project of China	This research was supported by National High Technology Research and Development Program of China (No. 2013AA102301); National Natural Science Foundation of China (No. 41271234); Zhejiang Provincial Science and Technology Project of China (No. 2011C13010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAO SD, 1981, SOIL AGR CHEM ANAL; Bogrekci I, 2005, BIOSYST ENG, V92, P527, DOI 10.1016/j.biosystemseng.2005.09.001; Bogrekci I, 2005, BIOSYST ENG, V91, P305, DOI 10.1016/j.biosystemseng.2005.04.015; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; Christy CD, 2008, COMPUT ELECTRON AGR, V61, P10, DOI 10.1016/j.compag.2007.02.010; Clark R.N., 1999, REMOTE SENSING EARTH, P3, DOI DOI 10.1111/J.1945-5100.2004.TB00079.X; Cogdill RP, 2004, J NEAR INFRARED SPEC, V12, P93, DOI 10.1255/jnirs.412; Cohen MJ, 2005, J ENVIRON QUAL, V34, P1422, DOI 10.2134/jeq2004.0353; Fystro G, 2002, PLANT SOIL, V246, P139, DOI 10.1023/A:1020612319014; Gebbers R, 2010, SCIENCE, V327, P828, DOI 10.1126/science.1183899; Gholizade A, 2013, J FOOD AGRIC ENVIRON, V11, P859; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo Y, 2012, SPECTROSC SPECT ANAL, V33, P1135; Ji W, 2012, SPECTROSC SPECT ANAL, V32, P2392; Kim YJ, 2013, J KOREAN SOC APPL BI, V56, P559, DOI 10.1007/s13765-013-3067-z; Kleinebecker T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070517; Kuang BY, 2013, SOIL TILL RES, V128, P125, DOI 10.1016/j.still.2012.11.006; Kuang B, 2012, ADV AGRON, V114, P155, DOI 10.1016/B978-0-12-394275-3.00003-1; Kusumo BH, 2010, EUR J SOIL SCI, V61, P1, DOI 10.1111/j.1365-2389.2009.01199.x; Li BB, 2002, CHEMOMETR INTELL LAB, V64, P79, DOI 10.1016/S0169-7439(02)00051-5; Li Q. K., 1992, PADDY SOILS CHINA; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lobell DB, 2002, SOIL SCI SOC AM J, V66, P722, DOI 10.2136/sssaj2002.0722; Morgan, 1996, SOIL EROSION CONSERV, P320; Mouazen AM, 2007, SOIL TILL RES, V93, P13, DOI 10.1016/j.still.2006.03.009; Mouazen AM, 2009, SOIL TILL RES, V103, P144, DOI 10.1016/j.still.2008.10.006; Nas T., 2002, MULTIVARIATE CALIBRA, V2nd ed.; R Development Core Team, 2012, R LANG ENV STAT COMP; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Rossel RAV, 2009, GEODERMA, V150, P253, DOI 10.1016/j.geoderma.2009.01.025; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Saeys W, 2005, BIOSYST ENG, V91, P393, DOI 10.1016/j.biosystemseng.2005.05.001; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shao YN, 2011, SOIL RES, V49, P166, DOI 10.1071/SR10098; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; SHERMAN DM, 1985, AM MINERAL, V70, P1262; Soil Science Society of China, 2000, SOIL AGR CHEM ANAL; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Tekin Y, 2013, SENSORS-BASEL, V13, P10177, DOI 10.3390/s130810177; Udelhoven T, 2003, PLANT SOIL, V251, P319, DOI 10.1023/A:1023008322682; Vapnik V., 2013, NATURE STAT LAERNING; Waiser TH, 2007, SOIL SCI SOC AM J, V71, P389, DOI 10.2136/sssaj2006.0211; Weyer L., 2002, HDB VIBRATIONAL SPEC, V3, P1817; Williams P., 2003, NEAR INFRARED TECHNO; WOLD S, 1983, LECT NOTES MATH, V973, P286	45	62	66	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105708	10.1371/journal.pone.0105708	http://dx.doi.org/10.1371/journal.pone.0105708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153132	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200072
J	Jonsson, S; Lundberg, AK; Jonasson, L				Jonsson, Simon; Lundberg, Anna K.; Jonasson, Lena			Overexpression of MMP-9 and Its Inhibitors in Blood Mononuclear Cells after Myocardial Infarction - Is It Associated with Depressive Symptomatology?	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; AGED NORMAL POPULATION; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; METALLOPROTEINASE EXPRESSION; ATHEROSCLEROTIC PLAQUE; MAJOR DEPRESSION; WHITEHALL-II; MATRIX-METALLOPROTEINASE-9; INFLAMMATION	Background: Matrix metalloproteinase (MMP)-9 may play a central role in the development and progression of atherosclerosis. Emerging evidence also indicates an association between MMP-9 and depressive symptomatology. Here, we investigated whether expression of MMP-9 and its inhibitors in blood mononuclear cells and plasma were related to depressive symptoms in patients with a recent myocardial infarction (MI). Methods and Results: Blood sampling was performed between 6 and 18 months after MI in 57 patients. Forty-one clinically healthy subjects were included as controls. Gene expression of MMP-9 and its main tissue inhibitors TIMP-1 and -2 were analyzed in freshly isolated or cultured blood mononuclear cells. Corresponding protein levels were assessed in cell supernatants and plasma. In post-MI patients, mRNA levels of MMP-9 and TIMP-1 and -2 were significantly higher than in controls while protein levels in cell supernatants and plasma did not differ between groups. The Center for Epidemiological Studies - Depression (CES-D) scale was used to assess depressive symptomatology. Repeated assessments during the first 18 months after MI showed significantly higher CES-D scores in patients compared with controls. However, there were no relationships between depressive mood and any of the measurements of MMP-9 or TIMPs. Conclusion: Our findings indicate that overexpression of MMP-9 and TIMPs in blood mononuclear cells and elevated depressive symptoms represent two unrelated phenomena after MI.	[Jonsson, Simon; Lundberg, Anna K.; Jonasson, Lena] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden	Linkoping University	Jonasson, L (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden.	lena.jonasson@liu.se			Swedish Research Council [521-2011-3847]; Swedish Heart-Lung Foundation [20120608]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This study was supported by Swedish Research Council, grant number 521-2011-3847, (www.vr.se) and the Swedish Heart-Lung Foundation, grant number 20120608, (www.hjart-lungfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham M, 2005, J NEUROIMMUNOL, V163, P157, DOI 10.1016/j.jneuroim.2005.02.001; Avolio C, 2005, MULT SCLER, V11, P441, DOI 10.1191/1352458505ms1193oa; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brunner S, 2010, AM J CARDIOL, V105, P429, DOI 10.1016/j.amjcard.2009.10.013; Chen F, 2005, INT J MOL MED, V15, P57; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; Davidson KW, 2009, AM J CARDIOL, V103, P755, DOI 10.1016/j.amjcard.2008.11.035; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Duivis HE, 2011, AM J PSYCHIAT, V168, P913, DOI 10.1176/appi.ajp.2011.10081163; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Garvin P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001774; Garvin P, 2009, PSYCHOSOM MED, V71, P292, DOI 10.1097/PSY.0b013e3181960e7f; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; HOWARD EW, 1991, J BIOL CHEM, V266, P13070; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340; Kouwenhoven M, 2001, J AUTOIMMUN, V16, P463, DOI 10.1006/jaut.2001.0505; Lane D, 2002, BRIT J HEALTH PSYCH, V7, P11, DOI 10.1348/135910702169321; Lesperance F, 1996, PSYCHOSOM MED, V58, P99, DOI 10.1097/00006842-199603000-00001; Lichtinghagen R, 2000, CLIN CHEM, V46, P183; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lundgren O, 2014, INT J BEHAV MED; Lutgendorf SK, 2008, CLIN CANCER RES, V14, P6839, DOI 10.1158/1078-0432.CCR-08-0230; Matache C, 2003, J AUTOIMMUN, V20, P323, DOI 10.1016/S0896-8411(03)00037-4; Matthews KA, 2004, CIRCULATION, V109, P66, DOI 10.1161/01.CIR.0000105766.33142.13; Mayou RA, 2000, PSYCHOSOM MED, V62, P212, DOI 10.1097/00006842-200003000-00011; Michal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072014; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Nabi H, 2010, PSYCHOL MED, V40, P405, DOI 10.1017/S0033291709990432; Nabi H, 2008, ARTERIOSCL THROM VAS, V28, P1398, DOI 10.1161/ATVBAHA.108.167239; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rybakowski JK, 2013, J AFFECT DISORDERS, V146, P286, DOI 10.1016/j.jad.2012.07.019; Sternberg Z, 2013, ATHEROSCLEROSIS, V229, P338, DOI 10.1016/j.atherosclerosis.2013.04.035; Suarez EC, 2004, PSYCHONEUROENDOCRINO, V29, P1119, DOI 10.1016/j.psyneuen.2004.01.002; Suarez EC, 2003, PSYCHOSOM MED, V65, P362, DOI 10.1097/01.PSY.0000035719.79068.2B; Thygesen K, 2007, EUR HEART J, V28, P2525; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; Zouridakis E, 2004, CIRCULATION, V110, P1747, DOI 10.1161/01.CIR.0000142664.18739.92	43	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105572	10.1371/journal.pone.0105572	http://dx.doi.org/10.1371/journal.pone.0105572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153995	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200062
J	Kelly, L; Patel, SA; Narayan, KMV; Prabhakaran, D; Cunningham, SA				Kelly, Laura; Patel, Shivani A.; Narayan, K. M. Venkat; Prabhakaran, Dorairaj; Cunningham, Solveig A.			Measuring Social Networks for Medical Research in Lower-Income Settings	PLOS ONE			English	Article							OBESITY EPIDEMIC; HEART-DISEASE; MORTALITY; HEALTH; SPREAD; ADULTS; TIES; BEHAVIORS; DURKHEIM; SMOKING	Social networks are believed to affect health-related behaviors and health. Data to examine the links between social relationships and health in low- and middle-income country settings are limited. We provide guidance for introducing an instrument to collect social network data as part of epidemiological surveys, drawing on experience in urban India. We describe development and fielding of an instrument to collect social network information relevant to health behaviors among adults participating in a large, population-based study of non-communicable diseases in Delhi, India. We discuss basic characteristics of social networks relevant to health including network size, health behaviors of network partners (i.e., network exposures), network homogeneity, network diversity, strength of ties, and multiplexity. Data on these characteristics can be collected using a short instrument of 11 items asked about up to 5 network members and 3 items about the network generally, administered in approximately 20 minutes. We found high willingness to respond to questions about social networks (97% response). Respondents identified an average of 3.8 network members, most often relatives (80% of network ties), particularly blood relationships. Ninety-one percent of respondents reported that their primary contacts for discussing health concerns were relatives. Among all listed ties, 91% of most frequent snack partners and 64% of exercise partners in the last two weeks were relatives. These results demonstrate that family relationships are the crux of social networks in some settings, including among adults in urban India. Collecting basic information about social networks can be feasibly and effectively done within ongoing epidemiological studies.	[Kelly, Laura] Univ Penn, Grad Grp Demog, Philadelphia, PA 19104 USA; [Patel, Shivani A.; Narayan, K. M. Venkat; Cunningham, Solveig A.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Prabhakaran, Dorairaj] Publ Hlth Fdn India, New Delhi, India	University of Pennsylvania; Emory University; Public Health Foundation of India	Kelly, L (corresponding author), Univ Penn, Grad Grp Demog, Philadelphia, PA 19104 USA.	kellyla@sas.upenn.edu	Prabhakaran, Dorairaj/B-4147-2011; Cunningham, Solveig/W-2672-2019; Narayan, K.M. Venkat/J-9819-2012; Cunningham, Solveig A/K-6760-2012	Prabhakaran, Dorairaj/0000-0002-3172-834X; Narayan, K.M. Venkat/0000-0001-8621-5405; Cunningham, Solveig A/0000-0002-2354-1526; Patel, Shivani/0000-0003-0082-5857	CoE-CARRS under National Heart, Lung, and Blood Institute, National Institutes of Health [HHSN268200900026C]; Fogarty International Center at Emory University [R25TW007733]; Population Research Training Grant by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [NIH T32 HD007242]; National Institute of Diabetes and Digestive and Kidney Diseases [R21DK081878]; United Health Group; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007242] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R25TW007733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081878] Funding Source: NIH RePORTER	CoE-CARRS under National Heart, Lung, and Blood Institute, National Institutes of Health; Fogarty International Center at Emory University; Population Research Training Grant by the Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United Health Group; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was coordinated by CoE-CARRS (Center of Excellence - Center for CArdio-metabolic Risk Reduction in South Asia) based at Public Health Foundation of India (PHFI), New Delhi, India in collaboration with Centre for Chronic Disease Control (CCDC), New Delhi, Emory University, Atlanta, U. S. A, All India Institute of Medical Sciences (AIIMS), New Delhi, Madras Diabetes Research Foundation (MDRF), Chennai, India and Aga Khan University, Karachi, Pakistan. CoE-CARRS was supported under Contract HHSN268200900026C from the National Heart, Lung, and Blood Institute, National Institutes of Health and the United Health Group. Kelly was supported by Award R25TW007733 from the Fogarty International Center at Emory University and by the Population Research Training Grant (NIH T32 HD007242) awarded to the Population Studies Center at the University of Pennsylvania by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Cunningham's and Narayan's work on this study was supported by grant R21DK081878 from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors.	Ali MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021179; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; Barefoot JC, 2005, AM J EPIDEMIOL, V161, P960, DOI 10.1093/aje/kwi128; Bearman PS, 2004, AM J PUBLIC HEALTH, V94, P89, DOI 10.2105/AJPH.94.1.89; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Blansky D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055944; Butts CT, 2008, ASIAN J SOC PSYCHOL, V11, P13, DOI 10.1111/j.1467-839X.2007.00241.x; Cacioppo JT, 2009, J PERS SOC PSYCHOL, V97, P977, DOI 10.1037/a0016076; Carrington P. J., 2005, MODELS METHODS SOCIA; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen Sheldon, 1997, JAMA (Journal of the American Medical Association), V277, P1940, DOI 10.1001/jama.277.24.1940; Eklund M, 2007, INT J SOC PSYCHIATR, V53, P293, DOI 10.1177/0020764006074540; Eng PM, 2002, AM J EPIDEMIOL, V155, P700, DOI 10.1093/aje/155.8.700; Ennett ST, 1999, J HEALTH SOC BEHAV, V40, P63, DOI 10.2307/2676379; Fowler JH, 2008, J HEALTH ECON, V27, P1400, DOI 10.1016/j.jhealeco.2008.07.001; Friedman SR, 1997, AM J PUBLIC HEALTH, V87, P1289, DOI 10.2105/AJPH.87.8.1289; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gyarmathy VA, 2009, AIDS BEHAV, V13, P196, DOI 10.1007/s10461-007-9285-9; Harris KM, 2009, NATL LONGITUDINAL ST; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; ISRAEL BA, 1982, PATIENT COUNS HEALTH, V4, P65, DOI 10.1016/S0190-2040(82)80002-5; Iwasaki M, 2002, INT J EPIDEMIOL, V31, P1208, DOI 10.1093/ije/31.6.1208; KAPLAN GA, 1988, AM J EPIDEMIOL, V128, P370, DOI 10.1093/oxfordjournals.aje.a114977; Kohler HP, 2007, DEMOGRAPHY, V44, P1, DOI 10.1353/dem.2007.0006; KROHN MD, 1988, SOC PSYCHOL QUART, V51, P346, DOI 10.2307/2786761; Kushner HI, 2005, AM J PUBLIC HEALTH, V95, P1139, DOI 10.2105/AJPH.2004.053314; Leroux JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046558; McCarty C, 1995, CONNECTIONS, V18, P20; McLaughlin D, 2010, J HEALTH PSYCHOL, V15, P671, DOI 10.1177/1359105310368177; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Mercken L, 2010, ADDICTION, V105, P1280, DOI 10.1111/j.1360-0443.2010.02930.x; Mercken L, 2009, SOC SCI MED, V69, P1506, DOI 10.1016/j.socscimed.2009.08.003; Miltiades HB, 2008, INT J SOC RES METHOD, V11, P277, DOI 10.1080/13645570701605921; Moestue H, 2007, PUBLIC HEALTH NUTR, V10, P1274, DOI 10.1017/S1368980007702896; PALINKAS LA, 1990, SOC SCI MED, V30, P441, DOI 10.1016/0277-9536(90)90346-T; Pollard MS, 2010, ADDICT BEHAV, V35, P678, DOI 10.1016/j.addbeh.2010.02.013; Price R K, 1995, NIDA Res Monogr, V151, P38; Richardson L, 2012, SOC SCI RES, V41, P624, DOI 10.1016/j.ssresearch.2011.12.004; Ronald SB, 1984, SOC NETWORKS, V6, P293; Rothenberg RB, 1998, SEX TRANSM DIS, V25, P154, DOI 10.1097/00007435-199803000-00009; Rutledge T, 2003, PSYCHOSOM MED, V65, P688, DOI 10.1097/01.PSY.0000041470.25130.6C; Rutledge T, 2008, PSYCHOSOM MED, V70, P282, DOI 10.1097/PSY.0b013e3181656e09; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Sivaram S, 2006, HARVARD HLTH POLICY, V7, P125; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Tyler KA, 2008, SOC SCI RES, V37, P673, DOI 10.1016/j.ssresearch.2007.09.004; Valente TW, 2007, AM J PUBLIC HEALTH, V97, P880, DOI 10.2105/AJPH.2005.063644; Valente Thomas W, 2004, Subst Use Misuse, V39, P1685, DOI 10.1081/JA-200033210; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WELLMAN B, 1979, URBAN AFF REV, V14, P363, DOI 10.1177/107808747901400305	56	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105161	10.1371/journal.pone.0105161	http://dx.doi.org/10.1371/journal.pone.0105161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153127	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200040
J	Rodriguez, SB; Leyh, TS				Rodriguez, Sofia B.; Leyh, Thomas S.			An Enzymatic Platform for the Synthesis of Isoprenoid Precursors	PLOS ONE			English	Article							ESCHERICHIA-COLI; COENZYME-A; DIRECTED EVOLUTION; KINETIC MECHANISM; PATHWAY; BIOSYNTHESIS; ARTEMISININ; OPTIMIZATION; SYNTHASE; ENZYMES	The isoprenoid family of compounds is estimated to contain similar to 65,000 unique structures including medicines, fragrances, and biofuels. Due to their structural complexity, many isoprenoids can only be obtained by extraction from natural sources, an inherently risky and costly process. Consequently, the biotechnology industry is attempting to genetically engineer microorganisms that can produce isoprenoid-based drugs and fuels on a commercial scale. Isoprenoid backbones are constructed from two, five-carbon building blocks, isopentenyl 5-pyrophosphate and dimethylallyl 5-pyrophosphate, which are end-products of either the mevalonate or non-mevalonate pathways. By linking the HMG-CoA reductase pathway (which produces mevalonate) to the mevalonate pathway, these building block can be synthesized enzymatically from acetate, ATP, NAD(P)H and CoA. Here, the enzymes in these pathways are used to produce pathway intermediates and end-products in single-pot reactions and in remarkably high yield, similar to 85%. A strategy for the regio-specific incorporation of isotopes into isoprenoid backbones is developed and used to synthesize a series of isotopomers of diphosphomevalonate, the immediate end-product of the mevalonate pathway. The enzymatic system is shown to be robust and capable of producing quantities of product in aqueous solutions that meet or exceed the highest levels achieved using genetically engineered organisms in high-density fermentation.	[Rodriguez, Sofia B.; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	tom.leyh@einstein.yu.edu			NIH [GM54469, AI068989, GM106158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106158, R01GM054469] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH GM54469, NIH AI068989, NIH GM106158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P16461, DOI 10.1021/bi048075t; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Arsenault PR, 2008, CURR MED CHEM, V15, P2886, DOI 10.2174/092986708786242813; Brown GD, 2010, MOLECULES, V15, P7603, DOI 10.3390/molecules15117603; BURBAUM JJ, 1989, BIOCHEMISTRY-US, V28, P9293, DOI 10.1021/bi00450a009; Caputi Lorenzo, 2011, Recent Pat Food Nutr Agric, V3, P9; CEDERSTAV AK, 1994, J AM CHEM SOC, V116, P4073, DOI 10.1021/ja00088a051; Cheng Q, 2007, NAT CHEM BIOL, V3, P557, DOI 10.1038/nchembio.2007.22; Clinkenbeard K D, 1975, Methods Enzymol, V35, P167, DOI 10.1016/0076-6879(75)35152-5; CORNFORTH JW, 1974, EUR J BIOCHEM, V42, P591, DOI 10.1111/j.1432-1033.1974.tb03374.x; CORNFORTH RH, 1960, NATURE, V185, P923, DOI 10.1038/185923a0; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Farhi M, 2011, NAT BIOTECHNOL, V29, P1072, DOI 10.1038/nbt.2054; Fokt I, 2013, CARBOHYD RES, V368, P111, DOI 10.1016/j.carres.2012.11.021; Fox JL, 2011, NAT BIOTECHNOL, V29, P1062, DOI 10.1038/nbt1211-1062; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; Gorenstein DG, 1984, PHOSPHORUS 31 NMR PR; Hale V, 2007, AM J TROP MED HYG, V77, P198, DOI 10.4269/ajtmh.2007.77.198; Hedl M, 2002, J BACTERIOL, V184, P2116, DOI 10.1128/JB.184.8.2116-2122.2002; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Hsu E, 2006, T ROY SOC TROP MED H, V100, P505, DOI 10.1016/j.trstmh.2005.09.020; Huang KT, 2006, CARBOHYD RES, V341, P2151, DOI 10.1016/j.carres.2006.04.047; Huang YQ, 2011, ANALYST, V136, P1515, DOI 10.1039/c0an00736f; Kajiwara Y, 2006, J AM CHEM SOC, V128, P9971, DOI 10.1021/ja062940a; Klinman JP, 2014, FEBS J, V281, P489, DOI 10.1111/febs.12477; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Krutsakorn B, 2013, METAB ENG, V20, P84, DOI 10.1016/j.ymben.2013.09.006; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Lacaze C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-142; Lefurgy ST, 2010, J BIOL CHEM, V285, P20654, DOI 10.1074/jbc.M109.098350; Levy GC., 1972, CARBON 13 NUCL MAGNE; Martin del Campo JS, 2013, ANGEW CHEM INT EDIT, V52, P4587, DOI 10.1002/anie.201300766; Melnick JS, 2003, BIOORG MED CHEM LETT, V13, P4139, DOI 10.1016/j.bmcl.2003.07.026; MIDDLETON B, 1974, BIOCHEM J, V139, P109, DOI 10.1042/bj1390109; MIZIORKO HM, 1977, J BIOL CHEM, V252, P1414; Miziorko HM, 2011, ARCH BIOCH BIOPHYS; Neuhoff V. SR, 1885, ELECTROPHORESIS, V6:, P427; NODA L, 1958, J BIOL CHEM, V232, P237; Noda L, 1962, ENZYMES, P139; Ohdan K, 2007, J BIOTECHNOL, V127, P496, DOI 10.1016/j.jbiotec.2006.07.023; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Osbourn A, 2011, NAT PROD REP, V28, P1261, DOI 10.1039/c1np00015b; OZER N, 1985, BIOCHEM MED METAB B, V33, P367, DOI 10.1016/0006-2944(85)90012-2; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; Pilloff DE, 2003, J BIOL CHEM, V278, P50435, DOI 10.1074/jbc.M306897200; Pohjanjoki P, 1998, BIOCHEMISTRY-US, V37, P1754, DOI 10.1021/bi971771r; Popjak G., 1970, ENZYMES, P115; Puri M, 2011, BIOTECHNOL ADV, V29, P781, DOI 10.1016/j.biotechadv.2011.06.006; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Romanowski MJ, 2002, PROTEINS, V47, P568, DOI 10.1002/prot.10118; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schultheisz HL, 2008, ACS CHEM BIOL, V3, P499, DOI 10.1021/cb800066p; Sen S, 2007, APPL BIOCHEM BIOTECH, V143, P212, DOI 10.1007/s12010-007-8003-4; SHAPIRO AL, 1967, BIOCHEM BIOPH RES CO, V28, P815, DOI 10.1016/0006-291X(67)90391-9; Sugiyama M, 2007, J AM CHEM SOC, V129, P14811, DOI 10.1021/ja073911i; Sutherlin A, 2004, BIOTECHNOL BIOENG, V87, P546, DOI 10.1002/bit.20157; Sutherlin A, 2002, J BACTERIOL, V184, P4065, DOI 10.1128/JB.184.15.4065-4070.2002; Thulasiram HV, 2008, J AM CHEM SOC, V130, P1966, DOI 10.1021/ja0771282; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; van den Heuvel RHH, 2001, J AGR FOOD CHEM, V49, P2954, DOI 10.1021/jf010093j; Wang C, 2010, BIOTECHNOL BIOENG, V107, P421, DOI 10.1002/bit.22831; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wouters J, 2003, J BIOL CHEM, V278, P11903, DOI 10.1074/jbc.M212823200; Wu Tao, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P1040; Xiao YS, 2013, ANAL CHEM, V85, P7478, DOI 10.1021/ac401415z; Yamaguchi S, 2007, APPL ENVIRON MICROB, V73, P5370, DOI 10.1128/AEM.00807-07; You C, 2013, P NATL ACAD SCI USA, V110, P7182, DOI 10.1073/pnas.1302420110; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zhao LS, 2013, ANNU REV BIOCHEM, V82, P497, DOI 10.1146/annurev-biochem-052010-100934; Zhu ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4026; Zyryanov AB, 2002, BIOCHEM J, V367, P901, DOI 10.1042/BJ20020880	80	8	8	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105594	10.1371/journal.pone.0105594	http://dx.doi.org/10.1371/journal.pone.0105594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153179	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200065
J	Van der Hiele, K; Middelkoop, HAM; Ruimschotel, R; Kamminga, NGA; Visser, LH				Van der Hiele, Karin; Middelkoop, Huub A. M.; Ruimschotel, Rob; Kamminga, Noelle G. A.; Visser, Leo H.			A Pilot Study on Factors Involved with Work Participation in the Early Stages of Multiple Sclerosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; EMPLOYMENT STATUS; COGNITIVE FUNCTION; DEPRESSION SCALE; HOSPITAL ANXIETY; IMPACT; DISABILITY; FATIGUE; HEALTH; INDIVIDUALS	Background: Up to 30% of recently diagnosed MS patients lose their jobs in the first four years after diagnosis. Taking into account the personal and socio-economic importance of sustaining employment, it is of the utmost importance to examine factors involved with work participation. Objective: To investigate differences in self-reported functioning in recently diagnosed MS patients with and without a paid job. Methods: Self-reports of physical and cognitive functioning, depression, anxiety and fatigue were gathered from 44 relapsing-remitting MS patients diagnosed within 3 years. Results: Patients with a paid job (57%) reported better physical functioning (p<0.001), better memory functioning (p = 0.01) and a lower physical impact of fatigue (p = 0.018) than patients without a paid job. Physical functioning was the main predictor of employment status in a logistic regression model. In those with a paid job better memory functioning (r = 0.54, p = 0.005) and a lower social impact of fatigue (r = -0.46, p = 0.029) correlated with an increased number of working hours. Conclusion: Better physical functioning is the primary factor involved with increased work participation in early MS. Better self-reported memory functioning and less social fatigue were associated with increased working hours. These findings highlight the importance of battling these symptoms in the early stages of MS.	[Van der Hiele, Karin] Natl Multiple Sclerosis Fdn, Maassluis, Netherlands; [Van der Hiele, Karin; Middelkoop, Huub A. M.] Leiden Univ, Dept Psychol, Sect Hlth Med & Neuropsychol, Leiden, Netherlands; [Ruimschotel, Rob] Med Psychiat Ctr PsyToBe, Rotterdam, Netherlands; [Middelkoop, Huub A. M.; Kamminga, Noelle G. A.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Visser, Leo H.] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Visser, Leo H.] Univ Humanist Studies, Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Van der Hiele, K (corresponding author), Natl Multiple Sclerosis Fdn, Maassluis, Netherlands.	hiele@fsw.leidenuniv.nl		van der Hiele, Karin/0000-0002-1567-0627	National Multiple Sclerosis Foundation, The Netherlands	National Multiple Sclerosis Foundation, The Netherlands	This research was financially supported by the National Multiple Sclerosis Foundation, The Netherlands. The first author, KH, was employed by the National Multiple Sclerosis Foundation and had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Volunteers working for the National Multiple Sclerosis Foundation helped with data collection by sending out questionnaires.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Arrindell WA, 2004, KLACHTENLIJST SCL 90; Bakshi R, 2003, MULT SCLER J, V9, P219, DOI 10.1191/1352458503ms904oa; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; de Groot V, 2006, BRAIN, V129, P2648, DOI 10.1093/brain/awl223; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Gommer A, 2010, VOLKSGEZONDHEID TOEK; Honarmand K, 2011, J NEUROL, V258, P244, DOI 10.1007/s00415-010-5736-8; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Ingram G, 2010, MULT SCLER J, V16, P472, DOI 10.1177/1352458509358902; Janssen B, 2011, EMANCIPATIEMONITOR 2, P72; Janssens ACJW, 2003, ACTA NEUROL SCAND, V108, P389, DOI 10.1034/j.1600-0404.2003.00166.x; Jonsson A, 2006, J NEUROL SCI, V245, P77, DOI 10.1016/j.jns.2005.09.016; Julian LJ, 2008, J NEUROL, V255, P1354, DOI 10.1007/s00415-008-0910-y; Klevan G, 2014, ACTA NEUROL SCAND, V129, P21, DOI 10.1111/ane.12142; Krabbendam L., 1997, BADS BEHAV ASSESSMEN; Krause I, 2013, MULT SCLER J, V19, P1792, DOI 10.1177/1352458513485655; Krokavcova M, 2010, DISABIL REHABIL, V32, P1742, DOI 10.3109/09638281003734334; Lankhorst GJ, 1996, J NEUROL, V243, P469, DOI 10.1007/BF00900502; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Morrow SA, 2010, CLIN NEUROPSYCHOL, V24, P1131, DOI 10.1080/13854046.2010.511272; Patti F, 2007, MULT SCLER J, V13, P783, DOI 10.1177/1352458506073511; Pompeii LA, 2005, J OCCUP REHABIL, V15, P69, DOI 10.1007/s10926-005-0875-y; Rijken M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-803; Roessler Richard T, 2003, Work, V21, P17; Ruet A, 2013, J NEUROL, V260, P776, DOI 10.1007/s00415-012-6705-1; Schiavolin S, 2013, INT J REHABIL RES, V36, P105, DOI 10.1097/MRR.0b013e32835c79ea; Schulz D, 2006, J NEUROL, V253, P1002, DOI 10.1007/s00415-006-0145-8; Simmons RD, 2010, J NEUROL, V257, P926, DOI 10.1007/s00415-009-5441-7; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Sweetland J, 2012, DISABIL REHABIL, V34, P2031, DOI 10.3109/09638288.2012.669019; van der Hiele K, 2012, EUR J NEUROL, V19, P562, DOI 10.1111/j.1468-1331.2011.03538.x; van der Hiele K, 2012, J NEUROL SCI, V320, P85, DOI 10.1016/j.jns.2012.06.023; Visser LH, 2014, NEURODEGENER DIS MAN, V4, P109, DOI [10.2217/nmt.14.15, 10.2217/NMT.14.15]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105673	10.1371/journal.pone.0105673	http://dx.doi.org/10.1371/journal.pone.0105673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153710	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200068
J	Cabello, M; Mendoza, Y; Bello, G				Cabello, Marina; Mendoza, Yaxelis; Bello, Gonzalo			Spatiotemporal Dynamics of Dissemination of Non-Pandemic HIV-1 Subtype B Clades in the Caribbean Region	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL DRUG-RESISTANCE; DIAGNOSED CUBAN PATIENTS; HIGH GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; PUERTO-RICO; EVOLUTIONARY HISTORY; POPULATION-DYNAMICS; MAXIMUM-LIKELIHOOD; RECOMBINANT FORMS	The Human immunodeficiency virus type-1 (HIV-1) epidemic in the Caribbean region is mostly driven by subtype B; but information about the pattern of viral spread in this geographic region is scarce and different studies point to quite divergent models of viral dissemination. In this study, we reconstructed the spatiotemporal and population dynamics of the HIV-1 subtype B epidemic in the Caribbean. A total of 1,806 HIV-1 subtype B pol sequences collected from 17 different Caribbean islands between 1996 and 2011 were analyzed together with sequences from the United States (n = 525) and France (n = 340) included as control. Maximum Likelihood phylogenetic analyses revealed that HIV-1 subtype B infections in the Caribbean are driven by dissemination of the pandemic clade (B-PANDEMIC) responsible for most subtype B infections across the world, and older non-pandemic lineages (B-CAR) characteristics of the Caribbean region. The non-pandemic B-CAR strains account for >40% of HIV-1 infections in most Caribbean islands; with exception of Cuba and Puerto Rico. Bayesian phylogeographic analyses indicate that B-CAR strains probably arose in the island of Hispaniola (Haiti/Dominican Republic) around the middle 1960s and were later disseminated to Trinidad and Tobago and to Jamaica between the late 1960s and the early 1970s. In the following years, the B-CAR strains were also disseminated from Hispaniola and Trinidad and Tobago to other Lesser Antilles islands at multiple times. The B-CAR clades circulating in Hispaniola, Jamaica and Trinidad and Tobago appear to have experienced an initial phase of exponential growth, with mean estimated growth rates of 0.35-0.45 year(-1), followed by a more recent stabilization since the middle 1990s. These results demonstrate that non-pandemic subtype B lineages have been widely disseminated through the Caribbean since the late 1960s and account for an important fraction of current HIV-1 infections in the region.	[Cabello, Marina; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil; [Mendoza, Yaxelis] Gorgas Mem Inst Hlth Studies, Dept Genom & Proteom, Panama City, Panama; [Mendoza, Yaxelis] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur City, Andhra Pradesh, India; [Mendoza, Yaxelis] Univ Panama, Dept Genet & Mol Biol, Panama City, Panama; [Mendoza, Yaxelis] INDICASAT AIP, INDICASAT AIP,City Knowledge,Clayton, Panama City, Panama	Fundacao Oswaldo Cruz; Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Universidad de Panama; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP)	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793	FAPERJ [E-26/111.758/2012, 472896/2012-1]; Instituto Oswaldo Cruz - FIOCRUZ; CNPq [472896/2012-1]	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Oswaldo Cruz - FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Public Health Service grants E-26/111.758/2012 from the FAPERJ and 472896/2012-1 from the CNPq. MC was funded by a fellowship from Instituto Oswaldo Cruz -FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; BARTHOLOMEW C, 1987, JAMA-J AM MED ASSOC, V257, P2604, DOI 10.1001/jama.257.19.2604; BARTHOLOMEW C, 1983, W INDIAN MED J, V32, P177; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Passaes CPB, 2009, INFECT GENET EVOL, V9, P474, DOI 10.1016/j.meegid.2009.01.008; Chen J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026827, 10.1371/journal.pone.0025286]; Cleghorn FR, 2000, P NATL ACAD SCI USA, V97, P10532, DOI 10.1073/pnas.97.19.10532; Cohen J, 2006, SCIENCE, V313, P473, DOI 10.1126/science.313.5786.473; Veras NMC, 2011, AIDS RES HUM RETROV, V27, P1173, DOI [10.1089/aid.2010.0333, 10.1089/AID.2010.0333]; Collins-Fairclough AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019995; Cuevas MT, 2002, AIDS, V16, P1643, DOI 10.1097/00002030-200208160-00010; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Arazoza H, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-130; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074072; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; Delatorre E, 2013, AIDS, V27, P1313, DOI 10.1097/QAD.0b013e32835f1df4; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Deren S, 2003, AM J PUBLIC HEALTH, V93, P812, DOI 10.2105/AJPH.93.5.812; Deren S, 2007, J URBAN HEALTH, V84, P243, DOI 10.1007/s11524-006-9151-5; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Figueras MA, 2001, LAT AM STUD ASS LASA; Figueroa JP, 2008, W INDIAN MED J, V57, P195; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gittens MV, 2003, AIDS RES HUM RETROV, V19, P313, DOI 10.1089/088922203764969519; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton CLC, 2012, AIDS RES HUM RETROV, V28, P923, DOI [10.1089/aid.2011.0312, 10.1089/AID.2011.0312]; Heslop OD, 2009, W INDIAN MED J, V58, P195; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; KOENIG RE, 1987, JAMA-J AM MED ASSOC, V257, P631, DOI 10.1001/jama.257.5.631; Kouri V, 2012, J CLIN VIROL, V55, P348, DOI 10.1016/j.jcv.2012.08.019; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Machado LY, 2013, AIDS RES HUM RETROV, V29, P411, DOI [10.1089/AID.2012.0183, 10.1089/aid.2012.0183]; Machado LY, 2012, AIDS RES HUM RETROV, V28, P956, DOI [10.1089/aid.2011.0295, 10.1089/AID.2011.0295]; Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095360; Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8; Murillo W, 2013, J VIROL, V87, P7463, DOI 10.1128/JVI.01602-12; MURPHY EL, 1988, J ACQ IMMUN DEF SYND, V1, P143; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Narain J P, 1989, Bull Pan Am Health Organ, V23, P42; Noel RJ, 2003, CELL MOL BIOL, V49, P1193; Pagan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069218; PAPE JW, 1983, NEW ENGL J MED, V309, P945, DOI 10.1056/NEJM198310203091603; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Perez L, 2013, INFECT GENET EVOL, V16, P144, DOI 10.1016/j.meegid.2013.02.002; Perez L, 2006, AIDS RES HUM RETROV, V22, P724, DOI 10.1089/aid.2006.22.724; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2007, TRACER V1 6; Rambaut A., 2014, FIGTREE V14 TREE FIG; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Rojas Patria, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P306, DOI 10.1177/1545109710397770; Roye ME, 2011, AIDS RES HUM RETROV, V27, P91, DOI 10.1089/aid.2010.0106; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sepulveda-Torres Ldel C, 2012, AIDS RES TREAT, V2012; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217; UNAIDS, 2013, REP GLOB AIDS EP; Vaughan HE, 2003, AIDS RES HUM RETROV, V19, P929, DOI 10.1089/088922203322493120; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	75	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e106045	10.1371/journal.pone.0106045	http://dx.doi.org/10.1371/journal.pone.0106045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148215	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600110
J	Leonhardt, SD; Kaltenpoth, M				Leonhardt, Sara D.; Kaltenpoth, Martin			Microbial Communities of Three Sympatric Australian Stingless Bee Species	PLOS ONE			English	Article							APIS-MELLIFERA; HONEY-BEES; CROP POLLINATION; GUT MICROBIOTA; ACID BACTERIA; BUMBLE-BEES; DIVERSITY; POLLEN; IDENTIFICATION; SYMBIONTS	Bacterial symbionts of insects have received increasing attention due to their prominent role in nutrient acquisition and defense. In social bees, symbiotic bacteria can maintain colony homeostasis and fitness, and the loss or alteration of the bacterial community may be associated with the ongoing bee decline observed worldwide. However, analyses of microbiota associated with bees have been largely confined to the social honeybees (Apis mellifera) and bumblebees (Bombus spec.), revealing - among other taxa - host-specific lactic acid bacteria (LAB, genus Lactobacillus) that are not found in solitary bees. Here, we characterized the microbiota of three Australian stingless bee species (Apidae: Meliponini) of two phylogenetically distant genera (Tetragonula and Austroplebeia). Besides common plant bacteria, we find LAB in all three species, showing that LAB are shared by honeybees, bumblebees and stingless bees across geographical regions. However, while LAB of the honeybee-associated Firm4-5 clusters were present in Tetragonula, they were lacking in Austroplebeia. Instead, we found a novel clade of likely host-specific LAB in all three Australian stingless bee species which forms a sister clade to a large cluster of Halictidae-associated lactobacilli. Our findings indicate both a phylogenetic and geographical signal of host-specific LAB in stingless bees and highlight stingless bees as an interesting group to investigate the evolutionary history of the bee-LAB association.	[Leonhardt, Sara D.] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [Kaltenpoth, Martin] Max Planck Inst Chem Ecol, Insect Symbiosis Res Grp, Jena, Germany	University of Wurzburg; Max Planck Society	Leonhardt, SD (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany.	sara.leonhardt@uni-wuerzburg.de; mkaltenpoth@ice.mpg.de	Kaltenpoth, Martin/M-8475-2014; Leonhardt, Sara/AAI-6901-2020	Kaltenpoth, Martin/0000-0001-9450-0345; Leonhardt, Sara/0000-0002-8154-9569	German Science Foundation [LE2750/1-1, KA2846/2-1]; Max Planck Society	German Science Foundation(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	The authors gratefully acknowledge funding from the German Science Foundation (LE2750/1-1 to SDL, and KA2846/2-1 to MK; www.dfg.de) and the Max Planck Society (MK; www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Banaszak J., 1995, CHANGES FAUNA WILD B; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Dollin A, 2009, TRIGONA CARBONARIA S; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Genin S, 2004, ANNU REV PHYTOPATHOL, V42, P107, DOI 10.1146/annurev.phyto.42.011204.104301; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; GILLIAM M, 1988, J INVERTEBR PATHOL, V52, P314, DOI 10.1016/0022-2011(88)90141-3; GOULSON D, 2003, BUMBLEBEES THEIR BEH; HEINRICH B, 1976, ECOL MONOGR, V46, P105, DOI 10.2307/1942246; HEINRICH B, 1977, BEHAV ECOL SOCIOBIOL, V2, P247, DOI 10.1007/BF00299738; HEITHAUS ER, 1979, ECOLOGY, V60, P190, DOI 10.2307/1936480; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Junker RR, 2011, PLANT BIOLOGY, V13, P918, DOI 10.1111/j.1438-8677.2011.00454.x; Keller A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078296; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2008, EC SOC AM ANN M; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Leonhardt SD, 2014, APIDOLOGIE, V45, P514, DOI 10.1007/s13592-013-0266-x; Leonhardt SD, 2011, AUSTRAL ECOL, V36, P537, DOI 10.1111/j.1442-9993.2010.02184.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loncaric I, 2009, APIDOLOGIE, V40, P40, DOI 10.1051/apido/2008062; Lyapunov YE, 2008, MICROBIOLOGY+, V77, P373, DOI 10.1134/S0026261708030181; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; McFrederick SQ, 2013, APPL ENVIRON MICROB; MERGAERT J, 1984, J GEN MICROBIOL, V130, P1893; Michener C.D., 2007, BEES WORLD, Vsecond; MILBORROW BV, 1987, AUST J BIOL SCI, V40, P15; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2009, J APICULT RES, V48, P233, DOI 10.3896/IBRA.1.48.4.02; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Promnuan Y, 2009, WORLD J MICROB BIOT, V25, P1685, DOI 10.1007/s11274-009-0051-1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rasmussen C, 2007, SYST ENTOMOL, V32, P26, DOI 10.1111/j.1365-3113.2006.00362.x; Rasmussen C, 2010, BIOL J LINN SOC, V99, P206, DOI 10.1111/j.1095-8312.2009.01341.x; Ryan MP, 2014, EUR J CLIN MICROBIOL, V33, P291, DOI 10.1007/s10096-013-1975-9; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Sun Y, 2011, METHODS MOL BIOL, V733, P129, DOI 10.1007/978-1-61779-089-8_9; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Walker K, 2010, AUSTROPLEBEIA AUSTRA; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1	62	34	34	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105718	10.1371/journal.pone.0105718	http://dx.doi.org/10.1371/journal.pone.0105718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148082	Green Published, gold			2022-12-27	WOS:000341230600074
J	Li, XQ; Choi, WW; Yan, R; Yu, HY; Krasnoperov, V; Kumar, SR; Schuckman, A; Klumpp, DJ; Pan, CX; Quinn, D; Gill, IS; Gill, PS; Liu, R				Li, Xiuqing; Choi, Wesley W.; Yan, Rui; Yu, Haiyang; Krasnoperov, Valery; Kumar, S. Ram; Schuckman, Anne; Klumpp, David J.; Pan, Chong-Xian; Quinn, David; Gill, Inderbir S.; Gill, Parkash S.; Liu, Ren			The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the Bladder	PLOS ONE			English	Article							COLORECTAL-CANCER PROGRESSION; TYROSINE KINASE; PROSTATE-CANCER; TUMOR ANGIOGENESIS; EPHRIN-B2; SURVIVAL; GROWTH; DISEASE; SIGNALS; TARGET	Effective treatment of transitional cell carcinoma (TCC) of the bladder requires early diagnosis. Identifying novel molecular markers in TCC would guide the development of diagnostic and therapeutic targets. Ephrins mediate signals via tyrosine kinase activity that modulates diverse physiologic and developmental processes, and ephrins are increasingly implicated in carcinogenesis. The aim of our study was to examine the differential regulation of EphB4 and EphB2 in normal bladder and in TCC of the bladder in 40 patients undergoing radical cystectomy for curative intent. Immunostaining and Western blotting revealed that normal urothelium expresses EphB2 (20 of 24 cases, 83% of the time) not EphB4 (0 of 24 cases, 0%). In sharp contrast, TCC specimens show loss of EphB2 expression (0 of 34 cases, 0%) and gain of EphB4 expression (32 of 34, 94%). Furthermore, EphB4 signal strength statistically correlated with higher tumor stage, and trended toward the presence of carcinoma in situ (CIS). These results are confirmed by analysis of normal urothelial and tumor cell lines. EphB2 is not a survival factor in normal urothelium, while EphB4 is a survival factor in TCC. Treatment of bladder tumor xenograft with an EphB4 inhibitor sEphB4-HSA leads to 62% tumor regression and complete remission when combined with Bevacizumab. Furthermore, tissue analysis revealed that sEphB4-HSA led to increased apoptosis, decreased proliferation, and reduced vessel density, implicating direct tumor cell targeting as well as anti-angiogenesis effect. In summary loss of EphB2 and gain of EphB4 expression represents an inflection point in the development, growth and possibly progression of TCC. Therapeutic compounds targeting EphB4 have potential for diagnosing and treating TCC.	[Li, Xiuqing; Yan, Rui; Yu, Haiyang; Quinn, David; Gill, Parkash S.; Liu, Ren] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Choi, Wesley W.; Gill, Inderbir S.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90033 USA; [Yu, Haiyang] Cent S Univ, Natl Hepatobiliary & Enter Surg Res Ctr, Dept Surg, Changsha, Hunan, Peoples R China; [Krasnoperov, Valery] VasGene Therapeut Inc, Los Angeles, CA USA; [Kumar, S. Ram; Schuckman, Anne] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Quinn, David] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Pan, Chong-Xian] Univ Calif Davis Comprehens Canc, Dept Internal Med, Sacramento, CA USA	University of Southern California; University of Southern California; Central South University; University of Southern California; Northwestern University; Feinberg School of Medicine	Gill, PS (corresponding author), Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA.	parkashg@usc.edu; renliu@usc.edu	Quinn, David/N-3730-2019; Quinn, David I/F-4343-2015	Quinn, David/0000-0002-1411-0417; Quinn, David I/0000-0002-1411-0417	Ezralow Family; Veterans Affairs [I01BX001784] Funding Source: NIH RePORTER	Ezralow Family; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Ezralow Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Chen MC, 2006, AM J PHYSIOL-RENAL, V291, pF741, DOI 10.1152/ajprenal.00081.2006; Djokovic D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-641; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Ferguson BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067668; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Hasina R, 2013, CANCER RES, V73, P184, DOI 10.1158/0008-5472.CAN-12-0915; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Kittles RA, 2006, J MED GENET, V43, P507, DOI 10.1136/jmg.2005.035790; Kumar SR, 2007, BRIT J CANCER, V96, P1083, DOI 10.1038/sj.bjc.6603642; Kumar SR, 2006, AM J PATHOL, V169, P279, DOI 10.2353/ajpath.2006.050889; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Lee YC, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-119; Liu R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-269; Masood R, 2006, INT J CANCER, V119, P1236, DOI 10.1002/ijc.21926; MESSING EM, 2002, CAMPBELLS UROLOGY; Mitra AP, 2006, J CLIN ONCOL, V24, P5552, DOI 10.1200/JCO.2006.08.2073; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Sinha UK, 2006, ARCH OTOLARYNGOL, V132, P1053, DOI 10.1001/archotol.132.10.1053; Spannuth WA, 2010, MOL CANCER THER, V9, P2377, DOI 10.1158/1535-7163.MCT-10-0200; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Tickle C, 1999, CURR OPIN GENET DEV, V9, P455, DOI 10.1016/S0959-437X(99)80069-0; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Xia G, 2006, ONCOGENE, V25, P769, DOI 10.1038/sj.onc.1209108; Xia GB, 2005, CANCER RES, V65, P4623, DOI 10.1158/0008-5472.CAN-04-2667; Xia GB, 2006, J UROLOGY, V175, P1245, DOI 10.1016/S0022-5347(05)00736-6	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105326	10.1371/journal.pone.0105326	http://dx.doi.org/10.1371/journal.pone.0105326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148033	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600043
J	Wu, AM; Zheng, YJ; Lin, Y; Wu, YS; Mao, FM; Ni, WF; Wang, XY; Xu, HZ				Wu, Ai-Min; Zheng, Yi-Jing; Lin, Yan; Wu, Yao-Sen; Mao, Fang-Min; Ni, Wen-Fei; Wang, Xiang-Yang; Xu, Hua-Zi			Transforaminal Decompression and Interbody Fusion in the Treatment of Thoracolumbar Fracture and Dislocation with Spinal Cord Injury	PLOS ONE			English	Article							LUMBAR; CLASSIFICATION; COMPLICATIONS; POSTERIOR	Study Design: A retrospective clinical study. Objective: To evaluate the efficacy and safety of transforaminal decompression and interbody fusion in the treatment of thoracolumbar fracture and dislocation with spinal cord injury. Methods: Twenty-six spinal cord injured patients with thoracolumbar fracture and dislocation were treated by transforaminal decompression and interbody fusion. The operation time, intraoperative blood loss, and complications were recorded; the Cobb angle and compressive rate (CR) of the anterior height of two adjacent vertebrae were measured; and the nerve injury was assessed according to sensory scores and motor scores of the American Spinal Injury Association (ASIA) standards for neurological classification of spinal cord injury. Results: The operative time was 250 +/- 57 min, and intraoperative blood loss was 440 +/- 168 ml. Cerebrospinal leakage was detected and repaired during the operation in two patients. A total of 24 of 26 patients were followed up for more than 2 years. ASIA sensory scores and motor scores were improved significantly at 3 months and 6 months after operation; the Cobb angle and CR of the anterior height of two adjacent vertebrae were corrected and showed a significant difference at post-operation; and the values were maintained at 3 months after operation and the last follow-up. Conclusion: We showed that transforaminal decompression together with interbody fusion is an alternative method to treat thoracolumbar fracture and dislocation.	[Wu, Ai-Min; Zheng, Yi-Jing; Lin, Yan; Wu, Yao-Sen; Mao, Fang-Min; Ni, Wen-Fei; Wang, Xiang-Yang; Xu, Hua-Zi] Wenzhou Med Univ, Affiliated Hosp 2, Zhejiang Spinal Res Ctr, Dept Orthoped, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Lin, Y (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Zhejiang Spinal Res Ctr, Dept Orthoped, Wenzhou, Zhejiang, Peoples R China.	linyanspine@126.com			National Natural Science Foundation of China [81372014]; Xinmiao talent plan of Zhejiang province; Department of Health of Zhejiang Province, Backbone of Talent Project [2012RCB037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinmiao talent plan of Zhejiang province; Department of Health of Zhejiang Province, Backbone of Talent Project	This work is supported by National Natural Science Foundation of China (81372014), Xinmiao talent plan of Zhejiang province; Department of Health of Zhejiang Province, Backbone of Talent Project (2012RCB037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acaroglu E R, 1996, Eur Spine J, V5, P56, DOI 10.1007/BF00307828; BAKER JK, 1993, SPINE, V18, P2227, DOI 10.1097/00007632-199311000-00014; Fang XQ, 2011, J SPINAL CORD MED, V34, P612, DOI 10.1179/2045772311Y.0000000025; Hu XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087501; Huang Russel C, 2010, HSS J, V6, P26, DOI 10.1007/s11420-009-9138-3; Humphreys SC, 2001, SPINE, V26, P567; Isiklar ZU, 1996, SPINE, V21, P2379, DOI 10.1097/00007632-199610150-00016; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; LOGUIDICE VA, 1988, SPINE, V13, P366, DOI 10.1097/00007632-198803000-00027; Rajaraman V, 1999, J NEUROSURG, V91, P60, DOI 10.3171/spi.1999.91.1.0060; Rene S, 2010, EUR SPINE J, V19, P1079, DOI 10.1007/s00586-010-1362-5; Rosenberg WS, 2001, NEUROSURGERY, V48, P569, DOI 10.1097/00006123-200103000-00022; Vaccaro AR, 2013, SPINE, V38, P2028, DOI 10.1097/BRS.0b013e3182a8a381; Vaccaro AR, 2006, J SPINAL DISORD TECH, V19, P1, DOI 10.1097/01.bsd.0000180080.59559.45; Wang L, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-40; Wood KB, 2014, SPINE J, V14, P145, DOI 10.1016/j.spinee.2012.10.041; Xia Qun, 2009, Orthop Surg, V1, P28, DOI 10.1111/j.1757-7861.2008.00006.x	17	2	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105625	10.1371/journal.pone.0105625	http://dx.doi.org/10.1371/journal.pone.0105625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148221	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600062
J	Pightling, AW; Petronella, N; Pagotto, F				Pightling, Arthur W.; Petronella, Nicholas; Pagotto, Franco			Choice of Reference Sequence and Assembler for Alignment of Listeria monocytogenes Short-Read Sequence Data Greatly Influences Rates of Error in SNP Analyses	PLOS ONE			English	Article							DISCOVERY; FRAMEWORK; GENOTYPE; BLOCKS	The wide availability of whole-genome sequencing (WGS) and an abundance of open-source software have made detection of single-nucleotide polymorphisms (SNPs) in bacterial genomes an increasingly accessible and effective tool for comparative analyses. Thus, ensuring that real nucleotide differences between genomes (i.e., true SNPs) are detected at high rates and that the influences of errors (such as false positive SNPs, ambiguously called sites, and gaps) are mitigated is of utmost importance. The choices researchers make regarding the generation and analysis of WGS data can greatly influence the accuracy of short-read sequence alignments and, therefore, the efficacy of such experiments. We studied the effects of some of these choices, including: i) depth of sequencing coverage, ii) choice of reference-guided short-read sequence assembler, iii) choice of reference genome, and iv) whether to perform read-quality filtering and trimming, on our ability to detect true SNPs and on the frequencies of errors. We performed benchmarking experiments, during which we assembled simulated and real Listeria monocytogenes strain 08-5578 short-read sequence datasets of varying quality with four commonly used assemblers (BWA, MOSAIK, Novoalign, and SMALT), using reference genomes of varying genetic distances, and with or without read pre-processing (i.e., quality filtering and trimming). We found that assemblies of at least 50-fold coverage provided the most accurate results. In addition, MOSAIK yielded the fewest errors when reads were aligned to a nearly identical reference genome, while using SMALT to align reads against a reference sequence that is similar to 0.82% distant from 08-5578 at the nucleotide level resulted in the detection of the greatest numbers of true SNPs and the fewest errors. Finally, we show that whether read pre-processing improves SNP detection depends upon the choice of reference sequence and assembler. In total, this study demonstrates that researchers should test a variety of conditions to achieve optimal results.	[Pightling, Arthur W.; Pagotto, Franco] Hlth Canada, Listeriosis Reference Serv Canada, Hlth Prod & Food Branch, Div Res,Food Directorate,Bur Microbial Hazards, Ottawa, ON K1A 0L2, Canada; [Petronella, Nicholas] Hlth Canada, Hlth Prod & Food Branch, Bur Food Surveillance & Sci Integrat, Biostat & Modelling Div,Food Directorate, Ottawa, ON K1A 0L2, Canada	Health Canada; Health Canada	Pagotto, F (corresponding author), Hlth Canada, Listeriosis Reference Serv Canada, Hlth Prod & Food Branch, Div Res,Food Directorate,Bur Microbial Hazards, Ottawa, ON K1A 0L2, Canada.	Franco.Pagotto@hc-sc.gc.ca	PIGHTLING, ARTHUR/AAD-6621-2020		Genomics R&D Initiative (GRDI) grant [4500834]; Natural Sciences and Engineering Research Council (NSERC)	Genomics R&D Initiative (GRDI) grant; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by Genomics R&D Initiative (GRDI) grant #4500834, awarded to FP. AWP was supported by a Natural Sciences and Engineering Research Council (NSERC) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Brockhurst MA, 2011, MOL ECOL, V20, P972, DOI 10.1111/j.1365-294X.2010.04835.x; Burrows M., 1994, BLOCK SORTING LOSSLE; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; Courvalin P, 2005, EMERG INFECT DIS, V11, P1503, DOI 10.3201/eid1110.051014; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Farrer RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01512; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Holch A, 2013, APPL ENVIRON MICROB, V79, P2944, DOI 10.1128/AEM.03715-12; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Knabel SJ, 2012, J CLIN MICROBIOL, V50, P1748, DOI 10.1128/JCM.06185-11; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Landan G, 2009, GENE, V441, P141, DOI 10.1016/j.gene.2008.05.016; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S8; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moorhead SM, 2003, J MICROBIOL METH, V55, P425, DOI 10.1016/S0167-7012(03)00188-X; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; SMITH TF, 1981, J MOL EVOL, V18, P38, DOI 10.1007/BF01733210; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874	38	55	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104579	10.1371/journal.pone.0104579	http://dx.doi.org/10.1371/journal.pone.0104579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144537	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100016
J	Stalmach, A; Johnsson, H; McInnes, IB; Husi, H; Klein, J; Dakna, M; Mullen, W; Mischak, H; Porter, D				Stalmach, Angelique; Johnsson, Hanna; McInnes, Iain B.; Husi, Holger; Klein, Julie; Dakna, Mohammed; Mullen, William; Mischak, Harald; Porter, Duncan			Identification of Urinary Peptide Biomarkers Associated with Rheumatoid Arthritis	PLOS ONE			English	Article							PROTEOME ANALYSIS; DIAGNOSIS; TOOL; PROGRESSION; VALIDATION; KALLIKREIN; CRITERIA; MMP-1	Early diagnosis and treatment of rheumatoid arthritis are associated with improved outcomes but current diagnostic tools such as rheumatoid factor or anti-citrullinated protein antibodies have shown limited sensitivity. In this pilot study we set out to establish a panel of urinary biomarkers associated with rheumatoid arthritis using capillary electrophoresis coupled to mass spectrometry. We compared the urinary proteome of 33 participants of the Scottish Early Rheumatoid Arthritis inception cohort study with 30 healthy controls and identified 292 potential rheumatoid arthritis-specific peptides. Amongst them, 39 were used to create a classifier model using support vector machine algorithms. Specific peptidic fragments were differentially excreted between groups; fragments of protein S100-A9 and gelsolin were less abundant in rheumatoid arthritis while fragments of uromodulin, complement C3 and fibrinogen were all increasingly excreted. The model generated was subsequently tested in an independent test-set of 31 samples. The classifier demonstrated a sensitivity of 88% and a specificity of 93% in diagnosing the condition, with an area under the receiver operating characteristic curve of 0.93 (p<0.0001). These preliminary results suggest that urinary biomarkers could be useful in the early diagnosis of rheumatoid arthritis. Further studies are currently being undertaken in larger cohorts of patients with rheumatoid arthritis and other athridities to assess the potential of the urinary peptide based classifier in the early detection of rheumatoid arthritis.	[Stalmach, Angelique; Husi, Holger; Mullen, William; Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Johnsson, Hanna] Western Gen Infirm, Edinburgh, Midlothian, Scotland; [McInnes, Iain B.; Porter, Duncan] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Klein, Julie; Dakna, Mohammed; Mischak, Harald] Mosaiques Diagnost GmbH, Hannover, Germany	University of Glasgow; University of Glasgow; Mosaiques Diagnostics GmbH (MOS)	Stalmach, A (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	Angelique.Stalmach@glasgow.ac.uk	Mullen, William/GWC-8078-2022; Stalmach, Angelique/B-3250-2009; Klein, Julie/M-7088-2017; Klein, Julie/ABE-2622-2020	Stalmach, Angelique/0000-0003-4491-654X; Klein, Julie/0000-0002-3279-0559; Klein, Julie/0000-0002-3279-0559; Porter, Duncan/0000-0001-8481-5204; Mullen, William/0000-0002-5685-1563; McInnes, Iain/0000-0002-6462-4280; Johnsson, Hanna/0000-0003-1916-6222; Mischak, Harald/0000-0003-0323-0306	Chief Scientist's Office, Scottish Government; Pfizer	Chief Scientist's Office, Scottish Government; Pfizer(Pfizer)	The Scottish Early Rheumatoid Arthritis (SERA) inception cohort and biobank is funded by the Chief Scientist's Office, Scottish Government and Pfizer; neither funder was involved in this study design, execution, analysis, decision to publish or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cader MZ, 2011, ANN RHEUM DIS, V70, P949, DOI 10.1136/ard.2010.143560; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Cassim B, 2009, RHEUMATOLOGY, V48, P490, DOI 10.1093/rheumatology/kep016; Chandra PE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3383; Dakna M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-594; Dawson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035879; De Franceschi L, 2011, PROTEOM CLIN APPL, V5, P78, DOI 10.1002/prca.201000069; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Eissa A, 2013, CLIN CHEM LAB MED, V51, P317, DOI 10.1515/cclm-2012-0251; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Green MJ, 2003, RHEUMATOLOGY, V42, P83, DOI 10.1093/rheumatology/keg037; Isordia-Salas I, 2004, ARCH MED RES, V35, P369, DOI 10.1016/j.arcmed.2004.05.004; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Judex MO, 2005, AM J PATHOL, V166, P645, DOI 10.1016/S0002-9440(10)62285-7; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Klein J, 2013, PROTEOMICS, V13, P1077, DOI 10.1002/pmic.201200493; Kriegsmann M, 2012, SCAND J RHEUMATOL, V41, P305, DOI 10.3109/03009742.2011.647925; Metzger J, 2010, KIDNEY INT, V78, P1252, DOI 10.1038/ki.2010.322; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Mischak H, 2010, NEPHROL DIAL TRANSPL, V25, P2843, DOI 10.1093/ndt/gfq363; Mischak H, 2010, PROTEOM CLIN APPL, V4, P464, DOI 10.1002/prca.200900189; Mullan RH, 2007, ARTHRITIS RHEUM, V56, P2919, DOI 10.1002/art.22843; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P283, DOI 10.1002/art.10092; Osborn TM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2520; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; RAHMAN MM, 1995, BRIT J RHEUMATOL, V34, P88; RAHMAN MM, 1995, ANN RHEUM DIS, V54, P345, DOI 10.1136/ard.54.5.345; Scarisbrick IA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018376; Schiffer E, 2012, INT J UROL, V19, P118, DOI 10.1111/j.1442-2042.2011.02901.x; Symmons DPM, 1998, J RHEUMATOL, V25, P1072; TRABANDT A, 1991, ARTHRITIS RHEUM, V34, P1444; Verstappen SMM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1882; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Whiting PF, 2010, ANN INTERN MED, V152, P456, DOI 10.7326/0003-4819-152-7-201004060-00010; Wild N, 2008, BIOMARKERS, V13, P88, DOI 10.1080/13547500701669410 ; Williams RJ, 1997, BRIT J RHEUMATOL, V36, P420; Wittke S, 2003, J CHROMATOGR A, V1013, P173, DOI 10.1016/S0021-9673(03)00713-1; Zhao XY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2478	44	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104625	10.1371/journal.pone.0104625	http://dx.doi.org/10.1371/journal.pone.0104625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144639	Green Published, gold, Green Accepted			2022-12-27	WOS:000341106100017
J	Straede, M; Brabrand, M				Straede, Mia; Brabrand, Mikkel			External Validation of the Simple Clinical Score and the HOTEL Score, Two Scores for Predicting Short-Term Mortality after Admission to an Acute Medical Unit	PLOS ONE			English	Article							SYSTEMS; ADULTS	Background: Clinical scores can be of aid to predict early mortality after admission to a medical admission unit. A developed scoring system needs to be externally validated to minimise the risk of the discriminatory power and calibration to be falsely elevated. We performed the present study with the objective of validating the Simple Clinical Score (SCS) and the HOTEL score, two existing risk stratification systems that predict mortality for medical patients based solely on clinical information, but not only vital signs. Methods: Pre-planned prospective observational cohort study. Setting: Danish 460-bed regional teaching hospital. Findings: We included 3046 consecutive patients from 2 October 2008 until 19 February 2009. 26 (0.9%) died within one calendar day and 196 (6.4%) died within 30 days. We calculated SCS for 1080 patients. We found an AUROC of 0.960 (95% confidence interval [CI], 0.932 to 0.988) for 24-hours mortality and 0.826 (95% CI, 0.774-0.879) for 30-day mortality, and goodness-of-fit test, chi(2) = 2.68 (10 degrees of freedom), P = 0.998 and chi(2) = 4.00, P = 0.947, respectively. We included 1470 patients when calculating the HOTEL score. Discriminatory power (AUROC) was 0.931 (95% CI, 0.901-0.962) for 24-hours mortality and goodness-of-fit test, chi(2) = 5.56 (10 degrees of freedom), P = 0.234. Conclusion: We find that both the SCS and HOTEL scores showed an excellent to outstanding ability in identifying patients at high risk of dying with good or acceptable precision.	[Straede, Mia] Sydvestjysk Sygehus Esbjerg, Dept Anaesthesiol, Esbjerg, Denmark; [Brabrand, Mikkel] Sydvestjysk Sygehus Esbjerg, Dept Med, Esbjerg, Denmark; [Brabrand, Mikkel] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital	Straede, M (corresponding author), Sydvestjysk Sygehus Esbjerg, Dept Anaesthesiol, Esbjerg, Denmark.	bjerrejepsen@gmail.com	Brabrand, Mikkel/F-7276-2011	Brabrand, Mikkel/0000-0002-3340-8251	Sydvestjysk Sygehus; Karola Jorgensens Forskningsfond; Edith og Vagn Hedegaard Jensens Fond; AB Fonden; Johs. M. Klein og Hustrus Mindelegat	Sydvestjysk Sygehus; Karola Jorgensens Forskningsfond; Edith og Vagn Hedegaard Jensens Fond; AB Fonden; Johs. M. Klein og Hustrus Mindelegat	The study was funded by Sydvestjysk Sygehus, Karola Jorgensens Forskningsfond, Edith og Vagn Hedegaard Jensens Fond, AB Fonden, and Johs. M. Klein og Hustrus Mindelegat. None of the funders have had influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript, as the researchers are independent from all sponsors.	Brabrand M, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Danis M, 1997, CRIT CARE MED, V25, P887; Frenkel WJ, 2014, J AM GERIATR SOC, V62, P342, DOI 10.1111/jgs.12635; Ghanem-Zoubi NO, 2011, CRIT CARE, V15, DOI 10.1186/cc10102; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Kellett J, 2006, QJM-INT J MED, V99, P771, DOI 10.1093/qjmed/hcl112; Kellett J, 2008, RESUSCITATION, V78, P52, DOI 10.1016/j.resuscitation.2008.02.011; Li JYZ, 2012, INTERN MED J, V42, P160, DOI 10.1111/j.1445-5994.2011.02498.x; Seymour CW, 2010, JAMA-J AM MED ASSOC, V304, P747, DOI 10.1001/jama.2010.1140; Subbe CP, 2010, CLIN MED, V10, P352, DOI 10.7861/clinmedicine.10-4-352; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511	12	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105695	10.1371/journal.pone.0105695	http://dx.doi.org/10.1371/journal.pone.0105695			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144186	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100111
J	Xiao, JQ; Cerminara, NL; Kotsurovskyy, Y; Aoki, H; Burroughs, A; Wise, AK; Luo, YJ; Marshall, SP; Sugihara, I; Apps, R; Lang, EJ				Xiao, Jianqiang; Cerminara, Nadia L.; Kotsurovskyy, Yuriy; Aoki, Hanako; Burroughs, Amelia; Wise, Andrew K.; Luo, Yuanjun; Marshall, Sarah P.; Sugihara, Izumi; Apps, Richard; Lang, Eric J.			Systematic Regional Variations in Purkinje Cell Spiking Patterns	PLOS ONE			English	Article							RAT CEREBELLAR CORTEX; ALDOLASE-C COMPARTMENTS; GLUTAMATE TRANSPORTER EAAT4; CLIMBING FIBER PROJECTION; ELECTROPHYSIOLOGICAL PROPERTIES; FUNCTIONAL-ORGANIZATION; SYNAPTIC-TRANSMISSION; PARAMEDIAN LOBULE; CHLORIDE CHANNEL; COPULA PYRAMIDIS	In contrast to the uniform anatomy of the cerebellar cortex, molecular and physiological studies indicate that significant differences exist between cortical regions, suggesting that the spiking activity of Purkinje cells (PCs) in different regions could also show distinct characteristics. To investigate this possibility we obtained extracellular recordings from PCs in different zebrin bands in crus IIa and vermis lobules VIII and IX in anesthetized rats in order to compare PC firing characteristics between zebrin positive (Z+) and negative (Z-) bands. In addition, we analyzed recordings from PCs in the A2 and C1 zones of several lobules in the posterior lobe, which largely contain Z+ and Z- PCs, respectively. In both datasets significant differences in simple spike (SS) activity were observed between cortical regions. Specifically, Z- and C1 PCs had higher SS firing rates than Z+ and A2 PCs, respectively. The irregularity of SS firing (as assessed by measures of interspike interval distribution) was greater in Z+ bands in both absolute and relative terms. The results regarding systematic variations in complex spike (CS) activity were less consistent, suggesting that while real differences can exist, they may be sensitive to other factors than the cortical location of the PC. However, differences in the interactions between SSs and CSs, including the post-CS pause in SSs and post-pause modulation of SSs, were also consistently observed between bands. Similar, though less strong trends were observed in the zonal recordings. These systematic variations in spontaneous firing characteristics of PCs between zebrin bands in vivo, raises the possibility that fundamental differences in information encoding exist between cerebellar cortical regions.	[Xiao, Jianqiang; Kotsurovskyy, Yuriy; Marshall, Sarah P.; Lang, Eric J.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY USA; [Cerminara, Nadia L.; Burroughs, Amelia; Apps, Richard] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Wise, Andrew K.] Bion Inst, East Melbourne, Vic, Australia; [Aoki, Hanako; Luo, Yuanjun; Sugihara, Izumi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Syst Neurophysiol, Tokyo, Japan; [Sugihara, Izumi] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan	New York University; University of Bristol; Bionics Institute; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Apps, R (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	r.apps@bristol.ac.uk; eric.lang@nyumc.org	; Wise, Andrew/B-5943-2014; Lang, Eric J/A-1136-2017	Kotsurovskyy, Yuriy/0000-0002-1288-518X; Cerminara, Nadia/0000-0001-8207-5871; Wise, Andrew/0000-0001-9715-8784; Lang, Eric J/0000-0002-8524-9854; Apps, Richard/0000-0002-2064-3359	National Science Foundation, United States of America [IOS-1051858]; National Institute of Neurological Disorders and Stroke [NS-37028]; Japan Society for the Promotion of Science (JSPS) [25430032]; Medical Research Council, United Kingdom [G1100626]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037028] Funding Source: NIH RePORTER; Medical Research Council [G1100626] Funding Source: researchfish; MRC [G1100626] Funding Source: UKRI; Direct For Biological Sciences [1051858] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [25430032, 26430035] Funding Source: KAKEN	National Science Foundation, United States of America(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants to EJL from the National Science Foundation, United States of America (www.NSF.gov) (Grant: IOS-1051858) and National Institute of Neurological Disorders and Stroke (www.ninds.nih.gov) (Grant: NS-37028), to RA and NLC from the Medical Research Council, United Kingdom (www.mrc.ac.uk/index.htm) (Grant: G1100626), and to IS from the Japan Society for the Promotion of Science (JSPS) (www.jsps.go.jp/english/) (Grants-in- Aid for Scientific Research-KAKENHI, 25430032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Alvina K, 2010, J NEUROSCI, V30, P7258, DOI 10.1523/JNEUROSCI.3582-09.2010; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Atkins MJ, 1997, J COMP NEUROL, V389, P249; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BLOEDEL JR, 1971, J NEUROPHYSIOL, V34, P17, DOI 10.1152/jn.1971.34.1.17; BLOEDEL JR, 1992, BEHAV BRAIN SCI, V15, P666; Braitenberg V, 2002, ANN NY ACAD SCI, V978, P175, DOI 10.1111/j.1749-6632.2002.tb07565.x; Brasnjo G, 2004, P NATL ACAD SCI USA, V101, P6273, DOI 10.1073/pnas.0308149101; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; BURG D, 1972, PFLUG ARCH EUR J PHY, V337, P367, DOI 10.1007/BF00586652; Cerminara NL, 2013, J NEUROSCI, V33, P16427, DOI 10.1523/JNEUROSCI.0861-13.2013; Cerminara NL, 2011, CEREBELLUM, V10, P484, DOI 10.1007/s12311-010-0209-2; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Chaumont J, 2013, P NATL ACAD SCI USA, V110, P16223, DOI 10.1073/pnas.1302310110; Chung SH, 2009, NEUROSCIENCE, V161, P123, DOI 10.1016/j.neuroscience.2009.03.037; Coddington LT, 2013, NEURON, V78, P1050, DOI 10.1016/j.neuron.2013.04.019; COLIN F, 1980, BRAIN RES, V187, P3, DOI 10.1016/0006-8993(80)90491-6; Dehnes Y, 1998, J NEUROSCI, V18, P3606; DEMER JL, 1985, BRAIN RES, V346, P22, DOI 10.1016/0006-8993(85)91090-X; Dino MR, 1999, J NEUROCYTOL, V28, P99, DOI 10.1023/A:1007072105919; EBNER TJ, 1981, J NEUROPHYSIOL, V45, P933, DOI 10.1152/jn.1981.45.5.933; ECCLES JC, 1973, J PHYSIOL-LONDON, V229, P1; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; ECCLES JC, 1966, EXP BRAIN RES, V2, P18; Eccles JC, 1967, CEREBELLUM NEURONAL; Gao WC, 2006, J NEUROSCI, V26, P8377, DOI 10.1523/JNEUROSCI.2434-06.2006; Glasauer S, 2011, ANN NY ACAD SCI, V1233, P162, DOI 10.1111/j.1749-6632.2011.06149.x; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; HAMORI J, 1980, BRAIN RES, V186, P454, DOI 10.1016/0006-8993(80)90990-7; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; Hawkes R, 1997, PROG BRAIN RES, V114, P39; Heck DH, 2013, J NEUROSCI, V33, P17603, DOI 10.1523/JNEUROSCI.2759-13.2013; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; JI Z, 1994, NEUROSCIENCE, V61, P935, DOI 10.1016/0306-4522(94)90414-6; Jorntell H, 2003, J NEUROSCI, V23, P9620; Kim YS, 2009, J NEUROSCI, V29, P8530, DOI 10.1523/JNEUROSCI.0468-09.2009; Lang EJ, 2002, J NEUROPHYSIOL, V87, P1993, DOI 10.1152/jn.00477.2001; Lang EJ, 1999, J NEUROSCI, V19, P2728; LATHAM A, 1971, J PHYSIOL-LONDON, V213, P135, DOI 10.1113/jphysiol.1971.sp009373; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Marshall SP, 2009, J NEUROSCI, V29, P14352, DOI 10.1523/JNEUROSCI.3498-09.2009; Mathews PJ, 2012, J NEUROSCI, V32, P17988, DOI 10.1523/JNEUROSCI.3916-12.2012; MCDEVITT CJ, 1982, BRAIN RES, V237, P484, DOI 10.1016/0006-8993(82)90460-7; MONTAROLO PG, 1982, J PHYSIOL-LONDON, V332, P187, DOI 10.1113/jphysiol.1982.sp014409; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nagao S, 1997, NEUROSCIENCE, V78, P929; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Ozden I, 2009, J NEUROSCI, V29, P10463, DOI 10.1523/JNEUROSCI.0967-09.2009; Pakan JMP, 2010, J COMP NEUROL, V518, P175, DOI 10.1002/cne.22192; PALKOVITS M, 1977, EXP BRAIN RES, V28, P189; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Pham NQ, 2011, J COMP NEUROL, V519, P874, DOI 10.1002/cne.22555; Pijpers A, 2006, J NEUROSCI, V26, P12067, DOI 10.1523/JNEUROSCI.2905-06.2006; Raman IM, 1999, J NEUROSCI, V19, P1663; RAWSON JA, 1981, NEUROSCI LETT, V25, P125, DOI 10.1016/0304-3940(81)90319-0; Ruigrok TJH, 2011, CEREBELLUM, V10, P464, DOI 10.1007/s12311-010-0164-y; SASAKI K, 1989, EUR J NEUROSCI, V1, P572, DOI 10.1111/j.1460-9568.1989.tb00364.x; SAVIO T, 1985, EXP BRAIN RES, V57, P456; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; Shin JH, 2008, P NATL ACAD SCI USA, V105, P746, DOI 10.1073/pnas.0709407105; Shin SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000485; Simpson JI, 2002, ANN NY ACAD SCI, V978, P232, DOI 10.1111/j.1749-6632.2002.tb07570.x; Stahl JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057895; STEIN RB, 1967, BIOPHYS J, V7, P797, DOI 10.1016/S0006-3495(67)86623-2; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Sugihara I, 2007, J COMP NEUROL, V500, P1076, DOI 10.1002/cne.21219; Sugihara I, 2007, J COMP NEUROL, V501, P13, DOI 10.1002/cne.21223; Sugihara I, 2011, CEREBELLUM, V10, P449, DOI 10.1007/s12311-010-0226-1; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; Szapiro G, 2007, NAT NEUROSCI, V10, P735, DOI 10.1038/nn1907; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Takayasu Y, 2004, EUR J NEUROSCI, V19, P1285, DOI 10.1111/j.1460-9568.2004.03224.x; Tanaka J, 1997, NEUROREPORT, V8, P2461, DOI 10.1097/00001756-199707280-00010; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Voogd J, 2012, CEREBELLUM, V11, P422, DOI 10.1007/s12311-012-0367-5; Voogd J, 2003, J NEUROSCI, V23, P4645; Voogd J, 1997, PROG BRAIN RES, V114, P21; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Winkelman BHJ, 2014, J NEUROSCI, V34, P3218, DOI 10.1523/JNEUROSCI.3080-13.2014; Wise AK, 2010, J PHYSIOL-LONDON, V588, P2373, DOI 10.1113/jphysiol.2010.189704; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536	90	46	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105633	10.1371/journal.pone.0105633	http://dx.doi.org/10.1371/journal.pone.0105633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144311	Green Published, gold			2022-12-27	WOS:000341106100103
J	Ma, YJ; Liu, JJ; Hou, J; Dong, YK; Lu, Y; Jin, L; Cao, R; Li, TM; Wu, J				Ma, Yanjun; Liu, Jingjing; Hou, Jing; Dong, Yuankai; Lu, Yong; Jin, Liang; Cao, Rongyue; Li, Taiming; Wu, Jie			Oral Administration of Recombinant Lactococcus lactis Expressing HSP65 and Tandemly Repeated P277 Reduces the Incidence of Type I Diabetes in Non-Obese Diabetic Mice	PLOS ONE			English	Article							SUBSP LACTIS; VACCINES; DELIVERY; PROTEIN; INTERLEUKIN-10; THERAPY	Diabetes mellitus type 1 (DM1) is an autoimmune disease that gradually destroys insulin-producing beta-cells. We have previously reported that mucosal administration of fusion protein of HSP65 with tandem repeats of P277 (HSP65-6P277) can reduce the onset of DM1 in non-obese diabetic (NOD) mice. To deliver large amounts of the fusion protein and to enhance long-term immune tolerance effects, in the present study, we investigated the efficacy of using orally administrated L. lactis expressing HSP65-6P277 to reduce the incidence of DM1 in NOD mice. L. lactis strain NZ9000 was engineered to express HSP65-6P277 either constitutively or by nisin induction. After immunization via gavage with the recombinant L. lactis strains to groups of 4-week old female NOD mice for 36 weeks, we observed that oral administration of recombinant L. Lactis resulted in the prevention of hyperglycemia, improved glucose tolerance and reduced insulitis. Immunologic analysis showed that treatment with recombinant L. lactis induced HSP65- and P277- specific T cell immuno-tolerance, as well as antigen-specific proliferation of splenocytes. The results revealed that the DM1-preventing function was in part caused by a reduction in the pro-inflammatory cytokine IFN-gamma and an increase in the anti-inflammatory cytokine IL-10. Orally administered recombinant L. lactis delivering HSP65-6P277 may be an effective therapeutic approach in preventing DM1.	[Ma, Yanjun] Nanjing Forest Police Coll, Forens Ctr, Nanjing, Jiangsu, Peoples R China; [Ma, Yanjun; Liu, Jingjing; Hou, Jing; Dong, Yuankai; Lu, Yong; Jin, Liang; Cao, Rongyue; Li, Taiming; Wu, Jie] China Pharmaceut Univ, Sch Life Sci & Technol, Minigene Pharm Lab, Nanjing, Jiangsu, Peoples R China	Nanjing Forest Police College; China Pharmaceutical University	Wu, J (corresponding author), Nanjing Forest Police Coll, Forens Ctr, Nanjing, Jiangsu, Peoples R China.	wujie@cpu.edu.cn			National Natural Science Foundation of China [81172973, 31270985, 30872393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 81172973, 31270985, and 30872393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2005, CLIN EXP ALLERGY, V35, P539, DOI 10.1111/j.1365-2222.2005.02225.x; Bahey-El-Din M, 2011, HUM VACCINES, V7, P106, DOI 10.4161/hv.7.1.13631; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; ELIAS D, 1994, LANCET, V343, P704, DOI 10.1016/S0140-6736(94)91582-2; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Hou J, 2011, VACCINE, V29, P4102, DOI 10.1016/j.vaccine.2011.03.105; Jin L, 2008, J IMMUNOL, V180, P58, DOI 10.4049/jimmunol.180.1.58; Jin L, 2007, VACCINE, V25, P2043, DOI 10.1016/j.vaccine.2006.11.052; Jin L, 2010, VACCINE, V28, P3312, DOI 10.1016/j.vaccine.2010.02.100; Lei H, 2010, VIROLOGY, V407, P319, DOI 10.1016/j.virol.2010.08.007; Lu Y, 2009, VACCINE, V27, P5411, DOI 10.1016/j.vaccine.2009.06.089; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; Martin S, 1996, J AUTOIMMUN, V9, P637, DOI 10.1006/jaut.1996.0083; MCINTYRE DA, 1989, APPL ENVIRON MICROB, V55, P604, DOI 10.1128/AEM.55.3.604-610.1989; Miettinen M, 1996, INFECT IMMUN, V64, P5403, DOI 10.1128/IAI.64.12.5403-5405.1996; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neirynck Sabine, 2006, Biotechnol Genet Eng Rev, V22, P253; Nitta Y, 1998, HUM GENE THER, V9, P1701, DOI 10.1089/hum.1998.9.12-1701; Nouaille Sebastien, 2003, Genet Mol Res, V2, P102; Petrovsky N, 2010, NAT REV ENDOCRINOL, V6, P131, DOI 10.1038/nrendo.2009.273; Portaro FCV, 2002, BIOCHEMISTRY-US, V41, P7400, DOI 10.1021/bi011999l; Prud'homme GJ, 1999, GENE THER, V6, P771, DOI 10.1038/sj.gt.3300879; Raz I, 2014, DIABETES CARE, V37, P1392, DOI 10.2337/dc13-1391; Robert S, 2014, DIABETES; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Steidler L, 2006, ANN NY ACAD SCI, V1072, P176, DOI 10.1196/annals.1326.031; Steidler Lothar, 2003, Discov Med, V3, P49; Takiishi T, 2012, J CLIN INVEST, V122, P1717, DOI 10.1172/JCI60530; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; VANASSELDONK M, 1990, GENE, V95, P155, DOI 10.1016/0378-1119(90)90428-T; Vandenbroucke K, 2010, MUCOSAL IMMUNOL, V3, P49, DOI 10.1038/mi.2009.116; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987; Xiong QY, 2009, AUTOIMMUNITY, V42, P475, DOI 10.1080/08916930902887086; Yam KK, 2011, J MED MICROBIOL, V60, P1248, DOI 10.1099/jmm.0.029959-0; Zoka A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/254874	35	42	51	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105701	10.1371/journal.pone.0105701	http://dx.doi.org/10.1371/journal.pone.0105701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157497	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200047
J	Garcia-Rio, F; Soriano, JB; Miravitlles, M; Munoz, L; Duran-Tauleria, E; Sanchez, G; Sobradillo, V; Ancochea, J				Garcia-Rio, Francisco; Soriano, Joan B.; Miravitlles, Marc; Munoz, Luis; Duran-Tauleria, Enric; Sanchez, Guadalupe; Sobradillo, Victor; Ancochea, Julio			Impact of Obesity on the Clinical Profile of a Population-Based Sample with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITIONAL DEPLETION; SYSTEMIC INFLAMMATION; PROGNOSTIC VALUE; LUNG-DISEASE; COPD; MORTALITY; RISK; PREVALENCE; EXERCISE	Aims: To characterize the distribution of BMI in a population-based sample of COPD patients and to evaluate the impact of obesity on their health status, exercise tolerance, systemic inflammation and comorbidity. Methods: A population-based sample of 3,797 subjects aged 40-80 years from the EPI-SCAN study was selected. Subjects were categorized according their body mass index (BMI) as underweight (<18.5 kg/m(2)), normal weight (18.5-24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)) or obese (BMI >= 30.0 kg/m(2)). Subjects were evaluated with post-bronchodilator spirometry and 6-minute walk tests. Smoking habits, respiratory symptoms, generic and specific quality of life, daily physical activities, comorbidities and systemic inflammatory biomarkers were recorded. Results: The prevalence of obesity or being overweight was higher in the 382 COPD patients than in the subjects without airflow limitation (29.4%, 95% CI 24.8-33.9% vs. 24.3, 95% CI 22.9-25.8; and 44.7%, 95% CI 39.7-49.6% vs. 43.0%, 95% CI 41.3-44.6, respectively; p = 0.020). In the COPD subgroup, obese subjects presented more dyspnea and less chronic cough, chronic bronchitis or chronic phlegm than normal-weight patients, as well as a worse health status. Moreover, reduced exercise tolerance and higher plasmatic C-reactive protein levels were found in the obese patients, who also presented a greater prevalence of cardiovascular disease (adjusted odds ratio 4.796, 95% CI 1.806-12.736, p = 0.002). Conclusions: In a population-based sample, obesity is more prevalent in COPD patients than in subjects without airflow limitation. Furthermore, obesity affects the clinical manifestations, quality of life and exercise tolerance of COPD patients, and it may contribute to a phenotype characterized by increased systemic inflammation and greater frequency of cardiovascular comorbidity.	[Garcia-Rio, Francisco] Hosp Univ La Paz, Serv Neumol, IdiPAZ, Madrid, Spain; [Garcia-Rio, Francisco] CIBER Enfermedades Resp, Madrid, Spain; [Soriano, Joan B.] Fdn Caubet CIMERA Illes Balears, Bunyola, Illes Balears, Spain; [Soriano, Joan B.] CIBER Enfermedades Resp, Illes Balears, Spain; [Miravitlles, Marc] Hosp Univ Vall Hebron, Dept Pneumol, Barcelona, Spain; [Munoz, Luis] Hosp Reina Sofia, Dept Pneumol, Cordoba, Spain; [Duran-Tauleria, Enric] Ctr Invest Epidemiol Ambiental CREAL, Barcelona, Spain; [Sanchez, Guadalupe] GlaxoSmithkline SA, Dept Med, Madrid, Spain; [Sobradillo, Victor] Hosp Cruces, Dept Pneumol, Bilbao, Spain; [Ancochea, Julio] Inst Invest Sanitaria Princesa, Hosp Univ La Princesa, Serv Neumol, Madrid, Spain	Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitari Vall d'Hebron; Hospital Universitario Reina Sofia - Cordoba; Pompeu Fabra University; GlaxoSmithKline; Hospital Universitario Cruces	Garcia-Rio, F (corresponding author), Hosp Univ La Paz, Serv Neumol, IdiPAZ, Madrid, Spain.	fgr01m@gmail.com	Garcia-Rio, Francisco/AAC-9981-2020; Miravitlles, Marc/AAH-5284-2019; Soriano, Joan B/O-1215-2017	Miravitlles, Marc/0000-0002-9850-9520; Soriano, Joan B/0000-0001-9740-2994; Ancochea, julio/0000-0001-7451-4133; Garcia-Rio, Francisco/0000-0002-7227-2238	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding for the EPI-SCAN study was provided by GlaxoSmithKline. The funder provided support in the form of salaries for authors (GS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	Ancochea J, 2009, ARCH BRONCONEUMOL, V45, P41, DOI 10.1016/j.arbres.2008.06.001; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Cao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043892; Cecere LM, 2011, COPD, V8, P275, DOI 10.3109/15412555.2011.586660; Cekerevac I, 2011, SRP ARK CELOK LEK, V139, P322, DOI 10.2298/SARH1106322C; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chailleux E, 2003, CHEST, V123, P1460, DOI 10.1378/chest.123.5.1460; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Oca MM, 2008, RESP MED, V102, P642, DOI 10.1016/j.rmed.2007.12.025; Deesomchok A, 2010, AM J RESP CRIT CARE, V181, P125, DOI 10.1164/rccm.200906-0934OC; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Figarska SM, 2012, EUR J EPIDEMIOL, V27, P867, DOI 10.1007/s10654-012-9736-0; Franssen FME, 2008, THORAX, V63, P1110, DOI 10.1136/thx.2007.086827; Rodriguez LAG, 2009, COPD, V6, P369, DOI 10.1080/15412550903156325; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Garcia-Rio F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-63; GesEPOC, 2012, ARCH BRONCONEUMOL S, V48, P2; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; GrayDonald K, 1996, AM J RESP CRIT CARE, V153, P961, DOI 10.1164/ajrccm.153.3.8630580; Guerra S, 2002, CHEST, V122, P1256, DOI 10.1378/chest.122.4.1256; Ischaki E, 2007, CHEST, V132, P164, DOI 10.1378/chest.06-2789; Jordan JG, 2010, SOUTH MED J, V103, P323, DOI 10.1097/SMJ.0b013e3181d394b4; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lavie CJ, 2003, J AM COLL CARDIOL, V42, P677, DOI 10.1016/S0735-1097(03)00784-8; Laviolette L, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-33; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miravitlles M, 2009, THORAX, V64, P863, DOI 10.1136/thx.2009.115725; Miravitlles M, 2013, RESP MED, V107, P1053, DOI 10.1016/j.rmed.2013.03.007; O'Donnell DE, 2011, CHEST, V140, P461, DOI 10.1378/chest.10-2582; Ora J, 2009, AM J RESP CRIT CARE, V180, P964, DOI [10.1164/rccm.200904-0530OC, 10.1164/rccm.200904-0503OC]; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; Rennard SI, 2003, EUR RESPIR J, V21, P916, DOI 10.1183/09031936.03.00111602; Salome CM, 2008, INT J OBESITY, V32, P502, DOI 10.1038/sj.ijo.0803752; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; SCHOLS AMWJ, 1993, AM REV RESPIR DIS, V147, P1151, DOI 10.1164/ajrccm/147.5.1151; Shim YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061022; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; van den Bemt L, 2009, THORAX, V64, P640, DOI 10.1136/thx.2008.111716; Vozoris NT, 2012, CAN RESPIR J, V19, pE18, DOI 10.1155/2012/732618	44	46	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105220	10.1371/journal.pone.0105220	http://dx.doi.org/10.1371/journal.pone.0105220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153331	gold, Green Submitted, Green Published			2022-12-27	WOS:000340952200042
J	Kim, GR; Kang, J; Kwak, JY; Chang, JH; Kim, SI; Youk, JH; Moon, HJ; Kim, MJ; Kim, EK				Kim, Ga Ram; Kang, Jeeun; Kwak, Jin Young; Chang, Jin Ho; Kim, Seung Il; Youk, Ji Hyun; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung			Photoacoustic Imaging of Breast Microcalcifications: A Preliminary Study with 8-Gauge Core-Biopsied Breast Specimens	PLOS ONE			English	Article							SONOGRAPHICALLY GUIDED BIOPSY; IN-VIVO; RAMAN-SPECTROSCOPY; IDENTIFYING MICROCALCIFICATIONS; HIGH-RESOLUTION; CANCER; LESIONS; US; MAMMOGRAPHY	Background: We presented the photoacoustic imaging (PAI) tool and to evaluate whether microcalcifications in breast tissue can be detected on photoacoustic (PA) images. Methods: We collected 21 cores containing microcalcifications (n = 11, microcalcification group) and none (n = 10, control group) in stereotactic or ultrasound (US) guided 8-gauge vacuum-assisted biopsies. Photoacoustic (PA) images were acquired through ex vivo experiments by transmitting laser pulses with two different wavelengths (700 nm and 800 nm). The presence of microcalcifications in PA images were blindly assessed by two radiologists and compared with specimen mammography. A ratio of the signal amplitude occurring at 700 nm to that occurring at 800 nm was calculated for each PA focus and was called the PAI ratio. Results: Based on the change of PA signal amplitude between 700 nm and 800 nm, 10 out of 11 specimens containing microcalcifications and 8 out of 10 specimens without calcifications were correctly identified on blind review; the sensitivity, specificity, accuracy, positive predictive and negative predictive values of our blind review were 90.91%, 80.0%, 85.71%, 83.33% and 88.89%. The PAI ratio in the microcalcification group was significantly higher than that in the control group (the median PAI ratio, 2.46 versus 1.11, respectively, P = .001). On subgroup analysis in the microcalcification group, neither malignant diagnosis nor the number or size of calcification-foci was proven to contribute to PAI ratios. Conclusion: Breast microcalcifications generated distinguishable PA signals unlike breast tissue without calcifications. So, PAI, a non-ionizing and non-invasive hybrid imaging technique, can be an alternative in overcoming the limitations of conventional US imaging.	[Kim, Ga Ram; Kwak, Jin Young; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea; [Kim, Ga Ram; Kwak, Jin Young; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci, Seoul, South Korea; [Kim, Seung Il] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; [Kang, Jeeun; Chang, Jin Ho] Sogang Univ, Sogang Inst Adv Technol, Seoul, South Korea; [Kang, Jeeun; Chang, Jin Ho] Interdisciplinary Program Integrated Biotechnol, Seoul, South Korea; [Youk, Ji Hyun] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sogang University; Yonsei University; Yonsei University Health System	Kim, EK (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea.	ekkim@yuhs.ac	Kim, Eun-Kyung/E-5211-2017; Kang, Jeeun/I-1149-2019	Kim, Eun-Kyung/0000-0002-3368-5013; Kang, Jeeun/0000-0001-6678-2744; Moon, Hee Jung/0000-0002-5643-5885; Kim, Ga Ram/0000-0002-4481-5792; Kwak, Jin Young/0000-0002-6212-1495; CHANG, JIN HO/0000-0002-8323-4202	Yonsei University College of Medicine [6-2012-0019]; International Collaborative R&D Program - Ministry of Knowledge Economy, Korea [2010-TD-500409-001]; Ministry of Science, ICT&Future Planning, Korea, under the C-ITRC support program [NIPA-2013-H0401-13-1007]	Yonsei University College of Medicine(General Electric); International Collaborative R&D Program - Ministry of Knowledge Economy, Korea; Ministry of Science, ICT&Future Planning, Korea, under the C-ITRC support program	This research was supported by a faculty research grant from Yonsei University College of Medicine for 2012 (No. 6-2012-0019). This work was also supported by International Collaborative R&D Program (2010-TD-500409-001) funded by the Ministry of Knowledge Economy, Korea, and by the Ministry of Science, ICT&Future Planning, Korea, under the C-ITRC support program (NIPA-2013-H0401-13-1007) supervised by the NIPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 1997, J ACOUST SOC AM, V101, P29, DOI 10.1121/1.417973; Bai XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092463; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Baker R, 2010, BRIT J CANCER, V103, P1034, DOI 10.1038/sj.bjc.6605873; DeAngelis GA, 2000, SEMIN ULTRASOUND CT, V21, P337, DOI 10.1016/S0887-2171(00)90028-3; Ermilov SA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3086616; FROUGE C, 1993, RADIOLOGY, V186, P681, DOI 10.1148/radiology.186.3.8430173; GOING JJ, 1990, HISTOPATHOLOGY, V16, P119; Guevara E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083045; Haka AS, 2002, CANCER RES, V62, P5375; Hendrick RE, 2010, RADIOLOGY, V257, P246, DOI 10.1148/radiol.10100570; Huang CS, 1999, ULTRASOUND OBST GYN, V13, P431, DOI 10.1046/j.1469-0705.1999.13060431.x; Kang J, 2013, J BIOPHOTONICS; Kang J, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3651333; Kim HS, 2008, KOREAN J RADIOL, V9, P503, DOI 10.3348/kjr.2008.9.6.503; Kong F, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3073749; Krishna CM, 2008, EXPERT REV MOL DIAGN, V8, P149, DOI 10.1586/14737159.8.2.149; Kruger RA, 2010, MED PHYS, V37, P6096, DOI 10.1118/1.3497677; Ku G, 2005, APPL OPTICS, V44, P770, DOI 10.1364/AO.44.000770; Liberman L, 1998, AM J ROENTGENOL, V171, P35, DOI 10.2214/ajr.171.1.9648759; Liberman L, 2002, RADIOL CLIN N AM, V40, P483, DOI 10.1016/S0033-8389(01)00011-2; Machado P, 2012, J ULTRAS MED, V31, P885, DOI 10.7863/jum.2012.31.6.885; Manohar S, 2007, OPT EXPRESS, V15, P12277, DOI 10.1364/OE.15.012277; MENGES V, 1981, FORTSCHR RONTG NEUEN, V135, P482; MEYER JE, 1990, JAMA-J AM MED ASSOC, V263, P2341, DOI 10.1001/jama.263.17.2341; Moon WK, 2000, RADIOLOGY, V217, P849, DOI 10.1148/radiology.217.3.r00nv27849; Morgan MP, 2005, J MAMMARY GLAND BIOL, V10, P181, DOI 10.1007/s10911-005-5400-6; Park JS, 2010, J ULTRAS MED, V29, P1687, DOI 10.7863/jum.2010.29.12.1687; Parker SH, 1996, RADIOLOGY, V200, P11, DOI 10.1148/radiology.200.1.8657896; Ranieri E, 1997, ANTICANCER RES, V17, P2831; Saha A, 2011, BIOMED OPT EXPRESS, V2, P2792, DOI 10.1364/BOE.2.002792; Song KH, 2008, MED PHYS, V35, P4524, DOI 10.1118/1.2977534; Soo MS, 2003, AM J ROENTGENOL, V180, P941, DOI 10.2214/ajr.180.4.1800941; Soo MS, 2002, AM J ROENTGENOL, V178, P1007, DOI 10.2214/ajr.178.4.1781007; Spinelli L, 2004, J BIOMED OPT, V9, P1137, DOI 10.1117/1.1803546; Stone N, 2007, ANALYST, V132, P899, DOI 10.1039/b705029a; TORNOS C, 1990, AM J SURG PATHOL, V14, P961, DOI 10.1097/00000478-199010000-00010; Yang WT, 1997, BRIT J RADIOL, V70, P685, DOI 10.1259/bjr.70.835.9245879; Yoon C, 2012, OPT EXPRESS, V20, P3082, DOI 10.1364/OE.20.003082; Youk JH, 2007, RADIOGRAPHICS, V27, P79, DOI 10.1148/rg.271065029; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	41	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105878	10.1371/journal.pone.0105878	http://dx.doi.org/10.1371/journal.pone.0105878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153128	Green Submitted, gold, Green Published			2022-12-27	WOS:000340952200088
J	Odhiambo, C; Venter, M; Limbaso, K; Swanepoel, R; Sang, R				Odhiambo, Collins; Venter, Marietjie; Limbaso, Konongoi; Swanepoel, Robert; Sang, Rosemary			Genome Sequence Analysis of In Vitro and In Vivo Phenotypes of Bunyamwera and Ngari Virus Isolates from Northern Kenya	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; PLAQUE PHENOTYPE; BATAI VIRUS; VERO CELLS; REPLICATION; ORTHOBUNYAVIRUSES; DETERMINANTS; REASSORTMENT; ATTENUATION; MUTAGENESIS	Biological phenotypes of tri-segmented arboviruses display characteristics that map to mutation/s in the S, M or L segments of the genome. Plaque variants have been characterized for other viruses displaying varied phenotypes including attenuation in growth and/or pathogenesis. In order to characterize variants of Bunyamwera and Ngari viruses, we isolated individual plaque size variants; small plaque (SP) and large plaque (LP) and determined in vitro growth properties and in vivo pathogenesis in suckling mice. We performed gene sequencing to identify mutations that may be responsible for the observed phenotype. The LP generally replicated faster than the SP and the difference in growth rate was more pronounced in Bunyamwera virus isolates. Ngari virus isolates were more conserved with few point mutations compared to Bunyamwera virus isolates which displayed mutations in all three genome segments but majority were silent mutations. Contrary to expectation, the SP of Bunyamwera virus killed suckling mice significantly earlier than the LP. The LP attenuation may probably be due to a non-synonymous substitution (T858I) that mapped within the active site of the L protein. In this study, we identify natural mutations whose exact role in growth and pathogenesis need to be determined through site directed mutagenesis studies.	[Odhiambo, Collins; Sang, Rosemary] Int Ctr Insect Physiol & Ecol, Human Hlth Div, Nairobi, Kenya; [Odhiambo, Collins; Venter, Marietjie; Swanepoel, Robert] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, ZA-0001 Pretoria, South Africa; [Odhiambo, Collins; Limbaso, Konongoi; Sang, Rosemary] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya; [Sang, Rosemary] US Army Med Res Unit, Div Emerging Infect Dis, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); University of Pretoria; Kenya Medical Research Institute	Odhiambo, C (corresponding author), Int Ctr Insect Physiol & Ecol, Human Hlth Div, POB 30772, Nairobi, Kenya.	coodhiambo@kemricdc.org	Venter, Marietjie/P-9604-2016	Venter, Marietjie/0000-0003-2696-824X; odhiambo, collins/0000-0002-5534-8720	Swedish International Development Agency (SIDA) under Capacity Building of the International Centre of Insect Physiology and Ecology	Swedish International Development Agency (SIDA) under Capacity Building of the International Centre of Insect Physiology and Ecology	This work was supported by funding from the Swedish International Development Agency (SIDA) administered through the African Region Postgraduate Programme in Insect Science (ARPPIS) under Capacity Building of the International Centre of Insect Physiology and Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blaney JE, 2002, VIROLOGY, V300, P125, DOI 10.1006/viro.2002.1528; Blaney JE, 2003, ARCH VIROL, V148, P999, DOI 10.1007/s00705-003-0007-y; Blaney JE, 2001, J VIROL, V75, P9731, DOI 10.1128/JVI.75.20.9731-9740.2001; Bowen MD, 2001, VIROLOGY, V291, P185, DOI 10.1006/viro.2001.1201; Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05; Davis CT, 2004, VIROLOGY, V330, P342, DOI 10.1016/j.virol.2004.09.016; EASTMAN PS, 1985, J VIROL, V55, P611, DOI 10.1128/JVI.55.3.611-616.1985; Elliot R.M., 2000, VIRUS TAXONOMY, P599; ENDRES MJ, 1991, J VIROL, V65, P5465, DOI 10.1128/JVI.65.10.5465-5470.1991; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; Gonzalez J. P., 1988, The arboviruses: epidemiology and ecology. Volume II., P87; Jost H, 2011, AM J TROP MED HYG, V84, P241, DOI 10.4269/ajtmh.2011.10-0483; Kanno T, 1998, ARCH VIROL, V143, P1055, DOI 10.1007/s007050050355; Kanno T, 1999, J VIROL, V73, P2710, DOI 10.1128/JVI.73.4.2710-2716.1999; Kohl A, 2006, J GEN VIROL, V87, P177, DOI 10.1099/vir.0.81227-0; Lowen AC, 2005, J VIROL, V79, P12861, DOI 10.1128/JVI.79.20.12861-12870.2005; Mazel-Sanchez B, 2012, J VIROL, V86, P13672, DOI 10.1128/JVI.02253-12; Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140; R Core Team, 2018, R LANG ENV STAT COMP; Ramsingh AI, 1995, ARCH VIROL, V140, P2215, DOI 10.1007/BF01323241; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; Shi XH, 2009, J GEN VIROL, V90, P297, DOI 10.1099/vir.0.007567-0; Sundstrom KB, 2011, J VIROL, V85, P1747, DOI 10.1128/JVI.01428-10; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yanase T, 2006, ARCH VIROL, V151, P2253, DOI 10.1007/s00705-006-0808-x; ZHANG H, 1995, ARCH VIROL, V140, P959, DOI 10.1007/BF01314972	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105446	10.1371/journal.pone.0105446	http://dx.doi.org/10.1371/journal.pone.0105446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153316	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200049
J	Bhaskara, VK; Mohanam, I; Gujrati, M; Mohanam, S				Bhaskara, Vasantha Kumar; Mohanam, Indra; Gujrati, Meena; Mohanam, Sanjeeva			Intermittent Hypoxia Effect on Osteoclastogenesis Stimulated by Neuroblastoma Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HIGH-RISK NEUROBLASTOMA; FACTOR-KAPPA-B; INDUCIBLE FACTOR; BONE METASTASIS; CANCER-THERAPY; BREAST-CANCER; TUMOR HYPOXIA; SIGNAL-TRANSDUCTION; RECEPTOR ACTIVATOR	Background: Neuroblastoma is the most common extracranial pediatric solid tumor. Intermittent hypoxia, which is characterized by cyclic periods of hypoxia and reoxygenation, has been shown to positively modulate tumor development and thereby induce tumor growth, angiogenic processes, and metastasis. Bone is one of the target organs of metastasis in advanced neuroblastoma Neuroblastoma cells produce osteoclast-activating factors that increase bone resorption by the osteoclasts. The present study focuses on how intermittent hypoxia preconditioned SH-SY5Y neuroblastoma cells modulate osteoclastogenesis in RAW 264.7 cells compared with neuroblastoma cells grown at normoxic conditions. Methods: We inhibited HIF-1 alpha and HIF-2 alpha in neuroblastoma SH-SY5Y cells by siRNA/shRNA approaches. Protein expression of HIF-1 alpha, HIF-2 alpha and MAPKs were investigated by western blotting. Expression of osteoclastogenic factors were determined by real-time RT-PCR. The influence of intermittent hypoxia and HIF-1 alpha siRNA on migration of neuroblastoma cells and in vitro differentiation of RAW 264.7 cells were assessed. Intratibial injection was performed with SH-SY5Y stable luciferase-expressing cells and in vivo bioluminescence imaging was used in the analysis of tumor growth in bone. Results: Upregulation of mRNAs of osteoclastogenic factors VEGF and RANKL was observed in intermittent hypoxia-exposed neuroblastoma cells. Conditioned medium from the intermittent hypoxia-exposed neuroblastoma cells was found to enhance osteoclastogenesis, up-regulate the mRNAs of osteoclast marker genes including TRAP, CaSR and cathepsin K and induce the activation of ERK, JNK, and p38 in RAW 264.7 cells. Intermittent hypoxia-exposed neuroblastoma cells showed an increased migratory pattern compared with the parental cells. A significant increase of tumor volume was found in animals that received the intermittent hypoxia-exposed cells intratibially compared with parental cells. Conclusions: Intermittent hypoxic exposure enhanced capabilities of neuroblastoma cells in induction of osteoclast differentiation in RAW 264.7 cells. Increased migration and intratibial tumor growth was observed in intermittent hypoxia-exposed neuroblastoma cells compared with parental cells.	[Bhaskara, Vasantha Kumar; Mohanam, Indra; Mohanam, Sanjeeva] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Mohanam, S (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	smohanam@uic.edu			NIH [CA138466]; NATIONAL CANCER INSTITUTE [R01CA138466] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds to S. M. (NIH CA138466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge SE, 2005, BRIT J CANCER, V92, P1531, DOI 10.1038/sj.bjc.6602417; Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Bhaskara VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030905; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brizel DM, 1996, CANCER RES, V56, P941; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cairns RA, 2004, CANCER RES, V64, P2054, DOI 10.1158/0008-5472.CAN-03-3196; Cairns RA, 2001, CANCER RES, V61, P8903; Dewhirst MW, 2007, CANCER RES, V67, P854, DOI 10.1158/0008-5472.CAN-06-4744; Dungwa JV, 2012, HISTOPATHOLOGY, V61, P417, DOI 10.1111/j.1365-2559.2012.04227.x; Durand RE, 2001, ACTA ONCOL, V40, P929; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; Fardin P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-185; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Goldsby Robert E, 2004, Paediatr Drugs, V6, P107, DOI 10.2165/00148581-200406020-00004; Granchi D, 2004, INT J CANCER, V111, P829, DOI 10.1002/ijc.20308; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Hoehner JC, 1996, LAB INVEST, V75, P659; Iguchi H, 2002, J EXP CLIN CANC RES, V21, P309; Janoueix-Lerosey I, 2010, ONCOGENE, V29, P1566, DOI 10.1038/onc.2009.518; Kizaka-Kondoh S, 2003, CANCER SCI, V94, P1021, DOI 10.1111/j.1349-7006.2003.tb01395.x; Knowles HJ, 2008, J PATHOL, V215, P56, DOI 10.1002/path.2319; Koukourakis MI, 2006, J CLIN ONCOL, V24, P727, DOI 10.1200/JCO.2005.02.7474; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; LittlewoodEvans A, 1997, BONE, V20, P81, DOI 10.1016/S8756-3282(96)00351-1; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Lu X, 2010, CANCER RES, V70, P3905, DOI 10.1158/0008-5472.CAN-09-3739; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Martinive P, 2009, FEBS J, V276, P509, DOI 10.1111/j.1742-4658.2008.06798.x; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mentaverri R, 2006, FASEB J, V20, P2562, DOI 10.1096/fj.06-6304fje; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Park HJ, 2011, MOL CELLS, V31, P573, DOI 10.1007/s10059-011-1055-x; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Pitson G, 2001, INT J RADIAT ONCOL, V51, P699, DOI 10.1016/S0360-3016(01)01662-5; Puppo M, 2008, MOL CANCER THER, V7, P1974, DOI 10.1158/1535-7163.MCT-07-2059; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Russell HV, 2004, J PEDIATR SURG, V39, P1506, DOI 10.1016/j.jpedsurg.2004.06.019; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shirakura M, 2010, BIOCHEM BIOPH RES CO, V393, P800, DOI 10.1016/j.bbrc.2010.02.086; Sohara Y, 2005, CANCER LETT, V228, P203, DOI 10.1016/j.canlet.2005.01.059; Sugatani T, 2003, J BIOL CHEM, V278, P5001, DOI 10.1074/jbc.M209299200; Sundfor K, 1998, BRIT J CANCER, V78, P822, DOI 10.1038/bjc.1998.586; Toffoli S, 2008, FEBS J, V275, P2991, DOI 10.1111/j.1742-4658.2008.06454.x; van Golen CM, 2006, CANCER RES, V66, P6570, DOI 10.1158/0008-5472.CAN-05-1448; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Weinstein JL, 2003, ONCOLOGIST, V8, P278, DOI 10.1634/theoncologist.8-3-278; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Winter SC, 2006, CANCER-AM CANCER SOC, V107, P757, DOI 10.1002/cncr.21983; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670; Zhao HY, 2012, CHILD NERV SYST, V28, P2047, DOI 10.1007/s00381-012-1909-3	64	9	9	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105555	10.1371/journal.pone.0105555	http://dx.doi.org/10.1371/journal.pone.0105555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148040	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600055
J	Gautam, D; Dobhal, S; Payton, ME; Fletcher, J; Ma, LM				Gautam, Dhiraj; Dobhal, Shefali; Payton, Mark E.; Fletcher, Jacqueline; Ma, Li Maria			Surface Survival and Internalization of Salmonella through Natural Cracks on Developing Cantaloupe Fruits, Alone or in the Presence of the Melon Wilt Pathogen Erwinia tracheiphila	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; ENTERICA SEROVAR TYPHIMURIUM; TOMATO PLANTS; BACTERIAL WILT; LACTUCA-SATIVA; UNITED-STATES; FRESH FRUITS; CUCUMIS-MELO; COLONIZATION; CONTAMINATION	Outbreaks of foodborne illness attributed to the consumption of Salmonella-tainted cantaloupe have occurred repeatedly, but understanding of the ecology of Salmonella on cantaloupe fruit surfaces is limited. We investigated the interactions between Salmonella enterica Poona, the plant pathogenic bacterium Erwinia tracheiphila, and cantaloupe fruit. Fruit surfaces were inoculated at the natural cracking stage by spreading S. enterica and E. tracheiphila, 20 mu l at 10(7) cfu/ml, independently or together, over a 2 x 2 cm rind area containing a crack. Microbial and microscopic analyses were performed at 0, 9 and 24 days post inoculation (DPI). Even at 24 DPI (fruit maturity) S. enterica was detected on 14% and 40% of the fruit inoculated with S. enterica alone and the two-pathogen mixture, respectively. However, the population of S. enterica declined gradually after initial inoculation. E. tracheiphila, inoculated alone or together with Salmonella, caused watersoaked lesions on cantaloupe fruit; but we could not conclude in this study that S. enterica survival on the fruit surface was enhanced by the presence of those lesions. Of fruit inoculated with E. tracheiphila alone and sampled at 24 DPI, 61% had watersoaked lesions on the surface. In nearly half of those symptomatic fruits the watersoaking extended into the sub-rind mesocarp, and E. tracheiphila was recovered from that tissue in 50% of the symptomatic fruit. In this work, E. tracheiphila internalized through natural cracks on developing fruits. S. enterica was never detected in the fruit interior (ca. 2-3 mm below rind surface) under the limited conditions of our experiments, but the possibility that it, or other human pathogens that contaminate fresh produce, might also do so should be investigated under a wider range of conditions and produce types.	[Gautam, Dhiraj; Dobhal, Shefali; Fletcher, Jacqueline; Ma, Li Maria] Oklahoma State Univ, Natl Inst Microbial Forens & Food & Agr Biosecur, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; [Payton, Mark E.] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Fletcher, J (corresponding author), Oklahoma State Univ, Natl Inst Microbial Forens & Food & Agr Biosecur, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA.	jacqueline.fletcher@okstate.edu; li.ma@okstate.edu		ma, li/0000-0002-9778-6032	Oklahoma Center for the Advancement of Science Technology [PSB 09-007]; Oklahoma Agricultural Experiment Station [OKL 02793, OKL 02059]	Oklahoma Center for the Advancement of Science Technology; Oklahoma Agricultural Experiment Station	This work was supported by Oklahoma Center for the Advancement of Science & Technology (JF, grant number PSB 09-007: https://www.ok.gov/ocast) and Oklahoma Agricultural Experiment Station (LMM, project number OKL 02793; JF, project number OKL 02059: http://oaes.okstate.edu/). The funders had no role in study design, data collection and analysis, decision for publication, or preparation of the manuscript.	Akins ED, 2008, J FOOD PROTECT, V71, P46, DOI 10.4315/0362-028X-71.1.46; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3025; Barak JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001657; Barak JD, 2012, ANNU REV PHYTOPATHOL, V50, P241, DOI 10.1146/annurev-phyto-081211-172936; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Bennik MHJ, 1999, LETT APPL MICROBIOL, V28, P226, DOI 10.1046/j.1365-2672.1999.00497.x; Beuchat LR, 2003, J FOOD PROTECT, V66, P1459, DOI 10.4315/0362-028X-66.8.1459; Bezanson G, 2012, J FOOD PROTECT, V75, P480, DOI 10.4315/0362-028X.JFP-11-306; Bowen A, 2006, EPIDEMIOL INFECT, V134, P675, DOI 10.1017/S0950268805005480; Brand MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025553; Brust GE, 1997, ENVIRON ENTOMOL, V26, P580, DOI 10.1093/ee/26.3.580; BURKHOLDER WH, 1960, PHYTOPATHOLOGY, V50, P179; CDC, 2008, MULT OUTBR SALM LITC; CDC, 2012, MULT OUTBR SALM TYPH; Centers for Disease Control and Prevention, 2021, CURR OUTBR SALM OUTB; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1044; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P549; Cevallos-Cevallos JM, 2012, INT J FOOD MICROBIOL, V158, P140, DOI 10.1016/j.ijfoodmicro.2012.07.009; Cevallos-Cevallos JM, 2012, J FOOD PROTECT, V75, P472, DOI 10.4315/0362-028X.JFP-11-399; Chitrakar Reejana, 2010, J Vis Exp, DOI 10.3791/2185; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Cutter EG, 1969, PLANT ANATOMY EXPT I; de Mackiewicz D, 1998, PLANT DIS, V82, P521, DOI 10.1094/PDIS.1998.82.5.521; Duffy B, 2008, EUR J HORTIC SCI, V73, P73; Erickson MC, 2014, J FOOD PROTECT, V77, P189, DOI 10.4315/0362-028X.JFP-13-216; FERGUSON W. E., 1964, CANADIAN JOUR BOT, V42, P333, DOI 10.1139/b64-030; Fett WF, 2006, J FOOD PROTECT, V69, P719, DOI 10.4315/0362-028X-69.4.719; Fleischer SJ, 1999, ENVIRON ENTOMOL, V28, P470, DOI 10.1093/ee/28.3.470; Gagliardi JV, 2003, J FOOD PROTECT, V66, P82, DOI 10.4315/0362-028X-66.1.82; Gautam D, 2011, PHYTOPATHOLOGY, V101, pS59; Gould G.E., 1942, BIOL CONTROL STRIPED, P1; Gu Ganyu, 2013, PLoS One, V8, pe53470, DOI 10.1371/journal.pone.0053470; Gu GY, 2013, PHYTOPATHOLOGY, V103, P381, DOI 10.1094/PHYTO-04-12-0072-FI; Gu GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027340; Guo X, 2001, APPL ENVIRON MICROB, V67, P4760, DOI 10.1128/AEM.67.10.4760-4764.2001; Guo XA, 2002, APPL ENVIRON MICROB, V68, P3639, DOI 10.1128/AEM.68.7.3639-3643.2002; Harris HA, 1940, PHYTOPATHOLOGY, V30, P625; Hauben L, 1998, SYST APPL MICROBIOL, V21, P384, DOI 10.1016/S0723-2020(98)80048-9; Holt PS, 2007, APPL ENVIRON MICROB, V73, P6030, DOI 10.1128/AEM.00803-07; Hora R, 2005, J FOOD PROTECT, V68, P2506, DOI 10.4315/0362-028X-68.12.2506; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437; Janisiewicz WJ, 1999, J FOOD PROTECT, V62, P1372, DOI 10.4315/0362-028X-62.12.1372; Keren-Keiserman A, 2004, J HORTIC SCI BIOTECH, V79, P107, DOI 10.1080/14620316.2004.11511721; Kisluk G, 2012, APPL ENVIRON MICROB, V78, P4030, DOI 10.1128/AEM.00087-12; Klerks MM, 2007, APPL ENVIRON MICROB, V73, P4905, DOI 10.1128/AEM.02522-06; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Salgado PL, 2009, REV FITOTEC MEX, V32, P209; Lopez-Velasco G, 2012, INT J FOOD MICROBIOL, V158, P65, DOI 10.1016/j.ijfoodmicro.2012.07.005; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018083; Materon LA, 2007, WORLD J MICROB BIOT, V23, P1281, DOI 10.1007/s11274-007-9362-2; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Mitchell RF, 2009, ENVIRON ENTOMOL, V38, P395, DOI 10.1603/022.038.0212; Morales-Hernandez L., 2009, Agricultura Tecnica en Mexico, V35, P135; NUTTALL V. W., 1958, CANADIAN JOUR PLANT SCI, V38, P401; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Pianetti A, 1998, WATER RES, V32, P1515, DOI 10.1016/S0043-1354(97)00340-0; Potnis N, 2014, APPL ENVIRON MICROB, V80, P3173, DOI 10.1128/AEM.00345-14; PREND J, 1961, PHYTOPATHOLOGY, V51, P255; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Rand FV, 1916, J AGRIC RES, V6, P417; REED GL, 1982, PLANT DIS, V66, P778, DOI 10.1094/PD-66-778; Richards GM, 2005, INT J FOOD MICROBIOL, V103, P1, DOI 10.1016/j.ijfoodmicro.2004.05.023; RIES AA, 1990, 30 INT C ANT AG CHEM, P238; Rojas ES, 2012, PLANT DIS, V96, P62, DOI 10.1094/PDIS-04-11-0277; Semenov AV, 2009, APPL ENVIRON MICROB, V75, P3206, DOI 10.1128/AEM.01791-08; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Smith EF, 1911, WILT CUCURBITS, V2; Solomon EB, 2005, J FOOD PROTECT, V68, P906, DOI 10.4315/0362-028X-68.5.906; Suslow T, 2001, FRESH CUT, V9, P12; Suslow T, 2001, FRESH CUT, V9, P32; Suslow T, 2001, FRESH CUT, P20; Ukuku DO, 2004, J FOOD PROTECT, V67, P432, DOI 10.4315/0362-028X-67.3.432; Walcott RR, 2005, PLANT HLTH INSTRUCTO, DOI [10.1094/PHI-I-2005-1025-02, DOI 10.1094/PHI-I-2005-1025-02]; WEBSTER BD, 1976, J AM SOC HORTIC SCI, V101, P412; Wells JM, 1999, PLANT DIS, V83, P722, DOI 10.1094/PDIS.1999.83.8.722; Wells JM, 1997, PLANT DIS, V81, P867, DOI 10.1094/PDIS.1997.81.8.867; WILLIAMS LANSING E., 1956, PLANT DIS REPORTER, V40, P479; WILSON J. D., 1956, PLANT DIS REPORTER, V40, P437; Xiao CL, 2004, PLANT DIS, V88, P114, DOI 10.1094/PDIS.2004.88.2.114; Zhang GD, 2009, J FOOD PROTECT, V72, P2028, DOI 10.4315/0362-028X-72.10.2028	84	11	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105248	10.1371/journal.pone.0105248	http://dx.doi.org/10.1371/journal.pone.0105248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147942	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230600036
J	Kehoe, MA; Coutts, BA; Buirchell, BJ; Jones, RAC				Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.			Split Personality of a Potyvirus: To Specialize or Not to Specialize?	PLOS ONE			English	Article							YELLOW-MOSAIC-VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; NON-NECROTIC STRAINS; MAIZE STREAK VIRUS; HOST ADAPTATION; VEIN-VIRUS; RECOMBINATION; EMERGENCE; EVOLUTION; RESISTANCE	Bean yellow mosaic virus (BYMV), genus Potyvirus, has an extensive natural host range encompassing both dicots and monocots. Its phylogenetic groups were considered to consist of an ancestral generalist group and six specialist groups derived from this generalist group during plant domestication. Recombination was suggested to be playing a role in BYMV's evolution towards host specialization. However, in subsequent phylogenetic analysis of whole genomes, group names based on the original hosts of isolates within each of them were no longer supported. Also, nine groups were found and designated I-IX. Recombination analysis was conducted on the complete coding regions of 33 BYMV genomes and two genomes of the related Clover yellow vein virus (CYVV). This analysis found evidence for 12 firm recombination events within BYMV phylogenetic groups I-VI, but none within groups VII-IX or CYVV. The greatest numbers of recombination events within a sequence (two or three each) occurred in four groups, three which formerly constituted the single ancestral generalist group (I, II and IV), and group VI. The individual sequences in groups III and V had one event each. These findings with whole genomes are consistent with recombination being associated with expanding host ranges, and call into question the proposed role of recombination in the evolution of BYMV, where it was previously suggested to play a role in host specialization. Instead, they (i) indicate that recombination explains the very broad natural host ranges of the three BYMV groups which infect both monocots and dicots (I, II, IV), and (ii) suggest that the three groups with narrow natural host ranges (III, V, VI) which also showed recombination now have the potential to reduce host specificity and broaden their natural host ranges.	[Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Inst Agr, Crawley, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Bentley Delivery Ctr, Dept Agr & Food Western Australia, Crop Protect & Lupin Breeding Branches, Perth, WA, Australia	University of Western Australia; University of Western Australia	Kehoe, MA (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia.	monica.kehoe@agric.wa.gov.au	Jones, Roger A.C./B-1200-2011	Jones, Roger A.C./0000-0003-3593-3102; Buirchell, Bevan/0000-0001-8247-3570	Australian Postgraduate Award (APA); Australian Grains Research and Development Corporation (GRDC) Studentship [GRS10039]	Australian Postgraduate Award (APA)(Australian Government); Australian Grains Research and Development Corporation (GRDC) Studentship(Grains R&D Corp)	This research was funded by an Australian Postgraduate Award (APA), and an Australian Grains Research and Development Corporation (GRDC) Studentship, Project number GRS10039. It was undertaken using the facilities at the Department of Agriculture and Food Western Australia. This study forms part of a PhD project by the first author at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlandier FA, 1997, ANN APPL BIOL, V131, P297, DOI 10.1111/j.1744-7348.1997.tb05158.x; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; BOS L, 1970, Netherlands Journal of Plant Pathology, V76, P8, DOI 10.1007/BF01976763; Bos L, 1970, DESCRIPTIONS PLANT V; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1075, DOI 10.1094/MPMI-20-9-1075; Buichell BJ, 2008, RLUPINS HLTH WEALTHW; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Cheng Y, 2000, ANN APPL BIOL, V136, P215, DOI 10.1111/j.1744-7348.2000.tb00028.x; Cheng Y, 1999, AUST J AGR RES, V50, P589, DOI 10.1071/A98116; Choi SH, 2013, J VIROL, V87, P7326, DOI 10.1128/JVI.00065-13; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Edwardson JR, 1991, CRC HDB VIRUSES INFE; Gibbs AJ, 2008, ARCH VIROL, V153, P1411, DOI 10.1007/s00705-008-0134-6; Gibbs A, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P229, DOI 10.1016/B978-0-12-374153-0.00011-4; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guyatt KJ, 1996, ARCH VIROL, V141, P1231, DOI 10.1007/BF01718827; Hammond J, 2003, ARCH VIROL, V148, P2461, DOI 10.1007/s00705-003-0185-7; HAMPTON RO, 1992, PHYTOPATHOLOGY, V82, P566, DOI 10.1094/Phyto-82-566; JONES RAC, 1993, ANN APPL BIOL, V122, P501, DOI 10.1111/j.1744-7348.1993.tb04053.x; JONES RAC, 1989, ANN APPL BIOL, V114, P609, DOI 10.1111/j.1744-7348.1989.tb03376.x; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Karasev AV, 2013, AM J POTATO RES, V90, P7, DOI 10.1007/s12230-012-9287-7; Kehoe MA, 2014, PLANT DIS, V98, P739, DOI [10.1094/PDIS-11-13-1144-RE, 10.1094/PDIS-11-13-1144-]; Kehoe MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104580; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Monjane AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-350; Nakamura Shigeo, 1994, Annals of the Phytopathological Society of Japan, V60, P295, DOI 10.3186/jjphytopath.60.295; Nakazono-Nagaoka Eiko, 2004, Journal of General Plant Pathology, V70, P359, DOI 10.1007/s10327-004-0138-3; Nakazono-Nagaoka E, 2009, PHYTOPATHOLOGY, V99, P251, DOI 10.1094/PHYTO-99-3-0251; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Revers F, 1996, J GEN VIROL, V77, P1953, DOI 10.1099/0022-1317-77-8-1953; Roossinck MJ, 2003, CURR OPIN MICROBIOL, V6, P406, DOI 10.1016/S1369-5274(03)00087-0; SMITH JM, 1992, J MOL EVOL, V34, P126; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; Takahashi Y, 1997, VIRUS GENES, V14, P235, DOI 10.1023/A:1007940028058; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tromas N, 2014, J GEN VIROL, V95, P724, DOI 10.1099/vir.0.060822-0; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; van der Walt E, 2009, J GEN VIROL, V90, P734, DOI 10.1099/vir.0.007724-0; Varsani A, 2008, J GEN VIROL, V89, P2063, DOI 10.1099/vir.0.2008/003590-0; Wen RH, 2010, VIROLOGY, V400, P1, DOI 10.1016/j.virol.2010.01.022; Wylie SJ, 2009, PHYTOPATHOLOGY, V99, P512, DOI 10.1094/PHYTO-99-5-0512; Wylie SJ, 2008, PLANT DIS, V92, P1596, DOI 10.1094/PDIS-92-12-1596; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003	50	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105770	10.1371/journal.pone.0105770	http://dx.doi.org/10.1371/journal.pone.0105770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148372	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600082
J	Parillo, F; Maranesi, M; Mignini, F; Marinelli, L; Di Stefano, A; Boiti, C; Zerani, M				Parillo, Francesco; Maranesi, Margherita; Mignini, Fiorenzo; Marinelli, Lisa; Di Stefano, Antonio; Boiti, Cristiano; Zerani, Massimo			Evidence for a Dopamine Intrinsic Direct Role in the Regulation of the Ovary Reproductive Function: In Vitro Study on Rabbit Corpora Lutea	PLOS ONE			English	Article							PROSTAGLANDIN-F2-ALPHA ANALOG; CORPUS-LUTEUM; NITRIC-OXIDE; RECEPTORS; EXPRESSION; SYNTHASES; EVOLUTION; DARPP-32; CELLS	Dopamine (DA) receptor (DR) type 1 (D1R) has been found to be expressed in luteal cells of various species, but the intrinsic role of the DA/DRs system on corpora lutea (CL) function is still unclear. Experiments were devised to characterize the expression of DR types and the presence of DA, as well as the in vitro effects of DA on hormone productions by CL in pseudopregnant rabbits. Immunoreactivity and gene expression for D1R decreased while that for D3R increased in luteal and blood vessel cells from early to late pseudopregnant stages. DA immunopositivity was evidenced only in luteal cells. The DA and D1R agonist increased in vitro release of progesterone and prostaglandin E2 (PGE2) by early CL, whereas the DA and D3R agonist decreased progesterone and increased PGF2 alpha in vitro release by mid- and late CL. These results provide evidence that the DA/DR system exerts a dual modulatory function in the lifespan of CL: the DA/D1R is luteotropic while the DA/D3R is luteolytic. The present data shed new light on the physiological mechanisms regulating luteal activity that might improve our ability to optimize reproductive efficiency in mammal species, including humans.	[Parillo, Francesco; Zerani, Massimo] Univ Camerino, Scuola Biosci & Med Vet, Matelica, Italy; [Maranesi, Margherita; Boiti, Cristiano] Univ Perugia, Dipartimento Sci Biopatol Vet & Igiene Prod Anim, I-06100 Perugia, Italy; [Mignini, Fiorenzo] Univ Camerino, Scuola Farmaco & Prodotti Salute, I-62032 Camerino, Italy; [Marinelli, Lisa; Di Stefano, Antonio] Univ G DAnnunzio, Dipartimento Farm, Chieti, Italy	University of Camerino; University of Perugia; University of Camerino; G d'Annunzio University of Chieti-Pescara	Zerani, M (corresponding author), Univ Camerino, Scuola Biosci & Med Vet, Matelica, Italy.	massimo.zerani@unicam.it	Zerani, Massimo/L-6348-2015; Maranesi, Margherita/AAG-5142-2021; Zerani, Massimo/AAF-4433-2020	Maranesi, Margherita/0000-0002-1727-4118; Zerani, Massimo/0000-0002-2476-5097; MARINELLI, LISA/0000-0001-8611-6538; DI STEFANO, Antonio/0000-0002-3042-2234	BC Red-water (Perugia, Italy) Trust; PFZM Kitchenbrown (Matelica, Italy) Trust	BC Red-water (Perugia, Italy) Trust; PFZM Kitchenbrown (Matelica, Italy) Trust	This study was supported by generous donations of the BC Red-water (Perugia, Italy) and PFZM Kitchenbrown (Matelica, Italy) Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Boiti C, 2005, ENDOCRINOLOGY, V146, P1293, DOI 10.1210/en.2004-1099; Boiti C, 2003, REPRODUCTION, V125, P807, DOI 10.1530/reprod/125.6.807; Boiti C, 2001, J ENDOCRINOL, V168, P141, DOI 10.1677/joe.0.1680141; Boiti C, 1998, PROSTAG OTH LIPID M, V56, P255; D'Albora H, 2002, MICROSC RES TECHNIQ, V59, P484, DOI 10.1002/jemt.10231; DAVIS JS, 2002, FRONT BIOSCI, V7, P1949, DOI DOI 10.2741/DAVIS1; DOUGLAS RH, 1975, J REPROD FERTIL, P257; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Gerendai I, 2005, ENDOCRINE, V28, P309, DOI 10.1385/ENDO:28:3:309; GUTHRIE HD, 1976, J REPROD FERTIL, V48, P423, DOI 10.1530/jrf.0.0480423; Helliwell RJA, 2004, PROSTAG LEUKOTR ESS, V70, P101, DOI 10.1016/j.plefa.2003.04.002; King SS, 2005, DOMEST ANIM ENDOCRIN, V28, P405, DOI 10.1016/j.domaniend.2005.02.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayerhofer A, 1999, J CLIN ENDOCR METAB, V84, P257, DOI 10.1210/jc.84.1.257; Mayerhofer A, 2000, J CLIN ENDOCR METAB, V85, P4750, DOI 10.1210/jc.85.12.4750; MICHAEL AE, 1993, J REPROD FERTIL, V97, P425; Nasuti C, 2013, TOXICOLOGY, V303, P162, DOI 10.1016/j.tox.2012.09.016; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Parillo F, 2012, MICROSC RES TECHNIQ, V75, P1682, DOI 10.1002/jemt.22116; Parillo F, 2013, ACTA SCI VET, V41; Parillo F, 2013, ANIM REPROD SCI, V138, P118, DOI 10.1016/j.anireprosci.2013.02.001; Polisca A, 2010, THERIOGENOLOGY, V74, P672, DOI 10.1016/j.theriogenology.2010.03.021; Rey-Ares V, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-40; Sarkar C, 2013, J NEUROIMMUNE PHARM, V8, P7, DOI 10.1007/s11481-012-9395-7; Stradaioli G., 1997, World Rabbit Science, V5, P143; Tamanini C, 2004, REPROD DOMEST ANIM, V39, P206, DOI 10.1111/j.1439-0531.2004.00505.x; Wiltbank Milo C, 2003, Reprod Biol Endocrinol, V1, P91, DOI 10.1186/1477-7827-1-91; Yamamoto K, 2013, MOL BIOL EVOL, V30, P833, DOI 10.1093/molbev/mss268; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Zerani M, 2007, REPRODUCTION, V133, P1005, DOI 10.1530/REP-06-0107; Zerani M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107383; Zerani M, 2010, J ENDOCRINOL, V207, P289, DOI 10.1677/JOE-10-0109	33	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104797	10.1371/journal.pone.0104797	http://dx.doi.org/10.1371/journal.pone.0104797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148384	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600022
J	Fernandez, T; Silva-Pereyra, J; Prieto-Corona, B; Rodriguez-Camacho, M; Reynoso-Alcantara, V				Fernandez, Thalia; Silva-Pereyra, Juan; Prieto-Corona, Belen; Rodriguez-Camacho, Mario; Reynoso-Alcantara, Vicenta			Event-Related Brain Potentials during a Semantic Priming Task in Children with Learning Disabilities Not Otherwise Specified	PLOS ONE			English	Article							RECOGNITION MEMORY; WORDS; SUBTYPES; DEFINITIONS; ADOLESCENTS; ATTENTION; DYSLEXIA; READERS	Learning disabilities (LDs) are the most common psychiatric disorders in children. LDs are classified either as "Specific'' or "Learning Disorder Not Otherwise Specified''. An important hypothesis suggests a failure in general domain process (i.e., attention) that explains global academic deficiencies. The aim of this study was to evaluate event-related potential (ERP) patterns of LD Not Otherwise Specified children with respect to a control group. Forty-one children (8-10.6 years old) participated and performed a semantic judgment priming task while ERPs were recorded. Twenty-one LD children had significantly lower scores in all academic skills (reading, writing and arithmetic) than twenty controls. Different ERP patterns were observed for each group. Control group showed smaller amplitudes of an anterior P200 for unrelated than related word pairs. This P200 effect was followed by a significant early N400a effect (greater amplitudes for unrelated than related word pairs; 350-550 ms) with a right topographical distribution. By contrast, LD Not Otherwise Specified group did not show a P200 effect or a significant N400a effect. This evidence suggests that LD Not Otherwise Specified children might be deficient in reading, writing and arithmetic domains because of their sluggish shifting of attention to process the incoming information.	[Fernandez, Thalia] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Juriquilla, Queretaro, Mexico; [Silva-Pereyra, Juan; Prieto-Corona, Belen; Rodriguez-Camacho, Mario] Univ Nacl Autonoma Mexico, Fac Estudios Super FES Iztacala, Proyecto Neurociencias, Mexico City, Estado De Mexic, Mexico; [Reynoso-Alcantara, Vicenta] Univ Veracruzana, Fac Psicol, Xalapa, Veracruz, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Veracruzana	Silva-Pereyra, J (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super FES Iztacala, Proyecto Neurociencias, Mexico City, Estado De Mexic, Mexico.	jsilvapereyra@gmail.com	Fernandez, Thalia/AGI-6073-2022	Silva-Pereyra, Juan/0000-0002-2982-1457; Reynoso-Alcantara, Vicenta/0000-0003-1834-6117; Corona, Prieto/0000-0003-3166-7214	PAPIIT UNAM-Mexico [IN226001, IN204103]; CONCYTEQ [E59]; CONACYT, Mexico [69145]	PAPIIT UNAM-Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONCYTEQ; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was partially supported by grants IN226001 and IN204103 from PAPIIT UNAM-Mexico, and by grants E59 from CONCYTEQ and 69145 from CONACYT, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada R, 2007, JUGUEMOS LEER LIBRO; Ahumada R, 1990, JUGUEMOS LEER LIBRO; American Psychiatric Association [APA], 2002, MAN DIAGN EST TRAST; Berninger V.W., 2008, BRAIN BEHAV LEARNING, P103; Brandeis D, 1994, Acta Paedopsychiatr, V56, P239; Buttner G, 2011, INT J DISABIL DEV ED, V58, P75, DOI 10.1080/1034912X.2011.548476; Conners C.K., 1997, CONNERSRATING SCALES; Dirks E, 2008, J LEARN DISABIL-US, V41, P460, DOI 10.1177/0022219408321128; Federmeier KD, 2005, MEM COGNITION, V33, P871, DOI 10.3758/BF03193082; Federmeier KD, 2002, NEUROPSYCHOLOGIA, V40, P730, DOI 10.1016/S0028-3932(01)00193-2; Fernandez T, 2002, CLIN ELECTROENCEPHAL, V33, P160, DOI 10.1177/155005940203300405; FLETCHER JM, 1985, J EXP CHILD PSYCHOL, V40, P244, DOI 10.1016/0022-0965(85)90088-8; FLETCHER TV, 1995, J LEARN DISABIL-US, V28, P530, DOI 10.1177/002221949502800901; Greenham SL, 2003, DEV NEUROPSYCHOL, V23, P339, DOI 10.1207/S15326942DN2303_2; Handler SM, 2011, PEDIATRICS, V127, pE818, DOI 10.1542/peds.2010-3670; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; HARMONY T, 1990, ELECTROEN CLIN NEURO, V75, P482, DOI 10.1016/0013-4694(90)90135-7; Huang HW, 2010, NEUROIMAGE, V49, P1116, DOI 10.1016/j.neuroimage.2009.07.031; Jednorog K, 2010, NEUROPSYCHOLOGIA, V48, P2447, DOI 10.1016/j.neuropsychologia.2010.04.017; JOHN ER, 1983, PROG NEUROBIOL, V21, P239, DOI 10.1016/0301-0082(83)90014-X; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P651, DOI 10.1111/j.1469-8986.1989.tb03167.x; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lagae L, 2008, PEDIATR CLIN N AM, V55, P1259, DOI 10.1016/j.pcl.2008.08.001; Lallier M, 2010, NEUROPSYCHOLOGIA, V48, P4125, DOI 10.1016/j.neuropsychologia.2010.09.027; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Lee Swanson H., 2001, RESEARCHGATE, V7, P1; Maehler C, 2011, INT J DISABIL DEV ED, V58, P5, DOI 10.1080/1034912X.2011.547335; Matute E, 2008, EVALUACION NEUROPSIC; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Mondada A, 1992, PRACTICAS ORTOGRAFIA; Neely JH, 1991, BASIC PROCESSES READ, DOI [10.4324/9780203052242-12, DOI 10.4324/9780203052242-12]; Pestum J, 1996, MAYA TRUCO HACER TAR; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Rodriguez M, 2006, LEARNING DISABILITIE, P187; Russeler J, 2003, J CLIN EXP NEUROPSYC, V25, P815, DOI 10.1076/jcen.25.6.815.16469; Schulz E, 2008, NEUROIMAGE, V41, P153, DOI 10.1016/j.neuroimage.2008.02.012; SEGALOWITZ SJ, 1992, BRAIN COGNITION, V20, P85, DOI 10.1016/0278-2626(92)90063-R; SHAFRIR U, 1994, J LEARN DISABIL-US, V27, P123, DOI 10.1177/002221949402700207; Siegel L, 2003, HDB PSYCHOL, P455; Silva-Pereyra J, 2005, COGNITIVE BRAIN RES, V23, P247, DOI 10.1016/j.cogbrainres.2004.10.015; Silva-Pereyra J, 2003, INT J PSYCHOPHYSIOL, V49, P187, DOI 10.1016/S0167-8760(03)00116-8; Silva-Pereyra J, 2010, NEUROREPORT, V21, P34, DOI 10.1097/WNR.0b013e328332c566; Silver CH, 2008, ARCH CLIN NEUROPSYCH, V23, P217, DOI 10.1016/j.acn.2007.09.006; Sotelo-Dynega M., 2010, ESSENTIALS SPECIFIC, P1; STELMACK RM, 1988, J CLIN EXP NEUROPSYC, V10, P185, DOI 10.1080/01688638808408235; Swanson HL, 2012, CHILD NEUROPSYCHOL, V18, P125, DOI 10.1080/09297049.2011.589377; SWANSON HL, 1987, J LEARN DISABIL-US, V20, P155, DOI 10.1177/002221948702000303; Swanson HL, 2012, LEARNING LEARNING DI; Taylor MJ, 2000, INT J PSYCHOPHYSIOL, V37, P135, DOI 10.1016/S0167-8760(00)00084-2; Torkoldsen JV, 2007, J NEUROLINGUIST, V20, P332, DOI 10.1016/j.jneuroling.2007.02.003; Weschler D., 2001, ESCALA INTELIGENCIA; Wlotko EW, 2007, NEUROPSYCHOLOGIA, V45, P3001, DOI 10.1016/j.neuropsychologia.2007.05.013; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124	54	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105318	10.1371/journal.pone.0105318	http://dx.doi.org/10.1371/journal.pone.0105318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144188	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100051
J	Goodin, DS; Corwin, M; Kaufman, D; Golub, H; Reshef, S; Rametta, MJ; Knappertz, V; Cutter, G; Pleimes, D				Goodin, Douglas S.; Corwin, Michael; Kaufman, David; Golub, Howard; Reshef, Shoshana; Rametta, Mark J.; Knappertz, Volker; Cutter, Gary; Pleimes, Dirk			Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States	PLOS ONE			English	Article							SURVIVAL; MORTALITY	Background: Information on causes of death (CODs) for patients with multiple sclerosis (MS) in the United States is sparse and limited by standard categorizations of underlying and immediate CODs on death certificates. Prior research indicated that excess mortality among MS patients was largely due to greater mortality from infectious, cardiovascular, or pulmonary causes. Objective: To analyze disease categories in order to gain insight to pathways, which lead directly to death in MS patients. Methods: Commercially insured MS patients enrolled in the OptumInsight Research database between 1996 and 2009 were matched to non-MS comparators on age/residence at index year and sex. The cause most-directly leading to death from the death certificate, referred to as the "principal'' COD, was determined using an algorithm to minimize the selection of either MS or cardiac/pulmonary arrest as the COD. Principal CODs were categorized into MS, cancer, cardiovascular, infectious, suicide, accidental, pulmonary, other, or unknown. Infectious, cardiovascular, and pulmonary CODs were further subcategorized. Results: 30,402 MS patients were matched to 89,818 controls, with mortality rates of 899 and 446 deaths/100,000 person-years, respectively. Excluding MS, differences in mortality rate between MS patients and non-MS comparators were largely attributable to infections, cardiovascular causes, and pulmonary problems. Of the 95 excessive deaths (per 100,000 person-years) related to infectious causes, 41 (43.2%) were due to pulmonary infections and 45 (47.4%) were attributed to sepsis. Of the 46 excessive deaths (per 100,000 person-years) related to pulmonary causes, 27 (58.7%) were due to aspiration. No single diagnostic entity predominated for the 60 excessive deaths (per 100,000 person-years) attributable to cardiac CODs. Conclusions: The principal COD algorithm improved on other methods of determining COD in MS patients from death certificates. A greater awareness of the common CODs in MS patients will allow physicians to anticipate potential problems and, thereby, improve the care that they provide.	[Goodin, Douglas S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Corwin, Michael; Kaufman, David] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Corwin, Michael; Golub, Howard] Care Safe, Boston, MA USA; [Reshef, Shoshana; Rametta, Mark J.] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Knappertz, Volker] Teva Pharmaceut, Frazer, PA USA; [Knappertz, Volker] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Cutter, Gary] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Pleimes, Dirk] Myelo Therapeut GmbH, Berlin, Germany	University of California System; University of California San Francisco; Boston University; Bayer AG; Bayer Healthcare Pharmaceuticals; Heinrich Heine University Dusseldorf; University of Alabama System; University of Alabama Birmingham	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu	Cutter, Gary/AAY-5392-2021	Cutter, Gary/0000-0002-8455-980X; Kaufman, David/0000-0002-2150-5070; Corwin, Michael/0000-0002-6591-209X; Pleimes, Dirk/0000-0002-0876-9418	Bayer HealthCare Pharmaceuticals	Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals)	This project was sponsored by Bayer HealthCare Pharmaceuticals. Other than comments that the authors were not obligated to accept, the funder provided support in the form of salaries for authors SR and MJR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; CDC, 2003, US STAND CERT DEATH; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Goodin DS, 2012, NEUROLOGY, V78, P1315, DOI 10.1212/WNL.0b013e3182535cf6; Goodin DS, 2012, BMJ OPEN, V30, P2, DOI DOI 10.1136/BMJ0PEN-2012-001972; Ho AMH, 2013, ANAESTHESIA, V68, P126, DOI 10.1111/anae.12120; Kaufman DW, MULT SCLER RELATED D, V3, P364; Kingwell E, 2012, J NEUROL NEUROSUR PS, V83, P61, DOI 10.1136/jnnp-2011-300616; Lalmohamed A, 2012, EUR J NEUROL, V19, P1007, DOI 10.1111/j.1468-1331.2012.03668.x; Lewis Adele, 2012, Tenn Med, V105, P37; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Poorjavad M, 2010, MULT SCLER J, V16, P362, DOI 10.1177/1352458509358089; Ragonese P, 2010, EUR J NEUROL, V17, P391, DOI 10.1111/j.1468-1331.2009.02814.x; SADOVNICK AD, 1992, NEUROLOGY, V42, P991, DOI 10.1212/WNL.42.5.991; Torkildsen NG, 2008, MULT SCLER J, V14, P1191, DOI 10.1177/1352458508093890	16	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105207	10.1371/journal.pone.0105207	http://dx.doi.org/10.1371/journal.pone.0105207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144226	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100042
J	Ikels, K; Kuschel, S; Fischer, J; Kaisers, W; Eberhard, D; Ruther, U				Ikels, Kathrin; Kuschel, Stefanie; Fischer, Julia; Kaisers, Wolfgang; Eberhard, Daniel; Ruether, Ulrich			FTO Is a Relevant Factor for the Development of the Metabolic Syndrome in Mice	PLOS ONE			English	Article							CONGENITAL LEPTIN DEFICIENCY; ADIPOSE-TISSUE; OBESE GENE; OB/OB MICE; DIABETES-MELLITUS; MORBID-OBESITY; FOOD-INTAKE; PPAR-GAMMA; FAT MASS; HYPERGLYCEMIA	The metabolic syndrome is a worldwide problem mainly caused by obesity. FTO was found to be a obesity-risk gene in humans and FTO deficiency in mice led to reduction in adipose tissue. Thus, FTO is an important factor for the development of obesity. Leptin-deficient mice are a well characterized model for analysing the metabolic syndrome. To determine the relevance of FTO for the development of the metabolic syndrome we analysed different parameters in combined homozygous deficient mice (Lep(ob/ob); Fto(-/-)). Lep(ob/ob); Fto(-/-) mice showed an improvement in analysed hallmarks of the metabolic syndrome in comparison to leptin-deficient mice wild type or heterozygous for Fto. Lep(ob/ob); Fto(-/-) mice did not develop hyperglycaemia and showed an improved glucose tolerance. Furthermore, extension of beta-cell mass was prevented in Lep(ob/ob); Fto(-/-) mice and accumulation of ectopic fat in the liver was reduced. In conclusion this study demonstrates that FTO deficiency has a protective effect not only on the development of obesity but also on the metabolic syndrome. Thus, FTO plays an important role in the development of metabolic disorders and is an interesting target for therapeutic agents.	[Ikels, Kathrin; Kuschel, Stefanie; Fischer, Julia; Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, Dusseldorf, Germany; [Eberhard, Daniel] Univ Dusseldorf, Inst Metab Physiol, Dusseldorf, Germany; [Kaisers, Wolfgang] Univ Dusseldorf, Coordinat Ctr Clin Trials, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Ruther, U (corresponding author), Univ Dusseldorf, Inst Anim Dev & Mol Biol, Dusseldorf, Germany.	ruether@hhu.de			BMBF (NGFN plus); DFG [SFB612]	BMBF (NGFN plus)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was supported by a grant from the BMBF (NGFN plus) and the DFG through SFB612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; [Anonymous], 2014, R LANG ENV STAT COMP; de Luis DA, 2013, J DIABETES COMPLICAT, V27, P346, DOI 10.1016/j.jdiacomp.2013.02.003; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Chen BE, 2012, J AM CHEM SOC, V134, P17963, DOI 10.1021/ja3064149; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2986, DOI 10.1172/JCI118007; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Doshi M, 2011, NUCLEOS NUCLEOT NUCL, V30, P1290, DOI 10.1080/15257770.2011.603711; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gat-Yablonski G, 2004, ENDOCRINOLOGY, V145, P343, DOI 10.1210/en.2003-0910; Gulati P, 2013, DIABETOLOGIA; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hauner H, 2004, PHYSIOL BEHAV, V83, P653, DOI 10.1016/j.physbeh.2004.09.016; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Lalonde J, 2004, PHYSIOL BEHAV, V80, P415, DOI 10.1016/j.physbeh.2003.08.013; Lee YS, 2010, BIOCHEM PHARMACOL, V79, P1674, DOI 10.1016/j.bcp.2010.01.034; Legry V, 2009, METABOLISM, V58, P971, DOI 10.1016/j.metabol.2009.02.019; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morton GJ, 2013, J CLIN INVEST; Naveilhan P, 2002, PEPTIDES, V23, P1087, DOI 10.1016/S0196-9781(02)00042-6; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pollex RL, 2006, NAT CLIN PRACT CARD, V3, P482, DOI 10.1038/ncpcardio0638; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Tabbi-Anneni I, 2008, ENDOCRINOLOGY, V149, P4043, DOI 10.1210/en.2007-1646; Tews D, 2013, ENDOCRINOLOGY, V154, P3141, DOI 10.1210/en.2012-1873; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Wang HN, 2012, MOL BIOL REP, V39, P5691, DOI 10.1007/s11033-011-1377-y; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049	46	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105349	10.1371/journal.pone.0105349	http://dx.doi.org/10.1371/journal.pone.0105349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144618	gold, Green Submitted, Green Published			2022-12-27	WOS:000341106100057
J	Kruse, W; Krause, M; Aarse, J; Mark, MD; Manahan-Vaughan, D; Herlitze, S				Kruse, Wolfgang; Krause, Martin; Aarse, Janna; Mark, Melanie D.; Manahan-Vaughan, Denise; Herlitze, Stefan			Optogenetic Modulation and Multi-Electrode Analysis of Cerebellar Networks In Vivo	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; NEURAL CIRCUITRY; GRANULE CELL; PURKINJE; ACTIVATION; NEURONS; INHIBITION; SPIKE; AXON; CHANNELRHODOPSIN-2	The firing patterns of cerebellar Purkinje cells (PCs), as the sole output of the cerebellar cortex, determine and tune motor behavior. PC firing is modulated by various inputs from different brain regions and by cell-types including granule cells (GCs), climbing fibers and inhibitory interneurons. To understand how signal integration in PCs occurs and how subtle changes in the modulation of PC firing lead to adjustment of motor behaviors, it is important to precisely record PC firing in vivo and to control modulatory pathways in a spatio-temporal manner. Combining optogenetic and multi-electrode approaches, we established a new method to integrate light-guides into a multi-electrode system. With this method we are able to variably position the light-guide in defined regions relative to the recording electrode with micrometer precision. We show that PC firing can be precisely monitored and modulated by light-activation of channelrhodopsin-2 (ChR2) expressed in PCs, GCs and interneurons. Thus, this method is ideally suited to investigate the spatio/temporal modulation of PCs in anesthetized and in behaving mice.	[Kruse, Wolfgang; Krause, Martin; Mark, Melanie D.; Herlitze, Stefan] Ruhr Univ Bochum, Dept Zool & Neurobiol, Fac Biol & Biotechnol, Bochum, Germany; [Aarse, Janna; Manahan-Vaughan, Denise] Ruhr Univ Bochum, Fac Med, Dept Neurophysiol, Bochum, Germany; [Kruse, Wolfgang; Aarse, Janna; Manahan-Vaughan, Denise; Herlitze, Stefan] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Kruse, W (corresponding author), Ruhr Univ Bochum, Dept Zool & Neurobiol, Fac Biol & Biotechnol, Univ Str 150, Bochum, Germany.	Wolfgang.Kruse@rub.de	Mark, Melanie/ABF-9102-2020	Mark, Melanie/0000-0002-2788-6003; Manahan-Vaughan, Denise/0000-0002-9283-9609	Deutsche Forschungsgemeinschaft (DFG) [Ma5806/1-1, He2471/8-1]; DFG [SFB 874]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grants to MDM (Ma5806/1-1) and to SH (He2471/8-1) and by DFG SFB 874 to DMV and SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Bower JM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00027; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chaumont J, 2013, P NATL ACAD SCI USA, V110, P16223, DOI 10.1073/pnas.1302310110; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; D'Angelo E, 2011, BRAIN RES REV, V66, P5, DOI 10.1016/j.brainresrev.2010.10.002; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; Dizon MJ, 2011, J NEUROSCI, V31, P10463, DOI 10.1523/JNEUROSCI.1350-11.2011; ECCLES JC, 1973, J PHYSIOL-LONDON, V229, P1; Eccles JC, 1967, CEREBELLUM NEURAL MA; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; Funfschilling U, 2002, GENESIS, V33, P160, DOI 10.1002/gene.10104; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Heiney SA, 2014, J NEUROSCI, V34, P2321, DOI 10.1523/JNEUROSCI.4547-13.2014; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Huang CM, 2006, EUR J NEUROSCI, V23, P1731, DOI 10.1111/j.1460-9568.2006.04690.x; Kravitz AV, 2011, CURR OPIN NEUROBIOL, V21, P433, DOI 10.1016/j.conb.2011.02.010; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Masseck OA, 2014, NEURON, V81, P1263, DOI 10.1016/j.neuron.2014.01.041; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Ozden I, 2013, J NEUROSCI METH, V219, P142, DOI 10.1016/j.jneumeth.2013.06.011; Raman IM, 1999, J NEUROSCI, V19, P1663; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; THACH WT, 1970, J NEUROPHYSIOL, V33, P537, DOI 10.1152/jn.1970.33.4.537; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsubota T, 2013, BEHAV BRAIN RES, V255, P26, DOI 10.1016/j.bbr.2013.04.019; Tsubota T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022400; Witter L, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00133; Womack MD, 2003, J NEUROSCI, V23, P2600; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007	55	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105589	10.1371/journal.pone.0105589	http://dx.doi.org/10.1371/journal.pone.0105589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144735	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100089
J	Rebourcet, D; O'Shaughnessy, PJ; Monteiro, A; Milne, L; Cruickshanks, L; Jeffrey, N; Guillou, F; Freeman, TC; Mitchell, RT; Smith, LB				Rebourcet, Diane; O'Shaughnessy, Peter J.; Monteiro, Ana; Milne, Laura; Cruickshanks, Lyndsey; Jeffrey, Nathan; Guillou, Florian; Freeman, Tom C.; Mitchell, Rod T.; Smith, Lee B.			Sertoli Cells Maintain Leydig Cell Number and Peritubular Myoid Cell Activity in the Adult Mouse Testis	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; NEONATALLY ADMINISTERED DIETHYLSTILBESTROL; CRE RECOMBINASE ACTIVITY; LUTEINIZING-HORMONE; GERM-CELL; METABOLIC SYNDROME; MESSENGER-RNA; POSTNATAL-DEVELOPMENT; INTERSTITIAL-CELLS; SEX REVERSAL	The Sertoli cells are critical regulators of testis differentiation and development. In the adult, however, their known function is restricted largely to maintenance of spermatogenesis. To determine whether the Sertoli cells regulate other aspects of adult testis biology we have used a novel transgenic mouse model in which Amh-Cre induces expression of the receptor for Diphtheria toxin (iDTR) specifically within Sertoli cells. This causes controlled, cell-specific and acute ablation of the Sertoli cell population in the adult animal following Diphtheria toxin injection. Results show that Sertoli cell ablation leads to rapid loss of all germ cell populations. In addition, adult Leydig cell numbers decline by 75% with the remaining cells concentrated around the rete and in the sub-capsular region. In the absence of Sertoli cells, peritubular myoid cell activity is reduced but the cells retain an ability to exclude immune cells from the seminiferous tubules. These data demonstrate that, in addition to support of spermatogenesis, Sertoli cells are required in the adult testis both for retention of the normal adult Leydig cell population and for support of normal peritubular myoid cell function. This has implications for our understanding of male reproductive disorders and wider androgen-related conditions affecting male health.	[Rebourcet, Diane; Milne, Laura; Cruickshanks, Lyndsey; Jeffrey, Nathan; Mitchell, Rod T.; Smith, Lee B.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [O'Shaughnessy, Peter J.; Monteiro, Ana] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Guillou, Florian] Univ Tours, INRA, CNRS, UMR 6073,Stn Physiol Reprod & Comportements PRC, Nouzilly, France; [Freeman, Tom C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Smith, LB (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	Lee.Smith@ed.ac.uk		Monteiro, Ana/0000-0003-2349-9716; Smith, Lee/0000-0002-4103-3074; Mitchell, Rod/0000-0003-4650-3765; Freeman, Thomas/0000-0001-5235-8483	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J015105/1]; Medical Research Council (MRC) [G1100354/1]; Biotechnology and Biological Sciences Research Council [BB/J016209/1, BBS/E/D/20211552, BB/J015105/1] Funding Source: researchfish; Medical Research Council [G1100354, G1002033] Funding Source: researchfish; BBSRC [BB/J016209/1, BB/J015105/1, BBS/E/D/20211552] Funding Source: UKRI; MRC [G1100354, G1002033] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Biotechnology and Biological Sciences Research Council (BBSRC) Project grant (BB/J015105/1) (to LBS, PJO and TFC), and Medical Research Council (MRC) Programme Grant (G1100354/1) (to LBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Baker PJ, 2001, REPRODUCTION, V122, P553, DOI 10.1530/reprod/122.4.553; BERGMANN M, 1983, ANAT EMBRYOL, V168, P269, DOI 10.1007/BF00315821; BERNDTSON WE, 1990, J ANDROL, V11, P429; Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chen M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114702; CHEN YDI, 1976, P SOC EXP BIOL MED, V153, P473; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; CHRISTENSEN AK, 1975, HDB PHYSIOLOGY     7, V5, P57; Cohen PE, 1997, BIOL REPROD, V56, P110, DOI 10.1095/biolreprod56.1.110; Combes AN, 2009, DEV DYNAM, V238, P1033, DOI 10.1002/dvdy.21925; Cool J, 2012, WIRES DEV BIOL, V1, P847, DOI 10.1002/wdev.62; COQUELIN A, 1982, AM J PHYSIOL, V243, pE257, DOI 10.1152/ajpendo.1982.243.3.E257; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; DALTERIO SL, 1983, PHARMACOL BIOCHEM BE, V18, P81, DOI 10.1016/0091-3057(83)90255-1; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; DONCEL GF, 1989, AM J REPROD IMMUNOL, V20, P44, DOI 10.1111/j.1600-0897.1989.tb00638.x; Dym M, 1970, Biology Reprod., V3, P308; Elkin ND, 2010, TOXICOL SCI, V117, P439, DOI 10.1093/toxsci/kfq210; Faria MJS, 2003, MICROSC MICROANAL, V9, P68, DOI 10.1017/S1431927603030101; Farrell JB, 2008, DIABETES EDUCATOR, V34, P799, DOI 10.1177/0145721708323100; Fawcett D W, 1970, J Reprod Fertil Suppl, V10, P105; FILLION C, 1994, MOL CELL ENDOCRINOL, V99, P25, DOI 10.1016/0303-7207(94)90142-2; Gaytan F, 1996, J ENDOCRINOL, V150, P57, DOI 10.1677/joe.0.1500057; HARDY MP, 1989, ENDOCRINOLOGY, V124, P762, DOI 10.1210/endo-124-2-762; Hazra R, 2013, ENDOCRINOLOGY, V154, P3410, DOI 10.1210/en.2012-2273; Herrera J, 1996, ARCH ANDROLOGY, V37, P127, DOI 10.3109/01485019608988513; Hosoi I, 2002, ANDROLOGIA, V34, P255, DOI 10.1046/j.1439-0272.2002.00502.x; JOHNSON L, 1991, BIOL REPROD, V45, P404, DOI 10.1095/biolreprod45.3.404; JOHNSON L, 1984, BIOL REPROD, V31, P785, DOI 10.1095/biolreprod31.4.785; KEENEY DS, 1990, J ANDROL, V11, P367; KEENEY DS, 1988, ENDOCRINOLOGY, V123, P2906, DOI 10.1210/endo-123-6-2906; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700; McGee SR, 2013, ENDOCRINOLOGY, V154, P3900, DOI 10.1210/en.2012-2179; MENDISHANDAGAMA SMLC, 1990, J ANDROL, V11, P548; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; MORRIS ID, 1986, ENDOCRINOLOGY, V118, P709, DOI 10.1210/endo-118-2-709; NEAVES WB, 1985, BIOL REPROD, V33, P259, DOI 10.1095/biolreprod33.1.259; NEAVES WB, 1984, J CLIN ENDOCR METAB, V59, P756, DOI 10.1210/jcem-59-4-756; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P851, DOI 10.1530/REP-07-0529; O'Shaughnessy PJ, 2009, MOL CELL ENDOCRINOL, V306, P2, DOI 10.1016/j.mce.2008.11.005; O'Shaughnessy PJ, 2011, MOL HUM REPROD, V17, P620, DOI 10.1093/molehr/gar032; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; OSHAUGHNESSY PJ, 1993, J MOL ENDOCRINOL, V11, P77, DOI 10.1677/jme.0.0110077; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; Rebourcet D, 2014, DEVELOPMENT IN PRESS; Russell L.D., 1990, HISTOLOGICAL HISTOPA, P119; Russell LD, 2001, BIOL REPROD, V65, P318, DOI 10.1095/biolreprod65.1.318; Saad F, 2009, J STEROID BIOCHEM, V114, P40, DOI 10.1016/j.jsbmb.2008.12.022; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P2805, DOI 10.1210/me.2003-0203; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Sekido R, 2013, SEX DEV, V7, P21, DOI 10.1159/000342221; SHARPE RM, 1990, AM J ANAT, V188, P3, DOI 10.1002/aja.1001880103; SKINNER MK, 1985, J CELL BIOL, V100, P1941, DOI 10.1083/jcb.100.6.1941; Stanley E, 2012, ENDOCRINOLOGY; SYED V, 1989, INT J ANDROL, V12, P464, DOI 10.1111/j.1365-2605.1989.tb01336.x; Tanwar PS, 2011, MOL ENDOCRINOL, V25, P1725, DOI 10.1210/me.2011-0057; TEERDS KJ, 1989, J ENDOCRINOL, V122, P689, DOI 10.1677/joe.0.1220689; Toyama Y, 2001, J ANDROL, V22, P413; Tyndall V, 2012, REPRODUCTION, V143, P21, DOI 10.1530/REP-11-0239; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; VIHKO KK, 1991, ENDOCRINOLOGY, V129, P1926, DOI 10.1210/endo-129-4-1926; VITALE R, 1973, ANAT REC, V176, P333, DOI 10.1002/ar.1091760309; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Warr N, 2012, WIRES DEV BIOL, V1, P559, DOI 10.1002/wdev.42; Welsh M, 2012, INT J ANDROL, V35, P25, DOI 10.1111/j.1365-2605.2011.01150.x; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505; XIONG YT, 1993, ENDOCRINOLOGY, V133, P2568, DOI 10.1210/en.133.6.2568; Yeap BB, 2010, CURR OPIN ENDOCRINOL, V17, P269, DOI 10.1097/MED.0b013e3283383031; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x; Zhang FP, 2004, ENDOCRINOLOGY, V145, P1453, DOI 10.1210/en.2003-1049; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	87	77	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105687	10.1371/journal.pone.0105687	http://dx.doi.org/10.1371/journal.pone.0105687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144714	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000341106100108
J	Wu, HP; Wang, YQ; Dong, N; Yang, F; Lin, ZR; Shang, XM; Li, C				Wu, Huping; Wang, Yuqian; Dong, Nuo; Yang, Fan; Lin, Zhirong; Shang, Xumin; Li, Cheng			Meibomian Gland Dysfunction Determines the Severity of the Dry Eye Conditions in Visual Display Terminal Workers	PLOS ONE			English	Article							COMPUTER VISION SYNDROME; TEAR FILM; INTERNATIONAL WORKSHOP; OCULAR SURFACE; DISEASE; SUBCOMMITTEE; KERATOGRAPH; PREVALENCE; DISCOMFORT; SYMPTOMS	Objective: To explore meibomian gland dysfunction (MGD) may determine the severity of dry eye conditions in visual display terminal (VDT) workers. Methodology: Prospective, case-control study carried out in China. 106 eyes of 53 patients (VDT work time >4 hour per day) were recruited as the Long time VDT group; 80 eyes of 40 control subjects (VDT work time <= 4 hour per day) served as the Short time VDT group. A questionnaire of Ocular Surface Disease Index (OSDI) and multiple tests were performed. Three dry eye tests: tear film breakup time (BUT), corneal fluorescein staining, Schirmer I test; and three MGD parameters: lid margin abnormality score, meibum expression assessment (meibum score), and meibomian gland dropout degree (meiboscore) using Keratograph 5 M. Principal Findings: OSDI and corneal fluorescein score were significantly higher while BUT was dramatically shorter in the long time VDT group than the short time VDT group. However, the average of Schirmer tear volumes was in normal ranges in both groups. Interestingly, the three MGD parameters were significantly higher in the long time VDT group than the short time one (P<0.0001). When 52 eyes with Schirmer <10 mm and 54 eyes with Schirmer >= 10 mm were separated from the long time VDT workers, no significant differences were found between the two subgroups in OSDI, fluorescein staining and BUT, as well as the three MGD parameters. All three MGD parameters were positively correlated with VDT working time (P<0.0001) and fluorescein scores (P<0.0001), inversely correlated with BUT (P<0.05), but not correlated with Schirmer tear volumes in the VDT workers. Conclusions: Our findings suggest that a malfunction of meibomian glands is associated with dry eye patients in long term VDT workers with higher OSDI scores whereas some of those patients presenting a normal tear volume.	[Wu, Huping; Wang, Yuqian; Dong, Nuo; Yang, Fan; Lin, Zhirong; Shang, Xumin; Li, Cheng] Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China	Xiamen University	Wu, HP (corresponding author), Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China.	wuhuping2014@163.com			Xiamen major technological innovation platform project of China [3502Z20131017, 3502Z20134039, 3502Z20124037]; Fujian medical innovation project [2012-CXB-30, 2013-2-112]	Xiamen major technological innovation platform project of China; Fujian medical innovation project	This work was supported by the Project supported by the Xiamen major technological innovation platform project of China (Grant No. 3502Z20131017, 3502Z20134039, 3502Z20124037) http://www.xminfo.net.cn/; Fujian medical innovation project (2012-CXB-30, 2013-2-112) http://www.fjkjt.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AA, 1999, OPHTHALMOLOGY, V106, P803, DOI 10.1016/S0161-6420(99)90170-7; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2012, CORNEA, V31, P1229, DOI 10.1097/ICO.0b013e31823f8e7d; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; Ban Y, 2011, MOL VIS, V17, P2533; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Collins Michael J, 2006, Eye Contact Lens, V32, P287, DOI 10.1097/01.icl.0000224551.58399.9a; Dong N, 2009, INVEST OPHTH VIS SCI, V50, P2710, DOI 10.1167/iovs.08-2905; Fenga C, 2008, EYE, V22, P91, DOI 10.1038/sj.eye.6703025; Foulks GN, 2012, OPHTHALMOLOGY, V119, pS1, DOI 10.1016/j.ophtha.2012.06.064; Green-Church KB, 2011, INVEST OPHTH VIS SCI, V52, P1979, DOI 10.1167/iovs.10-6997d; Hong JX, 2013, CORNEA, V32, P716, DOI 10.1097/ICO.0b013e3182714425; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Kojima T, 2011, AM J OPHTHALMOL, V152, P933, DOI 10.1016/j.ajo.2011.05.025; KORB DR, 1994, CORNEA, V13, P354, DOI 10.1097/00003226-199407000-00012; Miller KL, 2010, ARCH OPHTHALMOL-CHIC, V128, P94, DOI 10.1001/archophthalmol.2009.356; Murube J, 2002, ADV EXP MED BIOL, V506, P1205; Nakamura S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011119; Nelson JD, 2011, INVEST OPHTH VIS SCI, V52, P1930, DOI 10.1167/iovs.10-6997b; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE310, DOI 10.1097/OPX.0b013e318244e487; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; ROSSIGNOL AM, 1987, J OCCUP ENVIRON MED, V29, P112; Shimazaki J, 1998, OPHTHALMOLOGY, V105, P1485, DOI 10.1016/S0161-6420(98)98033-2; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Srinivasan S, 2012, OPTOMETRY VISION SCI, V89, P788, DOI 10.1097/OPX.0b013e318253de93; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Uchino M, 2014, AM J OPHTHALMOL, V157, P294, DOI 10.1016/j.ajo.2013.10.014; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Ye Zhaojia, 2007, Journal of Physiological Anthropology, V26, P69, DOI 10.2114/jpa2.26.69	31	47	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105575	10.1371/journal.pone.0105575	http://dx.doi.org/10.1371/journal.pone.0105575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144638	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100087
J	Zhang, YH; Pham, NK; Zhang, HX; Lin, JD; Lin, Q				Zhang, Yanhong; Pham, Nancy Kim; Zhang, Huixian; Lin, Junda; Lin, Qiang			Genetic Variations in Two Seahorse Species (Hippocampus mohnikei and Hippocampus trimaculatus): Evidence for Middle Pleistocene Population Expansion	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; PACIFIC MARGINAL SEAS; MARINE FISH; LIFE-HISTORY; GROWTH; FLOW; DIFFERENTIATION; CONSERVATION; DISPERSAL; DIVERSITY	Population genetic of seahorses is confidently influenced by their species-specific ecological requirements and life-history traits. In the present study, partial sequences of mitochondrial cytochrome b (cytb) and control region (CR) were obtained from 50 Hippocampus mohnikei and 92 H. trimaculatus from four zoogeographical zones. A total of 780 base pairs of cytb gene were sequenced to characterize mitochondrial DNA (mtDNA) diversity. The mtDNA marker revealed high haplotype diversity, low nucleotide diversity, and a lack of population structure across both populations of H. mohnikei and H. trimaculatus. A neighbour-joining (NJ) tree of cytb gene sequences showed that H. mohnikei haplotypes formed one cluster. A maximum likelihood (ML) tree of cytb gene sequences showed that H. trimaculatus belonged to one lineage. The star-like pattern median-joining network of cytb and CR markers indicated a previous demographic expansion of H. mohnikei and H. trimaculatus. The cytb and CR data sets exhibited a unimodal mismatch distribution, which may have resulted from population expansion. Mismatch analysis suggested that the expansion was initiated about 276,000 years ago for H. mohnikei and about 230,000 years ago for H. trimaculatus during the middle Pleistocene period. This study indicates a possible signature of genetic variation and population expansion in two seahorses under complex marine environments.	[Zhang, Yanhong; Zhang, Huixian; Lin, Qiang] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Pham, Nancy Kim; Lin, Junda] Florida Inst Technol, Vero Beach Marine Lab, Vero Beach, FL USA	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Florida Institute of Technology	Lin, Q (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	linqiangzsu@163.com			Outstanding Youth Foundation in Guangdong Province [S2013050014802]; National Natural Science Foundation of China [41176146, 41306148]; US National Science Foundation East Asia and Pacific Summer Institute Fellowship (EAPSI) [OISE-1209841]	Outstanding Youth Foundation in Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation East Asia and Pacific Summer Institute Fellowship (EAPSI)	This study was funded by the Outstanding Youth Foundation in Guangdong Province (S2013050014802), the National Natural Science Foundation of China (41176146, 41306148), and the US National Science Foundation East Asia and Pacific Summer Institute Fellowship (EAPSI, OISE-1209841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; [Anonymous], 1984, FISHES JAPANESE ARCH; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; Curtis JMR, 2006, J FISH BIOL, V68, P707, DOI 10.1111/j.0022-1112.2006.00952.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dsouli-Aymes N, 2011, INFECT GENET EVOL, V11, P334, DOI 10.1016/j.meegid.2010.11.001; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagao Z, 1987, CHIN J OCEANOL LIMN, V5, P67; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Friess C, 2011, J FISH BIOL, V78, P466, DOI 10.1111/j.1095-8649.2010.02857.x; Fu YX, 1997, GENETICS, V147, P915; Goswami M, 2009, HYDROBIOLOGIA, V621, P213, DOI 10.1007/s10750-008-9642-3; GREWE PM, 1993, CAN J FISH AQUAT SCI, V50, P2397, DOI 10.1139/f93-264; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hoarau G, 2000, CR ACAD SCI III-VIE, V323, P315, DOI 10.1016/S0764-4469(00)90124-0; Hu J., 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Kim Ik-Soo, 1995, Korean Journal of Zoology, V38, P74; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HJ, 2007, MOL ECOL, V16, P3084, DOI 10.1111/j.1365-294X.2007.03364.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Lourie S. A., 1999, SEAHORSES IDENTIFICA; Lourie S.A., 2004, GUIDE IDENTIFICATION; Lourie SA, 2004, J BIOGEOGR, V31, P1975, DOI 10.1111/j.1365-2699.2004.01153.x; MCKENZIE K G, 1991, Australian Systematic Botany, V4, P37, DOI 10.1071/SB9910037; Nei M., 1987, MOL EVOLUTIONARY GEN; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Saarman NP, 2010, CONSERV GENET, V11, P1989, DOI 10.1007/s10592-010-0092-x; Scales H, 2010, PROG PHYS GEOG, V34, P443, DOI 10.1177/0309133310364928; Silva SE, 2013, BIOL J LINN SOC, V108, P494, DOI 10.1111/j.1095-8312.2012.02041.x; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Song ZB, 2008, ENVIRON BIOL FISH, V81, P247, DOI 10.1007/s10641-007-9197-6; Swofford D., 2002, PAUP 4 0 B10 PHYLOGE; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teske PR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000614; Teske PR, 2003, MOL ECOL, V12, P1703, DOI 10.1046/j.1365-294X.2003.01852.x; Tinti F, 2002, MAR BIOTECHNOL, V4, P163, DOI 10.1007/s10126-002-0003-3; Varela AI, 2012, MAR BIOL, V159, P1049, DOI 10.1007/s00227-012-1885-x; Wang PX, 1999, MAR GEOL, V156, P5, DOI 10.1016/S0025-3227(98)00172-8; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033883; Woodall LC, 2011, J FISH BIOL, V78, P1738, DOI 10.1111/j.1095-8649.2011.02974.x; Xiao YS, 2010, BIOCHEM GENET, V48, P402, DOI 10.1007/s10528-009-9321-8; Xu X., 1980, SCI S CHINA OCEANOLO, P137	56	19	20	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105494	10.1371/journal.pone.0105494	http://dx.doi.org/10.1371/journal.pone.0105494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144384	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100074
J	Zheng, L; Feng, YH; Shi, YP; Zhang, J; Mu, QF; Qin, L; Berggren-Soderlund, M; Nilsson-Ehle, P; Zhang, XY; Luo, GH; Xu, N				Zheng, Lu; Feng, Yuehua; Shi, Yuanping; Zhang, Jun; Mu, Qinfeng; Qin, Li; Berggren-Soederlund, Maria; Nilsson-Ehle, Peter; Zhang, Xiaoying; Luo, Guanghua; Xu, Ning			Intralipid Decreases Apolipoprotein M Levels and Insulin Sensitivity in Rats	PLOS ONE			English	Article							EXPRESSION IN-VIVO; M GENE-EXPRESSION; PROTEIN-KINASE-C; METABOLIC SYNDROME; SKELETAL-MUSCLE; RESISTANCE; ACID; RECEPTOR; ELEVATION; HDL	Background: Apolipoprotein M (ApoM) is a constituent of high-density lipoproteins (HDL). It plays a crucial role in HDL-mediated reverse cholesterol transport. Insulin resistance is associated with decreased ApoM levels. Aims: To assess the effects of increased free fatty acids (FFAs) levels after short-term Intralipid infusion on insulin sensitivity and hepatic ApoM gene expression. Methods: Adult male Sprague-Dawley (SD) rats infused with 20% Intralipid solution for 6 h. Glucose infusion rates (GIR) were determined by hyperinsulinemic-euglycemic clamp during Intralipid infusion and plasma FFA levels were measured by colorimetry. Rats were sacrificed after Intralipid treatment and livers were sampled. Human embryonic kidney 293T cells were transfected with a lentivirus mediated human apoM overexpression system. Goto-Kakizaki (GK) rats were injected with the lentiviral vector and insulin tolerance was assessed. Gene expression was assessed by real-time RT-PCR and PCR array. Results: Intralipid increased FFAs by 17.6 folds and GIR was decreased by 27.1% compared to the control group. ApoM gene expression was decreased by 40.4% after Intralipid infusion. PPAR(beta/delta) expression was not changed by Intralipid. Whereas the mRNA levels of Acaca, Acox1, Akt1, V-raf murine sarcoma 3611 viral oncogene homolog, G6pc, Irs2, Ldlr, Map2k1, pyruvate kinase and RBC were significantly increased in rat liver after Intralipid infusion. The Mitogen-activated protein kinase 8 (MAPK8) was significantly down-regulated in 293T cells overexpressing ApoM. Overexpression of human ApoM in GK rats could enhance the glucose-lowering effect of exogenous insulin. Conclusion: These results suggest that Intralipid could decrease hepatic ApoM levels. ApoM overexpression may have a potential role in improving insulin resistance in vivo and modulating apoM expression might be a future therapeutic strategy against insulin resistance in type 2 diabetes.	[Zheng, Lu; Feng, Yuehua; Shi, Yuanping; Zhang, Jun; Mu, Qinfeng; Qin, Li; Luo, Guanghua] Soochow Univ, Affiliated Hosp 3, Comprehens Lab, Changzhou, Peoples R China; [Zhang, Xiaoying] Soochow Univ, Affiliated Hosp 3, Dept Cardiothorac Surg, Changzhou, Peoples R China; [Berggren-Soederlund, Maria; Nilsson-Ehle, Peter; Xu, Ning] Lund Univ, Dept Lab Med, Div Clin Chem & Pharmacol, Lund, Sweden	Soochow University - China; Soochow University - China; Lund University	Luo, GH (corresponding author), Soochow Univ, Affiliated Hosp 3, Comprehens Lab, Changzhou, Peoples R China.	shineroar@163.com; ning.xu@med.lu.se		Luo, Guanghua/0000-0001-8339-2828; Zheng, Lu/0000-0002-5563-4348	National Natural Science Foundation of China (NSFC) [81071414, 81201352]; Natural Science Foundation of Jiangsu Province [BK2011245, BK2012154]; Changzhou Science & Technology Bureau [CJ20122012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Changzhou Science & Technology Bureau	This research project was supported by the National Natural Science Foundation of China (NSFC) (81071414, 81201352, http://www.nsfc.gov.cn/), the Natural Science Foundation of Jiangsu Province (BK2011245, BK2012154, http://www.jskjjh.gov.cn/) and a research grant from the Changzhou Science & Technology Bureau (CJ20122012, http://new.czstb.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Brehm A, 2010, AM J PHYSIOL-ENDOC M, V299, pE33, DOI 10.1152/ajpendo.00756.2009; Choi CS, 2001, DIABETES, V50, P418, DOI 10.2337/diabetes.50.2.418; Chow LS, 2012, J CLIN ENDOCR METAB, V97, P2890, DOI 10.1210/jc.2012-1515; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Dissen GA, 2009, METHODS, V49, P70, DOI 10.1016/j.ymeth.2009.06.004; Dullaart RPF, 2009, CLIN CHIM ACTA, V406, P129, DOI 10.1016/j.cca.2009.06.010; Elsoe S, 2012, ATHEROSCLEROSIS, V221, P91, DOI 10.1016/j.atherosclerosis.2011.11.031; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; GARG A, 1990, JAMA-J AM MED ASSOC, V264, P723, DOI 10.1001/jama.264.6.723; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Gosmanov AR, 2012, METABOLISM, V61, P1370, DOI 10.1016/j.metabol.2012.03.006; GOTO Y, 1988, FRONTIERS DIABETES R, V2, P301; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hu YW, 2012, REJUV RES, V15, P423, DOI 10.1089/rej.2011.1295; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kashyap SR, 2009, OBESITY, V17, P2142, DOI 10.1038/oby.2009.179; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim MY, 2012, EXP DIABETES RES, DOI 10.1155/2012/716425; Krogh-Madsen R, 2008, AM J PHYSIOL-ENDOC M, V294, pE371, DOI 10.1152/ajpendo.00507.2007; Liu J, 2011, J CLIN ENDOCR METAB, V96, P438, DOI 10.1210/jc.2010-1174; Luo GH, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-102; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Ogata M, 1997, BIOL PHARM BULL, V20, P1026; Ooi EMM, 2010, ATHEROSCLEROSIS, V210, P326, DOI 10.1016/j.atherosclerosis.2009.11.024; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Sevvana M, 2009, J MOL BIOL, V393, P920, DOI 10.1016/j.jmb.2009.08.071; Skupien Jan, 2007, Rev Diabet Stud, V4, P231, DOI 10.1900/RDS.2007.4.231; Sullivan PW, 2005, DIABETES CARE, V28, P1599, DOI 10.2337/diacare.28.7.1599; Umpierrez GE, 2009, J CLIN ENDOCR METAB, V94, P609, DOI 10.1210/jc.2008-1590; Venteclef N, 2008, J BIOL CHEM, V283, P3694, DOI 10.1074/jbc.M706382200; Waitzberg DL, 2006, JPEN-PARENTER ENTER, V30, P351, DOI 10.1177/0148607106030004351; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 2006, BBA-MOL CELL BIOL L, V1761, P256, DOI 10.1016/j.bbalip.2006.02.002; Xu N, 2006, BIOCHEM BIOPH RES CO, V342, P1174, DOI 10.1016/j.bbrc.2006.02.022; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Zhang X, 2008, BIOCHEM BIOPH RES CO, V371, P114, DOI 10.1016/j.bbrc.2008.04.017; Zhang XY, 2007, BBA-MOL CELL BIOL L, V1771, P879, DOI 10.1016/j.bbalip.2007.04.020; Zhang YL, 2005, LIFE SCI, V77, P2071, DOI 10.1016/j.lfs.2004.12.047	41	13	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105681	10.1371/journal.pone.0105681	http://dx.doi.org/10.1371/journal.pone.0105681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144649	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100107
J	Husseneder, C; Simms, DM				Husseneder, Claudia; Simms, Dawn M.			Effects of Caste on the Expression of Genes Associated with Septic Injury and Xenobiotic Exposure in the Formosan Subterranean Termite	PLOS ONE			English	Article							CHITIN-BINDING ACTIVITY; JUVENILE-HORMONE; DROSOPHILA-MELANOGASTER; COPTOTERMES-FORMOSANUS; INSECT IMMUNITY; HOUSEKEEPING GENES; DISEASE RESISTANCE; ANOPHELES-GAMBIAE; SOCIAL INSECT; MANDUCA-SEXTA	As social insects, termites live in densely populated colonies with specialized castes under conditions conducive to microbial growth and transmission. Furthermore, termites are exposed to xenobiotics in soil and their lignocellulose diet. Therefore, termites are valuable models for studying gene expression involved in response to septic injury, immunity and detoxification in relation to caste membership. In this study, workers and soldiers of the Formosan subterranean termite, Coptotermes formosanus, were challenged by bacterial injection or by no-choice feeding with a sublethal concentration (0.5%) of phenobarbital. Constitutive and induced expression of six putative immune response genes (two encoding for lectin-like proteins, one for a ficolin-precursor, one for the Down syndrome cell adhesion molecule, one for a chitin binding protein, and one for the gram-negative binding protein 2) and four putative detoxification genes (two encoding for cytochrome P450s, one for glutathione S-transferase, and one for the multi antimicrobial extrusion protein), were measured via quantitative real time polymerase chain reaction and compared within and among 1) colonies, 2) treatment types and 3) castes via ANOVA. Eight genes were inducible by septic injury, feeding with phenobarbital or both. Colony origin had no effect on inducibility or differential gene expression. However, treatment type showed significant effects on the expression of the eight inducible genes. Caste effects on expression levels were significant in five of the eight inducible genes with constitutive and induced expression of most target genes being higher in workers than in soldiers.	[Husseneder, Claudia; Simms, Dawn M.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Husseneder, C (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	chusseneder@agcenter.lsu.edu		Husseneder, Claudia/0000-0001-5962-9354	USDA-ARS Specific Cooperative Agreements; state of Louisiana	USDA-ARS Specific Cooperative Agreements; state of Louisiana	This study was funded by USDA-ARS Specific Cooperative Agreements and grants by the state of Louisiana to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anspaugh DD, 2005, J INSECT PHYSIOL, V51, P523, DOI 10.1016/j.jinsphys.2004.12.008; Arai T, 1998, INSECT BIOCHEM MOLEC, V28, P987, DOI 10.1016/S0965-1748(98)00087-3; Basta-Kaim Agnieszka, 2008, Przegl Lek, V65, P799; Bechkage NE, 2008, INSECT IMMUNOLOGY, P360; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brown D, 2003, ARCH INSECT BIOCHEM, V53, P119, DOI 10.1002/arch.10089; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calleri DV, 2006, P ROY SOC B-BIOL SCI, V273, P2633, DOI 10.1098/rspb.2006.3622; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chouvenc T, 2011, BIOL CONTROL, V59, P69, DOI 10.1016/j.biocontrol.2011.06.015; Cornette R, 2006, INSECT MOL BIOL, V15, P235, DOI 10.1111/j.1365-2583.2006.00632.x; Destoumieux D, 2000, J CELL SCI, V113, P461; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; DUNN PE, 1986, ANNU REV ENTOMOL, V31, P321, DOI 10.1146/annurev.en.31.010186.001541; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Feyereisen R., 2005, P1; Gao Q, 2012, ARCH INSECT BIOCHEM, V80, P63, DOI 10.1002/arch.21026; Gatti SS, 2002, J ECON ENTOMOL, V95, P813, DOI 10.1603/0022-0493-95.4.813; Gatti SS, 1996, SOCIOBIOLOGY, V28, P23; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Global Invasive Species Database, 2013, 100 WORLDS WORST INV; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Guzov VM, 1998, ARCH BIOCHEM BIOPHYS, V359, P231, DOI 10.1006/abbi.1998.0901; Hamilton C, 2012, DEV COMP IMMUNOL, V36, P372, DOI 10.1016/j.dci.2011.07.008; Hamilton C, 2011, J INSECT PHYSIOL, V57, P1259, DOI 10.1016/j.jinsphys.2011.05.016; HARITOS VS, 1994, INSECT BIOCHEM MOLEC, V24, P929, DOI 10.1016/0965-1748(94)90021-3; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Higashiguchi DT, 2006, INT J SYST EVOL MICR, V56, P15, DOI 10.1099/ijs.0.63543-0; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hussain A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069543; Husseneder C, 2005, J ECON ENTOMOL, V98, P1421, DOI 10.1603/0022-0493-98.5.1421; Husseneder C, 2009, ANN ENTOMOL SOC AM, V102, P498, DOI 10.1603/008.102.0321; Husseneder C, 2012, BIOL INVASIONS, V14, P419, DOI 10.1007/s10530-011-0087-7; Husseneder C, 2012, COMP BIOCHEM PHYS D, V7, P14, DOI 10.1016/j.cbd.2011.10.002; Infante C, 2008, BMC MOL BIOL, V9, DOI [10.1186/1471-2199-9-19, 10.1186/1471-2199-9-28]; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Ishikawa Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-314; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Johansson KC, 2005, EXP CELL RES, V305, P145, DOI 10.1016/j.yexcr.2004.12.018; JOMORI T, 1990, EUR J BIOCHEM, V190, P201, DOI 10.1111/j.1432-1033.1990.tb15565.x; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; Kasai S, 2001, INSECT BIOCHEM MOLEC, V32, P1, DOI 10.1016/S0965-1748(01)00073-X; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kuballa AV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-575; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Matsushita M, 2010, J INNATE IMMUN, V2, P24, DOI 10.1159/000228160; Messenger MT, 2005, FLA ENTOMOL, V88, P99, DOI 10.1653/0015-4040(2005)088[0099:NFDRFC]2.0.CO;2; Middha S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-260; Moriyama Y, 2008, XENOBIOTICA, V38, P1107, DOI [10.1080/00498250701883753, 10.1080/00498250701883753 ]; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Omote H, 2006, TRENDS PHARM SCI, V27, DOI 10.10/j.tips.2006.09.001; Osbrink WLA, 2001, J ECON ENTOMOL, V94, P1217, DOI 10.1603/0022-0493-94.5.1217; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ratra GS, 2001, TOXICOL LETT, V122, P215, DOI 10.1016/S0378-4274(01)00366-6; Rosengaus RB, 2000, J CHEM ECOL, V26, P21, DOI 10.1023/A:1005481209579; Rosengaus RB, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P165, DOI 10.1007/978-90-481-3977-4_7; Rosengaus RB, 2007, NATURWISSENSCHAFTEN, V94, P25, DOI 10.1007/s00114-006-0151-9; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Scott JG, 1996, ARCH INSECT BIOCHEM, V31, P313, DOI 10.1002/(SICI)1520-6327(1996)31:3&lt;313::AID-ARCH6&gt;3.0.CO;2-Y; Simms DM, 2009, SOCIOBIOLOGY, V52, P1; Steller MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-463; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; SU NY, 1988, SOCIOBIOLOGY, V14, P353; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Tarver MR, 2012, ARCH INSECT BIOCHEM, V80, P92, DOI 10.1002/arch.21030; Tarver MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-28; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Thompson GJ, 2003, INSECT MOL BIOL, V12, P1, DOI 10.1046/j.1365-2583.2003.00381.x; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Traniello JFA, 2002, P NATL ACAD SCI USA, V99, P6838, DOI 10.1073/pnas.102176599; Tsakas S, 2010, ISJ-INVERT SURVIV J, V7, P228; Valles SM, 2002, COMP BIOCHEM PHYS C, V131, P469, DOI 10.1016/S1532-0456(02)00031-5; Valles SM, 2001, INSECT BIOCHEM MOLEC, V31, P715, DOI 10.1016/S0965-1748(00)00179-X; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Wang XG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-114; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wijffels G, 2001, J BIOL CHEM, V276, P15527, DOI 10.1074/jbc.M009393200; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Xu P, 2012, GENET MOL RES, V11, P2247, DOI 10.4238/2012.May.10.2; Yang J, 2011, PLOS ONE, V2; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zhou X, 2006, INSECT MOL BIOL, V15, P749, DOI 10.1111/j.1365-2583.2006.00675.x	96	6	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105582	10.1371/journal.pone.0105582	http://dx.doi.org/10.1371/journal.pone.0105582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141339	gold, Green Published, Green Submitted			2022-12-27	WOS:000342687200107
J	Lakshminarayana, SB; Boshoff, HIM; Cherian, J; Ravindran, S; Goh, A; Jiricek, J; Nanjundappa, M; Nayyar, A; Gurumurthy, M; Singh, R; Dick, T; Blasco, F; Barry, CE; Ho, PC; Manjunatha, UH				Lakshminarayana, Suresh B.; Boshoff, Helena I. M.; Cherian, Joseph; Ravindran, Sindhu; Goh, Anne; Jiricek, Jan; Nanjundappa, Mahesh; Nayyar, Amit; Gurumurthy, Meera; Singh, Ramandeep; Dick, Thomas; Blasco, Francesca; Barry, Clifton E., III; Ho, Paul C.; Manjunatha, Ujjini H.			Pharmacokinetics-Pharmacodynamics Analysis of Bicyclic 4-Nitroimidazole Analogs in a Murine Model of Tuberculosis	PLOS ONE			English	Article							EARLY BACTERICIDAL ACTIVITY; AEROSOL INFECTION MODEL; PLASMA-PROTEIN BINDING; INTRAPULMONARY PHARMACOKINETICS; MYCOBACTERIUM-TUBERCULOSIS; NITROIMIDAZOPYRAN PA-824; TISSUE DISTRIBUTION; IN-VITRO; DRUG; MOXIFLOXACIN	PA-824 is a bicyclic 4-nitroimidazole, currently in phase II clinical trials for the treatment of tuberculosis. Dose fractionation pharmacokinetic-pharmacodynamic studies in mice indicated that the driver of PA-824 in vivo efficacy is the time during which the free drug concentrations in plasma are above the MIC (fT(>MIC)). In this study, a panel of closely related potent bicyclic 4-nitroimidazoles was profiled in both in vivo PK and efficacy studies. In an established murine TB model, the efficacy of diverse nitroimidazole analogs ranged between 0.5 and 2.3 log CFU reduction compared to untreated controls. Further, a retrospective analysis was performed for a set of seven nitroimidazole analogs to identify the PK parameters that correlate with in vivo efficacy. Our findings show that the in vivo efficacy of bicyclic 4-nitroimidazoles correlated better with lung PK than with plasma PK. Further, nitroimidazole analogs with moderate-to-high volume of distribution and Lung to plasma ratios of >2 showed good efficacy. Among all the PK-PD indices, total lung T->MIC correlated the best with in vivo efficacy (r(s) = 0.88) followed by lung C-max/MIC and AUC/ MIC. Thus, lung drug distribution studies could potentially be exploited to guide the selection of compounds for efficacy studies, thereby accelerating the drug discovery efforts in finding new nitroimidazole analogs.	[Lakshminarayana, Suresh B.; Cherian, Joseph; Ravindran, Sindhu; Goh, Anne; Jiricek, Jan; Nanjundappa, Mahesh; Gurumurthy, Meera; Dick, Thomas; Blasco, Francesca; Manjunatha, Ujjini H.] Novartis Inst Trop Dis, Singapore, Singapore; [Boshoff, Helena I. M.; Nayyar, Amit; Singh, Ramandeep; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Ho, Paul C.] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore	Novartis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National University of Singapore	Lakshminarayana, SB (corresponding author), Novartis Inst Trop Dis, Singapore, Singapore.	suresh.b_lakshminarayana@novartis.com; manjunatha.ujjini@novartis.com	Dick, Thomas/AAB-4109-2019; Barry, III, Clifton/H-3839-2012; Ho, Paul C/O-9652-2014; Cherian, Joseph/Q-2522-2016; Barry, Clifton E/ABE-7992-2020; Jiricek, Jan/AAA-4701-2021; Dick, Thomas/AAC-4824-2019	Dick, Thomas/0000-0002-9604-9452; Barry, III, Clifton/0000-0002-2927-270X; Ho, Paul C/0000-0001-9213-7116; Barry, Clifton E/0000-0002-2927-270X; Singh, Ramandeep/0000-0003-2705-3826; Cherian, Joseph/0000-0003-2663-7192	NITD; NIAID; Bill and Melinda Gates Foundation; Wellcome Trust	NITD; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded in part by NITD, the Intramural Research Program of the NIAID to CEB, the Bill and Melinda Gates Foundation and the Wellcome Trust. NITD provided support in the form of salaries for authors SBL, JC, SR, AG, JJ, MN, MG, TD, FB and UHM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad Z, 2011, ANTIMICROB AGENTS CH, V55, P239, DOI 10.1128/AAC.00849-10; Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Avdeef A, 2007, J PHARM SCI-US, V96, P2893, DOI 10.1002/jps.21068; Balganesh TS, 2008, TRENDS PHARMACOL SCI, V29, P576, DOI 10.1016/j.tips.2008.08.001; Barbour A, 2010, INT J ANTIMICROB AG, V35, P431, DOI 10.1016/j.ijantimicag.2010.01.023; Barry CE, 2011, US Patent, Patent No. [WO 2011/087995, 2011087995]; Blaser A, 2012, J MED CHEM, V55, P312, DOI 10.1021/jm2012276; Brunner M, 2005, CURR OPIN PHARMACOL, V5, P495, DOI 10.1016/j.coph.2005.04.010; Burman W, 2011, PROG RESPIR RES, V40, P18; Chaurasia CS, 2007, PHARM RES, V24, P1014, DOI 10.1007/s11095-006-9206-z; Cherian J, 2011, J MED CHEM, V54, P5639, DOI 10.1021/jm1010644; Chierakul N, 2001, INT J TUBERC LUNG D, V5, P278; Conte JE, 1999, ANTIMICROB AGENTS CH, V43, P1329, DOI 10.1128/AAC.43.6.1329; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P2358, DOI 10.1128/AAC.46.8.2358-2364.2002; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128/AAC.46.5.1475-1480.2002; Conte JE, 2001, ANTIMICROB AGENTS CH, V45, P2891, DOI 10.1128/AAC.45.10.2891-2896.2001; Conte JE, 2000, ANTIMICROB AGENTS CH, V44, P985, DOI 10.1128/AAC.44.4.985-990.2000; Craig WA, 2001, CLIN INFECT DIS, V33, pS233, DOI 10.1086/321854; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Denny WA, 2010, FUTURE MED CHEM, V2, P1295, DOI 10.4155/FMC.10.207; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3027, DOI 10.1128/AAC.06125-11; Diacon AH, 2010, ANTIMICROB AGENTS CH, V54, P3402, DOI 10.1128/AAC.01354-09; Djukic M, 2012, ANTIMICROB AGENTS CH, V56, P979, DOI 10.1128/AAC.00437-11; Duijkers IJM, 2002, HUM REPROD, V17, P1987, DOI 10.1093/humrep/17.8.1987; Ferl GZ, 2007, J NUCL MED, V48, P2037, DOI 10.2967/jnumed.107.041061; Fung EN, 2003, J CHROMATOGR B, V795, P187, DOI 10.1016/S1570-0232(03)00564-6; Ginsberg AM, 2009, ANTIMICROB AGENTS CH, V53, P3720, DOI 10.1128/AAC.00106-09; Gonzalez D, 2013, CLIN MICROBIOL REV, V26, P274, DOI 10.1128/CMR.00092-12; Jayaram R, 2004, ANTIMICROB AGENTS CH, V48, P2951, DOI 10.1128/AAC.48.8.2951-2957.2004; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Jiricek J, 2007, US Patent, Patent No. [WO2007/075872, 2007075872]; Kaneko T, 2011, FUTURE MED CHEM, V3, P1373, DOI [10.4155/fmc.11.115, 10.4155/FMC.11.115]; Kiem S, 2008, ANTIMICROB AGENTS CH, V52, P24, DOI 10.1128/AAC.00133-06; Kim P, 2009, J MED CHEM, V52, P1329, DOI 10.1021/jm801374t; Kim P, 2009, J MED CHEM, V52, P1317, DOI 10.1021/jm801246z; Kjellsson MC, 2012, ANTIMICROB AGENTS CH, V56, P446, DOI 10.1128/AAC.05208-11; Kmentova I, 2010, J MED CHEM, V53, P8421, DOI 10.1021/jm101288t; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lin JH, 2006, CURR DRUG METAB, V7, P39, DOI 10.2174/138920006774832578; Liu P, 2002, INT J ANTIMICROB AG, V19, P285, DOI 10.1016/S0924-8579(02)00024-9; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Marino AM, 2005, INT J PHARMACEUT, V297, P235, DOI 10.1016/j.ijpharm.2005.03.008; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; Muller M, 2004, ANTIMICROB AGENTS CH, V48, P1441, DOI 10.1128/AAC.48.5.1441-1453.2004; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Nuermberger E, 2006, ANTIMICROB AGENTS CH, V50, P2621, DOI 10.1128/AAC.00451-06; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; Palmer BD, 2010, J MED CHEM, V53, P282, DOI 10.1021/jm901207n; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Prideaux B, 2011, ANAL CHEM, V83, P2112, DOI 10.1021/ac1029049; Rao SPS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007355; Rosenthal IM, 2012, ANTIMICROB AGENTS CH, V56, P4331, DOI 10.1128/AAC.00912-12; Rouan MC, 2012, ANTIMICROB AGENTS CH, V56, P1444, DOI 10.1128/AAC.00720-11; Scaglione Francesco, 2006, Expert Rev Anti Infect Ther, V4, P479, DOI 10.1586/14787210.4.3.479; Shandil RK, 2007, ANTIMICROB AGENTS CH, V51, P576, DOI 10.1128/AAC.00414-06; Siefert HM, 1999, J ANTIMICROB CHEMOTH, V43, P69, DOI 10.1093/jac/43.suppl_2.69; Siefert HM, 1999, J ANTIMICROB CHEMOTH, V43, P61, DOI 10.1093/jac/43.suppl_2.61; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Soman A, 1999, J ANTIMICROB CHEMOTH, V44, P835, DOI 10.1093/jac/44.6.835; Steingart KR, 2011, INT J TUBERC LUNG D, V15, P305; Stella VJ, 1997, PHARMACEUT RES, V14, P556, DOI 10.1023/A:1012136608249; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Theuretzbacher U, 2007, CURR OPIN PHARMACOL, V7, P498, DOI 10.1016/j.coph.2007.05.003; Thompson AM, 2011, J MED CHEM, V54, P6563, DOI 10.1021/jm200377r; Tyagi S, 2005, ANTIMICROB AGENTS CH, V49, P2289, DOI 10.1128/AAC.49.6.2289-2293.2005; van Ingen J, 2011, CLIN INFECT DIS, V52, pE194, DOI 10.1093/cid/cir184; VEBER B, 1993, J ANTIMICROB CHEMOTH, V32, P473, DOI 10.1093/jac/32.3.473; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, WHOHTMTB20103; Wohnsland F, 2001, J MED CHEM, V44, P923, DOI 10.1021/jm001020e; Zhou LP, 2007, J PHARM SCI-US, V96, P3052, DOI 10.1002/jps.20913; Ziglam HM, 2002, J ANTIMICROB CHEMOTH, V50, P1011, DOI 10.1093/jac/dkf214	76	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105222	10.1371/journal.pone.0105222	http://dx.doi.org/10.1371/journal.pone.0105222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141257	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200061
J	Jiang, MM; Jiao, YJ; Wang, YF; Xu, L; Wang, M; Zhao, BC; Jia, LF; Pan, H; Zhu, Y; Gao, XM				Jiang, Miaomiao; Jiao, Yujiao; Wang, Yuefei; Xu, Lei; Wang, Meng; Zhao, Buchang; Jia, Lifu; Pan, Hao; Zhu, Yan; Gao, Xiumei			Quantitative Profiling of Polar Metabolites in Herbal Medicine Injections for Multivariate Statistical Evaluation Based on Independence Principal Component Analysis	PLOS ONE			English	Article							MASS-SPECTROMETRY; ACID; NMR; IDENTIFICATION; DERIVATIZATION; FERMENTATION	Botanical primary metabolites extensively exist in herbal medicine injections (HMIs), but often were ignored to control. With the limitation of bias towards hydrophilic substances, the primary metabolites with strong polarity, such as saccharides, amino acids and organic acids, are usually difficult to detect by the routinely applied reversed-phase chromatographic fingerprint technology. In this study, a proton nuclear magnetic resonance (H-1 NMR) profiling method was developed for efficient identification and quantification of small polar molecules, mostly primary metabolites in HMIs. A commonly used medicine, Danhong injection (DHI), was employed as a model. With the developed method, 23 primary metabolites together with 7 polyphenolic acids were simultaneously identified, of which 13 metabolites with fully separated proton signals were quantified and employed for further multivariate quality control assay. The quantitative 1 H NMR method was validated with good linearity, precision, repeatability, stability and accuracy. Based on independence principal component analysis (IPCA), the contents of 13 metabolites were characterized and dimensionally reduced into the first two independence principal components (IPCs). IPC1 and IPC2 were then used to calculate the upper control limits (with 99% confidence ellipsoids) of chi(2) and Hotelling T-2 control charts. Through the constructed upper control limits, the proposed method was successfully applied to 36 batches of DHI to examine the out-of control sample with the perturbed levels of succinate, malonate, glucose, fructose, salvianic acid and protocatechuic aldehyde. The integrated strategy has provided a reliable approach to identify and quantify multiple polar metabolites of DHI in one fingerprinting spectrum, and it has also assisted in the establishment of IPCA models for the multivariate statistical evaluation of HMIs.	[Jiang, Miaomiao; Jiao, Yujiao; Wang, Yuefei; Xu, Lei; Wang, Meng; Zhu, Yan; Gao, Xiumei] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Jiang, Miaomiao; Jiao, Yujiao; Wang, Yuefei; Xu, Lei; Wang, Meng; Zhu, Yan] Tianjin Int Joint Acad Biotechnol & Med, Res & Dev Ctr TCM, Tianjin, Peoples R China; [Zhao, Buchang; Jia, Lifu; Pan, Hao] China Buchang Hosp Cardio Cerebral Vasc Dis, Xian, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin International Joint Academy of Biomedicine	Zhu, Y (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.	yanzhu.harvard@gmail.com; gaoxiumei@tjutcm.edu.cn	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936	National Natural Science Foundation of China [81303181]; National Key Technology R&D Program in the 12th Five Year Plan of China [2013ZX09201020, 2014ZX09201-023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program in the 12th Five Year Plan of China(National Key Technology R&D Program)	The authors gratefully acknowledge financial support provided by the National Natural Science Foundation of China (Grant No. 81303181), the National Key Technology R&D Program in the 12th Five Year Plan of China (Grant No. 2013ZX09201020, 2014ZX09201-023). The National Natural Science Foundation website address is: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, MULT STAT PROC CONTR; BABA T, 1979, J IMMUNOL, V122, P838; Bohni N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064006; Bouteille R, 2013, J DAIRY SCI, V96, P2071, DOI 10.3168/jds.2012-6092; Chauthe SK, 2012, PHYTOCHEM ANALYSIS, V23, P689, DOI 10.1002/pca.2375; Chen Qian, 2011, Zhongguo Zhong Yao Za Zhi, V36, P2817; Chen XF, 2011, RAPID COMMUN MASS SP, V25, P1661, DOI 10.1002/rcm.5003; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Dai H, 2010, J PROTEOME RES, V9, P1460, DOI 10.1021/pr900995m; Engreitz JM, 2010, J BIOMED INFORM, V43, P932, DOI 10.1016/j.jbi.2010.07.001; Fan G, 2012, ANAL CHIM ACTA, V747, P76, DOI 10.1016/j.aca.2012.08.038; Harvey DJ, 2011, J CHROMATOGR B, V879, P1196, DOI 10.1016/j.jchromb.2010.11.010; HUSEK P, 1991, J CHROMATOGR, V552, P289, DOI 10.1016/S0021-9673(01)95945-X; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; INGLIS AS, 1988, J BIOCHEM BIOPH METH, V15, P249, DOI 10.1016/0165-022X(88)90012-7; Jiang MM, 2014, PHYTOCHEM ANALYSIS, V25, P50, DOI 10.1002/pca.2461; Jiang Y, 2010, ANAL CHIM ACTA, V657, P9, DOI 10.1016/j.aca.2009.10.024; [金滢 Jin Ying], 2013, [中国新药杂志, Chinese Journal New Drugs], V22, P111; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kong W, 2008, BIOTECHNIQUES, V45, P501, DOI 10.2144/000112950; Lee SI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r76; LEE YC, 1990, ANAL BIOCHEM, V189, P151, DOI 10.1016/0003-2697(90)90099-U; Li Xuelin, 2011, Zhongguo Zhong Yao Za Zhi, V36, P2783; Liu HT, 2013, BIOMED CHROMATOGR, V27, P655, DOI 10.1002/bmc.2842; Lopez-Rituerto E, 2009, J AGR FOOD CHEM, V57, P2112, DOI 10.1021/jf803245r; Marcone MF, 2013, FOOD RES INT, V51, P729, DOI 10.1016/j.foodres.2012.12.046; MOPPER K, 1983, J CHROMATOGR, V256, P27, DOI 10.1016/S0021-9673(01)88209-1; Ohtsuki T, 2012, TALANTA, V99, P342, DOI 10.1016/j.talanta.2012.05.062; Pauli GF, 2012, J NAT PROD, V75, P834, DOI 10.1021/np200993k; Ruiz-Matute AI, 2011, J CHROMATOGR B, V879, P1226, DOI 10.1016/j.jchromb.2010.11.013; Santos-Fernandez E., 2013, MULTIVARIATE STAT QU; Simmler C, 2014, CURR OPIN BIOTECH, V25, P51, DOI 10.1016/j.copbio.2013.08.004; Soga T, 2001, ELECTROPHORESIS, V22, P3418, DOI 10.1002/1522-2683(200109)22:16<3418::AID-ELPS3418>3.0.CO;2-8; Sun M, 2009, PHYTOMEDICINE, V16, P683, DOI 10.1016/j.phymed.2009.03.020; Yao FZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-24; Zeng SS, 2012, ANAL CHIM ACTA, V733, P38, DOI 10.1016/j.aca.2012.04.025; Zhang L, 2014, J ANAL METHODS CHEM, V2014; Zhao Zhi-Wei, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P1212	38	28	32	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105412	10.1371/journal.pone.0105412	http://dx.doi.org/10.1371/journal.pone.0105412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157567	Green Published, gold, Green Submitted			2022-12-27	WOS:000341303200030
J	Silva-Baila, MG; Bailao, EFLC; Lechner, BE; Gauthier, GM; Lindner, H; Bailao, AM; Haas, H; Soares, CMD				Silva-Baila, Mirelle Garcia; Luiz Cardoso Bailao, Elisa Flavia; Lechner, Beatrix Elisabeth; Gauthier, Gregory M.; Lindner, Herbert; Bailao, Alexandre Melo; Haas, Hubertus; de Almeida Soares, Celia Maria			Hydroxamate Production as a High Affinity Iron Acquisition Mechanism in Paracoccidioides Spp.	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; SIDEROPHORE BIOSYNTHESIS; HISTOPLASMA-CAPSULATUM; EXTRACELLULAR SIDEROPHORES; PHYLOGENETIC ANALYSIS; MAGNAPORTHE-GRISEA; NEUROSPORA-CRASSA; OXIDATIVE-STRESS; CULTURE-MEDIUM; HUMAN PLASMA	Iron is a micronutrient required by almost all living organisms, including fungi. Although this metal is abundant, its bioavailability is low either in aerobic environments or within mammalian hosts. As a consequence, pathogenic microorganisms evolved high affinity iron acquisition mechanisms which include the production and uptake of siderophores. Here we investigated the utilization of these molecules by species of the Paracoccidioides genus, the causative agents of a systemic mycosis. It was demonstrated that iron starvation induces the expression of Paracoccidioides ortholog genes for siderophore biosynthesis and transport. Reversed-phase HPLC analysis revealed that the fungus produces and secretes coprogen B, which generates dimerumic acid as a breakdown product. Ferricrocin and ferrichrome C were detected in Paracoccidioides as the intracellular produced siderophores. Moreover, the fungus is also able to grow in presence of siderophores as the only iron sources, demonstrating that beyond producing, Paracoccidioides is also able to utilize siderophores for growth, including the xenosiderophore ferrioxamine. Exposure to exogenous ferrioxamine and dimerumic acid increased fungus survival during co-cultivation with macrophages indicating that these molecules play a role during host-pathogen interaction. Furthermore, cross-feeding experiments revealed that Paracoccidioides siderophores promotes growth of Aspergillus nidulans strain unable to produce these iron chelators. Together, these data denote that synthesis and utilization of siderophores is a mechanism used by Paracoccidioides to surpass iron limitation. As iron paucity is found within the host, siderophore production may be related to fungus pathogenicity.	[Silva-Baila, Mirelle Garcia; Luiz Cardoso Bailao, Elisa Flavia; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria] Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil; [Silva-Baila, Mirelle Garcia] Univ Brasilia, Programa Posgrad Patol Mol, Brasilia, DF, Brazil; [Luiz Cardoso Bailao, Elisa Flavia] Univ Estadual Goias, Unidade Univ Ipora, Ipora, Go, Brazil; [Lechner, Beatrix Elisabeth; Haas, Hubertus] Med Univ Innsbruck, Bioctr, Div Mol Biol, A-6020 Innsbruck, Austria; [Lindner, Herbert] Med Univ Innsbruck, Bioctr, Div Clin Biochem, A-6020 Innsbruck, Austria; [Gauthier, Gregory M.] Univ Wisconsin, Dept Med, Infect Dis Sect, Madison, WI USA	Universidade Federal de Goias; Universidade de Brasilia; Universidade Estadual de Goias; Medical University of Innsbruck; Medical University of Innsbruck; University of Wisconsin System; University of Wisconsin Madison	Soares, CMD (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil.	cmasoares@gmail.com	Soares, Celia/N-6395-2014; Bailao, Alexandre Melo/H-1272-2013; Bailão, Elisa Flávia Luiz Cardoso/M-6409-2015	Bailao, Alexandre Melo/0000-0001-7754-4047; Luiz Cardoso Bailao, Elisa Flavia/0000-0001-6737-7548; Lechner, Beatrix/0000-0002-4683-4997; Silva-Bailao, Mirelle/0000-0003-2053-204X	Financiadora de Estudos e Projetos (FINEP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG); Coordenacao de Pessoal do Ensino Superior (CAPES); Pronex; Austrian Science Foundation (FWF) [P21643-B11]; CAPES	Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); Coordenacao de Pessoal do Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pronex; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Work at Universidade Federal de Goias was supported by grants from Financiadora de Estudos e Projetos (FINEP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG), Coordenacao de Pessoal do Ensino Superior (CAPES) and Pronex. Work at Innsbruck Medical University was supported by the Austrian Science Foundation (FWF P21643-B11 to HH). MGSB was supported by a fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelo L, 2006, Z NATURFORSCH C, V61, P461; ARANGO R, 1988, J MED VET MYCOL, V26, P113; ATKIN CL, 1970, J BACTERIOL, V103, P722, DOI 10.1128/JB.103.3.722-733.1970; Bailao AM, 2007, FEMS IMMUNOL MED MIC, V51, P43, DOI 10.1111/j.1574-695X.2007.00277.x; Bailao AM, 2006, MICROBES INFECT, V8, P2686, DOI 10.1016/j.micinf.2006.07.019; Blatzer M, 2011, APPL ENVIRON MICROB, V77, P4959, DOI 10.1128/AEM.00182-11; Bocca AL, 2013, FUTURE MICROBIOL, V8, P1177, DOI 10.2217/fmb.13.68; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; BRUMMER E, 1989, INFECT IMMUN, V57, P2289, DOI 10.1128/IAI.57.8.2289-2294.1989; BURT WR, 1982, INFECT IMMUN, V35, P990, DOI 10.1128/IAI.35.3.990-996.1982; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; CANO LE, 1994, INFECT IMMUN, V62, P1494, DOI 10.1128/IAI.62.4.1494-1496.1994; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; CASTANEDA E, 1988, J MED VET MYCOL, V26, P351; Chao LY, 2008, BIOCHEMISTRY-US, V47, P7274, DOI 10.1021/bi800066s; CHARLANG G, 1981, MOL CELL BIOL, V1, P94, DOI 10.1128/MCB.1.2.94; COX CD, 1994, METHOD ENZYMOL, V235, P315; Dias-Melicio Luciane Alarcão, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P263, DOI 10.1590/S0036-46652005000500005; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Gauthier GM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000846; Greenshields DL, 2007, MOL PLANT PATHOL, V8, P411, DOI [10.1111/j.1364-3703.2007.00401.x, 10.1111/J.1364-3703.2007.00401.X]; Grossklaus DD, 2013, MICROBES INFECT, V15, P347, DOI 10.1016/j.micinf.2012.12.002; Grundlinger M, 2013, MOL MICROBIOL, V88, P862, DOI 10.1111/mmi.12225; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Haber F., 1934, P R SOC LOND A, V147, P332, DOI [10.1098/rspa.1934.0221, DOI 10.1098/RSPA.1934.0221, DOI 10.1098/rspa.1934.0221]; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Harrison KA, 2002, BIOCHEMISTRY-US, V41, P15288, DOI 10.1021/bi0204995; Hilty J, 2011, MED MYCOL, V49, P633, DOI 10.3109/13693786.2011.558930; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; Hof C, 2007, MOL PLANT PATHOL, V8, P163, DOI 10.1111/j.1364-3703.2007.00380.x; Howard DH, 2000, INFECT IMMUN, V68, P2338, DOI 10.1128/IAI.68.4.2338-2343.2000; Hwang LH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000044; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Longo LVG, 2013, FEMS MICROBIOL LETT, V341, P87, DOI 10.1111/1574-6968.12097; Machuca A, 2003, LETT APPL MICROBIOL, V36, P177, DOI 10.1046/j.1472-765X.2003.01290.x; Martinez R, 1978, Rev Inst Med Trop Sao Paulo, V20, P190; Martinez R, 1978, Rev Inst Med Trop Sao Paulo, V20, P195; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MATZANKE BF, 1987, J BACTERIOL, V169, P5873, DOI 10.1128/jb.169.12.5873-5876.1987; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; MOR H, 1992, BIOMETALS, V5, P213, DOI 10.1007/BF01061220; NEILANDS JB, 1993, ARCH BIOCHEM BIOPHYS, V302, P1, DOI 10.1006/abbi.1993.1172; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Nevitt T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001322; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; PANDEY A, 1994, APPL MICROBIOL BIOT, V40, P735, DOI [10.1007/BF00173337, 10.1007/s002530050058]; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Perez-Miranda S, 2007, J MICROBIOL METH, V70, P127, DOI 10.1016/j.mimet.2007.03.023; Plattner Hans Juergen, 1994, V11, P99; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Recalcati S, 2012, SEMIN IMMUNOL, V24, P393, DOI 10.1016/j.smim.2013.01.001; Renshaw JC, 2002, MYCOL RES, V106, P1123, DOI 10.1017/S0953756202006548; RESTREPO A, 1980, J CLIN MICROBIOL, V12, P279, DOI 10.1128/JCM.12.2.279-281.1980; Salgado-Salazar C, 2010, CLADISTICS, V26, P613, DOI 10.1111/j.1096-0031.2010.00307.x; Scazzocchio C, 2000, CURR OPIN MICROBIOL, V3, P126, DOI 10.1016/S1369-5274(00)00063-1; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2010, MICROBES INFECT, V12, P1035, DOI 10.1016/j.micinf.2010.07.005; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Silva MG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00049; Teixeira MD, 2014, MED MYCOL, V52, P19, DOI 10.3109/13693786.2013.794311; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Theodoro RC, 2008, FUNGAL GENET BIOL, V45, P1284, DOI 10.1016/j.fgb.2008.07.003; Van Der Helm Dick, 1994, V11, P39; Wallner A, 2009, APPL ENVIRON MICROB, V75, P4194, DOI 10.1128/AEM.00479-09; Weiss G, 2005, BEST PRACT RES CL HA, V18, P183, DOI 10.1016/j.beha.2004.09.001; Winterberg B, 2010, MOL MICROBIOL, V75, P1260, DOI 10.1111/j.1365-2958.2010.07048.x; Yasmin S, 2012, P NATL ACAD SCI USA, V109, pE497, DOI 10.1073/pnas.1106399108; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713	79	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105805	10.1371/journal.pone.0105805	http://dx.doi.org/10.1371/journal.pone.0105805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157575	gold, Green Published, Green Submitted			2022-12-27	WOS:000341303200066
J	Vercoulen, Y; Enders, FB; Meerding, J; Plantinga, M; Elst, EF; Varsani, H; van Schieveen, C; Bakker, MH; Klein, M; Scholman, RC; Spliet, W; Ricotti, V; Koenen, HJPM; de Weger, RA; Wedderburn, LR; van Royen-Kerkhof, A; Prakken, BJ				Vercoulen, Yvonne; Enders, Felicitas Bellutti; Meerding, Jenny; Plantinga, Maud; Elst, Elisabeth F.; Varsani, Hemlata; van Schieveen, Christa; Bakker, Mette H.; Klein, Mark; Scholman, Rianne C.; Spliet, Wim; Ricotti, Valeria; Koenen, Hans J. P. M.; de Weger, Roel A.; Wedderburn, Lucy R.; van Royen-Kerkhof, Annet; Prakken, Berent J.			Increased Presence of FOXP3(+) Regulatory T Cells in Inflamed Muscle of Patients with Active Juvenile Dermatomyositis Compared to Peripheral Blood	PLOS ONE			English	Article							INFLAMMATORY MYOPATHIES; IDIOPATHIC ARTHRITIS; DISEASE-ACTIVITY; SKIN; DIFFERENTIATE; SCLEROSIS; CYTOKINES; DAMAGE; VIVO	Juvenile dermatomyositis (JDM) is an immune-mediated inflammatory disease affecting the microvasculature of skin and muscle. CD4(+)CD25(+)FOXP3(+) regulatory T cells (Tregs) are key regulators of immune homeostasis. A role for Tregs in JDM pathogenesis has not yet been established. Here, we explored Treg presence and function in peripheral blood and muscle of JDM patients. We analyzed number, phenotype and function of Tregs in blood from JDM patients by flow cytometry and in vitro suppression assays, in comparison to healthy controls and disease controls (Duchenne's Muscular Dystrophy). Presence of Tregs in muscle was analyzed by immunohistochemistry. Overall, Treg percentages in peripheral blood of JDM patients were similar compared to both control groups. Muscle biopsies of new onset JDM patients showed increased infiltration of numbers of T cells compared to Duchenne's muscular dystrophy. Both in JDM and Duchenne's muscular dystrophy the proportion of FOXP3(+) T cells in muscles were increased compared to JDM peripheral blood. Interestingly, JDM is not a self-remitting disease, suggesting that the high proportion of Tregs in inflamed muscle do not suppress inflammation. In line with this, peripheral blood Tregs of active JDM patients were less capable of suppressing effector T cell activation in vitro, compared to Tregs of JDM in clinical remission. These data show a functional impairment of Tregs in a proportion of patients with active disease, and suggest a regulatory role for Tregs in JDM inflammation.	[Vercoulen, Yvonne; Enders, Felicitas Bellutti; Meerding, Jenny; Plantinga, Maud; Elst, Elisabeth F.; van Schieveen, Christa; Bakker, Mette H.; Klein, Mark; Scholman, Rianne C.; Prakken, Berent J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Lab Translat Immunol Pediat Immunol, Utrecht, Netherlands; [Enders, Felicitas Bellutti] Univ Hosp, Dept Pediat, Div Allergol Immunol & Rheumatol, Lausanne, Switzerland; [Varsani, Hemlata; Wedderburn, Lucy R.] UCL, Inst Child Hlth, Juvenile Dermatomyositis Res Grp, Rheumatol Unit, London, England; [Spliet, Wim; de Weger, Roel A.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Ricotti, Valeria] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Koenen, Hans J. P. M.] Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Sect Med Immunol, Nijmegen, Netherlands; [van Royen-Kerkhof, Annet] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Rheumatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; University College London; Utrecht University; Utrecht University Medical Center; University of London; University College London; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Vercoulen, Y (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	y.vercoulen@umcutrecht.nl; A.vanRoyen@umcutrecht.nl	Enders, Felicitas Bellutti/AAB-8916-2020; Koenen, Hans J.P.M./A-2852-2014	Vercoulen, Yvonne/0000-0002-5060-2603; Wedderburn, Lucy/0000-0002-7495-1429	Dutch League against Rheumatism; Dutch Organization for Scientific Research; Cathal Hayes Research Trust; Wellcome Trust UK [085860]; Action Medical Research UK [SP4252]; Henry Smith Charity; Arthritis Research UK [14518, 18796]; Raynaud's and Scleroderma Association; UK Myositis Support Group; Swiss Grants: Foundation of Ettore e Valeria Bossi, Switzerland; Great Ormond Street Hospital Childrens Charity [V1286] Funding Source: researchfish	Dutch League against Rheumatism; Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Cathal Hayes Research Trust; Wellcome Trust UK(Wellcome Trust); Action Medical Research UK; Henry Smith Charity; Arthritis Research UK(Versus Arthritis); Raynaud's and Scleroderma Association; UK Myositis Support Group; Swiss Grants: Foundation of Ettore e Valeria Bossi, Switzerland; Great Ormond Street Hospital Childrens Charity	Y.V. is supported by Dutch League against Rheumatism, B.P. by Dutch Organization for Scientific Research, JDM Cohort Study is supported by Cathal Hayes Research Trust, Wellcome Trust UK (085860), Action Medical Research UK (SP4252), The Henry Smith Charity, Arthritis Research UK (14518, 18796), Raynaud's and Scleroderma Association, UK Myositis Support Group. FBE was supported by Swiss Grants: Foundation of Ettore e Valeria Bossi, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga E, 2010, BRIT J DERMATOL, V162, P1056, DOI 10.1111/j.1365-2133.2010.09633.x; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Banica L, 2009, AUTOIMMUNITY, V42, P41, DOI 10.1080/08916930802282651; Bellutti Enders F, 2014, CXCL10 TNFR2 GALECTI; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Braitch M, 2009, ACTA NEUROL SCAND, V119, P239, DOI 10.1111/j.1600-0404.2008.01090.x; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chen X, 2006, EUR J IMMUNOL, V36, P2139, DOI 10.1002/eji.200635873; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; Deknuydt F, 2009, CLIN IMMUNOL, V131, P298, DOI 10.1016/j.clim.2008.12.008; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Haufe S, 2011, ARTHRITIS RHEUM-US, V63, P3153, DOI 10.1002/art.30503; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; MCDOUALL RM, 1990, J NEUROL SCI, V99, P199, DOI 10.1016/0022-510X(90)90156-H; Mendez EP, 2003, ARTHRIT RHEUM-ARTHR, V49, P300, DOI 10.1002/art.11122; Nistala K, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4311; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Pesenacker AM, 2013, BLOOD, V121, P2647, DOI 10.1182/blood-2012-08-443473; Reed AM, 2012, ARTHRITIS RHEUM-US, V64, P4078, DOI 10.1002/art.34659; Ruperto N, 2003, RHEUMATOLOGY, V42, P1452, DOI 10.1093/rheumatology/keg403; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Shen H, 2011, SCAND J RHEUMATOL, V40, P217, DOI 10.3109/03009742.2010.517215; SPENCER CH, 1984, J PEDIATR-US, V105, P399, DOI 10.1016/S0022-3476(84)80012-8; Tournadre A, 2012, CURR RHEUMATOL REP, V14, P252, DOI 10.1007/s11926-012-0242-x; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Waschbisch A, 2010, J NEUROIMMUNOL, V225, P137, DOI 10.1016/j.jneuroim.2010.03.013; Wehrens EJ, 2013, NAT REV RHEUMATOL, V9, P34, DOI 10.1038/nrrheum.2012.149; Wehrens EJ, 2011, BLOOD, V118, P3538, DOI 10.1182/blood-2010-12-328187	31	26	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105353	10.1371/journal.pone.0105353	http://dx.doi.org/10.1371/journal.pone.0105353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157414	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200028
J	Colabardini, AC; Ries, LNA; Brown, NA; Savoldi, M; Dinamarco, TM; von Zeska, MR; Goldman, MHS; Goldman, GH				Colabardini, Ana Cristina; Annick Ries, Laure Nicolas; Brown, Neil Andrew; Savoldi, Marcela; Dinamarco, Taisa Magnani; von Zeska, Marcia Regina; Goldman, Maria Helena S.; Goldman, Gustavo Henrique			Protein Kinase C Overexpression Suppresses Calcineurin-Associated Defects in Aspergillus nidulans and Is Involved in Mitochondrial Function	PLOS ONE			English	Article							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; SIGNALING PATHWAY; HYPHAL ELONGATION; CALCIUM; STRESS; GENE; PKCA; FUNGI	In filamentous fungi, intracellular signaling pathways which are mediated by changing calcium levels and/or by activated protein kinase C (Pkc), control fungal adaptation to external stimuli. A rise in intracellular Ca2+ levels activates calcineurin subunit A (CnaA), which regulates cellular calcium homeostasis among other processes. Pkc is primarily involved in maintaining cell wall integrity (CWI) in response to different environmental stresses. Cross-talk between the Ca2+ and Pkc-mediated pathways has mainly been described in Saccharomyces cerevisiae and in a few other filamentous fungi. The presented study describes a genetic interaction between CnaA and PkcA in the filamentous fungus Aspergillus nidulans. Overexpression of pkcA partially rescues the phenotypes caused by a cnaA deletion. Furthermore, CnaA appears to affect the regulation of a mitogen-activated kinase, MpkA, involved in the CWI pathway. Reversely, PkcA is involved in controlling intracellular calcium homeostasis, as was confirmed by microarray analysis. Furthermore, overexpression of pkcA in a cnaA deletion background restores mitochondrial number and function. In conclusion, PkcA and CnaA-mediated signaling appear to share common targets, one of which appears to be MpkA of the CWI pathway. Both pathways also regulate components involved in mitochondrial biogenesis and function. This study describes targets for PkcA and CnaA-signaling pathways in an A. nidulans and identifies a novel interaction of both pathways in the regulation of cellular respiration.	[Goldman, Gustavo Henrique] Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil; [Colabardini, Ana Cristina; Annick Ries, Laure Nicolas; Brown, Neil Andrew; Savoldi, Marcela; von Zeska, Marcia Regina] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Dinamarco, Taisa Magnani; Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Goldman, GH (corresponding author), Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Sao Paulo, Brazil.	ggoldman@usp.br	Dinamarco, Taisa M/J-8923-2012; Goldman, Gustavo Henrique/F-1848-2013; Dinamarco, Taisa/M-7174-2019; Goldman, Maria Helena S./D-1424-2012; Colabardini, Ana/P-1791-2015; von Zeska Kress, Marcia Regina/F-2651-2012	Dinamarco, Taisa M/0000-0001-6284-387X; Goldman, Gustavo Henrique/0000-0002-2986-350X; Dinamarco, Taisa/0000-0001-6284-387X; Goldman, Maria Helena S./0000-0002-6786-9320; Colabardini, Ana/0000-0002-2131-7969; Brown, Neil/0000-0002-3555-5765; von Zeska Kress, Marcia Regina/0000-0003-1239-7722	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brand A, 2009, CURR OPIN MICROBIOL, V12, P350, DOI 10.1016/j.mib.2009.05.007; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; Chen SC, 2010, FUNGAL GENET BIOL, V47, P268, DOI 10.1016/j.fgb.2009.12.008; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colabardini AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057630; Colabardini AC, 2010, MOL MICROBIOL, V78, P1259, DOI 10.1111/j.1365-2958.2010.07403.x; Cruz MC, 2001, EMBO J, V20, P1020, DOI 10.1093/emboj/20.5.1020; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; Denis V, 2005, EUKARYOT CELL, V4, P36, DOI 10.1128/EC.4.1.36-45.2005; Dinamarco TM, 2010, FUNGAL GENET BIOL, V47, P1055, DOI 10.1016/j.fgb.2010.07.006; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; Flipphi M, 2002, BIOCHEM J, V364, P25, DOI 10.1042/bj3640025; Fox DS, 2002, BIOESSAYS, V24, P894, DOI 10.1002/bies.10157; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Geysens S, 2009, FUNGAL GENET BIOL, V46, pS121, DOI 10.1016/j.fgb.2008.07.016; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; Harris SD, 2010, CELLULAR MOL BIOL FI; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Hernandez-Ortiz P, 2013, MOL MICROBIOL, V89, P532, DOI 10.1111/mmi.12294; Herrmann M, 2006, APPL ENVIRON MICROB, V72, P2957, DOI 10.1128/AEM.72.4.2957-2970.2006; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; JACKSON SL, 1993, MICROBIOL REV, V57, P367, DOI 10.1128/MMBR.57.2.367-382.1993; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Katayama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050503; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Kume K, 2011, NAT CELL BIOL, V13, P234, DOI 10.1038/ncb2166; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lodder AL, 1999, GENETICS, V152, P1487; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Morawetz R, 1996, MOL GEN GENET, V250, P17, DOI 10.1007/s004380050047; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Ponting CP, 1996, PROTEIN SCI, V5, P162; Ronen R, 2007, CURR GENET, V51, P321, DOI 10.1007/s00294-007-0129-y; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Steinbach WJ, 2007, ANTIMICROB AGENTS CH, V51, P2979, DOI 10.1128/AAC.01394-06; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001; Thewes S, 2014, EUKARYOT CE IN PRESS; Virag A, 2006, MYCOL RES, V110, P4, DOI 10.1016/j.mycres.2005.09.005; Wang G, 2006, PROTOPLASMA, V228, P159, DOI 10.1007/s00709-006-0181-3; Wang XY, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-51; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Xiang X, 2003, CURR OPIN MICROBIOL, V6, P628, DOI 10.1016/j.mib.2003.10.009	57	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104792	10.1371/journal.pone.0104792	http://dx.doi.org/10.1371/journal.pone.0104792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153325	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200026
J	Hebrant, A; Floor, S; Saiselet, M; Antoniou, A; Desbuleux, A; Snyers, B; La, C; de St Aubain, N; Leteurtre, E; Andry, G; Maenhaut, C				Hebrant, Aline; Floor, Sebastien; Saiselet, Manuel; Antoniou, Aline; Desbuleux, Alice; Snyers, Berengere; La, Caroline; de St Aubain, Nicolas; Leteurtre, Emmanuelle; Andry, Guy; Maenhaut, Carine			miRNA Expression in Anaplastic Thyroid Carcinomas	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; MICRORNAS; CANCER; PATHOGENESIS; SURVIVAL; DENSITY; TARGETS; CELLS	Anaplastic thyroid carcinoma (ATC) is the most lethal form of thyroid neoplasia and represents an end stage of thyroid tumor progression. No effective treatment exists so far. In this study, we analyzed the miRNA expression profiles of 11 ATC by microarrays and their relationship with the mRNA expression profiles of the same 11 ATC samples. ATC show distinct miRNA expression profiles compared to other less aggressive thyroid tumor types. ATC show 18 commonly deregulated miRNA compared to normal thyroid tissue (17 downregulated and 1 upregulated miRNA). First, the analysis of a combined approach of the mRNA gene expression and of the bioinformatically predicted mRNA targets of the deregulated miRNA suggested a role for these regulations in the epithelial to mesenchymal transition (EMT) process in ATC. Second, the direct interaction between one of the upregulated mRNA target, the LOX gene which is an EMT key player, and a downregulated miRNA, the miR-29a, was experimentally validated by a luciferase assay in HEK cell. Third, we confirmed that the ATC tissue is composed of about 50% of tumor associated macrophages (TAM) and suggested, by taking into account our data and published data, their most likely direct or paracrine intercommunication between them and the thyroid tumor cells, amplifying the tumor aggressiveness. Finally, we demonstrated by in situ hybridization a specific thyrocyte localization of 3 of the deregulated miRNA: let-7g, miR-29a and miR-30e and we pointed out the importance of identifying the cell type localization before drawing any conclusion on the physiopathological role of a given gene.	[Hebrant, Aline; Floor, Sebastien; Saiselet, Manuel; Antoniou, Aline; Desbuleux, Alice; Snyers, Berengere; La, Caroline; Maenhaut, Carine] Univ Libre Bruxelles, Sch Med, Inst Interdisciplinary Res IRIBHM, Brussels, Belgium; [de St Aubain, Nicolas; Andry, Guy] Inst Jules Bordet, B-1000 Brussels, Belgium; [Leteurtre, Emmanuelle] Univ Lille 2, Fac Med, Lille, France; [Leteurtre, Emmanuelle] CHRU Lille, Inst Pathol, F-59037 Lille, France; [Maenhaut, Carine] Univ Libre Bruxelles, Sch Med, WELBIO, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut Jules Bordet; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite Libre de Bruxelles; Vrije Universiteit Brussel; WELBIO	Maenhaut, C (corresponding author), Univ Libre Bruxelles, Sch Med, Inst Interdisciplinary Res IRIBHM, Campus Erasme, Brussels, Belgium.	cmaenhau@ulb.ac.be		andry, guy/0000-0001-7410-6519	Welbio; Televie; European Union (GENRISK-T project) [036495]; Fonds de la Recherche Scientifique Medicale; Fondation Van Buren; Les amis de l'Institut Bordet; Fondation Contre le Cancer; Fonds National de la Recherche Scientifique (FNRS)	Welbio(WELBIO); Televie; European Union (GENRISK-T project); Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fondation Van Buren; Les amis de l'Institut Bordet; Fondation Contre le Cancer; Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Welbio, Televie, European Union (GENRISK-T project 036495), Fonds de la Recherche Scientifique Medicale, Fondation Van Buren, Les amis de l'Institut Bordet, Fondation Contre le Cancer, Fonds National de la Recherche Scientifique (FNRS). ATC tissue samples from Lille were obtained from the tumour cell and tissue bank of Regional Reference Cancer Center of Lille "Tumorotheque du centre regional de Reference en Cancerologie'' (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner A, 2011, J MOL MED; Ain KB, 1999, SEMIN SURG ONCOL, V16, P64, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<64::AID-SSU10>3.3.CO;2-L; Are C, 2006, ANN SURG ONCOL, V13, P453, DOI 10.1245/ASO.2006.05.042; Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chen ZG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/695179; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hebrant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037807; Kim S, 2013, ENDOCRINOL METAB, V28, P192, DOI 10.3803/EnM.2013.28.3.192; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nagaiah G, 2011, J ONCOL, V2011, DOI 10.1155/2011/542358; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Pallante P, 2014, NAT REV ENDOCRINOL, V10, P88, DOI 10.1038/nrendo.2013.223; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Qing W, 2012, THYROID, V22, P905, DOI 10.1089/thy.2011.0452; Ryder M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054302; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Smallridge RC, 2009, ENDOCR-RELAT CANCER, V16, P17, DOI 10.1677/ERC-08-0154; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	40	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103871	10.1371/journal.pone.0103871	http://dx.doi.org/10.1371/journal.pone.0103871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153510	Green Submitted, gold, Green Published			2022-12-27	WOS:000340952200011
J	Jones, KH; Jones, PA; Middleton, RM; Ford, DV; Tuite-Dalton, K; Lockhart-Jones, H; Peng, J; Lyons, RA; John, A; Noble, JG				Jones, Kerina H.; Jones, Philip A.; Middleton, Rodden M.; Ford, David V.; Tuite-Dalton, Katie; Lockhart-Jones, Hazel; Peng, Jeffrey; Lyons, Ronan A.; John, Ann; Noble, J. Gareth			Physical Disability, Anxiety and Depression in People with MS: An Internet-Based Survey via the UK MS Register	PLOS ONE			English	Article							IMPACT SCALE MSIS-29; MULTIPLE-SCLEROSIS; HOSPITAL ANXIETY; MAJOR DEPRESSION; OUTCOME MEASURES; SEVERITY; MRI	Introduction: People with Multiple Sclerosis are known to have a relatively high prevalence of both anxiety and depression. Studies of the relationship between physical disability and mental health in people with MS have reported mixed results, showing the need for further work. Methods: Between May 2011 and April 2012, 4516 people completed the MSIS-29 (v.1) and HADS scales via the dedicated internet site of the UK MS Register within a 7 day time window. These responses were linked with basic demographic and descriptive data and analysed in SPSS (v.20). Results: The proportions of people experiencing anxiety or depression increased with physical disability such that 38.0% of respondents with low, and 66.7% with high disability reported at least mild anxiety, and 17.1% of people with low, and 71.7% with high disability experienced at least mild depression. The multiple regression model explained 18.4% of the variance in anxiety with MSIS-29-PHYS score being the strongest predictor of anxiety. The model for depression explained 37.8% of the variance with MSIS-29-PHYS score being the strongest predictor. Some of the other variables included showed negative associations with anxiety and depression, indicating that the influence of physical disability on mental wellbeing could be underestimated. Conclusions: This study indicates that there is a positive relationship between physical disability and anxiety and depression, that physical disability impacts on anxiety and depression to differing extents, and that the effects vary with gender, age, disease course and disease duration. We have shown that physical disability is a predictor of anxiety and depression, and that other factors may mask the extent of this effect. Whether the causes of anxiety and depression are reactive, organic or a combination, it is essential that mental wellbeing is given due attention in caring for people with MS so that all their health needs can be met.	[Jones, Kerina H.; Jones, Philip A.; Middleton, Rodden M.; Ford, David V.; Tuite-Dalton, Katie; Lockhart-Jones, Hazel; Peng, Jeffrey; Lyons, Ronan A.; John, Ann; Noble, J. Gareth] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Swansea University	Jones, KH (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	k.h.jones@swansea.ac.uk		Middleton, Rodden/0000-0002-2130-4420; Noble, Gareth/0000-0002-4588-049X; Jones, Kerina/0000-0001-8164-3718; Lyons, Ronan/0000-0001-5225-000X; John, Ann/0000-0002-5657-6995; Ford, David/0000-0001-6551-721X	UK MS Society [C001-13.3]; Economic and Social Research Council [ES/L007444/1] Funding Source: researchfish; Medical Research Council [MR/K006525/1] Funding Source: researchfish; ESRC [ES/L007444/1] Funding Source: UKRI; MRC [MR/K006525/1] Funding Source: UKRI	UK MS Society; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK MS Register is supported by a grant from the UK MS Society C001-13.3. The sponsor had no role in the design or conduct of the study; the interpretation or analysis of the data; or in the decision to submit for publication (http://www.mssociety.org.uk/).	Arnett PA, 2008, J INT NEUROPSYCH SOC, V14, P691, DOI 10.1017/S1355617708081174; Bakshi R, 2000, NEUROREPORT, V11, P1153, DOI 10.1097/00001756-200004270-00003; Beiske AG, 2008, EUR J NEUROL, V15, P239, DOI 10.1111/j.1468-1331.2007.02041.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boot CRL, 2010, HEALTH INFORM J, V16, P145, DOI 10.1177/1460458210364786; Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y; Cetin K, 2007, MULT SCLER, V13, P1046, DOI 10.1177/1352458507077864; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; da Silva AM, 2011, J NEUROL SCI, V306, P66, DOI 10.1016/j.jns.2011.03.042; Dahl OP, 2009, MULT SCLER J, V15, P1495, DOI 10.1177/1352458509351542; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Ford DV, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-73; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Gallacher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054331; GILCHRIST AC, 1994, J PSYCHOSOM RES, V38, P193, DOI 10.1016/0022-3999(94)90115-5; Good Alice, 2007, J Healthc Inf Manag, V21, P72; Gray OM, 2009, MULT SCLER, V15, P75, DOI 10.1177/1352458508096872; Haase R, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2133; Health Research Authority website, ETH REV RES DAT; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart J, 2009, HLTH TECHNOLOGY ASSE, V13; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Janssens ACJW, 2006, MULT SCLER J, V12, P794, DOI 10.1177/1352458506070935; Jones KH, 2014, J BIOMED INFORM, V50, P196, DOI 10.1016/j.jbi.2014.01.003; Jones KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065640; Jones KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055422; Jones KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041910; KRUPP LB, 1988, ARCH NEUROL-CHICAGO, V45, P435, DOI 10.1001/archneur.1988.00520280085020; Lynch SG, 2001, MULT SCLER J, V7, P411, DOI 10.1191/135245801701566998; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Marrie RA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2466; Michalski D, 2010, MENT ILLN, V2, DOI 10.4081/mi.2010.e5; MINDEN SL, 1987, GEN HOSP PSYCHIAT, V9, P426, DOI 10.1016/0163-8343(87)90052-1; Mohr DC, 2006, MULT SCLER J, V12, P204, DOI 10.1191/135248506ms1265oa; Noble JG, 2012, MULT SCLER J, V18, P1718, DOI 10.1177/1352458512457847; Osborne LA, 2014, PHYS THER REV, V19, P24, DOI 10.1179/1743288X13Y.0000000094; Osborne LA, 2013, INT J HEALTHC INF SY, V8, P1, DOI 10.4018/jhisi.2013010101; Osborne LA, 2013, INT J MED INFORM, V82, P1104, DOI 10.1016/j.ijmedinf.2013.07.005; Osborne LA, 2012, INT J HEALTHC INF SY, V7, P27, DOI 10.4018/jhisi.2012070103; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI 10.1016/j.genhosppsych.2008.05.001; Ramp M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-58; Sa MJ, 2008, CLIN NEUROL NEUROSUR, V110, P868, DOI 10.1016/j.clineuro.2007.10.001; Siegert RJ, 2005, J NEUROL NEUROSUR PS, V76, P469, DOI 10.1136/jnnp.2004.054635; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zorzon M, 2001, J NEUROL, V248, P416, DOI 10.1007/s004150170184	49	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e104604	10.1371/journal.pone.0104604	http://dx.doi.org/10.1371/journal.pone.0104604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9TR	25153835	gold, Green Published, Green Submitted			2022-12-27	WOS:000340952200021
J	Kwon, JT; Jin, S; Choi, H; Kim, J; Jeong, J; Kim, J; Kim, Y; Cho, BN; Cho, C				Kwon, Jun Tae; Jin, Sora; Choi, Heejin; Kim, Jihye; Jeong, Juri; Kim, Jaehwan; Kim, Youil; Cho, Byung-Nam; Cho, Chunghee			Identification and Characterization of Germ Cell Genes Expressed in the F9 Testicular Teratoma Stem Cell Line	PLOS ONE			English	Article							MOUSE TESTIS; TRANSCRIPTION FACTORS; DNA METHYLATION; RETINOIC ACID; SERTOLI-CELLS; MICE; SPERMATOGENESIS; DIFFERENTIATION; PROMOTER; MEIOSIS	The F9 cell line, which was derived from a mouse testicular teratoma that originated from pluripotent germ cells, has been used as a model for differentiation. However, it is largely unknown whether F9 cells possess the characteristics of male germ cells. In the present study, we investigated spermatogenic stage-and cell type-specific gene expression in F9 cells. Analysis of previous microarray data showed that a large number of stage-regulated germ cell genes are expressed in F9 cells. Specifically, genes that are prominently expressed in spermatogonia and have transcriptional regulatory functions appear to be enriched in F9 cells. Our in silico and in vitro analyses identified several germ cell-specific or - predominant genes that are expressed in F9 cells. Among them, strong promoter activities were observed in the regions upstream of the spermatogonial genes, Dmrt1 (doublesex and mab-3 related transcription factor 1), Stra8 (stimulated by retinoic acid gene 8) and Tex13 (testis expressed gene 13), in F9 cells. A detailed analysis of the Tex13 promoter allowed us to identify an enhancer and a region that is implicated in germ cell-specificity. We also found that Tex13 expression is regulated by DNA methylation. Finally, analysis of GFP (green fluorescent protein) TEX13 localization revealed that the protein distributes heterogeneously in the cytoplasm and nucleus, suggesting that TEX13 shuttles between these two compartments. Taken together, our results demonstrate that F9 cells express numerous spermatogonial genes and could be used for transcriptional studies focusing on such genes. As an example of this, we use F9 cells to provide comprehensive expressional information about Tex13, and report that this gene appears to encode a germ cell-specific protein that functions in the nucleus during early spermatogenesis.	[Kwon, Jun Tae; Jin, Sora; Choi, Heejin; Kim, Jihye; Jeong, Juri; Kim, Jaehwan; Kim, Youil; Cho, Chunghee] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Cho, Byung-Nam] Catholic Univ Korea, Dept Biol, Puchon, South Korea	Gwangju Institute of Science & Technology (GIST); Catholic University of Korea	Cho, C (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea.	choch@gist.ac.kr			General Researcher Program of the National Research Foundation of Korea [NRF-2012R1A1A2039947]; Bio & Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2013M3A9A7046297]; GIST Systems Biology Infrastructure Establishment grant	General Researcher Program of the National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); GIST Systems Biology Infrastructure Establishment grant	This work was supported by the General Researcher Program of the National Research Foundation of Korea (NRF-2012R1A1A2039947), the Bio & Medical Technology Development Program of the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9A7046297) and GIST Systems Biology Infrastructure Establishment grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Caires K, 2010, J ENDOCRINOL, V205, P133, DOI 10.1677/JOE-09-0275; Chen YC, 2006, BIOINFORMATICS, V22, P2180, DOI 10.1093/bioinformatics/btl358; Eddy EM, 1995, REPROD FERT DEVELOP, V7, P695, DOI 10.1071/RD9950695; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Havilio M, 2006, J COMPUT BIOL, V13, P63, DOI 10.1089/cmb.2006.13.63; Hayashi T, 2001, J ANDROL, V22, P999; Heaney JD, 2012, DEVELOPMENT, V139, P1577, DOI 10.1242/dev.076851; Herrada G, 1997, J CELL SCI, V110, P1543; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kato T, 2012, REPRODUCTION, V143, P663, DOI 10.1530/REP-11-0365; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Ketola I, 2002, EUR J ENDOCRINOL, V147, P397, DOI 10.1530/eje.0.1470397; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Lee K, 2002, BIOCHEM BIOPH RES CO, V296, P337, DOI 10.1016/S0006-291X(02)00801-X; LEHTONEN E, 1989, International Journal of Developmental Biology, V33, P105; Lei N, 2009, BIOL REPROD, V81, P118, DOI 10.1095/biolreprod.108.072314; Looijenga LHJ, 1997, AM J PATHOL, V151, P581; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Murphy K, 2005, GENE EXPR PATTERNS, V5, P475, DOI 10.1016/j.modgep.2004.12.007; Nakamura BN, 2010, FREE RADICAL BIO MED, V49, P1368, DOI 10.1016/j.freeradbiomed.2010.07.019; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Rath B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-43; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Romero Y, 2012, SEX DEV, V6, P169, DOI 10.1159/000338415; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Sarkar PS, 2004, HUM MOL GENET, V13, P1421, DOI 10.1093/hmg/ddh161; Sato S, 2011, J REPROD DEVELOP, V57, P526, DOI 10.1262/jrd.11-031A; Schmidt JA, 2009, BIOL REPROD, V81, P56, DOI 10.1095/biolreprod.108.075358; Scotland KB, 2009, DEV DYNAM, V238, P1863, DOI 10.1002/dvdy.22037; Shakya A, 2011, J BIOL CHEM, V286, P450, DOI 10.1074/jbc.M110.174045; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; Tedesco M, 2009, J BIOL CHEM, V284, P35781, DOI 10.1074/jbc.M109.056481; Thepot D, 2000, DEVELOPMENT, V127, P143; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; Tian LY, 2009, MOL REPROD DEV, V76, P656, DOI 10.1002/mrd.20997; Tominaga A, 2010, GENES CELLS, V15, P595, DOI 10.1111/j.1365-2443.2010.01403.x; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Zheng B, 2014, PROTEOMICS, V14, P274, DOI 10.1002/pmic.201300395; Zindy F, 2000, MOL CELL BIOL, V20, P372, DOI 10.1128/MCB.20.1.372-378.2000	56	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e103837	10.1371/journal.pone.0103837	http://dx.doi.org/10.1371/journal.pone.0103837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153150	Green Submitted, Green Published, gold			2022-12-27	WOS:000340952200009
J	Korhan, P; Erdal, E; Kandemis, E; Cokakli, M; Nart, D; Yilmaz, F; Can, A; Atabey, N				Korhan, Peyda; Erdal, Esra; Kandemis, Emine; Cokakli, Murat; Nart, Deniz; Yilmaz, Funda; Can, Alp; Atabey, Nese			Reciprocal Activating Crosstalk between c-Met and Caveolin 1 Promotes Invasive Phenotype in Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; POTENTIAL THERAPEUTIC TARGET; ENDOCYTIC REGULATION; FACTOR RECEPTOR; CELL BIOLOGY; EXPRESSION; IDENTIFICATION; PHOSPHORYLATION; PROTOONCOGENE; AMPLIFICATION	c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellular Carcinoma (HCC). Caveolin 1 (CAV1), a plasma membrane protein that modulates signal transduction molecules, is also overexpressed in HCC. The aim of this study was to investigate biological and clinical significance of co-expression and activation of c-Met and CAV1 in HCC. We showed that c-Met and CAV1 were co-localized in HCC cells and HGF treatment increased this association. HGF-triggered c-Met activation caused a concurrent rise in both phosphorylation and expression of CAV1. Ectopic expression of CAV1 accelerated c-Met signaling, resulted in enhanced migration, invasion, and branching-morphogenesis. Silencing of CAV1 downregulated c-Met signaling, and decreased migratory/invasive capability of cells and attenuated branching morphogenesis. In addition, activation and co-localization of c-Met and CAV1 were elevated during hepatocarcinogenesis. In conclusion reciprocal activating crosstalk between c-Met and CAV1 promoted oncogenic signaling of c-Met contributed to the initiation and progression of HCC.	[Korhan, Peyda; Erdal, Esra; Kandemis, Emine; Cokakli, Murat; Atabey, Nese] Dokuz Eylul Univ, Sch Med, Dept Med Biol, Izmir, Turkey; [Nart, Deniz; Yilmaz, Funda] Ege Univ, Sch Med, Dept Pathol, Izmir, Turkey; [Can, Alp] Ankara Univ, Sch Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey	Dokuz Eylul University; Ege University; Ankara University	Atabey, N (corresponding author), Dokuz Eylul Univ, Sch Med, Dept Med Biol, Izmir, Turkey.	nese.atabey@deu.edu.tr	Cokakli, Murat/P-5056-2017; Korhan, Peyda/AAI-5995-2021; Erdal, Esra/AAE-1339-2019; Can, Alp/AAO-5734-2020; Erdal, Esra/T-9057-2018; Atabey, Nese/A-1853-2018; Yilmaz, Funda/O-9646-2018; kandemis, emine/K-1646-2015; Barbet, Funda Yılmaz/V-9938-2017	Cokakli, Murat/0000-0002-1370-204X; Korhan, Peyda/0000-0003-1286-022X; Erdal, Esra/0000-0001-7264-0574; Erdal, Esra/0000-0001-7264-0574; Atabey, Nese/0000-0003-4966-2980; Yilmaz, Funda/0000-0003-1837-6498; Barbet, Funda Yılmaz/0000-0003-1837-6498	Turkish Scientific and Technological Research Council (TUBITAK) [SBAG-107S026]; Dokuz Eylul University Research Foundation [05.KB.SAG.71]	Turkish Scientific and Technological Research Council (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Dokuz Eylul University Research Foundation(Dokuz Eylul University)	This project was funded by grants to Prof. Dr. Atabey from Turkish Scientific and Technological Research Council (TUBITAK, SBAG-107S026) and Dokuz Eylul University Research Foundation (05.KB.SAG.71). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabey N, 2001, J BIOL CHEM, V276, P14308, DOI 10.1074/jbc.M010202200; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Bozkaya G, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-64; Chan SPL, 2012, J GASTROEN HEPATOL, V27, P862, DOI 10.1111/j.1440-1746.2012.07096.x; Cho KW, 2013, ONCOGENE, V32, P1018, DOI 10.1038/onc.2012.122; Chu JS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-16; Chua CL, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/348297; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Coleman DT, 2009, MOL CANCER THER, V8, P214, DOI 10.1158/1535-7163.MCT-08-0722; DErrico A, 1996, HEPATOLOGY, V24, P60, DOI 10.1002/hep.510240112; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gao JJ, 2012, BIOSCI TRENDS, V6, P153, DOI 10.5582/bst.2012.v6.4.153; Gao JJ, 2011, DRUG DISCOV THER, V5, P2, DOI 10.5582/ddt.2011.v5.1.2; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; Kondo S, 2013, INT J CLIN ONCOL, V18, P207, DOI 10.1007/s10147-011-0361-9; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Marx-Stoelting P, 2009, INT J CANCER, V124, P1767, DOI 10.1002/ijc.24167; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Mitchell KA, 2013, J CLIN GASTROENTEROL, V47, pS20, DOI 10.1097/MCG.0b013e318291f237; Montesano R, 1998, CELL GROWTH DIFFER, V9, P355; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Ng YS, 2004, LAB INVEST, V84, P1209, DOI 10.1038/labinvest.3700150; Osada S, 2008, HEPATO-GASTROENTEROL, V55, P544; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tse EYT, 2012, J PATHOL, V226, P645, DOI 10.1002/path.3957; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Urra H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033085; van Malenstein H, 2011, EUR J CANCER, V47, P1789, DOI 10.1016/j.ejca.2011.04.027; Venepalli NK, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/341636; Wang SJ, 2009, OLIGONUCLEOTIDES, V19, P81, DOI 10.1089/oli.2008.0166; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yang SF, 2010, PATHOLOGY, V42, P438, DOI 10.3109/00313025.2010.494293; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Zhang ZB, 2009, PATHOL ONCOL RES, V15, P495, DOI 10.1007/s12253-008-9144-7	44	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105278	10.1371/journal.pone.0105278	http://dx.doi.org/10.1371/journal.pone.0105278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148256	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600039
J	Nagata, E; Fujii, N; Hosomichi, K; Mitsunaga, S; Suzuki, Y; Mashimo, Y; Tsukamoto, H; Satoh, T; Osawa, M; Inoue, I; Hata, A; Takizawa, S				Nagata, Eiichiro; Fujii, Natsuko; Hosomichi, Kazuyoshi; Mitsunaga, Shigeki; Suzuki, Yoichi; Mashimo, Yoichi; Tsukamoto, Hideo; Satoh, Tadayuki; Osawa, Motoki; Inoue, Ituro; Hata, Akira; Takizawa, Shunya			Possible Association between Dysfunction of Vitamin D Binding Protein (GC Globulin) and Migraine Attacks	PLOS ONE			English	Article							IMMUNE-SYSTEM; GENE; CCL2; PAIN	To identify the genetic causality of migraine and acute, severe melalgia, we performed a linkage analysis and exome sequencing in a family with four affected individuals. We identified a variant (R21L) in exon 2 of the GC globulin gene, which is involved in the transportation of vitamin D metabolites and acts as a chemotaxic factor; this variant was co-segregated within the family. To investigate the relationship between GC globulin and melalgia, we investigated the cytokine levels in serum samples from the patients and control subjects using a cytokine antibody array. GC globulin can bind to both MCP-1 and RANTES in human serum but has a higher affinity to MCP-1. In cell culture systems, MCP-1 was able to bind to overexpressed wild-type GC globulin but not to the GC globulin variant, and the GC globulin binding affinity to MCP-1 was significantly lower in sera from the patients than in sera from control subjects. A higher concentration of MCP-1 was also observed in sera from the patients. Thus, the dysfunctional GC globulin affected cytokine release, especially the release of MCP-1, and MCP-1 might play important roles in melalgia and migraine.	[Nagata, Eiichiro; Fujii, Natsuko; Takizawa, Shunya] Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa 25911, Japan; [Hosomichi, Kazuyoshi; Inoue, Ituro] Natl Inst Genet, Dept Integrated Genet, Div Human Genet, Mishima, Shizuoka 411, Japan; [Mitsunaga, Shigeki] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Isehara, Kanagawa 25911, Japan; [Suzuki, Yoichi] Tohoku Univ, Sch Med, Div Genet Epidemiol Res Support, Sendai, Miyagi 980, Japan; [Mashimo, Yoichi; Hata, Akira] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Japan; [Tsukamoto, Hideo; Satoh, Tadayuki] Tokai Univ, Sch Med, Educ & Res Ctr, Isehara, Kanagawa 25911, Japan; [Osawa, Motoki] Tokai Univ, Sch Med, Dept Forens Med, Isehara, Kanagawa 25911, Japan	Tokai University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokai University; Tohoku University; Chiba University; Tokai University; Tokai University	Nagata, E (corresponding author), Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa 25911, Japan.	enagata@is.icc.u-tokai.ac.jp	Hosomichi, Kazuyoshi/K-9477-2015	Hosomichi, Kazuyoshi/0000-0003-2712-1825; HATA, AKIRA/0000-0003-0867-3704	Tokai University School of Medicine, Project Research	Tokai University School of Medicine, Project Research	Funding provided by 2010 similar to 2012 Tokai University School of Medicine, Project Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Binder R, 1999, MOL IMMUNOL, V36, P885, DOI 10.1016/S0161-5890(99)00110-8; Bo SH, 2009, CEPHALALGIA, V29, P365, DOI 10.1111/j.1468-2982.2008.01727.x; Bose S, 2013, ARCH PHARM RES, V36, P1039, DOI 10.1007/s12272-013-0161-z; Bruno PP, 2007, EUR REV MED PHARMACO, V11, P245; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dauvergne C, 2013, EUR J PAIN; Edvinsson L, 2005, BRAIN RES REV, V48, P438, DOI 10.1016/j.brainresrev.2004.09.007; Edvinsson L, 2001, Curr Pain Headache Rep, V5, P71, DOI 10.1007/s11916-001-0013-2; Edvinsson L, 2012, PHARMACOL THERAPEUT, V136, P319, DOI 10.1016/j.pharmthera.2012.08.011; Franceschini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052394; Goadsby PJ, 2000, PROG NEUROBIOL, V62, P509, DOI 10.1016/S0301-0082(00)00010-1; Goadsby PJ, 2003, INTERN MED J, V33, P436, DOI 10.1046/j.1445-5994.2003.00453.x; Goasby PJ, 1993, ANN NEUROL, V33, P48; Headache Classification Committee of the International Headache Society (IHS), 2013, CEPHALALGIA, V33, P629, DOI DOI 10.1177/0333102413485658; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kemper RHA, 2001, CEPHALALGIA, V21, P549, DOI 10.1046/j.1468-2982.2001.00196.x; Levy D, 2009, CURR PAIN HEADACHE R, V13, P237, DOI 10.1007/s11916-009-0040-y; Malik S, 2013, CRIT REV CL LAB SCI, V50, P1, DOI 10.3109/10408363.2012.750262; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OHSAWA M, 1989, BIOCHIM BIOPHYS ACTA, V992, P195, DOI 10.1016/0304-4165(89)90010-X; OSAWA M, 1992, BIOCHIM BIOPHYS ACTA, V1117, P271, DOI 10.1016/0304-4165(92)90024-O; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Prakash S, 2009, CEPHALALGIA, V29, P898, DOI 10.1111/j.1468-2982.2008.01809.x; Qin XM, 2005, J NEUROSCI RES, V82, P51, DOI 10.1002/jnr.20612; ROBBINS L, 1994, HEADACHE, V34, P214, DOI 10.1111/j.1526-4610.1994.hed3404214.x; Sakai F, 1997, CEPHALALGIA, V17, P15, DOI 10.1046/j.1468-2982.1997.1701015.x; Sauro KM, 2009, HEADACHE, V49, P1378, DOI [10.1111/j.1526-4610.2009.01486.x, 10.1111/j.1526-4610.2009.01476.x]; Webb EL, 2005, BIOINFORMATICS, V21, P3060, DOI 10.1093/bioinformatics/bti449	31	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105319	10.1371/journal.pone.0105319	http://dx.doi.org/10.1371/journal.pone.0105319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147936	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600042
J	Raevuori, A; Haukka, J; Vaarala, O; Suvisaari, JM; Gissler, M; Grainger, M; Linna, MS; Suokas, JT				Raevuori, Anu; Haukka, Jari; Vaarala, Outi; Suvisaari, Jaana M.; Gissler, Mika; Grainger, Marjut; Linna, Milla S.; Suokas, Jaana T.			The Increased Risk for Autoimmune Diseases in Patients with Eating Disorders	PLOS ONE			English	Article							ANOREXIA-NERVOSA; SEVERE INFECTIONS; CROHNS-DISEASE; HLA ANTIGENS; TYPE-1; AUTOANTIBODIES; ASSOCIATION; PREVALENCE; MICROBIOTA; CELLS	Objective: Research suggests autoimmune processes to be involved in psychiatric disorders. We aimed to address the prevalence and incidence of autoimmune diseases in a large Finnish patient cohort with anorexia nervosa, bulimia nervosa, and binge eating disorder. Methods: Patients (N = 2342) treated at the Eating Disorder Unit of Helsinki University Central Hospital between 1995 and 2010 were compared with general population controls (N = 9368) matched for age, sex, and place of residence. Data of 30 autoimmune diseases from the Hospital Discharge Register from 1969 to 2010 were analyzed using conditional and Poisson regression models. Results: Of patients, 8.9% vs. 5.4% of control individuals had been diagnosed with one or more autoimmune disease (OR 1.7, 95% CI 1.5-2.0, P<0.001). The increase in endocrinological diseases (OR 2.4, 95% CI 1.8-3.2, P<0.001) was explained by type 1 diabetes, whereas Crohn's disease contributed most to the risk of gastroenterological diseases (OR 1.8, 95% CI 1.4-2.5, P<0.001). Higher prevalence of autoimmune diseases among patients with eating disorders was not exclusively due to endocrinological and gastroenterological diseases; when the two categories were excluded, the increase in prevalence was seen in the patients both before the onset of the eating disorder treatment (OR 1.5, 95% CI 1.1-2.1, P = 0.02) and at the end of the follow-up (OR 1.4, 95% CI 1.1-1.8, P = 0.01). Conclusions: We observed an association between eating disorders and several autoimmune diseases with different genetic backgrounds. Our findings support the link between immune-mediated mechanisms and development of eating disorders. Future studies are needed to further explore the risk of autoimmune diseases and immunological mechanisms in individuals with eating disorders and their family members.	[Raevuori, Anu; Haukka, Jari; Linna, Milla S.] Univ Helsinki, Hjelt Inst, Dept Publ Hlth, Helsinki, Finland; [Raevuori, Anu] Univ Helsinki, Cent Hosp, Dept Adolescent Psychiat, Helsinki, Finland; [Raevuori, Anu] Univ Turku, Inst Clin Med Child Psychiat, Turku, Finland; [Raevuori, Anu; Haukka, Jari; Suvisaari, Jaana M.; Grainger, Marjut; Suokas, Jaana T.] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Raevuori, Anu; Haukka, Jari; Suvisaari, Jaana M.; Grainger, Marjut; Suokas, Jaana T.] Natl Inst Hlth & Welf, Substance Abuse Serv, Helsinki, Finland; [Vaarala, Outi] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Suvisaari, Jaana M.] Tampere Sch Publ Hlth, Dept Social Psychiat, Tampere, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Suokas, Jaana T.] Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Tampere University; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Raevuori, A (corresponding author), Univ Helsinki, Hjelt Inst, Dept Publ Hlth, Helsinki, Finland.	anu.raevuori@helsinki.fi	Haukka, Jari/G-1484-2014	Haukka, Jari/0000-0003-1450-6208; Suvisaari, Jaana/0000-0001-7167-0990; Raevuori, Anu/0000-0001-7704-9441; Gissler, Mika/0000-0001-8254-7525	Academy of Finland [259764]; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Academy of Finland(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by Academy of Finland (Dr. Raevuori, grant number 259764). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunay I, 2011, CLIN COSMET INVESTI, V4, P139, DOI 10.2147/CCID.S24165; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arigo D, 2012, CHRONIC ILLN, V8, P45, DOI 10.1177/1742395311417639; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Benros ME, 2013, JAMA PSYCHIAT, V70, P812, DOI 10.1001/jamapsychiatry.2013.1111; Benros ME, 2011, AM J PSYCHIAT, V168, P1303, DOI 10.1176/appi.ajp.2011.11030516; BIEDERMAN J, 1984, AM J PSYCHIAT, V141, P1109; Blanchet C, 2002, PRESSE MED, V31, P312; Boraska V, MOL PSYCHIA IN PRESS; Bulik CM, 2003, INT J EAT DISORDER, V34, pS39, DOI 10.1002/eat.10204; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Corcos M, 2003, PSYCHONEUROENDOCRINO, V28, P229, DOI 10.1016/S0306-4530(02)00021-5; Dalbeth N, 2002, LANCET, V360, P1300, DOI 10.1016/S0140-6736(02)11320-1; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Eaton WW, 2010, BIPOLAR DISORD, V12, P638, DOI 10.1111/j.1399-5618.2010.00853.x; Fetissov SO, 2011, CURR OPIN CLIN NUTR, V14, P477, DOI 10.1097/MCO.0b013e32834936e7; Fetissov SO, 2005, P NATL ACAD SCI USA, V102, P14865, DOI 10.1073/pnas.0507204102; Fetissov SO, 2002, P NATL ACAD SCI USA, V99, P17155, DOI 10.1073/pnas.222658699; Goebel-Fabbri A, 2009, CURR DIABETES REP, V9, P133, DOI 10.1007/s11892-009-0023-8; Hall R C, 1995, J Fla Med Assoc, V82, P187; Harboe E, 2009, ANN RHEUM DIS, V68, P1541, DOI 10.1136/ard.2008.098301; Hornig M, 2013, CURR OPIN RHEUMATOL, V25, P488, DOI 10.1097/BOR.0b013e32836208de; Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563; Karwautz A, 2008, PSYCHOSOMATICS, V49, P399, DOI 10.1176/appi.psy.49.5.399; KISS A, 1989, BIOL PSYCHIAT, V25, P803, DOI 10.1016/0006-3223(89)90255-2; KISS A, 1988, AM J PSYCHIAT, V145, P876; Klump KL, 2006, PSYCHOL MED, V36, P539, DOI 10.1017/S0033291705006653; Lammi N, 2008, DIABETOLOGIA, V51, P897, DOI 10.1007/s00125-008-0952-9; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Limone P, 2000, J ENDOCRINOL INVEST, V23, P422, DOI 10.1007/BF03343750; Lo Sauro C, 2008, NEUROPSYCHOBIOLOGY, V57, P95, DOI 10.1159/000138912; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McDermott JR, 2006, GUT, V55, P492, DOI 10.1136/gut.2005.081752; Mitchell JE, 2006, CURR OPIN PSYCHIATR, V19, P438, DOI 10.1097/01.yco.0000228768.79097.3e; Padmos RC, 2004, BIOL PSYCHIAT, V56, P476, DOI 10.1016/j.biopsych.2004.07.003; Pfleiderer A, 2013, EUR J CLIN MICROBIOL, V32, P1471, DOI 10.1007/s10096-013-1900-2; R Core Team, 2021, R LANGUAGE ENV STAT; Rayment D, 2012, INT J EAT DISORDER, V45, P460, DOI 10.1002/eat.20964; Solmi M, 2013, INT J EAT DISORDER, V46, P639, DOI 10.1002/eat.22153; Strober M, 2001, INT J EAT DISORDER, V29, P263, DOI 10.1002/eat.1017; Suokas JT, 2013, PSYCHIAT RES, V210, P1101, DOI 10.1016/j.psychres.2013.07.042; Terashi M, 2011, NUTRITION, V27, P407, DOI 10.1016/j.nut.2011.01.002; TILLER J, 1994, J PSYCHOSOM RES, V38, P609, DOI 10.1016/0022-3999(94)90058-2; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; World Health Organization, 1992, INT STAT CLASS DIS; Young V, 2013, DIABETIC MED, V30, P189, DOI 10.1111/j.1464-5491.2012.03771.x	47	76	77	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104845	10.1371/journal.pone.0104845	http://dx.doi.org/10.1371/journal.pone.0104845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147950	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600024
J	Mirza, AH; Kaur, S; Brorsson, CA; Pociot, F				Mirza, Aashiq H.; Kaur, Simranjeet; Brorsson, Caroline A.; Pociot, Flemming			Effects of GWAS-Associated Genetic Variants on lncRNAs within IBD and T1D Candidate Loci	PLOS ONE			English	Article							LONG NONCODING RNAS; GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; NATURAL-SELECTION; EXPRESSION; EVOLUTION; ANNOTATION; TRANSCRIPTION; PLURIPOTENCY; METAANALYSIS	Long non-coding RNAs are a new class of non-coding RNAs that are at the crosshairs in many human diseases such as cancers, cardiovascular disorders, inflammatory and autoimmune disease like Inflammatory Bowel Disease (IBD) and Type 1 Diabetes (T1D). Nearly 90% of the phenotype-associated single-nucleotide polymorphisms (SNPs) identified by genome-wide association studies (GWAS) lie outside of the protein coding regions, and map to the non-coding intervals. However, the relationship between phenotype-associated loci and the non-coding regions including the long non-coding RNAs (lncRNAs) is poorly understood. Here, we systemically identified all annotated IBD and T1D loci-associated lncRNAs, and mapped nominally significant GWAS/ImmunoChip SNPs for IBD and T1D within these lncRNAs. Additionally, we identified tissue-specific cis-eQTLs, and strong linkage disequilibrium (LD) signals associated with these SNPs. We explored sequence and structure based attributes of these lncRNAs, and also predicted the structural effects of mapped SNPs within them. We also identified lncRNAs in IBD and T1D that are under recent positive selection. Our analysis identified putative lncRNA secondary structure-disruptive SNPs within and in close proximity (+/25 kb flanking regions) of IBD and T1D loci-associated candidate genes, suggesting that these RNA conformation-altering polymorphisms might be associated with diseased-phenotype. Disruption of lncRNA secondary structure due to presence of GWAS SNPs provides valuable information that could be potentially useful for future structure-function studies on lncRNAs.	[Mirza, Aashiq H.; Kaur, Simranjeet; Brorsson, Caroline A.; Pociot, Flemming] Herlev Univ Hosp, Dept Pediat E, Copenhagen Diabet Res Ctr CPH DIRECT, DK-2730 Herlev, Denmark; [Mirza, Aashiq H.; Kaur, Simranjeet] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Mirza, Aashiq H.; Pociot, Flemming] Univ Copenhagen, Ctr Noncoding RNA Technol & Hlth, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen	Pociot, F (corresponding author), Herlev Univ Hosp, Dept Pediat E, Copenhagen Diabet Res Ctr CPH DIRECT, DK-2730 Herlev, Denmark.	flemming.pociot.01@regionh.dk	Kaur, Simranjeet/K-2487-2019	Kaur, Simranjeet/0000-0003-0490-1028; Brorsson, Caroline Anna/0000-0003-3473-1744; Pociot, Flemming/0000-0003-3274-5448	National Institute of Diabetes and Digestive and Kidney Diseases [U01-DK-062418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK-062418); FP, The Danish Strategic Research Council (09-067036/DSF); FP, AHM, and The Sehested Hansen Foundation; AHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Burren OS, 2011, NUCLEIC ACIDS RES, V39, pD997, DOI 10.1093/nar/gkq912; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen G, 2013, HUM MUTAT, V34, P338, DOI 10.1002/humu.22239; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cohen N, 2005, MOL BIOL EVOL, V22, P1260, DOI 10.1093/molbev/msi115; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Costantini M, 2008, P NATL ACAD SCI USA, V105, P3433, DOI 10.1073/pnas.0710587105; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Kumar V, 2012, SEMIN IMMUNOPATHOL, V34, P567, DOI 10.1007/s00281-012-0312-1; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martin JS, 2012, RNA, V18, P77, DOI 10.1261/rna.029900.111; Martin L, 2012, J CLIN INVEST, V122, P1589, DOI 10.1172/JCI60020; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Meola N, 2012, RNA, V18, P111, DOI 10.1261/rna.029454.111; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Merelli I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S5; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Niazi F, 2012, RNA, V18, P825, DOI 10.1261/rna.029520.111; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Pennisi E, 2010, SCIENCE, V330, P574, DOI 10.1126/science.330.6004.574; Petretto E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000737; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sabarinathan R, 2013, HUM MUTAT, V34, P546, DOI 10.1002/humu.22273; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1	76	57	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105723	10.1371/journal.pone.0105723	http://dx.doi.org/10.1371/journal.pone.0105723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144376	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100114
J	Nishimura, T; Higuchi, K; Sai, Y; Sugita, Y; Yoshida, Y; Tomi, M; Wada, M; Wakayama, T; Tamura, A; Tsukita, S; Soga, T; Nakashima, E				Nishimura, Tomohiro; Higuchi, Kei; Sai, Yoshimichi; Sugita, Yuki; Yoshida, Yuko; Tomi, Masatoshi; Wada, Masami; Wakayama, Tomohiko; Tamura, Atsushi; Tsukita, Sachiko; Soga, Tomoyoshi; Nakashima, Emi			Fetal Growth Retardation and Lack of Hypotaurine in Ezrin Knockout Mice	PLOS ONE			English	Article							ERM PROTEINS; TAURINE; CELLS; LIVER; SYNCYTIOTROPHOBLAST; ORGANIZATION; RESTRICTION; EXPRESSION; OXIDATION; BRAIN	Ezrin is a membrane-associated cytoplasmic protein that serves to link cell-membrane proteins with the actin-based cytoskeleton, and also plays a role in regulation of the functional activities of some transmembrane proteins. It is expressed in placental trophoblasts. We hypothesized that placental ezrin is involved in the supply of nutrients from mother to fetus, thereby influencing fetal growth. The aim of this study was firstly to clarify the effect of ezrin on fetal growth and secondly to determine whether knockout of ezrin is associated with decreased concentrations of serum and placental nutrients. Ezrin knockout mice (Ez(-/-)) were confirmed to exhibit fetal growth retardation. Metabolome analysis of fetal serum and placental extract of ezrin knockout mice by means of capillary electrophoresis-time-of-flight mass spectrometry revealed a markedly decreased concentration of hypotaurine, a precursor of taurine. However, placental levels of cysteine and cysteine sulfinic acid (precursors of hypotaurine) and taurine were not affected. Lack of hypotaurine in Ez(-/-) mice was confirmed by liquid chromatography with tandem mass spectrometry. Administration of hypotaurine to heterogenous dams significantly decreased the placenta-to-maternal plasma ratio of hypotaurine in wild-type fetuses but only slightly decreased it in ezrin knockout fetuses, indicating that the uptake of hypotaurine from mother to placenta is saturable and that disruption of ezrin impairs the uptake of hypotaurine by placental trophoblasts. These results indicate that ezrin is required for uptake of hypotaurine from maternal serum by placental trophoblasts, and plays an important role in fetal growth.	[Nishimura, Tomohiro; Higuchi, Kei; Sai, Yoshimichi; Sugita, Yuki; Yoshida, Yuko; Tomi, Masatoshi; Wada, Masami; Nakashima, Emi] Keio Univ, Fac Pharm, Div Pharmaceut, Minato Ku, Tokyo, Japan; [Sai, Yoshimichi] Kanazawa Univ Hosp, Dept Pharm, Kanazawa, Ishikawa, Japan; [Wakayama, Tomohiko] Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, Kanazawa, Ishikawa, Japan; [Wada, Masami; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Frontier Biosci, Biol Sci Lab, Suita, Osaka, Japan; [Wada, Masami; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Keio University; Kanazawa University; Kanazawa University; Osaka University; Osaka University; Keio University	Nakashima, E (corresponding author), Keio Univ, Fac Pharm, Div Pharmaceut, Minato Ku, Tokyo, Japan.	nakashima-em@pha.keio.ac.jp	SAI, Yoshimichi/L-3828-2015; Soga, Tomoyoshi/B-8105-2014; Tomi, Masatoshi/ABC-7011-2021	SAI, Yoshimichi/0000-0003-2954-1532; Soga, Tomoyoshi/0000-0001-9502-2509; Tomi, Masatoshi/0000-0002-9829-8436	Japan Society for the Promotion of Science (JSPS); Research Foundation for Pharmaceutical Sciences; Japan Science and Technology Agency (JST); Suzuken Memorial Foundation; Uehara Memorial Foundation; Nateglinide Memorial Toyoshima Research and Education Fund; Grants-in-Aid for Scientific Research [25860396] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Foundation for Pharmaceutical Sciences; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Suzuken Memorial Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Nateglinide Memorial Toyoshima Research and Education Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), the Research Foundation for Pharmaceutical Sciences, Research for Promoting Technological Seeds from Japan Science and Technology Agency (JST), Suzuken Memorial Foundation, the Uehara Memorial Foundation and Nateglinide Memorial Toyoshima Research and Education Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chaimbault P, 2004, ANAL BIOCHEM, V332, P215, DOI 10.1016/j.ab.2004.06.014; DAVISON AN, 1956, BIOCHIM BIOPHYS ACTA, V19, P66, DOI 10.1016/0006-3002(56)90386-9; EDWARDS HC, 1987, J CELL BIOL, V105, P303, DOI 10.1083/jcb.105.1.303; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Hayashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055623; Higuchi K, 2010, BIOL PHARM BULL, V33, P1400, DOI 10.1248/bpb.33.1400; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Nishimura T, 2010, PLACENTA, V31, P1003, DOI 10.1016/j.placenta.2010.08.003; Nishimura T, 2013, J PHARM SCI-US, V102, P3356, DOI 10.1002/jps.23551; Norberg S, 1998, PEDIATR RES, V44, P233, DOI 10.1203/00006450-199808000-00016; OJA SS, 1981, BIOCHIM BIOPHYS ACTA, V677, P350, DOI 10.1016/0304-4165(81)90246-4; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pecci L, 2000, ADV EXP MED BIOL, V483, P163; Pecci L, 1999, BIOCHEM BIOPH RES CO, V254, P661, DOI 10.1006/bbrc.1998.9886; Riquelme G, 2011, J MEMBRANE BIOL, V241, P127, DOI 10.1007/s00232-011-9369-3; Roos S, 2004, AM J PHYSIOL-REG I, V287, pR886, DOI 10.1152/ajpregu.00232.2004; Sakuragawa T, 2010, J CLIN BIOCHEM NUTR, V46, P126, DOI 10.3164/jcbn.09-91; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Tomi M, 2011, J PHARM SCI; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105423	10.1371/journal.pone.0105423	http://dx.doi.org/10.1371/journal.pone.0105423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144766	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100069
J	Sanders, NG; Sullivan, DJ; Mlambo, G; Dimopoulos, G; Tripathi, AK				Sanders, Natalie G.; Sullivan, David J.; Mlambo, Godfree; Dimopoulos, George; Tripathi, Abhai K.			Gametocytocidal Screen Identifies Novel Chemical Classes with Plasmodium falciparum Transmission Blocking Activity	PLOS ONE			English	Article							QUATERNARY AMMONIUM-COMPOUNDS; HIGH-THROUGHPUT ASSAY; METHYLENE-BLUE; ANTIMALARIAL ACTIVITY; COMBINATION THERAPY; PYRVINIUM PAMOATE; CEREBRAL MALARIA; INHIBITORS; EFFICACY; DRUGS	Discovery of transmission blocking compounds is an important intervention strategy necessary to eliminate and eradicate malaria. To date only a small number of drugs that inhibit gametocyte development and thereby transmission from the mosquito to the human host exist. This limitation is largely due to a lack of screening assays easily adaptable to high throughput because of multiple incubation steps or the requirement for high gametocytemia. Here we report the discovery of new compounds with gametocytocidal activity using a simple and robust SYBR Green I-based DNA assay. Our assay utilizes the exflagellation step in male gametocytes and a background suppressor, which masks the staining of dead cells to achieve healthy signal to noise ratio by increasing signal of viable parasites and subtracting signal from dead parasites. By determining the contribution of exflagellation to fluorescent signal and using appropriate cutoff values, we were able to screen for gametocytocidal compounds. After assay validation and optimization, we screened an FDA approved drug library of approximately 1500 compounds, as well as the 400 compound MMV malaria box and identified 44 gametocytocidal compounds with sub to low micromolar IC(50)s. Major classes of compounds with gametocytocidal activity included quaternary ammonium compounds with structural similarity to choline, acridine-like compounds similar to quinacrine and pyronaridine, as well as antidepressant, antineoplastic, and anthelminthic compounds. Top drug candidates showed near complete transmission blocking in membrane feeding assays. This assay is simple, reproducible and demonstrated robust Z-factor values at low gametocytemia levels, making it amenable to HTS for identification of novel and potent gametocytocidal compounds.	[Sanders, Natalie G.; Sullivan, David J.; Mlambo, Godfree; Dimopoulos, George; Tripathi, Abhai K.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tripathi, AK (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	atripat2@jhu.edu		Tripathi, Abhai/0000-0001-9848-0142	national Institutes of Health [R01AI061576]; Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Johns Hopkins University Libraries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061576] Funding Source: NIH RePORTER	national Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Johns Hopkins University Libraries(Johns Hopkins University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the national Institutes of Health R01AI061576, the Johns Hopkins Malaria Research Institute and The Bloomberg Family Foundation. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Auparakkitanon S, 2000, BIOCHEM BIOPH RES CO, V269, P406, DOI 10.1006/bbrc.2000.2305; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; BHATTACHARYA BK, 1965, BRIT J PHARM CHEMOTH, V24, P240, DOI 10.1111/j.1476-5381.1965.tb02099.x; Biagini GA, 2008, MOL PHARMACOL, V73, P1347, DOI 10.1124/mol.108.045120; Birkholtz LM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-431; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; Bowman JD, 2014, ANTIMICROB AGENTS CH, V58, P811, DOI 10.1128/AAC.01500-13; Calas M, 1997, J MED CHEM, V40, P3557, DOI 10.1021/jm9701886; Chavalitshewinkoon-Petmitr Porntip, 2000, Parasitology International, V48, P275, DOI 10.1016/S1383-5769(99)00028-8; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Coulibaly B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005318; D'Alessandro S, 2013, J ANTIMICROB CHEMOTH, V68, P2048, DOI 10.1093/jac/dkt165; DARCY PF, 1962, J PHARM PHARMACOL, V14, P129, DOI 10.1111/j.2042-7158.1962.tb11069.x; DARCY PF, 1962, J PHARM PHARMACOL, V14, P193, DOI 10.1111/j.2042-7158.1962.tb11081.x; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Dormoi J, 2013, ANTIMICROB AGENTS CH, V57, P3412, DOI 10.1128/AAC.02381-12; Dormoi J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-127; Downey AS, 2008, ANTIMICROB AGENTS CH, V52, P3106, DOI 10.1128/AAC.00207-08; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; Fernandez-Calienes A, 2011, BIOMED PHARMACOTHER, V65, P210, DOI 10.1016/j.biopha.2011.04.001; Guetzoyan L, 2009, BIOORGAN MED CHEM, V17, P8032, DOI 10.1016/j.bmc.2009.10.005; Krawczyk J, 2013, EXPERT OPIN INV DRUG, V22, P1315, DOI 10.1517/13543784.2013.826648; Lelievre J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035019; License A, 2011, PLOS MED, V8; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Pascual A, 2011, ANTIMICROB AGENTS CH, V55, P2472, DOI 10.1128/AAC.01466-10; Peatey CL, 2011, MOL BIOCHEM PARASIT, V180, P127, DOI 10.1016/j.molbiopara.2011.09.002; Peyrottes S, 2012, CURR PHARM DESIGN, V18, P3454; Pybus BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-212; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Sun W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03743; Tanaka TQ, 2013, MOL BIOCHEM PARASIT, V188, P20, DOI 10.1016/j.molbiopara.2013.02.005; Tanaka TQ, 2011, MOL BIOCHEM PARASIT, V177, P160, DOI 10.1016/j.molbiopara.2011.02.005; Teguh SC, 2013, J MED CHEM, V56, P6200, DOI 10.1021/jm400656s; Tischer M, 2012, CHEMMEDCHEM, V7, P22, DOI 10.1002/cmdc.201100404; Tomitsuka E, 2012, J BIOCHEM, V152, P171, DOI 10.1093/jb/mvs041; Valdes Ayme Fernandez-Calienes, 2011, Open Med Chem J, V5, P11, DOI 10.2174/1874104501105010011; Wein S, 2012, BRIT J PHARMACOL, V166, P2263, DOI 10.1111/j.1476-5381.2012.01966.x; Yu XM, 2012, CHEMMEDCHEM, V7, P587, DOI 10.1002/cmdc.201100554; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	45	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105817	10.1371/journal.pone.0105817	http://dx.doi.org/10.1371/journal.pone.0105817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25157792	gold, Green Submitted, Green Published			2022-12-27	WOS:000341303200068
J	Balsalobre-Fernandez, C; Tejero-Gonzalez, CM; del Campo-Vecino, J				Balsalobre-Fernandez, Carlos; Ma Tejero-Gonzalez, Carlos; del Campo-Vecino, Juan			Relationships between Training Load, Salivary Cortisol Responses and Performance during Season Training in Middle and Long Distance Runners	PLOS ONE			English	Article							ELITE MALE; FATIGUE; SPORT; INTENSITY; ENDOCRINE; SYMPTOMS; SCIENCE; PLAYERS; KENYAN; TOOL	Purpose: Monitoring training from a multifactorial point of view is of great importance in elite endurance athletes. This study aims to analyze the relationships between indicators of training load, hormonal status and neuromuscular performance, and to compare these values with competition performance, in elite middle and long-distance runners. Method: Fifteen elite middle and long-distance runners (12 men, 3 women; age = 26.3 +/- 5.1 yrs) were measured for training volume, training zone and session rate of perceived exertion (RPE) (daily), countermovement jump (CMJ) and salivary free cortisol (weekly) for 39 weeks (i.e., the whole season). Competition performance was also observed throughout the study, registering the season best and worst competitions. Results: Season average salivary free cortisol concentrations correlate significantly with CMJ (r = -0.777) and RPE (r = 0.551). Also, weekly averages of CMJ significantly correlates with RPE (r = -0.426), distance run (r = -0.593, p<0.001) and training zone (r = 0.437, p<0.05). Finally, it was found that the CMJ (+8.5%, g = 0.65) and the RPE (-17.6%, g = 0.94) measured the week before the best competition performance of the season were significantly different compared with the measurement conducted the week before the season's worst competition performance. Conclusions: Monitoring weekly measurements of CMJ and RPE could be recommended to control training process of such athletes in a non-invasive, field-based, systematic way.	[Balsalobre-Fernandez, Carlos; Ma Tejero-Gonzalez, Carlos; del Campo-Vecino, Juan] Autonomous Univ Madrid, Dept Phys Educ Sport & Human Movement, E-28049 Madrid, Spain	Autonomous University of Madrid	Balsalobre-Fernandez, C (corresponding author), Autonomous Univ Madrid, Dept Phys Educ Sport & Human Movement, E-28049 Madrid, Spain.	carlos.balsalobre@uam.es	/J-1248-2019; Tejero-González, Carlos M/A-1932-2013	/0000-0002-8329-1581; Tejero-González, Carlos M/0000-0002-2842-5911				Arrese AL, 2005, J SPORT MED PHYS FIT, V45, P435; Auersperger I, 2012, INT J SPORT NUTR EXE, V22, P55, DOI 10.1123/ijsnem.22.1.55; Billat V, 2003, MED SCI SPORT EXER, V35, P297, DOI 10.1249/01.MSS.0000053556.59992.A9; Borresen J, 2009, SPORTS MED, V39, P779, DOI 10.2165/11317780-000000000-00000; Bosquet L, 2007, MED SCI SPORT EXER, V39, P1358, DOI 10.1249/mss.0b013e31806010e0; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P359, DOI 10.1123/ijspp.3.3.359; Crewther BT, 2009, J STRENGTH COND RES, V23, P2046, DOI 10.1519/JSC.0b013e3181b73c19; Enoksen E, 2011, INT J SPORTS SCI COA, V6, P273, DOI 10.1260/1747-9541.6.2.273; Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86; Garcia-Pallares J, 2010, EUR J APPL PHYSIOL, V110, P99, DOI 10.1007/s00421-010-1484-9; Garcin M, 2002, INT J SPORTS MED, V23, P16, DOI 10.1055/s-2002-19275; Gorostiaga EM, 2006, MED SCI SPORT EXER, V38, P357, DOI 10.1249/01.mss.0000184586.74398.03; Ingham SA, 2012, INT J SPORT PHYSIOL, V7, P193, DOI 10.1123/ijspp.7.2.193; Izquierdo-Gabarren M, 2010, MED SCI SPORT EXER, V42, P1191, DOI 10.1249/MSS.0b013e3181c67eec; Jimenez-Reyes P., 2011, CULTURA CIENCIA DEPO, V6, P105, DOI DOI 10.1136/BJSP0RTS-2013-093073.18; Knicker AJ, 2011, SPORTS MED, V41, P307, DOI 10.2165/11586070-000000000-00000; Kraemer WJ, 2004, J STRENGTH COND RES, V18, P121; McGuigan MR, 2004, J SPORT SCI MED, V3, P8; McLean BD, 2010, INT J SPORT PHYSIOL, V5, P367, DOI 10.1123/ijspp.5.3.367; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; O'Connor PJ, 2007, SPORTS MED, V37, P408, DOI 10.2165/00007256-200737040-00035; Obminski Z., 2008, RES YB, V14, P103; Papacosta E, 2011, J SCI MED SPORT, V14, P424, DOI 10.1016/j.jsams.2011.03.004; Passelergue PA, 2012, J STRENGTH COND RES, V26, P3049, DOI 10.1519/JSC.0b013e3182473e3d; Petersen K, 2007, EUR J APPL PHYSIOL, V101, P385, DOI 10.1007/s00421-007-0504-x; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Stellingwerff T, 2012, INT J SPORT NUTR EXE, V22, P392, DOI 10.1123/ijsnem.22.5.392; Tjelta Leif Inge, 2013, IJASS(International Journal of Applied Sports Sciences), V25, P11; Tyndall GL, 1996, EUR J APPL PHYSIOL, V73, P61, DOI 10.1007/BF00262810; Wilber RL, 2012, INT J SPORT PHYSIOL, V7, P92, DOI 10.1123/ijspp.7.2.92	31	20	20	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e106066	10.1371/journal.pone.0106066	http://dx.doi.org/10.1371/journal.pone.0106066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153137	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200112
J	Guerbouj, S; Djilani, F; Bettaieb, J; Lambson, B; Diouani, MF; Ben Salah, A; Ben Ismail, R; Guizani, I				Guerbouj, Souheila; Djilani, Fattouma; Bettaieb, Jihene; Lambson, Bronwen; Diouani, Mohamed Fethi; Ben Salah, Afif; Ben Ismail, Riadh; Guizani, Ikram			Evaluation of a gp63-PCR Based Assay as a Molecular Diagnosis Tool in Canine Leishmaniasis in Tunisia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; VISCERAL LEISHMANIASIS; INFANTUM INFECTION; PCR METHODS; DOGS; PREVALENCE; AREA; DNA; IDENTIFICATION; SERODIAGNOSIS	A gp63PCR method was evaluated for the detection and characterization of Leishmania (Leishmania) (L.) parasites in canine lymph node aspirates. This tool was tested and compared to other PCRs based on the amplification of 18S ribosomal genes, a L. infantum specific repetitive sequence and kinetoplastic DNA minicircles, and to classical parasitological (smear examination and/or culture) or serological (IFAT) techniques on a sample of 40 dogs, originating from different L. infantum endemic regions in Tunisia. Sensitivity and specificity of all the PCR assays were evaluated on parasitologically confirmed dogs within this sample (N = 18) and control dogs (N = 45) originating from non-endemic countries in northern Europe and Australia. The gp63 PCR had 83.5% sensitivity and 100% specificity, a performance comparable to the kinetoplast PCR assay and better than the other assays. These assays had comparable results when the gels were southern transferred and hybridized with a radioactive probe. As different infection rates were found according to the technique, concordance of the results was estimated by (kappa) test. Best concordance values were between the gp63PCR and parasitological methods (74.6%, 95% confidence intervals CI: 58.8-95.4%) or serology IFAT technique (47.4%, 95% CI: 23.5-71.3%). However, taken together Gp63 and Rib assays covered most of the samples found positive making of them a good alternative for determination of infection rates. Potential of the gp63PCR-RFLP assay for analysis of parasite genetic diversity within samples was also evaluated using 5 restriction enzymes. RFLP analysis confirmed assignment of the parasites infecting the dogs to L. infantum species and illustrated occurrence of multiple variants in the different endemic foci. Gp63 PCR assay thus constitutes a useful tool in molecular diagnosis of L. infantum infections in dogs in Tunisia.	[Guerbouj, Souheila; Guizani, Ikram] Univ Tunis el Manar, Pasteur Inst Tunis, Lab Mol Epidemiol & Expt Pathol, Tunis, Tunisia; [Guerbouj, Souheila; Djilani, Fattouma; Diouani, Mohamed Fethi; Ben Ismail, Riadh; Guizani, Ikram] Pasteur Inst Tunis, Lab Epidemiol & Ecol Parasit Dis, Tunis, Tunisia; [Bettaieb, Jihene; Ben Salah, Afif] Pasteur Inst Tunis, Lab Med Epidemiol, Tunis, Tunisia; [Lambson, Bronwen] Univ Cambridge, Dept Pathol, Molteno Inst Parasitol, Cambridge CB2 1QP, England	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; University of Cambridge	Guizani, I (corresponding author), Univ Tunis el Manar, Pasteur Inst Tunis, Lab Mol Epidemiol & Expt Pathol, Tunis, Tunisia.	ikram.guizani@pasteur.rns.tn	Ben Salah, Afif/AGW-8941-2022; Diouani, mohamed fethi/A-7880-2015	Ben Salah, Afif/0000-0002-6696-4713; Guizani, Ikram/0000-0003-2763-8963; Diouani, mohamed fethi/0000-0001-5192-2927	EU-DGXII STD3 [CT930253]; INCO-DC programs [CT970256]; Ministry of Higher Education and Research in Tunisia [LR00SP04, LR11IPT04]	EU-DGXII STD3; INCO-DC programs; Ministry of Higher Education and Research in Tunisia	This work received financial support from the EU-DGXII STD3 (CT930253) and INCO-DC (CT970256) programs and from the Ministry of Higher Education and Research in Tunisia (LR00SP04 & LR11IPT04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Andreadou M, 2012, EXP PARASITOL, V131, P419, DOI 10.1016/j.exppara.2012.05.012; ASHFORD DA, 1995, AM J TROP MED HYG, V53, P251, DOI 10.4269/ajtmh.1995.53.251; Boelaert M, 1999, EPIDEMIOL INFECT, V123, P499, DOI 10.1017/S0950268899003040; Chargui N, 2009, PARASITE, V16, P65, DOI 10.1051/parasite/2009161065; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Diouani M F, 2008, Arch Inst Pasteur Tunis, V85, P55; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; Ferreira ED, 2007, VET PARASITOL, V146, P235, DOI 10.1016/j.vetpar.2007.02.015; Ferroglio E, 2007, VET PARASITOL, V144, P162, DOI 10.1016/j.vetpar.2006.09.017; Giudice E, 2011, ACTA VET HUNG, V59, P205, DOI 10.1556/AVet.2011.003; Gomes YM, 2008, VET J, V175, P45, DOI 10.1016/j.tvjl.2006.10.019; Gramiccia M, 2011, VET PARASITOL, V181, P23, DOI 10.1016/j.vetpar.2011.04.019; Gramiccia M, 2007, ECOL CONT VECTOR-BOR, V1, P75; Guerbouj S, 2001, PARASITOLOGY, V122, P25, DOI 10.1017/S0031182000007125; GUIZANI I, 1994, AM J TROP MED HYG, V50, P632, DOI 10.4269/ajtmh.1994.50.632; Hamarsheh O, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-183; Lachaud L, 2002, PARASITOLOGY, V125, P197, DOI 10.1017/S0031182002002081; Lachaud L, 2002, J CLIN MICROBIOL, V40, P210, DOI 10.1128/JCM.40.1.210-215.2002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maia C, 2008, VET PARASITOL, V158, P274, DOI 10.1016/j.vetpar.2008.07.028; Miro G, 2008, TRENDS PARASITOL, V24, P371, DOI 10.1016/j.pt.2008.05.003; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Oskam L, 1996, FEMS IMMUNOL MED MIC, V16, P235, DOI 10.1016/S0928-8244(96)00089-2; PIARROUX R, 1993, AM J TROP MED HYG, V49, P364, DOI 10.4269/ajtmh.1993.49.364; Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06; Schantz PM, 2005, JAVMA-J AM VET MED A, V226, P1316, DOI 10.2460/javma.2005.226.1316; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; SMYTH AJ, 1992, PARASITOLOGY, V105, P183, DOI 10.1017/S0031182000074096; Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Solca MD, 2012, VET PARASITOL, V184, P133, DOI 10.1016/j.vetpar.2011.08.026; Srividya G, 2012, PARASITOL RES, V110, P1065, DOI 10.1007/s00436-011-2680-1; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; Wang JY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-69	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105419	10.1371/journal.pone.0105419	http://dx.doi.org/10.1371/journal.pone.0105419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153833	Green Published, gold, Green Submitted			2022-12-27	WOS:000340952200045
J	Mouveaux, T; Oria, G; Werkmeister, E; Slomianny, C; Fox, BA; Bzik, DJ; Tomavo, S				Mouveaux, Thomas; Oria, Gabrielle; Werkmeister, Elisabeth; Slomianny, Christian; Fox, Barbara A.; Bzik, David J.; Tomavo, Stanislas			Nuclear Glycolytic Enzyme Enolase of Toxoplasma gondii Functions as a Transcriptional Regulator	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; STAGE CONVERSION; GENOME SEQUENCE; DNA-BINDING; PARASITE; APICOMPLEXAN; PROTEIN; IDENTIFICATION; ALDOLASE	Apicomplexan parasites including Toxoplasma gondii have complex life cycles within different hosts and their infectivity relies on their capacity to regulate gene expression. However, little is known about the nuclear factors that regulate gene expression in these pathogens. Here, we report that T. gondii enolase TgENO2 is targeted to the nucleus of actively replicating parasites, where it specifically binds to nuclear chromatin in vivo. Using a ChIP-Seq technique, we provide evidence for TgENO2 enrichment at the 5' untranslated gene regions containing the putative promoters of 241 nuclear genes. Ectopic expression of HA-tagged TgENO1 or TgENO2 led to changes in transcript levels of numerous gene targets. Targeted disruption of TgENO1 gene results in a decrease in brain cyst burden of chronically infected mice and in changes in transcript levels of several nuclear genes. Complementation of this knockout mutant with ectopic TgENO1-HA fully restored normal transcript levels. Our findings reveal that enolase functions extend beyond glycolytic activity and include a direct role in coordinating gene regulation in T. gondii.	[Mouveaux, Thomas; Oria, Gabrielle; Werkmeister, Elisabeth; Tomavo, Stanislas] Univ Lille Nord France, Inst Pasteur Lille, CNRS UMR 8204, Ctr Infect & Immun Lille,INSERM U 1019, Lille, France; [Slomianny, Christian] Univ Lille Nord France, Lab Cell Physiol, INSERM U 1003, Villeneuve Dascq, France; [Fox, Barbara A.; Bzik, David J.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Dartmouth College	Tomavo, S (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, CNRS UMR 8204, Ctr Infect & Immun Lille,INSERM U 1019, Lille, France.	Stan.Tomavo@pasteur-lille.fr	WERKMEISTER, Elisabeth/GLQ-7361-2022; Slomianny, Christian/L-8285-2018	Thomas, Mouveaux/0000-0003-1559-350X	Centre National de la Recherche Scientifique (CNRS); Institut Medicale de la Recherche Scientifique (INSERM); Institut Pasteur de Lille (IPL) and Laboratoire d'Excellence (LabEx) ParaFrap from the National Agency for Research [PIA] [ANR-11-LABX-0024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105563, R21AI084570, R21AI104514, R01AI041930, R21AI097018] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Medicale de la Recherche Scientifique (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur de Lille (IPL) and Laboratoire d'Excellence (LabEx) ParaFrap from the National Agency for Research [PIA]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Centre National de la Recherche Scientifique (CNRS), Institut Medicale de la Recherche Scientifique (INSERM) and the Institut Pasteur de Lille (IPL) and Laboratoire d'Excellence (LabEx) ParaFrap from the National Agency for Research [PIA, ANR-11-LABX-0024] to ST. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Callebaut I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-100; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Dzierszinski F, 1999, J BIOL CHEM, V274, P24888, DOI 10.1074/jbc.274.35.24888; Dzierszinski F, 2001, J MOL BIOL, V309, P1017, DOI 10.1006/jmbi.2001.4730; Fauquenoy S, 2008, MOL CELL PROTEOMICS, V7, P891, DOI 10.1074/mcp.M700391-MCP200; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Frenal K, 2006, BIOCHEMISTRY-US, V45, P4867, DOI 10.1021/bi051948e; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Hakimi MA, 2007, CURR OPIN MICROBIOL, V10, P357, DOI 10.1016/j.mib.2007.07.005; Holmes M, 2010, MICROBES INFECT, V12, P19, DOI 10.1016/j.micinf.2009.09.010; Hutson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014057; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kim K, 2008, MICROBES INFECT, V10, P978, DOI 10.1016/j.micinf.2008.07.015; Knoll LJ, 1998, MOL CELL BIOL, V18, P807, DOI 10.1128/MCB.18.2.807; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Manger ID, 1998, INFECT IMMUN, V66, P1632, DOI 10.1128/IAI.66.4.1632-1637.1998; Meissner M, 2005, MICROBES INFECT, V7, P1376, DOI 10.1016/j.micinf.2005.04.019; Mercier C, 1996, MOL MICROBIOL, V21, P421, DOI 10.1046/j.1365-2958.1996.6501361.x; Olguin-Lamas A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001328; PARMLEY SF, 1994, MOL BIOCHEM PARASIT, V66, P283, DOI 10.1016/0166-6851(94)90155-4; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; SOLDATI D, 1995, MOL CELL BIOL, V15, P87, DOI 10.1128/MCB.15.1.87; Starnes GL, 2009, CELL HOST MICROBE, V5, P353, DOI 10.1016/j.chom.2009.03.005; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Templeton TJ, 2004, GENOME RES, V14, P1686, DOI 10.1101/gr.2615304; Tomavo S, 2001, INT J PARASITOL, V31, P1023, DOI 10.1016/S0020-7519(01)00193-X; TOMAVO S, 1991, INFECT IMMUN, V59, P3750, DOI 10.1128/IAI.59.10.3750-3753.1991; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; Vanchinathan P, 2005, INFECT IMMUN, V73, P6680, DOI 10.1128/IAI.73.10.6680-6688.2005; Walker R, 2013, J BIOL CHEM, V288, P31127, DOI 10.1074/jbc.M113.486589; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	44	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105820	10.1371/journal.pone.0105820	http://dx.doi.org/10.1371/journal.pone.0105820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153525	Green Published, Green Submitted, gold			2022-12-27	WOS:000340952200083
J	Burkhardt, J; Blume, M; Petit-Teixeira, E; Teixeira, VH; Steiner, A; Quente, E; Wolfram, G; Scholz, M; Pierlot, C; Migliorini, P; Bombardieri, S; Balsa, A; Westhovens, R; Barrera, P; Radstake, TRDJ; Alves, H; Bardin, T; Prum, B; Emmrich, F; Cornelis, F; Ahnert, P; Kirsten, H				Burkhardt, Jana; Blume, Mechthild; Petit-Teixeira, Elisabeth; Teixeira, Vitor Hugo; Steiner, Anke; Quente, Elfi; Wolfram, Grit; Scholz, Markus; Pierlot, Celine; Migliorini, Paola; Bombardieri, Stefano; Balsa, Alejandro; Westhovens, Rene; Barrera, Pilar; Radstake, Timothy R. D. J.; Alves, Helena; Bardin, Thomas; Prum, Bernard; Emmrich, Frank; Cornelis, Francois; Ahnert, Peter; Kirsten, Holger			Cellular Adhesion Gene SELP Is Associated with Rheumatoid Arthritis and Displays Differential Allelic Expression	PLOS ONE			English	Article							SOLUBLE P-SELECTIN; GENOME-WIDE ASSOCIATION; MULTIPLE-SCLEROSIS; LINKAGE DISEQUILIBRIUM; MYOCARDIAL-INFARCTION; PTPN11 MUTATIONS; RISK; MOLECULES; DISEASES; EVENTS	In rheumatoid arthritis (RA), a key event is infiltration of inflammatory immune cells into the synovial lining, possibly aggravated by dysregulation of cellular adhesion molecules. Therefore, single nucleotide polymorphisms of 14 genes involved in cellular adhesion processes (CAST, ITGA4, ITGB1, ITGB2, PECAM1, PTEN, PTPN11, PTPRC, PXN, SELE, SELP, SRC, TYK2, and VCAM1) were analyzed for association with RA. Association analysis was performed consecutively in three European RA family sample groups (N-families = 407). Additionally, we investigated differential allelic expression, a possible functional consequence of genetic variants. SELP (selectin P, CD62P) SNP-allele rs6136-T was associated with risk for RA in two RA family sample groups as well as in global analysis of all three groups (p(total) = 0.003). This allele was also expressed preferentially (p<10(-6)) with a two- fold average increase in regulated samples. Differential expression is supported by data from Genevar MuTHER (p(1) = 0.004; p(2) = 0.0177). Evidence for influence of rs6136 on transcription factor binding was also found in silico and in public datasets reporting in vitro data. In summary, we found SELP rs6136-T to be associated with RA and with increased expression of SELP mRNA. SELP is located on the surface of endothelial cells and crucial for recruitment, adhesion, and migration of inflammatory cells into the joint. Genetically determined increased SELP expression levels might thus be a novel additional risk factor for RA.	[Burkhardt, Jana; Wolfram, Grit; Emmrich, Frank] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Blume, Mechthild; Steiner, Anke; Emmrich, Frank] Univ Leipzig, Inst Clin Immunol & Tranfus Med IKIT, D-04109 Leipzig, Germany; [Petit-Teixeira, Elisabeth; Pierlot, Celine] Univ Evry Val Essonne, Genhotel EA 3886, Evry, France; [Teixeira, Vitor Hugo] UCL, Ctr Resp Res, London, England; [Quente, Elfi; Emmrich, Frank; Kirsten, Holger] Fraunhofer Inst Celltherapy & Immunol IZI, Leipzig, Germany; [Scholz, Markus; Ahnert, Peter; Kirsten, Holger] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Migliorini, Paola; Bombardieri, Stefano] Univ Pisa, Pisa, Italy; [Balsa, Alejandro] La Paz Hosp, Madrid, Spain; [Westhovens, Rene] Rheumatol KU Leuven, Leuven, Belgium; [Barrera, Pilar] Univ Nijmegen, Nijmegen, Netherlands; [Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Alves, Helena] Porto San Joao Hosp, Oporto, Portugal; [Bardin, Thomas] Lariboisiere Hosp, Fed Rhumatol, Paris, France; [Prum, Bernard] Univ Evry Val Essonne, Lab Stat & Genome, Evry, France; [Cornelis, Francois] Univ Auvergne, GenHotel Auvergne, Clermont Ferrand, France; [Ahnert, Peter; Kirsten, Holger] Univ Leipzig, IMISE, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Fraunhofer Gesellschaft; Leipzig University; University of Pisa; Hospital Universitario La Paz; KU Leuven; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Sao Joao Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Universite Clermont Auvergne (UCA); Leipzig University	Burkhardt, J (corresponding author), Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany.	jana.burkhardt@trm.uni-leipzig.de	Migliorini, Paola/P-6176-2015; Balsa, Alejandro/ABF-6456-2020; Ahnert, Peter/I-8150-2015; Kirsten, Holger/AAP-7250-2020	Migliorini, Paola/0000-0001-6433-4964; Ahnert, Peter/0000-0002-1771-0856; Kirsten, Holger/0000-0002-3126-7950; Bardin, Thomas/0000-0002-5080-4790; Burkhardt, Jana/0000-0003-0781-2653; Elisabeth, PETIT-TEIXEIRA/0000-0001-9724-3575; Alves, Helena/0000-0001-5435-0047	German Federal Ministry of Education and Research (BMBF, PtJ-Bio) [1315883]; Sachsische Aufbaubank-Forderbank [7692/1187]; European Fund for Regional Development (EFRE) [4212/04-04]; German Federal Ministry for Education and Research (Hochschul- und Wissenschaftsprogramm; "Kompetenznetz Rheuma") [01GI9949]; Rosa-Luxemburg-Stiftung; Foundation for Science and Technology, Portugal [SFRH/BD/23304/2005]; LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony	German Federal Ministry of Education and Research (BMBF, PtJ-Bio)(Federal Ministry of Education & Research (BMBF)); Sachsische Aufbaubank-Forderbank; European Fund for Regional Development (EFRE)(European Commission); German Federal Ministry for Education and Research (Hochschul- und Wissenschaftsprogramm; "Kompetenznetz Rheuma"); Rosa-Luxemburg-Stiftung; Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology); LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 1315883, www.bmbf.de). This project was also supported by grant no. 7692/1187 from the Sachsische Aufbaubank-Forderbank (www.sab.sachsen.de), by grant no. 4212/04-04 from the European Fund for Regional Development (EFRE, ec.europa.eu), by the German Federal Ministry for Education and Research (Hochschul- und Wissenschaftsprogramm; "Kompetenznetz Rheuma" 01GI9949 to IM), by the Rosa-Luxemburg-Stiftung (www.rosalux.de) and by the Foundation for Science and Technology, Portugal (grant SFRH/BD/23304/2005, www.fct.pt). PA, MS and HK were also supported by LIFE - Leipzig Research Center for Civilization Diseases (life.uni-leipzig.de), Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel L, 1998, AM J HUM GENET, V63, P664, DOI 10.1086/301975; ANTOUN GR, 1991, LEUKEMIA RES, V15, P1029, DOI 10.1016/0145-2126(91)90108-6; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ay C, 2008, THROMB HAEMOSTASIS, V99, P899, DOI 10.1160/TH07-11-0672; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burkhardt J, 2009, J RHEUMATOL, V36, P2149, DOI 10.3899/jrheum.090059; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cobankara V, 2004, CLIN RHEUMATOL, V23, P430, DOI 10.1007/s10067-004-0915-6; Conde L, 2004, NUCLEIC ACIDS RES, V32, pW242, DOI 10.1093/nar/gkh438; Davis LS, 2003, AM J PATHOL, V162, P1399, DOI 10.1016/S0002-9440(10)64272-1; Diogo D, 2014, CURR OPIN RHEUMATOL, V26, P85, DOI 10.1097/BOR.0000000000000012; Elrayess MA, 2004, ATHEROSCLEROSIS, V177, P127, DOI 10.1016/j.atherosclerosis.2004.06.009; Ertenli I, 1998, J RHEUMATOL, V25, P1054; Fortea JOY, 2004, ARTHRITIS RHEUM-US, V50, P2757, DOI 10.1002/art.20458; Gasparyan AY, 2011, RHEUMATOL INT, V31, P153, DOI 10.1007/s00296-010-1446-x; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; GROBER JS, 1993, J CLIN INVEST, V91, P2609, DOI 10.1172/JCI116500; Herrmann SM, 1998, HUM MOL GENET, V7, P1277, DOI 10.1093/hmg/7.8.1277; Hillis GS, 2002, AM HEART J, V143, P235, DOI 10.1067/mhj.2002.120303; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ilgner S., 2002, Cellular and Molecular Biology Online Papers, V48, pOL243; Ingley E, 2006, GROWTH FACTORS, V24, P89, DOI 10.1080/08977190500368031; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishihara H, 2003, FEBS LETT, V554, P450, DOI 10.1016/S0014-5793(03)01225-0; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; Jacq L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2221; Kaila N, 2007, J MED CHEM, V50, P21, DOI 10.1021/jm0602256; Kee F, 2000, HEART, V84, P548, DOI 10.1136/heart.84.5.548; Kirsten H, 2006, BIOTECHNIQUES, V40, P158, DOI 10.2144/000112115; Kozma GT, 2010, EXP HEMATOL, V38, P489, DOI 10.1016/j.exphem.2010.03.006; Lally F, 2005, ARTHRITIS RHEUM-US, V52, P3460, DOI 10.1002/art.21394; Lee DS, 2008, J THROMB HAEMOST, V6, P20; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Littler AJ, 1997, BRIT J RHEUMATOL, V36, P164; Lowin T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3464; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Makarov SS, 2001, ARTHRITIS RES, V3, P200, DOI 10.1186/ar300; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; MIMORI T, 1995, P NATL ACAD SCI USA, V92, P7267, DOI 10.1073/pnas.92.16.7267; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nasonov EL, 1999, TERAPEVT ARKH, V71, P17; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Rachlin J, 2005, NUCLEIC ACIDS RES, V33, pW544, DOI 10.1093/nar/gki377; Ridker PM, 2001, CIRCULATION, V103, P491, DOI 10.1161/01.CIR.103.4.491; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Roos D, 2001, BLOOD CELL MOL DIS, V27, P1000, DOI 10.1006/bcmd.2001.0473; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Schmitt-Sody M, 2007, PLATELETS, V18, P365, DOI 10.1080/09537100701191315; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sfikakis PP, 1999, CLIN RHEUMATOL, V18, P28, DOI 10.1007/s100670050047; Sidiropoulos PI, 2008, ANN RHEUM DIS, V67, P1382, DOI 10.1136/ard.2007.078014; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Teixeira VH, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2654; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; Turesson C, 2004, ANN RHEUM DIS, V63, P952, DOI 10.1136/ard.2003.018101; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; Vogel A, 2003, GENES IMMUN, V4, P79, DOI 10.1038/sj.gene.6363918; Wenzel T, 2003, NUCLEOS NUCLEOT NUCL, V22, P1579, DOI 10.1081/NCN-120023038; Yamada KM, 2001, J CELL SCI, V114, P2375	67	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e103872	10.1371/journal.pone.0103872	http://dx.doi.org/10.1371/journal.pone.0103872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147926	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600006
J	Nordenvall, R; Bahmanyar, S; Adami, J; Mattila, VM; Fellander-Tsai, L				Nordenvall, Richard; Bahmanyar, Shahram; Adami, Johanna; Mattila, Ville M.; Fellander-Tsai, Li			Cruciate Ligament Reconstruction and Risk of Knee Osteoarthritis: The Association between Cruciate Ligament Injury and Post-Traumatic Osteoarthritis. A Population Based Nationwide Study in Sweden, 1987-2009	PLOS ONE			English	Article							UNITED-STATES; PREVALENCE; TEAR; BASKETBALL; ARTHRITIS; OUTCOMES; SOCCER; WOMEN; MEN	Objective: To study the association between Cruciate Ligament (CL) injury and development of post-traumatic osteoarthritis in the knee in patients treated operatively with CL reconstruction compared with patients treated non-operatively. Design: Population based cohort study; level of evidence II-2. Setting: Sweden, 1987-2009. Participants: All patients aged between 15-60 years being diagnosed and registered with a CL injury in The National Swedish Patient Register between 1987 and 2009. Main Outcome Measures: Knee osteoarthritis. Results: A total of 64,614 patients diagnosed with CL injury during 1987 to 2009 in Sweden were included in the study. Seven percent of the patients were diagnosed with knee OA in specialized healthcare during the follow-up (mean 9 years). Stratified analysis by follow-up showed that while those with shorter follow-up had a non-significant difference in risk (0.99, 95%CI 0.90-1.09 for follow-up less than five years compared with the non-operated cohort), those with longer follow-up had an increased risk of knee OA after CL reconstruction (HR = 1.42, 95%CI 1.27-1.58 for follow-up more than ten years compared with non-operated cohort). The risk to develop OA was not affected by sex. Conclusion: CL reconstructive surgery does not seem to have a protective effect on long term OA in either men or women.	[Nordenvall, Richard; Mattila, Ville M.; Fellander-Tsai, Li] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Orthoped & Biotechnol, Stockholm, Sweden; [Nordenvall, Richard; Mattila, Ville M.; Fellander-Tsai, Li] Karolinska Univ Hosp, Dept Orthoped, Stockholm, Sweden; [Bahmanyar, Shahram; Adami, Johanna] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Bahmanyar, Shahram] Karolinska Inst, Dept Med, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Bahmanyar, Shahram] Golestan Univ Med Sci, Fac Med, Gorgan, Iran; [Mattila, Ville M.] Tampere Univ Hosp, Dept Orthoped & Trauma Surg, Tampere, Finland	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Golestan University of Medical Sciences; Tampere University; Tampere University Hospital	Nordenvall, R (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Orthoped & Biotechnol, Stockholm, Sweden.	richard.nordenvall@ki.se	Adami, Johanna/AAA-3312-2021	Bahmanyar, Shahram/0000-0002-9205-6540; Fellander-Tsai, Li/0000-0003-0693-6080	Foundation of Martin Rind; Stockholm County Council; Karolinska Institutet	Foundation of Martin Rind; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This study was fully funded by the Foundation of Martin Rind and by research funds from the Stockholm County Council and Karolinska Institutet, http://ki.se/, http://www.martinrind.nu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriacchi TP, 2006, CURR OPIN RHEUMATOL, V18, P514, DOI 10.1097/01.bor.0000240365.16842.4e; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Bach BR, 1998, AM J SPORT MED, V26, P20, DOI 10.1177/03635465980260012101; Casteleyn PP, 1996, J BONE JOINT SURG BR, V78B, P446, DOI 10.1302/0301-620X.78B3.0780446; Chalmers PN, 2014, J BONE JOINT SURG AM, V96A, P292, DOI 10.2106/JBJS.L.01713; Claes S., 2012, KNEE SURG SPORTS TRA; Dahlberg LKP, 2009, INDIKATION MAGNETKAM; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Friel NA, 2013, CLIN SPORT MED, V32, P1, DOI 10.1016/j.csm.2012.08.017; Frobell RB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f232; Gwinn DE, 2000, AM J SPORT MED, V28, P98, DOI 10.1177/03635465000280012901; Jones JC, 2012, J ATHL TRAINING, V47, P67; Kim YM, 2011, AM J SPORT MED, V39, P425, DOI 10.1177/0363546510374452; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LINDENFELD TN, 1994, AM J SPORT MED, V22, P364, DOI 10.1177/036354659402200312; Louboutin H, 2009, KNEE, V16, P239, DOI 10.1016/j.knee.2008.11.004; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Maffulli N, 2009, NEW ENGL J MED, V360, P1463, DOI 10.1056/NEJMc082471; Messina DF, 1999, AM J SPORT MED, V27, P294, DOI 10.1177/03635465990270030401; Meuffels DE, 2009, BRIT J SPORT MED, V43, P347, DOI 10.1136/bjsm.2008.049403; Myklebust G, 1998, SCAND J MED SCI SPOR, V8, P149, DOI 10.1111/j.1600-0838.1998.tb00185.x; Neuman P, 2008, AM J SPORT MED, V36, P1717, DOI 10.1177/0363546508316770; Niu J, 2009, ARTHRIT RHEUM-ARTHR, V61, P329, DOI 10.1002/art.24337; Nordenvall R, 2012, AM J SPORT MED, V40, P1808, DOI 10.1177/0363546512449306; NOYES FR, 1984, J BONE JOINT SURG AM, V66A, P344, DOI 10.2106/00004623-198466030-00005; Oiestad BE, 2009, AM J SPORT MED, V37, P1434, DOI 10.1177/0363546509338827; Programme National Malaria Control, 2010, ANN REPORT 2010; Reinhardt KR, 2010, ORTHOP CLIN N AM, V41, P249, DOI 10.1016/j.ocl.2009.12.009; Spindler KP, 2008, NEW ENGL J MED, V359, P2135, DOI 10.1056/NEJMcp0804745; Stevenson H, 1998, Iowa Orthop J, V18, P64; Swirtun LR, 2006, SCAND J MED SCI SPOR, V16, P441, DOI 10.1111/j.1600-0838.2005.00505.x; van der Hart Cor P, 2008, J Orthop Surg Res, V3, P24, DOI 10.1186/1749-799X-3-24; van Eck CF, 2010, ARTHROSCOPY, V26, pS2, DOI 10.1016/j.arthro.2010.03.005; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	36	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e104681	10.1371/journal.pone.0104681	http://dx.doi.org/10.1371/journal.pone.0104681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148530	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600017
J	Presley, SJ; Scheiner, SM; Willig, MR				Presley, Steven J.; Scheiner, Samuel M.; Willig, Michael R.			Evaluation of an Integrated Framework for Biodiversity with a New Metric for Functional Dispersion	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; BETA DIVERSITY; HILL NUMBERS; TREE; COMMUNITIES; SIMILARITY; ABUNDANCE; PATTERNS	Growing interest in understanding ecological patterns from phylogenetic and functional perspectives has driven the development of metrics that capture variation in evolutionary histories or ecological functions of species. Recently, an integrated framework based on Hill numbers was developed that measures three dimensions of biodiversity based on abundance, phylogeny and function of species. This framework is highly flexible, allowing comparison of those diversity dimensions, including different aspects of a single dimension and their integration into a single measure. The behavior of those metrics with regard to variation in data structure has not been explored in detail, yet is critical for ensuring an appropriate match between the concept and its measurement. We evaluated how each metric responds to particular data structures and developed a new metric for functional biodiversity. The phylogenetic metric is sensitive to variation in the topology of phylogenetic trees, including variation in the relative lengths of basal, internal and terminal branches. In contrast, the functional metric exhibited multiple shortcomings: (1) species that are functionally redundant contribute nothing to functional diversity and (2) a single highly distinct species causes functional diversity to approach the minimum possible value. We introduced an alternative, improved metric based on functional dispersion that solves both of these problems. In addition, the new metric exhibited more desirable behavior when based on multiple traits.	[Presley, Steven J.; Willig, Michael R.] Univ Connecticut, Ctr Environm Sci & Engn, Storrs, CT 06269 USA; [Presley, Steven J.; Willig, Michael R.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Scheiner, Samuel M.] Natl Sci Fdn, Div Environm Biol, Arlington, VA 22230 USA	University of Connecticut; University of Connecticut; National Science Foundation (NSF); NSF - Directorate for Biological Sciences (BIO); NSF - Division of Environmental Biology (DEB)	Presley, SJ (corresponding author), Univ Connecticut, Ctr Environm Sci & Engn, Storrs, CT 06269 USA.	steven.presley@uconn.edu	Scheiner, Samuel M./A-4320-2009; Presley, Steven/AAE-9189-2020	Scheiner, Samuel M./0000-0003-1677-9752; Presley, Steven/0000-0002-5987-0735	National Science Foundation [1050680, DEB-0620910, DEB-1239764]; International Institute of Tropical Forestry, Long-Term Ecological Research Program in the Luquillo Experimental Forest; Center for Environmental Sciences and Engineering at the University of Connecticut; Direct For Biological Sciences [1239764] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); International Institute of Tropical Forestry, Long-Term Ecological Research Program in the Luquillo Experimental Forest; Center for Environmental Sciences and Engineering at the University of Connecticut; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This manuscript was inspired by the participation of SJP and MRW in a distributed graduate seminar funded by a National Science Foundation grant (1050680) to S. Andelman and J. Parrish entitled "The Dimensions of Biodiversity Distributed Graduate Seminar.'' SJP and MRW were supported by grants from the National Science Foundation (DEB-0620910, DEB-1239764) to the Institute of Tropical Ecosystem Studies, University of Puerto Rico and the International Institute of Tropical Forestry as part of the Long-Term Ecological Research Program in the Luquillo Experimental Forest, and by the Center for Environmental Sciences and Engineering at the University of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chiu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100014; Chiu CH, 2014, ECOL MONOGR, V84, P21, DOI 10.1890/12-0960.1; Cisneros LM, 2014, J ANIM ECOL, V83, P1124, DOI 10.1111/1365-2656.12201; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; CURTIS JT, 1950, ECOLOGY, V31, P434, DOI 10.2307/1931497; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Faith DP, 1991, BIOL CONSERV, V61, P1; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; FURNAS GW, 1984, J CLASSIF, V1, P187, DOI 10.1007/BF01890123; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Pavoine S, 2010, ECOL MONOGR, V80, P485, DOI 10.1890/09-1290.1; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Scheiner SM, 2012, OIKOS, V121, P1191, DOI 10.1111/j.1600-0706.2012.20607.x; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Vellend Mark, 2011, P194; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wilson E.O., 1988, P3	31	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105818	10.1371/journal.pone.0105818	http://dx.doi.org/10.1371/journal.pone.0105818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25148103	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230600086
J	Song, DF; Zhu, MY; Gu, Q				Song, Da-Feng; Zhu, Mu-Yuan; Gu, Qing			Purification and Characterization of Plantaricin ZJ5, a New Bacteriocin Produced by Lactobacillus plantarum ZJ5	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CLASS-II BACTERIOCIN; EAT TURKEY BOLOGNA; LISTERIA-MONOCYTOGENES; COMBINING NISIN; PEPTIDES; DNA; AMPLIFICATION; SEQUENCE; STRAIN	The aim of this study is to investigate the antimicrobial potential of Lactobacillus plantarum ZJ5, a strain isolated from fermented mustard with a broad range of inhibitory activity against both Gram-positive and Gram-negative bacteria. Here we present the peptide plantaricin ZJ5 ( PZJ5), which is an extreme pH and heat-stable. However, it can be digested by pepsin and proteinase K. This peptide has strong activity against Staphylococcus aureus. PZJ5 has been purified using a multi-step process, including ammonium sulfate precipitation, cation-exchange chromatography, hydrophobic interactions and reverse-phase chromatography. The molecular mass of the peptide was found to be 2572.9 Da using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The primary structure of this peptide was determined using amino acid sequencing and DNA sequencing, and these analyses revealed that the DNA sequence translated as a 44-residue precursor containing a 22-amino-acid N-terminal extension that was of the double-glycine type. The bacteriocin sequence exhibited no homology with known bacteriocins when compared with those available in the database, indicating that it was a new class IId bacteriocin. PZJ5 from a food-borne strain may be useful as a promising probiotic candidate.	[Song, Da-Feng; Gu, Qing] Zhejiang Gongshang Univ, Dept Biotechnol, Key Lab Food Microbial Technol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Song, Da-Feng; Zhu, Mu-Yuan] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Gongshang University; Zhejiang University	Zhu, MY (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	myzhu@zju.edu.cn; guqing2002@hotmail.com			National Natural Science Foundation of China [31071513, 31271821]; Natural Science Foundation of Zhejiang Province [Z3110399, LY13C00002]; National High Technology Research and Development Program of China [2012AA022105B]; International Science and Technology Cooperation Program of China [2013DFA32330]; Scientific Research Project for the Education Department of Zhejiang Province, China [Y201120078]; key science and technology innovation team of Zhejiang Province [010R50032]; National Agricultural System Program of China [CARS-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); International Science and Technology Cooperation Program of China; Scientific Research Project for the Education Department of Zhejiang Province, China; key science and technology innovation team of Zhejiang Province; National Agricultural System Program of China	This project was supported by the National Natural Science Foundation of China (No. 31071513 and 31271821), the Natural Science Foundation of Zhejiang Province (No. Z3110399 and LY13C00002), the National High Technology Research and Development Program "863" Program) of China (2012AA022105B), the International Science and Technology Cooperation Program of China (2013DFA32330), the Scientific Research Project for the Education Department of Zhejiang Province, China (No. Y201120078), the key science and technology innovation team of Zhejiang Province (No. 010R50032), and National Agricultural System Program of China (CARS-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Aunpad R, 2007, CURR MICROBIOL, V55, P308, DOI 10.1007/s00284-006-0632-2; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Franke CM, 1999, J BIOL CHEM, V274, P8484, DOI 10.1074/jbc.274.13.8484; Franz CMAP, 2007, FEMS MICROBIOL REV, V31, P293, DOI 10.1111/j.1574-6976.2007.00064.x; GONZALEZ B, 1994, APPL ENVIRON MICROB, V60, P2158; Hata T, 2010, INT J FOOD MICROBIOL, V137, P94, DOI 10.1016/j.ijfoodmicro.2009.10.021; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; HENDERSON JT, 1992, ARCH BIOCHEM BIOPHYS, V295, P5, DOI 10.1016/0003-9861(92)90480-K; Izquierdo E, 2009, APPL ENVIRON MICROB, V75, P4273, DOI 10.1128/AEM.02772-08; JIMENEZDIAZ R, 1995, APPL ENVIRON MICROB, V61, P4459; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Kotake Y, 2008, BIOCHEMISTRY-US, V47, P2531, DOI 10.1021/bi702253n; Lee CH, 1997, FOOD CONTROL, V8, P259, DOI 10.1016/S0956-7135(97)00015-7; Miguel MAL, 2008, CURR MICROBIOL, V57, P429, DOI 10.1007/s00284-008-9224-7; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Maldonado A, 2003, APPL ENVIRON MICROB, V69, P383, DOI 10.1128/AEM.69.1.383-389.2003; Mangalassary S, 2007, J FOOD PROTECT, V70, P2503, DOI 10.4315/0362-028X-70.11.2503; Masuda Y, 2011, APPL ENVIRON MICROB, V77, P8164, DOI 10.1128/AEM.06348-11; Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005; Morisset D, 2004, APPL ENVIRON MICROB, V70, P4672, DOI 10.1128/AEM.70.8.4672-4680.2004; Naas H, 2013, POULTRY SCI, V92, P1930, DOI 10.3382/ps.2012-02141; Nes IF, 2000, BIOPOLYMERS, V55, P50, DOI 10.1002/1097-0282(2000)55:1<50::AID-BIP50>3.0.CO;2-3; Remiger A, 1999, J APPL MICROBIOL, V86, P1053, DOI 10.1046/j.1365-2672.1999.00792.x; Singer T, 2003, METH MOL B, V236, P241; Soomro A. H., 2002, Pakistan Journal of Nutrition, V1, P20; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; Tanganurat W, 2009, J BASIC MICROB, V49, P377, DOI 10.1002/jobm.200800185; Tosukhowong A, 2012, APPL ENVIRON MICROB, V78, P1619, DOI 10.1128/AEM.06891-11; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yamazaki K, 2005, APPL ENVIRON MICROB, V71, P554, DOI 10.1128/AEM.71.1.554-557.2005	33	64	70	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105549	10.1371/journal.pone.0105549	http://dx.doi.org/10.1371/journal.pone.0105549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147943	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230600054
J	Lentz, MR; Peterson, KL; Ibrahim, WG; Lee, DE; Sarlls, J; Lizak, MJ; Maric, D; Reid, WC; Hammoud, DA				Lentz, Margaret R.; Peterson, Kristin L.; Ibrahim, Wael G.; Lee, Dianne E.; Sarlls, Joelle; Lizak, Martin J.; Maric, Dragan; Reid, William C.; Hammoud, Dima A.			Diffusion Tensor and Volumetric Magnetic Resonance Measures as Biomarkers of Brain Damage in a Small Animal Model of HIV	PLOS ONE			English	Article							VIRUS-POSITIVE PATIENTS; APPEARING WHITE-MATTER; CORPUS-CALLOSUM; ANTIRETROVIRAL THERAPY; COGNITIVE IMPAIRMENT; ANTIOXIDANT ENZYMES; TRANSGENIC RAT; AXONAL DAMAGE; DEMENTIA; INJURY	Background: There are currently no widely accepted neuro-HIV small animal models. We wanted to validate the HIV-1 Transgenic rat (Tg) as an appropriate neuro-HIV model and then establish in vivo imaging biomarkers of neuropathology, within this model, using MR structural and diffusion tensor imaging (DTI). Methods: Young and middle-aged Tg and control rats were imaged using MRI. A subset of middle-aged animals underwent longitudinal repeat imaging six months later. Total brain volume (TBV), ventricular volume (VV) and parenchymal volume (PV = TBV-VV) were measured. Fractional anisotropy (FA) and mean diffusivity (MD) values of the corpus callosum (CC) were calculated from DTI data. Results: TBV and PV were smaller in Tg compared to control rats in young and middle-aged cohorts (p<0.0001). VV increased significantly (p = 0.005) over time in the longitudinal Tg cohort. There were lower FA (p<0.002) and higher MD (p<0.003) values in the CC of middle-aged Tg rats compared to age-matched controls. Longitudinally, MD significantly decreased over time in Tg rats (p<0.03) while it did not change significantly in the control cohort over the same period of time (p>0.05). Conclusions: We detected brain volume loss in the Tg rat, probably due to astrocytic dysfunction/loss, loss of structural/axonal matrix and striatal neuronal loss as suggested by immunofluorescence. Increased MD and decreased FA in the CC probably reflect microstructural differences between the Tg and Control rats which could include increased extracellular space between white matter tracts, demyelination and axonal degeneration, among other pathologies. We believe that the Tg rat is an adequate model of neuropathology in HIV and that volumetric MR and DTI measures can be potentially used as biomarkers of disease progression.	[Lentz, Margaret R.; Peterson, Kristin L.; Ibrahim, Wael G.; Lee, Dianne E.; Reid, William C.; Hammoud, Dima A.] NIH, Ctr Infect Dis Imaging CIDI Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Sarlls, Joelle] Natl Inst Child Hlth & Human Dev NICHD, NIH, Bethesda, MD USA; [Lizak, Martin J.] NINDS, Magnet Resonance Imaging Res Facil NMRF, NIH, Bethesda, MD 20892 USA; [Maric, Dragan] NINDS, DIR, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hammoud, DA (corresponding author), NIH, Ctr Infect Dis Imaging CIDI Radiol & Imaging Sci, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	hammoudd@cc.nih.gov	Hammoud, Dima A/C-2286-2015	Hammoud, Dima/0000-0001-7406-7871	Intramural National Institutes of Health program Center for Infectious Diseases Imaging, Radiology and Imaging Sciences, CC/NIAID; CLINICAL CENTER [ZIACL090037] Funding Source: NIH RePORTER	Intramural National Institutes of Health program Center for Infectious Diseases Imaging, Radiology and Imaging Sciences, CC/NIAID; CLINICAL CENTER	Funding provided by Intramural National Institutes of Health program Center for Infectious Diseases Imaging, Radiology and Imaging Sciences, CC/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Agrawal L, 2012, NEUROBIOL DIS, V45, P657, DOI 10.1016/j.nbd.2011.10.005; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alfahad TB, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0387-7; AYLWARD EH, 1993, NEUROLOGY, V43, P2099, DOI 10.1212/WNL.43.10.2099; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bemelmans AP, 2006, J NEUROSCI RES, V83, P50, DOI 10.1002/jnr.20704; Bieniasz PD, 2000, J VIROL, V74, P9868, DOI 10.1128/JVI.74.21.9868-9877.2000; Calabrese E, 2013, NEUROIMAGE, V71, P196, DOI 10.1016/j.neuroimage.2013.01.017; Cardenas VA, 2009, J NEUROVIROL, V15, P324, DOI 10.1080/13550280902973960; Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005; Chang LD, 2008, J NEUROIMMUNE PHARM, V3, P265, DOI 10.1007/s11481-008-9120-8; Chen YS, 2009, NEUROIMAGE, V47, P1154, DOI 10.1016/j.neuroimage.2009.04.030; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Filippi CG, 2001, AM J NEURORADIOL, V22, P277; Filippi M, 1998, J NEUROL SCI, V159, P94, DOI 10.1016/S0022-510X(98)00144-0; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hua X, 2013, NEUROIMAGE-CLIN, V3, P132, DOI 10.1016/j.nicl.2013.07.009; Jernigan TL, 2011, J NEUROVIROL, V17, P248, DOI 10.1007/s13365-011-0032-7; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996; Lerner A, 2013, WORLD NEUROSURG; Li MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059582; Louboutin JP, 2007, GENE THER, V14, P1650, DOI 10.1038/sj.gt.3303030; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Meisner F, 2008, NEUROPSYCHOPHARMACOL, V33, P2228, DOI 10.1038/sj.npp.1301615; Meulendyke KA, 2012, J NEUROIMMUNE PHARM, V7, P454, DOI 10.1007/s11481-011-9332-1; Moran LM, 2013, J NEUROIMMUNE PHARM, V8, P988, DOI 10.1007/s11481-013-9472-6; Moran LM, 2012, CURR HIV RES, V10, P415, DOI 10.2174/157016212802138788; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Naganawa S, 2003, EUR RADIOL, V13, P6, DOI 10.1007/s00330-002-1549-1; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Pfefferbaum A, 2009, AIDS, V23, P1977, DOI 10.1097/QAD.0b013e32832e77fe; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pierpaoli C., 2010, TORTOISE INTEGRATED; Ragin AB, 2004, AM J NEURORADIOL, V25, P195; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Schifitto G, 2007, NEUROLOGY, V69, P1314, DOI 10.1212/01.wnl.0000268487.78753.0f; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stebbins GT, 2007, JAIDS-J ACQ IMM DEF, V46, P564, DOI 10.1097/QAI.0b013e318159d807; Stout JC, 1998, ARCH NEUROL-CHICAGO, V55, P161, DOI 10.1001/archneur.55.2.161; Sullivan EV, 2010, DEV NEUROPSYCHOL, V35, P233, DOI 10.1080/87565641003689556; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Thurnher MM, 2005, AM J NEURORADIOL, V26, P2275; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Wright PW, 2012, AIDS, V26, P1501, DOI 10.1097/QAD.0b013e3283550bec; Wu Y, 2006, AM J NEURORADIOL, V27, P656; Ye F, 2005, STRATEGY ENHANCE TIS, P830	58	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105752	10.1371/journal.pone.0105752	http://dx.doi.org/10.1371/journal.pone.0105752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144656	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100117
J	Mathis, SE; Alberico, A; Nande, R; Neto, W; Lawrence, L; McCallister, DR; Denvir, J; Kimmey, GA; Mogul, M; Oakley, G; Denning, KL; Dougherty, T; Valluri, JV; Claudio, PP				Mathis, Sarah E.; Alberico, Anthony; Nande, Rounak; Neto, Walter; Lawrence, Logan; McCallister, Danielle R.; Denvir, James; Kimmey, Gerrit A.; Mogul, Mark; Oakley, Gerard, III; Denning, Krista L.; Dougherty, Thomas; Valluri, Jagan V.; Claudio, Pier Paolo			Chemo-Predictive Assay for Targeting Cancer Stem-Like Cells in Patients Affected by Brain Tumors	PLOS ONE			English	Article							INTRADURAL EXTRAMEDULLARY EPENDYMOMA; EX-VIVO CHEMOSENSITIVITY; SPINAL-CORD EPENDYMOMAS; OVARIAN-CANCER; CHEMORESPONSE ASSAY; ISOTHIOCYANATES; CHEMOTHERAPY; MECHANISM; SERIES	Administration of ineffective anticancer therapy is associated with unnecessary toxicity and development of resistant clones. Cancer stem-like cells (CSLCs) resist chemotherapy, thereby causing relapse of the disease. Thus, development of a test that identifies the most effective chemotherapy management offers great promise for individualized anticancer treatments. We have developed an ex vivo chemotherapy sensitivity assay (ChemoID), which measures the sensitivity of CSLCs as well as the bulk of tumor cells to a variety of chemotherapy agents. Two patients, a 21-year old male (patient 1) and a 5-month female (patient 2), affected by anaplastic WHO grade-III ependymoma were screened using the ChemoID assay. Patient 1 was found sensitive to the combination of irinotecan and bevacizumab, which resulted in a prolonged disease progression free period of 18 months. Following recurrence, the combination of various chemotherapy drugs was tested again with the ChemoID assay. We found that benzyl isothiocyanate (BITC) greatly increased the chemosensitivity of the ependymoma cells to the combination of irinotecan and bevacizumab. After patient 1 was treated for two months with irinotecan, bevacizumab and supplements of cruciferous vegetable extracts containing BITC, we observed over 50% tumoral regression in comparison with pre-ChemoID scan as evidenced by MRI. Patient 2 was found resistant to all treatments tested and following 6 cycles of vincristine, carboplatin, cyclophosphamide, etoposide, and cisplatin in various combinations, the tumor of this patient rapidly progressed and proton beam therapy was recommended. As expected animal studies conducted with patient derived xenografts treated with ChemoID screened drugs recapitulated the clinical observation. This assay demonstrates that patients with the same histological stage and grade of cancer may vary considerably in their clinical response, suggesting that ChemoID testing which measures the sensitivity of CSLCs as well as the bulk of tumor cells to a variety of chemotherapy agents could lead to more effective and personalized anticancer treatments in the future.	[Mathis, Sarah E.; Nande, Rounak; Neto, Walter; Lawrence, Logan; McCallister, Danielle R.; Denvir, James; Claudio, Pier Paolo] Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA; [Mathis, Sarah E.; Nande, Rounak; Neto, Walter; Lawrence, Logan; McCallister, Danielle R.; Denvir, James; Claudio, Pier Paolo] Marshall Univ, Translat Genom Res Inst, Huntington, WV USA; [Alberico, Anthony] Marshall Univ, Dept Neurosurg, Joan C Edwards Sch Med, Huntington, WV USA; [Kimmey, Gerrit A.] St Marys Hosp, Dept Med Oncol, Huntington, WV USA; [Mogul, Mark] Marshall Univ, Dept Pediat, Joan C Edwards Sch Med, Huntington, WV USA; [Oakley, Gerard, III; Denning, Krista L.; Dougherty, Thomas] Marshall Univ, Dept Pathol, Joan C Edwards Sch Med, Huntington, WV USA; [Valluri, Jagan V.] Marshall Univ, Dept Biol, Huntington, WV USA; [Claudio, Pier Paolo] Marshall Univ, Dept Surg, Joan C Edwards Sch Med, Huntington, WV USA	Marshall University; Marshall University; Marshall University; Marshall University; Marshall University; Marshall University; Marshall University	Claudio, PP (corresponding author), Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	claudiop@marshall.edu	Claudio, Pier Paolo/AAW-7282-2021	Claudio, Pier Paolo/0000-0001-7790-1622	National Center for Advancing Translational Sciences, National Institutes of Health through the National Center for Research Resources (NCRR) [UL1TR000117]; National Cancer Institute [5P20RR020180]; WV-INBRE [5P20RR016477]; Marshall University; Marshall University Department of Neuroscience; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477, P20RR020180] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health through the National Center for Research Resources (NCRR); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WV-INBRE; Marshall University; Marshall University Department of Neuroscience; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The present studies were supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1TR000117 from the National Center for Research Resources (NCRR), and 5P20RR020180 from the National Cancer Institute, WV-INBRE 5P20RR016477, and in part by a Marshall University Translational Award, and an award from the Marshall University Department of Neuroscience (to PPC). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of NCRR and NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimola P, 2010, DRUG NEWS PERSPECT, V23, P175, DOI 10.1358/dnp.2010.23.3.1489979; Ballard KS, 2010, INT J GYNECOL CANCER, V20, P561, DOI 10.1111/IGC.0b013e3181d320dd; Bouffet E, 1999, CHILD NERV SYST, V15, P563, DOI 10.1007/s003810050544; Breidenbach M, 2002, ANTI-CANCER DRUG, V13, P173, DOI 10.1097/00001813-200202000-00010; Brower Stacey L., 2008, V414, P57; Chamberlain MC, 2011, CURR NEUROL NEUROSCI, V11, P320, DOI 10.1007/s11910-011-0190-2; Chou PM, 1996, PEDIATR PATHOL LAB M, V16, P551, DOI 10.1080/107710496175499; COOPER IS, 1951, SURG GYNECOL OBSTET, V92, P183; Di Pasqua AJ, 2010, CHEM RES TOXICOL, V23, P1307, DOI 10.1021/tx100187f; Duffau H, 2000, SPINE, V25, P1993, DOI 10.1097/00007632-200008010-00021; Duncan John A. Iii, 1995, P493; Gallion H, 2006, INT J GYNECOL CANCER, V16, P194, DOI 10.1111/j.1525-1438.2006.00301.x; Hanbali F, 2002, NEUROSURGERY, V51, P1162, DOI 10.1097/00006123-200211000-00010; Herzog TJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.01.059; Huh WK, 2011, INT J GYNECOL CANCER, V21, P494, DOI 10.1097/IGC.0b013e31820c4cb5; Iunes EA, 2011, J NEUROSURG-SPINE, V14, P65, DOI 10.3171/2010.9.SPINE09963; Kelloff GJ, 1999, ANN NY ACAD SCI, V889, P1, DOI 10.1111/j.1749-6632.1999.tb08718.x; Kelly SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010035; Kleinhans R, 2012, MED BIOL ENG COMPUT, V50, P117, DOI 10.1007/s11517-011-0855-7; Kocak Z, 2004, J EXP CLIN CANC RES, V23, P201; Lamy E, 2011, DRUG METAB REV, V43, P387, DOI 10.3109/03602532.2011.569551; Lin YH, 2005, J NEURO-ONCOL, V71, P205, DOI 10.1007/s11060-004-1386-y; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; McCormick P C, 1990, Neurosurg Clin N Am, V1, P591; Merchant TE, 2002, ONCOLOGY-NY, V16, P629; Metellus P, 2008, CANCER, V113, P175, DOI 10.1002/cncr.23530; Mi LX, 2011, CHEM RES TOXICOL, V24, P1735, DOI 10.1021/tx2002806; Michalova E, 2008, Klin Onkol, V21, P93; Modena P, 2012, NEURO-ONCOLOGY, V14, P1346, DOI 10.1093/neuonc/nos245; Myatt N, 1997, ANTI-CANCER DRUG, V8, P756, DOI 10.1097/00001813-199709000-00004; Ness RB, 2002, ANTICANCER RES, V22, P1145; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Ochs RL, 2005, METH MOLEC MED, V110, P155; Pejavar S, 2012, J NEURO-ONCOL, V106, P367, DOI 10.1007/s11060-011-0671-9; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reni M, 2004, CANCER, V100, P1221, DOI 10.1002/cncr.20074; Reni M, 2007, CRIT REV ONCOL HEMAT, V63, P81, DOI 10.1016/j.critrevonc.2007.03.004; Rice SD, 2011, CANCER BIOL THER, V11, P196, DOI 10.4161/cbt.11.2.13701; Rice SD, 2010, ANTICANCER RES, V30, P2805; Song KW, 2009, CLIN ORTHOP SURG, V1, P74, DOI 10.4055/cios.2009.1.2.74; Suchy SL, 2011, CANCER BIOL THER, V11, P1059, DOI 10.4161/cbt.11.12.15710; Tsubouchi H, 2000, Hum Cell, V13, P203; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Vandertop WP, 2003, NEUROSURGERY, V53, P246, DOI 10.1227/01.NEU.0000072306.16102.BD; Wichmann G, 2009, ONKOLOGIE, V32, P264, DOI 10.1159/000209148; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Yu Yang, 2012, Front Biosci (Elite Ed), V4, P1528; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425	49	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105710	10.1371/journal.pone.0105710	http://dx.doi.org/10.1371/journal.pone.0105710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144312	Green Published, gold, Green Submitted			2022-12-27	WOS:000341106100113
J	Micucci, C; Orciari, S; Catalano, A				Micucci, Carla; Orciari, Silvia; Catalano, Alfonso			Hyperglycemia Promotes K-Ras-Induced Lung Tumorigenesis through BASCs Amplification	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; GLUCOSE; CANCER; CELL; EXPRESSION; RISK; OVEREXPRESSION; ADENOCARCINOMA; TRANSPORTERS; PATHOGENESIS	Oncogenic K-Ras represents the most common molecular change in human lung adenocarcinomas, the major histologic subtype of non-small cell lung cancer (NSCLC). The presence of K-Ras mutation is associated with a poor prognosis, but no effective treatment strategies are available for K-Ras -mutant NSCLC. Epidemiological studies report higher lung cancer mortality rates in patients with type 2 diabetes. Here, we use a mouse model of K-Ras-mediated lung cancer on a background of chronic hyperglycemia to determine whether elevated circulating glycemic levels could influence oncogenic K-Ras-mediated tumor development. Inducible oncogenic K-Ras mouse model was treated with subtoxic doses of streptozotocin (STZ) to induce chronic hyperglycemia. We observed increased tumor mass and higher grade of malignancy in STZ treated diabetic mice analyzed at 4, 12 and 24 weeks, suggesting that oncogenic K-Ras increased lung tumorigenesis in hyperglycemic condition. This promoting effect is achieved by expansion of tumor-initiating lung bronchio-alveolar stem cells (BASCs) in bronchio-alveolar duct junction, indicating a role of hyperglycemia in the activity of K-Ras-transformed putative lung stem cells. Notably, after oncogene K-Ras activation, BASCs show upregulation of the glucose transporter (Glut1/Slc2a1), considered as an important player of the active control of tumor cell metabolism by oncogenic K-Ras. Our novel findings suggest that anti-hyperglycemic drugs, such as metformin, may act as therapeutic agent to restrict lung neoplasia promotion and progression.	[Micucci, Carla; Orciari, Silvia; Catalano, Alfonso] Polytech Univ Marche, Sch Med, Dept Clin & Mol Sci, Ancona, Italy	Marche Polytechnic University	Micucci, C (corresponding author), Polytech Univ Marche, Sch Med, Dept Clin & Mol Sci, Ancona, Italy.	carlamicucci@libero.it			Italian Ministry of Research (Progetti di ricerca di interesse nazionale, PRIN) [20098FRBAK_002]; Italian Association for Cancer Research (AIRC) [6348]	Italian Ministry of Research (Progetti di ricerca di interesse nazionale, PRIN)(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	AC was supported by Italian Ministry of Research (Progetti di ricerca di interesse nazionale, PRIN, grant number 20098FRBAK_002) and Italian Association for Cancer Research (AIRC, grant number 6348-MFAG Regional Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrimi G, 2011, APPL ENVIRON MICROB, V77, P2239, DOI 10.1128/AEM.01703-10; [Anonymous], 2009, GLO J PHARM, V3, P81; Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Chia JSJ, 2013, DIABETES, V62, P2026, DOI 10.2337/db12-0625; de Geus-Oei LF, 2007, LUNG CANCER, V55, P79, DOI 10.1016/j.lungcan.2006.08.018; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Harris CC, 2004, WHO CLASSIFICATION T, P9; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hogan B, 1994, MANIPULATING MOUSE E; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim HJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/639469; Liadis N, 2005, MOL CELL BIOL, V25, P3620, DOI 10.1128/MCB.25.9.3620-3629.2005; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Maki Y, 2013, ONCOL REP, V29, P133, DOI 10.3892/or.2012.2087; Mori M, 1996, CANCER, V77, P665, DOI 10.1002/(SICI)1097-0142(19960215)77:4<665::AID-CNCR12>3.0.CO;2-Z; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Piatkiewicz P, 2011, ARCH IMMUNOL THER EX, V59, P215, DOI 10.1007/s00005-011-0119-0; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Reddy MA, 2013, SEMIN NEPHROL, V33, P341, DOI 10.1016/j.semnephrol.2013.05.006; Sasaki H, 2012, MOL MED REP, V5, P599, DOI 10.3892/mmr.2011.736; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shyamasundar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065945; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stopper H, 2003, CANCER LETT, V190, P151, DOI 10.1016/S0304-3835(02)00626-2; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Xu Z. X., 2010, GLOBAL J PHARM, V4, P111; Yamagishi S, 2008, MED HYPOTHESES, V71, P259, DOI 10.1016/j.mehy.2008.03.020; Yamagishi S, 2005, MED HYPOTHESES, V64, P1208, DOI 10.1016/j.mehy.2005.01.015; Yang Y, 2008, PLOS ONE, V21; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	36	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105550	10.1371/journal.pone.0105550	http://dx.doi.org/10.1371/journal.pone.0105550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144301	Green Submitted, Green Published, gold			2022-12-27	WOS:000341106100083
J	Miyagawa, S; Mihashi, T; Kanda, H; Hirohara, Y; Endo, T; Morimoto, T; Miyoshi, T; Fujikado, T				Miyagawa, Suguru; Mihashi, Toshifumi; Kanda, Hiroyuki; Hirohara, Yoko; Endo, Takao; Morimoto, Takeshi; Miyoshi, Tomomitsu; Fujikado, Takashi			Asymmetric Wavefront Aberrations and Pupillary Shapes Induced by Electrical Stimulation of Ciliary Nerve in Cats Measured with Compact Wavefront Aberrometer	PLOS ONE			English	Article							MONOCHROMATIC ABERRATIONS; SUPERIOR COLLICULUS; LENS ACCOMMODATION; IMAGE QUALITY; MICROSTIMULATION; EYE; MOVEMENTS; GANGLION	To investigate the changes in the wavefront aberrations and pupillary shape in response to electrical stimulation of the branches of the ciliary nerves in cats. Seven eyes of seven cats were studied under general anesthesia. Trains of monophasic pulses (current, 0.1 to 1.0 mA; duration, 0.5 ms/phase; frequency, 5 to 40 Hz) were applied to the lateral or medial branch of the short ciliary nerve near the posterior pole of the eye. A pair of electrodes was hooked onto one or both branch of the short ciliary nerve. The electrodes were placed about 5 mm from the scleral surface. The wavefront aberrations were recorded continuously for 2 seconds before, 8 seconds during, and for 20 seconds after the electrical stimulation. The pupillary images were simultaneously recorded during the stimulation period. Both the wavefront aberrations and the pupillary images were obtained 10 times/sec with a custom-built wavefront aberrometer. The maximum accommodative amplitude was 1.19 diopters (D) produced by electrical stimulation of the short ciliary nerves. The latency of the accommodative changes was very short, and the accommodative level gradually increased up to 4 seconds and reached a plateau. When only one branch of the ciliary nerve was stimulated, the pupil dilated asymmetrically, and the oblique astigmatism and one of the asymmetrical wavefront terms was also altered. Our results showed that the wavefront aberrations and pupillary dilations can be measured simultaneously and serially with a compact wavefront aberrometer. The asymmetric pupil dilation and asymmetric changes of the wavefront aberrations suggest that each branch of the ciliary nerve innervates specific segments of the ciliary muscle and dilator muscle of the pupil.	[Miyagawa, Suguru; Kanda, Hiroyuki; Hirohara, Yoko; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan; [Miyagawa, Suguru; Hirohara, Yoko] Topcon Corp, Res Inst, Itabashi Ku, Tokyo, Japan; [Mihashi, Toshifumi] Tokyo Inst Technol, Innovat Res Initiat, Yokohama, Kanagawa 227, Japan; [Endo, Takao; Morimoto, Takeshi] Osaka Univ, Grad Sch Med, Dept Opthalmol, Suita, Osaka, Japan; [Miyoshi, Tomomitsu] Osaka Univ, Grad Sch Med, Dept Integrat Physiol, Suita, Osaka, Japan	Osaka University; Topcon Corporation; Tokyo Institute of Technology; Osaka University; Osaka University	Fujikado, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan.	fujikado@ophthal.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25670730]; Health Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan [H24-medical device-004]; Grants-in-Aid for Scientific Research [25670730] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (25670730) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by Health Sciences Research Grants (H24-medical device-004) from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHE JH, 1978, EXP NEUROL, V59, P413, DOI 10.1016/0014-4886(78)90233-9; ATCHISON DA, 1995, VISION RES, V35, P313, DOI 10.1016/0042-6989(94)00139-D; BANDO T, 1992, NEUROSCI RES, V15, P162, DOI 10.1016/0168-0102(92)90002-T; BANDO T, 1981, BRAIN RES, V213, P201, DOI 10.1016/0006-8993(81)91262-2; BELL RA, 1978, ARCH OPHTHALMOL-CHIC, V96, P638; Bharadwaj SR, 2005, VISION RES, V45, P17, DOI 10.1016/j.visres.2004.07.040; Bhatt UK, 2013, J CATARACT REFR SURG, V39, P36, DOI 10.1016/j.jcrs.2012.08.052; BLOOM M, 1977, VISION RES, V17, P723, DOI 10.1016/S0042-6989(77)80010-2; Cheng H, 2004, J VISION, V4, P272, DOI 10.1167/4.4.3; Christensen K, 1936, J ANAT, V70, P225; Dearworth JR, 2009, VISUAL NEUROSCI, V26, P309, DOI 10.1017/S0952523809090099; He JC, 2000, VISION RES, V40, P41, DOI 10.1016/S0042-6989(99)00156-X; HOSOBA M, 1978, BRAIN RES, V153, P495, DOI 10.1016/0006-8993(78)90334-7; Huxlin KR, 2004, VISION RES, V44, P2159, DOI 10.1016/j.visres.2004.03.017; Konno S, 1997, JPN J OPHTHALMOL, V41, P43, DOI 10.1016/S0021-5155(96)00010-X; KUCHIIWA S, 1990, ANAT EMBRYOL, V181, P299; KUCHIIWA S, 1989, ANAT EMBRYOL, V180, P199, DOI 10.1007/BF00309772; Liang JZ, 1997, J OPT SOC AM A, V14, P2873, DOI 10.1364/JOSAA.14.002873; MARG E, 1954, Am J Optom Arch Am Acad Optom, V31, P127; Netser S, 2010, J NEUROPHYSIOL, V104, P108, DOI 10.1152/jn.01142.2009; Ninomiya S, 2002, AM J OPHTHALMOL, V134, P924, DOI 10.1016/S0002-9394(02)01856-1; ONEILL WD, 1970, VISION RES, V10, P375, DOI 10.1016/0042-6989(70)90118-5; Ostrin LA, 2007, EXP EYE RES, V84, P302, DOI 10.1016/j.exer.2006.10.003; Porter J, 2001, J OPT SOC AM A, V18, P1793, DOI 10.1364/JOSAA.18.001793; Ramamirtham R, 2007, VISION RES, V47, P2751, DOI 10.1016/j.visres.2007.07.014; RIPPS H, 1961, Trans Am Ophthalmol Soc, V59, P176; Ripps H, 1965, AM J PHYSIOL, V203, P857; SAWA M, 1994, VISION RES, V34, P975, DOI 10.1016/0042-6989(94)90001-9; TERDIMAN J, 1969, BRAIN RES, V16, P288, DOI 10.1016/0006-8993(69)90105-X; THIBOS LN, 1990, VISION RES, V30, P33, DOI 10.1016/0042-6989(90)90126-6; Thibos LN, 2002, J REFRACT SURG, V18, pS652; Thibos LN, 2002, J OPT SOC AM A, V19, P2329, DOI 10.1364/JOSAA.19.002329; Vilupuru AS, 2002, VISION RES, V42, P125, DOI 10.1016/S0042-6989(01)00260-7; Wang CA, 2012, J NEUROSCI, V32, P3629, DOI 10.1523/JNEUROSCI.5512-11.2012; WATANABE T, 1990, JPN J APPL PHYS 1, V29, P445, DOI 10.1143/JJAP.29.445	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105615	10.1371/journal.pone.0105615	http://dx.doi.org/10.1371/journal.pone.0105615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144536	Green Published, Green Submitted, gold			2022-12-27	WOS:000341106100096
J	Pollux, PMJ; Hall, S; Guo, K				Pollux, Petra M. J.; Hall, Sophie; Guo, Kun			Facial Expression Training Optimises Viewing Strategy in Children and Adults	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; CONFIGURAL INFORMATION; DEVELOPMENTAL-CHANGES; EMOTION RECOGNITION; FACE RECOGNITION; PERCEPTION; INVERSION; CHILDHOOD; BEHAVIOR; SKILLS	This study investigated whether training-related improvements in facial expression categorization are facilitated by spontaneous changes in gaze behaviour in adults and nine-year old children. Four sessions of a self-paced, free-viewing training task required participants to categorize happy, sad and fear expressions with varying intensities. No instructions about eye movements were given. Eye-movements were recorded in the first and fourth training session. New faces were introduced in session four to establish transfer-effects of learning. Adults focused most on the eyes in all sessions and increased expression categorization accuracy after training coincided with a strengthening of this eye-bias in gaze allocation. In children, training-related behavioural improvements coincided with an overall shift in gaze-focus towards the eyes (resulting in more adult-like gaze-distributions) and towards the mouth for happy faces in the second fixation. Gaze-distributions were not influenced by the expression intensity or by the introduction of new faces. It was proposed that training enhanced the use of a uniform, predominantly eyes-biased, gaze strategy in children in order to optimise extraction of relevant cues for discrimination between subtle facial expressions.	[Pollux, Petra M. J.; Guo, Kun] Lincoln Univ, Sch Psychol, Lincoln, Lincs, England; [Hall, Sophie] Lincoln Univ, Sch Life Sci, Lincoln, Lincs, England	University of Lincoln; University of Lincoln	Pollux, PMJ (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, Lincs, England.	ppollux@lincoln.ac.uk		Pollux, Petra/0000-0001-7107-0848; Guo, Kun/0000-0001-6765-1957; Hall, Sophie/0000-0002-9847-8269	University of Lincoln	University of Lincoln	This study was supported by internal funds of the University of Lincoln. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Calder AJ, 2005, VIS COGN, V12, P495, DOI 10.1080/13506280444000418; CAREY S, 1977, SCIENCE, V195, P312, DOI 10.1126/science.831281; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; Carton JS, 1999, J NONVERBAL BEHAV, V23, P91, DOI 10.1023/A:1021339410262; Combs DR, 2011, SCHIZOPHR RES, V127, P151, DOI 10.1016/j.schres.2010.05.011; COSTANZO M, 1992, J EDUC PSYCHOL, V84, P308, DOI 10.1037/0022-0663.84.3.308; Dadds MR, 2012, PSYCHIAT RES, V199, P201, DOI 10.1016/j.psychres.2012.04.033; Durand K, 2007, J EXP CHILD PSYCHOL, V97, P14, DOI 10.1016/j.jecp.2006.12.001; Dwyer DM, 2009, VIS COGN, V17, P334, DOI 10.1080/13506280701757577; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; Elfenbein HA, 2006, J NONVERBAL BEHAV, V30, P21, DOI 10.1007/s10919-005-0002-y; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Grinspan D, 2003, J GENET PSYCHOL, V164, P88, DOI 10.1080/00221320309597505; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Heisz JJ, 2008, J VISION, V8, DOI 10.1167/8.1.9; Heron-Delaney M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019858; Izard C, 2001, PSYCHOL SCI, V12, P18, DOI 10.1111/1467-9280.00304; Izard C.E., 1971, FACE EMOTION; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Johnston PJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00026; Kohler CG, 2004, PSYCHIAT RES, V128, P235, DOI 10.1016/j.psychres.2004.07.003; Lundqvist D., 1998, KAROLINSKA DIRECTED; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McGugin RW, 2011, COGNITIVE SCI, V35, P330, DOI 10.1111/j.1551-6709.2010.01148.x; Mondloch CJ, 2003, J EXP CHILD PSYCHOL, V86, P67, DOI 10.1016/S0022-0965(03)00102-4; Naruse S, 2013, J MED INVESTIG, V60, P114, DOI 10.2152/jmi.60.114; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Palermo R, 2011, NEUROPSYCHOLOGIA, V49, P1226, DOI 10.1016/j.neuropsychologia.2011.02.021; Penton-Voak IS, 2013, PSYCHOL SCI, V24, P688, DOI 10.1177/0956797612459657; Pollak SD, 2009, COGNITION, V110, P242, DOI 10.1016/j.cognition.2008.10.010; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; van Belle G, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00020; Van Belle G, 2010, NEUROPSYCHOLOGIA, V48, P2620, DOI 10.1016/j.neuropsychologia.2010.04.034; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11; Widen SC, 2013, EMOT REV, V5, P72, DOI 10.1177/1754073912451492; Xiao WS, 2012, BEH DEV, V37, P100	43	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105418	10.1371/journal.pone.0105418	http://dx.doi.org/10.1371/journal.pone.0105418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WL	25144680	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000341106100067
J	Swati, S; Hayat, K; Shahid, Z				Swati, Salahuddin; Hayat, Khizar; Shahid, Zafar			A Watermarking Scheme for High Efficiency Video Coding (HEVC)	PLOS ONE			English	Article								This paper presents a high payload watermarking scheme for High Efficiency Video Coding (HEVC). HEVC is an emerging video compression standard that provides better compression performance as compared to its predecessor, i.e. H.264/AVC. Considering that HEVC may will be used in a variety of applications in the future, the proposed algorithm has a high potential of utilization in applications involving broadcast and hiding of metadata. The watermark is embedded into the Quantized Transform Coefficients (QTCs) during the encoding process. Later, during the decoding process, the embedded message can be detected and extracted completely. The experimental results show that the proposed algorithm does not significantly affect the video quality, nor does it escalate the bitrate.	[Swati, Salahuddin; Hayat, Khizar; Shahid, Zafar] COMSATS Inst Informat Technol, Abbottabad, Pakistan; [Hayat, Khizar] Univ Nizwa, Coll Arts & Sci, Nizwa, Oman	COMSATS University Islamabad (CUI); University of Nizwa	Hayat, K (corresponding author), COMSATS Inst Informat Technol, Abbottabad, Pakistan.	khizarhayat@ciit.net.pk	Hayat, Khizar/P-8954-2019	Shahid, Zafar/0000-0002-3759-1591; Hayat, Khizar/0000-0001-5216-6019; Din, Salah Ud/0000-0002-4145-7176				Alattar AM, 2003, IEEE T CIRC SYST VID, V13, P787, DOI 10.1109/TCSVT.2003.815958; Ayele EA, 2012, INT J COMPUTER APPL, V59, P1, DOI DOI 10.5120/9621-4265; Barni M, 2005, IEEE T MULTIMEDIA, V7, P23, DOI 10.1109/TMM.2004.840594; Bodo Y, 2004, EURASIP J APPL SIG P, V2004, P2224, DOI 10.1155/S1110865704401061; Boho A, 2013, IEEE SIGNAL PROC MAG, V30, P97, DOI 10.1109/MSP.2012.2230220; Bross B., 2012, HIGH EFFICIENCY VIDE; Cox I., 2001, DIGITAL WATERMARKING; Deshpande N, 2010, ABS10041770 CORR; Hartung F, 1998, SIGNAL PROCESS, V66, P283, DOI 10.1016/S0165-1684(98)00011-5; Kim SM, 2007, LECT NOTES COMPUT SC, V4633, P698; Langelaar GC, 2001, IEEE T IMAGE PROCESS, V10, P148, DOI 10.1109/83.892451; Liu Z, 2004, 2004 7TH INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING PROCEEDINGS, VOLS 1-3, P2358; Mansouri A, 2010, IEEE T INF FOREN SEC, V5, P649, DOI 10.1109/TIFS.2010.2076280; Mohaghegh N, 2008, 2008 INTERNATIONAL CONFERENCE ON AUDIO, LANGUAGE AND IMAGE PROCESSING, VOLS 1 AND 2, PROCEEDINGS, P1384, DOI 10.1109/ICALIP.2008.4590217; Nguyen CV, 2006, 2006 IEEE ASIA PACIFIC CONFERENCE ON CIRCUITS AND SYSTEMS, P81; Noorkami M, 2008, IEEE T INF FOREN SEC, V3, P441, DOI 10.1109/TIFS.2008.923825; Noorkami M, 2007, IEEE T INF FOREN SEC, V2, P14, DOI 10.1109/TIFS.2006.890306; Qiu G, 2004, INT C PATT RECOG, P865; Shahid Z, 2010, IEEE IMAGE PROC, P2105, DOI 10.1109/ICIP.2010.5652607; Shahid Z, 2011, SIGNAL IMAGE VIDEO P, V5; Sullivan GJ, 2012, IEEE T CIRC SYST VID, V22, P1649, DOI 10.1109/TCSVT.2012.2221191; Tardos G, 2003, P 35 ANN ACM S THEOR, P116, DOI DOI 10.1145/780542.780561; Xingguang Song, 2008, 2008 11th IEEE International Conference on Communication Technology (ICCT 2008), P738, DOI 10.1109/ICCT.2008.4716228; Xu DW, 2011, SIGNAL PROCESS-IMAGE, V26, P267, DOI 10.1016/j.image.2011.04.008; Zhang J, 2001, XIV BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P179, DOI 10.1109/SIBGRAPI.2001.963053; Zhang J, 2007, IEEE T CIRCUITS-II, V54, P205, DOI 10.1109/TCSII.2006.886247; Zou D, 2008, IEEE INT C AC SPEECH, V752	27	36	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105613	10.1371/journal.pone.0105613	http://dx.doi.org/10.1371/journal.pone.0105613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144455	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100095
J	Seo, J; Lee, BK; Jin, SU; Park, JW; Kim, YT; Ryeom, HK; Lee, J; Suh, KJ; Kim, SH; Park, SJ; Jeong, KS; Ham, JO; Kim, Y; Chang, Y				Seo, Jeehye; Lee, Byung-Kook; Jin, Seong-Uk; Park, Jang Woo; Kim, Yang-Tae; Ryeom, Hun-Kyu; Lee, Jongmin; Suh, Kyung Jin; Kim, Suk Hwan; Park, Sin-Jae; Jeong, Kyoung Sook; Ham, Jung-O; Kim, Yangho; Chang, Yongmin			Lead-Induced Impairments in the Neural Processes Related to Working Memory Function	PLOS ONE			English	Article							BLOOD LEAD; LONGITUDINAL DECLINE; COGNITIVE FUNCTION; NATIONAL-HEALTH; PARIETAL CORTEX; EXPOSURE; METAANALYSIS; ATTENTION; BRAIN; FMRI	Background: It is well known that lead exposure induces neurotoxic effects, which can result in a variety of neurocognitive dysfunction. Especially, occupational lead exposures in adults are associated with decreases in cognitive performance including working memory. Despite recent advances in human neuroimaging techniques, the neural correlates of lead-exposed cognitive impairment remain unclear. Therefore, this study was aimed to compare the neural activations in relation to working memory function between the lead-exposed subjects and healthy controls. Methodology/Principal Findings: Thirty-one lead-exposed subjects and 34 healthy subjects performed an n-back memory task during MRI scan. We performed fMRI using the 1-back and 2-back memory tasks differing in cognitive demand. Functional MRI data were analyzed using within-and between-group analysis. We found that the lead-exposed subjects showed poorer working memory performance during high memory loading task than the healthy subjects. In addition, between-group analyses revealed that the lead-exposed subjects showed reduced activation in the dorsolateral prefrontal cortex, ventrolateral prefrontal cortex, pre supplementary motor areas, and inferior parietal cortex. Conclusions/Significance: Our findings suggest that functional abnormalities in the frontoparietal working memory network might contribute to impairments in maintenance and manipulation of working memory in the lead-exposed subjects.	[Seo, Jeehye; Jin, Seong-Uk; Park, Jang Woo; Chang, Yongmin] Kyungpook Natl Univ, Dept Med & Biol Engn, Taegu, South Korea; [Lee, Byung-Kook] Korean Ind Hlth Assoc, Seoul, South Korea; [Kim, Yang-Tae] Keimyung Univ, Sch Med, Dept Psychiat, Taegu, South Korea; [Ryeom, Hun-Kyu; Lee, Jongmin; Chang, Yongmin] Kyungpook Natl Univ, Coll Med, Dept Radiol, Taegu, South Korea; [Suh, Kyung Jin] Dongguk Univ, Dept Radiol, Coll Med, Gyeongju, South Korea; [Kim, Suk Hwan; Kim, Yangho] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan 680749, South Korea; [Park, Sin-Jae] Univ Ulsan, Coll Med, Dept Psychiat, Ulsan Univ Hosp, Ulsan 680749, South Korea; [Jeong, Kyoung Sook] Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Coll Med, Goyang, South Korea; [Ham, Jung-O] Soonchunhyan Univ Hosp, Dept Occupat & Environm Med, Cheonan, South Korea; [Chang, Yongmin] Kyungpook Natl Univ, Coll Med, Dept Mol Med, Taegu, South Korea	Kyungpook National University; Keimyung University; Kyungpook National University; Dongguk University; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; Dongguk University; NHIS Ilsan Hospital; Kyungpook National University	Kim, Y (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan 680749, South Korea.	yanghokm@nuri.net; ychang@knu.ac.kr	Jeong, Kyoung Sook/AAI-6244-2021	Jeong, Kyoung Sook/0000-0002-6897-8289	Mid-career Researcher Program through NRF - MEST [2010-0004920]; Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092106]	Mid-career Researcher Program through NRF - MEST; Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported by Mid-career Researcher Program through NRF grant funded by the MEST (No. 2010-0004920). This study was also supported by a grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A092106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadin H, 2007, TOXICOLOGICAL PROFIL; Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; BAKER EL, 1984, BRIT J IND MED, V41, P352; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Benignus VA, 2005, ENVIRON HEALTH PERSP, V113, P532, DOI 10.1289/ehp.7518; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BLUMBERG WE, 1977, J LAB CLIN MED, V89, P712; Chein JM, 2003, J NEUROLINGUIST, V16, P315, DOI 10.1016/S0911-6044(03)00021-6; Fiedler N, 2003, AM J IND MED, V44, P413, DOI 10.1002/ajim.10287; Gidlow DA, 2004, OCCUP MED-OXFORD, V54, P76, DOI 10.1093/occmed/kqh019; Grajewski B, 2005, BIRTH DEFECTS RES B, V74, P157, DOI 10.1002/bdrb.20039; HEINEGAR.D, 1973, CLIN CHIM ACTA, V43, P305, DOI 10.1016/0009-8981(73)90466-X; Kennerley SW, 2004, J NEUROPHYSIOL, V91, P978, DOI 10.1152/jn.00651.2003; Khalil N, 2009, NEUROPSYCHOLOGY, V23, P10, DOI 10.1037/a0013757; Kim Y, 2012, ENVIRON RES, V118, P124, DOI 10.1016/j.envres.2012.06.003; Kneip T. J., 1988, METHODS BIOL MONITOR, P199; Kumar S, 2004, J OCCUP HEALTH, V46, P1, DOI 10.1539/joh.46.1; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Meyer-Baron M, 2000, ARCH TOXICOL, V73, P510, DOI 10.1007/s002040050002; Mikkelsen S, 1997, ENVIRON RES, V73, P101, DOI 10.1006/enrs.1997.3706; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DU, 2002, ANN OCCUP HYG, V46, P237, DOI 10.1093/annhyg/mef036; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; Pollmann S, 2000, EXP BRAIN RES, V133, P12, DOI 10.1007/s002210000396; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Sanders Talia, 2009, Reviews on Environmental Health, V24, P15; Schwartz BS, 2005, EPIDEMIOLOGY, V16, P106, DOI 10.1097/01.ede.0000147109.62324.51; Schwartz BS, 2000, NEUROLOGY, V55, P1144, DOI 10.1212/WNL.55.8.1144; Shih RA, 2006, NEUROLOGY, V67, P1556, DOI 10.1212/01.wnl.0000239836.26142.c5; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; THOMAS WJ, 1982, J PEDIATR-US, V101, P32, DOI 10.1016/S0022-3476(82)80175-3; Todd AC, 2001, OCCUP ENVIRON MED, V58, P73, DOI 10.1136/oem.58.2.73; TOMOKUNI K, 1992, IND HEALTH, V30, P119, DOI 10.2486/indhealth.30.119; Trope I, 2001, PEDIATRICS, V107, P1437, DOI 10.1542/peds.107.6.1437; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Weaver VM, 2003, OCCUP ENVIRON MED, V60, P551, DOI 10.1136/oem.60.8.551; Yuan WH, 2006, PEDIATRICS, V118, P971, DOI 10.1542/peds.2006-0467; [No title captured]	40	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105308	10.1371/journal.pone.0105308	http://dx.doi.org/10.1371/journal.pone.0105308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141213	Green Published, gold, Green Submitted			2022-12-27	WOS:000342687200070
J	Fan, WN; Zhang, SH; Du, HQ; Sun, XG; Shi, YH; Wang, CZ				Fan, Wenna; Zhang, Senhao; Du, Hongqi; Sun, Xiaoge; Shi, Yinghua; Wang, Chengzhang			Genome-Wide Identification of Different Dormant Medicago sativa L. MicroRNAs in Response to Fall Dormancy	PLOS ONE			English	Article							SMALL RNAS; ALFALFA VARIETIES; PLANT MICRORNAS; GENE-EXPRESSION; TRUNCATULA; PHYTOCHROME; PATHWAY; ROOTS; CARBOHYDRATE; ANNOTATION	Background: MicroRNAs (miRNAs) are a class of regulatory small RNAs (sRNAs) that regulate gene post-transcriptional expression in plants and animals. Highthroughput sequencing technology is capable of identifying small RNAs in plant species. Alfalfa (Medicago sativa L.) is one of the most widely cultivated perennial forage legumes worldwide, and fall dormancy is an adaptive characteristic related to the biomass production and winter survival in alfalfa. Here, we applied highthroughput sRNA sequencing to identify some miRNAs that were responsive to fall dormancy in standard variety (Maverick and CUF101) of alfalfa. Results: Four sRNA libraries were generated and sequenced from alfalfa leaves in two typical varieties at distinct seasons. Through integrative analysis, we identified 51 novel miRNA candidates of 206 families. Additionally, we identified 28 miRNAs associated with fall dormancy in standard variety (Maverick and CUF101), including 20 known miRNAs and eight novel miRNAs. Both high-throughput sequencing and RT-qPCR confirmed that eight known miRNA members were up-regulated and six known miRNA members were down-regulated in response to fall dormancy in standard variety (Maverick and CUF101). Among the 51 novel miRNA candidates, five miRNAs were up-regulated and three miRNAs were down-regulated in response to fall dormancy in standard variety (Maverick and CUF101), and five of them were confirmed by Northern blot analysis. Conclusion: We identified 20 known miRNAs and eight new miRNA candidates that were responsive to fall dormancy in standard variety (Maverick and CUF101) by high-throughput sequencing of small RNAs from Medicago sativa. Our data provide a useful resource for investigating miRNA-mediated regulatory mechanisms of fall dormancy in alfalfa, and these findings are important for our understanding of the roles played by miRNAs in the response of plants to abiotic stress in general and fall dormancy in alfalfa.	[Fan, Wenna; Zhang, Senhao; Du, Hongqi; Sun, Xiaoge; Shi, Yinghua; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China	Henan Agricultural University	Wang, CZ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	wangcz@henau.edu.cn		Zhang, Senhao/0000-0002-9231-9750	China Forage and Grass Research System [CARS-35]; National Natural Science Foundation of China [31172261]	China Forage and Grass Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by China Forage and Grass Research System (CARS-35) and the National Natural Science Foundation of China (No. 31172261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ariss JJ, 2007, CROP SCI, V47, P2274, DOI 10.2135/cropsci2006.12.0782; Arocho A, 2006, DIAGN MOL PATHOL, V15, P56, DOI 10.1097/00019606-200603000-00009; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BULA RJ, 1954, AGRON J, V46, P397, DOI 10.2134/agronj1954.00021962004600090001x; CASTONGUAY Y, 1995, CROP SCI, V35, P509, DOI 10.2135/cropsci1995.0011183X003500020038x; Chen L, 2012, PLANT SCI, V184, P14, DOI 10.1016/j.plantsci.2011.11.007; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cunningham SM, 2001, CROP SCI, V41, P1091, DOI 10.2135/cropsci2001.4141091x; Cunningham SM, 1998, J PLANT PHYSIOL, V153, P220, DOI 10.1016/S0176-1617(98)80069-2; Deng Y, 2013, STEM CELLS DEV, V22, P2278, DOI 10.1089/scd.2012.0686; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Du H, 2013, ACTA AGRESTIA SINICA, V21, P708; Fairey DT, 1996, CAN J PLANT SCI, V76, P429, DOI 10.4141/cjps96-076; Fan WenNa, 2014, Acta Prataculturae Sinica, V23, P177; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; HEINRICHS D. H., 1960, CANADIAN JOUR PLANT SCI, V40, P638; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Lacombe S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-123; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARSEN K. L., 1963, CROP SCI, V3, P234, DOI 10.2135/cropsci1963.0011183X000300030018x; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McKenzie J. S., 1988, Alfalfa and alfalfa improvement, P259; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Rimi F, 2014, AGRON J, V106, P1258, DOI 10.2134/agronj13.0495; Samac DA, 2006, CHEM IND-SER, V112, P79; Schneider M, 1984, UNIFOLIATE INTERNODE, P96; Schwab PM, 1996, CROP SCI, V36, P418, DOI 10.2135/cropsci1996.0011183X003600020034x; Sharma R, 2001, CURR SCI INDIA, V80, P178; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; SMITH D., 1961, Canadian Journal of Plant Science, V41, P244; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; STOUT DG, 1989, CAN J PLANT SCI, V69, P491, DOI 10.4141/cjps89-060; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Teuber L, 1998, FALL DORMANCY, P2; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Trinh TH, 1998, PLANT CELL REP, V17, P345, DOI 10.1007/s002990050405; Verdonk JC, 2013, BOTANY, V91, P117, DOI 10.1139/cjb-2012-0166; VOLENEC JJ, 1991, PLANT PHYSIOL, V96, P786, DOI 10.1104/pp.96.3.786; Wang CZ, 2008, J PLANT NUTR, V31, P1257, DOI 10.1080/01904160802135027; Wang CZ, 2009, AGRON J, V101, P1146, DOI 10.2134/agronj2009.0026; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang TZ, 2014, PLANT CELL, V18, P2051; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yifen C, 1990, PRATACULTURAL SCI, V7, P60; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	70	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114612	10.1371/journal.pone.0114612	http://dx.doi.org/10.1371/journal.pone.0114612			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473944	Green Published, gold, Green Submitted			2022-12-27	WOS:000346382500049
J	Shen, D; Mao, WD; Liu, T; Lin, QF; Lu, XD; Wang, Q; Lin, F; Ekelund, U; Wijndaele, K				Shen, Dong; Mao, Weidong; Liu, Tao; Lin, Qingfeng; Lu, Xiangdong; Wang, Qiong; Lin, Feng; Ekelund, Ulf; Wijndaele, Katrien			Sedentary Behavior and Incident Cancer: A Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							RECREATIONAL PHYSICAL-ACTIVITY; TELEVISION VIEWING TIME; ALL-CAUSE MORTALITY; NIH-AARP DIET; CARDIOVASCULAR-DISEASE; ENDOMETRIAL CANCER; BREAST-CANCER; SITTING TIME; RECTAL-CANCER; LARGE COHORT	Background: Sedentary behavior is ubiquitous in modern adults' daily lives and it has been suggested to be associated with incident cancer. However, the results have been inconsistent. In this study, we performed a systematic review and meta-analysis of prospective cohort studies to clarify the association between sedentary behavior and incident cancer. Method: PubMed and Embase databases were searched up to March 2014. All prospective cohort studies on the association between sedentary behavior and incident cancer were included. The summary relative risks (RRs) with 95% confidence intervals (CIs) were estimated using random effect model. Results: A total of 17 prospective studies from 14 articles, including a total of 857,581 participants and 18,553 cases, were included in the analysis for sedentary behavior and risk of incident cancer. The overall meta-analysis suggested that sedentary behavior increased risk of cancer (RR = 1.20, 95% CI = 1.12-1.28), with no evidence of heterogeneity between studies (I-2 = 7.3%, P = 0.368). Subgroup analyses demonstrated that there were statistical associations between sedentary behavior and some cancer types (endometrial cancer: RR = 1.28, 95% CI = 1.08-1.53; colorectal cancer: RR = 1.30, 95% CI = 1.12-1.49; breast cancer: RR = 1.17, 95% CI = 1.03-1.33; lung cancer: RR = 1.27, 95% CI = 1.06-1.52). However, there was no association of sedentary behavior with ovarian cancer (RR = 1.26, 95% CI = 0.87-1.82), renal cell carcinoma (RR = 1.11, 95% CI = 0.87-1.41) or non-Hodgkin lymphoid neoplasms (RR = 1.09, 95% CI = 0.82-1.43). Conclusion: The present meta-analysis suggested that prolonged sedentary behavior was independently associated with an increased risk of incident endometrial, colorectal, breast, and lung cancers, but not with ovarian cancer, renal cell carcinoma or non-Hodgkin lymphoid neoplasms.	[Shen, Dong; Mao, Weidong; Liu, Tao; Lin, Qingfeng; Lu, Xiangdong; Wang, Qiong; Lin, Feng] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Jiangyin, Peoples R China; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Ekelund, Ulf; Wijndaele, Katrien] Univ Cambridge, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England	Southeast University - China; Norwegian School of Sport Sciences; University of Cambridge	Shen, D (corresponding author), Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Oncol, Jiangyin, Peoples R China.	dong_shen2000@126.com; weidmao@126.com	Ekelund, Ulf/AAE-8471-2019; Zhou, Fan/GWU-9492-2022; Wijndaele, Katrien/H-5465-2013	Ekelund, Ulf/0000-0003-2115-9267; Wijndaele, Katrien/0000-0003-2199-7981; Liu, Yang/0000-0002-3424-7111; Lin, Qingfeng/0000-0001-5615-5130	Medical Research Council [MC_UU_12015/3]; British Heart Foundation [FS/12/58/29709]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work is partially funded by the Medical Research Council (MC_UU_12015/3) and the British Heart Foundation (FS/12/58/29709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cohen SS, 2013, CANCER PREV RES, V6, P566, DOI 10.1158/1940-6207.CAPR-13-0045; Cong YJ, 2014, BRIT J CANCER, V110, P817, DOI 10.1038/bjc.2013.709; Craft LL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-122; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekelund U, 2012, INT J EPIDEMIOL, V41, P1353, DOI 10.1093/ije/dys128; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Friberg E, 2006, CANCER EPIDEM BIOMAR, V15, P2136, DOI 10.1158/1055-9965.EPI-06-0465; George SM, 2011, ANN EPIDEMIOL, V21, P787, DOI 10.1016/j.annepidem.2011.04.012; George SM, 2010, AM J PUBLIC HEALTH, V100, P2288, DOI 10.2105/AJPH.2009.180828; Gierach GL, 2009, INT J CANCER, V124, P2139, DOI 10.1002/ijc.24059; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Howard RA, 2008, CANCER CAUSE CONTROL, V19, P939, DOI 10.1007/s10552-008-9159-0; Lam TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070672; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; MANTEL N, 1959, J NATL CANCER I, V22, P719; Patel AV, 2008, INT J CANCER, V123, P1877, DOI 10.1002/ijc.23716; Patel AV, 2006, AM J EPIDEMIOL, V163, P709, DOI 10.1093/aje/kwj098; Pronk A, 2011, BRIT J CANCER, V105, P1443, DOI 10.1038/bjc.2011.370; Robsahm TE, 2013, EUR J CANCER PREV, V22, P492, DOI 10.1097/CEJ.0b013e328360f434; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Simons CCJM, 2013, AM J EPIDEMIOL, V177, P514, DOI 10.1093/aje/kws280; Teras LR, 2012, INT J CANCER, V131, P1912, DOI 10.1002/ijc.27445; The Nielsen Company, 3 SCREEN REP; Ukawa S, 2013, CANCER CAUSE CONTROL, V24, P1547, DOI 10.1007/s10552-013-0231-z; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Xiao Q, 2013, CANCER EPIDEM BIOMAR, V22, P2000, DOI 10.1158/1055-9965.EPI-13-0154	35	115	123	5	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2014	9	8							e105709	10.1371/journal.pone.0105709	http://dx.doi.org/10.1371/journal.pone.0105709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9TR	25153314	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000340952200073
J	Lin, Y; Qian, XN; Krischer, J; Vehik, K; Lee, HS; Huang, S				Lin, Ying; Qian, Xiaoning; Krischer, Jeffrey; Vehik, Kendra; Lee, Hye-Seung; Huang, Shuai			A Rule-Based Prognostic Model for Type 1 Diabetes by Identifying and Synthesizing Baseline Profile Patterns	PLOS ONE			English	Article							RISK; PROGRESSION; GLUCOSE; PERIOD; TRIAL; ONSET; AGE	Objective: To identify the risk-predictive baseline profile patterns of demographic, genetic, immunologic, and metabolic markers and synthesize these patterns for risk prediction. Research Design and Methods: RuleFit is used to identify the risk-predictive baseline profile patterns of demographic, immunologic, and metabolic markers, using 356 subjects who were randomized into the control arm of the prospective Diabetes Prevention Trial-Type 1 (DPT-1) study. A novel latent trait model is developed to synthesize these baseline profile patterns for disease risk prediction. The primary outcome was Type 1 Diabetes (T1D) onset. Results: We identified ten baseline profile patterns that were significantly predictive to the disease onset. Using these ten baseline profile patterns, a risk prediction model was built based on the latent trait model, which produced superior prediction performance over existing risk score models for T1D. Conclusion: Our results demonstrated that the underlying disease progression process of T1D can be detected through some risk-predictive patterns of demographic, immunologic, and metabolic markers. A synthesis of these patterns provided accurate prediction of disease onset, leading to more cost-effective design of prevention trials of T1D in the future.	[Lin, Ying; Huang, Shuai] Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33606 USA; [Qian, Xiaoning] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA; [Krischer, Jeffrey; Vehik, Kendra; Lee, Hye-Seung] Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; Texas A&M University System; Texas A&M University College Station; State University System of Florida; University of South Florida	Huang, S (corresponding author), Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33606 USA.	shuaihuang@usf.edu	Lin, Ying/AAE-1879-2020; Lin, Zhenyue/O-1211-2019; Lin, Zhenyue/H-1569-2017	Lin, Zhenyue/0000-0002-6367-2459; Lin, Zhenyue/0000-0002-6367-2459; zhang, muqing/0000-0003-3138-3422	University of South Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061010, U01DK085476, UC4DK097835, U01DK061058, T32DK007161, UC4DK117009, U01DK085461] Funding Source: NIH RePORTER	University of South Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by the University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker F.B., 2004, ITEM RESPONSE THEORY; Bingley PJ, 1996, DIABETES, V45, P1720, DOI 10.2337/diabetes.45.12.1720; Bougneres P, 2008, J EXP MED, V205, P2953, DOI 10.1084/jem.20082622; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chase HP, 2001, J PEDIATR-US, V138, P244, DOI 10.1067/mpd.2001.111274; Diabetes Prevention Trial-Type 1 Diabetes Study Group, 2005, DIABETES CARE, V28, P1068; Frieman JH, 2008, ANN APPL STAT, V2, P916, DOI 10.1214/07-AOAS148; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gimenez M, 2007, DIABETES CARE, V30, P1593, DOI 10.2337/dc06-2578; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Lunn D., 2012, BUGS BOOK PRACTICAL; Mrena S, 2006, DIABETES CARE, V29, P662, DOI 10.2337/diacare.29.03.06.dc05-0774; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Sosenko JM, 2008, DIABETES CARE, V31, P2188, DOI 10.2337/dc08-0935; Sosenko JM, 2008, DIABETES CARE, V31, P528, DOI 10.2337/dc07-1459; Sosenko JM, 2011, DIABETES CARE, V34, P1785, DOI 10.2337/dc11-0641; Sosenko JM, 2006, DIABETES CARE, V29, P643, DOI 10.2337/diacare.29.03.06.dc05-1006; SRIKANTA S, 1984, DIABETOLOGIA, V27, P146, DOI 10.1007/BF00275674; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vella A, 2011, CLIN DILEMMAS DIABET; Xu P, 2010, DIABETES CARE, V33, P2508, DOI 10.2337/dc10-0802; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	24	56	72	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e91095	10.1371/journal.pone.0091095	http://dx.doi.org/10.1371/journal.pone.0091095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	25141192	Green Published, gold			2022-12-27	WOS:000338278100001
J	Lunt, H; Draper, N; Marshall, HC; Logan, FJ; Hamlin, MJ; Shearman, JP; Cotter, JD; Kimber, NE; Blackwell, G; Frampton, CMA				Lunt, Helen; Draper, Nick; Marshall, Helen C.; Logan, Florence J.; Hamlin, Michael J.; Shearman, Jeremy P.; Cotter, James D.; Kimber, Nicholas E.; Blackwell, Gavin; Frampton, Christopher M. A.			High Intensity Interval Training in a Real World Setting: A Randomized Controlled Feasibility Study in Overweight Inactive Adults, Measuring Change in Maximal Oxygen Uptake	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; LOW-VOLUME; EXERCISE; ADAPTATIONS; OLDER; RISK; DISEASE; HEALTH; MUSCLE	Background: In research clinic settings, overweight adults undertaking HIIT (high intensity interval training) improve their fitness as effectively as those undertaking conventional walking programs but can do so within a shorter time spent exercising. We undertook a randomized controlled feasibility (pilot) study aimed at extending HIIT into a real world setting by recruiting overweight/obese, inactive adults into a group based activity program, held in a community park. Methods: Participants were allocated into one of three groups. The two interventions, aerobic interval training and maximal volitional interval training, were compared with an active control group undertaking walking based exercise. Supervised group sessions (36 per intervention) were held outdoors. Cardiorespiratory fitness was measured using VO(2)max (maximal oxygen uptake, results expressed in ml/min/kg), before and after the 12 week interventions. Results: On ITT (intention to treat) analyses, baseline (N = 49) and exit (N = 39) VO2 was 25.3+/-4.5 and 25.3+/-3.9, respectively. Participant allocation and baseline/exit VO(2)max by group was as follows: Aerobic interval training N = 16, 24.2+/-4.8/ 25.6+/-4.8; maximal volitional interval training N = 16, 25.0+/-2.8/25.2+/-3.4; walking N = 17, 26.5+/-5.3/25.2+/-3.6. The post intervention change in VO(2)max was +1.01 in the aerobic interval training, 20.06 in the maximal volitional interval training and 21.03 in the walking subgroups. The aerobic interval training subgroup increased VO(2)max compared to walking (p = 0.03). The actual (observed, rather than prescribed) time spent exercising (minutes per week, ITT analysis) was 74 for aerobic interval training, 45 for maximal volitional interval training and 116 for walking (p = 0.001). On descriptive analysis, the walking subgroup had the fewest adverse events. Conclusions: In contrast to earlier studies, the improvement in cardiorespiratory fitness in a cohort of overweight/obese participants undertaking aerobic interval training in a real world setting was modest. The most likely reason for this finding relates to reduced adherence to the exercise program, when moving beyond the research clinic setting.	[Lunt, Helen; Logan, Florence J.] Canterbury Dist Hlth Board, Christchurch, New Zealand; [Draper, Nick; Marshall, Helen C.; Blackwell, Gavin] Univ Canterbury, Christchurch 1, New Zealand; [Hamlin, Michael J.] Lincoln Univ, Lincoln, New Zealand; [Shearman, Jeremy P.; Kimber, Nicholas E.] Christchurch Polytech Inst Technol, Christchurch, New Zealand; [Cotter, James D.] Univ Otago, Dunedin, New Zealand; [Lunt, Helen; Frampton, Christopher M. A.] Univ Otago, Christchurch, New Zealand	University of Canterbury; Christchurch Polytechnic Institute of Technology; University of Otago; University of Otago	Lunt, H (corresponding author), Canterbury Dist Hlth Board, Christchurch, New Zealand.	helen.lunt@cdhb.health.nz	Hamlin, Michael/D-7513-2018	Hamlin, Michael/0000-0001-7941-8554; Kimber, Nick/0000-0002-5323-2767; Lunt, Helen/0000-0003-0069-7402; Marshall, Helen/0000-0002-8271-8969	DHBRF (District Health Board Research Fund), New Zealand; DHBRF	DHBRF (District Health Board Research Fund), New Zealand; DHBRF	The study was funded by the DHBRF (District Health Board Research Fund), New Zealand. The DHBRF is a government funded organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2006, ACMS GUID EX TEST PR; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Courneya KS, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-81; CPMP, 2001, BRIT J CLIN PHARMACO, V52, P223; Edge J, 2013, EXP PHYSIOL, V98, P481, DOI 10.1113/expphysiol.2012.067603; Feinman RD, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-1; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gibala MJ, 2010, J PHYSIOL-LONDON, V588, P3341, DOI 10.1113/jphysiol.2010.196303; Gupta S, 2011, CIRCULATION, V123, P1377, DOI 10.1161/CIRCULATIONAHA.110.003236; Heydari M, 2012, J OBES, V2012, DOI 10.1155/2012/480467; Korkiakangas EE, 2009, HEALTH PROMOT INT, V24, P416, DOI 10.1093/heapro/dap031; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; LERMAN J, 1976, ARCH PHYS MED REHAB, V57, P355; Linke SE, 2011, ANN BEHAV MED, DOI [10.10007/s12160-011-9279-8, DOI 10.10007/S12160-011-9279-8]; Martin CK, 2009, ARCH INTERN MED, V169, P269, DOI 10.1001/archinternmed.2008.545; Murias JM, 2010, J APPL PHYSIOL, V108, P621, DOI 10.1152/japplphysiol.01152.2009; Nybo L, 2010, MED SCI SPORT EXER, V42, P1951, DOI 10.1249/MSS.0b013e3181d99203; Sherwood NE, 2000, ANNU REV NUTR, V20, P21, DOI 10.1146/annurev.nutr.20.1.21; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tjonna AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065382; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Whitehurst M, 2012, AM J LIFESTYLE MED, V6, P382, DOI 10.1177/1559827612450262; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Woods K, 2007, SPORTS MED, V37, P1089, DOI 10.2165/00007256-200737120-00006	35	86	87	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83256	10.1371/journal.pone.0083256	http://dx.doi.org/10.1371/journal.pone.0083256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454698	gold, Green Published, Green Submitted			2022-12-27	WOS:000329922500006
J	Hermann, P; Romero, C; Schmidt, C; Reis, C; Zerr, I				Hermann, Peter; Romero, Carlos; Schmidt, Christian; Reis, Clemens; Zerr, Inga			CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease	PLOS ONE			English	Article							WHITE-MATTER CHANGES; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; NINDS-AIREN; DIAGNOSIS; CRITERIA; PROTEIN; TAU; MRI	Despite existing criteria, differential diagnosis of Vascular Dementia (VD) and Alzheimer's disease (AD) remains difficult. The aim of this study is to figure out cognitive and biomarker profiles that may help to distinguish between VD, AD and AD + Cerebral Small Vessel Disease (CSVD). We examined a cohort of patients with CSVD (n = 92). After stratification of cognitive impaired patients (n = 59) using the standard CSF beta-amyloid 42/40 ratio cut-off point of 0.975, we obtained two groups which differed with respect to several features: 32 patients with normal beta-amyloid 42/40 ratio (>0.975) showed markedly impaired blood-brain-barrier function as indicated by an elevated albumin ratio (median 8.35). They also differed in cognitive profiles when compared to 27 patients with AD typical beta-amyloid ratio and normal albumin ratio. We also enrolled an additional group of patients with AD (no significant CSVD on MRI, n = 27) which showed no impairment of the blood-brain-barrier. We showed a negative correlation between the albumin ratio and executive cognitive function (p = 0.016) and a negative correlation between memory function and typical AD markers like Tau (p = 0.004) and p181-Tau (p = 0.023) in our cohort. We suppose that the group of patients with normal beta-amyloid ratio represents VD while patients in the other groups represent AD+CSVD and pure AD. Our results support the idea that a dysfunction of the blood-brain-barrier might be contributing factor in the development of cognitive decline in CSVD as it seems to be of more importance than the severity of white matter lesions.	[Hermann, Peter; Schmidt, Christian; Reis, Clemens; Zerr, Inga] Univ Gottingen, Dementia Res Grp, Dept Neurol, D-37073 Gottingen, Germany; [Zerr, Inga] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Romero, Carlos] FLENI, Dept Neuroradiol, Buenos Aires, DF, Argentina; [Romero, Carlos] FLENI, Dept Neuropathol, Buenos Aires, DF, Argentina	University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Zerr, I (corresponding author), Univ Gottingen, Dementia Res Grp, Dept Neurol, D-37073 Gottingen, Germany.	ingazerr@med.uni-goettingen.de		Romero, Teresa/0000-0002-1245-9906	mobility exchange program BMBF [ARG 07/008]	mobility exchange program BMBF(Federal Ministry of Education & Research (BMBF))	Part of the study was supported by the mobility exchange program BMBF ARG 07/008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibl M, 2008, DEMENT GERIATR COGN, V25, P256, DOI 10.1159/000115975; Broderick DF, 2009, NEUROLOGY, V73, P1934, DOI 10.1212/WNL.0b013e3181bd6a46; Bronge L, 2003, PSYCHIAT RES-NEUROIM, V122, P199, DOI 10.1016/S0925-4927(03)00005-2; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cavalieri M, 2010, NEURODEGENER DIS, V7, P122, DOI 10.1159/000285521; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; Jellinger KA, 2008, J ALZHEIMERS DIS, V14, P107; Jonsson M, 2010, EUR J NEUROL, V17, P377, DOI 10.1111/j.1468-1331.2009.02808.x; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Ma KC, 1997, CEREBROVASC DIS, V7, P324, DOI 10.1159/000108216; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Pohjasvaara T, 2000, STROKE, V31, P2952, DOI 10.1161/01.STR.31.12.2952; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Schmidtke K, 2002, J NEUROL SCI, V203, P17, DOI 10.1016/S0022-510X(02)00254-X; Silbert LC, 2009, NEUROLOGY, V73, P120, DOI 10.1212/WNL.0b013e3181ad53fd; Sjogren M, 2001, J NEUROSCI RES, V66, P510, DOI 10.1002/jnr.1242; Verdelho A, 2010, NEUROLOGY, V75, P160, DOI 10.1212/WNL.0b013e3181e7ca05; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318	23	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2014	9	8							e105000	10.1371/journal.pone.0105000	http://dx.doi.org/10.1371/journal.pone.0105000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LL	25147945	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230600030
J	Yuan, JS; Chen, S; Qiao, SB; Duan, FJ; Zhang, JF; Wang, H				Yuan, Jiansong; Chen, Shi; Qiao, Shubin; Duan, Fujian; Zhang, Jiafen; Wang, Hao			Characteristics of Myocardial Postsystolic Shortening in Patients with Symptomatic Hypertrophic Obstructive Cardiomyopathy before and Half a Year after Alcohol Septal Ablation Assessed by Speckle Tracking Echocardiography	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; VENTRICULAR DIASTOLIC FUNCTION; STRAIN-RATE; MICROVASCULAR FUNCTION; FOLLOW-UP; DYSFUNCTION; DOPPLER; FIBROSIS; FLOW	Objectives: Postsystolic shortening (PSS) has been proposed as a marker of myocardial dysfunction. Percutaneous transluminal septal myocardial ablation (PTSMA) is an alternative therapy for patients with hypertrophic obstructive cardiomyopathy (HOCM) that results in sustained improvements in atrial structure and function. We investigated the effects of PTSMA on PSS in HOCM patients using speckle tracking imaging. Methods: Conventional echocardiographic and PSS parameters were obtained in 18 healthy controls and 30 HOCM patients before and half a year after PTSMA. Results: Compared with the healthy controls, the number of segments having PSS and the average value of PSS were significantly increased in the HOCM patients. At 6 months after PTSMA, both the number of segments having PSS (10.5 +/- 2.8 vs. 13.2 +/- 2.6; P<0.001) and the average value of PSS (-1.24 +/- 0.57 vs. -1.55 +/- 0.56; P=0.009) were significantly reduced. Moreover, the reductions in the average value of PSS correlated well with the reductions in the E-to-Ea ratio (r = 0.705, P<0.001). Conclusions: Both the number of segments having PSS and the average value of PSS were significantly increased in the HOCM patients. PTSMA has a favourable effect on PSS, which may partly account for the persistent improvement in LV diastolic function in HOCM patients after PTSMA.	[Yuan, Jiansong; Qiao, Shubin] Peking Union Med Coll, Dept Cardiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China; [Yuan, Jiansong; Qiao, Shubin; Duan, Fujian; Zhang, Jiafen; Wang, Hao] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Chen, Shi] Sichuan Univ, Dept Cardiol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Duan, Fujian; Zhang, Jiafen; Wang, Hao] Peking Union Med Coll, Dept Echocardiog, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Qiao, SB (corresponding author), Peking Union Med Coll, Dept Cardiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China.	yuanjs100@sina.com			Immunonephrology Working Group ERA-EDTA	Immunonephrology Working Group ERA-EDTA	This study was partly supported by Immunonephrology Working Group ERA-EDTA. We thank Sonya Siragusa and Daniela Campanella (both of Department of Soil, Plant and Food Sciences, University of Bari Aldo Moro, Bari, Italy) for technical assistance.	BERTHA BG, 1986, CIRCULATION, V74, P901, DOI 10.1161/01.CIR.74.4.901; Biagini E, 2009, AM J CARDIOL, V104, P1727, DOI 10.1016/j.amjcard.2009.07.057; Bradham WS, 2002, J AM COLL CARDIOL, V40, P2165, DOI 10.1016/S0735-1097(02)02595-0; Carlhall C, 2003, AM J CARDIOL, V91, P1490, DOI 10.1016/S0002-9149(03)00407-7; Chen S, 2013, ECHOCARDIOGR-J CARD, V30, P564, DOI 10.1111/echo.12087; Dai ZH, 2012, J CARDIOL, V60, P416, DOI 10.1016/j.jjcc.2012.06.009; Ellims AH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-76; Geske JB, 2007, CIRCULATION, V116, P2702, DOI 10.1161/CIRCULATIONAHA.107.698985; Green JJ, 2012, JACC-CARDIOVASC IMAG, V5, P370, DOI 10.1016/j.jcmg.2011.11.021; Huang L, 2013, CLIN RADIOL, V68, P676, DOI 10.1016/j.crad.2013.01.003; Ito T, 2006, J AM SOC ECHOCARDIOG, V19, P987, DOI 10.1016/j.echo.2006.03.019; Jassal DS, 2006, EUR HEART J, V27, P1805, DOI 10.1093/eurheartj/ehl106; Jensen MK, 2011, CIRC-CARDIOVASC INTE, V4, P256, DOI 10.1161/CIRCINTERVENTIONS.110.959718; Kukulski T, 2002, J AM SOC ECHOCARDIOG, V15, P1, DOI 10.1067/mje.2002.114844; Malek LA, 2008, EUR J HEART FAIL, V10, P1123, DOI 10.1016/j.ejheart.2008.09.005; Matsumura Y, 2002, HEART, V87, P247, DOI 10.1136/heart.87.3.247; Nagueh SF, 2001, CIRCULATION, V103, P1844; Nakai H, 2009, EUR J ECHOCARDIOGR, V10, P926, DOI 10.1093/ejechocard/jep097; Olivotto I, 2011, J AM COLL CARDIOL, V58, P839, DOI 10.1016/j.jacc.2011.05.018; Plaksej R, 2009, J HYPERTENS, V27, P2483, DOI 10.1097/HJH.0b013e3283316c4d; Prinz C, 2012, ACTA CARDIOL, V67, P187, DOI 10.1080/AC.67.2.2154209; Soliman OII, 2008, AM J CARDIOL, V101, P1321, DOI 10.1016/j.amjcard.2007.12.032; Stoylen A, 2003, ECHOCARDIOGR-J CARD, V20, P167, DOI 10.1046/j.1540-8175.2003.03013.x; Stroud RE, 2005, J CARD FAIL, V11, P124, DOI 10.1016/j.cardfail.2004.05.002; Timmer SAJ, 2011, AM J PHYSIOL-HEART C, V301, pH129, DOI 10.1152/ajpheart.00077.2011; Tsai WC, 2012, J HYPERTENS, V30, P787, DOI 10.1097/HJH.0b013e32834f6b2b; Voigt JU, 2003, CIRCULATION, V107, P2120, DOI 10.1161/01.CIR.0000065249.69988.AA; Voigt JV, 2003, J AM SOC ECHOCARDIOG, V16, P415, DOI 10.1016/S0894-7317(03)00111-1; Yang L, 2007, CHINESE MED J-PEKING, V120, P1894, DOI 10.1097/00029330-200711010-00008; Yuan JS, 2010, AM J CARDIOL, V106, P1487, DOI 10.1016/j.amjcard.2010.07.017	30	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99014	10.1371/journal.pone.0099014	http://dx.doi.org/10.1371/journal.pone.0099014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922531	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300024
J	Fan, W; Xu, L; Xie, LC; Yang, DC; Liu, XZ; Zhang, JJ; Li, YR; Yi, CJ				Fan, Wen; Xu, Lei; Xie, Liangcai; Yang, Decai; Liu, Xuezheng; Zhang, Jiajun; Li, Yirong; Yi, Cunjian			Negative Interference by Rheumatoid Factor of Plasma B-Type Natriuretic Peptide in Chemiluminescent Microparticle Immunoassays	PLOS ONE			English	Article							HEART-FAILURE; SERUM; ANTIBODIES; DIAGNOSIS; ARTHRITIS; VALUES; BRAIN; NEED	Background: The chemiluminescent microparticle immunoassay (CMIA) is widely used for the quantitative determination of B-type natriuretic peptide (BNP) in human ethylenediaminetetraacetic acid plasma. Rheumatoid factor (RF) is usually thought to result in a positive interference in immunoassays, but it is not clear whether its presence in plasma can lead to interferences in the CMIA of BNP. Methods: The estimation of BNP recovery was carried out by diluting high-concentration BNP samples with RF-positive or RF-negative plasma at a ratio of 1:9. The diluted samples were then tested using the ARCHITECT i2000 System and ARCHITECT BNP Reagent Kits and the recovery was then calculated. Results: When the RF level ranged from 48 to 1420 IU/mL, the average recovery of BNP was 79.29% and 91.61% in the RF-positive and RF-negative plasma samples, respectively, and was thus significantly lower in the group of RF-positive plasma samples than in the group of RF-negative plasma samples. At a dilution of 1:16, the measured BNP level increased by >36% in six of the seven RF-positive plasma samples. The recovery of BNP increased significantly in the RF-positive plasma samples after pretreatment with IgG-sensitive latex particles. In addition, The BNP recovery was not significantly related to the plasma RF at concentrations ranging from 48 to 2720 IU/mL. Conclusions: Measurement of BNP by CMIA is susceptible to interference from RF leading to predominantly (but not exclusively) lower results. Pretreatment of samples with blocking reagents is advisable prior to the initiation of denying patient's necessary treatment.	[Fan, Wen; Xie, Liangcai; Liu, Xuezheng; Zhang, Jiajun] Jingzhou First Peoples Hosp, Dept Lab Med, Jinzhou, Hubei, Peoples R China; [Xu, Lei; Yang, Decai; Li, Yirong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Hubei, Peoples R China; [Yi, Cunjian] Jingzhou First Peoples Hosp, Dept Obstet & Gynecol, Jinzhou, Hubei, Peoples R China	Huazhong University of Science & Technology	Li, YR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Hubei, Peoples R China.	liyirong838@163.com; cunjiany@163.com		Zhang, Senhao/0000-0002-9231-9750	National Natural Science Foundation of China [30970060]; Scientific Research Foundation of the Education Ministry of China [2008890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of the Education Ministry of China	This study was supported by grants 30970060 from the National Natural Science Foundation of China and 2008890 from the Scientific Research Foundation of the Education Ministry of China for Returned Chinese Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels EM, 2013, METHODS, V61, P18, DOI 10.1016/j.ymeth.2012.12.015; BOSCATO LM, 1986, CLIN CHEM, V32, P1491; Eriksson S, 2003, CLIN CHEM, V49, P1095, DOI 10.1373/49.7.1095; Ismail AAA, 2009, J CLIN PATHOL, V62, P673, DOI 10.1136/jcp.2008.055848; Ismail AAA, 2011, ANN CLIN BIOCHEM, V48, P65, DOI 10.1258/acb.2010.010197; Ismail Y, 2007, CLIN MED, V7, P357, DOI 10.7861/clinmedicine.7-4-357; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Li YR, 2014, LABMEDICINE, V45, P82, DOI 10.1309/LMO7HLI8EODNAZSG; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Marks V, 2002, CLIN CHEM, V48, P2008; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; MOORE TL, 1993, CLIN BIOCHEM, V26, P75, DOI 10.1016/0009-9120(93)90032-2; Norden AGW, 1997, CLIN CHEM, V43, P957; Onuska KD, 2000, CLIN CHEM, V46, P307; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Tsavaris N, 2007, ANN RHEUM DIS, V66, P980, DOI 10.1136/ard.2007.070052; Wieczorek SJ, 2002, AM HEART J, V144, P834, DOI 10.1067/mhj.2002.125623; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080620; Xu L, 2013, CLIN BIOCHEM, V46, P799, DOI 10.1016/j.clinbiochem.2013.03.013; YANDLE TG, 1994, J INTERN MED, V235, P561, DOI 10.1111/j.1365-2796.1994.tb01263.x	21	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105304	10.1371/journal.pone.0105304	http://dx.doi.org/10.1371/journal.pone.0105304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25473944	gold, Green Published, Green Submitted			2022-12-27	WOS:000341106100048
J	Lin, ZY; Xu, SQ; Que, YX; Wang, JH; Comstock, JC; Wei, JJ; McCord, PH; Chen, BS; Chen, RK; Zhang, MQ				Lin, Zhenyue; Xu, Shiqiang; Que, Youxiong; Wang, Jihua; Comstock, Jack C.; Wei, Jinjin; McCord, Per H.; Chen, Baoshan; Chen, Rukai; Zhang, Muqing			Species-Specific Detection and Identification of Fusarium Species Complex, the Causal Agent of Sugarcane Pokkah Boeng in China	PLOS ONE			English	Article							REAL-TIME PCR; QUANTIFICATION; SEQUENCES; DIAGNOSIS; DIVERSITY; FUJIKUROI; STRAINS; BANANA; PLANTS; SPP.	Background: Pokkah boeng disease caused by the Fusarium species complex results in significant yield losses in sugarcane. Thus, the rapid and accurate detection and identification of the pathogen is urgently required to manage and prevent the spreading of sugarcane pokkah boeng. Methods: A total of 101 isolates were recovered from the pokkah boeng samples collected from five major sugarcane production areas in China throughout 2012 and 2013. The causal pathogen was identified by morphological observation, pathogenicity test, and phylogenetic analysis based on the fungus-conserved rDNA-ITS. Species-specific TaqMan real-time PCR and conventional PCR methods were developed for rapid and accurate detection of the causal agent of sugarcane pokkah boeng. The specificity and sensitivity of PCR assay were also evaluated on a total of 84 isolates of Fusarium from China and several isolates from other fungal pathogens of Sporisorium scitamineum and Phoma sp. and sugarcane endophyte of Acremonium sp. Result: Two Fusarium species (F. verticillioides and F. proliferatum) that caused sugarcane pokahh boeng were identified by morphological observation, pathogenicity test, and phylogenetic analysis. Species-specific TaqMan PCR and conventional PCR were designed and optimized to target their rDNA-ITS regions. The sensitivity of the TaqMan PCR was approximately 10 pg of fungal DNA input, which was 1,000-fold over conventional PCR, and successfully detected pokkah boeng in the field-grown sugarcane. Conclusions/Significance: This study was the first to identify two species, F. verticillioides and F. proliferatum, that were causal pathogens of sugarcane pokkah boeng in China. It also described the development of a species-specific PCR assay to detect and confirm these pathogens in sugarcane plants from mainland China. This method will be very useful for a broad range of research endeavors as well as the regulatory response and management of sugarcane pokkah boeng.	[Lin, Zhenyue; Xu, Shiqiang; Wang, Jihua; Chen, Baoshan; Zhang, Muqing] Guangxi Univ, Nanning 530004, Guangxi, Peoples R China; [Lin, Zhenyue; Que, Youxiong; Wei, Jinjin; Chen, Rukai; Zhang, Muqing] Fujian Agr & Forestry Univ, Fuzhou, Peoples R China; [Comstock, Jack C.; McCord, Per H.] ARS, USDA, Sugarcane Field Stn, Canal Point, FL USA	Guangxi University; Fujian Agriculture & Forestry University; United States Department of Agriculture (USDA)	Zhang, MQ (corresponding author), Guangxi Univ, Nanning 530004, Guangxi, Peoples R China.	mqzhang@ufl.edu	Lin, Ying/AAE-1879-2020; Lin, Zhenyue/O-1211-2019; Lin, Zhenyue/H-1569-2017	Lin, Zhenyue/0000-0002-6367-2459; Lin, Zhenyue/0000-0002-6367-2459; zhang, muqing/0000-0003-3138-3422	Guangxi special funding for distinguished experts and Funds from State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; Guangxi Natural Science Foundation [2014GXNSFFA118002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061010, U01DK085476, UC4DK097835, U01DK061058, T32DK007161, UC4DK117009, U01DK085461] Funding Source: NIH RePORTER	Guangxi special funding for distinguished experts and Funds from State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support was provided by Guangxi special funding for distinguished experts and Funds from State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources. This project is also supported by Guangxi Natural Science Foundation (2014GXNSFFA118002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatulli MT, 2012, EUR J PLANT PATHOL, V134, P401, DOI 10.1007/s10658-012-9998-0; BACON CW, 1994, J FOOD PROTECT, V57, P514, DOI 10.4315/0362-028X-57.6.514; Blackburn F, 1984, SUGAR CANE, P414; Bower NI, 2005, PLANT SCI, V168, P761, DOI 10.1016/j.plantsci.2004.10.006; Diamond M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069542; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Gonzalez-Jaen MT, 2004, EUR J PLANT PATHOL, V110, P525, DOI 10.1023/B:EJPP.0000032392.20106.81; Goswami D, 2013, J BASIC MICROB, V00, P1; Govender P., 2010, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P267; Irawan Whittle P, 2000, GUIDE SUGARCANE DIS, P136; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Khani KT., 2013, P IRNOP 2013 C JUNE, V28, P1; Kvas M, 2009, FUNGAL DIVERS, V34, P1; Leslie JF, 2006, FUSARIUM LAB MANUAL, P385; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; Lian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063380; Lin ZY, 2014, PLANT DIS, V98, P850, DOI 10.1094/PDIS-10-13-1061-PDN; Martin J, 1989, DIS SUGARCANE MAJOR, P157; Martin JP, 1961, SUGARCANE DIS WORLD, V1; McFarlane S. A., 2005, Proceedings of the 79th Annual Congress of South African Sugar Technologists' Association, held at Kwa-Shukela, Mount Edgecombe, South Africa, 19-22 July 2005, P120; Mohammadi A, 2012, PLANT PROTECT SCI, V48, P80, DOI 10.17221/49/2011-PPS; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Donnell Kerry, 2000, Mycoscience, V41, P61, DOI 10.1007/BF02464387; Sampietro DA, 2010, FUNGAL BIOL-UK, V114, P74, DOI 10.1016/j.mycres.2009.10.008; Sayler RJ, 2012, PLANT DIS, V96, P1757, DOI 10.1094/PDIS-12-11-1033-RE; Sheldon JL, 1904, AGR EXP STN NEBRASKA, V17, P23; Siddique S, 2007, THESIS U MALAYSIA MA; Siti Nordahliawate M. S., 2008, Pertanika Journal of Tropical Agricultural Science, V31, P279; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan MK, 2003, MYCOL RES, V107, P811, DOI 10.1017/S0953756203008013; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Vishwakarma S. K., 2013, Journal of Plant Pathology and Microbiology, V4, P170; Wang H, 2011, J CLIN MICROBIOL, V49, P1890, DOI 10.1128/JCM.02415-10; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wulff EG, 2010, ENVIRON MICROBIOL, V12, P649, DOI 10.1111/j.1462-2920.2009.02105.x; Zeng XY, 2007, J CLIN MICROBIOL, V45, P2872, DOI 10.1128/JCM.00687-07; Zhu YJ, 2010, EUR J PLANT PATHOL, V127, P263, DOI 10.1007/s10658-010-9591-3	38	56	72	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104195	10.1371/journal.pone.0104195	http://dx.doi.org/10.1371/journal.pone.0104195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141192	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200015
J	Shen, DX; Liu, Y; Zhou, F; Wang, GR; An, CJ				Shen, Dongxu; Liu, Yang; Zhou, Fan; Wang, Guirong; An, Chunju			Identification of Immunity-Related Genes in Ostrinia furnacalis against Entomopathogenic Fungi by RNA-Seq Analysis	PLOS ONE			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; PRO-PHENOL-OXIDASE; MANDUCA-SEXTA; INNATE IMMUNITY; PROPHENOLOXIDASE ACTIVATION; ANTIMICROBIAL PEPTIDES; TOBACCO HORNWORM; SERINE PROTEASES; PROTEOLYTIC ACTIVATION; ANTIBACTERIAL PROTEINS	Background: The Asian corn borer (Ostrinia furnacalis (Guenee)) is one of the most serious corn pests in Asia. Control of this pest with entomopathogenic fungus Beauveria bassiana has been proposed. However, the molecular mechanisms involved in the interactions between O. furnacalis and B. bassiana are unclear, especially under the conditions that the genomic information of O. furnacalis is currently unavailable. So we sequenced and characterized the transcriptome of O. furnacalis larvae infected by B. bassiana with special emphasis on immunity-related genes. Methodology/Principal Findings: Illumina Hiseq2000 was used to sequence 4.64 and 4.72 Gb of the transcriptome from water-injected and B. bassiana-injected O. furnacalis larvae, respectively. De novo assembly generated 62,382 unigenes with mean length of 729 nt. All unigenes were searched against Nt, Nr, Swiss-Prot, COG, and KEGG databases for annotations using BLASTN or BLASTX algorithm with an E-value cut-off of 10(-5). A total of 35,700 (57.2%) unigenes were annotated to at least one database. Pairwise comparisons resulted in 13,890 differentially expressed genes, with 5,843 up-regulated and 8,047 down-regulated. Based on sequence similarity to homologs known to participate in immune responses, we totally identified 190 potential immunity-related unigenes. They encode 45 pattern recognition proteins, 33 modulation proteins involved in the prophenoloxidase activation cascade, 46 signal transduction molecules, and 66 immune responsive effectors, respectively. The obtained transcriptome contains putative orthologs for nearly all components of the Toll, Imd, and JAK/STAT pathways. We randomly selected 24 immunity-related unigenes and investigated their expression profiles using quantitative RT-PCR assay. The results revealed variant expression patterns in response to the infection of B. bassiana. Conclusions/Significance: This study provides the comprehensive sequence resource and expression profiles of the immunity-related genes of O. furnacalis. The obtained data gives an insight into better understanding the molecular mechanisms of innate immune processes in O. furnacalis larvae against B. bassiana.	[Shen, Dongxu; Wang, Guirong; An, Chunju] China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China; [Liu, Yang; Zhou, Fan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	An, CJ (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China.	anchunju@cau.edu.cn	Ekelund, Ulf/AAE-8471-2019; Zhou, Fan/GWU-9492-2022; Wijndaele, Katrien/H-5465-2013	Ekelund, Ulf/0000-0003-2115-9267; Wijndaele, Katrien/0000-0003-2199-7981; Liu, Yang/0000-0002-3424-7111; Lin, Qingfeng/0000-0001-5615-5130	973 Program [2013CB114102, 2013CB127603]; National Natural Science Foundation of China [31172090, 31201578]; Program for New Century Excellent Talents in University [NCET-11-0476]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the 973 Program (2013CB114102 and 2013CB127603), National Natural Science Foundation of China (31172090, to C. A. and 31201578, to Y.L.), and Program for New Century Excellent Talents in University (NCET-11-0476, to C. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Afidchao MM, 2013, PEST MANAG SCI, V69, P792, DOI 10.1002/ps.3471; Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; Bao YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-160; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cheng TC, 2008, DEV COMP IMMUNOL, V32, P464, DOI 10.1016/j.dci.2007.03.010; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clark KD, 2013, J BIOL CHEM, V288, P14476, DOI 10.1074/jbc.M113.459222; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Feng CJ, 2008, COMP BIOCHEM PHYS B, V151, P139, DOI 10.1016/j.cbpb.2008.05.012; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gandhe AS, 2007, INSECT BIOCHEM MOLEC, V37, P655, DOI 10.1016/j.ibmb.2007.03.013; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jang IH, 2008, BMB REP, V41, P102, DOI 10.5483/BMBRep.2008.41.2.102; Ji CY, 2004, J BIOL CHEM, V279, P34101, DOI 10.1074/jbc.M404584200; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Jimenez-Cantizano RM, 2008, FISH SHELLFISH IMMUN, V25, P57, DOI 10.1016/j.fsi.2007.12.009; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kanost MR, 2001, ADV EXP MED BIOL, V484, P319; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kanost MR, 2009, INNATE IMMUNE RESPON, P271; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Knight JA, 2000, ANN CLIN LAB SCI, V30, P145; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LeshkoLindsay L, 1997, DEVELOPMENT, V124, P169; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam HJ, 2012, EMBO J, V31, P1253, DOI 10.1038/emboj.2011.476; OCHIAI M, 1988, J BIOL CHEM, V263, P12056; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Osta MA, 2004, J EXP BIOL, V207, P2551, DOI 10.1242/jeb.01066; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qu MB, 2011, BIOCHEM BIOPH RES CO, V404, P302, DOI 10.1016/j.bbrc.2010.11.111; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Shin SW, 2000, FEBS LETT, V467, P70, DOI 10.1016/S0014-5793(00)01127-3; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Sumathipala N, 2010, INSECT BIOCHEM MOLEC, V40, P487, DOI 10.1016/j.ibmb.2010.04.008; Takahasi K, 2009, P NATL ACAD SCI USA, V106, P11679, DOI 10.1073/pnas.0901671106; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wagner BL, 2000, APPL ENVIRON MICROB, V66, P3468, DOI 10.1128/AEM.66.8.3468-3473.2000; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; YASUHARA Y, 1995, ARCH BIOCHEM BIOPHYS, V320, P14, DOI 10.1006/abbi.1995.1337; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zhang Jianxian, 2011, Journal of Xidian University, V38, P95, DOI 10.3969/j.issn.1001-2400.2011.04.017; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	111	115	123	5	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86436	10.1371/journal.pone.0086436	http://dx.doi.org/10.1371/journal.pone.0086436			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	25153314	gold, Green Published, Green Submitted			2022-12-27	WOS:000330237000101
J	Jin, J; Li, WY; Peng, LM; Chen, J; Li, R; Wu, PH; Tan, S				Jin, Jun; Li, Wuying; Peng, Lingmei; Chen, Jian; Li, Rong; Wu, Peihua; Tan, Sheng			Relationship between Interleukin-10-1082A/G Polymorphism and Risk of Ischemic Stroke: A Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISMS; ASSOCIATION; HYPERTENSION; PROMOTER; SNPS	Objective: To analyze the association between -1082A/G polymorphism in interleukin-10 (IL-10) gene and ischemic stroke (IS) risk by meta-analysis. Methods: We carried out a systematic electronic search in PubMed, BIOSIS Previews, Science Direct, Chinese National Knowledge Infrastructure, Chinese Biomedical Database, Weipu database and WANGFANG Database. Pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated to assess the strength of the association. Results: 7 studies were included. There was no significant association between IL-10 -1082A/G polymorphism and IS risk under all genetic models in overall estimates (A vs. G: OR = 1.23,95% CI = 0.85-1.79; AA vs. GG: OR = 1.01,95% CI = 0.47-2.19; AG vs. GG: OR = 0.76, 95% CI = 0.38-1.55; AA+AG vs. GG: OR = 0.89,95% CI = 0.46-1.73; AA vs. AG+GG: OR = 1.39, 95% CI = 0.91-2.13). Similarly, no associations were found in subgroup analysis based on ethnicity and source of controls. However, removing the study deviating from Hardy-Weinberg equilibrium (HWE) produced statistically significant associations for overall estimates under recessive model(AA VS. AG+GG OR 1.58, 95% CI 1.04-2.42) and among Asians in all genetic models (A VS. G OR 1.64, 95% CI 1.07-2.53; AA vs. GG OR1.91, 95% CI 1.31-2.80; AG vs. GG OR1.44, 95% CI 1.09-1.91; AA+AG vs. GG OR 1.54, 95% CI 1.18-2.01; AA VS. AG+ GG OR 1.79, 95% CI 1.07-3.00). Even after Bonferroni correction, the associations were observed still significantly in Asians under the two models (AA vs. GG OR1.91, 95% CI 1.31-2.80, P = 0.0008; AA+AG vs. GG OR 1.54, 95% CI 1.18-2.01, P = 0.001). Conclusion: This meta-analysis indicates that IL10 -1082 A/G polymorphism is associated with IS susceptibility in Asians and the 21082 A allele may increase risk of IS in Asians. Considering the sample size is small and between-study heterogeneity is remarkable, more studies with subtle design are warranted in future.	[Jin, Jun; Li, Wuying; Chen, Jian; Li, Rong; Wu, Peihua; Tan, Sheng] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Peng, Lingmei] First Peoples Hosp Foshan, Dept Neurol, Foshan, Peoples R China; [Jin, Jun] Zhumadian Zhongxin Hosp, Dept Neurol, Zhumadian, Peoples R China	Southern Medical University - China	Tan, S (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	tansheng18@126.com	tan, sheng/GSN-2599-2022	/0000-0002-5091-7218; Kamalam, Biju Sam/0000-0003-1944-0244; Medale, Francoise/0000-0002-8083-1298; Panserat, Stephane/0000-0002-4479-9868				Amarenco P, 2009, CEREBROVASC DIS, V27, P493, DOI 10.1159/000210432; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Balding J, 2004, IRISH J MED SCI, V173, P200, DOI 10.1007/BF02914551; Bis JC, 2008, ATHEROSCLEROSIS, V198, P166, DOI 10.1016/j.atherosclerosis.2007.09.031; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eskdale J, 1998, P NATL ACAD SCI USA, V95, P9465, DOI 10.1073/pnas.95.16.9465; Fei GZ, 2004, ATHEROSCLEROSIS, V177, P409, DOI 10.1016/j.atherosclerosis.2004.07.026; Jin L, 2011, LAB MED, V26, P717; Kilpinen S, 2002, EUR CYTOKINE NETW, V13, P66; Li H, 2008, THESIS SO MED U; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin KX, 2009, THESIS FUJIAN MED U; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marousi S, 2011, EUR J NEUROL, V18, P637, DOI 10.1111/j.1468-1331.2010.03228.x; Marousi S, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/792923; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Munshi A, 2010, CYTOKINE, V52, P221, DOI 10.1016/j.cyto.2010.09.013; Park HK, 2013, MOL BIOL REP, V40, P1785, DOI 10.1007/s11033-012-2232-5; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stoica AL, 2010, J VASC SURG, V52, P103, DOI 10.1016/j.jvs.2010.01.088; Sultana S, 2011, J GENET, V90, P361, DOI 10.1007/s12041-011-0079-5; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Timasheva YR, 2008, BIOCHEM GENET, V46, P64, DOI 10.1007/s10528-007-9130-x; Trompet S, 2007, ANN NY ACAD SCI, V1100, P189, DOI 10.1196/annals.1395.018; Tuttolomondo A, 2012, CYTOKINE, V58, P398, DOI 10.1016/j.cyto.2012.02.012; Xie GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074126; Xie GQ, 2008, MOL CARDIOL CHINA, V8, P305; Yadav S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057305; Zhang GZ, 2007, CHIN J CEREBROVASC D, V4, P294; Zhang GZ, 2006, THESIS 1 MILITARY ME	33	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2014	9	4							e94631	10.1371/journal.pone.0094631	http://dx.doi.org/10.1371/journal.pone.0094631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GP	25141351	Green Submitted, Green Published, gold			2022-12-27	WOS:000336970400061
J	He, XL; Huang, X; Shen, YZ; Huang, ZJ				He, Xiaoliang; Huang, Xi; Shen, Yinzhu; Huang, Zhanjing			Wheat V-H+-ATPase Subunit Genes Significantly Affect Salt Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							PROTON TRANSPORT; NACL REGULATION; OSMOTIC-STRESS; EXPRESSION; PLANT; CLONING; MECHANISM; GROWTH; LEAVES	Genes for V-H+-ATPase subunits were identified and cloned from the salt-tolerant wheat mutant RH8706-49. Sequences of these genes are highly conserved in plants. Overexpression of these genes in Arabidopsis thaliana improved its salt tolerance, and increased the activities of V-H+-ATPase and Na+/H+ exchange, with the largest increase in plants carrying the c subunit of V-H+-ATPase. Results from quantitative RT-PCR analysis indicated that the mRNA level of each V-H+-ATPase subunit in the Arabidopsis increased under salt stress. Overall, our results suggest that each V-H+-ATPase subunit plays a key role in enhancing salt tolerance in plants.	[Huang, Xi; Shen, Yinzhu; Huang, Zhanjing] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China; [He, Xiaoliang] Hebei Univ Sci & Technol, Sch Biol Sci & Engn, Shijiazhuang, Hebei, Peoples R China	Hebei Normal University; Hebei University of Science & Technology	Huang, ZJ (corresponding author), Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China.	huangzhanjing@sohu.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Natural Science Fund [30971766]; Hebei Provincial Natural Science Fund [C2009000278]; Doctor Fund of Hebei University of Science and Technology [QD201046]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Hebei Provincial Natural Science Fund; Doctor Fund of Hebei University of Science and Technology	This work was supported by National Natural Science Fund (30971766), Hebei Provincial Natural Science Fund (No. C2009000278), and Doctor Fund of Hebei University of Science and Technology (QD201046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baisakh N, 2012, PLANT BIOTECHNOL J, V10, P453, DOI 10.1111/j.1467-7652.2012.00678.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Forgac M, 2000, J EXP BIOL, V203, P71; Gao CQ, 2011, MOL BIOL REP, V38, P957, DOI 10.1007/s11033-010-0189-9; Ge RC, 2007, PLANT SCI, V173, P55, DOI 10.1016/j.plantsci.2007.04.005; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; He XL, 2012, PLANT MOL BIOL REP, V30, P807, DOI 10.1007/s11105-011-0390-6; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Kirsch M, 1996, PLANT MOL BIOL, V32, P543, DOI 10.1007/BF00019107; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Lehr A, 1999, PLANT MOL BIOL, V39, P463, DOI 10.1023/A:1006158310891; Li PH, 2004, ACTA BOT SIN, V46, P93; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muller ML, 1996, J BIOL CHEM, V271, P1916; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NARASIMHAN ML, 1991, PLANT PHYSIOL, V97, P562, DOI 10.1104/pp.97.2.562; NIU XM, 1993, PLANT PHYSIOL, V103, P713, DOI 10.1104/pp.103.3.713; Ratajczak R, 2000, BBA-BIOMEMBRANES, V1465, P17, DOI 10.1016/S0005-2736(00)00129-2; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; Wang BS, 2001, J EXP BOT, V52, P2355, DOI 10.1093/jexbot/52.365.2355; Wang L, 2011, PLANTA, V234, P1, DOI 10.1007/s00425-011-1383-2; WARD JM, 1992, PLANT PHYSIOL, V99, P925, DOI 10.1104/pp.99.3.925; Xu CX, 2011, PLANT MOL BIOL REP, V29, P424, DOI 10.1007/s11105-010-0247-4; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200; Zhao Q, 2009, PLANT MOL BIOL, V69, P33, DOI 10.1007/s11103-008-9403-8; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	30	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86982	10.1371/journal.pone.0086982	http://dx.doi.org/10.1371/journal.pone.0086982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498005	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100043
J	Jiang, YH; Liu, HT; Kuo, HC				Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng			Decrease of Urinary Nerve Growth Factor but Not Brain-Derived Neurotrophic Factor in Patients with Interstitial Cystitis/Bladder Pain Syndrome Treated with Hyaluronic Acid	PLOS ONE			English	Article							DYSFUNCTION; THERAPY	Aims: To investigate urinary nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels in interstitial cystitis/bladder pain syndrome (IC/BPS) patients after hyaluronic acid (HA) therapy. Methods: Thirty-three patients with IC/BPS were prospectively studied; a group of 45 age-matched healthy subjects served as controls. All IC/BPS patients received nine intravesical HA instillations during the 6-month treatment regimen. Urine samples were collected for measuring urinary NGF and BDNF levels at baseline and 2 weeks after the last HA treatment. The clinical parameters including visual analog scale (VAS) of pain, daily frequency nocturia episodes, functional bladder capacity (FBC) and global response assessment (GRA) were recorded. Urinary NGF and BDNF levels were compared between IC/BPS patients and controls at baseline and after HA treatment. Results: Urinary NGF, NGF/Cr, BDNF, and BDNF/Cr levels were significantly higher in IC/BPS patients compared to controls. Both NGF and NGF/Cr levels significantly decreased after HA treatment. Urinary NGF and NGF/Cr levels significantly decreased in the responders with a VAS pain reduction by 2 (both p < 0.05) and the GRA improved by 2 (both p < 0.05), but not in non-responders. Urinary BDNF and BDNF/Cr did not decrease in responders or non-responders after HA therapy. Conclusions: Urinary NGF, but not BDNF, levels decreased significantly after HA therapy; both of these factors remained higher than in controls even after HA treatment. HA had a beneficial effect on IC/BPS, but it was limited. The reduction of urinary NGF levels was significant in responders, with a reduction of pain and improved GRA.	[Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw		Chen, Peisong/0000-0003-0640-3663; Liao, Chun-Hou/0000-0002-7340-110X				Antunes-Lopes T, 2013, J UROLOGY, V189, P359, DOI 10.1016/j.juro.2012.08.187; Chung SD, 2012, PAIN PHYSICIAN, V15, P197; Daha LK, 2005, EUR UROL, V47, P393, DOI 10.1016/j.eururo.2004.10.022; Daha LK, 2008, SCAND J UROL NEPHROL, V42, P369, DOI 10.1080/00365590701871518; Engelhardt PF, 2011, INT UROGYNECOL J, V22, P401, DOI 10.1007/s00192-010-1294-y; Frias B, 2011, CURR NEUROPHARMACOL, V9, P553, DOI 10.2174/157015911798376253; Ho DR, 2011, INT J UROL, V18, P525, DOI 10.1111/j.1442-2042.2011.02779.x; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Hurst RE, 1996, UROLOGY, V48, P817, DOI 10.1016/S0090-4295(96)00322-6; HURST RE, 1987, J UROLOGY, V138, P433, DOI 10.1016/S0022-5347(17)43180-6; Iavazzo C, 2007, EUR UROL, V51, P1534, DOI 10.1016/j.eururo.2007.03.020; Kallestrup EB, 2005, SCAND J UROL NEPHROL, V39, P143, DOI 10.1080/00365590410015876-1; Kuo HannChorng, 2012, Clinical Investigation, V2, P1085; Lai MC, 2013, INT J UROL, V20, P203, DOI 10.1111/j.1442-2042.2012.03135.x; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044687; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Lokeshwar VB, 2006, J UROLOGY, V176, P1001, DOI 10.1016/j.juro.2006.04.012; Morales A, 1996, J UROLOGY, V156, P45, DOI 10.1016/S0022-5347(01)65933-0; Nickel JC, 2005, UROLOGY, V65, P654, DOI 10.1016/j.urology.2004.10.071; Nickel JC, 2004, MED CLIN N AM, V88, P467, DOI 10.1016/S0025-7125(03)00151-2; Ochodnicky P, 2012, NAT REV UROL, V9, P628, DOI 10.1038/nrurol.2012.178; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Parsons CL, 2007, UROLOGY, V69, P9, DOI 10.1016/j.urology.2006.03.084; PARSONS CL, 1991, J UROLOGY, V145, P732, DOI 10.1016/S0022-5347(17)38437-9; Pezet S, 2002, BRAIN RES REV, V40, P240, DOI 10.1016/S0165-0173(02)00206-0; Pinto R, 2010, NEUROSCIENCE, V166, P907, DOI 10.1016/j.neuroscience.2010.01.015; Pinto R, 2010, EUR UROL, V58, P360, DOI 10.1016/j.eururo.2010.02.031; Porru D, 1997, UROL INT, V59, P26, DOI 10.1159/000283012; Riedl CR, 2008, INT UROGYNECOL J, V19, P717, DOI 10.1007/s00192-007-0515-5; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254	33	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91609	10.1371/journal.pone.0091609	http://dx.doi.org/10.1371/journal.pone.0091609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614892	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300143
J	He, X; Pu, GB; Tang, R; Zhang, DM; Pan, WQ				He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing			Activation of Nuclear Factor Kappa B in the Hepatic Stellate Cells of Mice with Schistosomiasis Japonica	PLOS ONE			English	Article							MICRORNAS; LIVER; EXPRESSION; FIBROSIS; DISEASE; FIBROGENESIS	Schistosomiasis japonica is a serious tropical parasitic disease in humans, which causes inflammation and fibrosis of the liver. Hepatic stellate cells (HSCs) are known to play an important role in schistosome-induced fibrosis, but their role in schistosome-induced inflammation is still largely unknown. Here, we use a murine model of schistosomiasis japonica to investigate the role that nuclear factor kappa B (NF-kappa B), a critical mediator of inflammatory responses, plays in schistosome-induced inflammation. We revealed that NF-kappa B was significantly activated in HSCs at the early stage of infection, but not at later stages. We also show that the expression levels of several chemokines regulated by NF-kappa B signaling (Ccl2, Ccl3 and Ccl5) were similarly elevated at early infection. TLR4 signaling, one of the strongest known inducers of NF-kappa B activation, seemed not activated in HSCs post-infection. Importantly, we found that levels of miR-146 (a known negative regulator of NF-kappa B signaling) in HSCs opposed those of NF-kappa B signaling, elevating at later stage of infection. These results indicate that HSCs might play an important role in the progression of hepatic schistosomiasis japonica by linking liver inflammation to fibrosis via NF-kappa B signaling. Moreover, our work suggests that miR-146 appeared to regulate this process. These findings are significant and imply that manipulating the function of HSCs by targeting either NF-kappa B signaling or miR-146 expression may provide a novel method of treating hepatic schistosomiasis japonica.	[He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing] Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China	Naval Medical University	Zhang, DM (corresponding author), Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China.	dmzhangcn@gmail.com; wqpan0912@aliyun.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Basic Research Program (973 Program) [2007CB513100]; National Science and Technology Program of China [2012ZX10004220]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Science and Technology Program of China	This study was supported by grants from the National Basic Research Program (973 Program) (2007CB513100) and the National Science and Technology Program of China (2012ZX10004220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Cai PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067037; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHEEVER A W, 1968, Bulletin of the World Health Organization, V39, P328; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chuah C, 2014, TRENDS PARA IN PRESS; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; He X, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-272; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kelada S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003451; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Liang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042490; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Ramm GA, 2009, HEPATOLOGY, V49, P533, DOI 10.1002/hep.22637; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wang ZX, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000596; Winau F, 2008, CURR OPIN IMMUNOL, V20, P68, DOI 10.1016/j.coi.2007.10.006	35	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104323	10.1371/journal.pone.0104323	http://dx.doi.org/10.1371/journal.pone.0104323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	24498005	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400042
J	Zhang, YG; Qiu, L; Li, SJ; Xiang, YC; Chen, JY; Ren, YG				Zhang, Yiguo; Qiu, Lu; Li, Shaojun; Xiang, Yuancai; Chen, Jiayu; Ren, Yonggang			The C-Terminal Domain of Nrf1 Negatively Regulates the Full-Length CNC-bZIP Factor and Its Shorter Isoform LCR-F1/Nrf1 beta; Both Are Also Inhibited by the Small Dominant-Negative Nrf1 gamma/delta Isoforms that Down-Regulate ARE-Battery Gene Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF1; TNF-ALPHA PROMOTER; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; EMBRYONIC LETHALITY; BINDING DOMAIN; BETA-TRCP; KEAP1	The C-terminal domain (CTD, aa 686-741) of nuclear factor-erythroid 2 p45-related factor 1 (Nrf1) shares 53% amino acid sequence identity with the equivalent Neh3 domain of Nrf2, a homologous transcription factor. The Neh3 positively regulates Nrf2, but whether the Neh3-like (Neh3L) CTD of Nrf1 has a similar role in regulating Nrf1-target gene expression is unknown. Herein, we report that CTD negatively regulates the full-length Nrf1 (i.e. 120-kDa glycoprotein and 95-kDa deglycoprotein) and its shorter isoform LCR-F1/Nrf1 beta (55-kDa). Attachment of its CTD-adjoining 112-aa to the C-terminus of Nrf2 yields the chimaeric Nrf2-C112(Nrf1) factor with a markedly decreased activity. Live-cell imaging of GFP-CTD reveals that the extra-nuclear portion of the fusion protein is allowed to associate with the endoplasmic reticulum (ER) membrane through the amphipathic Neh3L region of Nrf1 and its basic c-tail. Thus removal of either the entire CTD or the essential Neh3L portion within CTD from Nrf1, LCR-F1/Nrf1 beta and Nrf2-C112(Nrf1), results in an increase in their transcriptional ability to regulate antioxidant response element (ARE)-driven reporter genes. Further examinations unravel that two smaller isoforms, 36-kDa Nrf1 gamma and 25-kDa Nrf1 delta, act as dominant-negative inhibitors to compete against Nrf1, LCR-F1/Nrf1 beta and Nrf2. Relative to Nrf1, LCR-F1/Nrf1 beta is a weak activator, that is positively regulated by its Asn/Ser/Thr-rich (NST) domain and acidic domain 2 (AD2). Like AD1 of Nrf1, both AD2 and NST domain of LCR-F1/Nrf1 beta fused within two different chimaeric contexts to yield Gal4D:Nrf1 beta(607) and Nrf1 beta:C270(Nrf2), positively regulate their transactivation activity of cognate Gal4- and Nrf2-target reporter genes. More importantly, differential expression of endogenous ARE-battery genes is attributable to up-regulation by Nrf1 and LCR-F1/Nrf1 beta and down-regulation by Nrf1 gamma and Nrf1 delta.	[Zhang, Yiguo] Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China; Chongqing Univ, Fac Life Sci, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Zhang, YG (corresponding author), Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China.	yiguozhang@cqu.edu.cn		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	National Natural Science Foundation of China [91129703, 31270879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (key program 91129703 and project 31270879) awarded to Prof. Yiguo Zhang (University of Chongqing, China). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; Huang CF, 2000, J BIOL CHEM, V275, P12313, DOI 10.1074/jbc.275.16.12313; Husberg C, 2001, J BIOL CHEM, V276, P17641, DOI 10.1074/jbc.M007951200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x; Koch A, 2011, CELL CYCLE, V10, P1200, DOI 10.4161/cc.10.8.15327; Kusunoki H, 2002, NAT STRUCT BIOL, V9, P252, DOI 10.1038/nsb771; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwong EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048404; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Li X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002119; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Prieschl EE, 1998, NUCLEIC ACIDS RES, V26, P2291, DOI 10.1093/nar/26.10.2291; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rupert PB, 1998, NAT STRUCT BIOL, V5, P484, DOI 10.1038/nsb0698-484; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; Schultz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087204; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsuchiya Y, 2013, MOL CELL BIOL, V33, P3461, DOI 10.1128/MCB.01271-12; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Wang HY, 2013, CANCER RES, V73, P3097, DOI 10.1158/0008-5472.CAN-12-3386; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wu JL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-9; Xiao H, 2013, CURR CHEM BIOL, V7, P151, DOI [DOI 10.2174/2212796811307020008, 10.2174/2212796811307020008]; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang Y, 2014, MS1305858; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093458; Zhang YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02006; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhang Y, 2009, J BIOL CHEM, V284, P3195, DOI 10.1074/jbc.M805337200; [张玉台 Zhang Yutai], 2009, [管理世界, Management World], P1; Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798	71	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109159	10.1371/journal.pone.0109159	http://dx.doi.org/10.1371/journal.pone.0109159			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290918	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000041
J	Zhang, YJ; Wang, DM; Yang, LN; Zhou, D; Zhang, JF				Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang			Purification and Characterization of Flavonoids from the Leaves of Zanthoxylum bungeanum and Correlation between Their Structure and Antioxidant Activity	PLOS ONE			English	Article							ALDOSE REDUCTASE; DNA-DAMAGE; EXTRACTS; ALKYLAMIDES; PROTECTION; PERICARPS; QUERCETIN; CHROMATOGRAPHY; CONSTITUENTS; INHIBITION	Nine flavonoids were isolated and characterized from the leaves of Zanthoxylum bungeanum. Their structures were elucidated by spectroscopic techniques as quercetin (1), afzelin (2), quercitrin (3), trifolin (4), quercetin-3-O-beta-D-glucoside (5), isorhamnetin 3-O-alpha-L-rhamnoside (6), hyperoside (7), vitexin (8) and rutin (9). All compounds were isolated from the leaves of Z. bungeanum for the first time. Five compounds (2, 4, 5, 6 and 8) were found for the first time in the genus Zanthoxylum. To learn the mechanisms underlying its health benefits, in vitro (DPPH, ABTS, FRAP and lipid peroxidation inhibition assays) and in vivo (protective effect on Escherichia coli under peroxide stress) antioxidant activities of the nine flavonoids were measured. Quercetin and quercetin glycosides (compounds 1, 3, 5, 7, 9) showed the highest antioxidant activity. Structure-activity relationships indicated that the -OH in 49 position on the B ring and the -OH in 7 position on the A ring possessed high antioxidant activity; B ring and/or A ring with adjacent -OH groups could greatly increase their antioxidant ability. Also, due to the different structures of various flavonoids, they will certainly exhibit different antioxidant capacity when the reactions occur in solution or in oil-in-water emulsion. These findings suggest that Z. bungeanum leaves may have health benefits when consumed. It could become a useful supplement for pharmaceutical products and functional food ingredients in both nutraceutical and food industries as a potential source of natural antioxidants.	[Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Wang, DM (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	dmwli@163.com		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	Special Fund for Forestry Scientific Research in the Public Interest of China [201304811]; Fundamental Research Funds for the Central Universities [ZD2013010]	Special Fund for Forestry Scientific Research in the Public Interest of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to the research fund from the Special Fund for Forestry Scientific Research in the Public Interest of China (201304811) and the Fundamental Research Funds for the Central Universities (ZD2013010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne SA, 2000, FREE RADICAL BIO MED, V29, P507, DOI 10.1016/S0891-5849(00)00360-9; Azimova SS, 2013, PHYSICOCHEMCIAL PHAR; Bauer R, 2011, CURR CLIN UROL, P191, DOI 10.1007/978-1-60327-420-3_10; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Chang ZQ, 1981, ACTA PHARM SINICA, V16, P394; Costantino L, 1997, EXPERT OPIN THER PAT, V7, P843, DOI 10.1517/13543776.7.8.843; de Freitas V, 2001, J AGR FOOD CHEM, V49, P940, DOI 10.1021/jf000981z; Decker EA, 2005, J AGR FOOD CHEM, V53, P4303, DOI 10.1021/jf058012x; [邓振义 Deng Zhenyi], 2005, [西北林学院学报, Journal of Northwest Forestry College], V20, P179; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Dorman H. J. D., 1995, Journal of Essential Oil Research, V7, P645; Dubeau S, 2010, FOOD CHEM, V122, P539, DOI 10.1016/j.foodchem.2010.03.005; Duke J. A., 1985, MED PLANTS CHINA, P705; Ferrali M, 1997, FEBS LETT, V416, P123, DOI 10.1016/S0014-5793(97)01182-4; GALVEZ J, 1993, J PHARM PHARMACOL, V45, P157, DOI 10.1111/j.2042-7158.1993.tb03706.x; Gouveia S, 2012, PHYTOCHEM ANALYSIS, V23, P72, DOI 10.1002/pca.1326; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HUANG XL, 1993, PHYTOTHER RES, V7, P41, DOI 10.1002/ptr.2650070111; Ibrahim LF, 2002, MOLECULES, V7, P245; Jung HA, 2011, FOOD CHEM TOXICOL, V49, P376, DOI 10.1016/j.fct.2010.11.012; KIMUYA Y, 1981, CHEM PHARM BULL, V29, P2610; Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w; Li H, 2012, FOOD CHEM, V135, P2942, DOI 10.1016/j.foodchem.2012.07.048; Li Y, 2001, Zhong Yao Cai, V24, P572; Ma XF, 2005, J CHROMATOGR A, V1070, P211, DOI 10.1016/j.chroma.2005.02.052; Matsuda H, 2002, CHEM PHARM BULL, V50, P788, DOI 10.1248/cpb.50.788; Melidou M, 2005, FREE RADICAL BIO MED, V39, P1591, DOI 10.1016/j.freeradbiomed.2005.08.009; Miguel G, 2004, FOOD CHEM, V86, P183, DOI 10.1016/j.foodchem.2003.08.031; MIZUTANI K, 1988, CHEM PHARM BULL, V36, P2362, DOI 10.1248/cpb.36.2362; Nassar M. I., 2010, Revista Latinoamericana de Quimica, V38, P103; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; OSHIMA R, 1982, CARBOHYD RES, V107, P169, DOI 10.1016/S0008-6215(00)80536-4; Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1151, DOI 10.1016/S0968-0896(00)00052-3; Ren L, 1981, XAOXUE XUEBAO, V16, P672; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez P, 2010, FITOTERAPIA, V81, P1220, DOI 10.1016/j.fitote.2010.08.007; Smirnova GV, 2010, WORLD J MICROB BIOT, V26, P2269, DOI 10.1007/s11274-010-0417-4; Smirnova GV, 2009, FREE RADICAL BIO MED, V46, P759, DOI 10.1016/j.freeradbiomed.2008.11.017; Tachakittirungrod S, 2007, FOOD CHEM, V103, P381, DOI 10.1016/j.foodchem.2006.07.034; Tirillini B., 1994, Journal of Essential Oil Research, V6, P249; TK Lim, 2012, ZANTHOXYLUM SIMULANS, P904; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Wang DM, 2013, ALLELOPATHY J, V32, P67; Wang S, 2011, J LIQ CHROMATOGR R T, V34, P2640, DOI 10.1080/10826076.2011.593219; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; XIONG QB, 1995, PHYTOCHEMISTRY, V39, P723, DOI 10.1016/0031-9422(94)00965-V; Xiong QB, 1997, PHYTOCHEMISTRY, V46, P1123, DOI 10.1016/S0031-9422(97)84398-1; Xu HR, 2010, TEXTBOOK OF PERINATAL EPIDEMIOLOGY, P111; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yeung H., 1985, HDB CHINESE HERBS FO, VVolume 1; Zhou X, 2005, J CHROMATOGR A, V1092, P216, DOI 10.1016/j.chroma.2005.07.064	56	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105725	10.1371/journal.pone.0105725	http://dx.doi.org/10.1371/journal.pone.0105725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25290918	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200055
